Citrus Sinensis ID: 036970
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 337 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SKB2 | 641 | Leucine-rich repeat recep | yes | no | 1.0 | 0.525 | 0.644 | 1e-128 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.768 | 0.235 | 0.392 | 1e-44 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.830 | 0.231 | 0.350 | 6e-42 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.792 | 0.256 | 0.360 | 1e-41 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.827 | 0.275 | 0.361 | 1e-41 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.830 | 0.231 | 0.350 | 1e-41 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.839 | 0.243 | 0.354 | 2e-41 | |
| Q9LYU7 | 401 | Inactive leucine-rich rep | no | no | 0.884 | 0.743 | 0.331 | 2e-41 | |
| Q9SYM9 | 355 | Receptor-like serine/thre | no | no | 0.673 | 0.639 | 0.400 | 2e-41 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.842 | 0.243 | 0.342 | 2e-41 |
| >sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 458 bits (1179), Expect = e-128, Method: Compositional matrix adjust.
Identities = 218/338 (64%), Positives = 268/338 (79%), Gaps = 1/338 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+FS + KLI A+RG + GP+IFSPLI+K EDLAFL+ E+ ASLE I GEV+K
Sbjct: 304 VFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFK 363
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELPGS+G++I +KKVIQP K EL +DS+ L+ KM QI+SEI T G +RHRN++PLL
Sbjct: 364 AELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLL 423
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A V RP+C LVYE+ GSLQDIL DV G +EL W ARH+IA GIA+GLEYLHM H P
Sbjct: 424 AHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNP 483
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
RIIHRD++PANVL+DDDMEARIS+FGLAK +P+ T TT +A TVGYIAPE +QT
Sbjct: 484 RIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKF 543
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
+DKCDIYSFGV+L +L++GK PSD+FFQHT EMS ++WMRN++TSENPS ID KL+ G
Sbjct: 544 TDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQG 603
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
++EQMLLVLKIAC+CT DDP++RPNSKDVR MLSQI+H
Sbjct: 604 FDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 112/285 (39%), Positives = 163/285 (57%), Gaps = 26/285 (9%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYKAE+ G G VI +KK L S E D+ ++EI T G++RHRN
Sbjct: 811 GTVYKAEMSG--GEVIAVKK----LNSRGEGASSDNS--------FRAEISTLGKIRHRN 856
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRE--LDWLARHRIARGIASGLEY 172
IV L + +LL+YE+ GSL + + +G + LDW AR+RIA G A GL Y
Sbjct: 857 IVKLYGFCYHQNSNLLLYEYMSKGSLGE---QLQRGEKNCLLDWNARYRIALGAAEGLCY 913
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
LH RP+I+HRDI+ N+L+D+ +A + +FGLAK I +++ + ++A + GYIAPE
Sbjct: 914 LHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS-AVAGSYGYIAPE 972
Query: 233 CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS-RTI 291
T+ +++KCDIYSFGV+L L+ GK P Q V W+R + + P+
Sbjct: 973 YAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG---DLVNWVRRSIRNMIPTIEMF 1029
Query: 292 DSKLIGNGYE--EQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334
D++L N +M LVLKIA FCT + P RP ++V M+++
Sbjct: 1030 DARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 6e-42, Method: Compositional matrix adjust.
Identities = 107/305 (35%), Positives = 172/305 (56%), Gaps = 25/305 (8%)
Query: 36 FLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH 95
L+ + F + + S G+VYKA+L G V+ IKK+I + + +
Sbjct: 881 LLEATNGFHNDSLVGSGGFGDVYKAQL--KDGSVVAIKKLIH-VSGQGDR---------- 927
Query: 96 KMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELD 155
+ +E+ T G+++HRN+VPLL + LLVYE+ + GSL+D+L+D + +L+
Sbjct: 928 ---EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLN 984
Query: 156 WLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT 215
W AR +IA G A GL +LH + P IIHRD++ +NVL+D+++EAR+S+FG+A+ + T
Sbjct: 985 WPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDT 1044
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSD--DFFQHTKEMS 273
+ +LA T GY+ PE +Q+ S K D+YS+GV+L L+ GK P+D DF + +
Sbjct: 1045 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADF----GDNN 1100
Query: 274 FVQWMRNVMTSENPSRTIDSKLIGN--GYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331
V W++ + + D +L+ E ++L LK+AC C D +RP V M
Sbjct: 1101 LVGWVK-LHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAM 1159
Query: 332 LSQIQ 336
+IQ
Sbjct: 1160 FKEIQ 1164
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 103/286 (36%), Positives = 161/286 (56%), Gaps = 19/286 (6%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYKAE+P +G +I +KK+ K ++ ++ S L +E+ G VRHRN
Sbjct: 731 GTVYKAEMP--NGEIIAVKKLWGKNKENGKIRRRKSGVL--------AEVDVLGNVRHRN 780
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG-RRELDWLARHRIARGIASGLEYL 173
IV LL DC +L+YE+ NGSL D+L+ + +W A ++IA G+A G+ YL
Sbjct: 781 IVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTALYQIAIGVAQGICYL 840
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
H P I+HRD++P+N+L+D D EAR+++FG+AK I +T + +A + GYIAPE
Sbjct: 841 HHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI---QTDESMSVVAGSYGYIAPEY 897
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293
T+ + K DIYS+GV+L ++ GK + F S V W+R+ + ++ +
Sbjct: 898 AYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGN--SIVDWVRSKLKTKEDVEEVLD 955
Query: 294 KLIGNG---YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
K +G E+M +L+IA CT P +RP +DV +L + +
Sbjct: 956 KSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQEAK 1001
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 108/299 (36%), Positives = 172/299 (57%), Gaps = 20/299 (6%)
Query: 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQ 101
C I G VYKAE+ SS V+ +KK+ +S A++ +
Sbjct: 698 CIKESNMIGMGATGIVYKAEMSRSS-TVLAVKKL---WRSAADIEDGTTG-------DFV 746
Query: 102 SEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDV-SQGRRELDWLARH 160
E+ G++RHRNIV LL + ++VYEF NG+L D ++ + GR +DW++R+
Sbjct: 747 GEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRY 806
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
IA G+A GL YLH P +IHRDI+ N+L+D +++ARI++FGLA+ + R + T
Sbjct: 807 NIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--ARKKETVS 864
Query: 221 SLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM-R 279
+A + GYIAPE T+ + +K DIYS+GV+L L+ G+ P + F + ++ V+W+ R
Sbjct: 865 MVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDI--VEWVRR 922
Query: 280 NVMTSENPSRTIDSKLIGNG--YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
+ + + +D +GN +E+MLLVL+IA CT P++RP+ +DV ML + +
Sbjct: 923 KIRDNISLEEALDPN-VGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAK 980
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 107/305 (35%), Positives = 172/305 (56%), Gaps = 25/305 (8%)
Query: 36 FLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH 95
L+ + F + + S G+VYKA+L G V+ IKK+I + + +
Sbjct: 881 LLEATNGFHNDSLVGSGGFGDVYKAQL--KDGSVVAIKKLIH-VSGQGDR---------- 927
Query: 96 KMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELD 155
+ +E+ T G+++HRN+VPLL + LLVYE+ + GSL+D+L+D + +L+
Sbjct: 928 ---EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLN 984
Query: 156 WLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT 215
W AR +IA G A GL +LH + P IIHRD++ +NVL+D+++EAR+S+FG+A+ + T
Sbjct: 985 WPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDT 1044
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSD--DFFQHTKEMS 273
+ +LA T GY+ PE +Q+ S K D+YS+GV+L L+ GK P+D DF + +
Sbjct: 1045 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADF----GDNN 1100
Query: 274 FVQWMRNVMTSENPSRTIDSKLIGN--GYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331
V W++ + + D +L+ E ++L LK+AC C D +RP V M
Sbjct: 1101 LVGWVK-LHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAM 1159
Query: 332 LSQIQ 336
+IQ
Sbjct: 1160 FKEIQ 1164
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 107/302 (35%), Positives = 170/302 (56%), Gaps = 19/302 (6%)
Query: 36 FLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH 95
L+ + F++ I S G+VYKA+L + G V+ IKK+IQ + D E
Sbjct: 851 LLEATNGFSADSMIGSGGFGDVYKAKL--ADGSVVAIKKLIQVTG------QGDRE---- 898
Query: 96 KMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD-VSQGRREL 154
+E+ T G+++HRN+VPLL + LLVYE+ + GSL+ +L++ +G L
Sbjct: 899 ----FMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFL 954
Query: 155 DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR 214
DW AR +IA G A GL +LH S P IIHRD++ +NVL+D D AR+S+FG+A+ +
Sbjct: 955 DWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALD 1014
Query: 215 TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274
T + +LA T GY+ PE +Q+ + K D+YS+GV+L L+ GK P D + ++ +
Sbjct: 1015 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDP-EEFGEDNNL 1073
Query: 275 VQWMRNVMTSENPSRTIDSKLIGNGYEE-QMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333
V W + + + + +D +L+ + + ++L LKIA C D P +RP V M
Sbjct: 1074 VGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFK 1133
Query: 334 QI 335
++
Sbjct: 1134 EL 1135
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYU7|CRN_ARATH Inactive leucine-rich repeat receptor-like protein kinase CORYNE OS=Arabidopsis thaliana GN=CRN PE=1 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 106/320 (33%), Positives = 175/320 (54%), Gaps = 22/320 (6%)
Query: 20 RGPTIFSPLIEKEDL-AFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQP 78
+GP +FSP I + L A L ++ + S NG+ YK L +G V+ +K+ +
Sbjct: 99 KGPVVFSPKITPKSLHAALSN-----GIQLLGSDLNGKYYKMVL--DNGLVVAVKR-LGS 150
Query: 79 LKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNG 138
L+ S+ + ++ Q E+ +RHRN++ L A V D LVY++ NG
Sbjct: 151 LEGVGSPESSSSKSVKRRL---QKELELLAGLRHRNLMSLRAYVRESDEFSLVYDYMPNG 207
Query: 139 SLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198
SL+D++ V EL W R R+A GI GL+YLH S +I+H +++P NV++D + E
Sbjct: 208 SLEDVMNKVRTKEVELGWEIRLRVAVGIVKGLQYLHFSCETQILHYNLKPTNVMLDSEFE 267
Query: 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMG 258
R+++ GLAK +P+ T + +S APE Q+ +DK DI+SFG++L VL+ G
Sbjct: 268 PRLADCGLAKIMPSSHTAVSCYS--------APESSQSNRYTDKSDIFSFGMILGVLLTG 319
Query: 259 KFPSDDFFQHTKE-MSFVQWMRNVMTSENPSRTIDSKLIGNGYEE-QMLLVLKIACFCTF 316
+ P+ F + + S QW++++ S +D ++G EE +ML+ L+I C
Sbjct: 320 RDPTHPFCEESASGGSLGQWLKHLQQSGEAREALDKTILGEEVEEDEMLMALRITIICLS 379
Query: 317 DDPEERPNSKDVRCMLSQIQ 336
D P +RP+S ++ ML+Q+
Sbjct: 380 DFPADRPSSDELVHMLTQLH 399
|
Involved in the perception of CLV3 peptide that acts as a mobile signal regulating meristems maintenance. Modulates root, shoot and flower apical meristems maintenance and floral organ development regulation, probably via CLAVATA (CLV)-like pathways involving at least CLV3 and CLE19. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 95/237 (40%), Positives = 140/237 (59%), Gaps = 10/237 (4%)
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 162
E+ ++HRNIV L P +LL+YE NGSL L+ GR+ LDW +R+RI
Sbjct: 119 ELEAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLH----GRKALDWASRYRI 174
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
A G A G+ YLH P IIHRDI+ +N+L+D +MEAR+S+FGLA + +T +T+ +
Sbjct: 175 AVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTF-V 233
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDD-FFQHTKEMSFVQWMRNV 281
A T GY+APE T + K D+YSFGV+L L+ G+ P+DD FF+ ++ V W++ V
Sbjct: 234 AGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKL--VTWVKGV 291
Query: 282 MTSENPSRTIDSKLIGNGYE--EQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
+ + ID++L G+ + E+M V IA C +P RP +V +L I+
Sbjct: 292 VRDQREEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEVVKLLEYIK 348
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 104/304 (34%), Positives = 172/304 (56%), Gaps = 20/304 (6%)
Query: 36 FLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH 95
L+ + F++ + S GEVYKA+L G V+ IKK+I+ + Q
Sbjct: 852 LLEATNGFSAETMVGSGGFGEVYKAQL--RDGSVVAIKKLIR-------ITGQGDR---- 898
Query: 96 KMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVS--QGRRE 153
+ +E+ T G+++HRN+VPLL + LLVYE+ + GSL+ +L++ S +G
Sbjct: 899 ---EFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIY 955
Query: 154 LDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG 213
L+W AR +IA G A GL +LH S P IIHRD++ +NVL+D+D EAR+S+FG+A+ +
Sbjct: 956 LNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSAL 1015
Query: 214 RTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273
T + +LA T GY+ PE +Q+ + K D+YS+GV+L L+ GK P D + ++ +
Sbjct: 1016 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDP-GEFGEDNN 1074
Query: 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEE-QMLLVLKIACFCTFDDPEERPNSKDVRCML 332
V W + + + + +D +L+ + + ++ LKIA C D P +RP + M
Sbjct: 1075 LVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMIQLMAMF 1134
Query: 333 SQIQ 336
+++
Sbjct: 1135 KEMK 1138
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 337 | ||||||
| 224133744 | 630 | predicted protein [Populus trichocarpa] | 1.0 | 0.534 | 0.692 | 1e-139 | |
| 255540437 | 633 | BRASSINOSTEROID INSENSITIVE 1-associated | 1.0 | 0.532 | 0.690 | 1e-138 | |
| 224119518 | 627 | predicted protein [Populus trichocarpa] | 1.0 | 0.537 | 0.671 | 1e-136 | |
| 356508750 | 636 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.529 | 0.656 | 1e-132 | |
| 24421095 | 633 | receptor-like protein kinase [Nicotiana | 1.0 | 0.532 | 0.650 | 1e-129 | |
| 449440606 | 643 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.524 | 0.636 | 1e-129 | |
| 356516603 | 631 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.534 | 0.647 | 1e-129 | |
| 15225153 | 641 | putative leucine-rich repeat transmembra | 1.0 | 0.525 | 0.644 | 1e-126 | |
| 297822929 | 641 | hypothetical protein ARALYDRAFT_482113 [ | 1.0 | 0.525 | 0.642 | 1e-126 | |
| 16648755 | 641 | At2g31880/F20M17.8 [Arabidopsis thaliana | 1.0 | 0.525 | 0.644 | 1e-126 |
| >gi|224133744|ref|XP_002321650.1| predicted protein [Populus trichocarpa] gi|222868646|gb|EEF05777.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 501 bits (1289), Expect = e-139, Method: Compositional matrix adjust.
Identities = 234/338 (69%), Positives = 283/338 (83%), Gaps = 1/338 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+FS + K++ AAV+GG RD GP IFSPLI++ EDLAFL+K+D A+LE I GEVYK
Sbjct: 293 VFSLLFKIVLAAVKGGGRDGGPAIFSPLIKRAEDLAFLEKDDGLANLEVIGKGGCGEVYK 352
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELPGS+G++I IKK+IQP K AEL ++DS+ LH KM QIQSEI T G +RHRN++PLL
Sbjct: 353 AELPGSNGKMIAIKKIIQPPKDAAELTEEDSKLLHKKMRQIQSEINTVGHIRHRNLLPLL 412
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A V RPDC LVYE +NGSLQD L V++GRRELDWLARHRIA G+ASGLEYLH+SH P
Sbjct: 413 AHVSRPDCHYLVYELMKNGSLQDALNHVTEGRRELDWLARHRIAVGVASGLEYLHLSHSP 472
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
RIIHRD++PANVL+DD MEARI++FGLAK +P+ +T TT ++A TVGYIAPE HQT+
Sbjct: 473 RIIHRDLKPANVLLDDSMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF 532
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
+DKCDIYSFGV+L VL+MGK PSD+FFQ+T+EMS V+WMRN+MTSENP + ID KL+GNG
Sbjct: 533 TDKCDIYSFGVVLGVLVMGKLPSDEFFQNTREMSLVKWMRNIMTSENPRQAIDPKLMGNG 592
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
EEQMLLVLKIACFCT DDP++RPNSKDVRCMLSQI+H
Sbjct: 593 LEEQMLLVLKIACFCTIDDPKQRPNSKDVRCMLSQIKH 630
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540437|ref|XP_002511283.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550398|gb|EEF51885.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1284), Expect = e-138, Method: Compositional matrix adjust.
Identities = 234/339 (69%), Positives = 283/339 (83%), Gaps = 2/339 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSP-LIEK-EDLAFLKKEDCFASLEKIRSCWNGEVY 58
+FS + KLI A +RGG +D GP IFSP LI+K E+LAFL+KED ++LE I GEVY
Sbjct: 295 VFSVMFKLILATIRGGGKDSGPAIFSPHLIKKAENLAFLEKEDGLSNLELIGRGGCGEVY 354
Query: 59 KAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118
KAELPGS+G++I IKK++QP + AEL ++D++ L+ KM QI+SEI T GQ+RHRN++PL
Sbjct: 355 KAELPGSNGKMIAIKKIVQPPRDAAELTEEDTKLLNKKMRQIRSEINTVGQIRHRNLLPL 414
Query: 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHR 178
LA V RPDC LVYEF +NGSLQDIL DV QG+RELDWLARHRIA G+ASGLEYLH SH
Sbjct: 415 LAHVSRPDCHCLVYEFMKNGSLQDILSDVEQGKRELDWLARHRIAIGVASGLEYLHTSHS 474
Query: 179 PRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA 238
PRIIHRD++PANVL+DDDMEARI++FGLAK +P+ T TT ++A TVGYIAPE HQT+
Sbjct: 475 PRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDANTHVTTSNVAGTVGYIAPEYHQTLK 534
Query: 239 LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGN 298
+DKCDIYSFGVLL VL+MGK PSD+FFQ T+EMS V+WMRN+MTSENPS+ ID K+ GN
Sbjct: 535 FTDKCDIYSFGVLLGVLVMGKLPSDEFFQTTREMSLVKWMRNIMTSENPSQAIDPKMNGN 594
Query: 299 GYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
G+EEQMLLVLKIACFCT DDP +RPNSKD+RCMLSQI+H
Sbjct: 595 GFEEQMLLVLKIACFCTLDDPRQRPNSKDIRCMLSQIKH 633
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119518|ref|XP_002318094.1| predicted protein [Populus trichocarpa] gi|222858767|gb|EEE96314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 489 bits (1260), Expect = e-136, Method: Compositional matrix adjust.
Identities = 227/338 (67%), Positives = 284/338 (84%), Gaps = 1/338 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+FS + K++ AAV+GG RD GP IFSPLI+K EDLAFL+K++ A+LE I GEV+K
Sbjct: 290 VFSLLFKIVLAAVKGGGRDVGPAIFSPLIKKAEDLAFLEKDEGLANLEIIGRGGCGEVFK 349
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELPGS+G++I +KK+IQP K AEL ++DS+ L+ KM QIQSEI T G +RHRN++PLL
Sbjct: 350 AELPGSNGKMIAVKKIIQPPKDAAELSEEDSKVLNKKMRQIQSEINTVGHIRHRNLLPLL 409
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A V RPDC LVYEF +NGSLQD+L V++G+RELDWLARH+IA G+ASGLEYLH+SH P
Sbjct: 410 AHVSRPDCHYLVYEFMKNGSLQDVLNQVTEGKRELDWLARHKIAVGVASGLEYLHLSHSP 469
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
+IIHRD++PANVL+DDDMEARI++FGLAK +P+ +T TT ++A TVGYIAPE HQT+
Sbjct: 470 QIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAKTHITTSNVAGTVGYIAPEYHQTLKF 529
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
++KCDIYSFGV+L VL+MGK PSD FFQ T+E+S V+WMRN+M SENPS+ ID KLIG+G
Sbjct: 530 TEKCDIYSFGVVLGVLVMGKLPSDAFFQSTRELSLVKWMRNIMISENPSQAIDPKLIGHG 589
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
EEQMLLVLKIACFCT DDP++RP+SKDVRCMLSQI+H
Sbjct: 590 LEEQMLLVLKIACFCTIDDPKQRPSSKDVRCMLSQIKH 627
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508750|ref|XP_003523117.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 478 bits (1229), Expect = e-132, Method: Compositional matrix adjust.
Identities = 222/338 (65%), Positives = 277/338 (81%), Gaps = 1/338 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+FS + KL A ++G R GP I+SPLI+K EDLAFL+KE+ ASLE I GEVYK
Sbjct: 299 VFSLMFKLALALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGIASLEIIGRGGCGEVYK 358
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELPGS+G++I IKK++QP K AEL ++DS+ L+ KM QI+SEI T GQ+RHRN++PLL
Sbjct: 359 AELPGSNGKMIAIKKIVQPPKDGAELAEEDSKVLNKKMRQIRSEINTVGQIRHRNLLPLL 418
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A V RP+C LVYEF +NGSLQD L V +G ELDWL+RH+I+ G+A+GLEYLHM+H P
Sbjct: 419 AHVSRPECHYLVYEFMKNGSLQDTLSKVERGESELDWLSRHKISLGVAAGLEYLHMNHNP 478
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
RIIHRD++PAN+L+DDDMEARI++FGLAK +P+ +T TT ++A TVGYIAPE HQ +
Sbjct: 479 RIIHRDLKPANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKF 538
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
+DKCDIYS+GV+L VL++GK PSDDFFQHT+EMS V+WMR ++SENP I+SKL+GNG
Sbjct: 539 TDKCDIYSYGVILGVLVIGKLPSDDFFQHTEEMSLVKWMRKTLSSENPKEAINSKLLGNG 598
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
YEEQMLLVLKIACFCT DDP+ERPNSKDVRCMLSQI+H
Sbjct: 599 YEEQMLLVLKIACFCTMDDPKERPNSKDVRCMLSQIKH 636
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|24421095|dbj|BAC07504.2| receptor-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1205), Expect = e-129, Method: Compositional matrix adjust.
Identities = 220/338 (65%), Positives = 275/338 (81%), Gaps = 1/338 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+ S + KL+ VR G D TI+SPLI+K EDLAFL+KED ASLE I GEVY+
Sbjct: 296 LLSVLFKLVMFFVRKGKTDGSLTIYSPLIKKAEDLAFLEKEDGVASLEMIGKGGCGEVYR 355
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELPGS+G++I IKK++QP AEL ++D++ L+ KM Q++SEI GQ+RHRN++PLL
Sbjct: 356 AELPGSNGKIIAIKKILQPPMDAAELAEEDTKALNKKMRQVKSEIQILGQIRHRNLLPLL 415
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A + RPDC LVYE+ +NGSLQDIL V++G RELDWL RHRIA GIA+GLEYLH++H
Sbjct: 416 AHMPRPDCHYLVYEYMKNGSLQDILQQVTEGTRELDWLGRHRIAVGIATGLEYLHINHSQ 475
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
IIHRD++PANVL+DDDMEARI++FGLAK +P+ T TT ++A TVGYIAPE HQT+
Sbjct: 476 CIIHRDLKPANVLLDDDMEARIADFGLAKAVPDAHTHVTTSNVAGTVGYIAPEYHQTLKF 535
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
+DKCDIYSFGV+LAVL++GK PSD+FFQHT EMS V+W+RNVMTSE+P R ID KLIG+G
Sbjct: 536 TDKCDIYSFGVVLAVLVIGKLPSDEFFQHTPEMSLVKWLRNVMTSEDPKRAIDPKLIGSG 595
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
+EEQMLLVLKIACFCT ++P+ERPNSKDVRCML+QI+H
Sbjct: 596 FEEQMLLVLKIACFCTLENPKERPNSKDVRCMLTQIKH 633
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440606|ref|XP_004138075.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] gi|449501343|ref|XP_004161343.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 467 bits (1201), Expect = e-129, Method: Compositional matrix adjust.
Identities = 215/338 (63%), Positives = 274/338 (81%), Gaps = 1/338 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSP-LIEKEDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+FS + KL+ AA++GGS++ GP+IF+P LI+++DLAFL++++ ASL+ I GEVYK
Sbjct: 296 IFSLLFKLVIAAIKGGSKNSGPSIFAPKLIKRDDLAFLERDNALASLQLIGKGGCGEVYK 355
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELP SG++ IKK+ QP K AELI+++S + KM QI+SEI T G++RHRN++PL+
Sbjct: 356 AELPEKSGKMFAIKKITQPPKDAAELIEEESRHMSKKMRQIKSEIRTVGEIRHRNLLPLV 415
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A V RPDC LVYE +NGSLQD+L VS G +ELDWL RH IA G+ASGLEYLHM+H P
Sbjct: 416 AHVPRPDCHYLVYELMKNGSLQDMLNQVSAGVKELDWLTRHNIALGVASGLEYLHMNHTP 475
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
RIIHRD++PANVL+DD MEARI++FGLAK +P+ +T T ++A TVGYIAPE HQT+
Sbjct: 476 RIIHRDLKPANVLLDDGMEARIADFGLAKAMPDAQTHMTASNVAGTVGYIAPEYHQTLKF 535
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
+DKCDIY FGVLL VL++GK PSD+FFQ+T EMS V+WM+NVMTS+NP ID KL+GNG
Sbjct: 536 TDKCDIYGFGVLLGVLVIGKLPSDEFFQNTDEMSLVKWMKNVMTSDNPRGAIDPKLLGNG 595
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
+EEQMLL LKIACFCT D+P+ERPNSKDVRCMLSQI+H
Sbjct: 596 WEEQMLLALKIACFCTMDNPKERPNSKDVRCMLSQIKH 633
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516603|ref|XP_003526983.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 466 bits (1199), Expect = e-129, Method: Compositional matrix adjust.
Identities = 219/338 (64%), Positives = 273/338 (80%), Gaps = 1/338 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+FS + KL A ++G R GP I+SPLI+K EDLAFL+KE+ ASLE I GEVYK
Sbjct: 294 VFSLMFKLALALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGMASLEIIGRGGCGEVYK 353
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELPGS+G++I IKK+IQP K AEL ++DS+ L+ KM QI+SEI T GQ+RHRN++PLL
Sbjct: 354 AELPGSNGKMIAIKKIIQPPKEGAELAEEDSKVLNKKMRQIRSEITTVGQIRHRNLLPLL 413
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A V RP C LVYEF +NGSL D L V G ELDWL+RH+IA G+A+GLEYLH++H P
Sbjct: 414 AHVSRPGCHYLVYEFMKNGSLHDTLSKVEVGEFELDWLSRHKIALGVAAGLEYLHLNHNP 473
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
RIIHRD++PAN+L+DDDMEARI++FGLAK +P+ +T TT ++A TVGYIAPE HQ +
Sbjct: 474 RIIHRDLKPANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKF 533
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
+DKCDIYSFGV+L VL++GK PS +FFQHT+EMS V+WMR +++SENP ID+KL+GNG
Sbjct: 534 TDKCDIYSFGVILGVLVIGKLPSHEFFQHTEEMSLVKWMRKILSSENPKEAIDTKLLGNG 593
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
YE+QMLLVLKIACFCT DDP+ERPNSKDV CMLSQI+H
Sbjct: 594 YEDQMLLVLKIACFCTMDDPKERPNSKDVWCMLSQIKH 631
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225153|ref|NP_180747.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75265989|sp|Q9SKB2.1|SBIR1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1; AltName: Full=Protein EVERSHED; AltName: Full=Protein SUPPRESSOR OF BIR1-1; Flags: Precursor gi|13877675|gb|AAK43915.1|AF370596_1 putative receptor-like protein kinase [Arabidopsis thaliana] gi|4887748|gb|AAD32284.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589537|gb|ACN59302.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330253505|gb|AEC08599.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 458 bits (1179), Expect = e-126, Method: Compositional matrix adjust.
Identities = 218/338 (64%), Positives = 268/338 (79%), Gaps = 1/338 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+FS + KLI A+RG + GP+IFSPLI+K EDLAFL+ E+ ASLE I GEV+K
Sbjct: 304 VFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFK 363
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELPGS+G++I +KKVIQP K EL +DS+ L+ KM QI+SEI T G +RHRN++PLL
Sbjct: 364 AELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLL 423
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A V RP+C LVYE+ GSLQDIL DV G +EL W ARH+IA GIA+GLEYLHM H P
Sbjct: 424 AHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNP 483
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
RIIHRD++PANVL+DDDMEARIS+FGLAK +P+ T TT +A TVGYIAPE +QT
Sbjct: 484 RIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKF 543
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
+DKCDIYSFGV+L +L++GK PSD+FFQHT EMS ++WMRN++TSENPS ID KL+ G
Sbjct: 544 TDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQG 603
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
++EQMLLVLKIAC+CT DDP++RPNSKDVR MLSQI+H
Sbjct: 604 FDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297822929|ref|XP_002879347.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] gi|297325186|gb|EFH55606.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 458 bits (1178), Expect = e-126, Method: Compositional matrix adjust.
Identities = 217/338 (64%), Positives = 269/338 (79%), Gaps = 1/338 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+FS + KLI A+RG + GP+IFSPLI+K EDLAFL+ E+ ASLE I GEV+K
Sbjct: 304 VFSVLFKLIIQAIRGSGKPSGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFK 363
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELPGS+G++I +KKVIQP K EL +DS+ ++ KM QI+SEI T GQ+RHRN++PLL
Sbjct: 364 AELPGSNGKIIAVKKVIQPPKDADELTDEDSKFMNKKMRQIRSEISTVGQIRHRNLLPLL 423
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A V RP+C LVYE+ GSLQDIL DV G +EL W ARH+IA GIA+GLEYLHM H P
Sbjct: 424 AHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNP 483
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
RIIHRD++PANVL+DDDMEARIS+FGLAK +P+ T TT ++A TVGYIAPE +QT
Sbjct: 484 RIIHRDLKPANVLLDDDMEARISDFGLAKVMPDAVTHITTSNVAGTVGYIAPEFYQTHKF 543
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
+ KCDIYSFGV+L +L++GK PSD+FFQHT EMS ++WMRN++TSENPS ID KL+ G
Sbjct: 544 TAKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMEQG 603
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
++EQMLLVLKIAC+CT DDP++RPNSKDVR MLSQI+H
Sbjct: 604 FDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16648755|gb|AAL25569.1| At2g31880/F20M17.8 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1176), Expect = e-126, Method: Compositional matrix adjust.
Identities = 218/338 (64%), Positives = 267/338 (78%), Gaps = 1/338 (0%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+FS + KLI A+RG + GP+IFSPLI+K EDLAFL+ E+ ASLE I GEV+K
Sbjct: 304 VFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFK 363
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELPGS+G++I +KKVIQP K EL +DS+ L+ KM QI+SEI T G +RHRN++PLL
Sbjct: 364 AELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLL 423
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A V RP+C LVYE+ GSLQDIL DV G +EL W ARH+IA GIA+GLEYLHM H P
Sbjct: 424 AHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNP 483
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
RIIHRD +PANVL+DDDMEARIS+FGLAK +P+ T TT +A TVGYIAPE +QT
Sbjct: 484 RIIHRDSKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKF 543
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
+DKCDIYSFGV+L +L++GK PSD+FFQHT EMS ++WMRN++TSENPS ID KL+ G
Sbjct: 544 TDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQG 603
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
++EQMLLVLKIAC+CT DDP++RPNSKDVR MLSQI+H
Sbjct: 604 FDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 337 | ||||||
| TAIR|locus:2045228 | 641 | SOBIR1 "SUPPRESSOR OF BIR1 1" | 1.0 | 0.525 | 0.644 | 6.4e-115 | |
| TAIR|locus:2168907 | 966 | XIP1 "XYLEM INTERMIXED WITH PH | 0.771 | 0.269 | 0.388 | 1.3e-41 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.768 | 0.235 | 0.396 | 2.9e-41 | |
| TAIR|locus:2183906 | 401 | CRN "CORYNE" [Arabidopsis thal | 0.881 | 0.740 | 0.338 | 3.6e-41 | |
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.908 | 0.293 | 0.348 | 5.3e-41 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.783 | 0.235 | 0.373 | 4.5e-40 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.783 | 0.260 | 0.380 | 4.6e-40 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.813 | 0.266 | 0.367 | 4.7e-40 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.845 | 0.285 | 0.363 | 9.3e-40 | |
| TAIR|locus:2203000 | 355 | AT1G78530 [Arabidopsis thalian | 0.673 | 0.639 | 0.400 | 2.9e-39 |
| TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1133 (403.9 bits), Expect = 6.4e-115, P = 6.4e-115
Identities = 218/338 (64%), Positives = 268/338 (79%)
Query: 1 MFSFVLKLISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIRSCWNGEVYK 59
+FS + KLI A+RG + GP+IFSPLI+K EDLAFL+ E+ ASLE I GEV+K
Sbjct: 304 VFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFK 363
Query: 60 AELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
AELPGS+G++I +KKVIQP K EL +DS+ L+ KM QI+SEI T G +RHRN++PLL
Sbjct: 364 AELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLL 423
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A V RP+C LVYE+ GSLQDIL DV G +EL W ARH+IA GIA+GLEYLHM H P
Sbjct: 424 AHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNP 483
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
RIIHRD++PANVL+DDDMEARIS+FGLAK +P+ T TT +A TVGYIAPE +QT
Sbjct: 484 RIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKF 543
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299
+DKCDIYSFGV+L +L++GK PSD+FFQHT EMS ++WMRN++TSENPS ID KL+ G
Sbjct: 544 TDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQG 603
Query: 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
++EQMLLVLKIAC+CT DDP++RPNSKDVR MLSQI+H
Sbjct: 604 FDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
|
| TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 451 (163.8 bits), Expect = 1.3e-41, P = 1.3e-41
Identities = 108/278 (38%), Positives = 157/278 (56%)
Query: 54 NGEVYKAELPGSSGRVITIKKV-IQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
+G VY+ EL SG V+ +KK+ Q K A SE H ++++E+ T G +RH
Sbjct: 667 SGTVYRVEL--KSGEVVAVKKLWSQSNKDSA------SEDKMHLNKELKTEVETLGSIRH 718
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
+NIV L + DC LLVYE+ NG+L D L+ +G L+W RH+IA G+A GL Y
Sbjct: 719 KNIVKLFSYFSSLDCSLLVYEYMPNGNLWDALH---KGFVHLEWRTRHQIAVGVAQGLAY 775
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP-NGRTRTTTWSLAETVGYIAP 231
LH P IIHRDI+ N+L+D + + ++++FG+AK + G+ TTT +A T GY+AP
Sbjct: 776 LHHDLSPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGKDSTTT-VMAGTYGYLAP 834
Query: 232 ECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN-VMTSENPSRT 290
E + + KCD+YSFGV+L L+ GK P D F K + V W+ + T E T
Sbjct: 835 EYAYSSKATIKCDVYSFGVVLMELITGKKPVDSCFGENKNI--VNWVSTKIDTKEGLIET 892
Query: 291 IDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+D +L + M+ L++A CT P RP +V
Sbjct: 893 LDKRL-SESSKADMINALRVAIRCTSRTPTIRPTMNEV 929
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 2.9e-41, P = 2.9e-41
Identities = 113/285 (39%), Positives = 163/285 (57%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYKAE+ G G VI +KK L S E D+ ++EI T G++RHRN
Sbjct: 811 GTVYKAEMSG--GEVIAVKK----LNSRGEGASSDNS--------FRAEISTLGKIRHRN 856
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRE--LDWLARHRIARGIASGLEY 172
IV L + +LL+YE+ GSL + L +G + LDW AR+RIA G A GL Y
Sbjct: 857 IVKLYGFCYHQNSNLLLYEYMSKGSLGEQL---QRGEKNCLLDWNARYRIALGAAEGLCY 913
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
LH RP+I+HRDI+ N+L+D+ +A + +FGLAK I +++ + ++A + GYIAPE
Sbjct: 914 LHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS-AVAGSYGYIAPE 972
Query: 233 CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS-RTI 291
T+ +++KCDIYSFGV+L L+ GK P Q V W+R + + P+
Sbjct: 973 YAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG---DLVNWVRRSIRNMIPTIEMF 1029
Query: 292 DSKLIGNGYE--EQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334
D++L N +M LVLKIA FCT + P RP ++V M+++
Sbjct: 1030 DARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074
|
|
| TAIR|locus:2183906 CRN "CORYNE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 3.6e-41, P = 3.6e-41
Identities = 108/319 (33%), Positives = 179/319 (56%)
Query: 20 RGPTIFSPLIEKEDL-AFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQP 78
+GP +FSP I + L A L ++ + S NG+ YK L +G V+ +K+ +
Sbjct: 99 KGPVVFSPKITPKSLHAALSN-----GIQLLGSDLNGKYYKMVL--DNGLVVAVKR-LGS 150
Query: 79 LKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNG 138
L+ S+ + ++ Q + E++ AG +RHRN++ L A V D LVY++ NG
Sbjct: 151 LEGVGSPESSSSKSVKRRL-QKELELL-AG-LRHRNLMSLRAYVRESDEFSLVYDYMPNG 207
Query: 139 SLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198
SL+D++ V EL W R R+A GI GL+YLH S +I+H +++P NV++D + E
Sbjct: 208 SLEDVMNKVRTKEVELGWEIRLRVAVGIVKGLQYLHFSCETQILHYNLKPTNVMLDSEFE 267
Query: 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMG 258
R+++ GLAK +P+ T + +S APE Q+ +DK DI+SFG++L VL+ G
Sbjct: 268 PRLADCGLAKIMPSSHTAVSCYS--------APESSQSNRYTDKSDIFSFGMILGVLLTG 319
Query: 259 KFPSDDFFQHTKEM-SFVQWMRNVMTSENPSRTIDSKLIGNGYEE-QMLLVLKIACFCTF 316
+ P+ F + + S QW++++ S +D ++G EE +ML+ L+I C
Sbjct: 320 RDPTHPFCEESASGGSLGQWLKHLQQSGEAREALDKTILGEEVEEDEMLMALRITIICLS 379
Query: 317 DDPEERPNSKDVRCMLSQI 335
D P +RP+S ++ ML+Q+
Sbjct: 380 DFPADRPSSDELVHMLTQL 398
|
|
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 446 (162.1 bits), Expect = 5.3e-41, P = 5.3e-41
Identities = 115/330 (34%), Positives = 178/330 (53%)
Query: 13 VRGGSRDRGPTIFSPLIEKEDLAFLKKE--DCFASLEKIRSCWN-GEVYKAELPGSSGRV 69
V GG R+ G L + L F + +C + + I + G VYKAE+P +G +
Sbjct: 686 VDGGGRNGGDIGPWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMP--NGEI 743
Query: 70 ITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDL 129
I +KK+ K ++ ++ S L +E+ G VRHRNIV LL DC +
Sbjct: 744 IAVKKLWGKNKENGKIRRRKSGVL--------AEVDVLGNVRHRNIVRLLGCCTNRDCTM 795
Query: 130 LVYEFRRNGSLQDILYDVSQGRREL-DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188
L+YE+ NGSL D+L+ + +W A ++IA G+A G+ YLH P I+HRD++P
Sbjct: 796 LLYEYMPNGSLDDLLHGGDKTMTAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKP 855
Query: 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSF 248
+N+L+D D EAR+++FG+AK I + + +A + GYIAPE T+ + K DIYS+
Sbjct: 856 SNILLDADFEARVADFGVAKLIQTDESMSV---VAGSYGYIAPEYAYTLQVDKKSDIYSY 912
Query: 249 GVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVM-TSENPSRTIDSKLIGNG---YEEQM 304
GV+L ++ GK + F S V W+R+ + T E+ +D K +G E+M
Sbjct: 913 GVILLEIITGKRSVEPEFGEGN--SIVDWVRSKLKTKEDVEEVLD-KSMGRSCSLIREEM 969
Query: 305 LLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334
+L+IA CT P +RP +DV +L +
Sbjct: 970 KQMLRIALLCTSRSPTDRPPMRDVLLILQE 999
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 4.5e-40, P = 4.5e-40
Identities = 106/284 (37%), Positives = 165/284 (58%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VYKA+L G+V+ IKK+I + + D E +E+ T G+++HRN
Sbjct: 819 GDVYKAQL--KDGKVVAIKKLIH-VSGQG-----DRE--------FTAEMETIGKIKHRN 862
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+VPLL + LLVY++ + GSL+D+L+D + ++L+W AR +IA G A GL +LH
Sbjct: 863 LVPLLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWEARRKIAVGAARGLAFLH 922
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+ P IIHRD++ +NVLID+ +EAR+S+FG+A+ + T + +LA T GY+ PE +
Sbjct: 923 HNCIPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVDTHLSVSTLAGTPGYVPPEYY 982
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSK 294
Q+ + K D+YS+GV+L L+ GK P+D ++ + V W++ T + D +
Sbjct: 983 QSFRCTTKGDVYSYGVVLLELLTGKPPTDSA-DFGEDNNLVGWVKQ-HTKLKITDVFDPE 1040
Query: 295 LIGN--GYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
L+ E ++L LKIAC C D P RP V M +IQ
Sbjct: 1041 LLKEDPSVELELLEHLKIACACLDDRPSRRPTMLKVMAMFKEIQ 1084
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 4.6e-40, P = 4.6e-40
Identities = 108/284 (38%), Positives = 171/284 (60%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYKAE+ SS V+ +KK+ +S A++ +D E+ G++RHRN
Sbjct: 711 GIVYKAEMSRSS-TVLAVKKL---WRSAADI--EDGTTG-----DFVGEVNLLGKLRHRN 759
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ-GRRELDWLARHRIARGIASGLEYL 173
IV LL + ++VYEF NG+L D ++ + GR +DW++R+ IA G+A GL YL
Sbjct: 760 IVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYL 819
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
H P +IHRDI+ N+L+D +++ARI++FGLA+ + R + T +A + GYIAPE
Sbjct: 820 HHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--ARKKETVSMVAGSYGYIAPEY 877
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN-VMTSENPSRTID 292
T+ + +K DIYS+GV+L L+ G+ P + F + ++ V+W+R + + + +D
Sbjct: 878 GYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDI--VEWVRRKIRDNISLEEALD 935
Query: 293 SKLIGN-GY-EEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334
+GN Y +E+MLLVL+IA CT P++RP+ +DV ML +
Sbjct: 936 PN-VGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGE 978
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 4.7e-40, P = 4.7e-40
Identities = 104/283 (36%), Positives = 164/283 (57%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYKAE+ + +KK+ + + ++ +D + I E+ G +RHRN
Sbjct: 726 GIVYKAEVMRRPLLTVAVKKLWRSPSPQNDI--EDHHQEEDEEDDILREVNLLGGLRHRN 783
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV +L V ++VYE+ NG+L L+ + DWL+R+ +A G+ GL YLH
Sbjct: 784 IVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNYLH 843
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
P IIHRDI+ N+L+D ++EARI++FGLAK + + + T + +A + GYIAPE
Sbjct: 844 NDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMMLH-KNETVSM-VAGSYGYIAPEYG 901
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN-VMTSENPSRTIDS 293
T+ + +K DIYS GV+L L+ GK P D F+ + ++ V+W+R V +E+ ID+
Sbjct: 902 YTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSIDV--VEWIRRKVKKNESLEEVIDA 959
Query: 294 KLIGNGYE--EQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334
+ G+ E+MLL L+IA CT P++RP+ +DV ML++
Sbjct: 960 SIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAE 1002
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 434 (157.8 bits), Expect = 9.3e-40, P = 9.3e-40
Identities = 108/297 (36%), Positives = 163/297 (54%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQI 100
DC I +G+VYK EL G G V+ +KK+ + +K + DS L+ +
Sbjct: 681 DCLDEKNVIGFGSSGKVYKVELRG--GEVVAVKKLNKSVKGGDDEYSSDS--LNRDVFA- 735
Query: 101 QSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 160
+E+ T G +RH++IV L DC LLVYE+ NGSL D+L+ +G L W R
Sbjct: 736 -AEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGVVLGWPERL 794
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--QIPNGRTRTT 218
RIA A GL YLH P I+HRD++ +N+L+D D A++++FG+AK Q+ +T
Sbjct: 795 RIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSKTPEA 854
Query: 219 TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278
+A + GYIAPE T+ +++K DIYSFGV+L L+ GK P+D K+M+ +W+
Sbjct: 855 MSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGD-KDMA--KWV 911
Query: 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ ID KL ++E++ V+ I CT P RP+ + V ML ++
Sbjct: 912 CTALDKCGLEPVIDPKL-DLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQEV 967
|
|
| TAIR|locus:2203000 AT1G78530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 419 (152.6 bits), Expect = 2.9e-39, P = 2.9e-39
Identities = 95/237 (40%), Positives = 140/237 (59%)
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 162
E+ ++HRNIV L P +LL+YE NGSL L+ GR+ LDW +R+RI
Sbjct: 119 ELEAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLH----GRKALDWASRYRI 174
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
A G A G+ YLH P IIHRDI+ +N+L+D +MEAR+S+FGLA + +T +T+ +
Sbjct: 175 AVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTF-V 233
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDD-FFQHTKEMSFVQWMRNV 281
A T GY+APE T + K D+YSFGV+L L+ G+ P+DD FF+ ++ V W++ V
Sbjct: 234 AGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKL--VTWVKGV 291
Query: 282 MTSENPSRTIDSKLIGNGYEE--QMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
+ + ID++L G+ +E +M V IA C +P RP +V +L I+
Sbjct: 292 VRDQREEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEVVKLLEYIK 348
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 337 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-34 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-38
Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 38/274 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VY A +G+++ IK + + + +I EI +++H N
Sbjct: 13 GKVYLARD-KKTGKLVAIKVI-------------KKKKIKKDRERILREIKILKKLKHPN 58
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L D LV E+ G L D+L +GR D R I S LEYLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF--YLRQILSALEYLH 114
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
S I+HRD++P N+L+D+D ++++FGLA+Q+ G TT T Y+APE
Sbjct: 115 -SKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVL 168
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSK 294
DI+S GV+L L+ GK P F ++ + + + + P +
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLL--ELFKKIGKPKPPFPPPEWD 222
Query: 295 LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ E L+ K DPE+R +++
Sbjct: 223 I----SPEAKDLIRK--LLVK--DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-34
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 54 NGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G VY A + G+ + IK + + S + ++ EI ++ H
Sbjct: 6 FGTVYLARDKKT-GKKVAIKIIKKEDSSS-------------LLEELLREIEILKKLNHP 51
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
NIV L + LV E+ GSL+D+L + +L RI I GLEYL
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYL 108
Query: 174 HMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
H S+ IIHRD++P N+L+D D+ + ++++FGL+K + + ++ T + T Y+APE
Sbjct: 109 H-SNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPE 163
Query: 233 CH-QTVALSDKCDIYSFGVLLAVL 255
S+K DI+S GV+L L
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-34
Identities = 81/277 (29%), Positives = 123/277 (44%), Gaps = 34/277 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYKA+ G+ V +K + + + + E I+I + H N
Sbjct: 13 GTVYKAKHKGTGKIVA-VKILKKRSEKSKKDQTARRE------IRILRR------LSHPN 59
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L+ D LV E+ G L D L G L +IA I GLEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGP--LSEDEAKKIALQILRGLEYLH 115
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
S+ IIHRD++P N+L+D++ +I++FGLAK++ + TT T Y+APE
Sbjct: 116 -SNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVL 170
Query: 235 QTVALSD-KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293
K D++S GV+L L+ GK P F + +Q +R ++ D
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRRILGPPLEF---DE 223
Query: 294 KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330
+G EE L+ K DP +RP ++++
Sbjct: 224 PKWSSGSEEAKDLIKKCLNK----DPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-30
Identities = 67/296 (22%), Positives = 118/296 (39%), Gaps = 51/296 (17%)
Query: 47 EKIRSCWNGEVYKAELPGSSGRVIT--IKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI 104
+K+ GEVYK +L G G+ +K LK +A ++ E
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT----LKEDASEEER---------KDFLKEA 47
Query: 105 ITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL-----YDVSQGRRELDWLAR 159
++ H N+V LL + LV E+ G L D L S + L
Sbjct: 48 RVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
A IA G+EYL + +HRD+ N L+ +D+ +IS+FGL++ + +
Sbjct: 108 LSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK 164
Query: 220 WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP-----SDDFFQHTKEMS 273
+ ++APE + + K D++SFGVLL + +G P +++ ++ ++
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-- 222
Query: 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329
+ P +E + ++ C DPE+RP ++
Sbjct: 223 -----GYRL--PKPE---------YCPDE----LYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 75/229 (32%), Positives = 109/229 (47%), Gaps = 22/229 (9%)
Query: 64 GSSGRVITIKKVI-QPLKSEAEL--IKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120
GSSG V KV +P L I D + K Q+ E+ T +V
Sbjct: 12 GSSGVV---YKVRHKPTGKIYALKKIHVDGDEEFRK--QLLRELKTLRSCESPYVVKCYG 66
Query: 121 RVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
+ ++ +V E+ GSL D+L V E LA IAR I GL+YLH
Sbjct: 67 AFYKE-GEISIVLEYMDGGSLADLLKKV-GKIPEPV-LAY--IARQILKGLDYLHTKRH- 120
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
IIHRDI+P+N+LI+ E +I++FG++K + N + T+ TV Y++PE Q +
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGESY 177
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS 288
S DI+S G+ L +GKFP F + SF + M+ + PS
Sbjct: 178 SYAADIWSLGLTLLECALGKFP----FLPPGQPSFFELMQAICDGPPPS 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 2e-27
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 22/201 (10%)
Query: 55 GEVYKAEL---PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
GEVYK L + + +K LK A + + E ++
Sbjct: 13 GEVYKGTLKGDGEGTETKVAVKT----LKEGAS---------EEEREEFLEEASIMKKLS 59
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
H NIV LL + + +V E+ G L D L +L ++A IA G+E
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGME 116
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
YL S +HRD+ N L+ +++ +IS+FGL++ I + ++AP
Sbjct: 117 YLE-SKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
Query: 232 ECHQTVALSDKCDIYSFGVLL 252
E + + K D++SFGVLL
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-27
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEVYKA +G+ + IK + L+S K+ E +I +EI + +H N
Sbjct: 14 GEVYKA-RHKRTGKEVAIKVI--KLES-----KEKKE-------KIINEIQILKKCKHPN 58
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV ++ D +V EF GSL+D+L + +A + + + GLEYLH
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAY--VCKELLKGLEYLH 115
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
S+ IIHRDI+ AN+L+ D E ++ +FGL+ Q+ + + R T T ++APE
Sbjct: 116 -SNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVI 169
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFP 261
K DI+S G+ L GK P
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 22/201 (10%)
Query: 55 GEVYKAELPGSSGRVIT---IKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
GEVYK L G +K +K+D+ + E ++
Sbjct: 13 GEVYKGTLKGKGDGKEVEVAVKT-----------LKEDASEQQIEEFL--REARIMRKLD 59
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
H NIV LL + ++V E+ G L D L +EL A IA G+E
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGME 117
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
YL S IHRD+ N L+ +++ +IS+FGL++ + + + ++AP
Sbjct: 118 YLE-SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAP 173
Query: 232 ECHQTVALSDKCDIYSFGVLL 252
E + + K D++SFGVLL
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 23/201 (11%)
Query: 55 GEVYKAELPGSSGRVIT---IKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
GEVYK +L G G+ +K +K+D+ + E ++
Sbjct: 13 GEVYKGKLKGKGGKKKVEVAVKT-----------LKEDASEQQIEEFL--REARIMRKLD 59
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
H N+V LL + +V E+ G L L + R +L A IA G+E
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGME 116
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
YL S IHRD+ N L+ +++ +IS+FGL++ + + + ++AP
Sbjct: 117 YLE-SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAP 172
Query: 232 ECHQTVALSDKCDIYSFGVLL 252
E + + K D++SFGVLL
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 69/230 (30%), Positives = 112/230 (48%), Gaps = 20/230 (8%)
Query: 102 SEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
SEI G+++H NIV L+ L++E+ +L ++L R L W R +
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRK 784
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWS 221
IA GIA L +LH P ++ ++ P ++ID E L +P T
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPGLLCTDTKCF 839
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSD-DFFQHTKEMSFVQWMRN 280
++ Y+APE +T +++K DIY FG++L L+ GK P+D +F H S V+W R
Sbjct: 840 ISS--AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG---SIVEWARY 894
Query: 281 VMTSENPSRTIDSKLIGNG--YEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ + ID + G+ + +++ V+ +A CT DP RP + DV
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 39/273 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY A +G ++ +K V SE EL ++ ++ EI ++H N
Sbjct: 14 GSVYLALD-KDTGELMAVKSVELSGDSEEEL---EA---------LEREIRILSSLQHPN 60
Query: 115 IVPLL-ARVVRPDCDLLVY-EFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLE 171
IV + L ++ E+ GSL +L G+ E + R + R I GL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEP--VIR-KYTRQILEGLA 115
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
YLH S+ I+HRDI+ AN+L+D D ++++FG AK++ + T T S+ T ++AP
Sbjct: 116 YLH-SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 232 ECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTI 291
E + DI+S G + + GK P + + M+ + + + E P I
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP---WSELGNPMAAL--YKIGSSGEPPE--I 225
Query: 292 DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324
L E+ L+ C DP++RP
Sbjct: 226 PEHL-----SEEAKDFLR-KCLRR--DPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 75/282 (26%), Positives = 120/282 (42%), Gaps = 33/282 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH-R 113
GEVY A +++ +K + + L+S+++ +++ EI + H
Sbjct: 14 GEVYLARDR----KLVALKVLAKKLESKSKEVER-----------FLREIQILASLNHPP 58
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
NIV L LV E+ GSL+D+L + + + A I I S LEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF-ILAQILSALEYL 117
Query: 174 HMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPNGRTRTTTWSLAE----TVGY 228
H IIHRDI+P N+L+D D ++ +FGLAK +P+ + ++ +L T GY
Sbjct: 118 H---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 229 IAPECHQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285
+APE S DI+S G+ L L+ G P + + ++ + + T
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327
S S LL +A DP+ R +S
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAK-----DPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 5e-22
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 19/218 (8%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ-IQSEIITAGQVRHR 113
G VY + SSG ++ +K+V P S S+ M+ + EI +++H
Sbjct: 14 GSVYLG-MNASSGELMAVKQVELPSVSA------SSKDRKRSMLDALAREIALLKELQHE 66
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
NIV L + D + E+ GS+ +L + G E + L R+ + R I GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFE-ETLVRNFV-RQILKGLNYL 122
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP----NGRTRTTTWSLAETVGYI 229
H IIHRDI+ AN+L+D+ +IS+FG++K++ + +T SL +V ++
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ 267
APE + + + K DI+S G L+ ++ GK P D Q
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 3e-20
Identities = 66/290 (22%), Positives = 118/290 (40%), Gaps = 67/290 (23%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VY S G++ +K++ SE E ++D+ +E+ ++ H N
Sbjct: 14 GKVYLVR-RKSDGKLYVLKEIDLSNMSEKE--REDA----------LNEVKILKKLNHPN 60
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRE------LDWLARHRIARGIAS 168
I+ +V E+ G L + + + LDW + +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCL 114
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-VG 227
L+YLH S + I+HRDI+P N+ + + ++ +FG++K + ++T LA+T VG
Sbjct: 115 ALKYLH-SRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVL------SSTVDLAKTVVG 165
Query: 228 ---YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTS 284
Y++PE Q + K DI+S G +L L K P F+ + ++
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGENLLEL---ALKILKG 218
Query: 285 ENP------SRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ P S + L+ +L DPEERP+ +
Sbjct: 219 QYPPIPSQYSSEL-RNLV-----SSLLQK----------DPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 54 NGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G VYK L +G + IK++ L K E + I EI ++H
Sbjct: 13 FGVVYKG-LNLETGDFVAIKQI--------SLEKIKEE----ALKSIMQEIDLLKNLKHP 59
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIA---SGL 170
NIV + + D ++ E+ NGSL+ I+ ++ +A + GL
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQII-------KKFGPFPESLVAVYVYQVLQGL 112
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
YLH +IHRDI+ AN+L D ++++FG+A ++ S+ T ++A
Sbjct: 113 AYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMA 167
Query: 231 PECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
PE + S DI+S G + L+ G P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 1e-19
Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 8/109 (7%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I LEYLH II+RD++P N+L+D D ++++FGLAK++ + +RT T T
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274
Y+APE D +S GVLL ++ GK P F+ ++ +
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP---FYAEDRKEIY 202
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 50/144 (34%), Positives = 77/144 (53%), Gaps = 10/144 (6%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
+RH N+V LL V++ + +V E+ GSL D L S+GR + + A +
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCE 113
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
G+EYL +HRD+ NVL+ +D+ A++S+FGLAK+ G+ S V +
Sbjct: 114 GMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKW 165
Query: 229 IAPECHQTVALSDKCDIYSFGVLL 252
APE + S K D++SFG+LL
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 68/295 (23%), Positives = 119/295 (40%), Gaps = 43/295 (14%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
F K+ S + GEV++ I I +K D L + Q
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKI-------------LKSDDL-LKQQDFQ--K 51
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 162
E+ ++RH++++ L A + ++ E GSL L +G+ L + +
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQ-VLPVASLIDM 109
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
A +A G+ YL + IHRD+ N+L+ +D+ ++++FGLA+ I +
Sbjct: 110 ACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE--DVYLSSDK 164
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281
+ APE S K D++SFG+LL + G+ P H + Q
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITAGY 221
Query: 282 -MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
M P++ Q + + + C+ +PE+RP+ K +R L I
Sbjct: 222 RMPC--PAKC-----------PQEIYKIMLECWAA--EPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 72/289 (24%), Positives = 119/289 (41%), Gaps = 45/289 (15%)
Query: 46 LEKIRSCWNGEVYKAE-LPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI 104
+E I VY A LP + IK++ +L K + + +++ E+
Sbjct: 6 IEVIGVGATAVVYAAICLPN--NEKVAIKRI--------DLEKCQTS-----VDELRKEV 50
Query: 105 ITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL-YDVSQGRRELDWLARHRIA 163
Q H N+V V D LV + GSL DI+ +G + +A +
Sbjct: 51 QAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT--VL 108
Query: 164 RGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI--PNGRTRTTTWS 221
+ + GLEYLH IHRDI+ N+L+ +D +I++FG++ + RTR +
Sbjct: 109 KEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 222 LAETVGYIAPEC-HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280
T ++APE Q K DI+SFG+ L G P + M +
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP----YSKYPPMKVL----- 216
Query: 281 VMTSENPSRTI----DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325
++T +N ++ D K + + + L C DP +RP +
Sbjct: 217 MLTLQNDPPSLETGADYKKYSKSFRKMISL-------CLQKDPSKRPTA 258
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 4e-17
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 40/227 (17%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+ +LEKI +GEVYKA + G+ + IKK+ +++ ++ L I +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRAT-GKEVAIKKMR---------LRKQNKEL------IIN 64
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILY--DVSQGRRELDWLARH 160
EI+ +H NIV + D +V E+ GSL DI+ V +
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR--------MNEP 116
Query: 161 RIA---RGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT 217
+IA R + GLEYLH + IHRDI+ N+L+ D ++++FG A Q+ +++
Sbjct: 117 QIAYVCREVLQGLEYLHSQNV---IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173
Query: 218 TTWSLAETVG---YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
+ VG ++APE + K DI+S G++ + G+ P
Sbjct: 174 NS-----VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEII 105
LE++ G+VYK EL G + R+ I+ LK AE Q + + E
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---------EFRQEAE 60
Query: 106 TAGQVRHRNIVPLLARVVR--PDCDLLVYEFRRNGSLQDIL------------YDVSQGR 151
++H NIV LL + P C +++E+ +G L + L +
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTC--MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 152 RELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP 211
LD IA IA+G+EYL H +HRD+ N L+ + + +IS+FGL++ I
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 212 NGR-TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+ R + SL V ++ PE + + DI+SFGV+L
Sbjct: 176 SADYYRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY+ L G +K+V + D + + Q++ EI +++H N
Sbjct: 14 GSVYEG-LNLDDGDFFAVKEV---------SLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 115 IVPLLARVVRPDCDLLVY-EFRRNGSLQDILYDVSQGRRELDWLARHRIA---RGIASGL 170
IV L R + +L ++ E GSL +L ++ I R I GL
Sbjct: 64 IVQYLG-TEREEDNLYIFLELVPGGSLAKLL-------KKYGSFPEPVIRLYTRQILLGL 115
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
EYLH + +HRDI+ AN+L+D + ++++FG+AKQ+ + S + ++A
Sbjct: 116 EYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMA 169
Query: 231 PE-CHQTVALSDKCDIYSFGVLLAVLMM--GKFPSDDFFQ 267
PE Q DI+S G VL M GK P
Sbjct: 170 PEVIAQQGGYGLAADIWSLGC--TVLEMATGKPPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
++ + +++I S G+VYKA ++G ++ IK + L + +
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDI-ATGELVAIKVI--KL-EPGDDFEI----------- 46
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
IQ EI + RH NIV +R D +V E+ GSLQDI Y V++G +A
Sbjct: 47 IQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDI-YQVTRGPLSELQIAY 105
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
+ R GL YLH + + IHRDI+ AN+L+ +D + ++++FG++ Q+ + +
Sbjct: 106 --VCRETLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160
Query: 220 WSLAETVGYIAPECHQTVALSD---KCDIYSFGV 250
T ++APE KCDI++ G+
Sbjct: 161 --FIGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEII 105
KI G+VY A + +G ++ +K E+ QD++P K +I E+
Sbjct: 5 GNKIGGGTFGKVYTA-VNLDTGELMAVK----------EIRIQDNDPKTIK--EIADEMK 51
Query: 106 TAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARG 165
++H N+V V + + E+ G+L+++L + R LD
Sbjct: 52 VLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQ 107
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW--SLA 223
+ GL YLH I+HRDI+PAN+ +D + ++ +FG A ++ N T SLA
Sbjct: 108 LLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164
Query: 224 ETVGYIAPECHQTVALSDK---CDIYSFGVLLAVLMMGKFP 261
T Y+APE DI+S G ++ + GK P
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 51/133 (38%), Positives = 74/133 (55%), Gaps = 17/133 (12%)
Query: 133 EFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192
E+ GSL D + QGR L + IA + GL YLH H+ IIHRD++P+N+L
Sbjct: 79 EYMDGGSL-DKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--IIHRDVKPSNIL 133
Query: 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-VG---YIAPECHQTVALSDKCDIYSF 248
++ + ++ +FG++ Q+ N SLA+T VG Y+APE Q S K DI+S
Sbjct: 134 VNSRGQIKLCDFGVSGQLVN--------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSL 185
Query: 249 GVLLAVLMMGKFP 261
G+ L L G+FP
Sbjct: 186 GLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 54/243 (22%), Positives = 105/243 (43%), Gaps = 35/243 (14%)
Query: 95 HKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLL--VYEFRRNGSLQDILYDVSQGRR 152
+ Q+ SE+ +++H NIV R++ L V E+ G L + + + ++
Sbjct: 41 KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQL---IQKCKK 97
Query: 153 ELDWLARH---RIARGIASGLEYLH--MSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207
E ++ RI + L H ++HRD++PAN+ +D + ++ +FGLA
Sbjct: 98 ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
Query: 208 KQIPNGRTRTTTWSLAETVG---YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDD 264
K + + + T+ VG Y++PE ++ +K DI+S G L+ L P
Sbjct: 158 KILGHDSSFAKTY-----VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--- 209
Query: 265 FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324
F ++ ++ P R Y ++ V+K DP++RP+
Sbjct: 210 -FTARNQLQLASKIKEGKFRRIPYR----------YSSELNEVIK---SMLNVDPDKRPS 255
Query: 325 SKD 327
+++
Sbjct: 256 TEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 43/129 (33%), Positives = 67/129 (51%), Gaps = 10/129 (7%)
Query: 133 EFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192
E+ G L IL D G + ++ AR IA + EYLH II+RD++P N+L
Sbjct: 73 EYCLGGELWTILRDR--GLFD-EYTARFYIA-CVVLAFEYLHNRG---IIYRDLKPENLL 125
Query: 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+D + ++ +FG AK++ +G+ TW+ T Y+APE D +S G+LL
Sbjct: 126 LDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182
Query: 253 AVLMMGKFP 261
L+ G+ P
Sbjct: 183 YELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E+ F LEK+ G VYKA + +G+V+ IK V +++D +
Sbjct: 2 EEVFDILEKLGEGSYGSVYKA-IHKETGQVVAIKVV---------PVEEDLQE------- 44
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
I EI Q IV + +V E+ GS+ DI+ + L
Sbjct: 45 IIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM------KITNKTLTE 98
Query: 160 HRIA---RGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR 216
IA GLEYLH + + IHRDI+ N+L++++ +A++++FG++ Q+
Sbjct: 99 EEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQL------ 149
Query: 217 TTTWSLAETV-G---YIAPECHQTVALSDKCDIYSFGV 250
T T + TV G ++APE Q + ++K DI+S G+
Sbjct: 150 TDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI 187
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 55 GEVYKAELPGSSGRVITIKKV-IQPLKSEAELIKQDS--EPLHHKMIQIQSEIITAGQVR 111
VYKA +GR++ IKK+ + K + I + E I++ E+ +
Sbjct: 14 AVVYKAR-DKETGRIVAIKKIKLGERKEAKDGINFTALRE------IKLLQEL------K 60
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH--RIARGIASG 169
H NI+ LL LV+EF L+ ++ D + + G
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKD-----KSIVLTPADIKSYMLMTLRG 114
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
LEYLH I+HRD++P N+LI D ++++FGLA+ + + T T Y
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVVTRWYR 169
Query: 230 APEC-----HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
APE H V D++S G + A L++ P D
Sbjct: 170 APELLFGARHYGVG----VDMWSVGCIFAELLLRVPFLPGDS 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I LEYLH S IIHRDI+P N+L+D+ I++F +A ++ T+T + T
Sbjct: 109 IVLALEYLH-SKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST---SGT 162
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
GY+APE S D +S GV + GK P
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-16
Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 14/163 (8%)
Query: 102 SEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARH 160
+E Q+RH N+V LL +V L +V E+ GSL D L S+GR L
Sbjct: 48 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLL 105
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
+ + + +EYL ++ +HRD+ NVL+ +D A++S+FGL K+ ++T
Sbjct: 106 KFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQ 156
Query: 221 SLAE-TVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+ V + APE + S K D++SFG+LL + G+ P
Sbjct: 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 26/203 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQ----V 110
G V + E S G+VI + ++ LKS+ K+ I + + +
Sbjct: 9 GVVRRGEWSTSGGKVIPV--AVKCLKSD-------------KLSDIMDDFLKEAAIMHSL 53
Query: 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
H N++ L VV ++V E GSL D L + G + L A IA+G+
Sbjct: 54 DHENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTL--CDYAVQIANGM 110
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYI 229
YL R IHRD+ N+L+ D + +I +FGL + +P L +
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167
Query: 230 APECHQTVALSDKCDIYSFGVLL 252
APE +T S D++ FGV L
Sbjct: 168 APESLRTRTFSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV + L + I + I+ LK+ + KQ + L E GQ H N
Sbjct: 18 GEVCRGRLKLPGKKEIDV--AIKTLKAGSS-DKQRLDFLT--------EASIMGQFDHPN 66
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL- 173
I+ L V + +++ E+ NGSL L + + + RGIASG++YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
M++ +HRD+ N+L++ ++ ++S+FGL++++ + TT + + APE
Sbjct: 124 EMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179
Query: 234 HQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+ D++SFG+++ V+ G+ P
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 24/226 (10%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E+ F LE+I GEVYK + + V+ IK + D E ++
Sbjct: 3 EELFTKLERIGKGSFGEVYKG-IDNRTKEVVAIKII-------------DLEEAEDEIED 48
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
IQ EI Q I ++ ++ E+ GS D+L G E ++A
Sbjct: 49 IQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIAT 105
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
I R I GL+YLH R IHRDI+ ANVL+ + + ++++FG+A Q+ + + + T
Sbjct: 106 --ILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160
Query: 220 WSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265
+ T ++APE + A K DI+S G+ L G+ P+ D
Sbjct: 161 F--VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 46/154 (29%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
++ H+N+V LL V+ + +V E G+L + L ++GR + + + + +A
Sbjct: 55 KLHHKNLVRLLG-VILHNGLYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAE 111
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
G+EYL +++HRD+ N+L+ +D A++S+FGLA+ G + V +
Sbjct: 112 GMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PVKW 163
Query: 229 IAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
APE + S K D++S+GVLL V G+ P
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 15/213 (7%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY A L ++G ++ +K+V P A + + + ++SEI T + H N
Sbjct: 15 GRVYLA-LNVTTGEMMAVKQVELP----ATIAGRHDSRQKDMVKALRSEIETLKDLDHLN 69
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L + + E+ GS+ L + GR E L R + GL YLH
Sbjct: 70 IVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQ-LVRF-FTEQVLEGLAYLH 125
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
I+HRD++ N+L+D D +IS+FG++K+ + S+ +V ++APE
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 235 QT--VALSDKCDIYSFGVLLAVLMMGKFP-SDD 264
+ S K DI+S G ++ + G+ P SD+
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 68/234 (29%), Positives = 101/234 (43%), Gaps = 43/234 (18%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+ L KI G VYKA +G ++ IKK+ +SE ++
Sbjct: 1 YQKLGKIGEGTYGVVYKAR-DKLTGEIVAIKKIKLRFESEG-----------IPKTALR- 47
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
EI ++ H NI+ LL V R DL LV+EF + LY + + R+ L
Sbjct: 48 EIKLLKELNHPNIIKLLD-VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRG--LPESL 99
Query: 162 IAR---GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-PNGRTRT 217
I + GL + H SH I+HRD++P N+LI+ + ++++FGLA+ R T
Sbjct: 100 IKSYLYQLLQGLAFCH-SHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156
Query: 218 ----TTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGK--FPSDD 264
T W Y APE S DI+S G + A L+ + FP
Sbjct: 157 HYVVTRW-------YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 51/185 (27%), Positives = 89/185 (48%), Gaps = 13/185 (7%)
Query: 86 IKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILY 145
+K+D+ + + E +++H N+V LL R ++ EF G+L D L
Sbjct: 39 LKEDTMEVE----EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 94
Query: 146 DVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205
+ R+E++ + +A I+S +EYL + IHRD+ N L+ ++ ++++FG
Sbjct: 95 EC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG 149
Query: 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL---AVLMMGKFPS 262
L++ + G T T + + APE S K D+++FGVLL A M +P
Sbjct: 150 LSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
Query: 263 DDFFQ 267
D Q
Sbjct: 209 IDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 7/154 (4%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
++RH +V L A + +V E+ GSL D L + L L +A IA
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD--MAAQIAE 114
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
G+ YL IHRD+ N+L+ +++ +I++FGLA+ I + T + +
Sbjct: 115 GMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED-DEYTAREGAKFPIKW 170
Query: 229 IAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFP 261
APE + K D++SFG+LL ++ G+ P
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I GLE+LH + RI++RD++P NVL+DD RIS+ GLA ++ G A T
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGT 157
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273
GY+APE Q D ++ G L ++ G+ P F Q +++
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP---FRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 38/298 (12%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQI 100
+ L ++ G V K L + G + +K I D P K QI
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNT-GMIFALK-----------TITTDPNPDLQK--QI 46
Query: 101 QSEIITAGQVRHRNIVPLLARVVRP-DCDL-LVYEFRRNGSLQDILYDV-SQGRRELDWL 157
E+ + IV + + + E+ GSL I V +G R + +
Sbjct: 47 LRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106
Query: 158 ARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT 217
+IA + GL YLH +IIHRDI+P+N+L+ + ++ +FG++ ++ N T
Sbjct: 107 L-GKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT 162
Query: 218 TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF--V 275
T T Y+APE Q S D++S G+ L + +FP F E +
Sbjct: 163 FT----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP----FPPEGEPPLGPI 214
Query: 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333
+ + ++ NP D G + E+ + C DP RP D ML
Sbjct: 215 ELLSYIVNMPNP-ELKDEPGNGIKWSEEFKDFI---KQCLEKDPTRRPTPWD---MLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-15
Identities = 51/184 (27%), Positives = 91/184 (49%), Gaps = 27/184 (14%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
+IA + GL YL+ HR I+HRDI+P+N+L++ + ++ +FG++ ++ N
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-------- 156
Query: 221 SLAET-VG---YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP----SDDFFQHTKEM 272
S+A+T VG Y++PE Q + K D++S G+ + L +GKFP + D M
Sbjct: 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM 216
Query: 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332
+ ++ ++ P +L + + E + + C DP ERP + + M
Sbjct: 217 GILDLLQQIVQEPPP------RLPSSDFPEDLRDFVDA---CLLKDPTERPTPQQLCAMP 267
Query: 333 SQIQ 336
IQ
Sbjct: 268 PFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 60/235 (25%), Positives = 97/235 (41%), Gaps = 56/235 (23%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V A+ + + IK + + +LIK+ K ++I+ E++T H
Sbjct: 15 STVVLAKEK-ETNKEYAIKIL-----DKRQLIKEK----KVKYVKIEKEVLTRLN-GHPG 63
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ L + V E+ NG L + G + R A I LEYLH
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKC-TRFYAAE-ILLALEYLH 119
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--------------------QIPNGR 214
IIHRD++P N+L+D DM +I++FG AK QI R
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 215 TRTTTWSLAETVG---YIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGKFP 261
R ++ VG Y++PE L++K D+++ G ++ ++ GK P
Sbjct: 177 RRFASF-----VGTAEYVSPEL-----LNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 86 IKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD--LLVYEFRRNGSLQDI 143
+ E H + EI + H NIV +P L+ E+ +GSL+D
Sbjct: 41 LNHSGEEQH--RSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDY 98
Query: 144 LYDVSQGRRELDWLARHRI---ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200
L +R D + R+ + I G++YL R IHRD+ N+L++ + +
Sbjct: 99 L------QRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVK 149
Query: 201 ISEFGLAKQIPNGRTRTTTWSLAET-VGYIAPECHQTVALSDKCDIYSFGVLL 252
IS+FGLAK +P + E+ + + APEC +T S D++SFGV L
Sbjct: 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 54/260 (20%), Positives = 104/260 (40%), Gaps = 47/260 (18%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAEL----PGSSGRVITIKKVIQPLKSE 82
++++ + ++ E F G+V+ E P + ++ +K
Sbjct: 2 VQRDTIVLKRELGEGAF-----------GKVFLGECYHLEPENDKELVAVK--------- 41
Query: 83 AELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQD 142
+K+ + K + ++E++T Q H NIV D ++V+E+ +G L
Sbjct: 42 --TLKETASNDARKDFEREAELLTNFQ--HENIVKFYGVCTEGDPPIMVFEYMEHGDLNK 97
Query: 143 ----------ILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192
L EL +IA IASG+ YL H +HRD+ N L
Sbjct: 98 FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCL 154
Query: 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+ D+ +I +FG+++ + + ++ PE + + D++SFGV+L
Sbjct: 155 VGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVL 214
Query: 253 -AVLMMGKFPSDDFFQHTKE 271
+ GK P ++ + E
Sbjct: 215 WEIFTYGKQP---WYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 52/279 (18%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEVYKA + + +V+ IK VI ++E E + IQ EI Q R
Sbjct: 15 GEVYKA-IDKRTNQVVAIK-VIDLEEAEDE------------IEDIQQEIQFLSQCRSPY 60
Query: 115 IVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
I ++ L ++ E+ GS D+L G+ + ++A I R + GLEYL
Sbjct: 61 ITKYYGSFLK-GSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAF--ILREVLLGLEYL 114
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVG---YIA 230
H IHRDI+ AN+L+ ++ + ++++FG++ Q+ + ++ T VG ++A
Sbjct: 115 H---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-----FVGTPFWMA 166
Query: 231 PECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRT 290
PE + +K DI+S G+ L G+ P +S + MR V+ P
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPP----------LSDLHPMR-VLF-LIPKNN 214
Query: 291 IDSKLIGNGYEEQMLLVLK--IACFCTFDDPEERPNSKD 327
S L GN + + K ++ C DP+ERP++K+
Sbjct: 215 PPS-LEGNKFSKP----FKDFVSL-CLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 71/289 (24%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E+ F LE+I GEV+K + + +V+ IK + D E ++
Sbjct: 3 EELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKII-------------DLEEAEDEIED 48
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
IQ EI Q + ++ ++ E+ GS D+L D
Sbjct: 49 IQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQI 103
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
+ + I GL+YLH + IHRDI+ ANVL+ + + ++++FG+A Q+ + + + T
Sbjct: 104 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160
Query: 220 WSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279
+ T ++APE Q A K DI+S G+ L G+ P+ D H + F
Sbjct: 161 F--VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM--HPMRVLF----- 211
Query: 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ +N T+ + E C DP RP +K++
Sbjct: 212 --LIPKNNPPTLTGEFSKPFKE--------FIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 25/219 (11%)
Query: 55 GEVYKA--ELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
GEV++ ++PG + IK ++P +E KQ + L SE GQ H
Sbjct: 19 GEVFRGILKMPGRKEVAVAIK-TLKPGYTE----KQRQDFL--------SEASIMGQFSH 65
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
NI+ L V + +++ E+ NG+L L D G E + RGIA+G++Y
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDG--EFSSYQLVGMLRGIAAGMKY 122
Query: 173 L-HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-VGYIA 230
L M++ +HRD+ N+L++ ++E ++S+FGL++ + + T T S + + + A
Sbjct: 123 LSDMNY----VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 231 PECHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQH 268
PE + D++SFG+++ V+ G+ P D H
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 29/227 (12%)
Query: 109 QVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRI---AR 164
+V R IV L A + DL LV G L+ +Y+V + E R
Sbjct: 49 KVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDE---ENPGFPEPRACFYTA 104
Query: 165 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE 224
I SGLE+LH RII+RD++P NVL+D+D RIS+ GLA ++ +G+++T + A
Sbjct: 105 QIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY--AG 159
Query: 225 TVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTS 284
T G++APE Q D ++ GV L ++ + P F+ E V
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP----FRARGE--------KVENK 207
Query: 285 ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFD-DPEERPNSKDVRC 330
E R ++ + Y ++ K C DPE+R +D C
Sbjct: 208 ELKQRILNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 4e-14
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E+ F LEKI GEV+K + + +V+ IK + D E ++
Sbjct: 3 EELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII-------------DLEEAEDEIED 48
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
IQ EI Q + ++ ++ E+ GS D+L LD
Sbjct: 49 IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQI 103
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
I R I GL+YLH + IHRDI+ ANVL+ + E ++++FG+A Q+ + + + T
Sbjct: 104 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160
Query: 220 WSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265
+ T ++APE + A K DI+S G+ L G+ P +
Sbjct: 161 F--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 44/137 (32%), Positives = 65/137 (47%), Gaps = 25/137 (18%)
Query: 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI--------ARGIASGLEYLHMSHRPR 180
L+ E+ GSL D+L +H++ A+ I G+ YLH H
Sbjct: 84 QLIMEYVPLGSL-------------RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH--- 127
Query: 181 IIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-VGYIAPECHQTVAL 239
IHRD+ NVL+D+D +I +FGLAK +P G ++ V + A EC +
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187
Query: 240 SDKCDIYSFGVLLAVLM 256
S D++SFGV L L+
Sbjct: 188 SYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 7/153 (4%)
Query: 110 VRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASG 169
++H +V L A V + + ++ E+ GSL D L G+ L L + IA G
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--FSAQIAEG 115
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
+ Y+ R IHRD++ ANVL+ + + +I++FGLA+ I + T + +
Sbjct: 116 MAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWT 171
Query: 230 APECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
APE + + K D++SFG+LL ++ GK P
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 41/109 (37%), Positives = 60/109 (55%), Gaps = 10/109 (9%)
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
A I GLE LH + RI++RD++P N+L+DD RIS+ GLA +P G+T
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GR 161
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271
TVGY+APE + + D ++ G LL ++ G+ P FQ K+
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQRKK 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 43/109 (39%), Positives = 59/109 (54%), Gaps = 10/109 (9%)
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
A I GLE LH R RI++RD++P N+L+DD RIS+ GLA +IP G T
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGR 161
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271
TVGY+APE + + D + G L+ ++ GK P F+ KE
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP----FRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 52/154 (33%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
++RH +VPL A VV + +V EF GSL D L + +L L +A IA
Sbjct: 57 KLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD--MAAQIAD 113
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
G+ Y+ R IHRD++ AN+L+ D++ +I++FGLA+ I + T + +
Sbjct: 114 GMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKW 169
Query: 229 IAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFP 261
APE + K D++SFG+LL L+ G+ P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+ EKI +G VY A + ++G+ + IK++ L +Q + L I +
Sbjct: 21 YTRFEKIGQGASGTVYTA-IDVATGQEVAIKQM--------NLQQQPKKEL------IIN 65
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 162
EI+ + +H NIV L + D +V E+ GSL D++ + ++ +
Sbjct: 66 EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-----AAV 120
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-PNGRTRTTTWS 221
R LE+LH + +IHRDI+ N+L+ D ++++FG QI P R+T
Sbjct: 121 CRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--- 174
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
+ T ++APE A K DI+S G++ ++ G+ P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 33 DLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKV-IQPLKSEAELIKQDSE 91
DL+ ++ F +++I S G+VYKA ++G + IK + ++P + A
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKAR-NVNTGELAAIKVIKLEPGEDFA-------- 51
Query: 92 PLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR 151
+Q EII +H NIV +R D + EF GSLQDI Y V+
Sbjct: 52 -------VVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDI-YHVTGPL 103
Query: 152 RELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP 211
E ++R GL YLH + +HRDI+ AN+L+ D+ ++++FG++ QI
Sbjct: 104 SESQIA---YVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI- 156
Query: 212 NGRTRTTTWSLAETVGYIAPE---CHQTVALSDKCDIYSFGV 250
T S T ++APE + + CDI++ G+
Sbjct: 157 -TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 26/173 (15%)
Query: 98 IQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 157
QI EI V H N+V C + F NG +Q +L + G E +
Sbjct: 117 RQICREIEILRDVNHPNVV---------KCHDM---FDHNGEIQVLLEFMDGGSLEGTHI 164
Query: 158 ARHR----IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG 213
A + +AR I SG+ YLH H I+HRDI+P+N+LI+ +I++FG+++ +
Sbjct: 165 ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL--A 219
Query: 214 RTRTTTWSLAETVGYIAPECHQT---VALSDKC--DIYSFGVLLAVLMMGKFP 261
+T S T+ Y++PE T D DI+S GV + +G+FP
Sbjct: 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 32/200 (16%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
+V E+ NG L +L Q R L R I GL +LH +I+HRDI+
Sbjct: 76 IVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSL 130
Query: 190 NVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-VG---YIAPECHQTVALSDKCDI 245
N+ +D +I + G+AK + + + A T VG Y++PE + ++K D+
Sbjct: 131 NLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIVGTPYYLSPELCEDKPYNEKSDV 184
Query: 246 YSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQML 305
++ GV+L GK P D Q + ++ P + Y +Q+
Sbjct: 185 WALGVVLYECCTGKHPFDANNQ-------GALILKIIRGVFPP-------VSQMYSQQLA 230
Query: 306 LVLKIACFCTFDDPEERPNS 325
++ C D +RP++
Sbjct: 231 QLIDQ---CLTKDYRQRPDT 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 5e-13
Identities = 68/230 (29%), Positives = 101/230 (43%), Gaps = 61/230 (26%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS--EIITAGQVRH 112
G VYKA +G ++ +KK I+ D+E + I + EI +++H
Sbjct: 13 GVVYKARDK-KTGEIVALKK-----------IRLDNE---EEGIPSTALREISLLKELKH 57
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH-------RIARG 165
NIV LL + LV+E+ D+ ++ LD I
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEY--------CDMDL---KKYLDKRPGPLSPNLIKSIMYQ 106
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-PNGRTRT----TTW 220
+ GL Y H SHR I+HRD++P N+LI+ D ++++FGLA+ RT T T W
Sbjct: 107 LLRGLAYCH-SHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW 163
Query: 221 SLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FPSD 263
Y APE + L K DI+S G + A ++ GK FP D
Sbjct: 164 -------YRAPE----ILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-13
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 28/203 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V K SG+ + + ++ LK E + + E Q+ H
Sbjct: 9 GSVVKGVYLMKSGKEVEV--AVKTLKQEHIAAGKK---------EFLREASVMAQLDHPC 57
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L+ V + + +LV E G L L + RRE+ +A +A G+ YL
Sbjct: 58 IVRLIG-VCKGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLE 112
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVG-----YI 229
H +HRD+ NVL+ + +A+IS+FG+++ + G + + A T G +
Sbjct: 113 SKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG----SDYYRATTAGRWPLKWY 165
Query: 230 APECHQTVALSDKCDIYSFGVLL 252
APEC S K D++S+GV L
Sbjct: 166 APECINYGKFSSKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V K ++G ++ IKK + + E +K+ E+ Q+RH N
Sbjct: 15 GVVLKCR-NKATGEIVAIKKFKE--SEDDEDVKK----------TALREVKVLRQLRHEN 61
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L R LV+E+ L+ + + S G L A + + Y H
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLLELL--EASPG--GLPPDAVRSYIWQLLQAIAYCH 117
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
IIHRDI+P N+L+ + ++ +FG A+ + T +A T Y APE
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE-- 171
Query: 235 QTVALSDK-----CDIYSFGVLLAVLMMGK--FPSD 263
+ + D D+++ G ++A L+ G+ FP D
Sbjct: 172 --LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYK + S + +K+V S+ E ++D+ +EI V H N
Sbjct: 14 GSVYKVKRL-SDNQFYALKEVDLGSMSQKE--REDA----------VNEIRILASVNHPN 60
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ + + +V E+ G L + + R+ + RI + GL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+I+HRD++ AN+L+ + +I + G++K + +T T Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVW 173
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFP 261
+ S K DI+S G LL + P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-13
Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 64 GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV 123
G+SG V T V + + I +P +I +EI+ ++++ NIV L +
Sbjct: 30 GASGTVFTAIDVATGQEVAIKQINLQKQPKKELII---NEILVMKELKNPNIVNFLDSFL 86
Query: 124 RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183
D +V E+ GSL D++ + ++ + R LE+LH + ++IH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQI-----AAVCRECLQALEFLHAN---QVIH 138
Query: 184 RDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKC 243
RDI+ NVL+ D ++++FG QI +++ +T + T ++APE A K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 244 DIYSFGVLLAVLMMGKFP 261
DI+S G++ ++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 41/109 (37%), Positives = 57/109 (52%), Gaps = 10/109 (9%)
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
A + GLE L R RI++RD++P N+L+DD RIS+ GLA QIP G T
Sbjct: 108 AAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGR 161
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271
TVGY+APE + D + G L+ ++ G+ P F+ KE
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP----FRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 32/229 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKV-IQPLKSEAELIKQ--DSEPLHHKMIQIQSEIITAGQVR 111
G+V KA +G+++ IKKV I + ++ +Q +H ++ E+ +++
Sbjct: 23 GKVEKAY-DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR---ELKIMNEIK 78
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
H NI+ L+ V D LV + L+ ++ + L I I +GL
Sbjct: 79 HENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR----KIRLTESQVKCILLQILNGLN 133
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA-------------KQIPNGRTRTT 218
LH + +HRD+ PAN+ I+ +I++FGLA K R
Sbjct: 134 VLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 219 TWSLAETVGYIAPE-CHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
T S T+ Y APE D++S G + A L+ GK FP ++
Sbjct: 191 T-SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
++RH ++ L A + +V E + GSL + L + +L L +A +AS
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID--MAAQVAS 114
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK----QIPNGRTRTTTWSLAE 224
G+ YL + IHRD+ NVL+ ++ ++++FGLA+ I R
Sbjct: 115 GMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF----- 166
Query: 225 TVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFP 261
+ + APE S K D++SFG+LL ++ G+ P
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 8/136 (5%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
LV G L+ +Y+V G R L+ + I G+ LH+ H I++RD++P
Sbjct: 70 LVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGI--LHL-HSMDIVYRDMKPE 124
Query: 190 NVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFG 249
NVL+DD R+S+ GLA ++ +G+T T A T GY+APE + S D ++ G
Sbjct: 125 NVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILKEEPYSYPVDWFAMG 181
Query: 250 VLLAVLMMGKFPSDDF 265
+ ++ G+ P D
Sbjct: 182 CSIYEMVAGRTPFKDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 103 EIITAGQVRH----RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRREL-DWL 157
+I+ QV H + I L + P L F+ + +L ++ V G EL L
Sbjct: 38 KIVKLKQVEHVLNEKRI---LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG--ELFSHL 92
Query: 158 ARHR-----IAR----GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208
+ +AR + LEYLH I++RD++P N+L+D D +I++FG AK
Sbjct: 93 RKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK 149
Query: 209 QIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
++ T++L T Y+APE + D ++ G+L+
Sbjct: 150 RVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 33 DLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEP 92
D++ +K E+ + E GEV + L R I + I+ LKS KQ +
Sbjct: 2 DVSCVKIEEVIGAGE------FGEVCRGRLKLPGKREIFV--AIKTLKS-GYTEKQRRDF 52
Query: 93 LHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRR 152
L SE GQ H NI+ L V + +++ EF NG+L L Q
Sbjct: 53 L--------SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL---RQNDG 101
Query: 153 ELDWLARHRIARGIASGLEYL-HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP 211
+ + + RGIA+G++YL M++ +HRD+ N+L++ ++ ++S+FGL++ +
Sbjct: 102 QFTVIQLVGMLRGIAAGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRFLE 157
Query: 212 NGRTRTT-TWSLAET--VGYIAPECHQTVALSDKCDIYSFG-VLLAVLMMGKFP 261
+ + T T SL + + APE + D++S+G V+ V+ G+ P
Sbjct: 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 70/300 (23%), Positives = 123/300 (41%), Gaps = 53/300 (17%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VYKA +G ++ +KK+ +++E E P I EI ++RH N
Sbjct: 13 GQVYKAR-NKKTGELVALKKI--RMENEKEGF-----P-----ITAIREIKLLQKLRHPN 59
Query: 115 IVPLLARVVRPDCD--LLVYEFRR---NGSLQDILYDVSQGRRELDWLARHRIARGIASG 169
IV L V +V+E+ G L ++ + + + + G
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ------IKC-YMKQLLEG 112
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
L+YLH I+HRDI+ +N+LI++D ++++FGLA+ + T + T+ Y
Sbjct: 113 LQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT-NRVITLWYR 168
Query: 230 APEC--HQTVALSDKCDIYSFGVLLAVLMMGK--FP-SDDFFQHTK-------------- 270
PE T + D++S G +LA L +GK F S + Q K
Sbjct: 169 PPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330
+S + W N+ + R + + L+ K+ DP++R ++
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL----DPKKRISADQALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 8/154 (5%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
++RH +V L A VV + +V E+ GSL D L D +L L +A +A+
Sbjct: 57 KLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD--MAAQVAA 113
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
G+ Y+ R IHRD++ AN+L+ D + +I++FGLA+ I + T + +
Sbjct: 114 GMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKW 169
Query: 229 IAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFP 261
APE + K D++SFG+LL L+ G+ P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 64 GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV 123
GS G+V ++K+ P D+ L+ + ++ + +VR + +LA V
Sbjct: 7 GSFGKVFLVRKITGP----------DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56
Query: 124 RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI---------ARGIASGLEYLH 174
P L Y F+ G L IL D +G L++ + +A L++LH
Sbjct: 57 HPFIVKLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
II+RD++P N+L+D++ ++++FGL+K+ + + +S TV Y+APE
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVV 170
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFP 261
+ D +SFGVL+ ++ G P
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 29/205 (14%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
LV E+ G L +L +V G + D AR IA I LEYLH S+ IIHRD++P
Sbjct: 70 LVMEYLPGGDLASLLENV--GSLDEDV-ARIYIAE-IVLALEYLH-SNG--IIHRDLKPD 122
Query: 190 NVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE------TVGYIAPECHQTVALSDKC 243
N+LID + ++++FGL+K R E T YIAPE S
Sbjct: 123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTV 182
Query: 244 DIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQ 303
D +S G +L ++G P F T E F +N++ + I+ +E
Sbjct: 183 DWWSLGCILYEFLVGIPP---FHGETPEEIF----QNILNGK-----IEWPEDVEVSDEA 230
Query: 304 MLLVLKIACFCTFDDPEERPNSKDV 328
+ L+ K+ DPE+R +K +
Sbjct: 231 IDLISKLLVP----DPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
Q++H +V L A VV + ++ E+ NGSL D L + ++ L +A IA
Sbjct: 57 QLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID--MAAQIAE 113
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE-TVG 227
G+ ++ R IHRD++ AN+L+ + + +I++FGLA+ I + T A+ +
Sbjct: 114 GMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIK 168
Query: 228 YIAPECHQTVALSDKCDIYSFGVLLA-VLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286
+ APE + K D++SFG+LL ++ G+ P M N +N
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG-------------MTNPEVIQN 215
Query: 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332
R N EE L+ C + PEERP + +R +L
Sbjct: 216 LERGYRMPRPDNCPEELYELMRL----CWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV+ G++ I K ++P E Q+++ + ++RH
Sbjct: 20 GEVWMGTWNGTTRVAI---KTLKPGTMSPEAFLQEAQVMK--------------KLRHEK 62
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V L A VV + +V E+ GSL D L L L +A IASG+ Y+
Sbjct: 63 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIASGMAYVE 119
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
R +HRD++ AN+L+ +++ ++++FGLA+ I + T + + APE
Sbjct: 120 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAA 175
Query: 235 QTVALSDKCDIYSFGVLLAVLMM-GKFP 261
+ K D++SFG+LL L G+ P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 44/131 (33%), Positives = 72/131 (54%), Gaps = 9/131 (6%)
Query: 131 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190
V E+ G D+++ + R + AR A I GL++LH II+RD++ N
Sbjct: 74 VMEYLNGG---DLMFHIQSSGRFDEARARFYAAE-IICGLQFLHKKG---IIYRDLKLDN 126
Query: 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGV 250
VL+D D +I++FG+ K+ NG + +T+ T YIAPE + ++ D +SFGV
Sbjct: 127 VLLDKDGHIKIADFGMCKENMNGEGKASTF--CGTPDYIAPEILKGQKYNESVDWWSFGV 184
Query: 251 LLAVLMMGKFP 261
LL +++G+ P
Sbjct: 185 LLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 8/96 (8%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I LEYLH S I++RD++P N+L+D + ++++FG AK++ R TW+L T
Sbjct: 110 IVCALEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGT 161
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
Y+APE Q+ + D ++ G+L+ +++G P
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 55/219 (25%), Positives = 105/219 (47%), Gaps = 25/219 (11%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+ EKI +G VY A + ++G+ + IK++ + + ELI +
Sbjct: 21 YTRFEKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELII--------------N 65
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 162
EI+ + ++ NIV L + D +V E+ GSL D++ + ++ +
Sbjct: 66 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-----AAV 120
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
R L++LH + ++IHRDI+ N+L+ D ++++FG QI +++ +T +
Sbjct: 121 CRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--M 175
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
T ++APE A K DI+S G++ ++ G+ P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 40/232 (17%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+ +EKI G VYKA +G ++ +KK+ ++ + E + I+
Sbjct: 1 YQKVEKIGEGTYGVVYKA-RDKLTGEIVALKKI---------RLETEDEGVPSTAIR--- 47
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQ---DILYDVSQGRRELDWLAR 159
EI ++ H NIV LL V + LV+EF + L+ D +
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYL- 105
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ--IPNGRTRT 217
+++ +GIA Y H SH R++HRD++P N+LID + ++++FGLA+ +P RT
Sbjct: 106 YQLLQGIA----YCH-SH--RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP---VRT 155
Query: 218 TTWSLAETVGYIAPE----CHQTVALSDKCDIYSFGVLLAVLMMGK--FPSD 263
T + T+ Y APE Q S DI+S G + A ++ + FP D
Sbjct: 156 YTHEVV-TLWYRAPEILLGSRQ---YSTPVDIWSIGCIFAEMVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 39/227 (17%)
Query: 65 SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124
S+GR + +KK+ +L KQ L + +E++ +H NIV + + +
Sbjct: 42 STGRQVAVKKM--------DLRKQQRREL------LFNEVVIMRDYQHPNIVEMYSSYLV 87
Query: 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184
D +V EF G+L DI V+ R + +A + + L +LH +IHR
Sbjct: 88 GDELWVVMEFLEGGALTDI---VTHTRMNEEQIAT--VCLAVLKALSFLHAQ---GVIHR 139
Query: 185 DIQPANVLIDDDMEARISEFG----LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALS 240
DI+ ++L+ D ++S+FG ++K++P + SL T ++APE +
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK------SLVGTPYWMAPEVISRLPYG 193
Query: 241 DKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENP 287
+ DI+S G+++ ++ G+ P +F +Q M+ + + P
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPP---YFNE----PPLQAMKRIRDNLPP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
F +EKI G VYKA +G V+ +KK+ + ++E + I+
Sbjct: 2 FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 48
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDI--LYDVSQGRRELDWLAR 159
EI ++ H NIV LL V+ + L LV+EF QD+ D S L +
Sbjct: 49 EISLLKELNHPNIVKLL-DVIHTENKLYLVFEFLH----QDLKKFMDASP----LSGIPL 99
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ--IPNGRTRT 217
I + L+ L H R++HRD++P N+LI+ + ++++FGLA+ +P RT
Sbjct: 100 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRT 156
Query: 218 TTWSLAETVGYIAPEC-HQTVALSDKCDIYSFGVLLAVLMMGK--FPSD 263
T + T+ Y APE S DI+S G + A ++ + FP D
Sbjct: 157 YTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 41/167 (24%), Positives = 67/167 (40%), Gaps = 8/167 (4%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 158
+I E V H ++V LL + L+ + G L D V + +
Sbjct: 55 EILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDY---VRNHKDNIGSQY 110
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTT 218
IA G+ YL R++HRD+ NVL+ +I++FGLAK +
Sbjct: 111 LLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH 167
Query: 219 TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLM-MGKFPSDD 264
+ ++A E + K D++S+GV + LM G P +
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 43/115 (37%), Positives = 63/115 (54%), Gaps = 27/115 (23%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR--TTTWSLAETV 226
GL+Y+H + IIHRD++P+NV +++D E RI +FGLA+Q + T T W
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRW------ 180
Query: 227 GYIAPEC-------HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
Y APE +QTV DI+S G ++A L+ GK FP +D+ K +
Sbjct: 181 -YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 46/144 (31%), Positives = 74/144 (51%), Gaps = 14/144 (9%)
Query: 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188
V EF G D+++ + Q + D A I GL++LH II+RD++
Sbjct: 72 FFVMEFLNGG---DLMFHI-QDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKL 124
Query: 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSF 248
NV++D D +I++FG+ K+ G R +T+ T YIAPE Q + + D +SF
Sbjct: 125 DNVMLDRDGHIKIADFGMCKENVFGDNRASTF--CGTPDYIAPEILQGLKYTFSVDWWSF 182
Query: 249 GVLLAVLMMGKFP-----SDDFFQ 267
GVLL +++G+ P D+ F+
Sbjct: 183 GVLLYEMLIGQSPFHGDDEDELFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 26/292 (8%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+A LE + S G VYK + ++ +K++ + + ++ + + I S
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG----DIVS 57
Query: 103 EI-ITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
E+ I Q+RH NIV + D +V + L + + + ++
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWS 221
I + L YLH RI+HRD+ P N+++ +D + I++FGLAKQ T S
Sbjct: 118 IFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKLT-S 172
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281
+ T+ Y PE + +K D+++FG +L + + P F T +S +
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP----FYSTNMLSLATKIVEA 228
Query: 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333
+ P Y E + V+ C D E RP+ V M+S
Sbjct: 229 VYEPLPEGM---------YSEDVTDVIT---SCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 1e-11
Identities = 54/219 (24%), Positives = 105/219 (47%), Gaps = 25/219 (11%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+ EKI +G VY A + ++G+ + I+++ + + ELI +
Sbjct: 22 YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELII--------------N 66
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 162
EI+ + ++ NIV L + D +V E+ GSL D++ + ++ +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-----AAV 121
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
R LE+LH + ++IHRDI+ N+L+ D ++++FG QI +++ + ++
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TM 176
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
T ++APE A K DI+S G++ ++ G+ P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 54 NGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRH 112
G+VYKA +G+++ IK I + + E +I+ E I H
Sbjct: 19 YGKVYKARHK-KTGQLVAIK--IMDIIEDEE-------------EEIKEEYNILRKYSNH 62
Query: 113 RNIVPL----LARV--VRPDCDLLVYEFRRNGSLQDILYDV-SQGRR-ELDWLARHRIAR 164
NI + + D LV E GS+ D++ + +G+R + +W+A I R
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILR 120
Query: 165 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI--PNGRTRTTTWSL 222
GL YLH + +IHRDI+ N+L+ + E ++ +FG++ Q+ GR T
Sbjct: 121 ETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--- 174
Query: 223 AETVGYIAPE---CHQTVALS--DKCDIYSFGV 250
T ++APE C + S + D++S G+
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V+KA +G + +KKV +++ + ++ ++ EI +H
Sbjct: 14 GIVFKA-KDRETGETVALKKV---------ALRRLEGGIPNQALR---EIKALQACQHPY 60
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V LL +LV E+ L ++L D R L R + G+ Y+H
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
+ I+HRD++PAN+LI D +I++FGLA+ R + +A T Y APE
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 51/224 (22%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEA---ELIKQDSEPLHHKMIQIQSEIITAGQVR 111
G+V KAE G T ++ LK +A +L SE KMI +
Sbjct: 26 GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----------K 74
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAR------- 164
H+NI+ LL + +V E+ +G+L+D L + RR A R
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL----RARRPPGEYASPDDPRPPEETLT 130
Query: 165 ---------GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR- 214
+A G+E+L + IHRD+ NVL+ +D +I++FGLA+ I +
Sbjct: 131 QKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 215 -TRTTTWSLAETVGYIAPECHQTVALSDK-----CDIYSFGVLL 252
+TT L V ++APE AL D+ D++SFGVLL
Sbjct: 188 YRKTTNGRLP--VKWMAPE-----ALFDRVYTHQSDVWSFGVLL 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG---RTRTTT 219
A I GLE LH R ++RD++P N+L+DD RIS+ GLA +IP G R R
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVG- 163
Query: 220 WSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
TVGY+APE + D + G L+ ++ G+ P
Sbjct: 164 -----TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 32/204 (15%)
Query: 66 SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125
+G+ + IKK+++P + L K+ L K+++ +RH NI+ L + P
Sbjct: 34 TGQNVAIKKIMKPFSTPV-LAKRTYREL--KLLK---------HLRHENIISLSDIFISP 81
Query: 126 DCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184
D+ V E L L+ + R ++ I GL+Y+H + ++HR
Sbjct: 82 LEDIYFVTEL-----LGTDLHRLLTSRPLEKQFIQY-FLYQILRGLKYVHSAG---VVHR 132
Query: 185 DIQPANVLIDDDMEARISEFGLAK-QIPNGRTRTTTWSLAETVGYIAPECHQTVALSD-K 242
D++P+N+LI+++ + +I +FGLA+ Q P + T + T Y APE T D +
Sbjct: 133 DLKPSNILINENCDLKICDFGLARIQDP----QMTGY--VSTRYYRAPEIMLTWQKYDVE 186
Query: 243 CDIYSFGVLLAVLMMGK--FPSDD 264
DI+S G + A ++ GK FP D
Sbjct: 187 VDIWSAGCIFAEMLEGKPLFPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 64 GSSGRVITIKKVIQPLKSEAELIK-QDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARV 122
G+ G+V + L + A++I+ + E L M++I +I++ + +H NIV L
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEI--DILS--ECKHPNIVGLYEAY 71
Query: 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRII 182
+ ++ EF G+L I+ ++ +G E + + R + L +LH ++I
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTE-PQIRY--VCRQMLEALNFLH---SHKVI 125
Query: 183 HRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSD- 241
HRD++ N+L+ D + ++++FG++ + N T + T ++APE D
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 242 ----KCDIYSFGVLLAVLMMGKFPSDD 264
K DI+S G+ L L + P +
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 34/257 (13%)
Query: 64 GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSE-IITAGQVRHRNIVPLLARV 122
G+ G V KK +++K+ +++ +++E I Q + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRII 182
D LV E+ G ++ + G DW A+ IA + G+E LH II
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDW-AKQYIAE-VVLGVEDLHQRG---II 119
Query: 183 HRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDK 242
HRDI+P N+LID ++++FGL++ + T Y+APE V
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKM 173
Query: 243 CDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF-------VQWMRNVMTSENP------SR 289
D +S G ++ + G P F T + F + W V +P +R
Sbjct: 174 SDWWSLGCVIFEFLFGYPP---FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230
Query: 290 TIDS----KLIGNGYEE 302
+ +L NGY+E
Sbjct: 231 LLCMDPAKRLGANGYQE 247
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY A S+ I IK++ P + + +PLH EI ++HRN
Sbjct: 22 GIVYAAR-DLSTQVRIAIKEI--PERDS-----RYVQPLHE-------EIALHSYLKHRN 66
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIA-----RGIASG 169
IV L + E GSL +L R + L + + I G
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIIFYTKQILEG 120
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDD-DMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
L+YLH + +I+HRDI+ NVL++ +IS+FG +K++ T + T+ Y
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQY 175
Query: 229 IAPEC--HQTVALSDKCDIYSFGVLLAVLMMGKFP 261
+APE DI+S G + + GK P
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 24/197 (12%)
Query: 65 SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124
SSG+++ +KK+ +L KQ L + +E++ +H N+V + +
Sbjct: 43 SSGKLVAVKKM--------DLRKQQRREL------LFNEVVIMRDYQHENVVEMYNSYLV 88
Query: 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184
D +V EF G+L DI V+ R + +IA + L+ L + H +IHR
Sbjct: 89 GDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCD 244
DI+ ++L+ D ++S+FG Q+ R SL T ++APE + + D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPELISRLPYGPEVD 198
Query: 245 IYSFGVLLAVLMMGKFP 261
I+S G+++ ++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 55/240 (22%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+V A + GR + IKK+ +P +S +H K + E+ + H N
Sbjct: 29 GQVCSAFDTKT-GRKVAIKKLSRPFQSA----------IHAK--RTYRELRLLKHMDHEN 75
Query: 115 IVPLLARVVRPDCDL-------LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIA 167
++ LL V P L LV + L ++ + ++ D + + I
Sbjct: 76 VIGLL-DVFTPASSLEDFQDVYLVTHL-----MGADLNNIVKCQKLSDDHIQF-LVYQIL 128
Query: 168 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR--TTTWSLAET 225
GL+Y+H + IIHRD++P+N+ +++D E +I +FGLA+ + T T W
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRW----- 180
Query: 226 VGYIAPEC-------HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFF-QHTKEMSFV 275
Y APE +QTV DI+S G ++A L+ GK FP D Q + M+ V
Sbjct: 181 --YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 14/165 (8%)
Query: 102 SEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
SE GQ H NI+ L V + ++V E+ NGSL L G+ + L
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVG-- 110
Query: 162 IARGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI---PNGRTRT 217
+ RGIASG++YL M + +HRD+ N+L++ ++ ++S+FGL++ + P T
Sbjct: 111 MLRGIASGMKYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166
Query: 218 TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+ + + APE + D++S+G+++ V+ G+ P
Sbjct: 167 RGGKIP--IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 60/188 (31%), Positives = 86/188 (45%), Gaps = 33/188 (17%)
Query: 118 LLARVVRPDCDLLV---YEFRRNGSLQDILYDVSQGRRELDWLARHRI---------ARG 165
+L+ V DC +V Y F L IL D+ G L++H + A
Sbjct: 47 MLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAEMRFYAAE 105
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA----KQIPNGRTRTTTWS 221
I GLE++H +++RD++PAN+L+D+ RIS+ GLA K+ P+ T
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH--- 159
Query: 222 LAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH-TKEMSFVQWMR 279
GY+APE Q VA D +S G +L L+ G P F QH TK+ + M
Sbjct: 160 -----GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMT 211
Query: 280 NVMTSENP 287
M E P
Sbjct: 212 LTMAVELP 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 131 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190
V E+ G D+++ + + R + AR A I GL++LH II+RD++ N
Sbjct: 74 VMEYVNGG---DLMFHIQRSGRFDEPRARFYAAE-IVLGLQFLH-ERG--IIYRDLKLDN 126
Query: 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGV 250
VL+D + +I++FG+ K+ G T+T+ T YIAPE D ++ GV
Sbjct: 127 VLLDSEGHIKIADFGMCKEGILGGVTTSTF--CGTPDYIAPEILSYQPYGPAVDWWALGV 184
Query: 251 LLAVLMMGKFP-----SDDFFQH--TKEMSFVQWM 278
LL ++ G+ P D+ FQ E+ + +W+
Sbjct: 185 LLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 38/123 (30%), Positives = 65/123 (52%), Gaps = 22/123 (17%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
+IA I LEYLH + +IHRD++P+NVLI+ + + ++ +FG++ + +
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-------- 156
Query: 221 SLAETVG-----YIAPE----CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF---FQH 268
S+A+T+ Y+APE K D++S G+ + L G+FP D + FQ
Sbjct: 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
Query: 269 TKE 271
K+
Sbjct: 217 LKQ 219
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 72/277 (25%), Positives = 107/277 (38%), Gaps = 52/277 (18%)
Query: 56 EVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITA---GQVRH 112
V K PGS GRV K QP +P+ K+ Q + +I A V H
Sbjct: 69 TVIKTLTPGSEGRVFVATKPGQP------------DPVVLKIGQKGTTLIEAMLLQNVNH 116
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
+++ + +V +V + D+ +++ R L I + I GL Y
Sbjct: 117 PSVIRMKDTLVSGAITCMVLPHYSS----DLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
LH RIIHRD++ N+ I+D + I + G A Q P LA TV APE
Sbjct: 173 LHAQ---RIIHRDVKTENIFINDVDQVCIGDLG-AAQFP--VVAPAFLGLAGTVETNAPE 226
Query: 233 CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTID 292
+ K DI+S G++L M +PS F T E ++
Sbjct: 227 VLARDKYNSKADIWSAGIVL--FEMLAYPSTIFEDPPS------------TPEEYVKSCH 272
Query: 293 SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329
S L+ +++ LK+ PEE P R
Sbjct: 273 SHLL------KIISTLKV-------HPEEFPRDPGSR 296
|
Length = 357 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 25/201 (12%)
Query: 56 EVYKAELPGSSGRVITIKKV----IQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
VYKA GRV+ +KKV + K+ + +K EI Q+
Sbjct: 17 VVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLK---------------EIDLLKQLD 60
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
H N++ LA + + +V E G L ++ + +R + + + S LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
++H S R I+HRDI+PANV I ++ + GL + + +T T SL T Y++P
Sbjct: 121 HMH-SKR--IMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKT-TAAHSLVGTPYYMSP 175
Query: 232 ECHQTVALSDKCDIYSFGVLL 252
E + K DI+S G LL
Sbjct: 176 ERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-11
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
IQ EI + +H NIV + + + E+ GSLQDI Y V+ EL
Sbjct: 53 IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI-YHVTGPLSELQIA-- 109
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
+ R GL YLH + +HRDI+ AN+L+ D+ + ++++FG+A +I T
Sbjct: 110 -YVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKIT--ATIAKR 163
Query: 220 WSLAETVGYIAPECHQTVALSDK-------CDIYSFGV 250
S T ++APE VA +K CDI++ G+
Sbjct: 164 KSFIGTPYWMAPE----VAAVEKNGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 9e-11
Identities = 50/149 (33%), Positives = 76/149 (51%), Gaps = 16/149 (10%)
Query: 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184
PD V EF G D+++ + + RR + AR A I S L +LH II+R
Sbjct: 68 PDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAE-ITSALMFLH---DKGIIYR 120
Query: 185 DIQPANVLIDDDMEARISEFGLAKQ-IPNGRTRTTTWSLAETVGYIAPECHQTVALSDKC 243
D++ NVL+D + ++++FG+ K+ I NG+T +T T YIAPE Q +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST---FCGTPDYIAPEILQEMLYGPSV 177
Query: 244 DIYSFGVLLAVLMMGKFP-----SDDFFQ 267
D ++ GVLL ++ G P DD F+
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 66 SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125
+GR + +K+V DS ++ ++ EI ++H IV +R
Sbjct: 26 TGRELAVKQV---------PFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG-CLRD 75
Query: 126 DCDLLVY-EFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184
D L ++ E+ GS++D L + + R + R I G+EYLH I+HR
Sbjct: 76 DETLSIFMEYMPGGSVKDQL---KAYGALTETVTR-KYTRQILEGVEYLH---SNMIVHR 128
Query: 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW-SLAETVGYIAPECHQTVALSDKC 243
DI+ AN+L D ++ +FG +K++ + T S+ T +++PE K
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKA 188
Query: 244 DIYSFGVLLAVLMMGKFPSDDF 265
D++S G + ++ K P +F
Sbjct: 189 DVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 18/133 (13%)
Query: 133 EFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192
E GSL +L GR + L + I+ + GL YL H+ I+HRD++P+N+L
Sbjct: 79 EHMDGGSLDQVLKKA--GRIPENILGK--ISIAVLRGLTYLREKHK--IMHRDVKPSNIL 132
Query: 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-VG---YIAPECHQTVALSDKCDIYSF 248
++ E ++ +FG++ Q+ + S+A + VG Y++PE Q + + DI+S
Sbjct: 133 VNSRGEIKLCDFGVSGQLID--------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSL 184
Query: 249 GVLLAVLMMGKFP 261
G+ L + +G++P
Sbjct: 185 GLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 16/149 (10%)
Query: 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184
D V E+ G D+++ + + R+ + +R A + L +LH R +I+R
Sbjct: 68 KDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAE-VTLALMFLH---RHGVIYR 120
Query: 185 DIQPANVLIDDDMEARISEFGLAKQ-IPNGRTRTTTWSLAETVGYIAPECHQTVALSDKC 243
D++ N+L+D + ++++FG+ K+ I NG T TT T YIAPE Q +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT---FCGTPDYIAPEILQELEYGPSV 177
Query: 244 DIYSFGVLLAVLMMGKFP-----SDDFFQ 267
D ++ GVL+ +M G+ P DD F+
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 40/129 (31%), Positives = 69/129 (53%), Gaps = 10/129 (7%)
Query: 133 EFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192
E GSL +L + + E+ L + IA + GL YL H+ I+HRD++P+N+L
Sbjct: 83 EHMDGGSLDQVLKEAKRIPEEI--LGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSNIL 136
Query: 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
++ E ++ +FG++ Q+ + S T Y++PE Q S + DI+S G+ L
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 253 AVLMMGKFP 261
L +G++P
Sbjct: 193 VELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VYK +G++ IK V+ + E E IK + M++ S HRN
Sbjct: 30 GQVYKGRHV-KTGQLAAIK-VMDVTEDEEEEIKLEI-----NMLKKYSH--------HRN 74
Query: 115 IVPLLARVVRP------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
I ++ D LV EF GS+ D++ + + DW+A I R I
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILR 132
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
GL +LH +IHRDI+ NVL+ ++ E ++ +FG++ Q+ R T+ T +
Sbjct: 133 GLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYW 187
Query: 229 IAPE---CHQT--VALSDKCDIYSFGVLLAVLMMGKFP 261
+APE C + + DI+S G+ + G P
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 21/193 (10%)
Query: 62 LPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121
L ++G V+ +KK+ +++ E L +Q + I V+++ + R
Sbjct: 28 LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK----SLQHDNI----VKYKGVCYSAGR 79
Query: 122 V-VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPR 180
+R LV E+ GSL+D L + R LD A I G+EYL R
Sbjct: 80 RNLR-----LVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGSK---R 128
Query: 181 IIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-VGYIAPECHQTVAL 239
+HRD+ N+L++ + +I +FGL K +P + E+ + + APE
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188
Query: 240 SDKCDIYSFGVLL 252
S D++SFGV+L
Sbjct: 189 SVASDVWSFGVVL 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 27/201 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VYK L G++ + ++ +S L K +Q E Q H N
Sbjct: 9 GDVYKGVLKGNT------EVAVKTCRST------LPPDLKRKFLQ---EAEILKQYDHPN 53
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI---ARGIASGLE 171
IV L+ V+ +V E GSL L R++ + L ++ + A+G+E
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGME 107
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
YL + IHRD+ N L+ ++ +IS+FG++++ G + + + AP
Sbjct: 108 YLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP 164
Query: 232 ECHQTVALSDKCDIYSFGVLL 252
E + + D++S+G+LL
Sbjct: 165 EALNYGRYTSESDVWSYGILL 185
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 66 SGRVITIKKV--IQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV 123
+G ++ +K+V ++ SE E + + ++ EI ++ H +I+ +L
Sbjct: 24 TGTLMAVKQVTYVRNTSSEQEEVVE----------ALRKEIRLMARLNHPHIIRMLGATC 73
Query: 124 RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183
L E+ GS+ +L + + ++ RG++ YLH + +IIH
Sbjct: 74 EDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLS----YLHEN---QIIH 126
Query: 184 RDIQPANVLIDDD-MEARISEFGLAKQIPNGRTRTTTW--SLAETVGYIAPECHQTVALS 240
RD++ AN+LID RI++FG A ++ T + L T+ ++APE +
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG 186
Query: 241 DKCDIYSFGVLLAVLMMGKFP 261
CD++S G ++ + K P
Sbjct: 187 RSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 30/101 (29%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
+++ + GL YL H+ I+HRD++P+N+L++ E ++ +FG++ Q+ +
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---- 160
Query: 221 SLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
S T Y++PE Q S + DI+S G+ L + +G++P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 34/222 (15%)
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRH----RNIVPLLARVVRPDCDLLV---YEFRRNGS 139
K+D+ ++ + + EI+ +V H RNI L R + + +V + F+ +
Sbjct: 14 KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI---LVRTLLDESPFIVGLKFSFQTDSD 70
Query: 140 LQDILYDVSQGRRELDWLARH-------RIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192
L + +S G EL W + R IA + L H+ I++RD++P N+L
Sbjct: 71 LYLVTDYMSGG--ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENIL 128
Query: 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDK-----CDIYS 247
+D + +FGL+K N TT + T Y+APE V L +K D +S
Sbjct: 129 LDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPE----VLLDEKGYTKHVDFWS 182
Query: 248 FGVLLAVLMMG--KFPSDDFFQHTKEMSF--VQWMRNVMTSE 285
GVL+ + G F ++D Q + ++F V++ +NV++ E
Sbjct: 183 LGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDE 224
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VYK +G++ IK V+ E E IKQ+ M++ S HRN
Sbjct: 20 GQVYKGRHV-KTGQLAAIK-VMDVTGDEEEEIKQEI-----NMLKKYSH--------HRN 64
Query: 115 IVPLLARVVR---PDCD---LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
I ++ P D LV EF GS+ D++ + + +W+A I R I
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILR 122
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
GL +LH + ++IHRDI+ NVL+ ++ E ++ +FG++ Q+ R T+ T +
Sbjct: 123 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYW 177
Query: 229 IAPE---CHQT--VALSDKCDIYSFGVLLAVLMMGKFP 261
+APE C + K D++S G+ + G P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 46 LEKIRSCWNGEVYKAEL--PG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+E++ C G++YK L PG +++ IK +K + P Q ++
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKT-----------LKDINNPQQWGEFQQEA 58
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILY------DVSQGRRE--- 153
++ ++ H NIV LL V + +++E+ G L + L DV E
Sbjct: 59 SLM--AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 154 ----LDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209
LD IA IA+G+EYL SH +H+D+ N+LI + + +IS+ GL+++
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYL-SSHF--FVHKDLAARNILIGEQLHVKISDLGLSRE 173
Query: 210 IPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
I + + ++ PE S DI+SFGV+L
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 29/229 (12%)
Query: 102 SEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
+E++ +H+N+V + + + ++ EF + G+L DI VSQ R L +
Sbjct: 67 NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQTR-----LNEEQ 118
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWS 221
IA S L+ L H +IHRDI+ ++L+ D ++S+FG QI + S
Sbjct: 119 IATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--S 176
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281
L T ++APE + DI+S G+++ ++ G+ P +F + VQ M+ +
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP---YFSDSP----VQAMKRL 229
Query: 282 MTSENPSRTIDSKL--IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
S P K+ + + E+ML +P+ER ++++
Sbjct: 230 RDSPPPKLKNAHKISPVLRDFLERMLT----------REPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 56/184 (30%), Positives = 83/184 (45%), Gaps = 25/184 (13%)
Query: 118 LLARVVRPDCDLLV---YEFRRNGSLQDILYDVSQGRRELDWLARHRI---------ARG 165
+L+ V DC +V Y F L IL D+ G L++H + A
Sbjct: 47 MLSLVSTGDCPFIVCMTYAFHTPDKLCFIL-DLMNGGDLHYHLSQHGVFSEKEMRFYATE 105
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I GLE++H +++RD++PAN+L+D+ RIS+ GLA + + T
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 158
Query: 226 VGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH-TKEMSFVQWMRNVMT 283
GY+APE Q A D +S G +L L+ G P F QH TK+ + M +
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTVN 215
Query: 284 SENP 287
E P
Sbjct: 216 VELP 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 29/233 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYKA + R++ +K + PL EL KQ I SE+ +
Sbjct: 15 GTVYKAYHL-LTRRILAVKVI--PLDITVELQKQ-----------IMSELEILYKCDSPY 60
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ + + EF GSL DV R++ RIA + GL YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-----DVY---RKIPEHVLGRIAVAVVKGLTYLW 112
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+I+HRD++P+N+L++ + ++ +FG++ Q+ N +T T Y+APE
Sbjct: 113 ---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAPERI 165
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENP 287
D++S G+ L +G+FP ++ + +Q ++ ++ + P
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 19/234 (8%)
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 162
EI Q+ H N++ L + + +V E G L ++ + +R + +
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
+ S +E++H R++HRDI+PANV I ++ + GL + + T SL
Sbjct: 112 FVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSL 166
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVM 282
T Y++PE + K DI+S G LL + + P + +M+ + +
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLFSLCQKIE 221
Query: 283 TSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
+ P L Y E++ ++ C + DP++RP+ V + Q+
Sbjct: 222 QCDYPP------LPTEHYSEKL---RELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 49/222 (22%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRHR 113
G VY A +G ++ IKK+ + S E + + +++S + H
Sbjct: 13 GSVYLARNK-ETGELVAIKKMKKKFYSWEECMN---------LREVKSLRKLNE----HP 58
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIA---RGIASGL 170
NIV L D V+E+ ++ LY + + R+ + I I GL
Sbjct: 59 NIVKLKEVFRENDELYFVFEY-----MEGNLYQLMK-DRKGKPFSESVIRSIIYQILQGL 112
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT----TTWSLAETV 226
++H + HRD++P N+L+ +I++FGLA++I + T T W
Sbjct: 113 AHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRW------ 163
Query: 227 GYIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FP 261
Y APE + L DI++ G ++A L + FP
Sbjct: 164 -YRAPE----ILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 11/99 (11%)
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
EYLH II+RD++P N+L+D+ ++++FG AK++P+ T++L T Y+A
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLA 183
Query: 231 PECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269
PE Q+ D ++ GVLL + G P FF T
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP---FFDDT 219
|
Length = 329 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 29/183 (15%)
Query: 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAR------ 164
+H+NI+ LL + ++ E+ G+L++ L + RR + IAR
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYSYDIARVPDEQM 134
Query: 165 ----------GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR 214
+A G+EYL + IHRD+ NVL+ ++ +I++FGLA+ + N
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 215 TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMG-----KFPSDDFFQH 268
T + V ++APE + + D++SFGVL+ + +G P ++ F+
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 269 TKE 271
KE
Sbjct: 252 LKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 45/186 (24%), Positives = 86/186 (46%), Gaps = 18/186 (9%)
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLL--VYEFRRNGSLQ 141
+L++ D+ H+ + + E ++ H NIV LL P LL V+E+ +L+
Sbjct: 9 KLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRTLR 67
Query: 142 DILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDME 198
++L + G L R + L+ L +H I+HRD++P N+++
Sbjct: 68 EVL--AADGA-----LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 199 ARISEFGLAKQIPNGRT--RTTTWSLAETVG---YIAPECHQTVALSDKCDIYSFGVLLA 253
A++ +FG+ +P R T E +G Y APE + ++ D+Y++G++
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 254 VLMMGK 259
+ G+
Sbjct: 181 ECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VYK L G++ T I+ LK +AE PL + + E + +++H N
Sbjct: 19 GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG------PLRE---EFKHEAMMRSRLQHPN 69
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILY------------DVSQGRRELDWLARHRI 162
IV LL V + +++ + + L + L D + L+ I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
IA+G+E+L H ++H+D+ NVL+ D + +IS+ GL +++ +
Sbjct: 130 VTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+ +++PE S DI+S+GV+L
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 5e-10
Identities = 46/173 (26%), Positives = 79/173 (45%), Gaps = 47/173 (27%)
Query: 112 HRNIVPLLARVVRPDCDL---LVYEFR--------RNGSLQDILYDVSQGRRELDWLARH 160
H NIV LL V++ + D LV+E+ R L+D+ H
Sbjct: 66 HPNIVKLLN-VIKAENDKDIYLVFEYMETDLHAVIRANILEDV----------------H 108
Query: 161 R--IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTT 218
+ I + L+Y+H + +IHRD++P+N+L++ D ++++FGLA+ +
Sbjct: 109 KRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 219 TWSLAETVG---YIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FP 261
L + V Y APE + L D++S G +L +++GK FP
Sbjct: 166 NPVLTDYVATRWYRAPE----ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 60/239 (25%), Positives = 93/239 (38%), Gaps = 70/239 (29%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEVYKA +GRV+ +KK++ +E + I EI +++H N
Sbjct: 22 GEVYKAR-QIKTGRVVALKKILM--HNEKDGFP----------ITALREIKILKKLKHPN 68
Query: 115 IVPLLARVVRP------------------DCDLLVYEFRRNGSL--QDILYDVSQGRREL 154
+VPL+ V D DL +G L + SQ +
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDL-------SGLLENPSVKLTESQIKC-- 119
Query: 155 DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK------ 208
+ G+ YLH +H I+HRDI+ AN+LID+ +I++FGLA+
Sbjct: 120 -------YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 209 ---QIPNGRTRTTTWSLAETVGYIAPE-----CHQTVALSDKCDIYSFGVLLAVLMMGK 259
+ G +L T Y PE T A+ DI+ G + A + +
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 60/224 (26%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--- 111
G VYKA + GR + +KKV PL ++ PL ++ EI Q+
Sbjct: 13 GTVYKARDLNT-GRFVALKKVRVPLS-------EEGIPL--STLR---EIALLKQLESFE 59
Query: 112 HRNIVPLLARVVRPDCD-----LLVYEFRRNGSLQDILYDVSQGRRELDWLARH------ 160
H NIV LL P D LV+E + D++ +L++
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEH--------VDQDLAT------YLSKCPKPGLP 105
Query: 161 -----RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT 215
+ R + G+++LH SHR I+HRD++P N+L+ D + +I++FGLA+
Sbjct: 106 PETIKDLMRQLLRGVDFLH-SHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA 162
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDK----CDIYSFGVLLAVL 255
T S+ T+ Y APE V L D++S G + A L
Sbjct: 163 LT---SVVVTLWYRAPE----VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 57/231 (24%)
Query: 62 LPGSSGRVITIKKVIQPLKSE--AELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
L +G + IKK+ +P +SE A+ ++ L H ++H N++ LL
Sbjct: 35 LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH--------------MKHENVIGLL 80
Query: 120 ARVVRPDCDL-------LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
V PD L LV F L ++ + +L + GL+Y
Sbjct: 81 -DVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQ-----MLKGLKY 133
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR--TTTWSLAETVGYIA 230
+H + IIHRD++P N+ +++D E +I +FGLA+Q + T T W Y A
Sbjct: 134 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW-------YRA 183
Query: 231 PEC-------HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
PE QTV DI+S G ++A ++ GK F D E+
Sbjct: 184 PEVILNWMHYTQTV------DIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 39/286 (13%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKV----IQPLKSEAELIKQDSEPLHHKMI 98
F +KI EVY+A G + +KKV + K+ A+ IK
Sbjct: 4 FRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIK----------- 51
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 158
EI Q+ H N++ A + + +V E G L ++ + +R +
Sbjct: 52 ----EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKT 107
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTT 218
+ + S LE++H R++HRDI+PANV I ++ + GL + + T
Sbjct: 108 VWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162
Query: 219 TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278
SL T Y++PE + K DI+S G LL + + P + +M+
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLC 217
Query: 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324
+ + + P L + Y E++ ++ C DPE+RP+
Sbjct: 218 KKIEQCDYPP------LPSDHYSEEL---RQLVNMCINPDPEKRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 7e-10
Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 29/114 (25%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-PNGRTR-------TTTW 220
GL+YLH ++ +IHRD++P+N+L++ + + +I +FGLA+ + P+ + T W
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 221 SLAETVGYIAPE----CHQ-TVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQ 267
Y APE + T A+ DI+S G + A L+ K FP D+
Sbjct: 172 -------YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPGRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 16/179 (8%)
Query: 96 KMIQIQS----EIITAGQV----RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDV 147
KMI+ S E I +V H +V L + +V E+ NG L + L
Sbjct: 34 KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL--- 90
Query: 148 SQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207
+ + + + + G+ YL S + IHRD+ N L+DD ++S+FGL+
Sbjct: 91 REHGKRFQPSQLLEMCKDVCEGMAYLE-SKQ--FIHRDLAARNCLVDDQGCVKVSDFGLS 147
Query: 208 KQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDF 265
+ + + T++ V + PE S K D+++FGVL+ V +GK P + F
Sbjct: 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 55 GEVYKAE----LPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV 110
G+V+ AE LP ++ +K LK +E +QD Q ++E++T Q
Sbjct: 19 GKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQD--------FQREAELLTVLQ- 65
Query: 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILY-------------DVSQGRRELDWL 157
H++IV L+V+E+ R+G L L DV+ G+ L +
Sbjct: 66 -HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 158 ARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT 217
IA IASG+ YL H +HRD+ N L+ + +I +FG+++ I +
Sbjct: 125 LA--IASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179
Query: 218 TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+ ++ PE + + DI+SFGV+L + GK P
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 6/144 (4%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
Q H NIV L+ + +V E + G L ++G R L ++ A+
Sbjct: 49 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGPR-LKVKELIQMVENAAA 105
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
G+EYL H IHRD+ N L+ + +IS+FG++++ +G +T V +
Sbjct: 106 GMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162
Query: 229 IAPECHQTVALSDKCDIYSFGVLL 252
APE S + D++SFG+LL
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 31/219 (14%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
++ H N+V L + +V E+ NG L + L + +G+ +WL + +
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLD--MCSDVCE 111
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
+EYL IHRD+ N L+ +D ++S+FGLA+ + + + T++ V +
Sbjct: 112 AMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQGTKFPVKW 167
Query: 229 IAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENP 287
PE S K D++SFGVL+ V GK P + F +
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF--------------------SN 207
Query: 288 SRTIDSKLIGNGYEEQMLL---VLKIACFCTFDDPEERP 323
S ++S G L V I C + PE+RP
Sbjct: 208 SEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 45/294 (15%)
Query: 53 WNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV 110
W G+V E S RV V++ L++ A +Q E+ ++
Sbjct: 7 WFGKVLLGEAHRGMSKARV-----VVKELRASATPDEQL---------LFLQEVQPYREL 52
Query: 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRREL-DWLARHRIARGIASG 169
H N++ L + + LLV EF G L++ L ++ R+A +ASG
Sbjct: 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
L +LH + IH D+ N + D+ +I ++GLA + T A + ++
Sbjct: 113 LLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169
Query: 230 APEC----HQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVM 282
APE Q + K +I+S GV + L Q ++S Q ++ V+
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL------FTAADQPYPDLSDEQVLKQVV 223
Query: 283 TSEN---PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333
++ P +D K YE FC DPE RP +++V +L+
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYEVMQ--------FCWL-DPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 110 VRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASG 169
++H +V L A V + ++ EF GSL D L ++ L L + IA G
Sbjct: 58 LQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLID--FSAQIAEG 114
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
+ ++ + IHRD++ AN+L+ + +I++FGLA+ I + T + +
Sbjct: 115 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWT 170
Query: 230 APECHQTVALSDKCDIYSFGVLLA-VLMMGKFP 261
APE + + K D++SFG+LL ++ G+ P
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 55 GEVYKAELPG---SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
GEV+ A+ G G + + K +Q K E + + + E+ ++
Sbjct: 19 GEVFLAKAKGIEEEGGETLVLVKALQKTKDE------------NLQSEFRRELDMFRKLS 66
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRE------LDWLARHRIARG 165
H+N+V LL + ++ E+ G L+ L ++ + E L + +
Sbjct: 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
IA G+++L + R +HRD+ N L+ E ++S L+K + N +L
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLL 252
+ ++APE Q S K D++SFGVL+
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLM 208
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 102 SEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
+E +T GQ H NIV L + R + ++V E+ NG+L L R+ L +
Sbjct: 55 AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL------RKHEGQLVAGQ 108
Query: 162 IA---RGIASGLEYL-HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT 217
+ G+ASG++YL M + +H+ + VL++ D+ +IS F ++ ++
Sbjct: 109 LMGMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEA 161
Query: 218 --TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
TT S V + APE Q S D++SFG+++ V+ G+ P
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 29/236 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113
G+V AE G I K +P+ +++K D+ + + SE+ + +H+
Sbjct: 26 GQVVMAEAIG-----IDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHK 78
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLARHR 161
NI+ LL + ++ E+ G+L++ L +D + E L +
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWS 221
A +A G+EYL + IHRD+ NVL+ +D +I++FGLA+ + N T +
Sbjct: 139 CAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGK-----FPSDDFFQHTKE 271
V ++APE + + D++SFGVLL + +G P ++ F+ KE
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 39/112 (34%), Positives = 61/112 (54%), Gaps = 8/112 (7%)
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
A I GL++LH I++RD++ N+L+D D +I++FG+ K+ G +T T+
Sbjct: 102 AAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-- 156
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274
T YIAPE + D +SFGVLL +++G+ P F H +E F
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP---FHGHDEEELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 18/179 (10%)
Query: 96 KMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQD----------ILY 145
K Q ++E++T ++H +IV D ++V+E+ ++G L IL
Sbjct: 52 KDFQREAELLT--NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 109
Query: 146 DVS--QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203
D Q + EL IA IASG+ YL H +HRD+ N L+ ++ +I +
Sbjct: 110 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGD 166
Query: 204 FGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
FG+++ + + + ++ PE + + D++SFGV+L + GK P
Sbjct: 167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 77/301 (25%), Positives = 121/301 (40%), Gaps = 64/301 (21%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E F L +I G VY A + V+ IKK+ K E K
Sbjct: 14 EKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNE-----------KWQD 61
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
I E+ Q+RH N + +R LV E+ GS DIL + +E++ A
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAA- 119
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
I G GL YLH SH IHRDI+ N+L+ + ++++FG A +
Sbjct: 120 --ICHGALQGLAYLH-SHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----- 169
Query: 220 WSLAETVGYIAPECHQTVALS-------DKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272
S T ++APE V L+ K D++S G+ L K P F M
Sbjct: 170 -SFVGTPYWMAPE----VILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN----M 217
Query: 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDD------PEERPNSK 326
+ + + ++ +++P+ L N + + F F D P++RP+S+
Sbjct: 218 NAMSALYHIAQNDSPT------LSSNDWSD---------YFRNFVDSCLQKIPQDRPSSE 262
Query: 327 D 327
+
Sbjct: 263 E 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 15/154 (9%)
Query: 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 158
+H+NI+ LL + ++ E+ G+L++ L +D+++ E L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTT 218
A +A G+EYL R IHRD+ NVL+ +D +I++FGLA+ + +
Sbjct: 136 LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 219 TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
T + V ++APE + + D++SFG+L+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILM 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 32/205 (15%)
Query: 66 SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125
+G+++ IKK + E+E + K I ++ EI Q+RH N+V L+ R
Sbjct: 25 TGQIVAIKKFL-----ESE------DDKMVKKIAMR-EIRMLKQLRHENLVNLIEVFRRK 72
Query: 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRD 185
LV+EF + +L D+ + LD + I G+E+ H SH IIHRD
Sbjct: 73 KRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH-SHN--IIHRD 125
Query: 186 IQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSD---- 241
I+P N+L+ ++ +FG A+ + T + T Y APE + + D
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY--VATRWYRAPE----LLVGDTKYG 179
Query: 242 -KCDIYSFGVLLAVLMMGK--FPSD 263
DI++ G L+ ++ G+ FP D
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 21/139 (15%)
Query: 133 EFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192
E+ GSL D LY + RI + GL++L H IIHRD++P NVL
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135
Query: 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-VG---YIAPE------CHQTVALSDK 242
++ + + ++ +FG++ + SLA+T +G Y+APE +Q + +
Sbjct: 136 VNGNGQVKLCDFGVSGNL--------VASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ 187
Query: 243 CDIYSFGVLLAVLMMGKFP 261
D++S G+ + + +G++P
Sbjct: 188 SDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
IA G+EYL S+R IHRD+ N ++ +DM +++FGL+K+I +G
Sbjct: 122 IALGMEYL--SNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTS 284
V +IA E + K D+++FGV + + G+ P H E+ ++R+
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EI--YDYLRHGNRL 234
Query: 285 ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ P +D + + C DP++RP +R +L I
Sbjct: 235 KQPEDCLDE-------------LYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 54 NGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
E+ K GS G++ K + I P+ K + E+I +++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHP 59
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSL-------QDILYDVSQGRRELDWLARHRIARGI 166
NIV A +V E+ G L + +L+ Q L W + I
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ---ILSWFVQ------I 110
Query: 167 ASGLEYLHMSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKQIPNGRTRTTTWSLAET 225
+ GL+++H +I+HRDI+ N+ + + M A++ +FG+A+Q+ + + ++ T
Sbjct: 111 SLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGT 165
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
Y++PE Q ++K DI+S G +L L K P
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 24/196 (12%)
Query: 66 SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125
+G+ + +KK+ +L KQ L + +E++ H N+V + +
Sbjct: 46 TGKQVAVKKM--------DLRKQQRREL------LFNEVVIMRDYHHENVVDMYNSYLVG 91
Query: 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRD 185
D +V EF G+L DI V+ R + +IA S L L H +IHRD
Sbjct: 92 DELWVVMEFLEGGALTDI---VTHTR-----MNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 186 IQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDI 245
I+ ++L+ D ++S+FG Q+ + SL T ++APE + + DI
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK--SLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 246 YSFGVLLAVLMMGKFP 261
+S G+++ ++ G+ P
Sbjct: 202 WSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 30/91 (32%), Positives = 47/91 (51%)
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
+H H +IHRDI+ AN+L+ + ++ +FG +K + + T Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 233 CHQTVALSDKCDIYSFGVLLAVLMMGKFPSD 263
+ S K D++S GVLL L+ K P D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 32/197 (16%)
Query: 143 ILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202
+Y+V + + L + IA L YL + IIHRD++P+N+L+D + ++
Sbjct: 95 YVYEVLKSVIPEEILGK--IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLC 150
Query: 203 EFGLAKQIPNGRTRTTTWSLAETVG-----YIAPECHQTVALSD---KCDIYSFGVLLAV 254
+FG++ Q+ + S+A+T Y+APE A + D++S G+ L
Sbjct: 151 DFGISGQLVD--------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYE 202
Query: 255 LMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFC 314
+ GKFP + S + V+ + P + E V I C
Sbjct: 203 VATGKFPYPKW------NSVFDQLTQVVKGDPPILSNSE-----EREFSPSFVNFIN-LC 250
Query: 315 TFDDPEERPNSKDVRCM 331
D +RP K++
Sbjct: 251 LIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 70/238 (29%), Positives = 108/238 (45%), Gaps = 47/238 (19%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQI 100
D + +EKI G VYKA + I +KK+ ++Q+ E + I+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKAR-DRVTNETIALKKI---------RLEQEDEGVPSTAIR- 50
Query: 101 QSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR- 159
EI +++H NIV L V LV+E+ + D+ + A+
Sbjct: 51 --EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY--------LDLDLKKHMDSSPDFAKN 100
Query: 160 HRIARG----IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKQ--IPN 212
R+ + I G+ Y H SHR ++HRD++P N+LID A ++++FGLA+ IP
Sbjct: 101 PRLIKTYLYQILRGIAYCH-SHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156
Query: 213 GRTRTTTWSLAETVGYIAPE-----CHQTVALSDKCDIYSFGVLLAVLMMGK--FPSD 263
RT T + T+ Y APE H S DI+S G + A ++ K FP D
Sbjct: 157 --VRTFTHEVV-TLWYRAPEILLGSRH----YSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
+V EF NG L + L QG+ D L + + + G+EYL R IHRD+
Sbjct: 76 IVTEFMENGCLLNYLRQ-RQGKLSKDMLLS--MCQDVCEGMEYLE---RNSFIHRDLAAR 129
Query: 190 NVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFG 249
N L+ ++S+FG+ + + + T++ V + PE S K D++SFG
Sbjct: 130 NCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFG 188
Query: 250 VLL-AVLMMGKFP 261
VL+ V GK P
Sbjct: 189 VLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 36/219 (16%)
Query: 55 GEVYKAELPG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G V++A PG T+ V + LK EA Q Q E + H
Sbjct: 19 GRVFQARAPGLLPYEPFTMVAV-KMLKEEASADMQA---------DFQREAALMAEFDHP 68
Query: 114 NIVPLLA--RVVRPDCDLLVYEFRRNGSLQDILYDVS------------------QGRRE 153
NIV LL V +P C L++E+ G L + L S
Sbjct: 69 NIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 154 LDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG 213
L + IA+ +A+G+ YL S R + +HRD+ N L+ ++M +I++FGL++ I +
Sbjct: 127 LSCTEQLCIAKQVAAGMAYL--SER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 214 RTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+ + A + ++ PE + + D++++GV+L
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+ +EKI G VYK +G+++ +KK+ L+SE E + +
Sbjct: 2 YTKIEKIGEGTYGVVYKGR-NKKTGQIVAMKKI--RLESEEEGVPSTA----------IR 48
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR---RELDWLAR 159
EI +++H NIV L +++ L++EF + L+ L + +G+ EL
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEF-LSMDLKKYLDSLPKGQYMDAELVKSYL 107
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ--IPNGRTRT 217
++I +GI H R++HRD++P N+LID+ ++++FGLA+ IP R
Sbjct: 108 YQILQGIL-------FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VRV 157
Query: 218 TTWSLAETVGYIAPECHQTVAL-----SDKCDIYSFGVLLA 253
T + T+ Y APE V L S DI+S G + A
Sbjct: 158 YTHEVV-TLWYRAPE----VLLGSPRYSTPVDIWSIGTIFA 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 45/221 (20%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY+A +SG ++ +KKV + + E +D P I EI +RH N
Sbjct: 21 GIVYRAR-DTTSGEIVALKKV----RMDNE---RDGIP-----ISSLREITLLLNLRHPN 67
Query: 115 IVPLLARVV--RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
IV L VV D LV E+ L +L ++ E + + GL+Y
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSES---QVKCLMLQLLRGLQY 123
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI---PNGRTRT--TTWSLAETVG 227
LH + IIHRD++ +N+L+ D +I++FGLA+ T T W
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW------- 173
Query: 228 YIAPEC-----HQTVALSDKCDIYSFGVLLAVLMMGK--FP 261
Y APE T A+ D+++ G +LA L+ K P
Sbjct: 174 YRAPELLLGCTTYTTAI----DMWAVGCILAELLAHKPLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VYKA+ + KVI+ KSE EL M++I EI+ H
Sbjct: 26 GKVYKAK--NKETGALAAAKVIET-KSEEEL--------EDYMVEI--EILAT--CNHPY 70
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV LL ++ EF G++ I+ ++ +G E I R + L+YLH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI---QVICRQMLEALQYLH 127
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+IIHRD++ NVL+ D + ++++FG++ + N +T S T ++APE
Sbjct: 128 SM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPYWMAPEVV 182
Query: 235 QTVALSD-----KCDIYSFGVLL 252
+ D K DI+S G+ L
Sbjct: 183 MCETMKDTPYDYKADIWSLGITL 205
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 38/128 (29%), Positives = 65/128 (50%), Gaps = 7/128 (5%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
L+ EF +GSL++ L + + +++ + + A I G++YL + +HRD+
Sbjct: 85 LIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAAR 138
Query: 190 NVLIDDDMEARISEFGLAKQIPNGRTRTTTW-SLAETVGYIAPECHQTVALSDKCDIYSF 248
NVL++ + + +I +FGL K I + T L V + APEC D++SF
Sbjct: 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF 198
Query: 249 GVLLAVLM 256
GV L L+
Sbjct: 199 GVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 27/182 (14%)
Query: 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL-----------YDVSQGRREL----D 155
+H+NI+ LL + ++ E+ G+L++ L Y+ +Q E D
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 156 WLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT 215
++ A +A G+EYL + IHRD+ NVL+ +D +I++FGLA+ I +
Sbjct: 142 LVS---CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 195
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMG-----KFPSDDFFQHT 269
T + V ++APE + + D++SFGVLL + +G P ++ F+
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255
Query: 270 KE 271
KE
Sbjct: 256 KE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 59/201 (29%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR--TTTWSLA 223
I GL+Y+H + IIHRD++P+N+ +++D E +I +FGLA+ + T T W
Sbjct: 129 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW--- 182
Query: 224 ETVGYIAPEC-------HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQH------ 268
Y APE +QTV DI+S G ++A L+ G+ FP D
Sbjct: 183 ----YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232
Query: 269 ---TKEMSFVQWM-----RNVMTS--ENPSRTIDSKLIGNGYE-----EQMLLV------ 307
T ++ + RN + S + P + IG E+ML++
Sbjct: 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 292
Query: 308 -----LKIACFCTFDDPEERP 323
L A F + DP++ P
Sbjct: 293 TAAQALAHAYFAQYHDPDDEP 313
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
Q+E + H NI+ + ++V E+ G+L + + + L L
Sbjct: 46 AQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSL--LDE 100
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DMEARISEFGLAKQIPNGRTRTT 218
I L LH H I+HRD++ N+L+D M +I +FG++K + +++
Sbjct: 101 DTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSK 157
Query: 219 TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+++ T YI+PE + + K DI++ G +L
Sbjct: 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 18/149 (12%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRI--ARGIASGLEYLHMSHRPRIIHRDIQ 187
V E+ G D++Y + Q R + H + A IA GL +LH II+RD++
Sbjct: 78 FVMEYVNGG---DLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLK 128
Query: 188 PANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYS 247
NV++D + +I++FG+ K+ N TT + T YIAPE D ++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 248 FGVLLAVLMMGKFP-----SDDFFQHTKE 271
FGVLL ++ G+ P D+ FQ E
Sbjct: 187 FGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-09
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 38/221 (17%)
Query: 55 GEVYKA---ELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
G+V KA L G +G K+++ S +EL + SE QV
Sbjct: 14 GKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR------------DLLSEFNLLKQVN 61
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL--------------------YDVSQGR 151
H +++ L + LL+ E+ + GSL+ L Y +
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 152 RELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP 211
R L A I+ G++YL +++HRD+ NVL+ + + +IS+FGL++ +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 212 NGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+ V ++A E + + D++SFGVLL
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 219
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 85 LIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP--LLARVVRPDCDLLVYEFRRNGSLQD 142
L+++ + ++ M ++ E+I A + +L P L Y F+ + L
Sbjct: 13 LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 72
Query: 143 ILYDVSQGRRELDWLARHRI-----AR----GIASGLEYLHMSHRPRIIHRDIQPANVLI 193
++ + + G L+R R+ AR I S LEYLH +++RDI+ N+++
Sbjct: 73 VM-EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLML 128
Query: 194 DDDMEARISEFGLAKQ-IPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
D D +I++FGL K+ I +G T T E Y+APE + D + GV++
Sbjct: 129 DKDGHIKITDFGLCKEGISDGATMKTFCGTPE---YLAPEVLEDNDYGRAVDWWGLGVVM 185
Query: 253 AVLMMGKFPSDDFFQHTKEMSF 274
+M G+ P F+ E F
Sbjct: 186 YEMMCGRLP---FYNQDHERLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
A IA GL +LH II+RD++ NV++D + +I++FG+ K+ N TT +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE--NIFGGKTTRTF 161
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSD 263
T YIAPE D ++FGVLL ++ G+ P D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 31/220 (14%)
Query: 54 NGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
+ K + + ++ +KK+ L E + +Q EIIT+ Q++H
Sbjct: 15 IVHLAKHK---PTNTLVAVKKI--------NLDSCSKE----DLKLLQQEIITSRQLQHP 59
Query: 114 NIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDV-SQGRRELDWLARHRIARGIASGLE 171
NI+P + + D +L +V GS +D+L +G E LA I + + + L+
Sbjct: 60 NILPYVTSFIV-DSELYVVSPLMAYGSCEDLLKTHFPEGLPE---LAIAFILKDVLNALD 115
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTT-----TWSLAETV 226
Y+H IHR ++ +++L+ D + +S + + R S + +
Sbjct: 116 YIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 227 GYIAPECHQTVAL--SDKCDIYSFGVLLAVLMMGKFPSDD 264
+++PE Q ++K DIYS G+ L G P D
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 19/102 (18%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA-KQIPNGRTRTTTWSLAE 224
I GL+YLH + I+HRDI+P N+L++ + +I +FGLA + P+ T E
Sbjct: 112 ILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT----QE 164
Query: 225 TVG--YIAPEC-----HQTVALSDKCDIYSFGVLLAVLMMGK 259
V Y APE H T A+ DI+S G + A L+ +
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 12/92 (13%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
++ G++YL ++ +HRD+ NVL+ A+IS+FGL+K + + A+T
Sbjct: 104 VSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL----GADENYYKAKT 156
Query: 226 VG-----YIAPECHQTVALSDKCDIYSFGVLL 252
G + APEC S K D++SFGVL+
Sbjct: 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+V +A G S +K ++ LK A + E L ++ +I S + G H N
Sbjct: 49 GKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSEL-KIMSHL---GN--HEN 100
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV LL L++ E+ G L + L + L+ L + +A G+ +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS--FSYQVAKGMAFLA 158
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE-- 232
+ IHRD+ NVL+ +I +FGLA+ I N + V ++APE
Sbjct: 159 SKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 233 --CHQTVALSDKCDIYSFGVLL 252
C T + D++S+G+LL
Sbjct: 216 FNCVYTF----ESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 59/248 (23%)
Query: 112 HRNIVPLLARVV--RPDCDLLVYEFRRNGSLQDI-LYDVSQGRRELDWLARHRIARGIAS 168
H NI+ L+ + + LV+E L D+ LY++ +GR+ L R+ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFE------LMDMNLYELIKGRKRP--LPEKRVKSYMYQ 108
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI----PNGRTRTTTWSLAE 224
L+ L HR I HRDI+P N+LI DD ++++FG + I P +T W
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRW---- 163
Query: 225 TVGYIAPECHQTVALSD-----KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279
Y APEC L+D K DI++ G + ++ FP F T E+ + +
Sbjct: 164 ---YRAPEC----LLTDGYYGPKMDIWAVGCVF-FEILSLFP---LFPGTNELDQIAKIH 212
Query: 280 NVMTS--------ENPSRTID-----------SKLIGNGYEEQMLLVLKIACFCTFDDPE 320
+V+ + SR ++ KL+ N E + L+ K+ + DP+
Sbjct: 213 DVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKL---LAY-DPD 268
Query: 321 ERPNSKDV 328
ER +K
Sbjct: 269 ERITAKQA 276
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 31/105 (29%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
++ I L YL H +IHRD++P+N+L+D ++ +FG++ ++ + + +T +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS- 174
Query: 221 SLAETVGYIAPECHQTVALSDKCDI----YSFGVLLAVLMMGKFP 261
A Y+APE + K DI +S G+ L L G+FP
Sbjct: 175 --AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 9/134 (6%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
V EF G D+++ + + R+ + AR A + L+ H II+RD++
Sbjct: 73 FVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHERGIIYRDLKLD 125
Query: 190 NVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFG 249
NVL+D + +++++G+ K+ R TT + T YIAPE + D ++ G
Sbjct: 126 NVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 183
Query: 250 VLLAVLMMGKFPSD 263
VL+ +M G+ P D
Sbjct: 184 VLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDW-LARHRI-----AR----GIA 167
+L P L Y F+ + L ++ + G EL + L+R R+ AR I
Sbjct: 48 VLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAEIV 105
Query: 168 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ-IPNGRTRTTTWSLAETV 226
S L YLH +++RD++ N+++D D +I++FGL K+ I +G T T T
Sbjct: 106 SALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTP 159
Query: 227 GYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274
Y+APE + D + GV++ +M G+ P F+ E F
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
++ H +V L LV+EF +G L D L R + + +
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCE 111
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
G+ YL S+ +IHRD+ N L+ ++ ++S+FG+ + + + + ++T + V +
Sbjct: 112 GMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT-KFPVKW 167
Query: 229 IAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDD 264
+PE S K D++SFGVL+ V GK P ++
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 85 LIKQDSEPLHHKMIQIQSEIITA-GQVRH---RNIVPLLARVVRPDCDLLVYEFRRNGSL 140
L+K+ + ++ M ++ E+I A +V H N V L P L Y F+ + L
Sbjct: 13 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV--LQNSRHPFLTALKYSFQTHDRL 70
Query: 141 QDILYDVSQGRRELDWLARHRI-----AR----GIASGLEYLHMSHRPRIIHRDIQPANV 191
++ + + G L+R R+ AR I S L+YLH +++RD++ N+
Sbjct: 71 CFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENL 127
Query: 192 LIDDDMEARISEFGLAKQ-IPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGV 250
++D D +I++FGL K+ I +G T T E Y+APE + D + GV
Sbjct: 128 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE---YLAPEVLEDNDYGRAVDWWGLGV 184
Query: 251 LLAVLMMGKFPSDDFFQHTKEMSF 274
++ +M G+ P F+ E F
Sbjct: 185 VMYEMMCGRLP---FYNQDHEKLF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 30/107 (28%), Positives = 44/107 (41%), Gaps = 27/107 (25%)
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI------------------PNGR 214
L H+ IHRDI+P N+LID D ++++FGL K++ +
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 215 TRTTTW---------SLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
S T YIAPE + +CD +S GV+L
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 21/171 (12%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
IASG+EYL IHRD+ N +++++M +++FGL+K+I NG
Sbjct: 121 IASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTS 284
V +IA E + K D++SFGV + + G+ P + + ++R
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP----YPGVENSEIYDYLRQGNRL 233
Query: 285 ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ P +D L L +C+ +P++RP+ + +RC L +
Sbjct: 234 KQPPDCLDG-----------LYSLMSSCWLL--NPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 43/184 (23%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 88 QDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD- 146
+D+ K ++E++T ++H +IV V D ++V+E+ ++G L L
Sbjct: 44 KDASDNARKDFHREAELLT--NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAH 101
Query: 147 ------VSQGR--RELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198
+++G EL IA+ IA+G+ YL H +HRD+ N L+ +++
Sbjct: 102 GPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158
Query: 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMM 257
+I +FG+++ + + + ++ PE + + D++S GV+L +
Sbjct: 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 218
Query: 258 GKFP 261
GK P
Sbjct: 219 GKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 64 GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH----RNIVPLL 119
GS G+V+ K K D + K++Q + I+ + +H RN+ LL
Sbjct: 6 GSFGKVLLAKH------------KADGKFYAVKVLQ-KKAILKKKEQKHIMAERNV--LL 50
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQG------RRELDWL-ARHRI-ARGIASGLE 171
V P L Y F+ L +L V+ G +RE + R R A IAS L
Sbjct: 51 KNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG 110
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
YLH II+RD++P N+L+D +++FGL K+ T+T+ T Y+AP
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF--CGTPEYLAP 165
Query: 232 ECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFF-QHTKEM 272
E + D + G +L ++ G P F+ + T EM
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP---FYSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 110 VRHRNIVPLLARVVRPDCDL-------LVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 162
V H+NI+ LL V P L LV E Q I D+ R + +L +
Sbjct: 72 VNHKNIIGLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER--MSYLLYQML 128
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
G+++LH + IIHRD++P+N+++ D +I +FGLA RT T++ +
Sbjct: 129 C-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMM 174
Query: 223 AETV---GYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
V Y APE + + DI+S G ++ ++ G FP D
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 55 GEVYKAE-LPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G VYKA+ G G+ IKK + K + I Q + EI +++H
Sbjct: 14 GRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSA----------CREIALLRELKHE 62
Query: 114 NIVPLLARVVRPDCDL---LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
N+V L+ V D L++++ + Q I + R + + I +G+
Sbjct: 63 NVVSLV-EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEAR----ISEFGLAK 208
YLH + ++HRD++PAN+L+ + R I + GLA+
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 85 LIKQDSEPLHHKMIQIQSEIITA-GQVRHRNIVPLLARVVR-PDCDLLVYEFRRNGSLQD 142
L+++ + ++ M ++ E+I A +V H + + R P L Y F+ L
Sbjct: 13 LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCF 72
Query: 143 ILYDVSQGRRELDW-LARHRI---------ARGIASGLEYLHMSHRPRIIHRDIQPANVL 192
++ V+ G EL + L+R R+ I S L+YLH +I++RD++ N++
Sbjct: 73 VMEYVNGG--ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLM 127
Query: 193 IDDDMEARISEFGLAKQ-IPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVL 251
+D D +I++FGL K+ I + T T E Y+APE + D + GV+
Sbjct: 128 LDKDGHIKITDFGLCKEGITDAATMKTFCGTPE---YLAPEVLEDNDYGRAVDWWGLGVV 184
Query: 252 LAVLMMGKFPSDDFFQHTKEMSF 274
+ +M G+ P F+ E F
Sbjct: 185 MYEMMCGRLP---FYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 37/114 (32%), Positives = 59/114 (51%), Gaps = 10/114 (8%)
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
A I+ GL +LH R II+RD++ NV++D + +I++FG+ K+ + TT +
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTF 161
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP-----SDDFFQHTKE 271
T YIAPE D +++GVLL ++ G+ P D+ FQ E
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 26/170 (15%)
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWS 221
I R + L+Y+H +IHRDI+ AN+L+ + ++ +FG+A + ++ +T
Sbjct: 106 IIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-- 160
Query: 222 LAETVGYIAPECHQTVALSD-KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280
T ++APE D K DI+S G+ + + G P S V R
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP----------YSDVDAFRA 210
Query: 281 VM--TSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+M P R L NGY + + + C ++P+ER +++++
Sbjct: 211 MMLIPKSKPPR-----LEDNGYSKLL---REFVAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 41/210 (19%)
Query: 68 RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDC 127
R + IKK+ +P +++ H K + E++ V H+NI+ LL V P
Sbjct: 43 RNVAIKKLSRPFQNQT----------HAK--RAYRELVLMKCVNHKNIISLL-NVFTPQK 89
Query: 128 DL-------LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPR 180
L LV E Q I + ELD + + G+++LH +
Sbjct: 90 SLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHSAG--- 139
Query: 181 IIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETV---GYIAPECHQTV 237
IIHRD++P+N+++ D +I +FGLA RT T++ + V Y APE +
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 238 ALSDKCDIYSFGVLLAVLMMGK--FPSDDF 265
+ DI+S G ++ ++ K FP D+
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 41/210 (19%)
Query: 68 RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDC 127
R + IKK+ +P +++ H K + E++ V H+NI+ LL V P
Sbjct: 50 RNVAIKKLSRPFQNQT----------HAK--RAYRELVLMKCVNHKNIIGLL-NVFTPQK 96
Query: 128 DL-------LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPR 180
L +V E Q I + ELD + + G+++LH +
Sbjct: 97 SLEEFQDVYIVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHSAG--- 146
Query: 181 IIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETV---GYIAPECHQTV 237
IIHRD++P+N+++ D +I +FGLA RT T++ + V Y APE +
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 238 ALSDKCDIYSFGVLLAVLMMGK--FPSDDF 265
+ DI+S G ++ ++ G FP D
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 35/171 (20%)
Query: 110 VRHRNIVPLLARVVR-PDCDLLVYEFRRNGSLQDILYDVSQG---------RRELDWLAR 159
+ H+NI+P+L + + ++Y + G+L+ L G ++L +A
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-PN------ 212
IA G+ YLH + +IH+DI N +ID++++ +I++ L++ + P
Sbjct: 125 Q-----IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 213 -GRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLM-MGKFP 261
R W +A E S D++SFGVLL LM +G+ P
Sbjct: 177 DNENRPVKW--------MALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 42/140 (30%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
LV E GS+ +++ + + LD I G GL++LH + RIIHRD++
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGN 157
Query: 190 NVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVG---YIAPE---CHQTVALS--D 241
N+L+ + ++ +FG++ Q+ + R R T +VG ++APE C Q S
Sbjct: 158 NILLTTEGGVKLVDFGVSAQLTSTRLRRNT-----SVGTPFWMAPEVIACEQQYDYSYDA 212
Query: 242 KCDIYSFGVLLAVLMMGKFP 261
+CD++S G+ L G P
Sbjct: 213 RCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 65 SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124
+ G++I +K+V EL + + ++Q E+ ++H NIV L +
Sbjct: 22 NQGQLIAVKQV--------ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD 73
Query: 125 PDCDLLVY-EFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183
D + ++ EF GS+ IL L + + I G+ YLH + ++H
Sbjct: 74 -DNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC---VVH 125
Query: 184 RDIQPANVLIDDDMEARISEFGLAKQIP----NGRTRTTTWSLAETVGYIAPECHQTVAL 239
RDI+ NV++ + ++ +FG A+++ +G S+ T ++APE
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185
Query: 240 SDKCDIYSFGVLLAVLMMGKFP 261
K DI+S G + + GK P
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 24/199 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV+K L + + +K + L E + I+ SE Q H N
Sbjct: 9 GEVFKGTLKDKTP--VAVKTCKEDLPQELK-------------IKFLSEARILKQYDHPN 53
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L+ + +V E G D L + + + EL + A A+G+ YL
Sbjct: 54 IVKLIGVCTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE 110
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-VGYIAPEC 233
+ IHRD+ N L+ ++ +IS+FG+++Q +G ++ L + + + APE
Sbjct: 111 SKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS--GLKQIPIKWTAPEA 165
Query: 234 HQTVALSDKCDIYSFGVLL 252
S + D++S+G+LL
Sbjct: 166 LNYGRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 9/135 (6%)
Query: 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188
LV E+ G D+++ + + R+ + AR A I L +LH II+RD++
Sbjct: 72 FLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAE-ICIALNFLH---ERGIIYRDLKL 124
Query: 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSF 248
NVL+D D +++++G+ K+ TT + T YIAPE + D ++
Sbjct: 125 DNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182
Query: 249 GVLLAVLMMGKFPSD 263
GVL+ +M G+ P D
Sbjct: 183 GVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 34/173 (19%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+ LEKI G V+KA+ + ++ +K+V L + E + S L
Sbjct: 2 YEKLEKIGEGTYGTVFKAK-NRETHEIVALKRV--RLDDDDEGVP--SSALR-------- 48
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDI--LYDVSQGRRELDWLAR 159
EI +++H+NIV L V+ D L LV+E+ QD+ +D G ++D
Sbjct: 49 EICLLKELKHKNIV-RLYDVLHSDKKLTLVFEY----CDQDLKKYFDSCNG--DID---- 97
Query: 160 HRIARG----IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208
I + + GL + H SH ++HRD++P N+LI+ + E ++++FGLA+
Sbjct: 98 PEIVKSFMFQLLKGLAFCH-SHN--VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 52/238 (21%), Positives = 102/238 (42%), Gaps = 44/238 (18%)
Query: 101 QSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 160
+EI+ ++H NI+ + + L+ E+ G+L D + E + + +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
I S + Y+H + I+HRDI+ N+ + ++ +FG++K + + +
Sbjct: 107 LFQ--IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL------GSEY 155
Query: 221 SLAET-VG---YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276
S+AET VG Y++PE Q V + K DI++ G +L L+
Sbjct: 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT------------------- 196
Query: 277 WMRNVMTSENPSRTIDSKLIGN------GYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
++ + NP + + GN Y +++ ++ DPE+RP + +V
Sbjct: 197 -LKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS---LLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 35/112 (31%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
GL+Y+H + IIHRD++P N+ +++D E +I +FGLA+ + AE GY
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH-----------ADAEMTGY 174
Query: 229 I------APEC-------HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDF 265
+ APE +QTV DI+S G ++A ++ GK F D+
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTV------DIWSVGCIMAEMLTGKTLFKGKDY 220
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARG-IASGLEYLHMSHRPRIIHRDIQP 188
L+ ++ G L LY +RE + R+ I L++LH + II+RDI+
Sbjct: 82 LILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKL 133
Query: 189 ANVLIDDDMEARISEFGLAKQ-IPNGRTRTTTWSLAETVGYIAPEC--HQTVALSDKCDI 245
N+L+D + +++FGL+K+ + R +S T+ Y+APE + D
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191
Query: 246 YSFGVLLAVLMMG--KFPSDDFFQHTKEMSFVQWMRNVMTSENP 287
+S GVL L+ G F D E+S R ++ S+ P
Sbjct: 192 WSLGVLTFELLTGASPFTVDGEQNSQSEIS-----RRILKSKPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 12/133 (9%)
Query: 142 DILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201
++ Y + + R L+ AR A IAS L YLH + I++RD++P N+L+D +
Sbjct: 82 ELFYHLQRERCFLEPRARFYAAE-IASALGYLHSLN---IVYRDLKPENILLDSQGHIVL 137
Query: 202 SEFGLAKQ--IPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK 259
++FGL K+ NG TT + T Y+APE D + G +L ++ G
Sbjct: 138 TDFGLCKENIEHNG----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 193
Query: 260 FPSDDFFQHTKEM 272
P + ++T EM
Sbjct: 194 PPF--YSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 45/229 (19%)
Query: 70 ITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDL 129
+ +KK+ +P +++ H K + E++ V H+NI+ LL V P L
Sbjct: 49 VAVKKLSRPFQNQT----------HAK--RAYRELVLLKCVNHKNIISLL-NVFTPQKSL 95
Query: 130 -------LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRII 182
LV E Q I ++ R + +L + G+++LH + II
Sbjct: 96 EEFQDVYLVMELMDANLCQVIHMELDHER--MSYLLYQ-----MLCGIKHLHSAG---II 145
Query: 183 HRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETV---GYIAPECHQTVAL 239
HRD++P+N+++ D +I +FGLA RT T + + V Y APE +
Sbjct: 146 HRDLKPSNIVVKSDCTLKILDFGLA------RTACTNFMMTPYVVTRYYRAPEVILGMGY 199
Query: 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS 288
+ DI+S G ++ L+ G FQ T + QW + + PS
Sbjct: 200 KENVDIWSVGCIMGELVKGSV----IFQGTDHID--QWNKVIEQLGTPS 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VYKA+ V+ KVI KSE EL M++I +I+ + H N
Sbjct: 19 GKVYKAQ--NKETGVLAAAKVIDT-KSEEEL--------EDYMVEI--DILAS--CDHPN 63
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV LL + ++ EF G++ ++ ++ + L +I LE L+
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP------LTEPQIRVVCKQTLEALN 117
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
H +IIHRD++ N+L D + ++++FG++ + N RT S T ++APE
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVV 175
Query: 235 QTVALSD-----KCDIYSFGVLL 252
D K D++S G+ L
Sbjct: 176 MCETSKDRPYDYKADVWSLGITL 198
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 48/189 (25%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
R + +A G+++L + IHRD+ NVL+ D A+I +FGLA+ I N
Sbjct: 216 RFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 221 SLAETVGYIAPE----CHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQHTKEMSFV 275
+ V ++APE C TV + D++S+G+LL + +GK P
Sbjct: 273 NARLPVKWMAPESIFDCVYTV----QSDVWSYGILLWEIFSLGKSPY------------- 315
Query: 276 QWMRNVMTSENPSRTIDSK---LIGNGYEEQM-------LLVLKIACFCTFDDPEERPNS 325
P ++SK ++ GY QM + I C +P ERP
Sbjct: 316 -----------PGILVNSKFYKMVKRGY--QMSRPDFAPPEIYSIMKMCWNLEPTERPTF 362
Query: 326 KDVRCMLSQ 334
+ ++ +
Sbjct: 363 SQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 38/201 (18%)
Query: 106 TAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR------RE---LDW 156
TA RNI L V P L+Y F+ G L IL +S G RE ++
Sbjct: 44 TAHTKAERNI---LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMED 100
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR 216
A ++ I+ LE+LH + II+RD++P N+L+D ++++FGL K+ + T
Sbjct: 101 TACFYLSE-ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156
Query: 217 TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276
T T+ T+ Y+APE D +S G L+ ++ G P
Sbjct: 157 THTF--CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP--------------- 199
Query: 277 WMRNVMTSENPSRTIDSKLIG 297
T+EN +TID L G
Sbjct: 200 -----FTAENRKKTIDKILKG 215
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 49/173 (28%), Positives = 86/173 (49%), Gaps = 26/173 (15%)
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDW-LAR-- 159
EI +++H NIV L + + +LV+E+ + L+ + D R LD +
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYM-DTHGVRGALDPNTVKSF 105
Query: 160 -HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTT 218
+++ +GIA H R++HRD++P N+LI+ E ++++FGLA+ G T
Sbjct: 106 TYQLLKGIA-------FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNT 156
Query: 219 TWSLAETVGYIAPECHQTVAL-----SDKCDIYSFGVLLAVLMMGK--FPSDD 264
+ T+ Y AP+ V L S DI+S G ++A ++ G+ FP +
Sbjct: 157 FSNEVVTLWYRAPD----VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 64 GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH----RNIVPLL 119
GS GRVI A +D P+ K + +S+II QV H R I L
Sbjct: 41 GSFGRVIL-----------ATYKNEDFPPVAIKRFE-KSKIIKQKQVDHVFSERKI---L 85
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR---------IARGIASGL 170
+ P C L F+ L +L V G +L R++ A I
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF-FTFLRRNKRFPNDVGCFYAAQIVLIF 144
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
EYL + I++RD++P N+L+D D ++++FG AK + T T++L T YIA
Sbjct: 145 EYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIA 196
Query: 231 PECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
PE V D ++ G+ + +++G P
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 54 NGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
N E+ K G+ G+V ++KV + +K + K +Q R
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMK-----VLQKAALVQKAKTVEHTRTER 55
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG-------RRELDWLARHRIARG- 165
N++ + + P L Y F+ L IL VS G +R+ R G
Sbjct: 56 NVLEHVRQ--SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE 113
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I LE+LH + I++RDI+ N+L+D + +++FGL+K+ + + T+S T
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYSFCGT 169
Query: 226 VGYIAPECHQTVALSDKC-DIYSFGVLLAVLMMGKFP 261
+ Y+APE + K D +S G+L+ L+ G P
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 31/181 (17%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI---PNGRTRTTTWSLAET 225
GL+Y+H ++ +IHRD++P+N+L+++D E RI +FG+A+ + P T +A T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-T 174
Query: 226 VGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGK---FPSDDFFQHTKEMSFV-----Q 276
Y APE ++ + D++S G + A M+G+ FP ++ K + V +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAE-MLGRRQLFPGKNYVHQLKLILSVLGSPSE 233
Query: 277 WMRNVMTSENPSRTID----------SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326
+ N + S+ + I SK+ E + L+ ++ F DPEER +
Sbjct: 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF----DPEERITVE 289
Query: 327 D 327
Sbjct: 290 Q 290
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 24/113 (21%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWS-LAETV- 226
GL+Y+H ++ ++HRD++P+N+L++ + + +I +FGLA RT + + E V
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA------RTTSEKGDFMTEYVV 170
Query: 227 --GYIAPE-----CHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTK 270
Y APE T A+ D++S G + A L+ K FP D+ K
Sbjct: 171 TRWYRAPELLLNCSEYTTAI----DVWSVGCIFAELLGRKPLFPGKDYVHQLK 219
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 12/139 (8%)
Query: 134 FRRNGSLQDILYDVSQGRRELDWLARH-------RIARGIASGLEYLHMSHRPRIIHRDI 186
FRR G L + V + EL L ++ I ++ +H H+ I+HRDI
Sbjct: 69 FRRRGKLYLVFEYVEKNMLEL--LEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDI 126
Query: 187 QPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIY 246
+P N+LI + ++ +FG A+ + G T +A T Y +PE D++
Sbjct: 127 KPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPELLLGAPYGKAVDMW 185
Query: 247 SFGVLLAVLMMGK--FPSD 263
S G +L L G+ FP +
Sbjct: 186 SVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 30/119 (25%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR--------- 216
I GL+Y+H ++ ++HRD++P N+L++ D E +I +FGLA+
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 217 TTTWSLAETVGYIAPECHQTVALSDK-----CDIYSFGVLLAVLMMGK--FPSDDFFQH 268
T W Y APE + LS + D++S G +LA L+ K F D+
Sbjct: 171 ATRW-------YRAPE----IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 9/135 (6%)
Query: 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188
V E+ G D+++ + + R+ + AR A I+ L YLH II+RD++
Sbjct: 72 FFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH---ERGIIYRDLKL 124
Query: 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSF 248
NVL+D + +++++G+ K+ R TT + T YIAPE + D ++
Sbjct: 125 DNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182
Query: 249 GVLLAVLMMGKFPSD 263
GVL+ +M G+ P D
Sbjct: 183 GVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 30 EKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQD 89
++ + F + + L KI GEV+KA + +++ +KKV+ + E I
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKAR-HKKTKQIVALKKVLMENEKEGFPITAL 59
Query: 90 SEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD---------LLVYEFRRN--- 137
E K++Q ++H N+V L+ + R LV+EF +
Sbjct: 60 REI---KILQ---------LLKHENVVNLI-EICRTKATPYNRYKGSFYLVFEFCEHDLA 106
Query: 138 GSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197
G L + + + ++ + + +GL Y+H R +I+HRD++ AN+LI D
Sbjct: 107 GLLSNKNVKFTLSEIK-------KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDG 156
Query: 198 EARISEFGLAK--QIPNGRTRTTTWSLAETVGYIAPE 232
++++FGLA+ + + T+ Y PE
Sbjct: 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 64 GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRHRNIVPLLARV 122
G+ G+V + K+ +++ +P+H +I++E I H N+V
Sbjct: 29 GTYGKVFKVLNKKNGSKAAVKIL----DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 123 VRPDCD-----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH 177
+ D LV E GS+ D++ + ++ I GL++LH++
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVG---YIAPE-- 232
+ IHRD++ N+L+ + ++ +FG++ Q+ + R R T +VG ++APE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-----SVGTPFWMAPEVI 196
Query: 233 -CHQTV--ALSDKCDIYSFGVLLAVLMMGKFPSDDF 265
C Q + +CD++S G+ L G P D
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
+H H+ +HRDI+P NVL+D + R+++FG ++ T ++ ++ T YI+PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVG-TPDYISPE 173
Query: 233 CHQTVALSD-------KCDIYSFGVLLAVLMMGKFP 261
Q A+ D +CD +S GV + ++ G+ P
Sbjct: 174 ILQ--AMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 58/258 (22%), Positives = 104/258 (40%), Gaps = 51/258 (19%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V+ L G+ G++ +K + + E+IK++ + + + EI+ + H
Sbjct: 15 GRVFLVRLKGT-GKLFALKVL-----DKKEMIKRNK--VKR--VLTEQEILAT--LDHPF 62
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+ L A LV ++ G L +L G+ + +AR A + LEYLH
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLSEEVARFYAAE-VLLALEYLH 120
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ--------IPNGRTRTTTWSLAET- 225
+ I++RD++P N+L+ + +S+F L+KQ R + S+
Sbjct: 121 LLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 226 ---------------VG---YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ 267
VG YIAPE D ++ G+LL ++ G P F
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP---FKG 234
Query: 268 HTKEMSFVQWMRNVMTSE 285
++ +F N++ E
Sbjct: 235 SNRDETF----SNILKKE 248
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 45/227 (19%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEVY+ G G + ++ + K+ E + E E + + H+N
Sbjct: 20 GEVYEGLYRGRDGDAVELQVAV---KTLPESCSEQDE------SDFLMEALIMSKFNHQN 70
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIARG 165
IV L+ ++ E G L+ L + R D L AR
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFL---RENRPRPERPSSLTMKDLL---FCARD 124
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDD---DMEARISEFGLAKQI-------PNGRT 215
+A G +YL +H IHRDI N L+ A+I++FG+A+ I GR
Sbjct: 125 VAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+ ++ PE + K D++SFGVLL + +G P
Sbjct: 182 MLP-------IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 14/170 (8%)
Query: 98 IQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILY---DVSQGRREL 154
++ E + + H ++V LL + P L V + +G L D ++ D + L
Sbjct: 54 VEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLL 112
Query: 155 DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR 214
+W + IA G+ YL R++HRD+ NVL+ +I++FGLA+ +
Sbjct: 113 NWCVQ------IAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163
Query: 215 TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLM-MGKFPSD 263
+ ++A EC + + D++S+GV + LM G P D
Sbjct: 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 32/98 (32%), Positives = 58/98 (59%), Gaps = 7/98 (7%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
GL+YLH + +I++RD++ N+L+D + +I++FGL K+ RT+T+ T +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF--CGTPEF 167
Query: 229 IAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
+APE + + D + GVL+ +++G+ FP DD
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEVY +GR + +K+V P DS+ ++ ++ EI +RH
Sbjct: 16 GEVYLC-YDADTGRELAVKQV--PFDP-------DSQETSKEVNALECEIQLLKNLRHDR 65
Query: 115 IVPLLARVVRPDCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
IV + P+ L E+ GS++D L + L R R I G+ Y
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSY 121
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPN-GRTRTTTWSLAETVGYIAP 231
LH + I+HRDI+ AN+L D ++ +FG +K+I + T S+ T +++P
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 232 ECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265
E K D++S + ++ K P ++
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 40/146 (27%), Positives = 58/146 (39%), Gaps = 45/146 (30%)
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL---------- 206
LAR IA + +E +H + IHRDI+P N+LID D ++++FGL
Sbjct: 102 LARFYIAE-LTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 207 -------------------AKQIPNGR------------TRTTTWSLAETVGYIAPECHQ 235
+I R R SL T YIAPE
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 236 TVALSDKCDIYSFGVLLAVLMMGKFP 261
+ CD +S GV+L +++G+ P
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 29/175 (16%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
IASG+EYL + IHRD+ N +++++M +++FGL+K+I +G +
Sbjct: 122 IASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTS 284
V ++A E + D+++FGV + ++ G+ P V S
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP----------------YAGVENS 222
Query: 285 ENPSRTIDSKLIGNGYEEQ----MLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
E I + LI +Q + V ++ C C +P+ RP+ + +R L I
Sbjct: 223 E-----IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 34/115 (29%), Positives = 61/115 (53%), Gaps = 29/115 (25%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK----QIPNGRTRT---- 217
I GL+Y+H ++ ++HRD++P+N+L++ + + +I +FGLA+ + + T
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 218 TTWSLAETVGYIAPECHQTVALSDK-----CDIYSFGVLLAVLMMGK--FPSDDF 265
T W Y APE + L+ K DI+S G +LA ++ + FP D+
Sbjct: 172 TRW-------YRAPE----IMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 64 GSSGRVI--TIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITA-GQVRHRNIVPLLA 120
G+ G+VI IKK + + +++K+ + H+ + E++ G H NI+ LL
Sbjct: 13 GNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH--HPNIINLLG 70
Query: 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH------------RIARGIAS 168
+ E+ G+L D L + + H + A +A+
Sbjct: 71 ACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVAT 130
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE-TVG 227
G++YL + IHRD+ NVL+ +++ ++I++FGL++ G ++ V
Sbjct: 131 GMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRLPVR 183
Query: 228 YIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
++A E + K D++SFGVLL ++ +G P
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 23/171 (13%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARG--------IASGLEYLHMSHRPRI 181
L Y F+ + L IL ++ G R R I LE+LH + I
Sbjct: 70 LHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGI 126
Query: 182 IHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSD 241
I+RDI+ N+L+D + +++FGL+K+ +S T+ Y+AP+ V D
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPD---IVRGGD 182
Query: 242 -----KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENP 287
D +S GVL+ L+ G P F ++ S + R ++ SE P
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASP---FTVDGEKNSQAEISRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 18/161 (11%)
Query: 100 IQSEIITAGQVRHRNIVPLLAR---VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 156
++ E++ ++ H+ P + R V + +LV E G L L S + E+
Sbjct: 38 VRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL---SGKKDEITV 94
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG--- 213
+ ++ G++YL + +HRD+ NVL+ + A+IS+FGL+K +
Sbjct: 95 SNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151
Query: 214 -RTRTT-TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+ R+ W L + APEC S + D++S+G+ +
Sbjct: 152 YKARSAGKWPLK----WYAPECINFRKFSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQI 100
+ + L KI G V+K +G+++ IKK ++ SE +P+ K I +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCR-NRETGQIVAIKKFVE---SE-------DDPVIKK-IAL 48
Query: 101 QSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
+ EI Q++H N+V L+ V R L LV+E+ + +L ++ + R +
Sbjct: 49 R-EIRMLKQLKHPNLVNLI-EVFRRKRKLHLVFEYCDH----TVLNELEKNPRGVP---E 99
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
H I + I L+ ++ H+ IHRD++P N+LI + ++ +FG A+ + T
Sbjct: 100 HLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159
Query: 220 WSLAETVGYIAPE 232
+ T Y APE
Sbjct: 160 Y--VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 59/232 (25%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQI 100
D + L +I G VY+A +G ++ +KK +K + E + +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRA-RDKKTGEIVALKK-----------LKMEKEKEGFPITSL 52
Query: 101 QSEIITAGQVRHRNIVPLLARVVRPDCD--LLVYEFRRNGSLQDILYDVSQGRR--ELDW 156
+ EI +++H NIV + VV + D +V E+ + L+ ++ + Q E+
Sbjct: 53 R-EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC 110
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR 216
L ++ G+A H+ H I+HRD++ +N+L+++ +I +FGLA++ +
Sbjct: 111 LM-LQLLSGVA------HL-HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162
Query: 217 TTTWSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FP 261
T L T+ Y APE + L K D++S G + A L+ K FP
Sbjct: 163 YT--QLVVTLWYRAPE----LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWS-LAETVG 227
L+Y+H ++ + HRD++P N+L + D + +I +FGLA+ N W+ T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 228 YIAPE-CHQTVA-LSDKCDIYSFGVLLAVLMMGK--FPSDD 264
Y APE C + + DI+S G + A ++ GK FP +
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 38/137 (27%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-PNGRT--------- 215
IA + + H+ IHRDI+P N+L+D ++S+FGL + + RT
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 216 -----------------RTTTW-----SLA-ETVG---YIAPECHQTVALSDKCDIYSFG 249
+ TW +LA TVG YIAPE + +CD +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 250 VLLAVLMMG--KFPSDD 264
V++ +++G F SD+
Sbjct: 227 VIMYEMLVGYPPFCSDN 243
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 69/294 (23%), Positives = 123/294 (41%), Gaps = 48/294 (16%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E+ F L +I G VY A + V+ +KK + + + K
Sbjct: 20 EEIFVGLHEIGHGSFGAVYFAT-NSHTNEVVAVKK-----------MSYSGKQTNEKWQD 67
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
I E+ Q++H N + ++ LV E+ GS D+L + +E++ A
Sbjct: 68 IIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA- 125
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
I G GL YLH SH +IHRDI+ N+L+ + + ++++FG A +
Sbjct: 126 --ITHGALQGLAYLH-SHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN----- 175
Query: 220 WSLAETVGYIAPECHQTVALSD-----KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274
S T ++APE +A+ + K D++S G+ L K P F M+
Sbjct: 176 -SFVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN----MNA 225
Query: 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ + ++ +++P T+ S + + +C P+ERP S ++
Sbjct: 226 MSALYHIAQNDSP--TLQSNEWTDSFR-------GFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 31/156 (19%)
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR----------HRIA 163
++V LL V L+V E G L+ L + RR ++A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYL----RSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 164 RGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-------PNGRTR 216
IA G+ YL +HRD+ N ++ +D+ +I +FG+ + I G+
Sbjct: 126 AEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 217 TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
V ++APE + + K D++SFGV+L
Sbjct: 183 L-------PVRWMAPESLKDGVFTTKSDVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 39/297 (13%)
Query: 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIIT 106
++I + W G+V E+ +SG + V++ L+ A + +Q ++ E
Sbjct: 1 KEIGNGWFGKVILGEV--NSG-YTPAQVVVKELRVSASVQEQ---------MKFLEEAQP 48
Query: 107 AGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRREL---DWLARHRIA 163
++H N++ L + LLV EF G L+ L S + EL D R+A
Sbjct: 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLR--SCRKAELMTPDPTTLQRMA 106
Query: 164 RGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLA 223
IA GL LH+ H+ IH D+ N L+ D+ +I ++GL+ T L
Sbjct: 107 CEIALGL--LHL-HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW 163
Query: 224 ETVGYIAP----ECHQTVALSDKC---DIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276
+ +IAP E H + + D+ +++S GV + L + S + + E
Sbjct: 164 VPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF--ELGSQPYRHLSDEQVLTY 221
Query: 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333
+R + P + L YE + FC PE+RP++++V +LS
Sbjct: 222 TVRE-QQLKLPKPRLKLPLSDRWYE--------VMQFCWL-QPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 64 GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH----RNIVPLL 119
GS G+V+ K+ K D + K++Q + ++ + +H RN+ LL
Sbjct: 6 GSFGKVLLAKR------------KLDGKCYAVKVLQ-KKIVLNRKEQKHIMAERNV--LL 50
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQG------RRELDW---LARHRIARGIASGL 170
V P L Y F+ L +L V+ G +RE + AR A IAS L
Sbjct: 51 KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE-IASAL 109
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ-IPNGRTRTTTWSLAETVGYI 229
YLH I++RD++P N+L+D +++FGL K+ I T TT E Y+
Sbjct: 110 GYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPE---YL 163
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
APE + + D + G +L ++ G P
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 32/165 (19%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+A G+E+L + R + IHRD+ N+L+ ++ +I +FGLA+ I
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP------SDDFFQHTKEMSFVQWM 278
+ ++APE + + D++SFGVLL + +G P ++F + KE + M
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT---RM 295
Query: 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP 323
R P + I C ++PE+RP
Sbjct: 296 R------APEYATPE-------------IYSIMLDCWHNNPEDRP 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 29/85 (34%), Positives = 52/85 (61%), Gaps = 6/85 (7%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
GL++LH SHR ++HRD++P N+L+ + ++++FGLA+ I + + T S+ T+ Y
Sbjct: 122 GLDFLH-SHR--VVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALT--SVVVTLWY 175
Query: 229 IAPECHQTVALSDKCDIYSFGVLLA 253
APE + + D++S G + A
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFA 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 48/214 (22%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 64 GSSGRVI--TIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121
G+ G+V+ IKK + + + +K+ + H+ + E++ H NI+ LL
Sbjct: 6 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGHHPNIINLLGA 64
Query: 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH------------RIARGIASG 169
L E+ +G+L D L + + + A +A G
Sbjct: 65 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 124
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE-TVGY 228
++YL + + IHRD+ N+L+ ++ A+I++FGL++ G+ ++ V +
Sbjct: 125 MDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPVRW 177
Query: 229 IAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+A E + D++S+GVLL ++ +G P
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+A + +H H+ +HRDI+P NVLID ++++FG A ++ + + + T
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVG-T 166
Query: 226 VGYIAPECHQTVALSDK------CDIYSFGVLLAVLMMGKFP 261
YIAPE T+ K CD +S GV+ ++ G+ P
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 24/85 (28%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 177 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT 236
H R++HRDI+ N+ + + + ++ +FG A+ + + T+ T Y+ PE +
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPPEIWEN 174
Query: 237 VALSDKCDIYSFGVLLAVLMMGKFP 261
+ ++K DI+S G +L L K P
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 50/266 (18%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQI 100
D F + +I G+VYKA +G ++ +KKV L +E E I
Sbjct: 7 DKFDIIGQIGEGTYGQVYKAR-DKDTGELVALKKV--RLDNEKEGFP----------ITA 53
Query: 101 QSEIITAGQVRHRNIVPLLARVVRPDCDL----------LVYEFRRN---GSLQDILYDV 147
EI Q+ HRNIV L V L LV+E+ + G L+ L
Sbjct: 54 IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF 113
Query: 148 SQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207
S+ + + + GL Y H + +HRDI+ +N+L+++ + ++++FGLA
Sbjct: 114 SEDHIK-------SFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLA 163
Query: 208 KQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDK-----CDIYSFGVLLAVLMMGKFPS 262
+ + +R T + T+ Y PE + L ++ D++S G +L L F
Sbjct: 164 RLYNSEESRPYTNKVI-TLWYRPPE----LLLGEERYGPAIDVWSCGCILGEL----FTK 214
Query: 263 DDFFQHTKEMSFVQWMRNVMTSENPS 288
FQ +E++ ++ + + S P+
Sbjct: 215 KPIFQANQELAQLELISRLCGSPCPA 240
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 3e-06
Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 31/202 (15%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLL--VYEFRRNGSLQDILYDVSQGRRELDW 156
Q+ E+ +++H+NIV + R + L + EF G L + + +++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 157 LARHRIARGIASGLEYLH-MSHRP---RIIHRDIQPANVLIDDDME-------------- 198
A I R + L Y H + P R++HRD++P N+ + +
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 199 ---ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC--HQTVALSDKCDIYSFGVLLA 253
A+I +FGL+K I + S T Y +PE H+T + DK D+++ G ++
Sbjct: 178 RPIAKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 254 VLMMGKFP---SDDFFQHTKEM 272
L GK P +++F Q E+
Sbjct: 235 ELCSGKTPFHKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 12/93 (12%)
Query: 177 HRPRIIHRDIQPANVLIDDDMEARISEFG-LAKQIPNGRTRTTTWSLAETVGYIAPECHQ 235
H+ +HRDI+P NVL+D + R+++FG + + +G ++ T YI+PE Q
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVGTPDYISPEILQ 176
Query: 236 TVALSD-------KCDIYSFGVLLAVLMMGKFP 261
A+ D +CD +S GV + ++ G+ P
Sbjct: 177 --AMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 21/163 (12%)
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH-- 160
EI ++++ NI+ LL V D ++ E+ NG L L +RE++ H
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL-----SQREIESTFTHAN 121
Query: 161 -----------RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209
+A IASG++YL + +HRD+ N L+ + +I++FG+++
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRN 178
Query: 210 IPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+ +G + ++A E + D+++FGV L
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 13/97 (13%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE- 224
+A G+EYL + +HRD+ N ++D+ ++++FGLA+ I + +S+
Sbjct: 107 VAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD----KEYYSVHNH 159
Query: 225 -----TVGYIAPECHQTVALSDKCDIYSFGVLLAVLM 256
V ++A E QT + K D++SFGVLL LM
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEVY A P S RV +KK+ + L ++ L + ++ E A + H
Sbjct: 16 GEVYLAYDPVCSRRV-ALKKIREDL--------SENPLLKKRFLR---EAKIAADLIHPG 63
Query: 115 IVPLLARVVRPDCDLLVYE--FRRNGSLQDILYDVSQGRRELDWLARH-------RIARG 165
IVP+ + + D D + Y + +L+ +L V Q LA I
Sbjct: 64 IVPVYS--ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI--------------P 211
I + +EY+H ++HRD++P N+L+ E I ++G A
Sbjct: 122 ICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 212 NGRTRTTT--WSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
N + T + T Y+APE V S+ DIY+ GV+L ++ FP
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 21/214 (9%)
Query: 64 GSSGRVITIKKV----IQPLKS-EAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118
GS G+V+ ++K I LK+ I SE H +E QV IVPL
Sbjct: 4 GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTH-----TLAERTVLAQVNCPFIVPL 58
Query: 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHR 178
P+ LV F G L + + + R AR A + LE LH +
Sbjct: 59 KFSFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAE-LLCALENLH---K 111
Query: 179 PRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA 238
+I+RD++P N+L+D + +FGL K N + T + T Y+APE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 239 LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272
+ D ++ GVLL ++ G P D ++ EM
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYD--ENVNEM 201
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 177 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT 236
H IHRD++P N LID ++++FGL+K I T S+ + Y+APE +
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVVGSPDYMAPEVLRG 172
Query: 237 VALSDKCDIYSFGVLLAVLMMGKFP 261
D +S G +L + G FP
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCG-FP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 162
E+ ++H NIV L + C LV+E+ + L+ L + + ++ H +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG------NLMSMHNV 105
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL--AKQIPNGRTRTTTW 220
+ L L H+ +I+HRD++P N+LI++ E ++++FGL AK +P T T+
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-----TKTY 160
Query: 221 S-LAETVGYIAPEC-HQTVALSDKCDIYSFGVLLAVLMMGK--FP 261
S T+ Y P+ + S D++ G +L + G+ FP
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 41/165 (24%), Positives = 63/165 (38%), Gaps = 40/165 (24%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
L+ EF G + +L + D L IA + + H+ IHRDI+P
Sbjct: 78 LIMEFLPGGDMMTLLM-------KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPD 130
Query: 190 NVLIDDDMEARISEFGLAK------------------------QIPNGRTRTTTW----- 220
N+L+D ++S+FGL Q N + + TW
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190
Query: 221 ----SLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
S T YIAPE + CD +S GV++ +++G P
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 35/118 (29%), Positives = 51/118 (43%), Gaps = 33/118 (27%)
Query: 177 HRPRIIHRDIQPANVLIDDDMEARISEFGLAK------------------------QIPN 212
H+ IHRDI+P N+L+D ++S+FGL Q N
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 213 GRTRTTTW-----SLA-ETVG---YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
+ + TW LA TVG YIAPE + CD +S GV++ +++G P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 41/165 (24%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 98 IQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 157
IQ+++EI+ G++ H NI+ + ++R + + + + + L +YD DW
Sbjct: 208 IQLENEILALGRLNHENILKI-EEILRSEANTYMITQKYDFDLYSFMYD-----EAFDWK 261
Query: 158 AR------HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP 211
R I + + +EY+H ++IHRDI+ N+ ++ D + + +FG A
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 212 NGRT-RTTTWSLAETVGYIAPECHQTVALSDKC---DIYSFGVLL 252
R W VG +A + +A C DI+S G++L
Sbjct: 319 KEREAFDYGW-----VGTVATNSPEILAGDGYCEITDIWSCGLIL 358
|
Length = 501 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E F L +I G VY A + V+ IKK+ K E K
Sbjct: 24 EKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNE-----------KWQD 71
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
I E+ +++H N + +R LV E+ GS D+L + +E++ A
Sbjct: 72 IIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA- 129
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
I G GL YLH SH +IHRDI+ N+L+ + + ++++FG A
Sbjct: 130 --ITHGALQGLAYLH-SHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN----- 179
Query: 220 WSLAETVGYIAPECHQTVALSD-----KCDIYSFGVLLAVLMMGKFP 261
S T ++APE +A+ + K D++S G+ L K P
Sbjct: 180 -SFVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 32/123 (26%), Positives = 64/123 (52%), Gaps = 13/123 (10%)
Query: 177 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT 236
H+ +HRDI+P N+L+D + R+++FG ++ T ++ ++ T YI+PE Q
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG-TPDYISPEILQ- 176
Query: 237 VALSD-------KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSR 289
A+ D +CD +S GV + ++ G+ P F+ + ++ + M + + P++
Sbjct: 177 -AMEDGKGKYGPECDWWSLGVCMYEMLYGETP---FYAESLVETYGKIMNHKERFQFPAQ 232
Query: 290 TID 292
D
Sbjct: 233 VTD 235
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 43/176 (24%), Positives = 80/176 (45%), Gaps = 10/176 (5%)
Query: 89 DSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV-RPDCDLLVY-EFRRNGSLQDILYD 146
+S ++ ++ EI ++H IV + R + L ++ E+ GS++D L
Sbjct: 40 ESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-- 97
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
+ L + R I G+ YLH + I+HRDI+ AN+L D ++ +FG
Sbjct: 98 --KAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA 152
Query: 207 AKQIPN-GRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
+K++ + T S+ T +++PE K D++S G + ++ K P
Sbjct: 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYKA P SG + +K V + + E K ++ H N
Sbjct: 14 GTVYKARDP-HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLE---------AFDHPN 63
Query: 115 IVPLL-----ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASG 169
IV L+ +R R LV+E + L+ L V + + + R G
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFE-HVDQDLRTYLDKVPPPGLPAETI--KDLMRQFLRG 120
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK----QIPNGRTRTTTWSLAET 225
L++LH + I+HRD++P N+L+ + ++++FGLA+ Q+ T W
Sbjct: 121 LDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----- 172
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLA 253
Y APE + D++S G + A
Sbjct: 173 --YRAPEVLLQSTYATPVDMWSVGCIFA 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 17/158 (10%)
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG---------RRELDWLARHRIA 163
RN+ LL + P L Y F+ L +L V+ G R L+ AR A
Sbjct: 46 RNV--LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA 103
Query: 164 RGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLA 223
+AS + YLH + II+RD++P N+L+D +++FGL K+ TT +
Sbjct: 104 E-VASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFC 157
Query: 224 ETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
T Y+APE + D + G +L ++ G P
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPN-GRTRTTT 219
+ R I G+ YLH + I+HRDI+ AN+L D ++ +FG +K++ + T
Sbjct: 110 KYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166
Query: 220 WSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265
S+ T +++PE K DI+S G + ++ K P +F
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 46/206 (22%)
Query: 63 PGSSGRV--------ITIKKVI-------QPLKSEAELIKQDSEPLHHKMIQIQSEIITA 107
PGS G V KKVI + E +++K S H +I + I A
Sbjct: 102 PGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTIS---HRAIINL----IHA 154
Query: 108 GQVRHRNIVPLLARVVRPDCDLLVYEFRRNG-SLQDILYDVSQGRRELDWLARHRIARGI 166
R ++ V ++ + CDL Y R L+ + I R +
Sbjct: 155 --YRWKSTVCMVMPKYK--CDLFTYVDRSGPLPLEQAIT----------------IQRRL 194
Query: 167 ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETV 226
L YLH IIHRD++ N+ +D+ A + +FG A ++ + + T+
Sbjct: 195 LEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTL 251
Query: 227 GYIAPECHQTVALSDKCDIYSFGVLL 252
+PE K DI+S G++L
Sbjct: 252 ETNSPELLALDPYCAKTDIWSAGLVL 277
|
Length = 392 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 24/80 (30%), Positives = 43/80 (53%)
Query: 177 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT 236
H +++HRD++ AN+ + ++ +FG +KQ + + S T Y+APE +
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER 245
Query: 237 VALSDKCDIYSFGVLLAVLM 256
S K D++S GV+L L+
Sbjct: 246 KRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 21/51 (41%), Positives = 34/51 (66%), Gaps = 8/51 (15%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL--AKQIPNGRTRT 217
GL Y H R R++HRD++P N+LI + E ++++FGL AK +P ++T
Sbjct: 115 GLAYCH--QR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKT 159
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 162
E+ ++H NIV L + LV+E+ + L+ L D + + H +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG------NSINMHNV 106
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL--AKQIPNGRTRTTTW 220
+ L L+ HR +++HRD++P N+LI++ E ++++FGL AK IP T+T +
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYSN 163
Query: 221 SLAETVGYIAPEC-HQTVALSDKCDIYSFGVLLAVLMMGK--FP 261
+ T+ Y P+ + S + D++ G + + G+ FP
Sbjct: 164 EVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 32/216 (14%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E F+ L +I G VY A + V+ IKK+ K E K
Sbjct: 14 EKLFSDLREIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSGKQSNE-----------KWQD 61
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
I E+ ++RH N + +R LV E+ GS D+L + +E++ A
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA- 119
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
+ G GL YLH SH +IHRD++ N+L+ + ++ +FG A +
Sbjct: 120 --VTHGALQGLAYLH-SHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----- 169
Query: 220 WSLAETVGYIAPECHQTVALSD-----KCDIYSFGV 250
T ++APE +A+ + K D++S G+
Sbjct: 170 -XFVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 7/122 (5%)
Query: 132 YEFRRNGSLQDILYD-VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190
Y+ + ++++L D S+G LD L+ +A G+E+L + +HRD+ N
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLS---FTYQVARGMEFLASKN---CVHRDLAARN 267
Query: 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGV 250
VL+ +I +FGLA+ I + + S V ++APE + D++S+G+
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 251 LL 252
LL
Sbjct: 328 LL 329
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 42/137 (30%), Positives = 61/137 (44%), Gaps = 28/137 (20%)
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR 216
+AR A + + LEYLH I+HRD++P N+LI ++++FGL+K G
Sbjct: 102 MARMYFAETVLA-LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMS 154
Query: 217 TTTWSLAE-----------------TVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK 259
TT +L E T YIAPE D ++ G++L ++G
Sbjct: 155 LTT-NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213
Query: 260 FPSDDFFQHTKEMSFVQ 276
P FF T E F Q
Sbjct: 214 VP---FFGDTPEELFGQ 227
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 39/165 (23%), Positives = 77/165 (46%), Gaps = 25/165 (15%)
Query: 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDS-----EPLHHKMIQIQ 101
++I + W G+V +E+ +G + V++ LK+ A +Q+ +P ++++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTG---VARVVVKELKANASSKEQNEFLQQGDP--YRILQ-- 53
Query: 102 SEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
H NI+ L + V LLV+E+ G L+ L RR L R
Sbjct: 54 ----------HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR 103
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
+A IA+G+ ++H + +H D+ N + D+ ++ ++G+
Sbjct: 104 MACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 29/161 (18%)
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSL-------QDILYDVSQGRRELD 155
E+ ++H NIV +V ++ G L + +L+ + LD
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF---PEDQILD 105
Query: 156 WLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT 215
W + I L+++H +I+HRDI+ N+ + D ++ +FG+A R
Sbjct: 106 WFVQ------ICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIA------RV 150
Query: 216 RTTTWSLAET-VG---YIAPECHQTVALSDKCDIYSFGVLL 252
+T LA T +G Y++PE + ++K DI++ G +L
Sbjct: 151 LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS--- 168
H NI+ LL L E+ +G+L D L + + + A ++S
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 169 ---------GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
G++YL + + IHRD+ N+L+ ++ A+I++FGL++ G+
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 179
Query: 220 WSLAE-TVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
++ V ++A E + D++S+GVLL ++ +G P
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 36/146 (24%), Positives = 59/146 (40%), Gaps = 12/146 (8%)
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
N+V L +V D LV + G L + E + R A + L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC-------VKRWAAEMVVAL 98
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
HR I+ RD+ P N+L+DD +++ F ++ + ++ Y APE
Sbjct: 99 DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEV 153
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGK 259
++ CD +S G +L L+ GK
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 32/113 (28%), Positives = 57/113 (50%), Gaps = 10/113 (8%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+A G+E+L + IHRD+ N+L+ ++ +I +FGLA+ I S
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP------SDDFFQHTKE 271
+ ++APE + + D++SFGVLL + +G P +++F Q K+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 37/145 (25%), Positives = 65/145 (44%), Gaps = 9/145 (6%)
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDV------SQGRRELDWLARHRIARGIA 167
++V LL V + L+V E +G L+ L + + GR ++A IA
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 168 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVG 227
G+ YL+ + +HRD+ N ++ D +I +FG+ + I V
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 228 YIAPECHQTVALSDKCDIYSFGVLL 252
++APE + + D++SFGV+L
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 38/139 (27%), Positives = 63/139 (45%), Gaps = 19/139 (13%)
Query: 130 LVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQ 187
+V E+ G L +++ YD+ + W + A + L H IHRD++
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE-----KWARFY-----TAEVVLALDAIHSMGFIHRDVK 169
Query: 188 PANVLIDDDMEARISEFGLA-KQIPNGRTRTTTWSLAETVGYIAPECHQTVA----LSDK 242
P N+L+D ++++FG K NG R T T YI+PE ++ +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 243 CDIYSFGVLLAVLMMGKFP 261
CD +S GV L +++G P
Sbjct: 228 CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 64/247 (25%), Positives = 101/247 (40%), Gaps = 48/247 (19%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH-KMIQ 99
D + LEKI G+VYKA ++G+++ +KK L+ + E I L ++Q
Sbjct: 1 DAYEKLEKIGEGTYGKVYKAR-DKNTGKLVALKKTR--LEMDEEGIP--PTALREISLLQ 55
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRE 153
+ SE I IV LL V + LV+E+ + + + + R
Sbjct: 56 MLSESI--------YIVRLL-DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP 106
Query: 154 LDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAK--QI 210
L + G+ + H H ++HRD++P N+L+D +I++ GL + I
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCH-KHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
Query: 211 PNGRTR---TTTWSLAETVGYIAPECHQTVAL-----SDKCDIYSFGVLLAVLMMGK--F 260
P T W Y APE V L S DI+S G + A + + F
Sbjct: 164 PVKSYTHEIVTLW-------YRAPE----VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
Query: 261 PSDDFFQ 267
P D Q
Sbjct: 213 PGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 29/105 (27%), Positives = 53/105 (50%), Gaps = 28/105 (26%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPN--------GRTRTTT 219
GL+Y+H ++ ++HRD++PANV I+ +D+ +I +FGLA+ + T
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 220 WSLAETVGYIAPEC-----HQTVALSDKCDIYSFGVLLAVLMMGK 259
W Y +P + T A+ D+++ G + A ++ GK
Sbjct: 183 W-------YRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 38/149 (25%), Positives = 57/149 (38%), Gaps = 51/149 (34%)
Query: 177 HRPRIIHRDIQPANVLIDDDMEARISEFGL---------AKQIPNG-------------- 213
H+ IHRDI+P N+LID D ++++FGL +K +G
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 214 ----------RTRTTTW------------SLAETVGYIAPECHQTVALSDKCDIYSFGVL 251
R + SL T YIAPE + CD +S GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 252 LAVLMMGKFPSDDFFQHT---KEMSFVQW 277
L +++G+ P F T +M + W
Sbjct: 238 LYEMLVGQPP---FLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 38/142 (26%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 112 HRNIVPLL-ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
H ++ LL RVV L++ ++R D+ + R L +AR + S +
Sbjct: 219 HPAVLALLDVRVVGGLTCLVLPKYR-----SDLYTYLGARLRPLGLAQVTAVARQLLSAI 273
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
+Y+H IIHRDI+ NVL++ + + +FG A + + +A TV A
Sbjct: 274 DYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330
Query: 231 PECHQTVALSDKCDIYSFGVLL 252
PE + DI+S G+++
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVI 352
|
Length = 461 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 39/139 (28%), Positives = 65/139 (46%), Gaps = 19/139 (13%)
Query: 130 LVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQ 187
+V E+ G L +++ YDV + W AR A + + L H IHRD++
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KW-ARFYTAEVVLA----LDAIHSMGFIHRDVK 169
Query: 188 PANVLIDDDMEARISEFGLAKQI-PNGRTRTTTWSLAETVGYIAPECHQTVA----LSDK 242
P N+L+D ++++FG ++ G R T T YI+PE ++ +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 243 CDIYSFGVLLAVLMMGKFP 261
CD +S GV L +++G P
Sbjct: 228 CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 15/162 (9%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILY---DVSQGRREL 154
+I ++ G + H IV LL + P L LV + GSL D + D +R L
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLG--ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 155 DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR 214
+W + IA G+ YL R++HR++ N+L+ D +I++FG+A +
Sbjct: 113 NWCVQ------IAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163
Query: 215 TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLM 256
+ + ++A E + + D++S+GV + +M
Sbjct: 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 24/92 (26%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
++A IA G+ YL+ + + +HRD+ N ++ +D +I +FG+ + I
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 221 SLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
V +++PE + + D++SFGV+L
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 23/176 (13%)
Query: 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMI 98
K D + LEK+ VYK + +G+++ +K + L +++ P
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGK-SKVNGKLVALKVI--------RLQEEEGTPF----T 49
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 158
I+ + G ++H NIV L + + LV+E+ Q + D G + +
Sbjct: 50 AIREASLLKG-LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVK 106
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL--AKQIPN 212
+ GL Y+H + I+HRD++P N+LI D E ++++FGL AK +P+
Sbjct: 107 LFLFQ--LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 4/101 (3%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+A+G+E+L + +HRD+ NVLI + +I +FGLA+ I + S
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDF 265
+ ++APE + D++SFG+LL + +G P +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+A G+E+L + IHRD+ N+L+ ++ +I +FGLA+ I
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+ ++APE + + D++SFGVLL + +G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 12/98 (12%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA--KQIPNGRTRTTTWSLAETV 226
GL Y+H I+HRD++P N+LI E ++++FGLA K IP+ T S T+
Sbjct: 115 GLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS----QTYSSEVVTL 167
Query: 227 GYIAPEC-HQTVALSDKCDIYSFGVLLAVLMMGK--FP 261
Y P+ S DI+ G + ++ G+ FP
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 36/122 (29%), Positives = 64/122 (52%), Gaps = 16/122 (13%)
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
E+ ++H NIV L +V D L LV+E+ + L+ + D + ++ H
Sbjct: 54 EVSLLKDLKHANIVTL-HDIVHTDKSLTLVFEYL-DKDLKQYMDDCG------NIMSMHN 105
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL--AKQIPNGRTRTTT 219
+ + L L HR +++HRD++P N+LI++ E ++++FGL AK +P T T
Sbjct: 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP-----TKT 160
Query: 220 WS 221
+S
Sbjct: 161 YS 162
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 22/149 (14%)
Query: 109 QVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRREL-------DWLARH 160
Q++H NIV D L +V F G D+ + + + + +L +W +
Sbjct: 55 QLKHPNIVAYRESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQ- 110
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
IA L+YLH H I+HRD++ NV + ++ + G+A+ + N +T
Sbjct: 111 -----IAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST- 161
Query: 221 SLAETVGYIAPECHQTVALSDKCDIYSFG 249
L T Y++PE + K D+++ G
Sbjct: 162 -LIGTPYYMSPELFSNKPYNYKSDVWALG 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 8e-05
Identities = 44/193 (22%), Positives = 85/193 (44%), Gaps = 12/193 (6%)
Query: 64 GSSGRVITIK----KVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119
GS G V +K + LK E+ + P ++ +Q E ++ H IV
Sbjct: 11 GSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP--NETVQANQEAQLLSKLDHPAIVKFH 68
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179
A + D ++ E+ L L ++ + L + +++ L +H H+
Sbjct: 69 ASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL---SENQVCEWFIQLLLGVHYMHQR 125
Query: 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL 239
RI+HRD++ N+ + +++ +I +FG+++ + TT T Y++PE +
Sbjct: 126 RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALKHQGY 182
Query: 240 SDKCDIYSFGVLL 252
K DI+S G +L
Sbjct: 183 DSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 39/139 (28%), Positives = 65/139 (46%), Gaps = 19/139 (13%)
Query: 130 LVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQ 187
+V E+ G L +++ YDV + W A+ A + + L H +IHRD++
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KW-AKFYTAEVVLA----LDAIHSMGLIHRDVK 169
Query: 188 PANVLIDDDMEARISEFGLA-KQIPNGRTRTTTWSLAETVGYIAPECHQTVA----LSDK 242
P N+L+D ++++FG K G R T T YI+PE ++ +
Sbjct: 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 243 CDIYSFGVLLAVLMMGKFP 261
CD +S GV L +++G P
Sbjct: 228 CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 34/112 (30%), Positives = 51/112 (45%), Gaps = 10/112 (8%)
Query: 144 LYDVSQGRREL---DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200
LY +R + D LA I R + ++YLH + RIIHRDI+ N+ I+ +
Sbjct: 169 LYCYLAAKRNIAICDILA---IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVC 222
Query: 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+ +FG A P + A T+ APE DI+S G++L
Sbjct: 223 LGDFG-AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVL 273
|
Length = 391 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 10/115 (8%)
Query: 150 GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209
+ L+W + IA G+ YL ++HRD+ NVL+ +I++FGLAK
Sbjct: 108 SQYLLNWCVQ------IAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158
Query: 210 IPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLM-MGKFPSD 263
+ + ++A E + + D++S+GV + LM G P D
Sbjct: 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 19/43 (44%), Positives = 31/43 (72%), Gaps = 3/43 (6%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208
+A L+YLH R IIHRD++P N+LI ++ ++++FGL+K
Sbjct: 113 VALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 25/87 (28%), Positives = 44/87 (50%), Gaps = 3/87 (3%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+A G+ +L + IHRD+ N+L+ +I +FGLA+ I N +
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLL 252
V ++APE + + D++S+G+LL
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILL 306
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 34/130 (26%), Positives = 49/130 (37%), Gaps = 45/130 (34%)
Query: 177 HRPRIIHRDIQPANVLIDDDMEARISEFGLAK---------------------------- 208
H+ IHRDI+P N+LID D ++++FGL
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 209 -QIPNGR----------------TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVL 251
+ N R R SL T YIAPE + CD +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 252 LAVLMMGKFP 261
L +++G+ P
Sbjct: 238 LFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 4/101 (3%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
IA G+ YL R++HRD+ NVL+ +I++FGLA+ + T
Sbjct: 118 IAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLM-MGKFPSDDF 265
+ ++A E + + D++S+GV + LM G P D
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 54/247 (21%), Positives = 93/247 (37%), Gaps = 50/247 (20%)
Query: 102 SEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
E Q H +IV L+ V+ + +V E G L+ L + LD +
Sbjct: 56 QEAYIMRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYL---QVNKYSLDLASLIL 111
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWS 221
+ +++ L YL R +HRDI NVL+ ++ +FGL++ + + +
Sbjct: 112 YSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS-K 167
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQHTKEMSFVQWMRN 280
+ ++APE + D++ FGV + +LM+G P Q ++N
Sbjct: 168 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP-------------FQGVKN 214
Query: 281 ---VMTSENPSRTIDSKLIGNGYEEQMLLVLKIAC---------FCTFDDPEERPNSKDV 328
+ EN R L + C C DP +RP ++
Sbjct: 215 NDVIGRIENGER----------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258
Query: 329 RCMLSQI 335
+ LS I
Sbjct: 259 KAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 53/243 (21%), Positives = 96/243 (39%), Gaps = 40/243 (16%)
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDIL--YDVSQGRRE-------------LDWLA 158
NI+ LL V D ++ E+ NG L L + + + + +
Sbjct: 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS 139
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTT 218
+A IASG++YL + +HRD+ N L+ +++ +I++FG+++ + G
Sbjct: 140 LLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRI 196
Query: 219 TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-------GKFPSDDFFQHTKE 271
+ ++A EC + D+++FGV L ++M G+ + ++ E
Sbjct: 197 QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGE 256
Query: 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331
F R V P G E ML C D ERP+ D+
Sbjct: 257 F-FRDQGRQVYLFRPPP-------CPQGLYELMLQ-------CWSRDCRERPSFSDIHAF 301
Query: 332 LSQ 334
L++
Sbjct: 302 LTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 34/130 (26%), Positives = 49/130 (37%), Gaps = 45/130 (34%)
Query: 177 HRPRIIHRDIQPANVLIDDDMEARISEFGL---------------------AKQIPNGRT 215
H+ IHRDI+P N+LID ++S+FGL K + R
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 216 ---------------RTTTWS-----LA-ETVG---YIAPECHQTVALSDKCDIYSFGVL 251
+ TW +A TVG YIAPE +CD +S G +
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 252 LAVLMMGKFP 261
+ ++G P
Sbjct: 238 MFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 29/118 (24%), Positives = 55/118 (46%), Gaps = 10/118 (8%)
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD-------VSQGRRELD 155
EI +++ NI+ LLA + D ++ E+ NG L L +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 156 WLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG 213
+ +A IASG++YL + +HRD+ N L+ + +I++FG+++ + +G
Sbjct: 129 YSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 19/164 (11%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA---RHRIARG 165
QV H++IV L VR +++V EF G L + R+ D L + ++A+
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM------HRKSDVLTTPWKFKVAKQ 113
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+AS L YL ++H ++ N+L+ E E G ++ + T S E
Sbjct: 114 LASALSYL---EDKDLVHGNVCTKNILL--AREGIDGECGPFIKLSDPGIPITVLSRQEC 168
Query: 226 VG---YIAPEC-HQTVALSDKCDIYSFGVLL-AVLMMGKFPSDD 264
V +IAPEC + LS D +SFG L + G+ P D
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 61/323 (18%), Positives = 122/323 (37%), Gaps = 71/323 (21%)
Query: 24 IFSPLIEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEA 83
I S I+K +K+ D + +YK + I+ + K
Sbjct: 15 IESDDIDKYTSVLIKENDQNS------------IYKGIFNNKE---VIIRTFKKFHKGHK 59
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDL----LVYEFRRNGS 139
LI ++EI ++ NI+ + ++ DL L+ E+ G
Sbjct: 60 VLIDI-----------TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGY 108
Query: 140 LQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMS-HRPRIIHRDIQPANVLIDDDME 198
L+++L ++L + + +A GL L+ ++P ++++ + L+ ++ +
Sbjct: 109 LREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYK 161
Query: 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV--ALSDKCDIYSFGVLLAVLM 256
+I GL K + + + + Y + + + + K DIYS GV+L +
Sbjct: 162 LKIICHGLEKILSSPPFKNVN-----FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
Query: 257 MGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQM-----LLVLKIA 311
GK P F++ +T++ I +I ++ L + I
Sbjct: 217 TGKIP----FEN-------------LTTKE----IYDLIINKNNSLKLPLDCPLEIKCIV 255
Query: 312 CFCTFDDPEERPNSKDVRCMLSQ 334
CT D +RPN K++ LS
Sbjct: 256 EACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 20/52 (38%), Positives = 31/52 (59%), Gaps = 3/52 (5%)
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG 213
+ R + +GL LH R I+HRDI+P N+L+ D + +I +FG A + G
Sbjct: 314 VMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 16/174 (9%)
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGRRELDWLA 158
+Q E+ + H NIVP A + + +V F GS +D I G EL A
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---A 102
Query: 159 RHRIARGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEF-GLAKQIPNGRTR 216
I +G+ L+Y+H M + +HR ++ +++LI D + +S I +G+
Sbjct: 103 IAYILQGVLKALDYIHHMGY----VHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158
Query: 217 TTTWSL----AETVGYIAPECHQT--VALSDKCDIYSFGVLLAVLMMGKFPSDD 264
+ + +++PE Q K DIYS G+ L G P D
Sbjct: 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 337 | |||
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.79 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.78 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.31 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.03 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.89 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.86 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.81 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.62 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.61 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.6 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.29 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.25 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.19 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.16 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.14 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.06 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.79 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.76 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.74 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.64 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.61 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.6 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.94 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.86 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.8 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.75 | |
| PLN02236 | 344 | choline kinase | 95.73 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.49 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.29 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.27 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.8 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.52 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.49 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.79 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.43 | |
| PRK14559 | 645 | putative protein serine/threonine phosphatase; Pro | 91.45 | |
| PTZ00384 | 383 | choline kinase; Provisional | 90.77 |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=335.56 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=216.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
...+|+++++||+|.||+||++++. .+|..+|.|.+.-...... ....+..|+.+|++|+||||+++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~-~~g~l~a~K~i~f~~md~k------------~rq~~v~Ei~lLkQL~HpNIVqY 83 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCL-LDGKLVALKKIQFGMMDAK------------ARQDCVKEISLLKQLNHPNIVQY 83 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeec-cCcchhhhhhcchhhccHH------------HHHHHHHHHHHHHhcCCchHHHH
Confidence 4468999999999999999999865 4999999999864433322 26789999999999999999999
Q ss_pred hc-eeecCCC-ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC-CCCceeCCCCCCcEEecC
Q 036970 119 LA-RVVRPDC-DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH-RPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 119 ~~-~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-~~~~~h~di~~~nil~~~ 195 (337)
++ .+.++.. +++|||+|++|+|...++......+.+++.++|+++.|++.||.++|+.. +..+.||||||.||+++.
T Consensus 84 y~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~ 163 (375)
T KOG0591|consen 84 YAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA 163 (375)
T ss_pred HHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC
Confidence 98 4555555 79999999999999999999999999999999999999999999999742 234899999999999999
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+|.+||+|||+++.+.+..+... +..|||.||+||.+.+.+|+.++||||+||++|||+.-.+||.+. ++.
T Consensus 164 ~gvvKLGDfGL~r~l~s~~tfA~--S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~ 234 (375)
T KOG0591|consen 164 NGVVKLGDFGLGRFLSSKTTFAH--SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLL 234 (375)
T ss_pred CCceeeccchhHhHhcchhHHHH--hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHH
Confidence 99999999999998876655443 579999999999999999999999999999999999999999764 344
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+....+.+...+. ......+.++..+|..|+.+||..||+...++.
T Consensus 235 ~L~~KI~qgd~~~---------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 235 SLCKKIEQGDYPP---------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred HHHHHHHcCCCCC---------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 5554444332211 112345667888888899999999998544443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-50 Score=339.62 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=214.9
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++.+.++.||+|..|+||+++++. +++.+|+|++...... +...++.+|+.+++..+||+|+.+++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~-t~~i~AlK~I~~~~~~-------------~~~~Qi~rEl~il~~~~spyIV~~yg 144 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKP-TGKIYALKVILLNIDP-------------ALQKQILRELEILRSCQSPYIVGFYG 144 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcC-CCeEEEEEeecccCCH-------------HHHHHHHHHHHHHhhCCCCCeeeEeE
Confidence 478889999999999999999874 8999999999322221 12678999999999999999999999
Q ss_pred eeecCCC-ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCcEEecCCCc
Q 036970 121 RVVRPDC-DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHM-SHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 121 ~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~~ 198 (337)
.|+.+.. ..|+||||++|||.+++.. .+.+++....+++.+++.||.|||. .+ |+||||||+|||++..|.
T Consensus 145 aF~~~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGe 217 (364)
T KOG0581|consen 145 AFYSNGEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGE 217 (364)
T ss_pred EEEeCCceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCC
Confidence 9999995 9999999999999999843 3669999999999999999999994 44 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
|||+|||.+..+.+. ......||..|||||.+.+..|+.++||||||++++|+.+|+.||... ........+.+
T Consensus 218 VKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll 291 (364)
T KOG0581|consen 218 VKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIFELL 291 (364)
T ss_pred EEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHHHHH
Confidence 999999999887766 223578999999999999999999999999999999999999998754 23445566666
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..++.+.++...-. .++.++.++|..||++||.+|||+.++++
T Consensus 292 ~~Iv~~ppP~lP~~---------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 292 CAIVDEPPPRLPEG---------EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHhcCCCCCCCcc---------cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 66665544432111 23445889999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=357.81 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=210.5
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
.+|..++.||+|||+.||.+++. .+|..||+|++.+... ......+.+.+||.+.++|+||||+++++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~-~tge~~A~KvVpk~~l-----------~k~~~reKv~~EIeIHr~L~HpnIV~f~~ 85 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL-DTGEVVAVKVVPKKLL-----------KKPKQREKVLNEIEIHRSLKHPNIVQFYH 85 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc-CCCcEEEEEEeehHHh-----------cCcchHHHHHHHHHHHHhcCCCcEEeeee
Confidence 67999999999999999999963 3999999999965433 22233778999999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
+|++..+.|||+|+|..++|..++ ...+++++..+..++.||+.||.|||+++ |+|||||..|+|++++.++|
T Consensus 86 ~FEDs~nVYivLELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 86 FFEDSNNVYIVLELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred EeecCCceEEEEEecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEE
Confidence 999999999999999999999998 35678999999999999999999999555 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||+|+.+....... ...+|||-|+|||++....++..+||||+|||+|.|+.|++||+... +.+....
T Consensus 159 IgDFGLAt~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~ 229 (592)
T KOG0575|consen 159 IGDFGLATQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNK 229 (592)
T ss_pred ecccceeeeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHH
Confidence 99999999887543322 24799999999999999999999999999999999999999997532 2222222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+....... +...+....+||..+|+.||.+|||+++|+.
T Consensus 230 Ik~~~Y~~-----------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 230 IKLNEYSM-----------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHhcCccc-----------ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22222111 1122233789999999999999999999974
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=346.00 Aligned_cols=279 Identities=35% Similarity=0.562 Sum_probs=237.4
Q ss_pred hh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 37 LK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 37 l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
+. |+++|.....||+|+||.||+|... +|..||||++....... ..+|.+|+.++.+++|||+
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~~~~--------------~~eF~~Ei~~ls~l~H~Nl 133 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNSGQG--------------EREFLNEVEILSRLRHPNL 133 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCCCcc--------------hhHHHHHHHHHhcCCCcCc
Confidence 44 8999999999999999999999986 67999999774433210 1249999999999999999
Q ss_pred hhhhceeecCCC-ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 116 VPLLARVVRPDC-DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 116 ~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++|+|.+.+. .++|+||+.+|+|.+.+...... +++|..+.+|+.+++.||+|||+...+.++|||||++|||+|
T Consensus 134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 999999999994 99999999999999999542222 899999999999999999999998777899999999999999
Q ss_pred CCCcEEEecccccccCCC-CCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPN-GRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
++.+.||+|||++..... ....... ..||.+|+|||+......+.++||||||+++.|+++|+.|.+... ......
T Consensus 212 ~~~~aKlsDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~ 288 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELS 288 (361)
T ss_pred CCCCEEccCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-Cccccc
Confidence 999999999999966543 2221111 078999999999999899999999999999999999998876533 234445
Q ss_pred HHHHHHHHhhcCCCCcccccccc-CCChH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLI-GNGYE-EQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
+..|.+..+..+.....+|+.+. ..... .+...+..+...|++.+|.+||++.+|+++|..+.
T Consensus 289 l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 289 LVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 88898888888899999999987 44443 68888999999999999999999999999997653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=340.91 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=209.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..+-|.+.+.||+|+||.|-+|..+ .+|+.||||++.+....... . .........+|+.+|.+|+||||+++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~-~tgk~vAiKIi~krk~~~~s------~-~~~~~~~v~~EieILkkL~HP~IV~~ 241 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEK-KTGKQVAIKIINKRKSTGCS------R-AIAKTRDVQNEIEILKKLSHPNIVRI 241 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEc-ccCcEEEeeeeehhhccccc------c-cccchhhhHHHHHHHHhcCCCCEEEE
Confidence 3567888899999999999999754 59999999999764432211 1 11123457899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC--
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-- 196 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~-- 196 (337)
+++|+..+..||||||++||+|.+++ -.++.+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+
T Consensus 242 ~d~f~~~ds~YmVlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 242 KDFFEVPDSSYMVLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAE 314 (475)
T ss_pred eeeeecCCceEEEEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCc
Confidence 99999999999999999999999999 56677888888999999999999999555 9999999999999866
Q ss_pred -CcEEEecccccccCCCCCcccccccccCcccccCCccccCCC---CCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 197 -MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA---LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 197 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
-.+||+|||++...+....-+ ..+||+.|.|||++.+.. +..+.|+||+||++|-+++|.+||.+..+ .+
T Consensus 315 ~~llKItDFGlAK~~g~~sfm~---TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~---~~ 388 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSGEGSFMK---TLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT---DP 388 (475)
T ss_pred ceEEEecccchhhccccceehh---hhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC---Cc
Confidence 679999999999877544333 479999999999998765 33478999999999999999999987543 22
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+.+.+.. ..... ....+.+......+||.+||..||++|||+.|+++
T Consensus 389 sl~eQI~~---G~y~f-------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 SLKEQILK---GRYAF-------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cHHHHHhc---Ccccc-------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 23332222 11111 11346677788999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=335.60 Aligned_cols=206 Identities=29% Similarity=0.416 Sum_probs=183.2
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
++..++|...+.||+|+||+||+|+++. ++..||||.+.+..... ...+.+..|+.+|+.++||||+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~-~~~~VAIK~i~~~~l~~------------k~~e~L~~Ei~iLkel~H~nIV 72 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKK-SGTEVAIKCIAKKKLNK------------KLVELLLSEIKILKELKHPNIV 72 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEecc-CCceEEeeeehhhccCH------------HHHHHHHHHHHHHHhcCCccee
Confidence 4467899999999999999999999874 78999999996653211 1256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
.+++.+..++..|+|||||+||+|.++++ ..+.+++.++..++.||+.||++||+++ |+||||||+|||++.+
T Consensus 73 ~l~d~~~~~~~i~lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~ 145 (429)
T KOG0595|consen 73 RLLDCIEDDDFIYLVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTT 145 (429)
T ss_pred eEEEEEecCCeEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccC
Confidence 99999999999999999999999999994 4557999999999999999999999666 9999999999999865
Q ss_pred ------CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 197 ------MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 197 ------~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
..+||+|||+++.+....... ..+|++-|||||++....|+.|+|+||+|+++|++++|..||...
T Consensus 146 ~~~~~~~~LKIADFGfAR~L~~~~~a~---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 146 ARNDTSPVLKIADFGFARFLQPGSMAE---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred CCCCCCceEEecccchhhhCCchhHHH---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 468999999999988665544 469999999999999999999999999999999999999999753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=334.93 Aligned_cols=259 Identities=30% Similarity=0.436 Sum_probs=207.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcE-EEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRV-ITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
.+...+...||+|+||+||+|.++ |.. ||+|++......... ...|.+|+.+|.+++||||+++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~------------~~~f~~E~~il~~l~HpNIV~f 104 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDES------------RKAFRREASLLSRLRHPNIVQF 104 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHH------------HHHHHHHHHHHHhCCCCCeeeE
Confidence 344555666999999999999984 666 999999655433221 5689999999999999999999
Q ss_pred hceeecCC-CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 119 LARVVRPD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 119 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+|++.+.. ..++||||+++|+|.+++... ....+++..+..++.+|+.||.|||+++. ++||||||+|||++.+.
T Consensus 105 ~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~ 180 (362)
T KOG0192|consen 105 YGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKG 180 (362)
T ss_pred EEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCC
Confidence 99999988 789999999999999999653 46789999999999999999999995531 99999999999999997
Q ss_pred -cEEEecccccccCCCCCcccccccccCcccccCCcccc--CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 198 -EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ--TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 198 -~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
++||+|||+++...... .......||+.|||||++. ...|+.++||||||+++|||+||..||.+...
T Consensus 181 ~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------- 251 (362)
T KOG0192|consen 181 KTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------- 251 (362)
T ss_pred CEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------
Confidence 99999999998765432 1122357899999999999 55899999999999999999999999986432
Q ss_pred HHHHHHHh-hcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 275 VQWMRNVM-TSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 275 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+....+. ...++.. + ..+...+..++.+||+.||..||++.+++..|+.+.
T Consensus 252 ~~~~~~v~~~~~Rp~~--p--------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 252 VQVASAVVVGGLRPPI--P--------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred HHHHHHHHhcCCCCCC--C--------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 12222222 1111111 1 112334889999999999999999999999998764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=314.37 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=208.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
+.|+.+.++|.|++|.||+.+++ .+|+.||||++.- +++.+....-..+|+++|++|+|+|++.+.+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk-~TgqIVAIKkF~E------------sedd~~VkKIAlREIrmLKqLkH~NLVnLiE 68 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK-DTGQIVAIKKFVE------------SEDDPVVKKIALREIRMLKQLKHENLVNLIE 68 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC-CcccEEEEEeecc------------CCccHHHHHHHHHHHHHHHhcccchHHHHHH
Confidence 56889999999999999999976 4999999999843 3333444667899999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
+|...+.+++|+|||++ ++.+-+..... .++...+.+++.|++.|+.|+|+++ ++||||||+||+++.++.+|
T Consensus 69 VFrrkrklhLVFE~~dh-TvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvK 141 (396)
T KOG0593|consen 69 VFRRKRKLHLVFEYCDH-TVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVK 141 (396)
T ss_pred HHHhcceeEEEeeecch-HHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEE
Confidence 99999999999999987 45555544333 3889999999999999999999555 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||+++.+........ ....|.+|+|||.+.+ .+|..+.|||++||++.||++|.+.|.+... .+....+.
T Consensus 142 LCDFGFAR~L~~pgd~YT--DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD----iDQLy~I~ 215 (396)
T KOG0593|consen 142 LCDFGFARTLSAPGDNYT--DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD----IDQLYLIR 215 (396)
T ss_pred eccchhhHhhcCCcchhh--hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch----HHHHHHHH
Confidence 999999998874333222 3467999999999988 4799999999999999999999999876433 22222222
Q ss_pred HHhhc-----------------CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTS-----------------ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+.. ...+..-+.......++....-++++++.||..||++|++.++++.
T Consensus 216 ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 216 KTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22211 1111111222233345556667999999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=323.97 Aligned_cols=246 Identities=22% Similarity=0.270 Sum_probs=207.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+++.. ++++.||+|++.+....+. ...+...+|..+|..++||.|+++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~~-----------~e~~~~~~Er~IL~~v~hPFiv~l 90 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVEK-----------KEVRHTKAERNILSKIKHPFIVKL 90 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhhh-----------hhHHHHHHHHHHHHhCCCCcEeee
Confidence 5789999999999999999999965 6999999999976555332 225678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+..|++...+|+|++|+.||.|...+ +..+.+++..+.-++..|+.||.|||+.+ |+|||+||+|||++..|+
T Consensus 91 ~ysFQt~~kLylVld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GH 163 (357)
T KOG0598|consen 91 IYSFQTEEKLYLVLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGH 163 (357)
T ss_pred EEecccCCeEEEEEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCc
Confidence 99999999999999999999999999 45677999999999999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++........... ..+||+.|||||++.+..|+..+|.||||+++|+|++|.+||..... .++.
T Consensus 164 i~LtDFgL~k~~~~~~~~t~--tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-------~~~~ 234 (357)
T KOG0598|consen 164 IKLTDFGLCKEDLKDGDATR--TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-------KKMY 234 (357)
T ss_pred EEEeccccchhcccCCCccc--cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-------HHHH
Confidence 99999999986554433322 47999999999999999999999999999999999999999965432 3445
Q ss_pred HHHhhcC-CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC
Q 036970 279 RNVMTSE-NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP 323 (337)
Q Consensus 279 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 323 (337)
..++..+ ..... -......+++..+|..||++|.
T Consensus 235 ~~I~~~k~~~~p~-----------~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 235 DKILKGKLPLPPG-----------YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHhcCcCCCCCc-----------cCCHHHHHHHHHHhccCHHHhc
Confidence 5555444 11111 1223388999999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=333.54 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=210.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..+.+..++.||+|.||.||.|.++ ....||+|.+...... .+.|.+|+.+|.+|+|+||+++
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~~~m~---------------~~~f~~Ea~iMk~L~H~~lV~l 266 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKEGSMS---------------PEAFLREAQIMKKLRHEKLVKL 266 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEc--CCCcccceEEeccccC---------------hhHHHHHHHHHHhCcccCeEEE
Confidence 4456678899999999999999986 5668999988543221 3568899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+++|..+..++|||||++.|+|.+++.. .....+.....+.++.||++|++||++++ +|||||...||||++++.
T Consensus 267 ~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~ 341 (468)
T KOG0197|consen 267 YGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLV 341 (468)
T ss_pred EEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCce
Confidence 9999999999999999999999999965 35667899999999999999999999666 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||+++..... .........-+.-|.|||.+....++.++||||||++|+|++| |+.|+.+. ...+..+.
T Consensus 342 vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m----sn~ev~~~ 416 (468)
T KOG0197|consen 342 VKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM----SNEEVLEL 416 (468)
T ss_pred EEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC----CHHHHHHH
Confidence 999999999954433 3333323344778999999999999999999999999999999 66776543 23333333
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
+.+...-.. +..++..+.+++..||+.+|++|||++.+...|.++-
T Consensus 417 le~GyRlp~-------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 417 LERGYRLPR-------------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HhccCcCCC-------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 333332222 2334455999999999999999999999999988763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=317.11 Aligned_cols=273 Identities=23% Similarity=0.326 Sum_probs=220.7
Q ss_pred hhhhhhhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC
Q 036970 31 KEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV 110 (337)
Q Consensus 31 ~~~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 110 (337)
..+..|.-..++|++...||.|..++||+|++.. .+..||||++.-..... ..+.+.+|+..|..+
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p-~~e~VAIK~inLEkc~~-------------~ld~l~kE~~~msl~ 81 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIP-TNEVVAIKIINLEKCNN-------------DLDALRKEVQTMSLI 81 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecc-cCCEEEEEEeehhhhhh-------------hHHHHHHHHHHhhhc
Confidence 3455666678899999999999999999999764 77999999995543322 267899999999999
Q ss_pred CCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 111 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
+||||++++..|..+..+|+||+|+.+||+.+.+...-..+ +++..+..+++++++||.||| ++|.+|||+|+.|
T Consensus 82 ~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgn 156 (516)
T KOG0582|consen 82 DHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLH---QNGHIHRDVKAGN 156 (516)
T ss_pred CCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHH---hcCceeccccccc
Confidence 99999999999999999999999999999999997654433 899999999999999999999 5559999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCc-cccc-ccccCcccccCCccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRT-RTTT-WSLAETVGYIAPECHQT--VALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~-~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
||++.+|.|+|+|||.+..+..++. .... ....||++|||||++.. ..|+.|+||||||++..|+.+|..||...-
T Consensus 157 ILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 157 ILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred EEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 9999999999999998876654432 1112 35688999999999543 479999999999999999999999997643
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+ .+.+...+++.++... -..+..+........+.+++..||.+||+.|||++++++
T Consensus 237 P-------mkvLl~tLqn~pp~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 237 P-------MKVLLLTLQNDPPTLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred h-------HHHHHHHhcCCCCCcc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 3 4445555555444322 222222333344456889999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=328.02 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=214.3
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+.+.||+|.||.||+|+.+ .+.+.||+|.+.+....+.+ ...+.+|+++++.++||||+.+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK-~t~~~vAik~i~K~gr~~k~------------l~~l~~ev~i~r~lkHpniv~m~e 68 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK-YTIQVVAIKFIDKSGRNEKE------------LKNLRQEVRILRSLKHPNIVEMLE 68 (808)
T ss_pred cchhHHHHhcCCccceeeecccc-cceeEEEEEEehhcCCchHH------------HHHHHHHHHHHHhcCCcchhhHHH
Confidence 68999999999999999999854 68999999999766554433 567899999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
+|+.....|+|+|||.| +|+.++ .....++++.+..++.+++.||.|||++. ++|+|+||.||+++.++.+|
T Consensus 69 sfEt~~~~~vVte~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~K 140 (808)
T KOG0597|consen 69 SFETSAHLWVVTEYAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLK 140 (808)
T ss_pred hhcccceEEEEehhhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCcee
Confidence 99999999999999966 999999 55677999999999999999999999555 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
++|||+++....... +..+..|||.|||||...+..|+..+|+|||||++||++.|++||-. .++.+.+..
T Consensus 141 lcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~ 211 (808)
T KOG0597|consen 141 LCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKS 211 (808)
T ss_pred echhhhhhhcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHH
Confidence 999999988765433 33357899999999999999999999999999999999999999843 344556666
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
++..... .++.....+.+++...|.+||..|.|+.+++.
T Consensus 212 I~~d~v~-----------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 212 ILKDPVK-----------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HhcCCCC-----------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 5543322 23355666999999999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=324.34 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=209.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
..++|..+++||.|+||+||+|... .+|..||||.+.+...... ...-.+|+..|++|. ||||++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~-~~~~~VAIK~MK~Kf~s~e-------------e~~nLREvksL~kln~hpniik 73 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSK-ETGELVAIKKMKKKFYSWE-------------ECMNLREVKSLRKLNPHPNIIK 73 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeec-CCCceeeHHHHHhhhccHH-------------HHHHHHHHHHHHhcCCCCcchh
Confidence 4689999999999999999999854 5899999999966554322 224578999999998 999999
Q ss_pred hhceeecCC-CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 118 LLARVVRPD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 118 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
+.+++.+.+ .+++||||++ .+|.+++++ .++.+++..+..|+.||++||+|+| ++|+.|||+||+|||+...
T Consensus 74 L~Evi~d~~~~L~fVfE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~ 146 (538)
T KOG0661|consen 74 LKEVIRDNDRILYFVFEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGN 146 (538)
T ss_pred hHHHhhccCceEeeeHHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEeccc
Confidence 999999887 8999999994 589999965 3788999999999999999999999 6669999999999999998
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
..+||+|||+++.+........ ...|++|+|||++.. ..|+.+.|+|++|||++|+.+-++.|.+..+ .+..
T Consensus 147 ~~iKiaDFGLARev~SkpPYTe---YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE----~Dqi 219 (538)
T KOG0661|consen 147 DVIKIADFGLAREVRSKPPYTE---YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE----IDQI 219 (538)
T ss_pred ceeEecccccccccccCCCcch---hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH----HHHH
Confidence 8999999999999876655543 366999999998754 5689999999999999999999999876443 2222
Q ss_pred HHHHHHhhcCCCCcc-----------------ccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 276 QWMRNVMTSENPSRT-----------------IDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
..+..++........ ....+ ..-.+....+..++|..|++.||.+|||+.+.++.
T Consensus 220 ~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l-~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 220 YKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPL-KDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCCh-HHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 222223221111100 00011 11122356779999999999999999999998863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=327.93 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=209.4
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCCh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNI 115 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 115 (337)
.+-..+|.+++.||.|+|++|++|+.. .+++.||||++.+....... ....+..|-..|.+| .||.|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~-~t~keYAiKVl~K~~Iike~-----------KvkYV~~Ek~~l~~L~~hPgi 136 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREK-ATGKEYAIKVLDKRYIIKEK-----------KVKYVTREKEALTQLSGHPGI 136 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeec-CCCceeeHhhhhHHHHHhhc-----------ccchhhHHHHHHHHhhCCCCe
Confidence 346799999999999999999999865 59999999999665442221 144677788888888 89999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
++++..|.++..+|+|+||+++|+|.++|+. .+.+++...+.++.+|+.||+|||+++ |+||||||+|||+++
T Consensus 137 vkLy~TFQD~~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~ 209 (604)
T KOG0592|consen 137 VKLYFTFQDEESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDK 209 (604)
T ss_pred EEEEEEeecccceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcC
Confidence 9999999999999999999999999999954 467999999999999999999999555 999999999999999
Q ss_pred CCcEEEecccccccCCCCCcc-----------cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 196 DMEARISEFGLAKQIPNGRTR-----------TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
+++++|.|||.+..+...... .....+.||..|.+||++.....+..+|+|+|||++|.|+.|.+||.+
T Consensus 210 dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 210 DGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred CCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 999999999999877533221 112458999999999999999999999999999999999999999987
Q ss_pred cccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+ ...+..++.-.. ..++.....+.+||++.|..||++|+|+.+|.+
T Consensus 290 ~Ne-------yliFqkI~~l~y-----------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 290 ANE-------YLIFQKIQALDY-----------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ccH-------HHHHHHHHHhcc-----------cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 543 112222221111 111122244889999999999999999988864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=322.36 Aligned_cols=267 Identities=25% Similarity=0.301 Sum_probs=206.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..+.|+.+.+||+|+||.||+|++. .+|+.||+|++......+.. .....+||.+|++|+||||+++
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~-~tgkivALKKvr~d~~~~~~------------~~t~~REI~ILr~l~HpNIikL 181 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDL-ETGKIVALKKVRFDNEKEGF------------PITAIREIKILRRLDHPNIIKL 181 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeec-ccCcEEEEEEeecccCCCcc------------hHHHHHHHHHHHhcCCCcccce
Confidence 4678999999999999999999965 59999999999665532221 4467899999999999999999
Q ss_pred hceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 119 LARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 119 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
.+...+. ..+|||+|||++ +|..++. ...-.+++.++..++.||+.||+|||+++ ++|||||.+|||++.+
T Consensus 182 ~eivt~~~~~siYlVFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~ 254 (560)
T KOG0600|consen 182 EEIVTSKLSGSIYLVFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNN 254 (560)
T ss_pred eeEEEecCCceEEEEEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCC
Confidence 9999886 688999999987 7888872 33446999999999999999999999555 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
|.+||+|||+++.+....... .....-|.+|+|||.+.|. .|+.+.|+||+|||+.||+.|++.|.+..+ ....
T Consensus 255 G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE----veQl 329 (560)
T KOG0600|consen 255 GVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE----VEQL 329 (560)
T ss_pred CCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH----HHHH
Confidence 999999999999776443322 1134559999999999887 599999999999999999999999876533 2223
Q ss_pred HHHHHHhhcCCCCccccccc-------cCCC--------hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKL-------IGNG--------YEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~-------~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+.+-..+......-.--.++ .... ........++|+..+|..||.+|.|+.++++
T Consensus 330 ~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 330 HKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 33333332211110000000 0011 1112345888999999999999999998874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=313.04 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=199.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
..+|..++.||+|+||+||++.+.. +|...|+|........ ..+.+.+|+.+|.+++||||++++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~~~--------------~~~~l~~Ei~iL~~l~~p~IV~~~ 80 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKK-TGELMAVKSVELEDSP--------------TSESLEREIRILSRLNHPNIVQYY 80 (313)
T ss_pred cchhhhhccccCccceEEEEEEecC-CCcceeeeeeecccch--------------hHHHHHHHHHHHHhCCCCCEEeeC
Confidence 5678999999999999999998763 6999999998543110 045689999999999999999999
Q ss_pred ceeecCC--CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC-C
Q 036970 120 ARVVRPD--CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-D 196 (337)
Q Consensus 120 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~-~ 196 (337)
+...... .++++|||+.+|+|.+++... ++ .+++..+..+..||++||.|||+++ ++|+||||+|||++. +
T Consensus 81 G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~ 154 (313)
T KOG0198|consen 81 GSSSSRENDEYNIFMEYAPGGSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSN 154 (313)
T ss_pred CccccccCeeeEeeeeccCCCcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCC
Confidence 9755444 589999999999999999552 22 6999999999999999999999555 999999999999999 7
Q ss_pred CcEEEecccccccCCC-CCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 197 MEARISEFGLAKQIPN-GRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
+.+||+|||++..... ...........||+.|||||++... ....++|||||||++.||+||..||.... ..
T Consensus 155 ~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~ 228 (313)
T KOG0198|consen 155 GDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------EE 228 (313)
T ss_pred CeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------ch
Confidence 9999999999987664 1222223357889999999999853 33459999999999999999999997631 11
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...+-........+ .+ ++..+....+++..|+..||++|||+.++++
T Consensus 229 ~~~~~~ig~~~~~P-~i--------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 229 AEALLLIGREDSLP-EI--------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred HHHHHHHhccCCCC-CC--------CcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 12121222122111 11 1123344889999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=291.50 Aligned_cols=265 Identities=22% Similarity=0.261 Sum_probs=210.6
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
.+|...+.||+|.||.||+|++. .+|+.||||++......+.. .....+|+..|+.++|+||+.+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~-~t~~~VAIKKIkl~~~kdGi------------~~talREIK~Lqel~h~nIi~LiD 68 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT-ETGKRVAIKKIKLGNAKDGI------------NRTALREIKLLQELKHPNIIELID 68 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec-CCCcEEEEEEeeccccccCc------------cHHHHHHHHHHHHccCcchhhhhh
Confidence 57899999999999999999966 59999999999655332211 346789999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
+|.......+|+||++. +|+..+++ +...++...+..++.+++.|++|||+++ ++||||||.|+|++.+|.+|
T Consensus 69 ~F~~~~~l~lVfEfm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lK 141 (318)
T KOG0659|consen 69 VFPHKSNLSLVFEFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLK 141 (318)
T ss_pred hccCCCceEEEEEeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEE
Confidence 99999999999999966 89999954 6678999999999999999999999777 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||+++.+......... ..-|.+|+|||.+.|. .|....|+||.||++.||+-+.+-|.+.. +.+....+-
T Consensus 142 iADFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s----DidQL~~If 215 (318)
T KOG0659|consen 142 IADFGLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS----DIDQLSKIF 215 (318)
T ss_pred eecccchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc----hHHHHHHHH
Confidence 9999999998765544432 2568999999998876 58999999999999999999987765432 222222333
Q ss_pred HHhhcCCCCcc--------------ccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 280 NVMTSENPSRT--------------IDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 280 ~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
+.+....+... ++......-.+....+.++|+..||..||.+|+|+.|.++.
T Consensus 216 ~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 216 RALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 33322211111 11111112334455678999999999999999999998863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=318.33 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=212.4
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
.+....|....+||+|+.|.||.|+.. .+++.||||.+....... .+-+.+|+.+|+..+|+||+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~-~~~~~VaiK~m~l~~Q~~--------------keLilnEi~Vm~~~~H~NiV 333 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKI-STKQEVAIKRMDLRKQPK--------------KELLLNEILVMRDLHHPNIV 333 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeec-cCCceEEEEEEEeccCCc--------------hhhhHHHHHHHHhccchHHH
Confidence 446688999999999999999999855 589999999995443211 56789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
.+++.|...+.+|+||||++||+|.|.+. ...+++.++..++..++.||+||| ..||+|+|||.+||+++.+
T Consensus 334 nfl~Sylv~deLWVVMEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~ 405 (550)
T KOG0578|consen 334 NFLDSYLVGDELWVVMEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMD 405 (550)
T ss_pred HHHHHhcccceeEEEEeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccC
Confidence 99999999999999999999999999983 344899999999999999999999 4459999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
|.+||+|||++..+......+. ...||+.|||||++....|.++.||||||+++.||+.|++||-... .+.
T Consensus 406 g~vKltDFGFcaqi~~~~~KR~--TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------Plr- 476 (550)
T KOG0578|consen 406 GSVKLTDFGFCAQISEEQSKRS--TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------PLR- 476 (550)
T ss_pred CcEEEeeeeeeeccccccCccc--cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------hHH-
Confidence 9999999999998876655444 4689999999999999999999999999999999999999985322 122
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+..+..++.+.. ..+...+..+.+++.+||+.|+.+|+++.++|+
T Consensus 477 AlyLIa~ng~P~l--------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 477 ALYLIATNGTPKL--------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHhhcCCCCc--------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 2222333333332 223344556899999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=323.52 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=203.4
Q ss_pred ccCcccccccccccccceEEeeee----cCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAEL----PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
+.++|++.+.||.|+||.||+|.+ ...++..||+|++...... .....+.+|+.++..+ +||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~ 71 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA-------------SEHKALMSELKILIHIGNHL 71 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch-------------HHHHHHHHHHHHHHHhccCc
Confidence 567899999999999999999974 2235678999988533211 1145688999999999 899
Q ss_pred ChhhhhceeecC-CCceEEEEeecCCCHHHHHHhhhcC------------------------------------------
Q 036970 114 NIVPLLARVVRP-DCDLLVYEFRRNGSLQDILYDVSQG------------------------------------------ 150 (337)
Q Consensus 114 ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------ 150 (337)
||+++++++... ...+++|||+++|+|.+++......
T Consensus 72 niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (338)
T cd05102 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQP 151 (338)
T ss_pred ceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccc
Confidence 999999988764 4578999999999999998643210
Q ss_pred ----------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCC
Q 036970 151 ----------------RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR 214 (337)
Q Consensus 151 ----------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~ 214 (337)
..++++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~ 228 (338)
T cd05102 152 STSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 228 (338)
T ss_pred ccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCc
Confidence 23578888899999999999999955 49999999999999999999999999997654332
Q ss_pred cccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCccccc
Q 036970 215 TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293 (337)
Q Consensus 215 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (337)
.........++..|+|||++.+..++.++||||||+++|||++ |..||..... ...... ....+.....
T Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~---~~~~~~----~~~~~~~~~~--- 298 (338)
T cd05102 229 DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---NEEFCQ----RLKDGTRMRA--- 298 (338)
T ss_pred chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHH----HHhcCCCCCC---
Confidence 2222223345678999999998889999999999999999997 9999875322 111111 1111111110
Q ss_pred cccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 294 KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 294 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
+......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 299 ------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 299 ------PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1112234889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=318.85 Aligned_cols=258 Identities=24% Similarity=0.307 Sum_probs=206.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
..+.|.+++.||.|+||.|+.|.+. .++..||+|++.+...... . ......+.+|+.+++.++ ||||++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~~~--------~-~~~~~~i~rEi~~~~~~~~HpnI~~ 84 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVSSK--------S-QKLDELIKREISILRRLRSHPNIIR 84 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhccccc--------c-cccchhhHHHHHHHHHhccCCCEeE
Confidence 5789999999999999999999865 4889999997755411100 0 011446678999999998 999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC-
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD- 196 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~- 196 (337)
+++++......++||||+.+|+|.+++. ..+.+.+..+..++.|++.|++|||++ |++||||||+||+++.+
T Consensus 85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~ 157 (370)
T KOG0583|consen 85 LLEVFATPTKIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNE 157 (370)
T ss_pred EEEEEecCCeEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCC
Confidence 9999999999999999999999999993 356789999999999999999999955 49999999999999999
Q ss_pred CcEEEecccccccCC-CCCcccccccccCcccccCCccccCCC-CC-CcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 197 MEARISEFGLAKQIP-NGRTRTTTWSLAETVGYIAPECHQTVA-LS-DKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
+++||+|||++.... ...... ..+||+.|+|||++.+.. |+ .++||||+|+++|.|++|..||++...
T Consensus 158 ~~~Kl~DFG~s~~~~~~~~~l~---t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------ 228 (370)
T KOG0583|consen 158 GNLKLSDFGLSAISPGEDGLLK---TFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------ 228 (370)
T ss_pred CCEEEeccccccccCCCCCccc---CCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------
Confidence 999999999998874 322222 469999999999999977 76 679999999999999999999986321
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQ-MLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
......+....... +... +..+..|+.+||..||.+|+|+.+|+ .-..+
T Consensus 229 -~~l~~ki~~~~~~~-----------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~ 278 (370)
T KOG0583|consen 229 -PNLYRKIRKGEFKI-----------PSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWF 278 (370)
T ss_pred -HHHHHHHhcCCccC-----------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhh
Confidence 22222222221111 1111 34589999999999999999999998 44433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.54 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=218.0
Q ss_pred ccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
...+....+.||.|+||.||+|+... .....||||.+...... +....|++|+.++..|+|||
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-------------~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-------------QARQDFRREAELLAELQHPN 550 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-------------HHHHHHHHHHHHHHhccCCC
Confidence 34666778999999999999998542 23466999988433221 22678999999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC----------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG----------RRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~ 184 (337)
||+++|+|.+++.++||+||+++|+|.+|+....+. ..+++..+.+.++.||+.|+.||.++. +|||
T Consensus 551 IVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHR 627 (774)
T KOG1026|consen 551 IVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHR 627 (774)
T ss_pred eEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---cccc
Confidence 999999999999999999999999999999765331 233889999999999999999999776 9999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCC
Q 036970 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSD 263 (337)
Q Consensus 185 di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~ 263 (337)
||...|+||.++..|||+|||+++..-..++++......-+.+|||||.+...++++++||||+|++|||+++ |..||.
T Consensus 628 DLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 628 DLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred chhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 9999999999999999999999999887777776544455889999999999999999999999999999998 778987
Q ss_pred CcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 264 DFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+... .+..+.++. +.. -..+..++..+++|+..||+.+|.+||+++||-..|...
T Consensus 708 glSn----~EVIe~i~~----g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 708 GLSN----QEVIECIRA----GQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ccch----HHHHHHHHc----CCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 6432 222332222 221 234555667799999999999999999999999998753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=324.33 Aligned_cols=251 Identities=23% Similarity=0.264 Sum_probs=211.7
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.+-|+.++-||.|+-|.|-+|++. .+|+..|||++.+.... .......+.+|+.+|+.+.|||+++++
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~-~TGqlaaiKii~k~~~~-----------s~s~~~~IerEIviMkLi~HpnVl~Ly 78 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHA-ETGQLAAIKIIPKRSEL-----------SSSQPAGIEREIVIMKLIEHPNVLRLY 78 (786)
T ss_pred ccceeccccccCCCCceehhhhcc-cccceeEEEeecccccc-----------ccccccchhhhhHHHHHhcCCCeeeee
Confidence 577999999999999999999965 59999999999665311 111245688999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
++|++...+|+|+||+++|.|++++ ...+++++..+.+++.||+.|+.|||..+ ++|||+||+|+|++..+++
T Consensus 79 dVwe~~~~lylvlEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nI 151 (786)
T KOG0588|consen 79 DVWENKQHLYLVLEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNI 151 (786)
T ss_pred eeeccCceEEEEEEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCE
Confidence 9999999999999999999999999 56678999999999999999999999555 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALS-DKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
||+|||++.....+..... .||++.|.|||++.+.+|+ .++||||+|+|+|.|++|+.||++.+ +...+
T Consensus 152 KIADFGMAsLe~~gklLeT---SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LL 221 (786)
T KOG0588|consen 152 KIADFGMASLEVPGKLLET---SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLL 221 (786)
T ss_pred eeeccceeecccCCccccc---cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHH
Confidence 9999999987766655544 5999999999999999885 57999999999999999999997532 33444
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+..+.. +-+...+.++.+|+.+||..||+.|.|.++|++
T Consensus 222 lKV~~G~f-----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 222 LKVQRGVF-----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHHHcCcc-----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 44333222 112333455889999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=316.40 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=207.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|+- ..+|..||+|++.++..-.. .+.+.+..|-.+|...++|.||++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarK-k~Tg~iyAmK~LkKS~M~~~-----------~Qv~hV~aERdiL~~~ds~~vVKL 206 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARK-KDTGEIYAMKILKKSEMLKK-----------NQVEHVRAERDILAEVDSPWVVKL 206 (550)
T ss_pred CcccchhheeeccccceeEEEEEE-ccCCcEEeeecccHHHHHhh-----------hhHHHHHHHHHHhhhcCCCcEEEE
Confidence 468999999999999999999984 46999999999977654322 225678889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+..|++...+|+||||++||++..++ .....+++..+..++.+.+.|+..+| +.|++||||||+|+||+..|+
T Consensus 207 yYsFQD~~~LYLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GH 279 (550)
T KOG0605|consen 207 YYSFQDKEYLYLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGH 279 (550)
T ss_pred EEEecCCCeeEEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCC
Confidence 99999999999999999999999999 56678999999999999999999999 555999999999999999999
Q ss_pred EEEecccccccCCCC----------------------Ccc-----------------------cccccccCcccccCCcc
Q 036970 199 ARISEFGLAKQIPNG----------------------RTR-----------------------TTTWSLAETVGYIAPEC 233 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~----------------------~~~-----------------------~~~~~~~g~~~y~aPE~ 233 (337)
+||+|||++.-+... ... ....+..|||.|+|||+
T Consensus 280 iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEV 359 (550)
T KOG0605|consen 280 IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEV 359 (550)
T ss_pred EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHH
Confidence 999999998643210 000 00115678999999999
Q ss_pred ccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHH
Q 036970 234 HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACF 313 (337)
Q Consensus 234 ~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 313 (337)
+.+..|+..+|.||||||+|||+.|.+||....+.+.-..+..|..... .+... .......+||.+
T Consensus 360 ll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--fP~~~------------~~s~eA~DLI~r 425 (550)
T KOG0605|consen 360 LLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK--FPEEV------------DLSDEAKDLITR 425 (550)
T ss_pred HhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--CCCcC------------cccHHHHHHHHH
Confidence 9999999999999999999999999999987665444444444432221 11111 111448899999
Q ss_pred hcCCCCCCCCC---HHHHH
Q 036970 314 CTFDDPEERPN---SKDVR 329 (337)
Q Consensus 314 ~l~~~p~~Rps---~~~il 329 (337)
|+. ||+.|.. ++||.
T Consensus 426 ll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 426 LLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred Hhc-CHHHhcCcccHHHHh
Confidence 999 9999975 44443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=313.96 Aligned_cols=252 Identities=27% Similarity=0.373 Sum_probs=208.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
+...|.....||+|.||.||+|.+. .+++.||+|++.-... ....+.++.|+.++.+++++||.++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~-~t~k~vAiKii~Le~~-------------~deIediqqei~~Ls~~~~~~it~y 76 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDN-KTKKVVAIKIIDLEEA-------------EDEIEDIQQEISVLSQCDSPNITEY 76 (467)
T ss_pred cccccccchhccccccceeeeeeec-cccceEEEEEechhhc-------------chhhHHHHHHHHHHHhcCcchHHhh
Confidence 5678888999999999999999854 6999999999954332 2337789999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+..+..++++||||.||++.+.+ .....+.+..+.-++++++.|+.|||+.+ .+|+|||+.||++..+|.
T Consensus 77 ygsyl~g~~LwiiMey~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~ 149 (467)
T KOG0201|consen 77 YGSYLKGTKLWIIMEYCGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGD 149 (467)
T ss_pred hhheeecccHHHHHHHhcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCc
Confidence 99999999999999999999999999 44555688888889999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|++|||.+.........+ ....||+.|||||++....|+.++||||||++++||.+|.+|+.+..+.. ..
T Consensus 150 vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----vl--- 220 (467)
T KOG0201|consen 150 VKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----VL--- 220 (467)
T ss_pred EEEEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----EE---
Confidence 9999999998776544433 46799999999999998899999999999999999999999998654310 00
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+....++.+.+ .....+.+++..||++||+.||||.++++
T Consensus 221 ------flIpk~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 221 ------FLIPKSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ------EeccCCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 0011111112212 23344889999999999999999999885
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=294.63 Aligned_cols=241 Identities=23% Similarity=0.272 Sum_probs=204.3
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
-++|++++.||.|+||.|.+++.+. +|..||+|++.+..... ..+.+...+|..+|+.+.||.+++++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~-~g~yYAmKvL~k~~vVk-----------lKQveH~~nEk~vL~~v~~PFlv~l~ 110 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKH-SGNYYAMKVLDKQKVVK-----------LKQVEHTHNEKRVLKAVSHPFLVKLY 110 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEcc-CCceeehhhcCHHHHHH-----------HHHHHHHhhHHHHHhhccCceeEEEE
Confidence 3689999999999999999999774 79999999996554422 12367789999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+.+.+.++|||||++||.|..++ .+.+.+++..+.-++.||+.||+|||+++ +++||+||+||+++++|.+
T Consensus 111 ~t~~d~~~lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~i 183 (355)
T KOG0616|consen 111 GTFKDNSNLYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHI 183 (355)
T ss_pred EeeccCCeEEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcE
Confidence 9999999999999999999999999 44567999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||.|||.+...... .+..||||.|+|||++...++..++|.|+||+++|||+.|.+||.+..+ .+...
T Consensus 184 KitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~ 251 (355)
T KOG0616|consen 184 KITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYE 251 (355)
T ss_pred EEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHH
Confidence 99999999876443 3467999999999999999999999999999999999999999976543 23333
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCC
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEER 322 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 322 (337)
.++.... ..++-....+.+|++.+|+.|-+.|
T Consensus 252 KI~~~~v-----------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 252 KILEGKV-----------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHhCcc-----------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 3333322 1122333458899999999999988
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=286.61 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=210.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|.||.||+|+.+ .++..||+|++.++...... ...++.+|+.+...|+||||+++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi~~~~-----------v~~qlrREiEIqs~L~hpnilrl 87 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQILKTQ-----------VEHQLRREIEIQSHLRHPNILRL 87 (281)
T ss_pred chhhccccccccCCccccEeEeeec-cCCcEEEEeeeeHHHHHHhc-----------chhhhhheeEeecccCCccHHhh
Confidence 5689999999999999999999976 48999999999776543322 25689999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+++|.+....|+++||...|++...++. +....+++...+.++.|++.|+.|+|.++ ++||||||+|+|++..+.
T Consensus 88 Y~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~ 162 (281)
T KOG0580|consen 88 YGYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGE 162 (281)
T ss_pred hhheeccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCC
Confidence 9999999999999999999999999954 34566889999999999999999999655 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
.|++|||.+...+.... ...+||..|++||+..+..++...|+|++|++.||++.|.+||..... +..+..
T Consensus 163 lkiAdfGwsV~~p~~kR----~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~etYkr-- 233 (281)
T KOG0580|consen 163 LKIADFGWSVHAPSNKR----KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SETYKR-- 233 (281)
T ss_pred eeccCCCceeecCCCCc----eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHHHHH--
Confidence 99999999977653322 246899999999999999999999999999999999999999976432 111111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+..... ..++.......++|.+|+.++|.+|.+..++++
T Consensus 234 --I~k~~~-----------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 234 --IRKVDL-----------KFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --HHHccc-----------cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 111110 111223344889999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=284.79 Aligned_cols=268 Identities=21% Similarity=0.276 Sum_probs=213.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||.|||+.||+++. ..++..||+|++....... .+...+|++..++++|||++++
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~-~s~~~~YAlKkI~c~~~~~--------------~e~~~rEid~~rkf~s~~vl~l 83 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKG-LSTGHLYALKKILCHSQED--------------IEEALREIDNHRKFNSPNVLRL 83 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecc-cCcccchhhheeeccchHH--------------HHHHHHHHHHHHhhCCcchHHH
Confidence 568999999999999999999984 3589999999986555322 6788999999999999999999
Q ss_pred hceeecCC-----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 119 LARVVRPD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 119 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++...+. ..|++++|+..|+|.+.++...-++..+++.+...++.+|+.||++||+.. +++.|+||||.||++
T Consensus 84 ~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILl 162 (302)
T KOG2345|consen 84 VDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILL 162 (302)
T ss_pred HHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEe
Confidence 98876544 479999999999999999888778888999999999999999999999663 459999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcc-------cccccccCcccccCCccccCC---CCCCcccchhHhHHHHHHHhCCCCCC
Q 036970 194 DDDMEARISEFGLAKQIPNGRTR-------TTTWSLAETVGYIAPECHQTV---ALSDKCDIYSFGVLLAVLMMGKFPSD 263 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~vl~~l~~g~~pf~ 263 (337)
++.+.+++.|||.++...-.... ........|..|+|||.+.-. ..++++|||||||++|.|+.|..||+
T Consensus 163 s~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 163 SDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred cCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 99999999999999876422111 111123447889999988654 57889999999999999999999998
Q ss_pred CcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 264 DFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
...+......+.- . ...+.....+..+..+.++|++||+.||.+||++.+++..++++.
T Consensus 243 ~~~~~GgSlaLAv--------~------n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 243 RIYQQGGSLALAV--------Q------NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHhhcCCeEEEee--------e------ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 6544222111110 0 001111112225566999999999999999999999999988763
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=309.13 Aligned_cols=269 Identities=19% Similarity=0.295 Sum_probs=203.1
Q ss_pred cCcccccccccccccceEEeeeecC---------------CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHH
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG---------------SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI 104 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~---------------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 104 (337)
.++|.+.+.||+|+||.||+|.+.. ..+..||+|.+...... .....+.+|+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~ 70 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-------------NARNDFLKEV 70 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-------------HHHHHHHHHH
Confidence 5789999999999999999997532 13447999988543221 1145788999
Q ss_pred HHhcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc---------------CCCcCCHHHHHHHHHHHHHH
Q 036970 105 ITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ---------------GRRELDWLARHRIARGIASG 169 (337)
Q Consensus 105 ~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~l~~~~~~~~~~~i~~~ 169 (337)
.++.+++||||+++++++.+.+..+++|||+.+++|.+++..... ....+++..++.++.||+.|
T Consensus 71 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 150 (304)
T cd05096 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG 150 (304)
T ss_pred HHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999854321 12346788899999999999
Q ss_pred HHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHh
Q 036970 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFG 249 (337)
Q Consensus 170 l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG 249 (337)
|.|||+.+ ++|+||||+||+++.++.+||+|||++................++..|+|||++....++.++||||||
T Consensus 151 l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 227 (304)
T cd05096 151 MKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227 (304)
T ss_pred HHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHH
Confidence 99999555 999999999999999999999999998766444332222234457889999999888899999999999
Q ss_pred HHHHHHHh--CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 036970 250 VLLAVLMM--GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327 (337)
Q Consensus 250 ~vl~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 327 (337)
+++|+|++ +..||..... .................... ..++.....+.+++.+||+.||.+|||+.+
T Consensus 228 ~~l~el~~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTD----EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred HHHHHHHHccCCCCCCcCCH----HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 99999987 5577765322 11122222211111100000 011122345899999999999999999999
Q ss_pred HHHHHhh
Q 036970 328 VRCMLSQ 334 (337)
Q Consensus 328 il~~L~~ 334 (337)
|.+.|++
T Consensus 298 i~~~l~~ 304 (304)
T cd05096 298 IHAFLTE 304 (304)
T ss_pred HHHHHhC
Confidence 9998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=301.98 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=210.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..-+|++.+.||+|++|.|-+|... ..|+.||||.+.++.. ...+-.-.+.+|+.+|..|+||||+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~-~sgR~VAiKsIrKdkI-----------kdeqDlvhIRREIeIMSsLNHPhII~I 118 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEH-KSGREVAIKSIRKDKI-----------KDEQDLVHIRREIEIMSSLNHPHIIQI 118 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhc-cCCcEeehhhhhhhhc-----------ccHHHHHHHHHHHHHHhhcCCCceeeh
Confidence 4568999999999999999999754 4999999999955444 333336678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+++|+..+...+||||..+|.|.|++ +..+.+++.....+++||+.|+.|+| +++++|||||.+|||++++++
T Consensus 119 yEVFENkdKIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~N 191 (668)
T KOG0611|consen 119 YEVFENKDKIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNN 191 (668)
T ss_pred hhhhcCCceEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCC
Confidence 99999999999999999999999999 56677999999999999999999999 666999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALS-DKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++-.+....... .++|++.|.+||++++.+|. +..|.||||+++|.+..|..||++.+. ...
T Consensus 192 iKIADFGLSNly~~~kfLq---TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~l 261 (668)
T KOG0611|consen 192 IKIADFGLSNLYADKKFLQ---TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRL 261 (668)
T ss_pred eeeeccchhhhhccccHHH---HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHH
Confidence 9999999998776554443 46999999999999999875 569999999999999999999987543 233
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
++++-....-. +....+..-||++||..||+.|.|+++|..
T Consensus 262 vrQIs~GaYrE------------P~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 262 VRQISRGAYRE------------PETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred HHHhhcccccC------------CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 33333222111 111223778999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=307.33 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=199.5
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||+|+||.||+|.+. .+++.||+|++........ .....+.+|+.+++.++||||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~~ 68 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEVIRL-----------KQEQHVHNEKRVLKEVSHPFIIRLFW 68 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhh-----------HHHHHHHHHHHHHHhCCCCcHhhhHh
Confidence 47999999999999999999865 4799999999854322111 11456889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.++...++||||+++++|.+++. ..+.+++.....++.|++.||.|||+++ ++|+||+|+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~k 141 (291)
T cd05612 69 TEHDQRFLYMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIK 141 (291)
T ss_pred hhccCCeEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEE
Confidence 9999999999999999999999984 3456899999999999999999999555 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++....... ....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ......
T Consensus 142 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~ 209 (291)
T cd05612 142 LTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEK 209 (291)
T ss_pred EEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence 99999987654321 134679999999999998899999999999999999999999975321 112222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il~ 330 (337)
....... + +......+.+++.+||+.||.+||+ ++++++
T Consensus 210 i~~~~~~---~--------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 210 ILAGKLE---F--------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHhCCcC---C--------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 2222111 0 0111234889999999999999995 888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=306.38 Aligned_cols=267 Identities=24% Similarity=0.332 Sum_probs=209.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
--++|++++.||+|.||.|-+|++. .+++.||||++.+........+...........+...+||.+|.+++||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~-~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDE-VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeec-CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3589999999999999999999855 599999999998877655554444444443446789999999999999999999
Q ss_pred hceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCc-CCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 119 LARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRE-LDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 119 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++..+. +.+|||+|||..|.+... ...++ +++.++++++.+++.||+|||.++ ++||||||+|+|++.
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 9999874 577999999987766432 34555 999999999999999999999665 999999999999999
Q ss_pred CCcEEEecccccccCCCC---CcccccccccCcccccCCccccCCC----CCCcccchhHhHHHHHHHhCCCCCCCcccc
Q 036970 196 DMEARISEFGLAKQIPNG---RTRTTTWSLAETVGYIAPECHQTVA----LSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~vl~~l~~g~~pf~~~~~~ 268 (337)
+|++||+|||.+...... ..........|||.|+|||...+.. .+.+.||||+|++||.++.|+.||-+.+.
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~- 324 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE- 324 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-
Confidence 999999999998866322 1111222468999999999877632 45678999999999999999999976432
Q ss_pred cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 269 TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+....+.+.. +.....++....+.+||++||.+||+.|.+..+|..
T Consensus 325 ------~~l~~KIvn~p---------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 325 ------LELFDKIVNDP---------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred ------HHHHHHHhcCc---------ccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 23333333221 111122244566999999999999999999998864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=317.22 Aligned_cols=243 Identities=28% Similarity=0.454 Sum_probs=203.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
+....++.||.|+.|-||.|++ .+..||||++ .+.-..+|..|++|+||||+.|.+
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl---~netVAVKKV---------------------~elkETdIKHLRkLkH~NII~FkG 179 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL---HNETVAVKKV---------------------RELKETDIKHLRKLKHPNIITFKG 179 (904)
T ss_pred HHhhhhhhhccCcccceeeeec---cCceehhHHH---------------------hhhhhhhHHHHHhccCcceeeEee
Confidence 4445678999999999999998 5899999988 556677999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
+|.....++||||||..|-|...+ ...++++......|..+|+.|+.|||.+. |+|||||.-||||..+..||
T Consensus 180 VCtqsPcyCIiMEfCa~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 180 VCTQSPCYCIIMEFCAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred eecCCceeEEeeeccccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEE
Confidence 999999999999999999999999 56678999999999999999999999666 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||-++..... .....+.||..|||||++...+.++|.||||||+|||||+||..||.+.... ..++.
T Consensus 253 IsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------AIIwG 322 (904)
T KOG4721|consen 253 ISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------AIIWG 322 (904)
T ss_pred eccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-------eeEEe
Confidence 9999998876544 3445689999999999999999999999999999999999999999764331 11111
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
+..+.....+ ...++.. +.-|+++||+..|.+||++.+|+.-|+
T Consensus 323 -VGsNsL~Lpv----PstcP~G----fklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 323 -VGSNSLHLPV----PSTCPDG----FKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred -ccCCcccccC----cccCchH----HHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 1111111111 1233333 777888999999999999999987654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=305.07 Aligned_cols=269 Identities=17% Similarity=0.183 Sum_probs=199.2
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||+|+||.||+|++. .++..||+|++....... .....+.+|+.+++.++||||+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 67 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENE------------EVKETTLRELKMLRTLKQENIVELKE 67 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC-CCCcEEEEEEEecccccc------------cchhhHHHHHHHHHhCCCccccchhh
Confidence 47999999999999999999875 478999999985432211 11456788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++..++..++||||++++.+..+. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~k 140 (287)
T cd07848 68 AFRRRGKLYLVFEYVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLK 140 (287)
T ss_pred hEecCCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEE
Confidence 999999999999999887665543 2335689999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH----
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ---- 276 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~---- 276 (337)
|+|||++.......... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||..............
T Consensus 141 l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07848 141 LCDFGFARNLSEGSNAN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP 219 (287)
T ss_pred EeeccCccccccccccc-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence 99999998764332211 1134678999999999988899999999999999999999999975322111000000
Q ss_pred ----HHHHHhhcCCCCccccccc------cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 ----WMRNVMTSENPSRTIDSKL------IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ----~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
................+.. ........+..+.+++++||+.||++|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000000000 00011123456999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.53 Aligned_cols=255 Identities=25% Similarity=0.305 Sum_probs=199.6
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
.|+..+.||+|+||.||+|.+. .+|+.||+|.+........ .....+.+|+.++..++|+||+++++.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~~~~iv~~~~~ 68 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKR-----------KGEAMALNEKRILEKVNSRFVVSLAYA 68 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhhhh-----------hhHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence 4788999999999999999865 4899999999854432111 113457789999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+++..++++||+++++|.+.+... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 69 ~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl 143 (285)
T cd05631 69 YETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRI 143 (285)
T ss_pred EccCCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999887542 3346899999999999999999999554 999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||++......... ....||..|+|||++.+..++.++||||||+++|+|++|..||........ .+.....
T Consensus 144 ~Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~ 216 (285)
T cd05631 144 SDLGLAVQIPEGETV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRR 216 (285)
T ss_pred eeCCCcEEcCCCCee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHH
Confidence 999998765433221 134679999999999999999999999999999999999999975432111 1111111
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il~ 330 (337)
...... . .+......+.+++.+||+.||.+||+ ++++++
T Consensus 217 ~~~~~~--~--------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 217 VKEDQE--E--------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred hhcccc--c--------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111110 0 11112345889999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=310.30 Aligned_cols=255 Identities=18% Similarity=0.203 Sum_probs=214.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|..++.+|+|+||.+++++++. +++.|++|++.-....+.. +...+.|+.++.+++||||+.+.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~-~~~~~vlK~I~l~~~t~~~------------r~~A~~E~~lis~~~hP~iv~y~ 69 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS-DDKLYVLKKINLEKLTEPE------------RRSAIQEMDLLSKLLHPNIVEYK 69 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc-CCceEEEEEEeccccCchh------------hHHHHHHHHHHHhccCCCeeeec
Confidence 4789999999999999999999764 8889999999665543332 44678899999999999999999
Q ss_pred ceeecCCC-ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 120 ARVVRPDC-DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 120 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+.|.+++. .+|||+||+||++.+.+... ++..+++..+..|+.|++.|+.|||++. |+|||||+.|||++.++.
T Consensus 70 ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~ 144 (426)
T KOG0589|consen 70 DSFEEDGQLLCIVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKK 144 (426)
T ss_pred cchhcCCceEEEEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCc
Confidence 99999988 89999999999999999764 3567999999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
|+|+|||++..+...... .....||+.|++||.+.+.+|..++|||||||++|||++-+++|...+- ...+
T Consensus 145 VkLgDfGlaK~l~~~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li 215 (426)
T KOG0589|consen 145 VKLGDFGLAKILNPEDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELI 215 (426)
T ss_pred eeecchhhhhhcCCchhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-------HHHH
Confidence 999999999988766521 2246899999999999999999999999999999999999999976432 2333
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
..+..... ..-+...+..+..+|+.||+++|..||++.+++..
T Consensus 216 ~ki~~~~~----------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 216 LKINRGLY----------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHhhccC----------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33332221 11123445568999999999999999999999864
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=310.54 Aligned_cols=248 Identities=21% Similarity=0.249 Sum_probs=199.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|.+.+.||+|+||.||+|++. .+++.||+|++....... ......+.+|+.++..++||||++++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~~ 84 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILK-----------MKQVQHVAQEKSILMELSHPFIVNMM 84 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhh-----------hhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 478999999999999999999875 478999999985432211 11145688999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..+++|||+.+++|.+++. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 157 (329)
T PTZ00263 85 CSFQDENRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHV 157 (329)
T ss_pred EEEEcCCEEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCE
Confidence 99999999999999999999999984 3456889999999999999999999555 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
+|+|||++........ ...||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+...
T Consensus 158 kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~ 225 (329)
T PTZ00263 158 KVTDFGFAKKVPDRTF-----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYE 225 (329)
T ss_pred EEeeccCceEcCCCcc-----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHH
Confidence 9999999876543221 34689999999999998999999999999999999999999965321 11222
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVR 329 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il 329 (337)
........ ++ ......+.+++.+||+.||.+||+ +.+++
T Consensus 226 ~i~~~~~~---~p--------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 226 KILAGRLK---FP--------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred HHhcCCcC---CC--------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 22222111 00 011234789999999999999997 56665
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=297.44 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=211.0
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||+|+||.||+|+.. .+++.|++|.+....... ......+.+|+.+++.++||||+++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMD-----------AKARQDCVKEIDLLKQLNHPNVIKYLD 69 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe-CCCCEEEEEEeeccccCC-----------HHHHHHHHHHHHHHHhCCCcceeeeee
Confidence 68999999999999999999865 388999999874322111 112456888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+.+..++++||+++++|.+++.........+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~ 146 (267)
T cd08228 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEE
Confidence 999999999999999999999998765555667899999999999999999999554 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++.......... ....++..|+|||.+.+..++.++|+||||+++|++++|..||..... ........
T Consensus 147 l~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~ 219 (267)
T cd08228 147 LGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQK 219 (267)
T ss_pred ECccccceeccchhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHH
Confidence 99999987664332211 124578889999999888889999999999999999999999864321 11222222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
......+.. ........+.+++.+||+.+|++|||++++++.|++++
T Consensus 220 ~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 IEQCDYPPL---------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HhcCCCCCC---------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 221111111 11223355899999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=300.24 Aligned_cols=249 Identities=19% Similarity=0.262 Sum_probs=197.7
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeec--
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR-- 124 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~-- 124 (337)
..|+.|++|.||+|.+ +|+.||+|.+....... ....+.+.+|+.++.+++||||+++++++.+
T Consensus 26 ~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 26 VLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGH-----------KVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred eEEeeCCceEEEEEEE---CCEEEEEEecccccccc-----------HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 6799999999999986 68999999985432211 1224678899999999999999999999876
Q ss_pred --CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEe
Q 036970 125 --PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 125 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
....+++|||+++|+|.+++. ..+.+++.....++.+++.|+.|||+.. +++|+||+|+||+++.++.+||+
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEc
Confidence 346789999999999999994 3456889999999999999999999531 48899999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccCCccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 203 EFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT--VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|||++........ ...++..|+|||.+.+ ..++.++||||||+++|||++|..||..... .+....
T Consensus 166 dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------~~~~~~ 233 (283)
T PHA02988 166 CHGLEKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------KEIYDL 233 (283)
T ss_pred ccchHhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------HHHHHH
Confidence 9999876543222 2356889999999976 5789999999999999999999999975321 122222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
....... ..++ ......+.+++.+||+.||++|||+.++++.|+.++
T Consensus 234 i~~~~~~-~~~~--------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 234 IINKNNS-LKLP--------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHhcCCC-CCCC--------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2211111 1111 112345889999999999999999999999999876
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=306.57 Aligned_cols=201 Identities=25% Similarity=0.398 Sum_probs=174.1
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||.||++++. .++..+|+|.+...... .....+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~ 69 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGFY 69 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccCH-------------HHHHHHHHHHHHHHHCCCCCCCeEE
Confidence 579999999999999999999865 47899999988543211 1145788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~ 143 (331)
T cd06649 70 GAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEI 143 (331)
T ss_pred EEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcE
Confidence 999999999999999999999999843 456899999999999999999999642 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
+|+|||++........ ....|+..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 144 kl~Dfg~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 144 KLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred EEccCccccccccccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999876543221 134678999999999998899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.46 Aligned_cols=265 Identities=22% Similarity=0.317 Sum_probs=204.0
Q ss_pred ccCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|++++.||+|+||.||+|+.. ..++..||+|.+...... .....+.+|+.+++.+ +|+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~il~~l~~h~ 102 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-------------DEREALMSELKILSHLGQHK 102 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-------------HHHHHHHHHHHHHHhhccCC
Confidence 4568999999999999999999752 224467999998543221 1145688999999999 899
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc--------------------------------------------
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ-------------------------------------------- 149 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------- 149 (337)
||+++++.+.+.+..++||||+++|+|.+++.....
T Consensus 103 nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (374)
T cd05106 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182 (374)
T ss_pred ceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence 999999999999999999999999999999864321
Q ss_pred ----------------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccccc
Q 036970 150 ----------------------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207 (337)
Q Consensus 150 ----------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~ 207 (337)
...++++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla 259 (374)
T cd05106 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLA 259 (374)
T ss_pred ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceee
Confidence 1134788889999999999999999554 999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhhcCC
Q 036970 208 KQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286 (337)
Q Consensus 208 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (337)
................++..|+|||++....++.++||||||+++|+|++ |..||...... ........ ...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---~~~~~~~~----~~~ 332 (374)
T cd05106 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---SKFYKMVK----RGY 332 (374)
T ss_pred eeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---HHHHHHHH----ccc
Confidence 76644322222222334667999999988889999999999999999997 99998754221 11111111 111
Q ss_pred CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
... . +......+.+++..||+.||.+|||+.+++++|+++
T Consensus 333 ~~~-~--------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 333 QMS-R--------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred Ccc-C--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 0 001124488999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.53 Aligned_cols=255 Identities=19% Similarity=0.232 Sum_probs=201.5
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|+||.||+|++. .+++.||+|++....... ......+.+|+.++..++||||+++++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~h~~iv~~~~ 68 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLLFK-----------LNEVRHVLTERDILTTTKSEWLVKLLY 68 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhh-----------hhHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 47999999999999999999865 478999999986432211 112456888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.++...++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k 141 (333)
T cd05600 69 AFQDDEYLYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIK 141 (333)
T ss_pred EEEcCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEE
Confidence 9999999999999999999999984 3456899999999999999999999555 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... +....
T Consensus 142 L~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~ 209 (333)
T cd05600 142 LTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-------ETWEN 209 (333)
T ss_pred EEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-------HHHHH
Confidence 999999876543 112356899999999999989999999999999999999999999753221 11111
Q ss_pred HhhcCC-CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSEN-PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... .... ............+.+++.+||+.+|.+||++.++++
T Consensus 210 i~~~~~~~~~~----~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 210 LKYWKETLQRP----VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred HHhccccccCC----CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 111000 0000 000000123345889999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=314.53 Aligned_cols=265 Identities=21% Similarity=0.278 Sum_probs=203.8
Q ss_pred ccCcccccccccccccceEEeeee----cCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAEL----PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|++.+.||+|+||.||+|+. ...++..||+|++...... .....+.+|+.+++.+ +||
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-------------~~~~~~~~Ei~il~~l~~Hp 99 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-------------TEREALMSELKVLSYLGNHI 99 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-------------HHHHHHHHHHHHHHHhcCCc
Confidence 467899999999999999999974 2235678999988432211 1145688899999999 899
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc--------------------------------------------
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ-------------------------------------------- 149 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------- 149 (337)
||+++++++.+.+..++||||+++|+|.+++.....
T Consensus 100 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 179 (375)
T cd05104 100 NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV 179 (375)
T ss_pred ceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence 999999999999999999999999999999864221
Q ss_pred ---------------------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEe
Q 036970 150 ---------------------------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 150 ---------------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~ 256 (375)
T cd05104 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKIC 256 (375)
T ss_pred ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEe
Confidence 1124788889999999999999999554 9999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHH
Q 036970 203 EFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||..... .....+.+...
T Consensus 257 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~ 333 (375)
T cd05104 257 DFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---DSKFYKMIKEG 333 (375)
T ss_pred cCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---hHHHHHHHHhC
Confidence 9999976654332222222344667999999999999999999999999999998 8889865321 11122222211
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
. ... . +......+.+++..||+.||++|||+.+|++.|++.
T Consensus 334 ~---~~~---~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 Y---RML---S-------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred c---cCC---C-------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1 100 0 001123488999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=308.78 Aligned_cols=251 Identities=20% Similarity=0.214 Sum_probs=200.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|.+....+..||+|.+........ .....+.+|+.++..++||||+++
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~Iv~~ 96 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ-----------KQVDHVFSERKILNYINHPFCVNL 96 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhh-----------hhHHHHHHHHHHHHhCCCCCCcce
Confidence 456899999999999999999987654557899999854332111 114568889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++||||+.+|+|.+++. ..+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 97 ~~~~~~~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ 169 (340)
T PTZ00426 97 YGSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGF 169 (340)
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCC
Confidence 999999999999999999999999984 3456899999999999999999999554 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++....... ....||+.|+|||++.+..++.++|+|||||++|+|++|..||..... ....
T Consensus 170 ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~ 237 (340)
T PTZ00426 170 IKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-------LLIY 237 (340)
T ss_pred EEEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-------HHHH
Confidence 9999999987654321 234689999999999988899999999999999999999999975322 1111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
......... ++ ......+.+++++||+.||.+|+ +++++++
T Consensus 238 ~~i~~~~~~---~p--------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 238 QKILEGIIY---FP--------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHhcCCCC---CC--------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 222211110 11 11123378999999999999995 8888765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=306.06 Aligned_cols=245 Identities=19% Similarity=0.241 Sum_probs=194.1
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD 126 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 126 (337)
+.||+|+||.||+|++. .+|+.||+|++....... ......+.+|+.++..++||||+++++++..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 68 (323)
T cd05571 1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVIIA-----------KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD 68 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhh-----------hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC
Confidence 46999999999999865 489999999986432211 111456778999999999999999999999999
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccc
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~ 206 (337)
..++||||+++++|.+++. ..+.+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 69 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~ 141 (323)
T cd05571 69 RLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999999884 3456899999999999999999999554 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCC
Q 036970 207 AKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286 (337)
Q Consensus 207 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (337)
+......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ............
T Consensus 142 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~ 212 (323)
T cd05571 142 CKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEI 212 (323)
T ss_pred CcccccCCCc--ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCC
Confidence 8754322111 1234689999999999998999999999999999999999999965321 111222221111
Q ss_pred CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
. + +......+.+++.+||+.||++|| ++.++++
T Consensus 213 -~--~--------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 -R--F--------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -C--C--------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0 0 111234488999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=294.17 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=208.7
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.+.|+.++.||+|.-|+||+++.+. ++..+|+|++.+...... ....+.+.|-.+|..++||-++.++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~~l~~r-----------kKl~Ra~tE~eIL~~lDHPFlPTLY 143 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRG-TNCLFAMKVMDKESLASR-----------KKLKRAQTEREILSLLDHPFLPTLY 143 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecC-CCceEEEEEecHHHHhhh-----------hHHHHHHHHHHHHHhcCCCccchhh
Confidence 4678999999999999999999874 679999999966554322 2256788899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
..++.+...+++||||.||+|...++. +..+.+++..+.-++..++.||+||| -.|||+|||||+||||.++|++
T Consensus 144 a~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHI 218 (459)
T KOG0610|consen 144 ASFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHI 218 (459)
T ss_pred heeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcE
Confidence 999999999999999999999998865 56678999999999999999999999 5559999999999999999999
Q ss_pred EEecccccccCCCCCc--------------------------------c----------------------cccccccCc
Q 036970 200 RISEFGLAKQIPNGRT--------------------------------R----------------------TTTWSLAET 225 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~--------------------------------~----------------------~~~~~~~g~ 225 (337)
-|+||+++.......+ . ....+..||
T Consensus 219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT 298 (459)
T KOG0610|consen 219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT 298 (459)
T ss_pred EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence 9999998764321000 0 112256778
Q ss_pred ccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHH
Q 036970 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQML 305 (337)
Q Consensus 226 ~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (337)
-.|+|||++.+...+.+.|+|+||+++|||+.|..||.+... ... +.+++... +. ....+..+.
T Consensus 299 hEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~---~~T----l~NIv~~~-l~--------Fp~~~~vs~ 362 (459)
T KOG0610|consen 299 HEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN---KET----LRNIVGQP-LK--------FPEEPEVSS 362 (459)
T ss_pred cccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc---hhh----HHHHhcCC-Cc--------CCCCCcchh
Confidence 899999999999999999999999999999999999987532 122 22222211 11 111224556
Q ss_pred HHHHHHHHhcCCCCCCCCC----HHHHHH
Q 036970 306 LVLKIACFCTFDDPEERPN----SKDVRC 330 (337)
Q Consensus 306 ~l~~li~~~l~~~p~~Rps----~~~il~ 330 (337)
.+.+||+++|.+||++|.. +.||.+
T Consensus 363 ~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 363 AAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHHHHHHhccChhhhhccccchHHhhc
Confidence 6999999999999999998 666653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=312.50 Aligned_cols=262 Identities=22% Similarity=0.302 Sum_probs=205.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++..++..||+|.||+||+|++. ..||||++.-...... ..+.|.+|+..+++-+|.||+-+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh----GdVAVK~Lnv~~pt~~------------qlqaFKnEVa~lkkTRH~NIlLF 453 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH----GDVAVKLLNVDDPTPE------------QLQAFKNEVAVLKKTRHENILLF 453 (678)
T ss_pred CHHHhhccceeccccccceeecccc----cceEEEEEecCCCCHH------------HHHHHHHHHHHHhhcchhhheee
Confidence 4566788899999999999999874 4689999965544333 37889999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
.|++..... .||+-||+|.+|..+++..+ -.+...+.++|+.||++|+.|||.++ |+|+|||..|||+.+++.
T Consensus 454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 454 MGACMNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred ehhhcCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCc
Confidence 999998877 99999999999999997644 45889999999999999999999666 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC---CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV---ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
|||+|||++................|...|||||+++-. +|++.+||||||+|+|||++|..||.....+
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d------- 599 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD------- 599 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-------
Confidence 999999999765544332222234567789999998643 6899999999999999999999998732211
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
+.+. . .++-+...+. ......+...+.+|+..||.+++++||.+.+|+..|..+.
T Consensus 600 qIif-m--VGrG~l~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 600 QIIF-M--VGRGYLMPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred heEE-E--ecccccCccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 0000 0 1111111111 0122334456889999999999999999999999887653
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=321.08 Aligned_cols=260 Identities=21% Similarity=0.246 Sum_probs=208.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
..-++++.+.|.+|||+.||+|++.. .|..||+|++..... .....+.+|+.+|++|. |+|||.
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~-~~~~~AlKrm~~~de--------------~~L~~v~~EI~~MK~L~gh~nIV~ 99 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVK-GGKKYALKRMYVNDE--------------EALNAVKREIDIMKLLSGHKNIVS 99 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecC-CCceeeeeeeecCCH--------------HHHHHHHHHHHHHHHhcCCCceee
Confidence 55678889999999999999999762 459999999855421 22678999999999995 999999
Q ss_pred hhce-eecC------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 118 LLAR-VVRP------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 118 ~~~~-~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
+++. .... ...+++||||.+|+|-|+++...+.. |++.++++|+.+++.|+.+||.. +++++|||||.+|
T Consensus 100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiEN 176 (738)
T KOG1989|consen 100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIEN 176 (738)
T ss_pred EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhh
Confidence 9983 3221 24579999999999999998654433 99999999999999999999988 6789999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCc-c------cccccccCcccccCCccc---cCCCCCCcccchhHhHHHHHHHhCCC
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRT-R------TTTWSLAETVGYIAPECH---QTVALSDKCDIYSFGVLLAVLMMGKF 260 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~-~------~~~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslG~vl~~l~~g~~ 260 (337)
||++.++++||||||.++....... . ........|+.|+|||++ .+...++|+|||+|||+||.|++...
T Consensus 177 vLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~ 256 (738)
T KOG1989|consen 177 VLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTT 256 (738)
T ss_pred eEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence 9999999999999999976543331 1 111133458999999986 45678999999999999999999999
Q ss_pred CCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 261 PSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 261 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
||++.- ....+..+......+..+..+.+||..||+.||.+||++-++++.+.+|+
T Consensus 257 PFe~sg--------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 257 PFEESG--------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred CcCcCc--------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 997531 11122222222334567788999999999999999999999999998875
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.74 Aligned_cols=257 Identities=19% Similarity=0.208 Sum_probs=205.0
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
...|.+.+.||+|++|.||+|......+..|++|....... .....+.+|+.++..++||||++++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~~~ 131 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--------------RQAAYARSELHCLAACDHFGIVKHF 131 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--------------HHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 34599999999999999999986543378888887633221 1134677899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++..++..++||||+++|+|.+++........++++..+..++.||+.||.|||+. +++||||||+||+++.++.+
T Consensus 132 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~ 208 (478)
T PTZ00267 132 DDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGII 208 (478)
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcE
Confidence 999999999999999999999998866545556789999999999999999999955 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
+|+|||++................||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+.+.
T Consensus 209 kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~ 281 (478)
T PTZ00267 209 KLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQ 281 (478)
T ss_pred EEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence 99999999876544332233345789999999999998999999999999999999999999864321 22233
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... . +......+.+++..||+.||+.||++.+++.
T Consensus 282 ~~~~~~~~~--~--------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 282 QVLYGKYDP--F--------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHhCCCCC--C--------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 333222111 0 0112234889999999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=309.99 Aligned_cols=261 Identities=27% Similarity=0.343 Sum_probs=204.9
Q ss_pred CcccccccccccccceEEeeeecCCCC--cE-EEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSG--RV-ITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~-vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
++-.+.++||+|+||.||+|++...++ .. ||+|.... +.....+.+..+.+|.++|++++||||++
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~-----------~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG-----------SSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc-----------cccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 444556999999999999999875444 23 89998843 22233344789999999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
++|+......+++|||+|+||+|.+++... ...++..++..++.+.+.||+|||+++ ++||||..+|+|++.++
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKG 299 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCC
Confidence 999999999999999999999999999542 225999999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
.+||+|||+++.......... ...-+..|+|||.+....++.++||||||+++||+++ |..||.+... .....
T Consensus 300 ~vKISDFGLs~~~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----~~v~~ 373 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----YEVKA 373 (474)
T ss_pred eEEeCccccccCCcceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----HHHHH
Confidence 999999999876542111111 1234788999999999999999999999999999999 6789865432 22222
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+...+.... .+...+..+..++.+||..+|++|||+.++.+.|..+.
T Consensus 374 ---kI~~~~~r~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 374 ---KIVKNGYRMP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred ---HHHhcCccCC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 2212111111 11123344788888999999999999999999998764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=303.08 Aligned_cols=243 Identities=22% Similarity=0.243 Sum_probs=190.8
Q ss_pred ccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCc
Q 036970 49 IRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD 128 (337)
Q Consensus 49 lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 128 (337)
||+|+||.||+|++. .+++.||+|++....... ......+.+|+.++.+++||||+++++++.+.+..
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 68 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAHIVS-----------RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL 68 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE
Confidence 799999999999865 478999999985432111 11145678899999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 69 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~ 141 (312)
T cd05585 69 YLVLAFINGGELFHHLQ----REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCK 141 (312)
T ss_pred EEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccc
Confidence 99999999999999984 3456899999999999999999999555 9999999999999999999999999987
Q ss_pred cCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCC
Q 036970 209 QIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS 288 (337)
Q Consensus 209 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (337)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+...........
T Consensus 142 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~~~~~- 211 (312)
T cd05585 142 LNMKDDDK--TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQEPLR- 211 (312)
T ss_pred cCccCCCc--cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCCC-
Confidence 54322211 1234689999999999998999999999999999999999999975321 2222233222111
Q ss_pred ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 289 RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+ +......+.+++.+||+.||.+||++..+.+
T Consensus 212 --~--------~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 212 --F--------PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred --C--------CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 0 1112234889999999999999986543333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.04 Aligned_cols=273 Identities=22% Similarity=0.283 Sum_probs=209.0
Q ss_pred hhhhhhhccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHh
Q 036970 32 EDLAFLKKEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITA 107 (337)
Q Consensus 32 ~~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 107 (337)
++-++-...++|.+++.||+|+||.||+|.+.. ..+..||+|++...... ...+.+.+|+.++
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-------------~~~~~~~~Ei~~l 94 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS-------------SEKQALMSELKIM 94 (400)
T ss_pred CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh-------------HHHHHHHHHHHHH
Confidence 444555578899999999999999999998532 23457999988543221 1145788999999
Q ss_pred cCCC-CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc-------------------------------------
Q 036970 108 GQVR-HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------------------------------- 149 (337)
Q Consensus 108 ~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------- 149 (337)
..+. ||||+++++++.+....++||||+++|+|.+++.....
T Consensus 95 ~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (400)
T cd05105 95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK 174 (400)
T ss_pred HhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence 9996 99999999999999999999999999999999865321
Q ss_pred -------------------------------------------------------CCCcCCHHHHHHHHHHHHHHHHHHh
Q 036970 150 -------------------------------------------------------GRRELDWLARHRIARGIASGLEYLH 174 (337)
Q Consensus 150 -------------------------------------------------------~~~~l~~~~~~~~~~~i~~~l~~lh 174 (337)
....+++..+..++.|++.||.|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 254 (400)
T cd05105 175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA 254 (400)
T ss_pred ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 0134778888999999999999999
Q ss_pred cCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHH
Q 036970 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAV 254 (337)
Q Consensus 175 ~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~ 254 (337)
+. +++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+
T Consensus 255 ~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~e 331 (400)
T cd05105 255 SK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331 (400)
T ss_pred hC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHH
Confidence 55 599999999999999999999999999876543322222223345678999999988889999999999999999
Q ss_pred HHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 255 LMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 255 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
|++ |..||...... ......+ ....... .+......+.+++.+||+.+|++|||+.+|.++|.
T Consensus 332 llt~g~~P~~~~~~~---~~~~~~~---~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 332 IFSLGGTPYPGMIVD---STFYNKI---KSGYRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHCCCCCCcccchh---HHHHHHH---hcCCCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 997 88998653221 1111111 1111110 01122345889999999999999999999999998
Q ss_pred hhh
Q 036970 334 QIQ 336 (337)
Q Consensus 334 ~~~ 336 (337)
++-
T Consensus 396 ~l~ 398 (400)
T cd05105 396 SLL 398 (400)
T ss_pred HHc
Confidence 763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=301.19 Aligned_cols=264 Identities=16% Similarity=0.221 Sum_probs=196.0
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|.+.+.||.|+||.||+|++. .++..||+|.+...... .....+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~ 69 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEE-------------GAPCTAIREVSLLKNLKHANIVTLH 69 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccC-------------CcchhHHHHHHHHHhCCCCCEeeEE
Confidence 467999999999999999999865 48899999988433211 0133567899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+.+..++||||+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~ 142 (288)
T cd07871 70 DIIHTERCLTLVFEYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGEL 142 (288)
T ss_pred EEEcCCCeEEEEEeCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence 999999999999999964 89888743 3345788999999999999999999554 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
||+|||++......... .....+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||...... .....+
T Consensus 143 kl~DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~----~~~~~~ 216 (288)
T cd07871 143 KLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK----EELHLI 216 (288)
T ss_pred EECcCcceeeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence 99999998754332211 112456889999998865 46889999999999999999999999754321 111111
Q ss_pred HHHhhcCCCC------------ccccccccCC----ChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPS------------RTIDSKLIGN----GYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~------------~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......... ....+..... ..+.....+.+++.+||+.||.+|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111000000 0000000000 00112345789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=292.44 Aligned_cols=259 Identities=23% Similarity=0.285 Sum_probs=201.8
Q ss_pred cCcccccccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.++|++.+.||+|+||.||+|.+.. ..+..|++|.+...... .....+.+|+..+.+++||||++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~ 70 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-------------KQRRGFLAEALTLGQFDHSNIVR 70 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-------------HHHHHHHHHHHHHhcCCCCCcCe
Confidence 4678999999999999999997642 34678999988543211 11456889999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++..+...++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~ 144 (266)
T cd05064 71 LEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDL 144 (266)
T ss_pred EEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCC
Confidence 99999999999999999999999999854 2346899999999999999999999554 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
.++++|||.+......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||..... ..
T Consensus 145 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~ 216 (266)
T cd05064 145 VCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QD 216 (266)
T ss_pred cEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HH
Confidence 9999999987654322111 1112334678999999998899999999999999999775 9999865422 11
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
............ .+......+.+++..||+.+|.+|||+.+|++.|+++
T Consensus 217 ~~~~~~~~~~~~----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 217 VIKAVEDGFRLP----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHCCCCCC----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 121111111110 0112334588999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=291.60 Aligned_cols=265 Identities=23% Similarity=0.290 Sum_probs=210.5
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+.+.||+|++|.||+|+.. .++..+++|.+........ .....+.+|+.+++.++|+||+++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~h~~i~~~~~ 69 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDA-----------KARADCIKEIDLLKQLNHPNVIKYYA 69 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhhhH-----------HHHHHHHHHHHHHHHccCCchhhhhh
Confidence 57899999999999999999865 4789999998754322111 12457889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+++..++++||+++++|.+++.........+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~ 146 (267)
T cd08229 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999876555566789999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
++|||++.......... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........
T Consensus 147 l~dfg~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~ 219 (267)
T cd08229 147 LGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKK 219 (267)
T ss_pred ECcchhhhccccCCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhh
Confidence 99999887654332211 134678899999999888899999999999999999999999864321 11222222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
......+.. ........+.+++.+||+.||++|||+.+|++.+.++.
T Consensus 220 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 IEQCDYPPL---------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhcCCCCCC---------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 221111110 11123345889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=286.41 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=203.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|+.+..|+.|+||.||.|+++ .++..||+|++......+ .. -..-.+||.+|.+.+||||+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk-~t~eIVALKr~kmekek~---------GF---PItsLREIniLl~~~H~NIV~v 140 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDK-KTDEIVALKRLKMEKEKE---------GF---PITSLREINILLKARHPNIVEV 140 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccC-CcceeEEeeecccccccC---------CC---cchhHHHHHHHHhcCCCCeeee
Confidence 4578999999999999999999966 599999999996554211 11 2346789999999999999999
Q ss_pred hceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 119 LARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 119 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
-.+.... +..|||||||++ +|...+... .+++....+..++.|++.|++|||.++ |+|||||++|+|++..
T Consensus 141 kEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~ 213 (419)
T KOG0663|consen 141 KEVVVGSNMDKIYIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHK 213 (419)
T ss_pred EEEEeccccceeeeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccC
Confidence 8887653 568999999987 899999653 367999999999999999999999666 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
|.+||+|||+++.++....... ...-|.+|+|||.+.+. .|+++.|+||+|||+.|++++.+.|.+..+ .+..
T Consensus 214 G~lKiaDFGLAR~ygsp~k~~T--~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE----~dQl 287 (419)
T KOG0663|consen 214 GILKIADFGLAREYGSPLKPYT--PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE----IDQL 287 (419)
T ss_pred CcEEecccchhhhhcCCcccCc--ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch----HHHH
Confidence 9999999999999887644333 24569999999999887 599999999999999999999999876433 1112
Q ss_pred HHHHHHhhcCCCCcccccc-----------ccCCC-------hHH--HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSK-----------LIGNG-------YEE--QMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~-----------~~~~~-------~~~--~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+.+-..+. -+...+-+. +.... ... ....-++|+..+|..||.+|.|+++.++
T Consensus 288 ~~If~llG--tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 288 DKIFKLLG--TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred HHHHHHhC--CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 22221111 111111110 00000 011 2255778888999999999999999874
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=316.74 Aligned_cols=259 Identities=22% Similarity=0.251 Sum_probs=205.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||+||+|++. .+|+.||+|.+........ ....+.+|+..+..++|+|++++
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~------------~~~~~~~Ei~~l~~~~h~~iv~~ 96 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMSEA------------DKNRAQAEVCCLLNCDFFSIVKC 96 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCCHH------------HHHHHHHHHHHHhcCCCCcEEEe
Confidence 4589999999999999999999865 4899999999855433221 14567889999999999999998
Q ss_pred hceeecCC--------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 119 LARVVRPD--------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 119 ~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
++.+.... ..++||||+++|+|.+++.........+++..++.++.|++.||.|||+. +++|+||||+|
T Consensus 97 ~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~N 173 (496)
T PTZ00283 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSAN 173 (496)
T ss_pred ecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHH
Confidence 87765432 25799999999999999976555567799999999999999999999955 59999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
|+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 174 ILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---- 249 (496)
T PTZ00283 174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---- 249 (496)
T ss_pred EEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----
Confidence 9999999999999999876654322222334578999999999999899999999999999999999999996532
Q ss_pred cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+.+.......... ++ ......+.+++..||+.||.+||++.++++
T Consensus 250 ---~~~~~~~~~~~~~~~--~~--------~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 250 ---MEEVMHKTLAGRYDP--LP--------PSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred ---HHHHHHHHhcCCCCC--CC--------CCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 122333333222111 11 112344889999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=302.28 Aligned_cols=201 Identities=24% Similarity=0.401 Sum_probs=172.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||.|+||.||+|.+. .++..+++|.+...... .....+.+|+.++..++||||++++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~ 69 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGFY 69 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecccCH-------------HHHHHHHHHHHHHHHCCCCccccee
Confidence 578999999999999999999865 47888999987543211 1145788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~ 143 (333)
T cd06650 70 GAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI 143 (333)
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCE
Confidence 999999999999999999999999843 456889999999999999999999532 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
+|+|||++........ ....|+..|+|||.+.+..++.++|+||||+++|++++|..||..
T Consensus 144 kL~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 144 KLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred EEeeCCcchhhhhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999875533211 124678899999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=298.59 Aligned_cols=262 Identities=26% Similarity=0.380 Sum_probs=204.3
Q ss_pred CcccccccccccccceEEeeeecCC----CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
++|++.+.||+|++|.||+|..... ....+++|.+..... ......+.+|+..+..++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-------------~~~~~~~~~ei~~l~~l~h~~i~ 71 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-------------PKVQQEFRQEAELMSDLQHPNIV 71 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-------------HHHHHHHHHHHHHHHhcCCcccc
Confidence 5789999999999999999986431 226789998743221 11245688999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcC------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG------------RRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~ 184 (337)
++++++.+....++++||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+
T Consensus 72 ~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~ 148 (283)
T cd05048 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHR 148 (283)
T ss_pred eEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 9999999999999999999999999999653221 145888999999999999999999555 9999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCC
Q 036970 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSD 263 (337)
Q Consensus 185 di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~ 263 (337)
||+|+||++++++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|||++ |..||.
T Consensus 149 dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred ccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999876543332222223455788999999988889999999999999999998 999987
Q ss_pred CcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 264 DFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+... ......+ . ..... ..+...+..+.+++.+||+.||.+||++.+|++.|..+
T Consensus 229 ~~~~----~~~~~~i---~-~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 229 GFSN----QEVIEMI---R-SRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCH----HHHHHHH---H-cCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 5432 1122211 1 11111 01122335589999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=299.10 Aligned_cols=266 Identities=19% Similarity=0.245 Sum_probs=196.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
+.++|++.+.||.|+||.||+|++. .+++.||+|++...... .....+.+|+.+++.++||||+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~ 68 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEE-------------GTPFTAIREASLLKGLKHANIVLL 68 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEecccccc-------------ccchhHHHHHHHHhhCCCCCcCeE
Confidence 4588999999999999999999865 47899999998533211 012356789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 141 (303)
T cd07869 69 HDIIHTKETLTLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGE 141 (303)
T ss_pred EEEEecCCeEEEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCC
Confidence 999999999999999995 678887743 3355889999999999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++......... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.... .......
T Consensus 142 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~ 217 (303)
T cd07869 142 LKLADFGLARAKSVPSHT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERI 217 (303)
T ss_pred EEECCCCcceeccCCCcc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHH
Confidence 999999998654322211 1234678899999998654 5788999999999999999999999753221 1111111
Q ss_pred HHHHhhcCCCC--------ccccc-ccc---CCChH------HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPS--------RTIDS-KLI---GNGYE------EQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~--------~~~~~-~~~---~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. ........ ....+ ... ..... .....+.+++.+||+.||++|||+.++++
T Consensus 218 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 218 FL-VLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HH-HhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 11 11000000 00000 000 00000 01245789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=296.58 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=204.8
Q ss_pred cCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.++|.+.+.||+|+||.||+|.+.. .++..|++|.+...... +....+.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i 70 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-------------DARKDFEREAELLTNFQHENI 70 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-------------HHHHHHHHHHHHHHhcCCCCc
Confidence 4679999999999999999998642 24578999988543221 114578899999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhh----------cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVS----------QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRD 185 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~d 185 (337)
+++++++......+++|||+++++|.+++.... .....+++..+..++.|++.++.+||++ |++|+|
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~d 147 (280)
T cd05049 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRD 147 (280)
T ss_pred hheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Ceeccc
Confidence 999999999999999999999999999996542 1234578889999999999999999955 599999
Q ss_pred CCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCC
Q 036970 186 IQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDD 264 (337)
Q Consensus 186 i~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~ 264 (337)
|+|+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 148 lkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 148 LATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred cccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999876543322222223345678999999999999999999999999999998 9999864
Q ss_pred cccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
... ....+ .......... +......+.+++.+||++||++||++.++++.|++
T Consensus 228 ~~~----~~~~~---~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 228 LSN----EEVIE---CITQGRLLQR----------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCH----HHHHH---HHHcCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 322 11122 2211111110 01123448899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.61 Aligned_cols=265 Identities=25% Similarity=0.309 Sum_probs=210.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+.+.||.|++|.||+|.+. .+|+.|++|.+....... ......+.+|+.++++++|+|++++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~-----------~~~~~~~~~ei~~l~~~~~~~i~~~~~ 69 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMD-----------AKARQDCLKEIDLLKQLDHPNVIKYLA 69 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccc-----------hhhHHHHHHHHHHHHhCCCCCeeeeee
Confidence 68999999999999999999875 489999999875322211 112557889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+++..+++|||+++++|.+++.........+++..++.++.+++.||.|||+. |++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~ 146 (267)
T cd08224 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEE
Confidence 99999999999999999999999876555566789999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++.......... ....++..|+|||.+.+..++.++|+||||+++|++++|..||.... .+..+....
T Consensus 147 l~d~~~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~ 219 (267)
T cd08224 147 LGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKK 219 (267)
T ss_pred EeccceeeeccCCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhh
Confidence 99999987654332211 12456888999999988889999999999999999999999986432 112222222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
......+. . ........+.+++.+||..+|++|||+.+|+++|++++
T Consensus 220 ~~~~~~~~------~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 220 IEKCDYPP------L---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhcCCCCC------C---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111110 0 01123345889999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=309.30 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=201.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+.+.||+|+||+||+|++. .+|+.||+|++....... ......+.+|+.++..++||||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIK-----------RNQIAHVRAERDILADADSPWIVKLYY 68 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHHhh-----------ccHHHHHHHHHHHHHhcCCCCccchhh
Confidence 57999999999999999999865 489999999986432211 012457888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+++..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. |++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~k 141 (350)
T cd05573 69 SFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIK 141 (350)
T ss_pred heecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEE
Confidence 99999999999999999999999843 35689999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCC---------------------------cccccccccCcccccCCccccCCCCCCcccchhHhHHHH
Q 036970 201 ISEFGLAKQIPNGR---------------------------TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLA 253 (337)
Q Consensus 201 l~Dfg~~~~~~~~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~ 253 (337)
|+|||++....... .........||+.|+|||++.+..++.++|||||||++|
T Consensus 142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 221 (350)
T cd05573 142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221 (350)
T ss_pred eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence 99999987665432 001122346799999999999999999999999999999
Q ss_pred HHHhCCCCCCCcccccccchHHHHHHHHhhc-CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 036970 254 VLMMGKFPSDDFFQHTKEMSFVQWMRNVMTS-ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-SKDVRC 330 (337)
Q Consensus 254 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~il~ 330 (337)
+|++|..||..... .......... .... ++. .......+.++|.+||+ ||.+||+ +.++++
T Consensus 222 ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~--~p~------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 222 EMLYGFPPFYSDTL-------QETYNKIINWKESLR--FPP------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred hhccCCCCCCCCCH-------HHHHHHHhccCCccc--CCC------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 99999999975432 1111122110 0000 000 00023448899999998 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=300.89 Aligned_cols=245 Identities=20% Similarity=0.261 Sum_probs=193.5
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD 126 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 126 (337)
+.||+|+||.||++++. .+|+.||+|++....... ......+.+|+.+++.++||||+++++++..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 68 (328)
T cd05593 1 KLLGKGTFGKVILVREK-ASGKYYAMKILKKEVIIA-----------KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD 68 (328)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence 46899999999999865 489999999986432211 112457788999999999999999999999999
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccc
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~ 206 (337)
..++||||+++++|.+++. ..+.+++..+..++.||+.||.|||++ +++|+||||+||+++.++.+||+|||+
T Consensus 69 ~~~lv~Ey~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~ 141 (328)
T cd05593 69 RLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGL 141 (328)
T ss_pred EEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcC
Confidence 9999999999999988883 345689999999999999999999955 499999999999999999999999999
Q ss_pred cccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCC
Q 036970 207 AKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286 (337)
Q Consensus 207 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (337)
+........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+..........
T Consensus 142 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-------~~~~~~~~~~~~ 212 (328)
T cd05593 142 CKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEDI 212 (328)
T ss_pred CccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-------HHHHHHhccCCc
Confidence 875332211 11234689999999999988999999999999999999999999964321 122222221111
Q ss_pred CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
. ++ ......+.+++.+||++||++|| ++.++++
T Consensus 213 ~---~p--------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 213 K---FP--------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred c---CC--------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 0 11 11223488999999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=296.83 Aligned_cols=263 Identities=19% Similarity=0.299 Sum_probs=205.4
Q ss_pred cCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
..+|.+.+.||+|+||.||++... ..++..+++|.+...... ....+.+|+.++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i 69 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN--------------ARKDFHREAELLTNLQHEHI 69 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH--------------HHHHHHHHHHHHHhCCCCCc
Confidence 467899999999999999999752 224567899987433211 14568899999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhc---------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ---------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDI 186 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di 186 (337)
+++++++...+..++++||+++++|.+++..... ....+++..++.++.|++.||+|||+. |++|+||
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dl 146 (288)
T cd05093 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDL 146 (288)
T ss_pred ceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccc
Confidence 9999999999999999999999999999864321 223589999999999999999999955 5999999
Q ss_pred CCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCc
Q 036970 187 QPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDF 265 (337)
Q Consensus 187 ~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~ 265 (337)
||+||+++.++.++|+|||++................++..|+|||++.+..++.++|+||||+++|+|++ |..||...
T Consensus 147 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 147 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred CcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876644332222223345678999999998889999999999999999998 88998653
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.. ............... ... ....+.+++.+||+.||.+|||+.++.+.|+++.
T Consensus 227 ~~-------~~~~~~i~~~~~~~~------~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 227 SN-------NEVIECITQGRVLQR------PRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CH-------HHHHHHHHcCCcCCC------CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 32 111222221111110 001 1234899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=293.57 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=202.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|+++++||+|++|.||+|.+. ++..|++|.+..... ..+.+.+|+.+++.++|+||++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~ 67 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGTM---------------SVQAFLEEANLMKTLQHDKLVRLY 67 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccCCch---------------hHHHHHHHHHHHHhCCCCCeeeEE
Confidence 478999999999999999999865 677899998743221 145688899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+.+.+..++++||+.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~ 142 (261)
T cd05072 68 AVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMC 142 (261)
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcE
Confidence 9999999999999999999999998653 334578889999999999999999955 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++.......... .....++..|+|||...+..++.++|+||||+++|+|++ |..||..... ......
T Consensus 143 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~- 216 (261)
T cd05072 143 KIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----SDVMSA- 216 (261)
T ss_pred EECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----HHHHHH-
Confidence 999999998765432211 112344678999999988889999999999999999998 9999865321 111111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
........ .. ......+.+++.+||+.+|++|||++++.++|+++
T Consensus 217 --~~~~~~~~------~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 217 --LQRGYRMP------RM----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --HHcCCCCC------CC----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11111111 00 11223488999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=300.76 Aligned_cols=245 Identities=21% Similarity=0.254 Sum_probs=192.7
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD 126 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 126 (337)
+.||+|+||.||++++. .+|+.||+|++....... ......+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~ 68 (323)
T cd05595 1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIA-----------KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 68 (323)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhh-----------hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 46899999999999865 489999999986432211 111456778999999999999999999999999
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccc
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~ 206 (337)
..++||||+++++|..++. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 69 ~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 141 (323)
T cd05595 69 RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHH
Confidence 9999999999999988883 3456899999999999999999999554 99999999999999999999999998
Q ss_pred cccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCC
Q 036970 207 AKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286 (337)
Q Consensus 207 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (337)
+......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ............
T Consensus 142 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~~~~~~~ 212 (323)
T cd05595 142 CKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEI 212 (323)
T ss_pred hccccCCCCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCC
Confidence 8653222111 1234689999999999998999999999999999999999999865321 111222221111
Q ss_pred CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
. ++ ......+.+++.+||++||.+|| ++.++++
T Consensus 213 ~---~p--------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 R---FP--------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred C---CC--------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0 00 11223478999999999999998 7887764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=305.74 Aligned_cols=261 Identities=18% Similarity=0.181 Sum_probs=194.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|.+++.||+|+||.||+|.+. .+++.||+|... ...+.+|+.+++.++||||++++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~-~~~~~vaiK~~~--------------------~~~~~~E~~il~~l~HpnIv~~~ 149 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQ--------------------RGGTATEAHILRAINHPSIIQLK 149 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEEC-CCCCEEEEechh--------------------hhhhHHHHHHHHhCCCCCCCCEe
Confidence 468999999999999999999865 489999999642 23467899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++..+...++++|++. ++|..++. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 150 ~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~v 221 (391)
T PHA03212 150 GTFTYNKFTCLILPRYK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDV 221 (391)
T ss_pred EEEEECCeeEEEEecCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCE
Confidence 99999999999999994 68888873 3356889999999999999999999554 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc---chHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE---MSFVQ 276 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~---~~~~~ 276 (337)
+|+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||-........ .....
T Consensus 222 kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~ 300 (391)
T PHA03212 222 CLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK 300 (391)
T ss_pred EEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH
Confidence 99999998653322111 122357899999999999989999999999999999999999876432211100 00011
Q ss_pred HHHHHhhcCCCCcccc---------------------ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTID---------------------SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+.......+.....+ ..............+.+++.+||+.||.+|||+.++++
T Consensus 301 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 301 LIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1111000000000000 00000011123456889999999999999999999984
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.27 Aligned_cols=263 Identities=22% Similarity=0.340 Sum_probs=214.1
Q ss_pred cCcccccccccccccceEEeeeecCCCCc----EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
...-.....||+|+||.||.|+....+|. .||+|.+..... .+....|.+|..+|+.++||||
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-------------~~~~~~Fl~Ea~~m~~f~HpNi 757 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-------------EQEVSDFLKEALLMSKFDHPNI 757 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-------------HHHHHHHHHHHHHHhcCCCcce
Confidence 44566778999999999999998766665 388888744332 1226789999999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ---GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++|++.+....++++|||.+|+|..|+++.+. ....++....+.++.+|++|+.||++++ +|||||..+|+|
T Consensus 758 v~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCL 834 (1025)
T KOG1095|consen 758 VSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCL 834 (1025)
T ss_pred eeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhhee
Confidence 9999999999999999999999999999976532 2466899999999999999999999666 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~ 271 (337)
++....+||+|||+++.......++......-+..|||||.+....++.++||||||+++||+++ |..||.+...
T Consensus 835 L~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---- 910 (1025)
T KOG1095|consen 835 LDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---- 910 (1025)
T ss_pred ecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----
Confidence 99999999999999997665555554433344678999999999999999999999999999999 6688865432
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.+.+...+..++. ..+..+...+++++..||+.+|++||++..|++.+..+
T Consensus 911 ---~~v~~~~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 911 ---FEVLLDVLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred ---HHHHHHHHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 2223323333421 22344555699999999999999999999999976654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=291.85 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=199.7
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|+||.||+|+.. ++..+++|........ ...+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~~ 65 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEGAMS---------------EEDFIEEAKVMMKLSHPKLVQLY 65 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec--cCceEEEEecccCCcc---------------HHHHHHHHHHHHHCCCCCceeEE
Confidence 367899999999999999999875 5678999987433211 34678899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+....+++|||+++++|.+++.. ....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.+
T Consensus 66 ~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~ 139 (256)
T cd05114 66 GVCTQQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVV 139 (256)
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeE
Confidence 999999999999999999999998854 223588999999999999999999955 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||.+.......... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||..... .+..
T Consensus 140 kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~ 211 (256)
T cd05114 140 KVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVV 211 (256)
T ss_pred EECCCCCccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHH
Confidence 999999987654332221 112234567999999988889999999999999999999 8999865321 1222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
........+.. +. . ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 212 ~~i~~~~~~~~---~~---~----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 212 EMISRGFRLYR---PK---L----ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHCCCCCCC---CC---C----CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 22222111111 00 0 1234899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=297.42 Aligned_cols=265 Identities=20% Similarity=0.262 Sum_probs=191.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcC---CCCCChhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQ---VRHRNIVP 117 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~ni~~ 117 (337)
++|++.+.||+|+||.||+|++...++..||+|.+........ ....+.+|+.+++. ++||||++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~hpniv~ 68 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------------MPLSTIREVAVLRHLETFEHPNVVR 68 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC------------chHHHHHHHHHHHhhcccCCCCcce
Confidence 4799999999999999999987544678899998854332111 02234456655554 47999999
Q ss_pred hhceeec-----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 118 LLARVVR-----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 118 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
+++++.. ....++++||++ ++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 69 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil 142 (290)
T cd07862 69 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 142 (290)
T ss_pred EEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEE
Confidence 9998853 345789999995 5899988542 3345899999999999999999999554 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
++.++.++|+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|.+||.+.....
T Consensus 143 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--- 216 (290)
T cd07862 143 VTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--- 216 (290)
T ss_pred EcCCCCEEEccccceEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---
Confidence 99999999999999876543311 123467899999999988889999999999999999999999997543211
Q ss_pred hHHHHHHHHhhcCCCC----------ccccccc---cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWMRNVMTSENPS----------RTIDSKL---IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~----------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+...+ .......+. ..+.... .....+.....+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 217 QLGKIL-DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHH-HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 111111 111000000 0000000 00000112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=308.93 Aligned_cols=256 Identities=19% Similarity=0.282 Sum_probs=198.3
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||.|+||+||+|++. .+|+.||+|++........ .....+.+|+.++..++||||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~h~~iv~~~~ 68 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEMLEK-----------EQVAHVRAERDILAEADNPWVVKLYY 68 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhCCCCCCcceEE
Confidence 57999999999999999999865 4799999999864322111 11456788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.++...++||||+.+++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 141 (364)
T cd05599 69 SFQDENYLYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIK 141 (364)
T ss_pred EEEcCCeEEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEE
Confidence 9999999999999999999999984 3456899999999999999999999555 99999999999999999999
Q ss_pred EecccccccCCCCCccc------------------------------------ccccccCcccccCCccccCCCCCCccc
Q 036970 201 ISEFGLAKQIPNGRTRT------------------------------------TTWSLAETVGYIAPECHQTVALSDKCD 244 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~D 244 (337)
|+|||++..+....... ......||+.|+|||++....++.++|
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (364)
T cd05599 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221 (364)
T ss_pred EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence 99999986543211000 011246899999999999989999999
Q ss_pred chhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC
Q 036970 245 IYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324 (337)
Q Consensus 245 vwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 324 (337)
||||||++|+|++|..||..... .+........... ..+... ......+.+++.+|+. +|.+|++
T Consensus 222 iwSlG~il~el~~G~~Pf~~~~~-------~~~~~~i~~~~~~-~~~~~~------~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 222 WWSLGVIMYEMLVGYPPFCSDNP-------QETYRKIINWKET-LQFPDE------VPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred eecchhHHHHhhcCCCCCCCCCH-------HHHHHHHHcCCCc-cCCCCC------CCCCHHHHHHHHHHcc-CHhhcCC
Confidence 99999999999999999975432 1112222211110 001110 0112347888999997 9999998
Q ss_pred ---HHHHHH
Q 036970 325 ---SKDVRC 330 (337)
Q Consensus 325 ---~~~il~ 330 (337)
+.++++
T Consensus 287 ~~~~~~ll~ 295 (364)
T cd05599 287 NNGVNEIKS 295 (364)
T ss_pred CCCHHHHhc
Confidence 887765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=294.67 Aligned_cols=255 Identities=25% Similarity=0.297 Sum_probs=199.5
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||+|+||+||++.+. .+++.||+|++........ .....+.+|+.+++.++||||+++++.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~ 68 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKR-----------KGEAMALNEKQILEKVNSRFVVSLAYA 68 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhhhh-----------hhHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 5888999999999999999865 4789999999854322111 113457789999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+++..++||||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l 143 (285)
T cd05605 69 YETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRI 143 (285)
T ss_pred ecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEE
Confidence 9999999999999999999988754 23356899999999999999999999555 999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||++......... ....|+..|+|||++.+..++.++|+||+|+++|++++|..||.+.... ...+.+...
T Consensus 144 ~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~----~~~~~~~~~ 216 (285)
T cd05605 144 SDLGLAVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK----VKREEVERR 216 (285)
T ss_pred eeCCCceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh----hHHHHHHHH
Confidence 999998765433221 1346789999999999888999999999999999999999999753221 111111111
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
....... .+......+.+++..||+.||++|| ++.++++
T Consensus 217 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 217 VKEDQEE----------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred hhhcccc----------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1111100 1112234488999999999999999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=287.71 Aligned_cols=260 Identities=22% Similarity=0.329 Sum_probs=203.3
Q ss_pred cCcccccccccccccceEEeeeecCC--CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.++|.+.+.||+|+||.||+|.+... +...+++|........ .....+.+|+..++.++||||++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~ 69 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD-------------KQRLDFLTEASIMGQFDHPNIIR 69 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh-------------HHHHHHHHHHHHHHhCCCCCcce
Confidence 46799999999999999999987532 2457899987433211 11456888999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+.+..+++|||+++++|.+++.. ....+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++
T Consensus 70 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~ 143 (266)
T cd05033 70 LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNL 143 (266)
T ss_pred EeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 99999999999999999999999999854 234689999999999999999999955 599999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||..... .....
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~~ 219 (266)
T cd05033 144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIK 219 (266)
T ss_pred CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Confidence 999999999987753222222212344678999999998889999999999999999998 9999864321 11122
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.+ ........ +......+.+++.+||+.+|++||++.++++.|.++
T Consensus 220 ~~---~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 220 AV---EDGYRLPP----------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HH---HcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 11111110 011223488999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=300.88 Aligned_cols=257 Identities=19% Similarity=0.257 Sum_probs=196.8
Q ss_pred cccccccccccccceEEeeeec--CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPL 118 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~ 118 (337)
+|++++.||+|+||.||+++.. ..+++.||+|++........ ......+.+|+.+++.+ +|+||+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~~i~~~ 70 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQK----------AKTVEHTRTERNVLEHVRQSPFLVTL 70 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhh----------hhHHHHHHHHHHHHHhccCCCCcccE
Confidence 5889999999999999999753 23689999999854322111 11145678899999999 59999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~ 143 (332)
T cd05614 71 HYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGH 143 (332)
T ss_pred EEEEecCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCC
Confidence 999999999999999999999999984 3456899999999999999999999554 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++.......... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||......... ...
T Consensus 144 ~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~ 219 (332)
T cd05614 144 VVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEV 219 (332)
T ss_pred EEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHH
Confidence 9999999987654332221 1235689999999998875 4788999999999999999999999643221111 112
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
........... +......+.+++.+||+.||++|| +++++++
T Consensus 220 ~~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 220 SRRILKCDPPF-----------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHhcCCCCC-----------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 22222111111 011223478999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=297.18 Aligned_cols=248 Identities=20% Similarity=0.248 Sum_probs=193.6
Q ss_pred cccccccccceEEeeeec--CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceee
Q 036970 46 LEKIRSCWNGEVYKAELP--GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV 123 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 123 (337)
++.||+|+||.||+++.. ..+++.||+|.+......... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~----------~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 70 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ----------KDTAHTKAERNILEAVKHPFIVDLIYAFQ 70 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhh----------hhHHHHHHHHHHHHhCCCCchhceeeEEe
Confidence 368999999999999853 236889999998653221110 11346778999999999999999999999
Q ss_pred cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEec
Q 036970 124 RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203 (337)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~D 203 (337)
.++..++||||+.+++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D 143 (323)
T cd05584 71 TGGKLYLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTD 143 (323)
T ss_pred cCCeEEEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEee
Confidence 9999999999999999999984 3456788889999999999999999555 99999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhh
Q 036970 204 FGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT 283 (337)
Q Consensus 204 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 283 (337)
||++......... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... .........
T Consensus 144 fg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~ 214 (323)
T cd05584 144 FGLCKESIHEGTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILK 214 (323)
T ss_pred CcCCeecccCCCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHc
Confidence 9998654322221 1134689999999999988899999999999999999999999975322 122222222
Q ss_pred cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 284 SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
.... ++ +.....+.+++.+||++||++|| ++.++++
T Consensus 215 ~~~~---~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 215 GKLN---LP--------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCC---CC--------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 2111 11 11123488999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=293.51 Aligned_cols=251 Identities=24% Similarity=0.283 Sum_probs=195.8
Q ss_pred ccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCc
Q 036970 49 IRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD 128 (337)
Q Consensus 49 lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 128 (337)
||+|+||+||++.+. .+++.||+|.+........ .....+..|+.+++.++|+||+++.+++..+...
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 68 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKR-----------KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL 68 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHhhh-----------HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE
Confidence 799999999999865 4889999999854332111 1135677899999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
++||||+++++|.+.+.........+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 145 (280)
T cd05608 69 CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAV 145 (280)
T ss_pred EEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccce
Confidence 9999999999999888654445567999999999999999999999555 9999999999999999999999999987
Q ss_pred cCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCC
Q 036970 209 QIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS 288 (337)
Q Consensus 209 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (337)
........ .....||+.|+|||++.+..++.++|+||||+++|+|++|..||....... ..............
T Consensus 146 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~-- 218 (280)
T cd05608 146 ELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRILNDSV-- 218 (280)
T ss_pred ecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHHHhhcccCC--
Confidence 65443222 113467899999999999999999999999999999999999997532211 11111111111110
Q ss_pred ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 289 RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
..+......+.+++.+||+.||++|| +++++++
T Consensus 219 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 ---------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ---------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 01112334588999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=301.18 Aligned_cols=265 Identities=22% Similarity=0.335 Sum_probs=202.0
Q ss_pred ccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
+.++|++.+.||.|+||.||+|.... .+++.||+|++...... .....+.+|+.++..+ +|+
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~E~~~~~~l~~h~ 71 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-------------SEYKALMTELKILIHIGHHL 71 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-------------HHHHHHHHHHHHHHhhccCc
Confidence 45789999999999999999996421 24578999988533211 1134677899999999 899
Q ss_pred ChhhhhceeecC-CCceEEEEeecCCCHHHHHHhhhcC------------------------------------------
Q 036970 114 NIVPLLARVVRP-DCDLLVYEFRRNGSLQDILYDVSQG------------------------------------------ 150 (337)
Q Consensus 114 ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------ 150 (337)
||+++++++... ...++++||+++++|.+++......
T Consensus 72 niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (337)
T cd05054 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDK 151 (337)
T ss_pred chhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCc
Confidence 999999988654 5678999999999999998542211
Q ss_pred ---------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCc
Q 036970 151 ---------------RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT 215 (337)
Q Consensus 151 ---------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~ 215 (337)
...+++..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~ 228 (337)
T cd05054 152 SLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 228 (337)
T ss_pred chhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcc
Confidence 23688999999999999999999955 499999999999999999999999999987643332
Q ss_pred ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCcccccc
Q 036970 216 RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSK 294 (337)
Q Consensus 216 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (337)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...... ..... ......... .
T Consensus 229 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~~~-~--- 297 (337)
T cd05054 229 YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EEFCR----RLKEGTRMR-A--- 297 (337)
T ss_pred hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HHHHH----HHhccCCCC-C---
Confidence 222223345678999999999999999999999999999998 99998653221 11111 111111100 0
Q ss_pred ccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 295 LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 295 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+......+.+++.+||+.+|++||++.++++.|.++
T Consensus 298 -----~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 298 -----PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred -----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111224488999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=286.15 Aligned_cols=266 Identities=24% Similarity=0.329 Sum_probs=203.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
....|..++.||+|++|.|..|.++ .+|+.||||++.++...... ..+..+|+..|+.++|+||+.+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~F~~~~~------------akRtlRElklLr~~~HeNIi~l 86 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDK-RTGEKVAIKKILNPFENQID------------AKRTLRELKLLRHLRHENIIGL 86 (359)
T ss_pred ccceecccccccCcceeeEEEEEEc-CCCCEeehhhhhhhhhchHH------------HHHHHHHHHHHHHhcCCCcceE
Confidence 5677777899999999999999866 58999999999755433222 5678899999999999999999
Q ss_pred hceeec-----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 119 LARVVR-----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 119 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
.+++.. -...|+|+|++ +.+|...+ .+++.++...+..++.||+.||+|+||.+ ++|||+||+|+++
T Consensus 87 ~di~~p~~~~~f~DvYiV~elM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~ 158 (359)
T KOG0660|consen 87 LDIFRPPSRDKFNDVYLVFELM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLL 158 (359)
T ss_pred EeecccccccccceeEEehhHH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheee
Confidence 998876 24569999999 55899988 45566999999999999999999999776 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccc----
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH---- 268 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~---- 268 (337)
+.+...||+|||+++................|.+|+|||.+.. ..|+...||||+||++.||++|++.|.+....
T Consensus 159 n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 159 NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 9999999999999998865411112223466999999998654 47999999999999999999999998764331
Q ss_pred -------cccchHHHHH-----HHHhhc--CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 269 -------TKEMSFVQWM-----RNVMTS--ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 269 -------~~~~~~~~~~-----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.........+ +..... ..+...+...+ +......++|+.+||..||.+|+|++|.++
T Consensus 239 lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f-----p~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 239 LILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIF-----PNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHc-----CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111111111 111111 11111111111 122345899999999999999999999875
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=308.12 Aligned_cols=256 Identities=20% Similarity=0.272 Sum_probs=194.9
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
+.|..++.||+|+||+||+|++. .+++.||+|++........ .....+.+|+.+++.++||||+++++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~h~~iv~l~~ 68 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDVLNR-----------NQVAHVKAERDILAEADNEWVVKLYY 68 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------HHHHHHHHHHHHHHhcCCCCeeeeEE
Confidence 36899999999999999999865 4889999999864332111 11457889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+.+..++||||+++|+|.+++. ....+++..+..++.||+.||.|||+. |++||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~k 141 (381)
T cd05626 69 SFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIK 141 (381)
T ss_pred EEecCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEE
Confidence 9999999999999999999999984 345688999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCc---------------------------------------------ccccccccCcccccCCcccc
Q 036970 201 ISEFGLAKQIPNGRT---------------------------------------------RTTTWSLAETVGYIAPECHQ 235 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~---------------------------------------------~~~~~~~~g~~~y~aPE~~~ 235 (337)
|+|||++........ ........||+.|+|||++.
T Consensus 142 L~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 221 (381)
T cd05626 142 LTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221 (381)
T ss_pred EeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc
Confidence 999998754311000 00011346899999999999
Q ss_pred CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhh-cCCCCccccccccCCChHHHHHHHHHHHHH-
Q 036970 236 TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT-SENPSRTIDSKLIGNGYEEQMLLVLKIACF- 313 (337)
Q Consensus 236 ~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 313 (337)
+..++.++|||||||++|||++|..||...... ........ ..... +.. .......+.+++.+
T Consensus 222 ~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~~--~~~------~~~~s~~~~dli~~l 286 (381)
T cd05626 222 RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPT-------ETQLKVINWENTLH--IPP------QVKLSPEAVDLITKL 286 (381)
T ss_pred CCCCCCccceeehhhHHHHHHhCCCCCcCCCHH-------HHHHHHHccccccC--CCC------CCCCCHHHHHHHHHH
Confidence 888999999999999999999999999753321 11111111 11100 000 00112347778877
Q ss_pred -hcCCCCCCCCCHHHHHH
Q 036970 314 -CTFDDPEERPNSKDVRC 330 (337)
Q Consensus 314 -~l~~~p~~Rps~~~il~ 330 (337)
|+..+|..||++.++++
T Consensus 287 l~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 287 CCSAEERLGRNGADDIKA 304 (381)
T ss_pred ccCcccccCCCCHHHHhc
Confidence 44666777999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=290.89 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=205.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
+..+|.+.+.||.|++|.||+|.+. .+..+++|.+....... ...+.+|+.+++.++|+||+++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~--~~~~~~~k~~~~~~~~~--------------~~~~~~e~~~l~~l~~~~i~~~ 67 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWK--NRVRVAIKILKSDDLLK--------------QQDFQKEVQALKRLRHKHLISL 67 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEec--CCCcEEEEeccccchhh--------------HHHHHHHHHHHhcCCCcchhhe
Confidence 5678999999999999999999876 48899999985433211 3467889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....+++|||+++++|.+++... ....+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~ 142 (261)
T cd05148 68 FAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLV 142 (261)
T ss_pred eeeEecCCCeEEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCce
Confidence 99999999999999999999999999652 345689999999999999999999955 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||.+........... ...++..|+|||......++.++|+||||+++|++++ |..||..... .+.
T Consensus 143 ~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-------~~~ 213 (261)
T cd05148 143 CKVADFGLARLIKEDVYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-------HEV 213 (261)
T ss_pred EEEccccchhhcCCcccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-------HHH
Confidence 99999999876643322111 3345678999999988889999999999999999998 8899865321 111
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
............ +......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 214 ~~~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 214 YDQITAGYRMPC----------PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHhCCcCCC----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 222211111110 112224488999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=301.90 Aligned_cols=263 Identities=21% Similarity=0.304 Sum_probs=192.4
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||+|+||.||+|++. .+|..||+|.+....... .....+.+|+.+++.++||||++++++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~~~ 67 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVFEHV------------SDATRILREIKLLRLLRHPDIVEIKHI 67 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhhccc------------hhHHHHHHHHHHHHhCCCCCEeeecce
Confidence 5889999999999999999865 489999999885321111 113467899999999999999999998
Q ss_pred eecCC-----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 122 VVRPD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 122 ~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
+.... ..++||||+ +++|.+++. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 68 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 139 (338)
T cd07859 68 MLPPSRREFKDIYVVFELM-ESDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANAD 139 (338)
T ss_pred EeccCCCCCceEEEEEecC-CCCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCC
Confidence 86432 469999999 468988883 3456899999999999999999999555 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcc-cccccccCcccccCCccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 197 MEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQT--VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
+.++|+|||++......... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.... .
T Consensus 140 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~----~ 215 (338)
T cd07859 140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV----H 215 (338)
T ss_pred CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH----H
Confidence 99999999998765322211 11123467999999999876 57889999999999999999999999653211 0
Q ss_pred HHHHHHHHhhcCCC------------------CccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENP------------------SRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....+......... ....... .....+.....+.+++.+||+.||++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP-FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCc-hHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000000 0000000 00001112244789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=309.50 Aligned_cols=256 Identities=19% Similarity=0.262 Sum_probs=195.9
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+++.||.|+||.||+|+.. .+++.||+|++....... ......+.+|+.++..++||||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~hp~iv~~~~ 68 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSEMFK-----------KDQLAHVKAERDVLAESDSPWVVSLYY 68 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHHHH-----------hHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 47999999999999999999865 489999999985432211 112567888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+....++||||+++++|.+++. ..+.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~k 141 (377)
T cd05629 69 SFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIK 141 (377)
T ss_pred EEEcCCeeEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEE
Confidence 9999999999999999999999984 3456899999999999999999999555 99999999999999999999
Q ss_pred EecccccccCCCCCc------------cc---------------------------------ccccccCcccccCCcccc
Q 036970 201 ISEFGLAKQIPNGRT------------RT---------------------------------TTWSLAETVGYIAPECHQ 235 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~------------~~---------------------------------~~~~~~g~~~y~aPE~~~ 235 (337)
|+|||++........ .. ......||+.|+|||++.
T Consensus 142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (377)
T cd05629 142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221 (377)
T ss_pred EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence 999999863321000 00 001246899999999999
Q ss_pred CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhc
Q 036970 236 TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCT 315 (337)
Q Consensus 236 ~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 315 (337)
+..++.++|||||||++|||++|..||..... .+............ .+. ........+.+++.+||
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~-~~p------~~~~~s~~~~dli~~lL 287 (377)
T cd05629 222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENS-------HETYRKIINWRETL-YFP------DDIHLSVEAEDLIRRLI 287 (377)
T ss_pred cCCCCCceeeEecchhhhhhhcCCCCCCCCCH-------HHHHHHHHccCCcc-CCC------CCCCCCHHHHHHHHHHh
Confidence 98999999999999999999999999975332 11111221111000 000 00112244788999999
Q ss_pred CCCCCCC---CCHHHHHH
Q 036970 316 FDDPEER---PNSKDVRC 330 (337)
Q Consensus 316 ~~~p~~R---ps~~~il~ 330 (337)
. +|.+| +|+.+++.
T Consensus 288 ~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 288 T-NAENRLGRGGAHEIKS 304 (377)
T ss_pred c-CHhhcCCCCCHHHHhc
Confidence 7 67765 58888775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=278.33 Aligned_cols=259 Identities=26% Similarity=0.360 Sum_probs=212.5
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLL 119 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~ 119 (337)
+.|..-+.||+|..+.|-...++ .+|+.+++|++.-..... ..+...+..+.-..|+.+|+++ .||+|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~------~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTE------SGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhc-ccccceeEEEEEeccccc------CCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 45677789999999999888755 589999999986544422 2233445577788999999999 699999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
++|+.+...++|+|.|+.|.|+|++ .+.-.++++...+++.|+++|++|||..+ ||||||||+||+++++.++
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNI 162 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccce
Confidence 9999999999999999999999999 45567999999999999999999999555 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC------CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT------VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
+|+|||.++.+..+...+ ..+|||+|+|||.+.. ..|+...|+|++|+++|.++.|.+||-...+
T Consensus 163 ~isDFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------ 233 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------ 233 (411)
T ss_pred EEeccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------
Confidence 999999999987765554 3699999999998754 3578889999999999999999999843322
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.-+++.+..++.. +....+.+.+....+||++||+.||+.|.|++|.+.
T Consensus 234 -mlMLR~ImeGkyq-------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 234 -MLMLRMIMEGKYQ-------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -HHHHHHHHhcccc-------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2223333322221 123456777788999999999999999999999874
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=296.86 Aligned_cols=248 Identities=23% Similarity=0.266 Sum_probs=191.7
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHH---hcCCCCCChhhhh
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIIT---AGQVRHRNIVPLL 119 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~ni~~~~ 119 (337)
|++++.||+|+||.||+|++. .+++.||+|.+........ .....+.+|+.+ +..++||||++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~l~~e~~~~~~~~~l~hp~i~~~~ 68 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDIIAR-----------DEVESLMCEKRIFETANSERHPFLVNLF 68 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhccccCCCChhcee
Confidence 678999999999999999865 4899999999864322111 113445555554 4567899999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+....++||||+++++|...+. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~ 140 (324)
T cd05589 69 ACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFV 140 (324)
T ss_pred eEEEcCCEEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcE
Confidence 99999999999999999999988873 246899999999999999999999554 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .+...
T Consensus 141 kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-------~~~~~ 211 (324)
T cd05589 141 KIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-------EEVFD 211 (324)
T ss_pred EeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence 9999998865332211 11235689999999999998999999999999999999999999975322 12222
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
......... +......+.+++.+||+.||++|| ++.++++
T Consensus 212 ~i~~~~~~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 212 SIVNDEVRY-----------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHhCCCCC-----------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 222221110 011123478999999999999999 5666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=293.64 Aligned_cols=263 Identities=19% Similarity=0.306 Sum_probs=202.2
Q ss_pred ccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++.+.||+|++|.||+|.+.. ..+..|++|.+...... .....+.+|+.+++.++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~ 70 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-------------RERIEFLNEASVMKEFNCHH 70 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCC
Confidence 46789999999999999999997542 24577999987432111 11446888999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG------RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~ 188 (337)
|+++++++.++...++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||
T Consensus 71 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp 147 (277)
T cd05062 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAA 147 (277)
T ss_pred eeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcch
Confidence 999999999999999999999999999998653221 23467788899999999999999955 599999999
Q ss_pred CcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccc
Q 036970 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQ 267 (337)
Q Consensus 189 ~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~ 267 (337)
+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||.+...
T Consensus 148 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 148 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred heEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999876654333222222344678999999998889999999999999999999 6888864321
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
.+............ . +......+.+++.+||+.||++|||+.++++.|.+
T Consensus 228 -------~~~~~~~~~~~~~~--~--------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 228 -------EQVLRFVMEGGLLD--K--------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -------HHHHHHHHcCCcCC--C--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 12222222111111 0 01122348899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=306.71 Aligned_cols=247 Identities=22% Similarity=0.252 Sum_probs=205.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|.+++.||+|.||.|++|..+. +++.||||.+.+... -..+..+..+.|-++++.. +||-++.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~-~~e~yAIK~LKK~~I-----------l~~d~Ve~~~~EkrI~~la~~HPFL~~ 433 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKG-TNEYYAIKVLKKGDI-----------LQRDEVESLMCEKRIFELANRHPFLVN 433 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcC-CCcEEEEEEeeccce-----------eccccHHHHHHHHHHHHHhccCCeEee
Confidence 56899999999999999999999875 888999999955443 2223367788888888888 5999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
++..|....++|+||||+.||++..++ ..+.+++..+.-+++.|+.||.|||+++ |++||||.+|||+|.+|
T Consensus 434 L~~~fQT~~~l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eG 505 (694)
T KOG0694|consen 434 LFSCFQTKEHLFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEG 505 (694)
T ss_pred cccccccCCeEEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccC
Confidence 999999999999999999999954443 4467999999999999999999999555 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++||+|||++......+. .....+||+.|+|||++.+..|+.+.|.||||+++|||+.|..||.+.++ .+.
T Consensus 506 h~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------ee~ 576 (694)
T KOG0694|consen 506 HVKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------EEV 576 (694)
T ss_pred cEEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------HHH
Confidence 999999999987543322 22257999999999999999999999999999999999999999986544 344
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
...++.....+ +-..+.+..++++++|++||+.|..+
T Consensus 577 FdsI~~d~~~y-----------P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDEVRY-----------PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCCCCC-----------CCcccHHHHHHHHHHhccCcccccCC
Confidence 55555444322 23344568899999999999999865
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.98 Aligned_cols=257 Identities=22% Similarity=0.302 Sum_probs=202.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
..+|.+.+.||.|++|.||+|.+. ..++.+++|....... ....+.+|+..++.++|+||++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~ 68 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQLL 68 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEe-cCCceEEEEEecCCch---------------HHHHHHHHHHHHHhCCCCChhheE
Confidence 456888999999999999999865 4789999998743221 134678899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++..+...++++||+++++|.+++.. .....+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~ 143 (263)
T cd05052 69 GVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 143 (263)
T ss_pred EEEcCCCCcEEEEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcE
Confidence 999999999999999999999999854 2334589999999999999999999955 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... .+..
T Consensus 144 kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~ 215 (263)
T cd05052 144 KVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVY 215 (263)
T ss_pred EeCCCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHH
Confidence 999999987765432221 112233567999999998899999999999999999998 8899864321 1111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
........+. . +......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 216 ~~~~~~~~~~------~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 216 ELLEKGYRME------R----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHCCCCCC------C----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111111110 0 111224488999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=292.79 Aligned_cols=269 Identities=19% Similarity=0.277 Sum_probs=201.0
Q ss_pred cCcccccccccccccceEEeeeec---------------CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHH
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELP---------------GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI 104 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~---------------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 104 (337)
.++|++.+.||+|+||.||++++. ..++..+++|....... ......+.+|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-------------~~~~~~~~~E~ 70 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-------------KNARNDFLKEI 70 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-------------HHHHHHHHHHH
Confidence 467999999999999999998632 11345688898753321 11145788999
Q ss_pred HHhcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC-------CCcCCHHHHHHHHHHHHHHHHHHhcCC
Q 036970 105 ITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG-------RRELDWLARHRIARGIASGLEYLHMSH 177 (337)
Q Consensus 105 ~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~~~~~i~~~l~~lh~~~ 177 (337)
..++.++|+||+++++++..++..+++|||+++++|.+++...... ...+++..+..++.|++.||+|||+.+
T Consensus 71 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 150 (296)
T cd05095 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN 150 (296)
T ss_pred HHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999999999999999998653321 134778889999999999999999555
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM 257 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~ 257 (337)
++|+||||+||+++.++.++|+|||++................++..|+|||...+..++.++|+||||+++|||++
T Consensus 151 ---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 151 ---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred ---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence 99999999999999999999999999876543322222212334678999999888889999999999999999998
Q ss_pred --CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 258 --GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 258 --g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
|..||........ .................+ .+..+...+.+++.+||+.||++|||+.+|.+.|++
T Consensus 228 ~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 228 LCKEQPYSQLSDEQV----IENTGEFFRDQGRQVYLP------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hCCCCCccccChHHH----HHHHHHHHhhccccccCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 6788865322111 111111111110000000 011122458899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=305.97 Aligned_cols=206 Identities=23% Similarity=0.320 Sum_probs=174.2
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||+||+|++. .+++.||+|++........ .....+.+|+.++..++|+||+++++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~il~~~~~~~iv~~~~ 68 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADMLEK-----------EQVGHIRAERDILVEADSLWVVKMFY 68 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHh-----------hHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 57999999999999999999865 4789999999854322111 11456888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+....++||||+++|+|.+++. ..+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vk 141 (363)
T cd05628 69 SFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVK 141 (363)
T ss_pred EEecCCeEEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEE
Confidence 9999999999999999999999984 3456899999999999999999999554 99999999999999999999
Q ss_pred EecccccccCCCCCcc---------------------------------cccccccCcccccCCccccCCCCCCcccchh
Q 036970 201 ISEFGLAKQIPNGRTR---------------------------------TTTWSLAETVGYIAPECHQTVALSDKCDIYS 247 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws 247 (337)
|+|||++......... .......||+.|+|||++.+..++.++||||
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS 221 (363)
T cd05628 142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (363)
T ss_pred EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence 9999998754321100 0012347899999999999989999999999
Q ss_pred HhHHHHHHHhCCCCCCCc
Q 036970 248 FGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 248 lG~vl~~l~~g~~pf~~~ 265 (337)
|||++|||++|..||.+.
T Consensus 222 lGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 222 LGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred hHHHHHHHHhCCCCCCCC
Confidence 999999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=297.96 Aligned_cols=240 Identities=24% Similarity=0.268 Sum_probs=188.7
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .+++.||+|++........ .....+..|..++..+ +||||+++++++.+.
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 68 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVILQD-----------DDVECTMTEKRILSLARNHPFLTQLYCCFQTP 68 (320)
T ss_pred CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhc-----------cHHHHHHHHHHHHHhccCCCchhceeeEEEcC
Confidence 46899999999999865 4789999999854322110 1144567788888776 799999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++||||+++++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||
T Consensus 69 ~~~~iv~Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG 141 (320)
T cd05590 69 DRLFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG 141 (320)
T ss_pred CEEEEEEcCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCC
Confidence 99999999999999999884 345689999999999999999999955 59999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++......... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||..... .+.........
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~ 212 (320)
T cd05590 142 MCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDE 212 (320)
T ss_pred CCeecCcCCCc--ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCC
Confidence 98754322211 1234689999999999998999999999999999999999999975322 12222222221
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
... +......+.+++.+||+.||.+||++
T Consensus 213 ~~~-----------~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 VVY-----------PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCC-----------CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 111 01122348899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=294.15 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=205.5
Q ss_pred cCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
..+|.+.+.||+|+||.||+|.... .++..+++|........ ....+.+|+..++.++|+||
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i 69 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--------------ARKDFQREAELLTNLQHEHI 69 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH--------------HHHHHHHHHHHHhcCCCCCc
Confidence 4578899999999999999997532 24566888887443321 13468889999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h 183 (337)
+++++++......++||||+++++|.+++..... ....+++..++.++.||+.|+.|||+++ ++|
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H 146 (291)
T cd05094 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVH 146 (291)
T ss_pred ceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 9999999999999999999999999999965321 2245889999999999999999999554 999
Q ss_pred CCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCC
Q 036970 184 RDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPS 262 (337)
Q Consensus 184 ~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf 262 (337)
+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 147 ~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 226 (291)
T cd05094 147 RDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226 (291)
T ss_pred cccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876544332222223455788999999999899999999999999999998 99998
Q ss_pred CCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 263 DDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
..... . +............. ....+..+.+++.+||+++|++|||+.++++.|.++.
T Consensus 227 ~~~~~----~---~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 227 FQLSN----T---EVIECITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred CCCCH----H---HHHHHHhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 65322 1 11111111111110 0112344889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=290.52 Aligned_cols=265 Identities=23% Similarity=0.276 Sum_probs=199.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.-.|...+++|+|+||.||+|.... ++..+|||+...+.. .-.+|+.+|+.++||||+++.
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e-~~~~vAIKKv~~d~r------------------~knrEl~im~~l~HpNIV~L~ 83 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRE-TEEEVAIKKVLQDKR------------------YKNRELQIMRKLDHPNIVRLL 83 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcC-CCceeEEEEecCCCC------------------cCcHHHHHHHhcCCcCeeeEE
Confidence 3467888999999999999999764 689999999855432 345699999999999999998
Q ss_pred ceeecCC-----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 120 ARVVRPD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 120 ~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
-+|.... ...+||||++. +|.++++.....++.++...++-++.||+.||.|||+. ||+||||||+|+|+|
T Consensus 84 ~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD 159 (364)
T KOG0658|consen 84 YFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVD 159 (364)
T ss_pred EEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEc
Confidence 8876532 33689999965 89999987767788899999999999999999999954 599999999999999
Q ss_pred CC-CcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 195 DD-MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 195 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
.+ |.+||+|||.|..+..+.... +...|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+......-.
T Consensus 160 ~~tg~LKicDFGSAK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~ 236 (364)
T KOG0658|consen 160 PDTGVLKICDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLV 236 (364)
T ss_pred CCCCeEEeccCCcceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHH
Confidence 55 899999999998876554432 33558889999998886 59999999999999999999999998754322111
Q ss_pred hHHHHHH-----HHhhcCCCC-ccccccccCC-----ChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWMR-----NVMTSENPS-RTIDSKLIGN-----GYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~~-----~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+.+.+. .+-..+... ..-.+.+... .......+..+++.++|..+|.+|.++.+++.
T Consensus 237 eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 237 EIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111110 000000000 0000111111 11223456999999999999999999999874
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.57 Aligned_cols=245 Identities=22% Similarity=0.229 Sum_probs=191.5
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC-CChhhhhc
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH-RNIVPLLA 120 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~~~~ 120 (337)
+|++++.||+|+||.||+|... .+++.||+|++....... ......+..|..++..+.| ++|+++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVIIQ-----------DDDVECTMVEKRVLALPGKPPFLTQLHS 68 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHhcCCCCceeeeEE
Confidence 5889999999999999999865 478899999986432211 1114567788999999866 45888889
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+.+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k 141 (324)
T cd05587 69 CFQTMDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIK 141 (324)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEE
Confidence 9999999999999999999999884 345688999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||..... .+....
T Consensus 142 L~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~ 212 (324)
T cd05587 142 IADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DELFQS 212 (324)
T ss_pred EeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence 999999865322211 11234689999999999998899999999999999999999999975322 122222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
....... +. ......+.+++.+||++||.+|++.
T Consensus 213 i~~~~~~---~~--------~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 213 IMEHNVS---YP--------KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHcCCCC---CC--------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2221111 00 1122348899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=290.20 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=193.7
Q ss_pred cccccccccccceEEeeeec---CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 44 ASLEKIRSCWNGEVYKAELP---GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 44 ~~~~~lg~G~~g~vy~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
.+.+.||.|.||.||.|++. ...+..|+||.+....... ....+.+|+..+++++||||+++++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~ni~~~~g 68 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE-------------EEEEFLNEIQILRKLRHPNIVKLYG 68 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH-------------HHHHHHHHHHHHHTHSBTTBE-EEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc-------------cceeeeecccccccccccccccccc
Confidence 35678999999999999976 2356889999984432211 1567899999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++......++|+||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ ++|++|+++||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~K 143 (259)
T PF07714_consen 69 FCIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVK 143 (259)
T ss_dssp EEESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEE
T ss_pred ccccccccccccccccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccc
Confidence 999888899999999999999999653 3456899999999999999999999665 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||++....................|+|||.+....++.++||||||+++||+++ |..||.+... . +...
T Consensus 144 l~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~---~~~~ 216 (259)
T PF07714_consen 144 LSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----E---EIIE 216 (259)
T ss_dssp EESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----H---HHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----c---cccc
Confidence 999999987743333333334456778999999999889999999999999999999 6788765421 1 2222
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L 332 (337)
.......+.. +......+.+++..||+.+|.+|||+.++++.|
T Consensus 217 ~~~~~~~~~~----------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 217 KLKQGQRLPI----------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHTTEETTS----------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccee----------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2211111110 111233488999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.00 Aligned_cols=271 Identities=23% Similarity=0.284 Sum_probs=199.6
Q ss_pred Ccc-cccccccccccceEEeeeec---CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 41 DCF-ASLEKIRSCWNGEVYKAELP---GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 41 ~~~-~~~~~lg~G~~g~vy~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
++| .+.+.||+|+||+||++.+. ..++..|++|........ .....+.+|+..++.++||||+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~ 69 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-------------QNTSGWKKEINILKTLYHENIV 69 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh-------------HHHHHHHHHHHHHHhCCCCCEe
Confidence 455 88999999999999887532 236788999988543211 1145678899999999999999
Q ss_pred hhhceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 117 PLLARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 117 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++++... ...+++|||+++++|.+++.. ..+++..++.++.|++.||.|||+++ ++|+||||+||+++
T Consensus 70 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~ 141 (283)
T cd05080 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLD 141 (283)
T ss_pred eEEEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEc
Confidence 999987654 357899999999999999843 34899999999999999999999555 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 142 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~----- 216 (283)
T cd05080 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK----- 216 (283)
T ss_pred CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-----
Confidence 9999999999998876543221 1111224466799999998888999999999999999999999998643210
Q ss_pred HHHHHHHHhh---cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhhC
Q 036970 274 FVQWMRNVMT---SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337 (337)
Q Consensus 274 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~~ 337 (337)
..+....... ........+.......+......+.+++..||+.+|++|||+.++++.|.++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 283 (283)
T cd05080 217 FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283 (283)
T ss_pred hhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence 0000000000 000000000000001111223458899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=285.92 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=201.2
Q ss_pred ccccccccccccceEEeeeecCC--CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 43 FASLEKIRSCWNGEVYKAELPGS--SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
|.+++.||+|+||.||.|.+... .+..||+|.+....... .....+.+|+..++.++||||+++++
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 68 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY------------SEIEEFLSEAACMKDFDHPNVMKLIG 68 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH------------HHHHHHHHHHHHHHhCCCCCeeeEEe
Confidence 57889999999999999986432 34789999885332211 11457889999999999999999999
Q ss_pred eeecCCC------ceEEEEeecCCCHHHHHHhhhc--CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 121 RVVRPDC------DLLVYEFRRNGSLQDILYDVSQ--GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 121 ~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++.+... .++++||+++++|..++..... ....+++..+..++.|++.||.|||+. +++|+||||+||+
T Consensus 69 ~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil 145 (273)
T cd05035 69 VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCM 145 (273)
T ss_pred eeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEE
Confidence 8876554 6899999999999999855432 234689999999999999999999955 4999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~ 271 (337)
+++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus 146 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---- 221 (273)
T cd05035 146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---- 221 (273)
T ss_pred ECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999887654433322222334678999999988889999999999999999999 8888865321
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
. +............ .+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 222 ~---~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 222 H---EIYDYLRHGNRLK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred H---HHHHHHHcCCCCC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1222222111111 0112234589999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.21 Aligned_cols=245 Identities=20% Similarity=0.241 Sum_probs=191.3
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .+++.||+|++....... ......+..|..++..+ +||||+++++++.+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~ 68 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQ-----------DDDVDCTMTEKRILALAAKHPFLTALHCCFQTK 68 (321)
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhh-----------hhHHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 46999999999999865 478999999985432211 11144567788888766 799999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++||||+++++|.+.+. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg 141 (321)
T cd05591 69 DRLFFVMEYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFG 141 (321)
T ss_pred CeEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecc
Confidence 99999999999999998884 3456889999999999999999999554 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...........
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-------~~~~~~i~~~~ 212 (321)
T cd05591 142 MCKEGILNGVT--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-------DDLFESILHDD 212 (321)
T ss_pred cceecccCCcc--ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC
Confidence 98754322221 1234689999999999988999999999999999999999999975422 12222222221
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-------NSKDVRC 330 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-------s~~~il~ 330 (337)
... +......+.+++..||++||++|| ++.++++
T Consensus 213 ~~~-----------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 213 VLY-----------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCC-----------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111 011123488999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.25 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=193.9
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD 126 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 126 (337)
+.||+|+||.||+|++. .+++.+++|........ +....+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~g~~g~vy~~~~~-~~~~~~a~k~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 66 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPP-------------DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 66 (252)
T ss_pred CccCcccCccEEEEEEe-cCCceEEEEecCccCCH-------------HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC
Confidence 46999999999999865 37899999987432211 12457889999999999999999999999999
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccc
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~ 206 (337)
..++|+||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 67 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 140 (252)
T cd05084 67 PIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGM 140 (252)
T ss_pred CeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECcccc
Confidence 99999999999999999843 234588999999999999999999955 599999999999999999999999999
Q ss_pred cccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 207 AKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 207 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
+.................+..|+|||.+.+..++.++|+||||+++|++++ |..||..... ..... ......
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----~~~~~---~~~~~~ 213 (252)
T cd05084 141 SREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----QQTRE---AIEQGV 213 (252)
T ss_pred CcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----HHHHH---HHHcCC
Confidence 876443211111111122456999999988889999999999999999998 8888864321 11111 111111
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
... .+......+.+++.+||+.+|++|||+.+++++|..
T Consensus 214 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 214 RLP----------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 110 011123458899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=296.82 Aligned_cols=252 Identities=22% Similarity=0.266 Sum_probs=192.9
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .+++.||+|++........ .....+.+|..++..+ +||||+++++++.+.
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~~~-----------~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~ 68 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDD-----------EDIDWVQTEKHVFETASNHPFLVGLHSCFQTE 68 (329)
T ss_pred CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhccCCCCCCceEEEEEcC
Confidence 46899999999999865 4889999999864322111 1145678899999888 799999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
...++||||+++++|.+++. ..+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg 141 (329)
T cd05588 69 SRLFFVIEFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG 141 (329)
T ss_pred CEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCc
Confidence 99999999999999998883 3456999999999999999999999554 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc-ccchHHHHHHHHhhc
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT-KEMSFVQWMRNVMTS 284 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 284 (337)
++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||....... ......+........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (329)
T cd05588 142 MCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred cccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence 9864322111 1123578999999999999899999999999999999999999996421111 111122222222222
Q ss_pred CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC------HHHHH
Q 036970 285 ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN------SKDVR 329 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~~il 329 (337)
.... ++ ......+.+++.+||+.||.+||| +.+++
T Consensus 220 ~~~~--~p--------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 220 KQIR--IP--------RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCC--CC--------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 2111 11 111234889999999999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=307.46 Aligned_cols=256 Identities=20% Similarity=0.261 Sum_probs=193.7
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|..++.||+|+||+||+|++. .+++.||+|++....... ......+.+|+.+++.++||||+++++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~~~~-----------~~~~~~~~~E~~il~~~~h~~iv~~~~ 68 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKDVLL-----------RNQVAHVKAERDILAEADNEWVVRLYY 68 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHHhhh-----------HHHHHHHHHHHHHHHhCCCCcCCeEEE
Confidence 36899999999999999999865 488999999985432211 112557889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+++..++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~k 141 (382)
T cd05625 69 SFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIK 141 (382)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999843 356889999999999999999999555 99999999999999999999
Q ss_pred EecccccccCCCCCc---------------------------------------------ccccccccCcccccCCcccc
Q 036970 201 ISEFGLAKQIPNGRT---------------------------------------------RTTTWSLAETVGYIAPECHQ 235 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~---------------------------------------------~~~~~~~~g~~~y~aPE~~~ 235 (337)
|+|||++........ ........||+.|+|||++.
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 221 (382)
T cd05625 142 LTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL 221 (382)
T ss_pred EeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc
Confidence 999999753210000 00011346899999999999
Q ss_pred CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhc
Q 036970 236 TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCT 315 (337)
Q Consensus 236 ~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 315 (337)
+..++.++|||||||++|||++|..||...... +............ .... .......+.+++.+|+
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~-~~p~------~~~~s~~~~~li~~l~ 287 (382)
T cd05625 222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL-------ETQMKVINWQTSL-HIPP------QAKLSPEASDLIIKLC 287 (382)
T ss_pred CCCCCCeeeEEechHHHHHHHhCCCCCCCCCHH-------HHHHHHHccCCCc-CCCC------cccCCHHHHHHHHHHc
Confidence 989999999999999999999999999754321 1111111111000 0000 0111233667777766
Q ss_pred CCCCCCCCC---HHHHHH
Q 036970 316 FDDPEERPN---SKDVRC 330 (337)
Q Consensus 316 ~~~p~~Rps---~~~il~ 330 (337)
.+|.+|++ +.++++
T Consensus 288 -~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 288 -RGPEDRLGKNGADEIKA 304 (382)
T ss_pred -cCHhHcCCCCCHHHHhc
Confidence 49999997 777653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=287.99 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=201.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|++|.||+|.+. .++.|++|.+...... ...+.+|+.++++++||||++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~~ 67 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGTMD---------------PKDFLAEAQIMKKLRHPKLIQLY 67 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCccc---------------HHHHHHHHHHHHHCCCCCcccee
Confidence 467999999999999999999865 5678999987433211 34678899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++...+..++++||+++++|.+++... ....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 142 (261)
T cd05068 68 AVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNIC 142 (261)
T ss_pred EEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCE
Confidence 9999999999999999999999998542 234689999999999999999999955 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++.......... ......+..|+|||...+..++.++|+||||++++++++ |..||.+... . ...
T Consensus 143 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~---~~~ 214 (261)
T cd05068 143 KVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----A---EVL 214 (261)
T ss_pred EECCcceEEEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----H---HHH
Confidence 999999988765322211 111223457999999998889999999999999999999 9999865321 1 111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.......... ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 215 ~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 215 QQVDQGYRMP----------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHcCCCCC----------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1111111110 0111234589999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=299.06 Aligned_cols=246 Identities=20% Similarity=0.248 Sum_probs=192.3
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD 126 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 126 (337)
+.||+|+||.||++++. .+|+.||+|++....... ......+.+|+.++..++||||+++++++.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~ 68 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVA-----------KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 68 (325)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC
Confidence 46899999999999865 489999999985432211 111456778999999999999999999999999
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccc
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~ 206 (337)
..++||||+++++|..++. ..+.+++..+..++.||+.||.|||+. .|++|+||||+||+++.++.++|+|||+
T Consensus 69 ~~~lv~E~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~ 142 (325)
T cd05594 69 RLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGL 142 (325)
T ss_pred EEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCC
Confidence 9999999999999998883 345689999999999999999999952 2599999999999999999999999999
Q ss_pred cccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCC
Q 036970 207 AKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286 (337)
Q Consensus 207 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (337)
+......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ............
T Consensus 143 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-------~~~~~~i~~~~~ 213 (325)
T cd05594 143 CKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEI 213 (325)
T ss_pred CeecCCCCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-------HHHHHHHhcCCC
Confidence 8653322111 1134689999999999998999999999999999999999999965321 111112111111
Q ss_pred CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
. ++ ......+.+++.+||+.||++|+ ++.++++
T Consensus 214 ~---~p--------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 214 R---FP--------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred C---CC--------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 0 00 11123488999999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=309.74 Aligned_cols=262 Identities=20% Similarity=0.236 Sum_probs=192.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+++.||+|+||.||+|.+. .++..||||++.... ....+|+.+++.++||||+++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~------------------~~~~~Ei~il~~l~h~niv~l 124 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQDP------------------QYKNRELLIMKNLNHINIIFL 124 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecCc------------------chHHHHHHHHHhcCCCCCcce
Confidence 4578999999999999999999865 478999999884321 123469999999999999999
Q ss_pred hceeecC--------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 119 LARVVRP--------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 119 ~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
++++... ..+++||||++ ++|.+++.........+++..++.++.||+.||.|||+.+ ++||||||+|
T Consensus 125 ~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~N 200 (440)
T PTZ00036 125 KDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQN 200 (440)
T ss_pred eeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHH
Confidence 8876432 23568999996 4788887665556677999999999999999999999555 9999999999
Q ss_pred EEecCCC-cEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccc
Q 036970 191 VLIDDDM-EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268 (337)
Q Consensus 191 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~ 268 (337)
|+++.++ .+||+|||++.......... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....
T Consensus 201 ILl~~~~~~vkL~DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 277 (440)
T PTZ00036 201 LLIDPNTHTLKLCDFGSAKNLLAGQRSV---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277 (440)
T ss_pred EEEcCCCCceeeeccccchhccCCCCcc---cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999654 69999999998664332221 34678999999998764 6899999999999999999999999764321
Q ss_pred cccchHHHHHHHHhhcCC-----------CCcccc----ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 269 TKEMSFVQWMRNVMTSEN-----------PSRTID----SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~-----------~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
. .+...+ ..+.... ....++ ..+....+......+.+|+.+||++||.+|||+.++++
T Consensus 278 ~---~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 278 D---QLVRII-QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred H---HHHHHH-HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 1 111111 1110000 000000 00000011112346889999999999999999999873
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=292.95 Aligned_cols=260 Identities=21% Similarity=0.290 Sum_probs=199.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCc----EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
...+|++.+.||+|+||.||+|.+.. ++. .|++|.+...... .....+.+|+.+++.++|||
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~n 70 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSP-------------KANKEILDEAYVMASVDNPH 70 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEec-CCCccceeEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCC
Confidence 35679999999999999999998642 333 4899987432111 11456888999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
|+++++++..+ ..++++||+++|+|.+++.. ....+++...+.++.||+.||+|||+.+ ++|+||||+||+++
T Consensus 71 iv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~ 143 (316)
T cd05108 71 VCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVK 143 (316)
T ss_pred CCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEec
Confidence 99999988765 56799999999999999854 2345888899999999999999999555 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
.++.++|+|||++................++..|+|||.+.+..++.++||||||+++||+++ |..||.+... ..
T Consensus 144 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~ 219 (316)
T cd05108 144 TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE 219 (316)
T ss_pred CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HH
Confidence 999999999999987654333222222334678999999999899999999999999999997 9999865321 11
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
... ........ .. +..+...+.+++..||+.+|++|||+.+++..|.++.
T Consensus 220 ~~~----~~~~~~~~-~~--------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 220 ISS----ILEKGERL-PQ--------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HHH----HHhCCCCC-CC--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 11111100 00 0112234889999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=290.67 Aligned_cols=270 Identities=18% Similarity=0.275 Sum_probs=205.0
Q ss_pred ccCcccccccccccccceEEeeeecCC---------------CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHH
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGS---------------SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSE 103 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~---------------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 103 (337)
+.++|++++.||+|+||.||+|.+... .+..|++|.+...... ...+.+.+|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~e 69 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-------------NAREDFLKE 69 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-------------HHHHHHHHH
Confidence 457899999999999999999976431 2245889987543221 125678899
Q ss_pred HHHhcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc-------CCCcCCHHHHHHHHHHHHHHHHHHhcC
Q 036970 104 IITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ-------GRRELDWLARHRIARGIASGLEYLHMS 176 (337)
Q Consensus 104 ~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~lh~~ 176 (337)
+.++.+++||||+++++++..++..++++|++++++|.+++..... ....+++..++.++.|++.||.|||+.
T Consensus 70 ~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~ 149 (296)
T cd05051 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL 149 (296)
T ss_pred HHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 9999999999999999999999999999999999999999865431 123689999999999999999999955
Q ss_pred CCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHH
Q 036970 177 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLM 256 (337)
Q Consensus 177 ~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~ 256 (337)
+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+++
T Consensus 150 ~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 226 (296)
T cd05051 150 N---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226 (296)
T ss_pred C---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHH
Confidence 5 9999999999999999999999999987654443333222345577899999998888999999999999999999
Q ss_pred h--CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 257 M--GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 257 ~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
+ +..||..... .................... ..+...+..+.+++.+||+.||++|||+.+|++.|.+
T Consensus 227 ~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 227 TLCREQPYEHLTD----QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hcCCCCCCCCcCh----HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 8 6678754321 11111111111111111000 1111223458999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=283.29 Aligned_cols=269 Identities=22% Similarity=0.258 Sum_probs=203.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC-hhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN-IVPL 118 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~~ 118 (337)
...|..+++||+|++|+||+|+.. .+|+.||+|++.-....+. .-....+|+.+++.|+|+| |+++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~-~~g~~VALKkirl~~~~EG------------~P~taiREisllk~L~~~~~iv~L 76 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSK-RTGKFVALKKIRLEFEEEG------------VPSTAIREISLLKRLSHANHIVRL 76 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEe-cCCCEEEEEEEeccccccC------------CCchhhHHHHHHHHhCCCcceEEE
Confidence 456888899999999999999976 4899999999965543211 1345788999999999999 9999
Q ss_pred hceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++.... ..++|+||. .-+|..++.........++...+..++.||+.|++|||+++ |+||||||+||+
T Consensus 77 ~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlL 152 (323)
T KOG0594|consen 77 HDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLL 152 (323)
T ss_pred EeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEE
Confidence 99998877 778999999 55899999765543345777899999999999999999555 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++++|.+||+|||+++...-...... ...+|.+|+|||++.+. .|+...||||+||++.||+++++.|.+...
T Consensus 153 i~~~G~lKlaDFGlAra~~ip~~~yt--~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---- 226 (323)
T KOG0594|consen 153 ISSSGVLKLADFGLARAFSIPMRTYT--PEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---- 226 (323)
T ss_pred ECCCCcEeeeccchHHHhcCCccccc--ccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----
Confidence 99999999999999987653322222 34668999999999988 699999999999999999999999876543
Q ss_pred chHHHHHHHHhhcCCCC----c----cccccccC--------CChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPS----R----TIDSKLIG--------NGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~----~----~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
.+....+-..+...... . ........ ...+....+..+++.+||+.+|..|.|+..+++.
T Consensus 227 ~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 227 IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11122222222211111 0 00000000 0000111368899999999999999999998874
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=299.28 Aligned_cols=243 Identities=21% Similarity=0.270 Sum_probs=191.6
Q ss_pred cccccccccceEEeeeec--CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceee
Q 036970 46 LEKIRSCWNGEVYKAELP--GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV 123 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 123 (337)
++.||+|+||.||+++.. ..+|+.||+|++........ ....+.+|+.++.+++||||+++++++.
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~~~ 68 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR------------DRVRTKMERDILAEVNHPFIVKLHYAFQ 68 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh------------hHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 367999999999999752 24789999999865332111 1345678999999999999999999999
Q ss_pred cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEec
Q 036970 124 RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203 (337)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~D 203 (337)
+++..++||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 69 ~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~D 141 (318)
T cd05582 69 TEGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTD 141 (318)
T ss_pred cCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEee
Confidence 9999999999999999999883 3456899999999999999999999555 99999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhh
Q 036970 204 FGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT 283 (337)
Q Consensus 204 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 283 (337)
||++......... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... .........
T Consensus 142 fg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-------~~~~~~i~~ 212 (318)
T cd05582 142 FGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-------KETMTMILK 212 (318)
T ss_pred ccCCcccCCCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-------HHHHHHHHc
Confidence 9998765433221 1235689999999999988899999999999999999999999975321 122222222
Q ss_pred cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 036970 284 SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327 (337)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 327 (337)
.... ++ ......+.+++.+||++||++||++.+
T Consensus 213 ~~~~---~p--------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 AKLG---MP--------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCC---CC--------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1111 01 112234889999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=300.63 Aligned_cols=251 Identities=26% Similarity=0.334 Sum_probs=192.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|+.++.||+|+||.||+|++. .+++.||+|++...... .....+.+|+.+++.++|+||+++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~ 137 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHED-------------TVRRQICREIEILRDVNHPNVVKC 137 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCcH-------------HHHHHHHHHHHHHHhCCCCCccee
Confidence 3577899999999999999999865 47899999998433211 124578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++|+||+++++|.+.. ...+..+..++.||+.||.|||+.+ ++|+||||+||+++.++.
T Consensus 138 ~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 206 (353)
T PLN00034 138 HDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKN 206 (353)
T ss_pred eeEeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCC
Confidence 99999999999999999999986532 2467778899999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC-----CCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-----ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
++|+|||++......... .....||..|+|||++... ..+.++||||||+++|+|++|..||..... ..
T Consensus 207 ~kL~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~ 280 (353)
T PLN00034 207 VKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GD 280 (353)
T ss_pred EEEcccccceeccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----cc
Confidence 999999998765432211 1234689999999987532 344689999999999999999999973221 11
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.............+. ........+.++|.+||+.||++|||+.++++
T Consensus 281 ~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 281 WASLMCAICMSQPPE----------APATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHHHhccCCCC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122221111111111 01122344899999999999999999999986
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=294.96 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=187.6
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .+++.||+|.+........ ........|..++..+ +||||+++++++..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~ 68 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLED-----------DDVECTMVERRVLALAWEHPFLTHLFCTFQTK 68 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hhHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 46999999999999865 4789999999865332111 1133445566666544 899999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
...++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg 141 (316)
T cd05592 69 EHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFG 141 (316)
T ss_pred CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCc
Confidence 999999999999999998843 346899999999999999999999554 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+.........
T Consensus 142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~ 212 (316)
T cd05592 142 MCKENMNGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILNDR 212 (316)
T ss_pred CCeECCCCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCC
Confidence 9875433221 12235689999999999998899999999999999999999999975322 12222222111
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK-DVR 329 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~il 329 (337)
... + ......+.+++.+||+.||++||++. +++
T Consensus 213 ~~~---~--------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 213 PHF---P--------RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCC---C--------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 110 0 11223478899999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=289.10 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=201.0
Q ss_pred cccccccccccccceEEeeeecCC----CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
+|++.+.||+|+||.||+|..... ....+++|.+...... .....+.+|+..++.++||||++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~ 67 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-------------SELRDLLSEFNLLKQVNHPHVIK 67 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-------------HHHHHHHHHHHHHhhCCCCCEee
Confidence 478899999999999999985321 2356888877433221 11457889999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhc--------------------CCCcCCHHHHHHHHHHHHHHHHHHhcCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ--------------------GRRELDWLARHRIARGIASGLEYLHMSH 177 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 177 (337)
+++.+..++..++++||+.+++|.+++..... ....+++..++.++.|++.||.|||+.
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~- 146 (290)
T cd05045 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM- 146 (290)
T ss_pred EEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-
Confidence 99999999999999999999999999864321 123578899999999999999999955
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM 257 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~ 257 (337)
+++|+||+|+||++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++++|++
T Consensus 147 --~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t 224 (290)
T cd05045 147 --KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224 (290)
T ss_pred --CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence 499999999999999999999999999876543322222223345678999999988889999999999999999998
Q ss_pred -CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 258 -GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 258 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
|..||.+... ....+...... ... .+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 225 ~g~~p~~~~~~----~~~~~~~~~~~---~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 225 LGGNPYPGIAP----ERLFNLLKTGY---RME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred cCCCCCCCCCH----HHHHHHHhCCC---CCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 9999865321 11122211111 000 0111223488999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=289.67 Aligned_cols=265 Identities=23% Similarity=0.309 Sum_probs=205.8
Q ss_pred ccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|++.+.||+|++|.||+|.... .....+++|........ .....+.+|+.+++.+ +|+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~ 76 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-------------KDLSDLVSEMEMMKMIGKHK 76 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-------------HHHHHHHHHHHHHHhhcCCC
Confidence 45789999999999999999998642 23467899987532211 1145688899999999 799
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhh------------cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVS------------QGRRELDWLARHRIARGIASGLEYLHMSHRPRI 181 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~ 181 (337)
||+++++++..++..+++|||+++++|.+++.... .....+++..+..++.|++.||.|||+.+ +
T Consensus 77 ~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---i 153 (293)
T cd05053 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---C 153 (293)
T ss_pred CeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 99999999999999999999999999999986532 23456889999999999999999999554 9
Q ss_pred eeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCC
Q 036970 182 IHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKF 260 (337)
Q Consensus 182 ~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~ 260 (337)
+|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|++++ |..
T Consensus 154 vH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 233 (293)
T cd05053 154 IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233 (293)
T ss_pred cccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCC
Confidence 9999999999999999999999999987654433222222344677999999988889999999999999999997 888
Q ss_pred CCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 261 PSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 261 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
||..... .+............ .+......+.+++.+||+.||++|||+.++++.|+++-
T Consensus 234 p~~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 234 PYPGIPV-------EELFKLLKEGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCH-------HHHHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 9864321 11111111111111 11122345889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=295.53 Aligned_cols=248 Identities=22% Similarity=0.260 Sum_probs=189.5
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .+++.||+|++....... ......+.+|+.++.++ +||||+++++++.+.
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 68 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVND-----------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 68 (329)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcc-----------hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC
Confidence 46999999999999865 478999999986542211 11145677888888776 899999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
...++||||+++++|..++. ..+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG 141 (329)
T cd05618 69 SRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 141 (329)
T ss_pred CEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999999999988873 3456899999999999999999999555 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc-ccchHHHHHHHHhhc
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT-KEMSFVQWMRNVMTS 284 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 284 (337)
++......... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||....... ...............
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 219 (329)
T cd05618 142 MCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred ccccccCCCCc--cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence 98753322111 123568999999999999899999999999999999999999996321111 111112222222111
Q ss_pred CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 285 ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
.... + +......+.+++.+||+.||++||++
T Consensus 220 ~~~~--~--------p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 220 KQIR--I--------PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCC--C--------CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1111 1 11122347899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=303.41 Aligned_cols=256 Identities=20% Similarity=0.233 Sum_probs=199.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+.+.||+|+||.||+|++. .+|+.||+|++....... ......+.+|+.+++.++|+||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~i~~~~~~~~i~~~~~ 68 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLA-----------QETVSFFEEERDILSISNSPWIPQLQY 68 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHhCCCCCCcceee
Confidence 47999999999999999999865 489999999986433211 112456888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+....++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~k 142 (330)
T cd05601 69 AFQDKDNLYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIK 142 (330)
T ss_pred EEecCCeEEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEE
Confidence 999999999999999999999998542 346899999999999999999999554 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCcccc------CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ------TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
|+|||++.......... .....||+.|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 143 L~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------- 214 (330)
T cd05601 143 LADFGSAARLTANKMVN-SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------- 214 (330)
T ss_pred eccCCCCeECCCCCcee-eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------
Confidence 99999997765433221 12346799999999986 45678899999999999999999999965322
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............... ++ ........+.+++..||+ +|.+|||++++++
T Consensus 215 ~~~~~~i~~~~~~~~-~~------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 215 AKTYNNIMNFQRFLK-FP------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHcCCCccC-CC------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 112222222111100 00 011123447889999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.62 Aligned_cols=257 Identities=20% Similarity=0.236 Sum_probs=199.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+++.||+|.+........ .....+.+|+.+++.++||||+++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~il~~~~h~~iv~~ 108 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKR-----------SDSAFFWEERDIMAHANSEWIVQL 108 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hhHHHHHHHHHHHHhCCCCCcceE
Confidence 5689999999999999999999865 4899999999854321110 113457789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. |++||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ 180 (370)
T cd05596 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 180 (370)
T ss_pred EEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCC
Confidence 9999999999999999999999999843 3478888999999999999999955 4999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC----CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV----ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
++|+|||++.......... .....||+.|+|||++.+. .++.++|+|||||++|+|++|..||.....
T Consensus 181 ~kL~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------- 252 (370)
T cd05596 181 LKLADFGTCMKMDANGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------- 252 (370)
T ss_pred EEEEeccceeeccCCCccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------
Confidence 9999999987654332211 1234689999999998654 378899999999999999999999975322
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEE--RPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~il~ 330 (337)
.............. .++. ....+..+.+++.+||+.+|.+ |+|+.++++
T Consensus 253 ~~~~~~i~~~~~~~-~~~~------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 253 VGTYSKIMDHKNSL-TFPD------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHHHHHHHcCCCcC-CCCC------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 11222222211111 0111 1112345889999999999987 999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=308.05 Aligned_cols=256 Identities=20% Similarity=0.255 Sum_probs=194.5
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||.||+|++. .+++.||+|++........ .....+.+|+.+++.++|+||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~h~~iv~~~~ 68 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKADVLMR-----------NQAAHVKAERDILAEADNEWVVKLYY 68 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHHHHhh-----------hhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 47999999999999999999865 4799999999854321110 11456788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+++..++||||+++++|.+++. ..+.+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ik 141 (376)
T cd05598 69 SFQDKDNLYFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIK 141 (376)
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999984 3456889999999999999999999555 99999999999999999999
Q ss_pred EecccccccCCCCC-----------------------------------------cccccccccCcccccCCccccCCCC
Q 036970 201 ISEFGLAKQIPNGR-----------------------------------------TRTTTWSLAETVGYIAPECHQTVAL 239 (337)
Q Consensus 201 l~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~ 239 (337)
|+|||++..+.... .........||+.|+|||++.+..+
T Consensus 142 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 221 (376)
T cd05598 142 LTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221 (376)
T ss_pred EEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC
Confidence 99999975321000 0000112468999999999999999
Q ss_pred CCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCC
Q 036970 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDP 319 (337)
Q Consensus 240 ~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 319 (337)
+.++|||||||++|+|++|..||...... +.......... ...+.. .......+.+++.+|+ .+|
T Consensus 222 ~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~-~~~~~~------~~~~s~~~~~li~~l~-~~p 286 (376)
T cd05598 222 TQLCDWWSVGVILYEMLVGQPPFLADTPA-------ETQLKVINWET-TLHIPS------QAKLSREASDLILRLC-CGA 286 (376)
T ss_pred CcceeeeeccceeeehhhCCCCCCCCCHH-------HHHHHHhccCc-cccCCC------CCCCCHHHHHHHHHHh-cCH
Confidence 99999999999999999999999754321 11111111110 000000 0112233677777776 499
Q ss_pred CCCC---CHHHHHH
Q 036970 320 EERP---NSKDVRC 330 (337)
Q Consensus 320 ~~Rp---s~~~il~ 330 (337)
.+|+ ++.++++
T Consensus 287 ~~R~~~~t~~ell~ 300 (376)
T cd05598 287 EDRLGKNGADEIKA 300 (376)
T ss_pred hhcCCCCCHHHHhC
Confidence 9999 8888864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=287.84 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=203.8
Q ss_pred ccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|.+.+.||+|+||.||+|.... ..+..|++|........ .....+.+|+.++..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~ 70 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-------------RERIEFLNEASVMKEFNCHH 70 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-------------HHHHHHHHHHHHHHhCCCCc
Confidence 35789999999999999999998642 24578999997433211 11346788999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG------RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~ 188 (337)
|+++++++......++++||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||+|
T Consensus 71 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p 147 (277)
T cd05032 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAA 147 (277)
T ss_pred eeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCh
Confidence 999999999999999999999999999998653321 23478889999999999999999955 499999999
Q ss_pred CcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccc
Q 036970 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQ 267 (337)
Q Consensus 189 ~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~ 267 (337)
+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred heEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 999999999999999999876644332222222345778999999988889999999999999999998 8899864321
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
. +............ . +......+.+++.+||+.+|++|||+.++++.|++
T Consensus 228 ----~---~~~~~~~~~~~~~--~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 228 ----E---EVLKFVIDGGHLD--L--------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----H---HHHHHHhcCCCCC--C--------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 1111221111111 0 11113458899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=278.39 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=206.3
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
....++|++-..||+|.|+.|+...+. .+|+.+++|+++-...... ..+.+.+|+++-+.|+||||+
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~-~tg~~fa~kiin~~k~~~~------------~~e~l~rEarIC~~LqHP~Iv 73 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSAR------------DFQKLEREARICRKLQHPNIV 73 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhc-cchHHHHHHHhhhhhhccc------------cHHHHHHHHHHHHhcCCCcEe
Confidence 345688999999999999999999644 5999999998855433221 156789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC-
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD- 195 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~- 195 (337)
++.+.+.+....|+|+|++.|++|..-|- ..-.+++..+-..++||+++|.|+|.++ |+|||+||+|+++..
T Consensus 74 rL~~ti~~~~~~ylvFe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK 146 (355)
T KOG0033|consen 74 RLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASK 146 (355)
T ss_pred ehhhhhcccceeEEEEecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeec
Confidence 99999999999999999999999966652 2244788888999999999999999555 999999999999963
Q ss_pred --CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 196 --DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 196 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
..-+||+|||++..+.. ........|||+|||||++...+|+.++|||+.|+++|-++.|.+||-+..+ ..
T Consensus 147 ~~~A~vKL~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----~r 219 (355)
T KOG0033|consen 147 AKGAAVKLADFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HR 219 (355)
T ss_pred cCCCceeecccceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----HH
Confidence 34599999999988872 2334467899999999999999999999999999999999999999976332 12
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+.+.+.. ... ++....++.......+|+.+||..||++|+|+.|.++
T Consensus 220 lye~I~~---g~y-------d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 220 LYEQIKA---GAY-------DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHhc---ccc-------CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2222211 111 1112335555666899999999999999999998764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=289.98 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=199.3
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhcee
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARV 122 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~ 122 (337)
|++++.||+|+||+||+++.. .+++.||+|.+......... .....+|+..+++++||||+++++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~~~------------~~~~~~e~~~~~~l~~~~i~~~~~~~ 67 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEEEE------------REENIREIKILRRLRHPNIVQILDVF 67 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHHHH------------HHHHHHHHHHHHHHTBTTBCHEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC-CCCeEEEEEEeccccccccc------------cchhhhhhhccccccccccccccccc
Confidence 788999999999999999866 47889999999766543322 22345599999999999999999999
Q ss_pred ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEe
Q 036970 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
.+....+++||++++++|.+++. ..+.++...++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+
T Consensus 68 ~~~~~~~~v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~ 140 (260)
T PF00069_consen 68 QDDNYLYIVMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLI 140 (260)
T ss_dssp EESSEEEEEEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEES
T ss_pred ccccccccccccccccccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccc
Confidence 99999999999999999999995 3456899999999999999999999665 9999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccCCcccc-CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 203 EFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
|||.+...... ........++..|+|||.+. +..++.++|+||||+++++|++|..||...................
T Consensus 141 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~ 218 (260)
T PF00069_consen 141 DFGSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP 218 (260)
T ss_dssp SGTTTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH
T ss_pred ccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc
Confidence 99998764211 11222356788999999998 7789999999999999999999999997641111111111111111
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... .......+.+++.+||+.||++|||+.++++
T Consensus 219 ~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 219 LPSSSQQ-----------SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHTTS-----------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccc-----------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1001000 0000145999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=283.62 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=201.0
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+.+.||.|++|.||.|... .++..+++|.+......... ......+.+|+.++++++||||+++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 71 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPET---------KKEVNALECEIQLLKNLQHERIVQYYG 71 (263)
T ss_pred CcccccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchhh---------HHHHHHHHHHHHHHHhCCCCCeeeeEE
Confidence 57999999999999999999854 47899999988644322111 112457889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.++...++++||+++++|.+++.. .+.+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 72 ~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~ 144 (263)
T cd06625 72 CLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVK 144 (263)
T ss_pred EEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999843 356889999999999999999999554 99999999999999999999
Q ss_pred EecccccccCCCCCcccc-cccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTT-TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|++++|..||..... .....
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~ 217 (263)
T cd06625 145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIF 217 (263)
T ss_pred EeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHHHH
Confidence 999999876543211111 0134567889999999998899999999999999999999999865321 11111
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
........ ..+ +......+.+++.+||+++|.+|||+.++++.
T Consensus 218 ~~~~~~~~-~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 KIATQPTN-PQL--------PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHhccCCC-CCC--------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111111 101 11223348899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.70 Aligned_cols=253 Identities=21% Similarity=0.304 Sum_probs=199.2
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|.+.+.||+|++|.||.|++. .+..+++|.+...... .+.+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~~ 65 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMKLSHEKLVQLY 65 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCccc---------------HHHHHHHHHHHhcCCCCCeeeEE
Confidence 467899999999999999999865 4567999987533221 34688899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+....+++|||+.+++|.+++.. ....+++..++.++.||+.||.|||+. |++|+||+|+||+++.++.+
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~ 139 (256)
T cd05113 66 GVCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCV 139 (256)
T ss_pred EEEccCCCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCE
Confidence 999999999999999999999999854 223689999999999999999999955 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||.+......... ......++..|+|||...+..++.++|+||||+++|+|++ |..||..... . ...
T Consensus 140 kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~---~~~ 211 (256)
T cd05113 140 KVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----S---ETV 211 (256)
T ss_pred EECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----H---HHH
Confidence 99999998765433221 1112344677999999988889999999999999999998 9999865322 1 111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
........... . ......+.+++.+||+.+|.+|||+.++++.|+
T Consensus 212 ~~~~~~~~~~~--~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 212 EKVSQGLRLYR--P--------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHhcCCCCCC--C--------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 22222111110 0 011244899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=290.15 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=201.7
Q ss_pred CcccccccccccccceEEeeeec---CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELP---GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
++|++.+.||+|+||.||+|.+. ...+..+++|.+...... .....+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~ 71 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-------------QQWGEFQQEASLMAELHHPNIVC 71 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-------------HHHHHHHHHHHHHhhCCCCCeee
Confidence 57889999999999999999752 235678999988532211 11456888999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhc-------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ-------------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~ 184 (337)
+++++..+...+++|||+++++|.+++..... ....+++.....++.|++.||.|||+++ ++|+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~ 148 (283)
T cd05090 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHK 148 (283)
T ss_pred EEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehh
Confidence 99999999999999999999999999853221 1235788889999999999999999554 9999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCC
Q 036970 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSD 263 (337)
Q Consensus 185 di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~ 263 (337)
||+|+||+++.++.++|+|||++................++..|+|||++.+..++.++|+||||+++|+|++ |..||.
T Consensus 149 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred ccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987644332222223345678999999988889999999999999999998 888986
Q ss_pred CcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 264 DFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
+... ....+.... ..... .. ......+.+++.+||++||++||++.+|++.|..
T Consensus 229 ~~~~----~~~~~~~~~---~~~~~--~~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 229 GFSN----QEVIEMVRK---RQLLP--CS--------EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCH----HHHHHHHHc---CCcCC--CC--------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 4321 112222211 11110 00 1112348899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=294.32 Aligned_cols=241 Identities=22% Similarity=0.251 Sum_probs=187.1
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHH-HhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEII-TAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||+||+|++. .+|+.||+|++......... ....+..|.. +++.++||||+++++.+.+.
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~-----------~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~ 68 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKK-----------EQKHIMAERNVLLKNVKHPFLVGLHYSFQTA 68 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhh-----------HHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC
Confidence 46999999999999865 48999999998653221110 1233444544 56788999999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
...++||||+++++|..++. ....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg 141 (323)
T cd05575 69 DKLYFVLDYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG 141 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccC
Confidence 99999999999999999884 3456899999999999999999999554 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~ 212 (323)
T cd05575 142 LCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNKP 212 (323)
T ss_pred CCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCC
Confidence 9865432221 11234689999999999998999999999999999999999999965321 22222222221
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 326 (337)
.. +. +.....+.+++.+||+.||.+||++.
T Consensus 213 ~~---~~--------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 LR---LK--------PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC---CC--------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 11 11134488999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=293.08 Aligned_cols=263 Identities=21% Similarity=0.275 Sum_probs=203.9
Q ss_pred ccCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|.+.+.||+|+||.||+|... ...+..+|+|.+...... ...+.+.+|+.+++++ +||
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~ 99 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS-------------SEREALMSELKIMSHLGNHE 99 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh-------------HHHHHHHHHHHHHHhccCCC
Confidence 4578999999999999999999742 234567999987433211 1145788999999999 799
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
||+++++.+...+..++++||+.+++|.+++... ....+++.++..++.|++.||.|||+++ ++|+||+|+||++
T Consensus 100 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~ 174 (302)
T cd05055 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLL 174 (302)
T ss_pred CcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEE
Confidence 9999999999999999999999999999998542 2234899999999999999999999554 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccc
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEM 272 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~ 272 (337)
+.++.++++|||++................++..|+|||.+.+..++.++||||+|+++|++++ |..||..... ..
T Consensus 175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~---~~ 251 (302)
T cd05055 175 THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV---DS 251 (302)
T ss_pred cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc---hH
Confidence 9999999999999876654332222222345678999999998889999999999999999998 8999865322 11
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
...+... ...... .+......+.+++.+||+++|++|||+.++++.|.++
T Consensus 252 ~~~~~~~----~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 KFYKLIK----EGYRMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHH----cCCcCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1112111 111100 0011123488999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=288.58 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=202.2
Q ss_pred CcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
.+|++.+.||.|+||.||+|.+.. ..+..||+|.+...... ...+.+.+|+.++..++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~~iv 71 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-------------PLREEFKHEAMMRSRLQHPNIV 71 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-------------HHHHHHHHHHHHHhcCCCCCcC
Confidence 468889999999999999998642 23578999998543211 1145688899999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhh------------cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVS------------QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~ 184 (337)
++++++.+....++++||+.+++|.+++.... .....+++..+..++.|++.||.|||+. |++|+
T Consensus 72 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~ 148 (283)
T cd05091 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHK 148 (283)
T ss_pred eEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Ccccc
Confidence 99999999999999999999999999985321 1123578888999999999999999955 49999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCC
Q 036970 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSD 263 (337)
Q Consensus 185 di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~ 263 (337)
||||+||++++++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred ccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999876543332222222345678999999988889999999999999999998 778886
Q ss_pred CcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 264 DFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
+... .+............ + +......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 229 ~~~~-------~~~~~~i~~~~~~~--~--------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 229 GYSN-------QDVIEMIRNRQVLP--C--------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCH-------HHHHHHHHcCCcCC--C--------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 5322 12222222222111 0 11223448899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=294.74 Aligned_cols=245 Identities=22% Similarity=0.263 Sum_probs=191.5
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .++..||+|++........ .....+..|..++..+ +||||+++++++.+.
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~ 68 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQD-----------DDVECTMTEKRVLALAGKHPFLTQLHSCFQTK 68 (318)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhh-----------hHHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 46999999999999865 4788999999864432111 1144567788888877 799999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg 141 (318)
T cd05570 69 DRLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFG 141 (318)
T ss_pred CEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccC
Confidence 99999999999999998884 3346899999999999999999999554 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++......... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ...........
T Consensus 142 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~~ 212 (318)
T cd05570 142 MCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILEDE 212 (318)
T ss_pred CCeecCcCCCc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCC
Confidence 98653222211 1134678999999999999999999999999999999999999965321 11222222111
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS-----KDVRC 330 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~il~ 330 (337)
.. +. ......+.+++.+||+.||++|||+ .++++
T Consensus 213 ~~---~~--------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 213 VR---YP--------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CC---CC--------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11 00 1122348899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=293.70 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=213.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
....|.+.+.||+|.||.||.++.+ .+|+.+|+|.+.+....... ..+.+.+|+.+|+++. ||||+.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~~~-----------~~~~v~~Ev~il~~l~~hpniv~ 100 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRGKE-----------DREDVRREVAILQQLSGHPNIVQ 100 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccccc-----------cHHHHHHHHHHHHhccCCCCEEE
Confidence 5688999999999999999999976 47999999999665442211 2568999999999997 999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC-
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD- 196 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~- 196 (337)
++++|++....++|||+|.||.|.+.+... .+++..+..++.|++.++.|||+. |++|+|+||+|+++...
T Consensus 101 l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~ 172 (382)
T KOG0032|consen 101 LKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKD 172 (382)
T ss_pred EEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeecccc
Confidence 999999999999999999999999999553 299999999999999999999955 59999999999999733
Q ss_pred ---CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 197 ---MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 197 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
+.++++|||++....... .....+||+.|+|||++....|+..+|+||+|+++|.|++|.+||.+.....
T Consensus 173 ~~~~~ik~~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~---- 245 (382)
T KOG0032|consen 173 EGSGRIKLIDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE---- 245 (382)
T ss_pred CCCCcEEEeeCCCceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH----
Confidence 479999999999887622 2224689999999999999999999999999999999999999997643211
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....+..... .+....++..+..+.++|..|+..||..|+|+.++++
T Consensus 246 ---~~~~i~~~~~-------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 246 ---IFLAILRGDF-------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---HHHHHHcCCC-------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1112222221 2334566777788999999999999999999999986
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=288.44 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=191.6
Q ss_pred ccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCc
Q 036970 49 IRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD 128 (337)
Q Consensus 49 lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 128 (337)
||+|+||.||+++.. .+|+.|++|.+........ ........|+.+++.++||||+++++.+.++...
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~-----------~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~ 68 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLKKK-----------SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL 68 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhhcc-----------hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE
Confidence 799999999999865 4799999999854222110 0123455699999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
+++|||+++++|.+++.. .....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~ 143 (277)
T cd05607 69 CLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAV 143 (277)
T ss_pred EEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeee
Confidence 999999999999988854 2334588899999999999999999955 49999999999999999999999999987
Q ss_pred cCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCC
Q 036970 209 QIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS 288 (337)
Q Consensus 209 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (337)
......... ...|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ................
T Consensus 144 ~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 217 (277)
T cd05607 144 ELKDGKTIT---QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRTLEDEVKF 217 (277)
T ss_pred ecCCCceee---ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHhhcccccc
Confidence 665432221 3467889999999998889999999999999999999999997543211 1112222222111100
Q ss_pred ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 289 RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
. .......+.+++..||++||.+||++.++++
T Consensus 218 ---~-------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 218 ---E-------HQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ---c-------cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 0 0112334889999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=285.86 Aligned_cols=256 Identities=24% Similarity=0.349 Sum_probs=200.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|+++++||.|+||.||+|... +++.|++|.+...... ...+.+|+.+++.++|+|++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~~ 66 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSMS---------------PEAFLAEANLMKQLQHPRLVRL 66 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCCCc---------------HHHHHHHHHHHHhcCCcCeeeE
Confidence 3578999999999999999999865 7889999988532211 3467889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++. .+..++++||+.+++|.+++... ....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.
T Consensus 67 ~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~ 140 (260)
T cd05067 67 YAVVT-QEPIYIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLC 140 (260)
T ss_pred EEEEc-cCCcEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCC
Confidence 98764 45689999999999999998542 345688999999999999999999954 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++......... ......++..|+|||++....++.++|+||||+++|++++ |..||.+... ......
T Consensus 141 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~ 215 (260)
T cd05067 141 CKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQN 215 (260)
T ss_pred EEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHHHH
Confidence 999999998766532221 1112344678999999988889999999999999999998 9999975322 111221
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+.. ..... . +......+.+++.+||+.+|++|||++++++.|+.+
T Consensus 216 ~~~---~~~~~------~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 216 LER---GYRMP------R----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHc---CCCCC------C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 111 11110 0 011223499999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=294.62 Aligned_cols=245 Identities=21% Similarity=0.213 Sum_probs=191.4
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhc
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLA 120 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~ 120 (337)
+|++.+.||+|+||.||+|++. .++..||+|++.+...... ........|..++..+ +|++|+++++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQD-----------DDVECTMVEKRVLALSGKPPFLTQLHS 68 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhccCCCeEeeEEE
Confidence 5889999999999999999865 4788999999865322111 1134566677777777 5899999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+.+..++||||+++|+|.+++. ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~k 141 (323)
T cd05616 69 CFQTMDRLYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred EEecCCEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEE
Confidence 9999999999999999999999884 335689999999999999999999955 499999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++......... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||..... ......
T Consensus 142 L~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-------~~~~~~ 212 (323)
T cd05616 142 IADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQS 212 (323)
T ss_pred EccCCCceecCCCCCc--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence 9999998754322111 1234689999999999999999999999999999999999999975322 122222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
....... + +......+.+++.+||++||++|++.
T Consensus 213 i~~~~~~---~--------p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 213 IMEHNVA---Y--------PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHhCCCC---C--------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 2221111 0 11123448899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=294.14 Aligned_cols=247 Identities=23% Similarity=0.256 Sum_probs=190.1
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .+++.||+|++........ .....+.+|+.++.++ +||||+++++.+.+.
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 68 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELVHDD-----------EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT 68 (327)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC
Confidence 46999999999999865 4789999999865432111 1145678899988888 699999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
...++||||+++++|..++. ..+.+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg 141 (327)
T cd05617 69 SRLFLVIEYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYG 141 (327)
T ss_pred CEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccc
Confidence 99999999999999998883 3456999999999999999999999554 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++......... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||........ ....+.........
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 218 (327)
T cd05617 142 MCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEK 218 (327)
T ss_pred cceeccCCCCc--eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhC
Confidence 98753222111 1235789999999999998999999999999999999999999964322111 11112222222111
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
... ++ ......+.+++.+||++||.+|+++
T Consensus 219 ~~~--~p--------~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 PIR--IP--------RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCC--CC--------CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 111 11 1112337899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=288.89 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=201.0
Q ss_pred CcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
.+|...++||+|+||.||+|... ..++..+++|....... .....+.+|+..++.++|+||+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~ 70 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--------------SARQDFQREAELLTVLQHQHIV 70 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--------------HHHHHHHHHHHHHhcCCCCCCc
Confidence 57788999999999999999742 23567788887643221 1145788999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcC-----------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG-----------RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRD 185 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~d 185 (337)
++++++.+.+..++++||+++++|.+++...... ...+++..+..++.|++.|+.|||+. +++|+|
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~d 147 (280)
T cd05092 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRD 147 (280)
T ss_pred eEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence 9999999999999999999999999999654221 13578899999999999999999955 499999
Q ss_pred CCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCC
Q 036970 186 IQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDD 264 (337)
Q Consensus 186 i~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~ 264 (337)
|+|+||++++++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 148 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 148 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred ccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999999876543332222222344678999999999899999999999999999998 8899864
Q ss_pred cccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
... . .............. +......+.+++.+||+.||++||++.+|++.|+.
T Consensus 228 ~~~----~---~~~~~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 228 LSN----T---EAIECITQGRELER----------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred CCH----H---HHHHHHHcCccCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 322 1 11222221111110 01112348899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.06 Aligned_cols=265 Identities=21% Similarity=0.296 Sum_probs=205.1
Q ss_pred ccCcccccccccccccceEEeeeec------CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-C
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP------GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-R 111 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 111 (337)
..++|.+.+.||.|+||.||+|++. ...+..+++|........ .....+.+|+..++.+ +
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 79 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-------------KDLSDLVSEMEMMKMIGK 79 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch-------------HHHHHHHHHHHHHHhhcc
Confidence 5788999999999999999999742 123457899987433211 1145688999999999 8
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRP 179 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 179 (337)
||||+++++++......+++|||+.+++|.+++..... ....+++..+..++.|++.||.|||++
T Consensus 80 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--- 156 (304)
T cd05101 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ--- 156 (304)
T ss_pred CCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---
Confidence 99999999999999999999999999999999965422 123578888999999999999999955
Q ss_pred CceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-C
Q 036970 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-G 258 (337)
Q Consensus 180 ~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g 258 (337)
|++|+||||+||+++.++.++|+|||.+................+++.|+|||++.+..++.++||||||+++|++++ |
T Consensus 157 givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g 236 (304)
T cd05101 157 KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236 (304)
T ss_pred CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 499999999999999999999999999987654333222222345678999999988889999999999999999998 7
Q ss_pred CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
..||.... ..+............. +......+.+++.+||+.+|++|||+.++++.|.++.
T Consensus 237 ~~p~~~~~-------~~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 237 GSPYPGIP-------VEELFKLLKEGHRMDK----------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred CCCcccCC-------HHHHHHHHHcCCcCCC----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 78875421 1222222221111110 1122345889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=301.81 Aligned_cols=273 Identities=22% Similarity=0.283 Sum_probs=207.6
Q ss_pred hhhhhhhhccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHH
Q 036970 31 KEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIIT 106 (337)
Q Consensus 31 ~~~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 106 (337)
..+.+|--+.++|.+++.||+|+||.||+|++.. ..+..||+|++....... ....+.+|+.+
T Consensus 27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-------------~~~~~~~E~~~ 93 (401)
T cd05107 27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS-------------EKQALMSELKI 93 (401)
T ss_pred CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh-------------HHHHHHHHHHH
Confidence 4444554567889999999999999999998642 245789999985432211 13468899999
Q ss_pred hcCCC-CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------------------------------
Q 036970 107 AGQVR-HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------------------------------ 149 (337)
Q Consensus 107 l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------ 149 (337)
+.++. ||||+++++.+...+..++|+||+.+|+|.++++....
T Consensus 94 l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred HHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 99997 99999999999999999999999999999999965321
Q ss_pred ----------------------------------------------------------CCCcCCHHHHHHHHHHHHHHHH
Q 036970 150 ----------------------------------------------------------GRRELDWLARHRIARGIASGLE 171 (337)
Q Consensus 150 ----------------------------------------------------------~~~~l~~~~~~~~~~~i~~~l~ 171 (337)
....+++...+.++.|++.||.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 1124677788899999999999
Q ss_pred HHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHH
Q 036970 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVL 251 (337)
Q Consensus 172 ~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~v 251 (337)
|||+. +++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||++
T Consensus 254 ~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvi 330 (401)
T cd05107 254 FLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330 (401)
T ss_pred HHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHH
Confidence 99954 599999999999999999999999999876533222111222355788999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 252 LAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 252 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+|||++ |..||..... .+........+.... .+......+.+++.+||..+|.+||++.+|++
T Consensus 331 l~e~l~~g~~P~~~~~~-------~~~~~~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 331 LWEIFTLGGTPYPELPM-------NEQFYNAIKRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHcCCCCCCCCCc-------hHHHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 8889864321 111111111111000 01112345899999999999999999999999
Q ss_pred HHhhh
Q 036970 331 MLSQI 335 (337)
Q Consensus 331 ~L~~~ 335 (337)
.|+++
T Consensus 395 ~L~~~ 399 (401)
T cd05107 395 LVGDL 399 (401)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=289.09 Aligned_cols=269 Identities=19% Similarity=0.264 Sum_probs=200.2
Q ss_pred cCcccccccccccccceEEeeeecCC-------------CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHH
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGS-------------SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIIT 106 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~-------------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 106 (337)
.++|++.+.||+|+||.||++++... ....|++|........ .....+.+|+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~ei~~ 70 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-------------TARNDFLKEIKI 70 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-------------HHHHHHHHHHHH
Confidence 57899999999999999999975321 1235889987543221 114578899999
Q ss_pred hcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc--------CCCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 036970 107 AGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ--------GRRELDWLARHRIARGIASGLEYLHMSHR 178 (337)
Q Consensus 107 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 178 (337)
+.+++|+|++++++++..+...++||||+.+++|.+++..... ....+++..+..++.|++.||.|||+.
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-- 148 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-- 148 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc--
Confidence 9999999999999999999999999999999999999854321 112468888999999999999999955
Q ss_pred CCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-
Q 036970 179 PRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM- 257 (337)
Q Consensus 179 ~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~- 257 (337)
+++|+||+|+||+++.++.++|+|||++................++..|+|||...+..++.++|+||||+++++|++
T Consensus 149 -~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 149 -NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred -CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 499999999999999999999999999876543322222222344678999999988889999999999999999998
Q ss_pred -CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 258 -GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 258 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
+..||...... ................... ...+.....+.+++.+||+.||++|||+.+|++.|.+
T Consensus 228 ~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 228 CKEQPYSLLSDE----QVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCCCCCcccChH----HHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 56777643221 1111111111110000000 0001112359999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=299.99 Aligned_cols=257 Identities=19% Similarity=0.232 Sum_probs=196.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+++.+|+|.+........ .....+.+|+.+++.++||||+++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~i~~~~~hp~iv~~ 108 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEMIKR-----------SDSAFFWEERDIMAFANSPWVVQL 108 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hhHHHHHHHHHHHHhCCCCCEeeE
Confidence 5689999999999999999999876 4789999999854221110 113457789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+.++...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~ 180 (370)
T cd05621 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGH 180 (370)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCC
Confidence 9999999999999999999999999843 34788899999999999999999554 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCC----CCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA----LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
+||+|||++.......... .....||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 181 ~kL~DFG~a~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------- 252 (370)
T cd05621 181 LKLADFGTCMKMDETGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------- 252 (370)
T ss_pred EEEEecccceecccCCcee-cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------
Confidence 9999999987764332211 12457899999999987643 77899999999999999999999975321
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCC--CCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPE--ERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~--~Rps~~~il~ 330 (337)
............... ++. .......+.+++..||..++. .|+|+.++++
T Consensus 253 ~~~~~~i~~~~~~~~-~p~------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 253 VGTYSKIMDHKNSLN-FPE------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred HHHHHHHHhCCcccC-CCC------cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 111222221111100 000 111234478888999975553 3889999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=298.90 Aligned_cols=266 Identities=20% Similarity=0.227 Sum_probs=194.1
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||+|+||.||+|.+. .+|+.||+|.+....... .....+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 67 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQNL------------VSCKRVFRELKMLCFFKHDNVLSALDI 67 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccch------------HHHHHHHHHHHHHHhCCCCCcCCHhhe
Confidence 5788999999999999999864 489999999884322111 114567889999999999999999999
Q ss_pred eecCC-----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 122 VVRPD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 122 ~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
+.... ..++|+||+. ++|.+.+ .....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 68 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~ 139 (372)
T cd07853 68 LQPPHIDPFEEIYVVTELMQ-SDLHKII----VSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSN 139 (372)
T ss_pred ecCCCccccceEEEEeeccc-cCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCC
Confidence 98776 6799999995 5788877 34567899999999999999999999554 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH-
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF- 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~- 274 (337)
+.++|+|||++.......... .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||............
T Consensus 140 ~~~kL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 140 CVLKICDFGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred CCEEeccccceeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 999999999987654322211 1123568889999998875 4789999999999999999999999754321100000
Q ss_pred --------HH------HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 --------VQ------WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 --------~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. ................... ..........+.+++.+||+.||++|||+.++++
T Consensus 219 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 219 DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00 0000110000000000000 0001111345889999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=283.35 Aligned_cols=260 Identities=21% Similarity=0.341 Sum_probs=196.7
Q ss_pred ccccccccccccceEEeeeecCCCCc--EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGR--VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
|.+++.||+|+||.||+|.+.. ++. .+++|......... .....+.+|+..++.++|+||+++++
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~-~~~~~~~a~k~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 67 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQ-DDSILKVAVKTMKIAICTR------------SEMEDFLSEAVCMKEFDHPNVMRLIG 67 (272)
T ss_pred CccccccCcccCceEEEeEEcc-CCCeeeEEEEecccCcCCH------------HHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 3567899999999999998753 333 68999875432111 12567888999999999999999998
Q ss_pred eeecC------CCceEEEEeecCCCHHHHHHhhh--cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 121 RVVRP------DCDLLVYEFRRNGSLQDILYDVS--QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 121 ~~~~~------~~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++... ...++++||+.+++|.+++.... .....+++.....++.|++.||.|||+++ ++|+||||+||+
T Consensus 68 ~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil 144 (272)
T cd05075 68 VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCM 144 (272)
T ss_pred EEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheE
Confidence 77432 24589999999999999874332 22345899999999999999999999554 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~ 271 (337)
++.++.++|+|||++................+++.|+|||...+..++.++|+||||+++|++++ |..||.....
T Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 220 (272)
T cd05075 145 LNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---- 220 (272)
T ss_pred EcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence 99999999999999887654332222222345678999999999889999999999999999999 7889865321
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
. +............. .......+.+++.+||++||++|||+.++++.|+++
T Consensus 221 ~---~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 221 S---EIYDYLRQGNRLKQ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred H---HHHHHHHcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 11112211111110 111233488999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=293.70 Aligned_cols=244 Identities=22% Similarity=0.227 Sum_probs=187.2
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHH-HHhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .+++.||+|++......... ....+..|. .+++.++||||+++++++.+.
T Consensus 1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~-----------~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~ 68 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKK-----------EEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 68 (325)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHHhhh-----------HHHHHHHHHHHHHHhCCCCCCCceeEEEEcC
Confidence 46999999999999865 47889999998643221110 022334444 456778999999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG 141 (325)
T cd05602 69 DKLYFVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 141 (325)
T ss_pred CeEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCC
Confidence 99999999999999999884 3456788888999999999999999554 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.........
T Consensus 142 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~ 212 (325)
T cd05602 142 LCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKP 212 (325)
T ss_pred CCcccccCCCC--cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCC
Confidence 98754322211 1235689999999999999999999999999999999999999975322 12222222111
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
.. +. +.....+.+++.+||++||.+||++.+.+
T Consensus 213 ~~---~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 213 LQ---LK--------PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred cC---CC--------CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11 01 11223488999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=284.30 Aligned_cols=259 Identities=21% Similarity=0.266 Sum_probs=197.7
Q ss_pred cCcccccccccccccceEEeeeecCCCCc----EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.++|++.+.||.|+||.||+|.+.. ++. .+++|....... ......+..|+..+..++||||
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~~~~~~l~~l~h~~i 71 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDRSG-------------RQTFQEITDHMLAMGSLDHAYI 71 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcC-CCCceeeEEEEeecccccc-------------hHHHHHHHHHHHHHhcCCCCCc
Confidence 4688999999999999999998642 444 366676632211 1114567788889999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++++. +...++++||+.+++|.+++.. ..+.+++..+..++.||+.||.|||+.+ ++|+||||+||+++.
T Consensus 72 v~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~ 144 (279)
T cd05111 72 VRLLGICP-GASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKS 144 (279)
T ss_pred ceEEEEEC-CCccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcC
Confidence 99999875 4557889999999999999854 3356899999999999999999999554 999999999999999
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~ 274 (337)
++.++|+|||++................++..|+|||.+.+..++.++||||||+++||+++ |..||.+... ...
T Consensus 145 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~ 220 (279)
T cd05111 145 DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEV 220 (279)
T ss_pred CCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 99999999999976543322222223456778999999988889999999999999999998 9999865422 111
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+. ...+.... .+. .....+.+++.+||..||++|||+.++++.|..+.
T Consensus 221 ~~~----~~~~~~~~--~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 221 PDL----LEKGERLA--QPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HHH----HHCCCcCC--CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 11111110 000 11234788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=292.25 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=188.1
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcC-CCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQ-VRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .+++.||+|.+........ ........|..++.. ++||||+++++++.+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~ 68 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMD-----------DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK 68 (316)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhc-----------chHHHHHHHHHHHHhccCCCcCcceEEEEEeC
Confidence 46999999999999865 4789999999865322100 013345567777765 4899999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05619 69 ENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFG 141 (316)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCC
Confidence 999999999999999999843 35688999999999999999999955 59999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++......... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||..... .+.........
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~ 212 (316)
T cd05619 142 MCKENMLGDAK--TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMDN 212 (316)
T ss_pred cceECCCCCCc--eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC
Confidence 98653222111 1234689999999999998999999999999999999999999975321 11122211111
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK-DVR 329 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~il 329 (337)
.. ++ ......+.+++.+||+.||++||++. +++
T Consensus 213 ~~---~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 213 PC---YP--------RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CC---CC--------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11 01 11223478999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.56 Aligned_cols=263 Identities=21% Similarity=0.321 Sum_probs=203.2
Q ss_pred ccCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++.+.||+|+||.||+|.+. ..++..+++|.+...... .....+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~ei~~l~~l~h~~ 69 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------------DMQADFQREAALMAEFDHPN 69 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-------------HHHHHHHHHHHHHHhcCCCc
Confidence 3578999999999999999999864 235788999987533221 11456888999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------------CCCcCCHHHHHHHHHHHHHHHHHHhcC
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------------GRRELDWLARHRIARGIASGLEYLHMS 176 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~ 176 (337)
|+++++++.++...++++||+++++|.+++..... ....+++..++.++.|++.||.|||+.
T Consensus 70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~ 149 (288)
T cd05050 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER 149 (288)
T ss_pred hheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999964321 123478888999999999999999955
Q ss_pred CCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHH
Q 036970 177 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLM 256 (337)
Q Consensus 177 ~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~ 256 (337)
+++|+||+|+||+++.++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|+|+
T Consensus 150 ---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 226 (288)
T cd05050 150 ---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226 (288)
T ss_pred ---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHH
Confidence 49999999999999999999999999987654332222221223456799999998888999999999999999999
Q ss_pred h-CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 257 M-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 257 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
+ |..||.+... .+............ .+......+.+++.+||+.+|++|||+.++++.|++
T Consensus 227 ~~~~~p~~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 227 SYGMQPYYGMAH-------EEVIYYVRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred hCCCCCCCCCCH-------HHHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 7 7788754322 12222222111110 011123458999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=283.08 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=201.7
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|.+.+.||+|++|.||+|... .+++.|++|.+....... .....+.+|+.+++.++|||++++++.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNR------------REREEAIDEARVLAKLDSSYIIRYYES 67 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCCH------------HHHHHHHHHHHHHHhcCCCCeehheee
Confidence 5788899999999999999865 478999999885432211 115578899999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+++..++++||+++++|.+++... ....+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l 142 (256)
T cd08529 68 FLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKI 142 (256)
T ss_pred eccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEE
Confidence 99999999999999999999998653 245689999999999999999999955 5999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||++.......... ....+++.|+|||+..+..++.++|+||||+++++|++|..||..... .......
T Consensus 143 ~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~ 213 (256)
T cd08529 143 GDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-------GALILKI 213 (256)
T ss_pred cccccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence 9999987665432221 124578889999999988899999999999999999999999975431 1112222
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+. + .......+.+++.+||+.+|++||++.++++
T Consensus 214 ~~~~~~~--~--------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 214 IRGVFPP--V--------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HcCCCCC--C--------ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 2111111 0 0122344899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=287.39 Aligned_cols=265 Identities=21% Similarity=0.312 Sum_probs=205.4
Q ss_pred ccCcccccccccccccceEEeeeecCC---CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGS---SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
..++|.+.+.||+|+||.||+|.+... .+..|++|.+..... ......+.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni 70 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-------------EIQVTLLLQESCLLYGLSHQNI 70 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC-------------HHHHHHHHHHHHHHHhCCCCCC
Confidence 357899999999999999999987632 268889988743211 1125568889999999999999
Q ss_pred hhhhceeec-CCCceEEEEeecCCCHHHHHHhhhcC----CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 116 VPLLARVVR-PDCDLLVYEFRRNGSLQDILYDVSQG----RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 116 ~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
+++++++.+ +...+++++|+.+++|.+++...... ...+++..++.++.|++.||.|||+. +++|+||+|+|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~n 147 (280)
T cd05043 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARN 147 (280)
T ss_pred CeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhh
Confidence 999998776 46778999999999999998654332 15689999999999999999999955 59999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccccc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHT 269 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~ 269 (337)
|+++.++.++|+|||+++.+.............++..|+|||++.+..++.++||||||+++|++++ |..||.....
T Consensus 148 il~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-- 225 (280)
T cd05043 148 CVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-- 225 (280)
T ss_pred EEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--
Confidence 9999999999999999976644333222222345677999999988889999999999999999999 9999865322
Q ss_pred ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
......+.. ...... .......+.+++.+||+.+|++|||+.++++.|.++.
T Consensus 226 --~~~~~~~~~---~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 226 --FEMAAYLKD---GYRLAQ----------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred --HHHHHHHHc---CCCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 112222111 111111 0112234889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=292.19 Aligned_cols=244 Identities=23% Similarity=0.267 Sum_probs=188.1
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .+|..||+|.+........ ........|..++..+ +||||+++++.+.+.
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 68 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLID-----------DDVECTMVEKRVLALAWENPFLTHLYCTFQTK 68 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhc-----------chHHHHHHHHHHHHhccCCCCccCeeEEEEeC
Confidence 46999999999999876 4889999999865322110 0134556677777654 899999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05620 69 EHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFG 141 (316)
T ss_pred CEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccC
Confidence 999999999999999998843 35688999999999999999999955 59999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~~ 212 (316)
T cd05620 142 MCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVDT 212 (316)
T ss_pred CCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC
Confidence 9864322111 11235689999999999998999999999999999999999999965321 11222221111
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK-DVR 329 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~il 329 (337)
... +......+.+++.+||+.||++||++. +++
T Consensus 213 ~~~-----------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 PHY-----------PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCC-----------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 100 001223488999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=285.28 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=197.9
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
.+|++.+.||+|++|.||+|.+. .+..+++|.+...... ...+.+|+.+++.++||||+++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAMS---------------EDDFIEEAKVMMKLSHPNLVQLYG 66 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec--CCccEEEEEeccCCCC---------------HHHHHHHHHHHHhCCCCCEEEEEE
Confidence 56889999999999999999865 5778999987433211 345778999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+.+..++++||+++++|.+++.. ....+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~k 140 (256)
T cd05059 67 VCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVK 140 (256)
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEE
Confidence 99999999999999999999999854 2336899999999999999999999554 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||++.......... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||..... ... ..
T Consensus 141 l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~---~~ 212 (256)
T cd05059 141 VSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN----SEV---VE 212 (256)
T ss_pred ECCcccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH----HHH---HH
Confidence 99999987654322211 111223457999999998889999999999999999999 7899865322 111 11
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
.......+.. +......+.+++.+||+.+|++|||+.++++.|.
T Consensus 213 ~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 213 SVSAGYRLYR----------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred HHHcCCcCCC----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 2211111110 0112334899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=292.05 Aligned_cols=245 Identities=21% Similarity=0.211 Sum_probs=191.4
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhhc
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLLA 120 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~ 120 (337)
+|+..+.||+|+||.||+|++. .+|+.||+|++........ .....+..|..++..+. |++|+++++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQD-----------DDVECTMVEKRVLALQDKPPFLTQLHS 68 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhccCCCchhheee
Confidence 4788999999999999999865 4899999999864322110 11445677888888885 577888999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+.+..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ik 141 (323)
T cd05615 69 CFQTVDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEE
Confidence 9999999999999999999999884 3456899999999999999999999554 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++......... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||..... ......
T Consensus 142 L~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~ 212 (323)
T cd05615 142 IADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQS 212 (323)
T ss_pred EeccccccccCCCCcc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence 9999998754322211 1234689999999999988899999999999999999999999975422 122222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
........ +......+.+++.+||+++|.+|++.
T Consensus 213 i~~~~~~~-----------p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 IMEHNVSY-----------PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCCCCC-----------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 22211110 11122347899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.14 Aligned_cols=263 Identities=19% Similarity=0.217 Sum_probs=195.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
..+|.+.+.||+|+||.||+|.+. ..+..|++|... ...+.+|+.++++++|+||++++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~--------------------~~~~~~E~~iL~~L~HpnIv~l~ 226 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHP-DYPQRVVVKAGW--------------------YASSVHEARLLRRLSHPAVLALL 226 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEEC-CCCCEEEEeccc--------------------ccCHHHHHHHHHHCCCCCCCcEE
Confidence 457999999999999999999876 378899999531 22456799999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++..++..++++|++ .++|.+++.. ....+++..++.++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 227 ~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~v 299 (461)
T PHA03211 227 DVRVVGGLTCLVLPKY-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDI 299 (461)
T ss_pred EEEEECCEEEEEEEcc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCE
Confidence 9999999999999999 4688888743 334689999999999999999999955 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc----cchHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK----EMSFV 275 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~----~~~~~ 275 (337)
+|+|||++................||..|+|||++.+..++.++|||||||++|||++|..|+-....... ...+.
T Consensus 300 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~ 379 (461)
T PHA03211 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL 379 (461)
T ss_pred EEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH
Confidence 99999998765433222222245689999999999999999999999999999999998866432211111 11122
Q ss_pred HHHHHHhhcCCC-Ccc----------------ccccccCCChH---HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENP-SRT----------------IDSKLIGNGYE---EQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~-~~~----------------~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+......... ... .........+. .....+.+||.+||+.||.+|||+.|+++
T Consensus 380 ~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 380 RIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 222111100000 000 00000000111 12235889999999999999999999986
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=293.68 Aligned_cols=193 Identities=23% Similarity=0.284 Sum_probs=163.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
...+|++++.||.|+||.||+|+.. .++..||+|..... ....|+.+++.++||||+++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~--------------------~~~~E~~~l~~l~h~~iv~~ 122 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG--------------------TTLIEAMLLQNVNHPSVIRM 122 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc--------------------ccHHHHHHHHhCCCCCCcCh
Confidence 5678999999999999999999865 37889999974211 23458899999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++|+|++. ++|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 123 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~ 195 (357)
T PHA03209 123 KDTLVSGAITCMVLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQ 195 (357)
T ss_pred hheEEeCCeeEEEEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCC
Confidence 999999999999999994 588888743 3456899999999999999999999554 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCC
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPS 262 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf 262 (337)
++|+|||++......... ....||+.|+|||++.+..++.++||||||+++|||+++..|+
T Consensus 196 ~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 196 VCIGDLGAAQFPVVAPAF---LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred EEEecCccccccccCccc---ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999999998653322111 1346799999999999989999999999999999999866554
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=288.97 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=203.6
Q ss_pred hccCcccccccccccccceEEeeeec------CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELP------GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV- 110 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 110 (337)
...++|.+.+.||+|+||.||+|+.. ......+++|........ .....+.+|+.+++.+
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~ 75 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-------------KDLADLISEMELMKLIG 75 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-------------HHHHHHHHHHHHHHhcc
Confidence 34578999999999999999999752 124567899987432211 1145688899999999
Q ss_pred CCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 036970 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHR 178 (337)
Q Consensus 111 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 178 (337)
+||||+++++++.+++..++++||+++++|.+++..... ....+++..+..++.|++.||.|||++
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-- 153 (314)
T cd05099 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-- 153 (314)
T ss_pred CCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC--
Confidence 699999999999999999999999999999999965321 124588899999999999999999955
Q ss_pred CCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-
Q 036970 179 PRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM- 257 (337)
Q Consensus 179 ~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~- 257 (337)
|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 154 -gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 154 -RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred -CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence 599999999999999999999999999976643322221112233467999999988889999999999999999999
Q ss_pred CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 258 GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 258 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
|..||..... .............. .+......+.+++.+||+.+|++|||+.++++.|.++.
T Consensus 233 g~~p~~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 233 GGSPYPGIPV-------EELFKLLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred CCCCCCCCCH-------HHHHHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 8888864321 11111111111110 01122334889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=279.86 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=198.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.++||.|++|.||+|++. ....|++|....... ..+.+.+|+.+++.++||||++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~i~~~~ 67 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTM---------------SPEAFLQEAQVMKKLRHEKLVQLY 67 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEec--CCceEEEEecccCcc---------------CHHHHHHHHHHHHhCCCCCcceEE
Confidence 467999999999999999999865 445699998853221 034678899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+. ....+++|||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+
T Consensus 68 ~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~ 141 (262)
T cd05071 68 AVVS-EEPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVC 141 (262)
T ss_pred EEEC-CCCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcE
Confidence 8775 45679999999999999999542 234578899999999999999999955 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||.+.......... .....++..|+|||...+..++.++|+||||+++|++++ |..||..... . ...
T Consensus 142 ~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----~---~~~ 213 (262)
T cd05071 142 KVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----R---EVL 213 (262)
T ss_pred EeccCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----H---HHH
Confidence 999999987654332211 112345677999999988889999999999999999999 8888865321 1 111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.......... ........+.+++.+||+++|++|||+.++++.|++.
T Consensus 214 ~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 214 DQVERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHhcCCCCC----------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1221111110 0112334588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=285.95 Aligned_cols=255 Identities=26% Similarity=0.342 Sum_probs=197.7
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
.|++.+.||+|+||+||++.+. .+++.||+|.+........ .....+.+|+.+++.++|++++++++.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~~~~i~~~~~~ 68 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKR-----------KGESMALNEKQILEKVNSRFVVSLAYA 68 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccch-----------HHHHHHHHHHHHHHhCCCCCeeeeeEE
Confidence 4778899999999999999865 4899999998854322111 113456789999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+++..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|
T Consensus 69 ~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l 143 (285)
T cd05630 69 YETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRI 143 (285)
T ss_pred EecCCEEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999988542 334589999999999999999999955 4999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||++......... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||...................
T Consensus 144 ~Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd05630 144 SDLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 220 (285)
T ss_pred eeccceeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh
Confidence 999998765433221 12467899999999998889999999999999999999999997532211111111111100
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il~ 330 (337)
... . .......+.+++..||+.||.+||| +.++++
T Consensus 221 -~~~---------~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 -QEE---------Y----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhh---------c----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 0 0111234789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=297.69 Aligned_cols=260 Identities=20% Similarity=0.229 Sum_probs=198.6
Q ss_pred cCcccccccccccccceEEeeeecC-CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..+|.+++.||.|+||.||++.... ..+..|++|.+... ....+|+.+++.++||||+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------------~~~~~E~~il~~l~h~~iv~~ 151 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------------KTPGREIDILKTISHRAIINL 151 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------------ccHHHHHHHHHhcCCCCccce
Confidence 4579999999999999999997532 35678999987322 134579999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++......+++||++. ++|.+++ .....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.
T Consensus 152 ~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~ 223 (392)
T PHA03207 152 IHAYRWKSTVCMVMPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPEN 223 (392)
T ss_pred eeeEeeCCEEEEEehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCC
Confidence 999999999999999995 6888888 33456899999999999999999999554 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 224 ~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~ 303 (392)
T PHA03207 224 AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII 303 (392)
T ss_pred EEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH
Confidence 99999999977655443333334678999999999999899999999999999999999999986543322222222211
Q ss_pred HHHhhcCC-----------------------CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSEN-----------------------PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. +...+ +....+..+.. ......+.++|.+||..||++|||+.+++.
T Consensus 304 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 304 RC-MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK---YGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HH-hccCccccCCccchhHHHHHHhhcccccCCccccchhhc---cCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 11000 00000000000 011245788999999999999999999875
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=288.36 Aligned_cols=263 Identities=23% Similarity=0.306 Sum_probs=201.7
Q ss_pred cCcccccccccccccceEEeeeecC------CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CC
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG------SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RH 112 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 112 (337)
.++|.+.+.||+|+||.||+|++.. ..+..+|+|.+...... .....+.+|+.++..+ +|
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~h 83 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE-------------KDLSDLISEMEMMKMIGKH 83 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh-------------HHHHHHHHHHHHHHHhcCC
Confidence 4789999999999999999998532 12356999988543211 1145678899999999 79
Q ss_pred CChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 036970 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRPR 180 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 180 (337)
|||+++++++..++..++++||+.+++|.+++..... ....+++..+..++.|++.||.|||+. |
T Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---g 160 (307)
T cd05098 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---K 160 (307)
T ss_pred CCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 9999999999999999999999999999999965322 123588899999999999999999955 5
Q ss_pred ceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CC
Q 036970 181 IIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GK 259 (337)
Q Consensus 181 ~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~ 259 (337)
++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 161 i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~ 240 (307)
T cd05098 161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 240 (307)
T ss_pred cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999876543222111111233567999999988889999999999999999998 88
Q ss_pred CCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 260 FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 260 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.||..... .+............ .+......+.+++.+||..+|++|||+.++++.|.++
T Consensus 241 ~p~~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 241 SPYPGVPV-------EELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred CCCCcCCH-------HHHHHHHHcCCCCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 88854211 12222211111111 1112234588999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.90 Aligned_cols=241 Identities=22% Similarity=0.243 Sum_probs=186.1
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHH-HHhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .++..||+|++........ .....+..|. .+++.++||||+++++++.+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~ 68 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTILKK-----------KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA 68 (321)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHh-----------hHHHHHHHHHHHHHHhCCCCCccceeeEEEcC
Confidence 46999999999999865 4889999999864332111 1123444554 467888999999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++||||+++++|...+. ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 141 (321)
T cd05603 69 EKLYFVLDYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG 141 (321)
T ss_pred CEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCC
Confidence 99999999999999988873 345688999999999999999999955 49999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~ 212 (321)
T cd05603 142 LCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILHKP 212 (321)
T ss_pred CCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhcCC
Confidence 9875322211 11234689999999999988899999999999999999999999965321 12222222211
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 326 (337)
. . + +......+.+++.+||+.||.+||++.
T Consensus 213 ~-~--~--------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 L-Q--L--------PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C-C--C--------CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1 1 0 111223488999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=283.26 Aligned_cols=264 Identities=21% Similarity=0.312 Sum_probs=202.5
Q ss_pred ccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++.+.||+|+||.||+|..+. ..+..|++|.+...... .....+.+|+..++.++|||
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~ 70 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-------------RERIEFLNEASVMKGFTCHH 70 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-------------HHHHHHHHHHHHHHhCCCCC
Confidence 46789999999999999999997532 24568999987432211 11345778999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~ 188 (337)
|+++++++.+....+++|||+++++|.+++..... ....++...+..++.|++.||.|||++ +++|+||||
T Consensus 71 i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp 147 (288)
T cd05061 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAA 147 (288)
T ss_pred eeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCCh
Confidence 99999999999999999999999999999965322 124456778889999999999999955 499999999
Q ss_pred CcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccc
Q 036970 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQ 267 (337)
Q Consensus 189 ~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~ 267 (337)
+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||.+...
T Consensus 148 ~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 148 RNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred heEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876543332222222344677999999988889999999999999999998 7788865321
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.+............. +......+.+++.+||+.||++|||+.++++.|.+.
T Consensus 228 -------~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 228 -------EQVLKFVMDGGYLDQ----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -------HHHHHHHHcCCCCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 122222221211110 001124599999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=282.76 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=200.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCc----EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++.+.||.|+||+||+|++.. ++. .||+|........ .....+.+|+.++..+.|||
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~ 70 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIP-DGENVKIPVAIKVLRENTSP-------------KANKEILDEAYVMAGVGSPY 70 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEec-CCCccceEEEEEEecCCCCH-------------HHHHHHHHHHHHHHhcCCCC
Confidence 35789999999999999999998643 444 4889987432211 11456888999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
|+++++++.. ...+++++|+++|+|.+++.. ..+.+++..+..++.|++.||.|||+++ ++|+||||+||+++
T Consensus 71 i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~ 143 (279)
T cd05109 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVK 143 (279)
T ss_pred CceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999998875 456799999999999999843 2346899999999999999999999555 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
+++.++|+|||++................++..|+|||...+..++.++||||||+++||+++ |..||..... ..
T Consensus 144 ~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~ 219 (279)
T cd05109 144 SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----RE 219 (279)
T ss_pred CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HH
Confidence 999999999999887654322211112234677999999988889999999999999999998 8899865321 11
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
....+.. ...+.. +......+.+++..||+.||++||++.++++.|.++.
T Consensus 220 ~~~~~~~---~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 220 IPDLLEK---GERLPQ----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HHHHHHC---CCcCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 2222211 111110 0112234889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=282.35 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=194.1
Q ss_pred ccccccccceEEeeeec-CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELP-GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 125 (337)
++||+|+||.||+|.+. ..++..+++|++....... .....+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 67 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP------------ALKDELLREANVMQQLDNPYIVRMIGICE-A 67 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH------------HHHHHHHHHHHHHHhCCCCCcceEEEEEc-C
Confidence 36899999999999753 2367889999875332211 12567889999999999999999999875 4
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
...+++|||+++++|.+++. ....+++..+..++.|++.||.|||+. |++|+||+|.||+++.++.++|+|||
T Consensus 68 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg 140 (257)
T cd05116 68 ESWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFG 140 (257)
T ss_pred CCcEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCc
Confidence 56789999999999999984 334689999999999999999999955 59999999999999999999999999
Q ss_pred ccccCCCCCccc-ccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhh
Q 036970 206 LAKQIPNGRTRT-TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMT 283 (337)
Q Consensus 206 ~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 283 (337)
++.......... ......++..|+|||.+....++.++|+||||+++||+++ |..||..... ....+.+..
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i~~--- 213 (257)
T cd05116 141 LSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMIES--- 213 (257)
T ss_pred cccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHC---
Confidence 998765433211 1112233578999999988888999999999999999998 9999875422 122222211
Q ss_pred cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 284 SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
...+. . +......+.++|.+||++||++||++.+|.+.|.++
T Consensus 214 ~~~~~--~--------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 214 GERME--C--------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCC--C--------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11111 0 111234488999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=281.41 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=197.0
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||+|++|.||+|.+. .++..|++|........ .....+.+|+.++.+++||||+++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 66 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDITV-------------ELQKQIMSELEILYKCDSPYIIGFYG 66 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCh-------------HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 47889999999999999999865 48899999988543211 11456888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+..+...++++||+++++|..+. .+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~ 135 (279)
T cd06619 67 AFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVK 135 (279)
T ss_pred EEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEE
Confidence 999999999999999999986542 367888899999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++........ ....++..|+|||++.+..++.++|+||||+++|+|++|..||..................
T Consensus 136 l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 211 (279)
T cd06619 136 LCDFGVSTQLVNSIA----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC 211 (279)
T ss_pred EeeCCcceecccccc----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH
Confidence 999999876543221 1346788999999999888999999999999999999999999754332222111122111
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
...... ... . .......+.+++.+||+.+|.+||++.++++.
T Consensus 212 ~~~~~~-~~~-----~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 212 IVDEDP-PVL-----P---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HhccCC-CCC-----C---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111 110 0 01122348899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=315.66 Aligned_cols=259 Identities=22% Similarity=0.278 Sum_probs=199.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+++.||.|+||+||+|++. .++..+++|.+........ ....+..|+.++..|+||||+++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~e~------------~~~~~~~EI~IL~~L~HPNIVrl 77 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLKER------------EKSQLVIEVNVMRELKHKNIVRY 77 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccCHH------------HHHHHHHHHHHHHHcCCCCcCeE
Confidence 4579999999999999999999876 4788999998854332211 14578889999999999999999
Q ss_pred hceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC----CCCceeCCCCCCcEE
Q 036970 119 LARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH----RPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~----~~~~~h~di~~~nil 192 (337)
+++|.+. ..+++||||+++++|.+++.........+++..++.++.||+.||.|||+.+ ..+|+|+||||+|||
T Consensus 78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 9988653 4679999999999999999765555567999999999999999999999642 135999999999999
Q ss_pred ecC-----------------CCcEEEecccccccCCCCCcccccccccCcccccCCccccC--CCCCCcccchhHhHHHH
Q 036970 193 IDD-----------------DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT--VALSDKCDIYSFGVLLA 253 (337)
Q Consensus 193 ~~~-----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~vl~ 253 (337)
++. .+.++|+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 964 234899999999765433221 23468999999999864 35788999999999999
Q ss_pred HHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 254 VLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 254 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+|++|..||..... ....+.... ..+.. .+ ......+.+||..||+.+|.+||++.+++.
T Consensus 235 ELLTGk~PF~~~~~------~~qli~~lk-~~p~l-pi---------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 235 ELCSGKTPFHKANN------FSQLISELK-RGPDL-PI---------KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHCCCCCCcCCc------HHHHHHHHh-cCCCC-Cc---------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999999964321 112222211 11110 00 111244889999999999999999999983
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=283.21 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=198.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|++|.||+|... .+..+++|.+...... ...+.+|+.+++.++|+|+++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~~---------------~~~~~~E~~~l~~l~~~~i~~~~ 67 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTMS---------------PESFLEEAQIMKKLRHDKLVQLY 67 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec--CCceeEEEEecCCCCC---------------HHHHHHHHHHHHhcCCCceEEEE
Confidence 468999999999999999999765 6778999988543211 34588899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++. ....+++|||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+
T Consensus 68 ~~~~-~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~ 141 (260)
T cd05070 68 AVVS-EEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVC 141 (260)
T ss_pred eEEC-CCCcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceE
Confidence 8875 4567899999999999999854 23345899999999999999999999555 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++.......... .....++..|+|||...+..++.++|+||||+++|++++ |..||.+... .+..
T Consensus 142 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~ 213 (260)
T cd05070 142 KIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------REVL 213 (260)
T ss_pred EeCCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-------HHHH
Confidence 999999987654332211 112234567999999988889999999999999999999 8899865321 1122
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
.......... .+......+.+++.+||.++|++|||+.++.+.|++
T Consensus 214 ~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 214 EQVERGYRMP----------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHcCCCCC----------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2221111110 011122448999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=283.66 Aligned_cols=252 Identities=17% Similarity=0.245 Sum_probs=199.9
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||++.+. .++..+++|.+...... ...+.+.+|+.+++.++|+|++++++.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 66 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKSS-------------SAVEDSRKEAVLLAKMKHPNIVAFKES 66 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcch-------------HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 5889999999999999999865 48899999988533211 114567789999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+++..++++||+++++|.+++.. .....+++.....++.|++.||.+||+. +++|+||+|+||+++.++.+++
T Consensus 67 ~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l 141 (255)
T cd08219 67 FEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKL 141 (255)
T ss_pred EEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEE
Confidence 9999999999999999999998854 2345688999999999999999999955 5999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||.+.......... ....++..|+|||++.+..++.++|+||||+++|+|++|..||..... .......
T Consensus 142 ~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~ 212 (255)
T cd08219 142 GDFGSARLLTSPGAYA--CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKV 212 (255)
T ss_pred cccCcceeeccccccc--ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHH
Confidence 9999987654332211 124578889999999888899999999999999999999999964321 1112222
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
....... ++ ......+.+++.+||+.||++|||+.+++..
T Consensus 213 ~~~~~~~--~~--------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 213 CQGSYKP--LP--------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred hcCCCCC--CC--------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2111110 11 1122348899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=292.18 Aligned_cols=242 Identities=23% Similarity=0.244 Sum_probs=187.2
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHH-HhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEII-TAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|++. .+|+.||+|++........ .....+..|.. +++.++||||+++++.+..+
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~ 68 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNR-----------KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT 68 (325)
T ss_pred CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHHhCCCCCCccEEEEEecC
Confidence 46999999999999865 4899999999854322111 11234445544 56778999999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++||||+.+++|..++. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG 141 (325)
T cd05604 69 EKLYFVLDFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFG 141 (325)
T ss_pred CEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecC
Confidence 99999999999999988883 4456899999999999999999999554 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~~~~~~ 212 (325)
T cd05604 142 LCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHKP 212 (325)
T ss_pred CcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-------HHHHHHHHcCC
Confidence 9865322211 11234689999999999999999999999999999999999999965321 12222222221
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 327 (337)
... . +.....+.+++.+||+.+|.+||++.+
T Consensus 213 ~~~---~--------~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 213 LVL---R--------PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred ccC---C--------CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 111 1 112234789999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=293.22 Aligned_cols=266 Identities=22% Similarity=0.270 Sum_probs=194.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+. .+|..||+|.+....... .....+.+|+.+++.++||||+++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~ 85 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQNQ------------THAKRAYRELVLLKCVNHKNIISL 85 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccccch------------hHHHHHHHHHHHHHhCCCCCEeee
Confidence 4589999999999999999999865 489999999985442211 114567789999999999999999
Q ss_pred hceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++.... ..+++|||+++ +|.+.+. ..++...+..++.|++.||.|||+++ ++||||||+||+
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl 155 (359)
T cd07876 86 LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 155 (359)
T ss_pred eeeeccCCCccccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 99886543 46899999965 6766652 23788889999999999999999554 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc--
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK-- 270 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~-- 270 (337)
++.++.++|+|||++......... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 156 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 156 VKSDCTLKILDFGLARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred ECCCCCEEEecCCCccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999998764332211 134678899999999999999999999999999999999999975432100
Q ss_pred ---------cchH----HHHHHHHhhcCCCCcccc--ccc-------cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 036970 271 ---------EMSF----VQWMRNVMTSENPSRTID--SKL-------IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328 (337)
Q Consensus 271 ---------~~~~----~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 328 (337)
.... .................. ... ...........+.+++.+||+.||++|||+.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 312 (359)
T cd07876 233 KVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312 (359)
T ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence 0000 001111111111000000 000 000001113457899999999999999999999
Q ss_pred HH
Q 036970 329 RC 330 (337)
Q Consensus 329 l~ 330 (337)
++
T Consensus 313 l~ 314 (359)
T cd07876 313 LR 314 (359)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=282.07 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=199.8
Q ss_pred cCcccccccccccccceEEeeeecCC----CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.++|.+.+.||+|++|.||+|.+... .+..|++|......... ....+.+|+.+++.++|+||
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-------------~~~~~~~e~~~l~~l~~~~i 71 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-------------DESDFLMEALIMSKFNHQNI 71 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-------------HHHHHHHHHHHHHhCCCCCE
Confidence 46799999999999999999987531 46778888774322111 13467889999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG---RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
+++++++.+....+++|||+++++|.+++...... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil 148 (277)
T cd05036 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCL 148 (277)
T ss_pred eeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEE
Confidence 99999999999999999999999999999654321 235889999999999999999999555 999999999999
Q ss_pred ecCCC---cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccc
Q 036970 193 IDDDM---EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQH 268 (337)
Q Consensus 193 ~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~ 268 (337)
++.++ .++|+|||++.................+..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 149 ~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~- 227 (277)
T cd05036 149 LTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN- 227 (277)
T ss_pred EeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 98654 589999999887643322211112233567999999988889999999999999999997 9999865322
Q ss_pred cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 269 TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
. +............. +......+.+++.+||+.+|++|||+.++++.|.
T Consensus 228 ---~---~~~~~~~~~~~~~~----------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 228 ---Q---EVMEFVTGGGRLDP----------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---H---HHHHHHHcCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 11222211111110 1112345889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=287.11 Aligned_cols=263 Identities=21% Similarity=0.256 Sum_probs=189.0
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcC---CCCCChhhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQ---VRHRNIVPL 118 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~ni~~~ 118 (337)
+|++.+.||+|+||+||+|++. .+++.||+|.+........ ......+|+.+++. ++||||+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~h~ni~~~ 67 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDG------------LPLSTVREVALLKRLEAFDHPNIVRL 67 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCC------------CchHHHHHHHHHHHhhhcCCCCeeee
Confidence 5889999999999999999865 4899999998854321110 01234455555554 479999999
Q ss_pred hceeecC-----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 119 LARVVRP-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 119 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
++++... ...++++||+. ++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 68 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili 141 (288)
T cd07863 68 MDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILV 141 (288)
T ss_pred eeeeccccCCCCceEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9988653 34689999996 4898888542 2345899999999999999999999554 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
+.++.++|+|||++.......... ...++..|+|||++.+..++.++||||||+++|+|++|.+||...... ..
T Consensus 142 ~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~---~~ 215 (288)
T cd07863 142 TSGGQVKLADFGLARIYSCQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQ 215 (288)
T ss_pred CCCCCEEECccCccccccCcccCC---CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH---HH
Confidence 999999999999987664332211 245688999999999888999999999999999999999998653221 11
Q ss_pred HHHHHHHHhhcC----CC------Cccccc---cccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSE----NP------SRTIDS---KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~----~~------~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... ..... .+ ...+.+ .......+.....+.+++.+||++||++|||+.+++.
T Consensus 216 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 216 LGKIFD-LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHH-HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111 10000 00 000000 0000011122345789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.45 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=200.0
Q ss_pred ccCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|++.+.||+|+||.||+|.+. ..+++.||+|.+...... .....+.+|+.++..+ +||
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~ 71 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------------SEHRALMSELKILIHIGHHL 71 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-------------HHHHHHHHHHHHHHhccCCc
Confidence 5678999999999999999999742 236789999998533211 1145688899999999 689
Q ss_pred ChhhhhceeecC-CCceEEEEeecCCCHHHHHHhhhcC------------------------------------------
Q 036970 114 NIVPLLARVVRP-DCDLLVYEFRRNGSLQDILYDVSQG------------------------------------------ 150 (337)
Q Consensus 114 ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------ 150 (337)
||+++++++... ...+++|||+++|+|.+++......
T Consensus 72 niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (343)
T cd05103 72 NVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSG 151 (343)
T ss_pred cHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccc
Confidence 999999988654 4678999999999999998643210
Q ss_pred ---------------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccccccc
Q 036970 151 ---------------------RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209 (337)
Q Consensus 151 ---------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~ 209 (337)
...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~ 228 (343)
T cd05103 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARD 228 (343)
T ss_pred ccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccc
Confidence 12467888889999999999999955 499999999999999999999999999876
Q ss_pred CCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhhcCCCC
Q 036970 210 IPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPS 288 (337)
Q Consensus 210 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (337)
..............++..|+|||.+.+..++.++|+||||+++|++++ |..||..... ...... ........
T Consensus 229 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~~~~~~ 301 (343)
T cd05103 229 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEFCR----RLKEGTRM 301 (343)
T ss_pred cccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc---cHHHHH----HHhccCCC
Confidence 533222211112344677999999988889999999999999999997 8899865321 111111 11111110
Q ss_pred ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 289 RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
. ... . ....+.+++..||+.+|++|||+.+|++.|..+-
T Consensus 302 ~-~~~----~----~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 302 R-APD----Y----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred C-CCC----C----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 000 0 1124889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=301.32 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=194.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||.||+|++. .+++.||+|++....... ......+.+|+.++..++||||+++++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~iv~~~~ 68 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADMLE-----------KEQVAHIRAERDILVEADGAWVVKMFY 68 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHhh-----------hhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 47899999999999999999865 489999999985432111 112557888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+.+..++||||+++++|.+++. ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vk 141 (360)
T cd05627 69 SFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVK 141 (360)
T ss_pred EEEcCCEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEE
Confidence 9999999999999999999999983 345689999999999999999999955 499999999999999999999
Q ss_pred EecccccccCCCCCcc---------------------------------cccccccCcccccCCccccCCCCCCcccchh
Q 036970 201 ISEFGLAKQIPNGRTR---------------------------------TTTWSLAETVGYIAPECHQTVALSDKCDIYS 247 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws 247 (337)
|+|||++......... .......||+.|+|||++.+..++.++|+||
T Consensus 142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 221 (360)
T cd05627 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (360)
T ss_pred EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence 9999998654321100 0011346899999999999999999999999
Q ss_pred HhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC---
Q 036970 248 FGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN--- 324 (337)
Q Consensus 248 lG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps--- 324 (337)
|||++|+|++|..||..... ............ ...+++. ......+.+++.+|+. ||.+|++
T Consensus 222 lGvilyel~tG~~Pf~~~~~-------~~~~~~i~~~~~-~~~~p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~ 286 (360)
T cd05627 222 LGVIMYEMLIGYPPFCSETP-------QETYRKVMNWKE-TLVFPPE------VPISEKAKDLILRFCT-DSENRIGSNG 286 (360)
T ss_pred ccceeeecccCCCCCCCCCH-------HHHHHHHHcCCC-ceecCCC------CCCCHHHHHHHHHhcc-ChhhcCCCCC
Confidence 99999999999999975432 112222221111 0001110 0112347778888764 9999996
Q ss_pred HHHHH
Q 036970 325 SKDVR 329 (337)
Q Consensus 325 ~~~il 329 (337)
+.+++
T Consensus 287 ~~ei~ 291 (360)
T cd05627 287 VEEIK 291 (360)
T ss_pred HHHHh
Confidence 45554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=283.18 Aligned_cols=257 Identities=24% Similarity=0.342 Sum_probs=197.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|+.. .+++.|++|+........ ...+.+|+.++.+++||||+++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~~--------------~~~~~~e~~~l~~~~h~~ii~~ 71 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPGDD--------------FSLIQQEIFMVKECKHCNIVAY 71 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCccch--------------HHHHHHHHHHHHhcCCCCeeee
Confidence 4678999999999999999999865 478999999985432111 3457789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+..+...++|+||+++++|.+++. ...++++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.
T Consensus 72 ~~~~~~~~~~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~ 144 (267)
T cd06646 72 FGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGD 144 (267)
T ss_pred eEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCC
Confidence 999999999999999999999999884 335689999999999999999999955 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++|+|||++......... .....++..|+|||.+. ...++.++|+||||+++|+|++|..||..........
T Consensus 145 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--- 219 (267)
T cd06646 145 VKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--- 219 (267)
T ss_pred EEECcCccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---
Confidence 999999998765432211 11345788999999874 3447789999999999999999999985432110000
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L 332 (337)
......... +.. .........+.+++.+||+.+|++|||++++++-|
T Consensus 220 ----~~~~~~~~~----~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 220 ----LMSKSNFQP----PKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ----eeecCCCCC----CCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000000 000 00112234588999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.25 Aligned_cols=257 Identities=18% Similarity=0.228 Sum_probs=196.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+++.||+|++........ .....+.+|+.+++.++||||+++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~~~~-----------~~~~~~~~e~~i~~~~~hp~iv~~ 108 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKR-----------SDSAFFWEERDIMAFANSPWVVQL 108 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHhhhh-----------HHHHHHHHHHHHHHhCCCCCCCeE
Confidence 5699999999999999999999866 4889999999854322111 113457789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+.++...++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCC
Confidence 9999999999999999999999999843 34788889999999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCC----CCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA----LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
++|+|||++.......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 181 ikL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------- 252 (371)
T cd05622 181 LKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------- 252 (371)
T ss_pred EEEEeCCceeEcCcCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------
Confidence 9999999987664332211 12357899999999987543 78899999999999999999999975322
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEE--RPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~il~ 330 (337)
............... +. ........+.++|..||+.++.. |+++.++++
T Consensus 253 ~~~~~~i~~~~~~~~-~~------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 253 VGTYSKIMNHKNSLT-FP------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred HHHHHHHHcCCCccc-CC------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 122222222211111 00 01122344788899999844432 778888876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=289.09 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=196.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcE--EEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRV--ITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
++|++.+.||+|+||.||+|++.. ++.. +++|....... ......+.+|+.++.++ +|+||++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~-~~~~~~~~ik~~~~~~~-------------~~~~~~~~~Ei~~l~~l~~h~~iv~ 72 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYAS-------------KDDHRDFAGELEVLCKLGHHPNIIN 72 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEcc-CCceeeEEEEEecccCC-------------HHHHHHHHHHHHHHHHhcCCCCcce
Confidence 688999999999999999998753 5544 46665532111 11245788899999999 8999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRD 185 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~d 185 (337)
+++++.+++..++++||+++++|.+++..... ....+++..++.++.|++.|++|||+. |++|+|
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~d 149 (303)
T cd05088 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRD 149 (303)
T ss_pred EEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99999999999999999999999999965321 123588999999999999999999955 599999
Q ss_pred CCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCC
Q 036970 186 IQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDD 264 (337)
Q Consensus 186 i~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~ 264 (337)
|+|+||+++.++.++|+|||++........ ......+..|+|||.+.+..++.++||||||+++|++++ |..||..
T Consensus 150 lkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 226 (303)
T cd05088 150 LAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226 (303)
T ss_pred cchheEEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence 999999999999999999999864321111 111223567999999988889999999999999999998 9999864
Q ss_pred cccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
... .+............. +......+.+++.+||+.+|++||++.++++.|.++
T Consensus 227 ~~~-------~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 227 MTC-------AELYEKLPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred CCh-------HHHHHHHhcCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 322 111111111101100 011223488999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=289.57 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=193.9
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
.+..++|.+++.||.|+||.||+|.+. .+++.||+|.+........ ....+.+|+.+++.++||||+
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv 77 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQSLI------------HARRTYRELRLLKHMKHENVI 77 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhhhH------------HHHHHHHHHHHHHhcCCCchh
Confidence 446789999999999999999999865 4889999999854322111 144577899999999999999
Q ss_pred hhhceeecC------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 117 PLLARVVRP------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 117 ~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
++++++... ...+++++++ +++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~N 148 (343)
T cd07878 78 GLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSN 148 (343)
T ss_pred hhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhh
Confidence 999988643 3458999988 778988772 346899999999999999999999554 9999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
|+++.++.+||+|||++........ ...+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 149 il~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~- 222 (343)
T cd07878 149 VAVNEDCELRILDFGLARQADDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI- 222 (343)
T ss_pred EEECCCCCEEEcCCccceecCCCcC-----CccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-
Confidence 9999999999999999876543321 3467899999999877 46889999999999999999999999653211
Q ss_pred ccchHHHHHHHHhhcCCCC-----------------ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 270 KEMSFVQWMRNVMTSENPS-----------------RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+........+. ..................+.+++.+||+.||.+|||+.++++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 223 ---DQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred ---HHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011110000000000 000000000000001123789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=282.69 Aligned_cols=260 Identities=22% Similarity=0.338 Sum_probs=201.4
Q ss_pred cCcccccccccccccceEEeeeecCC--CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.++|++.+.||+|+||.||+|.+... .+..+++|.+...... .....+.+|+..+..++||||++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~ 69 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-------------KQRRDFLSEASIMGQFDHPNIIH 69 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-------------HHHHHHHHHHHHHHhCCCCCcce
Confidence 36789999999999999999986422 2347899987433211 11457888999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+++..+++|||+++++|.+++.. ....+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~ 143 (267)
T cd05066 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNL 143 (267)
T ss_pred EEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCC
Confidence 99999999999999999999999999854 2346899999999999999999999555 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccc-cccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHH
Q 036970 198 EARISEFGLAKQIPNGRTRTT-TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~ 275 (337)
.++++|||++........... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||..... .
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~--- 216 (267)
T cd05066 144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----Q--- 216 (267)
T ss_pred eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----H---
Confidence 999999999987654322111 111222467999999998889999999999999999886 9999865322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+............. ....+..+.+++.+||+++|.+||++.++++.|+++
T Consensus 217 ~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 217 DVIKAIEEGYRLPA----------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHhCCCcCCC----------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11111111111110 011223478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=281.31 Aligned_cols=259 Identities=27% Similarity=0.375 Sum_probs=214.2
Q ss_pred hhhhhhhh--ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhc
Q 036970 31 KEDLAFLK--KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAG 108 (337)
Q Consensus 31 ~~~~~~l~--~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 108 (337)
+.+..-|. .++-|+++.+||.|.+|.||+|.++ .+|..+|||.+.-... ..++..|+.++.
T Consensus 21 KLd~~sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV~sD----------------LQEIIKEISIMQ 83 (502)
T KOG0574|consen 21 KLDSSALNKPPEEVFDIVGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPVDTD----------------LQEIIKEISIMQ 83 (502)
T ss_pred ccChhhhcCChHHHHHHHHHhcCCcchHHHHHHHh-ccCcEEEEEecCccch----------------HHHHHHHHHHHH
Confidence 34444444 5688999999999999999999876 4999999999854332 667899999999
Q ss_pred CCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 036970 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188 (337)
Q Consensus 109 ~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~ 188 (337)
+.+.|+++++++.|.....+|+|||||..|+..+.++ ..++++++..+..++...+.||+|||... -+|||||.
T Consensus 84 QC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKA 157 (502)
T KOG0574|consen 84 QCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKA 157 (502)
T ss_pred HcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhccc
Confidence 9999999999999999999999999999999999984 46788999999999999999999999554 89999999
Q ss_pred CcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc
Q 036970 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268 (337)
Q Consensus 189 ~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~ 268 (337)
.|||++.+|..||+|||.+-.+..--..+ ....||+.|||||++..-.|+.++||||||++..||..|++||.+.-+
T Consensus 158 GNILLNT~G~AKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP- 234 (502)
T KOG0574|consen 158 GNILLNTDGIAKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP- 234 (502)
T ss_pred ccEEEcccchhhhhhccccchhhhhHHhh--CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-
Confidence 99999999999999999987664322222 246899999999999999999999999999999999999999976322
Q ss_pred cccchHHHHHHHHh-hcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 269 TKEMSFVQWMRNVM-TSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 269 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
++.+. -+..+. .-...+...+..+.+++++||-++|++|.|+.++++
T Consensus 235 ---------MRAIFMIPT~PP------PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 235 ---------MRAIFMIPTKPP------PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ---------cceeEeccCCCC------CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11110 011111 112345667778999999999999999999998875
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=279.59 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=199.7
Q ss_pred CcccccccccccccceEEeeeecCCCC---cEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSG---RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
++|++.+.||+|+||.||+|++.. ++ ..|++|.+..... ......+..|+..++.++||||++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni~~ 69 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKL-PGKREIFVAIKTLKSGYT-------------EKQRRDFLSEASIMGQFDHPNIIH 69 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEec-CCCCceeEEEEEcCCCCC-------------HHHHHHHHHHHHHHHhCCCcCcce
Confidence 568899999999999999998753 33 3699998743321 112457889999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.++...++++||+++++|.+++.. ..+.+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~ 143 (269)
T cd05065 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNL 143 (269)
T ss_pred EEEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCC
Confidence 99999999999999999999999999854 234689999999999999999999955 499999999999999999
Q ss_pred cEEEecccccccCCCCCccccccccc---CcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLA---ETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~---g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
.++++|||++................ .+..|+|||.+.+..++.++||||||+++||+++ |..||..... ..
T Consensus 144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~ 219 (269)
T cd05065 144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QD 219 (269)
T ss_pred cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HH
Confidence 99999999987654332211111111 1357999999998899999999999999999886 9999865321 11
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
..+.+ ........ +......+.+++.+||+.+|++||++.++++.|+++
T Consensus 220 ~~~~i---~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 220 VINAI---EQDYRLPP----------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHH---HcCCcCCC----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22222 11111110 111223488999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=280.43 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=189.4
Q ss_pred ccccccccceEEeeeecC-CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|.... .++..+++|.+....... ....+.+|+.+++.++||||+++++.+.+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 67 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ-------------EQMKFLEEAQPYRSLQHSNLLQCLGQCTEV 67 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH-------------HHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 468999999999997542 245678999874432211 134688899999999999999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQG-RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 204 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Df 204 (337)
...++||||+++++|.+++...... ....++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~df 144 (269)
T cd05087 68 TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDY 144 (269)
T ss_pred CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCc
Confidence 9999999999999999999654322 234567778889999999999999554 999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccCCccccCC-------CCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 205 GLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-------ALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 205 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
|++................++..|+|||++.+. .++.++|+||||+++|+|++ |..||...... ....
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~ 220 (269)
T cd05087 145 GLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLT 220 (269)
T ss_pred cccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHH
Confidence 998765433332222234567889999988642 35789999999999999996 99999653221 1111
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
. ...... .....+...... ...+.+++..|| .+|++|||+.+|...|+
T Consensus 221 ~---~~~~~~-~~~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 221 Y---TVREQQ-LKLPKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred H---Hhhccc-CCCCCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 111110 111111111111 123677888899 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=313.74 Aligned_cols=264 Identities=24% Similarity=0.264 Sum_probs=200.0
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||+|+||.||+|.+. .+|+.||+|++...... .......+.+|+.+++.++||||+++++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l~~-----------~e~~~~rflrEi~ILs~L~HPNIVkl~~ 69 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDLSE-----------NPLLKKRFLREAKIAADLIHPGIVPVYS 69 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC-CCCcEEEEEEECccccc-----------CHHHHHHHHHHHHHHHhCCCcCcCeEEE
Confidence 68999999999999999999865 47999999998543211 1112457889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcC-------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQG-------RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
++.+++..+++|||+++++|.+++...... ....+...+..++.||+.||.|||+.+ ++||||||+||++
T Consensus 70 v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILL 146 (932)
T PRK13184 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILL 146 (932)
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEE
Confidence 999999999999999999999998653221 233566778899999999999999554 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCc----------------ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh
Q 036970 194 DDDMEARISEFGLAKQIPNGRT----------------RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM 257 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~ 257 (337)
+.++.++|+|||++........ ........||+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 147 d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT 226 (932)
T PRK13184 147 GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226 (932)
T ss_pred cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999999999999976521100 001112468999999999999999999999999999999999
Q ss_pred CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhh
Q 036970 258 GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-NSKDVRCMLSQ 334 (337)
Q Consensus 258 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~il~~L~~ 334 (337)
|..||...... ....... ...+... ......+..+.+++.+||+.||++|| +++++++.|..
T Consensus 227 G~~PF~~~~~~-------ki~~~~~-i~~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 227 LSFPYRRKKGR-------KISYRDV-ILSPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred CCCCCCCcchh-------hhhhhhh-ccChhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999652211 0000000 0000000 00112234478899999999999996 56667666654
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.97 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=202.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||.|++|.||+|.+. ++..+++|.+...... ...+.+|+..++.++|+||+++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGTMS---------------PEAFLQEAQIMKKLRHDKLVQL 66 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCccC---------------HHHHHHHHHHHhhCCCCCEeee
Confidence 4578999999999999999999865 5688999987543221 3468889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++++||+++++|.+++... ....+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.
T Consensus 67 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~ 141 (261)
T cd05034 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLV 141 (261)
T ss_pred eeeeecCCceEEEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCC
Confidence 99999989999999999999999998542 2346899999999999999999999554 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
++++|||.+......... .......+..|+|||.+.+..++.++|+||||++++++++ |..||.+... ...
T Consensus 142 ~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~ 213 (261)
T cd05034 142 CKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REV 213 (261)
T ss_pred EEECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence 999999998766432211 1112234567999999998889999999999999999998 9999864321 111
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
............ +......+.+++.+||+.+|++||++.++.+.|+++
T Consensus 214 ~~~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 214 LEQVERGYRMPR----------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHcCCCCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 222221111110 011123488999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=283.79 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=197.2
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
.|+..+.||.|+||+||+|.+. .+++.+|+|.+........ .....+.+|+.+++.++|+|++++.+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~~~~i~~~~~~ 68 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKR-----------KGESMALNEKQILEKVNSQFVVNLAYA 68 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhhhh-----------hHHHHHHHHHHHHHHcCCcCceeEEEE
Confidence 4778899999999999999865 4899999999854322111 113457789999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+++..++++||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl 143 (285)
T cd05632 69 YETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRI 143 (285)
T ss_pred EecCCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEE
Confidence 99999999999999999999888542 334689999999999999999999955 5999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||++......... ....|+..|+|||.+.+..++.++|+||||+++|++++|..||....... .........
T Consensus 144 ~Dfg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~ 217 (285)
T cd05632 144 SDLGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRV 217 (285)
T ss_pred ecCCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhh
Confidence 999988665432221 13467899999999998889999999999999999999999997532210 111111111
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il~ 330 (337)
. .... .+ .......+.+++..||+.||.+||+ +.+++.
T Consensus 218 ~-~~~~--~~--------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 218 L-ETEE--VY--------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred h-cccc--cc--------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1 1110 01 1112234788999999999999999 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=276.27 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=201.3
Q ss_pred ccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeec
Q 036970 47 EKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 124 (337)
+.||+|+||.||+|.... ..+..|++|.+....... ....+.+|+..+..++|+|++++++++.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-------------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 67 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-------------ERKDFLKEARVMKKLGHPNVVRLLGVCTE 67 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-------------HHHHHHHHHHHHhhcCCCChheeeeeecC
Confidence 479999999999998753 128889999985543321 15678899999999999999999999999
Q ss_pred CCCceEEEEeecCCCHHHHHHhhhcC-----CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 125 PDCDLLVYEFRRNGSLQDILYDVSQG-----RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+...++++||+++++|.+++...... ...+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.+
T Consensus 68 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~ 144 (262)
T cd00192 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVV 144 (262)
T ss_pred CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcE
Confidence 99999999999999999999653211 36799999999999999999999954 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||.+................++..|+|||.+....++.++|+||||+++|++++ |..||..... .+..
T Consensus 145 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~ 217 (262)
T cd00192 145 KISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVL 217 (262)
T ss_pred EEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHH
Confidence 9999999987765432222233456888999999988889999999999999999999 5899875421 1222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
.......... .+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 218 ~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 218 EYLRKGYRLP----------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHcCCCCC----------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2222111110 11122345889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=288.65 Aligned_cols=264 Identities=17% Similarity=0.214 Sum_probs=195.0
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|.+.+.||+|+||.||+|++. .++..||+|.+....... ....+.+|+.+++.++||||++++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~~~ 70 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEG-------------APCTAIREVSLLKDLKHANIVTLH 70 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccccCC-------------cchhHHHHHHHHHhCCCCCcceEE
Confidence 478999999999999999999865 478899999885332110 123567899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++..++..++||||+++ +|.+++.. ....++...+..++.|++.||.|||+. |++||||+|+||+++.++.+
T Consensus 71 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~ 143 (309)
T cd07872 71 DIVHTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGEL 143 (309)
T ss_pred EEEeeCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCE
Confidence 999999999999999965 78887743 334578899999999999999999955 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++.......... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... .....
T Consensus 144 kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~----~~~~~ 217 (309)
T cd07872 144 KLADFGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED----ELHLI 217 (309)
T ss_pred EECccccceecCCCcccc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHH
Confidence 999999987643322211 12356889999998865 457899999999999999999999997543211 11111
Q ss_pred HHHhhcCCC----------------CccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENP----------------SRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... .............+.....+.+++.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 218 FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 110000000 0000000000001122345789999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=285.94 Aligned_cols=263 Identities=21% Similarity=0.278 Sum_probs=198.6
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|+||.||+|.+. .++..+++|.+...... ....++.+|+.++.+++||||+++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 66 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIKP-------------AIRNQIIRELKVLHECNSPYIVGFYG 66 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccCH-------------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 47999999999999999999865 47888999987533211 11456888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+++..++++||+++++|.+++.. .+.+++..+..++.|++.||.|||+. .+++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~ 140 (308)
T cd06615 67 AFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIK 140 (308)
T ss_pred EEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEE
Confidence 99999999999999999999999843 35689999999999999999999953 2599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++........ ....++..|+|||.+.+..++.++|+||||+++|++++|..||..... .........
T Consensus 141 l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~ 212 (308)
T cd06615 141 LCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGR 212 (308)
T ss_pred EccCCCccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch----hhHHHhhcC
Confidence 999998865533211 134678899999999888899999999999999999999999864321 111111100
Q ss_pred HhhcCCCCcc------------------------ccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 281 VMTSENPSRT------------------------IDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 281 ~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
.......... ................+.+++.+||+.+|++|||+.++++-
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 00000000000123458899999999999999999998864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=281.02 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=196.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
..+|.+.+.||+|++|.||+|.. .|..+++|....... ...+.+|+.+++.++|+|+++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~~~~----------------~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT----------------AQAFLAEASVMTQLRHSNLVQLL 65 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCCCch----------------HHHHHHHHHHHHhCCCCCeeeEE
Confidence 45889999999999999999975 588899998743221 34688899999999999999999
Q ss_pred ceee-cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 120 ARVV-RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 120 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+++. ++...++++||+++++|.+++.. .....+++..++.++.|++.||.|||++ |++|+||+|+||+++.++.
T Consensus 66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~ 140 (256)
T cd05082 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNV 140 (256)
T ss_pred EEEEcCCCceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCc
Confidence 8764 45678999999999999999854 2334588999999999999999999955 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++........ ...++..|+|||++.+..++.++||||||+++|+|++ |..||.... ..+.
T Consensus 141 ~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-------~~~~ 208 (256)
T cd05082 141 AKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDV 208 (256)
T ss_pred EEecCCccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-------HHHH
Confidence 99999999875433221 1233567999999998889999999999999999997 899986421 1122
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
...... ..... . .+.....+.+++.+||+.+|++|||+.++++.|+++
T Consensus 209 ~~~~~~-~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 209 VPRVEK-GYKMD-----A----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhc-CCCCC-----C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 222111 11110 0 111234488999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=276.97 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=195.1
Q ss_pred ccccccccceEEeeeecCCC--CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeec
Q 036970 47 EKIRSCWNGEVYKAELPGSS--GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 124 (337)
++||+|+||.||+|.+...+ +..+++|.+...... .....+.+|+.+++.++|+|++++++++.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 66 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------------AGKKEFLREASVMAQLDHPCIVRLIGVCK- 66 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-
Confidence 47999999999999865433 378999988544321 11457888999999999999999999776
Q ss_pred CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecc
Q 036970 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 204 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Df 204 (337)
....++++||+++++|.+++.. ...+++..+..++.|++.++.|||.. +++|+||+|+||+++.++.++|+||
T Consensus 67 ~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df 139 (257)
T cd05060 67 GEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDF 139 (257)
T ss_pred CCceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccc
Confidence 4567999999999999999943 34689999999999999999999955 4999999999999999999999999
Q ss_pred cccccCCCCCccc-ccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHh
Q 036970 205 GLAKQIPNGRTRT-TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVM 282 (337)
Q Consensus 205 g~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (337)
|++.......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||..... ......+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~--- 212 (257)
T cd05060 140 GMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLE--- 212 (257)
T ss_pred cccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHH---
Confidence 9988764432211 1111223467999999998899999999999999999998 9999865321 12222221
Q ss_pred hcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 283 TSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
...... .+......+.+++.+||+.+|++|||+.++++.|.++.
T Consensus 213 ~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 213 SGERLP----------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCcCC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111111 01112245889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=280.67 Aligned_cols=268 Identities=23% Similarity=0.310 Sum_probs=199.0
Q ss_pred cCcccccccccccccceEEeeeec---CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELP---GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..+|++.+.||.|+||.||.|... ..++..|++|.+..... .....+.+|+.+++.++||||+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv 68 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--------------EHLRDFEREIEILKSLQHDNIV 68 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCCCee
Confidence 468899999999999999999742 34688999999754321 1145688999999999999999
Q ss_pred hhhceeec--CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 117 PLLARVVR--PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 117 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++++.. ....++|+||+++++|.+++.. ....+++..++.++.|++.||.|||+. |++|+||||+||+++
T Consensus 69 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~ 142 (284)
T cd05081 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVE 142 (284)
T ss_pred EEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEEC
Confidence 99987654 3467899999999999999853 234589999999999999999999955 499999999999999
Q ss_pred CCCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc-----
Q 036970 195 DDMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH----- 268 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~----- 268 (337)
.++.++|+|||++......... .......++..|+|||++.+..++.++|+||||++++||++|..|+......
T Consensus 143 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~ 222 (284)
T cd05081 143 SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM 222 (284)
T ss_pred CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhc
Confidence 9999999999999876433221 1111122345699999998888999999999999999999988775432110
Q ss_pred ---cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 269 ---TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 269 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.........+.......... .........+.+++.+||+.+|++|||+.+|++.|+.++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 223 GNDKQGQMIVYHLIELLKNNGRL---------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred ccccccccchHHHHHHHhcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00000000011111111000 001112345889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=281.10 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=197.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
+++-|++.+.||.|++|.||+|.+. .++..+++|....... .....+.+|+.+++.++|||++++
T Consensus 3 ~~~~~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~ii~~ 67 (282)
T cd06643 3 PEEFWEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSE--------------EELEDYMVEIDILASCDHPNIVKL 67 (282)
T ss_pred HHHHHHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCCCH--------------HHHHHHHHHHHHHHHCCCCCeeeE
Confidence 4455789999999999999999865 3788899998743321 114567889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+..+...++++||+++++|..++.. ...++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 68 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~ 141 (282)
T cd06643 68 LDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGD 141 (282)
T ss_pred EEEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCC
Confidence 9999999999999999999999888743 3456899999999999999999999554 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
++|+|||++......... .....++..|+|||++. +..++.++|+||||+++|+|++|..||.....
T Consensus 142 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------ 213 (282)
T cd06643 142 IKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------ 213 (282)
T ss_pred EEEccccccccccccccc--cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------
Confidence 999999998765432211 12346788999999874 34577899999999999999999999875322
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............+.... +......+.+++.+||++||.+||++.++++
T Consensus 214 -~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 214 -MRVLLKIAKSEPPTLAQ--------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -HHHHHHHhhcCCCCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111111111111 1112345889999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=292.42 Aligned_cols=266 Identities=22% Similarity=0.257 Sum_probs=195.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+. ..++.||+|.+....... .....+.+|+.+++.++||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~ 81 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIISL 81 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEec-CCCceEEEEEeCCcccCh------------HHHHHHHHHHHHHHHhCCCchhce
Confidence 4579999999999999999999854 488999999985433211 114567789999999999999999
Q ss_pred hceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++.... ..+++|||+++ +|.+.+. ..++...+..++.|++.||.|||+. |++||||||+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nil 151 (355)
T cd07874 82 LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIV 151 (355)
T ss_pred eeeeeccccccccceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEE
Confidence 99886543 46899999965 6777662 2378889999999999999999955 5999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
++.++.++|+|||++......... ....+|..|+|||++.+..++.++||||||+++|+|++|..||.+......-.
T Consensus 152 l~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 152 VKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred ECCCCCEEEeeCcccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999765433221 13467899999999999899999999999999999999999997543211000
Q ss_pred h-----------HH----HHHHHHhhcCCCCc------cccccc---cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 036970 273 S-----------FV----QWMRNVMTSENPSR------TIDSKL---IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328 (337)
Q Consensus 273 ~-----------~~----~~~~~~~~~~~~~~------~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 328 (337)
. .. .............. ...... ...........+.+++.+||+.||++|||+.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 0 00 00001110000000 000000 000111123457899999999999999999999
Q ss_pred HH
Q 036970 329 RC 330 (337)
Q Consensus 329 l~ 330 (337)
++
T Consensus 309 l~ 310 (355)
T cd07874 309 LQ 310 (355)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=276.72 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=199.7
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|+||.||+|.+. .+..+++|.+..... ..+.+.+|+.+++.++|+||++++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~ 67 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSM---------------SVEAFLAEANVMKTLQHDKLVKLH 67 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec--CCccEEEEecCCChh---------------HHHHHHHHHHHHHhcCCCCcceEE
Confidence 578999999999999999999854 667799998753221 145688899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+.+ ...++++||+++++|.+++... ....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.+
T Consensus 68 ~~~~~-~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~ 141 (260)
T cd05073 68 AVVTK-EPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVC 141 (260)
T ss_pred EEEcC-CCeEEEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcE
Confidence 98887 7789999999999999998542 334578888999999999999999955 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||.+.......... .....++..|+|||++....++.++|+||||+++|++++ |..||..... .......
T Consensus 142 ~l~d~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~ 216 (260)
T cd05073 142 KIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRAL 216 (260)
T ss_pred EECCCcceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH
Confidence 999999987654332211 112344677999999988889999999999999999998 8999865321 1111211
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
. ...... ........+.+++.+||+++|++||++.++.+.|+.+
T Consensus 217 ~----~~~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 217 E----RGYRMP---------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred h----CCCCCC---------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 1 111100 0111224488999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=284.91 Aligned_cols=258 Identities=22% Similarity=0.284 Sum_probs=196.4
Q ss_pred CcccccccccccccceEEeeeecCCCCc--EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGR--VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
++|++.+.||.|+||.||+|.... ++. .+++|.+...... .....+.+|+.++.++ +||||++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~~ik~~~~~~~~-------------~~~~~~~~E~~~l~~l~~hp~iv~ 67 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK-DGLKMNAAIKMLKEFASE-------------NDHRDFAGELEVLCKLGHHPNIIN 67 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC-CCCcceeEEEEccccCCH-------------HHHHHHHHHHHHHHhhcCCCchhh
Confidence 579999999999999999998653 443 4677776321110 1145688899999999 7999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRD 185 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~d 185 (337)
+++++.+.+..++++||+++++|.+++..... ....+++..++.++.|++.||+|||+. |++|+|
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~d 144 (297)
T cd05089 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRD 144 (297)
T ss_pred eEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCc
Confidence 99999999999999999999999999854221 123588999999999999999999955 599999
Q ss_pred CCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCC
Q 036970 186 IQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDD 264 (337)
Q Consensus 186 i~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~ 264 (337)
|||+||+++.++.++|+|||++.......... ....+..|+|||+..+..++.++||||||+++|+|++ |..||..
T Consensus 145 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 145 LAARNVLVGENLASKIADFGLSRGEEVYVKKT---MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred CCcceEEECCCCeEEECCcCCCccccceeccC---CCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999986432211111 1122457999999988889999999999999999997 9999865
Q ss_pred cccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
... .+............ .+......+.+++.+||+.+|.+|||++++++.|.++
T Consensus 222 ~~~-------~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 222 MTC-------AELYEKLPQGYRME----------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred CCH-------HHHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 322 11122221111110 0111223488999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=292.21 Aligned_cols=266 Identities=20% Similarity=0.248 Sum_probs=194.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|.+. ..++.||+|++....... .....+.+|+.+++.++||||+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~ii~~ 88 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIIGL 88 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccCc------------hhHHHHHHHHHHHHhcCCCCcccc
Confidence 4689999999999999999999865 478999999985432211 114567789999999999999999
Q ss_pred hceeecC------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRP------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++... ...++||||+++ +|.+.+. ..++...+..++.|++.||.|||++ |++|+||||+||+
T Consensus 89 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 158 (364)
T cd07875 89 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIV 158 (364)
T ss_pred ceeecccccccccCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEE
Confidence 9987653 346899999955 7777762 2378888999999999999999955 5999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc-
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE- 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~- 271 (337)
++.++.++|+|||++......... ....+|..|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 159 l~~~~~~kL~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 235 (364)
T cd07875 159 VKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235 (364)
T ss_pred ECCCCcEEEEeCCCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999765433221 1346789999999999999999999999999999999999999753221100
Q ss_pred ----------chHHH----HHHHHhhcCCCCcccc-----ccc----cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 036970 272 ----------MSFVQ----WMRNVMTSENPSRTID-----SKL----IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328 (337)
Q Consensus 272 ----------~~~~~----~~~~~~~~~~~~~~~~-----~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 328 (337)
..... .........+...... ... ...........+.+++.+||+.||.+|||+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~ 315 (364)
T cd07875 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315 (364)
T ss_pred HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence 00000 0001111111000000 000 000011123458899999999999999999999
Q ss_pred HH
Q 036970 329 RC 330 (337)
Q Consensus 329 l~ 330 (337)
++
T Consensus 316 L~ 317 (364)
T cd07875 316 LQ 317 (364)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.23 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=196.5
Q ss_pred ccccccccceEEeeeecCCCCc--EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeec
Q 036970 47 EKIRSCWNGEVYKAELPGSSGR--VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 124 (337)
+.||+|++|.||+|.+....++ .+++|.+...... .....+.+|+..+.+++||||+++++++.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 67 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT 67 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------------HHHHHHHHHHHHHhhcCCCCccceeEEEcC
Confidence 4689999999999987543343 6899988554432 225678899999999999999999999988
Q ss_pred CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecc
Q 036970 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 204 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Df 204 (337)
...++++||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 68 -~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~df 141 (257)
T cd05040 68 -HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDF 141 (257)
T ss_pred -CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccc
Confidence 888999999999999999865321 5689999999999999999999955 5999999999999999999999999
Q ss_pred cccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHh
Q 036970 205 GLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVM 282 (337)
Q Consensus 205 g~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (337)
|++......... .......++..|+|||.+.+..++.++|+||||+++++|++ |..||..... .+......
T Consensus 142 g~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~ 214 (257)
T cd05040 142 GLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-------SQILKKID 214 (257)
T ss_pred cccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence 999876543221 12223345778999999998899999999999999999998 9999864322 11111111
Q ss_pred hcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 283 TSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
....... . +...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 215 ~~~~~~~-~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 215 KEGERLE-R--------PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred hcCCcCC-C--------CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1111000 0 1112345889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=279.04 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=197.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|++. .+++.|++|.+...... ....+.+|+.+++.++||||+++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~--------------~~~~~~~e~~~~~~l~h~~ii~~ 71 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPGE--------------DFAVVQQEIIMMKDCKHSNIVAY 71 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCchh--------------HHHHHHHHHHHHHhCCCCCeeeE
Confidence 4578999999999999999999865 47899999987543211 13457789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+...+..++++||+++++|.+++. ..+.+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 144 (267)
T cd06645 72 FGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGH 144 (267)
T ss_pred EEEEEeCCEEEEEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCC
Confidence 999999999999999999999999984 345689999999999999999999955 4999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++|+|||++......... .....|+..|+|||++. ...++.++|+||||+++|+|++|..||......
T Consensus 145 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~------- 215 (267)
T cd06645 145 VKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM------- 215 (267)
T ss_pred EEECcceeeeEccCcccc--cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-------
Confidence 999999998765432211 12346789999999874 445788999999999999999999998643221
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
................... ......+.+++.+||+.+|++|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 216 RALFLMTKSNFQPPKLKDK------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hhHHhhhccCCCCCccccc------CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0011111011111101000 011234789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=280.18 Aligned_cols=254 Identities=25% Similarity=0.361 Sum_probs=197.3
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++...||.|++|.||+|.+. .+..+++|....... ....+.+|+.+++.++|+|+++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~ 67 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPGTM---------------MPEAFLQEAQIMKKLRHDKLVPLY 67 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccCCc---------------cHHHHHHHHHHHHhCCCCCeeeEE
Confidence 367999999999999999999865 455789998743221 134678899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++. ....+++|||+.+++|.+++... ....+++..+..++.|++.||.|||+. |++|+||+|+||++++++.+
T Consensus 68 ~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~ 141 (260)
T cd05069 68 AVVS-EEPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVC 141 (260)
T ss_pred EEEc-CCCcEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeE
Confidence 8775 45678999999999999998542 334578999999999999999999955 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||.+......... ......++..|+|||...+..++.++|+||||+++|++++ |..||.+... .....
T Consensus 142 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~-- 214 (260)
T cd05069 142 KIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----REVLE-- 214 (260)
T ss_pred EECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH--
Confidence 99999998765433221 1112345678999999988889999999999999999999 8899865321 11111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
......... .+......+.+++.+||++||++||++.++++.|++
T Consensus 215 -~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 215 -QVERGYRMP----------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -HHHcCCCCC----------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111111110 011223458899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=281.59 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=204.0
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|++|+||+|.+. .+|+.|++|+....... .....+.+|+.+++.++||||++++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~ 69 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAKS-------------SVRKQILRELQIMHECRSPYIVSFY 69 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCcc-------------hHHHHHHHHHHHHHHcCCCCcceEe
Confidence 468999999999999999999865 47899999987533211 1145788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+......++|+||+++++|.+++. ..+.+++.....++.+++.+|.|||+. .+++|+||+|+||+++.++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~ 143 (284)
T cd06620 70 GAFLNENNICMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQI 143 (284)
T ss_pred eeEecCCEEEEEEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcE
Confidence 99999999999999999999999884 345689999999999999999999953 259999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc----ccchHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT----KEMSFV 275 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~----~~~~~~ 275 (337)
+|+|||++........ ....++..|+|||++.+..++.++|+||||+++|++++|..||....... ......
T Consensus 144 ~l~d~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~ 219 (284)
T cd06620 144 KLCDFGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL 219 (284)
T ss_pred EEccCCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH
Confidence 9999998865432211 13467889999999988889999999999999999999999997543321 111122
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L 332 (337)
...........+.. ........+.+++.+||++||++|||+.++++..
T Consensus 220 ~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 220 DLLQQIVQEPPPRL---------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHhhccCCCC---------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 23333222211110 0111334588999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=286.59 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=202.7
Q ss_pred cCcccccccccccccceEEeeeecC------CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CC
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG------SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RH 112 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 112 (337)
..+|.+++.||+|+||.||+|++.. ..+..|++|........ .....+.+|+.+++++ +|
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h 77 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-------------KDLSDLVSEMEMMKMIGKH 77 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-------------HHHHHHHHHHHHHHhhcCC
Confidence 4579999999999999999997532 12346899977432211 1145788899999999 79
Q ss_pred CChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 036970 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRPR 180 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 180 (337)
|||+++++++.++...++++||+++++|.+++..... ....+++..+..++.|++.||.|||++ |
T Consensus 78 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---g 154 (334)
T cd05100 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---K 154 (334)
T ss_pred CCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 9999999999999999999999999999999865321 223578889999999999999999955 5
Q ss_pred ceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CC
Q 036970 181 IIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GK 259 (337)
Q Consensus 181 ~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~ 259 (337)
++|+||+|+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 155 ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 234 (334)
T cd05100 155 CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 234 (334)
T ss_pred eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999876654322222212233567999999999889999999999999999998 88
Q ss_pred CCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 260 FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 260 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.||.... ..+............. +......+.+++.+||+.+|++|||+.++++.|.++.
T Consensus 235 ~p~~~~~-------~~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 235 SPYPGIP-------VEELFKLLKEGHRMDK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CCCCCCC-------HHHHHHHHHcCCCCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 8886432 1222222221111110 1112235889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=278.46 Aligned_cols=251 Identities=28% Similarity=0.376 Sum_probs=201.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||.|++|.||+|.. .|+.+++|....... ...++.+|+.+++.++|+||++++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~ 66 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKDDST---------------AAQAFLAEASVMTTLRHPNLVQLL 66 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe---cCcEEEEEEeccchh---------------HHHHHHHHHHHHHhcCCcceeeeE
Confidence 46889999999999999999975 588999999854322 155788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+....++++||+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+
T Consensus 67 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~ 141 (256)
T cd05039 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVA 141 (256)
T ss_pred EEEcCCCCeEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCE
Confidence 9999989999999999999999998542 2236899999999999999999999554 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||.+........ ....+..|+|||.+....++.++|+||||++++++++ |..||..... ......+
T Consensus 142 ~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~ 212 (256)
T cd05039 142 KVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHV 212 (256)
T ss_pred EEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH
Confidence 9999999877643222 1233567999999988889999999999999999997 9999864321 1111111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
....... . +...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 213 ---~~~~~~~--~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 213 ---EKGYRME--A--------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---hcCCCCC--C--------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111110 0 111234588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=275.53 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=201.0
Q ss_pred cCcccccccccccccceEEeeeecCCC--CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSS--GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.++|+..+.||+|++|.||+|++.... ...+++|........ .....+.+|+.+++.++|+|+++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~ 70 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-------------KQRQDFLSEASIMGQFSHHNIIR 70 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH-------------HHHHHHHHHHHHHhcCCCCCeeE
Confidence 357888999999999999999875312 237899987433211 11456888999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+.+++.+.+..+++|||+++++|.+++.. ..+.+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~ 144 (268)
T cd05063 71 LEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNL 144 (268)
T ss_pred EEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCC
Confidence 99999999999999999999999999854 3356899999999999999999999555 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccc-cccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHH
Q 036970 198 EARISEFGLAKQIPNGRTRTT-TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~ 275 (337)
.++++|||++........... ......+..|+|||++.+..++.++|+||||+++|++++ |..||..... .
T Consensus 145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~ 217 (268)
T cd05063 145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------H 217 (268)
T ss_pred cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------H
Confidence 999999999876643322111 111223457999999988889999999999999999997 9999864321 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+............. .......+.+++.+||+.+|++||++.++++.|.++
T Consensus 218 ~~~~~i~~~~~~~~----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 218 EVMKAINDGFRLPA----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHhcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22222221111111 011224488999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=274.05 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=202.5
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|+.++.||.|++|.||.++.. .++..+++|.+........ ....+.+|+.++++++|+||++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~------------~~~~~~~e~~~l~~~~h~~i~~~~~~ 67 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEK------------ERRDALNEIVILSLLQHPNIIAYYNH 67 (256)
T ss_pred CceEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccchh------------HHHHHHHHHHHHHhCCCCCeeEEEeE
Confidence 5889999999999999999865 4889999999854432221 14567899999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+.+..++++||+++++|.+++... ....+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl 142 (256)
T cd08221 68 FMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKL 142 (256)
T ss_pred EecCCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEE
Confidence 99999999999999999999998542 235689999999999999999999955 4999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||.+........ ......+++.|+|||...+..++.++|+||||+++++|++|..||..... .+.....
T Consensus 143 ~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~ 213 (256)
T cd08221 143 GDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKI 213 (256)
T ss_pred CcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHH
Confidence 99999876644332 11234678899999999888889999999999999999999999864321 1222222
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
........ .......+.+++.+||+.+|.+|||+.++++.
T Consensus 214 ~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 214 VQGNYTPV----------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HcCCCCCC----------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 22211110 01223458899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.47 Aligned_cols=200 Identities=25% Similarity=0.305 Sum_probs=171.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-C-----CC
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-H-----RN 114 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~n 114 (337)
.+|.+++.||+|+||.|-+|.+. .+++.||||++.+.... ..+...|+.+|..|+ | -|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~-~T~e~VAIKIiKN~k~f---------------~~Q~~~Ei~iL~~ln~~d~~~~~n 249 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDH-KTGEIVAIKIIKNKKRF---------------LRQAQIEIRILELLNKHDPDDKYN 249 (586)
T ss_pred EEEEEEEEecccccceeEEEEec-CCCcEEEEEeeccChHH---------------HHHHHHHHHHHHHHhccCCCCCee
Confidence 48999999999999999999654 58999999999665432 446677899988885 3 57
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
+++++++|...+.+|||+|.+ ..+|.++++. ++.+.++...++.++.||+.+|.+||+.+ |+|+||||+|||+.
T Consensus 250 ~Vrm~d~F~fr~HlciVfELL-~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~ 323 (586)
T KOG0667|consen 250 IVRMLDYFYFRNHLCIVFELL-STNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLK 323 (586)
T ss_pred EEEeeeccccccceeeeehhh-hhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeec
Confidence 999999999999999999999 6699999976 56667999999999999999999999555 99999999999997
Q ss_pred C--CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccc
Q 036970 195 D--DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ 267 (337)
Q Consensus 195 ~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~ 267 (337)
+ ...+||+|||.++....... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+
T Consensus 324 ~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 324 DPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 4 34799999999987654433 23558889999999999999999999999999999999888766544
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=276.77 Aligned_cols=248 Identities=25% Similarity=0.313 Sum_probs=193.5
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD 126 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 126 (337)
+.||.|++|.||+|... ++..+++|.+....... ....+.+|+.+++.++||||+++++++....
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 65 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQE-------------LKIKFLSEARILKQYDHPNIVKLIGVCTQRQ 65 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCCHH-------------HHHHHHHHHHHHHhCCCCCcCeEEEEEecCC
Confidence 36899999999999864 78899999875433211 1346888999999999999999999999999
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccc
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~ 206 (337)
..++||||+++++|.+++.. ....+++..+..++.|++.+|.|||+. |++|+||+|+||+++.++.++|+|||+
T Consensus 66 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~ 139 (250)
T cd05085 66 PIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGM 139 (250)
T ss_pred ccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCcc
Confidence 99999999999999998843 234578999999999999999999954 599999999999999999999999999
Q ss_pred cccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 207 AKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 207 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
+........... ....++..|+|||++.+..++.++|+||||+++|++++ |..||...... ..........
T Consensus 140 ~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~ 211 (250)
T cd05085 140 SRQEDDGIYSSS-GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGY 211 (250)
T ss_pred ceeccccccccC-CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCC
Confidence 875443322111 11233567999999988889999999999999999998 88998653221 1111111111
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
... .+......+.+++.+||+.+|++|||+.++++.|.
T Consensus 212 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 RMS----------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 110 01112345899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=279.73 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=187.0
Q ss_pred ccccccccceEEeeeecC-CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|.... .....+++|........ .....+.+|+..++.++|+||+++++.+.+.
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~ 67 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP-------------DEQLLFLQEVQPYRELNHPNVLQCLGQCIES 67 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCCh-------------HHHHHHHHHHHHHHhCCCCCcceEEEEECCC
Confidence 469999999999997532 23456888876432211 1145678899999999999999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQG-RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 204 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Df 204 (337)
...+++|||+++++|.+++...... ....++.....++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~df 144 (269)
T cd05042 68 IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDY 144 (269)
T ss_pred CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecc
Confidence 9999999999999999999664332 233567788899999999999999554 999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccCCccccC-------CCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 205 GLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-------VALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 205 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
|++................++..|+|||+... ..++.++||||||+++|+|++ |..||..... .+
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~ 217 (269)
T cd05042 145 GLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-------EQ 217 (269)
T ss_pred ccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-------HH
Confidence 99865433322222223345677999998643 356789999999999999999 7788864321 11
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
............ ...+... ......+.+++..|| .||++|||+++|++.|+
T Consensus 218 ~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 218 VLKQVVREQDIK-LPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHhhccCcc-CCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 122222221111 1111111 112233667778888 59999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=279.64 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=199.4
Q ss_pred hhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 36 FLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 36 ~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.+...+.|++++.||.|++|.||+|++. .++..+++|....... .....+.+|+.+++.++|+|+
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i 71 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSE--------------EELEDYMVEIEILATCNHPYI 71 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCCcE
Confidence 3445688999999999999999999865 3789999999854321 114568889999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++.+..+...++||||+++++|..++.. ....+++..+..++.|++.++.|||+. +++|+||+|+||+++.
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~ 145 (292)
T cd06644 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTL 145 (292)
T ss_pred eeeEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcC
Confidence 9999999999999999999999999888743 234589999999999999999999954 5999999999999999
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
++.++|+|||++......... .....++..|+|||++. ...++.++|+||||+++|+|++|..||.....
T Consensus 146 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--- 220 (292)
T cd06644 146 DGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--- 220 (292)
T ss_pred CCCEEEccCccceeccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---
Confidence 999999999988654322111 11345688899999885 33467889999999999999999999865321
Q ss_pred cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............+... .+......+.+++.+||+.+|++||+++++++
T Consensus 221 ----~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 221 ----MRVLLKIAKSEPPTLS--------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----HHHHHHHhcCCCccCC--------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111122111111100 01122334889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=273.57 Aligned_cols=258 Identities=20% Similarity=0.302 Sum_probs=187.1
Q ss_pred ccccccccceEEeeeecCC-CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGS-SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|+.... ....+++|........ .....+.+|+..++.++||||+++++.+.+.
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 67 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-------------KEQNEFLQQGDPYRILQHPNILQCLGQCVEA 67 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-------------HHHHHHHHHHHHHhccCCcchhheEEEecCC
Confidence 3699999999999975421 2344566665332111 1145788999999999999999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
...++||||+++++|.+++..........+...+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 68 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg 144 (268)
T cd05086 68 IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYG 144 (268)
T ss_pred CccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccc
Confidence 9999999999999999999764444455677788899999999999999555 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccC-------CCCCCcccchhHhHHHHHHHhC-CCCCCCcccccccchHHHH
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQT-------VALSDKCDIYSFGVLLAVLMMG-KFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~vl~~l~~g-~~pf~~~~~~~~~~~~~~~ 277 (337)
++................++..|+|||++.. ..++.++||||||+++|+|+++ ..||..... .+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~ 217 (268)
T cd05086 145 IGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REV 217 (268)
T ss_pred cccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence 8754322221112223456888999998743 2457789999999999999974 567754321 122
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
........ .....++.+... ....+.+++..|| .+|++||++.+|++.|.
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 218 LNHVIKDQ-QVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHhhc-ccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222111 111122222111 2234777888899 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=278.63 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=200.0
Q ss_pred CcccccccccccccceEEeeeec---CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELP---GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.-|.+++.||+|+||.||.+++. ..++..|++|.+...... .....+.+|+.+++.++|||+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~ 70 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-------------NHIADLKKEIEILRNLYHENIVK 70 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-------------HHHHHHHHHHHHHHhCCCCCeee
Confidence 34689999999999999999753 236888999987433211 11457889999999999999999
Q ss_pred hhceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 118 LLARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 118 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+.+++.+. ...+++|||+++++|.+++.. ....+++..+..++.|++.||.|||++ |++|+||+|+||+++.
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~ 144 (284)
T cd05079 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVES 144 (284)
T ss_pred eeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcC
Confidence 99988775 567899999999999999843 234589999999999999999999955 4999999999999999
Q ss_pred CCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc------
Q 036970 196 DMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH------ 268 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~------ 268 (337)
++.++|+|||++......... .......++..|+|||++.+..++.++|+||||+++|+++++..|+......
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~ 224 (284)
T cd05079 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG 224 (284)
T ss_pred CCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcc
Confidence 999999999998876543221 1222345567899999998888999999999999999999987664321110
Q ss_pred --cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 269 --TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 269 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.................... .+......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 225 PTHGQMTVTRLVRVLEEGKRLP----------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccccHHHHHHHHHcCccCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 01111111111111111100 0111234599999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.39 Aligned_cols=250 Identities=28% Similarity=0.403 Sum_probs=199.1
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|++|.||+|.+. .++..+++|........ .....+.+|+.+++.++|+|++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAE-------------DEIEDIQQEIQFLSQCRSPYITKYYG 66 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccccc-------------hHHHHHHHHHHHHHHcCCCCeeeeeE
Confidence 57899999999999999999865 48899999998543211 11456788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.++...++++||+++++|.+++.. ..+++..++.++.|++.++.|||+. +++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~ 138 (274)
T cd06609 67 SFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVK 138 (274)
T ss_pred EEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999843 2789999999999999999999954 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++.......... ....++..|+|||.+.+..++.++|+||||+++|++++|..||..... ......
T Consensus 139 l~d~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-------~~~~~~ 209 (274)
T cd06609 139 LADFGVSGQLTSTMSKR--NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-------MRVLFL 209 (274)
T ss_pred Ecccccceeeccccccc--ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-------HHHHHH
Confidence 99999987765432211 134567889999999988899999999999999999999999965332 111111
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..... .... . .. .....+.+++.+||..+|++|||++++++
T Consensus 210 ~~~~~-~~~~-~----~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 210 IPKNN-PPSL-E----GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred hhhcC-CCCC-c----cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111 1110 0 00 02334889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.02 Aligned_cols=200 Identities=21% Similarity=0.279 Sum_probs=159.1
Q ss_pred cccccccccceEEeeeecC-CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeec
Q 036970 46 LEKIRSCWNGEVYKAELPG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 124 (337)
+.+||+|+||.||+|++.. .+++.||+|.+..... ...+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------------SMSACREIALLRELKHPNVISLQKVFLS 69 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------------cHHHHHHHHHHHhcCCCCCcceeeeEec
Confidence 5789999999999998642 3678899998843321 2346789999999999999999998864
Q ss_pred --CCCceEEEEeecCCCHHHHHHhhhc-----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe----
Q 036970 125 --PDCDLLVYEFRRNGSLQDILYDVSQ-----GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---- 193 (337)
Q Consensus 125 --~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~---- 193 (337)
+...++++||+. ++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 70 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~ 145 (317)
T cd07868 70 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEG 145 (317)
T ss_pred CCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCC
Confidence 345689999985 588888754321 1235899999999999999999999555 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 194 DDDMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
+.++.+||+|||++......... .......+|+.|+|||++.+. .++.++|+||+||++|+|++|.+||...
T Consensus 146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 45678999999999766433221 112235678999999998774 5889999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=276.14 Aligned_cols=268 Identities=23% Similarity=0.325 Sum_probs=206.1
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcC-CCCCChhhhhc
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQ-VRHRNIVPLLA 120 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~ni~~~~~ 120 (337)
+|.+.+.||.|+||.||+|.+....++.+++|.+........ +...........+.+|+.++.+ ++||||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~----~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG----KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccc----cccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 588899999999999999997654678999998854332111 0001112235567788888875 69999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+++..++++||+++++|.+++.........+++..++.++.|++.+|.|||+. .+++|+||+|.||+++.++.++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~ 154 (269)
T cd08528 77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVT 154 (269)
T ss_pred eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEE
Confidence 99999999999999999999999866555566789999999999999999999942 2599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|++++|..||..... ......
T Consensus 155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~ 224 (269)
T cd08528 155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATK 224 (269)
T ss_pred Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHH
Confidence 99999987654432 12234678889999999988899999999999999999999999864321 111112
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
........ ... ......+.+++.+||+.||++||++.++.+++.+
T Consensus 225 ~~~~~~~~--~~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 225 IVEAVYEP--LPE-------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HhhccCCc--CCc-------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 21111110 000 0112348899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=283.94 Aligned_cols=266 Identities=23% Similarity=0.252 Sum_probs=194.2
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|.+.+.||.|++|.||+|++. .++..|++|.+....... .....+.+|+.++++++|||+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEEE------------GVPSTAIREISLLKELQHPNIVCLQDV 67 (285)
T ss_pred CceEeeEecccCceEEEEEEEC-CCCcEEEEEEeccccccC------------CchHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 5888999999999999999865 478999999884322111 113467789999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.++...++|+||+. ++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l 142 (285)
T cd07861 68 LMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKL 142 (285)
T ss_pred EeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEE
Confidence 999999999999996 58988875432 235689999999999999999999955 5999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
+|||++........ ......+++.|+|||.+.+. .++.++|+||||+++++|++|..||........ .......
T Consensus 143 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~---~~~~~~~ 217 (285)
T cd07861 143 ADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ---LFRIFRI 217 (285)
T ss_pred CcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHH
Confidence 99999875532211 11123557889999987654 478899999999999999999999975322110 0000000
Q ss_pred Hhhc--------------CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTS--------------ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.... ......................+.+++++||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 218 LGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0000000000000001112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=281.68 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=195.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
+.+.|++.+.||+|+||.||+|... .++..+++|........ ...+.+|+.++..+ +|+|+++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~---------------~~~~~~e~~~l~~~~~h~~i~~ 67 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTGDE---------------EEEIKQEINMLKKYSHHRNIAT 67 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcCCcc---------------HHHHHHHHHHHHHhcCCCCeee
Confidence 6789999999999999999999865 47899999998543211 34577889988888 7999999
Q ss_pred hhceeecC------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 118 LLARVVRP------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 118 ~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
+++++... ...++++||+.+++|.+++.. .....+++..+..++.|++.|+.|||+.+ ++|+||+|+||
T Consensus 68 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~ni 142 (272)
T cd06637 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNV 142 (272)
T ss_pred EeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHE
Confidence 99998753 346899999999999999854 23456889999999999999999999555 99999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
+++.++.++|+|||++......... .....|+..|+|||++. ...++.++|+||||+++|+|++|..||.+..
T Consensus 143 li~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 143 LLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred EECCCCCEEEccCCCceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9999999999999998765432211 22356788999999986 3357889999999999999999999986432
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. .... ..... ...... .......+.+++.+||+.+|.+|||+.++++
T Consensus 221 ~~------~~~~-~~~~~--~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 221 PM------RALF-LIPRN--PAPRLK-------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HH------HHHH-HHhcC--CCCCCC-------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11 1111 11111 110000 0112234889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=285.72 Aligned_cols=264 Identities=17% Similarity=0.225 Sum_probs=195.2
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|.+.+.||.|+||.||+|++. .++..||+|.+....... ....+.+|+..++.++||||++++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~nI~~~~ 70 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEEG-------------APCTAIREVSLLKDLKHANIVTLH 70 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEecccccC-------------chhHHHHHHHHHHhcCCCCcceEE
Confidence 468999999999999999999865 478999999884332110 023567899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++..+...++|+||++ ++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+
T Consensus 71 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~ 143 (301)
T cd07873 71 DIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGEL 143 (301)
T ss_pred EEEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcE
Confidence 99999999999999996 589888754 334588999999999999999999955 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++.......... ....+++.|+|||++.+. .++.++||||||+++|+|++|.+||...... .....+
T Consensus 144 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~----~~~~~~ 217 (301)
T cd07873 144 KLADFGLARAKSIPTKTY--SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE----EQLHFI 217 (301)
T ss_pred EECcCcchhccCCCCCcc--cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence 999999987643322111 123457889999987654 4788999999999999999999999754221 111111
Q ss_pred HHHhhcCCCC---cccc---------ccccC----CChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPS---RTID---------SKLIG----NGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~---~~~~---------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......... ..+. +.... .........+.++|.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 218 FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111000000 0000 00000 001112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=286.24 Aligned_cols=258 Identities=20% Similarity=0.196 Sum_probs=193.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||.||++++. .+++.||+|++........ .....+.+|+.++..++|+||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWEMLKR-----------AETACFREERDVLVNGDRRWITNLHY 68 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhh-----------hhHHHHHHHHHHHHhCCCCCCCceEE
Confidence 57999999999999999999866 4789999999854221110 11456788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+++..++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~k 142 (331)
T cd05597 69 AFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIR 142 (331)
T ss_pred EEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEE
Confidence 99999999999999999999999854 2345899999999999999999999555 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-----VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
|+|||++........... ....||+.|+|||++.. ..++.++||||||+++|+|++|..||..... .
T Consensus 143 l~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~ 214 (331)
T cd05597 143 LADFGSCLRLLADGTVQS-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------V 214 (331)
T ss_pred EEECCceeecCCCCCccc-cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------H
Confidence 999999876543322211 12368999999999863 3578899999999999999999999965321 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCC--CCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDD--PEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~--p~~Rps~~~il~ 330 (337)
+............. +... .......+.+++.+||..+ +..||++.++++
T Consensus 215 ~~~~~i~~~~~~~~-~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 215 ETYGKIMNHKEHFQ-FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred HHHHHHHcCCCccc-CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 22222222111110 1110 1112334778888877543 334788888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=279.64 Aligned_cols=259 Identities=26% Similarity=0.360 Sum_probs=199.6
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|.+.+.||.|++|.||+|.+. .+++.+++|.+......... ........+.+.+|+.++++++||||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASS-----KDRKRSMLDALAREIALLKELQHENIVQYLGS 74 (267)
T ss_pred CccccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccch-----hHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 4788999999999999999865 37899999988554321110 00111224678899999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+....++++||+++++|.+++.. .+.+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 75 SLDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEe
Confidence 9999999999999999999999943 35688999999999999999999955 4999999999999999999999
Q ss_pred ecccccccCCCCCc----ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 202 SEFGLAKQIPNGRT----RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+|||.+........ ........++..|+|||.+.+..++.++|+||||+++|++++|..||..... ...
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~ 220 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQA 220 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HHH
Confidence 99999876652211 1111134578889999999888889999999999999999999999975321 111
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+........+. . +......+.+++++||++||++||++.++++
T Consensus 221 ~~~~~~~~~~~------~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 IFKIGENASPE------I----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHhccCCCc------C----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111111110 1 1112344889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.14 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=201.1
Q ss_pred hhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 36 FLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 36 ~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
......+|.+.+.||.|++|.||+|... .++..+++|.+....... ...+.+|+.+++.++|+|+
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~--------------~~~~~~e~~~l~~~~h~~v 79 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPK--------------KELIINEILVMRENKNPNI 79 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEEC-CCCcEEEEEEEecCCcch--------------HHHHHHHHHHHHhCCCCCE
Confidence 3457789999999999999999999854 478999999885432211 3467889999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++.+..+...++|+||+++++|.+++.. ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~ 151 (296)
T cd06654 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGM 151 (296)
T ss_pred eeEEEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcC
Confidence 9999999999999999999999999999832 3578899999999999999999955 4999999999999999
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++.++|+|||++.......... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~------~~ 223 (296)
T cd06654 152 DGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LR 223 (296)
T ss_pred CCCEEECccccchhcccccccc--CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH------HH
Confidence 9999999999887653322111 123578899999999888889999999999999999999999964322 01
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
... .......+.. ..+......+.+++.+||.++|++|||+.++++
T Consensus 224 ~~~-~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 224 ALY-LIATNGTPEL--------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred hHH-HHhcCCCCCC--------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 111 1111111110 011122345889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=292.41 Aligned_cols=251 Identities=27% Similarity=0.347 Sum_probs=205.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
++..|.-++.||.|+||-||-|++. .+...||||++.-+.....+ .-..+..|+..|++++|||++.+
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~-~n~evVAIKKMsySGKQs~E-----------KWqDIlKEVrFL~~l~HPntieY 91 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNE-----------KWQDILKEVRFLRQLRHPNTIEY 91 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeecc-CccceeeeeeccccccccHH-----------HHHHHHHHHHHHHhccCCCcccc
Confidence 5688999999999999999999854 58999999999665542222 13468899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
-+.|..+.+.|+||||| -||..|++.- -.+++.+..+..+..+.+.||.|||+.+ .+|||||..|||+++.|.
T Consensus 92 kgCyLre~TaWLVMEYC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~ 164 (948)
T KOG0577|consen 92 KGCYLREHTAWLVMEYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGL 164 (948)
T ss_pred cceeeccchHHHHHHHH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCe
Confidence 99999999999999999 5588888854 3467999999999999999999999776 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT---VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
|||+|||.+...... .++.|||.|||||++.. +.|+.++||||||++..|+...++|.-.. +.+
T Consensus 165 VKLaDFGSAsi~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-------NAM 231 (948)
T KOG0577|consen 165 VKLADFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NAM 231 (948)
T ss_pred eeeccccchhhcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-------hHH
Confidence 999999998764322 25789999999998754 57999999999999999999999996432 233
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+-.+..+..|.. ..++.+..+.+++..||++-|.+|||.++++.
T Consensus 232 SALYHIAQNesPtL---------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 232 SALYHIAQNESPTL---------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHhcCCCCC---------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 33334443333321 13345556778888899999999999998874
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=277.41 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=192.3
Q ss_pred cccccccceEEeeeecCC-CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCC
Q 036970 48 KIRSCWNGEVYKAELPGS-SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD 126 (337)
Q Consensus 48 ~lg~G~~g~vy~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 126 (337)
.||.|+||.||+|.+... .+..|++|........ ...+.+.+|+.++++++||||+++++++. ..
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~ 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-------------SVRDEMMREAEIMHQLDNPYIVRMIGVCE-AE 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh-------------HHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CC
Confidence 489999999999976432 4567999987543211 11457889999999999999999999875 45
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccc
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~ 206 (337)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||+
T Consensus 68 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~ 141 (257)
T cd05115 68 ALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGL 141 (257)
T ss_pred CeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCc
Confidence 67999999999999999843 345689999999999999999999955 599999999999999999999999999
Q ss_pred cccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhhc
Q 036970 207 AKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTS 284 (337)
Q Consensus 207 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 284 (337)
+......... .......++..|+|||.+....++.++|+||||+++|++++ |..||..... . +........
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~---~~~~~~~~~ 214 (257)
T cd05115 142 SKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----P---EVMSFIEQG 214 (257)
T ss_pred cccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----H---HHHHHHHCC
Confidence 8765433221 11111223568999999988889999999999999999996 9999875422 1 112111111
Q ss_pred CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 285 ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
..+. .+......+.+++.+||..+|++||++.+|.+.|..+
T Consensus 215 ~~~~----------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 215 KRLD----------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111 0112234588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=291.72 Aligned_cols=282 Identities=20% Similarity=0.264 Sum_probs=221.7
Q ss_pred ccCCccchhhhhhhh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHH
Q 036970 24 IFSPLIEKEDLAFLK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102 (337)
Q Consensus 24 ~~~~~~~~~~~~~l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (337)
++.+..+.+...--+ +.+...+.++||+|.||.|.+.+.. .+..||+|.+..... ...+..|.+
T Consensus 520 ~y~~~~~~k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~-------------~~~r~~F~k 584 (807)
T KOG1094|consen 520 PYLPPGVGKGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDAT-------------KNARNDFLK 584 (807)
T ss_pred cccCcccccCcchhhcchhheehhhhhcCcccceeEEEEec--CceEEEEeecCcccc-------------hhHHHHHHH
Confidence 344444333333333 5677889999999999999999875 479999999854433 222678999
Q ss_pred HHHHhcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 036970 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRII 182 (337)
Q Consensus 103 E~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~ 182 (337)
|+++|.+|+||||++++++|..++.+++++||++.|+|.+|+..+... ........+++.||+.|++||.+.+ +|
T Consensus 585 EIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fV 659 (807)
T KOG1094|consen 585 EIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FV 659 (807)
T ss_pred HHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hh
Confidence 999999999999999999999999999999999999999999554222 2345556779999999999999877 99
Q ss_pred eCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh--CCC
Q 036970 183 HRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM--GKF 260 (337)
Q Consensus 183 h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~--g~~ 260 (337)
||||.+.|+|++.++++||+|||+++.+-.+..+++.....-+.+|||+|.+.-.++++++|+|+||+++||+++ ...
T Consensus 660 Hrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~ 739 (807)
T KOG1094|consen 660 HRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQ 739 (807)
T ss_pred hccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhC
Confidence 999999999999999999999999998888877777666667899999999999999999999999999999865 568
Q ss_pred CCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 261 PSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 261 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
||++.. +....+.............. -..+.-+...+++++.+||+.+..+|||++++-..|.+.
T Consensus 740 Py~~lt----~e~vven~~~~~~~~~~~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 740 PYSQLT----DEQVVENAGEFFRDQGRQVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred chhhhh----HHHHHHhhhhhcCCCCccee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 887542 22223323333322222111 122334455589999999999999999999999888764
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=273.35 Aligned_cols=255 Identities=28% Similarity=0.386 Sum_probs=201.1
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||.|++|.||+|... .+++.+++|........ ....+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~--------------~~~~~~~e~~~l~~~~h~~i~~~~ 66 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLEPGD--------------DFEIIQQEISMLKECRHPNIVAYF 66 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEec-CCCCEEEEEEEEcCchh--------------hHHHHHHHHHHHHhCCCCChhceE
Confidence 578999999999999999999865 37788999998543221 156788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+.++...+++|||+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+
T Consensus 67 ~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~ 140 (262)
T cd06613 67 GSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDV 140 (262)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCE
Confidence 999999999999999999999998854 225689999999999999999999955 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCC---CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV---ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+|+|||.+.......... ....++..|+|||.+... .++.++|+||||+++|+|++|..||...... +
T Consensus 141 ~l~d~g~~~~~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~ 211 (262)
T cd06613 141 KLADFGVSAQLTATIAKR--KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------R 211 (262)
T ss_pred EECccccchhhhhhhhcc--ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------H
Confidence 999999987654332111 124568889999998776 7889999999999999999999998653221 1
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............. . ..........+.+++.+||..+|.+|||+.+++.
T Consensus 212 ~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 212 ALFLISKSNFPPP-----K-LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHhccCCCc-----c-ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111111100000 0 0112234456899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.44 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=199.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||.|++|.||+|.+.. ++..+++|........ ....+.+|+.+++.++|+|++++
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~ 67 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIESEE--------------ELEDFMVEIDILSECKHPNIVGL 67 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeCCHH--------------HHHHHHHHHHHHHhCCCCceeEE
Confidence 45789999999999999999998753 7899999998533211 14568889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+.++...++||||+++++|.+++.. ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~ 141 (280)
T cd06611 68 YEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGD 141 (280)
T ss_pred EEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCC
Confidence 9999999999999999999999999854 2346899999999999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
++|+|||++.......... ....++..|+|||.+. ...++.++|+||||+++|+|++|..||.....
T Consensus 142 ~~l~d~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------ 213 (280)
T cd06611 142 VKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------ 213 (280)
T ss_pred EEEccCccchhhccccccc--ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------
Confidence 9999999876654322211 1345788999999875 33467899999999999999999999875422
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............+... .+......+.+++..||+.+|.+||++.++++
T Consensus 214 -~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 214 -MRVLLKILKSEPPTLD--------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -HHHHHHHhcCCCCCcC--------CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1112222221111110 11122345889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=280.41 Aligned_cols=259 Identities=23% Similarity=0.290 Sum_probs=201.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCc----EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++++.||.|+||.||+|.+.. +|. .+++|....... ......+.+|+..+..++|||
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~~~~aik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~ 70 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIP-EGEKVKIPVAIKVLREETS-------------PKANKEILDEAYVMASVDHPH 70 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEec-CCCCcceEEEEEeccCCCC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999998653 333 588887744322 112467889999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
|+++++++.. ...++++||+.+++|.+++.. ....+++..+..++.|++.|+.|||+. +++|+||+|+||+++
T Consensus 71 i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~ 143 (279)
T cd05057 71 VVRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVK 143 (279)
T ss_pred cceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEc
Confidence 9999999887 788999999999999999854 234589999999999999999999955 499999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
.++.++|+|||.+................++..|+|||.+....++.++|+||||++++++++ |..||.....
T Consensus 144 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------ 217 (279)
T cd05057 144 TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------ 217 (279)
T ss_pred CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------
Confidence 999999999999987654332222112233567999999988889999999999999999998 9999875322
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.+............. +..+...+.+++.+||..+|++||++.++++.|+++
T Consensus 218 -~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 218 -VEIPDLLEKGERLPQ----------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -HHHHHHHhCCCCCCC----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111111111110 011123488999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=278.25 Aligned_cols=268 Identities=22% Similarity=0.329 Sum_probs=203.8
Q ss_pred cCcccccccccccccceEEeeeecC---CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG---SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..+|.+.+.||+|+||.||+|++.. .++..+++|.+...... .....+.+|+..++.++|+||+
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------------~~~~~~~~ei~~l~~l~~~~i~ 69 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------------QHRSDFEREIEILRTLDHENIV 69 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------------HHHHHHHHHHHHHHhCCCCChh
Confidence 3578888999999999999998642 25789999998544332 1256789999999999999999
Q ss_pred hhhceeec--CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 117 PLLARVVR--PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 117 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++++.. ....++++||+++++|.+++... ...+++..+..++.|++.||.|||+. |++|+||+|+||+++
T Consensus 70 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~ 143 (284)
T cd05038 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVE 143 (284)
T ss_pred eEEeeeecCCCCceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEc
Confidence 99998887 55789999999999999998542 23589999999999999999999955 599999999999999
Q ss_pred CCCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc--
Q 036970 195 DDMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE-- 271 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~-- 271 (337)
.++.++|+|||.+......... .......++..|+|||...+..++.++|+||||+++++|++|..|+.........
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~ 223 (284)
T cd05038 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI 223 (284)
T ss_pred CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccc
Confidence 9999999999999877533221 1111223456799999998888999999999999999999999998643221100
Q ss_pred ------chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 272 ------MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 272 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
....... ......... ..+......+.+++.+||+.+|++|||+.+++++|..+.
T Consensus 224 ~~~~~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 224 GIAQGQMIVTRLL-ELLKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred ccccccccHHHHH-HHHHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 0111111 111111100 001122245889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=275.82 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=201.9
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|+..+.||.|++|.||+|.+.. +++.+++|.+...... .....+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 66 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDPNP-------------DLQKQILRELEINKSCKSPYIVKYYG 66 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC-CCeEEEEEEEecCCch-------------HHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 578999999999999999998753 7899999988543221 11457889999999999999999999
Q ss_pred eeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 121 RVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 121 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+. ...+++|||+++++|.+++.........++...+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~ 143 (287)
T cd06621 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQ 143 (287)
T ss_pred EEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCe
Confidence 88654 3679999999999999988765555667899999999999999999999554 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++......... ...++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+..
T Consensus 144 ~~l~dfg~~~~~~~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~ 217 (287)
T cd06621 144 VKLCDFGVSGELVNSLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELL 217 (287)
T ss_pred EEEeeccccccccccccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHH
Confidence 999999998655432221 235678899999998888999999999999999999999999754221 11111222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........+. +...... .......+.+++.+||+.+|++|||+.++++
T Consensus 218 ~~~~~~~~~~--~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 218 SYIVNMPNPE--LKDEPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHhcCCchh--hccCCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 2222111111 1111100 0112345889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=275.75 Aligned_cols=257 Identities=22% Similarity=0.278 Sum_probs=198.4
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|.+.+.||.|+||.||+|... ++..+++|.+........ ........+.+|+..++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~--------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVL--------AAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchh--------hHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 5888999999999999999864 789999998754322111 011224678899999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+.+..++++||+++++|.+++.. ..++++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l 143 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKL 143 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEe
Confidence 9999999999999999999999843 34588999999999999999999955 4999999999999999999999
Q ss_pred ecccccccCCCCC----cccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 202 SEFGLAKQIPNGR----TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 202 ~Dfg~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+|||++....... .........++..|+|||++.+..++.++|+||||+++|++++|..||...... ..
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~- 216 (265)
T cd06631 144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL------AA- 216 (265)
T ss_pred ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH------HH-
Confidence 9999887653211 111112345788999999999888999999999999999999999999653211 01
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............ .. +......+.+++++||+.+|++||++.++++
T Consensus 217 ~~~~~~~~~~~~----~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 217 MFYIGAHRGLMP----RL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHhhhccCCCC----CC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111100000 01 1112344889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=280.44 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=198.1
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
+.|...+.||.|++|.||+|.+. .++..|++|........ .....+.+|+.+++.++||||+++++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAE-------------DEIEDIQQEITVLSQCDSPYITRYYG 69 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccch-------------HHHHHHHHHHHHHHcCCCCccHhhhc
Confidence 56788899999999999999865 47889999987433211 11457889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+..+...++|+||+++++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~ 141 (277)
T cd06642 70 SYLKGTKLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVK 141 (277)
T ss_pred ccccCCceEEEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEE
Confidence 9999999999999999999999883 34688999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
++|||++.......... ....++..|+|||.+.+..++.++|+||||++++++++|..||....... ....
T Consensus 142 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~ 212 (277)
T cd06642 142 LADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFL 212 (277)
T ss_pred EccccccccccCcchhh--hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhh
Confidence 99999987654332211 12356888999999998889999999999999999999999986532211 1111
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+ .. .......+.+++.+||+.+|++|||+.++++
T Consensus 213 ~~~~~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 213 IPKNSPP------TL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred hhcCCCC------CC----CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1001111 01 1122345889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=286.74 Aligned_cols=202 Identities=23% Similarity=0.298 Sum_probs=164.2
Q ss_pred cccccccc--ccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhcee
Q 036970 45 SLEKIRSC--WNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARV 122 (337)
Q Consensus 45 ~~~~lg~G--~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~ 122 (337)
++.+||+| +|++||+++.. .+|+.||+|.+....... .....+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~hpniv~~~~~~ 68 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACTN------------EMVTFLQGELHVSKLFNHPNIVPYRATF 68 (327)
T ss_pred hhhhccccccceEEEEEEeec-ccCcEEEEEEechhhccH------------HHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 56889999 78999999865 489999999985433211 1145678899999999999999999999
Q ss_pred ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEe
Q 036970 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
..++..++|+||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+++.
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~ 143 (327)
T cd08227 69 IADNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLS 143 (327)
T ss_pred EECCEEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEc
Confidence 9999999999999999999998542 2345889999999999999999999555 9999999999999999999999
Q ss_pred cccccccCCCCCcc-----cccccccCcccccCCccccC--CCCCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 203 EFGLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQT--VALSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 203 Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
||+........... .......++..|+|||++.+ ..++.++||||||+++|++++|..||..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99865443221110 01112345677999999876 4588999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=274.76 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=201.1
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||.|++|.||+|.... ++..+++|.+..... ...+.+|+..++.++|+||++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~----------------~~~~~~e~~~~~~l~~~~i~~~~ 64 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEED----------------LQEIIKEISILKQCDSPYIVKYY 64 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHHH----------------HHHHHHHHHHHHhCCCCcEeeee
Confidence 5789999999999999999998663 689999998843221 45788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+.++...++++||+.+++|.+++.. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+
T Consensus 65 ~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~ 138 (256)
T cd06612 65 GSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQA 138 (256)
T ss_pred eeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcE
Confidence 999999999999999999999999843 3456899999999999999999999554 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
+|+|||++......... .....++..|+|||++.+..++.++|+||||+++++|++|..||...... ....
T Consensus 139 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-------~~~~ 209 (256)
T cd06612 139 KLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-------RAIF 209 (256)
T ss_pred EEcccccchhcccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-------hhhh
Confidence 99999998876543221 11234688899999999888999999999999999999999998753221 1111
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... ... ..+......+.+++.+||+.||++|||+.++++
T Consensus 210 ~~~~~~~--~~~------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 MIPNKPP--PTL------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhccCCC--CCC------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1110000 000 011223345889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=281.36 Aligned_cols=268 Identities=20% Similarity=0.277 Sum_probs=197.0
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|++|.||+|++. .+|+.|++|++....... .....+.+|+.+++.++|+|++++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~~~h~~i~~~~~ 67 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDDP------------VIKKIALREIRMLKQLKHPNLVNLIE 67 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccCc------------cccHHHHHHHHHHHhCCCCCEeeeee
Confidence 57999999999999999999865 378999999885332110 11345788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+......++++||+++++|..++ .....+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~ 140 (286)
T cd07847 68 VFRRKRKLHLVFEYCDHTVLNELE----KNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIK 140 (286)
T ss_pred EEeeCCEEEEEEeccCccHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEE
Confidence 999999999999999988887776 2344689999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||++........... ...++..|+|||.+.+ ..++.++|+||||+++++|++|..||.+....+..........
T Consensus 141 l~dfg~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07847 141 LCDFGFARILTGPGDDYT--DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG 218 (286)
T ss_pred ECccccceecCCCccccc--CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999987654332111 2346788999999876 4578899999999999999999999975432111111110000
Q ss_pred H-------HhhcCCCCc--ccccccc----CCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 N-------VMTSENPSR--TIDSKLI----GNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~-------~~~~~~~~~--~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
. ......... ....... ....+.....+.+++.+||+.+|++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 000000000 0000000 0001122455889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=279.72 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=199.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
...+|++.+.||.|++|.||+|.+. .+|+.|++|.+...... ....+.+|+..++.++|||++++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~iv~~ 81 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDV-ATGQEVAIKQINLQKQP--------------KKELIINEILVMKELKNPNIVNF 81 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEc-CCCcEEEEEEEecccCc--------------hHHHHHHHHHHHHhcCCCceeee
Confidence 4568999999999999999999854 48999999988432211 14567889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++..+...++|+||+++++|..++.. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~ 153 (296)
T cd06655 82 LDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGS 153 (296)
T ss_pred eeeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 9999999999999999999999998832 35899999999999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++.......... ....++..|+|||.+.+..++.++|+||||+++|++++|..||..... . ...
T Consensus 154 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~------~-~~~ 224 (296)
T cd06655 154 VKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP------L-RAL 224 (296)
T ss_pred EEEccCccchhcccccccC--CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------H-HHH
Confidence 9999999887654332211 134678899999999988899999999999999999999999865322 1 111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........+.. ..+......+.++|.+||..||++|||+.++++
T Consensus 225 ~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 225 YLIATNGTPEL--------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHhcCCccc--------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11111111110 011112234888999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=276.32 Aligned_cols=262 Identities=20% Similarity=0.320 Sum_probs=200.5
Q ss_pred cCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.++|++.+.||.|+||.||+|+... ...+.+++|........ .....+.+|+.++++++|+||
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i 70 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-------------NLQSEFRRELDMFRKLSHKNV 70 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-------------HHHHHHHHHHHHHHhcCCcce
Confidence 3688999999999999999998642 23567888887432211 125678899999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCC-----CcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-----RELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
+++++++.+....++||||+++++|.+++....... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+|
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~N 147 (275)
T cd05046 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARN 147 (275)
T ss_pred eeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccce
Confidence 999999999999999999999999999996543221 26899999999999999999999555 9999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccccc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHT 269 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~ 269 (337)
|+++.++.++++|||++......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||.....
T Consensus 148 ili~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-- 224 (275)
T cd05046 148 CLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-- 224 (275)
T ss_pred EEEeCCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--
Confidence 99999999999999988654322211 1112344677999999988888999999999999999998 7788864321
Q ss_pred ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
. ....... ........ .......+.+++.+||+.+|++|||+.++++.|++
T Consensus 225 --~---~~~~~~~-~~~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 225 --E---EVLNRLQ-AGKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred --H---HHHHHHH-cCCcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 1 1111111 11111100 01122348899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=274.66 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=202.2
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|+..+.||.|++|.||+|.+. .+++.+++|.+...... .....+.+|+..++.++||||+++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINE-------------AIQKQILRELDILHKCNSPYIVGFYG 66 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccCh-------------HHHHHHHHHHHHHHHCCCCchhhhhe
Confidence 47889999999999999999865 47899999988554321 12557888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+..+...++++||+.+++|.+++... ..++++..+..++.|++.++.|||+. .+++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~ 141 (265)
T cd06605 67 AFYNNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIK 141 (265)
T ss_pred eeecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999998542 26789999999999999999999950 4599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||.+......... ...++..|+|||.+.+..++.++|+||||++++++++|..||..... ......+.+..
T Consensus 142 l~d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~ 215 (265)
T cd06605 142 LCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND--PPDGIFELLQY 215 (265)
T ss_pred EeecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--ccccHHHHHHH
Confidence 9999988655322111 14678889999999998999999999999999999999999865422 11112222333
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+... .......+.++|.+||..||++|||+.+++.
T Consensus 216 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 216 IVNEPPPRLP---------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HhcCCCCCCC---------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 2222211110 0013344889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=277.22 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=202.9
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||+|.+. .++..+++|.+....... ...+.+.+|+.+++.++|+||+++++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMTE------------KEKQQLVSEVNILRELKHPNIVRYYDR 67 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCCH------------HHHHHHHHHHHHHHhcCCCccceeeee
Confidence 5888999999999999999865 488999999885433221 114578889999999999999999997
Q ss_pred eec--CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC--CCCceeCCCCCCcEEecCCC
Q 036970 122 VVR--PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH--RPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 122 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~~~h~di~~~nil~~~~~ 197 (337)
+.. +...++++||+++++|.+++........++++..++.++.|++.||.+||..+ +.+++|+||+|+||+++.++
T Consensus 68 ~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~ 147 (265)
T cd08217 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN 147 (265)
T ss_pred eecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC
Confidence 764 34568999999999999999776555678999999999999999999999332 33499999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.++|+|||++........... ...++..|+|||.+.+..++.++|+||||+++++|++|..||..... ...
T Consensus 148 ~~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~ 218 (265)
T cd08217 148 NVKLGDFGLAKILGHDSSFAK--TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQL 218 (265)
T ss_pred CEEEecccccccccCCccccc--ccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHH
Confidence 999999999887754432111 24578899999999988899999999999999999999999875321 111
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..... ..... . .+......+.+++.+||+.+|++|||+.+|++
T Consensus 219 ~~~~~-~~~~~-~--------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 219 ASKIK-EGKFR-R--------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHh-cCCCC-C--------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11111 11111 1 11123355899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=272.44 Aligned_cols=252 Identities=20% Similarity=0.226 Sum_probs=197.3
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||++.+. .+++.+++|.+........ ....+.+|+.+++.++|+|++++++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRR------------ERKAAEQEAQLLSQLKHPNIVAYRES 67 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc-CCCcEEEEEEEehhhcCHH------------HHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 5899999999999999999875 4788999999854322111 14567889999999999999999988
Q ss_pred eec-CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 122 VVR-PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 122 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
+.. +...++++||+++++|.+++.. .....+++..++.++.+++.++.+||+. |++|+||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~ 142 (257)
T cd08223 68 WEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIK 142 (257)
T ss_pred ecCCCCEEEEEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEE
Confidence 764 4457899999999999999864 2345689999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++......... .....+++.|+|||+..+..++.++|+||||++++++++|..||..... ......
T Consensus 143 l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~ 213 (257)
T cd08223 143 VGDLGIARVLENQCDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYR 213 (257)
T ss_pred EecccceEEecccCCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHH
Confidence 9999998765432221 1134568899999999998899999999999999999999999864321 111222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+. ........+.+++.+||+.+|++|||+.++++
T Consensus 214 ~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 214 IIEGKLPP----------MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHhcCCCC----------CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 22111111 11123345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=272.38 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=189.9
Q ss_pred ccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceee-
Q 036970 47 EKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV- 123 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~- 123 (337)
+.||+|+||.||+|.+.. ..+..+++|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 67 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-------------LEEVEQFLKEGIIMKDFSHPNVLSLLGICLP 67 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-------------HHHHHHHHHHHHHHccCCCCCcceEEEEeec
Confidence 468999999999998532 2456799998743211 111457888999999999999999999775
Q ss_pred cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEec
Q 036970 124 RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203 (337)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~D 203 (337)
.++..++++||+.+++|.+++.. .....++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 68 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~d 141 (262)
T cd05058 68 SEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVAD 141 (262)
T ss_pred CCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECC
Confidence 45567899999999999999854 223467778889999999999999955 499999999999999999999999
Q ss_pred ccccccCCCCCcc--cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhC-CCCCCCcccccccchHHHHHHH
Q 036970 204 FGLAKQIPNGRTR--TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMG-KFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 204 fg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g-~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
||++......... .......++..|+|||.+.+..++.++||||||+++|||++| .+||..... .+....
T Consensus 142 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~ 214 (262)
T cd05058 142 FGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDITVY 214 (262)
T ss_pred ccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHH
Confidence 9998755332111 111123446789999999888899999999999999999995 556643221 122222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
......+.. + ...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 215 ~~~~~~~~~--~--------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 215 LLQGRRLLQ--P--------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HhcCCCCCC--C--------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 222211110 0 011234889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=277.32 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=198.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||.|++|.||+|.+. .+..+++|.+...... ...+.+|+.+++.++|||+++++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGAMS---------------EEDFIEEAQVMMKLSHPKLVQLY 65 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCCCC---------------HHHHHHHHHHHHhCCCCCeeeEE
Confidence 457899999999999999999865 5778999987433211 34678899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++......++++||+++++|.+++.. ....+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.+
T Consensus 66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~ 139 (256)
T cd05112 66 GVCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVV 139 (256)
T ss_pred EEEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeE
Confidence 999999999999999999999998843 2345789999999999999999999555 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||..... ....
T Consensus 140 ~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~ 211 (256)
T cd05112 140 KVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVV 211 (256)
T ss_pred EECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHH
Confidence 99999998765433221 1112234578999999988889999999999999999998 8999864321 1112
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
......... ..+.. ....+.+++.+||+.+|++|||+.++++.|.
T Consensus 212 ~~~~~~~~~---~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 212 ETINAGFRL---YKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHhCCCCC---CCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111111111 11110 1244899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=275.72 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=194.9
Q ss_pred ccccccccceEEeeeecC-----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 47 EKIRSCWNGEVYKAELPG-----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+.||+|++|.||+|++.. ..+..+++|.+...... .....+.+|+..++.++||||++++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD-------------QEKKEFLKEAHLMSNFNHPNIVKLLGV 67 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch-------------hhHHHHHHHHHHHHhcCCCCeeeEeee
Confidence 468999999999998642 12367888887432211 114568889999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC-
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQG---RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM- 197 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~- 197 (337)
+......++++||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 68 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~ 144 (269)
T cd05044 68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGY 144 (269)
T ss_pred ecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCC
Confidence 99999999999999999999999654322 244788999999999999999999554 99999999999999877
Q ss_pred ----cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccc
Q 036970 198 ----EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEM 272 (337)
Q Consensus 198 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~ 272 (337)
.++++|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .
T Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~ 220 (269)
T cd05044 145 DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----Q 220 (269)
T ss_pred CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----H
Confidence 899999999876543322222222344678999999998889999999999999999998 9999864321 1
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
..... ....... ..+...+..+.+++.+||+++|++||++.++++.|.+
T Consensus 221 ~~~~~---~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 221 EVLQH---VTAGGRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHH---HhcCCcc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111 1111111 0111223458899999999999999999999998864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=273.41 Aligned_cols=252 Identities=17% Similarity=0.223 Sum_probs=200.6
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|+||.+|+++.. .+|+.|++|.+........ ....+.+|+.++++++||||+++++.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPK------------EREESRKEVAVLSNMKHPNIVQYQES 67 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCChH------------HHHHHHHHHHHHHhCCCCCeeeeEee
Confidence 5889999999999999999865 4789999999854322111 14568889999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+.+..++|+||+.+++|.+++.. .....+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l 142 (256)
T cd08218 68 FEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKL 142 (256)
T ss_pred ecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999998854 2233578899999999999999999955 4999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||++.......... ....++..|+|||+..+..++.++|+||||++++++++|..||..... .+.....
T Consensus 143 ~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~ 213 (256)
T cd08218 143 GDFGIARVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKI 213 (256)
T ss_pred eeccceeecCcchhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHH
Confidence 9999987664432211 123568889999999888899999999999999999999999864321 2222222
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+.. +......+.+++.+||+++|++||++.++++
T Consensus 214 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 214 IRGSYPPV----------SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred hcCCCCCC----------cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 22221110 1122345899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=278.04 Aligned_cols=247 Identities=22% Similarity=0.281 Sum_probs=198.2
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+.+.||.|++|.||+|.+. .+++.+++|.+........ .....+.+|+.+++.++||||+++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK-GSGKYYALKILSKAKIVKL-----------KQVEHVLNEKRILQSIRHPFLVNLYG 68 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhCCCCCccceee
Confidence 47899999999999999999865 3789999999854322111 11567889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.++...+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||+|.||+++.++.++
T Consensus 69 ~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~k 141 (290)
T cd05580 69 SFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIK 141 (290)
T ss_pred EEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999843 35689999999999999999999955 499999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......
T Consensus 142 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~ 209 (290)
T cd05580 142 ITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEK 209 (290)
T ss_pred EeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence 9999998776443 1234678899999999888889999999999999999999999864321 111111
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVR 329 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il 329 (337)
....... ++. .....+.+++.+||+.||.+|+ ++++++
T Consensus 210 ~~~~~~~---~~~--------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 210 ILEGKVR---FPS--------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred HhcCCcc---CCc--------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 2111111 111 1123488999999999999999 777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=276.91 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=199.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
...|+..+.||.|++|.||+|.+. .++..|++|.+...... .....+.+|+.+++.++|+||++++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~ 68 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAE-------------DEIEDIQQEITVLSQCDSPYVTKYY 68 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEeccccH-------------HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 356888999999999999999865 37889999987532211 1246788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+.++...++|+||+++++|.+++. ..++++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~ 140 (277)
T cd06640 69 GSYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDV 140 (277)
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCE
Confidence 99999999999999999999999883 24588899999999999999999955 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
+++|||++.......... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....
T Consensus 141 ~l~dfg~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~ 211 (277)
T cd06640 141 KLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-------RVLF 211 (277)
T ss_pred EEcccccceeccCCcccc--ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-------hHhh
Confidence 999999987664432221 1235678899999998888999999999999999999999998754321 1010
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
.. ....+. .........+.+++.+||+.+|++||++.++++-
T Consensus 212 ~~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 212 LI-PKNNPP---------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hh-hcCCCC---------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11 011110 1122344568899999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=275.04 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=200.3
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIV 116 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~ 116 (337)
.+.++|++.+.||.|++|.||+|.+. .++..+++|.+..... ....+.+|+.+++.+ .|+||+
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~---------------~~~~~~~e~~~l~~~~~h~~i~ 66 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHK-KTGQLVAIKIMDIIED---------------EEEEIKEEYNILRKYSNHPNIA 66 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEEC-CCCcEEEEEEEecCch---------------hHHHHHHHHHHHHHhcCCCChh
Confidence 36799999999999999999999875 3688999998854322 145688999999999 799999
Q ss_pred hhhceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 117 PLLARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 117 ~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
++++++.+.. ..++++||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+|
T Consensus 67 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~n 143 (275)
T cd06608 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQN 143 (275)
T ss_pred eEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHH
Confidence 9999997654 37999999999999999876554456789999999999999999999955 49999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-----VALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
|+++.++.++|+|||++.......... ....++..|+|||++.. ..++.++||||||+++|++++|..||...
T Consensus 144 i~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 144 ILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred EEEccCCeEEECCCccceecccchhhh--cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 999999999999999987654332221 23457889999998754 24678899999999999999999999643
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. . ........... .. . .........+.+++.+||..||++|||+.++++
T Consensus 222 ~~---~----~~~~~~~~~~~-~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 222 HP---M----RALFKIPRNPP-PT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ch---H----HHHHHhhccCC-CC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 21 1 11111111111 11 0 111223456889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=297.98 Aligned_cols=266 Identities=17% Similarity=0.189 Sum_probs=185.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||+||+|.+. ..++.||||++......... .....++..++.......|.+++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~~~~~~---------~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVPKYTRD---------AKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecchhhHHH---------HHHHHHHHHHHhhcCcccCcceeee
Confidence 3578999999999999999999865 47899999998532211000 0002223333433333456678888
Q ss_pred hceeecC-CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 119 LARVVRP-DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 119 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
++++..+ ...++|||++ +++|.+++.. .+.+++..+..++.||+.||.|||+. .|++||||||+||+++.++
T Consensus 197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 197 QRYFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSD 269 (467)
T ss_pred EEEEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCC
Confidence 8888765 4678999988 7789888843 35689999999999999999999952 2599999999999998665
Q ss_pred ----------------cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCC
Q 036970 198 ----------------EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 198 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~p 261 (337)
.+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~-----~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERHSR-----TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcccc-----ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 49999999875432221 235789999999999999999999999999999999999999
Q ss_pred CCCcccccccchHHHHHHHHhhc---------------------CCCCcccccc----ccCCC-h--HHHHHHHHHHHHH
Q 036970 262 SDDFFQHTKEMSFVQWMRNVMTS---------------------ENPSRTIDSK----LIGNG-Y--EEQMLLVLKIACF 313 (337)
Q Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~----~~~~~-~--~~~~~~l~~li~~ 313 (337)
|..... ......+...+.. .......++. ..... . ......+.+||..
T Consensus 345 f~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 420 (467)
T PTZ00284 345 YDTHDN----LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420 (467)
T ss_pred CCCCCh----HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence 975322 1111111111100 0000000000 00000 0 0012457899999
Q ss_pred hcCCCCCCCCCHHHHHH
Q 036970 314 CTFDDPEERPNSKDVRC 330 (337)
Q Consensus 314 ~l~~~p~~Rps~~~il~ 330 (337)
||+.||.+|||+.|+++
T Consensus 421 mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 421 LLHYDRQKRLNARQMTT 437 (467)
T ss_pred hCCcChhhCCCHHHHhc
Confidence 99999999999999985
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.96 Aligned_cols=264 Identities=19% Similarity=0.206 Sum_probs=193.4
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||+|++. .+|..|++|.+....... .....+.+|+.+++.++||||++++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~~------------~~~~~~~~ei~~l~~l~h~~i~~~~~~ 67 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDE------------GVPSSALREICLLKELKHKNIVRLYDV 67 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC-CCCcEEEEEEeecccccc------------cCccchhHHHHHHHhcCCCCeeeHHHH
Confidence 5888999999999999999865 478999999885432111 013456789999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+....++++||++ ++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l 140 (284)
T cd07839 68 LHSDKKLTLVFEYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKL 140 (284)
T ss_pred hccCCceEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEE
Confidence 999999999999996 578877643 2456899999999999999999999554 999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
+|||++.......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..|+...... ...+.. +..
T Consensus 141 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~-~~~ 215 (284)
T cd07839 141 ADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKR-IFR 215 (284)
T ss_pred CccchhhccCCCCCCc--CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHH-HHH
Confidence 9999987654322111 123557889999998765 4788999999999999999999886432211 111111 111
Q ss_pred Hhhc-----------CCCCcccccccc----CCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTS-----------ENPSRTIDSKLI----GNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~-----------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.... ............ ....+.....+.+++.+||+.||.+|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 216 LLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 1000 000000000000 0011123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=277.20 Aligned_cols=255 Identities=19% Similarity=0.309 Sum_probs=197.7
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||.|++|.||+|++. .++..|++|.+...... .....+.+|+.++.+++|+||+++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELDE-------------SKFNQIIMELDILHKAVSPYIVDFYG 66 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccCH-------------HHHHHHHHHHHHHHhcCCCcHHhhhh
Confidence 47899999999999999999865 47899999987432211 11457888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+..++..++++||+++++|..++... .....+++..+..++.|++.||.|||+. .+++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~ 143 (286)
T cd06622 67 AFFIEGAVYMCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVK 143 (286)
T ss_pred heecCCeEEEEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEE
Confidence 999999999999999999999888542 1134689999999999999999999953 2599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCC------CCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA------LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
|+|||++......... ...++..|+|||.+.+.. ++.++|+||||+++|++++|..||..... ...
T Consensus 144 l~dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~ 215 (286)
T cd06622 144 LCDFGVSGNLVASLAK----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANI 215 (286)
T ss_pred EeecCCcccccCCccc----cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhH
Confidence 9999998765433221 235678899999985543 47899999999999999999999964321 111
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............+. .++.....+.+++.+||+.+|++||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 216 FAQLSAIVDGDPPT----------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHhhcCCCC----------CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11111121111111 11223455889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=276.92 Aligned_cols=259 Identities=19% Similarity=0.274 Sum_probs=199.8
Q ss_pred cCcccccccccccccceEEeeeecCC--CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.++|.+.+.||.|++|.||+|.+... ....+++|........ ...+.+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-------------~~~~~~~~e~~~l~~~~h~~i~~ 71 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-------------SVREKFLQEAYIMRQFDHPHIVK 71 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-------------HHHHHHHHHHHHHHhCCCCchhc
Confidence 46788999999999999999986432 2356899987543321 12557889999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+ ...+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 72 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~ 144 (270)
T cd05056 72 LIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPD 144 (270)
T ss_pred eeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCC
Confidence 9998875 457899999999999999853 2335899999999999999999999554 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
.++++|||++............ ...++..|+|||.+....++.++|+||||++++++++ |..||...... +
T Consensus 145 ~~~l~d~g~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~ 216 (270)
T cd05056 145 CVKLGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-------D 216 (270)
T ss_pred CeEEccCceeeecccccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------H
Confidence 9999999998765443222111 2233567999999988889999999999999999986 99998654321 1
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
............. +......+.+++.+||..+|++|||+.++++.|.++.
T Consensus 217 ~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 217 VIGRIENGERLPM----------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred HHHHHHcCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111111110 1112345889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=277.47 Aligned_cols=253 Identities=22% Similarity=0.278 Sum_probs=192.0
Q ss_pred ccccccccceEEeeeecCCCCc--EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceee
Q 036970 47 EKIRSCWNGEVYKAELPGSSGR--VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVV 123 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~ 123 (337)
+.||+|+||.||+|.+.. ++. .+++|........ .....+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 66 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASK-------------DDHRDFAGELEVLCKLGHHPNIINLLGACE 66 (270)
T ss_pred CcCCCCCCceEEEEEEcC-CCCeeEEEEEEccccCCH-------------HHHHHHHHHHHHHHhhccCCCeeeEEEEEe
Confidence 368999999999998753 444 4677776422111 1145678899999999 7999999999999
Q ss_pred cCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 124 RPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
..+..+++|||+++++|.+++..... ....+++..+..++.|++.||+|||+. |++|+||+|+||
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~ni 143 (270)
T cd05047 67 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 143 (270)
T ss_pred cCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceE
Confidence 99999999999999999999865321 123578999999999999999999955 599999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccc
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTK 270 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~ 270 (337)
+++.++.++++|||++........ ......+..|+|||++....++.++|+||||+++|+|++ |..||.....
T Consensus 144 li~~~~~~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--- 217 (270)
T cd05047 144 LVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--- 217 (270)
T ss_pred EEcCCCeEEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---
Confidence 999999999999998753221111 111223567999999988889999999999999999997 9999864321
Q ss_pred cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+............ .+......+.+++.+||+.+|.+|||+.++++.|.+|-
T Consensus 218 ----~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 218 ----AELYEKLPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----HHHHHHHhCCCCCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11122221111110 01112234889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=273.12 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=199.5
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|...+.||.|++|.||+|... .+|+.+++|.+......... .........+.+.+|+.+++.++|||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~----~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGR----HDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeec-CCCceeeeeeeechhhhhcc----cchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 4778899999999999999854 47899999988543221110 001111224578889999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+......++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+++
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEE
Confidence 9999999999999999999999843 35689999999999999999999955 4999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCC--CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA--LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
+|||++................++..|+|||.+.... ++.++|+||||++++++++|..||..... .....
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~ 222 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMF 222 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHHH
Confidence 9999987654332222222345788999999987654 78899999999999999999999864221 11111
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
... .......++... .......+.+++.+||+++|++|||+.++++
T Consensus 223 ~~~-~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 223 KLG-NKRSAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred Hhh-ccccCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111 111111111111 1123355889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=273.97 Aligned_cols=261 Identities=22% Similarity=0.341 Sum_probs=198.1
Q ss_pred ccccccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 43 FASLEKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
|.+.+.||+|++|.||+|.+.. .++..+++|.+........ ..+++.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~i~~~~~ 68 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS------------DIEEFLREAACMKEFDHPNVIKLIG 68 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH------------HHHHHHHHHHHHhcCCCCCcceEEE
Confidence 6778999999999999998642 2578899999854332211 1556888999999999999999999
Q ss_pred eeecCC------CceEEEEeecCCCHHHHHHhhhc--CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 121 RVVRPD------CDLLVYEFRRNGSLQDILYDVSQ--GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 121 ~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++.... ..+++++|+.+++|.+++..... ....++......++.|++.||.|||+.+ ++|+||+|+||+
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nil 145 (273)
T cd05074 69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCM 145 (273)
T ss_pred EEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEE
Confidence 886532 23688999999999988754322 2235788899999999999999999555 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~ 271 (337)
++.++.++++|||++................++..|++||......++.++||||||+++|++++ |..||.....
T Consensus 146 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---- 221 (273)
T cd05074 146 LNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---- 221 (273)
T ss_pred EcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----
Confidence 99999999999999887654332222222344677999999988889999999999999999999 8888865322
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
. +............. .......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 222 ~---~~~~~~~~~~~~~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 222 S---EIYNYLIKGNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H---HHHHHHHcCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 11111111111110 011234589999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=276.51 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=193.5
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHH-hcCCCCCChhhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIIT-AGQVRHRNIVPLL 119 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~ni~~~~ 119 (337)
++|++.+.||.|+||.||+|++. .+|+.||+|.+........ ...+..|+.. ++.++||||++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~-------------~~~~~~e~~~~~~~~~~~~iv~~~ 66 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQE-------------QKRLLMDLDISMRSVDCPYTVTFY 66 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcHH-------------HHHHHHHHHHHHHHcCCCCeeeee
Confidence 47899999999999999999865 4799999998854322111 2234445554 5666899999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++..+...++++||++ ++|.+++.........+++..++.++.|++.||.|||++. +++|+||+|+||+++.++.+
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~ 143 (283)
T cd06617 67 GALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQV 143 (283)
T ss_pred EEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCE
Confidence 99999999999999996 6898888665445567999999999999999999999541 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC----CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT----VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+|+|||++......... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... . .
T Consensus 144 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~-~ 214 (283)
T cd06617 144 KLCDFGISGYLVDSVAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----P-F 214 (283)
T ss_pred EEeeccccccccccccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----C-H
Confidence 99999998765432211 12356788999998865 3468899999999999999999999864221 1 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+..........+... ....+..+.+++.+||+.+|.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 215 QQLKQVVEEPSPQLP---------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHhcCCCCCC---------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111122211111110 0112345889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=273.34 Aligned_cols=251 Identities=22% Similarity=0.249 Sum_probs=199.6
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|+||.||+|.+. .++..|++|.+....... ......+.+|+..+++++||||+++++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 68 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCVE-----------KGSVRNVLNERRILQELNHPFLVNLWYS 68 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhcc-----------hhHHHHHHHHHHHHHhCCCCChHHHHHh
Confidence 5889999999999999999865 479999999986433211 1125678899999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.++...++++||+.+++|.+++.. ..++++..+..++.|++++|.|||++ +++|+||+|+||+++.++.++|
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l 141 (258)
T cd05578 69 FQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHI 141 (258)
T ss_pred hcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEE
Confidence 9999999999999999999999843 35789999999999999999999955 4999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||.+......... ....++..|+|||.+.+..++.++|+||||+++|++++|..||...... ........
T Consensus 142 ~d~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~ 213 (258)
T cd05578 142 TDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAK 213 (258)
T ss_pred eecccccccCCCccc---cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHH
Confidence 999998776543221 2345788899999998888999999999999999999999998754321 11111111
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS--KDVR 329 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~~il 329 (337)
... ..... +......+.+++.+||+.||.+||++ .+++
T Consensus 214 ~~~--~~~~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 214 QET--ADVLY--------PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred hcc--ccccC--------cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111 00101 11123558899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=277.39 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=197.5
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIV 116 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~ 116 (337)
.+.++|++.+.||+|+||.||+|.+. .+++.+++|........ ...+.+|+.+++.+ +||||+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~---------------~~~~~~e~~~l~~l~~h~~i~ 78 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPIHDI---------------DEEIEAEYNILKALSDHPNVV 78 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEEC-CCCceeEEEeeccccch---------------HHHHHHHHHHHHHHhcCCCee
Confidence 37899999999999999999999865 47899999987432110 23567788899898 699999
Q ss_pred hhhceee-----cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 117 PLLARVV-----RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 117 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
++++++. .+...+++|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~ni 155 (286)
T cd06638 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNI 155 (286)
T ss_pred eeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhE
Confidence 9999874 34567999999999999998865444456789999999999999999999955 599999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-----VALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
+++.++.++|+|||++......... .....|+..|+|||++.. ..++.++|+||||+++|+|++|..||....
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 156 LLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EECCCCCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999998765433221 113467899999998753 347889999999999999999999986532
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
.. ........... ..... +......+.+++.+||+.||++|||+.++++-
T Consensus 234 ~~-------~~~~~~~~~~~-~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 234 PM-------RALFKIPRNPP-PTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hh-------HHHhhccccCC-CcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 10 11111111111 11101 01112348899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=273.19 Aligned_cols=251 Identities=19% Similarity=0.259 Sum_probs=198.9
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||+|... .++..+++|.+....... .....+.+|+.+++.++|||++++++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~ 67 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTK------------DERLAAQNECQVLKLLSHPNIIEYYEN 67 (256)
T ss_pred CceEEEEecccCceEEEEEEEc-CCCcEEEEEEEecccccc------------HHHHHHHHHHHHHhhCCCCchhheeee
Confidence 5889999999999999999865 488999999986543221 115578899999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC-cEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EAR 200 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~k 200 (337)
+..++..++|+||+++++|.+++... ....+++..+..++.+++.++.|||+++ ++|+||+|+||+++.++ .++
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~ 142 (256)
T cd08220 68 FLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVK 142 (256)
T ss_pred EecCCEEEEEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999542 2445899999999999999999999555 99999999999998654 579
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
++|||.+......... ....++..|+|||.+.+..++.++|+||||++++++++|..||..... ......
T Consensus 143 l~d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~ 212 (256)
T cd08220 143 IGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLK 212 (256)
T ss_pred EccCCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHH
Confidence 9999998876543221 124568899999999988889999999999999999999999865321 111222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........ + +......+.+++.+||+.+|++|||+.++++
T Consensus 213 ~~~~~~~~--~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 213 IMSGTFAP--I--------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHhcCCCC--C--------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 22111110 0 1112334889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=278.44 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=197.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
+.+.|.....||.|+||.||++.+. .++..|+||.+..... ...+.+.+|+..++.++|+|++++
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~ii~~ 84 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQ--------------QRRELLFNEVVIMRDYHHENVVDM 84 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEEC-CCCCEEEEEEEecchH--------------HHHHHHHHHHHHHHhCCCCcHHHH
Confidence 4466677788999999999999865 3789999998743221 114568899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+..++..++++||+++++|.+++. .+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~ 156 (292)
T cd06658 85 YNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGR 156 (292)
T ss_pred HHheecCCeEEEEEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCC
Confidence 999999999999999999999999873 235889999999999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++......... .....++..|+|||...+..++.++|+||||+++|++++|..||..... . ...
T Consensus 157 ~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~---~~~ 227 (292)
T cd06658 157 IKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----L---QAM 227 (292)
T ss_pred EEEccCcchhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H---HHH
Confidence 999999998755332211 1234578899999999888899999999999999999999999864321 1 111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
....... ...... .......+.+++..||..||++|||++++++.
T Consensus 228 ~~~~~~~-~~~~~~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 228 RRIRDNL-PPRVKD-------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHhcC-CCcccc-------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111 000000 01122347889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=279.14 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=198.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCc----EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
+.++|+..+.||+|+||.||+|.+.. +|. .+++|........ .....+.+|+.+++.++|||
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~n 70 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVP-EGETVKIPVAIKILNETTGP-------------KANVEFMDEALIMASMDHPH 70 (303)
T ss_pred chhhceeccccccCCCccEEEEEEec-CCCcceeeEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCC
Confidence 46788999999999999999998653 443 4688877432211 11346788999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
|+++++++... ..++++||+++|+|.+++.. ....+++..++.++.|++.||.|||++ +++|+||+|+||+++
T Consensus 71 iv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~ 143 (303)
T cd05110 71 LVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVK 143 (303)
T ss_pred cccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---Ceeccccccceeeec
Confidence 99999988754 46789999999999999853 234588999999999999999999955 499999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|++++ |..||.+... ..
T Consensus 144 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~ 219 (303)
T cd05110 144 SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----RE 219 (303)
T ss_pred CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HH
Confidence 999999999999987653322222222344678999999998889999999999999999997 8899865321 11
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
....+ ....... . +......+.+++..||..+|++||++.++++.|.++.
T Consensus 220 ~~~~~----~~~~~~~-~--------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 220 IPDLL----EKGERLP-Q--------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHHHH----HCCCCCC-C--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12221 1111100 0 0112235889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=285.05 Aligned_cols=258 Identities=19% Similarity=0.187 Sum_probs=194.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||+|+||.||++++. .+++.+|+|.+........ .....+.+|+.++..++|+||+++++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKR-----------AETACFREERDVLVNGDNQWITTLHY 68 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHHh-----------hHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 47999999999999999999876 3788999999854221111 11345778999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+....++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~k 142 (332)
T cd05623 69 AFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIR 142 (332)
T ss_pred EEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEE
Confidence 99999999999999999999999954 2345899999999999999999999554 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
|+|||++.......... .....||+.|+|||++. ...++.++||||||+++|+|++|..||..... .
T Consensus 143 L~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~ 214 (332)
T cd05623 143 LADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------V 214 (332)
T ss_pred EeecchheecccCCcce-ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------H
Confidence 99999987653322211 11346899999999986 34578899999999999999999999965321 2
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCC--CCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDP--EERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p--~~Rps~~~il~ 330 (337)
+............ .++. ........+.+++.+|+..++ ..|+++.++++
T Consensus 215 ~~~~~i~~~~~~~-~~p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 215 ETYGKIMNHKERF-QFPA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred HHHHHHhCCCccc-cCCC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 2222222221100 0111 011223447888888885544 34688888865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.63 Aligned_cols=260 Identities=26% Similarity=0.406 Sum_probs=203.2
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|++|+||+|... .++..+++|......... ....+.+|+..++.++|+|++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~-------------~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL-PNNEKVAIKRIDLEKCQT-------------SVDELRKEVQAMSQCNHPNVVKYYT 66 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc-CCCcEEEEEEeccCCcch-------------HHHHHHHHHHHHHhcCCCCEEEEEE
Confidence 57999999999999999999865 378899999885332211 1567899999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+..+...++++|++++++|.+++..... ...+++..+..++.|++.|+.+||+.+ ++|+||+|+||++++++.++
T Consensus 67 ~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~ 142 (267)
T cd06610 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVK 142 (267)
T ss_pred EEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEE
Confidence 99999999999999999999999854322 246899999999999999999999554 99999999999999999999
Q ss_pred EecccccccCCCCCcc--cccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 201 ISEFGLAKQIPNGRTR--TTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
|+|||++......... .......++..|+|||++... .++.++|+||||+++++|++|..||...... +.
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~ 215 (267)
T cd06610 143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KV 215 (267)
T ss_pred EcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-------hh
Confidence 9999998766543222 122344678899999998776 7889999999999999999999999754221 11
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........... +... ..+......+.+++.+||+.||++|||+.++++
T Consensus 216 ~~~~~~~~~~~--~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 216 LMLTLQNDPPS--LETG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHhcCCCCC--cCCc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11222211111 1100 011233455889999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.01 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=200.7
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|++|.||+|... .+++.|++|.+....... ......+.+|+..++.++|+||+++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 68 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIK-----------RNKVKRVLTEQEILATLDHPFLPTLYA 68 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc-CCCcEEEEEEEeccccch-----------HHHHHHHHHHHHHHHhCCCCCchhhee
Confidence 47899999999999999999865 378999999986543221 112557889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.++...++++||+.+++|.+++.. .....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~ 143 (316)
T cd05574 69 SFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIM 143 (316)
T ss_pred eeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEE
Confidence 99999999999999999999999853 2335689999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCccc---------------------------ccccccCcccccCCccccCCCCCCcccchhHhHHHH
Q 036970 201 ISEFGLAKQIPNGRTRT---------------------------TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLA 253 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~ 253 (337)
|+|||++.......... ......|+..|+|||++.+..++.++||||||+++|
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~ 223 (316)
T cd05574 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223 (316)
T ss_pred EeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHH
Confidence 99999887543221100 111235688899999999888999999999999999
Q ss_pred HHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC----HHHHH
Q 036970 254 VLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN----SKDVR 329 (337)
Q Consensus 254 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~il 329 (337)
++++|..||...... ............. .........+.+++.+||..||++||| +.+++
T Consensus 224 ~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 224 EMLYGTTPFKGSNRD-------ETFSNILKKEVTF---------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HHhhCCCCCCCCchH-------HHHHHHhcCCccC---------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 999999999754321 1111111111110 001113345999999999999999999 77776
Q ss_pred H
Q 036970 330 C 330 (337)
Q Consensus 330 ~ 330 (337)
.
T Consensus 288 ~ 288 (316)
T cd05574 288 Q 288 (316)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=286.89 Aligned_cols=244 Identities=20% Similarity=0.184 Sum_probs=183.8
Q ss_pred ccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC---CCCChhhhhceeecC
Q 036970 49 IRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV---RHRNIVPLLARVVRP 125 (337)
Q Consensus 49 lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~ni~~~~~~~~~~ 125 (337)
||+|+||+||+|++. .+++.||+|++......... .......|..++... .||||+++++++.+.
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~-----------~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~ 68 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEIVAKK-----------EVAHTIGERNILVRTLLDESPFIVGLKFSFQTD 68 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHHhhhh-----------HHHHHHHHHHHHHHhccCCCCcCcceEEEEecC
Confidence 799999999999865 48999999998643221111 123344555555444 699999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
...++||||+.+++|.+++. ..+.+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg 141 (330)
T cd05586 69 SDLYLVTDYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFG 141 (330)
T ss_pred CeEEEEEcCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCC
Confidence 99999999999999998884 3456899999999999999999999555 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhc
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTS 284 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 284 (337)
++......... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||..... .+........
T Consensus 142 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~ 212 (330)
T cd05586 142 LSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFG 212 (330)
T ss_pred cCcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcC
Confidence 98754322221 1235689999999998764 478999999999999999999999865321 1222222211
Q ss_pred CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHH
Q 036970 285 ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP----NSKDVRC 330 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----s~~~il~ 330 (337)
... +.. ......+.+++.+||+.||.+|| ++.++++
T Consensus 213 ~~~---~~~-------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 KVR---FPK-------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCC---CCC-------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 110 000 01123478999999999999998 4666554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=273.29 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=194.4
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD 126 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 126 (337)
++||.|++|.||+|.+. .++.|++|........ .....+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~~lg~g~~g~v~~~~~~--~~~~v~~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 65 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK--GNTEVAVKTCRSTLPP-------------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ 65 (251)
T ss_pred CccccCCCceEEEEEEe--CCCcEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Confidence 47999999999999865 4999999987543321 12457889999999999999999999999999
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccc
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~ 206 (337)
..++++||+++++|.+++.. ....++...+..++.+++.++.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 66 ~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~ 139 (251)
T cd05041 66 PIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGM 139 (251)
T ss_pred CeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccc
Confidence 99999999999999999854 2346789999999999999999999554 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 207 AKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 207 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
+.................+..|+|||.+.+..++.++|+||||+++|++++ |..||..... ...... .....
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----~~~~~~---~~~~~ 212 (251)
T cd05041 140 SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----QQTRER---IESGY 212 (251)
T ss_pred cccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----HHHHHH---HhcCC
Confidence 876543222111111233567999999988889999999999999999999 7888865422 111111 11111
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
... .+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 213 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 RMP----------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCC----------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 000 01122345899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=279.19 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=196.0
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|++|.||+|.+. .+++.|++|.+....... .....+.+|+.+++.++||||+++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 67 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDK------------MVKKIAMREIRMLKQLRHENLVNLIE 67 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCcc------------hhhHHHHHHHHHHHhcCCcchhhHHH
Confidence 47899999999999999999875 378999999874322111 11456788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++..+...++|+||+++++|..+.. ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~ 140 (286)
T cd07846 68 VFRRKKRLYLVFEFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVK 140 (286)
T ss_pred hcccCCeEEEEEecCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEE
Confidence 9999999999999999988887762 3345899999999999999999999554 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||++......... .....++..|+|||++.+. .++.++||||||+++++|++|.+||...... .......
T Consensus 141 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~----~~~~~~~ 214 (286)
T cd07846 141 LCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI----DQLYHII 214 (286)
T ss_pred EEeeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHH
Confidence 9999998765433221 1123568889999998753 4678999999999999999999998643211 1000000
Q ss_pred HHhhc-----------CC-----CCcccc-ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTS-----------EN-----PSRTID-SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~-----------~~-----~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..... .. ...... ........+.....+.+++.+||+.+|++||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 215 KCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 00 000000 00000011223456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.18 Aligned_cols=265 Identities=20% Similarity=0.233 Sum_probs=198.3
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|++|.||+|.+. .+++.|++|.+...... ......+.+|+.+++.++|+||+++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~vK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 67 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK-ATGEIVAIKKFKESEDD------------EDVKKTALREVKVLRQLRHENIVNLKE 67 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC-CCCcEEEEehhhhhccc------------ccchhHHHHHHHHHHhcCCCCeeehhh
Confidence 47999999999999999999865 37889999987433221 112467889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+++..++++||++++.+..+. .....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++
T Consensus 68 ~~~~~~~~~iv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~k 140 (288)
T cd07833 68 AFRRKGRLYLVFEYVERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLK 140 (288)
T ss_pred eEEECCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEE
Confidence 999999999999999886666555 2345589999999999999999999955 499999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||++........... ....++..|+|||++.+. .++.++|+||||+++|++++|..||...... +......
T Consensus 141 l~d~g~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~ 215 (288)
T cd07833 141 LCDFGFARALRARPASPL-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI----DQLYLIQ 215 (288)
T ss_pred EEeeecccccCCCccccc-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH
Confidence 999999877654432111 124567889999999888 7899999999999999999999998753221 1111111
Q ss_pred HHhhcCCC-----------Ccc--cccccc-----CCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENP-----------SRT--IDSKLI-----GNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~-----------~~~--~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......+ ... ..+... ...+......+.+++++||..+|++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 216 KCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 11100000 000 000000 0011112466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=283.84 Aligned_cols=258 Identities=19% Similarity=0.200 Sum_probs=194.9
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+.+.||+|+||.||++++. .+++.||+|.+....... ......+.+|..++..++|+||+++++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~~~~i~~l~~ 68 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLK-----------RAETACFREERNVLVNGDCQWITTLHY 68 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHh-----------hHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 57999999999999999999865 478999999985432111 011445788899999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+.+++..++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~k 142 (331)
T cd05624 69 AFQDENYLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIR 142 (331)
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEE
Confidence 999999999999999999999999542 34688999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-----VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
|+|||++........... ....||+.|+|||++.+ ..++.++|+||||+++|+|++|..||..... .
T Consensus 143 l~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~ 214 (331)
T cd05624 143 LADFGSCLKMNQDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------V 214 (331)
T ss_pred EEeccceeeccCCCceee-ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------H
Confidence 999999876543322211 12468999999999875 4578899999999999999999999964321 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEE--RPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~il~ 330 (337)
+........... ..++.. ....+..+.+++.+||..++++ |++++++++
T Consensus 215 ~~~~~i~~~~~~-~~~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 215 ETYGKIMNHEER-FQFPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHHHcCCCc-ccCCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 222222221110 001111 1112345888899999865543 457777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=286.92 Aligned_cols=256 Identities=18% Similarity=0.281 Sum_probs=206.6
Q ss_pred cccccccccccccceEEeeeecCC-CC--cEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGS-SG--RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
.....+.||.|-||.||+|.+... .| -.||||.+...-.. +..+.|..|..+|+.++||||+++
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-------------d~tekflqEa~iMrnfdHphIikL 456 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-------------DDTEKFLQEASIMRNFDHPHIIKL 456 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-------------hhHHHHHHHHHHHHhCCCcchhhe
Confidence 334557899999999999998643 33 34888887443221 126789999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+|+|.+. ..|+|||.++-|.|..++.. ....++..+...++.||+.+|.|||+.. .|||||...||++....-
T Consensus 457 IGv~~e~-P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~C 529 (974)
T KOG4257|consen 457 IGVCVEQ-PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQC 529 (974)
T ss_pred eeeeecc-ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcce
Confidence 9999875 67999999999999999954 4456888999999999999999999776 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
||++|||+++.+.....+... ...-+.-|||||.++...++.++|||.||+.+||++. |..||.+....
T Consensus 530 VKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--------- 599 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--------- 599 (974)
T ss_pred eeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------
Confidence 999999999998877665544 2233677999999999999999999999999999987 77999764321
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+....+...-.-..++.++..++.|+.+||.++|.+||.+.+|...|+++
T Consensus 600 --------DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 600 --------DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred --------ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 11111111112234555666699999999999999999999999998875
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.37 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=194.5
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+.+.||+|+||.||++.. .++.+++|....... ...+.+|+.+++.++|||++++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~~----------------~~~~~~e~~~l~~~~~~~i~~~~~ 66 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDVT----------------AQAFLEETAVMTKLHHKNLVRLLG 66 (254)
T ss_pred HHceeeeeeccCCCCceEeccc---CCCceEEEeecCcch----------------HHHHHHHHHHHHhCCCCCcCeEEE
Confidence 6789999999999999999964 688899998743211 346788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++..+ ..++++||+.+++|.+++... ....+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 67 ~~~~~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~k 140 (254)
T cd05083 67 VILHN-GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAK 140 (254)
T ss_pred EEcCC-CcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEE
Confidence 88765 478999999999999998542 334588999999999999999999954 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||.+........ ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .+...
T Consensus 141 l~Dfg~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~ 208 (254)
T cd05083 141 VSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KEVKE 208 (254)
T ss_pred ECCCccceeccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HHHHH
Confidence 999998865432211 1233567999999988889999999999999999997 8999865322 11111
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
......... .....+..+.+++.+||+.+|++||++.++++.|.+
T Consensus 209 ~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 209 CVEKGYRME----------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHhCCCCCC----------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111111110 011123448899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.80 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=193.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
.+|...+.||.|++|.||+|.+. .++..|++|......... ........+.+|+.+++.++||||+++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 71 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESP---------ETSKEVSALECEIQLLKNLQHERIVQYYG 71 (266)
T ss_pred CCccccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCc---------hhHHHHHHHHHHHHHHHHcCCCCeeeEEE
Confidence 57999999999999999999865 478999999875432111 11112557889999999999999999999
Q ss_pred eeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 121 RVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 121 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
.+.+. ...++++||+++++|.+++. ....+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.
T Consensus 72 ~~~~~~~~~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~ 144 (266)
T cd06651 72 CLRDRAEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGN 144 (266)
T ss_pred EEEcCCCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence 88753 56689999999999999984 334588999999999999999999955 4999999999999999999
Q ss_pred EEEecccccccCCCCCc-ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++........ ........++..|+|||.+.+..++.++|+||||+++|++++|..||..... ...
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~ 217 (266)
T cd06651 145 VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAA 217 (266)
T ss_pred EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHH
Confidence 99999999876533211 1111124568899999999988899999999999999999999999975321 111
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... ...+ +......+..++ +||..+|++||+++++++
T Consensus 218 ~~~~~~~~~-~~~~--------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 IFKIATQPT-NPQL--------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHhcCCC-CCCC--------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111111111 0000 111223355666 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=279.84 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=200.3
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
-...++|.+.+.||.|++|.||+|... .++..|++|.+...... ..+.+.+|+.+++.++|+|++
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~--------------~~~~~~~e~~~l~~~~h~~i~ 79 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDI-ATGQEVAIKQMNLQQQP--------------KKELIINEILVMRENKNPNIV 79 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEEC-CCCCEEEEEEEecCccc--------------hHHHHHHHHHHHHhCCCCCEe
Confidence 346699999999999999999999854 48999999988533221 134678899999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++.+..+...++|+||+++++|.+++.. ..+++..+..++.|++.+|.|||+. |++|+||+|+||+++.+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~ 151 (297)
T cd06656 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMD 151 (297)
T ss_pred eEEEEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 999999999999999999999999999832 3578889999999999999999955 49999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+.++|+|||++.......... ....+++.|+|||.+.+..++.++|+||||+++|++++|..||........
T Consensus 152 ~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~------ 223 (297)
T cd06656 152 GSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------ 223 (297)
T ss_pred CCEEECcCccceEccCCccCc--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh------
Confidence 999999999987654332211 124578889999999988899999999999999999999999965322100
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.........+. ...+......+.+++.+||+.+|++||++.++++
T Consensus 224 -~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 224 -LYLIATNGTPE--------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -eeeeccCCCCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000011000 0011222344789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=289.82 Aligned_cols=259 Identities=21% Similarity=0.276 Sum_probs=210.7
Q ss_pred hhhhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCC
Q 036970 34 LAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113 (337)
Q Consensus 34 ~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 113 (337)
.+-+.+.+-|.++..||.|+||.||+|..+ .++-..|-|++..... +..+.+.-||.+|...+||
T Consensus 25 ~rdlnP~d~WeIiGELGDGAFGKVyKA~nk-et~~lAAaKvIetkse--------------EELEDylVEIeILa~CdHP 89 (1187)
T KOG0579|consen 25 YRDLNPRDHWEIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIETKSE--------------EELEDYLVEIEILAECDHP 89 (1187)
T ss_pred hccCCHHHHHHHHhhhcCccchhhhhhhcc-cchhhhhhhhhcccch--------------hHHhhhhhhhhhhhcCCCh
Confidence 344678899999999999999999999865 4666666676643322 2266788899999999999
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+|+++++.|+.++.+||++|||.||-....+-. -+..+++.++..++.|++.||.|||++. |+|||||..|||+
T Consensus 90 ~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~ 163 (1187)
T KOG0579|consen 90 VIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILL 163 (1187)
T ss_pred HHHHHHHHHhccCceEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEE
Confidence 999999999999999999999999988887743 3467999999999999999999999776 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCcccc
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~ 268 (337)
+-+|.++|+|||.+.....- ......+.|||.|||||+.. ..+|+.++||||||++|.||..+.+|-+...+
T Consensus 164 TldGdirLADFGVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp- 240 (1187)
T KOG0579|consen 164 TLDGDIRLADFGVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP- 240 (1187)
T ss_pred EecCcEeeecccccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-
Confidence 99999999999998654322 23344679999999999864 45799999999999999999999999765433
Q ss_pred cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 269 TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+..+..+....++.. ..++.....+.+++..||.+||..||++.++++
T Consensus 241 ------MRVllKiaKSePPTL--------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 241 ------MRVLLKIAKSEPPTL--------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------HHHHHHHhhcCCCcc--------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 344444443444332 234556667888999999999999999999875
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=274.98 Aligned_cols=258 Identities=23% Similarity=0.307 Sum_probs=198.8
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCCh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNI 115 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 115 (337)
.++.++|.+.+.||.|++|.||+|... .+++.+++|.+..... ....+.+|+.+++.+ +|||+
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~~---------------~~~~~~~e~~~l~~l~~h~ni 81 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPISD---------------VDEEIEAEYNILQSLPNHPNV 81 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEeccccc---------------HHHHHHHHHHHHHHhcCCCCe
Confidence 346899999999999999999999865 4789999998843211 134567788888888 79999
Q ss_pred hhhhceeecC-----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 116 VPLLARVVRP-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 116 ~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
+++++++... ...++|+||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~n 158 (291)
T cd06639 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNN 158 (291)
T ss_pred EEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHH
Confidence 9999988754 357999999999999999865544556789999999999999999999955 49999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-----CCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-----ALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
|+++.++.++|+|||++.......... ....++..|+|||.+... .++.++|+||||+++|+|++|..||...
T Consensus 159 ili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 159 ILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEEcCCCCEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999987654332211 123568889999987543 3678999999999999999999998753
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
... .......... ...... .......+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~-------~~~~~~~~~~-~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 237 HPV-------KTLFKIPRNP-PPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cHH-------HHHHHHhcCC-CCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 221 1111111111 111111 1122345899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=270.87 Aligned_cols=253 Identities=25% Similarity=0.294 Sum_probs=198.6
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|+..+.||+|++|.||+|... .++..|++|.+....... ...+....+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~---------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 70 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQ---------TGQEAVKQLEQEIALLSKLQHPNIVQYLGT 70 (258)
T ss_pred CccccceeeecCCceEEEEEEc-CCCcEEEEEEEEEccccc---------cchHHHHHHHHHHHHHHhcCCCCchheeee
Confidence 5788899999999999999865 478999999885433211 112225678899999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.++...++++||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl 143 (258)
T cd06632 71 EREEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKL 143 (258)
T ss_pred EecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999843 345889999999999999999999555 999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
+|||++........ .....++..|+|||.+.... ++.++|+||||+++|++++|..||..... ......
T Consensus 144 ~d~~~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~ 213 (258)
T cd06632 144 ADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFK 213 (258)
T ss_pred ccCccceecccccc---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHH
Confidence 99999876544331 12346788899999987766 89999999999999999999999875421 111111
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... ...+ +......+.+++.+||+.+|++||++.+++.
T Consensus 214 ~~~~~~-~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 214 IGRSKE-LPPI--------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHhccc-CCCc--------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111011 0011 1112344788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=280.97 Aligned_cols=252 Identities=20% Similarity=0.269 Sum_probs=209.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..+=|+..+-||+|.|..|-+|++- -+|..||||++.+....... ...+..|++.|..++||||+++
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHV-FTGekVAVKviDKTKlD~~s------------t~hlfqEVRCMKLVQHpNiVRL 82 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLDTLS------------TGHLFQEVRCMKLVQHPNIVRL 82 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhh-cccceeEEEEecccccchhh------------hhHHHHHHHHHHHhcCcCeeee
Confidence 4466888999999999999999854 48999999999765443221 4568889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec-CCC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID-DDM 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~-~~~ 197 (337)
|++......+|+|+|.-++|+|.+||-++..+ +.+....+++.||+.|+.|+|+.+ +|||||||+|+.+. +-|
T Consensus 83 YEViDTQTKlyLiLELGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlG 156 (864)
T KOG4717|consen 83 YEVIDTQTKLYLILELGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLG 156 (864)
T ss_pred eehhcccceEEEEEEecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecC
Confidence 99999999999999999999999999776554 899999999999999999999666 99999999999887 558
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALS-DKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
-|||.|||++-.+..+.... ..+|+..|-|||++.+..|+ ++.||||||+++|.+.+|++||+.-...+ .+
T Consensus 157 lVKLTDFGFSNkf~PG~kL~---TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---TL-- 228 (864)
T KOG4717|consen 157 LVKLTDFGFSNKFQPGKKLT---TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---TL-- 228 (864)
T ss_pred ceEeeeccccccCCCcchhh---cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---hh--
Confidence 89999999998876655444 35899999999999999886 46899999999999999999997533211 11
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...+|.+ ..-++..+.++.+||.+||..||.+|.|.++|..
T Consensus 229 -----------TmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 229 -----------TMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----------hhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1112222 1335667788999999999999999999999864
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=290.42 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=199.0
Q ss_pred ccCcc-cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 39 KEDCF-ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 39 ~~~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
..++| +....||+|+|-+||+|.+ ..+|..||==.+. ..+........++|..|+.+|..|+||||++
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~D-e~~giEVAWnqvk----------~~d~~q~~~~leR~~~Ev~lLKsL~H~NIir 105 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFD-EEEGIEVAWNQVK----------IRDVTQSPEELERLYSEVHLLKSLKHPNIIR 105 (632)
T ss_pred CCCceeehhhhcccccceeeeeccc-cccchhhHHHHHh----------HHHhhcChHHHHHHHHHHHHHccCCCCceee
Confidence 55666 4557899999999999975 4577776521110 1112222333688999999999999999999
Q ss_pred hhceeecCCC--ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 118 LLARVVRPDC--DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 118 ~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
++.+|.+... ..+|+|.+..|+|+.|+++ .+.+....+.+|++||+.||.|||++ .++|+|||||-+||||+.
T Consensus 106 fy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG 180 (632)
T KOG0584|consen 106 FYDSWVDTDNKTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNG 180 (632)
T ss_pred eeeheecCCCceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcC
Confidence 9999988765 6789999999999999954 45578889999999999999999998 788999999999999984
Q ss_pred -CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 196 -DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 196 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
.|.|||+|+|+++........ ...|||.|||||+.. ..|++..||||||+++.||.|+..||..-. . -
T Consensus 181 ~~G~VKIGDLGLAtl~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~---n---~ 249 (632)
T KOG0584|consen 181 NLGEVKIGDLGLATLLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT---N---P 249 (632)
T ss_pred CcCceeecchhHHHHhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC---C---H
Confidence 589999999999887654333 258999999999987 689999999999999999999999987432 1 2
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+..+.+-++..|..+ ..-..++ +.++|.+||.. .++|||+.|+|+
T Consensus 250 AQIYKKV~SGiKP~sl-----~kV~dPe----vr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 250 AQIYKKVTSGIKPAAL-----SKVKDPE----VREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHHHcCCCHHHh-----hccCCHH----HHHHHHHHhcC-chhccCHHHHhh
Confidence 3333333333322211 1112222 88999999998 999999999985
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=277.48 Aligned_cols=264 Identities=23% Similarity=0.268 Sum_probs=198.2
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||+|.+. .+|+.|++|++....... .....+.+|+.+++.++||||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~ 67 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLEG------------GIPNQALREIKALQACQHPYVVKLLDV 67 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccccc------------hhhHHHHHHHHHHHhCCCCCCcceeeE
Confidence 5889999999999999999865 378999999985543211 114568899999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.++...++|+||+ +++|.+++.. ...++++..++.++.||+.+|.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l 140 (286)
T cd07832 68 FPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKI 140 (286)
T ss_pred EecCCeeEEEeccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEE
Confidence 99999999999999 9999999854 2356899999999999999999999554 999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
+|||++........ .......++..|+|||.+.+. .++.++||||+|++++++++|.+||..... .........
T Consensus 141 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~ 215 (286)
T cd07832 141 ADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFR 215 (286)
T ss_pred eeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHH
Confidence 99999877654321 111124578899999998654 468899999999999999999888764321 111111111
Q ss_pred HhhcCCC-----------Cccc--ccc---ccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENP-----------SRTI--DSK---LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~-----------~~~~--~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... ...+ ... ......+.....+.+++.+||+.+|++|||+++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1100000 0000 000 000011122366899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=274.52 Aligned_cols=256 Identities=21% Similarity=0.248 Sum_probs=195.6
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
.+|.+.+.||.|+||.||.|.+. .++..|++|.+....... ........+.+|+.+++.++||||+++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 71 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESP---------ETSKEVNALECEIQLLKNLLHERIVQYYG 71 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCc---------ccHHHHHHHHHHHHHHHhcCCCCeeeEEe
Confidence 67999999999999999999865 478999999874322110 11122567888999999999999999999
Q ss_pred eeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 121 RVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 121 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
.+.+. ...++++||+++++|.+++.. ...+++.....++.|++.+|.|||+.+ ++|+||+|+||+++.++.
T Consensus 72 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~ 144 (265)
T cd06652 72 CLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGN 144 (265)
T ss_pred EeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCC
Confidence 88764 456899999999999999843 345788889999999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||.+......... .......++..|+|||.+.+..++.++|+||||+++|++++|..||..... ...
T Consensus 145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~- 217 (265)
T cd06652 145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAA- 217 (265)
T ss_pred EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHH-
Confidence 999999988765422111 111234578899999999888899999999999999999999999864311 111
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... .. ..+......+.+++.+|+. +|++||+++++++
T Consensus 218 ~~~~~~~~~-~~--------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 218 IFKIATQPT-NP--------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHhcCCC-CC--------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111111110 00 1122334558889999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=277.90 Aligned_cols=259 Identities=19% Similarity=0.201 Sum_probs=198.1
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|+||.||++.+. ..++.|++|.+....... ......+.+|+.+++.++||||+++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQNLIL-----------RNQIQQVFVERDILTFAENPFVVSMFC 68 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhhhhh-----------HHHHHHHHHHHHHHHhCCCCCeeeeEE
Confidence 47899999999999999999865 478999999875432211 111456788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+..++..+++|||+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~ 141 (305)
T cd05609 69 SFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIK 141 (305)
T ss_pred EEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEE
Confidence 99999999999999999999999843 35689999999999999999999955 499999999999999999999
Q ss_pred EecccccccCCCCCc-------------ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccc
Q 036970 201 ISEFGLAKQIPNGRT-------------RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ 267 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~ 267 (337)
++|||++........ ........++..|+|||.+....++.++|+||||+++|++++|..||.+...
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999998763211100 0011123567889999999888899999999999999999999999864321
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
.+................ ......+.+++.+||+++|++||+..++.++|+
T Consensus 222 -------~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 222 -------EELFGQVISDDIEWPEGD--------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred -------HHHHHHHHhcccCCCCcc--------ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 122222222211110000 012334889999999999999999766666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=279.81 Aligned_cols=200 Identities=21% Similarity=0.280 Sum_probs=158.2
Q ss_pred cccccccccceEEeeeecC-CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeec
Q 036970 46 LEKIRSCWNGEVYKAELPG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 124 (337)
+.+||+|+||.||+|+... .++..||+|.+..... ...+.+|+.+++.++||||+++++++..
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------------SMSACREIALLRELKHPNVIALQKVFLS 69 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------------cHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 4689999999999998642 3568899998743221 2356789999999999999999998854
Q ss_pred --CCCceEEEEeecCCCHHHHHHhhhc-----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe----
Q 036970 125 --PDCDLLVYEFRRNGSLQDILYDVSQ-----GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---- 193 (337)
Q Consensus 125 --~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~---- 193 (337)
+...++++||+. ++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 70 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~ 145 (317)
T cd07867 70 HSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEG 145 (317)
T ss_pred cCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCC
Confidence 456789999985 478887753221 2235889999999999999999999554 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 194 DDDMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
+.++.++|+|||++......... .......+|+.|+|||++.+. .++.++||||||+++|+|++|.+||...
T Consensus 146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 45678999999999866433221 112234678899999998764 5789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=296.82 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=211.1
Q ss_pred cCcccccccccccccceEEeeeecCC--CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.+...+.+.||.|.||.|+.|+++.. ....||||.+.....+. ++..|..|..+|-+++||||++
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek-------------qrrdFL~EAsIMGQFdHPNIIr 694 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK-------------QRRDFLSEASIMGQFDHPNIIR 694 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH-------------HHhhhhhhhhhcccCCCCcEEE
Confidence 46678889999999999999998642 23569999985444322 2668999999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+.|+.......+||+|||++|+|..|++. ..+.++..+...+++.|+.|++||. .+++|||||...|||++.+.
T Consensus 695 LEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnL 768 (996)
T KOG0196|consen 695 LEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNL 768 (996)
T ss_pred EEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccce
Confidence 99999999999999999999999999965 4456899999999999999999999 55599999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccC--cccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAE--TVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~ 274 (337)
.+|++|||+++.+..... .......| +.+|.|||.+...+++.++||||+|+++||+++ |..||=+. .-
T Consensus 769 vCKVsDFGLSRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-------SN 840 (996)
T KOG0196|consen 769 VCKVSDFGLSRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------SN 840 (996)
T ss_pred EEEeccccceeecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-------ch
Confidence 999999999997754431 11111222 678999999999999999999999999999887 77886432 33
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
++.++.+...-+.... ..++..|.+|+..||++|-++||++.+|+..|++|
T Consensus 841 QdVIkaIe~gyRLPpP----------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 841 QDVIKAIEQGYRLPPP----------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHHHHHHHhccCCCCC----------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 4444444433333332 33445599999999999999999999999999986
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=270.05 Aligned_cols=242 Identities=21% Similarity=0.284 Sum_probs=183.1
Q ss_pred ccccccccceEEeeeecCC-----------CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 47 EKIRSCWNGEVYKAELPGS-----------SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~-----------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
+.||+|+||.||+|..... ....+++|....... .....+..|+.++..++||||
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--------------~~~~~~~~~~~~l~~l~hp~i 66 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--------------DISLAFFETASMMRQVSHKHI 66 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--------------hHHHHHHHHHHHHHhCCCCCE
Confidence 4689999999999985321 223578887643221 114467888999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++++..+...++++||+++++|..++.. ....+++..++.++.||+.||.|||+. +++|+||+|+||+++.
T Consensus 67 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~ 140 (262)
T cd05077 67 VLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAR 140 (262)
T ss_pred eeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEec
Confidence 9999999999999999999999999888743 335689999999999999999999955 4999999999999986
Q ss_pred CCc-------EEEecccccccCCCCCcccccccccCcccccCCcccc-CCCCCCcccchhHhHHHHHHH-hCCCCCCCcc
Q 036970 196 DME-------ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-TVALSDKCDIYSFGVLLAVLM-MGKFPSDDFF 266 (337)
Q Consensus 196 ~~~-------~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~vl~~l~-~g~~pf~~~~ 266 (337)
++. ++++|||++....... ...++..|+|||.+. +..++.++||||||+++|+|+ .|..||....
T Consensus 141 ~~~~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 141 EGIDGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCccCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 654 8999999886553221 234678899999886 456889999999999999998 5778876432
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
. .+.. ........ .. .. ....+.+++.+||+.||++||++.+|++.|+
T Consensus 215 ~-------~~~~-~~~~~~~~--~~-----~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 215 L-------AEKE-RFYEGQCM--LV-----TP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h-------hHHH-HHHhcCcc--CC-----CC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1 1111 11111100 00 01 1234789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=271.35 Aligned_cols=260 Identities=21% Similarity=0.308 Sum_probs=199.5
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|+..+.||.|++|.||+|... .+++.+++|.+........ ........+.+|+..++.++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~alk~~~~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSS--------EQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEc-CCCcEEEEEEeecccCCch--------hHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 5888999999999999999864 4889999998854321110 011125678999999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC-cEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EAR 200 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~k 200 (337)
+.+.+..++++||+++++|.+++.. .+++++..++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~ 144 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLR 144 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999843 346889999999999999999999554 99999999999998765 599
Q ss_pred EecccccccCCCCCcc--cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 201 ISEFGLAKQIPNGRTR--TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
|+|||.+......... .......++..|+|||.+.+..++.++|+||+|++++++++|..||...... ......
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~ 220 (268)
T cd06630 145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS----NHLALI 220 (268)
T ss_pred EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc----chHHHH
Confidence 9999998776543211 1112345688999999998888999999999999999999999998643211 111111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... . ..+......+.+++.+||+.+|++|||+.++++
T Consensus 221 ~~~~~~~~~-~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKIASATTA-P--------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHhccCCC-C--------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111111100 0 111223355889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.95 Aligned_cols=242 Identities=19% Similarity=0.263 Sum_probs=182.1
Q ss_pred ccccccccceEEeeeecC-----------------------CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHH
Q 036970 47 EKIRSCWNGEVYKAELPG-----------------------SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSE 103 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~-----------------------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 103 (337)
..||+|+||.||+|.+.. .....+++|.+..... .....+.+|
T Consensus 1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--------------~~~~~~~~~ 66 (274)
T cd05076 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--------------DIALAFFET 66 (274)
T ss_pred CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--------------HHHHHHHHH
Confidence 369999999999997421 1123477787743221 113467888
Q ss_pred HHHhcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 036970 104 IITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183 (337)
Q Consensus 104 ~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h 183 (337)
+.+++.++||||+++++++.++...++||||+++++|..++.. ..+.+++..+..++.|++.||.|||+. +++|
T Consensus 67 ~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH 140 (274)
T cd05076 67 ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVH 140 (274)
T ss_pred HHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccC
Confidence 9999999999999999999999999999999999999988843 345688999999999999999999955 5999
Q ss_pred CCCCCCcEEecCCC-------cEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHH
Q 036970 184 RDIQPANVLIDDDM-------EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVL 255 (337)
Q Consensus 184 ~di~~~nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l 255 (337)
+||||+||+++..+ .++++|||.+....... ...++..|+|||.+.+ ..++.++|+||||+++||+
T Consensus 141 ~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred CCCCcccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999997543 37999999875432221 1245778999998865 4688999999999999998
Q ss_pred H-hCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 256 M-MGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 256 ~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
+ +|..||...... ........ ...... . ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 215 ~~~g~~p~~~~~~~----~~~~~~~~---~~~~~~--------~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 215 CFDGEVPLKERTPS----EKERFYEK---KHRLPE--------P----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HhCCCCCccccChH----HHHHHHHh---ccCCCC--------C----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 5 688998653221 11111111 011110 0 1124889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.66 Aligned_cols=262 Identities=27% Similarity=0.453 Sum_probs=204.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
....|.....||+|+||.||+|++. .++..||+|.+..... ....|+..+++++||||+++
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~------------------~~~~~~~~l~~l~HpnIv~~ 748 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNS------------------IPSSEIADMGKLQHPNIVKL 748 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCcc------------------ccHHHHHHHhhCCCCCcceE
Confidence 3456777889999999999999864 3889999998743211 11235788899999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++|+|.++++ .+++..+..++.|++.|++|||....++++||||||+||+++.++.
T Consensus 749 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~ 821 (968)
T PLN00113 749 IGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE 821 (968)
T ss_pred EEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc
Confidence 999999999999999999999999993 2789999999999999999999665567999999999999998888
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
.++. ++........ ....+++.|+|||++.+..++.++||||||+++|||++|+.||..... ......++.
T Consensus 822 ~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~ 892 (968)
T PLN00113 822 PHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWA 892 (968)
T ss_pred eEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHH
Confidence 7765 5544322111 122568899999999998999999999999999999999999864332 233455555
Q ss_pred HHHhhcCCCCccccccccC--CChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIG--NGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+...........+++.+.. .....+...+.+++.+||+.||++|||+.++++.|+++
T Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 893 RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 5444333333333333321 23345667789999999999999999999999999876
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=276.24 Aligned_cols=262 Identities=23% Similarity=0.269 Sum_probs=194.0
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|+..+.||.|++|.||+|++. .+|+.|++|.+....... .....+.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 67 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETE------------GVPSTAIREISLLKELNHPNIVKLLDV 67 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC-CCCCEEEEEEcccccccc------------ccchHHHHHHHHHHhcCCCCCcchhhh
Confidence 5889999999999999999865 478999999874332111 113568889999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.++...++++||+. ++|.+++.. .....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l 141 (284)
T cd07860 68 IHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKL 141 (284)
T ss_pred cccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence 999999999999995 589888854 2345689999999999999999999955 5999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
+|||++.......... ....++..|+|||.+.+.. ++.++|+||||+++|++++|..||....... ...+....
T Consensus 142 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~ 216 (284)
T cd07860 142 ADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRT 216 (284)
T ss_pred eeccchhhcccCcccc--ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHH
Confidence 9999987654322111 1234578899999887654 5888999999999999999999986532211 11111100
Q ss_pred HhhcCCCCccc--------------c---ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTI--------------D---SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~--------------~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+.+.... . ........+.....+.++|.+||+.||++|||+.++++
T Consensus 217 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 217 ---LGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ---hCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000 0 00000001112244789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=275.51 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=196.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
...|+....||.|+||.||+|.+. .++..|++|.+...... ....+.+|+..++.++|||+++++
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~--------------~~~~~~~e~~~l~~l~hp~i~~~~ 84 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQ--------------RRELLFNEVVIMRDYQHQNVVEMY 84 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEc-CCCCEEEEEEEEecccc--------------hHHHHHHHHHHHHhCCCCchhhhh
Confidence 355666778999999999999865 47899999987432211 134678899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+..++..++++||+++++|..++. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~iv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~ 156 (297)
T cd06659 85 KSYLVGEELWVLMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRV 156 (297)
T ss_pred hheeeCCeEEEEEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcE
Confidence 99999999999999999999998773 245889999999999999999999554 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
+|+|||++.......... ....++..|+|||++.+..++.++|+||||+++++|++|..||..... .....
T Consensus 157 kL~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~ 227 (297)
T cd06659 157 KLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMK 227 (297)
T ss_pred EEeechhHhhcccccccc--cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence 999999986554322211 134678899999999888899999999999999999999999864321 11111
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........... ........+.+++.+||+.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 228 RLRDSPPPKLK--------NAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHhccCCCCcc--------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 11111111100 01112234789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.21 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=198.2
Q ss_pred ccccccccccccceEEeeeecCCC---CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSS---GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
+.+.+.||.|+||.||.+.+.... +..+++|......... ....+..|+..+..++|+||++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~l~~l~~~~i~~~~ 67 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-------------QIEEFLREARIMRKLDHPNIVKLL 67 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-------------HHHHHHHHHHHHHhcCCCchheEE
Confidence 457789999999999999876422 4889999985432211 256788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+.+..+++|||+++++|.+++..... ..+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.+
T Consensus 68 ~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~ 142 (258)
T smart00219 68 GVCTEEEPLMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVV 142 (258)
T ss_pred EEEcCCCeeEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeE
Confidence 999999999999999999999999854221 1289999999999999999999955 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++............ ...++..|+|||.+.+..++.++|+||||+++++|++ |..||.... . ....
T Consensus 143 ~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~----~---~~~~ 214 (258)
T smart00219 143 KISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS----N---EEVL 214 (258)
T ss_pred EEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----H---HHHH
Confidence 99999999876554332221 2236788999999988889999999999999999998 778876421 1 1112
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L 332 (337)
........... .......+.+++.+||+.+|++|||+.++++.|
T Consensus 215 ~~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 215 EYLKKGYRLPK----------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHhcCCCCCC----------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 22221111110 111334588999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=276.12 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=194.8
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIV 116 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~ 116 (337)
.+.+.|++.+.||.|+||.||+|.+. .+++.+++|....... ....+..|+.++..+ +|+|++
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~~~---------------~~~~~~~e~~~l~~~~~h~~i~ 76 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTED---------------EEEEIKLEINMLKKYSHHRNIA 76 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecChH---------------HHHHHHHHHHHHHHhcCCCcEE
Confidence 36799999999999999999999875 4889999998744321 134577888888888 799999
Q ss_pred hhhceeec------CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 117 PLLARVVR------PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 117 ~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
++++++.. ....+++|||+.+++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~n 151 (282)
T cd06636 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQN 151 (282)
T ss_pred EEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 99998853 45678999999999999998653 2345788888999999999999999554 9999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
|+++.++.++|+|||++........ ......++..|+|||.+. ...++.++|+||||+++|+|++|..||...
T Consensus 152 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 152 VLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred EEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 9999999999999999876542211 112346788999999875 345788999999999999999999999653
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
... ........... .. +. .......+.+++.+||+.||.+|||+.++++
T Consensus 230 ~~~-------~~~~~~~~~~~-~~-~~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 230 HPM-------RALFLIPRNPP-PK-LK-------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHH-------hhhhhHhhCCC-CC-Cc-------ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 211 00001111111 00 00 1112345899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=268.43 Aligned_cols=255 Identities=26% Similarity=0.365 Sum_probs=199.1
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||+|... .++..|++|.+...... ......+.+|+.+++.++|+||+++++.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~ 67 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDND------------PKTIKEIADEMKVLELLKHPNLVKYYGV 67 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccc------------hHHHHHHHHHHHHHHhCCCCChhheeee
Confidence 6889999999999999999865 47899999998544322 1226678999999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+......++++||+++++|.+++. ....+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl 140 (264)
T cd06626 68 EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKL 140 (264)
T ss_pred EecCCEEEEEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999984 3445888999999999999999999555 999999999999999999999
Q ss_pred ecccccccCCCCCcccc--cccccCcccccCCccccCCC---CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 202 SEFGLAKQIPNGRTRTT--TWSLAETVGYIAPECHQTVA---LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+|||++........... .....++..|+|||.+.+.. ++.++|+||||++++++++|..||..... .. .
T Consensus 141 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~-~ 214 (264)
T cd06626 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EF-Q 214 (264)
T ss_pred cccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hH-H
Confidence 99999877654322211 11245678999999988766 88999999999999999999999965321 11 1
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..........+. +.. .......+.+++.+||+.+|.+|||+.+++.
T Consensus 215 ~~~~~~~~~~~~--~~~------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 215 IMFHVGAGHKPP--IPD------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHhcCCCCC--CCc------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111111111 000 1111344789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=270.10 Aligned_cols=255 Identities=28% Similarity=0.392 Sum_probs=204.0
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|++|.||+|.+.. +++.|++|++...... .....+.+|+..+..++|+|++++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDE-------------EFRKQLLRELKTLRSCESPYVVKCYG 66 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcch-------------HHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 478999999999999999998764 7999999998544321 12567889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+..+...++++||+++++|.+++.. ...+++..++.++.|++.++.|||+. .+++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~ 140 (264)
T cd06623 67 AFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVK 140 (264)
T ss_pred EEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999943 36689999999999999999999950 4599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||.+.......... ....++..|+|||.+....++.++|+||||+++|++++|..||..... ....+....
T Consensus 141 l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~ 214 (264)
T cd06623 141 IADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQA 214 (264)
T ss_pred EccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHH
Confidence 99999987765433322 123567889999999988899999999999999999999999875432 122222222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+. .+. . .....+.+++..||+.+|++|||+.++++
T Consensus 215 ~~~~~~~~--~~~----~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 215 ICDGPPPS--LPA----E---EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HhcCCCCC--CCc----c---cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 22211111 110 0 02345899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.51 Aligned_cols=282 Identities=17% Similarity=0.216 Sum_probs=191.7
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchh---hHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKS---EAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
.++|++++.||+|+||+||++..+...+...+.|.+...... ......+...........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 478999999999999999999866444444444422211110 00111111111122356788999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG-RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
++++++.+.+..+++++++. ++|.+++...... ........+..++.||+.||.|||+++ ++||||||+||+++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 99999999999999999994 5777776432211 222345667789999999999999555 999999999999999
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCC-CCCcccccccchH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP-SDDFFQHTKEMSF 274 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~p-f~~~~~~~~~~~~ 274 (337)
++.+||+|||++..+....... .....||..|+|||++.+..++.++|||||||++|||++|..+ |... .......+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~-~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG-GGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC-CCCHHHHH
Confidence 9999999999998765432221 1235789999999999999999999999999999999998854 4322 11111222
Q ss_pred HHHHHHHhhcCCCCcccccc-----------cc---CCChH------HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSK-----------LI---GNGYE------EQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~-----------~~---~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+.+.... .....+... .. ....+ ....++.+++.+||+.||.+|||+.|+++
T Consensus 381 ~~~~~~~~---~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLS---VCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcc---cChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 22111110 000000000 00 00000 01234678899999999999999999986
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=271.14 Aligned_cols=242 Identities=18% Similarity=0.256 Sum_probs=182.7
Q ss_pred ccccccccceEEeeeecCC------CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 47 EKIRSCWNGEVYKAELPGS------SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
+.||.|+||.||+|..... ....+++|....... ...+.+.+|+.++..++|||++++++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~iv~~~~ 66 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR--------------NYSESFFEAASMMSQLSHKHLVLNYG 66 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH--------------HHHHHHHHHHHHHHhCCCCChhheee
Confidence 4699999999999986421 123467776632211 11456788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc--
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME-- 198 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~-- 198 (337)
++..+...++||||+++++|.+++.. ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.
T Consensus 67 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~ 140 (258)
T cd05078 67 VCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRK 140 (258)
T ss_pred EEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccc
Confidence 99998999999999999999999853 233588999999999999999999955 5999999999999987665
Q ss_pred ------EEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCC-CCCCCcccccc
Q 036970 199 ------ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGK-FPSDDFFQHTK 270 (337)
Q Consensus 199 ------~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~-~pf~~~~~~~~ 270 (337)
++++|||.+....... ...++..|+|||++.+. .++.++|+||||+++|++++|. .||.....
T Consensus 141 ~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--- 211 (258)
T cd05078 141 TGNPPFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--- 211 (258)
T ss_pred cCCCceEEecccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---
Confidence 6899999876543221 23567889999998874 5788999999999999999995 56543221
Q ss_pred cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
..... ....... ++ ......+.+++.+||+.||++|||+.++++.|+
T Consensus 212 -~~~~~----~~~~~~~---~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 212 -QKKLQ----FYEDRHQ---LP--------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHHHH----HHHcccc---CC--------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 1111100 01 011234889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=275.37 Aligned_cols=266 Identities=22% Similarity=0.242 Sum_probs=196.4
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||+|.+. .+++.|++|.+........ .......+..|+.+++.++|+||++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~---------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 70 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEA---------KDGINFTALREIKLLQELKHPNIIGLLDV 70 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC-CCCcEEEEEEEeccccccc---------cchhhHHHHHHHHHHhhcCCCCChhhhhe
Confidence 5888999999999999999865 3789999999865433210 00113456789999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+....++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+. |++|+||+|+||+++.++.++|
T Consensus 71 ~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l 143 (298)
T cd07841 71 FGHKSNINLVFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKL 143 (298)
T ss_pred eecCCEEEEEEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEE
Confidence 99999999999999 8899999843 223689999999999999999999955 4999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
+|||++........... ...++..|+|||.+.+ ..++.++|+||||++++++++|.+||..... .........
T Consensus 144 ~dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~----~~~~~~~~~ 217 (298)
T cd07841 144 ADFGLARSFGSPNRKMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD----IDQLGKIFE 217 (298)
T ss_pred ccceeeeeccCCCcccc--ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc----HHHHHHHHH
Confidence 99999977654322111 2245778999998855 3578899999999999999999888764322 111111111
Q ss_pred HhhcCCCC---------ccc-----cccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPS---------RTI-----DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~---------~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........ ... ...............+.+++.+||+++|++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 218 ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 11000000 000 000000111223466899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=278.65 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=203.2
Q ss_pred hhhh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CC
Q 036970 35 AFLK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RH 112 (337)
Q Consensus 35 ~~l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 112 (337)
+++. ....|++++.||+||.+.||++... +.+.||+|.+.... ...+....+.+|+..|.+| .|
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s--~~~iyalkkv~~~~------------~D~qtl~gy~nEI~lL~KLkg~ 419 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNS--DKQIYALKKVVLLE------------ADNQTLDGYRNEIALLNKLKGH 419 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecC--CCcchhhhHHHHhh------------cCHHHHHHHHHHHHHHHHhcCC
Confidence 4556 6789999999999999999999754 67888888763322 2223377899999999999 59
Q ss_pred CChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
.+|+.+++|-..++.+||||||- ..+|..+++.. ....+.-.+..+..|++.++.++|+.+ |||.||||.|++
T Consensus 420 ~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFL 492 (677)
T KOG0596|consen 420 DKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFL 492 (677)
T ss_pred ceEEEEeeeeccCceEEEEeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEE
Confidence 99999999999999999999986 45899999542 233443477889999999999999554 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCC-----------CCCcccchhHhHHHHHHHhCCCC
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-----------LSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----------~~~~~DvwslG~vl~~l~~g~~p 261 (337)
+-. |.+||+|||.+..+....+.-.....+||+-||+||.+.... .+.++|||||||++|+|+.|+.|
T Consensus 493 lVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktP 571 (677)
T KOG0596|consen 493 LVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTP 571 (677)
T ss_pred EEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCc
Confidence 987 489999999999998888888888999999999999875432 45689999999999999999999
Q ss_pred CCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 262 SDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
|+... ...........+.-.+.-+-....+. ++++++.||..||.+|||+.++++
T Consensus 572 f~~~~---------n~~aKl~aI~~P~~~Iefp~~~~~~~-----li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 572 FGQII---------NQIAKLHAITDPNHEIEFPDIPENDE-----LIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hHHHH---------HHHHHHHhhcCCCccccccCCCCchH-----HHHHHHHHHhcCcccCCCcHHHhc
Confidence 97531 12222222222211111111111111 899999999999999999999985
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=265.17 Aligned_cols=252 Identities=23% Similarity=0.252 Sum_probs=203.0
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||++... .++..+++|.+........ ....+.+|+..++.++|+||+++++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMSQK------------EREDAVNEIRILASVNHPNIISYKEA 67 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhccHH------------HHHHHHHHHHHHHhCCCCCchhhhhh
Confidence 5889999999999999999865 4789999999854332211 14567789999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+....++++||+++++|.+++.........+++..++.++.|++.||.+||+. |++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl 144 (256)
T cd08530 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKI 144 (256)
T ss_pred hccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEE
Confidence 9999999999999999999999876555556789999999999999999999955 5999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||++........ ....++..|+|||...+..++.++|+||||++++++++|..||..... .+.....
T Consensus 145 ~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~ 213 (256)
T cd08530 145 GDLGISKVLKKNMA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-------QDLRYKV 213 (256)
T ss_pred eeccchhhhccCCc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence 99999877654411 123568899999999888889999999999999999999999865321 1111111
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+. .......++.+++.+||+.+|++|||+.++++
T Consensus 214 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 214 QRGKYPP----------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hcCCCCC----------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111111 11233455899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=275.44 Aligned_cols=265 Identities=18% Similarity=0.233 Sum_probs=193.7
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||.|++|.||+|... .+++.|++|.+....... ....+.+|+.+++.++|+||++++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i~~~~ 69 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEG-------------APFTAIREASLLKDLKHANIVTLH 69 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccC-------------CchhHHHHHHHHhhCCCcceeeEE
Confidence 478999999999999999999865 478999999985432110 023456799999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++|+||+.+ +|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~ 142 (291)
T cd07844 70 DIIHTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGEL 142 (291)
T ss_pred EEEecCCeEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCE
Confidence 999999999999999974 89988854 234688999999999999999999955 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++.......... ....++..|+|||++.+ ..++.++||||+|+++|+|++|..||...... .......
T Consensus 143 kl~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~ 217 (291)
T cd07844 143 KLADFGLARAKSVPSKTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV---EDQLHKI 217 (291)
T ss_pred EECccccccccCCCCccc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHH
Confidence 999999986543221111 11245778999998875 45788999999999999999999999653311 1111111
Q ss_pred HHHhhcCCCCc----------------cccccccCCChHHH--HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSR----------------TIDSKLIGNGYEEQ--MLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~--~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...+....... .............. ...+.+++.+||+.+|++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 11110000000 00000000000011 145789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=272.03 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=194.8
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC---CCChhhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR---HRNIVPL 118 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~ 118 (337)
.|++.+.||.|++|.||+|.+. .+++.|++|.+...... .....+.+|+.+++.++ |||++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~~~~vi~~ 67 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTPD-------------DDVSDIQREVALLSQLRQSQPPNITKY 67 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCCCc-------------hhHHHHHHHHHHHHHhccCCCCCeeeE
Confidence 5788999999999999999865 48899999987543211 11456778888888886 9999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++++||+++++|.+++.. ..+++..++.++.|++.++.|||+. |++|+||+|+||+++.++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~ 139 (277)
T cd06917 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGN 139 (277)
T ss_pred eeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCC
Confidence 9999999999999999999999998832 3689999999999999999999955 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++.......... ....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...... ..
T Consensus 140 ~~l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~ 210 (277)
T cd06917 140 VKLCDFGVAALLNQNSSKR--STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RA 210 (277)
T ss_pred EEEccCCceeecCCCcccc--ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hh
Confidence 9999999987765443222 234678889999988654 5688999999999999999999999753221 11
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..... ...+ +.+... .....+.+++.+||+.||++||++.++++
T Consensus 211 ~~~~~-~~~~-----~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 211 MMLIP-KSKP-----PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred hhccc-cCCC-----CCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11110 1111 111111 12345889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=269.63 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=198.2
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|.+.+.||+|++|.||+|... .+|..+++|.+........ ....+.+|+.+++.++|+|++++++.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~------------~~~~~~~E~~~l~~~~h~~i~~~~~~ 67 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVK------------EKEASKKEVILLAKMKHPNIVTFFAS 67 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc-CCCceEEEEEeeHhhccch------------hhHHHHHHHHHHHhCCCCChhhhhhe
Confidence 5888999999999999999865 4788999998854321111 14567889999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc-EE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME-AR 200 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~-~k 200 (337)
+.++...++++||+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++. ++
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~ 142 (257)
T cd08225 68 FQENGRLFIVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAK 142 (257)
T ss_pred eccCCeEEEEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEE
Confidence 99999999999999999999998542 2335789999999999999999999555 999999999999998754 69
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
++|||.+.......... ....|++.|+|||...+..++.++|+||||++++++++|..||.... ..+....
T Consensus 143 l~d~~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~ 213 (257)
T cd08225 143 LGDFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLK 213 (257)
T ss_pred ecccccchhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHH
Confidence 99999887664332211 12357888999999988889999999999999999999999986432 1222222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........ . .+.....+.+++.+||+.+|++|||+.++++
T Consensus 214 ~~~~~~~~--~--------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 214 ICQGYFAP--I--------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HhcccCCC--C--------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 22211110 0 1122345889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=301.98 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=191.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
-..+|+.++.||+||||.||+++++ -+|..||||++.... ... ....+.+|+..+.+|+||||+++
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNK-lDGr~YAIKKIpl~~-s~~------------~~skI~rEVk~LArLnHpNVVRY 542 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNK-LDGREYAIKKIPLKA-SDK------------LYSKILREVKLLARLNHPNVVRY 542 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeec-ccchhhhhhhccCch-HHH------------HHHHHHHHHHHHhhcCCcceeee
Confidence 3568899999999999999999976 499999999996654 211 15678999999999999999999
Q ss_pred hceeec--------------------------------------------------------------------------
Q 036970 119 LARVVR-------------------------------------------------------------------------- 124 (337)
Q Consensus 119 ~~~~~~-------------------------------------------------------------------------- 124 (337)
+..|.+
T Consensus 543 ysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d 622 (1351)
T KOG1035|consen 543 YSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDD 622 (1351)
T ss_pred ehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccc
Confidence 876543
Q ss_pred -------------------------------------C--------CCceEEEEeecCCCHHHHHHhhhcCCCcC-CHHH
Q 036970 125 -------------------------------------P--------DCDLLVYEFRRNGSLQDILYDVSQGRREL-DWLA 158 (337)
Q Consensus 125 -------------------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l-~~~~ 158 (337)
. ..+||-||||+...+.+++... ... ....
T Consensus 623 ~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~ 698 (1351)
T KOG1035|consen 623 SDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDE 698 (1351)
T ss_pred ccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHH
Confidence 0 1246789999887777777432 111 5778
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCC----C------------CCcccccccc
Q 036970 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP----N------------GRTRTTTWSL 222 (337)
Q Consensus 159 ~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~----~------------~~~~~~~~~~ 222 (337)
.|+++++|++||.|+|+. |++||||||.|||++..++|||+|||+++... . +.......+.
T Consensus 699 ~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~ 775 (1351)
T KOG1035|consen 699 AWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQ 775 (1351)
T ss_pred HHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccc
Confidence 899999999999999944 59999999999999999999999999998721 0 0111123367
Q ss_pred cCcccccCCccccCCC---CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCC
Q 036970 223 AETVGYIAPECHQTVA---LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNG 299 (337)
Q Consensus 223 ~g~~~y~aPE~~~~~~---~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (337)
.||..|+|||++.+.. |+.|+|+||||+|++||+. ||. ..++....+...- .+..+.. ..+
T Consensus 776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~------TsMERa~iL~~LR-~g~iP~~--~~f---- 839 (1351)
T KOG1035|consen 776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG------TSMERASILTNLR-KGSIPEP--ADF---- 839 (1351)
T ss_pred cceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC------chHHHHHHHHhcc-cCCCCCC--ccc----
Confidence 8899999999987764 9999999999999999994 454 3333333333322 2222211 111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 300 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......-..+|++|++.||++|||+.|++.
T Consensus 840 ~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 840 FDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 2222333578899999999999999999985
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=275.78 Aligned_cols=273 Identities=19% Similarity=0.229 Sum_probs=197.1
Q ss_pred cccccccccccccceEEeeeecCC-CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGS-SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
+|++.+.||+|++|.||+|..... ++..||+|.+...... .......+.+|+.++..++||||+++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-----------YTGISQSACREIALLRELKHENVVSLVE 69 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-----------ccCccHHHHHHHHHHHhcCCCCccceEE
Confidence 588899999999999999986532 6899999998653210 0111346778999999999999999999
Q ss_pred eeecC--CCceEEEEeecCCCHHHHHHhhhcCC-CcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC--
Q 036970 121 RVVRP--DCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-- 195 (337)
Q Consensus 121 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~-- 195 (337)
++.+. ...++|+||+++ +|.+++....... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.
T Consensus 70 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~ 145 (316)
T cd07842 70 VFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEG 145 (316)
T ss_pred EEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCC
Confidence 99988 778999999964 7877775544333 37899999999999999999999555 999999999999999
Q ss_pred --CCcEEEecccccccCCCCCc-ccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 196 --DMEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 196 --~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++.++|+|||++........ ........++..|+|||.+.+. .++.++|+||||+++++|++|..||.........
T Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~ 225 (316)
T cd07842 146 PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK 225 (316)
T ss_pred CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence 89999999999887644322 1122234568889999987764 5788999999999999999999999754332100
Q ss_pred ------chHHHHHHHHhhcCCC------------Cc---cccc-cccCCChH-------HHHHHHHHHHHHhcCCCCCCC
Q 036970 272 ------MSFVQWMRNVMTSENP------------SR---TIDS-KLIGNGYE-------EQMLLVLKIACFCTFDDPEER 322 (337)
Q Consensus 272 ------~~~~~~~~~~~~~~~~------------~~---~~~~-~~~~~~~~-------~~~~~l~~li~~~l~~~p~~R 322 (337)
......+ ..+..... .. .... ........ .....+.+++.+||+.||++|
T Consensus 226 ~~~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 304 (316)
T cd07842 226 SNPFQRDQLERIF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR 304 (316)
T ss_pred cchhHHHHHHHHH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccC
Confidence 0011110 00000000 00 0000 00000000 223458899999999999999
Q ss_pred CCHHHHHH
Q 036970 323 PNSKDVRC 330 (337)
Q Consensus 323 ps~~~il~ 330 (337)
||+.++++
T Consensus 305 ps~~eil~ 312 (316)
T cd07842 305 ITAEEALE 312 (316)
T ss_pred cCHHHHhc
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=269.12 Aligned_cols=254 Identities=25% Similarity=0.293 Sum_probs=193.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
+.+.+.....||+|+||.||+|++. .++..|++|........ ....+.+|+.+++.++|+||+++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~iv~~ 70 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDL-STQVRIAIKEIPERDSR--------------YVQPLHEEIALHSYLKHRNIVQY 70 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEec-CCCcEEEEEEecCCCHH--------------HHHHHHHHHHHHHhcCCCCeeee
Confidence 5666667789999999999999865 37888999987543321 14568899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcC--CHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC-
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRREL--DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD- 195 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~- 195 (337)
++++..++..++++||+++++|.+++... ..++ +...+..++.|++.||.|||+. |++|+||+|+||+++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~ 144 (268)
T cd06624 71 LGSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTY 144 (268)
T ss_pred eeeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCC
Confidence 99999999999999999999999998542 2234 7788889999999999999955 5999999999999986
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV--ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
++.++|+|||.+......... .....++..|+|||.+... .++.++|+||||+++|++++|..||...... .
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~ 218 (268)
T cd06624 145 SGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----Q 218 (268)
T ss_pred CCeEEEecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----h
Confidence 678999999998765432221 1123568899999998654 3788999999999999999999998643211 0
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............+ .+ +......+.+++.+||+.+|++|||+.++++
T Consensus 219 -~~~~~~~~~~~~~--~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 219 -AAMFKVGMFKIHP--EI--------PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -hhHhhhhhhccCC--CC--------CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0000000000000 00 1122344889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.63 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=197.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.+-|++.+.||.|+||.||+|.+. .++..+|+|........ .....+.+|+..++.++||||++++
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~ 68 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAE-------------DEIEDIQQEITVLSQCDSPYVTKYY 68 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEEC-CCCcEEEEEEeccccch-------------HHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 355788999999999999999864 37899999987432211 1145788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+.++...++|+||+++++|.+++. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~ 140 (277)
T cd06641 69 GSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEV 140 (277)
T ss_pred EEEEeCCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCE
Confidence 99999999999999999999999883 24588999999999999999999955 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
+++|||++......... .....++..|+|||.+.+..++.++|+||||++++++++|..||..... .....
T Consensus 141 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~ 211 (277)
T cd06641 141 KLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVLF 211 (277)
T ss_pred EEeecccceecccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHHH
Confidence 99999988765433221 1124568889999999888889999999999999999999999865321 11111
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......+. ++ ......+.+++.+||+.+|.+||++.++++
T Consensus 212 ~~~~~~~~~--~~--------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 212 LIPKNNPPT--LE--------GNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred HHhcCCCCC--CC--------cccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111111110 11 112344888999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=271.88 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=198.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||.|+||.||+|... .++..+++|.+...... ..+.+.+|+.+++.++|||++++
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~--------------~~~~~~~e~~~l~~l~hp~i~~~ 81 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQQP--------------KKELIINEILVMRENKHPNIVNY 81 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEeccccch--------------HHHHHHHHHHHHhhcCCCCeeeh
Confidence 4589999999999999999999754 47889999987432111 14567889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+......++|+||+++++|.+++.. ..+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~ 153 (293)
T cd06647 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGS 153 (293)
T ss_pred hheeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCC
Confidence 9999999999999999999999999832 3478889999999999999999955 4999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++.......... ....+++.|+|||.+....++.++|+||||+++|++++|..||........ .
T Consensus 154 ~kL~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-------~ 224 (293)
T cd06647 154 VKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------L 224 (293)
T ss_pred EEEccCcceeccccccccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-------e
Confidence 9999999887654332221 124578889999999888889999999999999999999999975322110 0
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
........+. ..........+.+++.+||..+|++||++.+++..
T Consensus 225 ~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 225 YLIATNGTPE--------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred eehhcCCCCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011110 01111223458899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=266.72 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=194.1
Q ss_pred ccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCc
Q 036970 49 IRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD 128 (337)
Q Consensus 49 lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 128 (337)
||.|++|.||+|++. .+++.+++|.+....... ......+.+|+.+++.++||||+++++.+.++...
T Consensus 1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (262)
T cd05572 1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVE-----------TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI 68 (262)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEEehhcchh-----------hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc
Confidence 699999999999875 378999999985433211 11245788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
++++||+++++|.+++.. ...++...+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~ 141 (262)
T cd05572 69 YMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK 141 (262)
T ss_pred EEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence 999999999999999943 34589999999999999999999955 49999999999999999999999999988
Q ss_pred cCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCC
Q 036970 209 QIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS 288 (337)
Q Consensus 209 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (337)
....... .....++..|+|||.+.+..++.++|+||||+++|++++|..||..... +............. .
T Consensus 142 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-~ 212 (262)
T cd05572 142 KLKSGQK---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNG-K 212 (262)
T ss_pred ccCcccc---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCC-C
Confidence 7654321 1124568889999999888899999999999999999999999975432 11122222221000 0
Q ss_pred ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 036970 289 RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVRC 330 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il~ 330 (337)
.. .+......+.+++.+||+.+|++||+ +.++++
T Consensus 213 ~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 213 LE--------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CC--------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 00 01111345899999999999999999 788776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=272.51 Aligned_cols=269 Identities=14% Similarity=0.140 Sum_probs=186.0
Q ss_pred cCcccccccccccccceEEeeeecCCC---CcEEEEEEeeccchhh-HHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSS---GRVITIKKVIQPLKSE-AELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~---~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.++|.+.+.||+|+||.||+|.+.. + +..+++|......... .+..... .........++..+..++|+|+
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~-~~~~~~~~~~k~~~~~~~~~~~e~~~~~----~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCAS-DHCINNQAVAKIENLENETIVMETLVYN----NIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcC-CcccccceEEEeccccCCchhhHHHHHH----hhhhHHHHHHHHHhccCCCCCC
Confidence 4789999999999999999998653 3 5567777543221100 0000000 0001223345566777899999
Q ss_pred hhhhceeecCC----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 116 VPLLARVVRPD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 116 ~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
+++++.+.... ..+++++++ ..++.+.+.. ....++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni 157 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI 157 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 99998665543 236777776 3467666632 233577888999999999999999554 99999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcc-----cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
+++.++.++|+|||++......... .......||+.|+|||++.+..++.++||||||+++++|++|..||....
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999766422111 11123468999999999999999999999999999999999999997652
Q ss_pred cccccc--hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 267 QHTKEM--SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 267 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
...... ...+........... .+.....+.+++..|++.+|++||++.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLHEGKIK------------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred cchHHHHHhHHHHHHHhhhhhhc------------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 211111 111122222111110 0111244889999999999999999999999874
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=275.12 Aligned_cols=273 Identities=20% Similarity=0.264 Sum_probs=196.7
Q ss_pred hhhhhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC
Q 036970 33 DLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112 (337)
Q Consensus 33 ~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 112 (337)
+..+.+..++|.+.+.||.|++|.||+|... .+++.||+|.+....... .....+.+|+.++++++|
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~------------~~~~~~~~e~~~l~~l~h 70 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKE------------GFPITALREIKILQLLKH 70 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcC------------CchhHHHHHHHHHHhCCC
Confidence 3456667789999999999999999999865 489999999885432111 012345679999999999
Q ss_pred CChhhhhceeecCCC--------ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 036970 113 RNIVPLLARVVRPDC--------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~--------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~ 184 (337)
|||+++++++..... .++|+||+. ++|.+.+.. ....+++..++.++.|++.||.|||++ +++|+
T Consensus 71 ~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~ 143 (310)
T cd07865 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHR 143 (310)
T ss_pred CCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---Ceecc
Confidence 999999998876543 389999995 478887733 334689999999999999999999955 49999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCCCcc--cccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCC
Q 036970 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTR--TTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 185 di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~p 261 (337)
||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..|
T Consensus 144 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 144 DMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred CCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999998765432211 111123567889999988664 368899999999999999999999
Q ss_pred CCCcccccccchHHHHHHHHhhcCCCCccccc----------cccCCC---------hHHHHHHHHHHHHHhcCCCCCCC
Q 036970 262 SDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS----------KLIGNG---------YEEQMLLVLKIACFCTFDDPEER 322 (337)
Q Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~---------~~~~~~~l~~li~~~l~~~p~~R 322 (337)
|...... .....+..... ..+....+. ...... .......+.++|.+||+.||.+|
T Consensus 224 ~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R 298 (310)
T cd07865 224 MQGNTEQ----HQLTLISQLCG-SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKR 298 (310)
T ss_pred CCCCCHH----HHHHHHHHHhC-CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhc
Confidence 8754321 11111111111 000000000 000000 00012347789999999999999
Q ss_pred CCHHHHHH
Q 036970 323 PNSKDVRC 330 (337)
Q Consensus 323 ps~~~il~ 330 (337)
||+.++++
T Consensus 299 ~t~~e~l~ 306 (310)
T cd07865 299 IDADTALN 306 (310)
T ss_pred cCHHHHhc
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=274.28 Aligned_cols=265 Identities=22% Similarity=0.226 Sum_probs=195.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
-++|++.+.||.|++|.||+|.+. .+++.+++|.+....... .....+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~ni~~~~ 70 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEKE------------GFPITSLREINILLKLQHPNIVTVK 70 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccccc------------cchhhHHHHHHHHHhcCCCCEEEEE
Confidence 368999999999999999999865 478999999985443211 0133567899999999999999999
Q ss_pred ceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 120 ARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 120 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++... ...++++||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 71 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~ 143 (293)
T cd07843 71 EVVVGSNLDKIYMVMEYVE-HDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRG 143 (293)
T ss_pred EEEEecCCCcEEEEehhcC-cCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCC
Confidence 998877 78899999996 489888854 2236899999999999999999999555 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
.++|+|||++.......... ....++..|+|||.+.+.. ++.++|+||||+++++|++|..||....... ....
T Consensus 144 ~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~---~~~~ 218 (293)
T cd07843 144 ILKICDFGLAREYGSPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID---QLNK 218 (293)
T ss_pred cEEEeecCceeeccCCcccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHH
Confidence 99999999988765432211 1234578899999887644 6889999999999999999999997543211 1111
Q ss_pred HHHHHhhc-----------------CCCCccccccccCCChHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTS-----------------ENPSRTIDSKLIGNGYEE-QMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+...+.. ..........+....... ....+.+++.+||+.+|++|||+.++++
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 219 -IFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred -HHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 1000000 000000000000001111 2455889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=273.19 Aligned_cols=269 Identities=26% Similarity=0.357 Sum_probs=201.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhc--CCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAG--QVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~ni~~ 117 (337)
....+....+|+|.||.||+|.+ +++.||||++.... .+.+.+|-.+.+ .|.|+||++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL---~~~~VAVKifp~~~-----------------kqs~~~Ek~Iy~lp~m~h~nIl~ 268 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL---DNRLVAVKIFPEQE-----------------KQSFQNEKNIYSLPGMKHENILQ 268 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc---cCceeEEEecCHHH-----------------HHHHHhHHHHHhccCccchhHHH
Confidence 45567789999999999999998 57999999984322 345555555554 458999999
Q ss_pred hhceeecCC----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeCCCC
Q 036970 118 LLARVVRPD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMS------HRPRIIHRDIQ 187 (337)
Q Consensus 118 ~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~------~~~~~~h~di~ 187 (337)
|++.-.... .+++|++|.+.|||.+++ ....++|....+++..++.||+|||+. .+++|+|||||
T Consensus 269 Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlk 343 (534)
T KOG3653|consen 269 FIGAEKRGTADRMEYWLVTEFHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLK 343 (534)
T ss_pred hhchhccCCccccceeEEeeeccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccccc
Confidence 998766554 789999999999999999 445689999999999999999999964 36789999999
Q ss_pred CCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCC-CC-----CcccchhHhHHHHHHHhCCCC
Q 036970 188 PANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-LS-----DKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 188 ~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-----~~~DvwslG~vl~~l~~g~~p 261 (337)
..|||+..++.+.|+|||++..+.............||.+|||||++.+.- +. .+.||||+|.|+||+++...-
T Consensus 344 SkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~ 423 (534)
T KOG3653|consen 344 SKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTD 423 (534)
T ss_pred ccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccc
Confidence 999999999999999999999887554444444579999999999987752 22 258999999999999997654
Q ss_pred CCCcccccc----------cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 262 SDDFFQHTK----------EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 262 f~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
+.....++. .+.+.+....++..+.-+. +...-... .-...+.+.+..||..||+.|.|+.=+-+.
T Consensus 424 ~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~-~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 424 ADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPK-IPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred ccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCC-ChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 432112222 2223333333332222111 11111111 224558999999999999999999999999
Q ss_pred HhhhhC
Q 036970 332 LSQIQH 337 (337)
Q Consensus 332 L~~~~~ 337 (337)
+.++.+
T Consensus 500 ~~~l~~ 505 (534)
T KOG3653|consen 500 MAELMM 505 (534)
T ss_pred HHHHhc
Confidence 988753
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=270.59 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=195.5
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLL 119 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~ 119 (337)
++|...+.||.|+||.||++.+. .++..+++|.+...... .....+.+|+..+.++. |+||++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~~iv~~~ 69 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDE-------------KEQKRLLMDLDVVMRSSDCPYIVKFY 69 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhccCh-------------HHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 46778899999999999999865 47899999988543221 11456788999999995 99999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhh-hcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDV-SQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+++..+...++++||+. +++.++.... ......+++..+..++.|++.||+|||+. .+++|+||+|+||+++.++.
T Consensus 70 ~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~ 146 (288)
T cd06616 70 GALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGN 146 (288)
T ss_pred eEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCc
Confidence 99999889999999985 4666654321 12346789999999999999999999953 14999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC---CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV---ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++|+|||++.......... ...++..|+|||.+.+. .++.++|+||||+++|++++|..||.... ...
T Consensus 147 ~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~ 217 (288)
T cd06616 147 IKLCDFGISGQLVDSIAKT---RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVF 217 (288)
T ss_pred EEEeecchhHHhccCCccc---cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHH
Confidence 9999999987654332221 23568889999998776 68899999999999999999999986532 111
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+.+........+. +...........+.+++.+||+++|++|||+.+|++
T Consensus 218 ~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 218 DQLTQVVKGDPPI------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHhhhcCCCCCc------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2222222111111 111111223445899999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=271.73 Aligned_cols=251 Identities=26% Similarity=0.349 Sum_probs=195.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
...+|++.+.||+|++|+||+|... .+++.|++|.+....... .+....+.+|+.+++.++|||++++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~-----------~~~~~~~~~Ei~~l~~l~h~niv~~ 80 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQQLRHPNTIEY 80 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCc-----------HHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 5678999999999999999999865 478999999885432211 1124568899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++|+||+. +++.+++.. ..+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~ 153 (307)
T cd06607 81 KGCYLREHTAWLVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGT 153 (307)
T ss_pred EEEEEeCCeEEEEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCC
Confidence 999999999999999996 577777643 2346899999999999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++|+|||++....... ...++..|+|||++. ...++.++||||||+++|++++|..||..... .
T Consensus 154 ~kL~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-------~ 220 (307)
T cd06607 154 VKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------M 220 (307)
T ss_pred EEEeecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-------H
Confidence 9999999886543221 235678899999874 34678899999999999999999999864321 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...........+. .........+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 221 SALYHIAQNDSPT---------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred HHHHHHhcCCCCC---------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1111111111111 011123345899999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=265.02 Aligned_cols=239 Identities=20% Similarity=0.309 Sum_probs=184.1
Q ss_pred ccccccccceEEeeeecCCCC----------cEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 47 EKIRSCWNGEVYKAELPGSSG----------RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
+.||+|+||.||+|.+.. .+ ..+++|........ ...+.+|+.+++.++||||+
T Consensus 1 ~~lg~G~~~~v~~~~~~~-~~~~~~~~~~~~~~v~~k~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~ 64 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRV-QSDLDIVGPGQEVSVVLKVLGSDHRD---------------SLAFFETASLMSQLSHKHLV 64 (259)
T ss_pred CcccccccceEEEEEEec-cCCccccCCccceeeeeeccccchhh---------------HHHHHHHHHHHHcCCCcchh
Confidence 468999999999999763 33 24667765322110 35678899999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.. ...++++||+++++|.+++... ...+++..+..++.||+.||.|||+. +++|+||||+||+++.+
T Consensus 65 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~ 137 (259)
T cd05037 65 KLYGVCVR-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARY 137 (259)
T ss_pred heeeEEec-CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecC
Confidence 99999988 7789999999999999998542 22688999999999999999999955 49999999999999987
Q ss_pred C-------cEEEecccccccCCCCCcccccccccCcccccCCccccCC--CCCCcccchhHhHHHHHHHh-CCCCCCCcc
Q 036970 197 M-------EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV--ALSDKCDIYSFGVLLAVLMM-GKFPSDDFF 266 (337)
Q Consensus 197 ~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~vl~~l~~-g~~pf~~~~ 266 (337)
+ .++|+|||++....... ...++..|+|||++.+. .++.++|+||||++++++++ |..||....
T Consensus 138 ~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 138 GLNEGYVPFIKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred ccccCCceeEEeCCCCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 7 79999999987654311 23456779999998876 78899999999999999999 577776542
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
.. ....... ...... .+ ....+.+++.+||..+|++|||+.++++.|+
T Consensus 212 ~~----~~~~~~~---~~~~~~--~~----------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 212 SS----EKERFYQ---DQHRLP--MP----------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ch----hHHHHHh---cCCCCC--CC----------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11 1111111 111000 00 0145889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=262.21 Aligned_cols=277 Identities=20% Similarity=0.242 Sum_probs=202.3
Q ss_pred hccCcccccccccccccceEEeeeecCCCC---cEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSG---RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
+-...|+....||+|++|.||+|...+.++ +.+|||.+...... .......-+|+.+++.++|||
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~------------tGiS~SAcREiaL~REl~h~n 88 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG------------TGISMSACREIALLRELKHPN 88 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC------------CCcCHHHHHHHHHHHHhcCCc
Confidence 345689999999999999999995443232 36899987433211 111345678999999999999
Q ss_pred hhhhhceeec-CCCceEEEEeecCCCHHHHHHhhhc-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 115 IVPLLARVVR-PDCDLLVYEFRRNGSLQDILYDVSQ-GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 115 i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++.+..++.. +...++++||+++ +|...|+-++. ..+.++...+.+++.||+.|+.|||+++ ++||||||.||+
T Consensus 89 vi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIl 164 (438)
T KOG0666|consen 89 VISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANIL 164 (438)
T ss_pred chhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEE
Confidence 9999999887 7889999999987 79998876654 3467899999999999999999999999 999999999999
Q ss_pred ecCC----CcEEEecccccccCCCCCccc-ccccccCcccccCCccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 193 IDDD----MEARISEFGLAKQIPNGRTRT-TTWSLAETVGYIAPECHQTVA-LSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 193 ~~~~----~~~kl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
+..+ |.|||+|+|+++.+.+.-..- ......-|.+|+|||.+.+.. |+.+.|+|+.||++.||++..+.|.+..
T Consensus 165 vmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 165 VMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred EeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9877 899999999999886653322 333456699999999998875 8999999999999999999999987643
Q ss_pred cccccc-h--HHHH--HHHHhhcCCCCcc-----ccc------cccCCChHHH------------HHHHHHHHHHhcCCC
Q 036970 267 QHTKEM-S--FVQW--MRNVMTSENPSRT-----IDS------KLIGNGYEEQ------------MLLVLKIACFCTFDD 318 (337)
Q Consensus 267 ~~~~~~-~--~~~~--~~~~~~~~~~~~~-----~~~------~~~~~~~~~~------------~~~l~~li~~~l~~~ 318 (337)
...... + ..+. +-.++......+. ++. .+....++.. ....++|+..||+.|
T Consensus 245 ~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yD 324 (438)
T KOG0666|consen 245 EKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYD 324 (438)
T ss_pred hhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccC
Confidence 322111 1 1111 1111111100000 000 0000000110 122788999999999
Q ss_pred CCCCCCHHHHHH
Q 036970 319 PEERPNSKDVRC 330 (337)
Q Consensus 319 p~~Rps~~~il~ 330 (337)
|..|.|+++.++
T Consensus 325 P~kRIta~qAle 336 (438)
T KOG0666|consen 325 PIKRITAEQALE 336 (438)
T ss_pred chhhccHHHHhc
Confidence 999999999875
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=267.02 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=203.6
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|.+.+.||+|++|.||++.+. .++..+++|.+...... ......+.+|+..++.++|+|++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~~~~~~~~ 67 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMS------------EKEREDALNEVKILKKLNHPNIIKYYES 67 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCC------------hHHHHHHHHHHHHHHhcCCCChhheEEE
Confidence 5888999999999999999865 47899999998544321 1125568889999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+..+...++++||+++++|.+++.........+++..+..++.+++.||.+||+. |++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l 144 (258)
T cd08215 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKL 144 (258)
T ss_pred EecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEE
Confidence 9999999999999999999999976544457799999999999999999999955 5999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||.+........ ......+++.|+|||...+..++.++|+||+|++++++++|..||..... .......
T Consensus 145 ~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~ 215 (258)
T cd08215 145 GDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKI 215 (258)
T ss_pred CCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHH
Confidence 99999877654431 11234678889999999888899999999999999999999999864321 1222222
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... +. ......+.+++.+||+.+|++|||+.++++
T Consensus 216 ~~~~~~~--~~--------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 216 LKGQYPP--IP--------SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred hcCCCCC--CC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2211111 11 112244889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=270.55 Aligned_cols=266 Identities=21% Similarity=0.245 Sum_probs=193.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLL 119 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~ 119 (337)
++|++.+.||.|+||.||+|++. .+++.|++|......... .....+.+|+.+++.+. ||||++++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~~i~~~~ 67 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDEE------------GIPPTALREISLLQMLSESIYIVRLL 67 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhcccc------------CCchHHHHHHHHHHHccCCCCcccee
Confidence 47999999999999999999865 378999999874432110 11346778999999994 69999999
Q ss_pred ceeecCCC-----ceEEEEeecCCCHHHHHHhhhcC-CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 120 ARVVRPDC-----DLLVYEFRRNGSLQDILYDVSQG-RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 120 ~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++..... .++++||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +++|+||+|+||++
T Consensus 68 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~ 143 (295)
T cd07837 68 DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLV 143 (295)
T ss_pred eeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEE
Confidence 98887665 7999999975 898888654332 45689999999999999999999955 59999999999999
Q ss_pred cC-CCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 194 DD-DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 194 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
+. ++.++|+|||++........... ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 144 ~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-- 219 (295)
T cd07837 144 DKQKGLLKIADLGLGRAFSIPVKSYT--HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-- 219 (295)
T ss_pred ecCCCeEEEeecccceecCCCccccC--CcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--
Confidence 98 88999999999876533211111 2245778999998765 457899999999999999999999986532211
Q ss_pred chHHHHHHHHhhcCCCCccc---------------cccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTI---------------DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... ... ....... .+.......+.....+.++|.+||++||++|||+.+++.
T Consensus 220 -~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 220 -QLLHIFK-LLG-TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred -HHHHHHH-HhC-CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1111111 000 0000000 000000001123455889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=264.57 Aligned_cols=254 Identities=25% Similarity=0.319 Sum_probs=202.2
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|...+.||+|++|.||+|.... +++.+++|........ ......+.+|+..+++++|+||+++++.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDS------------EEELEALEREIRILSSLQHPNIVRYYGS 67 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC-CCcEEEEEEeeccccc------------hHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 47888999999999999998653 7999999998554321 1225678999999999999999999999
Q ss_pred eecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 122 VVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 122 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.+. ...++++||+++++|.+++.. ...+++..++.++.|++.++.|||+. +++|+||+|+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~ 140 (260)
T cd06606 68 ERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVV 140 (260)
T ss_pred EecCCCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCE
Confidence 9988 888999999999999999843 33789999999999999999999955 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
+|+|||.+................++..|+|||.......+.++|+||||++++++++|..||.... .......
T Consensus 141 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~ 214 (260)
T cd06606 141 KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALY 214 (260)
T ss_pred EEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHH
Confidence 9999999887765433111223467889999999988889999999999999999999999997543 1111111
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........ .. .+......+.+++.+||+.+|++||++.++++
T Consensus 215 ~~~~~~~~-~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 215 KIGSSGEP-PE--------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred hccccCCC-cC--------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11110111 00 11112355999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=268.21 Aligned_cols=253 Identities=22% Similarity=0.278 Sum_probs=199.3
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLL 119 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~ 119 (337)
++|.+.+.||.|++|.||+|... .+|..|++|+........ ......+.+|+.+++.++ |+||++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~-----------~~~~~~~~~e~~~~~~l~~~~~i~~~~ 68 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIK-----------EKKVKYVKIEKEVLTRLNGHPGIIKLY 68 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhccc-----------hHHHHHHHHHHHHHHhcccCCCchhHH
Confidence 47999999999999999999865 489999999985532211 111456788999999998 99999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.++...+++||++++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~ 141 (280)
T cd05581 69 YTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHI 141 (280)
T ss_pred HHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCE
Confidence 999999999999999999999999843 347999999999999999999999555 9999999999999999999
Q ss_pred EEecccccccCCCCCcc------------------cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCC
Q 036970 200 RISEFGLAKQIPNGRTR------------------TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~p 261 (337)
+++|||++......... .......++..|+|||......++.++|+||||++++++++|..|
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p 221 (280)
T cd05581 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221 (280)
T ss_pred EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence 99999998766433221 112234567889999999888889999999999999999999999
Q ss_pred CCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH
Q 036970 262 SDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS----KDVRC 330 (337)
Q Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~il~ 330 (337)
|..... ............. + +......+.+++.+||+.+|++|||+ +++++
T Consensus 222 ~~~~~~-------~~~~~~~~~~~~~---~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 222 FRGSNE-------YLTFQKILKLEYS---F--------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCccH-------HHHHHHHHhcCCC---C--------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 875421 1111111111110 0 11113348899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=284.79 Aligned_cols=246 Identities=26% Similarity=0.325 Sum_probs=196.9
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD 126 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 126 (337)
-.||+|++|+||.|++. .+....|||.+.-....+ ...++.||.+.++|+|.||+++.|.+.+++
T Consensus 581 vVLGKGTYG~VYA~RD~-~tqvrIaIKEIpekdsr~--------------~QPLhEEIaLH~~LrHkNIVrYLGs~senG 645 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDM-DTQVRIAIKEIPEKDSRE--------------VQPLHEEIALHSTLRHKNIVRYLGSVSENG 645 (1226)
T ss_pred EEeecCceeEEEeeccc-cceeEEEeeecccccchh--------------hccHHHHHHHHHHHhhHhHHHHhhccCCCC
Confidence 36999999999999965 467778999884333221 456899999999999999999999999999
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcC--CHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec-CCCcEEEec
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRREL--DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISE 203 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~-~~~~~kl~D 203 (337)
..-|.||-++||+|.++++. +=+++ .+.++--+..||++||.|||++. |||||||-+|++++ ..|-+||+|
T Consensus 646 f~kIFMEqVPGGSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISD 719 (1226)
T KOG4279|consen 646 FFKIFMEQVPGGSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISD 719 (1226)
T ss_pred eEEEEeecCCCCcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecc
Confidence 99999999999999999965 33456 78888899999999999999666 99999999999997 678899999
Q ss_pred ccccccCCCCCcccccccccCcccccCCccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 204 FGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV--ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 204 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
||-+..+..-.. ....+.||..|||||++..+ .|..++|||||||++.||.||++||...-. .-..+++-.
T Consensus 720 FGTsKRLAginP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-----pqAAMFkVG 792 (1226)
T KOG4279|consen 720 FGTSKRLAGINP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS-----PQAAMFKVG 792 (1226)
T ss_pred cccchhhccCCc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC-----hhHhhhhhc
Confidence 999877653322 23356889999999998765 588999999999999999999999965321 111122111
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.-... ...+.+.+.....+|.+|+.+||.+||+++++++
T Consensus 793 myKvH----------P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 793 MYKVH----------PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ceecC----------CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11111 1124556777999999999999999999999875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=270.90 Aligned_cols=264 Identities=23% Similarity=0.247 Sum_probs=193.1
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhcee
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARV 122 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~ 122 (337)
|++.+.||.|++|.||+|.+. .+|..|++|++....... .....+.+|+..++.++|||++++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~iv~~~~~~ 67 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK-LTGEIVALKKIRLETEDE------------GVPSTAIREISLLKELNHPNIVRLLDVV 67 (283)
T ss_pred CchheEecCCCCeEEEEEEEc-CCCCEEEEEEeecccccc------------cchhHHHHHHHHHHhcCCCCccCHhhee
Confidence 678899999999999999865 389999999885432111 1134677899999999999999999999
Q ss_pred ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEe
Q 036970 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
.++...++++||++ ++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+
T Consensus 68 ~~~~~~~iv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~ 141 (283)
T cd07835 68 HSENKLYLVFEFLD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLA 141 (283)
T ss_pred ccCCeEEEEEeccC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEe
Confidence 99999999999995 6899988432 223689999999999999999999955 59999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 203 EFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
|||.+.......... ....++..|+|||++.+. .++.++|+||||+++|+|++|..||...... ..........
T Consensus 142 df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~ 216 (283)
T cd07835 142 DFGLARAFGVPVRTY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI---DQLFRIFRTL 216 (283)
T ss_pred ecccccccCCCcccc--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence 999987654322111 122457889999987664 4688999999999999999999998653221 1111111100
Q ss_pred hhcC-----------CC---CccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSE-----------NP---SRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~-----------~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.... .. .............+.....+.+++.+||+.+|++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 00 0000000000111122345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=270.57 Aligned_cols=266 Identities=18% Similarity=0.204 Sum_probs=192.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
+.++|.+.+.||.|+||.||+|... .+|..|++|.+....... ....+.+|+..++.++|+||+++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~ni~~~ 68 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEG-------------VPFTAIREASLLKGLKHANIVLL 68 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCC-------------CcHHHHHHHHHHHhcCCCCEeEE
Confidence 5689999999999999999999865 378899999984332110 12356789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++++||+. ++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~ 141 (291)
T cd07870 69 HDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGE 141 (291)
T ss_pred EEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCc
Confidence 999999999999999995 677777632 234578888889999999999999955 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++.......... ....++..|+|||.+.+. .++.++|+||||+++|++++|..||...... ...+.+
T Consensus 142 ~~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~- 216 (291)
T cd07870 142 LKLADFGLARAKSIPSQTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEK- 216 (291)
T ss_pred EEEeccccccccCCCCCCC--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHH-
Confidence 9999999987543322111 123468889999998764 5788999999999999999999999753221 000000
Q ss_pred HHHHhh-----------cCC--CCcccc---ccccCCC--hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMT-----------SEN--PSRTID---SKLIGNG--YEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~-----------~~~--~~~~~~---~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... ..+ ...... ....... .......+.+++.+|+..||++|||+.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 000 000000 0000000 0001245788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=275.68 Aligned_cols=266 Identities=22% Similarity=0.285 Sum_probs=194.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+. .+|+.||+|.+....... .....+.+|+.+++.++|+||+++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~ 80 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQNV------------THAKRAYRELVLMKLVNHKNIIGL 80 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccCh------------hHHHHHHHHHHHHHhcCCCCCcce
Confidence 4588999999999999999999865 489999999885432211 114467789999999999999999
Q ss_pred hceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++.... ..++|+||+. ++|.+.+.. .++...+..++.|++.||.|||+. |++|+||||+||+
T Consensus 81 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil 150 (353)
T cd07850 81 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIV 150 (353)
T ss_pred eeeeccCCCccccCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEE
Confidence 99886543 4689999995 588887732 178889999999999999999955 5999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc--
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK-- 270 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~-- 270 (337)
++.++.++|+|||++......... ....++..|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus 151 ~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 151 VKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred ECCCCCEEEccCccceeCCCCCCC---CCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999999999999765433221 123568889999999998999999999999999999999999965321100
Q ss_pred ---------cchHHHHH----HHHhhcCCCC------ccccccc----cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 036970 271 ---------EMSFVQWM----RNVMTSENPS------RTIDSKL----IGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327 (337)
Q Consensus 271 ---------~~~~~~~~----~~~~~~~~~~------~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 327 (337)
...+.... .......... ....... ...........+.+++.+||+.||++|||+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 307 (353)
T cd07850 228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307 (353)
T ss_pred HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence 00000000 0000000000 0000000 00001123455789999999999999999999
Q ss_pred HHH
Q 036970 328 VRC 330 (337)
Q Consensus 328 il~ 330 (337)
+++
T Consensus 308 iL~ 310 (353)
T cd07850 308 ALQ 310 (353)
T ss_pred Hhc
Confidence 985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=267.91 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=196.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
.+|...+.||.|++|.||+|... .++..+++|.+...... ....+.+|+.+++.++|||++++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~--------------~~~~~~~e~~~l~~~~h~~vv~~~~ 83 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDK-STGRQVAVKKMDLRKQQ--------------RRELLFNEVVIMRDYQHPNIVEMYS 83 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEEC-CCCCEEEEEEEeccchh--------------HHHHHHHHHHHHHHcCCCChheEEE
Confidence 46677789999999999999865 37889999987432211 1446788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++..++..++++||+.+++|.+++.. ..++...+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++
T Consensus 84 ~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~ 155 (285)
T cd06648 84 SYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVK 155 (285)
T ss_pred EEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEE
Confidence 99999999999999999999999843 45889999999999999999999554 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
++|||.+......... .....|+..|+|||...+..++.++|+||||+++|++++|..||..... ......
T Consensus 156 l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~ 226 (285)
T cd06648 156 LSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKR 226 (285)
T ss_pred EcccccchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHH
Confidence 9999987654432211 1234578899999999888899999999999999999999999864321 111222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+. . . ........+.+++.+||+.+|++|||+.++++
T Consensus 227 ~~~~~~~~-~-~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 227 IRDNLPPK-L-K------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHhcCCCC-C-c------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 21111111 0 0 01112245899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=268.01 Aligned_cols=248 Identities=26% Similarity=0.299 Sum_probs=189.7
Q ss_pred ccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCc
Q 036970 49 IRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD 128 (337)
Q Consensus 49 lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 128 (337)
||.|+||+||+|... .+|+.|++|.+........ .....+.+|+.+++.++|||++++++.+...+..
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 68 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLKKR-----------KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL 68 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhhhh-----------hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE
Confidence 689999999999755 4799999999854322111 1144567899999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
++|+||+++++|.+++... ....+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||.+.
T Consensus 69 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~ 143 (277)
T cd05577 69 CLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAV 143 (277)
T ss_pred EEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchh
Confidence 9999999999999998542 224689999999999999999999955 49999999999999999999999999887
Q ss_pred cCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCC
Q 036970 209 QIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS 288 (337)
Q Consensus 209 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (337)
........ ....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .............
T Consensus 144 ~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~-- 215 (277)
T cd05577 144 ELKGGKKI---KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---KEELKRRTLEMAV-- 215 (277)
T ss_pred hhccCCcc---ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---HHHHHhccccccc--
Confidence 65432111 123567789999999888899999999999999999999999965432111 1111111111000
Q ss_pred ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 289 RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
. .+......+.+++.+||+.+|++|| ++.+++.
T Consensus 216 -----~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 -----E----YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -----c----CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0 0111234488999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=273.44 Aligned_cols=259 Identities=20% Similarity=0.274 Sum_probs=190.0
Q ss_pred cccccc--ccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeec
Q 036970 47 EKIRSC--WNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124 (337)
Q Consensus 47 ~~lg~G--~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 124 (337)
..||+| ++|+||.|.+. .+|+.||+|+........ ...+.+.+|+.++..++||||+++++++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 70 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT-PTGTLVTVRITDLENCTE------------EHLKALQNEVVLSHFFRHPNIMTSWTVFTT 70 (328)
T ss_pred HHhCCcccCceeEEEEEEc-CCCcEEEEEEeccccCCH------------HHHHHHHHHHHHHHhCCCCCcceEeeeEec
Confidence 456766 99999999864 489999999985432211 125678889999999999999999999999
Q ss_pred CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecc
Q 036970 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 204 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Df 204 (337)
++..++++||+.+++|.+++.... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++++||
T Consensus 71 ~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~ 145 (328)
T cd08226 71 GSWLWVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGL 145 (328)
T ss_pred CCceEEEEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEech
Confidence 999999999999999999986532 23588999999999999999999955 4999999999999999999999999
Q ss_pred cccccCCCCCcc-----cccccccCcccccCCccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 205 GLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQTV--ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 205 g~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+........... .......++..|+|||++.+. .++.++|+||||+++|++++|..||....... .
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-------~ 218 (328)
T cd08226 146 SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-------M 218 (328)
T ss_pred HHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-------H
Confidence 755433211110 001112345679999998764 47889999999999999999999997543211 0
Q ss_pred HHHHhhcCC------------------------------------CCccccccccCCChHHHHHHHHHHHHHhcCCCCCC
Q 036970 278 MRNVMTSEN------------------------------------PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEE 321 (337)
Q Consensus 278 ~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 321 (337)
......... ....................+.+++++||+.||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 298 (328)
T cd08226 219 LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK 298 (328)
T ss_pred HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCccc
Confidence 000000000 00000011111122345567899999999999999
Q ss_pred CCCHHHHHH
Q 036970 322 RPNSKDVRC 330 (337)
Q Consensus 322 Rps~~~il~ 330 (337)
|||+.++++
T Consensus 299 Rpta~e~l~ 307 (328)
T cd08226 299 RPSASSLLS 307 (328)
T ss_pred CCCHHHHhh
Confidence 999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=269.12 Aligned_cols=268 Identities=21% Similarity=0.267 Sum_probs=195.6
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||+|++. .+|..|++|.+...... .....+.+|+.+++.++|+||+++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 66 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEE-------------GTPSTAIREISLMKELKHENIVRLHDV 66 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC-CCCeEEEEEEecccccc-------------cchHHHHHHHHHHHhhcCCCEeeeeee
Confidence 5889999999999999999865 47999999988543211 013456789999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+.+..++|+||+.+ +|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+++
T Consensus 67 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l 141 (284)
T cd07836 67 IHTENKLMLVFEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKL 141 (284)
T ss_pred EeeCCcEEEEEecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEE
Confidence 9999999999999975 8888875432 2356899999999999999999999554 999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH--
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM-- 278 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~-- 278 (337)
+|||++.......... ....++..|+|||.+.+. .++.++|+||||+++|++++|..||.+..............
T Consensus 142 ~d~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 219 (284)
T cd07836 142 ADFGLARAFGIPVNTF--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT 219 (284)
T ss_pred eecchhhhhcCCcccc--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 9999987554322111 123457889999988664 56889999999999999999999997543211100000000
Q ss_pred -----HHHhhcCC-CCccccc---cccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 -----RNVMTSEN-PSRTIDS---KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 -----~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...+.... ....+.. .......+.....+.+++..||+.||.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 220 PTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0000000 0000011223456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=283.86 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=210.0
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCc--EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGR--VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
+-..++....++||.|.||.|+.|.++..+|+ .||||.+....... .+..|.+|+.+|.+|+|+|
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-------------~mddflrEas~M~~L~H~h 172 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-------------IMDDFLREASHMLKLQHPH 172 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-------------hHHHHHHHHHHHHhccCcc
Confidence 44567778889999999999999999876665 47999885543321 3788999999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++||+..+ ....||+|.+..|+|.+.+++ .....+.....-.++.||+.|+.||.+++ +||||+...|+++.
T Consensus 173 liRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNllla 246 (1039)
T KOG0199|consen 173 LIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLA 246 (1039)
T ss_pred eeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheec
Confidence 9999999987 678899999999999999976 34556788888899999999999999666 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccc-cccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccc
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTT-TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEM 272 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~ 272 (337)
....|||+|||+.+.++......+ .....-+..|+|||.++...++.++|||++|+++|||++ |+.||-+...
T Consensus 247 sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----- 321 (1039)
T KOG0199|consen 247 SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----- 321 (1039)
T ss_pred ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----
Confidence 999999999999998875544332 222233678999999999999999999999999999998 5689976433
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
.+.+..+-.... -..+..++.++++++..||..+|++|||+..|.+.
T Consensus 322 --~qIL~~iD~~er----------LpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 322 --IQILKNIDAGER----------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred --HHHHHhcccccc----------CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 222222211111 12345567789999999999999999999999744
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.71 Aligned_cols=253 Identities=26% Similarity=0.326 Sum_probs=204.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
-.+.|+.-+.||+||||.|+..+.+ ++|+.||.|.+.+...... .......+|-.+|.+++.+-|+.+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvr-aTGKMYAcKkL~KKRiKkr-----------~ge~maLnEk~iL~kV~s~FiVsl 250 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVR-ATGKMYACKKLDKKRIKKR-----------KGETMALNEKQILEKVSSPFIVSL 250 (591)
T ss_pred cccceeeeEEEecccccceeEEEEe-cchhhHHHHHHHHHHHHHh-----------hhhHHhhHHHHHHHHhccCcEEEE
Confidence 3588999999999999999999865 5999999999865543221 124567789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
--.|+..+.+++|+..++||+|.-.|+++ +++.+++..+.-++.+|+.||++|| +.+||.||+||+|||+|+.|+
T Consensus 251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~Gh 325 (591)
T KOG0986|consen 251 AYAFETKDALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGH 325 (591)
T ss_pred eeeecCCCceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCC
Confidence 98999999999999999999999998764 4467999999999999999999999 555999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|+|++..+..+.... ...||.+|||||++.+..|+.+.|.|||||++|||+.|+.||....+..... +.-
T Consensus 326 vRISDLGLAvei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evd 399 (591)
T KOG0986|consen 326 VRISDLGLAVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVD 399 (591)
T ss_pred eEeeccceEEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHH
Confidence 9999999999987766554 3489999999999999999999999999999999999999997643321111 111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
+.++.... ..++..+.+..++.+..|.+||++|...
T Consensus 400 rr~~~~~~-----------ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 400 RRTLEDPE-----------EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHhcchh-----------hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 22221111 1123334456777777999999999754
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=267.17 Aligned_cols=260 Identities=21% Similarity=0.243 Sum_probs=198.0
Q ss_pred cccccccccccccceEEeeeec--CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPL 118 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~ 118 (337)
+|++.+.||.|++|.||+|+.. ..++..|++|.+........ ......+.+|+.++.++ +||||+++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~----------~~~~~~~~~E~~~l~~~~~~~~i~~~ 70 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQK----------AKTAEHTRTERQVLEAVRRCPFLVTL 70 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhh----------hhHHHHHHHHHHHHHhccCCcchhhh
Confidence 4788999999999999999753 23678899998854322111 11145678899999999 69999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+..+...++|+||+++++|.+++. ....+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~ 143 (288)
T cd05583 71 HYAFQTDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGH 143 (288)
T ss_pred heeeecCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCC
Confidence 999999999999999999999999883 335688999999999999999999955 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCC--CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA--LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
++|+|||++........... ....++..|+|||...+.. .+.++|+||||+++|+|++|..||...... ....+
T Consensus 144 ~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~ 219 (288)
T cd05583 144 VVLTDFGLSKEFLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ---NSQSE 219 (288)
T ss_pred EEEEECcccccccccccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc---chHHH
Confidence 99999999876543322111 1245788999999987654 788999999999999999999998642211 11122
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
..........+. +......+.+++.+||+.||++|||+.++.+.|+
T Consensus 220 ~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 220 ISRRILKSKPPF-----------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHHHHccCCCC-----------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 222222221111 0112234789999999999999999988877664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=263.43 Aligned_cols=249 Identities=25% Similarity=0.311 Sum_probs=193.0
Q ss_pred ccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCc
Q 036970 49 IRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD 128 (337)
Q Consensus 49 lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 128 (337)
||.|++|.||+|.+. .+|+.+++|.+....... ......+.+|+..+..++||||+++++.+..+...
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 68 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIR-----------KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL 68 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhhhh-----------hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE
Confidence 689999999999865 479999999885433211 12256788899999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
++++||+++++|.+++.. .+.+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~ 141 (265)
T cd05579 69 YLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSK 141 (265)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccch
Confidence 999999999999999854 23689999999999999999999955 59999999999999999999999999887
Q ss_pred cCCCCCc------ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHh
Q 036970 209 QIPNGRT------RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVM 282 (337)
Q Consensus 209 ~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (337)
....... ........++..|+|||.......+.++|+||||++++++++|..||..... .+......
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~ 214 (265)
T cd05579 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNIL 214 (265)
T ss_pred hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHh
Confidence 6543321 1112234567889999999888889999999999999999999999865321 12222222
Q ss_pred hcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 036970 283 TSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332 (337)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L 332 (337)
... ...... ......+.+++.+||+.+|.+|||+..+.+.|
T Consensus 215 ~~~-~~~~~~--------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 215 NGK-IEWPED--------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cCC-cCCCcc--------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 111 110000 00134588999999999999999995555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=272.76 Aligned_cols=266 Identities=24% Similarity=0.300 Sum_probs=193.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||.|++|.||+|.+. .+|..||+|.+....... .....+.+|+.++++++|+||+++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~ 71 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERD------------GIPISSLREITLLLNLRHPNIVEL 71 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCC------------CCcchhhHHHHHHHhCCCCCCcce
Confidence 4578999999999999999999865 489999999885332111 012245679999999999999999
Q ss_pred hceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 119 LARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 119 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++.+. +..++|+||+.+ +|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~ 144 (309)
T cd07845 72 KEVVVGKHLDSIFLVMEYCEQ-DLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDK 144 (309)
T ss_pred EEEEecCCCCeEEEEEecCCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 9998765 457999999964 88888754 2356899999999999999999999555 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+.++|+|||.+........... ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ...
T Consensus 145 ~~~kL~dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~----~~~ 218 (309)
T cd07845 145 GCLKIADFGLARTYGLPAKPMT--PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI----EQL 218 (309)
T ss_pred CCEEECccceeeecCCccCCCC--cccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHH
Confidence 9999999999887654321111 2234778999999865 45789999999999999999999999653221 111
Q ss_pred HHHHHHhhcCCC-----------Cccc--cccc---cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENP-----------SRTI--DSKL---IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~-----------~~~~--~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+......... ...+ .... ...........+.++|.+||+.||++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 219 DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111111100000 0000 0000 00000112345788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=263.79 Aligned_cols=247 Identities=21% Similarity=0.233 Sum_probs=185.9
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHH-HhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEII-TAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~ 125 (337)
+.||.|++|.||+|.+. .+|+.||+|.+......... ....+..|.. .....+|+|++++++.+..+
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 69 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIAKN-----------QVTNVKAERAIMMIQGESPYVAKLYYSFQSK 69 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhHHH-----------HHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC
Confidence 57999999999999865 47899999988543221111 0222334443 34455899999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++++||+++++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 70 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 142 (260)
T cd05611 70 DYLYLVMEYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFG 142 (260)
T ss_pred CeEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecc
Confidence 99999999999999999984 3356899999999999999999999554 9999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC
Q 036970 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285 (337)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
++...... ....++..|+|||.+.+..++.++|+||||+++|++++|..||..... ...........
T Consensus 143 ~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~ 209 (260)
T cd05611 143 LSRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-------DAVFDNILSRR 209 (260)
T ss_pred cceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcc
Confidence 88654331 123567889999999888889999999999999999999999965322 11111111111
Q ss_pred CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 036970 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332 (337)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L 332 (337)
... .... .......+.+++.+||+.+|++||++.++.+.|
T Consensus 210 ~~~---~~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 210 INW---PEEV----KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCC---CCcc----cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 100 0000 111234489999999999999999886665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=273.28 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=195.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||.|++|.||+|... .+|..|++|.+....... .....+.+|+.+++.++||||+++
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~ 69 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDVP------------TLAKRTLRELKILRHFKHDNIIAI 69 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeccccccc------------cchHHHHHHHHHHHhcCCCCccCH
Confidence 3578999999999999999999865 479999999885432111 114567789999999999999999
Q ss_pred hceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 119 LARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 119 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++.. ....++|+||+. ++|.+++ .....+++..++.++.|++.||.|||++ +++|+||+|+||+++
T Consensus 70 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~ 141 (334)
T cd07855 70 RDILRPPGADFKDVYVVMDLME-SDLHHII----HSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVN 141 (334)
T ss_pred HHhccccCCCCceEEEEEehhh-hhHHHHh----ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc
Confidence 998764 345789999995 5898887 3445699999999999999999999955 499999999999999
Q ss_pred CCCcEEEecccccccCCCCCccc--ccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 195 DDMEARISEFGLAKQIPNGRTRT--TTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
.++.++|+|||++.......... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.....
T Consensus 142 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-- 219 (334)
T cd07855 142 EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-- 219 (334)
T ss_pred CCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--
Confidence 99999999999987654332211 1113467889999998765 457899999999999999999999996543210
Q ss_pred chHHHHHHHHhhcCCCCcccc---------------cc--c-cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTID---------------SK--L-IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~---------------~~--~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....+.... ..++...+. .. . .....+.....+.+++++||+.+|++|||+.+++.
T Consensus 220 --~~~~~~~~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 220 --QLKLILSVL-GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred --HHHHHHHHh-CCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011111100 000000000 00 0 00001123456899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=265.81 Aligned_cols=254 Identities=27% Similarity=0.386 Sum_probs=201.9
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
+..+.|+....||.|++|.||+|.+. .++..+++|.+..... ....+.+|+..++.++|+|+++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~ 79 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDR-ATGKEVAIKKMRLRKQ---------------NKELIINEILIMKDCKHPNIVD 79 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEc-cCCcEEEEEEEecCch---------------hHHHHHHHHHHHHHCCCCCeeE
Confidence 36788999999999999999999875 3788999999854322 1456888999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++.+......++++||+++++|.+++.... ..+++..+..++.|++.+|.+||+ .|++|+||+|+||+++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~ 153 (286)
T cd06614 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDG 153 (286)
T ss_pred EEEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCC
Confidence 9999999999999999999999999995422 368999999999999999999995 4599999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|++++|..||...... ..
T Consensus 154 ~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~ 224 (286)
T cd06614 154 SVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RA 224 (286)
T ss_pred CEEECccchhhhhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HH
Confidence 9999999988655433221 11235678899999998888999999999999999999999998643221 11
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.........+.. .........+.+++.+||+.+|..|||+.++++
T Consensus 225 ~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 225 LFLITTKGIPPL--------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHhcCCCCC--------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111111111110 011112345889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=256.46 Aligned_cols=263 Identities=20% Similarity=0.297 Sum_probs=206.8
Q ss_pred chhhhhhhh--ccCccccc-ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHH
Q 036970 30 EKEDLAFLK--KEDCFASL-EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIIT 106 (337)
Q Consensus 30 ~~~~~~~l~--~~~~~~~~-~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 106 (337)
+...+.|-+ ..++|.+- ++||-|-.|.|-...++ .++..+|+|++... ....+|++.
T Consensus 48 ~~~~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k-~T~ekfALKvL~Ds-------------------~KARrEVeL 107 (400)
T KOG0604|consen 48 EESDMDFKEYSITEDYSISWQVLGAGINGKVVQCVHK-RTQEKFALKVLLDS-------------------PKARREVEL 107 (400)
T ss_pred hhhhcchhcccchhhheehhhhhccccCCceEEEEec-cchhhhHHHHHhcC-------------------HHHHhHhhh
Confidence 345566644 57889876 78999999999888755 59999999988433 245566665
Q ss_pred hcCC-CCCChhhhhceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 036970 107 AGQV-RHRNIVPLLARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRI 181 (337)
Q Consensus 107 l~~l-~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~ 181 (337)
.-.- .||||+.++++|+. ...+.+|||.++||.|+..+.+ .+.+.+++..+..++.||..|+.|||+.+ |
T Consensus 108 Hw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---I 182 (400)
T KOG0604|consen 108 HWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---I 182 (400)
T ss_pred hhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---h
Confidence 5444 69999999998865 3566899999999999999966 56678999999999999999999999666 9
Q ss_pred eeCCCCCCcEEecC---CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhC
Q 036970 182 IHRDIQPANVLIDD---DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMG 258 (337)
Q Consensus 182 ~h~di~~~nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g 258 (337)
.||||||+|+|... +..+||+|||++.......... ..+-|+.|.|||++...+|+..+|+||+|+++|-|++|
T Consensus 183 AHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~---TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCG 259 (400)
T KOG0604|consen 183 AHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLM---TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_pred hhccCChhheeeecCCCCcceEecccccccccCCCcccc---CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcC
Confidence 99999999999974 4568999999998766433322 23568999999999999999999999999999999999
Q ss_pred CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+||-..-.....+....-++...-. +....|+..+....++|+.+|+.+|++|.|+.++++
T Consensus 260 yPPFYS~hg~aispgMk~rI~~gqy~----------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 260 YPPFYSNHGLAISPGMKRRIRTGQYE----------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCcccccCCccCChhHHhHhhccCcc----------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 99997543322222222222221111 223457888899999999999999999999999874
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=265.07 Aligned_cols=256 Identities=21% Similarity=0.261 Sum_probs=195.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
.+|++.+.||+|++|.||+|++. .++..|++|......... ........+.+|+.+++.++|+||+++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~---------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 71 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQ---------ETSKEVNALECEIQLLKNLRHDRIVQYYG 71 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccc---------hhhHHHHHHHHHHHHHHHcCCCCcceEEE
Confidence 57999999999999999999865 479999999874322110 01122567889999999999999999999
Q ss_pred eeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 121 RVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 121 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
.+.+. ...++++||+++++|.+++. ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 72 ~~~~~~~~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~ 144 (264)
T cd06653 72 CLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGN 144 (264)
T ss_pred EEEcCCCCEEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCC
Confidence 88764 45789999999999999984 3345889999999999999999999555 999999999999999999
Q ss_pred EEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++......... .......++..|+|||.+.+..++.++|+||||++++++++|..||..... ...
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~ 217 (264)
T cd06653 145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAA 217 (264)
T ss_pred EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHH
Confidence 999999998765322111 111134578889999999988899999999999999999999999975321 111
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+....... ....+ +......+.+++.+||+ +|..||++.+++.
T Consensus 218 ~~~~~~~~-~~~~~--------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 IFKIATQP-TKPML--------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHcCC-CCCCC--------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11211111 11111 12233458899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.97 Aligned_cols=259 Identities=23% Similarity=0.241 Sum_probs=189.8
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhhce
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLLAR 121 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~ 121 (337)
|++.+.||.|++|.||+|... .++..|++|.......... .....+|+..++++. |+|+++++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~-------------~~~~~~e~~~l~~l~~h~~i~~~~~~ 66 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSLE-------------QVNNLREIQALRRLSPHPNILRLIEV 66 (282)
T ss_pred CceEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCch-------------hhhHHHHHHHHhhcCCCCCccceEEE
Confidence 678899999999999999865 4789999998754321110 123456888888884 9999999999
Q ss_pred eecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 122 VVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 122 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+.++ +..++|+||++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.+
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~ 138 (282)
T cd07831 67 LFDRKTGRLALVFELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DIL 138 (282)
T ss_pred EecCCCCcEEEEEecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCe
Confidence 9987 88899999996 578887743 2356899999999999999999999555 999999999999999 999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++.......... ...++..|+|||.+.. ..++.++|+||||+++|+|++|..||...... ......
T Consensus 139 kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~----~~~~~~ 211 (282)
T cd07831 139 KLADFGSCRGIYSKPPYT---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL----DQIAKI 211 (282)
T ss_pred EEEecccccccccCCCcC---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH----HHHHHH
Confidence 999999997764433222 2356888999997644 45788999999999999999999999653321 111111
Q ss_pred HHHhhc------------CCCCcccccccc---CCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTS------------ENPSRTIDSKLI---GNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~------------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... ............ ..........+.+++.+||+++|++|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 212 HDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 111100 000000000000 0001123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=259.91 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=199.8
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|.+.+.||.|++|.||+|... .+++.|++|......... .....+.+|+.++++++|+|+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKE------------EALKSIMQEIDLLKNLKHPNIVKYIGS 67 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccCH------------HHHHHHHHHHHHHHhCCCCCccEEEEE
Confidence 5888999999999999999865 478899999986543321 125678999999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.++...++++||+++++|.+++.. ...+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l 140 (254)
T cd06627 68 IETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKL 140 (254)
T ss_pred EEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999843 35689999999999999999999955 5999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||.+......... .....++..|+|||...+..++.++|+||+|++++++++|..||..... .......
T Consensus 141 ~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~~ 211 (254)
T cd06627 141 ADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFRI 211 (254)
T ss_pred eccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHH
Confidence 999999876544332 1234568889999999888889999999999999999999999864321 1111111
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+ .+. ......+.+++.+||..+|++|||+.+++.
T Consensus 212 ~~~~~~--~~~--------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 VQDDHP--PLP--------EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred hccCCC--CCC--------CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111111 111 111234889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=259.48 Aligned_cols=250 Identities=30% Similarity=0.428 Sum_probs=199.6
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|...+.||.|++|.||+|.+.. ++..+++|+...... .....+.+|+..++.++|+|++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~~~~ 65 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESK--------------EKKEKIINEIQILKKCKHPNIVKYYGS 65 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC-CCcEEEEEEecccch--------------hHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 47888999999999999998653 789999999855432 115678899999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+..+...++++||+++++|.+++.. ....+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|
T Consensus 66 ~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l 139 (253)
T cd05122 66 YLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKL 139 (253)
T ss_pred EecCCeEEEEEecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEE
Confidence 9999999999999999999999844 225789999999999999999999954 5999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||.+........ .....++..|+|||.+.+..++.++|+||||++++++++|..||..... . ......
T Consensus 140 ~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~---~~~~~~ 209 (253)
T cd05122 140 IDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP----M---KALFKI 209 (253)
T ss_pred eecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch----H---HHHHHH
Confidence 99999877654432 1234678899999999888889999999999999999999999875321 1 111111
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. ..... ... .......+.+++.+||+.||++|||+.++++
T Consensus 210 ~~-~~~~~-~~~------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 210 AT-NGPPG-LRN------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred Hh-cCCCC-cCc------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 11110 000 0111345889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=266.19 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=194.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
..|+....||+|++|.||+|... .++..|++|.+..... .....+.+|+.+++.++|+|++++++
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 84 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQ--------------QRRELLFNEVVIMRDYQHENVVEMYN 84 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEc-CCCeEEEEEEecccch--------------hHHHHHHHHHHHHHhcCCcchhheee
Confidence 34445578999999999999865 4899999998743221 11456889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+..++..+++|||+++++|.+++. ...+++..+..++.|++.++.|||+. |++|+||+|+||+++.++.++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~ 156 (292)
T cd06657 85 SYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVK 156 (292)
T ss_pred EEEeCCEEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999998772 24578999999999999999999955 499999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++......... .....++..|+|||.+.+..++.++|+||+|+++|++++|..||..... .........
T Consensus 157 l~dfg~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~~~~~ 230 (292)
T cd06657 157 LSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRD 230 (292)
T ss_pred Ecccccceeccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Confidence 9999988665432211 1234578899999999888889999999999999999999999864321 111111111
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. +.... ........+.+++.+||+.+|.+||++.++++
T Consensus 231 ~~---~~~~~--------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 231 NL---PPKLK--------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred hC---CcccC--------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11 10000 00112234788999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=273.17 Aligned_cols=266 Identities=20% Similarity=0.255 Sum_probs=193.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||.|++|.||+|.+. .+|+.|++|.+..... ......+.+|+.+++.++|+||+++
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~~ 68 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEH-------------QTFCQRTLREIKILRRFKHENIIGI 68 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEc-CCCCeEEEEEeccccc-------------chhHHHHHHHHHHHHhCCCCCcCch
Confidence 3578999999999999999999865 4889999998843111 0114567789999999999999999
Q ss_pred hceeecCC-----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 119 LARVVRPD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 119 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
++++.... ..++++||+. ++|.+.+ ..+.+++..++.++.|++.||.+||+.+ ++|+||+|+||++
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill 139 (336)
T cd07849 69 LDIIRPPSFESFNDVYIVQELME-TDLYKLI-----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLL 139 (336)
T ss_pred hheeecccccccceEEEEehhcc-cCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEE
Confidence 99876543 4689999995 4787777 2346899999999999999999999554 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCccc-ccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRT-TTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
+.++.++|+|||++.......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+...
T Consensus 140 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---- 215 (336)
T cd07849 140 NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---- 215 (336)
T ss_pred CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 999999999999987654322211 1123467889999998654 4688999999999999999999999964321
Q ss_pred chHHHHHHHHhhcCCCCc--------------ccc--ccc-cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSR--------------TID--SKL-IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~--------------~~~--~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
......+...+....... ..+ ... .....+.....+.+++.+||+.+|++|||+.++++-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011111111111000000 000 000 000011224558899999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=273.31 Aligned_cols=265 Identities=19% Similarity=0.263 Sum_probs=195.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||.|++|+||+|++. .++..|++|.+....... .....+.+|+.+++.++|+||+++
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~ni~~~ 69 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDNR------------IDAKRTLREIKLLRHLDHENVIAI 69 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEec-CCCCeEEEEEeccccccc------------chhHHHHHHHHHHHhcCCCCccch
Confidence 3568999999999999999999865 589999999875432111 113456789999999999999999
Q ss_pred hceeecCC-----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 119 LARVVRPD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 119 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
++++.... ..++++||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++
T Consensus 70 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~ 141 (337)
T cd07858 70 KDIMPPPHREAFNDVYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLL 141 (337)
T ss_pred HHheecccccccCcEEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEE
Confidence 99886543 4699999995 68888873 445699999999999999999999955 49999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
+.++.++|+|||++......... .....++..|+|||.+.. ..++.++|+||||+++|+|++|..||......
T Consensus 142 ~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---- 215 (337)
T cd07858 142 NANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---- 215 (337)
T ss_pred cCCCCEEECcCccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH----
Confidence 99999999999998776443211 112356888999998765 46889999999999999999999999653211
Q ss_pred hHHHHHHHHhhcCCCC------------------ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 273 SFVQWMRNVMTSENPS------------------RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
................ ....... ....+.....+.+++.+||+.+|++|||++++++-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 216 HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0011111111000000 0000000 00111234558899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=267.32 Aligned_cols=264 Identities=22% Similarity=0.220 Sum_probs=191.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++.+.||.|++|.||+|.+. .+|+.|++|.+....... .....+.+|+.+++.++||||+++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQEDE------------GVPSTAIREISLLKEMQHGNIVRLQD 68 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhccccc------------cchHHHHHHHHHHHhccCCCEeeEEE
Confidence 57999999999999999999865 378999999874332111 11356788999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC-CCcE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DMEA 199 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~ 199 (337)
++.++...++|+||++ ++|.+++.. .....+++..++.++.||+.||.|||++ +++|+||+|+||+++. ++.+
T Consensus 69 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~ 142 (294)
T PLN00009 69 VVHSEKRLYLVFEYLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNAL 142 (294)
T ss_pred EEecCCeEEEEEeccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEE
Confidence 9999999999999995 578777743 2223467888889999999999999955 4999999999999985 5679
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++.......... ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....... ...+..
T Consensus 143 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~ 217 (294)
T PLN00009 143 KLADFGLARAFGIPVRTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIF 217 (294)
T ss_pred EEcccccccccCCCcccc--ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 999999987654321111 123457889999988664 57889999999999999999999997532211 111110
Q ss_pred HHHhhcCCCCccc----------------cccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTI----------------DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... ..... .........+.....+.+++.+||+.+|++||++.++++
T Consensus 218 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 218 -RILGTP-NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred -HHhCCC-ChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00000 000000001122344889999999999999999999875
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=252.15 Aligned_cols=253 Identities=19% Similarity=0.337 Sum_probs=199.0
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLL 119 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~ 119 (337)
++.+.+..||.|..|.||+.+++. +|...|||.+.+....+ ...++...+.++..- +.|.|++.+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs-~~~iiAVK~M~rt~Nke-------------e~kRILmDldvv~~s~dcpyIV~c~ 157 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRS-TGHIIAVKQMRRTGNKE-------------ENKRILMDLDVVLKSHDCPYIVQCF 157 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcc-cceEEEEEeecccCCHH-------------HHHHHHHhhhHHhhccCCCeeeeee
Confidence 455667889999999999999874 89999999996654322 256677777777665 489999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
|+|..+...++-||.+ ..+++.++.. -.+++++...-++...++.||.||.+++ |++|||+||+|||++..|++
T Consensus 158 GyFi~n~dV~IcMelM-s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~Gni 231 (391)
T KOG0983|consen 158 GYFITNTDVFICMELM-STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNI 231 (391)
T ss_pred eEEeeCchHHHHHHHH-HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCE
Confidence 9999999999999988 4467776643 4456999999999999999999998765 89999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCC---CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV---ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
|++|||.+-.+..+..+. ...|.+.|||||.+... .|+.++||||||++++|+.||..||..-.. +. +
T Consensus 232 KlCDFGIsGrlvdSkAht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---dF---e 302 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSKAHT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---DF---E 302 (391)
T ss_pred Eeecccccceeecccccc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---cH---H
Confidence 999999998776554433 34678999999988654 689999999999999999999999976321 11 2
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+..+++..++. ++... ..+.++.+++..||++|+.+||...++++
T Consensus 303 ~ltkvln~ePP~--L~~~~------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 303 VLTKVLNEEPPL--LPGHM------GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHhcCCCC--CCccc------CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 233344433322 22111 13455888999999999999999999875
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=270.09 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=196.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
....|...+.||.|+||.||+|.+. .++..+++|.+....... ......+.+|+..++.++|||++++
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~ 90 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQS-----------NEKWQDIIKEVKFLQRIKHPNSIEY 90 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCCc-----------hHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 4567999999999999999999865 378999999885432211 1124578889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++|+||+.+ +|.+.+.. ...++++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.
T Consensus 91 ~~~~~~~~~~~lv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~ 163 (317)
T cd06635 91 KGCYLREHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQ 163 (317)
T ss_pred EEEEeeCCeEEEEEeCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCC
Confidence 9999999999999999964 77777643 345689999999999999999999955 4999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++|+|||++....... ...++..|+|||.+. ...++.++|+||||+++|+|++|..||..... .
T Consensus 164 ~kl~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~ 230 (317)
T cd06635 164 VKLADFGSASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------M 230 (317)
T ss_pred EEEecCCCccccCCcc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------H
Confidence 9999999876543221 235688899999874 44688899999999999999999999864321 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L 332 (337)
...........+.. ........+.+++.+||+.+|.+||++.++++..
T Consensus 231 ~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 231 SALYHIAQNESPTL---------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred HHHHHHHhccCCCC---------CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 11111111111110 0112234488999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=261.83 Aligned_cols=244 Identities=19% Similarity=0.221 Sum_probs=186.5
Q ss_pred cCcccccccc--cccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChh
Q 036970 40 EDCFASLEKI--RSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIV 116 (337)
Q Consensus 40 ~~~~~~~~~l--g~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~ 116 (337)
.++|.+.+.+ |.|+||.||++... .++..+++|......... . |+.....+ +|||++
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~--------------~-----e~~~~~~~~~h~~iv 72 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNA--------------I-----EPMVHQLMKDNPNFI 72 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEc-CCCcEEEEEEEehhhcch--------------h-----hHHHHHHhhcCCCEE
Confidence 4567777776 99999999999865 478999999985432111 0 11111112 699999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++.+..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.+
T Consensus 73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRA 145 (267)
T ss_pred EEEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCC
Confidence 999999999999999999999999999843 34789999999999999999999955 49999999999999988
Q ss_pred C-cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 M-EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+ .++|+|||++....... ...++..|+|||++.+..++.++|+||||+++|+|++|..||..... ......
T Consensus 146 ~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~ 217 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLE 217 (267)
T ss_pred CCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHH
Confidence 8 99999999987654322 23568899999999988899999999999999999999999974322 111222
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-SKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~il~ 330 (337)
.+.... . .... ........+.+++.+||+.+|..||+ ++++++
T Consensus 218 ~~~~~~-~-~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 218 SLLKRQ-Q-KKLP----------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhh-c-ccCC----------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 222221 1 1100 01123345899999999999999996 588874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=276.99 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=205.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..+.|.+.+.||+|.|+.|.+|++. .++..||||.+.+....... ...+.+|+.+|..|+||||+++
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~-~t~~~VaiK~idkt~ln~~~------------~~k~~rev~imk~l~HPnIvkl 120 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHI-LTGTEVAIKIIDKTQLNPSK------------RQKLGREVDIMKSLNHPNIVKL 120 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEec-CCCceEEEEEehhcccChHH------------HHHHHHHHHHHHhcCCcceeee
Confidence 4688999999999999999999976 48999999998655433221 4558999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+++......+|+||||+.+|.+++++. +.+...+..+...+.|++.|++|||++. ++|||||++||+++.+.+
T Consensus 121 ~~v~~t~~~lylV~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mn 193 (596)
T KOG0586|consen 121 FSVIETEATLYLVMEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMN 193 (596)
T ss_pred eeeeeecceeEEEEEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccc
Confidence 999999999999999999999999994 4455666888999999999999999666 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALS-DKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++..+....... .++|++.|.|||++.+..|+ +.+|+||+|+++|.++.|..||++..- ...
T Consensus 194 ikIaDfgfS~~~~~~~~lq---t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------k~L 263 (596)
T KOG0586|consen 194 IKIADFGFSTFFDYGLMLQ---TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------KEL 263 (596)
T ss_pred eeeeccccceeeccccccc---ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------ccc
Confidence 9999999999887443333 56999999999999998764 579999999999999999999985322 111
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+++..+. .-+.-.+.++.++++++|-.+|..|++.+++.+
T Consensus 264 r~rvl~gk~-----------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 264 RPRVLRGKY-----------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cchheeeee-----------cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111111110 011122344889999999999999999999875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=263.62 Aligned_cols=245 Identities=22% Similarity=0.243 Sum_probs=183.2
Q ss_pred cccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHH---HHhcCCCCCChhhhhceeec
Q 036970 48 KIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI---ITAGQVRHRNIVPLLARVVR 124 (337)
Q Consensus 48 ~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~ni~~~~~~~~~ 124 (337)
.||+|+||.||+|... .+++.+|+|.+......... ......+|. ..+...+|||++.+++.+..
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 68 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQ-----------GETLALNERIMLSLVSTGDCPFIVCMTYAFHT 68 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccch-----------HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec
Confidence 4899999999999865 47999999988654321110 011223333 33444579999999999999
Q ss_pred CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecc
Q 036970 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 204 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Df 204 (337)
++..++||||+++++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++||
T Consensus 69 ~~~~~lv~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~df 141 (279)
T cd05633 69 PDKLCFILDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141 (279)
T ss_pred CCeEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccC
Confidence 999999999999999999884 3456899999999999999999999555 999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccCCcccc-CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhh
Q 036970 205 GLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT 283 (337)
Q Consensus 205 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 283 (337)
|++........ ....|+..|+|||... +..++.++|+||+|+++|++++|..||....... . ........
T Consensus 142 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~---~~~~~~~~ 212 (279)
T cd05633 142 GLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--K---HEIDRMTL 212 (279)
T ss_pred CcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--H---HHHHHHhh
Confidence 99875543222 1246789999999886 4568899999999999999999999997543211 1 11111111
Q ss_pred cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 284 SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
... ..+ +......+.+++.+||+.||++|| |+.++++
T Consensus 213 ~~~------~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 213 TVN------VEL----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCC------cCC----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 110 001 112234588999999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=262.24 Aligned_cols=265 Identities=21% Similarity=0.266 Sum_probs=192.6
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhhce
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLLAR 121 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~ 121 (337)
|.+.+.||.|++|+||+|... .+++.|++|.+........ .....+|+..++.++ |+|+++++++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~-------------~~~~~~e~~~l~~~~~h~~i~~~~~~ 66 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWE-------------ECMNLREVKSLRKLNEHPNIVKLKEV 66 (283)
T ss_pred CeeheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccchh-------------HHHHHHHHHHHHhccCCCCchhHHHH
Confidence 678899999999999999865 3788999998754322110 223456889999998 9999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+++..++||||+ +++|.+.+... ....+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|
T Consensus 67 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l 140 (283)
T cd07830 67 FRENDELYFVFEYM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKI 140 (283)
T ss_pred hhcCCcEEEEEecC-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEE
Confidence 99999999999999 78998888442 2346899999999999999999999555 999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH----
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ---- 276 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~---- 276 (337)
+|||.+.......... ...++..|+|||++.. ..++.++|+||||++++++++|..||..............
T Consensus 141 ~d~~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 217 (283)
T cd07830 141 ADFGLAREIRSRPPYT---DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT 217 (283)
T ss_pred eecccceeccCCCCcC---CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCC
Confidence 9999987664432221 2356788999998754 4578999999999999999999999865432111000000
Q ss_pred -----HHHHHhhcCCCCccccc---cccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 -----WMRNVMTSENPSRTIDS---KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 -----~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+.............+.. .......+.....+.+++.+||+.+|++|||+++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 218 PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000000000 0000001111355899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=259.21 Aligned_cols=256 Identities=18% Similarity=0.224 Sum_probs=195.2
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|.+.+.||+|++|.||++.+.. .+..+++|.......... .......+..|+.+++.++||||+++++.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGEL---------NPNETVQANQEAQLLSKLDHPAIVKFHAS 70 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC-CCCcceEEEecccccccc---------CcchHHHHHHHHHHHHhCCCCcHHHHHHH
Confidence 58899999999999999998653 455555665532211100 00113456678999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+.+....++++||+++++|.+++.........+++..++.++.|++.|+.|||+. |++|+||+|+||+++. +.++|
T Consensus 71 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l 146 (260)
T cd08222 71 FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKI 146 (260)
T ss_pred HhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEee
Confidence 9999999999999999999999876555667799999999999999999999955 5999999999999975 57999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||.+......... .....++..|+|||...+..++.++|+||||++++++++|..||..... .......
T Consensus 147 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~ 217 (260)
T cd08222 147 GDFGVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRI 217 (260)
T ss_pred cccCceeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHH
Confidence 999988765433221 1134568889999999888889999999999999999999999864221 1222222
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+. .+......+.+++.+||+.+|++||++.++++
T Consensus 218 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 218 VEGPTPS----------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HcCCCCC----------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 2111111 11233345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=264.63 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=194.4
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhcee
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARV 122 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~ 122 (337)
|++.+.||.|++|.||+|... .+++.+++|.+....... .....+.+|+.+++.++|+|++++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 67 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKE------------GFPITAIREIKLLQKLRHPNIVRLKEIV 67 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC-CCCeEEEEEEEecccccc------------cchHHHHHHHHHHHhccCCCeeeheeeE
Confidence 678899999999999999865 478999999996543111 1134677899999999999999999999
Q ss_pred ecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 123 VRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 123 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.+. +..++++||+++ +|.+++.. ....+++..++.++.|++.||.+||+. +++|+||+|+||++++++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~ 140 (287)
T cd07840 68 TSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLK 140 (287)
T ss_pred ecCCCCcEEEEeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEE
Confidence 988 789999999965 88888743 225689999999999999999999955 599999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||.+.......... .....++..|+|||.+.+ ..++.++||||||++++++++|..||...... .....+.
T Consensus 141 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~----~~~~~~~ 215 (287)
T cd07840 141 LADFGLARPYTKRNSAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL----EQLEKIF 215 (287)
T ss_pred EccccceeeccCCCccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHH
Confidence 99999988765443211 112345778999998765 35788999999999999999999998754321 1111111
Q ss_pred HHhhcCCCC-----------------ccccccccCCChHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPS-----------------RTIDSKLIGNGYEE-QMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~-----------------~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... ......+ ...... +...+.+++.+||+.+|.+||+++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 216 ELCGSPTDENWPGVSKLPWFENLKPKKPYKRRL-REFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHhCCCchhhccccccchhhhhccccccchhHH-HHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111100000 0000000 000011 1456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=262.32 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=196.3
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhcee
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARV 122 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~ 122 (337)
|.+.+.||.|++|.||+|... .+++.+++|.+....... .....+.+|+.+++.++|+||+++++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 67 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESE------------GIPKTALREIKLLKELNHPNIIKLLDVF 67 (283)
T ss_pred CccceeeecCCCceEEEEEcC-CCCcEEEEEEeccccccc------------hhHHHHHHHHHHHHHhcCCCcchHHHhh
Confidence 567899999999999999864 479999999885443221 1145678899999999999999999999
Q ss_pred ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEe
Q 036970 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
.++...++++||+++ +|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 68 ~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~ 140 (283)
T cd05118 68 RHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLA 140 (283)
T ss_pred ccCCCEEEEEeccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEe
Confidence 999999999999965 88888744 2357899999999999999999999555 9999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 203 EFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
|||.+......... .....++..|+|||.+.+. .++.++|+||||+++|++++|..||...... .........
T Consensus 141 df~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~~~ 214 (283)
T cd05118 141 DFGLARSFGSPVRP--YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI----DQLFKIFRT 214 (283)
T ss_pred eeeeeEecCCCccc--ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHH
Confidence 99998776543311 1123467789999998776 7889999999999999999999998653221 111111111
Q ss_pred hhcCCCC--ccc--------------cccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPS--RTI--------------DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~--~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+....+. ..+ .........+.....+.++|.+||++||.+||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred cCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 000 000000112234567999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=257.58 Aligned_cols=244 Identities=22% Similarity=0.254 Sum_probs=197.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|+.++.||+|.||.|.+++.+ ++++.||+|++.+... -.++..+.-..|-++|..-+||-+..+.
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEK-at~k~YAiKIlkKevi-----------iakdEVAHTlTE~RVL~~~~HPFLt~LK 234 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREK-ATGKLYAIKILKKEVI-----------IAKDEVAHTLTENRVLQNCRHPFLTSLK 234 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeec-ccCceeehhhhhhhhe-----------eehHHhhhhhhHHHHHHhccCcHHHHhh
Confidence 489999999999999999999865 6999999999854332 2223355677899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
-.|...+.+++||||++||.|.-.+ +..+.+++....-+-..|+.||.|||+.+ ||.||+|.+|.+++.+|++
T Consensus 235 YsFQt~drlCFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHI 307 (516)
T KOG0690|consen 235 YSFQTQDRLCFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHI 307 (516)
T ss_pred hhhccCceEEEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCce
Confidence 9999999999999999999998888 45567899999999999999999999666 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||.|||++..-...+. .....+|||.|+|||++....|..+.|.|.+|+++|||++|+.||...+. ..+-+.
T Consensus 308 KitDFGLCKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----~kLFeL-- 379 (516)
T KOG0690|consen 308 KITDFGLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----EKLFEL-- 379 (516)
T ss_pred Eeeecccchhcccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----hHHHHH--
Confidence 9999999976443322 22257999999999999999999999999999999999999999965432 111111
Q ss_pred HHhhc-CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC
Q 036970 280 NVMTS-ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP 323 (337)
Q Consensus 280 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 323 (337)
++.. -..++ ........|+..+|.+||.+|.
T Consensus 380 -Il~ed~kFPr------------~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 380 -ILMEDLKFPR------------TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -HHhhhccCCc------------cCCHHHHHHHHHHhhcChHhhc
Confidence 1111 11111 1122377888889999999996
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=263.90 Aligned_cols=264 Identities=21% Similarity=0.272 Sum_probs=187.2
Q ss_pred cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceee
Q 036970 44 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV 123 (337)
Q Consensus 44 ~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 123 (337)
.+++.+|.|++ ||.++... +++.||+|++....... .....+.+|+..++.++|+||+++++++.
T Consensus 5 ~i~~~~~~~~~--v~~~~~~~-~~~~~avK~~~~~~~~~------------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~ 69 (314)
T cd08216 5 LIGKCFEDLMI--VHLAKHKP-TNTLVAVKKINLDSCSK------------EDLKLLQQEIITSRQLQHPNILPYVTSFI 69 (314)
T ss_pred hhhHhhcCCce--EEEEEecC-CCCEEEEEEEeccccch------------hHHHHHHHHHHHHHhcCCcchhhhhheee
Confidence 33444444444 55555442 89999999986542111 11567899999999999999999999999
Q ss_pred cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEec
Q 036970 124 RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203 (337)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~D 203 (337)
++...++++||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|
T Consensus 70 ~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d 144 (314)
T cd08216 70 VDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSG 144 (314)
T ss_pred cCCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEec
Confidence 999999999999999999998653 2345889999999999999999999555 99999999999999999999999
Q ss_pred ccccccCCCCCc-----ccccccccCcccccCCccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 204 FGLAKQIPNGRT-----RTTTWSLAETVGYIAPECHQTV--ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 204 fg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
|+.+........ ........++..|+|||++... .++.++|+||||+++++|++|..||....... ...+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~ 221 (314)
T cd08216 145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLE 221 (314)
T ss_pred CccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence 998865532211 1111233457789999998663 57889999999999999999999997532111 1111
Q ss_pred HHHHHhhc-----------CCCCc----ccc----ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTS-----------ENPSR----TID----SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~-----------~~~~~----~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........ ..... ..+ ..............+.+++.+||+.||++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 11000000 00000 000 00001112223456889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=278.92 Aligned_cols=272 Identities=21% Similarity=0.233 Sum_probs=206.0
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
...|..-+.||+||||.||.|+++ .+|..||||.+...... ...+...+|+.++++|+|+|||+++
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnk-etG~~vAvK~~~~~~~~-------------r~~e~~~~EieilkKLnh~NIVk~f 77 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNK-ETGRLVAVKTFNKESSL-------------RPRERWCREIEILKKLNHPNIVKLF 77 (732)
T ss_pred CcceeehhhhcCCccceeeeeccc-ccccchhHHhhhhhccc-------------chHHHHHHHHHHHHHcCchhhhhhc
Confidence 356777899999999999999966 49999999998654321 1267888999999999999999999
Q ss_pred ceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 120 ARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 120 ~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
++=++.. ...++||||.+|+|...++...+ ...+++...+.++.+++.||.|||+++ |+||||||.||++
T Consensus 78 ~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl 153 (732)
T KOG4250|consen 78 DIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVL 153 (732)
T ss_pred ccCCccccCcccccceEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEE
Confidence 8766544 45799999999999999976543 455999999999999999999999666 9999999999999
Q ss_pred cC--CC--cEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccc
Q 036970 194 DD--DM--EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268 (337)
Q Consensus 194 ~~--~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~ 268 (337)
.. +| ..||+|||.++.+...... .+..||..|++||+... ..|+..+|.||||+++|++.||..||.+...+
T Consensus 154 ~~Gedgq~IyKLtDfG~Arel~d~s~~---~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 154 QIGEDGQSIYKLTDFGAARELDDNSLF---TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred eecCCCceEEeeecccccccCCCCCee---eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 63 23 4799999999988766532 35799999999999984 78899999999999999999999999865443
Q ss_pred cccchHHHHHHHHhhcCCCCcc--------------ccccccCCChHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHH
Q 036970 269 TKEMSFVQWMRNVMTSENPSRT--------------IDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP--NSKDVRCML 332 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp--s~~~il~~L 332 (337)
. ...+.++.....++.... ..-+....-.+.....+-.++..+|.-+|.+|- ...+....+
T Consensus 231 k---~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 231 K---NNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV 307 (732)
T ss_pred c---ccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence 2 222223222222111100 000111122334456677888888999999998 666666555
Q ss_pred hhh
Q 036970 333 SQI 335 (337)
Q Consensus 333 ~~~ 335 (337)
+++
T Consensus 308 ~dI 310 (732)
T KOG4250|consen 308 DDI 310 (732)
T ss_pred HHH
Confidence 543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=271.99 Aligned_cols=268 Identities=20% Similarity=0.290 Sum_probs=193.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|.+.+.||.|++|.||+|.+. .+|..+++|.+........ ....+.+|+.+++++ +||||++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~------------~~~~~~~E~~~l~~l~~h~ni~~ 71 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNAT------------DAQRTFREIMFLQELGDHPNIVK 71 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCcch------------hhhhhhHHHHHHHHhcCCCCccc
Confidence 4578999999999999999999865 4789999998853221111 134567899999999 9999999
Q ss_pred hhceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 118 LLARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 118 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++... ...++|+||++ ++|..++.. ..+++..++.++.|++.||.|||+. |++|+||+|+||+++.
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~ 142 (337)
T cd07852 72 LLNVIKAENDKDIYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNS 142 (337)
T ss_pred eeeeeccCCCceEEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcC
Confidence 99988654 35799999996 589888732 2678889999999999999999955 5999999999999999
Q ss_pred CCcEEEecccccccCCCCCcc---cccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 196 DMEARISEFGLAKQIPNGRTR---TTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.........
T Consensus 143 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~ 222 (337)
T cd07852 143 DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL 222 (337)
T ss_pred CCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999998766443221 12223457889999998755 45788999999999999999999998653221100
Q ss_pred chHHHH----------------HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 272 MSFVQW----------------MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 272 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
...... ....+...... ...............+.+++..||+.||++|||+.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 223 EKIIEVIGPPSAEDIESIKSPFAATMLDSLPSR---PRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccc---cccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 00000000000 0000000011124558899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=265.82 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=194.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
....|...+.||.|++|.||+|+.. .++..+++|.+....... ......+.+|+.+++.++|+|++++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~ 80 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQKLRHPNTIQY 80 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccC-----------hHHHHHHHHHHHHHHhCCCCCcccE
Confidence 5678999999999999999999865 478899999885322111 1114467789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
.+++......++|+||+. +++.+.+.. ...++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~ 153 (308)
T cd06634 81 RGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 153 (308)
T ss_pred EEEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCc
Confidence 999999999999999996 578777643 3355899999999999999999999554 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++|+|||++....... ...++..|+|||.+. ...++.++||||||+++|++++|..||..... .
T Consensus 154 ~kl~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~ 220 (308)
T cd06634 154 VKLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------M 220 (308)
T ss_pred EEECCcccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------H
Confidence 9999999886543221 235688899999874 34578899999999999999999999865321 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
...........+.. ........+.++|.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 221 SALYHIAQNESPAL---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHHHhhcCCCCc---------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11111111111100 011223448899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=272.99 Aligned_cols=278 Identities=21% Similarity=0.197 Sum_probs=195.7
Q ss_pred ccCcccc-cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 39 KEDCFAS-LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~-~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
..++|.. .+.||.|++|.||+|.+. .+++.||+|.+........................+.+|+.+++.++|+||++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 3567765 477999999999999865 48999999998543321100000000000001224678999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++..++..+++|||+. ++|.+++. ....+++.....++.|++.||.|||+. |++|+||+|+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKG 156 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCC
Confidence 9999999999999999996 58988883 345689999999999999999999955 599999999999999999
Q ss_pred cEEEecccccccCCCCCc------------ccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 198 EARISEFGLAKQIPNGRT------------RTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
.++|+|||++........ ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999876652111 0111122457789999998764 468899999999999999999999975
Q ss_pred cccccccchHHHHHHHHhhcCCCCcccc---------------ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTID---------------SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
.... .....+....... ...... +.............+.+++..||+.+|++|||+++++
T Consensus 237 ~~~~----~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 237 ENEI----DQLGRIFELLGTP-NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCHH----HHHHHHHHHhCCC-chhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 4321 1111111111100 000000 0000000112235588999999999999999999998
Q ss_pred H
Q 036970 330 C 330 (337)
Q Consensus 330 ~ 330 (337)
.
T Consensus 312 ~ 312 (335)
T PTZ00024 312 K 312 (335)
T ss_pred c
Confidence 5
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=261.32 Aligned_cols=263 Identities=25% Similarity=0.311 Sum_probs=191.4
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcC---CCCCChhhhh
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQ---VRHRNIVPLL 119 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~ni~~~~ 119 (337)
|++.+.||.|++|.||+|++.. +++.|++|.+........ ....+.+|+.+++. ++|+|+++++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~h~~i~~~~ 67 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEEG------------IPLSTLREIALLKQLESFEHPNIVRLL 67 (287)
T ss_pred CeEEEEecccCceEEEEEEECC-CCCEEEEEEeccccccch------------hhhhHHHHHHHHHHhhccCCCCcceEE
Confidence 6788999999999999999763 789999999854322111 12234456655544 4699999999
Q ss_pred ceeecCCC-----ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 120 ARVVRPDC-----DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 120 ~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
+.+.+.+. .++++||+. ++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++
T Consensus 68 ~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~ 141 (287)
T cd07838 68 DVCHGPRTDRELKLTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVT 141 (287)
T ss_pred EEEeeccCCCCceeEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEc
Confidence 99988776 899999996 4898887542 223589999999999999999999955 499999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
.++.++|+|||.+.......... ...++..|+|||.+.+..++.++|+||||+++|+|++|.+||......+ ..
T Consensus 142 ~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~ 215 (287)
T cd07838 142 SDGQVKIADFGLARIYSFEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QL 215 (287)
T ss_pred cCCCEEEeccCcceeccCCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HH
Confidence 99999999999987764432221 2346788999999998889999999999999999999999987543211 11
Q ss_pred HHHHHHHhhcCC---C-C-----cccccc---ccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSEN---P-S-----RTIDSK---LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~---~-~-----~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............ + . ...... ......+.....+.+++.+||+.||++||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 216 DKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 111111100000 0 0 000000 001112233466889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=272.43 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=197.4
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
+|++.+.||.|++|.||+|+.. .++..|++|.+...... ......+.+|+..++.++|+||+++.++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDD------------LIDAKRILREIKLLRHLRHENIIGLLDI 67 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC-CCCcEEEEEeecccccc------------chhhhhHHHHHHHHHhcCCcchhhhhhh
Confidence 5889999999999999999865 47899999988543211 1114568889999999999999999999
Q ss_pred eecCC-----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 122 VVRPD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 122 ~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
+.... ..++++||+. ++|.+++. ....+++..++.++.|++.||.+||+. |++|+||+|+||+++.+
T Consensus 68 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~ 139 (330)
T cd07834 68 LRPPSPEDFNDVYIVTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSN 139 (330)
T ss_pred hcccCcccccceEEEecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 98775 6799999996 47888873 344799999999999999999999955 49999999999999999
Q ss_pred CcEEEecccccccCCCCCcc-cccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 197 MEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
+.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... ..
T Consensus 140 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~----~~ 215 (330)
T cd07834 140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI----DQ 215 (330)
T ss_pred CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH----HH
Confidence 99999999999876544210 111233568889999999887 7899999999999999999999999754321 11
Q ss_pred HHHHHHHhhcCCCCcc-----------cc------ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRT-----------ID------SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~-----------~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...+............ +. ........+.....+.+++.+||+++|.+|||+.+++.
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1111111100000000 00 00000001123456899999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=292.70 Aligned_cols=261 Identities=22% Similarity=0.234 Sum_probs=204.9
Q ss_pred hhhhh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC
Q 036970 34 LAFLK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112 (337)
Q Consensus 34 ~~~l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 112 (337)
.+-++ ..++|.+++.||+|+||.|.+++++ .+++.||+|++++..... .. ..+.|..|-.+|.--+.
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK~eMlK-----r~------~tA~F~EERDimv~~ns 134 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHK-STEKVYAMKILNKWEMLK-----RA------ETACFREERDIMVFGNS 134 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEee-ccccchhHHHhhHHHHhh-----ch------hHHHHHHHhHHHHcCCc
Confidence 33366 6799999999999999999999987 499999999997644321 11 14567778888877778
Q ss_pred CChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
+=|+.++-.|.++.++|+||||++||+|-.++ ++...+++..+.-++..++.||.-+| +.|+|||||||+|||
T Consensus 135 ~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLl----Sk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvL 207 (1317)
T KOG0612|consen 135 EWIVQLHYAFQDERYLYLVMDYMPGGDLLTLL----SKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVL 207 (1317)
T ss_pred HHHHHHHHHhcCccceEEEEecccCchHHHHH----hhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeE
Confidence 88999999999999999999999999999999 44447999999999999999999999 556999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-----VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ 267 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~ 267 (337)
++..|++||+|||.+..+...+..... ...|||.|++||++.. +.|...+|.||+|+++|||+.|..||...
T Consensus 208 ld~~GHikLADFGsClkm~~dG~V~s~-~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-- 284 (1317)
T KOG0612|consen 208 LDKSGHIKLADFGSCLKMDADGTVRSS-VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-- 284 (1317)
T ss_pred ecccCcEeeccchhHHhcCCCCcEEec-cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--
Confidence 999999999999999888766555443 4689999999999754 35888999999999999999999999542
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC---HHHHH
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN---SKDVR 329 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il 329 (337)
.+.+-...+.+..... .++ .....+....+||.+.+. +|+.|.. ++++.
T Consensus 285 -----slveTY~KIm~hk~~l-~FP------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 285 -----SLVETYGKIMNHKESL-SFP------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred -----HHHHHHHHHhchhhhc-CCC------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 2222222233221110 001 011234557788888777 7888887 66654
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=262.85 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=192.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|++.+.||.|++|.||+|.+. .+++.|++|.+....... ....+..|+..+... .||||++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~-------------~~~~~~~e~~~~~~~~~~~~i~~ 78 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFK-KTGHVMAVKQMRRTGNKE-------------ENKRILMDLDVVLKSHDCPYIVK 78 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEEC-CCCeEEEEEEEeccCChH-------------HHHHHHHHHHHHHhccCCCchHh
Confidence 4578999999999999999999875 369999999985432211 133455666666566 5999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.++...++++||+ ++++.+++.. ....+++..+..++.|++.|+.|||+. .+++|+||+|+||+++.++
T Consensus 79 ~~~~~~~~~~~~~v~e~~-~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~ 152 (296)
T cd06618 79 CYGYFITDSDVFICMELM-STCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASG 152 (296)
T ss_pred hheeeecCCeEEEEeecc-CcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCC
Confidence 999999999999999998 4578777644 234689999999999999999999953 2599999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCC----CCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA----LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
.++|+|||++.......... ...++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... .
T Consensus 153 ~~kL~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~ 224 (296)
T cd06618 153 NVKLCDFGISGRLVDSKAKT---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----E 224 (296)
T ss_pred CEEECccccchhccCCCccc---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----H
Confidence 99999999987654332221 234678899999987653 78899999999999999999999864211 0
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
.+..........+.. ... ......+.+++.+||+.||++||+++++++.
T Consensus 225 -~~~~~~~~~~~~~~~--~~~------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 225 -FEVLTKILQEEPPSL--PPN------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -HHHHHHHhcCCCCCC--CCC------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112222222221111 000 0122348899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=268.24 Aligned_cols=267 Identities=24% Similarity=0.297 Sum_probs=194.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||.|++|.||+|.+. .+|+.|++|.+....... .....+.+|+.+++.++|||++++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~------------~~~~~~~~e~~~~~~l~h~~i~~~ 71 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDK-DTGELVALKKVRLDNEKE------------GFPITAIREIKILRQLNHRNIVNL 71 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEEC-CCCcEEEEEEEeeccccc------------CchHHHHHHHHHHHhCCCCCeeee
Confidence 4678999999999999999999875 378999999885432211 113456789999999999999999
Q ss_pred hceeecCC----------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 036970 119 LARVVRPD----------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188 (337)
Q Consensus 119 ~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~ 188 (337)
++++.+.. ..++++||+++ ++.+.+.. ....+++..++.++.|++.||.|||+. +++|+||+|
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p 144 (302)
T cd07864 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKC 144 (302)
T ss_pred eheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 99887654 68999999976 67777632 344689999999999999999999955 599999999
Q ss_pred CcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCccc
Q 036970 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ 267 (337)
Q Consensus 189 ~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~ 267 (337)
+||++++++.++|+|||.+......... ......++..|+|||.+.+. .++.++||||||++++++++|..||.....
T Consensus 145 ~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~ 223 (302)
T cd07864 145 SNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223 (302)
T ss_pred HHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999998766443221 11112346789999987653 578899999999999999999999874322
Q ss_pred ccccchHHHHHHHHhhcCCCCc-----------cccccc-----cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 268 HTKEMSFVQWMRNVMTSENPSR-----------TIDSKL-----IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+........+.. ..+... ...........+.+++..||+.+|++|||+.++++
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 224 ----LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ----HHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111112111111100 000000 00001112355899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=266.06 Aligned_cols=266 Identities=23% Similarity=0.276 Sum_probs=191.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|.+.+.||.|++|.||+|.+. .+++.+++|.+........ ....+.+|+.+++.++||||++++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~~ 73 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKDG------------FPITALREIKILKKLKHPNVVPLI 73 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCCC------------cchhHHHHHHHHHhcCCCCccchh
Confidence 589999999999999999999865 4789999998854332110 023467899999999999999999
Q ss_pred ceeecCC--------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 120 ARVVRPD--------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 120 ~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
+++.+.. ..++++||+.+ ++...+.. ....+++..+..++.|++.||.|||+. |++|+||+|+||
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~ni 146 (311)
T cd07866 74 DMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANI 146 (311)
T ss_pred hheecccccccccCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 9876543 35899999954 67776632 345699999999999999999999955 499999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcccc---------cccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCC
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTRTT---------TWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~p 261 (337)
+++.++.++|+|||++........... .....+++.|+|||.+.+. .++.++||||||+++|+|++|.+|
T Consensus 147 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~ 226 (311)
T cd07866 147 LIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226 (311)
T ss_pred EECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence 999999999999999876543221111 1123457789999987654 578899999999999999999999
Q ss_pred CCCcccccccchHHHHHHHHhhcCCCC-----------------ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC
Q 036970 262 SDDFFQHTKEMSFVQWMRNVMTSENPS-----------------RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324 (337)
Q Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 324 (337)
|.+.... ...+.+........+. ...+... ..........+.+++.+||+.||.+|||
T Consensus 227 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t 301 (311)
T cd07866 227 LQGKSDI----DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL-EERFGKLGPEGLDLLSKLLSLDPYKRLT 301 (311)
T ss_pred CCCCCHH----HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccH-HHHcccCChhHHHHHHHHcccCcccCcC
Confidence 8753321 1111111111100000 0000000 0001112245889999999999999999
Q ss_pred HHHHHH
Q 036970 325 SKDVRC 330 (337)
Q Consensus 325 ~~~il~ 330 (337)
+.+++.
T Consensus 302 ~~ell~ 307 (311)
T cd07866 302 ASDALE 307 (311)
T ss_pred HHHHhc
Confidence 999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=254.44 Aligned_cols=240 Identities=23% Similarity=0.266 Sum_probs=190.3
Q ss_pred ccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCc
Q 036970 49 IRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD 128 (337)
Q Consensus 49 lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 128 (337)
||.|++|.||++... .+++.+++|.+....... ......+.+|+.+++.++|+|++++++.+..+...
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIK-----------RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL 68 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcc-----------hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee
Confidence 699999999999865 478999999885443211 12256788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
+++|||+.+++|.+++. ..+.+++.....++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~ 141 (250)
T cd05123 69 YLVLEYAPGGELFSHLS----KEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK 141 (250)
T ss_pred EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcce
Confidence 99999999999999984 334689999999999999999999955 49999999999999999999999999987
Q ss_pred cCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCC
Q 036970 209 QIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS 288 (337)
Q Consensus 209 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (337)
....... ......++..|+|||...+...+.++|+||||+++|++++|..||..... .............
T Consensus 142 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~- 211 (250)
T cd05123 142 ELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKDPLR- 211 (250)
T ss_pred ecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCCC-
Confidence 6644321 11234568889999999888889999999999999999999999965322 1222222221111
Q ss_pred ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 036970 289 RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327 (337)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 327 (337)
++. .....+.+++.+||..||++||++.+
T Consensus 212 --~~~--------~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 --FPE--------FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCC--------CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111 11244889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.50 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=194.3
Q ss_pred cccccccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPL 118 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~ 118 (337)
+|++.+.||.|+||.||.|+... .+|..|++|.+........ ....+.+.+|+.+++.+ +|+||+++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~~i~~~ 70 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK----------AKTTEHTRTERQVLEHIRQSPFLVTL 70 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc----------chHHHHHHHHHHHHHhcccCCChhce
Confidence 47889999999999999998632 3689999999854322110 11145678899999999 69999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++.+..+...++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 143 (290)
T cd05613 71 HYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGH 143 (290)
T ss_pred eeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCC
Confidence 9999999999999999999999999843 35688999999999999999999954 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV--ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
++|+|||++......... ......++..|+|||.+... .++.++|+||||+++|++++|..||..... ......
T Consensus 144 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~ 219 (290)
T cd05613 144 VVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAE 219 (290)
T ss_pred EEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHH
Confidence 999999998765432221 11134578899999998753 467889999999999999999999863211 112222
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
..........+. +......+.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~~~~~~~~~-----------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 220 ISRRILKSEPPY-----------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHhhccCCCC-----------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 222222222111 011223478999999999999997 6676654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=260.37 Aligned_cols=269 Identities=24% Similarity=0.335 Sum_probs=204.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
...+..+.+.||+|.||.||.|++ -|..||||++..-... .-.-..|+..-.-|+|+||+.|
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w---rGe~VAVKiF~srdE~---------------SWfrEtEIYqTvmLRHENILgF 270 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW---RGEDVAVKIFSSRDER---------------SWFRETEIYQTVMLRHENILGF 270 (513)
T ss_pred hhheeEEEEEecCccccceeeccc---cCCceEEEEecccchh---------------hhhhHHHHHHHHHhccchhhhh
Confidence 346778889999999999999998 4999999999532211 1123446666666799999999
Q ss_pred hceeecCC----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhc-----CCCCCceeCCCCCC
Q 036970 119 LARVVRPD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHM-----SHRPRIIHRDIQPA 189 (337)
Q Consensus 119 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-----~~~~~~~h~di~~~ 189 (337)
++.-..+. .+|+|++|.++|||.||++ ...++.....+++..++.||+|||. .+++.|.|||||..
T Consensus 271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hhccccCCCceEEEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 98665443 4689999999999999993 3679999999999999999999993 46889999999999
Q ss_pred cEEecCCCcEEEecccccccCCCC--CcccccccccCcccccCCccccCCC------CCCcccchhHhHHHHHHHhC---
Q 036970 190 NVLIDDDMEARISEFGLAKQIPNG--RTRTTTWSLAETVGYIAPECHQTVA------LSDKCDIYSFGVLLAVLMMG--- 258 (337)
Q Consensus 190 nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslG~vl~~l~~g--- 258 (337)
||++.+++.+.|+|+|++...... ..........||.+|||||++...- .-..+||||||.|+||+.-.
T Consensus 346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ 425 (513)
T KOG2052|consen 346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES 425 (513)
T ss_pred cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc
Confidence 999999999999999999876543 1222333578999999999986532 11368999999999999762
Q ss_pred -------CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 259 -------KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 259 -------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
.+||.+..+ .++++.++..-+. .......++. .-...+....+.++++.||..||.-|.|+-.|.+.
T Consensus 426 ggi~eey~~Pyyd~Vp--~DPs~eeMrkVVC-v~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 426 GGIVEEYQLPYYDVVP--SDPSFEEMRKVVC-VQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred CCEehhhcCCcccCCC--CCCCHHHHhccee-ecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 367766544 4444444333222 1111111111 12345667889999999999999999999999999
Q ss_pred Hhhhh
Q 036970 332 LSQIQ 336 (337)
Q Consensus 332 L~~~~ 336 (337)
|.++.
T Consensus 500 l~~l~ 504 (513)
T KOG2052|consen 500 LAKLS 504 (513)
T ss_pred HHHHh
Confidence 98874
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=259.04 Aligned_cols=248 Identities=21% Similarity=0.226 Sum_probs=184.1
Q ss_pred cccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCC
Q 036970 48 KIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDC 127 (337)
Q Consensus 48 ~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 127 (337)
.||.|+||.||+|++. .+++.||+|.+.......... ..........+..++...||+|+++.+.+.+.+.
T Consensus 1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQG--------ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchh--------HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 4899999999999865 478999999986543211100 0001111222344555689999999999999999
Q ss_pred ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccccc
Q 036970 128 DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207 (337)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~ 207 (337)
.++|+||+.+++|.+++. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~v~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~ 144 (278)
T cd05606 72 LSFILDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 144 (278)
T ss_pred EEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCc
Confidence 999999999999998883 3456899999999999999999999554 999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCC
Q 036970 208 KQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286 (337)
Q Consensus 208 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (337)
........ ....|+..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+..... ......... ...
T Consensus 145 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~-~~~ 215 (278)
T cd05606 145 CDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTL-TMA 215 (278)
T ss_pred cccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc----hHHHHHHhh-ccC
Confidence 76543222 134678999999998754 58899999999999999999999997532211 011111111 111
Q ss_pred CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
.. . +......+.+++.+||..+|.+|| ++.++++
T Consensus 216 ~~------~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 VE------L----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC------C----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 00 0 111234588999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=302.47 Aligned_cols=263 Identities=23% Similarity=0.281 Sum_probs=209.3
Q ss_pred hhhhhhh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC
Q 036970 32 EDLAFLK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV 110 (337)
Q Consensus 32 ~~~~~l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 110 (337)
+...+++ -.-+|.....||.|.||.||.|.+ ..+|.-.|+|.+.-.... ........+|..+++.|
T Consensus 1225 kla~~lsnV~~rWqrg~~Ig~G~fG~VYtavN-~~tGellAvKEI~iq~~~------------~k~~~~i~eEm~vlE~l 1291 (1509)
T KOG4645|consen 1225 KLASSLSNVTFRWQRGNFIGGGTFGKVYTAVN-LDTGELLAVKEIKIQDSD------------HKTFKLIAEEMKVLEGL 1291 (1509)
T ss_pred HHHHHhccceeeeccccccCCcceeeeEEeec-CCccchhhhhhhhcCccc------------cccCcchHHHHHHHHhc
Confidence 3444555 578899999999999999999974 458999999987443322 11245678899999999
Q ss_pred CCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 111 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
+|||+++++++-.+.+..+|.||||++|+|.+.+. -++..++.....+..|++.|+.|||+++ ||||||||.|
T Consensus 1292 nHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aN 1364 (1509)
T KOG4645|consen 1292 NHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPAN 1364 (1509)
T ss_pred cCccccccCceeecHHHHHHHHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccc
Confidence 99999999999999999999999999999999983 3444677777789999999999999555 9999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCc--ccccccccCcccccCCccccCC---CCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRT--RTTTWSLAETVGYIAPECHQTV---ALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
|+++.+|.+|++|||.+..+.++.. ........||+-|||||++.+. ....++||||||||+.||+||+.||...
T Consensus 1365 I~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1365 ILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred eeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 9999999999999999998876531 2233367899999999999775 3566899999999999999999999865
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+ .+..++..+..+..+..|. ..+..-.+++..||..||..|.++.|+++
T Consensus 1445 d---ne~aIMy~V~~gh~Pq~P~-------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1445 D---NEWAIMYHVAAGHKPQIPE-------------RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred c---chhHHHhHHhccCCCCCch-------------hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 3 2233333333322222222 23455789999999999999999998876
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=270.42 Aligned_cols=263 Identities=19% Similarity=0.267 Sum_probs=189.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||.|++|.||+|... .+|+.|++|.+..... .....+.+|+.+++.++||||+++
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~--------------~~~~~~~~Ei~~l~~l~h~~i~~~ 67 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDP--------------QSVKHALREIKIIRRLDHDNIVKV 67 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCC--------------chHHHHHHHHHHHHhcCCCcchhh
Confidence 3589999999999999999999865 4899999998854332 114567889999999999999999
Q ss_pred hceeecC--------------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 036970 119 LARVVRP--------------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184 (337)
Q Consensus 119 ~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~ 184 (337)
++.+... ...++++||++ ++|.+++. ...+++..++.++.||+.||.|||+. |++|+
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~ 138 (342)
T cd07854 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHR 138 (342)
T ss_pred HhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 9876654 34689999996 58888873 23588999999999999999999955 59999
Q ss_pred CCCCCcEEec-CCCcEEEecccccccCCCCCccc-ccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCC
Q 036970 185 DIQPANVLID-DDMEARISEFGLAKQIPNGRTRT-TTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 185 di~~~nil~~-~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~p 261 (337)
||+|+||+++ .++.++++|||.+.......... ......++..|+|||.+.. ..++.++|+||||+++|+|++|..|
T Consensus 139 dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 218 (342)
T cd07854 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218 (342)
T ss_pred CCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999998 45578999999987654321111 1112346788999998654 4578899999999999999999999
Q ss_pred CCCcccccccchHH------------HH---HHHHhh--cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC
Q 036970 262 SDDFFQHTKEMSFV------------QW---MRNVMT--SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324 (337)
Q Consensus 262 f~~~~~~~~~~~~~------------~~---~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 324 (337)
|............. .. ...... ......... .........+.+++.+||+.||.+|||
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 219 FAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLR-----DLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred CCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHH-----HHccCCCHHHHHHHHHHhCCCchhccC
Confidence 96543211000000 00 000000 000000000 000112345889999999999999999
Q ss_pred HHHHHH
Q 036970 325 SKDVRC 330 (337)
Q Consensus 325 ~~~il~ 330 (337)
+.+++.
T Consensus 294 ~~ell~ 299 (342)
T cd07854 294 AEEALM 299 (342)
T ss_pred HHHHhC
Confidence 999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=262.92 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=192.2
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.+.|...+.||.|++|.||+|.+. .++..|++|.+....... ......+.+|+.+++.++|||+++++
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~ 87 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQT-----------NEKWQDIIKEVKFLQQLKHPNTIEYK 87 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCc-----------hHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 345777788999999999999865 478999999985432211 11245678899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.++...++++||+. +++.+++.. ...++++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.+
T Consensus 88 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~ 160 (313)
T cd06633 88 GCYLKEHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQV 160 (313)
T ss_pred EEEEeCCEEEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCE
Confidence 99999999999999995 577777643 3456899999999999999999999554 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCcccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+|+|||++...... ....++..|+|||.+. ...++.++|+||||+++|+|++|..||..... ..
T Consensus 161 kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~ 227 (313)
T cd06633 161 KLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS 227 (313)
T ss_pred EEeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HH
Confidence 99999987643221 1246788899999974 35678899999999999999999999865321 11
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..........+.. . .......+.+++.+||+.+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~-~--------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 228 ALYHIAQNDSPTL-Q--------SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHHhcCCCCC-C--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111111 0 0111234889999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=269.11 Aligned_cols=267 Identities=22% Similarity=0.317 Sum_probs=210.3
Q ss_pred CCccchhhhhhhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHH
Q 036970 26 SPLIEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEII 105 (337)
Q Consensus 26 ~~~~~~~~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 105 (337)
||.-++++.. ..+...-.+||-|.+|.||.|.++. ..-.||||.+.-+.. ..++|..|..
T Consensus 256 SPn~DkWEme----RtdItMkhKLGGGQYGeVYeGvWKk-yslTvAVKtLKEDtM---------------eveEFLkEAA 315 (1157)
T KOG4278|consen 256 SPNADKWEME----RTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTM---------------EVEEFLKEAA 315 (1157)
T ss_pred cCCcchhhcc----chheeeeeccCCCcccceeeeeeec-cceeeehhhhhhcch---------------hHHHHHHHHH
Confidence 3444444443 2344556899999999999998763 566789998733222 2678999999
Q ss_pred HhcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCC
Q 036970 106 TAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRD 185 (337)
Q Consensus 106 ~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~d 185 (337)
+|..++|||+++++++|..+...|||+||+..|+|.++++.. ....++......++.||..|++||..++ ++|||
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRD 390 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRD 390 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhh
Confidence 999999999999999999999999999999999999999763 3456788888999999999999999555 99999
Q ss_pred CCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCC
Q 036970 186 IQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDD 264 (337)
Q Consensus 186 i~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~ 264 (337)
|...|+|+.++..|||+|||+++.+... ++.......-+.-|.|||-+....++.++|||+||++|||+.| |..||.+
T Consensus 391 LAARNCLVgEnhiVKvADFGLsRlMtgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 391 LAARNCLVGENHIVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhhhhccccccceEEeeccchhhhhcCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999887543 3333223333678999999999999999999999999999987 7788755
Q ss_pred cccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
. +.-+....+........ +..+...+++|++.||+.+|++||++.|+-+.|+.|
T Consensus 470 i----dlSqVY~LLEkgyRM~~-------------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 470 I----DLSQVYGLLEKGYRMDG-------------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred c----cHHHHHHHHhccccccC-------------CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 3 22222333333322222 223334499999999999999999999999988765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=267.57 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=193.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||.|++|.||+|++.. ++..|++|++....... .....+.+|+.+++.++|+|++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~ 79 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK-TGRKVAIKKLSRPFQSA------------IHAKRTYRELRLLKHMDHENVIGL 79 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC-CCcEEEEEecccccchh------------hHHHHHHHHHHHHHhccCCCHHHH
Confidence 57889999999999999999998753 78999999875432111 113457789999999999999999
Q ss_pred hceeecCCC------ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPDC------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
.+++..... .++|+||+ +++|.+++. ...+++..++.++.|++.||.|||+. |++|+||+|+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil 150 (343)
T cd07851 80 LDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIA 150 (343)
T ss_pred HHHhhccccccccccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeE
Confidence 998876654 79999999 679999883 24689999999999999999999955 5999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++.++.++|+|||++........ ...++..|+|||.+.+ ..++.++||||||+++|++++|..||......
T Consensus 151 l~~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--- 222 (343)
T cd07851 151 VNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--- 222 (343)
T ss_pred ECCCCCEEEcccccccccccccc-----CCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---
Confidence 99999999999999876643311 2356788999998765 36788999999999999999999999653221
Q ss_pred chHHHHHHHHhhcCCCCccccccc-------------------cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKL-------------------IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........... ..+ ..+.... ...........+.+++.+||+++|++|||+.++++
T Consensus 223 -~~~~~i~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 223 -DQLKRIMNLVG-TPD-EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred -HHHHHHHHhcC-CCC-HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 11111111100 000 0000000 00000112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=267.95 Aligned_cols=265 Identities=21% Similarity=0.271 Sum_probs=192.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||.|+||.||+|... .++..|++|++....... .....+.+|+.+++.++||||+++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~ 74 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFSTP------------VLAKRTYRELKLLKHLRHENIISL 74 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEEC-CCCCEEEEEEeccccccc------------chhHHHHHHHHHHHhcCCCCeeeE
Confidence 6789999999999999999999855 489999999875432111 114567789999999999999999
Q ss_pred hceeec-CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 119 LARVVR-PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 119 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
.+++.. ....++++||+ +++|.+++. ...++......++.|++.||.|||+. +++|+||+|+||+++.++
T Consensus 75 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~ 145 (328)
T cd07856 75 SDIFISPLEDIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENC 145 (328)
T ss_pred eeeEecCCCcEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCC
Confidence 998876 45778999998 568988873 34578888889999999999999955 499999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
.++|+|||.+........ ...++..|+|||.+.+ ..++.++|+||||+++|++++|..||.............+
T Consensus 146 ~~~l~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~ 220 (328)
T cd07856 146 DLKICDFGLARIQDPQMT-----GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220 (328)
T ss_pred CEEeCccccccccCCCcC-----CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999875432211 2355778999998766 5688999999999999999999999965332110000000
Q ss_pred --------HHHHHhhcCCCCccccccccC-----CChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 --------WMRNVMTSENPSRTIDSKLIG-----NGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 --------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+.................... ...+.....+.++|++||+.+|++|||+.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000000000 000112355889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=265.91 Aligned_cols=260 Identities=24% Similarity=0.315 Sum_probs=192.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||.|++|.||+|... .++..||+|.+....... .....+.+|+.+++.++||||+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~ 79 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQSE------------LFAKRAYRELRLLKHMKHENVIGL 79 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccch------------HHHHHHHHHHHHHHhcCCCCccce
Confidence 5788999999999999999999865 479999999885432111 114467889999999999999999
Q ss_pred hceeecCCC------ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPDC------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++..+.. .++|+||+ +++|.+++. ...+++..+..++.|++.||.|||+. |++|+||+|+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nil 150 (343)
T cd07880 80 LDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLA 150 (343)
T ss_pred eeeecCCccccccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 998876543 48999998 778988873 24689999999999999999999954 5999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++.++.++++|||++........ ...+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.......
T Consensus 151 l~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-- 223 (343)
T cd07880 151 VNEDCELKILDFGLARQTDSEMT-----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-- 223 (343)
T ss_pred EcCCCCEEEeecccccccccCcc-----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99999999999999876543221 2356788999998876 357889999999999999999999997532210
Q ss_pred chHHHHHHH----------HhhcCC-------CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 272 MSFVQWMRN----------VMTSEN-------PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 272 ~~~~~~~~~----------~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
........ .+.... ....... ............+.+++.+||+.||++|||+.+++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 224 -QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKK-DFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred -HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcc-hHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 01110000 000000 0000000 00000112234588999999999999999999988
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=261.23 Aligned_cols=262 Identities=24% Similarity=0.267 Sum_probs=195.0
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhcee
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARV 122 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~ 122 (337)
|+..+.||+|++|.||+|... .+++.+++|......... .....+..|+..++.++|+|++++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 67 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEE------------GIPSTALREISLLKELKHPNIVKLLDVI 67 (282)
T ss_pred CeeehcccccCcceEEEeeec-CCCcEEEEEEeccccccc------------cccHHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 567889999999999999865 479999999985543111 1134677899999999999999999999
Q ss_pred ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEe
Q 036970 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
.+.+..++++||++ ++|.+++... ...+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++.++|+
T Consensus 68 ~~~~~~~~v~e~~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~ 140 (282)
T cd07829 68 HTERKLYLVFEYCD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLA 140 (282)
T ss_pred hcCCceEEEecCcC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEe
Confidence 99999999999997 5899998542 14689999999999999999999955 49999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 203 EFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
|||.+........... ...++..|+|||.+.+. .++.++|+||||++++++++|..||........ ...+...
T Consensus 141 d~g~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----~~~~~~~ 214 (282)
T cd07829 141 DFGLARAFGIPLRTYT--HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ----LFKIFQI 214 (282)
T ss_pred cCCcccccCCCccccC--ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHHH
Confidence 9999876644322111 22446779999998776 788999999999999999999999865432111 1111111
Q ss_pred hhcCCC---------------CccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENP---------------SRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... .............+.....+.+++.+||+.||++||++++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 215 LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 0000000000111122456999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=264.20 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=190.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|.+. .++..||+|++....... .....+.+|+.++++++||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~Ei~~l~~l~h~~iv~~ 81 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSI------------IHAKRTYRELRLLKHMKHENVIGL 81 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchhh------------HHHHHHHHHHHHHHHcCCCcccce
Confidence 6799999999999999999999864 478999999885432211 113467789999999999999999
Q ss_pred hceeecC------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRP------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++... ...+++++++ +++|.+++. ...+++..++.++.|++.||.|||+. |++|+||+|+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl 152 (345)
T cd07877 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLA 152 (345)
T ss_pred eeeeeecccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEE
Confidence 9988643 2357788877 779988873 23589999999999999999999955 4999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++.++.++|+|||++....... ....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.......
T Consensus 153 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-- 225 (345)
T cd07877 153 VNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-- 225 (345)
T ss_pred EcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 9999999999999987653321 12356888999998766 467889999999999999999999986432210
Q ss_pred chHHHHHHHHhhc----------------------CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 272 MSFVQWMRNVMTS----------------------ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 272 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
...... ..... ..+....... .......+.+++.+||+.||.+||++.+++
T Consensus 226 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 226 -QLKLIL-RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-----FIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred -HHHHHH-HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhh-----cCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 011100 00000 0000000000 001234478999999999999999999987
Q ss_pred H
Q 036970 330 C 330 (337)
Q Consensus 330 ~ 330 (337)
.
T Consensus 299 ~ 299 (345)
T cd07877 299 A 299 (345)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=247.28 Aligned_cols=256 Identities=20% Similarity=0.276 Sum_probs=199.4
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~ 125 (337)
..||.|+++.|-.+. .-.+|..||||++.+.... .+.++.+|+.++.+. .|+||+.++++|+++
T Consensus 84 e~LGeGAyasVqtcv-~i~t~~EYAVKiidKq~gH--------------sR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCV-SIQTGKEYAVKIIDKQPGH--------------SRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred HHhcCccceeeeeee-eeccchhhhhhhhhcCCch--------------HHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 679999999998886 4469999999999655332 267899999999999 599999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc---EEEe
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME---ARIS 202 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~---~kl~ 202 (337)
...|+|||.+.||+|...| .+.+-+++..+..++.+|+.||.+|| +.||.|||+||+|||....++ +||+
T Consensus 149 ~~FYLVfEKm~GGplLshI----~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHI----QKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHH----HHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeee
Confidence 9999999999999999999 45567999999999999999999999 556999999999999987665 7999
Q ss_pred cccccccCCCC-----CcccccccccCcccccCCccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCcccc----
Q 036970 203 EFGLAKQIPNG-----RTRTTTWSLAETVGYIAPECHQT-----VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH---- 268 (337)
Q Consensus 203 Dfg~~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~---- 268 (337)
||.+..-.... .........+|+..|||||+..- ..|+.++|.||||+|+|-|++|.+||.+....
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 99887643211 11112224577889999998532 35899999999999999999999999875432
Q ss_pred ---cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 269 ---TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 269 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+.-...++.+-.-.+.+.-. +....|-..+....++++.+|-.++.+|.++.+++.
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYe------FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYE------FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCc------CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22222333322222222111 122345566777889999999999999999988764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=264.62 Aligned_cols=260 Identities=23% Similarity=0.282 Sum_probs=189.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
-.++|.+...||.|++|.||+|.+. .+|..||+|.+....... .....+.+|+.+++.++||||+++
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~~ 79 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQSE------------IFAKRAYRELTLLKHMQHENVIGL 79 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeC-CCCcEEEEEEecCccccc------------cchhHHHHHHHHHHhcCCCCccch
Confidence 3578999999999999999999865 378999999885432111 113457889999999999999999
Q ss_pred hceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++.... ..++++||+. .+|..+. ...+++..+..++.|++.||.|||+. +++|+||+|+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIl 149 (342)
T cd07879 80 LDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLA 149 (342)
T ss_pred hheecccccCCCCceEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence 99887643 3489999985 4676654 23588999999999999999999955 5999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++.++.++|+|||++........ ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......
T Consensus 150 l~~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--- 221 (342)
T cd07879 150 VNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--- 221 (342)
T ss_pred ECCCCCEEEeeCCCCcCCCCCCC-----CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 99999999999999876432211 2355788999999876 45888999999999999999999999753211
Q ss_pred chHHHHHHHHhhcCC-----------CC------ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSEN-----------PS------RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~-----------~~------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.............. .. ......-.....+.....+.+++.+||+.||.+||++.+++.
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 222 -DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred -HHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000000000 00 000000000001112345889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=263.96 Aligned_cols=263 Identities=20% Similarity=0.240 Sum_probs=188.0
Q ss_pred cccccccccccccceEEeeeecCCC--CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSS--GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPL 118 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~ 118 (337)
+|.+.+.||+|+||.||+|+... . +..||+|.+...... ......+.+|+.++..+ +||||+++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~-~~~~~~~aiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~~h~~iv~~ 67 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAE-TSEEETVAIKKITNVFSK------------KILAKRALRELKLLRHFRGHKNITCL 67 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCC-CCcCceEEEEEecccccc------------chhHHHHHHHHHHHHHhcCCCChhee
Confidence 58889999999999999998753 4 788999987432111 01134677899999999 59999999
Q ss_pred hceeecC----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 119 LARVVRP----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 119 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++.+... ...+++++++. ++|.+++ .....+++..++.++.||+.||.|||+. |++|+||+|+||+++
T Consensus 68 ~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~ 139 (332)
T cd07857 68 YDMDIVFPGNFNELYLYEELME-ADLHQII----RSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVN 139 (332)
T ss_pred eeeeeeccccCCcEEEEEeccc-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEc
Confidence 9865432 34678889885 6898888 3456789999999999999999999955 599999999999999
Q ss_pred CCCcEEEecccccccCCCCCccc--ccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 195 DDMEARISEFGLAKQIPNGRTRT--TTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
.++.++|+|||++.......... ......|+..|+|||.+.+ ..++.++|+||||+++|++++|..||.........
T Consensus 140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~ 219 (332)
T cd07857 140 ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQL 219 (332)
T ss_pred CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHH
Confidence 99999999999997654322211 1123467889999998765 46889999999999999999999998753211000
Q ss_pred ch--------HHHHHHHHhh----------cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MS--------FVQWMRNVMT----------SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~--------~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. ..+....... ...+...+. ...+.....+.+++.+||+.||.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 220 NQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-----SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH-----hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 0000000000 000000000 001112345889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=275.04 Aligned_cols=259 Identities=22% Similarity=0.299 Sum_probs=205.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCc----EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
++...+-.+.||.|+||+||+|.+-- .|+ +||||++...... ....++.+|...|.+|+|||
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~P-ege~vKipVaiKvl~~~t~~-------------~~s~e~LdeAl~masldHpn 759 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIP-EGENVKIPVAIKVLIEFTSP-------------KASIELLDEALRMASLDHPN 759 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEec-CCceecceeEEEEeeccCCc-------------hhhHHHHHHHHHHhcCCCch
Confidence 45566778899999999999998753 343 4777776433221 11567999999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++++++..+. ..||++|++.|+|.++++.++ ..+..+..+.|..||++|+.|||... ++||||...|+|+.
T Consensus 760 l~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVk 832 (1177)
T KOG1025|consen 760 LLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVK 832 (1177)
T ss_pred HHHHhhhcccch-HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeec
Confidence 999999998776 789999999999999997643 45888899999999999999999555 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
...++||.|||++................-.+-|||-|.+....|+..+||||||+++||++| |..|+.+.... +
T Consensus 833 sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----e 908 (1177)
T KOG1025|consen 833 SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----E 908 (1177)
T ss_pred CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----H
Confidence 999999999999988765433332222233677999999999999999999999999999998 77898764321 1
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+...+..+ ..-..++-+..+++-++.+||..|+..||+++++...++++
T Consensus 909 ----I~dlle~g---------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 909 ----IPDLLEKG---------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ----hhHHHhcc---------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 11111111 11134555667799999999999999999999999999876
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=254.34 Aligned_cols=260 Identities=17% Similarity=0.193 Sum_probs=200.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-C-CC--
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-H-RN-- 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~n-- 114 (337)
..++|.++..+|.|+||.|-..-+.. .+..||+|++..... ..+...-|+.++.++. + |+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~-~~~~vAlKIik~V~k---------------YreAa~iEi~vLqki~~~DP~g~ 150 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRE-TKEHVALKIIKNVDK---------------YREAALIEIEVLQKINESDPNGK 150 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecC-CCceehHHHHHHHHH---------------HhhHHHHHHHHHHHHHhcCCCCc
Confidence 37899999999999999999986554 589999999844322 1445667899999883 2 22
Q ss_pred --hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 115 --IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 115 --i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++.+.+||+-.+..++|+|.+ |.|+.+++.. ++..+++...+..++.|+++++++||+.. ++|.||||+||+
T Consensus 151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENIL 224 (415)
T KOG0671|consen 151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENIL 224 (415)
T ss_pred eEEEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEE
Confidence 677888899999999999998 7799999954 56678999999999999999999999554 999999999999
Q ss_pred ecC--------------------CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHH
Q 036970 193 IDD--------------------DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252 (337)
Q Consensus 193 ~~~--------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl 252 (337)
+.+ +..++|+|||.++....... ....|..|+|||++.+-+++.++||||+||||
T Consensus 225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL 299 (415)
T ss_pred EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheeccCcCCccCceeeeeEE
Confidence 831 23589999999987655443 34568999999999999999999999999999
Q ss_pred HHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCcccccc---------------------------------ccCCC
Q 036970 253 AVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSK---------------------------------LIGNG 299 (337)
Q Consensus 253 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~ 299 (337)
+|+++|...|..-. +.+-..++..++.+ .|...+... ..-..
T Consensus 300 ~ElytG~~LFqtHe----n~EHLaMMerIlGp-~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~ 374 (415)
T KOG0671|consen 300 VELYTGETLFQTHE----NLEHLAMMERILGP-IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ 374 (415)
T ss_pred EEeeccceecccCC----cHHHHHHHHHhhCC-CcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc
Confidence 99999999986432 11212344444331 111111100 01112
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 300 YEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 300 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+.+...|++|++.||..||++|+|+.|++.
T Consensus 375 ~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 375 DDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred CcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 3445677999999999999999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=246.21 Aligned_cols=260 Identities=21% Similarity=0.325 Sum_probs=199.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPL 118 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~ 118 (337)
.++.+-+..||+|+||+|++-.++ .+|+..|||.+.......+ ..++..|.....+- +.|||+++
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~n~~ke-------------q~rll~e~d~~mks~~cp~IVkf 128 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSNNIEKE-------------QKRLLMEHDTVMKSSNCPNIVKF 128 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcC-ccCcEEEEEEeeeccchHH-------------HHHHHHHHHHHHhhcCCcHHHHH
Confidence 355667788999999999999876 4999999999966554221 45677777655544 79999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHh-hhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYD-VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+|.+..++..||-||.++ .||..+... ..-....+++...-++.-..+.||.||...- .++|||+||+|||++..|
T Consensus 129 yGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G 205 (361)
T KOG1006|consen 129 YGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHG 205 (361)
T ss_pred hhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCC
Confidence 999999999999999994 466554322 2234566899888899999999999997553 499999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV--ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
.+||+|||.+-.+..+..... -.|...|||||.+... .|+.++|+||||+++||+.||..|+..+.. ..
T Consensus 206 ~vKLCDFGIcGqLv~SiAkT~---daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vf 276 (361)
T KOG1006|consen 206 DVKLCDFGICGQLVDSIAKTV---DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VF 276 (361)
T ss_pred CEeeecccchHhHHHHHHhhh---ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HH
Confidence 999999999977765533332 3567889999988654 589999999999999999999999876532 33
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+.+..+....++....+.. ..+.+..+..+|..||.+|.+.||+..++++
T Consensus 277 eql~~Vv~gdpp~l~~~~~-----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 277 EQLCQVVIGDPPILLFDKE-----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHHcCCCCeecCccc-----ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 3444444444333322222 1233444888899999999999999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=257.79 Aligned_cols=265 Identities=22% Similarity=0.232 Sum_probs=197.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|-.+.+||+|||+.||+|.+- ...+.||+|+-.-......+. .........+|.++...|+||.|++++
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl-~EqRYvAvKIHqlNK~WrdEK-------KeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDL-TEQRYVAVKIHQLNKNWRDEK-------KENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhccc-chhheeeEeeehhccchhhHh-------hhhHHHHHHHHHhhhhccCcceeeeee
Confidence 478999999999999999999743 477888999753222111111 011144567899999999999999999
Q ss_pred ceeec-CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC---
Q 036970 120 ARVVR-PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--- 195 (337)
Q Consensus 120 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~--- 195 (337)
++|.- .+..|.|+|||+|.+|.-+++ ..+.+++..+..++.||+.||.||.+. +++|+|-||||.|||+..
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence 99964 467899999999999999984 456689999999999999999999988 788999999999999964
Q ss_pred CCcEEEecccccccCCCCCccc-----ccccccCcccccCCccccCC----CCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 196 DMEARISEFGLAKQIPNGRTRT-----TTWSLAETVGYIAPECHQTV----ALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
.|.+||.|||++..+....... ......||.+|++||.+.-. ..+.+.||||+|+++|.++.|+.||+...
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 4789999999999876543321 22245789999999987543 57889999999999999999999998532
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
........... +... ...++ .-+........+|++||++.-++|....++.
T Consensus 689 sQQdILqeNTI----lkAt--EVqFP------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 689 SQQDILQENTI----LKAT--EVQFP------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hHHHHHhhhch----hcce--eccCC------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 21111111111 1111 11111 1122334588999999999999998877664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=223.45 Aligned_cols=264 Identities=20% Similarity=0.225 Sum_probs=197.9
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
..|+-.++||.|.+|+||+|+++ .++..||+|.+.-+...+. ......+|+-+++.++|.||+++++
T Consensus 2 ~~ydkmekigegtygtvfkarn~-~t~eivalkrvrlddddeg------------vpssalreicllkelkhknivrl~d 68 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNR-ETHEIVALKRVRLDDDDEG------------VPSSALREICLLKELKHKNIVRLHD 68 (292)
T ss_pred cchHHHHhhcCCcceeeEecccC-CccceEEEEEEeccCCCCC------------CcHHHHHHHHHHHHhhhcceeehhh
Confidence 45777899999999999999965 4899999999865433221 1456789999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
+...+..+-+|+||| +.+|+.+.. +-++.+.......++.|++.|+.++|+++ +.|||+||+|.+++.+|..|
T Consensus 69 vlhsdkkltlvfe~c-dqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelk 141 (292)
T KOG0662|consen 69 VLHSDKKLTLVFEFC-DQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELK 141 (292)
T ss_pred hhccCceeEEeHHHh-hHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEE
Confidence 999999999999999 558988874 45677999999999999999999999777 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCC-CCCcccchhHhHHHHHHHhCCCC-CCCcccccccchHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-LSDKCDIYSFGVLLAVLMMGKFP-SDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~vl~~l~~g~~p-f~~~~~~~~~~~~~~~~ 278 (337)
++|||+++.++-..... ..-.-|.+|++|.++.+.. |+++.|+||-||++.|+.....| |.+.+ ...++....
T Consensus 142 ladfglarafgipvrcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d---vddqlkrif 216 (292)
T KOG0662|consen 142 LADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIF 216 (292)
T ss_pred ecccchhhhcCCceEee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc---HHHHHHHHH
Confidence 99999999876543222 1234588999999998875 89999999999999999986655 43322 122222222
Q ss_pred HHHhhcC-----------CCCccccccccCCChHHHH----HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSE-----------NPSRTIDSKLIGNGYEEQM----LLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+. +... +....++.-.....+++.+ ..-.++++..|.-+|.+|.+++..++
T Consensus 217 ~~-lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 217 RL-LGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HH-hCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 21 1110 0111111111122233333 33456777778889999999998765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=277.63 Aligned_cols=150 Identities=25% Similarity=0.340 Sum_probs=129.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|.++++||.|+||.||+|.+. .+++.||+|++....... ......+..|+.++..++||||++++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~Iv~~~ 70 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMIN-----------KNMVHQVQAERDALALSKSPFIVHLY 70 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhccC-----------HHHHHHHHHHHHHHHhcCCCCcCeEE
Confidence 368999999999999999999865 479999999985432211 11245788899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
..+......++||||+.+++|.+++.. .+.+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+
T Consensus 71 ~~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~v 143 (669)
T cd05610 71 YSLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHI 143 (669)
T ss_pred EEEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCE
Confidence 999999999999999999999999843 34588899999999999999999955 49999999999999999999
Q ss_pred EEecccccc
Q 036970 200 RISEFGLAK 208 (337)
Q Consensus 200 kl~Dfg~~~ 208 (337)
+|+|||++.
T Consensus 144 kL~DFGls~ 152 (669)
T cd05610 144 KLTDFGLSK 152 (669)
T ss_pred EEEeCCCCc
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=265.29 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=201.7
Q ss_pred ccCccccc--ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASL--EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~--~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
...-|++. +.||.|-||+||-|.++ .+|+.||||++.+-..... ..+++.+|+.+|.++.||.|+
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp~k------------qesqlR~EVaILq~l~HPGiV 626 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFPTK------------QESQLRNEVAILQNLHHPGIV 626 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceec-ccCceeeeeeeecccCCCc------------hHHHHHHHHHHHHhcCCCCee
Confidence 33445443 78999999999999976 4999999999955433221 157899999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC-
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD- 195 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~- 195 (337)
.+...|+..+..++|||.+.| +..+.|- .+..+.+++....-++.||+.||.|||-++ |+|+||||+|||+..
T Consensus 627 ~le~M~ET~ervFVVMEKl~G-DMLEMIL--SsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~ 700 (888)
T KOG4236|consen 627 NLECMFETPERVFVVMEKLHG-DMLEMIL--SSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASA 700 (888)
T ss_pred EEEEeecCCceEEEEehhhcc-hHHHHHH--HhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccC
Confidence 999999999999999999955 5544442 245567999999999999999999999555 999999999999974
Q ss_pred --CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 196 --DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 196 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
-.++||+|||.++.++.....+ ...||+.|+|||++....|...-|+||+|+++|.-++|..||......
T Consensus 701 ~~FPQvKlCDFGfARiIgEksFRr---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI----- 772 (888)
T KOG4236|consen 701 SPFPQVKLCDFGFARIIGEKSFRR---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI----- 772 (888)
T ss_pred CCCCceeeccccceeecchhhhhh---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-----
Confidence 3579999999999988765544 468999999999999999999999999999999999999999754321
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
.+.+.. ....++ ...+.+.....++||...|+..-..|-|...-+
T Consensus 773 -ndQIQN------AaFMyP----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 773 -NDQIQN------AAFMYP----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -hHHhhc------cccccC----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 111111 111111 234667777799999999999999998877544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=272.93 Aligned_cols=264 Identities=25% Similarity=0.314 Sum_probs=206.9
Q ss_pred ccCcccccccccccccceEEeeeecCCC------CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-C
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSS------GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-R 111 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 111 (337)
..++..+.+.||.|+||.|++|...... ...||+|........ .....+..|+.+|..+ .
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-------------~~~~~~~~El~~m~~~g~ 360 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-------------SEKKDLMSELNVLKELGK 360 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-------------HHHHHHHHHHHHHHHhcC
Confidence 4455567779999999999999854222 456899987443332 2267899999999999 6
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhh---cC-------C--CcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVS---QG-------R--RELDWLARHRIARGIASGLEYLHMSHRP 179 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~-------~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 179 (337)
|+||+.+.+.+...+..++|+||+.+|+|.++++..+ .- . ..++......++.||+.|++||++..
T Consensus 361 H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-- 438 (609)
T KOG0200|consen 361 HPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-- 438 (609)
T ss_pred CcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 9999999999999999999999999999999997755 00 1 24889999999999999999999665
Q ss_pred CceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccc-cCcccccCCccccCCCCCCcccchhHhHHHHHHHh-
Q 036970 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL-AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM- 257 (337)
Q Consensus 180 ~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~- 257 (337)
++|||+...||++..+..+||+|||+++.............. .-+..|||||.+....|+.++||||+|+++||+++
T Consensus 439 -~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsL 517 (609)
T KOG0200|consen 439 -CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTL 517 (609)
T ss_pred -ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhC
Confidence 999999999999999999999999999976655444432111 13556999999999999999999999999999999
Q ss_pred CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 258 GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 258 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
|..||.+.. ...++.+.++.+..... +..+..+++++++.||+.+|++||++.++.+.|..
T Consensus 518 G~~PYp~~~---~~~~l~~~l~~G~r~~~-------------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 518 GGTPYPGIP---PTEELLEFLKEGNRMEQ-------------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred CCCCCCCCC---cHHHHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 558875421 12233333333322221 22334558999999999999999999999999876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=246.09 Aligned_cols=220 Identities=21% Similarity=0.197 Sum_probs=171.4
Q ss_pred cccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCceEE
Q 036970 52 CWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLV 131 (337)
Q Consensus 52 G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lv 131 (337)
|.+|.||++++. .+++.|++|.+.... ...+|...+....||||+++++++.+....+++
T Consensus 4 g~~~~v~~~~~~-~~~~~~~~K~i~~~~-------------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 63 (237)
T cd05576 4 GVIDKVLLVMDT-RTQQTFILKGLRKSS-------------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLV 63 (237)
T ss_pred cccceEEEEEEc-cCCcEEEEEeecchh-------------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEE
Confidence 899999999865 589999999984431 122334444455799999999999999999999
Q ss_pred EEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCC
Q 036970 132 YEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP 211 (337)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~ 211 (337)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++++|||.+....
T Consensus 64 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 64 LQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred EecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 999999999999843 34589999999999999999999954 59999999999999999999999999876554
Q ss_pred CCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccc
Q 036970 212 NGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTI 291 (337)
Q Consensus 212 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (337)
.... ...++..|+|||...+..++.++|+||+|+++|++++|..|+...... ..... . +
T Consensus 137 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~~--~--~ 195 (237)
T cd05576 137 DSCD-----GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTHT--T--L 195 (237)
T ss_pred cccc-----cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccccc--c--c
Confidence 3211 224467799999998888899999999999999999999886431100 00000 0 0
Q ss_pred cccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 292 DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 292 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
..+......+.+++.+||++||++||++
T Consensus 196 ------~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 196 ------NIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ------CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 0111123448899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=248.46 Aligned_cols=247 Identities=23% Similarity=0.221 Sum_probs=194.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
...+|..+..||+|+||.|-+|..+ .+...||||++.++..- ..+ -.+--+.|-++|... +.|-++.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerk-gtdELyAiKiLkKDVii-----QdD------Dvectm~EKrvLAL~~kppFL~q 414 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERK-GTDELYAIKILKKDVII-----QDD------DVECTMVEKRVLALPGKPPFLVQ 414 (683)
T ss_pred eecccceEEEeccCccceeeeeccc-Ccchhhhhhhhccceee-----ecC------cccceehhhhheecCCCCchHHH
Confidence 4578999999999999999999855 47788999998654331 111 133455677777777 5677889
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
++..|..-+.+|+||||++||+|-..++ .-+.+.+..+.-++..|+.||-+||+. ||+.||||.+||+++.+|
T Consensus 415 lHScFQTmDRLyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 415 LHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEG 487 (683)
T ss_pred HHHHhhhhhheeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCC
Confidence 9999999999999999999999988884 445678888889999999999999955 499999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++||.|||++..-....... ...+||+.|+|||++...+|..+.|.||+|++||||+.|++||++.++ .+.
T Consensus 488 HiKi~DFGmcKEni~~~~TT--kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-------~el 558 (683)
T KOG0696|consen 488 HIKIADFGMCKENIFDGVTT--KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DEL 558 (683)
T ss_pred ceEeeecccccccccCCcce--eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-------HHH
Confidence 99999999997644332222 257999999999999999999999999999999999999999987544 223
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 324 (337)
...+...... .+-..+.+...+.+..|.++|..|..
T Consensus 559 F~aI~ehnvs-----------yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 559 FQAIMEHNVS-----------YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHccCc-----------CcccccHHHHHHHHHHhhcCCccccC
Confidence 3333222211 12223345777888889999999964
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=261.22 Aligned_cols=241 Identities=21% Similarity=0.244 Sum_probs=189.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..+.|.+...+|.|+|+.|-.+.+. .+++..++|++.+.. ....+|+.++... +||||++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~~------------------~~~~~e~~~~~~~~~h~niv~ 380 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESS-PTDQEPAVKIISKRA------------------DDNQDEIPISLLVRDHPNIVK 380 (612)
T ss_pred cchhhccccccCCCCccceeeeecc-ccccchhheeccccc------------------cccccccchhhhhcCCCccee
Confidence 3678899999999999999988755 589999999985441 1234455444444 7999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe-cCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI-DDD 196 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~-~~~ 196 (337)
+++++.++...|+|||.++++-+.+.+. ..+... ..+..|+++|+.++.|||+++ ++|||+||+|||+ +..
T Consensus 381 ~~~v~~~~~~~~~v~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~ 452 (612)
T KOG0603|consen 381 SHDVYEDGKEIYLVMELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSA 452 (612)
T ss_pred ecceecCCceeeeeehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCC
Confidence 9999999999999999999988888773 223333 677789999999999999655 9999999999999 588
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
++++|+|||.+........ ..+-|..|.|||++....|+.++|+||||++||+|++|+.||...-. + .+
T Consensus 453 g~lrltyFG~a~~~~~~~~-----tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~---~---~e 521 (612)
T KOG0603|consen 453 GHLRLTYFGFWSELERSCD-----TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA---G---IE 521 (612)
T ss_pred CcEEEEEechhhhCchhhc-----ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc---h---HH
Confidence 9999999999987765511 22347889999999999999999999999999999999999864221 1 22
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... .+... ...+....+|+.+||+.||.+||++.++..
T Consensus 522 i~~~i~-~~~~s------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 522 IHTRIQ-MPKFS------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHhhc-CCccc------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 222221 22111 223345889999999999999999999864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=263.38 Aligned_cols=267 Identities=24% Similarity=0.328 Sum_probs=213.3
Q ss_pred CCccchhhhhhhh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHH
Q 036970 26 SPLIEKEDLAFLK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI 104 (337)
Q Consensus 26 ~~~~~~~~~~~l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 104 (337)
++...-..++.+. ..+-|++...||.|.+|.||+++.. .+++..|+|+.......+ +++..|.
T Consensus 3 ~~~~~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~~d~d---------------eEiE~ey 66 (953)
T KOG0587|consen 3 AKSLMDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPTEDEE---------------EEIELEY 66 (953)
T ss_pred cccccccchhhCCCCCCccEEEEEEeeccceeEEEEeee-ecCceeeeEeecCCcccc---------------HHHHHHH
Confidence 4445555666666 7899999999999999999999865 489999999986655432 3566688
Q ss_pred HHhcCC-CCCChhhhhceeec-----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCC
Q 036970 105 ITAGQV-RHRNIVPLLARVVR-----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHR 178 (337)
Q Consensus 105 ~~l~~l-~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 178 (337)
.+++.+ .|||++.+++++.- ++.+|+|||||.+||..|+++... +..+.+..+..+++.++.|+.+||.+.
T Consensus 67 nil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk- 143 (953)
T KOG0587|consen 67 NMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK- 143 (953)
T ss_pred HHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc-
Confidence 888888 79999999999864 578899999999999999998765 677999999999999999999999554
Q ss_pred CCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-----CCCCcccchhHhHHHH
Q 036970 179 PRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-----ALSDKCDIYSFGVLLA 253 (337)
Q Consensus 179 ~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~vl~ 253 (337)
++|||||-.||+++.++.||+.|||.+..+..-...+ ....||+.|||||++... .|+..+|+||||++..
T Consensus 144 --viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaI 219 (953)
T KOG0587|consen 144 --VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAI 219 (953)
T ss_pred --eeeecccCceEEEeccCcEEEeeeeeeeeeecccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceee
Confidence 9999999999999999999999999998775443322 246899999999998654 4778899999999999
Q ss_pred HHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 254 VLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 254 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
||--|.+|+.+.-+ ...+-.+. ..++.. ...+...+..+.++|..||.+|-..||+..++++
T Consensus 220 EladG~PPl~DmHP-------mraLF~Ip-RNPPPk-------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 220 EMAEGAPPLCDMHP-------MRALFLIP-RNPPPK-------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhcCCCCCccCcch-------hhhhccCC-CCCCcc-------ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 99999999865322 11111111 111111 1335566777889999999999999999998874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=257.46 Aligned_cols=252 Identities=22% Similarity=0.275 Sum_probs=205.5
Q ss_pred hhhh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCC
Q 036970 35 AFLK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113 (337)
Q Consensus 35 ~~l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 113 (337)
.|-+ +-++++++.-||-||||.|=+++.+. ....+|+|++ ++.+.....+.+.+..|-.+|...+.|
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~-~~~~fAlKil-----------kK~hIVdtkQqeHv~sEr~Im~~~~s~ 480 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNS-QKATFALKIL-----------KKKHIVDTKQQEHVFSERNIMMECRSD 480 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecc-cchHHHHHHH-----------hHhhccchhHHHHHHhHHHHHHhcCch
Confidence 3344 56888999999999999999998753 3335888887 344444445577888999999999999
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
.|++++.-|.++...||+||-|-||.|...+ ...+.+...+..-++.++++|++|||+++ +++|||||+|.++
T Consensus 481 fIvrLYrTfrd~kyvYmLmEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllL 553 (732)
T KOG0614|consen 481 FIVRLYRTFRDSKYVYMLMEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLL 553 (732)
T ss_pred HHHHHHHHhccchhhhhhHHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheee
Confidence 9999999999999999999999999999999 45567899999999999999999999555 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
+.+|-+||.|||.+..+..+.. .+.++||+.|.|||++.+..++.++|.||||+++||+++|.+||.+.++...-..
T Consensus 554 d~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ 630 (732)
T KOG0614|consen 554 DNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL 630 (732)
T ss_pred ccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 9999999999999998865533 3467999999999999999999999999999999999999999987655322222
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 324 (337)
+...+..... +........+||+++.+.+|.+|..
T Consensus 631 ILkGid~i~~----------------Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 631 ILKGIDKIEF----------------PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHhhhhhhhc----------------ccccchhHHHHHHHHHhcCcHhhhc
Confidence 2222222211 1222334778999999999999976
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=236.51 Aligned_cols=272 Identities=22% Similarity=0.322 Sum_probs=197.2
Q ss_pred hhhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 35 AFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 35 ~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
.|....+.|.-+.+||+|.||.||+|+..+ .|+.|++|+...... .+.. -....+|+.+|..|.|+|
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n-~~kkvalkkvlmene---------KeGf---pitalreikiL~~lkHen 77 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKN-TGKKVALKKVLMENE---------KEGF---PITALREIKILQLLKHEN 77 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcC-ccchhHHHHHHHhcc---------ccCC---cHHHHHHHHHHHHhcchh
Confidence 344566788889999999999999999664 788889887633221 1111 235678999999999999
Q ss_pred hhhhhceeec--------CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 036970 115 IVPLLARVVR--------PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDI 186 (337)
Q Consensus 115 i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di 186 (337)
++.+++.|.. ....|+|+.+|++ +|...+. .....++..++.+++.++..||.|+|.+. ++|||+
T Consensus 78 v~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDm 150 (376)
T KOG0669|consen 78 VVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDM 150 (376)
T ss_pred HHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcc
Confidence 9999988754 2346999999977 7888882 23356899999999999999999999555 999999
Q ss_pred CCCcEEecCCCcEEEecccccccCCCCCc--ccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCC
Q 036970 187 QPANVLIDDDMEARISEFGLAKQIPNGRT--RTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSD 263 (337)
Q Consensus 187 ~~~nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~ 263 (337)
|+.|++++.++.++|+|||+++.+..... ........-|..|++||.+.+. .|.++.|+|.-||++.||+++.+.+.
T Consensus 151 KaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 151 KAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred cHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 99999999999999999999976653322 1112233458899999998887 58999999999999999999998876
Q ss_pred CcccccccchHHHHHHHHhhcCC----C-------Ccccccc-ccCCCh---HHHH------HHHHHHHHHhcCCCCCCC
Q 036970 264 DFFQHTKEMSFVQWMRNVMTSEN----P-------SRTIDSK-LIGNGY---EEQM------LLVLKIACFCTFDDPEER 322 (337)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~----~-------~~~~~~~-~~~~~~---~~~~------~~l~~li~~~l~~~p~~R 322 (337)
+... ......+...+.+-. | ...+... +..... .+.. ....+|+..++..||.+|
T Consensus 231 gnte----qqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR 306 (376)
T KOG0669|consen 231 GNTE----QQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKR 306 (376)
T ss_pred CChH----HHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccC
Confidence 5432 222222222221100 0 0111000 111111 1111 247789999999999999
Q ss_pred CCHHHHHH
Q 036970 323 PNSKDVRC 330 (337)
Q Consensus 323 ps~~~il~ 330 (337)
+++.+++.
T Consensus 307 ~~ad~aln 314 (376)
T KOG0669|consen 307 IDADQALN 314 (376)
T ss_pred cchHhhhc
Confidence 99998864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=260.52 Aligned_cols=265 Identities=20% Similarity=0.218 Sum_probs=166.8
Q ss_pred ccCcccccccccccccceEEeeeecCCC----CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSS----GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|.+.+.||+|+||.||+|.+.. + +..||+|++...... +....+ .++...+.+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~-~~~~~~~~vAvK~~~~~~~~----------------e~~~~e--~l~~~~~~~ 190 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVN-KQSKKEGKYVLKKATEYGAV----------------EIWMNE--RVRRACPNS 190 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcC-CccccCcEEEEEEecccchh----------------HHHHHH--HHHhhchhh
Confidence 56899999999999999999998753 5 789999987432211 111111 111112223
Q ss_pred hhhhhce------eecCCCceEEEEeecCCCHHHHHHhhhcC----------------CCcCCHHHHHHHHHHHHHHHHH
Q 036970 115 IVPLLAR------VVRPDCDLLVYEFRRNGSLQDILYDVSQG----------------RRELDWLARHRIARGIASGLEY 172 (337)
Q Consensus 115 i~~~~~~------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------~~~l~~~~~~~~~~~i~~~l~~ 172 (337)
+..+... ...+...++|+||+.+++|.+++...... ........+..++.|++.||.|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~y 270 (566)
T PLN03225 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDG 270 (566)
T ss_pred HHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHH
Confidence 3333222 23456789999999999999998542100 0111233456799999999999
Q ss_pred HhcCCCCCceeCCCCCCcEEecC-CCcEEEecccccccCCCCCcccccccccCcccccCCccccCC--------------
Q 036970 173 LHMSHRPRIIHRDIQPANVLIDD-DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-------------- 237 (337)
Q Consensus 173 lh~~~~~~~~h~di~~~nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------------- 237 (337)
||+. +++||||||+||+++. ++.+||+|||++.......... .....+++.|+|||.+...
T Consensus 271 LH~~---gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~ 346 (566)
T PLN03225 271 LHST---GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 346 (566)
T ss_pred HHHC---CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCcccccccc
Confidence 9955 4999999999999985 5789999999997654332221 1235678999999965322
Q ss_pred --------CCCCcccchhHhHHHHHHHhCCCCCCCcccc------cccchHHHHHHHHhhcCCCCccccccccCCChHHH
Q 036970 238 --------ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH------TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQ 303 (337)
Q Consensus 238 --------~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (337)
.++.++|||||||++|||+++..|++..... ....+...|...... . ........ ....+..
T Consensus 347 ~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~-~~~~~~~~--~~~~d~~ 422 (566)
T PLN03225 347 LSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-R-ASPDLRRG--FEVLDLD 422 (566)
T ss_pred ccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-c-cchhhhhh--hhhcccc
Confidence 2344669999999999999977665431100 001111111111100 0 00000000 0000111
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 304 MLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 304 ~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+|+.+||++||++|||+.++++
T Consensus 423 ~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 423 GGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred chHHHHHHHHHccCCcccCCCHHHHhC
Confidence 223568999999999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=231.12 Aligned_cols=240 Identities=29% Similarity=0.381 Sum_probs=187.7
Q ss_pred ccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCceEEE
Q 036970 53 WNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVY 132 (337)
Q Consensus 53 ~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 132 (337)
+||.||+|... .+|..+++|+......... ...+.+|+..+++++|+|++++++.+......++++
T Consensus 1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~-------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 66 (244)
T smart00220 1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKKK-------------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVM 66 (244)
T ss_pred CceEEEEEEEC-CCCcEEEEEEecccccccH-------------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEE
Confidence 58999999875 3689999999865433111 357888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCC
Q 036970 133 EFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPN 212 (337)
Q Consensus 133 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~ 212 (337)
||+.+++|.+++.. ...++...++.++.+++.++.+||+. +++|+||+|+||+++.++.++++|||.+.....
T Consensus 67 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 67 EYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDP 139 (244)
T ss_pred eCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence 99999999999843 22388999999999999999999955 599999999999999999999999999887654
Q ss_pred CCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCcccc
Q 036970 213 GRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTID 292 (337)
Q Consensus 213 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (337)
... .....++..|+|||...+..++.++|+||||++++++++|..||..... . .................
T Consensus 140 ~~~---~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~---~---~~~~~~~~~~~~~~~~~- 209 (244)
T smart00220 140 GGL---LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ---L---LELFKKIGKPKPPFPPP- 209 (244)
T ss_pred ccc---cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---H---HHHHHHHhccCCCCccc-
Confidence 421 1134568889999999888889999999999999999999999865211 1 11111111111111000
Q ss_pred ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 293 SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 293 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......+.+++.+||..+|++||++.++++
T Consensus 210 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 -------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0002345889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=222.87 Aligned_cols=255 Identities=22% Similarity=0.261 Sum_probs=192.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
.+++|++.+++|+|.++.||.|+.. .++..++||++.+.. ...+.+|+.+|+.|. ||||++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~-~~~eK~ViKiLKPVk-----------------kkKIkREikIL~nL~gg~NIi~ 97 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINI-TNNEKCVIKILKPVK-----------------KKKIKREIKILQNLRGGPNIIK 97 (338)
T ss_pred ccchHHHHHHHcCccHhhHhccccc-CCCceEEEeeechHH-----------------HHHHHHHHHHHHhccCCCCeee
Confidence 6789999999999999999999854 488899999984432 457899999999996 999999
Q ss_pred hhceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 118 LLARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 118 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
++++..+. ....+++||+++.+...+. +.++...+..++.+++.||.|+||.| |.|||+||.|++++.
T Consensus 98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh 167 (338)
T KOG0668|consen 98 LLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDH 167 (338)
T ss_pred hhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeech
Confidence 99998764 5678999999888777766 34788889999999999999999555 999999999999995
Q ss_pred C-CcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 196 D-MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 196 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
. -..+|+|+|++.....+....+. ..+..|--||.+... .|+.+-|+|||||++..|++.+.||-.... ...+
T Consensus 168 ~~rkLrlIDWGLAEFYHp~~eYnVR---VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d--N~DQ 242 (338)
T KOG0668|consen 168 ELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQ 242 (338)
T ss_pred hhceeeeeecchHhhcCCCceeeee---eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC--CHHH
Confidence 4 56999999999988766555443 456778899987664 589999999999999999999999843211 1111
Q ss_pred HHHHHH------------HHhhc--------------CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 036970 274 FVQWMR------------NVMTS--------------ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327 (337)
Q Consensus 274 ~~~~~~------------~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 327 (337)
+..... ...-. .+-...+.+..... .....++++...|+.|.++|+|+.|
T Consensus 243 LVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl----~~peaiDlldklLrYDHqeRlTakE 318 (338)
T KOG0668|consen 243 LVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHL----VSPEAIDLLDKLLRYDHQERLTAKE 318 (338)
T ss_pred HHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccccc----CChHHHHHHHHHHhhccccccchHH
Confidence 111111 10000 00001111111111 1245889999999999999999998
Q ss_pred HHH
Q 036970 328 VRC 330 (337)
Q Consensus 328 il~ 330 (337)
.+.
T Consensus 319 am~ 321 (338)
T KOG0668|consen 319 AMA 321 (338)
T ss_pred Hhc
Confidence 753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=248.81 Aligned_cols=278 Identities=19% Similarity=0.223 Sum_probs=182.0
Q ss_pred ccCcccccccccccccceEEeeeec---------------CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHH
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP---------------GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSE 103 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~---------------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 103 (337)
..++|++.++||+|+||.||+|... ...++.||||.+..........+.+.........+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4679999999999999999999641 1245679999986543322111111100001112334557
Q ss_pred HHHhcCCCCCCh-----hhhhceeec--------CCCceEEEEeecCCCHHHHHHhhhc--------------------C
Q 036970 104 IITAGQVRHRNI-----VPLLARVVR--------PDCDLLVYEFRRNGSLQDILYDVSQ--------------------G 150 (337)
Q Consensus 104 ~~~l~~l~h~ni-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~ 150 (337)
+.++.+++|.++ ++++++|.. .+..++|+||+.+++|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 667777653 3567999999999999999864211 0
Q ss_pred CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccC
Q 036970 151 RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230 (337)
Q Consensus 151 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a 230 (337)
...+++..+..++.|++.+|.|||+. +++|+||||+||+++.++.++|+|||++........... ....+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeC
Confidence 12345677889999999999999955 499999999999999999999999999876543322111 12234789999
Q ss_pred CccccCCC----------------------CCCcccchhHhHHHHHHHhCCC-CCCCcccccc-----cchHHHHHHHHh
Q 036970 231 PECHQTVA----------------------LSDKCDIYSFGVLLAVLMMGKF-PSDDFFQHTK-----EMSFVQWMRNVM 282 (337)
Q Consensus 231 PE~~~~~~----------------------~~~~~DvwslG~vl~~l~~g~~-pf~~~~~~~~-----~~~~~~~~~~~~ 282 (337)
||.+.... ...+.|+||+||++++|+++.. ||........ ......|. ..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~ 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MY 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hh
Confidence 99875422 1124699999999999999885 7653211110 01111111 11
Q ss_pred hcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHH
Q 036970 283 TSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDP---EERPNSKDVRC 330 (337)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~~il~ 330 (337)
.... .+ ....+.......+++.+||.++| .+|+|+.++++
T Consensus 457 ~~~~----~~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 KGQK----YD----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccC----CC----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1111 01 11123334558899999998766 68999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=231.44 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=197.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|+.++.||+|++..|-++++. .+.+.||+|++.+....+.+ -+.-.+.|-.+..+- +||-++-
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~ndde-----------didwvqtek~vfe~asn~pflvg 315 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELVNDDE-----------DIDWVQTEKHVFEQASNNPFLVG 315 (593)
T ss_pred ccccceeeeeecCcchhhhhheehc-ccceeeehhhHHHHhcCCcc-----------cchhHHhhHHHHHhccCCCeEEe
Confidence 3579999999999999999999976 48899999998554332211 134456666666666 7999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
++..|..+..+++|.||++||+|--.+ +..++++++.+.-+...|+.||.|||+.+ |+.||+|.+|++++..|
T Consensus 316 lhscfqtesrlffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeg 388 (593)
T KOG0695|consen 316 LHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEG 388 (593)
T ss_pred hhhhhcccceEEEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCC
Confidence 999999999999999999999997777 45677999999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+.|+|++..-...... ....+||+-|.|||++.+..|..+.|.|+||++++||+.|+.||+-.-....+.+-...
T Consensus 389 hikltdygmcke~l~~gd~--tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy 466 (593)
T KOG0695|consen 389 HIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY 466 (593)
T ss_pred ceeecccchhhcCCCCCcc--cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH
Confidence 9999999999765433322 23579999999999999999999999999999999999999999732111222222222
Q ss_pred HHHHhhcC--CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC
Q 036970 278 MRNVMTSE--NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324 (337)
Q Consensus 278 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 324 (337)
+-++...+ ++++.+. .....+++.-|++||.+|..
T Consensus 467 lfqvilekqiriprsls------------vkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 467 LFQVILEKQIRIPRSLS------------VKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHHHhhhcccccceee------------hhhHHHHHHhhcCCcHHhcC
Confidence 22222222 2222222 22567788889999999964
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=247.59 Aligned_cols=221 Identities=21% Similarity=0.323 Sum_probs=182.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
..-|-.++-||-|+||.|-+++ +.++...||+|.+.+..... ......+..|-.+|..-+.+=|++++
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~-KvDT~~lYAmKTLrKaDVl~-----------rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVR-KVDTRALYAMKTLRKADVLM-----------RNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred ccceEEEeeecccccceeEEEe-ecchhhHHHHhhhHHHHHHh-----------hhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 3556677889999999999997 66688999999985543211 11245677888999998999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
-.|.+.+.+|+||+|++||++-.++.. -+.+++..+.-++..+.+|+++.| ++|++||||||+|||||.+|++
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCce
Confidence 999999999999999999999998854 356899999999999999999999 7789999999999999999999
Q ss_pred EEecccccccCC---CCCcc-------------------------------------cccccccCcccccCCccccCCCC
Q 036970 200 RISEFGLAKQIP---NGRTR-------------------------------------TTTWSLAETVGYIAPECHQTVAL 239 (337)
Q Consensus 200 kl~Dfg~~~~~~---~~~~~-------------------------------------~~~~~~~g~~~y~aPE~~~~~~~ 239 (337)
||.|||+++-+. +...+ .......||+-|+|||++....|
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 999999987321 10000 01125678999999999999999
Q ss_pred CCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 240 SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 240 ~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
+..+|.||.|+|||||+.|++||....+.+.......|..
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh
Confidence 9999999999999999999999998777666666555543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=235.65 Aligned_cols=267 Identities=20% Similarity=0.268 Sum_probs=207.5
Q ss_pred hh-ccCcccccccccccccceEEeeeecCC----CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC
Q 036970 37 LK-KEDCFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111 (337)
Q Consensus 37 l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 111 (337)
+. ...+++...++.+|.||.||.|.++.. +.+.|.+|.+.+ .. ..-+...+..|...+..+.
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-----------~A--S~iQv~~~L~es~lly~~s 345 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-----------HA--SQIQVNLLLQESMLLYGAS 345 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-----------cc--cHHHHHHHHHHHHHHhcCc
Confidence 44 457788889999999999999976421 223445554421 11 1122567888999999999
Q ss_pred CCChhhhhceeecC-CCceEEEEeecCCCHHHHHHhhh----cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 036970 112 HRNIVPLLARVVRP-DCDLLVYEFRRNGSLQDILYDVS----QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDI 186 (337)
Q Consensus 112 h~ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di 186 (337)
|||++.+.+++.++ ...++++.+...|+|+.|+...+ ...+.++..+...++.|++.|++||| +.|++|.||
T Consensus 346 H~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDi 422 (563)
T KOG1024|consen 346 HPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDI 422 (563)
T ss_pred CCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchh
Confidence 99999999998765 56688889998999999997332 34566788888999999999999999 555999999
Q ss_pred CCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCc
Q 036970 187 QPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDF 265 (337)
Q Consensus 187 ~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~ 265 (337)
...|+.+++..++||+|=.+++.+-..+.+.....-..+..||+||.+....|+.++|+||||+++|||++ |+.|+.+.
T Consensus 423 AaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 423 AARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred hhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 99999999999999999999998877766655555555788999999999999999999999999999998 77898764
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
++.+ ....+.... +. ..+.+++.+++.++.-||+..|++||+++++..-|+++.
T Consensus 503 DPfE----m~~ylkdGy---Rl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 503 DPFE----MEHYLKDGY---RL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred CHHH----HHHHHhccc---ee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 4321 122222211 11 123345556999999999999999999999999888763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=257.51 Aligned_cols=242 Identities=25% Similarity=0.381 Sum_probs=184.8
Q ss_pred ccccccccce-EEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeec
Q 036970 47 EKIRSCWNGE-VYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVR 124 (337)
Q Consensus 47 ~~lg~G~~g~-vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~ 124 (337)
+.+|.|+.|+ ||.|.+ .|+.||||.+.... .....+|+..|+.- .||||+++++.-.+
T Consensus 515 eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll~e~-----------------~~~A~rEi~lL~eSD~H~NviRyyc~E~d 574 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY---EGREVAVKRLLEEF-----------------FDFAQREIQLLQESDEHPNVIRYYCSEQD 574 (903)
T ss_pred HHcccCCCCcEEEEEee---CCceehHHHHhhHh-----------------HHHHHHHHHHHHhccCCCceEEEEeeccC
Confidence 5688998865 799987 68999999883321 34567899999888 69999999999999
Q ss_pred CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC---C--CcE
Q 036970 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD---D--MEA 199 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~---~--~~~ 199 (337)
+...||..|.| ..+|.+++...............+.++.|++.|+++||+.+ +|||||||+||||+. + .++
T Consensus 575 ~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra 650 (903)
T KOG1027|consen 575 RQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRA 650 (903)
T ss_pred CceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeE
Confidence 99999999999 55999999653111111111445789999999999999666 999999999999985 2 468
Q ss_pred EEecccccccCCCCCc-ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhC-CCCCCCcccccccchHHHH
Q 036970 200 RISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMG-KFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g-~~pf~~~~~~~~~~~~~~~ 277 (337)
+|+|||++..+..... ........||-+|+|||++.....+.++||||+||++|++++| ..||++....
T Consensus 651 ~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--------- 721 (903)
T KOG1027|consen 651 KISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--------- 721 (903)
T ss_pred EecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh---------
Confidence 9999999998875433 2334567889999999999999888999999999999999997 6999875331
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
...++........+.+. .++ ...+||.+|++++|..||++.+|+
T Consensus 722 ~~NIl~~~~~L~~L~~~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 722 QANILTGNYTLVHLEPL------PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hhhhhcCccceeeeccC------chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11122222222111111 111 588999999999999999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=233.99 Aligned_cols=266 Identities=22% Similarity=0.221 Sum_probs=195.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-----C-
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-----H- 112 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h- 112 (337)
..++|-+.++||.|-|++||++ ++.+..+.||+|+..... ...+....||.+|.+++ |
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLa-wDtq~~r~VAlKVvKSAq---------------hYtEaAlDEIklL~~v~~~Dp~~~ 139 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLA-WDTQNKRYVALKVVKSAQ---------------HYTEAALDEIKLLQQVREGDPNDP 139 (590)
T ss_pred cCceEEEEEeccccccceeEEE-eeccCCeEEEEEEEehhh---------------HHHHHHHHHHHHHHHHHhcCCCCC
Confidence 4589999999999999999999 466789999999984321 11456778999998883 2
Q ss_pred --CChhhhhceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 036970 113 --RNIVPLLARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDI 186 (337)
Q Consensus 113 --~ni~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di 186 (337)
.+|+++++.|.. +...+||+|++ |.+|..+|.. ...+-++...+..|+.||+.||.|||..+ ||+|.||
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDl 214 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDL 214 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCC
Confidence 358999999875 44669999999 6689888865 45667999999999999999999999887 8999999
Q ss_pred CCCcEEecCC----------------------------------------------------------------------
Q 036970 187 QPANVLIDDD---------------------------------------------------------------------- 196 (337)
Q Consensus 187 ~~~nil~~~~---------------------------------------------------------------------- 196 (337)
||+|||+..+
T Consensus 215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~ 294 (590)
T KOG1290|consen 215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI 294 (590)
T ss_pred CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence 9999996000
Q ss_pred --------------------------------------------------------------------------------
Q 036970 197 -------------------------------------------------------------------------------- 196 (337)
Q Consensus 197 -------------------------------------------------------------------------------- 196 (337)
T Consensus 295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~ 374 (590)
T KOG1290|consen 295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI 374 (590)
T ss_pred cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence
Q ss_pred ----------------CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCC
Q 036970 197 ----------------MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKF 260 (337)
Q Consensus 197 ----------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~ 260 (337)
.+|||+|||.+++...+.+.. ..|..|+|||++.+..|++.+||||++|+++||.||..
T Consensus 375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~D-----IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDy 449 (590)
T KOG1290|consen 375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTED-----IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDY 449 (590)
T ss_pred ccccccCCCCCCCccceeEEEeeccchhhhhhhhchh-----hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCce
Confidence 014555555555444333322 23778999999999999999999999999999999999
Q ss_pred CCCCcccccccchHHHHHHHHhh----------cCCCC-ccccc-------------c---c---cCCChHHHHHHHHHH
Q 036970 261 PSDDFFQHTKEMSFVQWMRNVMT----------SENPS-RTIDS-------------K---L---IGNGYEEQMLLVLKI 310 (337)
Q Consensus 261 pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~-~~~~~-------------~---~---~~~~~~~~~~~l~~l 310 (337)
.|++........+-.....-+.. .+.-. ..+.. . + ....+.+...++.++
T Consensus 450 LFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdF 529 (590)
T KOG1290|consen 450 LFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDF 529 (590)
T ss_pred eecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHH
Confidence 99876554443333332221111 11110 00100 0 0 012244567889999
Q ss_pred HHHhcCCCCCCCCCHHHHHH
Q 036970 311 ACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 311 i~~~l~~~p~~Rps~~~il~ 330 (337)
+.-||+.+|+.||||.+.++
T Consensus 530 L~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 530 LSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHHhcCccccccHHHHhc
Confidence 99999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=212.78 Aligned_cols=207 Identities=22% Similarity=0.344 Sum_probs=174.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
+.++...+..||+|++|.|-+-++. .+|...|+|.+..... .+...++.+|+.+...- .+|.++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~-~sg~imAvKri~~tvn-------------~q~q~r~L~dldi~~r~~~CPf~V~ 109 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVN-------------SQEQKRLLMDLDIIMRTVDCPFTVH 109 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeec-cCCeEEEEeeehhhcC-------------hHHHHHHHHhhhhhccCCCCCeEEE
Confidence 5566777889999999999999876 6999999999844322 12256778888766555 7899999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++.+......|+-||.++. ||..+....-..++.+++...-+++..++.||.|||++- .++|||+||+|||++..|
T Consensus 110 FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~G 186 (282)
T KOG0984|consen 110 FYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDG 186 (282)
T ss_pred eehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCC
Confidence 99999999999999999954 898888777778889999999999999999999999763 599999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCC----CCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV----ALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
++|++|||.+-.+.++-.... ..|...|+|||.+... .|+.++||||||+++.||.+++.||...
T Consensus 187 qVKiCDFGIsG~L~dSiAkt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDSIAKTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cEEEcccccceeehhhhHHHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 999999999987765544332 2567789999987543 6899999999999999999999998754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-33 Score=226.51 Aligned_cols=204 Identities=25% Similarity=0.342 Sum_probs=166.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
+.+.+..+.||.|+||.||.++++ .+|+.|++|++.+-...... -..+.+|+.++..++|.|++...
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDP-RdgrrvalkK~pnvfq~L~s------------~krvFre~kmLcfFkHdNVLSaL 118 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDP-RSGKRVALKKMPNVFQNLAS------------CKRVFREIKMLSSFRHDNVLSLL 118 (449)
T ss_pred cccCCCCCcccccceeEEEeccCC-CCccchhHhhcchHHHHHHH------------HHHHHHHHHHHHhhccccHHHHH
Confidence 345667799999999999999976 59999999998664432221 45788999999999999999999
Q ss_pred ceeecCC-----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 120 ARVVRPD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 120 ~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
+...... ..|+++|.+.. +|...| .+.+.++...+.-++.||+.||+|||+.+ |.||||||.|.+++
T Consensus 119 DILQPph~dfFqEiYV~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVN 190 (449)
T KOG0664|consen 119 DILQPANPSFFQELYVLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVN 190 (449)
T ss_pred HhcCCCCchHHHHHHHHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEec
Confidence 8876543 34677887744 677766 67788999999999999999999999666 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
.+...||+|||+++........... .-.-|..|+|||.+.+. .|+.+.||||+||++.|++..+..|...
T Consensus 191 SNCvLKICDFGLARvee~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 191 SNCILKICDFGLARTWDQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred cCceEEecccccccccchhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 9999999999999876533222211 12337789999999887 4899999999999999999988888653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=239.91 Aligned_cols=208 Identities=24% Similarity=0.296 Sum_probs=176.6
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC---CCC
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR---HRN 114 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~n 114 (337)
+.-.+|..++.+|.|+||.|++|.++. +...|+||.+.+...-.....+..... .+-.|+.+|..|+ |+|
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~-n~~eVViK~I~KeRIL~DtWvrDrkLG------tVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKE-NNYEVVIKMIFKERILVDTWVRDRKLG------TVPSEIQILATLNKHSHEN 630 (772)
T ss_pred cccccceeeeeccccccceEEEeeecc-cceEEEeeehhhhhhhhhhhhcccccC------ccchhHHHHHHhhhcCccc
Confidence 345679999999999999999999875 689999999987766555444433222 3456999999996 999
Q ss_pred hhhhhceeecCCCceEEEEeec-CCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 115 IVPLLARVVRPDCDLLVYEFRR-NGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
|++++++|++++.+|++||... +.+|+++|. -.+.+++.....++.|++.|+++||+. ||+|||||.+|+.+
T Consensus 631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenviv 703 (772)
T KOG1152|consen 631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIV 703 (772)
T ss_pred hhhhhheeecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEE
Confidence 9999999999999999999873 579999993 445689999999999999999999955 59999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCC-CcccchhHhHHHHHHHhCCCCCC
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALS-DKCDIYSFGVLLAVLMMGKFPSD 263 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~vl~~l~~g~~pf~ 263 (337)
+.+|-+||+|||.+....++... ..+||..|.|||++.+.+|- ..-|||++|+++|.++....||-
T Consensus 704 d~~g~~klidfgsaa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ecCCeEEEeeccchhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999999876655443 35899999999999998874 46899999999999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=234.47 Aligned_cols=269 Identities=17% Similarity=0.183 Sum_probs=203.0
Q ss_pred hh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC----
Q 036970 37 LK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR---- 111 (337)
Q Consensus 37 l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---- 111 (337)
.+ ..++|.+....|+|-||+|-.|++. ..|..||||++.+...+. ..=..|+.+|.+|.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~-~r~~~vAiKIIRnNE~M~---------------KtGl~EleiLkKL~~AD~ 490 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQ-ARGQEVAIKIIRNNEVMH---------------KTGLKELEILKKLNDADP 490 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeecccc-CCCCeeEEEEeecchHHh---------------hhhhHHHHHHHHhhccCc
Confidence 55 5789999999999999999999855 477899999998776643 23466999999994
Q ss_pred --CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCC
Q 036970 112 --HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189 (337)
Q Consensus 112 --h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ 189 (337)
-.|+++++..|...+.+|||+|-+ ..+|.+.+...... -.|....+..++.|++.||.+|-.++ ++|.||||.
T Consensus 491 Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPD 565 (752)
T KOG0670|consen 491 EDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPD 565 (752)
T ss_pred hhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCcc
Confidence 357999999999999999999988 77999999876443 44788899999999999999999666 999999999
Q ss_pred cEEecCC-CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc
Q 036970 190 NVLIDDD-MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268 (337)
Q Consensus 190 nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~ 268 (337)
|||+++. ..+||||||.+.......... ..-+..|.|||++.|.+|+...|+||+||+|||+.||+..|.+....
T Consensus 566 NiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 566 NILVNESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred ceEeccCcceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 9999965 567999999998765432211 12256799999999999999999999999999999999988764321
Q ss_pred cccchHHH--------HHHHH-----------------------------hhcCCCCccccccc-----cCCChHHHHHH
Q 036970 269 TKEMSFVQ--------WMRNV-----------------------------MTSENPSRTIDSKL-----IGNGYEEQMLL 306 (337)
Q Consensus 269 ~~~~~~~~--------~~~~~-----------------------------~~~~~~~~~~~~~~-----~~~~~~~~~~~ 306 (337)
.+..-.++ +++.. +....|...+.+.+ ..+..+..+..
T Consensus 642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~ 721 (752)
T KOG0670|consen 642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ 721 (752)
T ss_pred HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence 11111110 00000 00001111111111 11223455788
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 307 VLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 307 l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+.+|+..||..||+.|.|.++.|+
T Consensus 722 ~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 722 LRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHHHhccChhhcCCHHHHhc
Confidence 999999999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=218.21 Aligned_cols=267 Identities=24% Similarity=0.319 Sum_probs=197.4
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..-..+|.-++.+|.|+. .|-.|- +...+++|++|+...+.... ....+..+|...+..+.|+||+
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~-D~v~~~~v~ikk~~~pf~n~------------~~akra~rel~l~~~v~~~nii 78 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAF-DQVLGRPVAIKKLSRPFQNQ------------THAKRAYRELKLMKCVNHKNII 78 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecc-hhhccCceehhhhcCccccC------------ccchhhhhhhhhhhhhccccee
Confidence 345678999999999999 565664 55689999999997763221 1145678899999999999999
Q ss_pred hhhceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 117 PLLARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 117 ~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
+++.+|.-.. ..|+|||++ +.+|...+. -.+.-.++..++.|.+.|++|||+. |++||||||+|
T Consensus 79 ~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsn 148 (369)
T KOG0665|consen 79 SLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSN 148 (369)
T ss_pred eeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCccc
Confidence 9999997654 348999999 568988884 2366778889999999999999955 59999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccc---
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ--- 267 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~--- 267 (337)
|++..+..+||.|||+++.-... -.......|..|.|||++.+..+.+.+||||+||++.||++|...|.+...
T Consensus 149 ivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ 225 (369)
T KOG0665|consen 149 IVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ 225 (369)
T ss_pred ceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence 99999999999999999875433 111234568889999999999999999999999999999999988875332
Q ss_pred --------ccccchHHHHHHH----HhhcCC------CCccccccc---cCCChHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 036970 268 --------HTKEMSFVQWMRN----VMTSEN------PSRTIDSKL---IGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326 (337)
Q Consensus 268 --------~~~~~~~~~~~~~----~~~~~~------~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 326 (337)
+..+..+...+.. ...+.+ ..+.++... ...........+.+++.+||-.||++|.|+.
T Consensus 226 ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~ 305 (369)
T KOG0665|consen 226 WNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD 305 (369)
T ss_pred HHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH
Confidence 1122222222221 111111 011111111 0111223346688999999999999999999
Q ss_pred HHHH
Q 036970 327 DVRC 330 (337)
Q Consensus 327 ~il~ 330 (337)
+++.
T Consensus 306 daL~ 309 (369)
T KOG0665|consen 306 DALR 309 (369)
T ss_pred HHhc
Confidence 9874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=210.66 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=192.5
Q ss_pred cchhhhhhhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhc
Q 036970 29 IEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAG 108 (337)
Q Consensus 29 ~~~~~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 108 (337)
|-..++.-+...+.|.+.+.||.|.||.+-+++++ .+.+.+++|.+..+.+. ...|.+|...--
T Consensus 12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p~tt---------------~~dF~rEfhY~~ 75 (378)
T KOG1345|consen 12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRPQTT---------------QADFVREFHYSF 75 (378)
T ss_pred cccccccccchhhhhhHHHHhcccceeeEEeeecc-CCceEEEeeccCcchhh---------------HHHHHHHhccce
Confidence 33344444567899999999999999999999977 48899999999777654 456888886655
Q ss_pred CC-CCCChhhhhce-eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 036970 109 QV-RHRNIVPLLAR-VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDI 186 (337)
Q Consensus 109 ~l-~h~ni~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di 186 (337)
.| .|.||+..+++ |+..+.+++++||++.|+|...+ ....+.+....+++.|+++||.|||+.+ +|||||
T Consensus 76 ~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdl 147 (378)
T KOG1345|consen 76 FLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDL 147 (378)
T ss_pred eeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhccc
Confidence 55 58999988764 56677888999999999999988 3345788888999999999999999777 999999
Q ss_pred CCCcEEecC--CCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-----CCCCcccchhHhHHHHHHHhCC
Q 036970 187 QPANVLIDD--DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-----ALSDKCDIYSFGVLLAVLMMGK 259 (337)
Q Consensus 187 ~~~nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~vl~~l~~g~ 259 (337)
|.+|||+.. ..++||+|||.++..+.--... .-+..|.+||..... ...+.+|+|.||+++|.+++|.
T Consensus 148 K~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~-----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~ 222 (378)
T KOG1345|consen 148 KAENILIFDADFYRVKLCDFGLTRKVGTTVKYL-----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGK 222 (378)
T ss_pred ccceEEEecCCccEEEeeecccccccCceehhh-----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCC
Confidence 999999973 4589999999998765322211 124558888864322 3467899999999999999999
Q ss_pred CCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 260 FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 260 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
.||.... ..+..+.+|..- ..+... .++. . .......+..+.++-|..+|++|=.+.+..++
T Consensus 223 ~PWQka~--~~d~~Y~~~~~w--~~rk~~-~~P~-~----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 223 FPWQKAS--IMDKPYWEWEQW--LKRKNP-ALPK-K----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred Ccchhhh--ccCchHHHHHHH--hcccCc-cCch-h----hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 9998432 234444443321 111111 1111 1 11222347788888999999999555554443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-29 Score=206.79 Aligned_cols=212 Identities=31% Similarity=0.444 Sum_probs=179.6
Q ss_pred ccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCc
Q 036970 49 IRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD 128 (337)
Q Consensus 49 lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 128 (337)
||.|.+|.||++... .++..+++|......... ....+.+|+..++.+.|++++++++++......
T Consensus 1 l~~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~-------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 66 (215)
T cd00180 1 LGEGGFGTVYLARDK-KTGKKVAIKIIKKEDSSS-------------LLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66 (215)
T ss_pred CCcCCceEEEEEEec-CCCcEEEEEEeccccchh-------------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeE
Confidence 689999999999865 369999999986554321 145788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC-CCcEEEeccccc
Q 036970 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DMEARISEFGLA 207 (337)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~~kl~Dfg~~ 207 (337)
++++|++.+++|.+++.... ..++...++.++.+++.++.+||+. +++|+||+|.||+++. ++.++|+||+.+
T Consensus 67 ~~~~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~ 140 (215)
T cd00180 67 YLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLS 140 (215)
T ss_pred EEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCce
Confidence 99999999899999985421 4688999999999999999999955 5999999999999999 899999999998
Q ss_pred ccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCC
Q 036970 208 KQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286 (337)
Q Consensus 208 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (337)
........ ......+...|++||..... .++.++|+|++|++++++
T Consensus 141 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------- 187 (215)
T cd00180 141 KLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------- 187 (215)
T ss_pred EEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence 76654321 11123457789999998887 788899999999999998
Q ss_pred CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 128899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=235.36 Aligned_cols=255 Identities=27% Similarity=0.367 Sum_probs=202.5
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
+..++|+.+..+|.|++|.||+|++. .+++..|+|.+.-..... .+-++.|+.+++..+||||+.
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~-~s~elaavkvVkLep~dd--------------~~~iqqei~~~~dc~h~niva 76 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDK-RSGELAAVKVVKLEPGDD--------------FSGIQQEIGMLRDCRHPNIVA 76 (829)
T ss_pred CCccchhheeeecCCcccchhhhccc-ccCchhhheeeeccCCcc--------------ccccccceeeeecCCCcChHH
Confidence 57899999999999999999999966 599999999985443322 456788999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++.+...+.+|+.||||.+|+|.+.. ..-+++++.++..+.+..+.|++|||+. |-+|||||-.||++++.|
T Consensus 77 y~gsylr~dklwicMEycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~g 149 (829)
T KOG0576|consen 77 YFGSYLRRDKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEG 149 (829)
T ss_pred HHhhhhhhcCcEEEEEecCCCccccee----eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccC
Confidence 999999999999999999999999987 5667899999999999999999999955 499999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccc---cCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH---QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
.+|+.|||.+..+..-..++. ...||+.|||||+. ....|...+|+|++|+...|+-.-++|-.+.- +.
T Consensus 150 DvklaDfgvsaqitati~Krk--sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh------pm 221 (829)
T KOG0576|consen 150 DVKLADFGVSAQITATIAKRK--SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH------PM 221 (829)
T ss_pred ceeecccCchhhhhhhhhhhh--cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc------hH
Confidence 999999999877764433332 46899999999975 34578999999999999999998888843211 11
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
+......-+...+..+-| .......+.++++.+|.++|..|||++.++
T Consensus 222 r~l~LmTkS~~qpp~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred HHHHHhhccCCCCCcccC-------CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 111111111111111111 122334577888889999999999998765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=217.40 Aligned_cols=212 Identities=23% Similarity=0.296 Sum_probs=174.3
Q ss_pred CccchhhhhhhhccCcccccccccccccceEEeeeecCC--CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHH
Q 036970 27 PLIEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI 104 (337)
Q Consensus 27 ~~~~~~~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 104 (337)
+.+.+.-+.+-...+.|..+.+||.|.|++||+|.+..+ ....||+|.+..... ..++.+|+
T Consensus 22 ee~~~l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----------------p~ri~~El 85 (418)
T KOG1167|consen 22 EEIEQLRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----------------PSRILNEL 85 (418)
T ss_pred hHHHHHHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------------chHHHHHH
Confidence 444455555556788999999999999999999987643 578899999855433 45789999
Q ss_pred HHhcCC-CCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 036970 105 ITAGQV-RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183 (337)
Q Consensus 105 ~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h 183 (337)
.+|..+ .+.||+++.+.+..++...+|+||+++..-.+++.. ++...+..+++.++.||.++| ++||+|
T Consensus 86 ~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h---~~GIvH 155 (418)
T KOG1167|consen 86 EMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLH---KNGIVH 155 (418)
T ss_pred HHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhh---ccCccc
Confidence 999999 699999999999999999999999999999998832 678889999999999999999 555999
Q ss_pred CCCCCCcEEec-CCCcEEEecccccccCCCC------------------------------------------Ccccccc
Q 036970 184 RDIQPANVLID-DDMEARISEFGLAKQIPNG------------------------------------------RTRTTTW 220 (337)
Q Consensus 184 ~di~~~nil~~-~~~~~kl~Dfg~~~~~~~~------------------------------------------~~~~~~~ 220 (337)
|||||+|++.+ ..+...|.|||++...... .......
T Consensus 156 RDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~a 235 (418)
T KOG1167|consen 156 RDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERA 235 (418)
T ss_pred cCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceec
Confidence 99999999998 5678999999999721100 0001122
Q ss_pred cccCcccccCCccccCCC-CCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 221 SLAETVGYIAPECHQTVA-LSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 221 ~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
...||++|+|||++...+ .+++.||||.|+++..++++..||-.
T Consensus 236 nrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 236 NRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred ccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccccccc
Confidence 456799999999987764 68899999999999999999999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=203.27 Aligned_cols=200 Identities=29% Similarity=0.389 Sum_probs=168.2
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhcee
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARV 122 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~ 122 (337)
|.+.+.||.|++|.||+|... .++..+++|........ .....+.+|+..++.++|+|++++++.+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~~~~~~~~~i~~~~~~~ 66 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK-GTGELVAVKVLKKEKTE-------------KQREEFLREIRILKKLKHPNIVKLYGVF 66 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc-CCCcEEEEEeeccccch-------------HHHHHHHHHHHHHHhCCCCChhhheeee
Confidence 567889999999999999875 36899999998654332 1256788899999999999999999999
Q ss_pred ecCCCceEEEEeecCCCHHHHHHhhhcCCCc-CCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRE-LDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
......++++|++++++|.+++... .. +++...+.++.+++.++.+||+. +++|+|++|.||+++.++.++|
T Consensus 67 ~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l 139 (225)
T smart00221 67 EDPEPLYLVMEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKL 139 (225)
T ss_pred ecCCceEEEEeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999998542 23 78999999999999999999955 5999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccc-cCCCCCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH-QTVALSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
+|||.+......... ......++..|++||.. ....++.++|+|+||++++++++|..||..
T Consensus 140 ~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 140 ADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999988876544210 11124567789999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=194.54 Aligned_cols=262 Identities=20% Similarity=0.262 Sum_probs=206.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPL 118 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~ 118 (337)
.-.|+++++||+|.||.++.|.+ --++..||||.-..... ..++..|.+..+.| ..++|...
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~N-l~nne~VAIKfEPrkS~----------------APQLrdEYr~YKlL~g~~GIP~v 89 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKN-LYNNEPVAIKFEPRKSE----------------APQLRDEYRTYKLLGGTEGIPQV 89 (449)
T ss_pred cccceeccccccCcceeeecccc-cccCceEEEEeccccCC----------------cchHHHHHHHHHHHcCCCCCCce
Confidence 35799999999999999999984 45899999998744322 45788999999888 57999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC--
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-- 196 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~-- 196 (337)
+-+..++....+|+|.+ |.||+|+.. -.++.++..++..++.|++.-++++|++. ++.|||||+|+||...
T Consensus 90 YYFGqeG~~NiLVidLL-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~ 162 (449)
T KOG1165|consen 90 YYFGQEGKYNILVIDLL-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGT 162 (449)
T ss_pred eeeccccchhhhhhhhh-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCC
Confidence 98888888889999998 889999984 46778999999999999999999999777 9999999999999743
Q ss_pred ---CcEEEecccccccCCCCCc-----ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc
Q 036970 197 ---MEARISEFGLAKQIPNGRT-----RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268 (337)
Q Consensus 197 ---~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~ 268 (337)
+.+.++|||++..+....+ .+...+..||.+||+-..+.+...+.+.|+-|||-|+++++-|..||.+....
T Consensus 163 k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 163 KDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred CCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 3489999999998765544 34455788999999999999999999999999999999999999999986553
Q ss_pred cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 269 TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.....+.+ .+...+......+....+++...-...++++ +-.+-|..+-+..+|.++
T Consensus 243 tnK~kYeK-------IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L---~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 243 TNKEKYEK-------IGETKRSTPIEVLCEGFPEEFATYLRYVRRL---DFFETPDYDYLRKLFDDV 299 (449)
T ss_pred chHHHHHH-------hccccccCCHHHHHhcCHHHHHHHHHHHHhc---CcccCCCHHHHHHHHHHH
Confidence 32222222 2333333333333444555555555554443 777889988888777654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=233.17 Aligned_cols=194 Identities=17% Similarity=0.200 Sum_probs=134.6
Q ss_pred CC-CChhhhhcee-------ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 036970 111 RH-RNIVPLLARV-------VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRII 182 (337)
Q Consensus 111 ~h-~ni~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~ 182 (337)
+| +||.++++++ .+....+.++|++ +++|.+++.. ....+++..+..++.||+.||.|||+++ |+
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 45 5788888877 2334567788987 6699999953 2456899999999999999999999555 99
Q ss_pred eCCCCCCcEEecCCCc-------------------EEEecccccccCCCCCc--------------ccccccccCccccc
Q 036970 183 HRDIQPANVLIDDDME-------------------ARISEFGLAKQIPNGRT--------------RTTTWSLAETVGYI 229 (337)
Q Consensus 183 h~di~~~nil~~~~~~-------------------~kl~Dfg~~~~~~~~~~--------------~~~~~~~~g~~~y~ 229 (337)
||||||+|||++..+. +|++|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999965444 45555555543211000 00011235788899
Q ss_pred CCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHH
Q 036970 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLK 309 (337)
Q Consensus 230 aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 309 (337)
|||++.+..++.++|||||||++|||+++.+|+..... ......... .+ +.. .........
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~~----~~-----~~~-----~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHRV----LP-----PQI-----LLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHhh----cC-----hhh-----hhcCHHHHH
Confidence 99999999999999999999999999999888643110 111111110 00 000 011223567
Q ss_pred HHHHhcCCCCCCCCCHHHHHH
Q 036970 310 IACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 310 li~~~l~~~p~~Rps~~~il~ 330 (337)
++.+||+++|.+||++.++++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999975
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=199.79 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=189.4
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC----CCChhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR----HRNIVP 117 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~ni~~ 117 (337)
+|.+.++||.|+||.||.|.+.......+|+|......... ...+..|+.++..+. ..++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--------------~~~l~~E~~vl~~l~~~~~~~~~~~ 84 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--------------PSVLKIEIQVLKKLEKKNGPSHFPK 84 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--------------CccchhHHHHHHHHhhhcCCCCCCE
Confidence 89999999999999999998763234678888875432211 114556777777765 257888
Q ss_pred hhcee-ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 118 LLARV-VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 118 ~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
+++.. ..+...++||+.+ |.+|.++..... .+.++..++..++.|++.+|++||+.+ ++||||||.|+.+...
T Consensus 85 ~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~ 158 (322)
T KOG1164|consen 85 LLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQS 158 (322)
T ss_pred EEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCC
Confidence 88888 5777889999998 889999875533 577999999999999999999999555 9999999999999865
Q ss_pred -----CcEEEecccccc--cCC-CCC----cccc-cccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCC
Q 036970 197 -----MEARISEFGLAK--QIP-NGR----TRTT-TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSD 263 (337)
Q Consensus 197 -----~~~kl~Dfg~~~--~~~-~~~----~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~ 263 (337)
..+.+.|||+++ ... ... ..+. .....||..|.++..+.+...+.+.|+||+++++.+++.|..||.
T Consensus 159 ~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~ 238 (322)
T KOG1164|consen 159 SRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWE 238 (322)
T ss_pred CCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCc
Confidence 358999999998 332 111 1111 234569999999999999999999999999999999999999997
Q ss_pred CcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 264 DFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
...................... .....+.+...+... +-..+..++|....+...|.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 239 ALEMTDLKSKFEKDPRKLLTDR----------FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred cccccchHHHHHHHhhhhcccc----------ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHHH
Confidence 6433222111111111111110 122233333334443 4446999999999999887654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=183.20 Aligned_cols=261 Identities=23% Similarity=0.254 Sum_probs=197.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC-CChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH-RNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~ 117 (337)
-.+.|.++++||.|+||.+|.|... .+|..||||.-.+... ..++..|..+.+.|++ ..|..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i-~~ge~VAiK~Es~~a~----------------hpqL~yEskvY~iL~~g~GiP~ 75 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISI-TSGEEVAIKLESSKAK----------------HPQLLYESKVYRILQGGVGIPH 75 (341)
T ss_pred eccceEEEEeecCCchhheeeeeec-cCCceEEEEeecccCC----------------CcchhHHHHHHHHhccCCCCch
Confidence 4578999999999999999999865 4999999998754332 3467778888888864 77888
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec---
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID--- 194 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~--- 194 (337)
+..+..+.+...+||+.. |.||+++.+- ..+.++..++.-++-|++.-++|+|..+ .+||||||+|.+..
T Consensus 76 i~~y~~e~~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgr 148 (341)
T KOG1163|consen 76 IRHYGTEKDYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGR 148 (341)
T ss_pred hhhhccccccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeecccc
Confidence 888899999999999999 9999999864 4456999999999999999999999555 99999999999997
Q ss_pred CCCcEEEecccccccCCCC-----CcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 195 DDMEARISEFGLAKQIPNG-----RTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
....+.++|||++..+-.. ...+....+.||.+|.+-..+.+...+.+.|+-|+|.++.++.-|..||.+.....
T Consensus 149 h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 149 HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 3457899999999876433 23344456788999999888888888899999999999999999999999865533
Q ss_pred ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
....... +...-...++. .++...+.+ +.-.+..|=...-++-|+..-+.+++.
T Consensus 229 k~QKyEk-I~EkK~s~~ie-----~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 229 KKQKYEK-ISEKKMSTPIE-----VLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHHHHHH-HHHhhcCCCHH-----HHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 3322222 22211111111 122222333 334444466667777787777766654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-26 Score=184.19 Aligned_cols=167 Identities=19% Similarity=0.193 Sum_probs=123.9
Q ss_pred CCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCccc
Q 036970 138 GSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT 217 (337)
Q Consensus 138 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 217 (337)
|+|.+++.. ....+++..++.++.|++.||.|||+. + ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 688998853 245699999999999999999999944 3 999999999999999 99887653321
Q ss_pred ccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccC
Q 036970 218 TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIG 297 (337)
Q Consensus 218 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (337)
..||+.|+|||++.+..++.++||||||+++|||++|..||..... ............. ...+.. .
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~-~~~~~~-------~ 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMP-ADDPRD-------R 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhc-cCCccc-------c
Confidence 2578999999999999999999999999999999999999864322 1111222221111 111000 0
Q ss_pred CChHHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 298 NGYEEQML--LVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 298 ~~~~~~~~--~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
........ .+.+++.+||+.+|.+||++.++++.+..+
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 01112222 589999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=189.24 Aligned_cols=173 Identities=20% Similarity=0.176 Sum_probs=127.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||+||+|.+...++..+|||+........ ........+.+|+.++.+++|+|+++.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~---------~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWW---------SKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccc---------ccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 46889999999999999999998764467888999874221000 001124568999999999999999853
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC-CCCcEEecCCC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDI-QPANVLIDDDM 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di-~~~nil~~~~~ 197 (337)
+.. .+..++||||+++++|.. + .. .. ...++.+++.+|.|||+. |++|||| ||+||+++.++
T Consensus 87 l~~---~~~~~LVmE~~~G~~L~~-~----~~---~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 87 LLA---TGKDGLVRGWTEGVPLHL-A----RP---HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred EEE---cCCcEEEEEccCCCCHHH-h----Cc---cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCC
Confidence 321 246799999999999963 2 11 11 146789999999999955 5999999 99999999999
Q ss_pred cEEEecccccccCCCCCcccc------cccccCcccccCCccccCC
Q 036970 198 EARISEFGLAKQIPNGRTRTT------TWSLAETVGYIAPECHQTV 237 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~~ 237 (337)
.++|+|||++..+........ .....++..|+|||.+...
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999999987654322111 1244567789999987543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-24 Score=175.68 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=187.7
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++.....+|.....|..|+|++ .|..++.|++.-... .......|..|.-.|+-+.||||+.+++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw---qgndivakil~vr~~------------t~risrdfneefp~lrifshpnilpvlg 254 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW---QGNDIVAKILNVREV------------TARISRDFNEEFPALRIFSHPNILPVLG 254 (448)
T ss_pred hhhhhhhhhccCCCcccccccc---cCcchhhhhhhhhhc------------chhhcchhhhhCcceeeecCCchhhhhh
Confidence 3445667888999999999997 566777777633222 1222456888999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
.|.....+.++..|++.|+|...++. +..-.....++.+++.+++.|++|||+.. +-+.---+....++++++...+
T Consensus 255 acnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltar 331 (448)
T KOG0195|consen 255 ACNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTAR 331 (448)
T ss_pred hccCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhh
Confidence 99999999999999999999999965 44445677788999999999999999885 2244446888999999887665
Q ss_pred Ee--cccccccCCCCCcccccccccCcccccCCccccCCCC---CCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 201 IS--EFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL---SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 201 l~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
|+ |--++.. .. ...-.+.|++||.+...+- -.++|+|||++++||+.|...||.+..+-+-.+
T Consensus 332 ismad~kfsfq--e~-------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--- 399 (448)
T KOG0195|consen 332 ISMADTKFSFQ--EV-------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--- 399 (448)
T ss_pred eecccceeeee--cc-------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---
Confidence 53 3222211 00 1122678999999887653 347899999999999999999998765422111
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhhC
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~~ 337 (337)
+.....+.. ..++..+..+.+|+.-|.+.||.+||.+..|+-.|++|+.
T Consensus 400 kialeglrv-------------~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~~ 448 (448)
T KOG0195|consen 400 KIALEGLRV-------------HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMIL 448 (448)
T ss_pred hhhhccccc-------------cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhcC
Confidence 111122211 2233445558888888999999999999999999998863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=203.53 Aligned_cols=261 Identities=20% Similarity=0.214 Sum_probs=184.6
Q ss_pred cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceee
Q 036970 44 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV 123 (337)
Q Consensus 44 ~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 123 (337)
.....+|.|++|.|+.+... ...+.+..|....... ..+.+ ......+..|+-+-..+.|+|++.....+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~-~~~~~~~~~~~r~~~~------~~~s~--~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRR-SDLKSFPEKEFRVRVK------PTESE--RKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEec-CCCccchhhhhhcccC------CcccH--HHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 45678999999988777643 2444444443321000 00000 001122777888888999999998888888
Q ss_pred cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEec
Q 036970 124 RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203 (337)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~D 203 (337)
+.....-+||||+. +|..++ .....+....+-.++.|++.|++|+|+.+ +.|+|+|++|+++..++.+||+|
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~----~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~D 463 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLV----MSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIID 463 (601)
T ss_pred hcccchhhhhcccH-HHHHHH----hcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEee
Confidence 77766666999999 999998 34456888888999999999999999554 99999999999999999999999
Q ss_pred ccccccCCCCCcc--cccccccCcccccCCccccCCCCCC-cccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 204 FGLAKQIPNGRTR--TTTWSLAETVGYIAPECHQTVALSD-KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 204 fg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
||.+..+...... ......+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||..-....... .. .
T Consensus 464 fg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~--~- 538 (601)
T KOG0590|consen 464 FGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KT--N- 538 (601)
T ss_pred cCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hh--h-
Confidence 9999876544333 3444678899999999999988876 4899999999999999999997432211110 00 0
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......+.. -...-..........++.+||+.||..|.|+++|++
T Consensus 539 ---~~~~~~~~~~-~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 539 ---NYSDQRNIFE-GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---cccccccccc-ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000000000 000112233455788999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-22 Score=175.07 Aligned_cols=264 Identities=27% Similarity=0.351 Sum_probs=194.3
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCC-Chhhhhce
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR-NIVPLLAR 121 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-ni~~~~~~ 121 (337)
|.+.+.||.|+||.||.+.+. ..+++|.+........ .....+.+|+..++.+.|+ +++++.+.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~-----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 66 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKS-----------KEVERFLREIQILASLNHPPNIVKLYDF 66 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccch-----------hHHHHHHHHHHHHHHccCCcceeeEEEE
Confidence 678899999999999999854 7888888855443221 1256788999999999887 79999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC-cEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EAR 200 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-~~k 200 (337)
+......+++++++.++++.+++...... ..++......++.|++.++.++|+.+ ++|||+||+||+++..+ .++
T Consensus 67 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~ 142 (384)
T COG0515 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVK 142 (384)
T ss_pred EecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEE
Confidence 97777789999999999999776332111 36899999999999999999999555 99999999999999988 799
Q ss_pred EecccccccCCCCCccc----ccccccCcccccCCccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 201 ISEFGLAKQIPNGRTRT----TTWSLAETVGYIAPECHQT---VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
+.|||.+.......... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||...........
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~ 222 (384)
T COG0515 143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222 (384)
T ss_pred EeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH
Confidence 99999988655433221 2235678999999999988 5788899999999999999999999764322100111
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....+...... ......... ........+.+++..|+..+|..|.+..+...
T Consensus 223 ~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 223 TLKIILELPTP-SLASPLSPS----NPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred HHHHHHhcCCc-ccccccCcc----ccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 22222111111 000001100 00222345788999999999999999887654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=172.68 Aligned_cols=197 Identities=20% Similarity=0.271 Sum_probs=138.4
Q ss_pred CCCChhhhhceeec---------------------------CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHH
Q 036970 111 RHRNIVPLLARVVR---------------------------PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIA 163 (337)
Q Consensus 111 ~h~ni~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~ 163 (337)
.||||+++++.|.+ ..++|+||..++. +|..++. .+..+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence 59999999988765 3456899988855 8999983 3456778888999
Q ss_pred HHHHHHHHHHhcCCCCCceeCCCCCCcEEec--CC--CcEEEecccccccCCCCCccc----ccccccCcccccCCcccc
Q 036970 164 RGIASGLEYLHMSHRPRIIHRDIQPANVLID--DD--MEARISEFGLAKQIPNGRTRT----TTWSLAETVGYIAPECHQ 235 (337)
Q Consensus 164 ~~i~~~l~~lh~~~~~~~~h~di~~~nil~~--~~--~~~kl~Dfg~~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~ 235 (337)
.|+++|+.||| ++|+.|||+|.+||++. ++ ...+|+|||++.....++..- ..-...|+...||||+..
T Consensus 348 aQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999 55699999999999995 22 357899999886554432211 111345677889999876
Q ss_pred CCC------CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHH
Q 036970 236 TVA------LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLK 309 (337)
Q Consensus 236 ~~~------~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 309 (337)
..+ .-.++|.|+.|.+.||++....||-.. .+...+........+ + .-++.+...+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r--Gem~L~~r~Yqe~qL----P----------alp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR--GEMLLDTRTYQESQL----P----------ALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc--chheechhhhhhhhC----C----------CCcccCChHHHH
Confidence 543 125799999999999999999999652 122222222111111 0 011222233778
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHH
Q 036970 310 IACFCTFDDPEERPNSKDVRCML 332 (337)
Q Consensus 310 li~~~l~~~p~~Rps~~~il~~L 332 (337)
++...|+.||++|+|..-....|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 88889999999999987554443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=194.19 Aligned_cols=253 Identities=19% Similarity=0.184 Sum_probs=179.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
...++...+.||++.|=.|.+|+++ .|. |+||++.+.....+ .....+...|++ ...+++||.+++
T Consensus 21 ~~~e~~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~~s----------L~~~~qrL~~ik-~~l~~~pn~lPf 86 (1431)
T KOG1240|consen 21 LSVECHYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPTIS----------LRPFKQRLEEIK-FALMKAPNCLPF 86 (1431)
T ss_pred CccceeeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCCCC----------chHHHHHHHHHH-HHhhcCCcccch
Confidence 3348888999999999999999875 555 89999866543211 111344555666 666799999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
.-+...+...|||-+|..+ +|.|.+ +..+-+...+.+-++.|++.|+.-+| +.|++|||||.+|||++.-+.
T Consensus 87 qk~~~t~kAAylvRqyvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW 158 (1431)
T KOG1240|consen 87 QKVLVTDKAAYLVRQYVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNW 158 (1431)
T ss_pred HHHHHhhHHHHHHHHHHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeech
Confidence 9998888888999999966 899998 55556777788889999999999999 556999999999999999999
Q ss_pred EEEecccccccC--CCCCcc---cccccccCcccccCCccccCC----------C-CCCcccchhHhHHHHHHHhC-CCC
Q 036970 199 ARISEFGLAKQI--PNGRTR---TTTWSLAETVGYIAPECHQTV----------A-LSDKCDIYSFGVLLAVLMMG-KFP 261 (337)
Q Consensus 199 ~kl~Dfg~~~~~--~~~~~~---~~~~~~~g~~~y~aPE~~~~~----------~-~~~~~DvwslG~vl~~l~~g-~~p 261 (337)
+.|+||..-... +..... .--.......+|+|||.+... . .+++.||||+||++.|+++- .+|
T Consensus 159 ~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl 238 (1431)
T KOG1240|consen 159 LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL 238 (1431)
T ss_pred hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCc
Confidence 999999754322 111111 111122334579999986542 1 56789999999999999985 677
Q ss_pred CCCc--ccc-cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 262 SDDF--FQH-TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 262 f~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
|.-. ..- ..+....+. .+..-. . ..+.+++..|++.||+.|.|+++.++.-.
T Consensus 239 F~LSQL~aYr~~~~~~~e~---~Le~Ie------d-----------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 239 FTLSQLLAYRSGNADDPEQ---LLEKIE------D-----------VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred ccHHHHHhHhccCccCHHH---HHHhCc------C-----------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 6520 000 000000000 010000 0 12789999999999999999999988643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=164.21 Aligned_cols=180 Identities=14% Similarity=0.168 Sum_probs=132.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|+..+.||.|+||.||++. . ++..+++|.+.......+..... ....+.+.+|+..+.++.|++|...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~-~--~~~~~iiKvf~~~~~~~~~~~~~-----f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLID-T--DYGKYILKVFAPKVKRTERFLKS-----FVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEe-c--CCCcEEEEEechhcCchHHHHHh-----hhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 58999999999999999999975 3 46789999986544333221110 0002337899999999999999999
Q ss_pred hceeecC--------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 119 LARVVRP--------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 119 ~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
..++... ...+++|||++|.+|.++.. ++. ....+++.++..+|+. |++|+|++|+|
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~N 165 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGN 165 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHH
Confidence 8876543 35789999999999988741 222 2466999999999954 59999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHH
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLM 256 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~ 256 (337)
++++.++ ++++|||............. +.....+..++|+|+||+++..+.
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~d~--------------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAKDR--------------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhHHH--------------HHHHhHhcccccccceeEeehHHH
Confidence 9999888 99999998765432211110 223334567899999999986544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=159.11 Aligned_cols=154 Identities=15% Similarity=0.121 Sum_probs=110.3
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHH---Hh------h---cCCcchhhhHHHHHHHHHHhcCCCCC
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAE---LI------K---QDSEPLHHKMIQIQSEIITAGQVRHR 113 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~---~~------~---~~~~~~~~~~~~~~~E~~~l~~l~h~ 113 (337)
...||.|++|.||.|.+. +|+.||+|++......... .. . ...............|+..+..+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 468999999999999865 8999999999765321111 00 0 00001111123445699999999877
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHH-hcCCCCCceeCCCCCCcEE
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL-HMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~~~~h~di~~~nil 192 (337)
++.....+.. ...++||||++++++..... ....++......++.|++.+|.++ |+.+ ++|+||||+||+
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIl 150 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLL 150 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 7644332222 23489999998877765431 235688999999999999999999 7555 999999999999
Q ss_pred ecCCCcEEEecccccccCC
Q 036970 193 IDDDMEARISEFGLAKQIP 211 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~ 211 (337)
++ ++.++|+|||++....
T Consensus 151 i~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred EE-CCcEEEEEccccccCC
Confidence 98 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=166.34 Aligned_cols=240 Identities=18% Similarity=0.177 Sum_probs=151.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC-------
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH------- 112 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------- 112 (337)
.......+.||.|+++.||.+++. .+|+.+++|++..+.. ......+++.+|.-....+.+
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~-~t~~~~avkvf~~~~~-----------~~~~~~~~~~~e~l~~~~~~~~~~p~~a 78 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDV-ETGEEFAVKVFLLPAD-----------ASANEYEQLKEEQLAITLFPGVKNPKEA 78 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEEESST-----------THTTHHHHHHHHHHGGGGSTT--SHHHH
T ss_pred ceEEEEccccccCCceEEEEEEEc-cCCceEEEEEEecccc-----------cchHHHHHHHHHHHHhhhhccCCCHHHH
Confidence 345677889999999999999965 5899999999866542 112225667777655555322
Q ss_pred ---CChhhhhceee---------cCC--------CceEEEEeecCCCHHHHHHhhh---cCCCcCCHHHHHHHHHHHHHH
Q 036970 113 ---RNIVPLLARVV---------RPD--------CDLLVYEFRRNGSLQDILYDVS---QGRRELDWLARHRIARGIASG 169 (337)
Q Consensus 113 ---~ni~~~~~~~~---------~~~--------~~~lv~e~~~~~~L~~~l~~~~---~~~~~l~~~~~~~~~~~i~~~ 169 (337)
-.++..++... ... +.+++|+-+ .++|.+++.... .....+....+..+..|++..
T Consensus 79 ~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~l 157 (288)
T PF14531_consen 79 YRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRL 157 (288)
T ss_dssp HHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHH
T ss_pred HHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHH
Confidence 11222222221 111 235677777 558888864322 222335555666788999999
Q ss_pred HHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC--------CCCCC
Q 036970 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT--------VALSD 241 (337)
Q Consensus 170 l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~ 241 (337)
+++||+.+ ++|+||+|+|++++.+|.++|+||+.....+..... ...+..|.|||.... ..++.
T Consensus 158 vA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~ 229 (288)
T PF14531_consen 158 VANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTF 229 (288)
T ss_dssp HHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-H
T ss_pred HHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeee
Confidence 99999555 999999999999999999999999877665433221 123567889986533 24688
Q ss_pred cccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCC
Q 036970 242 KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEE 321 (337)
Q Consensus 242 ~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 321 (337)
+.|.|+||+++|.+.++..||+.......... ....+. +.+..+..||..+|+.||.+
T Consensus 230 ~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~ 287 (288)
T PF14531_consen 230 ATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPED 287 (288)
T ss_dssp HHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGG
T ss_pred ccCHHHHHHHHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCccc
Confidence 89999999999999999999985432111111 112233 56667899999999999998
Q ss_pred C
Q 036970 322 R 322 (337)
Q Consensus 322 R 322 (337)
|
T Consensus 288 R 288 (288)
T PF14531_consen 288 R 288 (288)
T ss_dssp S
T ss_pred C
Confidence 7
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.8e-21 Score=172.49 Aligned_cols=217 Identities=25% Similarity=0.384 Sum_probs=161.2
Q ss_pred hcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCc-eeCC
Q 036970 107 AGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRI-IHRD 185 (337)
Q Consensus 107 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~-~h~d 185 (337)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.|.+.. ....+++.....++.+|+.||.|+|... + +|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4678999999999999999999999999999999999954 4556888888899999999999999553 5 9999
Q ss_pred CCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCC-------CCCcccchhHhHHHHHHHhC
Q 036970 186 IQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-------LSDKCDIYSFGVLLAVLMMG 258 (337)
Q Consensus 186 i~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DvwslG~vl~~l~~g 258 (337)
+++.|++++....+|++|||+.....................|.|||.+.+.. .+.++|+||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987764311111111112245689999987741 46679999999999999999
Q ss_pred CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
..||...............+... ...+ +.+.+.... +....+..++..||..+|.+||++.++...+..+.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~--~~~~---~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKG--GSNP---FRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cCccccccccCChHHHHHHHHhc--CCCC---cCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99998643322222233332220 1111 111111010 22235999999999999999999999998887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=154.09 Aligned_cols=156 Identities=16% Similarity=0.164 Sum_probs=112.1
Q ss_pred ccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHH---HhhcC---------CcchhhhHHHHHHHHHHhcCCCC
Q 036970 45 SLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAE---LIKQD---------SEPLHHKMIQIQSEIITAGQVRH 112 (337)
Q Consensus 45 ~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~E~~~l~~l~h 112 (337)
+...||+|++|.||+|.+. +|+.||||+.......... ..... ..........+..|...+.++.|
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05145 1 INGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE 78 (190)
T ss_pred CCceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3578999999999999865 8999999998765321100 00000 00111112345689999999998
Q ss_pred CChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCcE
Q 036970 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHM-SHRPRIIHRDIQPANV 191 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~~~h~di~~~ni 191 (337)
+++.....+... ..++||||++++++..... ....++......++.|++.++.++|+ . |++|+||||+||
T Consensus 79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NI 149 (190)
T cd05145 79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNI 149 (190)
T ss_pred CCCCCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhE
Confidence 887544443333 3489999998875543321 22357788889999999999999996 4 599999999999
Q ss_pred EecCCCcEEEecccccccCCC
Q 036970 192 LIDDDMEARISEFGLAKQIPN 212 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~ 212 (337)
+++ ++.++|+|||++....+
T Consensus 150 ll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEE-CCCEEEEEcccceecCC
Confidence 999 78999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=179.56 Aligned_cols=201 Identities=21% Similarity=0.258 Sum_probs=159.9
Q ss_pred hhh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 36 FLK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 36 ~l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..+ -...|.|-+.||.|++|+||.|... +|+.||+|+-.++...+-.+ -.+++..+. .. --+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~WEfYI-----------~~q~~~RLk--~~-~~~~ 755 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNPWEFYI-----------CLQVMERLK--PQ-MLPS 755 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCceeeee-----------hHHHHHhhc--hh-hhcc
Confidence 344 4578899999999999999999866 59999999987666543321 233333333 11 1346
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
|+.+...+.-.+.-++|+||.+.|+|.+++ +..+.+++..+..+..|++..+++||.. +|+||||||+|.++.
T Consensus 756 ~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~----N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~ 828 (974)
T KOG1166|consen 756 IMHISSAHVFQNASVLVSEYSPYGTLLDLI----NTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLR 828 (974)
T ss_pred hHHHHHHHccCCcceeeeeccccccHHHhh----ccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEee
Confidence 788877777777888999999999999999 4667799999999999999999999954 599999999999995
Q ss_pred -------CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCC
Q 036970 195 -------DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK 259 (337)
Q Consensus 195 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~ 259 (337)
....++|+|||.+..+.--.....-...++|-.|-.+|+..|..++..+|.|.|+.+++.|++|+
T Consensus 829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 829 REICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 23458999999997764332222223456788899999999999999999999999999999997
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=147.20 Aligned_cols=190 Identities=14% Similarity=0.068 Sum_probs=135.7
Q ss_pred cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhhcee
Q 036970 44 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLLARV 122 (337)
Q Consensus 44 ~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~ 122 (337)
.+...|++|+||+||.+.. .+..++.+.+.-......... ...+.+|+.+|++|. |+++++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~~~~~~----------~~l~~rE~~iL~~L~~~~~vP~ll~~- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWWLRGVA----------WWLARREALALRQLDGLPRTPRLLHW- 70 (218)
T ss_pred ccceeecCCCcceEEEeec---CCceeeecccccchhhhhhHH----------HHHHHHHHHHHHhcCCCCCCCEEEEE-
Confidence 4578899999999998753 678888776644333211110 225789999999995 5788888775
Q ss_pred ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC-CCCcEEecCCCcEEE
Q 036970 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDI-QPANVLIDDDMEARI 201 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di-~~~nil~~~~~~~kl 201 (337)
...+++|||+.|.+|.... .. ....++.|++.++.++|+.+ ++|+|| ||.||+++.++.++|
T Consensus 71 ---~~~~lvmeyI~G~~L~~~~----~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~L 133 (218)
T PRK12274 71 ---DGRHLDRSYLAGAAMYQRP----PR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAV 133 (218)
T ss_pred ---cCEEEEEeeecCccHHhhh----hh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEE
Confidence 3468999999998886543 11 11347889999999999554 999999 799999999999999
Q ss_pred ecccccccCCCCCcc----c-------ccccccCcccccCCccccCC-CCC-CcccchhHhHHHHHHHhCCCCCCC
Q 036970 202 SEFGLAKQIPNGRTR----T-------TTWSLAETVGYIAPECHQTV-ALS-DKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~----~-------~~~~~~g~~~y~aPE~~~~~-~~~-~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
+|||++......... . .......++.+++|+...-- ..+ ...+.++.|+.+|.++|+..++-+
T Consensus 134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 999999865533310 0 01112235667777643322 222 467889999999999999988644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-21 Score=174.23 Aligned_cols=229 Identities=22% Similarity=0.248 Sum_probs=175.7
Q ss_pred cccccccceEEeeeec--CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhhceeec
Q 036970 48 KIRSCWNGEVYKAELP--GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLLARVVR 124 (337)
Q Consensus 48 ~lg~G~~g~vy~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~ 124 (337)
.+|.|++|.|++++-- ...|.-|++|...+....... ......|-.++...+ ||.+++++..+..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~------------~~~t~~er~il~~~~~~~f~v~lhyafqt 68 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD------------RTHTKQERIILAFVHNTPFLVKLHYAFQT 68 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc------------ccccccHHHHHhhccCCCceeeeeeeecc
Confidence 3789999999998621 124677888887554332211 112334556666675 9999999999999
Q ss_pred CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecc
Q 036970 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 204 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Df 204 (337)
+...++++++..+|.|...+ .....+.+.....+...++-+++++| +.+++|+|+|++||+++.+|++++.||
T Consensus 69 ~~kl~l~ld~~rgg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdf 141 (612)
T KOG0603|consen 69 DGKLYLILDFLRGGDLFTRL----SKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDF 141 (612)
T ss_pred ccchhHhhhhcccchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCc
Confidence 99999999999999998887 45556788888889999999999999 555999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhc
Q 036970 205 GLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTS 284 (337)
Q Consensus 205 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 284 (337)
|++......... +||..|||||+++ ......|.||+|++++++++|..||.. +.+..++..
T Consensus 142 glske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~ 202 (612)
T KOG0603|consen 142 GLSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKA 202 (612)
T ss_pred hhhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhh
Confidence 998775433322 8899999999998 567889999999999999999999975 223333321
Q ss_pred CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 285 ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
.. ..+.+......+++..++..+|..|.-.
T Consensus 203 ~~-----------~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 EL-----------EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cc-----------CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11 1123344557778888888899988755
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=147.84 Aligned_cols=166 Identities=16% Similarity=0.107 Sum_probs=118.0
Q ss_pred hhhhhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHH--hh--------cCCcchhhhHHHHHH
Q 036970 33 DLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAEL--IK--------QDSEPLHHKMIQIQS 102 (337)
Q Consensus 33 ~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~--------~~~~~~~~~~~~~~~ 102 (337)
..++++...-|.+.+.||.|++|.||.|.++..+|..||+|+........... .. ............+.+
T Consensus 20 ~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 20 LYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred HHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 34455566679999999999999999997333489999999987543211100 00 000111112234678
Q ss_pred HHHHhcCCCCCC--hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 036970 103 EIITAGQVRHRN--IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPR 180 (337)
Q Consensus 103 E~~~l~~l~h~n--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 180 (337)
|+..+.++.+.+ +.++++ . ...++||||+++.+|.... .....+.......++.|++.++.+|| ..|
T Consensus 100 E~~~L~~L~~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g 168 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLY---KEG 168 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeE---e-cCceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHH---hcC
Confidence 999999996532 333332 2 2458999999988886654 22334566667889999999999999 777
Q ss_pred -ceeCCCCCCcEEecCCCcEEEecccccccC
Q 036970 181 -IIHRDIQPANVLIDDDMEARISEFGLAKQI 210 (337)
Q Consensus 181 -~~h~di~~~nil~~~~~~~kl~Dfg~~~~~ 210 (337)
++|+||+|+||+++ ++.++|+|||.+...
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 789999999988654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=142.86 Aligned_cols=136 Identities=14% Similarity=0.152 Sum_probs=101.8
Q ss_pred cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-----CCCChhhh
Q 036970 44 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-----RHRNIVPL 118 (337)
Q Consensus 44 ~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~ni~~~ 118 (337)
.-...||+|++|.||. ++. ++.. +||+....... ....+.+|+..++.+ .||||+++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~-~~~k-~IKv~~~~~~~--------------~~~~~~rEi~~l~~L~~~~~~h~nIvr~ 66 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPE-DAQR-CIKIVYHRGDG--------------GDKEIRRELKYYAHLSRRLIDWSGIPRY 66 (210)
T ss_pred CCcceecCCCceEEEE--CCC-CcCe-EEEEEeccccc--------------hHHHHHHHHHHHHHhhccCCCCccccee
Confidence 3457899999999995 442 4444 69988543211 145688999999999 57999999
Q ss_pred hceeecCC---Cce-EEEEe--ecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHH-HHHhcCCCCCceeCCCCCCcE
Q 036970 119 LARVVRPD---CDL-LVYEF--RRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL-EYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 119 ~~~~~~~~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l-~~lh~~~~~~~~h~di~~~ni 191 (337)
+++++++. ..+ +|+|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+|+||||+||
T Consensus 67 yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NI 136 (210)
T PRK10345 67 YGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNI 136 (210)
T ss_pred eEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHE
Confidence 99999874 323 78999 447899999943 225554 35688888887 9999555 99999999999
Q ss_pred EecC----CCcEEEeccccc
Q 036970 192 LIDD----DMEARISEFGLA 207 (337)
Q Consensus 192 l~~~----~~~~kl~Dfg~~ 207 (337)
+++. +..++|+|++-+
T Consensus 137 Ll~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 137 LCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEeccCCCCCcEEEEECCCC
Confidence 9974 337999995433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-19 Score=158.57 Aligned_cols=287 Identities=18% Similarity=0.184 Sum_probs=171.1
Q ss_pred HhcCCCCCCCCcccCCccchhhhhhhh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeecc-chhhHHHhhcC
Q 036970 12 AVRGGSRDRGPTIFSPLIEKEDLAFLK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQP-LKSEAELIKQD 89 (337)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~ 89 (337)
+.++.+.++.+....|.-...+..--+ ...+..-......++++.+.++.... .+..+-.|..... ...+...-...
T Consensus 202 ~~rk~s~~k~~~~~~~~~tdsd~~ed~~~~~~s~~~~~~~~~~s~~~~k~~~~~-~~~~~~~~q~~~~~s~~E~~~s~~~ 280 (516)
T KOG1033|consen 202 EFRKTSVSKASRFEGPDCTDSDLEEDEMQGSDSKESSRHEESGSSSISKSSERV-SSGIVFEKQGKNNSSLREWLKSKRA 280 (516)
T ss_pred hhhhhhhccccccCCCccccccccccccccCcccCccccccccccccccccccc-ccCCchhhhhcccchhhhhccchhh
Confidence 444555556666555555554444433 33444444555666666666665332 3333333333221 11111111111
Q ss_pred CcchhhhHHHHHHHHHHhcCCC-CCChhhhh------ceeec-----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHH
Q 036970 90 SEPLHHKMIQIQSEIITAGQVR-HRNIVPLL------ARVVR-----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 157 (337)
Q Consensus 90 ~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 157 (337)
.......-....+++..+.... |++.+..- ..+.. ...++|.|++|...+|++++...+ .....+..
T Consensus 281 ~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s 359 (516)
T KOG1033|consen 281 DVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRR-TGEERSLS 359 (516)
T ss_pred hccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCC-cccccchh
Confidence 1111011223344555554443 43332211 11111 224689999999999999995432 23346777
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCC----cccccccccCcccccCCcc
Q 036970 158 ARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR----TRTTTWSLAETVGYIAPEC 233 (337)
Q Consensus 158 ~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~g~~~y~aPE~ 233 (337)
....++.|++.+++| ++ .+|+|+||.||+...+..++|+|||+.+...... .........||..||+||.
T Consensus 360 ~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQ 433 (516)
T KOG1033|consen 360 LMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQ 433 (516)
T ss_pred HHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHH
Confidence 888999999999999 44 9999999999999999999999999998876554 1223335688999999999
Q ss_pred ccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHH
Q 036970 234 HQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIAC 312 (337)
Q Consensus 234 ~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 312 (337)
+.+..|+.++|||+||++++|++. -..+|.. ...+... ..+ .+++....+. +. =..++.
T Consensus 434 i~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~-r~g----~ip~~~~~d~-p~----e~~ll~ 493 (516)
T KOG1033|consen 434 IRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDI-RDG----IIPPEFLQDY-PE----EYTLLQ 493 (516)
T ss_pred HhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhh-hcC----CCChHHhhcC-cH----HHHHHH
Confidence 999999999999999999999997 2222211 1111111 111 1111111122 22 357788
Q ss_pred HhcCCCCCCCCCHH
Q 036970 313 FCTFDDPEERPNSK 326 (337)
Q Consensus 313 ~~l~~~p~~Rps~~ 326 (337)
+++...|.+||++.
T Consensus 494 ~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 494 QLLSPSPEERPSAI 507 (516)
T ss_pred HhcCCCcccCchHH
Confidence 89999999999544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-18 Score=165.36 Aligned_cols=214 Identities=21% Similarity=0.275 Sum_probs=143.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
.+++|+.++.+..|++|-||.++++. +.+.+|+| +++... +. +||..+
T Consensus 81 ~e~df~~IklisngAygavylvrh~~-trqrfa~k-iNkq~l-------------------il-----------Rnilt~ 128 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKE-TRQRFAMK-INKQNL-------------------IL-----------RNILTF 128 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccc-cccchhhc-ccccch-------------------hh-----------hccccc
Confidence 57999999999999999999999763 67778884 322211 00 123322
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
-+ ..+.| |+-...+ ...++++... +.+++|+| +.|++|+|+||+|.+|..-|+
T Consensus 129 a~------npfvv------gDc~tll----k~~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGh 181 (1205)
T KOG0606|consen 129 AG------NPFVV------GDCATLL----KNIGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGH 181 (1205)
T ss_pred cC------Cccee------chhhhhc----ccCCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeeccc
Confidence 21 22233 2222333 2223444332 78999999 555999999999999999999
Q ss_pred EEEecccccccCCCCCc------------cc-ccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 199 ARISEFGLAKQIPNGRT------------RT-TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~------------~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
+|+.|||++........ .. .....+||+.|+|||++....|..+.|+|++|+++||.+-|..||.+.
T Consensus 182 iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 182 IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 99999998875432211 11 112458999999999999999999999999999999999999999765
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 326 (337)
.+ .+.+..+......-..-+. ....+..+++.++|+++|.+|.-..
T Consensus 262 tp-------eelfg~visd~i~wpE~de--------a~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 262 TP-------EELFGQVISDDIEWPEEDE--------ALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred CH-------HHHHhhhhhhhccccccCc--------CCCHHHHHHHHHHHHhChHhhcccc
Confidence 33 1222222221111100011 1123377888889999999996443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.5e-18 Score=140.57 Aligned_cols=143 Identities=21% Similarity=0.291 Sum_probs=112.7
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecC
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 125 (337)
++.||+|++|.||+|+. .|..+++|............. .......+.+|+.++..+.|+++.....++.+.
T Consensus 1 ~~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 71 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELD------ERIRRERTRREARIMSRARKAGVNVPAVYFVDP 71 (211)
T ss_pred CcccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHH------HHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC
Confidence 36799999999999985 677899998654332111100 001135678899999999999988777777777
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
...+++|||++|++|.+.+.. . .. ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||
T Consensus 72 ~~~~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 72 ENFIIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred CCCEEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECC
Confidence 888999999999999998843 1 12 77889999999999999554 99999999999999 7889999999
Q ss_pred cccc
Q 036970 206 LAKQ 209 (337)
Q Consensus 206 ~~~~ 209 (337)
.+..
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 8754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.1e-17 Score=155.86 Aligned_cols=145 Identities=20% Similarity=0.252 Sum_probs=111.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
...|...+.||+|+||+||+|.+. +..+++|+.......... .......+.+.+|+.++..++|++++...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRHPE------LDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec---CccceeEEEecccccchh------HHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 345567899999999999999864 444555544322111100 00111245688999999999999998877
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
.++.+....++||||+++++|.+++. ....++.+++.+|.+||+. +++|+|+||+||++ .++.+
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcE
Confidence 77777778899999999999999883 3467899999999999955 59999999999999 67799
Q ss_pred EEeccccccc
Q 036970 200 RISEFGLAKQ 209 (337)
Q Consensus 200 kl~Dfg~~~~ 209 (337)
+|+|||++..
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=136.18 Aligned_cols=138 Identities=20% Similarity=0.303 Sum_probs=106.2
Q ss_pred cccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCC
Q 036970 48 KIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDC 127 (337)
Q Consensus 48 ~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 127 (337)
.||+|++|.||+|.. .|..+++|........... ........++.+|+.++..+.|+++.....++.....
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPE------LDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN 71 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCch------HHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC
Confidence 489999999999984 6788999986543211100 0001114678889999999988877665556666777
Q ss_pred ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccccc
Q 036970 128 DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207 (337)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~ 207 (337)
.+++|||++|++|.+.+.. ... .++.+++.+|.+||+. |++|+|++|.||+++ ++.+++.|||++
T Consensus 72 ~~lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred CEEEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 8999999999999988732 110 7899999999999954 599999999999999 789999999987
Q ss_pred cc
Q 036970 208 KQ 209 (337)
Q Consensus 208 ~~ 209 (337)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 54
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.4e-16 Score=132.15 Aligned_cols=155 Identities=16% Similarity=0.122 Sum_probs=110.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHH------hhc--CCcchhhhHHHHHHHHHHhcCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAEL------IKQ--DSEPLHHKMIQIQSEIITAGQV 110 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~------~~~--~~~~~~~~~~~~~~E~~~l~~l 110 (337)
..-.|.+.+.||.|++|.||++... +|+.+++|++.......... ... ..............|+..+..+
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 3344888999999999999999864 79999999876533111100 000 0000111133467888888888
Q ss_pred CCCC--hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 036970 111 RHRN--IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188 (337)
Q Consensus 111 ~h~n--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~ 188 (337)
.|++ ++..++ ....+++|||+++++|..... ......++.+++.++.++|+. |++|+||+|
T Consensus 91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHcCCCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 7764 333322 345689999999998876541 023457889999999999954 599999999
Q ss_pred CcEEecCCCcEEEecccccccCCC
Q 036970 189 ANVLIDDDMEARISEFGLAKQIPN 212 (337)
Q Consensus 189 ~nil~~~~~~~kl~Dfg~~~~~~~ 212 (337)
.||++++++.++|+|||++.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.5e-17 Score=137.12 Aligned_cols=208 Identities=20% Similarity=0.250 Sum_probs=147.6
Q ss_pred HHHHHHHhcCCCCCChhhhhceeecCC-----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHh
Q 036970 100 IQSEIITAGQVRHRNIVPLLARVVRPD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174 (337)
Q Consensus 100 ~~~E~~~l~~l~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh 174 (337)
...-...+.++.|.||++++.+|.+.. ...+++||+..|++..+++........+....+.+|+.||+.||.|||
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 333345556667999999999997643 357899999999999999999888899999999999999999999999
Q ss_pred cCCCCCceeCCCCCCcEEecCCCcEEEeccccc--ccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHH
Q 036970 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLA--KQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252 (337)
Q Consensus 175 ~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~--~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl 252 (337)
+. .+.++|+++.-..|++..++-+|++--.-. ....+...........+.++|.+||.-.....+.++|||+||+..
T Consensus 194 s~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 SC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred cc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 98 788999999999999999988887532111 000000001111123456889999987777788899999999999
Q ss_pred HHHHhCCCCCC-CcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 253 AVLMMGKFPSD-DFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 253 ~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
.+|..+..--. ....-..+..... ....+...+ -..++..|++..|+.||++.+++
T Consensus 273 lemailEiq~tnseS~~~~ee~ia~----------~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVEVEENIAN----------VIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHHHheeccCCCcceeehhhhhhh----------heeeccCcc-----------ccCcCcccccCCCCCCcchhhhh
Confidence 99998875422 1111001110000 000111111 34678889999999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.2e-18 Score=161.58 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=194.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
....|.+.+.||.|+++.|-...........++.|.+..+.... ........|..+...+. |.|++.
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~------------~~~~~i~~e~~~~~~~s~h~n~~~ 85 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE------------DSSEHIDTETDIQKKLSKHSNTVH 85 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc------------chhhhcCccccccccccccccccc
Confidence 35678888899999999999887654455666767665543111 11345556777777776 999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHh-cCCCCCceeCCCCCCcEEecCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~~~h~di~~~nil~~~~ 196 (337)
+++...+.+..++++++..++++.+.+.. ......+......++.|+..++.|+| ..+ +.|+|++|+|.+++..
T Consensus 86 ~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s 160 (601)
T KOG0590|consen 86 MIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDES 160 (601)
T ss_pred cCCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccC
Confidence 99999999999999999999999888731 12113555566789999999999999 666 9999999999999999
Q ss_pred C-cEEEecccccccCCC-CCcccccccccC-cccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 197 M-EARISEFGLAKQIPN-GRTRTTTWSLAE-TVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 197 ~-~~kl~Dfg~~~~~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
+ ..++.|||++..... ..........+| ++.|.|||...+. ......|+||+|+++..+++|..||....... .
T Consensus 161 ~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~ 238 (601)
T KOG0590|consen 161 GSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--G 238 (601)
T ss_pred CCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--c
Confidence 9 999999999998877 555555556677 9999999998884 45677899999999999999999987533211 1
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
.+..+.... .. .....+........+++..++..+|..|.+.+++.
T Consensus 239 ~~~~~~~~~---~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 239 RYSSWKSNK---GR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cceeecccc---cc--------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 111111110 00 01122333334478888889999999999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.2e-15 Score=122.74 Aligned_cols=151 Identities=18% Similarity=0.129 Sum_probs=96.0
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHh--------hcCCcch--hhhHHHHHHHHHHhcCCCCCC-
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI--------KQDSEPL--HHKMIQIQSEIITAGQVRHRN- 114 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~E~~~l~~l~h~n- 114 (337)
.+.||+|+||.||+|.+. +|..|+||+............ ....... .........|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 578999999999999865 799999999865432211100 0000000 000111234555555553322
Q ss_pred -hhhhhceeecCCCceEEEEeecCCCHHH-HHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 115 -IVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 115 -i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
+.+.++. ...+++|||++++.+.. .+.... .. .....++.+++.++.++|.. .+++|+||+|+||+
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nil 147 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNIL 147 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEE
Confidence 2333221 34689999998843321 111100 11 55678999999999999951 45999999999999
Q ss_pred ecCCCcEEEecccccccCC
Q 036970 193 IDDDMEARISEFGLAKQIP 211 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~ 211 (337)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8899999999986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.8e-15 Score=125.96 Aligned_cols=149 Identities=13% Similarity=0.065 Sum_probs=105.6
Q ss_pred ccccc-ccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh--hhhhcee
Q 036970 46 LEKIR-SCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI--VPLLARV 122 (337)
Q Consensus 46 ~~~lg-~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--~~~~~~~ 122 (337)
...|| .||.|+||.+.. .+..+++|.......-... ..............+.+|+.++..|.|+++ ++.+++.
T Consensus 36 ~~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~i~kv-~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGLIGKL-SKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred CceeecCCCCccEEEEEe---CCceEEEEEeeEcchHHhh-hhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 35687 899999999975 5788999988654321111 011111111225678899999999988775 5566554
Q ss_pred ecCC-C---ceEEEEeecC-CCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 123 VRPD-C---DLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 123 ~~~~-~---~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
.... . .++|+|++++ .+|.+++.. .+++.. .+.+++.++.+||+. |++|+||+|.||+++.++
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 3322 2 2599999987 689888732 234443 367899999999955 599999999999999988
Q ss_pred cEEEecccccccC
Q 036970 198 EARISEFGLAKQI 210 (337)
Q Consensus 198 ~~kl~Dfg~~~~~ 210 (337)
.++|+|||.+...
T Consensus 180 ~v~LIDfg~~~~~ 192 (239)
T PRK01723 180 KFWLIDFDRGELR 192 (239)
T ss_pred CEEEEECCCcccC
Confidence 9999999988653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.1e-15 Score=117.36 Aligned_cols=135 Identities=19% Similarity=0.205 Sum_probs=109.1
Q ss_pred ccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC--CChhhhhcee
Q 036970 45 SLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH--RNIVPLLARV 122 (337)
Q Consensus 45 ~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~~~~~~ 122 (337)
+++.||.|.++.||++... +..+++|....... ...+.+|+..++.++| .++++++.+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~ 62 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK---DEDYVLKINPSREK----------------GADREREVAILQLLARKGLPVPKVLASG 62 (155)
T ss_pred cceecccccccceEEEEec---CCeEEEEecCCCCc----------------hhHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 4678999999999999863 47899998744321 2357788888888865 5888888888
Q ss_pred ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEe
Q 036970 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
...+..++++||++++.+..+ +......++.+++.++..+|.....+++|+|++|.||++++.+.+++.
T Consensus 63 ~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~ 131 (155)
T cd05120 63 ESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGII 131 (155)
T ss_pred CCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEE
Confidence 877889999999988766432 445567789999999999996543579999999999999998999999
Q ss_pred ccccccc
Q 036970 203 EFGLAKQ 209 (337)
Q Consensus 203 Dfg~~~~ 209 (337)
||+.+..
T Consensus 132 Df~~~~~ 138 (155)
T cd05120 132 DWEYAGY 138 (155)
T ss_pred ecccccC
Confidence 9998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-12 Score=119.95 Aligned_cols=166 Identities=17% Similarity=0.180 Sum_probs=123.9
Q ss_pred CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHH
Q 036970 65 SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL 144 (337)
Q Consensus 65 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 144 (337)
+++.+|.+........ ...+...+-+..++.++||||+++++.++.++..|+|+|.+ .-|..++
T Consensus 35 ~~~~~vsVF~~~~~~~--------------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~l 98 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG--------------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVL 98 (690)
T ss_pred ccCCceEEEEEeCCCc--------------hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHH
Confidence 4777887777644332 11445677788999999999999999999999999999998 3477777
Q ss_pred HhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccC
Q 036970 145 YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE 224 (337)
Q Consensus 145 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 224 (337)
+. +....+..-+.||+.||.+||..+ +++|+++..+.++++..|.+||++|.++........ .......
T Consensus 99 k~-------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~ 167 (690)
T KOG1243|consen 99 KE-------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYL 167 (690)
T ss_pred HH-------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchh
Confidence 44 335566678999999999998554 599999999999999999999999988765432221 1101122
Q ss_pred cccccCCccccCCCCCCcccchhHhHHHHHHHhCC
Q 036970 225 TVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK 259 (337)
Q Consensus 225 ~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~ 259 (337)
-..|..|+.+.... ...|.|.||+++++++.|.
T Consensus 168 ~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 168 IESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 23456666543322 4569999999999999994
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.4e-14 Score=127.88 Aligned_cols=255 Identities=18% Similarity=0.197 Sum_probs=183.7
Q ss_pred ccCcccccccccc--cccceEEeeeec-CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCC
Q 036970 39 KEDCFASLEKIRS--CWNGEVYKAELP-GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~--G~~g~vy~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 114 (337)
....|.+.+.+|. |.+|.+|.++.. ..++..+|+|.-..+...... ...-.+|+.....+ .|+|
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~------------~~~k~~~~~s~~~i~~~~~ 179 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD------------SKRKLREFLSHHKIDSHEN 179 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc------------cccccchhhcccccCcccc
Confidence 4567788899999 999999999861 247788888875433322111 23445677777777 5999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHH----HHHHHhcCCCCCceeCCCCCCc
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS----GLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~----~l~~lh~~~~~~~~h~di~~~n 190 (337)
.++.+..+...+..++-+|+| +.+|..+... ...-++....+..+.+... |+.++|+.+ ++|-|++|.|
T Consensus 180 ~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~ 252 (524)
T KOG0601|consen 180 PVRDSPAWEGSGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPAN 252 (524)
T ss_pred ccccCcccccCCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhh
Confidence 999999999999999999999 5688887743 3334778888888888888 999999666 9999999999
Q ss_pred EEecCC-CcEEEecccccccCCCCCccc---ccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 191 VLIDDD-MEARISEFGLAKQIPNGRTRT---TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 191 il~~~~-~~~kl~Dfg~~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
|+...+ ..++++|||+...+....... ......|...|++||..++ -++...|+|++|.+..+..++..+.....
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 999999 889999999998887654322 2233466788999999877 66888999999999999999876543221
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. . |....... +....+. .-...+...+..|++.+|-.|++.+.+..
T Consensus 332 ~~-------~--W~~~r~~~----ip~e~~~----~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 332 NS-------S--WSQLRQGY----IPLEFCE----GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CC-------C--cccccccc----Cchhhhc----CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 0 00000000 1111111 11223555888899999999999887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.6e-13 Score=123.52 Aligned_cols=153 Identities=19% Similarity=0.282 Sum_probs=97.5
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHH----H-------hhcCCc-----chhh----------hHHHH
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAE----L-------IKQDSE-----PLHH----------KMIQI 100 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~----~-------~~~~~~-----~~~~----------~~~~~ 100 (337)
+.||.|++|+||+|+.+ +|+.||||+..+.....-. . ...... .... ..-.+
T Consensus 123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 67999999999999986 8999999998654221100 0 000000 0000 01124
Q ss_pred HHHHHHhcCCC-----CCChhhhhcee-ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHH-HHHHH
Q 036970 101 QSEIITAGQVR-----HRNIVPLLARV-VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS-GLEYL 173 (337)
Q Consensus 101 ~~E~~~l~~l~-----h~ni~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~-~l~~l 173 (337)
.+|...+.++. ++++ .+-.++ ......++||||++|++|.+.......+ .. ...++.+++. .+..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---LD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---CC---HHHHHHHHHHHHHHHH
Confidence 55666555552 2332 221222 2234568999999999998876432111 12 2345666655 46788
Q ss_pred hcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCC
Q 036970 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP 211 (337)
Q Consensus 174 h~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~ 211 (337)
|. .|++|+|++|.||+++.++.++++|||++..+.
T Consensus 274 ~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred Hh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 84 459999999999999999999999999987765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.8e-12 Score=98.17 Aligned_cols=151 Identities=21% Similarity=0.250 Sum_probs=112.6
Q ss_pred ccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeec
Q 036970 45 SLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124 (337)
Q Consensus 45 ~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 124 (337)
.+..+-+|+.+.|+.+.+ +|+.++||.-..+....+..-.+ -...+..+|++.+.++.--.|.--.-++.+
T Consensus 11 ~l~likQGAEArv~~~~~---~Ge~~iIK~Rf~K~YRHP~LD~k------Ltr~Rt~~Ear~l~k~~~~GI~~P~l~~~D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF---SGEAAIIKERFSKRYRHPALDQK------LTRKRTKQEARLLAKCRALGIPAPRLIFID 81 (229)
T ss_pred cceeeeccceeeEeeecc---CCceeEEeecccccccchHHHHH------HHHHHHHHHHHHHHHHHHhCCCCceEEEEe
Confidence 678899999999999986 79999999876655443332211 115677889999988865566555556777
Q ss_pred CCCceEEEEeecC-CCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc---EE
Q 036970 125 PDCDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME---AR 200 (337)
Q Consensus 125 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~---~k 200 (337)
.....++|||+++ .++.+++...-.. +........++.+|-+.+.-||.+ +++|+||..+||++..++. +.
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence 7788899999966 4889998654322 222333367899999999999954 5999999999999975543 58
Q ss_pred Eeccccccc
Q 036970 201 ISEFGLAKQ 209 (337)
Q Consensus 201 l~Dfg~~~~ 209 (337)
++|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.3e-12 Score=99.09 Aligned_cols=139 Identities=21% Similarity=0.322 Sum_probs=106.2
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecCC
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD 126 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 126 (337)
..+++|+-+.+|.+.+ .|..+++|.-.++....+..-.+ =...+..+|..+++++.-..+..-.-+..+..
T Consensus 2 ~~i~~GAEa~i~~~~~---~g~~av~K~Ri~K~YR~p~LD~k------lrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF---LGLPAVVKERIPKRYRHPELDEK------LRRERTRREARILAKAREAGVPVPIVYDVDPD 72 (204)
T ss_pred chhhCCcceeEEeeec---cCcceEEEeecCcccCChHHHHH------HHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence 4688999999999965 46668888776554433322111 11567888999999987666666666677778
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccc
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~ 206 (337)
...|+|||++|..|++.+... ...++..+-.-+.-|| +.|++|+|+.++||++..++ +.++|||+
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGL 137 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGL 137 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCc
Confidence 888999999999999998542 1457777778888999 55699999999999999875 99999999
Q ss_pred ccc
Q 036970 207 AKQ 209 (337)
Q Consensus 207 ~~~ 209 (337)
+..
T Consensus 138 g~~ 140 (204)
T COG3642 138 GEF 140 (204)
T ss_pred ccc
Confidence 853
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=9e-12 Score=101.51 Aligned_cols=153 Identities=14% Similarity=0.086 Sum_probs=101.0
Q ss_pred cccccccccceEEeeeecCC-----CCcEEEEEEeeccch---hhHHHhhcCCcc-----hhhhHHH----HHHHHHHhc
Q 036970 46 LEKIRSCWNGEVYKAELPGS-----SGRVITIKKVIQPLK---SEAELIKQDSEP-----LHHKMIQ----IQSEIITAG 108 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~~~~~-----~~~~~~~----~~~E~~~l~ 108 (337)
...||.|..+.||.|..... .+..+|+|+...... .......++..- ....... ..+|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 46799999999999974311 357899998754221 122222222110 0112233 348999999
Q ss_pred CCCC--CChhhhhceeecCCCceEEEEeecCCCHHH-HHHhhhcCCCcCCHHHHHHHHHHHHHHHHHH-hcCCCCCceeC
Q 036970 109 QVRH--RNIVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGRRELDWLARHRIARGIASGLEYL-HMSHRPRIIHR 184 (337)
Q Consensus 109 ~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~~~~h~ 184 (337)
++.. -++++.+.+ ...++||||+.+..+.. .+. ...++......+..+++.+|..| |.. |++|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 9853 345555543 56789999996643321 221 12345556677889999999988 844 59999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCC
Q 036970 185 DIQPANVLIDDDMEARISEFGLAKQIP 211 (337)
Q Consensus 185 di~~~nil~~~~~~~kl~Dfg~~~~~~ 211 (337)
||++.||++.+ +.++++|||.+....
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999974 689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.7e-12 Score=121.31 Aligned_cols=158 Identities=16% Similarity=0.160 Sum_probs=94.5
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHH-----------HhhcCC-----cc----hhhhHHHH
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAE-----------LIKQDS-----EP----LHHKMIQI 100 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~-----~~----~~~~~~~~ 100 (337)
..|+. +.||+|++|+||.|+++. +|+.||||+..+.....-. ...... .. ..+....+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 35665 789999999999999872 5999999999764321100 000000 00 00112233
Q ss_pred HHHHHHhcCCCCCChhhhhceeec-------------CCCceEEEEeecCCCHHHHHHhhhcC--CCcCCHHHHHHHHHH
Q 036970 101 QSEIITAGQVRHRNIVPLLARVVR-------------PDCDLLVYEFRRNGSLQDILYDVSQG--RRELDWLARHRIARG 165 (337)
Q Consensus 101 ~~E~~~l~~l~h~ni~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~~~~~ 165 (337)
.+|+...+.. +|+.++...+.+ ....++||||++|+.+.+.-.-...+ ...+....+..++.|
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 3344333332 244444433332 23456999999999998753211111 112333333344444
Q ss_pred HHHHHHHHhcCCCCCceeCCCCCCcEEecCCC----cEEEecccccccCCC
Q 036970 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDM----EARISEFGLAKQIPN 212 (337)
Q Consensus 166 i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~----~~kl~Dfg~~~~~~~ 212 (337)
+ . ..|++|+|++|.||+++.++ .+++.|||++..+..
T Consensus 276 i-------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 V-------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 3 33599999999999999887 999999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.2e-12 Score=117.90 Aligned_cols=249 Identities=20% Similarity=0.204 Sum_probs=173.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
...+|..+..||.|.|+.|+....+..++..|++|...+.......- ..-..|+.+...+ .|.+++.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d------------i~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD------------IFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh------------hcchhhhhHhhHhhcccccCC
Confidence 45789999999999999999987554688999999886665543321 1223455555555 5889999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC-
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD- 196 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~- 196 (337)
+...|...+..++=.|||+++++...+ .....+.+...+++..|++.++.++|+.. .+|.|++|+||++..+
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccch
Confidence 888888888888999999999887776 33455788888999999999999999554 9999999999999986
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccc-cCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGY-IAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y-~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+..+++||+.++.+.-..... ...+..| .++.......+..+.|++|||.-+.+.+++.+.-.....
T Consensus 404 ~~~~~~~~~~~t~~~~~~~~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------- 471 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSSGVF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------- 471 (524)
T ss_pred hhhhccccccccccceecccc----cccccccccchhhccccccccccccccccccccccccCcccCccccc--------
Confidence 778899999886533221111 1112223 355555666788899999999999999998754221110
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 331 (337)
+. ....+... ..+....++..+.+.+...++..||.+.++...
T Consensus 472 -~~--~i~~~~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 472 -SL--TIRSGDTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred -ce--eeeccccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhccc
Confidence 00 00001000 001111335566666888999999988876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-11 Score=99.29 Aligned_cols=131 Identities=19% Similarity=0.230 Sum_probs=92.6
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh-hhhceeec
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV-PLLARVVR 124 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~-~~~~~~~~ 124 (337)
++.|+.|.++.||.++. .+..|++|........ ...+.+|+..++.+.+.+++ +++.. .
T Consensus 3 ~~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~~---------------~~~~~~E~~~l~~l~~~~~~P~~~~~--~ 62 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTEL---------------LINRENEAENSKLAAEAGIGPKLYYF--D 62 (170)
T ss_pred eeecCCcccCceEEEEE---CCeEEEEEeCCCCccc---------------ccCHHHHHHHHHHHHHhCCCCceEEE--e
Confidence 46789999999999985 5788999987433210 12356678888777544443 34433 2
Q ss_pred CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC--CCCceeCCCCCCcEEecCCCcEEEe
Q 036970 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH--RPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
....++||||+++.++...- . .....+.+++.++..||+.+ ..+++|+|++|.||+++ ++.++++
T Consensus 63 ~~~~~lv~e~i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~li 129 (170)
T cd05151 63 PETGVLITEFIEGSELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLI 129 (170)
T ss_pred CCCCeEEEEecCCCcccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEE
Confidence 33468999999998775420 1 11345789999999999654 22359999999999999 6689999
Q ss_pred ccccccc
Q 036970 203 EFGLAKQ 209 (337)
Q Consensus 203 Dfg~~~~ 209 (337)
||+.+..
T Consensus 130 Df~~a~~ 136 (170)
T cd05151 130 DWEYAGM 136 (170)
T ss_pred ecccccC
Confidence 9998743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.2e-09 Score=93.73 Aligned_cols=265 Identities=14% Similarity=0.108 Sum_probs=160.0
Q ss_pred cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhce-
Q 036970 44 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLAR- 121 (337)
Q Consensus 44 ~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~- 121 (337)
...+.||+|+.+.+|..- .-...+-|+...+.... ..+ .+..|... .||-+-.-+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~----e~~d~VAKIYh~Pppa~--------------~aq---k~a~la~~p~~p~~~~rvaWP 72 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG----EVRDQVAKIYHAPPPAA--------------QAQ---KVAELAATPDAPLLNYRVAWP 72 (637)
T ss_pred CCCccccCCccceeeecc----hhhchhheeecCCCchH--------------HHH---HHHHhccCCCCcchhhhhccc
Confidence 456889999999999874 22233457765554321 111 22233333 45544331111
Q ss_pred -----eecC-CCceEEEEeecCCC-HHHHHH--hhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 122 -----VVRP-DCDLLVYEFRRNGS-LQDILY--DVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 122 -----~~~~-~~~~lv~e~~~~~~-L~~~l~--~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
.-+. ....++|+.+.+-. ..++++ ..+++.....|....++++.++.+..-||..+ .+-+|++++|++
T Consensus 73 qa~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~l 149 (637)
T COG4248 73 QATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFL 149 (637)
T ss_pred HHHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCcccee
Confidence 1112 22567888876532 222221 11234455788889999999999999999554 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhC-CCCCCCcc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMG-KFPSDDFF 266 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g-~~pf~~~~ 266 (337)
+++++.|.|.|-+.-....++.... ...|...|.+||.-+ +..-+...|.|.||+++++++.| +.||.+..
T Consensus 150 Vsd~~~V~LVdsDsfqi~~ng~~~~---cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 150 VSDDSKVVLVDSDSFQINANGTLHL---CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eecCceEEEEcccceeeccCCceEe---cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 9999999999855433322332222 246788999999755 33456678999999999999998 79998754
Q ss_pred cccccchHHH-HHHHH---hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHHhhhh
Q 036970 267 QHTKEMSFVQ-WMRNV---MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFD--DPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 267 ~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--~p~~Rps~~~il~~L~~~~ 336 (337)
.......-.+ -+... .... ......+.-..-.+.-...++-.+..+|+.. ++.-|||++..+..|..+.
T Consensus 227 ~~~~ap~p~E~~Ia~g~f~ya~~-~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 227 LISDAPNPLETDIAHGRFAYASD-QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred ccCCCCCcchhhhhcceeeechh-ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 4332222222 11111 1110 0000111111111222234477778888853 4678999999999888764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.6e-11 Score=115.41 Aligned_cols=254 Identities=21% Similarity=0.175 Sum_probs=166.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..+++.+.+.+.+|.++.++.+. +...|...++|.......-... + .+....+-.++-...+|-++..
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~-pa~sgh~~~~~v~~~ap~i~~~----~-------~~s~r~~s~~~i~p~~P~v~~~ 869 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPAS-PAGSGHTRPSKVHGLAPKIRTN----D-------YESIRSKSNILITPRSPAVVRS 869 (1205)
T ss_pred CCccceecccccCCCCcccccCC-ccccccccchhhhccchhhccc----c-------ccccCCccCccccCCCCceecc
Confidence 56788889999999999999997 4446655555544221110000 0 0111111111111233444444
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
.--+......+++++|.++++|...++ +.+..+..........+..+.++||+.. +.|+|++|.|.+...+++
T Consensus 870 ~~s~~~rsP~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh 942 (1205)
T KOG0606|consen 870 FPSFPCRSPLPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGH 942 (1205)
T ss_pred cCCCCCCCCcchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCC
Confidence 444445667799999999999999884 3345666666778888999999999665 899999999999999999
Q ss_pred EEEecccccccCCCC-----------------------------CcccccccccCcccccCCccccCCCCCCcccchhHh
Q 036970 199 ARISEFGLAKQIPNG-----------------------------RTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFG 249 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~-----------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG 249 (337)
.++.||+.....+.. ..........+|+.|.+||...+......+|+|++|
T Consensus 943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen 943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence 999999733321100 000123355679999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 036970 250 VLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326 (337)
Q Consensus 250 ~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 326 (337)
+++++.++|.+||..... .+.+..+.....+-... +....-...+++...+..+|.+|..+.
T Consensus 1023 ~~l~e~l~g~pp~na~tp-------q~~f~ni~~~~~~~p~g--------~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFNAETP-------QQIFENILNRDIPWPEG--------PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhcCCCCCCCcch-------hhhhhccccCCCCCCCC--------ccccChhhhhhhhhhhccCchhccCcc
Confidence 999999999999976543 22222222222211111 111122256667778888999887765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.1e-10 Score=92.70 Aligned_cols=144 Identities=21% Similarity=0.239 Sum_probs=101.9
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC--CChhhhhceee
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH--RNIVPLLARVV 123 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~~~~~~~ 123 (337)
.+.|+.|..+.+|+++.. +|..+++|........ .....+..|+.++..+.+ .++.+++.+..
T Consensus 3 ~~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~-------------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~ 67 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALL-------------PSAHDVAREYRVLRALAGTGVPVPKVLALCE 67 (223)
T ss_pred ceecCCCccceEEEEEec--CCcceEEEeCCCcccC-------------cccccHHHHHHHHHHhhCCCCCCCCEEEECC
Confidence 367899999999999864 4688999987543221 013467788888888865 34566666665
Q ss_pred cC---CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC-----------------------
Q 036970 124 RP---DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH----------------------- 177 (337)
Q Consensus 124 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~----------------------- 177 (337)
.. +..+++|||++|.++.+.+. . ..++......++.+++.+|..||+..
T Consensus 68 ~~~~~~~~~~v~e~i~G~~l~~~~~----~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (223)
T cd05154 68 DPSVLGTPFYVMERVDGRVLRDRLL----R-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARW 142 (223)
T ss_pred CCCccCCceEEEEEeCCEecCCCCC----C-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHH
Confidence 53 25689999999887766541 0 23555566666777777777776321
Q ss_pred ------------------------------CCCceeCCCCCCcEEecC--CCcEEEeccccccc
Q 036970 178 ------------------------------RPRIIHRDIQPANVLIDD--DMEARISEFGLAKQ 209 (337)
Q Consensus 178 ------------------------------~~~~~h~di~~~nil~~~--~~~~kl~Dfg~~~~ 209 (337)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 143 RRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.6e-09 Score=94.91 Aligned_cols=218 Identities=16% Similarity=0.184 Sum_probs=146.8
Q ss_pred ccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeec----CCCc
Q 036970 53 WNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR----PDCD 128 (337)
Q Consensus 53 ~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~----~~~~ 128 (337)
-..+.|++. .+.+|..|++|++.-... .. .-....-++.++++.|+|++++.+++.. +..+
T Consensus 288 ~~~Ttyk~~-s~~DG~~YvLkRlhg~r~-----------~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Sl 352 (655)
T KOG3741|consen 288 FSITTYKAT-SNVDGNAYVLKRLHGDRD-----------QS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSL 352 (655)
T ss_pred ccceeEeee-eccCCceeeeeeeccccc-----------cC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceE
Confidence 347889997 446999999999822111 00 1122334677888999999999998873 4566
Q ss_pred eEEEEeecC-CCHHHHHHhhhc-----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 129 LLVYEFRRN-GSLQDILYDVSQ-----------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 129 ~lv~e~~~~-~~L~~~l~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++|++|.++ ++|.++.-.... .+...++...|.++.|+..||.++|+.| +..+-+.+.+|+++++
T Consensus 353 vlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~ 429 (655)
T KOG3741|consen 353 VLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGK 429 (655)
T ss_pred EEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCc
Confidence 899999975 677776432211 2345788999999999999999999555 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCC-CCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP-SDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~p-f~~~~~~~~~~~~~ 275 (337)
.+++|+.+|....+...... .+.. -.+-|.=.||.++..+.+|..- +..... ..
T Consensus 430 ~RIriS~C~i~Dvl~~d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~----~~-- 484 (655)
T KOG3741|consen 430 MRIRISGCGIMDVLQEDPTE----------------PLES---QQQNDLRDLGLLLLALATGTENSNRTDST----QS-- 484 (655)
T ss_pred ceEEEecccceeeecCCCCc----------------chhH---HhhhhHHHHHHHHHHHhhcccccccccch----HH--
Confidence 99999988876554433211 1111 2345888999999999999643 111100 00
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L 332 (337)
..+.. -.+..+.++.+++......++++ -++.+++.++
T Consensus 485 s~~~~------------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 485 SHLTR------------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHH------------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 00000 11233455667777777777776 7777777654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.3e-09 Score=88.85 Aligned_cols=151 Identities=19% Similarity=0.162 Sum_probs=103.6
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhh-------cCC-cchhhhHHHHHHHHHHhcCCCCC
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIK-------QDS-EPLHHKMIQIQSEIITAGQVRHR 113 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------~~~-~~~~~~~~~~~~E~~~l~~l~h~ 113 (337)
=..++..||-|.-|.||.|... +|.++++|.=.-..+....... +.+ .+..-.+....+|...|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred HHhhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 4567799999999999999865 8999999964332221111110 011 11122356678899999998643
Q ss_pred --ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 114 --NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 114 --ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
.+++.++ .+...+|||+++|..|...- +.......++..|+..+..+-.. |++|+|+++-||
T Consensus 170 G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNI 233 (304)
T COG0478 170 GVKVPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNI 233 (304)
T ss_pred CCCCCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheE
Confidence 5666554 45678999999886554432 12333445666677777766633 599999999999
Q ss_pred EecCCCcEEEecccccccC
Q 036970 192 LIDDDMEARISEFGLAKQI 210 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~ 210 (337)
+++++|.++++||.-+...
T Consensus 234 lV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 234 LVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EEecCCCEEEEeCcccccC
Confidence 9999999999999776543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.7e-08 Score=81.96 Aligned_cols=140 Identities=21% Similarity=0.212 Sum_probs=83.1
Q ss_pred eEEeeeecCCCCcEEEEEEeeccchhhHH---HhhcCC---------cchhhhHHHHHHHHHHhcCCCCC--Chhhhhce
Q 036970 56 EVYKAELPGSSGRVITIKKVIQPLKSEAE---LIKQDS---------EPLHHKMIQIQSEIITAGQVRHR--NIVPLLAR 121 (337)
Q Consensus 56 ~vy~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~--ni~~~~~~ 121 (337)
.||.|... +|..+|+|+.......... ...... ...........+|...|.++... ++++.+.+
T Consensus 1 ~Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 38999765 7889999987553221111 111111 12223356678899999999765 45555533
Q ss_pred eecCCCceEEEEeec--CCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHH-HhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 122 VVRPDCDLLVYEFRR--NGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY-LHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~-lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
....+||||++ |..+..+. ... ++......++.+++..+.. +|. .|++|||+++.||+++++ .
T Consensus 79 ----~~~~ivME~I~~~G~~~~~l~-~~~-----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 ----NRNVIVMEYIGEDGVPLPRLK-DVD-----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ----ETTEEEEE--EETTEEGGCHH-HCG-----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-C
T ss_pred ----eCCEEEEEecCCCccchhhHH-hcc-----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-e
Confidence 24679999998 55554433 211 1123345577777775544 674 459999999999999988 9
Q ss_pred EEEecccccccCC
Q 036970 199 ARISEFGLAKQIP 211 (337)
Q Consensus 199 ~kl~Dfg~~~~~~ 211 (337)
+.++|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999886654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.8e-08 Score=84.80 Aligned_cols=143 Identities=17% Similarity=0.160 Sum_probs=95.6
Q ss_pred ceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh--hhhhceeec-----CCC
Q 036970 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI--VPLLARVVR-----PDC 127 (337)
Q Consensus 55 g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--~~~~~~~~~-----~~~ 127 (337)
..|..+.. .|+.|.||........+ .++... ........+.+|+..+..+...+| +....+.+. ...
T Consensus 36 rrvvr~~~---~g~~~~vKr~~~~~~~~--~~k~l~-~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 36 RRTLRFEL---AGKSYFLKWHRGTGWGE--IFKNLL-SLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred ceEEEEEE---CCEEEEEEEecCCcHHH--Hhhhhc-ccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 33556654 67889999775544321 111100 000112246788888888844343 334444433 224
Q ss_pred ceEEEEeecCC-CHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC-------CCcE
Q 036970 128 DLLVYEFRRNG-SLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-------DMEA 199 (337)
Q Consensus 128 ~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~-------~~~~ 199 (337)
.++|+|++++. +|.+++.... ..+.+......++.+++..+.-||.. |++|+|++++||+++. +..+
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence 68999999875 8999985432 23456667788999999999999955 5999999999999975 4679
Q ss_pred EEecccccc
Q 036970 200 RISEFGLAK 208 (337)
Q Consensus 200 kl~Dfg~~~ 208 (337)
.++||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999875
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.9e-08 Score=79.07 Aligned_cols=155 Identities=13% Similarity=0.073 Sum_probs=108.5
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC--h
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN--I 115 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--i 115 (337)
..+.++-..-.-|+||.|.|+...+ .|+.+-+|...+-...... . +-....+.+|+..+..|...+ +
T Consensus 15 ~~~~~wve~pN~~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s~r------~--P~g~ptf~rE~~~L~~L~~~GvPV 83 (216)
T PRK09902 15 ATEGDWVEEPNYRRNGMSGVQCVER---NGKKLYVKRMTHHLFHSVR------Y--PFGRPTIVREVAVIKELERAGVIV 83 (216)
T ss_pred hCCCceecCCCcCCCCcceEEEEEe---CCcEEEEEeccCccccccc------C--CCCchHHHHHHHHHHHHHHcCCCC
Confidence 3455665556667899999999876 4557889987533322111 0 112568999999999995323 4
Q ss_pred hhhhceeecC-----CCceEEEEeecC-CCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCC
Q 036970 116 VPLLARVVRP-----DCDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189 (337)
Q Consensus 116 ~~~~~~~~~~-----~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ 189 (337)
++.. ++... -..+||+|-+++ .+|.+++.+. ...+.+...+..++.+++..+.-||.. |+.|+|+.+.
T Consensus 84 P~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~k 157 (216)
T PRK09902 84 PKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVR 157 (216)
T ss_pred Cccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHh
Confidence 4444 33211 124799997753 6898887432 233567778889999999999999944 5999999999
Q ss_pred cEEecCCCc--EEEeccccccc
Q 036970 190 NVLIDDDME--ARISEFGLAKQ 209 (337)
Q Consensus 190 nil~~~~~~--~kl~Dfg~~~~ 209 (337)
||+++.++. +.++||.-++.
T Consensus 158 hIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 158 HIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred heeecCCCCeeEEEEEhhccch
Confidence 999986667 99999976654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.1e-09 Score=100.22 Aligned_cols=151 Identities=17% Similarity=0.233 Sum_probs=97.8
Q ss_pred HHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcc-----c--ccccccCcccccCCccccC
Q 036970 164 RGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR-----T--TTWSLAETVGYIAPECHQT 236 (337)
Q Consensus 164 ~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~-----~--~~~~~~g~~~y~aPE~~~~ 236 (337)
.+++.|+.++|... ++||++|.|++|.++.++.+|+++|+.+......... . ..--......|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34458999999664 6999999999999999999999999988655431111 0 0101112346999999999
Q ss_pred CCCCCcccchhHhHHHHHHHhCCCC-CCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhc
Q 036970 237 VALSDKCDIYSFGVLLAVLMMGKFP-SDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCT 315 (337)
Q Consensus 237 ~~~~~~~DvwslG~vl~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 315 (337)
...+.++|+||+|+++|.+..|..+ +..... .......... .+.... ....+...++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~----~~~~~~~~~~--~~~~~~--------~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG----LLSYSFSRNL--LNAGAF--------GYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCC----cchhhhhhcc--cccccc--------cccccCcHHHHHHHHHHh
Confidence 8888999999999999999955544 332111 1111110000 000011 111233344777778889
Q ss_pred CCCCCCCCCHHHHHH
Q 036970 316 FDDPEERPNSKDVRC 330 (337)
Q Consensus 316 ~~~p~~Rps~~~il~ 330 (337)
..++.-||++..+..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999997766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.2e-07 Score=77.26 Aligned_cols=130 Identities=22% Similarity=0.253 Sum_probs=90.3
Q ss_pred CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC--hhhhhceeecCC----CceEEEEeecC-C
Q 036970 66 SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN--IVPLLARVVRPD----CDLLVYEFRRN-G 138 (337)
Q Consensus 66 ~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~~~~~~~~~~----~~~lv~e~~~~-~ 138 (337)
.++.|.+|..........-... -......+|...+..|...+ .++.+.+.+... ..++|+|++++ .
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~-------~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~ 103 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFP-------LRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQ 103 (206)
T ss_pred cceEEEECCeechhccchhhhc-------ccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcc
Confidence 5677777765443322211111 01346777888777774333 345555555422 34799999987 4
Q ss_pred CHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC---cEEEeccccccc
Q 036970 139 SLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM---EARISEFGLAKQ 209 (337)
Q Consensus 139 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~---~~kl~Dfg~~~~ 209 (337)
+|.+++.... ..+......++.+++..+.-||..+ ++|+|+++.|||++.++ .+.++||+.+..
T Consensus 104 ~L~~~~~~~~----~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 104 DLRDLLQQWE----QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred cHHHHHHhhc----ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 7999984422 2566677889999999999999555 99999999999999887 899999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.9e-07 Score=73.92 Aligned_cols=150 Identities=15% Similarity=0.180 Sum_probs=95.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|...+.+.......|.+... +|+.+++|.........+..+..-... ....++......++...-..+..+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~~~sf~kg--~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI---DGKKYILKEPREENRRPERRFKSFFKG--SEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHHHHHHhcc--HHHHHHHHHHHHHHHcCccccccc
Confidence 679999999999999888888764 789999999866554433332211111 112223333333333222233333
Q ss_pred hceeec-----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 119 LARVVR-----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 119 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+.+.+- ....+++|||++|..|.+... +++ .+...+.+++.-+| +.|++|+|+.|.|+++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv 168 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLV 168 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEE
Confidence 322222 223468999999988876541 222 25566778899999 5559999999999999
Q ss_pred cCCCcEEEeccccccc
Q 036970 194 DDDMEARISEFGLAKQ 209 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~ 209 (337)
+++ .+++.|++....
T Consensus 169 ~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 169 SNN-GIRIIDTQGKRM 183 (229)
T ss_pred ECC-cEEEEECccccc
Confidence 865 599999976543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.8e-07 Score=84.52 Aligned_cols=156 Identities=22% Similarity=0.261 Sum_probs=92.8
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHH-----------HhhcCCc-----chhhhH----------HHH
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAE-----------LIKQDSE-----PLHHKM----------IQI 100 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~~-----~~~~~~----------~~~ 100 (337)
..|+.++-|+||.|+++ +|+.||||+..+.....-. ....... ...... -.+
T Consensus 131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 67899999999999998 7999999998663221110 0000000 000111 113
Q ss_pred HHHHHHhcCCC-----CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHH-HHHHh
Q 036970 101 QSEIITAGQVR-----HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASG-LEYLH 174 (337)
Q Consensus 101 ~~E~~~l~~l~-----h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~-l~~lh 174 (337)
.+|...+.+++ .+++.--.=+++-.....++|||++|..+.+...... ...+... ++..++.+ +..+-
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~---ia~~~~~~f~~q~~ 282 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKE---LAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHH---HHHHHHHHHHHHHH
Confidence 44554444442 2222111112233455679999999988888743222 2234333 33333222 23333
Q ss_pred cCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCC
Q 036970 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG 213 (337)
Q Consensus 175 ~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~ 213 (337)
..|+.|+|..|.||++..+|++.+.|||+.......
T Consensus 283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 335999999999999999999999999998776543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.5e-06 Score=69.86 Aligned_cols=140 Identities=14% Similarity=0.092 Sum_probs=82.1
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCC--Chhhhhceeec
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR--NIVPLLARVVR 124 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~~~~~~~~ 124 (337)
..||.|..+.||+. .|..+++|....... ...+.+|.+.++.+..- .+.+.+.+..+
T Consensus 7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~~----------------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~ 65 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----KTGKWMLKLYNPGFD----------------KETIKREFDASRKVFSLGIPTPHPFDLVED 65 (226)
T ss_pred eeecCCCCcceeEe-----cCCCEEEEeCCCCCC----------------HHHHHHHHHHHHHHHHcCCCCCceEEEEec
Confidence 67899999999983 344677887743221 33467788888887533 34667777777
Q ss_pred CCCceEEEEeecCCC-HHHHH--------------Hh----hhcC-CCcCCHHHHH-HHHHH----------HHHH-HHH
Q 036970 125 PDCDLLVYEFRRNGS-LQDIL--------------YD----VSQG-RRELDWLARH-RIARG----------IASG-LEY 172 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~-L~~~l--------------~~----~~~~-~~~l~~~~~~-~~~~~----------i~~~-l~~ 172 (337)
.+...++||+++|.. +...+ .. ...- ....+..... .+..+ +... ..+
T Consensus 66 ~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~ 145 (226)
T TIGR02172 66 GGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAF 145 (226)
T ss_pred CCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHH
Confidence 777889999998853 11111 00 0000 0011111111 11000 1111 122
Q ss_pred HhcC-CCCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 173 LHMS-HRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 173 lh~~-~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
|.+. ....++|+|+.|.|+++++++ +.++||+.+.
T Consensus 146 l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 146 IKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 2211 133579999999999999887 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=9e-06 Score=75.92 Aligned_cols=154 Identities=16% Similarity=0.164 Sum_probs=88.8
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhH-----------HHhhcCCcch------------hhhHHHHHHH
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEA-----------ELIKQDSEPL------------HHKMIQIQSE 103 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~~~------------~~~~~~~~~E 103 (337)
+.|+....|.||+|+.+ +|+.||||+-.+...... ..+.+..... ....-.|.+|
T Consensus 167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 67999999999999988 699999999866332210 0000000000 0001113334
Q ss_pred HHHhcCC----CCCC------hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHH
Q 036970 104 IITAGQV----RHRN------IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173 (337)
Q Consensus 104 ~~~l~~l----~h~n------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~l 173 (337)
....++. .|-+ |++++..+ .....++|||++|..+.|.-.-... .++...+...+.+... ..+
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~--~qI 317 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYL--EQI 317 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHH--HHH
Confidence 3333332 2222 33333222 2355799999999877665322122 2444443333333322 223
Q ss_pred hcCCCCCceeCCCCCCcEEecC----CCcEEEecccccccCCC
Q 036970 174 HMSHRPRIIHRDIQPANVLIDD----DMEARISEFGLAKQIPN 212 (337)
Q Consensus 174 h~~~~~~~~h~di~~~nil~~~----~~~~kl~Dfg~~~~~~~ 212 (337)
- ..|.+|+|-.|.||++.. +..+.+.|||+......
T Consensus 318 f---~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 F---KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred H---hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3 336999999999999994 66899999999876643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.6e-06 Score=68.28 Aligned_cols=151 Identities=17% Similarity=0.164 Sum_probs=91.2
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHH---------HhhcCCcchh-hhHHHHHHHHHHhcCCCCC--C
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAE---------LIKQDSEPLH-HKMIQIQSEIITAGQVRHR--N 114 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~---------~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~--n 114 (337)
..|..|..+.||+|... ++..+|+|+.......... .+........ ....=..+|+..|.++... .
T Consensus 54 g~istGKEA~Vy~a~~~--~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 54 GCISTGKEANVYLAETG--DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eeecCCcceEEEeeccC--CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 46777999999999743 7999999998654332221 0011111100 0011134566666665322 2
Q ss_pred hhhhhceeecCCCceEEEEeecCC-CHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNG-SLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++-+. -....+||||+... .-.-.+ +.-++.......+..+++..+.-|... .++||+||+.=|||+
T Consensus 132 vP~Pi~----~~~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~ 200 (268)
T COG1718 132 VPEPIA----FRNNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILV 200 (268)
T ss_pred CCCcee----ecCCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEE
Confidence 222222 12346899999542 111111 112233335677888888888888752 359999999999999
Q ss_pred cCCCcEEEecccccccCC
Q 036970 194 DDDMEARISEFGLAKQIP 211 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~ 211 (337)
. ++.+.++|++-+....
T Consensus 201 ~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred E-CCeEEEEECccccccC
Confidence 9 7899999999887654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.3e-06 Score=65.96 Aligned_cols=137 Identities=14% Similarity=0.104 Sum_probs=92.5
Q ss_pred hhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 36 FLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 36 ~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
+......-+..+.|++|++|.||++.+ .|..+++|+-..+.. +..+..|.+++..+.-.++
T Consensus 17 ~~~~~~~~~v~~~L~KG~~s~Vyl~~~---~~~~~a~Kvrr~ds~----------------r~~l~kEakiLeil~g~~~ 77 (201)
T COG2112 17 VEEGKYELRVEKELAKGTTSVVYLGEW---RGGEVALKVRRRDSP----------------RRNLEKEAKILEILAGEGV 77 (201)
T ss_pred eeccchhhhhhhhhhcccccEEEEeec---cCceEEEEEecCCcc----------------hhhHHHHHHHHHHhhhcCC
Confidence 334555667789999999999999987 577999998865544 5578889988888765554
Q ss_pred hh-hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC-CcEEe
Q 036970 116 VP-LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP-ANVLI 193 (337)
Q Consensus 116 ~~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~-~nil~ 193 (337)
.+ ++.+. ..++.|||++|..|.+.-.. ... +-+..+++..--|. ..||-|+.|+- ....+
T Consensus 78 ~p~vy~yg----~~~i~me~i~G~~L~~~~~~-------~~r----k~l~~vlE~a~~LD---~~GI~H~El~~~~k~vl 139 (201)
T COG2112 78 TPEVYFYG----EDFIRMEYIDGRPLGKLEIG-------GDR----KHLLRVLEKAYKLD---RLGIEHGELSRPWKNVL 139 (201)
T ss_pred CceEEEec----hhhhhhhhhcCcchhhhhhc-------ccH----HHHHHHHHHHHHHH---HhccchhhhcCCceeEE
Confidence 33 22221 23355999988888776521 122 23444555544555 55699999875 44444
Q ss_pred cCCCcEEEeccccccc
Q 036970 194 DDDMEARISEFGLAKQ 209 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~ 209 (337)
..++.+.|+||..++.
T Consensus 140 v~~~~~~iIDFd~At~ 155 (201)
T COG2112 140 VNDRDVYIIDFDSATF 155 (201)
T ss_pred ecCCcEEEEEccchhh
Confidence 4445999999998863
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.7e-05 Score=65.85 Aligned_cols=144 Identities=19% Similarity=0.241 Sum_probs=78.6
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCC--Chhhhhceee
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR--NIVPLLARVV 123 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~~~~~~~ 123 (337)
++.|+.|..+.||.+... + ..+++|...... ....+.+|..+++.+... .+.+++....
T Consensus 2 i~~l~~G~~n~~~~v~~~--~-~~~vlK~~~~~~----------------~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~ 62 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD--D-GRYVLKFYRPPD----------------AAERLRREAAVLRQLAEHGIPVPRVLAFDT 62 (239)
T ss_dssp EEEEEESSSSEEEEEEET--T-SEEEEEEESSHH----------------HHHHHHHHHHHHHHHHHTTSBS--EEEEEE
T ss_pred CccCCCCCeeeEEEEEEC--C-cEEEEEEeCCCC----------------CHHHHHHHHHHHHHHHhcCCCCceEEeecc
Confidence 467899999999999854 3 689999875441 134566777777777322 3455555332
Q ss_pred c---CCCceEEEEeecCCCHHH----------------HHHhhhcC---CCcCCHHHHH------H---H----------
Q 036970 124 R---PDCDLLVYEFRRNGSLQD----------------ILYDVSQG---RRELDWLARH------R---I---------- 162 (337)
Q Consensus 124 ~---~~~~~lv~e~~~~~~L~~----------------~l~~~~~~---~~~l~~~~~~------~---~---------- 162 (337)
. ....+++|+++++..+.. .+...... .......... . .
T Consensus 63 ~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (239)
T PF01636_consen 63 SDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELF 142 (239)
T ss_dssp ETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCH
T ss_pred cccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhh
Confidence 2 234589999999887776 11111111 1111111000 0 0
Q ss_pred --HHHHHH-HHHHHhc----CCCCCceeCCCCCCcEEec-CCCcEEEecccccc
Q 036970 163 --ARGIAS-GLEYLHM----SHRPRIIHRDIQPANVLID-DDMEARISEFGLAK 208 (337)
Q Consensus 163 --~~~i~~-~l~~lh~----~~~~~~~h~di~~~nil~~-~~~~~kl~Dfg~~~ 208 (337)
...+.. .+..++. .....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 143 DDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 111111 2222221 1245699999999999999 55666799998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.8e-05 Score=63.39 Aligned_cols=141 Identities=20% Similarity=0.281 Sum_probs=91.4
Q ss_pred ccCccccccccccccc-ceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCC-------cchhhhHHHHHHHHHHhcCC
Q 036970 39 KEDCFASLEKIRSCWN-GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDS-------EPLHHKMIQIQSEIITAGQV 110 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~-g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~E~~~l~~l 110 (337)
-..+++.++.||.|.. |.||+++. .|+.||+|.+............... .......+.|..|.+...+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 3489999999999999 99999987 6889999994331111111100000 00112245788899888877
Q ss_pred C---CCCh--hhhhceeecCC------------------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHH
Q 036970 111 R---HRNI--VPLLARVVRPD------------------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIA 167 (337)
Q Consensus 111 ~---h~ni--~~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~ 167 (337)
+ +.++ ++++||..-.. ...||.||.+... .++. .-+.++.
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~ 174 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQML 174 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHH
Confidence 4 4455 88888873220 1146777765432 1222 2355666
Q ss_pred HHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccccc
Q 036970 168 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207 (337)
Q Consensus 168 ~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~ 207 (337)
.-+..+| +.||+-+|+++.|.. .-+|+|||.+
T Consensus 175 ~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 7778889 556999999998876 4578898864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.4e-05 Score=64.75 Aligned_cols=142 Identities=11% Similarity=0.057 Sum_probs=82.2
Q ss_pred cccccccc-ceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhhceeec
Q 036970 47 EKIRSCWN-GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLLARVVR 124 (337)
Q Consensus 47 ~~lg~G~~-g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~ 124 (337)
..|..|.. +.||+... .+..+.+|...... ...+.+|+.+++.+. +-.+.+++.+...
T Consensus 4 ~~~~~g~~~~~v~~~~~---~~~~~~vk~~~~~~-----------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 63 (244)
T cd05150 4 ERVTEGQSGATVYRLDG---KNPGLYLKIAPSGP-----------------TYELEREAERLRWLAGKLPVPEVIDYGSD 63 (244)
T ss_pred eecCCCCCcCeEEEEcC---CCCcEEEEecCCCc-----------------ccchHHHHHHHHHHHhcCCCCeEEEEEec
Confidence 34555666 88899964 34678888874332 123556777777762 3446677777776
Q ss_pred CCCceEEEEeecCCCHHHHH----------------HhhhcC---CCcCCHH--HHHHH---------------------
Q 036970 125 PDCDLLVYEFRRNGSLQDIL----------------YDVSQG---RRELDWL--ARHRI--------------------- 162 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l----------------~~~~~~---~~~l~~~--~~~~~--------------------- 162 (337)
++..++|||+++|.++.... .....- ..+.... .....
T Consensus 64 ~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (244)
T cd05150 64 DGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRG 143 (244)
T ss_pred CCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcC
Confidence 66789999999987765432 000000 0011100 00000
Q ss_pred --HHHHHHHHHHHh-cCCCCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 163 --ARGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 163 --~~~i~~~l~~lh-~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
..++...+.... ......++|+|+.|.||++++++.+.|+||+.+.
T Consensus 144 ~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 144 WSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 111111111111 1113458999999999999997778899998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.9e-05 Score=76.38 Aligned_cols=198 Identities=18% Similarity=0.186 Sum_probs=133.7
Q ss_pred HHHHHHHHHHhcCCCCCChhhhhceeecCCCc----eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHH
Q 036970 97 MIQIQSEIITAGQVRHRNIVPLLARVVRPDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172 (337)
Q Consensus 97 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~ 172 (337)
+.....|+..+.++.|+|+..++.|..+.... .+..++|...++...+ +.-...+..+.+.+..++.+|+.+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHH
Confidence 44556677888888999999999887765433 3456788888888887 455678999999999999999999
Q ss_pred HhcCCCCCceeCCCCCC---cEEecCCCcEEEe--cccccccCCCCCcccccccccCcccccCCccccCCCCCC--cccc
Q 036970 173 LHMSHRPRIIHRDIQPA---NVLIDDDMEARIS--EFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSD--KCDI 245 (337)
Q Consensus 173 lh~~~~~~~~h~di~~~---nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Dv 245 (337)
+|+.. +.|.-+..+ +.-.+..+.+..+ ||+.+........... ...+..+.+||......++. ..|+
T Consensus 302 ~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 302 LHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred HHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHH
Confidence 99664 555544444 4444555666666 8887776654332221 23345577888776665544 4799
Q ss_pred hhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 246 YSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 246 wslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
|.+|.....+..+..+-..... ....+ +. .... .+......|+.-++++|+++
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~----------~~~~l---------~~----~~~~----~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAV----------PVSLL---------DV----LSTS----ELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccc----------hhhhh---------cc----ccch----hhhhhhhhhcchhhhhccch
Confidence 9999999999988755221100 00000 00 0000 26677788999899999999
Q ss_pred HHHHHH
Q 036970 326 KDVRCM 331 (337)
Q Consensus 326 ~~il~~ 331 (337)
.+++..
T Consensus 429 ~~ll~~ 434 (1351)
T KOG1035|consen 429 LELLTH 434 (1351)
T ss_pred hhhhhc
Confidence 998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.7e-06 Score=80.59 Aligned_cols=186 Identities=19% Similarity=0.118 Sum_probs=127.9
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC-hhhhhce
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN-IVPLLAR 121 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~~~~~ 121 (337)
+.....+++|+.+.+++.|.. ..+....+.+... ....-++++|.+.+||| .+..++-
T Consensus 244 s~~fh~fvK~altknpKkRpt--aeklL~h~fvs~~-------------------l~~rl~~eLLdK~n~P~~~v~~~~d 302 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPT--AEKLLQHPFVSQT-------------------LSRRLAIELLDKVNNPNPVVRYLED 302 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCC--hhhheeceeeccc-------------------hhhHHHHHHHHHccCCCCccccccc
Confidence 455677899999999999843 2333334444222 23444788899999999 6666676
Q ss_pred eecCCCceEEEEeecCC-CHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 122 VVRPDCDLLVYEFRRNG-SLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+...++.++++.++ +....+. ...-.+..-......+.-..+++++|+.. -+|+| ||+..+ +..+
T Consensus 303 ~~~E~~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~ 371 (829)
T KOG0576|consen 303 YDGEDYLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVK 371 (829)
T ss_pred CCcccccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccc
Confidence 77778889999999766 2222110 01111222333446666677889999554 58887 665554 6889
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCC
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSD 263 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~ 263 (337)
.+||+....+...... ....+++.++|||+.....+....|.|++|.-..++--|.+|-.
T Consensus 372 ~~~~~v~~~L~~~~~~---~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 372 LLDFAVPPQLTRTMKP---RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccccCCcccCccccc---ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9999988777654322 24577999999999999999999999999987777777777643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00015 Score=59.58 Aligned_cols=140 Identities=19% Similarity=0.187 Sum_probs=88.4
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhH----HHhhcCCcchhhhHHHHHHHHHHhcCCC------CCCh
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEA----ELIKQDSEPLHHKMIQIQSEIITAGQVR------HRNI 115 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ni 115 (337)
...||+|+.-.||.= + .....+||+......... ....+.... ....+..+|+.....+. +.+|
T Consensus 6 ~~~i~~G~~R~cy~H--P--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~E~~~y~~l~~~~~~~~~~i 79 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPK--SRYRQNRRELRYYKQLSLRRGVDWSHI 79 (199)
T ss_pred CcccccCCCceEEEC--C--CCCCeEEEEEccccccccccchhHHHhhccc--chhHHHHHHHHHHHHHhhccCCccccc
Confidence 467999999999975 3 566678898866550000 000000000 01334455555444443 8899
Q ss_pred hhhhceeecCCCceEEEEeecC------CCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRN------GSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ 189 (337)
.+++|+.+++....+|+|.+.+ .+|.+++. ...++. .....+.++ ..+|-..+ |+.+|++|.
T Consensus 80 ~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~ 147 (199)
T PF10707_consen 80 PRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPH 147 (199)
T ss_pred ccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcc
Confidence 9999999999999999998753 35777772 233554 333444444 45566444 999999999
Q ss_pred cEEecCCC----cEEEec
Q 036970 190 NVLIDDDM----EARISE 203 (337)
Q Consensus 190 nil~~~~~----~~kl~D 203 (337)
||++.... .++|+|
T Consensus 148 NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 148 NIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cEEEEecCCCceEEEEEe
Confidence 99997432 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.89 E-value=4.7e-05 Score=62.14 Aligned_cols=105 Identities=20% Similarity=0.177 Sum_probs=80.3
Q ss_pred HHHHHHhcCCCC-CChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 036970 101 QSEIITAGQVRH-RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRP 179 (337)
Q Consensus 101 ~~E~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 179 (337)
.+|..++..+.+ +++++++|.|- .+++.||...+++.+.... -......+|..+.+++.++++.+.+++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 457888888865 69999999883 3578999987655421000 01112368999999999999999999976444
Q ss_pred CceeCCCCCCcEEecCCCcEEEecccccccC
Q 036970 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQI 210 (337)
Q Consensus 180 ~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~ 210 (337)
.+.-.|++++|+-+++++++|+.|.+.....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5888999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00018 Score=72.39 Aligned_cols=82 Identities=6% Similarity=0.082 Sum_probs=55.3
Q ss_pred ccccccccccceEEeeeecCCC-CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCCh--hhhhc
Q 036970 45 SLEKIRSCWNGEVYKAELPGSS-GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNI--VPLLA 120 (337)
Q Consensus 45 ~~~~lg~G~~g~vy~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--~~~~~ 120 (337)
.+..++.|.++.+|........ ...+++|+........ ....+.+|+.+++.+. |.++ ++++.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-------------~~~~~~rE~~~l~~L~~~~~vpVP~v~~ 108 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-------------SAHAVEREYQVLRALGEHTDVPVPKVYC 108 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-------------cHHHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 3677899999999998764211 1467778764322100 0235778999999885 6654 67777
Q ss_pred eeecC---CCceEEEEeecCCC
Q 036970 121 RVVRP---DCDLLVYEFRRNGS 139 (337)
Q Consensus 121 ~~~~~---~~~~lv~e~~~~~~ 139 (337)
++.+. +..++||||++|..
T Consensus 109 ~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 109 LCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred EecCCCcCCCceEEEEecCCcc
Confidence 77654 46789999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00016 Score=61.40 Aligned_cols=31 Identities=29% Similarity=0.565 Sum_probs=25.8
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
..+++|+|+.+.|++++++...-|.||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4458999999999999876556799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00059 Score=60.14 Aligned_cols=79 Identities=14% Similarity=0.019 Sum_probs=54.0
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC---CChhhhh
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH---RNIVPLL 119 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~ni~~~~ 119 (337)
-.-.+.||.|..+.||..... ++ .+.+|....... ...+.+|...++.|.. -.+++++
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~~~~----------------~~~~~~Ea~~L~~L~~~~~vpVP~V~ 76 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS--QG-NPMPLMARSFST----------------PGVAQQEAWKLSMLARSGTVRMPTVY 76 (297)
T ss_pred hheeeecCCccceeEEEEEcC--CC-CEEEEEeccccc----------------chHHHHHHHHHHHHccCCCCCcCcEE
Confidence 344578999999999999643 34 466676421101 2367788888888742 3677888
Q ss_pred ceeec---CCCceEEEEeecCCCH
Q 036970 120 ARVVR---PDCDLLVYEFRRNGSL 140 (337)
Q Consensus 120 ~~~~~---~~~~~lv~e~~~~~~L 140 (337)
+++.. .+..++|||++++.++
T Consensus 77 ~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 77 GVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred EEeccCCcCCCeEEEEeccCCEec
Confidence 77654 3567999999988654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00071 Score=61.66 Aligned_cols=82 Identities=10% Similarity=0.051 Sum_probs=50.8
Q ss_pred cccccccccceEEeeeecCCCC-cEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC---CCChhhhhce
Q 036970 46 LEKIRSCWNGEVYKAELPGSSG-RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR---HRNIVPLLAR 121 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~~~ 121 (337)
.+.||.|.++.||.+... +| +.++||.-........ ....-..++...|...|..+. ..++++++.+
T Consensus 31 ~~elggGn~N~VyrV~~~--~g~~svIVKqa~p~~r~~g-------~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDT--EGGKSVIVKQALPYVRVVG-------ESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEeC--CCCeEEEEEecCccccccc-------ccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 468999999999999865 55 5899998632111000 000011445666777777662 2446666654
Q ss_pred eecCCCceEEEEeecCC
Q 036970 122 VVRPDCDLLVYEFRRNG 138 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~ 138 (337)
+....++||||+++.
T Consensus 102 --D~~~~~lVME~L~~~ 116 (401)
T PRK09550 102 --DEELAVTVMEDLSDH 116 (401)
T ss_pred --CCCCCEEEEecCCCc
Confidence 445578999998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00014 Score=63.09 Aligned_cols=175 Identities=13% Similarity=0.071 Sum_probs=107.2
Q ss_pred CCCCCCcccCCccchhhhhhhh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhh--------
Q 036970 17 SRDRGPTIFSPLIEKEDLAFLK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIK-------- 87 (337)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------- 87 (337)
++.++=+..-...+=..+.-|. ...-+.++..||-|.-+.||.+-+. .|++.++|.=.-..+.......
T Consensus 67 ~k~dGYRLTy~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~--~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r 144 (465)
T KOG2268|consen 67 KKYDGYRLTYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADE--EGNPLILKLHRLGRTSFRNVKNKRDYLRKR 144 (465)
T ss_pred ccccceEeeeccchHHHHHHHHhcchhhhhccccccccccceEEEecC--CCCchhHHHHhhhhhhHHHhhhhhhhHhcC
Confidence 3444444444444433333344 3346788899999999999999865 7999999864332222211111
Q ss_pred cCCcchhhhHHHHHHHHHHhcCCCC--CChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHH
Q 036970 88 QDSEPLHHKMIQIQSEIITAGQVRH--RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARG 165 (337)
Q Consensus 88 ~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~ 165 (337)
....+..-.+-...+|...|..|.. -.+++.+ +.+..++|||++++..|...-+ .....+ +...
T Consensus 145 ~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~---ly~~ 210 (465)
T KOG2268|consen 145 KSGSWLYLSRLAATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRH-------VEDPPT---LYDD 210 (465)
T ss_pred CccchhhhHHHHHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeee-------cCChHH---HHHH
Confidence 1111222223445678888877732 2344444 3456789999998876655421 122223 3444
Q ss_pred HHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccC
Q 036970 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI 210 (337)
Q Consensus 166 i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~ 210 (337)
+..-+--|. +.|++|+|..-=||++.+++.++++||.-....
T Consensus 211 lm~~Iv~la---~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 211 LMGLIVRLA---NHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred HHHHHHHHH---HcCceecccchheeEEecCCCEEEeechHhhcc
Confidence 444455666 566999999999999999999999999755443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0067 Score=54.05 Aligned_cols=32 Identities=28% Similarity=0.375 Sum_probs=26.5
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEeccccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~ 209 (337)
..+++|+|+.|.||+++++...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 34799999999999999765568999998743
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.011 Score=52.42 Aligned_cols=31 Identities=35% Similarity=0.512 Sum_probs=27.1
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
..+++|+|+.+.|+++++++.+.|.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4579999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0022 Score=55.26 Aligned_cols=140 Identities=11% Similarity=0.056 Sum_probs=74.5
Q ss_pred cccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh-hhhhceeecCC
Q 036970 48 KIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI-VPLLARVVRPD 126 (337)
Q Consensus 48 ~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~~~~~~ 126 (337)
.+..|-.+.+|+... ++..+++|......... .....+|..+++.+...++ .+++...
T Consensus 3 ~~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~--------------~~~r~~E~~~l~~l~~~g~~P~~i~~~---- 61 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH---PGISFVWRPQSPVCKAL--------------GVDRQREYQILQALSALGLAPKPILVN---- 61 (256)
T ss_pred cCCCcCcCCeEEEEe---CCccEEEeeCCcccccc--------------cCcHHHHHHHHHHHHhcCCCCceEEEe----
Confidence 456788889998862 67788888753321100 0124567777777743333 2333222
Q ss_pred CceEEEEeecCCCHHH--------------HHHhhhc---CCCcCCHHH-HHHHHHHH---------HHHHHHHhcC---
Q 036970 127 CDLLVYEFRRNGSLQD--------------ILYDVSQ---GRRELDWLA-RHRIARGI---------ASGLEYLHMS--- 176 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~--------------~l~~~~~---~~~~l~~~~-~~~~~~~i---------~~~l~~lh~~--- 176 (337)
..++|+||++|..+.. .+..... ...+++... ...+..++ ...+..+...
T Consensus 62 ~~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 141 (256)
T TIGR02721 62 EHWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEP 141 (256)
T ss_pred CCEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCC
Confidence 2468999998765431 1111111 111222211 11111111 1112222111
Q ss_pred --CCCCceeCCCCCCcEEecCCCcEEEeccccccc
Q 036970 177 --HRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209 (337)
Q Consensus 177 --~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~ 209 (337)
....++|+|+.|.||++++++ +.++||..+..
T Consensus 142 ~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 142 APLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCCCCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 123589999999999999876 78999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.007 Score=53.26 Aligned_cols=146 Identities=17% Similarity=0.131 Sum_probs=80.2
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC--hhhhhc
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN--IVPLLA 120 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~~~~ 120 (337)
..-.+.|..|....+|.... ++..+++|+..... ...+..|+.++..+.+.+ +.+.+.
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~---~~~~~vLr~~~~~~-----------------~~~~~~e~~~l~~L~~~g~~vp~~i~ 75 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTT---DSGRYVLTLFEKVS-----------------AEELPFFLALLDHLAERGLPVPRPIA 75 (296)
T ss_pred hhheecccCccccceEEEEe---CCCcEEEEEcCCCC-----------------hHhccHHHHHHHHHHHCCCCCCcccc
Confidence 33467788888899999864 44578889874311 223445666665553222 333332
Q ss_pred ------eeecCCCceEEEEeecCCCHHH-----------HH---HhhhcCCC-------cCCHHHHH----------HHH
Q 036970 121 ------RVVRPDCDLLVYEFRRNGSLQD-----------IL---YDVSQGRR-------ELDWLARH----------RIA 163 (337)
Q Consensus 121 ------~~~~~~~~~lv~e~~~~~~L~~-----------~l---~~~~~~~~-------~l~~~~~~----------~~~ 163 (337)
+...++..+++++|++|..+.. .+ +....... ...+.... ...
T Consensus 76 ~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 155 (296)
T cd05153 76 DRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDR 155 (296)
T ss_pred CCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHH
Confidence 1223445689999998765421 11 11100100 00111000 011
Q ss_pred HHHHHHHHHHhc----CCCCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 164 RGIASGLEYLHM----SHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 164 ~~i~~~l~~lh~----~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
..+..++.++.. ....+++|+|+.|.|+++++++.+.|.||+.+.
T Consensus 156 ~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 156 ALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 112233444432 113469999999999999987777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0055 Score=51.91 Aligned_cols=31 Identities=13% Similarity=0.326 Sum_probs=26.7
Q ss_pred CCCceeCCCCCCcEEecC-CCcEEEecccccc
Q 036970 178 RPRIIHRDIQPANVLIDD-DMEARISEFGLAK 208 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~-~~~~kl~Dfg~~~ 208 (337)
..+++|+|+.+.||++++ ++.+.++||..+.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 346899999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0051 Score=54.20 Aligned_cols=154 Identities=12% Similarity=0.150 Sum_probs=86.9
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC--CCChhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--HRNIVPL 118 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~ 118 (337)
.+..+++.+..|....+|.... +++.++++ ........ .......+|+..++.+. .-...+.
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~---~~~~~vlR-~P~~~~~~------------~~~~~~~re~~~i~~l~~~~vP~p~~ 88 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGD---TGQKYVLR-KPPRGDPV------------ESAHDEKREYRVIAALLDVDVPVPRA 88 (321)
T ss_pred CCCceeeeccCCcccceEEEec---CCceEEEe-cCCccccc------------hhhhHHHhHHHHHHHhcCCCCCCccc
Confidence 4556666676677777777753 48888888 32111111 11445677888887773 3445666
Q ss_pred hceeecCC--CceEEEEeecCCCHHHH----------HH--------hhhcC--------CCc--CCHHHHHHHHHHH--
Q 036970 119 LARVVRPD--CDLLVYEFRRNGSLQDI----------LY--------DVSQG--------RRE--LDWLARHRIARGI-- 166 (337)
Q Consensus 119 ~~~~~~~~--~~~lv~e~~~~~~L~~~----------l~--------~~~~~--------~~~--l~~~~~~~~~~~i-- 166 (337)
++.|.++. ..+.||+|++|..+.+. .. ...+- ..+ ....+...+..+.
T Consensus 89 ~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~ 168 (321)
T COG3173 89 FGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRR 168 (321)
T ss_pred ccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHH
Confidence 77777766 67999999987322211 11 11000 000 0000111111111
Q ss_pred ------------HHHHHHHhcC-----CCCCceeCCCCCCcEEecCCCcEEEecccccccC
Q 036970 167 ------------ASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI 210 (337)
Q Consensus 167 ------------~~~l~~lh~~-----~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~ 210 (337)
.....+++.+ +...++|+|+.+.|++++.+.-+-|.||+++..-
T Consensus 169 ~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 169 AKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1112333322 1335899999999999998888999999988653
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0036 Score=55.60 Aligned_cols=155 Identities=16% Similarity=0.127 Sum_probs=94.8
Q ss_pred ccccccccccceEEeeeecCCCCcEEEEEEeeccchhhH---HHhhc---------CCcchhhhHHHHHHHHHHhcCCCC
Q 036970 45 SLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEA---ELIKQ---------DSEPLHHKMIQIQSEIITAGQVRH 112 (337)
Q Consensus 45 ~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~~E~~~l~~l~h 112 (337)
+-..|..|.-+.||.|.-. +|..+|||+...+..... ..... .+.+.+-..-=...|++.|.+|..
T Consensus 148 inGCiSTGKEANVYHat~~--dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE--DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred cccccccCccceeEeeecC--CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3466778999999999754 899999999744322110 00000 011111111223556777766654
Q ss_pred CChhhhhceeecCCCceEEEEeecC-CCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 113 RNIVPLLARVVRPDCDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
..|..---+.. ....+||+++.. |-..-.+ ..-.++...+..+-.+++..+.-|.+.+ ++||.||+-=|+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~ 296 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNL 296 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhh
Confidence 44431111111 245789999842 1111112 3344677778888888888888887665 599999999999
Q ss_pred EecCCCcEEEecccccccCC
Q 036970 192 LIDDDMEARISEFGLAKQIP 211 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~ 211 (337)
|+.+ |.++++|.+-+....
T Consensus 297 Lyhd-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 297 LYHD-GKLYIIDVSQSVEHD 315 (520)
T ss_pred eEEC-CEEEEEEccccccCC
Confidence 9876 489999987765543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0098 Score=53.27 Aligned_cols=88 Identities=9% Similarity=0.009 Sum_probs=49.8
Q ss_pred ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC--CC-Chhhhhceee
Q 036970 47 EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--HR-NIVPLLARVV 123 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~-ni~~~~~~~~ 123 (337)
+.||.|....||.+... ..++.++||.-..-..... ...+-...+..-|...|+... .| .+++++ +.
T Consensus 1 ~EigdGnlN~VfrV~~~-~g~~svIVKQAlp~vRv~g-------~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~ 70 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQ-EGDRAAIVKQALPYVRVVG-------ESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HF 70 (370)
T ss_pred CcCCCCceEEEEEEEcC-CCCeeEEEEEcCHHHhhcC-------CCCCCCccHHHHHHHHHHHhhccCccccCeEE--EE
Confidence 36899999999999854 2236899998643221100 011111345556666666652 23 344433 34
Q ss_pred cCCCceEEEEeecC-CCHHHHH
Q 036970 124 RPDCDLLVYEFRRN-GSLQDIL 144 (337)
Q Consensus 124 ~~~~~~lv~e~~~~-~~L~~~l 144 (337)
+.....++||+++. ..|+..+
T Consensus 71 D~e~~~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 71 DTEMAVTVMEDLSHHKIARKGL 92 (370)
T ss_pred ccccceehHhhCccchHHHHHH
Confidence 45556689999843 3444444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.00025 Score=72.87 Aligned_cols=163 Identities=12% Similarity=0.012 Sum_probs=115.9
Q ss_pred HHHHHHHHhcCCCCCChhhhhceeec--CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC
Q 036970 99 QIQSEIITAGQVRHRNIVPLLARVVR--PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMS 176 (337)
Q Consensus 99 ~~~~E~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 176 (337)
-...|....+...|+++.....-... +...+..++|+.+|.+.+.+-+.....+++....+.....+.+....-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 34445555566678887766554433 3355889999999999999976555555555555545555546666666655
Q ss_pred C--CCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHH
Q 036970 177 H--RPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAV 254 (337)
Q Consensus 177 ~--~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~ 254 (337)
. ....+|+++++-|.++..+.+++++++|+.+... +...... ...+++-|++|+..+.-.++.++|+|..|+-+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~G-l~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFG-LELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhh-hhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 3 2336899999999999999999999999987322 2111111 2355777899999888888888999999999999
Q ss_pred HHhCCCCCC
Q 036970 255 LMMGKFPSD 263 (337)
Q Consensus 255 l~~g~~pf~ 263 (337)
...|..+|-
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 988877753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.016 Score=51.19 Aligned_cols=31 Identities=23% Similarity=0.344 Sum_probs=26.9
Q ss_pred CCCceeCCCCCCcEEecCC----CcEEEecccccc
Q 036970 178 RPRIIHRDIQPANVLIDDD----MEARISEFGLAK 208 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~----~~~kl~Dfg~~~ 208 (337)
...++|+|+.+.||+++++ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4468999999999999974 789999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0064 Score=53.09 Aligned_cols=76 Identities=17% Similarity=0.139 Sum_probs=46.6
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC---CCChhhhh
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR---HRNIVPLL 119 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~ 119 (337)
..-.+.++.|..+.+|... . +++.+.+|.-.... ...+..|..-|+.|. .-.+++.+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~--~~~~~FvK~~~~~~-----------------~~~f~~Ea~gL~~L~~~~~~~vP~vi 78 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-T--DGGSYFVKVNSESG-----------------RDMFEGEAEGLKALAEANPIRVPKVI 78 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-T--TS-EEEEEEEEGGG-----------------CCHHHHHHHHHHHHCHTTTSBS--EE
T ss_pred eeeeEecCCCChhheEEEE-C--CCccEEEEecChhh-----------------HHHHHHHHHHHHHHHhcCCCCCCeEE
Confidence 4455778889999999987 3 78899999875221 235666777777662 44577888
Q ss_pred ceeecCCCceEEEEeecCC
Q 036970 120 ARVVRPDCDLLVYEFRRNG 138 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~ 138 (337)
.+....+..++++||++.+
T Consensus 79 ~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 79 AWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE-SSCCEEEEE-----
T ss_pred EEEeecCCceEEEEeecCC
Confidence 8888777789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.023 Score=51.94 Aligned_cols=88 Identities=11% Similarity=0.019 Sum_probs=52.1
Q ss_pred ccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC---CCChhhhhce
Q 036970 45 SLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR---HRNIVPLLAR 121 (337)
Q Consensus 45 ~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~~~ 121 (337)
..+.||.|....||.... .+..++||.-......... ..+....+-..|...|..+. ..++++++.+
T Consensus 36 ~~~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vga-------~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIGE-------SWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred eEEEcCCCceeeEEEEEc---CCccEEEEeCCccccCCCc-------cccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 367889999999999974 3456889987532221110 00001233344555555542 3467777776
Q ss_pred eecCCCceEEEEeecC--CCHHHHH
Q 036970 122 VVRPDCDLLVYEFRRN--GSLQDIL 144 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~--~~L~~~l 144 (337)
+. +..+++||++++ ..+.+.+
T Consensus 106 de--d~~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 106 DR--TMALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CC--CCCEEEEeecCCcceehhhhh
Confidence 66 456789999966 3444443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0084 Score=54.37 Aligned_cols=88 Identities=11% Similarity=0.001 Sum_probs=52.6
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC--CC-Chhhhhcee
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--HR-NIVPLLARV 122 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~-ni~~~~~~~ 122 (337)
.+.||.|....||.+.+.. .++.++||.-..-.. ..+..+-..++..-|...|+... .| .+++++ +
T Consensus 34 ~~eigdGnlN~VfrV~~~~-~~~svIVKQAlp~vR--------v~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~ 102 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ-KNISVIVKQAGDTAR--------ISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--L 102 (409)
T ss_pred eeEcCCCceEEEEEEeeCC-CCceEEEEeccHhhc--------cCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--E
Confidence 6789999999999998632 357799998643221 11111222456666777776652 23 344444 3
Q ss_pred ecCCCceEEEEeecC-CCHHHHH
Q 036970 123 VRPDCDLLVYEFRRN-GSLQDIL 144 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~-~~L~~~l 144 (337)
.+.....+|||+++. ..|++.+
T Consensus 103 ~D~e~~~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 103 FDSVMNCCVMEDLSDHTILRTAL 125 (409)
T ss_pred ECcHHhhHHHHhCcccHHHHHHH
Confidence 444556688998843 3344444
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.019 Score=47.58 Aligned_cols=88 Identities=11% Similarity=-0.003 Sum_probs=58.2
Q ss_pred HHHHHHHHHhcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC
Q 036970 98 IQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH 177 (337)
Q Consensus 98 ~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 177 (337)
..+.++.++++++. .|+++.. .+.-.+.+++|+|-.... .+ ..++.-=+.+|...|+.
T Consensus 103 ~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i-------------~~----~N~i~agi~~L~~fH~~- 160 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI-------------NF----SNFITAGIKDLMDFHSE- 160 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc-------------ch----hHHHHHhHHHHHHhhcc-
Confidence 34567777777764 5666652 123345689999844211 00 01122224567788865
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEeccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLA 207 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~ 207 (337)
..+.+|||..|+||+.+..|.+||.|.+.-
T Consensus 161 ~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 161 NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 457999999999999999999999998753
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.11 Score=46.10 Aligned_cols=30 Identities=23% Similarity=0.371 Sum_probs=25.7
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
..+++|+|+.+.|++++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 356899999999999988 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.099 Score=46.72 Aligned_cols=71 Identities=17% Similarity=0.174 Sum_probs=51.2
Q ss_pred CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccc
Q 036970 127 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206 (337)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~ 206 (337)
..|++|++. |+++.- + +.-.+.+...++.+.+..+.-+... ...-|||+.-.||+++ +|++.|+||-+
T Consensus 300 y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence 446677765 333322 2 2235667777888877777666543 3689999999999999 89999999999
Q ss_pred ccc
Q 036970 207 AKQ 209 (337)
Q Consensus 207 ~~~ 209 (337)
++.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.29 Score=42.59 Aligned_cols=31 Identities=29% Similarity=0.613 Sum_probs=25.3
Q ss_pred CCceeCCCCCCcEEecCCCc-EEEeccccccc
Q 036970 179 PRIIHRDIQPANVLIDDDME-ARISEFGLAKQ 209 (337)
Q Consensus 179 ~~~~h~di~~~nil~~~~~~-~kl~Dfg~~~~ 209 (337)
..++|+|+.+.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.086 Score=47.53 Aligned_cols=144 Identities=19% Similarity=0.252 Sum_probs=77.2
Q ss_pred cccccccccceEEeeeecCC---CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh-hhhhce
Q 036970 46 LEKIRSCWNGEVYKAELPGS---SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI-VPLLAR 121 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~ 121 (337)
+..|..|-...+|++..... .++.|++|+...... . .-...+|..+++.+...++ .++++.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---~------------~idR~~E~~~~~~l~~~gl~P~~~~~ 105 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---L------------FFDRDDEIRTFECMSRHGQGPRLLGR 105 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---e------------eechHHHHHHHHHHHHcCCCCceEEE
Confidence 45566688899999875321 246788998754321 0 1123557777777743333 334444
Q ss_pred eecCCCceEEEEeecCCCHHHH--------------HHhhhcCC---C--cCCHHHHHHHHHHH----------------
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDI--------------LYDVSQGR---R--ELDWLARHRIARGI---------------- 166 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~--------------l~~~~~~~---~--~l~~~~~~~~~~~i---------------- 166 (337)
+.. + .|.+|+++.++... +....... . ...+..+..+..++
T Consensus 106 ~~~-g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~ 181 (344)
T PLN02236 106 FPN-G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDS 181 (344)
T ss_pred ECC-c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHH
Confidence 432 2 58899877665311 11111111 1 11122222332221
Q ss_pred -HHHHHH----Hhc-CCCCCceeCCCCCCcEEecC-CCcEEEecccccc
Q 036970 167 -ASGLEY----LHM-SHRPRIIHRDIQPANVLIDD-DMEARISEFGLAK 208 (337)
Q Consensus 167 -~~~l~~----lh~-~~~~~~~h~di~~~nil~~~-~~~~kl~Dfg~~~ 208 (337)
...+.. +.. .....++|+|+.+.||++++ ++.+.++||..+.
T Consensus 182 l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 182 LEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111111 121 11335899999999999986 4679999998764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.015 Score=54.00 Aligned_cols=48 Identities=27% Similarity=0.262 Sum_probs=37.5
Q ss_pred HHHHHHHHHHhcCCCCCChhhhhceeecC-CCceEEEEeecCCCHHHHHH
Q 036970 97 MIQIQSEIITAGQVRHRNIVPLLARVVRP-DCDLLVYEFRRNGSLQDILY 145 (337)
Q Consensus 97 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 145 (337)
..++.-...++..+.|+|...+.++-... .+..+|+|++ +.||++.+.
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 44677788899999999999888766543 3457889998 669999884
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.29 E-value=1.1 Score=40.01 Aligned_cols=30 Identities=27% Similarity=0.412 Sum_probs=24.8
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEeccccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~ 209 (337)
..+++|+|+.+.||+++ + .+.++||+.+..
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 44689999999999995 3 578999998753
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.098 Score=43.68 Aligned_cols=80 Identities=14% Similarity=0.092 Sum_probs=56.2
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC---CChhhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH---RNIVPL 118 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~ni~~~ 118 (337)
+.+..+.+.-|.--..|...+ ....+.+|.-.... ...+..|+.-|+.|.- -.+.++
T Consensus 17 ~i~er~~v~gG~inea~~v~d---g~~~~FvK~n~~~~-----------------~~~f~AEa~gL~~la~s~ti~VP~v 76 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRD---GTDPFFVKCNQREQ-----------------LSMFTAEADGLELLARSNTITVPKV 76 (286)
T ss_pred hhhcccccCCccccceeEeec---CCcceEEEecchhh-----------------HHHHHHHHHHHHHHHhcCCccccce
Confidence 445556777787788888763 56778888652221 3457778877777743 456777
Q ss_pred hceeecCCCceEEEEeecCCCHH
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQ 141 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~ 141 (337)
+.+..+....|+|+||.+.+.+.
T Consensus 77 i~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 77 IAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred EEecCCCCeeEEEEeeccCCCCC
Confidence 88888888999999999875543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.80 E-value=1.1 Score=40.01 Aligned_cols=28 Identities=46% Similarity=0.760 Sum_probs=25.3
Q ss_pred ceeCCCCCCcEEecCCCc-EEEecccccc
Q 036970 181 IIHRDIQPANVLIDDDME-ARISEFGLAK 208 (337)
Q Consensus 181 ~~h~di~~~nil~~~~~~-~kl~Dfg~~~ 208 (337)
++|+|+.|.||+++.+.. +.+.||+.+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998875 8899999764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.28 Score=43.93 Aligned_cols=30 Identities=13% Similarity=0.355 Sum_probs=25.4
Q ss_pred CceeCCCCCCcEEecC-CCcEEEeccccccc
Q 036970 180 RIIHRDIQPANVLIDD-DMEARISEFGLAKQ 209 (337)
Q Consensus 180 ~~~h~di~~~nil~~~-~~~~kl~Dfg~~~~ 209 (337)
-.+|+|+.+.||++++ ++.++++||..+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3799999999999975 57899999987743
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.2 Score=45.56 Aligned_cols=61 Identities=21% Similarity=0.280 Sum_probs=39.3
Q ss_pred eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 129 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
.++=+|..|.++..++. ....++....+++.--+.|+--|-.-. ..+|.|+.|.||++..+
T Consensus 321 vl~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRFN 381 (565)
T ss_pred eeeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEec
Confidence 35556777888888883 233455555566655555554333221 38999999999999643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.016 Score=53.36 Aligned_cols=74 Identities=12% Similarity=0.144 Sum_probs=59.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
-.++|+.+..+|+|+||+|+.+... .++..++||.+..+..... ..+..+|...+..+.|++++++
T Consensus 47 ~a~~~e~~~~~~~~g~~~~~~~~n~-~d~~~~avkritlkn~e~s-------------~~rvl~~~~s~a~feh~g~~~~ 112 (516)
T KOG1033|consen 47 EANDFEPGQCLGRGGFGVVFSAQNK-ADENKYAVKRITLKNREES-------------RSRVLREVSSLAEFEHPGIKRY 112 (516)
T ss_pred hhccccccccccccCccccCCcccc-ccchhhHHHHhcccchhhh-------------hhhhhccccchhhhcccchhhh
Confidence 5688999999999999999999866 3677899998865544322 4567788888999999999999
Q ss_pred hceeecCC
Q 036970 119 LARVVRPD 126 (337)
Q Consensus 119 ~~~~~~~~ 126 (337)
+..|..+.
T Consensus 113 ~ha~~~~~ 120 (516)
T KOG1033|consen 113 FHAWYERP 120 (516)
T ss_pred eeceecCC
Confidence 88887654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.43 E-value=1.7 Score=45.11 Aligned_cols=32 Identities=31% Similarity=0.529 Sum_probs=26.4
Q ss_pred CCCceeCCCCCCcEEecCCC--cEE-Eeccccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDM--EAR-ISEFGLAKQ 209 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~--~~k-l~Dfg~~~~ 209 (337)
..+++|+|+.+.||+++.++ ++. |+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 44699999999999999775 555 999998754
|
|
| >PRK14559 putative protein serine/threonine phosphatase; Provisional | Back alignment and domain information |
|---|
Probab=91.45 E-value=1.7 Score=42.40 Aligned_cols=175 Identities=12% Similarity=0.080 Sum_probs=97.7
Q ss_pred cccCCccchhhhhhhhccCccccccc---ccccccceEEeeee-cCCCCcEEEEEEeeccchhhHHHhh---cCCcchhh
Q 036970 23 TIFSPLIEKEDLAFLKKEDCFASLEK---IRSCWNGEVYKAEL-PGSSGRVITIKKVIQPLKSEAELIK---QDSEPLHH 95 (337)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~~~~~~~~---lg~G~~g~vy~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~---~~~~~~~~ 95 (337)
..+.|..+....+||+...||+++.. +.....+..+.++. +.+.-+.-.++.+............ ........
T Consensus 80 ~~~~~~~~~~~~~~ld~~~ry~l~~~~~~~~~~~~~~~~~~~v~d~~p~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (645)
T PRK14559 80 SSLTPSSSPLYGSYLDPGQRYQLLASSEEIPTAAAHTELQGRVLDCQPLQPSPLEALLEQLEDLLNPLADPTEVLPTLLW 159 (645)
T ss_pred ccCCCcccchhhhhcCcccceEeccccccccccccCcceeeEEeecCCCccCHHHHHHHHhhhhhhcccCcccccCccch
Confidence 34445555667779999999999887 44445555444442 1111111111111000000000000 00000000
Q ss_pred hHHHHHHHHHHhcCC---CCCChhhhhceeecCCCceEEEEeecC-CCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHH
Q 036970 96 KMIQIQSEIITAGQV---RHRNIVPLLARVVRPDCDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171 (337)
Q Consensus 96 ~~~~~~~E~~~l~~l---~h~ni~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~ 171 (337)
....+-..+.-..+| ++.||..+|+++..++...+++|+... ..|.+.. . ....+......|+.|++.-..
T Consensus 160 ~~~~~p~~~~~Yl~L~~~~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w----~-~~~~~~l~~l~Wl~q~~~LW~ 234 (645)
T PRK14559 160 QQLGIPALAIPYLALQDQFPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLW----Q-DQTLPTLQILYWLNQMTQLWK 234 (645)
T ss_pred hccCCcHHhhhHHhccccccccCcchheeecCCCCcEEEeCCCCCCchHHHHh----h-hcCCcHHHHHHHHHHHHHHHH
Confidence 011122233333333 345699999999998888899998643 3344443 1 123566788899999999999
Q ss_pred HHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 172 ~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
-|...+ ++..=|.+.|+.++++..+.|-.+-
T Consensus 235 ~l~~~~---~~~sll~~~nlrv~~~~~~~l~~l~ 265 (645)
T PRK14559 235 ALEPWG---CCQSLLELENLRVDEDQTLGLQQLY 265 (645)
T ss_pred HHHhcC---eehhccchhheeeCCCceehHhhhh
Confidence 998554 8888999999999877666665543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.77 E-value=0.94 Score=41.44 Aligned_cols=29 Identities=21% Similarity=0.193 Sum_probs=23.8
Q ss_pred CCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 179 PRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 179 ~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
...+|.|+-+.||+.++ +.+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 35799999999998754 469999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 337 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-17 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-77
Identities = 94/279 (33%), Positives = 149/279 (53%), Gaps = 17/279 (6%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VYK L G ++ +K+ LK E Q E +Q Q+E+ HRN
Sbjct: 44 GKVYKGRLA--DGTLVAVKR----LKEER---TQGGE------LQFQTEVEMISMAVHRN 88
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
++ L + P LLVY + NGS+ L + + + LDW R RIA G A GL YLH
Sbjct: 89 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
P+IIHRD++ AN+L+D++ EA + +FGLAK + T TT ++ T+G+IAPE
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYL 207
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSD-DFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293
T S+K D++ +GV+L L+ G+ D + ++ + W++ ++ + +D
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267
Query: 294 KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332
L GN +E++ ++++A CT P ERP +V ML
Sbjct: 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 7e-63
Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 21/282 (7%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYK + + +KK L + + +E L Q EI + +H N
Sbjct: 45 GVVYKGYVNN---TTVAVKK----LAAMVD---ITTEELKQ---QFDQEIKVMAKCQHEN 91
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V LL D LVY + NGSL D L G L W R +IA+G A+G+ +LH
Sbjct: 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+H IHRDI+ AN+L+D+ A+IS+FGLA+ T + T Y+APE
Sbjct: 151 ENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA- 206
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSK 294
++ K DIYSFGV+L ++ G D +H + + + E K
Sbjct: 207 LRGEITPKSDIYSFGVVLLEIITGLPAVD---EHREPQLLLDIKEEIEDEEKTIEDYIDK 263
Query: 295 LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
+ + + + +A C + +RP+ K V+ +L ++
Sbjct: 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-62
Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 22/284 (7%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VYK L G + +K+ +S + ++EI T RH +
Sbjct: 53 GKVYKGVLRD--GAKVALKR-----------RTPESSQGIE---EFETEIETLSFCRHPH 96
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V L+ + +L+Y++ NG+L+ LY + W R I G A GL YL
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL- 155
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG-RTRTTTWSLAETVGYIAPEC 233
H IIHRD++ N+L+D++ +I++FG++K+ +T +T + T+GYI PE
Sbjct: 156 --HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGTLGYIDPEY 212
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293
L++K D+YSFGV+L ++ + + ++ +W + + +D
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ-SLPREMVNLAEWAVESHNNGQLEQIVDP 271
Query: 294 KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
L E + A C E+RP+ DV L
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-50
Identities = 70/320 (21%), Positives = 123/320 (38%), Gaps = 46/320 (14%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
LE G V+KA+L + +K + + + Q
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQLLN---EYVAVKI----FPIQDK-----------QSWQ 64
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCD----LLVYEFRRNGSLQDILYDVSQGRRELD 155
+ E+ + ++H NI+ + R L+ F GSL D L +
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVS 119
Query: 156 WLARHRIARGIASGLEYLHM-------SHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208
W IA +A GL YLH H+P I HRDI+ NVL+ +++ A I++FGLA
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 209 QIPNGRTRTTTWSLAETVGYIAPE-----CHQTVALSDKCDIYSFGVLLAVLMMGKFPSD 263
+ G++ T T Y+APE + + D+Y+ G++L L +D
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 264 DFFQHTKEMSFVQWMRNVMTSENPSRTIDSKL----IGNGY--EEQMLLVLKIACFCTFD 317
+ F + + + E+ + K + + + M ++ + C
Sbjct: 240 G-PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 318 DPEERPNSKDVRCMLSQIQH 337
D E R ++ V ++Q+Q
Sbjct: 299 DAEARLSAGCVGERITQMQR 318
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-40
Identities = 61/283 (21%), Positives = 116/283 (40%), Gaps = 43/283 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V KA+ + + IK+ ++SE+E E+ +V H N
Sbjct: 22 GVVCKAKW---RAKDVAIKQ----IESESE------------RKAFIVELRQLSRVNHPN 62
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L + P C LV E+ GSL ++L+ ++ + G+ YLH
Sbjct: 63 IVKLYGACLNPVC--LVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 175 MSHRPRIIHRDIQPANVLIDDDME-ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
+IHRD++P N+L+ +I +FG A I T + ++APE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----GSAAWMAPEV 174
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293
+ S+KCD++S+G++L ++ + P D+ + + V P
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-----VHNGTRPP----- 224
Query: 294 KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
+ + + ++ C DP +RP+ +++ +++ +
Sbjct: 225 --LIKNLPKPIESLMTR---CWSKDPSQRPSMEEIVKIMTHLM 262
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-40
Identities = 66/285 (23%), Positives = 126/285 (44%), Gaps = 41/285 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V++AE G + +K +++ + + E+ ++RH N
Sbjct: 51 GTVHRAEW---HGSDVAVKILMEQDFHAERVN------------EFLREVAIMKRLRHPN 95
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV + V +P +V E+ GSL +L+ S R +LD R +A +A G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+ P I+HR+++ N+L+D ++ +FGL++ + + S A T ++APE
Sbjct: 155 -NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK--SAAGTPEWMAPEVL 211
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT-SENP--SRTI 291
+ ++K D+YSFGV+L L + P + ++ Q + V + R +
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGN-------LNPAQVVAAVGFKCKRLEIPRNL 264
Query: 292 DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
+ ++ I C ++P +RP+ + +L +
Sbjct: 265 NPQVA------------AIIEGCWTNEPWKRPSFATIMDLLRPLI 297
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 64/290 (22%), Positives = 121/290 (41%), Gaps = 44/290 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V+K L V+ IK +I + + + + Q E+ + H N
Sbjct: 33 GLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIEKFQ-------EFQREVFIMSNLNHPN 84
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L + P +V EF G L L D + W + R+ IA G+EY+
Sbjct: 85 IVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 175 MSHRPRIIHRDIQPANVLID-----DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
+ P I+HRD++ N+ + + A++++FGL++Q + + L ++
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS-----GLLGNFQWM 193
Query: 230 APE--CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENP 287
APE + + ++K D YSF ++L ++ G+ P D++ ++ F+ + P
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY--SYGKIKFINMI--REEGLRP 249
Query: 288 S--RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ +L + C DP++RP+ + LS++
Sbjct: 250 TIPEDCPPRLR------------NVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 66/317 (20%), Positives = 109/317 (34%), Gaps = 59/317 (18%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYK L R + +K + I + I + H N
Sbjct: 27 GAVYKGSL---DERPVAVKVF--SFANRQNFINE-------------KNIYRVPLMEHDN 68
Query: 115 IVPLLARVVRPDCD-----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASG 169
I + R D LLV E+ NGSL L DW++ R+A + G
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRG 123
Query: 170 LEYLHMS------HRPRIIHRDIQPANVLIDDDMEARISEFGLAK------QIPNGRTRT 217
L YLH ++P I HRD+ NVL+ +D IS+FGL+ + G
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 218 TTWSLAETVGYIAPE-------CHQTVALSDKCDIYSFGVLL---AVLMMGKFPSDD--- 264
S T+ Y+APE + + D+Y+ G++ + FP +
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 265 ----FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPE 320
F + M+ +++ E N + + + C D E
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN--SLAVRSLKETIEDCWDQDAE 301
Query: 321 ERPNSKDVRCMLSQIQH 337
R ++ ++++
Sbjct: 302 ARLTAQXAEERMAELMM 318
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 61/288 (21%), Positives = 106/288 (36%), Gaps = 48/288 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GE++K G I +K + S K E H N
Sbjct: 24 GELWKGRW---QGNDIVVKVLKVRDWSTR------------KSRDFNEECPRLRIFSHPN 68
Query: 115 IVPLLARVVRPDCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
++P+L P + + GSL ++L++ +D + A +A G+ +
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAF 126
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
LH + P I + +V+ID+DM ARIS + + + ++APE
Sbjct: 127 LH-TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSP-GRMYAPAWVAPE 178
Query: 233 C---HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT-SENPS 288
D++SF VLL L+ + P D +S ++ V P+
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD-------LSNMEIGMKVALEGLRPT 231
Query: 289 RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
I G + ++KI C +DP +RP + +L ++Q
Sbjct: 232 -------IPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 64/289 (22%), Positives = 111/289 (38%), Gaps = 46/289 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VY+A G + +K + ++ ++ E ++H N
Sbjct: 21 GKVYRAFW---IGDEVAVKAARHDPDEDISQTIEN----------VRQEAKLFAMLKHPN 67
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ L ++ LV EF R G L +L + + A IA G+ YLH
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLH 122
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEAR--------ISEFGLAKQIPNGRTRTTTWSLAETV 226
IIHRD++ +N+LI +E I++FGLA++ +
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAG----AY 178
Query: 227 GYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286
++APE + S D++S+GVLL L+ G+ P + + V + N
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG-------IDGLAVAYGV--AMN 229
Query: 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
I + E +++ C DP RP+ ++ L+ I
Sbjct: 230 KLALP----IPSTCPEPFAKLMED---CWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 58/296 (19%), Positives = 115/296 (38%), Gaps = 52/296 (17%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+ K + G V+ +K+ LI+ D E E+ + H N
Sbjct: 24 GQAIKVTHRET-GEVMVMKE----------LIRFDEE----TQRTFLKEVKVMRCLEHPN 68
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
++ + + + + E+ + G+L+ I+ + W R A+ IASG+ YLH
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG------------RTRTTTWSL 222
+ IIHRD+ N L+ ++ +++FGLA+ + + R +++
Sbjct: 126 SMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 223 AETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE--MSFVQWMRN 280
++APE + +K D++SFG++L ++ D+ T + ++ ++
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
P I C DPE+RP+ + L ++
Sbjct: 243 YCPPNCPPS-----------------FFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 58/307 (18%), Positives = 113/307 (36%), Gaps = 50/307 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV+ + G + +K + E ++EI +RH N
Sbjct: 51 GEVWMGKW---RGEKVAVKV----FFTTEE-----------ASWFRETEIYQTVLMRHEN 92
Query: 115 IVPLLARVVRPDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
I+ +A ++ L+ ++ NGSL D L LD + ++A SGL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGL 147
Query: 171 EYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE- 224
+LH +P I HRD++ N+L+ + I++ GLA + +
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 225 -TVGYIAPEC-HQTVALSD-----KCDIYSFGVLLAVLMMGKFPSDD-------FFQHTK 270
T Y+ PE +++ + D+YSFG++L + +
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330
+ MR ++ + + ++ + QM ++ C +P R + V+
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKK 324
Query: 331 MLSQIQH 337
L+++
Sbjct: 325 TLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 63/305 (20%), Positives = 116/305 (38%), Gaps = 50/305 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV++ G + +K S E K ++E+ +RH N
Sbjct: 22 GEVWRGSW---QGENVAVKI----FSSRDE-----------KSWFRETELYNTVMLRHEN 63
Query: 115 IVPLLARVVRPDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
I+ +A + L+ + GSL D L LD ++ RI IASGL
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGL 118
Query: 171 EYLHM-----SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE- 224
+LH+ +P I HRD++ N+L+ + + I++ GLA + +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 225 -TVGYIAPE------CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDD-------FFQHTK 270
T Y+APE + DI++FG++L + + F+
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330
+ MR V+ + I ++ + + ++K C + +P R + ++
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE---CWYQNPSARLTALRIKK 295
Query: 331 MLSQI 335
L++I
Sbjct: 296 TLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-35
Identities = 60/307 (19%), Positives = 115/307 (37%), Gaps = 50/307 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV++ + G + +K S + ++EI +RH N
Sbjct: 56 GEVWRGKW---RGEEVAVKI----FSSR-----------EERSWFREAEIYQTVMLRHEN 97
Query: 115 IVPLLARVVRPDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
I+ +A + + LV ++ +GSL D L R + ++A ASGL
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGL 152
Query: 171 EYLHM-----SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE- 224
+LHM +P I HRD++ N+L+ + I++ GLA + +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 225 -TVGYIAPEC-HQTVALSD-----KCDIYSFGVLLAVLMMGKFPSDD-------FFQHTK 270
T Y+APE ++ + + DIY+ G++ + ++
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330
V+ MR V+ + I ++ M +++ C + + R + ++
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE---CWYANGAARLTALRIKK 329
Query: 331 MLSQIQH 337
LSQ+
Sbjct: 330 TLSQLSQ 336
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 60/294 (20%), Positives = 111/294 (37%), Gaps = 56/294 (19%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYK + G V +K + + +L ++E+ + RH N
Sbjct: 38 GTVYKGKW---HGDV-AVKMLNVTAPTPQQLQ------------AFKNEVGVLRKTRHVN 81
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ + +V ++ SL L+ + + IAR A G++YLH
Sbjct: 82 ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLH 137
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE-- 232
IIHRD++ N+ + +D +I +FGLA + L+ ++ ++APE
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 233 -CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTI 291
+ S + D+Y+FG++L LM G+ P + + + M
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIEM------------- 237
Query: 292 DSKLIGNGYEEQMLLVLKIAC---------FCTFDDPEERPNSKDVRCMLSQIQ 336
+G G L ++ C C +ERP+ + + ++
Sbjct: 238 ----VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-31
Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 51/294 (17%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VY G V I+ + +E +L + E++ Q RH N
Sbjct: 47 GQVYHGRW---HGEV-AIRLIDIERDNEDQLK------------AFKREVMAYRQTRHEN 90
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V + + P ++ + +L ++ D + LD +IA+ I G+ YL
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYL- 146
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLA--KQIPNGRTRTTTWSLAE-TVGYIAP 231
H I+H+D++ NV D+ + I++FGL + R + + ++AP
Sbjct: 147 --HAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 232 ECHQTVAL---------SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVM 282
E + ++ S D+++ G + L ++P + +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-------QPAEAIIWQMG 256
Query: 283 TSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
T P+ L G +++ +L FC + EERP + ML ++
Sbjct: 257 TGMKPN------LSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEKLP 301
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 58/302 (19%), Positives = 108/302 (35%), Gaps = 57/302 (18%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V E G +K+++ + + E ++ E + H N
Sbjct: 43 SYVDLVE-GLHDGHFYALKRILCHEQQDREEAQR--E------ADMHR------LFNHPN 87
Query: 115 IVPLLARVVRPDCD----LLVYEFRRNGSLQDILYDVSQGRRELD----WLARHRIARGI 166
I+ L+A +R L+ F + G+L + + + L + GI
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL----WLLLGI 143
Query: 167 ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK----QIPNGRTRTTTWSL 222
GLE +H HRD++P N+L+ D+ + + + G + R T
Sbjct: 144 CRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 223 AETVG---YIAPE---CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276
A Y APE + ++ D++S G +L +M G+ P D FQ ++
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260
Query: 277 WMRNVMTSENPSRTID-SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ ++P + +L+ M+ V DP +RP+ + L +
Sbjct: 261 -QNQLSIPQSPRHSSALWQLL-----NSMMTV----------DPHQRPHIPLLLSQLEAL 304
Query: 336 QH 337
Q
Sbjct: 305 QP 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-28
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
VY+AE +G + IK +I + + K ++Q+E+ Q++H +
Sbjct: 25 AGVYRAESI-HTGLEVAIK-MI----DKKAMYKAGMVQ------RVQNEVKIHCQLKHPS 72
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ L + LV E NG + L ++ + + ARH + I +G+ YLH
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFM-HQIITGMLYLH 129
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI--PNGRTRTTTWSLAETVGYIAPE 232
SH I+HRD+ +N+L+ +M +I++FGLA Q+ P+ + T + YI+PE
Sbjct: 130 -SHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN----YISPE 182
Query: 233 CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDD 264
A + D++S G + L++G+ P D
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 25/219 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
+ ++ + V K ++ ++ L+K ++ EI + H++
Sbjct: 55 AKCFEISDA-DTKEVFAGK-IV----PKSLLLKPHQRE------KMSMEISIHRSLAHQH 102
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYL 173
+V D +V E R SL ++ + E AR R I G +YL
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTE--PEAR-YYLRQIVLGCQYL 157
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
H +R +IHRD++ N+ +++D+E +I +FGLA ++ R L T YIAPE
Sbjct: 158 H-RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEV 212
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272
S + D++S G ++ L++GK P + KE
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--SCLKET 249
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 36/217 (16%), Positives = 89/217 (41%), Gaps = 14/217 (6%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
++ E + +K + K + D + K ++E+ +++
Sbjct: 45 NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDIL-----YDVSQGRRELDWLARHRIARGIASG 169
+ + D ++YE+ N S+ D + + + I + + +
Sbjct: 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-CIIKSVLNS 163
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
Y+H + + I HRD++P+N+L+D + ++S+FG ++ + + + + + + ++
Sbjct: 164 FSYIH-NEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYE----FM 217
Query: 230 APE--CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDD 264
PE +++ K DI+S G+ L V+ P
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
+ ++ + V K ++ ++ L+K ++ EI + H++
Sbjct: 29 AKCFEISDA-DTKEVFAGK-IV----PKSLLLKPHQRE------KMSMEISIHRSLAHQH 76
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V D +V E R SL ++ + AR R I G +YLH
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEP-EAR-YYLRQIVLGCQYLH 132
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI--PNGRTRTTTWSLAETVGYIAPE 232
+R +IHRD++ N+ +++D+E +I +FGLA ++ R + + YIAPE
Sbjct: 133 -RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIAPE 185
Query: 233 CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272
S + D++S G ++ L++GK P + KE
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--SCLKET 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-27
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMI-QIQSEIITAGQVRHR 113
G VY A S ++ +K V+ K++ L K + Q++ E+ +RH
Sbjct: 23 GNVYLAREK-QSKFILALK-VLF--KAQ--LEK-------AGVEHQLRREVEIQSHLRHP 69
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
NI+ L L+ E+ G++ L + + + +A+ L Y
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFD-EQRTA-TYITELANALSYC 125
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
H +IHRDI+P N+L+ E +I++FG + P+ R +L Y+ PE
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLD----YLPPEM 178
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGKFPSDD 264
+ +K D++S GVL ++GK P +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 63/300 (21%), Positives = 109/300 (36%), Gaps = 64/300 (21%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+V KA R IKK I+ E K+ I SE++ + H+
Sbjct: 20 GQVVKAR-NALDSRYYAIKK-----------IRHTEE----KLSTILSEVMLLASLNHQY 63
Query: 115 IVPLLARVVRPDCDL-------------LVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
+V A + + + E+ NG+L D++ S+ + R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYW-R 120
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWS 221
+ R I L Y+H IIHRD++P N+ ID+ +I +FGLAK + S
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 222 LAE------------TVGYIAPE-CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268
T Y+A E T ++K D+YS G++ ++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST------- 230
Query: 269 TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
M V ++ + + S N + + ++ DP +RP ++ +
Sbjct: 231 --GMERVNILKKLR---SVSIEFPPDFDDNKMKVEKKIIRL--LIDH--DPNKRPGARTL 281
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 32/246 (13%), Positives = 71/246 (28%), Gaps = 32/246 (13%)
Query: 55 GEVYKAELPGSSGRVITIK----------KVIQPLKSEAELIKQDSEPLHHKMIQIQSEI 104
+A +G + I+ +K E ++ + K ++
Sbjct: 92 YAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 105 ITAGQVRHRNIVPLLARVVRPDCDLLVYEF-----RRNGSLQDI---LYDVSQGRRELDW 156
I + + RV + D+ V R +LQ L S + L
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR 216
AR ++ + L LH ++H ++P ++++D ++ F
Sbjct: 211 HARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-RDGASAV 266
Query: 217 TTTWSLAETVGYIAPEC-----HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271
+ A H ++ D ++ G+ + + P
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAA 322
Query: 272 MSFVQW 277
+ +W
Sbjct: 323 LGGSEW 328
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-26
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY A + ++ +K V+ +++L K+ E Q++ EI +RH N
Sbjct: 28 GNVYLAREK-QNKFIMALK-VL----FKSQLEKEGVEH------QLRREIEIQSHLRHPN 75
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ + L+ EF G L L GR + + + +A L Y H
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFD-EQRSA-TFMEELADALHYCH 131
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+IHRDI+P N+L+ E +I++FG + P+ R RT +L Y+ PE
Sbjct: 132 ERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLD----YLPPEMI 184
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDD 264
+ +K D++ GVL ++G P D
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 55/278 (19%), Positives = 107/278 (38%), Gaps = 43/278 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
VYK L + + ++ +++E + + E ++H N
Sbjct: 40 KTVYKG-LDTETTVEVAWCELQDRKLTKSERQ------------RFKEEAEMLKGLQHPN 86
Query: 115 IVPLL---ARVVRPDCDLLVY-EFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
IV V+ +++ E +G+L+ L + + + R I GL
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGL 142
Query: 171 EYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
++LH + P IIHRD++ N+ I +I + GLA + ++ T ++
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFM 197
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSR 289
APE ++ + D+Y+FG+ + + ++P + + Q R V TS
Sbjct: 198 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC------QNAAQIYRRV-TSGVKPA 249
Query: 290 TIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327
+ D I E ++ C + +ER + KD
Sbjct: 250 SFDKVAI----PEVKEIIEG--CIRQ--NKDERYSIKD 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 50/285 (17%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G K S G+++ K++ +EAE SE + + +++H N
Sbjct: 20 GRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSE------VNLLR------ELKHPN 66
Query: 115 IVPLLARVVRPDCDLL--VYEFRRNGSLQDILYDVSQGRRELD----WLARHRIARGIAS 168
IV R++ L V E+ G L ++ ++ R+ LD R+ +
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMTQLTL 122
Query: 169 GLEYLHMSHRP--RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETV 226
L+ H ++HRD++PANV +D ++ +FGLA+ + + + T+ V
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-----V 177
Query: 227 G---YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT 283
G Y++PE ++ ++K DI+S G LL L P F S + +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF---SQKELAGKIRE 230
Query: 284 SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ I Y +++ ++ RP+ +++
Sbjct: 231 GKFRR-------IPYRYSDELNEIIT-RMLNL--KDYHRPSVEEI 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 65/283 (22%), Positives = 113/283 (39%), Gaps = 49/283 (17%)
Query: 55 GEVYKAELPGSSGRVITIKKV-IQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
EVY+A G + +KKV I L EI Q+ H
Sbjct: 46 SEVYRA-ACLLDGVPVALKKVQIFDLMDAKARA------------DCIKEIDLLKQLNHP 92
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELD----WLARHRIARGIASG 169
N++ A + + +V E G L ++ + +R + W + + S
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSA 148
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-VG- 227
LE++H R++HRDI+PANV I ++ + GL + ++ + A + VG
Sbjct: 149 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHSLVGT 199
Query: 228 --YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285
Y++PE + K DI+S G LL + + P F + +M+ + + +
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---F--YGDKMNLYSLCKKIEQCD 254
Query: 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
P L + Y E++ ++ C DPE+RP+ V
Sbjct: 255 YP------PLPSDHYSEELRQLVN-MCINP--DPEKRPDVTYV 288
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 40/259 (15%)
Query: 7 KLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPG 64
+L + + +G + I +E L K + CF GEV+ G
Sbjct: 242 RLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCF-----------GEVWMGTWNG 290
Query: 65 SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124
+ RV IK + S ++ E ++RH +V L A VV
Sbjct: 291 T-TRVA-IKTLKPGTMSPEAFLQ---------------EAQVMKKLRHEKLVQLYA-VVS 332
Query: 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184
+ +V E+ GSL D L + + L +A IASG+ Y+ R +HR
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 185 DIQPANVLIDDDMEARISEFGLAKQIPNGR-TRTTTWSLAETVGYIAPECHQTVALSDKC 243
D++ AN+L+ +++ ++++FGLA+ I + T + + APE + K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKS 445
Query: 244 DIYSFGVLL-AVLMMGKFP 261
D++SFG+LL + G+ P
Sbjct: 446 DVWSFGILLTELTTKGRVP 464
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 36/236 (15%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
+E+ D+ K + GEVY+ S V +K + + E +
Sbjct: 217 MERTDITMKHKLGGGQY-----------GEVYEGVWKKYSLTVA-VKTLKEDTMEVEEFL 264
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD 146
K E +++H N+V LL R ++ EF G+L D L
Sbjct: 265 K---------------EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-- 307
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
R+E+ + +A I+S +EYL + IHR++ N L+ ++ ++++FGL
Sbjct: 308 RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGL 364
Query: 207 AKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
++ + + + + APE S K D+++FGVLL + G P
Sbjct: 365 SRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 63/259 (24%), Positives = 109/259 (42%), Gaps = 40/259 (15%)
Query: 7 KLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPG 64
+L + + +G + I +E L K + CF GEV+ G
Sbjct: 159 RLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCF-----------GEVWMGTWNG 207
Query: 65 SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124
+ RV IK + S ++ E ++RH +V L A VV
Sbjct: 208 T-TRVA-IKTLKPGTMSPEAFLQ---------------EAQVMKKLRHEKLVQLYA-VVS 249
Query: 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184
+ +V E+ GSL D L + + L +A IASG+ Y+ + +HR
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 185 DIQPANVLIDDDMEARISEFGLAKQIPNGR-TRTTTWSLAETVGYIAPECHQTVALSDKC 243
D++ AN+L+ +++ ++++FGLA+ I + T + + APE + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKS 362
Query: 244 DIYSFGVLL-AVLMMGKFP 261
D++SFG+LL + G+ P
Sbjct: 363 DVWSFGILLTELTTKGRVP 381
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 29/221 (13%)
Query: 40 EDCFASLEKIRSCWN--GEVYKA-ELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHK 96
C+ L I + V A P +G +T++++ L +E +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKP--TGEYVTVRRI--------NLEACSNEMVT-- 71
Query: 97 MIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 156
+Q E+ + H NIVP A + + +V F GS +D++
Sbjct: 72 --FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA 129
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPN--GR 214
+A I +G+ L+Y+H +HR ++ +++LI D + +S + + R
Sbjct: 130 IAY--ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 215 TRTTTWSLAETVG---YIAPE-CHQTVALSD-KCDIYSFGV 250
R +V +++PE Q + D K DIYS G+
Sbjct: 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 64/326 (19%), Positives = 119/326 (36%), Gaps = 51/326 (15%)
Query: 28 LIEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIK 87
L +K+ + LK +D F + ++ + G V+K SG V+ K + L+ + +
Sbjct: 21 LTQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHK-PSGLVMARKLI--HLEIKPAIRN 76
Query: 88 QDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDV 147
Q I E+ + IV + E GSL +L
Sbjct: 77 Q-----------IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125
Query: 148 SQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207
GR L + ++ + GL YL H+ I+HRD++P+N+L++ E ++ +FG++
Sbjct: 126 --GRIPEQILGK--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 208 KQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP--SDDF 265
Q+ + + T Y++PE Q S + DI+S G+ L + +G++P D
Sbjct: 180 GQLIDSMANS----FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACF------------ 313
+ T P + + ++ +
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295
Query: 314 ------------CTFDDPEERPNSKD 327
C +P ER + K
Sbjct: 296 VFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 5e-24
Identities = 34/293 (11%), Positives = 74/293 (25%), Gaps = 37/293 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQ-------DSEPLHHKMIQIQSE--II 105
V+ +K ++ +++ + L + + ++
Sbjct: 76 SVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134
Query: 106 TAGQVRHRNIVPLLARVVRPDCD------LLVYEF--RRNGSLQDILYDVSQGRRELDWL 157
P A++ D LL+ L L V R + L
Sbjct: 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGIL 194
Query: 158 ARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT 217
A H + + L ++H P N+ I D + + ++ +
Sbjct: 195 ALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS 251
Query: 218 TTWSLAETVGYIAPEC--HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275
+ V Y E T + + + G+ + + P F
Sbjct: 252 SV-----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTPGIKG 302
Query: 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
W R + ++ + L+ + F D R +
Sbjct: 303 SWKRPSLRVPGT-DSLAFGSCTPLPDFVKTLIGRFLNF----DRRRRLLPLEA 350
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 51/241 (21%), Positives = 88/241 (36%), Gaps = 44/241 (18%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
+ EDL ++ F GEV+ L + V +K
Sbjct: 111 LNHEDLVLGEQIGRGNF-----------GEVFSGRLRADNTLV-AVK-----------SC 147
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD 146
++ P + E Q H NIV L+ + +V E + G L
Sbjct: 148 RETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-- 203
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
L ++ A+G+EYL IHRD+ N L+ + +IS+FG+
Sbjct: 204 -RTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGM 259
Query: 207 AKQIPNGRTRTTTWSLAETVGYI-----APECHQTVALSDKCDIYSFGVLL-AVLMMGKF 260
+++ +G ++ + + + APE S + D++SFG+LL +G
Sbjct: 260 SREEADG-----VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314
Query: 261 P 261
P
Sbjct: 315 P 315
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 6e-24
Identities = 31/252 (12%), Positives = 79/252 (31%), Gaps = 43/252 (17%)
Query: 55 GEVYKAELPGSSGRVITIK----------KVIQPLKSEAELIKQDSEPLHHKMIQIQSEI 104
+A +G + I+ +K E ++ + K ++
Sbjct: 87 YAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145
Query: 105 ITAGQVRHRNIVPLLARVVRPDCD------LLVYEFRR--NGSLQDILYDVSQGRRELDW 156
I + + RV + D +Y + + ++L S + L
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 205
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR 216
AR ++ + L LH ++H ++P ++++D ++ F +G
Sbjct: 206 HARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGARV 260
Query: 217 TTTWSLAETVGYIAPE-----------CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265
++ + G+ PE + ++ D ++ G+++ + P
Sbjct: 261 VSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP---- 312
Query: 266 FQHTKEMSFVQW 277
+ +W
Sbjct: 313 ITKDAALGGSEW 324
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 60/288 (20%), Positives = 110/288 (38%), Gaps = 56/288 (19%)
Query: 54 NGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G + + R + +K++ L + E +Q+ E H
Sbjct: 37 EGTIVYRGM--FDNRDVAVKRI---LPECFSFADR--E------VQLLRES-----DEHP 78
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
N++ + E +LQ+ + L+ + + SGL +L
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHL 134
Query: 174 HMSHRPRIIHRDIQPANVLI-----DDDMEARISEFGLAKQIPNGRTRTTTWS-LAETVG 227
H S I+HRD++P N+LI ++A IS+FGL K++ GR + S + T G
Sbjct: 135 H-SLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 228 YIAPE---CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM-SFVQWMRNVMT 283
+IAPE + DI+S G + ++ F + + + + +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH---PFGKSLQRQANILLGACSLD 248
Query: 284 SENPSRTIDSK---LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+P + D LI E+M+ + DP++RP++K V
Sbjct: 249 CLHPEKHEDVIARELI-----EKMIAM----------DPQKRPSAKHV 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-24
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 55 GEVYKAE---LPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
VY AE L + IK + P + + E +K+ + E+ + Q+
Sbjct: 25 STVYLAEDTIL----NIKVAIKAIFIPPREKEETLKR-----------FEREVHNSSQLS 69
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
H+NIV ++ DC LV E+ +L + + + L I G++
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIK 125
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
+ +H RI+HRDI+P N+LID + +I +FG+AK + + + T T + TV Y +P
Sbjct: 126 H---AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSP 181
Query: 232 ECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
E + A + DIYS G++L +++G+ P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-24
Identities = 62/337 (18%), Positives = 108/337 (32%), Gaps = 84/337 (24%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVIT---IKKVIQPLKSEA 83
EK L ++ E F G+V +K
Sbjct: 18 FEKRFLKRIRDLGEGHF-----------GKVELCRYDPEGDNTGEQVAVKS--------- 57
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD--LLVYEFRRNGSLQ 141
+K +S H ++ EI + H NIV + L+ EF +GSL+
Sbjct: 58 --LKPESGGNHIA--DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113
Query: 142 DILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201
+ L + + +++ + + A I G++YL + +HRD+ NVL++ + + +I
Sbjct: 114 EYL---PKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKI 167
Query: 202 SEFGLAKQIPNG----RTRTTT-----WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+FGL K I + W APEC D++SFGV L
Sbjct: 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWY--------APECLMQSKFYIASDVWSFGVTL 219
Query: 253 -AVLMMGKFPSDDFFQHTKEMSFVQW-MRNVMTSENPSRTIDSKLIGNGYE--------- 301
+L S K + M +R + + G
Sbjct: 220 HELLTYCDSDSSPMALFLKMIGPTHGQMTV-------TRLV--NTLKEGKRLPCPPNCPD 270
Query: 302 ---EQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ M C P R + +++ +
Sbjct: 271 EVYQLMRK-------CWEFQPSNRTSFQNLIEGFEAL 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 56/277 (20%), Positives = 96/277 (34%), Gaps = 46/277 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV++ +G +KKV L+ E++ +
Sbjct: 72 GEVHRM-KDKQTGFQCAVKKV--RLEV-----------------FRVEELVACAGLSSPR 111
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IVPL V + E GSL ++ Q + A + GLEYLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALY-YLGQALEGLEYLH 167
Query: 175 MSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKQIPN---GRTRTTTWSLAETVGYIA 230
RI+H D++ NVL+ D A + +FG A + G++ T + T ++A
Sbjct: 168 TR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 231 PECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRT 290
PE K DI+S ++ ++ G P +F+ + + P R
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-------GPLCLKIASEPPPIRE 277
Query: 291 IDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327
I ++ +P R ++ +
Sbjct: 278 IPPSC-----APLTAQAIQ-EGLRK--EPVHRASAME 306
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 51/281 (18%), Positives = 104/281 (37%), Gaps = 51/281 (18%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+ + GR IK++ S E + E + + + ++H N
Sbjct: 38 GKAILVK-STEDGRQYVIKEINISRMSSKEREESRRE------VAVLA------NMKHPN 84
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RE---LDWLARHRIARGIASGL 170
IV +V ++ G L + +E LDW + I L
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLAL 138
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVG--- 227
+++H +I+HRDI+ N+ + D ++ +FG+A+ + + +G
Sbjct: 139 KHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-----IGTPY 190
Query: 228 YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENP 287
Y++PE + ++K DI++ G +L L K F+ S + +++ P
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHA----FEAG---SMKNLVLKIISGSFP 243
Query: 288 SRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ Y + ++ F +P +RP+ +
Sbjct: 244 P-------VSLHYSYDLRSLVS-QLFKR--NPRDRPSVNSI 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 54/274 (19%), Positives = 98/274 (35%), Gaps = 61/274 (22%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V++A+ IK++ P + A ++ E+ ++ H
Sbjct: 19 GVVFEAKN-KVDDCNYAIKRIRLPNRELARE-------------KVMREVKALAKLEHPG 64
Query: 115 IV---------PLLARVVRPDCDLLVY---EFRRNGSLQDILYDVSQGRRELDWLARHRI 162
IV ++ + +Y + R +L+D + + E + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVCLHI 123
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSL 222
IA +E+LH ++HRD++P+N+ D ++ +FGL + T +
Sbjct: 124 FLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 223 AET-------VG---YIAPECHQTVALSDKCDIYSFGVLLAVLMM--------------- 257
VG Y++PE + S K DI+S G++L L+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDV 240
Query: 258 --GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSR 289
KFP ++ E VQ M S +P
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQD----MLSPSPME 270
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 55/240 (22%), Positives = 88/240 (36%), Gaps = 55/240 (22%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVIT---IKKVIQPLKSEA 83
E+ L FL++ + F G V +KK L+
Sbjct: 7 FEERHLKFLQQLGKGNF-----------GSVEMCRYDPLQDNTGEVVAVKK----LQHST 51
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD--LLVYEFRRNGSLQ 141
E +D + EI ++H NIV L+ E+ GSL+
Sbjct: 52 EEHLRD----------FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 142 DILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201
D L + + +D + + I G+EYL R IHRD+ N+L++++ +I
Sbjct: 102 DYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKI 155
Query: 202 SEFGLAKQIPNG----RTRTTT-----WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+FGL K +P + + W APE S D++SFGV+L
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWY--------APESLTESKFSVASDVWSFGVVL 207
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-23
Identities = 55/240 (22%), Positives = 88/240 (36%), Gaps = 55/240 (22%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVIT---IKKVIQPLKSEA 83
E+ L FL++ + F G V +KK L+
Sbjct: 38 FEERHLKFLQQLGKGNF-----------GSVEMCRYDPLQDNTGEVVAVKK----LQHST 82
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD--LLVYEFRRNGSLQ 141
E +D + EI ++H NIV L+ E+ GSL+
Sbjct: 83 EEHLRD----------FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 142 DILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201
D L + + +D + + I G+EYL R IHRD+ N+L++++ +I
Sbjct: 133 DYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKI 186
Query: 202 SEFGLAKQIPNG----RTRTTT-----WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+FGL K +P + + W APE S D++SFGV+L
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWY--------APESLTESKFSVASDVWSFGVVL 238
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-23
Identities = 59/291 (20%), Positives = 118/291 (40%), Gaps = 67/291 (23%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+V+KA+ G+ IK+V +E + + E+ ++ H N
Sbjct: 25 GQVFKAKHR-IDGKTYVIKRV--KYNNE----------------KAEREVKALAKLDHVN 65
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ--GRREL-DWLARHR---------- 161
IV D D + S L+ + + L W+ + R
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 162 -IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
+ I G++Y+H ++I+RD++P+N+ + D + +I +FGL + N RT
Sbjct: 126 ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR-- 180
Query: 221 SLAETVG---YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277
+ G Y++PE + + D+Y+ G++LA L+ F+ +K + +
Sbjct: 181 ----SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFTDL-- 231
Query: 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
R+ + S+ + L+ +++L PE+RPN+ ++
Sbjct: 232 -RDGIISDIFDKKE-KTLL-----QKLLSK----------KPEDRPNTSEI 265
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-23
Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 19/195 (9%)
Query: 77 QPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLL--VYEF 134
+P + Q+ EI ++ H N+V L+ + P+ D L V+E
Sbjct: 60 RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119
Query: 135 RRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194
G + ++ + D AR + + G+EYLH +IIHRDI+P+N+L+
Sbjct: 120 VNQGPVMEV---PTLKPLSED-QAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVG 171
Query: 195 DDMEARISEFGLAKQI--PNGRTRTTTWSLAETVGYIAPECHQTVALS---DKCDIYSFG 249
+D +I++FG++ + + T + A ++APE D+++ G
Sbjct: 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPA----FMAPESLSETRKIFSGKALDVWAMG 227
Query: 250 VLLAVLMMGKFPSDD 264
V L + G+ P D
Sbjct: 228 VTLYCFVFGQCPFMD 242
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 7e-23
Identities = 61/306 (19%), Positives = 111/306 (36%), Gaps = 62/306 (20%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HR 113
VY+A+ SGR +K+++ + + I Q E+ ++ H
Sbjct: 42 AFVYEAQ-DVGSGREYALKRLLSNEEEKNRAIIQ--------------EVCFMKKLSGHP 86
Query: 114 NIVPLLA-------RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRR--ELDWLARHRIAR 164
NIV + + L+ G L + L + L +I
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL---KIFY 143
Query: 165 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI---PNGRTRTTTWS 221
++++H +P IIHRD++ N+L+ + ++ +FG A I P+ +
Sbjct: 144 QTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 222 LAE-------TVGYIAPE---CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271
L E T Y PE + + +K DI++ G +L +L + P F+ +
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAK 258
Query: 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCM 331
+ V ++ + LI ML V +PEER + +V
Sbjct: 259 LRIVNGKYSIPPHDTQYTVF-HSLI-----RAMLQV----------NPEERLSIAEVVHQ 302
Query: 332 LSQIQH 337
L +I
Sbjct: 303 LQEIAA 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 50/262 (19%), Positives = 96/262 (36%), Gaps = 38/262 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V++ +G + IK V + + Q E ++ ++ H+N
Sbjct: 23 ANVFRGRHK-KTGDLFAIK-VFNNISFLRPVDVQMRE------FEVLK------KLNHKN 68
Query: 115 IVPLLARVVRPDCDL--LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
IV L A L+ EF GSL +L + S + + R + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNH 127
Query: 173 LHMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
L + I+HR+I+P N++ D ++++FG A+++ + + L T Y
Sbjct: 128 LR-ENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEY 181
Query: 229 IAPECHQTVALSD--------KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280
+ P+ ++ L D++S GV G P F + M
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP---FRPFEGPRRNKEVMYK 238
Query: 281 VMTSENPSRTIDSKLIGNGYEE 302
++T + + NG +
Sbjct: 239 IITGKPSGAISGVQKAENGPID 260
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E+ F LEK+ G VYKA +G+++ IK+V P++S+ + I +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAI-HKETGQIVAIKQV--PVESDLQEIIK----------- 73
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
EI Q ++V + +V E+ GS+ DI+ ++ E D +A
Sbjct: 74 ---EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE-DEIAT 129
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
I + GLEYLH IHRDI+ N+L++ + A++++FG+A Q+ + + T
Sbjct: 130 --ILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184
Query: 220 WSLAETVG---YIAPECHQTVALSDKCDIYSFGV 250
+G ++APE Q + + DI+S G+
Sbjct: 185 V-----IGTPFWMAPEVIQEIGYNCVADIWSLGI 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 43/213 (20%), Positives = 86/213 (40%), Gaps = 29/213 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRHR 113
G+V+K +G VI +K++ + +I ++ +
Sbjct: 39 GQVWKMRF-RKTGHVIAVKQM-------------RRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
IV + + E + + L QG L + + I L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERILGK--MTVAIVKALYYL 140
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
H +IHRD++P+N+L+D+ + ++ +FG++ ++ + + + + A Y+APE
Sbjct: 141 KEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AGCAAYMAPER 195
Query: 234 HQTVALSD-----KCDIYSFGVLLAVLMMGKFP 261
+ + D++S G+ L L G+FP
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 39/211 (18%), Positives = 69/211 (32%), Gaps = 35/211 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV+K GR+ +K+ + P + + ++ +E +H
Sbjct: 71 GEVFKVRSK-EDGRLYAVKRSMSPFRGPKDRARKLAE-----------VGSHEKVGQHPC 118
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRE---LDWLARHRIARGIASGLE 171
V L L E SLQ E +L L
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD------TLLALA 171
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVG---Y 228
+LH ++H D++PAN+ + ++ +FGL ++ G Y
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV------QEGDPRY 222
Query: 229 IAPECHQTVALSDKCDIYSFGVLLAVLMMGK 259
+APE Q D++S G+ + +
Sbjct: 223 MAPELLQGSY-GTAADVFSLGLTILEVACNM 252
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 76/309 (24%), Positives = 126/309 (40%), Gaps = 39/309 (12%)
Query: 30 EKEDLAFLKKEDCFASLEKIRSCWNGEVYKA-ELPGSSGRVITIKKVIQPLKSEAELIKQ 88
+ L + D + E I S V A P + IK++
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAP--KKEKVAIKRI------------- 48
Query: 89 DSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL-YDV 147
+ E M ++ EI Q H NIV V D LV + GS+ DI+ + V
Sbjct: 49 NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIV 108
Query: 148 SQGRRELDWLARHRIA---RGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 204
++G + L IA R + GLEYLH + IHRD++ N+L+ +D +I++F
Sbjct: 109 AKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADF 165
Query: 205 GLAKQIPNGRTRTTTWSLAETVG---YIAPE-CHQTVALSDKCDIYSFGVLLAVLMMGKF 260
G++ + G T VG ++APE Q K DI+SFG+ L G
Sbjct: 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225
Query: 261 PSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLK--IACFCTFDD 318
P + K + ++T +N ++++ + ++ + I+ C D
Sbjct: 226 PYHK-YPPMKVL--------MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-CLQKD 275
Query: 319 PEERPNSKD 327
PE+RP + +
Sbjct: 276 PEKRPTAAE 284
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 1e-22
Identities = 31/220 (14%), Positives = 68/220 (30%), Gaps = 27/220 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
+VY+A G +K + +K + +
Sbjct: 79 AQVYEAT-QGDLNDAKNKQKFV---------LKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIARGIASGLEY 172
+ + + + +LV E G+L + + Y + + L A + +E
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS-FAMRMLYMIEQ 187
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEA-----------RISEFGLAKQIPNGRTRTTTWS 221
+ H IIH DI+P N ++ + + + G + + T +
Sbjct: 188 V---HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
ET G+ E + + D + + ++ G +
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 50/198 (25%), Positives = 79/198 (39%), Gaps = 24/198 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY S+ I IK++ P + + EI ++H+N
Sbjct: 36 GIVYAG-RDLSNQVRIAIKEI--PERDSRYSQ------------PLHEEIALHKHLKHKN 80
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L + E GSL +L ++ + + I GL+YLH
Sbjct: 81 IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLH 139
Query: 175 MSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE- 232
+ +I+HRDI+ NVLI+ +IS+FG +K++ T + T+ Y+APE
Sbjct: 140 DN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMAPEI 194
Query: 233 -CHQTVALSDKCDIYSFG 249
DI+S G
Sbjct: 195 IDKGPRGYGKAADIWSLG 212
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-22
Identities = 56/311 (18%), Positives = 106/311 (34%), Gaps = 52/311 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V++ +G + IK V + + Q E ++ ++ H+N
Sbjct: 23 ANVFRGRHK-KTGDLFAIK-VFNNISFLRPVDVQMRE------FEVLK------KLNHKN 68
Query: 115 IVPLLARVVRPDCDL--LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
IV L A L+ EF GSL +L + S + + R + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNH 127
Query: 173 LHMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
L + I+HR+I+P N++ D ++++FG A+++ + + L T Y
Sbjct: 128 LR-ENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEY 181
Query: 229 IAPECHQTVALSD--------KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280
+ P+ ++ L D++S GV G P F + M
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP---FRPFEGPRRNKEVMYK 238
Query: 281 VMTSENPSRTIDSKLIGNG---YEEQMLLVLKIACFCTFD-----------DPEERPNSK 326
++T + + NG + M + ++ D E+
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298
Query: 327 DVRCMLSQIQH 337
S I H
Sbjct: 299 QFFAETSDILH 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
+ + EKI +G VY A + ++G+ + I+++ L +Q + L
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA-MDVATGQEVAIRQM--------NLQQQPKKEL------ 63
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
I +EI+ + ++ NIV L + D +V E+ GSL D+ V++ + +A
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAA 120
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
+ R LE+LH + +IHRDI+ N+L+ D ++++FG QI +++ +T
Sbjct: 121 --VCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 220 WSLAETVGYIAPECHQTVALSDKCDIYSFGV 250
+ T ++APE A K DI+S G+
Sbjct: 176 --MVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 52/218 (23%), Positives = 83/218 (38%), Gaps = 39/218 (17%)
Query: 55 GEVYKAELPGSSGRVITIKKV-IQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G V K V ++ LK+EA + L +++ E Q+ +
Sbjct: 31 GTVKKGYYQMKKVVK----TVAVKILKNEA-----NDPALKDELLA---EANVMQQLDNP 78
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
IV ++ + + +LV E G L L Q R + + ++ G++YL
Sbjct: 79 YIVRMIG-ICEAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT---------WSLAE 224
+HRD+ NVL+ A+IS+FGL+K + W
Sbjct: 134 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY--- 187
Query: 225 TVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
APEC S K D++SFGVL+ G+ P
Sbjct: 188 -----APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E+ F LEKI GEV+K + + +V+ IK + D E ++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII-------------DLEEAEDEIED 66
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
IQ EI Q + ++ ++ E+ GS D+L G + +A
Sbjct: 67 IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIAT 123
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
I R I GL+YLH + IHRDI+ ANVL+ + E ++++FG+A Q+ + + + T
Sbjct: 124 --ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178
Query: 220 WSLAETVG---YIAPECHQTVALSDKCDIYSFGV 250
+ VG ++APE + A K DI+S G+
Sbjct: 179 F-----VGTPFWMAPEVIKQSAYDSKADIWSLGI 207
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 52/243 (21%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
I +E L KK F GEV+ A +V +K + S +
Sbjct: 185 IPRESLKLEKKLGAGQF-----------GEVWMATYNKH-TKVA-VKTMKPGSMSVEAFL 231
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD 146
E ++H +V L A VV + ++ EF GSL D L
Sbjct: 232 A---------------EANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLK- 274
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
S + + IA G+ ++ + IHRD++ AN+L+ + +I++FGL
Sbjct: 275 -SDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGL 330
Query: 207 AKQIPNGRTRTTT-------WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMG 258
A+ I + W+ APE + + K D++SFG+LL ++ G
Sbjct: 331 ARVIEDNEYTAREGAKFPIKWT--------APEAINFGSFTIKSDVWSFGILLMEIVTYG 382
Query: 259 KFP 261
+ P
Sbjct: 383 RIP 385
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 55/240 (22%), Positives = 86/240 (35%), Gaps = 55/240 (22%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVIT---IKKVIQPLKSEA 83
E+ L ++ + + F G V +K+ L+
Sbjct: 20 FEERHLKYISQLGKGNF-----------GSVELCRYDPLGDNTGALVAVKQ----LQHSG 64
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD--LLVYEFRRNGSLQ 141
++D Q EI + IV P LV E+ +G L+
Sbjct: 65 PDQQRD----------FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 142 DILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201
D L + R LD + I G+EYL S R +HRD+ N+L++ + +I
Sbjct: 115 DFL---QRHRARLDASRLLLYSSQICKGMEYLG-SRR--CVHRDLAARNILVESEAHVKI 168
Query: 202 SEFGLAKQIPNG----RTRTTT-----WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
++FGLAK +P R W APE S + D++SFGV+L
Sbjct: 169 ADFGLAKLLPLDKDYYVVREPGQSPIFW--------YAPESLSDNIFSRQSDVWSFGVVL 220
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 54/242 (22%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQP--LKSEAE 84
+ ++L L+ + F G+V + G+ V IK +EA
Sbjct: 190 LNMKELKLLQTIGKGEF-----------GDVMLGDYRGNKVAVKCIKNDATAQAFLAEAS 238
Query: 85 LIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDI 143
++ Q +RH N+V LL +V L +V E+ GSL D
Sbjct: 239 VMTQ---------------------LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277
Query: 144 LYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203
L S+GR L + + + +EYL ++ +HRD+ NVL+ +D A++S+
Sbjct: 278 L--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD 332
Query: 204 FGLAKQIPNGRTRT---TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGK 259
FGL K+ + + W+ APE + S K D++SFG+LL + G+
Sbjct: 333 FGLTKEASSTQDTGKLPVKWT--------APEALREKKFSTKSDVWSFGILLWEIYSFGR 384
Query: 260 FP 261
P
Sbjct: 385 VP 386
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-22
Identities = 51/313 (16%), Positives = 106/313 (33%), Gaps = 57/313 (18%)
Query: 4 FVLKLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELP 63
+ +K I R +R++ + E + LA L+ + + + W +
Sbjct: 34 YAIKRIRLPNRELAREK------VMREVKALAKLEHP----GIVRYFNAWLETPPEKWQE 83
Query: 64 GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV 123
+ + PL S + + + ++ + + +
Sbjct: 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL------- 136
Query: 124 RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183
+ + R +L+D + + + + I IA +E+LH ++H
Sbjct: 137 -----YIQMQLCRKENLKDWM-NRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMH 187
Query: 184 RDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET-------VG---YIAPEC 233
RD++P+N+ D ++ +FGL + T + VG Y++PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 234 HQTVALSDKCDIYSFGV-----------------LLAVLMMGKFPSDDFFQHTKEMSFVQ 276
S K DI+S G+ ++ + KFP ++ +E VQ
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ 307
Query: 277 WMRNVMTSENPSR 289
M S +P+
Sbjct: 308 D----MLSPSPTE 316
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 46/219 (21%), Positives = 85/219 (38%), Gaps = 30/219 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRHR 113
G V K SG+++ +K++ + + KQ + ++ +
Sbjct: 36 GSVNKMVHK-PSGQIMAVKRI--RSTVDEKEQKQ-----------LLMDLDVVMRSSDCP 81
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDIL---YDVSQGRRELDWLARHRIARGIASGL 170
IV + R + E + S Y V + L + I L
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKAL 138
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
+L + + IIHRDI+P+N+L+D ++ +FG++ Q+ + +T A Y+A
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMA 193
Query: 231 PE----CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265
PE + D++S G+ L L G+FP +
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 46/247 (18%), Positives = 87/247 (35%), Gaps = 49/247 (19%)
Query: 27 PLIEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKV-IQPLKSEA 83
++++ + +K F G VYK +V V I+ L+
Sbjct: 10 RILKETEFKKIKVLGSGAF-----------GTVYKGLWIPEGEKVKI--PVAIKELREAT 56
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDI 143
S + +++ E V + ++ LL + L+ + G L D
Sbjct: 57 ------SPKANKEILD---EAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDY 106
Query: 144 LYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203
+ + + + IA G+ YL R ++HRD+ NVL+ +I++
Sbjct: 107 V---REHKDNIGSQYLLNWCVQIAKGMNYLE-DRR--LVHRDLAARNVLVKTPQHVKITD 160
Query: 204 FGLAKQIPNGRTRTTT--------WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AV 254
FGLAK + W +A E + + D++S+GV + +
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIKW--------MALESILHRIYTHQSDVWSYGVTVWEL 212
Query: 255 LMMGKFP 261
+ G P
Sbjct: 213 MTFGSKP 219
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRHR 113
G V K SG+++ +K++ ++ K+ + ++ I+ V
Sbjct: 21 GVVEKMRHV-PSGQIMAVKRI--RATVNSQEQKR-----------LLMDLDISMRTVDCP 66
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRREL--DWLARHRIARGIASGLE 171
V + R + E + SL V + + D L + IA I LE
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALE 123
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
+LH +IHRD++P+NVLI+ + ++ +FG++ + + + A Y+AP
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID---AGCKPYMAP 178
Query: 232 E----CHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
E S K DI+S G+ + L + +FP
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-22
Identities = 50/232 (21%), Positives = 91/232 (39%), Gaps = 38/232 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH-- 112
+V++ ++ IK V L + D++ L ++EI +++
Sbjct: 23 SKVFQVL--NEKKQIYAIKYV--------NLEEADNQTLD----SYRNEIAYLNKLQQHS 68
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELD-WLARHRIARGIASGLE 171
I+ L + +V E N L L + ++ +D W + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKS-YWKNMLEAVH 122
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
+H H I+H D++PAN LI D M ++ +FG+A Q+ T S TV Y+ P
Sbjct: 123 TIH-QHG--IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 232 E-----------CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272
E +S K D++S G +L + GK P ++
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 39/218 (17%)
Query: 55 GEVYKAELPGSSGRV-ITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G V + ++ + IK +KQ +E + ++ E Q+ +
Sbjct: 24 GSVRQGVYRMRKKQIDVAIKV-----------LKQGTEKADTE--EMMREAQIMHQLDNP 70
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
IV L+ V + + +LV E G L L R E+ + ++ G++YL
Sbjct: 71 YIVRLIG-VCQAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT---------WSLAE 224
+HRD+ NVL+ + A+IS+FGL+K + + T W
Sbjct: 127 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY--- 180
Query: 225 TVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
APEC S + D++S+GV + L G+ P
Sbjct: 181 -----APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-22
Identities = 49/232 (21%), Positives = 92/232 (39%), Gaps = 38/232 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
+V++ ++ IK V L + D++ + ++EI +++ +
Sbjct: 42 SKVFQVL--NEKKQIYAIKYV--------NLEEADNQ----TLDSYRNEIAYLNKLQQHS 87
Query: 115 --IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELD-WLARHRIARGIASGLE 171
I+ L + +V E N L L + ++ +D W + + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKS-YWKNMLEAVH 141
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
+H H I+H D++PAN LI D M ++ +FG+A Q+ T S TV Y+ P
Sbjct: 142 TIH-QHG--IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 232 E-----------CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272
E +S K D++S G +L + GK P ++
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 41/213 (19%), Positives = 74/213 (34%), Gaps = 37/213 (17%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G +Y A +GR + +K L+ +E +V H +
Sbjct: 94 GWIYLALDRNVNGRPVVLK----------GLVHSGDAEAQAM---AMAERQFLAEVVHPS 140
Query: 115 IVPLLARVVRPDCDL-----LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASG 169
IV + V D +V E+ SL+ ++L I
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPA 194
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
L YLH +++ D++P N+++ ++ + ++ + G + L T G+
Sbjct: 195 LSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAV------SRINSFGYLYGTPGFQ 244
Query: 230 APECHQ-TVALSDKCDIYSFGVLLAVLMMGKFP 261
APE + DIY+ G LA L +
Sbjct: 245 APE--IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-22
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
S KI G V A SGR + +K + +L KQ L
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLA-REKHSGRQVAVKMM--------DLRKQQRREL------ 88
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
+ +E++ +H N+V + + + ++ EF + G+L DI VSQ R + +A
Sbjct: 89 LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQVRLNEEQIAT 145
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
+ + L YLH +IHRDI+ ++L+ D ++S+FG QI + +
Sbjct: 146 --VCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200
Query: 220 WSLAETVGYIAPECHQTVALSDKCDIYSFGV 250
L T ++APE + + DI+S G+
Sbjct: 201 --LVGTPYWMAPEVISRSLYATEVDIWSLGI 229
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 12/166 (7%)
Query: 101 QSEIITAGQVRHRNIVPLL----ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 156
+ E A + H IV + A +V E+ +L+DI+ +
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTP 115
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-PNGRT 215
+ L + SH+ IIHRD++PAN++I ++ +FG+A+ I +G +
Sbjct: 116 KRAIEVIADACQALNF---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
T T ++ T Y++PE + ++ + D+YS G +L ++ G+ P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-22
Identities = 54/219 (24%), Positives = 80/219 (36%), Gaps = 38/219 (17%)
Query: 55 GEVYKAELPGSSGRVIT--IKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
G V + E SG+ ++ +K +K D M E+ + H
Sbjct: 32 GVVRRGEWDAPSGKTVSVAVKC-----------LKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
RN++ L VV +V E GSL D L + + R A +A G+ Y
Sbjct: 81 RNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT---------WSLA 223
L R IHRD+ N+L+ +I +FGL + +P W
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-- 191
Query: 224 ETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
APE +T S D + FGV L + G+ P
Sbjct: 192 ------APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 48/232 (20%), Positives = 89/232 (38%), Gaps = 38/232 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH-- 112
+V++ ++ IK V L + D++ + ++EI +++
Sbjct: 70 SKVFQVL--NEKKQIYAIKYV--------NLEEADNQ----TLDSYRNEIAYLNKLQQHS 115
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELD-WLARHRIARGIASGLE 171
I+ L + +V E N L L ++ +D W + + + +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK----KKSIDPWERKS-YWKNMLEAVH 169
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
+H H I+H D++PAN LI D M ++ +FG+A Q+ T S V Y+ P
Sbjct: 170 TIH-QHG--IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 232 E-----------CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272
E +S K D++S G +L + GK P ++
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 277
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 55/248 (22%), Positives = 96/248 (38%), Gaps = 60/248 (24%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
+E+ D+ K + GEVY+ S V +K + + E +
Sbjct: 10 MERTDITMKHKLGGGQY-----------GEVYEGVWKKYSLTV-AVKTLKEDTMEVEEFL 57
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD 146
E +++H N+V LL R ++ EF G+L D L
Sbjct: 58 ---------------KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-- 100
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
R+E+ + +A I+S +EYL + IHRD+ N L+ ++ ++++FGL
Sbjct: 101 RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL 157
Query: 207 AKQIPNGRTRTTT-------WSLAETVGYIAPECHQTVALSD-----KCDIYSFGVLL-A 253
++ + W+ APE +L+ K D+++FGVLL
Sbjct: 158 SRLMTGDTYTAHAGAKFPIKWT--------APE-----SLAYNKFSIKSDVWAFGVLLWE 204
Query: 254 VLMMGKFP 261
+ G P
Sbjct: 205 IATYGMSP 212
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 60/240 (25%), Positives = 86/240 (35%), Gaps = 56/240 (23%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVIT---IKKVIQPLKSEA 83
K L ++ E F G+V ++ +K +
Sbjct: 28 FHKRYLKKIRDLGEGHF-----------GKVSLYCYDPTNDGTGEMVAVKAL-------- 68
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCD--LLVYEFRRNGSLQ 141
K D+ P H + EI + H +I+ LV E+ GSL+
Sbjct: 69 ---KADAGPQHRS--GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123
Query: 142 DILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201
D L R + A+ I G+ YLH IHRD+ NVL+D+D +I
Sbjct: 124 DYLP-----RHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKI 175
Query: 202 SEFGLAKQIPNG----RTRTTT-----WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
+FGLAK +P G R R W APEC + D++SFGV L
Sbjct: 176 GDFGLAKAVPEGHEYYRVREDGDSPVFW--------YAPECLKEYKFYYASDVWSFGVTL 227
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 55 GEVYKAELPGSSGRV-ITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G V + ++ + IK +KQ +E + ++ E Q+ +
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKV-----------LKQGTEKADTE--EMMREAQIMHQLDNP 396
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
IV L+ V + + +LV E G L L R E+ + ++ G++YL
Sbjct: 397 YIVRLIG-VCQAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE-TVGYIAPE 232
+HR++ NVL+ + A+IS+FGL+K + + T S + + + APE
Sbjct: 453 E---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 233 CHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
C S + D++S+GV + L G+ P
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 39/219 (17%)
Query: 55 GEVYKAELPGSSGRVIT--IKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
GEV L R + IK LK+ +E + E GQ H
Sbjct: 63 GEVCYGRLRVPGQRDVPVAIKA----LKAGY------TERQRRDFLS---EASIMGQFDH 109
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
NI+ L V R ++V E+ NGSL L + + + RG+ +G+ Y
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR--TRTTT-------WSLA 223
L +HRD+ NVL+D ++ ++S+FGL++ + + TTT W+
Sbjct: 167 LSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-- 221
Query: 224 ETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
APE S D++SFGV++ VL G+ P
Sbjct: 222 ------APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 20/207 (9%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+VY+AE R++ +K + + L S+ + +Q E TAG+++ +
Sbjct: 48 GDVYEAEDT-VRERIVALKLMSETLSSDPVFRTR-----------MQREARTAGRLQEPH 95
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+VP+ + L +L + + L I R I S L+
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDA-- 149
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+H HRD++P N+L+ D A + +FG+A T + T+ Y+APE
Sbjct: 150 -AHAAGATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERF 207
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFP 261
+ + DIY+ +L + G P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 66/303 (21%), Positives = 119/303 (39%), Gaps = 65/303 (21%)
Query: 54 NGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
+G V GR + +K++ L ++ + I++ +E H
Sbjct: 28 SGTVVFQGS--FQGRPVAVKRM---LIDFCDIALME--------IKLLTESD-----DHP 69
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDIL---YDVSQGRRELDWLARHRIARGIASGL 170
N++ + E N +LQD++ + + + R IASG+
Sbjct: 70 NVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 171 EYLHMSHRPRIIHRDIQPANVLID-------------DDMEARISEFGLAKQIPNGRT-- 215
+LH S + IIHRD++P N+L+ +++ IS+FGL K++ +G++
Sbjct: 129 AHLH-SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 216 RTTTWSLAETVGYIAPE-------CHQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQ 267
RT + + T G+ APE L+ DI+S G + +L GK P D +
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYE--EQMLLVLKIACFCTFDDPEERPNS 325
+ +R + + + D LI + QM+ DP +RP +
Sbjct: 246 RESNI-----IRGIFSLDEMKCLHDRSLIAEATDLISQMIDH----------DPLKRPTA 290
Query: 326 KDV 328
V
Sbjct: 291 MKV 293
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKV-IQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
GEVYK L SSG+ V I+ LK+ +E + E GQ H
Sbjct: 58 GEVYKGMLKTSSGKKEV--PVAIKTLKAGY------TEKQRVDFLG---EAGIMGQFSHH 106
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
NI+ L + + +++ E+ NG+L L + E L + RGIA+G++YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT---------WSLAE 224
+ +HRD+ N+L++ ++ ++S+FGL++ + + T T W+
Sbjct: 164 ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT--- 217
Query: 225 TVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
APE + D++SFG+++ V+ G+ P
Sbjct: 218 -----APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 39/219 (17%)
Query: 55 GEVYKAELPGSSGRVIT--IKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
GEV L S + I+ IK LK +E + E GQ H
Sbjct: 59 GEVCSGRLKLPSKKEISVAIKT----LKVGY------TEKQRRDFLG---EASIMGQFDH 105
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
NI+ L V + ++V E+ NGSL L + + + + RGIASG++Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR--TRTTT-------WSLA 223
L +HRD+ N+LI+ ++ ++S+FGL + + + TT W+
Sbjct: 163 LSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-- 217
Query: 224 ETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+PE + D++S+G++L V+ G+ P
Sbjct: 218 ------SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 27/225 (12%)
Query: 86 IKQDSEPLHHKMIQ-IQSEIITAGQVRHRNIVPLLA------RVVRPDCDLLVYEFRRNG 138
IKQ + L K + EI ++ H N+V ++ D LL E+ G
Sbjct: 44 IKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGG 103
Query: 139 SLQDIL--YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196
L+ L ++ G +E R + I+S L YLH + IIHRD++P N+++
Sbjct: 104 DLRKYLNQFENCCGLKEGP--IRT-LLSDISSALRYLHENR---IIHRDLKPENIVLQPG 157
Query: 197 MEAR---ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLA 253
+ I + G AK++ G T T+ Y+APE + + D +SFG L
Sbjct: 158 PQRLIHKIIDLGYAKELDQGELCTE---FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214
Query: 254 VLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGN 298
+ G P +Q VQW V N + L G
Sbjct: 215 ECITGFRPFLPNWQP------VQWHGKVREKSNEHIVVYDDLTGA 253
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-21
Identities = 51/309 (16%), Positives = 98/309 (31%), Gaps = 61/309 (19%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
F LEKI S G V+K + G + IK+ +PL +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC-VKRLDGCIYAIKRSKKPLAGSVDEQNA----------- 57
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
++ A +H ++V + D L+ E+ GSL D + + +
Sbjct: 58 LREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-------------------MEAR 200
+ + GL Y+H ++H DI+P+N+ I + +
Sbjct: 118 KDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE-CHQTVALSDKCDIYSFGVLLAVLMMGK 259
I + G +I + + ++A E + K DI++ + + +
Sbjct: 175 IGDLGHVTRISSPQVEEG------DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
Query: 260 FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDP 319
+ + P I ++ +LK DP
Sbjct: 229 PLPRNG----------DQWHEIRQGRLPR-------IPQVLSQEFTELLK-VMIHP--DP 268
Query: 320 EERPNSKDV 328
E RP++ +
Sbjct: 269 ERRPSAMAL 277
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-21
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 41/226 (18%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
F +E + + G+VYK +G++ IK + ++ + E +
Sbjct: 23 AGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVM--------DVTGDEEE-------E 66
Query: 100 IQSEI-ITAGQVRHRNIVP-----LLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRR 152
I+ EI + HRNI + D L LV EF GS+ D++ +
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 153 ELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPN 212
+ +W+A I R I GL +LH + ++IHRDI+ NVL+ ++ E ++ +FG++ Q+
Sbjct: 127 KEEWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 213 GRTRTTTWSLAETVG---YIAPECHQTVALSD-----KCDIYSFGV 250
R T+ +G ++APE D K D++S G+
Sbjct: 182 TVGRRNTF-----IGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 52/257 (20%), Positives = 92/257 (35%), Gaps = 63/257 (24%)
Query: 22 PTIFSPLIEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPL 79
I++ D+ + E F G+V+ AE + ++ L
Sbjct: 31 SDACVHHIKRRDIVLKWELGEGAF-----------GKVFLAECHNLLPEQDKMLVAVKAL 79
Query: 80 KSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGS 139
K +E +QD Q E ++H++IV L+V+E+ R+G
Sbjct: 80 KEASESARQD----------FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129
Query: 140 LQDIL-----------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188
L L L +A +A+G+ YL H +HRD+
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLAT 186
Query: 189 ANVLIDDDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQTVALS 240
N L+ + +I +FG+++ I + R T W + PE ++
Sbjct: 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW--------MPPE-----SIL 233
Query: 241 D-----KCDIYSFGVLL 252
+ D++SFGV+L
Sbjct: 234 YRKFTTESDVWSFGVVL 250
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 46/249 (18%), Positives = 87/249 (34%), Gaps = 53/249 (21%)
Query: 27 PLIEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVIT---IKKVIQPLKS 81
++++ + +K F G VYK +V IK+
Sbjct: 10 RILKETEFKKIKVLGSGAF-----------GTVYKGLWIPEGEKVKIPVAIKE------- 51
Query: 82 EAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQ 141
+++ + P +I E V + ++ LL + L+ + G L
Sbjct: 52 ----LREATSP--KANKEILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLL 104
Query: 142 DILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201
D + + + + IA G+ YL R ++HRD+ NVL+ +I
Sbjct: 105 DYV---REHKDNIGSQYLLNWCVQIAKGMNYLE-DRR--LVHRDLAARNVLVKTPQHVKI 158
Query: 202 SEFGLAKQIPNGRTRTTT--------WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL- 252
++FGLAK + W +A E + + D++S+GV +
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKW--------MALESILHRIYTHQSDVWSYGVTVW 210
Query: 253 AVLMMGKFP 261
++ G P
Sbjct: 211 ELMTFGSKP 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 44/221 (19%), Positives = 80/221 (36%), Gaps = 44/221 (19%)
Query: 55 GEVYKAELPGSSGRVIT---IK--KVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQ 109
G V+K + IK + +S + ++ G
Sbjct: 27 GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT---------------DHMLAIGS 71
Query: 110 VRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASG 169
+ H +IV LL + LV ++ GSL D + Q R L IA G
Sbjct: 72 LDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKG 127
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT--------WS 221
+ YL ++HR++ NVL+ + ++++FG+A +P + W
Sbjct: 128 MYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW- 183
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+A E + + D++S+GV + ++ G P
Sbjct: 184 -------MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-20
Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 64/247 (25%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQP--LKSEAE 84
+ ++L L+ + F G+V + G+ V IK +EA
Sbjct: 18 LNMKELKLLQTIGKGEF-----------GDVMLGDYRGNKVAVKCIKNDATAQAFLAEAS 66
Query: 85 LIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDI 143
++ Q +RH N+V LL +V L +V E+ GSL D
Sbjct: 67 VMTQ---------------------LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 105
Query: 144 LYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203
L S+GR L + + + +EYL ++ +HRD+ NVL+ +D A++S+
Sbjct: 106 LR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD 160
Query: 204 FGLAKQIPNGRTRTTT---WSLAETVGYIAPECHQTVALSD-----KCDIYSFGVLL-AV 254
FGL K+ + + W+ APE AL + K D++SFG+LL +
Sbjct: 161 FGLTKEASSTQDTGKLPVKWT--------APE-----ALREKKFSTKSDVWSFGILLWEI 207
Query: 255 LMMGKFP 261
G+ P
Sbjct: 208 YSFGRVP 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 27/187 (14%)
Query: 94 HHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGR- 151
+ ++ E+ + H NIV L V+ + L L+ E+ G + D Y V+ GR
Sbjct: 55 PTSLQKLFREVRIMKILNHPNIVKLF-EVIETEKTLYLIMEYASGGEVFD--YLVAHGRM 111
Query: 152 RELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIP 211
+E + AR R I S ++Y H + RI+HRD++ N+L+D DM +I++FG + +
Sbjct: 112 KEKE--AR-SKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165
Query: 212 NGRTRTTTWSLAETVGYIAPECHQTVALSDKC------DIYSFGVLLAVLMMGKFPSDDF 265
G Y APE K D++S GV+L L+ G P D
Sbjct: 166 VGGKLDAF---CGAPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG- 216
Query: 266 FQHTKEM 272
Q+ KE+
Sbjct: 217 -QNLKEL 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 30/217 (13%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
+ + + ++ G+VYKA +G + K + KSE EL
Sbjct: 18 NEVWEIVGELGDGAFGKVYKA-KNKETGALAAAKVI--ETKSEEELE------------D 62
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
EI H IV LL ++ EF G++ I+ ++ +G E +
Sbjct: 63 YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQV 121
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
+ R + L +LH IIHRD++ NVL+ + + R+++FG++ + + +
Sbjct: 122 --VCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
Query: 220 ------WSLAETVGYIAPECHQTVALSDKCDIYSFGV 250
W +A V + E + K DI+S G+
Sbjct: 177 FIGTPYW-MAPEV--VMCETMKDTPYDYKADIWSLGI 210
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 53/243 (21%), Positives = 93/243 (38%), Gaps = 52/243 (21%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
I+ +L F+++ F G V+ +V IK + + SE + I
Sbjct: 5 IDPSELTFVQEIGSGQF-----------GLVHLGYWLNK-DKV-AIKTIREGAMSEEDFI 51
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD 146
+ E ++ H +V L + LV EF +G L D L
Sbjct: 52 E---------------EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-- 94
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
R + + G+ YL + +IHRD+ N L+ ++ ++S+FG+
Sbjct: 95 -RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 150
Query: 207 AKQIPNGRTRTTT-------WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMG 258
+ + + + ++T W+ +PE S K D++SFGVL+ V G
Sbjct: 151 TRFVLDDQYTSSTGTKFPVKWA--------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202
Query: 259 KFP 261
K P
Sbjct: 203 KIP 205
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 36/216 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKV-IQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G+V++ + V I+ K+ S+ + K +Q E +T Q H
Sbjct: 29 GDVHQGIYMSPENPAL---AVAIKTCKNCT------SDSVREKFLQ---EALTMRQFDHP 76
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
+IV L+ V+ + ++ E G L+ L + LD + A +++ L YL
Sbjct: 77 HIVKLIG-VITENPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYL 132
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT-------WSLAETV 226
R +HRDI NVL+ + ++ +FGL++ + + + W
Sbjct: 133 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----- 184
Query: 227 GYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
APE + D++ FGV + +LM G P
Sbjct: 185 ---APESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 27/214 (12%)
Query: 55 GEVYKAELPGSSGRVIT--IKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
G VY L + G+ I +K L ++ ++ Q +E I H
Sbjct: 39 GCVYHGTLLDNDGKKIHCAVKS----LNRITDI---------GEVSQFLTEGIIMKDFSH 85
Query: 113 RNIVPLLARVVRPDCDLL-VYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
N++ LL +R + L V + ++G L++ + + +A G++
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 142
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG---RTRTTTWSLAETVGY 228
YL +HRD+ N ++D+ ++++FGLA+ + + T + V +
Sbjct: 143 YLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKW 198
Query: 229 IAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+A E QT + K D++SFGVLL ++ G P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-20
Identities = 52/217 (23%), Positives = 88/217 (40%), Gaps = 34/217 (15%)
Query: 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQ 99
E F+ L +I G VY A + V+ IKK + + + K
Sbjct: 53 EKLFSDLREIGHGSFGAVYFA-RDVRNSEVVAIKK-----------MSYSGKQSNEKWQD 100
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
I E+ ++RH N + +R LV E+ GS D+L + +E +A
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQE-VEIAA 158
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
+ G GL YLH + +IHRD++ N+L+ + ++ +FG A + +
Sbjct: 159 --VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS 209
Query: 220 WSLAETVG---YIAPE---CHQTVALSDKCDIYSFGV 250
+ VG ++APE K D++S G+
Sbjct: 210 F-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-20
Identities = 52/230 (22%), Positives = 89/230 (38%), Gaps = 51/230 (22%)
Query: 55 GEVYKAELPGSSGRVIT--IKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
G V + L G + +K +K + ++ E L SE H
Sbjct: 48 GSVMEGNLKQEDGTSLKVAVKT----MKLDNSSQREIEEFL--------SEAACMKDFSH 95
Query: 113 RNIVPLLARVVRPD-----CDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIARG 165
N++ LL + +++ F + G L L + G + + +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG---RTRTTT--- 219
IA G+EYL + +HRD+ N ++ DDM +++FGL+K+I +G R
Sbjct: 156 IALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 220 --WSLAETVGYIAPECHQTVALSD-----KCDIYSFGVLL-AVLMMGKFP 261
W IA E +L+D K D+++FGV + + G P
Sbjct: 213 VKW--------IAIE-----SLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-20
Identities = 54/251 (21%), Positives = 95/251 (37%), Gaps = 64/251 (25%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
I++ D+ ++ E F G+V+ AE S + ++ LK
Sbjct: 12 IKRRDIVLKRELGEGAF-----------GKVFLAECYNLSPTKDKMLVAVKALKDPTLAA 60
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL-- 144
++D Q E ++H +IV D ++V+E+ ++G L L
Sbjct: 61 RKD----------FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA 110
Query: 145 ----------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194
Q + EL IA IASG+ YL H +HRD+ N L+
Sbjct: 111 HGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 167
Query: 195 DDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQTVALSD----- 241
++ +I +FG+++ + + R T W PE ++
Sbjct: 168 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM--------PPE-----SIMYRKFTT 214
Query: 242 KCDIYSFGVLL 252
+ D++SFGV+L
Sbjct: 215 ESDVWSFGVIL 225
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 8e-20
Identities = 48/221 (21%), Positives = 89/221 (40%), Gaps = 41/221 (18%)
Query: 55 GEVYKAELPGSSGRVIT--IKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
G VY L + G+ I +K L ++ ++ Q +E I H
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKS----LNRITDI---------GEVSQFLTEGIIMKDFSH 149
Query: 113 RNIVPLLARVVRPDCDLL-VYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
N++ LL +R + L V + ++G L++ + + +A G++
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 206
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG---RTRTTT-------WS 221
+L +HRD+ N ++D+ ++++FGLA+ + + T W
Sbjct: 207 FLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW- 262
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+A E QT + K D++SFGVLL ++ G P
Sbjct: 263 -------MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-20
Identities = 53/259 (20%), Positives = 93/259 (35%), Gaps = 80/259 (30%)
Query: 27 PLIEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVI----TIK-----KV 75
P+++ D+ F E F G+V KA + R+ +K
Sbjct: 20 PVLDWNDIKFQDVIGEGNF-----------GQVLKARIKKDGLRMDAAIKRMKEYASKDD 68
Query: 76 IQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFR 135
+ E E+ + ++ H NI+ LL L E+
Sbjct: 69 HRDFAGELEV-----------LCKLG---------HHPNIINLLGACEHRGYLYLAIEYA 108
Query: 136 RNGSLQDIL------------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183
+G+L D L + L A +A G++YL S + + IH
Sbjct: 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQK-QFIH 165
Query: 184 RDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT-----WSLAETVGYIAPECHQTVA 238
RD+ N+L+ ++ A+I++FGL++ +T W +A E +
Sbjct: 166 RDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW--------MAIE-----S 212
Query: 239 LSD-----KCDIYSFGVLL 252
L+ D++S+GVLL
Sbjct: 213 LNYSVYTTNSDVWSYGVLL 231
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 45/223 (20%)
Query: 55 GEVYKAELPGSSGRVIT--IK--KVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV 110
G VY E + I IK I ++ + E + +
Sbjct: 35 GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL---------------REGLLMRGL 79
Query: 111 RHRNIVPLLARVVRPD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASG 169
H N++ L+ ++ P+ ++ + +G L + +R +A G
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARG 136
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG---RTRTTT------- 219
+EYL +HRD+ N ++D+ ++++FGLA+ I + +
Sbjct: 137 MEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 220 WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
W A E QT + K D++SFGVLL +L G P
Sbjct: 194 W--------TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 43/219 (19%), Positives = 78/219 (35%), Gaps = 42/219 (19%)
Query: 55 GEVYKAELPGSSGRVIT--IK--KVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV 110
GEVY+ G I +K K L ++ + + E + +
Sbjct: 26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---------------EAVIMKNL 70
Query: 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
H +IV L+ ++ + ++ E G L L + + L L + I +
Sbjct: 71 DHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAM 126
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT-------WSLA 223
YL +HRDI N+L+ ++ +FGL++ I + + W
Sbjct: 127 AYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-- 181
Query: 224 ETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+PE + D++ F V + +L GK P
Sbjct: 182 ------SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 52/243 (21%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
+ +E L +++ F GEV+ G +V +K + Q S +
Sbjct: 10 VPRETLKLVERLGAGQF-----------GEVWMGYYNGH-TKV-AVKSLKQGSMSPDAFL 56
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD 146
E Q++H+ +V L A VV + ++ E+ NGSL D L
Sbjct: 57 A---------------EANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK- 99
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
+ +L +A IA G+ ++ + IHRD++ AN+L+ D + +I++FGL
Sbjct: 100 -TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGL 155
Query: 207 AKQIPNGRTRTTT-------WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMG 258
A+ I + W+ APE + K D++SFG+LL ++ G
Sbjct: 156 ARLIEDNEYTAREGAKFPIKWT--------APEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 259 KFP 261
+ P
Sbjct: 208 RIP 210
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 54/248 (21%), Positives = 92/248 (37%), Gaps = 62/248 (25%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
I+ +DL FLK+ F G V + G + IK + + SE E I
Sbjct: 21 IDPKDLTFLKELGTGQF-----------GVVKYGKWRGQ--YDVAIKMIKEGSMSEDEFI 67
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD 146
+ E + H +V L + ++ E+ NG L + L
Sbjct: 68 E---------------EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-- 110
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
+ R + + + +EYL +HRD+ N L++D ++S+FGL
Sbjct: 111 -REMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGL 166
Query: 207 AKQIPNGRTRTTT-------WSLAETVGYIAPECHQTVALSD-----KCDIYSFGVLL-A 253
++ + + ++ WS PE L K DI++FGVL+
Sbjct: 167 SRYVLDDEYTSSVGSKFPVRWS--------PPE-----VLMYSKFSSKSDIWAFGVLMWE 213
Query: 254 VLMMGKFP 261
+ +GK P
Sbjct: 214 IYSLGKMP 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 48/255 (18%), Positives = 91/255 (35%), Gaps = 58/255 (22%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
+ +E + ++ + F G VY+ G + I+ + A
Sbjct: 22 VAREKITMSRELGQGSF-----------GMVYEGVAKGVVKDEPETRVAIKTVNEAAS-- 68
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL-- 144
E I+ +E + ++V LL V + L++ E G L+ L
Sbjct: 69 --MRE-----RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
Query: 145 ----YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200
+ ++A IA G+ YL+ + +HRD+ N ++ +D +
Sbjct: 122 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178
Query: 201 ISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQTVALSD-----KCDIYS 247
I +FG+ + I R W ++PE +L D D++S
Sbjct: 179 IGDFGMTRDIYETDYYRKGGKGLLPVRW--------MSPE-----SLKDGVFTTYSDVWS 225
Query: 248 FGVLL-AVLMMGKFP 261
FGV+L + + + P
Sbjct: 226 FGVVLWEIATLAEQP 240
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 50/243 (20%), Positives = 94/243 (38%), Gaps = 52/243 (21%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
+++E++ LK+ F G V + G + +K + + SE E
Sbjct: 5 LKREEITLLKELGSGQF-----------GVVKLGKWKGQ--YDVAVKMIKEGSMSEDEFF 51
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD 146
+ E T ++ H +V + +V E+ NG L + L
Sbjct: 52 Q---------------EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-- 94
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
+ L+ + + G+ +L IHRD+ N L+D D+ ++S+FG+
Sbjct: 95 -RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGM 150
Query: 207 AKQIPNGRTRTTT-------WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMG 258
+ + + + ++ WS APE S K D+++FG+L+ V +G
Sbjct: 151 TRYVLDDQYVSSVGTKFPVKWS--------APEVFHYFKYSSKSDVWAFGILMWEVFSLG 202
Query: 259 KFP 261
K P
Sbjct: 203 KMP 205
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 54/271 (19%), Positives = 102/271 (37%), Gaps = 65/271 (23%)
Query: 17 SRDRGPTIFSPLIEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVIT--I 72
S + + LI ++ + + F G V +A+L G + +
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEF-----------GSVREAQLKQEDGSFVKVAV 56
Query: 73 KKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPD------ 126
K LK++ E L E + H ++ L+ +R
Sbjct: 57 KM----LKADIIASSDIEEFL--------REAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104
Query: 127 CDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184
+++ F ++G L L + + L R IA G+EYL + IHR
Sbjct: 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHR 161
Query: 185 DIQPANVLIDDDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQT 236
D+ N ++ +DM +++FGL+++I +G R + W +A E
Sbjct: 162 DLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW--------LALE---- 209
Query: 237 VALSD-----KCDIYSFGVLL-AVLMMGKFP 261
+L+D D+++FGV + ++ G+ P
Sbjct: 210 -SLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 22/220 (10%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV ++ + G++ KK+ E + IK+ +E +V R
Sbjct: 198 GEVCACQVRAT-GKMYACKKL------EKKRIKKRKGEAM-----ALNEKQILEKVNSRF 245
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V L D LV G L+ +Y + Q A A I GLE LH
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR-AVFYAAE-ICCGLEDLH 303
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
R RI++RD++P N+L+DD RIS+ GLA +P G T TVGY+APE
Sbjct: 304 ---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVV 357
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
+ + D ++ G LL ++ G+ F +E+
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-19
Identities = 60/183 (32%), Positives = 90/183 (49%), Gaps = 29/183 (15%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGR-RELDW 156
+I+ EI RH +I+ L +V+ D +V E+ G L D Y GR E++
Sbjct: 57 KIKREIQNLKLFRHPHIIKLY-QVISTPTDFFMVMEYVSGGELFD--YICKHGRVEEME- 112
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL-AKQIPNGRT 215
AR R+ + I S ++Y H R ++HRD++P NVL+D M A+I++FGL
Sbjct: 113 -AR-RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDK------CDIYSFGVLLAVLMMGKFPSDDFFQHT 269
RT+ S Y APE +S + DI+S GV+L L+ G P DD +H
Sbjct: 168 RTSCGSPN----YAAPE-----VISGRLYAGPEVDIWSCGVILYALLCGTLPFDD--EHV 216
Query: 270 KEM 272
+
Sbjct: 217 PTL 219
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 24/210 (11%)
Query: 55 GEVYKAELPGSSGRVIT--IKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
G+V++ + IK K+ S+ + K +Q E +T Q H
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKT----CKNCT------SDSVREKFLQ---EALTMRQFDH 450
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
+IV L+ V+ + ++ E G L+ L + LD + A +++ L Y
Sbjct: 451 PHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAY 506
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
L R +HRDI NVL+ + ++ +FGL++ + + + + ++APE
Sbjct: 507 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 562
Query: 233 CHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+ D++ FGV + +LM G P
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV+ ++ + G++ KK L + +K+ E +V R
Sbjct: 199 GEVFACQMKAT-GKLYACKK----LNKKR--LKKRKGYQG-----AMVEKKILAKVHSRF 246
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELD-WLARHRIARGIASGLEYL 173
IV L LV G ++ +Y+V + A A+ I SGLE+L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHL 305
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
H + II+RD++P NVL+DDD RIS+ GLA ++ G+T+T A T G++APE
Sbjct: 306 H---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPEL 360
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
D ++ GV L ++ + F + KE+
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-19
Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 24/190 (12%)
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGS-LQ 141
E + +D K+ ++ EI +V H NI+ +L + LV E +G L
Sbjct: 60 EKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL-DIFENQGFFQLVMEKHGSGLDLF 118
Query: 142 DILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201
+ R + LA I R + S + YL IIHRDI+ N++I +D ++
Sbjct: 119 A--FIDRHPRLDEP-LAS-YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKL 171
Query: 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDK------CDIYSFGVLLAVL 255
+FG A + G+ T T+ Y APE L +++S GV L L
Sbjct: 172 IDFGSAAYLERGKLFYTF---CGTIEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTL 223
Query: 256 MMGKFPSDDF 265
+ + P +
Sbjct: 224 VFEENPFCEL 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 47/185 (25%), Positives = 76/185 (41%), Gaps = 40/185 (21%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL----YDVSQGRREL 154
++ EI ++RH+N++ L + N Q + Y G +E+
Sbjct: 52 NVKKEIQLLRRLRHKNVIQL-------------VDVLYNEEKQKMYMVMEY-CVCGMQEM 97
Query: 155 -DWLARHRI----ARG----IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205
D + R A G + GLEYLH I+H+DI+P N+L+ +IS G
Sbjct: 98 LDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALG 154
Query: 206 LAKQIPNGRT----RTTTWSLAETVGYIAPECHQTVALSD--KCDIYSFGVLLAVLMMGK 259
+A+ + RT+ S A + PE + K DI+S GV L + G
Sbjct: 155 VAEALHPFAADDTCRTSQGSPA----FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
Query: 260 FPSDD 264
+P +
Sbjct: 211 YPFEG 215
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 58/251 (23%), Positives = 103/251 (41%), Gaps = 63/251 (25%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
I + F+++ ED F G+VYK L G + T I+ LK +A
Sbjct: 6 ISLSAVRFMEELGEDRF-----------GKVYKGHLFGPAPGEQTQAVAIKTLKDKA--- 51
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL-- 144
PL + + E + +++H N+V LL V + +++ + +G L + L
Sbjct: 52 ---EGPL---REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 105
Query: 145 ----------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194
D + L+ + IA+G+EYL H ++H+D+ NVL+
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 162
Query: 195 DDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQTVALSD----- 241
D + +IS+ GL +++ + + W +APE A+
Sbjct: 163 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRW--------MAPE-----AIMYGKFSI 209
Query: 242 KCDIYSFGVLL 252
DI+S+GV+L
Sbjct: 210 DSDIWSYGVVL 220
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 51/256 (19%), Positives = 89/256 (34%), Gaps = 70/256 (27%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIK---KVIQPLKSEA 83
+ L+F K F G+V +A G + K+++P
Sbjct: 20 FPRNRLSFGKTLGAGAF-----------GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDI 143
E SE +++ S + H NIV LL L++ E+ G L +
Sbjct: 69 EREALMSE------LKVLSYL-----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
Query: 144 L--------------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
L + LD + +A G+ +L + IHRD+
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174
Query: 190 NVLIDDDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQTVALSD 241
N+L+ +I +FGLA+ I N + W +APE ++ +
Sbjct: 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKW--------MAPE-----SIFN 221
Query: 242 -----KCDIYSFGVLL 252
+ D++S+G+ L
Sbjct: 222 CVYTFESDVWSYGIFL 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 49/219 (22%)
Query: 64 GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH----RNIVPLL 119
GS V+ ++ S K+++ + II +V + R++ +
Sbjct: 41 GSFSTVVLARE------------LATSREYAIKILEKR-HIIKENKVPYVTRERDV---M 84
Query: 120 ARVVRP----------DCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIA 167
+R+ P D + L + +NG L L + + + R A I
Sbjct: 85 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAE-IV 140
Query: 168 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVG 227
S LEYLH IIHRD++P N+L+++DM +I++FG AK + + S T
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 228 YIAPECHQTVALSDK-----CDIYSFGVLLAVLMMGKFP 261
Y++PE L++K D+++ G ++ L+ G P
Sbjct: 198 YVSPE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 34/200 (17%)
Query: 104 IITAGQVRH----RNIVPLLARVVRPDCDLLV---YEFRRNGSLQDILYDVSQGRRELDW 156
I R + L+ V DC +V Y F L IL ++ G +L +
Sbjct: 227 IKMKQGETLALNERIM---LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHY 281
Query: 157 -LARHRI---------ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
L++H + A I GLE++H +++RD++PAN+L+D+ RIS+ GL
Sbjct: 282 HLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 338
Query: 207 AKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKC-DIYSFGVLLAVLMMGKFPSDDF 265
A + T GY+APE Q D D +S G +L L+ G P
Sbjct: 339 ACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---- 390
Query: 266 FQHTKEMSFVQWMRNVMTSE 285
F+ K + R +T
Sbjct: 391 FRQHKTKDKHEIDRMTLTMA 410
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-18
Identities = 48/176 (27%), Positives = 73/176 (41%), Gaps = 26/176 (14%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWL 157
I+ EI + H N+V + L E+ G L D E D
Sbjct: 51 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD--RIEPDIGMPEPD-- 106
Query: 158 ARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT 217
A+ R + +G+ YLH I HRDI+P N+L+D+ +IS+FGLA
Sbjct: 107 AQ-RFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 218 TTWSLAETVG---YIAPECHQTVALSDK------CDIYSFGVLLAVLMMGKFPSDD 264
L + G Y+APE L + D++S G++L ++ G+ P D
Sbjct: 163 L---LNKMCGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 28/177 (15%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGR-RELDW 156
I+ EI + H N+V R L E+ G L D E D
Sbjct: 51 NIKKEICINKMLNHENVVKFY-GHRREGNIQYLFLEYCSGGELFD--RIEPDIGMPEPD- 106
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR 216
A+ R + +G+ YLH I HRDI+P N+L+D+ +IS+FGLA
Sbjct: 107 -AQ-RFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 217 TTTWSLAETVG---YIAPECHQTVALSDK------CDIYSFGVLLAVLMMGKFPSDD 264
L + G Y+APE L + D++S G++L ++ G+ P D
Sbjct: 162 RL---LNKMCGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 52/215 (24%), Positives = 83/215 (38%), Gaps = 40/215 (18%)
Query: 55 GEVYKAELPGSSGRVITIK---KVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
GEVY+ ++ G ++ K + + SE + + E + +
Sbjct: 44 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD------------FLMEALIISKFN 91
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR---IARGIAS 168
H+NIV + ++ ++ E G L+ L + + LA +AR IA
Sbjct: 92 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLID---DDMEARISEFGLAKQIPNG---RTRTTT--- 219
G +YL +H IHRDI N L+ A+I +FG+A+ I R
Sbjct: 152 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 220 --WSLAETVGYIAPECHQTVALSDKCDIYSFGVLL 252
W + PE + K D +SFGVLL
Sbjct: 209 VKW--------MPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 53/224 (23%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEA-ELIKQD--SEPLHHKMIQIQSEIITAGQVR 111
G+V +A G +K ++ LKS A K+ SE ++I S + +
Sbjct: 60 GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE------LKIMSHL-----GQ 108
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL----------YDVSQGRRELDWLARHR 161
H NIV LL L++ E+ G L + L +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG---RTRTT 218
+ +A G+ +L + IHRD+ NVL+ + A+I +FGLA+ I N +
Sbjct: 169 FSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 219 T-----WSLAETVGYIAPECHQTVALSD-----KCDIYSFGVLL 252
W +APE ++ D + D++S+G+LL
Sbjct: 226 ARLPVKW--------MAPE-----SIFDCVYTVQSDVWSYGILL 256
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-18
Identities = 57/256 (22%), Positives = 97/256 (37%), Gaps = 70/256 (27%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIK-----KVIQPLKS 81
++ L K E F G+V AE G K+++ +
Sbjct: 32 FPRDKLTLGKPLGEGAF-----------GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 82 EAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQ 141
E +L SE +++ I +H+NI+ LL + ++ E+ G+L+
Sbjct: 81 EKDLSDLVSE------MEMMKMI-----GKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 142 DIL------------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
+ L ++ + +A G+EYL IHRD+
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 190 NVLIDDDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQTVALSD 241
NVL+ ++ +I++FGLA+ I N + T W +APE AL D
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW--------MAPE-----ALFD 233
Query: 242 -----KCDIYSFGVLL 252
+ D++SFGVL+
Sbjct: 234 RVYTHQSDVWSFGVLM 249
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-18
Identities = 37/225 (16%), Positives = 83/225 (36%), Gaps = 46/225 (20%)
Query: 55 GEVYKAEL--PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
+++K G G++ + +++ L + ++ H
Sbjct: 22 TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES----------FFEAASMMSKLSH 71
Query: 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
+++V V D ++LV EF + GSL L + ++ L + +A+ +A+ + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHF 128
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEAR--------ISEFGLAKQIPNGRTRTTTWSLAE 224
L + +IH ++ N+L+ + + + +S+ G++ +
Sbjct: 129 LEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------------LP 173
Query: 225 TVGY------IAPEC-HQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+ PEC L+ D +SFG L + G P
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-18
Identities = 51/217 (23%), Positives = 83/217 (38%), Gaps = 44/217 (20%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEVY+ ++ G ++ ++ L + + + E + + H+N
Sbjct: 85 GEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDE-----LDFLMEALIISKFNHQN 135
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR---IARGIASGLE 171
IV + ++ ++ E G L+ L + + LA +AR IA G +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 172 YLHMSHRPRIIHRDIQPANVLID---DDMEARISEFGLAKQIPNG---RTRTTT-----W 220
YL +H IHRDI N L+ A+I +FG+A+ I R W
Sbjct: 196 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 221 SLAETVGYIAPECHQTVALSD-----KCDIYSFGVLL 252
+ PE A + K D +SFGVLL
Sbjct: 253 --------MPPE-----AFMEGIFTSKTDTWSFGVLL 276
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 61/183 (33%), Positives = 94/183 (51%), Gaps = 29/183 (15%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGR-RELDW 156
+I+ EI RH +I+ L +V+ D+ +V E+ G L D Y GR E +
Sbjct: 62 KIRREIQNLKLFRHPHIIKLY-QVISTPSDIFMVMEYVSGGELFD--YICKNGRLDEKE- 117
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT- 215
+R R+ + I SG++Y H R ++HRD++P NVL+D M A+I++FGL+ + +G
Sbjct: 118 -SR-RLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDK------CDIYSFGVLLAVLMMGKFPSDDFFQHT 269
RT+ S Y APE +S + DI+S GV+L L+ G P DD H
Sbjct: 173 RTSCGSPN----YAAPE-----VISGRLYAGPEVDIWSSGVILYALLCGTLPFDD--DHV 221
Query: 270 KEM 272
+
Sbjct: 222 PTL 224
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 36/188 (19%), Positives = 71/188 (37%), Gaps = 26/188 (13%)
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHR--NIVPLLARVVRPDCDLLVYEF-RRNGSLQDI 143
+ ++ E++ +V ++ LL RPD +L+ E L D
Sbjct: 80 RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD- 138
Query: 144 LYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID-DDMEARIS 202
+ +G + + LAR + + + H ++HRDI+ N+LID + E ++
Sbjct: 139 -FITERGALQEE-LAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI 192
Query: 203 EFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKC------DIYSFGVLLAVLM 256
+FG + + + Y PE + ++S G+LL ++
Sbjct: 193 DFGSGALLKDTVYTDFDGTRV----YSPPE-----WIRYHRYHGRSAAVWSLGILLYDMV 243
Query: 257 MGKFPSDD 264
G P +
Sbjct: 244 CGDIPFEH 251
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 27/223 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV A + + + I+ +I K S + +++EI ++ H
Sbjct: 149 GEVKLAFER-KTCKKVAIR-IISKRK-----FAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYL 173
I+ + D +V E G L D V R +E + + ++YL
Sbjct: 202 IIKIKNFFDAEDY-YIVLELMEGGELFD--KVVGNKRLKEAT--CKL-YFYQMLLAVQYL 255
Query: 174 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
H IIHRD++P NVL+ ++D +I++FG +K + T L T Y+A
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLA 309
Query: 231 PE---CHQTVALSDKCDIYSFGVLLAVLMMGKFP-SDDFFQHT 269
PE T + D +S GV+L + + G P S+ Q +
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 59/265 (22%), Positives = 97/265 (36%), Gaps = 70/265 (26%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLK---SEA 83
++ L K F G+V +A+ G ++ LK + +
Sbjct: 24 FPRDRLKLGKPLGRGAF-----------GQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLV-YEFRRNGSLQD 142
E SE ++I I H N+V LL +P L+V EF + G+L
Sbjct: 73 EHRALMSE------LKILIHI-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 143 IL------------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190
L + L + +A G+E+L + R + IHRD+ N
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASR-KCIHRDLAARN 178
Query: 191 VLIDDDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQTVALSD- 241
+L+ + +I +FGLA+ I + W +APE + D
Sbjct: 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW--------MAPE-----TIFDR 225
Query: 242 ----KCDIYSFGVLL-AVLMMGKFP 261
+ D++SFGVLL + +G P
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 62/266 (23%), Positives = 104/266 (39%), Gaps = 71/266 (26%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPG-SSGRVITIKKV-IQPLK---S 81
++ L K E CF G+V AE G + V ++ LK +
Sbjct: 78 FPRDKLTLGKPLGEGCF-----------GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 126
Query: 82 EAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQ 141
E +L SE +++ I +H+NI+ LL + ++ E+ G+L+
Sbjct: 127 EKDLSDLVSE------MEMMKMI-----GKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 142 DIL------------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
+ L ++ + +A G+EYL IHRD+
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 232
Query: 190 NVLIDDDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQTVALSD 241
NVL+ ++ +I++FGLA+ I N + T W +APE AL D
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW--------MAPE-----ALFD 279
Query: 242 -----KCDIYSFGVLL-AVLMMGKFP 261
+ D++SFGVL+ + +G P
Sbjct: 280 RVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 31/109 (28%), Positives = 51/109 (46%), Gaps = 12/109 (11%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+ L+YL IIHRD++P N+L+D+ I++F +A +P T ++A T
Sbjct: 124 LVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGT 177
Query: 226 VGYIAPE--CHQTVALSDKC-DIYSFGVLLAVLMMGKFPSDDFFQHTKE 271
Y+APE + A D +S GV L+ G+ P + +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP---YHIRSST 223
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 63/256 (24%), Positives = 102/256 (39%), Gaps = 70/256 (27%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPG-SSGRVITIKKV-IQPLK---S 81
+ ++ L K E F G+V AE G + + KV ++ LK +
Sbjct: 66 LPRDRLVLGKPLGEGAF-----------GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 114
Query: 82 EAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQ 141
E +L SE +++ I +H+NI+ LL + ++ E+ G+L+
Sbjct: 115 EKDLSDLISE------MEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 142 DIL------------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
+ L +L A +A G+EYL IHRD+
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 220
Query: 190 NVLIDDDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQTVALSD 241
NVL+ +D +I++FGLA+ I + + T W +APE AL D
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW--------MAPE-----ALFD 267
Query: 242 -----KCDIYSFGVLL 252
+ D++SFGVLL
Sbjct: 268 RIYTHQSDVWSFGVLL 283
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 51/259 (19%), Positives = 92/259 (35%), Gaps = 71/259 (27%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI 86
+ ++ +++ E F G V++A PG ++ LK EA
Sbjct: 44 YPRNNIEYVRDIGEGAF-----------GRVFQARAPGLLPYEPFTMVAVKMLKEEAS-- 90
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL-- 144
Q E + + NIV LL L++E+ G L + L
Sbjct: 91 --ADM-----QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143
Query: 145 ------------------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDI 186
S G L + IAR +A+G+ YL +HRD+
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200
Query: 187 QPANVLIDDDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQTVA 238
N L+ ++M +I++FGL++ I + + W + PE +
Sbjct: 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRW--------MPPE-----S 247
Query: 239 LSD-----KCDIYSFGVLL 252
+ + D++++GV+L
Sbjct: 248 IFYNRYTTESDVWAYGVVL 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 56/261 (21%), Positives = 96/261 (36%), Gaps = 75/261 (28%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIK---KVIQPLKSEA 83
+E+L F K F G+V A G S ++I+ K+++ +
Sbjct: 42 FPRENLEFGKVLGSGAF-----------GKVMNATAYGISKTGVSIQVAVKMLKEKADSS 90
Query: 84 ELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDI 143
E SE +++ +++ H NIV LL L++E+ G L +
Sbjct: 91 EREALMSE------LKMMTQL-----GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 139
Query: 144 L-------------------YDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184
L + + L + A +A G+E+L +HR
Sbjct: 140 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196
Query: 185 DIQPANVLIDDDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETVGYIAPECHQT 236
D+ NVL+ +I +FGLA+ I + R W +APE
Sbjct: 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW--------MAPE---- 244
Query: 237 VALSD-----KCDIYSFGVLL 252
+L + K D++S+G+LL
Sbjct: 245 -SLFEGIYTIKSDVWSYGILL 264
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 53/185 (28%), Positives = 93/185 (50%), Gaps = 30/185 (16%)
Query: 97 MIQIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGR-REL 154
++++ EI +RH +I+ L V+ D+ +V E+ G L D Y V + R E
Sbjct: 53 HMRVEREISYLKLLRHPHIIKLY-DVITTPTDIVMVIEYA-GGELFD--YIVEKKRMTED 108
Query: 155 DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL-AKQIPNG 213
+ R R + I +EY H R +I+HRD++P N+L+DD++ +I++FGL
Sbjct: 109 E--GR-RFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
Query: 214 RTRTTTWSLAETVGYIAPECHQTVALSDK------CDIYSFGVLLAVLMMGKFPSDDFFQ 267
+T+ S Y APE ++ K D++S G++L V+++G+ P DD +
Sbjct: 163 FLKTSCGSPN----YAAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD--E 211
Query: 268 HTKEM 272
+
Sbjct: 212 FIPNL 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-17
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 27/223 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV A + + + IK +I K S + +++EI ++ H
Sbjct: 24 GEVKLAFE-RKTCKKVAIK-IISKRK-----FAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYL 173
I+ + D +V E G L D V R +E + + ++YL
Sbjct: 77 IIKIKNFFDAEDY-YIVLELMEGGELFD--KVVGNKRLKEAT--CKL-YFYQMLLAVQYL 130
Query: 174 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
H + IIHRD++P NVL+ ++D +I++FG +K + T L T Y+A
Sbjct: 131 H-ENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLA 184
Query: 231 PE---CHQTVALSDKCDIYSFGVLLAVLMMGKFP-SDDFFQHT 269
PE T + D +S GV+L + + G P S+ Q +
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 68/286 (23%), Positives = 116/286 (40%), Gaps = 48/286 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV + + IK VI+ + + D++ + +I +EI + H N
Sbjct: 50 GEVLLCKEK-NGHSEKAIK-VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN 107
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYL 173
I+ L LV EF G L + + +++ + E D A + I + I SG+ YL
Sbjct: 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECD--AAN-IMKQILSGICYL 162
Query: 174 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
H + I+HRDI+P N+L+ + + +I +FGL+ T YIA
Sbjct: 163 HKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIA 216
Query: 231 PECHQTVAL----SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT-SE 285
PE L ++KCD++S GV++ +L+ G P F + + +
Sbjct: 217 PE-----VLKKKYNEKCDVWSCGVIMYILLCGYPP---FGGQNDQDIIKKVEKGKYYFDF 268
Query: 286 NPSRTIDSK---LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
N + I + LI ML D +R +++
Sbjct: 269 NDWKNISDEAKELIK-----LMLTY----------DYNKRCTAEEA 299
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 57/271 (21%), Positives = 95/271 (35%), Gaps = 95/271 (35%)
Query: 29 IEKEDLAFLKK--EDCFASLEKIRSCWNGEVYKAELPGSSGR-------VITIK-----K 74
+++L K E F G+V KA GR V +K
Sbjct: 20 FPRKNLVLGKTLGEGEF-----------GKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 75 VIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEF 134
++ L SE ++KQ V H +++ L + LL+ E+
Sbjct: 69 ELRDLLSEFNVLKQ---------------------VNHPHVIKLYGACSQDGPLLLIVEY 107
Query: 135 RRNGSLQDIL--------------------YDVSQGRRELDWLARHRIARGIASGLEYLH 174
+ GSL+ L R L A I+ G++YL
Sbjct: 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNG---RTRTTT-----WSLAETV 226
++HRD+ N+L+ + + +IS+FGL++ + R+ W
Sbjct: 168 EMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKW------ 218
Query: 227 GYIAPECHQTVALSD-----KCDIYSFGVLL 252
+A E +L D + D++SFGVLL
Sbjct: 219 --MAIE-----SLFDHIYTTQSDVWSFGVLL 242
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 33/179 (18%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGR-RELDW 156
+Q EII +RH NIV V+ L ++ E+ G L + + GR E +
Sbjct: 62 NVQREIINHRSLRHPNIVRFK-EVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDE- 117
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKQIPNGR 214
AR + + SG+ Y H +I HRD++ N L+D R I +FG +K
Sbjct: 118 -AR-FFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
Query: 215 TRTTTWSLAETVG---YIAPECHQTVALSDK------CDIYSFGVLLAVLMMGKFPSDD 264
+ TVG YIAPE L + D++S GV L V+++G +P +D
Sbjct: 173 QPKS------TVGTPAYIAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 35/190 (18%), Positives = 67/190 (35%), Gaps = 28/190 (14%)
Query: 87 KQDSEPLHHKMIQIQSEIITAGQVR----HRNIVPLLARVVRPDCDLLVYEFRRNGS-LQ 141
+ + E+ +V H ++ LL + +LV E L
Sbjct: 68 RVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLF 127
Query: 142 DILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EAR 200
D Y +G +R + + +++ H ++HRDI+ N+LID A+
Sbjct: 128 D--YITEKGPLGEG-PSR-CFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK 180
Query: 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDK------CDIYSFGVLLAV 254
+ +FG + + + Y PE +S ++S G+LL
Sbjct: 181 LIDFGSGALLHDEPYTDFDGTRV----YSPPE-----WISRHQYHALPATVWSLGILLYD 231
Query: 255 LMMGKFPSDD 264
++ G P +
Sbjct: 232 MVCGDIPFER 241
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 48/196 (24%), Positives = 80/196 (40%), Gaps = 23/196 (11%)
Query: 74 KVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRHRNIVPLLARVVRPDCDLLVY 132
K+I +E + E+ I H NI+ L LV+
Sbjct: 48 KII----DVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103
Query: 133 EFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191
+ + G L D L + E + R I R + + LH + I+HRD++P N+
Sbjct: 104 DLMKKGELFDYL--TEKVTLSEKE--TRK-IMRALLEVICALHKLN---IVHRDLKPENI 155
Query: 192 LIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE------CHQTVALSDKCDI 245
L+DDDM ++++FG + Q+ G + T Y+APE + D+
Sbjct: 156 LLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 246 YSFGVLLAVLMMGKFP 261
+S GV++ L+ G P
Sbjct: 213 WSTGVIMYTLLAGSPP 228
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
EV+ + +G++ +K + + ++ + L ++H N
Sbjct: 23 SEVFLVK-QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKK--------------IKHEN 67
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGR-RELDWLARHRIARGIASGLEY 172
IV L LV + G L D I + +G E D A + + + S ++Y
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEKD--ASL-VIQQVLSAVKY 121
Query: 173 LHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
LH + I+HRD++P N+L +++ + I++FGL+K NG T T GY+
Sbjct: 122 LH-ENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYV 174
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
APE S D +S GV+ +L+ G P
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 64/242 (26%), Positives = 101/242 (41%), Gaps = 55/242 (22%)
Query: 41 DCFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH 95
+ + +L + GE V K +GR++ IKK + +
Sbjct: 25 EKYENLGLV-----GEGSYGMVMKCR-NKDTGRIVAIKK-----------FLESDDDKMV 67
Query: 96 KMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRREL 154
K I ++ EI Q+RH N+V LL V + LV+EF IL D+ L
Sbjct: 68 KKIAMR-EIKLLKQLRHENLVNLL-EVCKKKKRWYLVFEF----VDHTILDDLELFPNGL 121
Query: 155 DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPN-G 213
D+ + I +G+ + H SH IIHRDI+P N+L+ ++ +FG A+ + G
Sbjct: 122 DYQVVQKYLFQIINGIGFCH-SHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
Query: 214 RTRT----TTWSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FPS 262
T W Y APE + + D D+++ G L+ + MG+ FP
Sbjct: 179 EVYDDEVATRW-------YRAPE----LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227
Query: 263 DD 264
D
Sbjct: 228 DS 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 54/242 (22%), Positives = 97/242 (40%), Gaps = 55/242 (22%)
Query: 41 DCFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH 95
+ + + KI GE V+K +G+++ IKK + +
Sbjct: 3 EKYEKIGKI-----GEGSYGVVFKCR-NRDTGQIVAIKK-----------FLESEDDPVI 45
Query: 96 KMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRREL 154
K I ++ EI Q++H N+V LL V R L LV+E+ +L+++ + +R +
Sbjct: 46 KKIALR-EIRMLKQLKHPNLVNLL-EVFRRKRRLHLVFEYCD----HTVLHELDRYQRGV 99
Query: 155 DWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPN-G 213
I + + H H IHRD++P N+LI ++ +FG A+ +
Sbjct: 100 PEHLVKSITWQTLQAVNFCH-KHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156
Query: 214 RTRT----TTWSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FPS 262
T W Y +PE + + D D+++ G + A L+ G +P
Sbjct: 157 DYYDDEVATRW-------YRSPE----LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG 205
Query: 263 DD 264
Sbjct: 206 KS 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 11/165 (6%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 158
++ EI T +RH +V L + +++YEF G L + + D E + A
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE--A 257
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI--SEFGLAKQIPNGRTR 216
R + GL ++H ++ +H D++P N++ + +FGL + ++
Sbjct: 258 VE-YMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313
Query: 217 TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
T + APE + + D++S GVL +L+ G P
Sbjct: 314 KV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 21/180 (11%)
Query: 112 HRNIVPLLA----RVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGRRELDWLARHRIARGI 166
+IV +L C L++ E G L I Q E + A I R I
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE--AAE-IMRDI 137
Query: 167 ASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLA 223
+ +++LH + I HRD++P N+L + D ++++FG AK+ +T
Sbjct: 138 GTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP----C 190
Query: 224 ETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT 283
T Y+APE CD++S GV++ +L+ G P F+ +T + R +
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP---FYSNTGQAISPGMKRRIRL 247
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 45/226 (19%)
Query: 55 GEVYKAELPGS----SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV 110
VY+ + G+ + +V+ + +++E ++ + +
Sbjct: 67 SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLR---------------------L 105
Query: 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGR-RELDWLARHRIARGIAS 168
H NI+ L P LV E G L D I V +G E D A + I
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGELFDRI---VEKGYYSERD--AAD-AVKQILE 159
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+ YLH + I+HRD++P N+L D +I++FGL+K + + T + T
Sbjct: 160 AVAYLH-ENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGT 213
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271
GY APE + A + D++S G++ +L+ G P F+ +
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---FYDERGD 256
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 9e-15
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV + IK + + + + ++ E+ + H N
Sbjct: 51 GEVLLCRDK-VTHVERAIKII-----RKTSVSTSSNS-------KLLEEVAVLKLLDHPN 97
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYL 173
I+ L LV E + G L D + + + + E+D A I + + SG+ YL
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVD--AAV-IIKQVLSGVTYL 152
Query: 174 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
H + I+HRD++P N+L+ + D +I +FGL+ N + T YIA
Sbjct: 153 HKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLGTAYYIA 206
Query: 231 PECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
PE + +KCD++S GV+L +L+ G P
Sbjct: 207 PEVLRK-KYDEKCDVWSIGVILFILLAGYPP 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWL 157
+ E+ Q+ H NI+ L LV E G L D + +S+ R E+D
Sbjct: 72 SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVD-- 127
Query: 158 ARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGR 214
A I R + SG+ Y+H + I+HRD++P N+L+ D RI +FGL+ +
Sbjct: 128 AAR-IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 215 TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
T YIAPE +KCD++S GV+L +L+ G P
Sbjct: 184 KMKD---KIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 19/184 (10%)
Query: 86 IKQDSEPLHHKMIQIQSEI-ITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDIL 144
+ E L + E I H +I+ L+ LV++ R G L D
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD-- 189
Query: 145 YDVSQGR-RELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203
Y + E + R I R + + +LH ++ I+HRD++P N+L+DD+M+ R+S+
Sbjct: 190 YLTEKVALSEKE--TRS-IMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243
Query: 204 FGLAKQIPNGRTRTTTWSLAETVGYIAPE------CHQTVALSDKCDIYSFGVLLAVLMM 257
FG + + G L T GY+APE + D+++ GV+L L+
Sbjct: 244 FGFSCHLEPGEKLRE---LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
Query: 258 GKFP 261
G P
Sbjct: 301 GSPP 304
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 25/212 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V K S+G K I+ +S A E +I+ E+ QV H N
Sbjct: 26 AIVKKCR-EKSTGLEYAAK-FIKKRQSRASRRGVCRE-------EIEREVSILRQVLHPN 76
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYL 173
I+ L +L+ E G L D L + E + A + I G+ YL
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEE--ATS-FIKQILDGVNYL 131
Query: 174 HMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
H I H D++P N+++ ++ +FGLA +I +G + T ++
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFV 185
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
APE L + D++S GV+ +L+ G P
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 36/108 (33%), Positives = 49/108 (45%), Gaps = 11/108 (10%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKQIPNGRTRTT 218
I R I S L YLH I HRDI+P N L + + +FGL+K+
Sbjct: 172 NIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 219 TWSLAETVG---YIAPE--CHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
+ G ++APE + KCD +S GVLL +L+MG P
Sbjct: 229 Y-GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 48/181 (26%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGRR--ELDW 156
++ E ++H +IV LL +V+EF L I+ G E
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV- 131
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNG 213
A H R I L Y H + IIHRD++P VL+ ++ ++ FG+A Q+
Sbjct: 132 -ASH-YMRQILEALRYCH-DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 214 RTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273
T ++APE + D++ GV+L +L+ G P F TKE
Sbjct: 187 GLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP----FYGTKERL 240
Query: 274 F 274
F
Sbjct: 241 F 241
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 25/212 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V K S+G K I+ +S A E +I+ E+ QV H N
Sbjct: 26 AIVKKCR-EKSTGLEYAAK-FIKKRQSRASRRGVSRE-------EIEREVSILRQVLHHN 76
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYL 173
++ L +L+ E G L D L + E + A + I G+ YL
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEE--ATS-FIKQILDGVNYL 131
Query: 174 HMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
H I H D++P N+++ ++ +FGLA +I +G + T ++
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFV 185
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
APE L + D++S GV+ +L+ G P
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 11/164 (6%)
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
+++EI Q+ H ++ L +L+ EF G L D + E +
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE--VI 152
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI--SEFGLAKQIPNGRTRT 217
+ R GL+++H I+H DI+P N++ + + + +FGLA ++
Sbjct: 153 N-YMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208
Query: 218 TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
T + APE + D+++ GVL VL+ G P
Sbjct: 209 V---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLA 158
++ E +++H NIV L + LV++ G L + + V++ E D A
Sbjct: 52 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD--A 107
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRT 215
H + I + Y H S+ I+HR+++P N+L+ ++++FGLA ++ +
Sbjct: 108 SH-CIQQILESIAYCH-SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
A T GY++PE + S DI++ GV+L +L++G P
Sbjct: 164 WHG---FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 27/190 (14%)
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGR-RELDWLARHRIARGIASG 169
HRN++ L+ D LV+E R GS+ I + EL+ A + + +AS
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI---HKRRHFNELE--ASV-VVQDVASA 123
Query: 170 LEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRT--TTWSLAE 224
L++LH I HRD++P N+L + +I +F L I + +T L
Sbjct: 124 LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 225 TVG---YIAPE-----CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276
G Y+APE + +CD++S GV+L +L+ G P F
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP---FVGRCGSDCGWD 237
Query: 277 WMRNVMTSEN 286
+N
Sbjct: 238 RGEACPACQN 247
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-14
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+V+ E SSG IK + K + E QI++EI + H N
Sbjct: 36 GDVHLVEER-SSGLERVIKTI---NKD---RSQVPME-------QIEAEIEVLKSLDHPN 81
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGRR--ELDWLARHRIARGIASGLE 171
I+ + +V E G L + I+ ++G+ E + + + + L
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY--VA-ELMKQMMNALA 138
Query: 172 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
Y H H ++H+D++P N+L +I +FGLA+ + T A T Y
Sbjct: 139 YFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALY 192
Query: 229 IAPECHQTV---ALSDKCDIYSFGVLLAVLMMGKFP 261
+APE V ++ KCDI+S GV++ L+ G P
Sbjct: 193 MAPE----VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 25/184 (13%)
Query: 110 VRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGR---RELDWLARHRIARG 165
+H NI+ L +V E + G L D I + Q RE A +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI---LRQKFFSERE----ASA-VLFT 124
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA----RISEFGLAKQIPNGRTRTTTWS 221
I +EYLH + ++HRD++P+N+L D+ RI +FG AKQ+ T
Sbjct: 125 ITKTVEYLH-AQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-- 179
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281
T ++APE + CDI+S GVLL ++ G P F + + + + + +
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP----FANGPDDTPEEILARI 235
Query: 282 MTSE 285
+ +
Sbjct: 236 GSGK 239
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV K + + + +K + ++A +D+ I E+ ++ H N
Sbjct: 36 GEVLKCKDR-ITQQEYAVKVI-----NKASAKNKDTS-------TILREVELLKKLDHPN 82
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYL 173
I+ L + +V E G L D + + + R E D A I + + SG+ Y+
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHD--AAR-IIKQVFSGITYM 137
Query: 174 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
H + I+HRD++P N+L+ + D + +I +FGL+ T YIA
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIA 191
Query: 231 PECHQTVAL----SDKCDIYSFGVLLAVLMMGKFP 261
PE L +KCD++S GV+L +L+ G P
Sbjct: 192 PE-----VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-14
Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 25/212 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V K +G+ K I+ + + E +I+ E+ ++RH N
Sbjct: 19 AIVRKCR-QKGTGKEYAAK-FIKKRRLSSSRRGVSRE-------EIEREVNILREIRHPN 69
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYL 173
I+ L +L+ E G L D L + E + A + I G+ YL
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDE--ATQ-FLKQILDGVHYL 124
Query: 174 HMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
H I H D++P N+++ + ++ +FG+A +I G + T ++
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFV 178
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
APE L + D++S GV+ +L+ G P
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 43/163 (26%), Positives = 80/163 (49%), Gaps = 15/163 (9%)
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLA 158
++ E +++H NIV L + LV++ G L + + V++ E D A
Sbjct: 75 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD--A 130
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRT 215
H + I + Y H S+ I+HR+++P N+L+ ++++FGLA ++ +
Sbjct: 131 SH-CIQQILESIAYCH-SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMG 258
A T GY++PE + S DI++ GV+L +L++G
Sbjct: 187 WHG---FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 27/101 (26%), Positives = 49/101 (48%), Gaps = 9/101 (8%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+ ++ +H H +HRDI+P N+L+D + R+++FG ++ T + T
Sbjct: 184 MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGT 239
Query: 226 VGYIAPECHQTVALSDK-----CDIYSFGVLLAVLMMGKFP 261
YI+PE Q + CD +S GV + ++ G+ P
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 32/180 (17%)
Query: 102 SEIITAGQVRH----RNIVPLLARVVRP----------DCDLL--VYEFRRNGSLQDILY 145
E+I R+I +A P D L V E+ G D++
Sbjct: 105 FEMIKRSDSAFFWEERDI---MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG---DLVN 158
Query: 146 DVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205
+S W AR A + L+ +H IHRD++P N+L+D ++++FG
Sbjct: 159 LMSNYDVPEKW-ARFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213
Query: 206 LAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDK----CDIYSFGVLLAVLMMGKFP 261
++ N + T YI+PE ++ CD +S GV L +++G P
Sbjct: 214 TCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 75/261 (28%), Positives = 117/261 (44%), Gaps = 66/261 (25%)
Query: 27 PLIEKEDLAFLKKEDCFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKVIQPLKS 81
+E+L F + + LEK+ GE VYKA+ S GR++ +K++ L +
Sbjct: 7 HSSGRENLYFQGLMEKYQKLEKV-----GEGTYGVVYKAK--DSQGRIVALKRI--RLDA 57
Query: 82 EAELIKQDSEPLHHKMIQIQS--EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGS 139
E E I P + EI ++ H NIV L+ + C LV+EF
Sbjct: 58 EDEGI-----P-------STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKD 104
Query: 140 LQDILYDVSQGRRELDWLARHRI---ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196
L+ +L + G L +I + G+ + H HR I+HRD++P N+LI+ D
Sbjct: 105 LKKVLDENKTG------LQDSQIKIYLYQLLRGVAHCH-QHR--ILHRDLKPQNLLINSD 155
Query: 197 MEARISEFGLAKQ--IPNGRTRT----TTWSLAETVGYIAPECHQTVALSDKC-----DI 245
++++FGLA+ IP R+ T T W Y AP+ V + K DI
Sbjct: 156 GALKLADFGLARAFGIPV-RSYTHEVVTLW-------YRAPD----VLMGSKKYSTSVDI 203
Query: 246 YSFGVLLAVLMMGK--FPSDD 264
+S G + A ++ GK FP
Sbjct: 204 WSIGCIFAEMITGKPLFPGVT 224
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
RH + L D V E+ G ++ + +S+ R + AR A I S
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAE-IVS 259
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
L+YLH +++RD++ N+++D D +I++FGL K+ T T Y
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315
Query: 229 IAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
+APE + D + GV++ +M G+ F + D
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV K + + + +K + ++A +D+ I E+ ++ H N
Sbjct: 36 GEVLKCK-DRITQQEYAVKVI-----NKASAKNKDTS-------TILREVELLKKLDHPN 82
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGR-RELDWLARHRIARGIASGLEY 172
I+ L + +V E G L D I + + R E D A I + + SG+ Y
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHD--AAR-IIKQVFSGITY 136
Query: 173 LHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
+H + I+HRD++P N+L+ + D + +I +FGL+ T YI
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYI 190
Query: 230 APECHQTVAL---SDKCDIYSFGVLLAVLMMGKFP 261
APE V +KCD++S GV+L +L+ G P
Sbjct: 191 APE----VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
+++EI Q+ H N++ L + +LV E+ G L D + D S ELD
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD--TI 190
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI--SEFGLAKQIPNGRTRT 217
+ I G+ ++H I+H D++P N+L + +I +FGLA++
Sbjct: 191 -LFMKQICEGIRHMH-QMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246
Query: 218 TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
T ++APE +S D++S GV+ +L+ G P
Sbjct: 247 V---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 40/212 (18%)
Query: 64 GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH----RNIVPLL 119
GS GRV+ +K K+ K++ Q +++ Q+ H + I L
Sbjct: 52 GSFGRVMLVKH------------KESGNHYAMKILDKQ-KVVKLKQIEHTLNEKRI---L 95
Query: 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR------IAR----GIASG 169
V P L + F+ N +L ++ V+ G E+ R AR I
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
EYLH +I+RD++P N+LID ++++FG AK++ TW+L T +
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEAL 205
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
APE + + D ++ GVL+ + G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 32/210 (15%), Positives = 65/210 (30%), Gaps = 56/210 (26%)
Query: 55 GEVYKAE---LPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
+ ++A L R + + V +++++ S + ++
Sbjct: 45 LQFWQALDTAL----DRQVALTFVDPQGVLPDDVLQE-----------TLSRTLRLSRID 89
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
+ +L V L+V E+ R GSLQ++ + R + +A+ +
Sbjct: 90 KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAAD 143
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
+HR + P+ V + D G LA +
Sbjct: 144 A---AHRAGVALSIDHPSRVRVSID--------GDVV-------------LA-YPATMPD 178
Query: 232 ECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
Q DI G L L++ ++P
Sbjct: 179 ANPQD-------DIRGIGASLYALLVNRWP 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 25/212 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V K S+G K I+ ++++ E I+ E+ +++H N
Sbjct: 25 AVVKKCR-EKSTGLQYAAK-FIKKRRTKSSRRGVSRE-------DIEREVSILKEIQHPN 75
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIARGIASGLEYL 173
++ L +L+ E G L D L + E + A + I +G+ YL
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEE--AT-EFLKQILNGVYYL 130
Query: 174 HMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
H I H D++P N+++ +I +FGLA +I G + T ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
APE L + D++S GV+ +L+ G P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 17/197 (8%)
Query: 95 HKMIQIQSEIITAGQVR-HRNIVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGR- 151
Q EI H NIV L LV E G L + I +
Sbjct: 47 RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI---KKKKHF 103
Query: 152 RELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAK 208
E + A + I R + S + ++H ++HRD++P N+L +D++E +I +FG A+
Sbjct: 104 SETE--ASY-IMRKLVSAVSHMH-DVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157
Query: 209 QIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268
P T T+ Y APE + CD++S GV+L ++ G+ P +
Sbjct: 158 LKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215
Query: 269 TKEMSFVQWMRNVMTSE 285
S V+ M+ + +
Sbjct: 216 LTCTSAVEIMKKIKKGD 232
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 46/230 (20%), Positives = 89/230 (38%), Gaps = 44/230 (19%)
Query: 55 GEVYKA-ELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G VYKA G + +K+ I+ + EI +++H
Sbjct: 35 GHVYKAKRKDGKDDKDYALKQ-----------IEGTGIS-----MSACREIALLRELKHP 78
Query: 114 NIVPLLARVV-RPDCDL-LVYEFRRN--GSLQDILYDVSQGRRELDWLARHR--IARGIA 167
N++ L + D + L++++ + + ++ + + I
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 168 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR----ISEFGLAK--QIPNGRTRTTTWS 221
G+ YLH ++ ++HRD++PAN+L+ + R I++ G A+ P +
Sbjct: 139 DGIHYLH-ANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL-KPLADLDP 194
Query: 222 LAETVGYIAPEC-----HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
+ T Y APE H T A+ DI++ G + A L+ + F
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSEPIFHCRQ 240
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 43/209 (20%), Positives = 90/209 (43%), Gaps = 29/209 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V + +G+ +I + +L +D + +++ E ++H N
Sbjct: 25 SVVRRCV-KVLAGQEYAAM-II----NTKKLSARDHQ-------KLEREARICRLLKHPN 71
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGR-RELDWLARHRIARGIASGLEY 172
IV L + L+++ G L + I V++ E D A H + I + +
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEAD--ASH-CIQQILEAVLH 125
Query: 173 LHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
H ++HR+++P N+L+ ++++FGLA ++ + A T GY+
Sbjct: 126 CH-QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 180
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMG 258
+PE + D+++ GV+L +L++G
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 59/236 (25%), Positives = 102/236 (43%), Gaps = 68/236 (28%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKS---EAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
G VY+A+L SG ++ IKKV+Q + E +++++ +
Sbjct: 68 GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRK---------------------LD 105
Query: 112 HRNIVPLLARVVRPDCDL-------LVYEFRRNGSLQDILYDVSQGRRELDW----LARH 160
H NIV L + LV ++ ++ + S+ ++ L L +
Sbjct: 106 HCNIVRLRY-FFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKQIPNGRTRT-- 217
++ R +A Y+H S I HRDI+P N+L+D D ++ +FG AKQ+ G
Sbjct: 164 QLFRSLA----YIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 218 --TTWSLAETVGYIAPEC-----HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
+ + Y APE T ++ D++S G +LA L++G+ FP D
Sbjct: 217 ICSRY-------YRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFPGDS 261
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 65/250 (26%), Positives = 105/250 (42%), Gaps = 67/250 (26%)
Query: 41 DCFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSE---P 92
F LEK+ G VYK L ++G + +K+ +K DSE P
Sbjct: 5 SQFKQLEKL-----GNGTYATVYKG-LNKTTGVYVALKE-----------VKLDSEEGTP 47
Query: 93 LHHKMIQIQS--EIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQ 149
+ EI +++H NIV L V+ + L LV+EF + L+ + +
Sbjct: 48 -------STAIREISLMKELKHENIVRLY-DVIHTENKLTLVFEFM-DNDLKKYMDSRTV 98
Query: 150 GRRELDWLARH--RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207
G + GL + H ++ I+HRD++P N+LI+ + ++ +FGLA
Sbjct: 99 GNTPRGLELNLVKYFQWQLLQGLAFCH-ENK--ILHRDLKPQNLLINKRGQLKLGDFGLA 155
Query: 208 --KQIPNGRTRT----TTWSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLM 256
IP T + T W Y AP+ V + + DI+S G +LA ++
Sbjct: 156 RAFGIPV-NTFSSEVVTLW-------YRAPD----VLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 257 MGK--FPSDD 264
GK FP +
Sbjct: 204 TGKPLFPGTN 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 28/107 (26%), Positives = 47/107 (43%), Gaps = 19/107 (17%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ-IPNGRTRTTTWSLAE 224
I ++ +H +HRDI+P N+L+D R+++FG + +G R+
Sbjct: 171 IVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV----- 222
Query: 225 TVG---YIAPECHQTVALSDK-------CDIYSFGVLLAVLMMGKFP 261
VG Y++PE Q V CD ++ GV + G+ P
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 32/115 (27%), Positives = 52/115 (45%), Gaps = 16/115 (13%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I LE+LH II+RDI+ N+L+D + +++FGL+K+ T + T
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGT 223
Query: 226 VGYIAPECHQTVALSDK------CDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
+ Y+AP+ + D +S GVL+ L+ G F D E+
Sbjct: 224 IEYMAPD----IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 8e-13
Identities = 66/247 (26%), Positives = 102/247 (41%), Gaps = 62/247 (25%)
Query: 41 DCFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH 95
+ L+ + GE VYKA ++ +++ IKK+ K +D
Sbjct: 10 KRYEKLDFL-----GEGQFATVYKARDK-NTNQIVAIKKI----KLGHRSEAKDGIN--- 56
Query: 96 KMIQIQS--EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRE 153
+ EI ++ H NI+ LL LV++F L+ I+ D S
Sbjct: 57 ----RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLV--- 108
Query: 154 LDWLARHRI---ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ- 209
L I GLEYLH H I+HRD++P N+L+D++ ++++FGLAK
Sbjct: 109 ---LTPSHIKAYMLMTLQGLEYLH-QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162
Query: 210 -IPNGRTRT----TTWSLAETVGYIAPEC-----HQTVALSDKCDIYSFGVLLAVLMMGK 259
PN R T T W Y APE V + D+++ G +LA L++
Sbjct: 163 GSPN-RAYTHQVVTRW-------YRAPELLFGARMYGVGV----DMWAVGCILAELLLRV 210
Query: 260 --FPSDD 264
P D
Sbjct: 211 PFLPGDS 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-13
Identities = 46/169 (27%), Positives = 71/169 (42%), Gaps = 22/169 (13%)
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLA 158
+ EI + H NI+ L LV E G L + V + RE D A
Sbjct: 53 FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFE--RVVHKRVFRESD--A 108
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRT 215
I + + S + Y H + + HRD++P N L D ++ +FGLA + G+
Sbjct: 109 AR-IMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164
Query: 216 RTTTWSLAETVGYIAPECHQTVAL---SDKCDIYSFGVLLAVLMMGKFP 261
T T Y++P+ V +CD +S GV++ VL+ G P
Sbjct: 165 MRTK---VGTPYYVSPQ----VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+ LEYLH II+RD++P N+L+D + +I++FG AK +P T++L T
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGT 166
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLL 252
YIAPE T + D +SFG+L+
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILI 193
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 25/174 (14%)
Query: 112 HRNIVPLLA----RVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGRR---ELDWLARHRIA 163
+IV ++ C L+V E G L I +G + E + A I
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTERE--ASE-IM 167
Query: 164 RGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTW 220
+ I ++YLH + I HRD++P N+L + ++++FG AK+ + + TT
Sbjct: 168 KSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224
Query: 221 SLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
T Y+APE CD++S GV++ +L+ G F S+ + M
Sbjct: 225 Y---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 31/154 (20%), Positives = 70/154 (45%), Gaps = 13/154 (8%)
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQD-ILYDVSQGRRELDWLARHRIARGIASGL 170
++ L +L+ E+ G + L ++++ E D + + I G+
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND--VIR-LIKQILEGV 144
Query: 171 EYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVG 227
YLH ++ I+H D++P N+L+ + +I +FG++++I + + T
Sbjct: 145 YYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPE 198
Query: 228 YIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
Y+APE ++ D+++ G++ +L+ P
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 65/234 (27%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEA-ELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G V++A+L S V IKKV+Q + + E +QI V+H
Sbjct: 54 GVVFQAKLV-ESDEV-AIKKVLQDKRFKNRE-------------LQIMRI------VKHP 92
Query: 114 NIVPLLARVVRPDCDL-------LVYEFRRNGSLQDILYDVSQGRRELDW----LARHRI 162
N+V L A + D LV E+ ++ ++ ++ + L +++
Sbjct: 93 NVVDLKA-FFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 163 ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKQIPNGRTRT---- 217
R +A Y+H S I HRDI+P N+L+D ++ +FG AK + G
Sbjct: 151 LRSLA----YIH-SIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 218 TTWSLAETVGYIAPEC-----HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
+ + Y APE + T + DI+S G ++A LM G+ FP +
Sbjct: 204 SRY-------YRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQPLFPGES 246
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 53/237 (22%), Positives = 90/237 (37%), Gaps = 64/237 (27%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPL---KSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
G V + S+G + IKKVIQ E ++++ L +
Sbjct: 37 GTVQLGKEK-STGMSVAIKKVIQDPRFRNRELQIMQD----LAV--------------LH 77
Query: 112 HRNIVPLLARVVRPDCD--------LLVYEFRRNGSLQDILYDVSQGRRELDW----LAR 159
H NIV L + + +V E+ +L + + + +
Sbjct: 78 HPNIVQLQS-YFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPNGRTRT- 217
++ R I LH + HRDI+P NVL++ D ++ +FG AK++
Sbjct: 136 FQLIRSIG----CLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 218 ---TTWSLAETVGYIAPE-----CHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
+ + Y APE H T A+ DI+S G + A +M+G+ F D+
Sbjct: 191 YICSRY-------YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGEPIFRGDN 236
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 11/165 (6%)
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 158
++ EI RHRNI+ L + ++++EF + + + + E +
Sbjct: 47 LVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE--I 104
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA--RISEFGLAKQIPNGRTR 216
+ L++LH + I H DI+P N++ + +I EFG A+Q+ G
Sbjct: 105 VS-YVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
Query: 217 TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
++ Y APE HQ +S D++S G L+ VL+ G P
Sbjct: 161 RLLFT---APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 58/249 (23%), Positives = 96/249 (38%), Gaps = 70/249 (28%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+ +L+ I S G V A R + IKK+ +P ++ H K +
Sbjct: 64 YQNLKPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRPFQN----------QTHAK--RAYR 110
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDL-------LVYEF---------RRNGSLQDILYD 146
E++ V H+NI+ LL V P L LV E + + + Y
Sbjct: 111 ELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
+ Q G+++LH + IIHRD++P+N+++ D +I +FGL
Sbjct: 170 LYQMLC----------------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210
Query: 207 AKQIPNGRTRT----TTWSLAETVGYIAPE----CHQTVALSDKCDIYSFGVLLAVLMMG 258
A+ T T + Y APE + DI+S G ++ ++
Sbjct: 211 ARTAGTSFMMTPYVVTRY-------YRAPEVILGMGYKENV----DIWSVGCIMGEMVRH 259
Query: 259 K--FPSDDF 265
K FP D+
Sbjct: 260 KILFPGRDY 268
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 51/259 (19%), Positives = 91/259 (35%), Gaps = 81/259 (31%)
Query: 41 DCFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH 95
+ + +I GE V+KA + GR + +K+V +++ E + P
Sbjct: 11 QQYECVAEI-----GEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGM-----P--- 55
Query: 96 KMIQIQSEIITA----------GQVRHRNIVPLLARVVRPDCDL-----LVYEFRRNGSL 140
++ H N+V L D LV+E
Sbjct: 56 ---------LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH------ 100
Query: 141 QDILYDV-----SQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195
+ D+ + + + GL++LH SHR ++HRD++P N+L+
Sbjct: 101 --VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH-SHR--VVHRDLKPQNILVTS 155
Query: 196 DMEARISEFGLAKQIPNGRTRT----TTWSLAETVGYIAPE----CHQTVALSDKCDIYS 247
+ ++++FGLA+ T T W Y APE + D++S
Sbjct: 156 SGQIKLADFGLARIYSFQMALTSVVVTLW-------YRAPEVLLQSSYATPV----DLWS 204
Query: 248 FGVLLAVLMMGK--FPSDD 264
G + A + K F
Sbjct: 205 VGCIFAEMFRRKPLFRGSS 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 54/243 (22%), Positives = 101/243 (41%), Gaps = 58/243 (23%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQI 100
+ + L+K+ VYK + + ++ +K++ + E E + P
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEI----RLEHE----EGAP-------C 45
Query: 101 QS--EIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWL 157
+ E+ ++H NIV L ++ + L LV+E+ + L+ L D +
Sbjct: 46 TAIREVSLLKDLKHANIVTLH-DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI------I 97
Query: 158 ARHRI---ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA--KQIPN 212
H + + GL Y H R +++HRD++P N+LI++ E ++++FGLA K IP
Sbjct: 98 NMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154
Query: 213 GRTRT----TTWSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FP 261
+T T W Y P+ + L D++ G + + G+ FP
Sbjct: 155 -KTYDNEVVTLW-------YRPPD----ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
Query: 262 SDD 264
Sbjct: 203 GST 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-12
Identities = 68/249 (27%), Positives = 106/249 (42%), Gaps = 70/249 (28%)
Query: 41 DCFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSE---- 91
+ + LEKI GE VYKA+ + G +KK I+ + E
Sbjct: 2 EKYHGLEKI-----GEGTYGVVYKAQ--NNYGETFALKK-----------IRLEKEDEGI 43
Query: 92 PLHHKMIQIQS--EIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVS 148
P + EI +++H NIV L V+ L LV+E + L+ +L
Sbjct: 44 P-------STTIREISILKELKHSNIVKLY-DVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 149 QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208
G L+ + + +G+ Y H R ++HRD++P N+LI+ + E +I++FGLA+
Sbjct: 95 GG---LESVTAKSFLLQLLNGIAYCH-DRR--VLHRDLKPQNLLINREGELKIADFGLAR 148
Query: 209 --QIPNGRTRT----TTWSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLMM 257
IP R T T W Y AP+ V + K DI+S G + A ++
Sbjct: 149 AFGIPV-RKYTHEIVTLW-------YRAPD----VLMGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 258 GK--FPSDD 264
G FP
Sbjct: 197 GTPLFPGVS 205
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 33/109 (30%), Positives = 58/109 (53%), Gaps = 11/109 (10%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+A L++LH II+RD++P N+L+D++ ++++FGL+K+ + + + T
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
V Y+APE + D +SFGVL+ ++ G F D KE
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD----RKET 234
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 51/217 (23%)
Query: 66 SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125
R + IKK+ +P ++ H K + E++ V H+NI+ LL V P
Sbjct: 49 LERNVAIKKLSRPFQN----------QTHAK--RAYRELVLMKCVNHKNIIGLL-NVFTP 95
Query: 126 DCDL-------LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHR 178
L +V E + +L ++ + ELD + + G+++LH +
Sbjct: 96 QKSLEEFQDVYIVMEL-MDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG- 147
Query: 179 PRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT----TTWSLAETVGYIAPE-- 232
IIHRD++P+N+++ D +I +FGLA+ T T + Y APE
Sbjct: 148 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-------YRAPEVI 198
Query: 233 --CHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDF 265
+ DI+S G ++ ++ G FP D
Sbjct: 199 LGMGYKENV----DIWSVGCIMGEMIKGGVLFPGTDH 231
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 29/109 (26%), Positives = 54/109 (49%), Gaps = 11/109 (10%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I+ L +LH II+RD++P N++++ ++++FGL K+ + T T T T
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
+ Y+APE + D +S G L+ ++ G F ++ K+
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN----RKKT 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 41/169 (24%), Positives = 72/169 (42%), Gaps = 38/169 (22%)
Query: 112 HRNIVPLLARVVRPDC---DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
NI+ L +V+ LV+E N + + ++ D+ R + I
Sbjct: 90 GPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYM-YEILK 141
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPNGRTRT----TTWSLA 223
L+Y H S I+HRD++P NV+ID + + R+ ++GLA+ G+ + +
Sbjct: 142 ALDYCH-SMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY--- 195
Query: 224 ETVGYIAPE-----CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ 267
+ PE +L D++S G +LA ++ K P FF
Sbjct: 196 ----FKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP---FFH 233
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 11/109 (10%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
IAS L YLH + I++RD++P N+L+D +++FGL K+ N +TT + T
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGT 202
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
Y+APE D + G +L ++ G F S + T EM
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEM 247
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 51/249 (20%), Positives = 88/249 (35%), Gaps = 59/249 (23%)
Query: 41 DCFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH 95
+ + +I G VYKA SG + +K ++ +
Sbjct: 9 SRYEPVAEI-----GVGAYGTVYKA-RDPHSGHFVALKS-----------VRVPNGGGGG 51
Query: 96 KMIQIQS--EIIT---AGQVRHRNIVPLLARVVRPDCDL-----LVYEFRRNGSLQDILY 145
+ I + E+ H N+V L+ D LV+E + L+ L
Sbjct: 52 GGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLD 110
Query: 146 DVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205
L + R GL++LH ++ I+HRD++P N+L+ ++++FG
Sbjct: 111 KAPP--PGLPAETIKDLMRQFLRGLDFLH-ANC--IVHRDLKPENILVTSGGTVKLADFG 165
Query: 206 LAKQIPNGRTRT----TTWSLAETVGYIAPE----CHQTVALSDKCDIYSFGVLLAVLMM 257
LA+ T T W Y APE + D++S G + A +
Sbjct: 166 LARIYSYQMALTPVVVTLW-------YRAPEVLLQSTYATPV----DMWSVGCIFAEMFR 214
Query: 258 GK--FPSDD 264
K F +
Sbjct: 215 RKPLFCGNS 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 67/354 (18%), Positives = 122/354 (34%), Gaps = 105/354 (29%)
Query: 29 IEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQ 88
+ + F + + L KI GEV+KA +G+ + +KKV+ +++E E
Sbjct: 5 YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKA-RHRKTGQKVALKKVL--MENEKEGFP- 60
Query: 89 DSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDV- 147
I EI ++H N+V L+ ++ + + +Y V
Sbjct: 61 ---------ITALREIKILQLLKHENVVNLI--------EICRTKASPYNRCKGSIYLVF 103
Query: 148 -----------SQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196
S + R+ + + +GL Y+H R +I+HRD++ ANVLI D
Sbjct: 104 DFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRD 160
Query: 197 MEARISEFGLAKQI-PNGRTRT--------TTWSLAETVGYIAPE-----CHQTVALSDK 242
++++FGLA+ ++ T W Y PE +
Sbjct: 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW-------YRPPELLLGERDYGPPI--- 210
Query: 243 CDIYSFGVLLAVLMMGK--FPSDD-------FFQ-----------------HTKEMSFVQ 276
D++ G ++A + + Q +++ V+
Sbjct: 211 -DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVK 269
Query: 277 WMRNVMTSENPSRTIDSK---LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327
+ + + D LI LLVL DP +R +S D
Sbjct: 270 GQKRKVKDRLKAYVRDPYALDLI------DKLLVL---------DPAQRIDSDD 308
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 2e-11
Identities = 58/252 (23%), Positives = 98/252 (38%), Gaps = 74/252 (29%)
Query: 41 DCFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSE---- 91
+ LEKI GE V+KA + ++ +K+ ++ D +
Sbjct: 2 QKYEKLEKI-----GEGTYGTVFKA-KNRETHEIVALKR-----------VRLDDDDEGV 44
Query: 92 PLHHKMIQIQS--EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ 149
P + EI +++H+NIV L + LV+EF + L+ +
Sbjct: 45 P-------SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNG 96
Query: 150 GRRELDWLARHRI---ARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
L + + GL + H S ++HRD++P N+LI+ + E +++ FGL
Sbjct: 97 D------LDPEIVKSFLFQLLKGLGFCH-SRN--VLHRDLKPQNLLINRNGELKLANFGL 147
Query: 207 AK--QIPNGRTRT----TTWSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVL 255
A+ IP R + T W Y P+ V K D++S G + A L
Sbjct: 148 ARAFGIPV-RCYSAEVVTLW-------YRPPD----VLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 256 MMGK---FPSDD 264
FP +D
Sbjct: 196 ANAGRPLFPGND 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 11/109 (10%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I GL++LH I++RD++ N+L+D D +I++FG+ K+ N T + T
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGT 181
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
YIAPE + D +SFGVLL +++G+ F D +E+
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEEL 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 4/101 (3%)
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWS 221
+ +A G+E+L + IHRD+ N+L+ + +I +FGLA+ I
Sbjct: 198 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLL-AVLMMGKFP 261
+ ++APE + + D++SFGVLL + +G P
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-11
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I S LEYLH +++RDI+ N+++D D +I++FGL K+ + T T
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
Y+APE + D + GV++ +M G+ F + D
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 39/232 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS--EIITAGQVRH 112
VY+ P SG + + IK+ P ++ ++ E+ +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 113 RNIVPLLARVVRPDCDL-------LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARG 165
N++ LL V PD L LV F + L + + +L +
Sbjct: 84 ENVIGLL-DVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMK-HEKLGEDRIQFLVYQ 136
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR--TTTWSLA 223
+ GL Y+H + IIHRD++P N+ +++D E +I +FGLA+Q + T T W
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--- 190
Query: 224 ETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FPSDDFFQH 268
Y APE V L+ DI+S G ++A ++ GK F D
Sbjct: 191 ----YRAPE----VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
IA GL +L II+RD++ NV++D + +I++FG+ K+ T T T
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 184
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
YIAPE D ++FGVLL ++ G+ F +D
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 43/263 (16%), Positives = 83/263 (31%), Gaps = 90/263 (34%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKS---EAELIKQDSEPLHHKMIQIQSEIITAGQVR 111
G V + SG+ +KKV+Q + E +++K +
Sbjct: 21 GIVCEVFD-IESGKRFALKKVLQDPRYKNRELDIMKV---------------------LD 58
Query: 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR------------ 159
H NI+ L+ D + + + +
Sbjct: 59 HVNIIKLVD-YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 160 -------HRIARGIAS-------------------GLEYLHMSHRPRIIHRDIQPANVLI 193
H++ + + ++H S I HRDI+P N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLG--ICHRDIKPQNLLV 174
Query: 194 D-DDMEARISEFGLAKQIPNGRTRT----TTWSLAETVGYIAPE-----CHQTVALSDKC 243
+ D ++ +FG AK++ + + Y APE T ++
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-------YRAPELMLGATEYTPSI---- 223
Query: 244 DIYSFGVLLAVLMMGK--FPSDD 264
D++S G + L++GK F +
Sbjct: 224 DLWSIGCVFGELILGKPLFSGET 246
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
IA GL +L II+RD++ NV++D + +I++FG+ K+ T T T
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 505
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
YIAPE D ++FGVLL ++ G+ F +D
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 64/251 (25%), Positives = 101/251 (40%), Gaps = 69/251 (27%)
Query: 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102
+ S + S G V A + SG + IKK+ +P +S + K +
Sbjct: 26 YVSPTHVGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQS----------EIFAK--RAYR 72
Query: 103 EIITAGQVRHRNIVPLLARVVRPDCDL-------LVYEF---------RRNGSLQDILYD 146
E++ ++H N++ LL V P L LV F S + I Y
Sbjct: 73 ELLLLKHMQHENVIGLL-DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL 131
Query: 147 VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 206
V Q + GL+Y+H + ++HRD++P N+ +++D E +I +FGL
Sbjct: 132 VYQ----------------MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172
Query: 207 AKQIPNGRTR--TTTWSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK 259
A+ T T W Y APE V LS DI+S G ++A ++ GK
Sbjct: 173 ARHADAEMTGYVVTRW-------YRAPE----VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
Query: 260 --FPSDDFFQH 268
F D+
Sbjct: 222 TLFKGKDYLDQ 232
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-11
Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 37/176 (21%)
Query: 109 QVRHRNIVPLLARVVRPDCDL-------LVYEFRRNGSLQDILYDVSQGRRELDWLARHR 161
++H N++ LL V P L LV + L ++ + ++ D +
Sbjct: 84 HMKHENVIGLL-DVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQF- 136
Query: 162 IARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR--TTT 219
+ I GL+Y+H + IIHRD++P+N+ +++D E +I +FGLA+ + T T
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
Query: 220 WSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FPSDDFFQH 268
W Y APE + L+ DI+S G ++A L+ G+ FP D
Sbjct: 194 W-------YRAPE----IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 56/254 (22%), Positives = 96/254 (37%), Gaps = 75/254 (29%)
Query: 41 DCFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSE---- 91
D + + K+ GE VYKA + + IK+ I+ + E
Sbjct: 34 DRYRRITKL-----GEGTYGEVYKAI-DTVTNETVAIKR-----------IRLEHEEEGV 76
Query: 92 PLHHKMIQIQS--EIITAGQVRHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVS 148
P + E+ +++HRNI+ L V+ + L L++E+ ++ L
Sbjct: 77 P-------GTAIREVSLLKELQHRNIIELK-SVIHHNHRLHLIFEY-----AENDLKKYM 123
Query: 149 QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR-----ISE 203
++ + +G+ + H R +HRD++P N+L+ + I +
Sbjct: 124 DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 204 FGLA--KQIPNGRTRT----TTWSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLL 252
FGLA IP R T T W Y PE + L + DI+S +
Sbjct: 181 FGLARAFGIPI-RQFTHEIITLW-------YRPPE----ILLGSRHYSTSVDIWSIACIW 228
Query: 253 AVLMMGK--FPSDD 264
A ++M FP D
Sbjct: 229 AEMLMKTPLFPGDS 242
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I S L +LH II+RD++ NVL+D + ++++FG+ K+ T T T
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDD 264
YIAPE Q + D ++ GVLL ++ G F +++
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 47/236 (19%), Positives = 80/236 (33%), Gaps = 69/236 (29%)
Query: 65 SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS--EIITAGQVRHRNIVPLLARV 122
S G + IK+V + L + + EI H NI+ L +
Sbjct: 44 SEGIPVAIKRV-----FNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR-DI 97
Query: 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRREL---DWLARHRIARG-------------- 165
++ + Y V+ EL D ++
Sbjct: 98 FVHF---------EEPAMHKL-YLVT----ELMRTDL---AQVIHDQRIVISPQHIQYFM 140
Query: 166 --IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT----TT 219
I GL LH + ++HRD+ P N+L+ D+ + I +F LA++ +T
Sbjct: 141 YHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 220 WSLAETVGYIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FPSDDFFQH 268
W Y APE + + K D++S G ++A + K F F+
Sbjct: 198 W-------YRAPE----LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 40/188 (21%), Positives = 76/188 (40%), Gaps = 46/188 (24%)
Query: 109 QVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRREL---DWLARHRIARG 165
++ H NIV + ++ P L + L + Y V E D +
Sbjct: 64 RLDHDNIVKVFE-ILGPSGSQLTDDVGSLTELNSV-YIVQ----EYMETDL---ANVLEQ 114
Query: 166 --------------IASGLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQI 210
+ GL+Y+H ++ ++HRD++PAN+ I+ +D+ +I +FGLA+ +
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 211 PNGRTRTTTWSLAETVG---YIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--F 260
+ S E + Y +P + LS D+++ G + A ++ GK F
Sbjct: 172 DPHYSHKGHLS--EGLVTKWYRSPR----LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
Query: 261 PSDDFFQH 268
+
Sbjct: 226 AGAHELEQ 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I+ L YLH II+RD++ NVL+D + +++++G+ K+ T+T T
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 173
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
YIAPE + D ++ GVL+ +M G+ P
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
I+ L YLH II+RD++ NVL+D + +++++G+ K+ T+T T
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
YIAPE + D ++ GVL+ +M G+ P
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 19/110 (17%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVG- 227
GL+Y+H ++ ++HRD++P+N+L++ + +I +FGLA+ T + E V
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT--EYVAT 194
Query: 228 --YIAPECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FPSDDFFQH 268
Y APE + L+ K DI+S G +LA ++ + FP +
Sbjct: 195 RWYRAPE----IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 9e-09
Identities = 30/112 (26%), Positives = 58/112 (51%), Gaps = 22/112 (19%)
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETV-- 226
++ LH S+ +IHRD++P+N+LI+ + + ++ +FGLA+ I + + ++
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 227 GYI------APECHQTVALSDKC-----DIYSFGVLLAVLMMGK--FPSDDF 265
++ APE V L+ D++S G +LA L + + FP D+
Sbjct: 181 EFVATRWYRAPE----VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 39/173 (22%), Positives = 67/173 (38%), Gaps = 44/173 (25%)
Query: 112 HRNIVPLLA----RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRR---ELDWLARHRIAR 164
+IV ++ C L+V E G L + +G + E + A I +
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTERE--ASE-IMK 124
Query: 165 GIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWS 221
I ++YLH S I HRD++P N+L + ++++FG AK+
Sbjct: 125 SIGEAIQYLH-SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE-------- 173
Query: 222 LAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM 272
Y CD++S GV++ +L+ G F S+ + M
Sbjct: 174 -----KY-----------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 210
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 45/199 (22%), Positives = 77/199 (38%), Gaps = 69/199 (34%)
Query: 112 HRNIVPLLARVVRPDCDL---LVYEFR--------RNGSLQD-----ILYDVSQGRRELD 155
H NIV LL V+R D D LV+++ R L+ ++Y Q
Sbjct: 68 HENIVNLL-NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY---Q------ 117
Query: 156 WLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT 215
+ ++YLH ++HRD++P+N+L++ + ++++FGL++ N R
Sbjct: 118 ----------LIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 216 RTTTWSLAETVG-------------------YIAPECHQTVALSDKC-----DIYSFGVL 251
T L+ Y APE + L D++S G +
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPE----ILLGSTKYTKGIDMWSLGCI 220
Query: 252 LAVLMMGK--FPSDDFFQH 268
L ++ GK FP
Sbjct: 221 LGEILCGKPIFPGSSTMNQ 239
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 32/153 (20%), Positives = 57/153 (37%), Gaps = 43/153 (28%)
Query: 109 QVRHRNIVPLLARVVRPDC-----DL-LVYEF---------RRNGSLQD-----ILYDVS 148
+++ I+ L ++ PD +L +V E + L + ILY
Sbjct: 81 RLKSDYIIRLY-DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY--- 136
Query: 149 QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 208
+ G ++H S IIHRD++PAN L++ D ++ +FGLA+
Sbjct: 137 N----------------LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 209 QIPNGRTRTTTWSLAETVGYIAPECHQTVALSD 241
I + + L E + L+
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 29/120 (24%), Positives = 51/120 (42%), Gaps = 43/120 (35%)
Query: 111 RHRNIVPLLARVVRPDC-----DL-LVYEF---------RRNGSLQD-----ILYDVSQG 150
H ++V +L +V P +L +V E R L + +LY
Sbjct: 110 NHDHVVKVL-DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY---N- 164
Query: 151 RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI 210
+ G++Y+H S I+HRD++PAN L++ D ++ +FGLA+ +
Sbjct: 165 ---------------LLVGVKYVH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 4e-06
Identities = 30/209 (14%), Positives = 48/209 (22%), Gaps = 33/209 (15%)
Query: 30 EKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQD 89
+ + EKI GEV++ V IK + Q
Sbjct: 9 GPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADH--TPVA-IKIIAIEGPDLVNGSHQK 65
Query: 90 SEPLHHKMIQIQSEII---TAGQVRHRNIVPLLARVV----RPDCDLLVYEF--RRNGSL 140
+ I I E+ R + L + P L ++ GS
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 141 QDILYDVSQ-------------------GRRELDWLARHRIARGIASGLEYLHMSHRPRI 181
D + I + + L R
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRF 183
Query: 182 IHRDIQPANVLIDDDMEARISEFGLAKQI 210
HRD+ NVL+ ++ K
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 29/139 (20%), Positives = 60/139 (43%), Gaps = 20/139 (14%)
Query: 144 LYDVSQ--GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA-- 199
LYD+ + R + + A+ + + L +L + IIH D++P N+L+ + +
Sbjct: 142 LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAI 200
Query: 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL----SDKCDIYSFGVLLAVL 255
+I +FG + Q+ + ++ Y +PE V L D++S G +L +
Sbjct: 201 KIVDFGSSCQLGQ-----RIYQYIQSRFYRSPE----VLLGMPYDLAIDMWSLGCILVEM 251
Query: 256 MMGK--FPSDDFFQHTKEM 272
G+ F + ++
Sbjct: 252 HTGEPLFSGANEVDQMNKI 270
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 25/130 (19%), Positives = 57/130 (43%), Gaps = 12/130 (9%)
Query: 139 SLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198
SLQ L + L + ++A + LE+LH + +H ++ N+ +D + +
Sbjct: 143 SLQSALDV--SPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQ 197
Query: 199 ARI--SEFGLAKQ-IPNGR----TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVL 251
+++ + +G A + P+G+ + + +I+ + H+ S + D+ S G
Sbjct: 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYC 257
Query: 252 LAVLMMGKFP 261
+ + G P
Sbjct: 258 MLKWLYGFLP 267
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 34/124 (27%), Positives = 57/124 (45%), Gaps = 23/124 (18%)
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD------DMEARISEFGLAKQIPNG 213
+I++ + GL+Y+H IIH DI+P NVL++ ++ +I++ G A
Sbjct: 134 KQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 214 RTRTTTWSLAETVGYIAPECHQTVAL----SDKCDIYSFGVLLAVLMMGK--FPSDDFFQ 267
T + +T Y +PE V L DI+S L+ L+ G F D+
Sbjct: 192 YT-----NSIQTREYRSPE----VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242
Query: 268 HTKE 271
+TK+
Sbjct: 243 YTKD 246
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 31/109 (28%), Positives = 50/109 (45%), Gaps = 11/109 (10%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKQIPNGRTRT 217
+A + S +EY+H + IHRD++P N L+ + I +FGLAK+ + RT
Sbjct: 109 LLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 218 -----TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
+L T Y + H + S + D+ S G +L +G P
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 23/108 (21%), Positives = 48/108 (44%), Gaps = 10/108 (9%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI--SEFGLAKQIPNGRTRT- 217
++ + LEY+H + +H DI+ AN+L+ ++ +++GL+ +
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 218 ----TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
T+ + + + H+ VALS + D+ G + + GK P
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 33/127 (25%), Positives = 50/127 (39%), Gaps = 32/127 (25%)
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI--DDDMEARISEFGLAKQIPNGRTRT 217
+ A I L+ LH + RIIH D++P N+L+ ++ +FG + +
Sbjct: 203 RKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVY 257
Query: 218 TTWSLAETVGYI------APECHQTVAL----SDKCDIYSFGVLLAVLMMGK--FPSDDF 265
T YI APE V L D++S G +LA L+ G P +D
Sbjct: 258 T---------YIQSRFYRAPE----VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304
Query: 266 FQHTKEM 272
M
Sbjct: 305 GDQLACM 311
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 22/111 (19%), Positives = 46/111 (41%), Gaps = 13/111 (11%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR-----ISEFGLAKQIPNGRT 215
A+ + + ++ +H +++RDI+P N LI + +FG+ K + T
Sbjct: 110 MAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 216 RT-----TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
+ +L+ T Y++ H S + D+ + G + + G P
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 22/108 (20%), Positives = 45/108 (41%), Gaps = 10/108 (9%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI--SEFGLAKQIPNGRTRT- 217
+++ I LEY+H +H DI+ +N+L++ ++ ++GLA +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 218 ----TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
T+ + + + H VA S + D+ G + + G P
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 13/94 (13%), Positives = 26/94 (27%), Gaps = 4/94 (4%)
Query: 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH--- 174
L R+ + R L ++ G + R + + +H
Sbjct: 128 FLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187
Query: 175 -MSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207
S + H D N++ D+ + G
Sbjct: 188 PFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 11/109 (10%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR---ISEFGLAKQIPNGRTRT 217
+A + + +E++H +HRDI+P N L+ A I +FGLAK+ + T
Sbjct: 107 MLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 218 -----TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
+L T Y + H + S + D+ S G +L + G P
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 29/111 (26%), Positives = 48/111 (43%), Gaps = 13/111 (11%)
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR-----ISEFGLAKQIPNGRT 215
IA + S +EY+H + +I+RD++P N LI I +F LAK+ + T
Sbjct: 109 MIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 216 RT-----TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261
+ SL T Y++ H S + D+ + G + + G P
Sbjct: 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 5e-04
Identities = 31/181 (17%), Positives = 57/181 (31%), Gaps = 59/181 (32%)
Query: 130 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189
+V+E + L + + L + +I + + GL+YLH + RIIH DI+P
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPLPCV--KKIIQQVLQGLDYLH--TKCRIIHTDIKPE 176
Query: 190 NVLI-------------------------------------------------DDDMEAR 200
N+L+ + ++ +
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKF 260
I++ G A + T T Y + E + DI+S + L G +
Sbjct: 237 IADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
Query: 261 P 261
Sbjct: 292 L 292
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 30/135 (22%), Positives = 44/135 (32%), Gaps = 33/135 (24%)
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTT 219
I L YL + + H D++P N+L+DD + T
Sbjct: 140 KLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 220 WSLA-------------ETVGYI-------APECHQTVAL----SDKCDIYSFGVLLAVL 255
S + G I APE V L D++SFG +LA L
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQYRAPE----VILNLGWDVSSDMWSFGCVLAEL 252
Query: 256 MMGK--FPSDDFFQH 268
G F + + +H
Sbjct: 253 YTGSLLFRTHEHMEH 267
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 7e-04
Identities = 45/367 (12%), Positives = 104/367 (28%), Gaps = 91/367 (24%)
Query: 35 AFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAE---------L 85
AF+ DC + +S + E + S V ++ L S+ E +
Sbjct: 28 AFVDNFDCKDVQDMPKSILSKEEID-HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV 86
Query: 86 IKQD----SEPLHHKMIQIQSEIITAGQVRHR--NIVPLLAR--VVRPDCDL----LVYE 133
++ + P+ + Q + R R N + A+ V R L + E
Sbjct: 87 LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE 146
Query: 134 FRRNGSLQDILY------------DVSQGRRELD-------WL--ARHRIARGIASGLEY 172
R ++ ++ DV + WL + L+
Sbjct: 147 LRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK 204
Query: 173 LHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPNGRTRTTTWSL--------A 223
L P R +N+ + ++A + +K N L A
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN--------CLLVLLNVQNA 256
Query: 224 ETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF---FQHTKEMS-FVQWMR 279
+ C + + + + F L+ D + S ++++
Sbjct: 257 KAWNAFNLSC-KILLTTRFKQVTDF---LSAATTTHISLDHHSMTLTPDEVKSLLLKYL- 311
Query: 280 NVMTSENPSRTIDS-----KLIG----------NGYE----EQMLLVLKIACFCTFDDPE 320
+ + P + + +I + ++ +++ +++ + + E
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE-SSLNVLEPAE 370
Query: 321 ERPNSKD 327
R
Sbjct: 371 YRKMFDR 377
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 337 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.1 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.9 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.84 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.68 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.62 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.19 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.93 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.67 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.58 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.46 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.05 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.91 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.74 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 82.83 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.09 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.35 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=396.74 Aligned_cols=263 Identities=20% Similarity=0.308 Sum_probs=212.3
Q ss_pred cCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.++|.+.+.||+|+||+||+|++.. .++..||||++..... ...+.|.+|+.++++++||||
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--------------~~~~~f~~E~~il~~l~HpnI 77 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--------------NARKDFHREAELLTNLQHEHI 77 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH--------------HHHHHHHHHHHHHTTCCCTTB
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--------------HHHHHHHHHHHHHHhCCCCCC
Confidence 4678999999999999999998642 3578899999854321 125679999999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhh---------cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVS---------QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDI 186 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di 186 (337)
+++++++.+++..++|||||++|+|.+++.... .....+++..+..++.||+.||.|||+++ ++||||
T Consensus 78 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDl 154 (299)
T 4asz_A 78 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDL 154 (299)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCcc
Confidence 999999999999999999999999999997532 23456999999999999999999999665 999999
Q ss_pred CCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCc
Q 036970 187 QPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDF 265 (337)
Q Consensus 187 ~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~ 265 (337)
||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 155 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 155 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999987654444333334568999999999999999999999999999999998 89999764
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.. .+.+..+.....+.. +..++..+.+|+.+||+.||++|||+.+|.+.|+++.
T Consensus 235 ~~-------~~~~~~i~~~~~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 235 SN-------NEVIECITQGRVLQR----------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp CH-------HHHHHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CH-------HHHHHHHHcCCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22 223333333322211 1122344889999999999999999999999998763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-57 Score=401.44 Aligned_cols=256 Identities=18% Similarity=0.230 Sum_probs=205.9
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
+..++|++++.||+|+||+||+|++. .+|+.||||++........ ..+.+.+|+.++++|+||||++
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIV~ 87 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMSSK------------EREESRREVAVLANMKHPNIVQ 87 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEET-TTCCEEEEEEEECTTSCHH------------HHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccceEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHCCHH------------HHHHHHHHHHHHHHCCCCCCCc
Confidence 45689999999999999999999865 4899999999965433221 2567899999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+++..|+|||||++|+|.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g 162 (350)
T 4b9d_A 88 YRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDG 162 (350)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTC
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCC
Confidence 99999999999999999999999999964 34456899999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.. ..+.
T Consensus 163 ~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~ 233 (350)
T 4b9d_A 163 TVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNL 233 (350)
T ss_dssp CEEECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHH
T ss_pred CEEEcccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHH
Confidence 999999999987643221 1224579999999999999999999999999999999999999997532 2333
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+..+.....+.. +...+..+.+||.+||++||++|||+.++++
T Consensus 234 ~~~i~~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 234 VLKIISGSFPPV----------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHTCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCCCC----------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 444444332211 1112344889999999999999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-56 Score=389.71 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=202.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..+++.+.++||+|+||+||+|++. ..||||++...... .+..+.|.+|+.++++++||||+++
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~------------~~~~~~f~~E~~il~~l~HpNIV~l 97 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPT------------PEQFQAFRNEVAVLRKTRHVNILLF 97 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCC------------HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCC------------HHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3578889999999999999999853 35899988433221 1225689999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+ +..++|||||++|+|.+++.. ....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.
T Consensus 98 ~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~ 170 (307)
T 3omv_A 98 MGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLT 170 (307)
T ss_dssp EEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEE
T ss_pred EEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCc
Confidence 998865 568999999999999999953 3456999999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC---CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV---ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+||+|||+++...............||+.|||||++.+. .|+.++|||||||++|||++|..||.+... .
T Consensus 171 ~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-------~ 243 (307)
T 3omv_A 171 VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-------R 243 (307)
T ss_dssp EEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------H
T ss_pred EEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-------H
Confidence 999999999876544333333356899999999998643 589999999999999999999999975322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhhC
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~~ 337 (337)
..+......+.....+. ..+..++..+.+++.+||+.||++|||+.+|++.|+.|+|
T Consensus 244 ~~~~~~~~~~~~~p~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 244 DQIIFMVGRGYASPDLS-----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHHHHTTCCCCCST-----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCCCCCCcc-----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111222211111000 1112233458899999999999999999999999998875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-57 Score=396.57 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=211.7
Q ss_pred ccCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..+++++.++||+|+||+||+|++. ..+++.||||++..... ....+.|.+|+.++.+++|||
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-------------~~~~~~f~~E~~il~~l~HpN 90 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-------------GPLREEFRHEAMLRARLQHPN 90 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-------------C-CHHHHHHHHHHHHHCCCTT
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-------------hHHHHHHHHHHHHHHhCCCCC
Confidence 3467888999999999999999863 23678999999853321 112567999999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRPRII 182 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~ 182 (337)
|+++++++.+++..++|||||++|+|.+++..... ....+++..+..++.||+.||.|||+++ ++
T Consensus 91 IV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---ii 167 (308)
T 4gt4_A 91 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VV 167 (308)
T ss_dssp BCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred CCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CC
Confidence 99999999999999999999999999999965321 1246899999999999999999999665 99
Q ss_pred eCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCC
Q 036970 183 HRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFP 261 (337)
Q Consensus 183 h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~p 261 (337)
||||||+|||+++++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |..|
T Consensus 168 HRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~P 247 (308)
T 4gt4_A 168 HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247 (308)
T ss_dssp CSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654433333334678999999999999999999999999999999998 8999
Q ss_pred CCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 262 SDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
|.+... . +.+..+.....+.. ++.++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 248 f~~~~~----~---~~~~~i~~~~~~~~----------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 248 YCGYSN----Q---DVVEMIRNRQVLPC----------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TTTCCH----H---HHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCH----H---HHHHHHHcCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 976432 2 22223332222111 122334588999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=395.22 Aligned_cols=263 Identities=21% Similarity=0.290 Sum_probs=205.0
Q ss_pred cCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.++|.+.++||+|+||.||+|++.. .++..||||++..... ...+.|.+|+.+|++++||||
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--------------~~~~~f~~E~~il~~l~HpnI 105 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--------------SARQDFQREAELLTMLQHQHI 105 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH--------------HHHHHHHHHHHHHTTCCCTTB
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH--------------HHHHHHHHHHHHHHhCCCCCC
Confidence 4678888999999999999998642 3688999999854321 125679999999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhc-----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ-----------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~ 184 (337)
+++++++.+++..++|||||++|+|.++++.... ...++++..+..++.||+.||.|||+.+ ++||
T Consensus 106 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHR 182 (329)
T 4aoj_A 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHR 182 (329)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecc
Confidence 9999999999999999999999999999965432 2356999999999999999999999665 9999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCC
Q 036970 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSD 263 (337)
Q Consensus 185 di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~ 263 (337)
||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 183 DLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp CCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred cccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987655444433345678999999999999999999999999999999999 899997
Q ss_pred CcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 264 DFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
+... .+.+..+.....+.. +..++..+.+|+.+||+.||++|||+.+|++.|+.|.
T Consensus 263 ~~~~-------~~~~~~i~~g~~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 263 QLSN-------TEAIDCITQGRELER----------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp SSCH-------HHHHHHHHHTCCCCC----------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCH-------HHHHHHHHcCCCCCC----------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 5422 222333333222211 1112244889999999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-57 Score=393.34 Aligned_cols=254 Identities=20% Similarity=0.243 Sum_probs=210.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||+||+|++. .+|+.||||++.+...... .....+.+|+.++++++||||+++
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~-~~~~~~AiK~i~k~~~~~~-----------~~~~~~~~E~~il~~l~HpnIv~l 97 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKE-----------NKVPYVTRERDVMSRLDHPFFVKL 97 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CccccEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEEHHHCCCH-----------HHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3478999999999999999999866 4899999999965432111 115678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..|+|||||++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~ 170 (311)
T 4aw0_A 98 YFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMH 170 (311)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCC
Confidence 9999999999999999999999999954 356999999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+||+|||++..+............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+... .+..
T Consensus 171 vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~ 243 (311)
T 4aw0_A 171 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------GLIF 243 (311)
T ss_dssp EEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH
T ss_pred EEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHH
Confidence 999999999877544333333356899999999999999999999999999999999999999975322 2333
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
..+...... ++. ..+..+.+||.+||++||++|||++|++
T Consensus 244 ~~i~~~~~~---~p~--------~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 244 AKIIKLEYD---FPE--------KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHTCCC---CCT--------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHcCCCC---CCc--------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 333333221 111 1223488999999999999999999863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=394.82 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=206.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.+.|+++++||+|+||+||+|++. .+|+.||||++...... ..+.+.+|+.+|++++||||++++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIV~l~ 137 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQ--------------RRELLFNEVVIMRDYQHENVVEMY 137 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCS--------------SGGGGHHHHHHHHHCCCTTBCCEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEEC-CCCCEEEEEEEecCchh--------------HHHHHHHHHHHHHhCCCCCCCcEE
Confidence 467999999999999999999876 48999999998543211 134578899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..|||||||++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 138 ~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~v 209 (346)
T 4fih_A 138 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 209 (346)
T ss_dssp EEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCE
Confidence 999999999999999999999999843 35999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++..+....... ...+||+.|+|||++.+..|+.++|||||||++|||++|..||.+... .+.+.
T Consensus 210 Kl~DFGla~~~~~~~~~~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~ 280 (346)
T 4fih_A 210 KLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMK 280 (346)
T ss_dssp EECCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHH
T ss_pred EEecCcCceecCCCCCcc--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHH
Confidence 999999998765433222 246899999999999999999999999999999999999999975322 22222
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+.....+.. ..+...+..+.+||.+||++||++|||+.|+++
T Consensus 281 ~i~~~~~~~~--------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 281 MIRDNLPPRL--------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHSSCCCC--------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHcCCCCCC--------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2222222111 112223345889999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-56 Score=391.85 Aligned_cols=254 Identities=21% Similarity=0.247 Sum_probs=203.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..+.|++.++||+|+||.||+|++. .+|+.||||++.... ...+|+.+++.++||||+++
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~-~~g~~vAiK~i~~~~-------------------~~~~E~~il~~l~HpnIV~l 115 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDK-QTGFQCAVKKVRLEV-------------------FRVEELVACAGLSSPRIVPL 115 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT-------------------CCTHHHHTTTTCCCTTBCCE
T ss_pred chhheEeCcEeccCCCeEEEEEEEC-CCCCEEEEEEECHHH-------------------hHHHHHHHHHhCCCCCCCcE
Confidence 4567889999999999999999876 489999999985321 12369999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC-
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM- 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~- 197 (337)
++++.+++..|||||||++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~ 188 (336)
T 4g3f_A 116 YGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGS 188 (336)
T ss_dssp EEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCC
Confidence 9999999999999999999999999954 346999999999999999999999555 99999999999999887
Q ss_pred cEEEecccccccCCCCCcc---cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 198 EARISEFGLAKQIPNGRTR---TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
++||+|||++......... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+..... .
T Consensus 189 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~ 264 (336)
T 4g3f_A 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----L 264 (336)
T ss_dssp CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----C
T ss_pred EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----H
Confidence 6999999999876543221 12234579999999999999999999999999999999999999997643321 1
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
. ..+.....+...+ ++..+..+.++|.+||++||++|||+.|+++.|..
T Consensus 265 ~---~~i~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 265 C---LKIASEPPPIREI--------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp H---HHHHHSCCGGGGS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHHcCCCCchhc--------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1 1222222221111 12223458899999999999999999999887754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=378.29 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=191.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
-++|++++.||+|+||+||+|++. .+|+.||+|++.+...... .....+.+|+.++++++||||++++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~~~ 79 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHT-TTGQKVALKIINKKVLAKS-----------DMQGRIEREISYLRLLRHPHIIKLY 79 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECT-TTCCEEEEEEEECC-----------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEeHHHcCCH-----------HHHHHHHHHHHHHHHCCCCCCCeEE
Confidence 378999999999999999999865 4899999999965433221 1256789999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..|+||||| +|+|.+++.. .+.+++..+..++.||+.||+|||+++ ++||||||+||+++.++++
T Consensus 80 ~~~~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~v 151 (275)
T 3hyh_A 80 DVIKSKDEIIMVIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNV 151 (275)
T ss_dssp EEEECSSEEEEEEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCE
T ss_pred EEEEECCEEEEEEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCE
Confidence 9999999999999999 6799999843 456999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
||+|||+++........ ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. .....
T Consensus 152 kl~DFGla~~~~~~~~~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-------~~~~~ 221 (275)
T 3hyh_A 152 KIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-------IPVLF 221 (275)
T ss_dssp EECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHH
T ss_pred EEeecCCCeecCCCCcc---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHH
Confidence 99999999866443222 24589999999999998876 578999999999999999999997532 12333
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......... + ...+..+.+++.+||++||++|||+.|+++
T Consensus 222 ~~i~~~~~~~---p--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 222 KNISNGVYTL---P--------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHHTCCCC---C--------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCC---C--------CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3333322211 1 111234889999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=376.66 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=199.3
Q ss_pred cCcc-cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 40 EDCF-ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 40 ~~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
.++| ++.++||+|+||+||+|++. .++..||+|++........ ..+.+.+|+.++++++||||+++
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIV~~ 90 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKS------------ERQRFKEEAEMLKGLQHPNIVRF 90 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHH------------HHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCceEEeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHH------------HHHHHHHHHHHHHhCCCCCCCcE
Confidence 4555 67788999999999999876 4899999999865433221 25679999999999999999999
Q ss_pred hceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 119 LARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 119 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++.+ +...++|||||++|+|.+++.. .+.+++..+..++.||+.||.|||++ ..+|+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~ 165 (290)
T 3fpq_A 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFIT 165 (290)
T ss_dssp EEEEEEEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEES
T ss_pred EEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEE
Confidence 999875 3457999999999999999954 35689999999999999999999954 22499999999999998
Q ss_pred C-CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 195 D-DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
. ++.+||+|||+++....... ...+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+...
T Consensus 166 ~~~g~vKl~DFGla~~~~~~~~----~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------ 234 (290)
T 3fpq_A 166 GPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------ 234 (290)
T ss_dssp STTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------
T ss_pred CCCCCEEEEeCcCCEeCCCCcc----CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------
Confidence 4 78999999999976433222 24589999999999876 699999999999999999999999964321
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............. ...++. ... ..+.+||.+||++||++|||+.++++
T Consensus 235 ~~~~~~~i~~~~~-~~~~~~----~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 235 AAQIYRRVTSGVK-PASFDK----VAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHTTTCC-CGGGGG----CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCC-CCCCCc----cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222223322222 111111 112 24889999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-55 Score=396.31 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=206.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.+.|+++++||+|+||.||+|++. .+|+.||||++...... ..+.+.+|+.+|+.++||||++++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIV~l~ 214 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQ--------------RRELLFNEVVIMRDYQHENVVEMY 214 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEESTTCS--------------SGGGHHHHHHHHHHCCCTTBCCEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEEC-CCCCEEEEEEEeccchh--------------HHHHHHHHHHHHHhCCCCCCCceE
Confidence 467999999999999999999876 48999999998543211 134688999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++.+|||||||++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 215 ~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~v 286 (423)
T 4fie_A 215 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 286 (423)
T ss_dssp EEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCE
Confidence 999999999999999999999999843 35899999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++..+....... ...+||+.|||||++.+..|+.++|||||||++|||++|..||.+... .+.+.
T Consensus 287 Kl~DFGla~~~~~~~~~~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~ 357 (423)
T 4fie_A 287 KLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMK 357 (423)
T ss_dssp EECCCTTCEECCSSCCCB--CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHH
T ss_pred EEecCccceECCCCCccc--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHH
Confidence 999999998765433222 246899999999999999999999999999999999999999975322 22222
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+.....+... .+...+..+.+||.+||++||++|||+.|+++
T Consensus 358 ~i~~~~~~~~~--------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 358 MIRDNLPPRLK--------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHSCCCCCS--------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHcCCCCCCc--------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23322221111 11122345889999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=382.73 Aligned_cols=252 Identities=20% Similarity=0.270 Sum_probs=197.9
Q ss_pred cCcccccccccccccceEEeeeec--CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.++|++++.||+|+||+||+|++. ..+++.||+|++.+....... ...+.+|+.++++++||||++
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~------------~~~~~~E~~il~~l~HpnIv~ 90 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------------RVRTKMERDILVEVNHPFIVK 90 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE------------CC------CCCCCCCCTTEEC
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH------------HHHHHHHHHHHHHCCCCCCCe
Confidence 478999999999999999999863 236789999998654332111 235778999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+++..|+|||||++|+|.+++.. .+.+++..+..++.||+.||.|||+++ ++||||||+|||++.++
T Consensus 91 l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g 163 (304)
T 3ubd_A 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEG 163 (304)
T ss_dssp EEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTS
T ss_pred EEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCC
Confidence 99999999999999999999999999954 356999999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.+||+|||+++........ ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+... .+.
T Consensus 164 ~vKl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~ 234 (304)
T 3ubd_A 164 HIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KET 234 (304)
T ss_dssp CEEEESSEEEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred CEEecccccceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HHH
Confidence 9999999999865433222 1246899999999999999999999999999999999999999975422 233
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS-----KDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~il~ 330 (337)
...+....... + ...+..+.+||.+||++||++|||+ +|+++
T Consensus 235 ~~~i~~~~~~~---p--------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 235 MTMILKAKLGM---P--------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHCCCCC---C--------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHcCCCCC---C--------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 33333322211 1 1122348899999999999999985 56653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=381.90 Aligned_cols=265 Identities=21% Similarity=0.293 Sum_probs=211.3
Q ss_pred ccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC-C
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH-R 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ 113 (337)
..++|++++.||+|+||.||+|++.. ..++.||||.+...... .....+.+|+.+|.+++| |
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-------------~~~~~~~~E~~il~~l~hhp 128 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------------SEHRALMSELKILIHIGHHL 128 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCCCT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh-------------HHHHHHHHHHHHHHHcCCCC
Confidence 45789999999999999999998643 24578999998543321 114578999999999965 8
Q ss_pred ChhhhhceeecC-CCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 036970 114 NIVPLLARVVRP-DCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRPR 180 (337)
Q Consensus 114 ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 180 (337)
||++++++|.+. ...++|||||++|+|.++++.... ....+++..+..++.||+.||.|||+++
T Consensus 129 nIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--- 205 (353)
T 4ase_A 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--- 205 (353)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred cEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---
Confidence 999999998764 568999999999999999976432 1345899999999999999999999666
Q ss_pred ceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CC
Q 036970 181 IIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GK 259 (337)
Q Consensus 181 ~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~ 259 (337)
++||||||+|||++.++.+||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |.
T Consensus 206 iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence 99999999999999999999999999987765444333335678999999999999999999999999999999998 89
Q ss_pred CCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 260 FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 260 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.||.+... ...+...+.. ...+.. ++..+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 286 ~Pf~~~~~---~~~~~~~i~~---g~~~~~----------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 286 SPYPGVKI---DEEFCRRLKE---GTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CSSTTCCC---SHHHHHHHHH---TCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCH---HHHHHHHHHc---CCCCCC----------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 99976432 1222222222 211111 111223488999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=367.99 Aligned_cols=253 Identities=20% Similarity=0.280 Sum_probs=188.9
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||+||+|++. .+|+.||||++...... ...+.+.+|+.++++++||||+++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~-------------~~~~~~~~E~~il~~l~HpnIV~~~~ 70 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRE-------------LAREKVMREVKALAKLEHPGIVRYFN 70 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET-TTCCEEEEEEEEECSSH-------------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccCCH-------------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 46999999999999999999865 48999999998544321 11467899999999999999999999
Q ss_pred eeecCCC------------ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 036970 121 RVVRPDC------------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188 (337)
Q Consensus 121 ~~~~~~~------------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~ 188 (337)
++.+.+. .|+|||||++|+|.+++... ......++..++.++.||+.||+|||+++ ++||||||
T Consensus 71 ~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp 146 (299)
T 4g31_A 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKP 146 (299)
T ss_dssp EEEEEC----------CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred EEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcH
Confidence 9876543 58999999999999999542 12234566778899999999999999665 99999999
Q ss_pred CcEEecCCCcEEEecccccccCCCCCcc----------cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhC
Q 036970 189 ANVLIDDDMEARISEFGLAKQIPNGRTR----------TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMG 258 (337)
Q Consensus 189 ~nil~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g 258 (337)
+|||++.++.+||+|||+++........ ......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 147 ~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~- 225 (299)
T 4g31_A 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225 (299)
T ss_dssp GGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS-
T ss_pred HHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc-
Confidence 9999999999999999999876543221 11224579999999999999999999999999999999996
Q ss_pred CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
||.... +....+........+. .++.....+.++|.+||++||++|||+.++++
T Consensus 226 --Pf~~~~------~~~~~~~~~~~~~~p~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 --PFSTQM------ERVRTLTDVRNLKFPP----------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --CCSSHH------HHHHHHHHHHTTCCCH----------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCcc------HHHHHHHHHhcCCCCC----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 775321 1112222222111111 12233344678999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=371.42 Aligned_cols=269 Identities=22% Similarity=0.275 Sum_probs=202.2
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
.+|.+.+.||+|+||+||+|++ +|+.||||++...... ......|+..+.+++||||+++++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~~~---------------~~~~e~Ei~~~~~l~HpNIv~l~g 64 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREER---------------SWFREAEIYQTVMLRHENILGFIA 64 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGGHH---------------HHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccchh---------------hHHHHHHHHHHhcCCCCCCCcEEE
Confidence 4688889999999999999986 6899999998543211 223456788888899999999999
Q ss_pred eeecCC----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceeCCCCCCcE
Q 036970 121 RVVRPD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMS-----HRPRIIHRDIQPANV 191 (337)
Q Consensus 121 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-----~~~~~~h~di~~~ni 191 (337)
++.+++ ..++|||||++|+|.++++. ..+++..+.+++.|++.||.|||++ .+++++||||||+||
T Consensus 65 ~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NI 139 (303)
T 3hmm_A 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139 (303)
T ss_dssp EEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGE
T ss_pred EEEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccE
Confidence 998764 46899999999999999954 3589999999999999999999965 133699999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcc--cccccccCcccccCCccccCC------CCCCcccchhHhHHHHHHHhCCCCCC
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTR--TTTWSLAETVGYIAPECHQTV------ALSDKCDIYSFGVLLAVLMMGKFPSD 263 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~vl~~l~~g~~pf~ 263 (337)
|++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.
T Consensus 140 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred EECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 9999999999999999766433221 122245799999999998764 36778999999999999999988775
Q ss_pred Cccccc--------ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 264 DFFQHT--------KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 264 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
...... ................ ....++.. ....+....+.+|+.+||+.||++|||+.+|++.|++|
T Consensus 220 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~rp~~p~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQK-LRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-CCCCCCGG---GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccccchhcccccchHHHHHHHHhccc-CCCCCCcc---ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 322110 1112222222222221 11111111 11234566789999999999999999999999999987
Q ss_pred h
Q 036970 336 Q 336 (337)
Q Consensus 336 ~ 336 (337)
.
T Consensus 296 ~ 296 (303)
T 3hmm_A 296 S 296 (303)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=364.96 Aligned_cols=265 Identities=18% Similarity=0.262 Sum_probs=200.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|++. .+|+.||||++....... .....+.+|+.+|+.++||||++++
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~-~t~~~vAiK~i~~~~~~~------------~~~~~~~~Ei~il~~l~HpnIv~l~ 119 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRR-LTGQQVAIKKIPNAFDVV------------TNAKRTLRELKILKHFKHDNIIAIK 119 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEETTTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEECccccch------------HHHHHHHHHHHHHHhcCCCCcceEe
Confidence 368999999999999999999865 489999999985433221 1145788999999999999999999
Q ss_pred ceeec------CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 120 ARVVR------PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 120 ~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++.. .+..|+|||||+ |+|.+++ ...+.+++..+..++.||+.||.|||+++ ++||||||+||++
T Consensus 120 ~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~ 191 (398)
T 4b99_A 120 DILRPTVPYGEFKSVYVVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLV 191 (398)
T ss_dssp EECCCSSCTTTCCCEEEEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEE
T ss_pred eeeecccccccCCEEEEEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCcccccc
Confidence 98764 356799999995 6799998 45678999999999999999999999665 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCc--ccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 194 DDDMEARISEFGLAKQIPNGRT--RTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
+.++.+||+|||+++.+..... .......+||+.|+|||++.+. .++.++||||+||++|||++|.+||.+...
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--- 268 (398)
T 4b99_A 192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--- 268 (398)
T ss_dssp CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---
T ss_pred CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---
Confidence 9999999999999987643321 2223356899999999998875 468999999999999999999999975432
Q ss_pred cchHHHHHHHHhhcCCCCccccc--------------cccCCC----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDS--------------KLIGNG----YEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+....... +...... ...... .+.....+.+||.+||.+||++|||+.|+++
T Consensus 269 -~~~l~~I~~~~g~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 269 -VHQLQLIMMVLGTP-SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -HHHHHHHHHHHCCC-CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHHHHHHhcCCC-ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11222222211111 1000000 000000 0112345889999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=356.93 Aligned_cols=201 Identities=22% Similarity=0.335 Sum_probs=169.6
Q ss_pred hccCcccccccccccccceEEeeeec--CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCC
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRN 114 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 114 (337)
+..++|++.+.||+|+||+||+|+++ ..+++.||+|.+..... ..++.+|+.++..+ +|||
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----------------~~~~~~E~~~l~~~~~h~n 81 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----------------PIRIAAELQCLTVAGGQDN 81 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----------------HHHHHHHHHHHHHTCSBTT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----------------HHHHHHHHHHHHHhcCCCC
Confidence 35688999999999999999999864 23678999998854321 34678899999988 6999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
|+++++++.+.+..++||||+++++|.+++ +.+++..+..++.||+.||+|||+++ ++||||||+|||++
T Consensus 82 Iv~l~~~~~~~~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~ 151 (361)
T 4f9c_A 82 VMGVKYCFRKNDHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYN 151 (361)
T ss_dssp BCCCSEEEEETTEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred CceEEEEEEECCEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEe
Confidence 999999999999999999999999999998 24899999999999999999999665 99999999999998
Q ss_pred CC-CcEEEecccccccCCCCCcc--------------------------cccccccCcccccCCccccCC-CCCCcccch
Q 036970 195 DD-MEARISEFGLAKQIPNGRTR--------------------------TTTWSLAETVGYIAPECHQTV-ALSDKCDIY 246 (337)
Q Consensus 195 ~~-~~~kl~Dfg~~~~~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvw 246 (337)
.+ +.+||+|||+++........ ......+||+.|+|||++.+. .++.++|||
T Consensus 152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW 231 (361)
T 4f9c_A 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231 (361)
T ss_dssp TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence 76 79999999999765432111 111234799999999999876 489999999
Q ss_pred hHhHHHHHHHhCCCCCCC
Q 036970 247 SFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 247 slG~vl~~l~~g~~pf~~ 264 (337)
|+||++|+|++|..||..
T Consensus 232 SlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 232 SAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHHHHTCSSSSC
T ss_pred hhHHHHHHHHHCCCCCCC
Confidence 999999999999999954
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=373.34 Aligned_cols=255 Identities=22% Similarity=0.228 Sum_probs=202.1
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||.||+|++. .+|+.||+|++.+....... ..........++.++..++||||++++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~-~tg~~~AiK~i~K~~i~~~~--------~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTT--------CHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEeHHHcchhh--------hHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 488999999999999999999976 58999999999654332111 001122233457788889999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
++|.+.+.+|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.+|++
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~v 331 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV 331 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCE
Confidence 999999999999999999999999954 35699999999999999999999955 49999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
||+|||++........ ...+||+.|+|||++.. ..|+.++|+|||||++|||++|..||.+.... ...+..
T Consensus 332 KL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~----~~~~i~ 403 (689)
T 3v5w_A 332 RISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEID 403 (689)
T ss_dssp EECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC----CHHHHH
T ss_pred EecccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHH
Confidence 9999999987654432 24689999999999964 57999999999999999999999999753321 122333
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVR 329 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il 329 (337)
.......... +...+..+.+||.+||++||++|++ +++|+
T Consensus 404 ~~i~~~~~~~-----------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 404 RMTLTMAVEL-----------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp HHHHHCCCCC-----------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred HhhcCCCCCC-----------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 3333322211 1112344889999999999999998 57765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=372.30 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=207.7
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||.||+|+++ .+|+.||+|++....... .+.+.+|+.+|+.++||||++++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~-~tg~~~AiK~i~~~~~~~--------------~~~~~~Ei~il~~l~hpnIv~l~ 220 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESD--------------KETVRKEIQTMSVLRHPTLVNLH 220 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHH--------------HHHHHHHHHHHHHTCCTTBCCEE
T ss_pred ccccEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEeccchhh--------------HHHHHHHHHHHHhCCCCCCCeEE
Confidence 368999999999999999999876 489999999986543221 45688999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC--C
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD--M 197 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~--~ 197 (337)
+++.++...++|||||++|+|.+++. .....+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +
T Consensus 221 ~~~~~~~~~~iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~ 294 (573)
T 3uto_A 221 DAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSN 294 (573)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCC
T ss_pred EEEEECCEEEEEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCC
Confidence 99999999999999999999999983 23456999999999999999999999665 9999999999999854 8
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.+||+|||++..+....... ..+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+... .+.
T Consensus 295 ~vKl~DFG~a~~~~~~~~~~---~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-------~~~ 364 (573)
T 3uto_A 295 ELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DET 364 (573)
T ss_dssp CEEECCCSSCEECCTTSEEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHH
T ss_pred CEEEeeccceeEccCCCcee---eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHH
Confidence 99999999998876543332 35799999999999999999999999999999999999999975432 222
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+..+....... +. ..+...+..+.+||.+||+.||.+|||+.|+++
T Consensus 365 ~~~i~~~~~~~---~~----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 365 LRNVKSCDWNM---DD----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHHTTCCCC---CS----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCC---Cc----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33333222111 11 111222345889999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=341.25 Aligned_cols=277 Identities=26% Similarity=0.416 Sum_probs=229.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. +|+.||+|....... ...+.+.+|+.+++.++||||+++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~~ 100 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESS--------------QGIEEFETEIETLSFCRHPHLVSL 100 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCS--------------SHHHHHHHHHHGGGSCCCTTBCCE
T ss_pred HHhccCccceeecCCCeeEEEEEEC--CCCEEEEEEecccCh--------------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence 6799999999999999999999864 799999998754321 125678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~ 177 (321)
T 2qkw_B 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177 (321)
T ss_dssp EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCC
T ss_pred EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCC
Confidence 99999999999999999999999998543333446899999999999999999999655 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++|..||...... .......+.
T Consensus 178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~ 256 (321)
T 2qkw_B 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWA 256 (321)
T ss_dssp EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-SCCCHHHHT
T ss_pred EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-HHHHHHHHh
Confidence 9999999997654333322223446799999999998889999999999999999999999999764432 223344444
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
............+++.......+.....+.+++.+||+.||++|||+.++++.|+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 444444555555666665566778888999999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=343.92 Aligned_cols=286 Identities=32% Similarity=0.538 Sum_probs=235.6
Q ss_pred hhhhhh-ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC
Q 036970 33 DLAFLK-KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111 (337)
Q Consensus 33 ~~~~l~-~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 111 (337)
....+. ..++|++.+.||+|+||.||+|++. +|+.||+|++....... ....+.+|+.+++.++
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~ 85 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQG-------------GELQFQTEVEMISMAV 85 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC------------------CCCHHHHHHHGGGTCC
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCch-------------HHHHHHHHHHHHHhcc
Confidence 333445 7899999999999999999999854 79999999985433211 0235889999999999
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
||||+++++++.+....++||||+++++|.+++........++++..++.++.|++.||.|||+....|++|+||||+||
T Consensus 86 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred CCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 99999999999999999999999999999999976555666799999999999999999999976222599999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcc-cccc
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFF-QHTK 270 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~-~~~~ 270 (337)
+++.++.++|+|||++.......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred EECCCCCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence 99999999999999998765433322 223468999999999988889999999999999999999999996321 2224
Q ss_pred cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
......+..............+..............+.+++.+||+.||.+|||+.++++.|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred chhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 4445566666555666666666666677788889999999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=328.24 Aligned_cols=260 Identities=21% Similarity=0.387 Sum_probs=210.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||+||+|++. .++..||+|.+..... .....+.+|+.++++++||||+++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~~~~--------------~~~~~~~~E~~~l~~l~hp~iv~~ 72 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDE--------------ETQRTFLKEVKVMRCLEHPNVLKF 72 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEESCCCH--------------HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ChhHeeccceecCCCCEEEEEEEEC-CCCcEEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCcCcccE
Confidence 4689999999999999999999865 4899999998844221 125678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~ 146 (310)
T 3s95_A 73 IGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKN 146 (310)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSC
T ss_pred EEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCC
Confidence 9999999999999999999999999954 3456899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCccc------------ccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 199 ARISEFGLAKQIPNGRTRT------------TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
+||+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 147 VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp EEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred EEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 9999999998764432211 1114578999999999999999999999999999999999999987643
Q ss_pred cccc--cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 267 QHTK--EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 267 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.... ............... + ...+.+++.+||+.||++|||+.++++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-----~------------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 227 PRTMDFGLNVRGFLDRYCPPN-----C------------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp CBCTTSSBCHHHHHHHTCCTT-----C------------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhhhccccccCCCC-----C------------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3221 112222222111111 1 122889999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=334.82 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=205.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|++........ ....+.+|+.+++.++||||+++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~hpnIv~l 79 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQLNPT------------SLQKLFREVRIMKILNHPNIVKL 79 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHH------------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhcCCHH------------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 3578999999999999999999865 4899999999865433211 15578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+.+..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~ 152 (328)
T 3fe3_A 80 FEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMN 152 (328)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCC
Confidence 9999999999999999999999999854 345899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALS-DKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++......... ....||+.|+|||++.+..++ .++||||||+++|+|++|..||.+... .+.
T Consensus 153 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~ 222 (328)
T 3fe3_A 153 IKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KEL 222 (328)
T ss_dssp EEECSTTCCGGGSSSCGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred EEEeeccCceecCCCCcc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHH
Confidence 999999999766543322 245789999999999988775 689999999999999999999975422 222
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............ ......+.+++.+||+.||.+|||+.++++
T Consensus 223 ~~~i~~~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 223 RERVLRGKYRIP-----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHHCCCCCC-----------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHHhCCCCCC-----------CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 333333222111 112234889999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=335.83 Aligned_cols=277 Identities=25% Similarity=0.320 Sum_probs=212.1
Q ss_pred hhhhhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC
Q 036970 33 DLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112 (337)
Q Consensus 33 ~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 112 (337)
..++.-..++|++.+.||+|+||+||+|++ .++.||+|++...... ......|+.++++++|
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h 77 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPIQDKQ---------------SWQNEYEVYSLPGMKH 77 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEE---TTEEEEEEEECGGGHH---------------HHHHHHHHHTSTTCCC
T ss_pred ccccccchhhchhhheecccCceEEEEEEE---CCCEEEEEEeecCchH---------------HHHHHHHHHHHhcCCC
Confidence 344444678999999999999999999986 4899999998543211 3455669999999999
Q ss_pred CChhhhhceeecCCC----ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC-------CCCCc
Q 036970 113 RNIVPLLARVVRPDC----DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMS-------HRPRI 181 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-------~~~~~ 181 (337)
|||+++++++.+... .++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. .+.++
T Consensus 78 pniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~i 152 (322)
T 3soc_A 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152 (322)
T ss_dssp TTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEE
T ss_pred CCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCE
Confidence 999999999988654 5999999999999999944 3489999999999999999999955 00159
Q ss_pred eeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-----CCCCcccchhHhHHHHHHH
Q 036970 182 IHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-----ALSDKCDIYSFGVLLAVLM 256 (337)
Q Consensus 182 ~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~vl~~l~ 256 (337)
+|+||||+||+++.++.+||+|||++................||+.|+|||++.+. .++.++||||||+++|+|+
T Consensus 153 vH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~ 232 (322)
T 3soc_A 153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232 (322)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHH
Confidence 99999999999999999999999999876554443333345789999999998873 4566889999999999999
Q ss_pred hCCCCCCCcccccc---------cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 036970 257 MGKFPSDDFFQHTK---------EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327 (337)
Q Consensus 257 ~g~~pf~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 327 (337)
+|..||.+...... .............. .....+.... ........+.+++.+||+.||++|||+.+
T Consensus 233 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (322)
T 3soc_A 233 SRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK-KKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGC 308 (322)
T ss_dssp TTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS-CCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcc-cCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHH
Confidence 99999976432111 11222222222211 1111111111 12234566999999999999999999999
Q ss_pred HHHHHhhhh
Q 036970 328 VRCMLSQIQ 336 (337)
Q Consensus 328 il~~L~~~~ 336 (337)
+++.|++|+
T Consensus 309 ll~~L~~l~ 317 (322)
T 3soc_A 309 VGERITQMQ 317 (322)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999886
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=328.92 Aligned_cols=261 Identities=26% Similarity=0.346 Sum_probs=200.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||+||+|++ +|+.||+|++....... .....+.+|+.++++++||||+++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~~ 99 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHA------------ERVNEFLREVAIMKRLRHPNIVLF 99 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSH------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCH------------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence 468999999999999999999985 68899999985543221 125678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCcEEecCC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPR--IIHRDIQPANVLIDDD 196 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--~~h~di~~~nil~~~~ 196 (337)
++++.+....++||||+++++|.+++.... ....+++..++.++.|++.||.||| +.| ++|+||||+||+++.+
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~ 175 (309)
T 3p86_A 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKK 175 (309)
T ss_dssp EEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTT
T ss_pred EEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCC
Confidence 999999999999999999999999995421 1234899999999999999999999 666 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+
T Consensus 176 ~~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~ 246 (309)
T 3p86_A 176 YTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-------AQ 246 (309)
T ss_dssp CCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-------HH
T ss_pred CcEEECCCCCCccccccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH
Confidence 99999999998754433221 2235789999999999999999999999999999999999999975432 11
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
............ .+. ......+.+++.+||+.||.+|||+.++++.|+.+-
T Consensus 247 ~~~~~~~~~~~~-~~~--------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 247 VVAAVGFKCKRL-EIP--------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp HHHHHHHSCCCC-CCC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCC-CCC--------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111111111 011 112234889999999999999999999999998763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=327.87 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=205.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||+||+|++. .+|+.||+|++....... .+.+.+|+.+++.++||||+++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~hp~iv~~ 82 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPK--------------KELIINEILVMRENKNPNIVNY 82 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBT-TTCCEEEEEEEEGGGCSC--------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhceeeeeeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccH--------------HHHHHHHHHHHhcCCCCCCCeE
Confidence 5689999999999999999999854 489999999985432211 4568889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~ 154 (297)
T 3fxz_A 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGS 154 (297)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred eEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCC
Confidence 9999999999999999999999999854 35899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+||+|||++.......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ....
T Consensus 155 ~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~ 225 (297)
T 3fxz_A 155 VKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRAL 225 (297)
T ss_dssp EEECCCTTCEECCSTTCCB--CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHH
T ss_pred EEEeeCCCceecCCccccc--CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHH
Confidence 9999999987765433322 235789999999999999999999999999999999999999975322 1111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........+... .+......+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 226 YLIATNGTPELQ--------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHCSCCCS--------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHhCCCCCCC--------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111112211111 11223345889999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.65 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=211.4
Q ss_pred ccCcccccccccccccceEEeeeec------CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-C
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP------GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-R 111 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 111 (337)
..++|.+++.||+|+||.||+|++. ..++..||+|++...... .....+.+|+.+++.+ +
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 145 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-------------KDLSDLVSEMEMMKMIGK 145 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-------------HHHHHHHHHHHHHHHSCC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-------------HHHHHHHHHHHHHHHhcC
Confidence 4578999999999999999999863 135678999998543221 1256789999999999 8
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRP 179 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 179 (337)
||||+++++++.+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+
T Consensus 146 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 223 (370)
T 2psq_A 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-- 223 (370)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999999999999999999999999976432 1245899999999999999999999665
Q ss_pred CceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-C
Q 036970 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-G 258 (337)
Q Consensus 180 ~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g 258 (337)
++|+||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |
T Consensus 224 -ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g 302 (370)
T 2psq_A 224 -CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302 (370)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999987655433333334566889999999999999999999999999999999 9
Q ss_pred CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
..||.+... ......+.. ..... .+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 303 ~~p~~~~~~----~~~~~~~~~---~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 303 GSPYPGIPV----EELFKLLKE---GHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp CCSSTTCCG----GGHHHHHHT---TCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCH----HHHHHHHhc---CCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999875322 122222211 11111 0111233488999999999999999999999999886
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=325.39 Aligned_cols=264 Identities=23% Similarity=0.346 Sum_probs=206.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .++..||+|.+....... ......+.+|+.++++++||||+++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~hp~iv~~ 76 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIPPREK-----------EETLKRFEREVHNSSQLSHQNIVSM 76 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEET-TTCSEEEEEEEECCSSCC-----------HHHHHHHHHHHHHHTTCCBTTBCCE
T ss_pred hhccEEEEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccCcccc-----------HHHHHHHHHHHHHHhcCCCCCCceE
Confidence 3578999999999999999999865 489999999985433211 2225678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++||||+++++|.+++.. .+++++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 77 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~ 149 (294)
T 4eqm_A 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKT 149 (294)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSC
T ss_pred EEeeeeCCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 9999999999999999999999999954 346899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++........... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+... ....
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~ 221 (294)
T 4eqm_A 150 LKIFDFGIAKALSETSLTQT-NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-------VSIA 221 (294)
T ss_dssp EEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-------HHHH
T ss_pred EEEEeCCCcccccccccccc-CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHH
Confidence 99999999987654322221 235689999999999999999999999999999999999999975432 1111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-NSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~il~~L~~~ 335 (337)
........+.. .... ....+..+.+++.+||++||++|| ++.++.+.|.++
T Consensus 222 ~~~~~~~~~~~--~~~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 222 IKHIQDSVPNV--TTDV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHSSCCCCH--HHHS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHHhhccCCCc--chhc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 22222221111 0011 111224488999999999999998 999999998875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=327.08 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=204.1
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||.||+|++. .+|+.||+|++.+..... ......+.+|+.++..++||||++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~l~ 71 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIA-----------KDEVAHTVTESRVLQNTRHPFLTALK 71 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhh-----------hhHHHHHHHHHHHHHhCCCCcCcceE
Confidence 478999999999999999999865 489999999986532211 11156788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+.+..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 72 ~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~v 144 (337)
T 1o6l_A 72 YAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCE
Confidence 999999999999999999999999854 346899999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++......... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.+... .....
T Consensus 145 kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~ 215 (337)
T 1o6l_A 145 KITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFE 215 (337)
T ss_dssp EECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred EEeeccchhhcccCCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HHHHH
Confidence 99999999764332221 2245789999999999999999999999999999999999999965321 12222
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
......... + ......+.++|.+||+.||++|| ++.++++
T Consensus 216 ~i~~~~~~~---p--------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 216 LILMEEIRF---P--------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHCCCCC---C--------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHcCCCCC---C--------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 222222110 0 11223488999999999999999 8888864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=328.18 Aligned_cols=259 Identities=22% Similarity=0.271 Sum_probs=207.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|..||+|++........ ......+.+.+|+.+++.++||||+++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv~l 80 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRAS--------RRGVCREEIEREVSILRQVLHPNIITL 80 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTTC--------SSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEccccccc--------cchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence 4678999999999999999999876 4899999999865443211 000114678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC-
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM- 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~- 197 (337)
++++.+....++||||+++++|.+++ .....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~ 153 (361)
T 2yab_A 81 HDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNI 153 (361)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHH----TTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTS
T ss_pred EEEEEeCCEEEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCC
Confidence 99999999999999999999999999 44567999999999999999999999665 99999999999998776
Q ss_pred ---cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 198 ---EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 198 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 154 ~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------- 223 (361)
T 2yab_A 154 PIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------- 223 (361)
T ss_dssp SSCCEEECCCSSCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------
T ss_pred CccCEEEEecCCceEcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------
Confidence 7999999999876543222 235789999999999998999999999999999999999999975322
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+........... ++... +......+.++|.+||.+||++|||+.++++
T Consensus 224 ~~~~~~i~~~~~~---~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 224 QETLANITAVSYD---FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHTTCCC---CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCC---CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1222222222111 11111 1122345889999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=329.97 Aligned_cols=265 Identities=21% Similarity=0.322 Sum_probs=212.0
Q ss_pred ccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++++.||+|+||.||+|++.. .+++.||+|.+..... ......+.+|+.+++.++|||
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hp~ 111 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-------------ADMQADFQREAALMAEFDNPN 111 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-------------HHHHHHHHHHHHHHHTCCCTT
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 67999999999999999999999753 3568999999854322 112567899999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC--------------------CCcCCHHHHHHHHHHHHHHHHHHh
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG--------------------RRELDWLARHRIARGIASGLEYLH 174 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~l~~~~~~~~~~~i~~~l~~lh 174 (337)
|+++++++.+++..++||||+++++|.+++...... ...+++..++.++.||+.||.|||
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 191 (343)
T 1luf_A 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 191 (343)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999764221 257899999999999999999999
Q ss_pred cCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHH
Q 036970 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAV 254 (337)
Q Consensus 175 ~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~ 254 (337)
+.+ ++|+||||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+
T Consensus 192 ~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 268 (343)
T 1luf_A 192 ERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268 (343)
T ss_dssp HTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHH
Confidence 665 99999999999999999999999999976544333223334567889999999998899999999999999999
Q ss_pred HHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 255 LMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 255 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
|++ |..||.+... .+............ . +......+.+++.+||+.||++|||+.++++.|+
T Consensus 269 l~t~g~~p~~~~~~-------~~~~~~~~~~~~~~--~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 269 IFSYGLQPYYGMAH-------EEVIYYVRDGNILA--C--------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp HHTTTCCTTTTSCH-------HHHHHHHHTTCCCC--C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcCCCcCCCCCh-------HHHHHHHhCCCcCC--C--------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 999 9999875322 12222222222111 0 1112234889999999999999999999999999
Q ss_pred hhh
Q 036970 334 QIQ 336 (337)
Q Consensus 334 ~~~ 336 (337)
++.
T Consensus 332 ~~~ 334 (343)
T 1luf_A 332 RMC 334 (343)
T ss_dssp HTT
T ss_pred HHH
Confidence 874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=315.31 Aligned_cols=258 Identities=21% Similarity=0.309 Sum_probs=209.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. ++..||+|++...... ...+.+|+.++.+++||||+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~~ 68 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSMS---------------EDEFFQEAQTMMKLSHPKLVKF 68 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTTBC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred chhheeeeeeeccCCCceEEEEEec--CceeEEEEEeccCCCc---------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 4688999999999999999999876 6788999998543221 3468899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~ 142 (268)
T 3sxs_A 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLC 142 (268)
T ss_dssp EEEECSSSSEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCC
T ss_pred EEEEccCCceEEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCC
Confidence 99999999999999999999999999653 345899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++........... ....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 143 ~~l~Dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~ 214 (268)
T 3sxs_A 143 VKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-------SEV 214 (268)
T ss_dssp EEECCTTCEEECCTTCEEEC-CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHH
T ss_pred EEEccCccceecchhhhhcc-cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-------HHH
Confidence 99999999987654433222 23456778999999999889999999999999999999 9999875322 112
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhhC
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~~ 337 (337)
............ + ......+.+++.+||+.||++|||+.++++.|+.+++
T Consensus 215 ~~~~~~~~~~~~---~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 215 VLKVSQGHRLYR---P-------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHTTCCCCC---C-------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCCCCC---C-------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 222222211111 0 0112348899999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.67 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=208.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|++. .+++.||+|.+...... .....+.+|+.++++++||||+++
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~~ 177 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPP-------------DLKAKFLQEARILKQYSHPNIVRL 177 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTTSCH-------------HHHTTTTHHHHHHTTCCCTTBCCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEe-cCCeEEEEEEccccCCH-------------HHHHHHHHHHHHHHhCCCCCEEEE
Confidence 5678999999999999999999875 47899999998543211 113467889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 178 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~ 251 (377)
T 3cbl_A 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNV 251 (377)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEecCCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCc
Confidence 99999999999999999999999999642 345899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ....+.
T Consensus 252 ~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----~~~~~~ 327 (377)
T 3cbl_A 252 LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQTREF 327 (377)
T ss_dssp EEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----HHHHHH
T ss_pred EEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 99999999976544322222212234678999999998889999999999999999998 9999875422 112222
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
+ ........ +......+.+++.+||+.||++|||+.++++.|++++
T Consensus 328 ~---~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 328 V---EKGGRLPC----------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp H---HTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HcCCCCCC----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 2 11111110 1112234889999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=325.68 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=206.8
Q ss_pred ccCcccccccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|++.+.||+|+||.||+|++.. ..+..||||.+...... .....+.+|+.+++.++||||+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv 113 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-------------RQRRDFLSEASIMGQFDHPNII 113 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH-------------HHHHHHHHHHHHHTTCCCTTBC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH-------------HHHHHHHHHHHHHHhCCCCCCC
Confidence 46899999999999999999998752 23456999998543221 1256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 114 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 187 (325)
T 3kul_A 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSN 187 (325)
T ss_dssp CEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred cEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCC
Confidence 999999999999999999999999999853 3456999999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCc-ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchH
Q 036970 197 MEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~ 274 (337)
+.++|+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 188 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------- 260 (325)
T 3kul_A 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------- 260 (325)
T ss_dssp CCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------
T ss_pred CCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------
Confidence 9999999999987654322 112223345778999999998899999999999999999999 9999865322
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+............. +......+.+++..||+.||++|||+.++++.|+.+.
T Consensus 261 ~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 261 RDVISSVEEGYRLPA----------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp HHHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCC----------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 122222222211110 1112234889999999999999999999999998863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=320.45 Aligned_cols=273 Identities=19% Similarity=0.242 Sum_probs=212.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||+||+|++. .+|+.||+|++....... ....+.+|+.+++.++||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~~ 72 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLR-------------PVDVQMREFEVLKKLNHKNIVKL 72 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGS-------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEEC-CCCcEEEEEEeccccccc-------------hHHHHHHHHHHHHhcCCCCcceE
Confidence 3578999999999999999999876 479999999985432211 14567899999999999999999
Q ss_pred hceeecCC--CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe---
Q 036970 119 LARVVRPD--CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI--- 193 (337)
Q Consensus 119 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~--- 193 (337)
++++.... ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 148 (319)
T 4euu_A 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148 (319)
T ss_dssp EEEEECTTTCCEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEEC
T ss_pred EEEeecCCCceEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEecc
Confidence 99988765 66899999999999999965322 234899999999999999999999665 9999999999999
Q ss_pred -cCCCcEEEecccccccCCCCCcccccccccCcccccCCcccc--------CCCCCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 194 -DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ--------TVALSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 194 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
+.++.+||+|||++.......... ...||+.|+|||++. +..++.++||||||+++|+|++|..||..
T Consensus 149 ~~~~~~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 149 EDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp TTSCEEEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCCceEEEccCCCceecCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 777789999999998765443322 346899999999986 46789999999999999999999999975
Q ss_pred cccccccchHHHHHHHHhhcCCCCccc--------------cccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTI--------------DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........ +.+.......+....- ...............+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 226 FEGPRRNK---EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp TTCGGGCH---HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCccchhH---HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 44322222 2233333222211000 001112334566778999999999999999999999999
Q ss_pred HHhhh
Q 036970 331 MLSQI 335 (337)
Q Consensus 331 ~L~~~ 335 (337)
-.++-
T Consensus 303 h~~d~ 307 (319)
T 4euu_A 303 ETSDI 307 (319)
T ss_dssp HHHHH
T ss_pred ccHHH
Confidence 87754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=317.18 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=209.5
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
-..++|++.+.||+|+||.||+|++. ++..||+|++...... .+.+.+|+.++++++||||++
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~ 69 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQ 69 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTSBC---------------HHHHHHHHHHHHTCCCTTBCC
T ss_pred eChhhceeeheecCCCccEEEEEEec--CCCeEEEEEecccccC---------------HHHHHHHHHHHHhCCCCCEee
Confidence 35689999999999999999999876 6888999998543321 346889999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.++...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~ 143 (269)
T 4hcu_A 70 LYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQ 143 (269)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGG
T ss_pred EEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCC
Confidence 99999999999999999999999999853 3456899999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
.++|+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... .+
T Consensus 144 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------~~ 215 (269)
T 4hcu_A 144 VIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SE 215 (269)
T ss_dssp CEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH
T ss_pred CEEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------HH
Confidence 9999999999866443222 2223456778999999998899999999999999999999 9999875322 12
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
............. +......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 216 ~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 216 VVEDISTGFRLYK----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp HHHHHHTTCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCccCCC----------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 2222222111110 0111234889999999999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=336.04 Aligned_cols=256 Identities=17% Similarity=0.235 Sum_probs=204.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|.+. .+|+.||+|++........ ....+.+|+.+++.++||||+++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~-~~~~~~a~K~i~~~~~~~~------------~~~~~~~E~~il~~l~hpnIv~l 75 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLSAR------------DHQKLEREARICRLLKHPNIVRL 75 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEET-TTTEEEEEEEEESCSCHHH------------HHHHHHHHHHHHHHCCBTTBCCE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEEC-CCCcEEEEEEEEcccCCHH------------HHHHHHHHHHHHHhCCCcCCCeE
Confidence 4578999999999999999999865 4899999999865543222 14578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec---C
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID---D 195 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~---~ 195 (337)
++++.+++..++||||+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++ .
T Consensus 76 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~ 148 (444)
T 3soa_A 76 HDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLK 148 (444)
T ss_dssp EEEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSST
T ss_pred EEEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCC
Confidence 9999999999999999999999999843 456999999999999999999999665 99999999999998 4
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++.+||+|||++.......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .
T Consensus 149 ~~~vkL~DFG~a~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~ 219 (444)
T 3soa_A 149 GAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------H 219 (444)
T ss_dssp TCCEEECCCSSCBCCCTTCCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------H
T ss_pred CCcEEEccCceeEEecCCCcee--ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------H
Confidence 5789999999997765433221 235789999999999998999999999999999999999999965322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.............. . ..+......+.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~~i~~~~~~~~---~----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 220 RLYQQIKAGAYDFP---S----PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHHTCCCCC---T----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhCCCCCC---c----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22222222211110 0 111122344889999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=318.39 Aligned_cols=272 Identities=29% Similarity=0.455 Sum_probs=213.3
Q ss_pred ccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhcee
Q 036970 43 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARV 122 (337)
Q Consensus 43 ~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~ 122 (337)
|...+.||+|+||.||+|.+ +++.||+|++...... ........+.+|+.++++++||||+++++++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 99 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDI----------TTEELKQQFDQEIKVMAKCQHENLVELLGFS 99 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTS----------CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE---CCceEEEEEEecccCc----------chHHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 34449999999999999985 6889999998543211 1112256789999999999999999999999
Q ss_pred ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEe
Q 036970 123 VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
.+.+..+++|||+++++|.+++.... ...++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~ 175 (307)
T 2nru_A 100 SDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175 (307)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 99999999999999999999986532 3456899999999999999999999665 9999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHh
Q 036970 203 EFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVM 282 (337)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (337)
|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||.............. ...
T Consensus 176 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~ 251 (307)
T 2nru_A 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE---EIE 251 (307)
T ss_dssp CCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHH---HHH
T ss_pred ecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHH---Hhh
Confidence 9999887654433333334578999999998876 578999999999999999999999986543322222222 111
Q ss_pred hcCCC-CccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 283 TSENP-SRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 283 ~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
..... ...++. ............+.+++.+||+.||++|||+.++++.|+++.
T Consensus 252 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 252 DEEKTIEDYIDK-KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTSCCHHHHSCS-SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhhhhhhhccc-cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111 111111 123345667788999999999999999999999999999886
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=321.96 Aligned_cols=264 Identities=20% Similarity=0.301 Sum_probs=211.9
Q ss_pred ccCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|.+.+.||+|+||.||+|++. ..++..||+|++..... ......+.+|+.+++.++|||
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hp~ 87 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-------------PSELRDLLSEFNVLKQVNHPH 87 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-------------HHHHHHHHHHHHHHTTCCCTT
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-------------HHHHHHHHHHHHHHhhCCCCc
Confidence 5789999999999999999999863 23568899999854321 112567889999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc--------------------CCCcCCHHHHHHHHHHHHHHHHHHh
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ--------------------GRRELDWLARHRIARGIASGLEYLH 174 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~~i~~~l~~lh 174 (337)
|+++++++.+++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 167 (314)
T 2ivs_A 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167 (314)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999976432 1245899999999999999999999
Q ss_pred cCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHH
Q 036970 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAV 254 (337)
Q Consensus 175 ~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~ 254 (337)
+.+ ++|+||||+||+++.++.++|+|||++................+|+.|+|||.+.+..++.++||||||+++|+
T Consensus 168 ~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 244 (314)
T 2ivs_A 168 EMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244 (314)
T ss_dssp HTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred HCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence 665 99999999999999999999999999987655444333334566888999999998889999999999999999
Q ss_pred HHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 255 LMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 255 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
|++ |..||..... ......+.. ...... +......+.+++.+||+.||++|||+.++++.|+
T Consensus 245 l~t~g~~p~~~~~~----~~~~~~~~~---~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 245 IVTLGGNPYPGIPP----ERLFNLLKT---GHRMER----------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp HHTTSCCSSTTCCG----GGHHHHHHT---TCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCCH----HHHHHHhhc---CCcCCC----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999 9999875432 122222211 111110 1112244889999999999999999999999998
Q ss_pred hh
Q 036970 334 QI 335 (337)
Q Consensus 334 ~~ 335 (337)
++
T Consensus 308 ~~ 309 (314)
T 2ivs_A 308 KM 309 (314)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=329.55 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=207.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|++........ . ....+.+.+|+.+++.++||||+++
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~------~---~~~~~~~~~E~~~l~~l~hpnIv~~ 91 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSS------P---GLSTEDLKREASICHMLKHPHIVEL 91 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHTS------S---SCCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceEEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhcccc------c---cchHHHHHHHHHHHHhCCCCCCCcE
Confidence 3578999999999999999999865 4899999999854322110 0 0114678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++||||+++++|.+.+.........+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp EEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSST
T ss_pred EEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCC
Confidence 99999999999999999999999988765555667899999999999999999999665 999999999999986554
Q ss_pred ---EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ---ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ---~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------- 238 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------- 238 (351)
T ss_dssp TCCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------
T ss_pred CCcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------
Confidence 999999999876543322 1235789999999999998999999999999999999999999975311
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.............. .. .+......+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~i~~~~~~~~---~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 239 RLFEGIIKGKYKMN---PR----QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHTCCCCC---HH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCCCC---cc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 12222222211110 00 01112345889999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=329.20 Aligned_cols=266 Identities=20% Similarity=0.292 Sum_probs=209.5
Q ss_pred ccCcccccccccccccceEEeeee----cCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAEL----PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|++++.||+|+||.||+|++ ...+++.||+|++...... .....+.+|+.++.++ +||
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~hp 86 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------------SEHRALMSELKILIHIGHHL 86 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCCCT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH-------------HHHHHHHHHHHHHHhhcCCc
Confidence 679999999999999999999974 3347799999998543221 1145789999999999 799
Q ss_pred ChhhhhceeecCCC-ceEEEEeecCCCHHHHHHhhhcC------------------------------------------
Q 036970 114 NIVPLLARVVRPDC-DLLVYEFRRNGSLQDILYDVSQG------------------------------------------ 150 (337)
Q Consensus 114 ni~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------ 150 (337)
||+++++++.+.+. .++||||+++|+|.+++......
T Consensus 87 niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp TBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred ceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 99999999887654 89999999999999999654321
Q ss_pred --------------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccC
Q 036970 151 --------------------RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI 210 (337)
Q Consensus 151 --------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~ 210 (337)
...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 122899999999999999999999665 999999999999999999999999999876
Q ss_pred CCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCc
Q 036970 211 PNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSR 289 (337)
Q Consensus 211 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (337)
.............+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+... .......+.. ......
T Consensus 244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~---~~~~~~ 317 (359)
T 3vhe_A 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEFCRRLKE---GTRMRA 317 (359)
T ss_dssp TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SHHHHHHHHH---TCCCCC
T ss_pred cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch---hHHHHHHHHc---CCCCCC
Confidence 54433333334567889999999999899999999999999999998 9999975432 1112222211 111110
Q ss_pred cccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 290 TIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 290 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
+......+.+++..||+.||++|||+.++++.|+++.
T Consensus 318 ----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 318 ----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 0111234889999999999999999999999998763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=330.25 Aligned_cols=265 Identities=23% Similarity=0.291 Sum_probs=213.0
Q ss_pred ccCcccccccccccccceEEeeeecC------CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-C
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG------SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-R 111 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 111 (337)
..++|.+.+.||+|+||.||+|++.. ..+..||+|++...... .....+.+|+.++..+ +
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 133 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-------------KDLSDLISEMEMMKMIGK 133 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCC
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-------------HHHHHHHHHHHHHHHhcC
Confidence 45899999999999999999998632 24568999998544221 1256788999999999 8
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG------------RRELDWLARHRIARGIASGLEYLHMSHRP 179 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 179 (337)
||||+++++++.+++..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+
T Consensus 134 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 211 (382)
T 3tt0_A 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-- 211 (382)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 999999999999999999999999999999999764321 245899999999999999999999665
Q ss_pred CceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-C
Q 036970 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-G 258 (337)
Q Consensus 180 ~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g 258 (337)
++|+||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 212 -ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g 290 (382)
T 3tt0_A 212 -CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290 (382)
T ss_dssp -CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987765443333334567889999999999999999999999999999999 9
Q ss_pred CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
..||..... .+............. +......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 291 ~~p~~~~~~-------~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 291 GSPYPGVPV-------EELFKLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp CCSSTTCCH-------HHHHHHHHTTCCCCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCH-------HHHHHHHHcCCCCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999865321 122222222211111 0112234889999999999999999999999998763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=320.54 Aligned_cols=268 Identities=22% Similarity=0.316 Sum_probs=204.0
Q ss_pred ccCcccccccccccccceEEeeee---cCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAEL---PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
..++|++++.||+|+||+||+|++ ...+++.||+|++..... .....+.+|+.++++++||||
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i 73 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--------------EHLRDFEREIEILKSLQHDNI 73 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--------------HHHHHHHHHHHHHHTCCCTTB
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--------------HHHHHHHHHHHHHHhCCCCCE
Confidence 458899999999999999999984 334789999999854322 124578899999999999999
Q ss_pred hhhhceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 116 VPLLARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 116 ~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++++++... ...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 74 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~ 147 (295)
T 3ugc_A 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILV 147 (295)
T ss_dssp CCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred eeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEE
Confidence 9999988653 568999999999999999954 2345899999999999999999999665 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCc-ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc----
Q 036970 194 DDDMEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH---- 268 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~---- 268 (337)
+.++.++|+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~ 227 (295)
T 3ugc_A 148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227 (295)
T ss_dssp EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH
T ss_pred cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh
Confidence 9999999999999987654322 12222345677899999999999999999999999999999999998653210
Q ss_pred -----cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 269 -----TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 269 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.................... .+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 228 IGNDKQGQMIVFHLIELLKNNGRLP----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HCTTCCTHHHHHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCccccchhHHHHHHHHhccCcCC----------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00000111111111111111 11122345889999999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=323.62 Aligned_cols=265 Identities=22% Similarity=0.329 Sum_probs=193.6
Q ss_pred hccCcccccccccccccceEEeeeecCCCC---cEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSG---RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
-..++|++.+.||+|+||.||+|++.. ++ ..||+|++....... ...+.+.+|+.++++++|||
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~ 86 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQ-EDGSFVKVAVKMLKADIIAS------------SDIEEFLREAACMKEFDHPH 86 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC--------CEEEEEEC------C------------HHHHHHHHHHHHHTTCCCTT
T ss_pred cChhHeEEeceecccCCeEEEEEEEcc-cCCcceeEEEEEecccccCH------------HHHHHHHHHHHHHHHCCCCc
Confidence 367899999999999999999998653 33 379999985432211 11567899999999999999
Q ss_pred hhhhhceeecCCCc------eEEEEeecCCCHHHHHHhhhcC--CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 036970 115 IVPLLARVVRPDCD------LLVYEFRRNGSLQDILYDVSQG--RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDI 186 (337)
Q Consensus 115 i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di 186 (337)
|+++++++...... ++++||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 87 iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Di 163 (323)
T 3qup_A 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDL 163 (323)
T ss_dssp BCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCC
Confidence 99999999887665 8999999999999999654432 235899999999999999999999665 999999
Q ss_pred CCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCc
Q 036970 187 QPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDF 265 (337)
Q Consensus 187 ~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~ 265 (337)
||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 164 kp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 164 AARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp SGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999987655444333334556788999999999899999999999999999999 89998764
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.. ..... .......... +......+.+++.+||+.||++|||+.++++.|+++
T Consensus 244 ~~----~~~~~---~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 244 EN----AEIYN---YLIGGNRLKQ----------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp CG----GGHHH---HHHTTCCCCC----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ch----HHHHH---HHhcCCCCCC----------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 32 11222 1221111111 111224488999999999999999999999999876
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=327.77 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=202.3
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|++. .+++.||+|++....... ..+.+.+|+.+++.++||||++++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~hpnIv~~~ 71 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVD-------------CPENIKKEICINKMLNHENVVKFY 71 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC--------------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhceeeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEcccccc-------------hHHHHHHHHHHHHhCCCCCCCeEE
Confidence 578999999999999999999865 489999999985433211 134678899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++||||+++++|.+++ .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~ 144 (323)
T 3tki_A 72 GHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNL 144 (323)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEecCCeEEEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCE
Confidence 9999999999999999999999988 45567999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
||+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ......+.
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~ 222 (323)
T 3tki_A 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWK 222 (323)
T ss_dssp EECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHHH
T ss_pred EEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh
Confidence 9999999976643333333334678999999999988765 67899999999999999999999754321 11111111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... .........+.+++.+||+.||++|||+.++++
T Consensus 223 ----~~~~~~---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 223 ----EKKTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ----TTCTTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cccccC---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111100 011222344789999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=332.83 Aligned_cols=265 Identities=23% Similarity=0.309 Sum_probs=208.1
Q ss_pred ccCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++++.||+|+||.||+|++. ..++..||+|++...... .....+.+|+.++.+++|||
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpn 135 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-------------QDELDFLMEALIISKFNHQN 135 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH-------------HHHHHHHHHHHHHHHCCCTT
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh-------------hhHHHHHHHHHHHHhCCCCC
Confidence 3578999999999999999999853 236778999998533221 11456888999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ---GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
|+++++++.+....++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ ++||||||+||
T Consensus 136 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 212 (367)
T 3l9p_A 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNC 212 (367)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhE
Confidence 99999999999999999999999999999976542 2245899999999999999999999665 99999999999
Q ss_pred EecCCC---cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccc
Q 036970 192 LIDDDM---EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQ 267 (337)
Q Consensus 192 l~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~ 267 (337)
+++.++ .+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 213 ll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292 (367)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999554 599999999975432222222223467889999999999899999999999999999998 9999875322
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+............. +......+.+++.+||+.||++|||+.++++.|..+.
T Consensus 293 -------~~~~~~i~~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 293 -------QEVLEFVTSGGRMDP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp -------HHHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHHHHHHcCCCCCC----------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 222222222221111 1112234889999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=330.64 Aligned_cols=252 Identities=22% Similarity=0.251 Sum_probs=200.3
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPL 118 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~ 118 (337)
.++|++++.||+|+||.||+|++. .+|+.||+|++.+...... .....+.+|..++..+ +||||+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~~~~~-----------~~~~~~~~E~~il~~~~~hp~Iv~l 89 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVILQD-----------DDVECTMTEKRILSLARNHPFLTQL 89 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHH-----------TTHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHHhcch-----------hHHHHHHHHHHHHHhccCCCceeeE
Confidence 578999999999999999999876 4899999999965432111 1155678899999888 79999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCC
Confidence 9999999999999999999999999854 355999999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+||+|||++......... ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||..... .+..
T Consensus 163 ikL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~ 233 (353)
T 3txo_A 163 CKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-------DDLF 233 (353)
T ss_dssp EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH
T ss_pred EEEccccceeecccCCcc--ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-------HHHH
Confidence 999999999764333222 2245789999999999998899999999999999999999999975422 2233
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS------KDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~il~ 330 (337)
..+........ ......+.+++.+||++||++||++ .++++
T Consensus 234 ~~i~~~~~~~p-----------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 234 EAILNDEVVYP-----------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHCCCCCC-----------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHcCCCCCC-----------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 33333222111 1122348899999999999999998 66654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=327.81 Aligned_cols=255 Identities=19% Similarity=0.275 Sum_probs=205.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+. .+|..||+|++........ ....+.+|+.+++.++||||+++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~------------~~~~~~~E~~il~~l~hpnIv~~ 93 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSAR------------DFQKLEREARICRKLQHPNIVRL 93 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCHH------------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCeEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEcccCCHH------------HHHHHHHHHHHHHhCCCCCCCeE
Confidence 3578999999999999999999865 4899999999865432211 15678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC--
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-- 196 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~-- 196 (337)
++++.++...++||||+++++|.+++ .....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~ 166 (362)
T 2bdw_A 94 HDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK 166 (362)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHH----TTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSST
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCC
Confidence 99999999999999999999999998 44567899999999999999999999665 9999999999999865
Q ss_pred -CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 -MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .
T Consensus 167 ~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~ 236 (362)
T 2bdw_A 167 GAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------H 236 (362)
T ss_dssp TCCEEECCCTTCBCCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------H
T ss_pred CCCEEEeecCcceEecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------H
Confidence 45999999999876543222 235789999999999998999999999999999999999999965322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.............. ...+......+.++|.+||+.||++|||+.++++
T Consensus 237 ~~~~~i~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 237 RLYAQIKAGAYDYP-------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHHHHHTCCCCC-------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhCCCCCC-------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22222222211110 0111222345889999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=319.66 Aligned_cols=265 Identities=21% Similarity=0.288 Sum_probs=212.7
Q ss_pred ccCcccccccccccccceEEeeee----cCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAEL----PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|.+.+.||+|+||.||+|++ +..++..||+|++...... ...+.+.+|+.++.++ +||
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~ 87 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-------------TEREALMSELKVLSYLGNHM 87 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCCCT
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-------------HHHHHHHHHHHHHhhcccCC
Confidence 568999999999999999999985 3457889999998543221 1156788999999999 899
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC--------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG--------------RRELDWLARHRIARGIASGLEYLHMSHRP 179 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 179 (337)
||+++++++.+++..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+
T Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-- 165 (313)
T 1t46_A 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-- 165 (313)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999999999999999999999764321 235899999999999999999999665
Q ss_pred CceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-C
Q 036970 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-G 258 (337)
Q Consensus 180 ~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g 258 (337)
++|+||||+||+++.++.++|+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 166 -i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 244 (313)
T 1t46_A 166 -CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (313)
T ss_dssp -CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred -eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987765544333334556788999999998899999999999999999998 9
Q ss_pred CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
..||..... ................ +......+.+++.+||+.||.+|||+.++++.|+++
T Consensus 245 ~~p~~~~~~---~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 245 SSPYPGMPV---DSKFYKMIKEGFRMLS-------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp CCSSTTCCS---SHHHHHHHHHTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcccc---hhHHHHHhccCCCCCC-------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 999875432 1122222222111100 011223488999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=319.05 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=203.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|++...... .......+.+|+.+++.++||||+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~ 97 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFDLM-----------DAKARADCIKEIDLLKQLNHPNVIKY 97 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEET-TTCCEEEEEEECTTSSC-----------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccceEEEEeecCCCCceEEEEEEc-CCCceEEEEeeehhhcc-----------CHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 4578999999999999999999865 48999999998542211 11225678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~ 174 (310)
T 2wqm_A 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGV 174 (310)
T ss_dssp EEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSC
T ss_pred EEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCC
Confidence 99999999999999999999999999776666778999999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.+... ......
T Consensus 175 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~ 247 (310)
T 2wqm_A 175 VKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLC 247 (310)
T ss_dssp EEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHH
T ss_pred EEEEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHH
Confidence 999999998765433221 1234678999999999998999999999999999999999999865321 122222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
........+... .......+.+++.+||+.||++|||+.++++.|++++
T Consensus 248 ~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 248 KKIEQCDYPPLP---------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp HHHHTTCSCCCC---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcccCCCCc---------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 222222211100 0112234889999999999999999999999999885
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=321.57 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=203.7
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||.||+|++. .+|+.||+|++........ ...+.+.+|..+++.++||||++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~Iv~~~ 72 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRL-----------KQVEHTNDERLMLSIVTHPFIIRMW 72 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHSCCBTTBCCEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHhhCCCCCCceEe
Confidence 478999999999999999999865 4899999999865332110 1155788899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++ |++||||||+||+++.++.+
T Consensus 73 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~ 145 (318)
T 1fot_A 73 GTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHI 145 (318)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCE
Confidence 999999999999999999999999953 35689999999999999999999955 59999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++....... ....||+.|+|||++.+..++.++|+||||+++|+|++|..||.+... .....
T Consensus 146 kL~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~ 213 (318)
T 1fot_A 146 KITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYE 213 (318)
T ss_dssp EECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH
T ss_pred EEeecCcceecCCcc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence 999999997654321 235789999999999999999999999999999999999999965321 22223
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
......... + ......+.+++.+||+.||++|| +++++++
T Consensus 214 ~i~~~~~~~---p--------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 214 KILNAELRF---P--------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHCCCCC---C--------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhCCCCC---C--------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 333222110 0 11123488999999999999999 8888873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=328.01 Aligned_cols=254 Identities=20% Similarity=0.232 Sum_probs=203.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||.||+|++. .+++.||+|++........ .....+.+|+.+++.++||||++++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~hp~Iv~l~ 81 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVER-----------NEVRNVFKELQIMQGLEHPFLVNLW 81 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhcccH-----------HHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 478999999999999999999865 4899999999865432111 1156788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+....++||||+.+|+|.+++. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~v 154 (384)
T 4fr4_A 82 YSFQDEEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHV 154 (384)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCE
Confidence 99999999999999999999999984 4566999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT---VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+|+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... .....
T Consensus 155 kL~DFG~a~~~~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~ 227 (384)
T 4fr4_A 155 HITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKE 227 (384)
T ss_dssp EECCCTTCEECCTTCCB---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHH
T ss_pred EEeccceeeeccCCCce---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHH
Confidence 99999999876543222 24578999999999874 4589999999999999999999999975322 11222
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-SKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~il~ 330 (337)
............ +......+.++|.+||+.||.+||+ ++++++
T Consensus 228 ~~~~~~~~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 228 IVHTFETTVVTY-----------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHCCCCC-----------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHhhcccCC-----------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 222222221111 1112244899999999999999998 666653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=321.69 Aligned_cols=253 Identities=23% Similarity=0.268 Sum_probs=205.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|.+. .++..||+|.+..... ....+.+|+.+++.++||||+++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~---------------~~~~~~~E~~~l~~l~hpnIv~~ 66 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKGT---------------DQVLVKKEISILNIARHRNILHL 66 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCTH---------------HHHHHHHHHHHHHHSCCTTBCCE
T ss_pred hhhceEeeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecCcc---------------cHHHHHHHHHHHHhCCCCCCCeE
Confidence 3579999999999999999999865 4899999999853321 14568899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC--C
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--D 196 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~--~ 196 (337)
++++.+.+..++||||+++++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +
T Consensus 67 ~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~ 140 (321)
T 1tki_A 67 HESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRS 140 (321)
T ss_dssp EEEEEETTEEEEEECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSC
T ss_pred eEEEecCCEEEEEEEeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCC
Confidence 999999999999999999999999983 23346999999999999999999999665 999999999999997 7
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+.++|+|||++.......... ...||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+
T Consensus 141 ~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~ 210 (321)
T 1tki_A 141 STIKIIEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQ 210 (321)
T ss_dssp CCEEECCCTTCEECCTTCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HH
T ss_pred CCEEEEECCCCeECCCCCccc---cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-------HH
Confidence 899999999998765443322 34689999999999998889999999999999999999999975322 22
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............. .. .+...+..+.+++.+||+.||.+|||+.++++
T Consensus 211 ~~~~i~~~~~~~~---~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 211 IIENIMNAEYTFD---EE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHHTCCCCC---HH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCCC---hh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2223332221110 00 01122345899999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=320.55 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=201.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||+||+|++. +|+.||+|++....... .....+.+|+.++++++||||+++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~~ 84 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAEDE------------GIPSTAIREISLLKELHHPNIVSL 84 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------------------CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEecccccc------------hhhHHHHHHHHHHHHcCCCCEeee
Confidence 4689999999999999999999875 69999999985432211 114578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~ 157 (311)
T 3niz_A 85 IDVIHSERCLTLVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGA 157 (311)
T ss_dssp EEEECCSSCEEEEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred eeEEccCCEEEEEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCC
Confidence 9999999999999999975 78888743 4456899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++.......... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.... .....
T Consensus 158 ~kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~ 231 (311)
T 3niz_A 158 LKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD----DQLPK 231 (311)
T ss_dssp EEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT----THHHH
T ss_pred EEEccCcCceecCCCcccc--cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH----HHHHH
Confidence 9999999998765332221 13467999999999876 46899999999999999999999999764332 12222
Q ss_pred HHHHhhcCCCCccc----------------cccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTI----------------DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+........+.... .........+.....+.+++.+||+.||++|||+.++++
T Consensus 232 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 232 IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22222221111000 000000001112345889999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=327.86 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=201.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|++. .+++.||+|++........ .....+.+|+.+++.++||||+++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpnIv~l 74 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHY-KTQQKVALKFISRQLLKKS-----------DMHMRVEREISYLKLLRHPHIIKL 74 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHccch-----------hHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3589999999999999999999865 4899999999864332111 113578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+ +|+|.+++.. .+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 75 ~~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~ 146 (336)
T 3h4j_B 75 YDVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLN 146 (336)
T ss_dssp EEEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCC
T ss_pred EEEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCC
Confidence 99999999999999999 6789998854 346899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++.......... ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+........
T Consensus 147 ~kl~DFG~s~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----- 218 (336)
T 3h4j_B 147 VKIADFGLSNIMTDGNFLK---TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----- 218 (336)
T ss_dssp EEECCSSCTBTTTTSBTTC---CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----
T ss_pred EEEEEeccceeccCCcccc---cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----
Confidence 9999999998765443322 3578999999999988776 678999999999999999999997543211000
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
. +... ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 219 -------~-----i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 219 -------K-----VNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -------C-----CCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -------H-----HHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 0000 00011122344889999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=313.61 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=203.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+++.||+|++............ .....+.+|+.+++.++||||+++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMI-------EKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTCCHHHH-------CCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhccceehhccccCCceeEEEEEEc-CCceEEEEEEeeccccccchhHH-------HHHHHHHHHHHHHHhCCCCCchhh
Confidence 4689999999999999999999865 48999999998654332111100 113678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCcEEecCC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPR--IIHRDIQPANVLIDDD 196 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--~~h~di~~~nil~~~~ 196 (337)
++++.+.. ++||||+++++|.+++.. ....+++..++.++.|++.||.||| ..+ ++|+||||+||+++.+
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~ 160 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSL 160 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCC
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEecc
Confidence 99886654 799999999999988843 4457999999999999999999999 666 9999999999999877
Q ss_pred Cc-----EEEecccccccCCCCCcccccccccCcccccCCcccc--CCCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 197 ME-----ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ--TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 197 ~~-----~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
+. ++|+|||++...... .....||+.|+|||++. ...++.++||||||+++|+|++|..||......
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~- 234 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG- 234 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-
T ss_pred CCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-
Confidence 76 999999998754332 12356899999999984 445788999999999999999999999754321
Q ss_pred ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
. .............. .+. ......+.+++.+||+.||++|||+.++++.|++|
T Consensus 235 -~---~~~~~~~~~~~~~~-~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 235 -K---IKFINMIREEGLRP-TIP--------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -H---HHHHHHHHHSCCCC-CCC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -H---HHHHHHHhccCCCC-CCC--------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1 11111111111111 111 11223488999999999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=328.97 Aligned_cols=257 Identities=21% Similarity=0.290 Sum_probs=195.5
Q ss_pred hhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 36 FLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 36 ~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.....++|++++.||+|+||+||+|++. .+++.||+|++...... ...+.+|+.+++.++||||
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hpni 78 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGAAI---------------DENVQREIINHRSLRHPNI 78 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEEEET-TTCCEEEEEEEESSTTS---------------CHHHHHHHHHHHHCCCTTB
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCccc---------------cHHHHHHHHHHHhCCCCCC
Confidence 3446789999999999999999999865 48999999998543221 3467889999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++++.+....++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 79 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~ 151 (361)
T 3uc3_A 79 VRFKEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDG 151 (361)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECS
T ss_pred CcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence 9999999999999999999999999999844 345899999999999999999999665 999999999999987
Q ss_pred CCc--EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCc-ccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 196 DME--ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDK-CDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 196 ~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
++. +||+|||++......... ....||+.|+|||++.+..++.+ +||||||+++|+|++|..||.+.... .
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~ 225 (361)
T 3uc3_A 152 SPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---R 225 (361)
T ss_dssp SSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---C
T ss_pred CCCceEEEeecCccccccccCCC---CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---H
Confidence 665 999999998754322221 23468999999999988887666 89999999999999999999764322 2
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
................. . .......+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~---~------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 226 DYRKTIQRILSVKYSIP---D------DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CHHHHHHHHHTTCCCCC---T------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHhcCCCCCC---C------cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 22333333332221110 0 0011234889999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=329.76 Aligned_cols=255 Identities=21% Similarity=0.236 Sum_probs=199.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|++++.||+|+||.||+|++. .+++.||+|++.+...... .....+.+|..++.++ +||||++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~~~~-----------~~~~~~~~E~~il~~~~~hp~Iv~ 117 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELVNDD-----------EDIDWVQTEKHVFEQASNHPFLVG 117 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGTC---------------CCHHHHHHHHHHHHTTCTTBCC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCH-----------HHHHHHHHHHHHHHhcCCCCCcCe
Confidence 4578999999999999999999876 4889999999965433211 1134577888888776 8999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+....++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.+ ++||||||+||+++.++
T Consensus 118 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g 190 (396)
T 4dc2_A 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEG 190 (396)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTS
T ss_pred eEEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCC
Confidence 99999999999999999999999999854 346999999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc--ccchHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT--KEMSFV 275 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~--~~~~~~ 275 (337)
.+||+|||++......... ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||....... ......
T Consensus 191 ~ikL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~ 268 (396)
T 4dc2_A 191 HIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268 (396)
T ss_dssp CEEECCCTTCBCCCCTTCC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH
T ss_pred CEEEeecceeeecccCCCc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH
Confidence 9999999999763322221 224688999999999999999999999999999999999999996432111 111111
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
............. +......+.++|.+||+.||++||++
T Consensus 269 ~~~~~i~~~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 269 YLFQVILEKQIRI-----------PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHCCCCC-----------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHhccccCC-----------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 2222222222111 11122348899999999999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=315.49 Aligned_cols=265 Identities=20% Similarity=0.208 Sum_probs=200.6
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||+||+|++. .+++.||+|++....... .....+.+|+.++++++||||+++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 68 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDE------------GVPSSALREICLLKELKHKNIVRLHD 68 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSST------------THHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCceeeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccCCcC------------CcchHHHHHHHHHhcCCCCCEeeEEe
Confidence 68999999999999999999865 489999999986443211 12467889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.++...++||||+++ ++.+.+.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~k 141 (292)
T 3o0g_A 69 VLHSDKKLTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEEETTEEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred EEEeCCEEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 99999999999999975 56666533 3466999999999999999999999665 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||++.......... ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.... ........+.
T Consensus 142 l~Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~---~~~~~~~~i~ 216 (292)
T 3o0g_A 142 LANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIF 216 (292)
T ss_dssp ECCCTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS---SHHHHHHHHH
T ss_pred EeecccceecCCccccc--cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC---CHHHHHHHHH
Confidence 99999998764332221 2357799999999998765 7999999999999999999988853221 1111122222
Q ss_pred HHhhcCCCCcc--------------cc-ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRT--------------ID-SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~--------------~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........... .. ........+.....+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 21111111000 00 00001111223455889999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=325.34 Aligned_cols=266 Identities=22% Similarity=0.259 Sum_probs=209.1
Q ss_pred ccCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|.+.+.||+|+||.||+|++. ..++..||+|++...... .....+.+|+.++.++ +||
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~hp 109 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-------------SEREALMSELKMMTQLGSHE 109 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------CHHHHHHHHHHHHHCCCT
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH-------------HHHHHHHHHHHHHHhhcCCC
Confidence 6789999999999999999999862 336778999998543211 1146788999999999 899
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC-------------------CCcCCHHHHHHHHHHHHHHHHHHh
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG-------------------RRELDWLARHRIARGIASGLEYLH 174 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~l~~~~~~~~~~~i~~~l~~lh 174 (337)
||+++++++.+.+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||
T Consensus 110 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 189 (344)
T 1rjb_A 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 189 (344)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred CeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999653221 134799999999999999999999
Q ss_pred cCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHH
Q 036970 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAV 254 (337)
Q Consensus 175 ~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~ 254 (337)
+.+ ++|+||||+||+++.++.++|+|||++................+|+.|+|||.+.+..++.++||||||+++|+
T Consensus 190 ~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 266 (344)
T 1rjb_A 190 FKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 266 (344)
T ss_dssp HTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHH
Confidence 665 99999999999999999999999999987654433333334566889999999998899999999999999999
Q ss_pred HHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 255 LMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 255 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
|++ |..||.+... .......+... ..... +......+.+++.+||+.||.+|||+.++++.|+
T Consensus 267 l~t~g~~p~~~~~~---~~~~~~~~~~~---~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 267 IFSLGVNPYPGIPV---DANFYKLIQNG---FKMDQ----------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HTTTSCCSSTTCCC---SHHHHHHHHTT---CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHcCCCCCcccCCc---HHHHHHHHhcC---CCCCC----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 998 9999975432 11222222111 11100 1111234889999999999999999999999998
Q ss_pred hhh
Q 036970 334 QIQ 336 (337)
Q Consensus 334 ~~~ 336 (337)
.+-
T Consensus 331 ~~~ 333 (344)
T 1rjb_A 331 CQL 333 (344)
T ss_dssp HHC
T ss_pred HHH
Confidence 763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=317.75 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=200.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHH--HHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQ--SEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~E~~~l~~l~h~ni~ 116 (337)
..++|++.+.||+|+||+||+|++ +++.||+|++.... ...+. .|+.....++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~l~h~niv 65 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSRD-----------------EKSWFRETELYNTVMLRHENIL 65 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGGG-----------------HHHHHHHHHHHHHTCCCCTTBC
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEecccc-----------------chhhHHHHHHHHHhhccCcCee
Confidence 468999999999999999999986 68999999985432 12233 344445558999999
Q ss_pred hhhceeecC----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceeC
Q 036970 117 PLLARVVRP----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH--------MSHRPRIIHR 184 (337)
Q Consensus 117 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~~~~h~ 184 (337)
++++++.+. ...++||||+++++|.+++ ....+++..++.++.|++.||.||| +.+ ++|+
T Consensus 66 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~ 137 (301)
T 3q4u_A 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHR 137 (301)
T ss_dssp CEEEEEEEEETTEEEEEEEECCCTTCBHHHHH-----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECS
T ss_pred eEEEeeccccCCCceeEEehhhccCCCHHHHH-----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecC
Confidence 999986553 4578999999999999999 3356999999999999999999999 665 9999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCCCccc--ccccccCcccccCCccccCC------CCCCcccchhHhHHHHHHH
Q 036970 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTRT--TTWSLAETVGYIAPECHQTV------ALSDKCDIYSFGVLLAVLM 256 (337)
Q Consensus 185 di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~vl~~l~ 256 (337)
||||+||+++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|+|+
T Consensus 138 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~ 217 (301)
T 3q4u_A 138 DLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217 (301)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999987654332211 12234789999999999876 4456899999999999999
Q ss_pred hC----------CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 036970 257 MG----------KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326 (337)
Q Consensus 257 ~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 326 (337)
+| ..||......... ..... ...........+... .........+.+++.+||+.||++|||+.
T Consensus 218 tg~~~~~~~~~~~~pf~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 291 (301)
T 3q4u_A 218 RRMVSNGIVEDYKPPFYDVVPNDPS--FEDMR-KVVCVDQQRPNIPNR---WFSDPTLTSLAKLMKECWYQNPSARLTAL 291 (301)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCC--HHHHH-HHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred hhhcCccccccccccccccCCCCcc--hhhhh-HHHhccCCCCCCChh---hccCccHHHHHHHHHHHhhcChhhCCCHH
Confidence 99 7887654332222 22222 212111111111111 12234567799999999999999999999
Q ss_pred HHHHHHhhhh
Q 036970 327 DVRCMLSQIQ 336 (337)
Q Consensus 327 ~il~~L~~~~ 336 (337)
++++.|++++
T Consensus 292 ~i~~~L~~i~ 301 (301)
T 3q4u_A 292 RIKKTLTKID 301 (301)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHhccC
Confidence 9999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=311.07 Aligned_cols=256 Identities=24% Similarity=0.308 Sum_probs=204.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++ .++.||+|++....... .....+.+|+.++++++||||+++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~ 72 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWST------------RKSRDFNEECPRLRIFSHPNVLPV 72 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECCTTCCH------------HHHHHHHHHGGGGCCCSCTTEECE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE---CCeeEEEEEecccccCH------------HHHHHHHHHHHHHHhcCCCchhhe
Confidence 457899999999999999999986 58899999986543221 124678999999999999999999
Q ss_pred hceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCcEEec
Q 036970 119 LARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPR--IIHRDIQPANVLID 194 (337)
Q Consensus 119 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--~~h~di~~~nil~~ 194 (337)
++++.+. ...++||||+++++|.+++.. .....+++..++.++.|++.||.||| ..+ ++|+||||+||+++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~ 147 (271)
T 3kmu_A 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMID 147 (271)
T ss_dssp EEEECTTTSSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEEC
T ss_pred EEEEccCCCCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEc
Confidence 9999887 778999999999999999954 23336899999999999999999999 555 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCC---cccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSD---KCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
.++.++|.|||+....... ...+|+.|+|||.+.+..++. ++||||||+++|+|++|..||.+...
T Consensus 148 ~~~~~~l~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---- 216 (271)
T 3kmu_A 148 EDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---- 216 (271)
T ss_dssp TTSCEEEEGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----
T ss_pred CCcceeEEeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----
Confidence 9999999999887543221 246789999999998765554 79999999999999999999975422
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhhC
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~~ 337 (337)
............... +. ......+.+++..||+.||++|||+.++++.|+++++
T Consensus 217 ---~~~~~~~~~~~~~~~-~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 217 ---MEIGMKVALEGLRPT-IP--------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---HHHHHHHHHSCCCCC-CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---HHHHHHHHhcCCCCC-CC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111122221211110 11 1122348899999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=324.65 Aligned_cols=262 Identities=19% Similarity=0.208 Sum_probs=207.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|++..... ...+.+|+.+++.+ +||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~~h~~i~~ 69 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNL-YTNEYVAIKLEPMKSR----------------APQLHLEYRFYKQLGSGDGIPQ 69 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEET-TTTEEEEEEEEETTCS----------------SCCHHHHHHHHHHHCSCTTSCC
T ss_pred EcCCeEEEEEeeccCCceEEEEEEC-CCCcEEEEEEeccccc----------------hHHHHHHHHHHHHhhCCCCCCE
Confidence 3578999999999999999999865 4899999998854321 22577899999999 8999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.++...++||||+ +++|.+++... .+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~ 142 (330)
T 2izr_A 70 VYYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPG 142 (330)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGG
T ss_pred EEEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCC
Confidence 999999999999999999 99999999652 456999999999999999999999665 99999999999999887
Q ss_pred c-----EEEecccccccCCCCCccc-----ccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccc
Q 036970 198 E-----ARISEFGLAKQIPNGRTRT-----TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ 267 (337)
Q Consensus 198 ~-----~kl~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~ 267 (337)
. ++|+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 143 ~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 143 NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 7 9999999998764432211 12356789999999999999999999999999999999999999986532
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
............... .... .......+ .+.+++..||+.||.+||++.+|.+.|+++
T Consensus 223 ~~~~~~~~~i~~~~~-~~~~------~~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 223 DTLKERYQKIGDTKR-ATPI------EVLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SSHHHHHHHHHHHHH-HSCH------HHHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHHhhhc-cCCH------HHHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 221111111111111 1100 00001111 489999999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=322.05 Aligned_cols=254 Identities=22% Similarity=0.251 Sum_probs=199.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPL 118 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~ 118 (337)
.++|++++.||+|+||.||+|++. .+++.||+|++....... ......+.+|..++.++ +||||+++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~~~~hp~iv~l 75 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKELVND-----------DEDIDWVQTEKHVFEQASNHPFLVGL 75 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGSCS-----------HHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hhheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHHhcc-----------hHHHHHHHHHHHHHHhcCCCCccCeE
Confidence 478999999999999999999875 489999999996543211 12255688899999887 89999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ ++||||||+||+++.+++
T Consensus 76 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~ 148 (345)
T 3a8x_A 76 HSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH 148 (345)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCC
Confidence 9999999999999999999999999854 345899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc--ccchHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT--KEMSFVQ 276 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~--~~~~~~~ 276 (337)
+||+|||++......... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||....... .......
T Consensus 149 ~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 226 (345)
T 3a8x_A 149 IKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226 (345)
T ss_dssp EEECCGGGCBCSCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH
T ss_pred EEEEeccccccccCCCCc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH
Confidence 999999999764332221 224578999999999999999999999999999999999999996422111 0111111
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
........... ++ ......+.+++.+||+.||++||++
T Consensus 227 ~~~~i~~~~~~---~p--------~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 227 LFQVILEKQIR---IP--------RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHCCCC---CC--------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHcCCCC---CC--------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 22222222111 11 1122348899999999999999996
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=326.73 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=196.6
Q ss_pred ccCcccccccccccccceEEeeeec--CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|.+.+.||+|+||.||+|++. ..++..||||.+...... .....+.+|+.++.+++||||+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv 109 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-------------KQRRDFLGEASIMGQFDHPNII 109 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-------------HHHHHHHHHHHHHTTCCCTTBC
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-------------HHHHHHHHHHHHHHhCCCCCCC
Confidence 4679999999999999999999864 235778999998543211 1256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.+....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 183 (373)
T 2qol_A 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN 183 (373)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred eEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCC
Confidence 999999999999999999999999999953 3456899999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchH
Q 036970 197 MEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~ 274 (337)
+.+||+|||++......... .......+++.|+|||++.+..++.++||||||+++||+++ |..||..... .
T Consensus 184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----~-- 257 (373)
T 2qol_A 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----Q-- 257 (373)
T ss_dssp CCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----H--
T ss_pred CCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----H--
Confidence 99999999999876543221 11112234678999999999899999999999999999998 9999865322 1
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+............ .+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 258 -~~~~~i~~~~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 258 -DVIKAVDEGYRLP----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -HHHHHHHTTEECC----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCCC----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 1222221111110 0111224488999999999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=313.30 Aligned_cols=259 Identities=25% Similarity=0.324 Sum_probs=195.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+ .+..||+|++........ ....+.+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDI----------SQTIENVRQEAKLFAMLKHPNIIAL 71 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE---TTEEEEEEEC--------------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred chhheeeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCCcccH----------HHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 357899999999999999999986 589999999855432111 1125678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC---
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--- 195 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~--- 195 (337)
++++.+++..++||||+++++|.+++ ..+.+++..++.++.|++.||.|||+.+..+++|+||||+||+++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~ 146 (271)
T 3dtc_A 72 RGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146 (271)
T ss_dssp EEEECCC--CEEEEECCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS
T ss_pred EEEEecCCceEEEEEcCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc
Confidence 99999999999999999999999998 3457999999999999999999999654333889999999999986
Q ss_pred -----CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 196 -----DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 196 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
++.++|+|||++......... ...||+.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 147 ~~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--- 219 (271)
T 3dtc_A 147 NGDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--- 219 (271)
T ss_dssp SSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---
T ss_pred cccccCcceEEccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 678999999999765433222 34679999999999998899999999999999999999999975322
Q ss_pred cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
............. .... ......+.+++.+||+.||++|||+.++++.|++|
T Consensus 220 ----~~~~~~~~~~~~~-~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 220 ----LAVAYGVAMNKLA-LPIP--------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----HHHHHHHHTSCCC-CCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----HHHHHhhhcCCCC-CCCC--------cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111112111111 1111 11223488999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=312.58 Aligned_cols=263 Identities=21% Similarity=0.339 Sum_probs=193.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||+||+|++. ..+|+|++....... .....+.+|+.++++++||||+++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~ 85 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTP------------QQLQAFKNEVGVLRKTRHVNILLF 85 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCCH------------HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCCH------------HHHHHHHHHHHHHHhCCCCcEEEE
Confidence 4688999999999999999999743 359999985433221 225678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
+++. .....++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 86 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~ 158 (289)
T 3og7_A 86 MGYS-TAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNT 158 (289)
T ss_dssp EEEE-CSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred Eeec-cCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCC
Confidence 9954 55678999999999999999842 4456899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++|+|||++................||+.|+|||.+. +..++.++||||||+++|+|++|..||..... .....
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~ 235 (289)
T 3og7_A 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQII 235 (289)
T ss_dssp EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC---HHHHH
T ss_pred EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch---HHHHH
Confidence 9999999997665433333333457899999999986 55678899999999999999999999975432 11122
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
+.... ..... ... .. ....+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 236 ~~~~~---~~~~~-~~~-~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 236 EMVGR---GSLSP-DLS-KV----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHH---TSCCC-CTT-SS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHhcc---cccCc-chh-hc----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 22211 11111 000 01 1122345899999999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=319.55 Aligned_cols=257 Identities=20% Similarity=0.299 Sum_probs=205.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. ++..||+|++...... ...+.+|+.++..++||||+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~~ 84 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMNLSHEKLVQL 84 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTSBC---------------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCCCC---------------HHHHHHHHHHHhcCCCCCEeeE
Confidence 6789999999999999999999876 7888999998543221 3468899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~ 158 (283)
T 3gen_A 85 YGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGV 158 (283)
T ss_dssp EEEECSSSSEEEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSC
T ss_pred EEEEecCCCeEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCC
Confidence 99999999999999999999999999542 345999999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... . ..
T Consensus 159 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~---~~ 230 (283)
T 3gen_A 159 VKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----S---ET 230 (283)
T ss_dssp EEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----H---HH
T ss_pred EEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----h---HH
Confidence 999999999866443222 1223456788999999998899999999999999999998 9999975432 1 12
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
............ +......+.+++.+||+.||++|||+.++++.|.++.
T Consensus 231 ~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 231 AEHIAQGLRLYR----------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHHHTTCCCCC----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcccCCCC----------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 222221111110 0011234889999999999999999999999998863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=320.81 Aligned_cols=259 Identities=22% Similarity=0.277 Sum_probs=206.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+|..||+|++........ ......+.+.+|+.+++.++||||+++
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~ 79 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSS--------RRGVSREDIEREVSILKEIQHPNVITL 79 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCSTTC--------SSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceEeceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccccc--------cchhhHHHHHHHHHHHHhCCCCCCCcE
Confidence 3478999999999999999999865 4899999999865433111 000115678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC-
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM- 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~- 197 (337)
++++.+....++||||+++++|.+++ .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 80 ~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~ 152 (326)
T 2y0a_A 80 HEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNV 152 (326)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHH----TTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSS
T ss_pred EEEEEeCCEEEEEEEcCCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCC
Confidence 99999999999999999999999998 44567999999999999999999999665 99999999999999877
Q ss_pred ---cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 198 ---EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 198 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------- 222 (326)
T 2y0a_A 153 PKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------- 222 (326)
T ss_dssp SSCCEEECCCTTCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------
T ss_pred CCCCEEEEECCCCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------
Confidence 7999999999876543222 134689999999999998999999999999999999999999965322
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+............ .... +......+.+++.+||+.||++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~---~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 223 QETLANVSAVNYEF---EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHHTCCCC---CHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCc---Cccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12222222111110 0000 1112344889999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=323.85 Aligned_cols=249 Identities=20% Similarity=0.214 Sum_probs=204.3
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||.||+|++. .+|+.||+|++........ .....+.+|+.+++.++||||++++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~ 107 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKL-----------KQIEHTLNEKRILQAVNFPFLVKLE 107 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHhccH-----------HHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 479999999999999999999865 4899999999865432111 1156788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+....++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 108 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~ 180 (350)
T 1rdq_E 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYI 180 (350)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCE
Confidence 999999999999999999999999954 245899999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++....... ....||+.|+|||++.+..++.++|+||||+++|+|++|..||..... .+...
T Consensus 181 kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~ 248 (350)
T 1rdq_E 181 QVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYE 248 (350)
T ss_dssp EECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred EEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHH
Confidence 999999998764332 235789999999999999999999999999999999999999975321 22223
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il~ 330 (337)
......... + ......+.++|.+||+.||++||+ +.++++
T Consensus 249 ~i~~~~~~~---p--------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 249 KIVSGKVRF---P--------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHCCCCC---C--------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHcCCCCC---C--------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 333222110 1 112234889999999999999998 777764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=326.49 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=201.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|.+.+.||+|+||.||+|++. .+|+.||+|++........ .....+..|..++..+ +||||++
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~E~~il~~~~~hp~iv~ 82 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMD-----------DDVECTMVEKRVLSLAWEHPFLTH 82 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHHTTCTTBCC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHhhhh-----------hhHHHHHHHHHHHHhcCCCCCCCc
Confidence 5689999999999999999999976 4899999999965432110 1145677888888876 8999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+....++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++
T Consensus 83 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g 155 (345)
T 1xjd_A 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDG 155 (345)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTS
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCC
Confidence 99999999999999999999999999954 345899999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.+||+|||++......... ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+... .+.
T Consensus 156 ~vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~ 226 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EEL 226 (345)
T ss_dssp CEEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred CEEEeEChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------HHH
Confidence 9999999999764332221 2245789999999999999999999999999999999999999975322 222
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK-DVR 329 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~il 329 (337)
........... + ......+.+++.+||+.||++||++. +++
T Consensus 227 ~~~i~~~~~~~---p--------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 227 FHSIRMDNPFY---P--------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHCCCCC---C--------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHhCCCCC---C--------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 22222222111 1 11223488999999999999999987 554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=334.44 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=205.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+++.||+|+||.||+|++. .+|+.||+|++....... .+....+.+|+.+++.++||||+++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~~~-----------~~~~~~~~~Ei~~l~~l~HpnIv~l 81 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKIRS-----------LDVVGKIRREIQNLKLFRHPHIIKL 81 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHHHH-----------TTTHHHHHHHHHHHTTCCCTTBCCE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccC-----------HHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 4689999999999999999999865 489999999986543211 1115678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++++|.+++ ...+.+++..++.++.||+.||.|||+. |++||||||+||+++.++.
T Consensus 82 ~~~~~~~~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~ 154 (476)
T 2y94_A 82 YQVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMN 154 (476)
T ss_dssp EEEEECSSEEEEEEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCC
Confidence 99999999999999999999999998 4556799999999999999999999955 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++.......... ..+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+... ...
T Consensus 155 vkL~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~ 224 (476)
T 2y94_A 155 AKIADFGLSNMMSDGEFLR---TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTL 224 (476)
T ss_dssp EEECCCSSCEECCTTCCBC---CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHH
T ss_pred eEEEeccchhhcccccccc---ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHH
Confidence 9999999998765433222 3578999999999988765 6789999999999999999999975322 122
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........... +......+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~i~~~~~~~-----------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 225 FKKICDGIFYT-----------PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHTTCCCC-----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhcCCcCC-----------CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 22222221110 0111234889999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=316.98 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=201.8
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhce
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLAR 121 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~ 121 (337)
.|...+.||+|+||.||+|++. .+|+.||||++..... ...+.+.+|+.+++.++||||++++++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 110 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQ--------------QRRELLFNEVVIMRDYQHFNVVEMYKS 110 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTC--------------CSHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccch--------------hHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4788889999999999999865 4899999999854321 114578899999999999999999999
Q ss_pred eecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEE
Q 036970 122 VVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 201 (337)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl 201 (337)
+......++||||+++++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 111 ~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 182 (321)
T 2c30_A 111 YLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKL 182 (321)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEE
T ss_pred EEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEE
Confidence 999999999999999999999982 346899999999999999999999655 999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||++.......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .......
T Consensus 183 ~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------~~~~~~~ 253 (321)
T 2c30_A 183 SDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRL 253 (321)
T ss_dssp CCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHH
T ss_pred eeeeeeeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence 9999987765432221 245789999999999998999999999999999999999999965322 1122222
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+... ........+.+++.+||+.||++|||+.++++
T Consensus 254 ~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 254 RDSPPPKLK--------NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHSSCCCCT--------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCCCCcC--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222211110 01122344889999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=316.91 Aligned_cols=266 Identities=21% Similarity=0.323 Sum_probs=199.2
Q ss_pred ccCcccccccccccccceEEeeeecCC--CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|.+.+.||+|+||.||+|++... ++..||+|.+....... .....+.+|+.++++++||||+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv 99 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ------------REIEEFLSEAACMKDFSHPNVI 99 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH------------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch------------hHHHHHHHHHHHHhcCCCCCee
Confidence 679999999999999999999986532 45689999985433211 1256788999999999999999
Q ss_pred hhhceeecCCC-----ceEEEEeecCCCHHHHHHhhh--cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCC
Q 036970 117 PLLARVVRPDC-----DLLVYEFRRNGSLQDILYDVS--QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189 (337)
Q Consensus 117 ~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ 189 (337)
++++++.+... .++++||+++++|.+++.... .....+++..++.++.|++.||.|||+. |++|+||||+
T Consensus 100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~ 176 (313)
T 3brb_A 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAAR 176 (313)
T ss_dssp CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGG
T ss_pred eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcc
Confidence 99999987653 489999999999999985433 2346699999999999999999999955 5999999999
Q ss_pred cEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccc
Q 036970 190 NVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQH 268 (337)
Q Consensus 190 nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~ 268 (337)
||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 177 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 255 (313)
T 3brb_A 177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN- 255 (313)
T ss_dssp GEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred eEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-
Confidence 99999999999999999987654433333334456889999999999899999999999999999999 8899875432
Q ss_pred cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 269 TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
...... ......... +......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 256 ---~~~~~~---~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 256 ---HEMYDY---LLHGHRLKQ----------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp ---GGHHHH---HHTTCCCCC----------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHH---HHcCCCCCC----------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112221 222211111 1112234899999999999999999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=317.68 Aligned_cols=264 Identities=16% Similarity=0.166 Sum_probs=207.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|++..... ...+.+|+..++.+ +|+|+++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~i~~ 70 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRSD----------------APQLRDEYRTYKLLAGCTGIPN 70 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCTT----------------SCCHHHHHHHHHHTTTCTTCCC
T ss_pred cccceEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeccCCc----------------cHHHHHHHHHHHHHhcCCCCCe
Confidence 4578999999999999999999864 4899999998854321 23477899999999 7999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.++...++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+. |++|+||||+||+++.++
T Consensus 71 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 143 (298)
T 1csn_A 71 VYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPN 143 (298)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSS
T ss_pred EEeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCC
Confidence 999999999999999999 9999999954 234699999999999999999999955 599999999999998776
Q ss_pred c-----EEEecccccccCCCCCcc-----cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccc
Q 036970 198 E-----ARISEFGLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ 267 (337)
Q Consensus 198 ~-----~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~ 267 (337)
. ++|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 144 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 144 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp STTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred CCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 5 999999999876543221 122345789999999999998999999999999999999999999986433
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
............... ...... ... .....+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~-~~~~~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 224 ATNKQKYERIGEKKQ-STPLRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp CCHHHHHHHHHHHHH-HSCHHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cccHHHHHHHHhhcc-CccHHH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 222222222211111 111000 000 11234889999999999999999999999998763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=329.39 Aligned_cols=275 Identities=20% Similarity=0.265 Sum_probs=206.6
Q ss_pred hhhhccCccccccccccc--ccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC
Q 036970 35 AFLKKEDCFASLEKIRSC--WNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112 (337)
Q Consensus 35 ~~l~~~~~~~~~~~lg~G--~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 112 (337)
.++...++|++++.||+| +||.||+|++. .+|+.||+|++....... .....+.+|+.+++.++|
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h 85 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACSN------------EMVTFLQGELHVSKLFNH 85 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGGSCH------------HHHHHHHHHHHHHHHCCC
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccccCh------------HHHHHHHHHHHHHHhCCC
Confidence 456678899999999999 99999999976 489999999996543221 125678899999999999
Q ss_pred CChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
|||+++++++.+++..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ ++||||||+||+
T Consensus 86 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIl 160 (389)
T 3gni_B 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHIL 160 (389)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999998652 3356899999999999999999999665 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCc-----ccccccccCcccccCCccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRT-----RTTTWSLAETVGYIAPECHQT--VALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
++.++.++|+|||.+........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 161 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp ECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999998765432211 111223467899999999987 57899999999999999999999999764
Q ss_pred ccccccchHHHHHHHHhhc----C-CCCc-------------cc-------------cccccCCChHHHHHHHHHHHHHh
Q 036970 266 FQHTKEMSFVQWMRNVMTS----E-NPSR-------------TI-------------DSKLIGNGYEEQMLLVLKIACFC 314 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~----~-~~~~-------------~~-------------~~~~~~~~~~~~~~~l~~li~~~ 314 (337)
...... .......... . .+.. .+ ...............+.+|+.+|
T Consensus 241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 317 (389)
T 3gni_B 241 PATQML---LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317 (389)
T ss_dssp CSTTHH---HHC--------------------------------------------------------CCHHHHHHHHHH
T ss_pred CHHHHH---HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence 321111 1100000000 0 0000 00 00000011122345589999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 036970 315 TFDDPEERPNSKDVRC 330 (337)
Q Consensus 315 l~~~p~~Rps~~~il~ 330 (337)
|+.||++|||+.++++
T Consensus 318 L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 318 LQRNPDARPSASTLLN 333 (389)
T ss_dssp TCSCTTTSCCHHHHTT
T ss_pred hhcCcccCCCHHHHhc
Confidence 9999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=318.04 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=197.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||+||+|++. +|+.||+|++....... .....+.+|+.+++.++||||+++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 67 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDE------------GIPSTTIREISILKELKHSNIVKLYD 67 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGG------------CCCHHHHHHHHGGGGCCCTTBCCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcC--CCCEEEEEEEecccccc------------ccchhHHHHHHHHHhcCCCCEeeeee
Confidence 68999999999999999999874 79999999985443211 11356789999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+.+..++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 68 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 140 (288)
T 1ob3_A 68 VIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELK 140 (288)
T ss_dssp EEECSSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred EEccCCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEE
Confidence 99999999999999965 89988843 3456899999999999999999999665 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||++.......... ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+... ......+.
T Consensus 141 l~Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~ 214 (288)
T 1ob3_A 141 IADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIF 214 (288)
T ss_dssp ECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred EeECccccccCcccccc--ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 99999987654322211 134679999999998764 589999999999999999999999975432 11111111
Q ss_pred HHhhcCCCC--------cccccccc-------CCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPS--------RTIDSKLI-------GNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~--------~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... ...++... ..........+.+++.+||+.||++|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111000 00000000 0001122345889999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=320.59 Aligned_cols=264 Identities=19% Similarity=0.299 Sum_probs=210.9
Q ss_pred ccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++.+.||+|+||.||+|++.. .+++.||+|.+...... .....+.+|+.+++.++|||
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~ 89 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-------------RERIEFLNEASVMKEFNCHH 89 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-------------HHHHHHHHHHHHGGGCCCTT
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-------------HHHHHHHHHHHHHHhcCCCC
Confidence 57899999999999999999998642 35788999998543221 12456889999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~ 188 (337)
|+++++++.+.+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||
T Consensus 90 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp 166 (322)
T 1p4o_A 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAA 166 (322)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSG
T ss_pred EeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCcc
Confidence 99999999999999999999999999999965432 1245789999999999999999999665 99999999
Q ss_pred CcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccc
Q 036970 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQ 267 (337)
Q Consensus 189 ~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~ 267 (337)
+||+++.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 999999999999999999976644333333333456888999999998889999999999999999999 8899875322
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.+............. +......+.+++.+||+.||++|||+.++++.|+++
T Consensus 247 -------~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 247 -------EQVLRFVMEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp -------HHHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -------HHHHHHHHcCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 122222222221110 111224488999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=322.43 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=199.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcE----EEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRV----ITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++.+.||+|+||+||+|++.. +++. |++|.+..... ......+.+|+.++++++|||
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~ 78 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATS-------------PKANKEILDEAYVMASVDNPH 78 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC--------------------CHHHHHHHHHHHHHCCBTT
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeecccccC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 46889999999999999999998653 5554 46776632211 111567889999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
|+++++++.++. .+++++|+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++
T Consensus 79 iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~ 151 (327)
T 3poz_A 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVK 151 (327)
T ss_dssp BCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred EeEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEEC
Confidence 999999998764 7889999999999999854 3456899999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 152 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~ 227 (327)
T 3poz_A 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE 227 (327)
T ss_dssp ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GG
T ss_pred CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH----HH
Confidence 999999999999987655444333334566889999999999999999999999999999999 9999975432 12
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
....+... .... .+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 228 ~~~~~~~~---~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 228 ISSILEKG---ERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHTT---CCCC----------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcC---CCCC----------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 22222211 1111 01112234889999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=320.34 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=209.3
Q ss_pred ccCcccccccccccccceEEeeeecC------CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-C
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG------SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-R 111 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 111 (337)
..++|++.+.||+|+||.||+|++.. .++..||+|++...... .....+.+|+.+++.+ +
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 99 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-------------KDLSDLVSEMEMMKMIGK 99 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-------------HHHHHHHHHHHHHHHHCC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-------------HHHHHHHHHHHHHHHhhc
Confidence 57899999999999999999998642 35778999998543221 1256788999999999 8
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG------------RRELDWLARHRIARGIASGLEYLHMSHRP 179 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 179 (337)
||||+++++++.+.+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+
T Consensus 100 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 177 (334)
T 2pvf_A 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-- 177 (334)
T ss_dssp CTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 999999999999999999999999999999999653321 234899999999999999999999665
Q ss_pred CceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-C
Q 036970 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-G 258 (337)
Q Consensus 180 ~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g 258 (337)
++|+||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 178 -ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 256 (334)
T 2pvf_A 178 -CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256 (334)
T ss_dssp -EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred -eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987665443333334466888999999988889999999999999999999 9
Q ss_pred CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
..||..... .+............. +......+.+++.+||+.||.+|||+.++++.|+++
T Consensus 257 ~~p~~~~~~-------~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 257 GSPYPGIPV-------EELFKLLKEGHRMDK----------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp CCSSTTCCH-------HHHHHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCcCCH-------HHHHHHHhcCCCCCC----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999865321 122222222211110 111223488999999999999999999999999876
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=322.37 Aligned_cols=252 Identities=21% Similarity=0.221 Sum_probs=202.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|++.+...... ...+.+.+|..++..+ +||||++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~~~~hp~iv~ 85 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQD-----------DDVECTMVEKRVLALPGKPPFLTQ 85 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHTCTTCCTTBCC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhcc-----------hHHHHHHHHHHHHHhcCCCCEEee
Confidence 4689999999999999999999875 4789999999865432110 1156788899999988 7999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+.+..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.+ ++||||||+||+++.++
T Consensus 86 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g 158 (353)
T 2i0e_A 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 158 (353)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTS
T ss_pred EEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCC
Confidence 99999999999999999999999999954 245899999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.+||+|||++........ .....+||+.|+|||++.+..++.++|+||||+++|||++|..||.+... .+.
T Consensus 159 ~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~ 229 (353)
T 2i0e_A 159 HIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DEL 229 (353)
T ss_dssp CEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred cEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------HHH
Confidence 999999999976432222 12245789999999999999999999999999999999999999975322 222
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVR 329 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il 329 (337)
........... + ......+.+++.+||+.||++||+ +.+++
T Consensus 230 ~~~i~~~~~~~---p--------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 230 FQSIMEHNVAY---P--------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp HHHHHHCCCCC---C--------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred HHHHHhCCCCC---C--------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 33333322111 1 112244889999999999999996 46665
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=324.50 Aligned_cols=253 Identities=22% Similarity=0.273 Sum_probs=203.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||.||+|.+. .+|+.||+|.+....... ...+.+|+.+++.++||||++++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~--------------~~~~~~E~~il~~l~hpnIv~~~ 114 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLD--------------KYTVKNEISIMNQLHHPKLINLH 114 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHH--------------HHHHHHHHHHHTTCCSTTBCCEE
T ss_pred ccceEEEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccchhh--------------HHHHHHHHHHHHhCCCcCCCeEE
Confidence 478999999999999999999865 489999999986543211 34688999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC--CC
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--DM 197 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~--~~ 197 (337)
+++.+....++||||+++++|.+++. .....+++..++.++.||+.||.|||+.+ ++|+||||+||+++. .+
T Consensus 115 ~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~ 188 (387)
T 1kob_A 115 DAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKAS 188 (387)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCC
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCC
Confidence 99999999999999999999999883 23346899999999999999999999665 999999999999974 46
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.+||+|||++.......... ...||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+.
T Consensus 189 ~vkL~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~ 258 (387)
T 1kob_A 189 SVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LET 258 (387)
T ss_dssp CEEECCCTTCEECCTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHH
T ss_pred ceEEEecccceecCCCccee---eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHH
Confidence 79999999998765443222 34689999999999998999999999999999999999999975322 122
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........... +.. ........+.++|.+||+.||++|||+.++++
T Consensus 259 ~~~i~~~~~~~---~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 259 LQNVKRCDWEF---DED----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHHHCCCCC---CSS----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCCC---Ccc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 22222211110 111 11122344889999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=315.30 Aligned_cols=265 Identities=18% Similarity=0.242 Sum_probs=196.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhc------------CCcchhhhHHHHHHHHHH
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQ------------DSEPLHHKMIQIQSEIIT 106 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~E~~~ 106 (337)
..++|++.+.||+|+||.||+|++. .+++.||+|++..........+.. .........+.+.+|+.+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3578999999999999999999865 489999999987654322110000 000111124568899999
Q ss_pred hcCCCCCChhhhhceeec--CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 036970 107 AGQVRHRNIVPLLARVVR--PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184 (337)
Q Consensus 107 l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~ 184 (337)
++.++||||+++++++.+ ....++||||+++++|.+++ ....+++..++.++.|++.||.|||+.+ ++|+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 999999999999999987 56789999999999998764 4467999999999999999999999665 9999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCC---CCCcccchhHhHHHHHHHhCCCC
Q 036970 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA---LSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 185 di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~vl~~l~~g~~p 261 (337)
||||+||+++.++.+||+|||++.......... ....||+.|+|||.+.+.. ++.++||||||+++|+|++|..|
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 999999999999999999999998765432221 2357899999999998765 36789999999999999999999
Q ss_pred CCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 262 SDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
|.+... ............... . .......+.+++.+||+.||++|||+.++++
T Consensus 240 f~~~~~-------~~~~~~~~~~~~~~~-~--------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDERI-------MCLHSKIKSQALEFP-D--------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSSH-------HHHHHHHHHCCCCCC-S--------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccH-------HHHHHHHhcccCCCC-C--------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 975321 112222221111110 0 0112234889999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=325.39 Aligned_cols=280 Identities=16% Similarity=0.163 Sum_probs=205.0
Q ss_pred ccCcccccccccccccceEEeeeecCC----CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++++.||+|+||.||+|.+... .++.||+|++............. -..........|+..+..++|||
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~---~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKF---YQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHH---HHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHH---HHhhhhhHHHHHHHHHhhccCCC
Confidence 567999999999999999999987532 35889999986654311110000 00001234567888899999999
Q ss_pred hhhhhceeecC----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 115 IVPLLARVVRP----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 115 i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
|+++++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~N 182 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASN 182 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHH
Confidence 99999998775 3479999999 9999999954 3456999999999999999999999665 9999999999
Q ss_pred EEec--CCCcEEEecccccccCCCCCcc-----cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCC
Q 036970 191 VLID--DDMEARISEFGLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSD 263 (337)
Q Consensus 191 il~~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~ 263 (337)
|+++ .++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999 8899999999999766432211 11123458999999999999999999999999999999999999997
Q ss_pred CcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 264 DFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+.... .............. ....++..+.. ...+..+.+++..||+.||.+||++.+|++.|.++
T Consensus 263 ~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 263 DNLKD---PKYVRDSKIRYREN-IASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp GGTTC---HHHHHHHHHHHHHC-HHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccccC---HHHHHHHHHHhhhh-HHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 53221 11111111111111 01111100000 01123488999999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.60 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=180.8
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhhceeec
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLLARVVR 124 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~ 124 (337)
.+.||+|+||.||+|.+. .+|+.||+|++.... ...+.+|+.+++.+. ||||+++++++.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~-----------------~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHK-KSNQAFAVKIISKRM-----------------EANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp SCCSEEETTEEEEEEEET-TTCCEEEEEEEEGGG-----------------HHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CCccccCCCeEEEEEEEC-CCCCEEEEEEEChhh-----------------hhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 378999999999999875 489999999985321 346778999999996 9999999999999
Q ss_pred CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC---cEEE
Q 036970 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM---EARI 201 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~---~~kl 201 (337)
+...++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl 150 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKI 150 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEE
T ss_pred CCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEE
Confidence 9999999999999999999953 456999999999999999999999665 99999999999998665 7999
Q ss_pred ecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHH
Q 036970 202 SEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNV 281 (337)
Q Consensus 202 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (337)
+|||++.......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.............+.....
T Consensus 151 ~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i 228 (325)
T 3kn6_A 151 IDFGFARLKPPDNQPL--KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228 (325)
T ss_dssp CCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH
T ss_pred eccccceecCCCCCcc--cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH
Confidence 9999997654332221 23467999999999999999999999999999999999999998654433333334444443
Q ss_pred hhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 282 MTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
........ ...+......+.+++.+||+.||++|||+.+++
T Consensus 229 ~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 229 KKGDFSFE-------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp TTTCCCCC-------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred HcCCCCCC-------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 33221110 011122345589999999999999999999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=315.40 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=194.6
Q ss_pred ccCcccccccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|++.+.||+|+||.||+|++.. ..+..|++|....... ....+.+.+|+..+++++||||+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv 79 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-------------DSVREKFLQEALTMRQFDHPHIV 79 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-------------HHHHHHHHHHHHHHHTCCCTTBC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-------------HHHHHHHHHHHHHHHhCCCCccc
Confidence 56899999999999999999998753 2356799998744221 12256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++. ++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 80 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 152 (281)
T 1mp8_A 80 KLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSN 152 (281)
T ss_dssp CEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET
T ss_pred eEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCC
Confidence 9999875 5678999999999999999954 3346899999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~ 275 (337)
+.++|+|||++........... ....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....
T Consensus 153 ~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~----~~~~ 227 (281)
T 1mp8_A 153 DCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVI 227 (281)
T ss_dssp TEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHH
T ss_pred CCEEECccccccccCccccccc-ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH----HHHH
Confidence 9999999999987654332221 13355788999999998899999999999999999996 8999975432 1122
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.. ........ . +......+.+++.+||+.||++|||+.++++.|+++
T Consensus 228 ~~---i~~~~~~~--~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 228 GR---IENGERLP--M--------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HH---HHTTCCCC--C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HHcCCCCC--C--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 21 22111111 1 111224488999999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=320.96 Aligned_cols=260 Identities=21% Similarity=0.278 Sum_probs=201.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcE----EEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRV----ITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++++.||+|+||+||+|++.. ++.. |++|.+...... .....+.+|+.++..++|||
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~ 76 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGR-------------QSFQAVTDHMLAIGSLDHAH 76 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTTSC-------------SCBCSCCHHHHHHHTCCCTT
T ss_pred CHhHceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEeccccccH-------------HHHHHHHHHHHHHhcCCCCC
Confidence 46899999999999999999998653 5555 666766332110 01235677999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
|+++++++. +...++|+||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 77 iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~ 149 (325)
T 3kex_A 77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLK 149 (325)
T ss_dssp BCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEES
T ss_pred cCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEEC
Confidence 999999886 5668899999999999999853 3456899999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
.++.+||+|||++................+|..|+|||++.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 150 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~ 225 (325)
T 3kex_A 150 SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL----AE 225 (325)
T ss_dssp SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT----TH
T ss_pred CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH----HH
Confidence 999999999999988765544333334567889999999998899999999999999999999 9999976432 12
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
....+........ .... ...+.+++.+||+.||++|||+.++++.|+++.
T Consensus 226 ~~~~~~~~~~~~~-~~~~------------~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 226 VPDLLEKGERLAQ-PQIC------------TIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HHHHHHTTCBCCC-CTTB------------CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCCC-CCcC------------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2222221111111 1111 112788999999999999999999999998763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=313.29 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=210.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+. .++..||+|.+..... ..+.+.+|+.++++++||||+++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~ 74 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQL 74 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSCST---------------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceeEEeecCCCCceeEEEeEec-CCCEEEEEEecCcCHH---------------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 5788999999999999999999876 3789999999854322 14578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 75 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~ 149 (288)
T 3kfa_A 75 LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHL 149 (288)
T ss_dssp EEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGC
T ss_pred EEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCC
Confidence 9999999999999999999999999965 34466899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....+.
T Consensus 150 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~----~~~~~~ 224 (288)
T 3kfa_A 150 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYEL 224 (288)
T ss_dssp EEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHHHH
T ss_pred EEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 999999999876544322 2223456788999999998899999999999999999999 9999875432 122222
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+........ +......+.+++.+||+.||.+|||+.++++.|+++
T Consensus 225 ~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 225 LEKDYRMER-------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCCCCC-------------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 221111110 111224488999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=319.10 Aligned_cols=268 Identities=23% Similarity=0.271 Sum_probs=188.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|++...... .....+.+|+.+++.++||||+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~ 68 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDSEE-------------GTPSTAIREISLMKELKHENIVRL 68 (317)
T ss_dssp ----------------CEEEEEECS-SSCCEEEEEEEECCSTT-------------CSCHHHHHHHHHHTTCCBTTBCCE
T ss_pred cccceeEeeEECCCCCEEEEEEEEC-CCCcEEEEEEeeccccc-------------ccHHHHHHHHHHHHhcCCCCcceE
Confidence 4578999999999999999999865 48999999998543211 113567889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcC--CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQG--RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++.+++..++||||++ ++|.+++...... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~ 144 (317)
T 2pmi_A 69 YDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKR 144 (317)
T ss_dssp EEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT
T ss_pred EEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCC
Confidence 999999999999999997 5999998654322 245899999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+.+||+|||++......... .....+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+... ....
T Consensus 145 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~ 218 (317)
T 2pmi_A 145 GQLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND----EEQL 218 (317)
T ss_dssp CCEEECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHH
T ss_pred CCEEECcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHH
Confidence 99999999999876433221 1134679999999998764 589999999999999999999999975432 1111
Q ss_pred HHHHHHhhcCCCCc--------cccccc------------cCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSR--------TIDSKL------------IGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~--------~~~~~~------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+........... ...... ...........+.+++.+||+.||++|||+.++++
T Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 219 KLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 22212111110000 000000 00000112345899999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=314.85 Aligned_cols=267 Identities=19% Similarity=0.287 Sum_probs=207.3
Q ss_pred cCcccccccccccccceEEeeee---cCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAEL---PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
.++|++++.||+|+||.||+|++ ...+++.||+|++...... .....+.+|+.+++.++||||+
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~ 86 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-------------NHIADLKKEIEILRNLYHENIV 86 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------------CCHHHHHHHHHHHHTCCCTTBC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc-------------hhHHHHHHHHHHHHhCCCCCee
Confidence 45689999999999999999984 3347899999998543211 1156788999999999999999
Q ss_pred hhhceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 117 PLLARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 117 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++++.+. ...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~ 160 (302)
T 4e5w_A 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVE 160 (302)
T ss_dssp CEEEEEEC---CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEc
Confidence 999999877 5679999999999999999543 345899999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccc------
Q 036970 195 DDMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ------ 267 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~------ 267 (337)
.++.++|+|||++......... .......+|..|+|||.+.+..++.++||||||+++|+|++|..|+.....
T Consensus 161 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 240 (302)
T 4e5w_A 161 SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240 (302)
T ss_dssp ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc
Confidence 9999999999999877544322 223345678889999999998899999999999999999999998653211
Q ss_pred --ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 268 --HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
..................... .+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 241 GPTHGQMTVTRLVNTLKEGKRLP----------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp CSCCGGGHHHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccCHHHHHHHHhccCCCC----------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 011112222222222111111 1112234588999999999999999999999999886
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=308.80 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=208.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+. ++..|++|.+...... .+.+.+|+.+++.++||||+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~ 68 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQL 68 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTBC---------------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred chhheeeeeEecCCCceeEEEEEec--CCCeEEEEEccccCCC---------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 4578999999999999999999875 6889999998543221 3568899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~ 142 (267)
T 3t9t_A 69 YGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQV 142 (267)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGC
T ss_pred EEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCC
Confidence 9999999999999999999999999954 3356899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... .+.
T Consensus 143 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~ 214 (267)
T 3t9t_A 143 IKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEV 214 (267)
T ss_dssp EEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHH
T ss_pred EEEccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHH
Confidence 999999998766432211 1223456788999999998889999999999999999999 8999875322 122
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
............ +......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 215 ~~~i~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 215 VEDISTGFRLYK----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHTTCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCcCCC----------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 222222211110 0111234889999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=316.90 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=197.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEE----EEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVI----TIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++++.||+|+||.||+|++.. +++.+ ++|.+..... ......+.+|+.+++.++|||
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hp~ 78 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATS-------------PKANKEILDEAYVMASVDNPH 78 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCSS-------------CCCHHHHHHHHHHHTTCCBTT
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeeccccC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 46899999999999999999998653 55554 5565532211 112567889999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
|+++++++.++. .+++++|+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 79 iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~ 151 (327)
T 3lzb_A 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVK 151 (327)
T ss_dssp BCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred eeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEc
Confidence 999999998764 7889999999999999864 3456899999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
.++.++|+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 152 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~ 227 (327)
T 3lzb_A 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE 227 (327)
T ss_dssp ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GG
T ss_pred CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH----HH
Confidence 999999999999987754444333334556888999999999999999999999999999999 9999976432 12
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
....+.. ...... +......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 228 ~~~~~~~---~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 228 ISSILEK---GERLPQ----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHT---TCCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHc---CCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2222221 111110 1112234889999999999999999999999998874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.54 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=200.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
+.++|++.+.||+|+||.||+|++. .++..||+|++........ .....+.+|+.+++.++||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~ 74 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKA-----------GVEHQLRREVEIQSHLRHPNILRL 74 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHH-----------TCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEc-cCCcEEEEEEEeccccchh-----------hHHHHHHHHHHHHHcCCCCCCcch
Confidence 4688999999999999999999865 4788999999865432211 114578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++++|.+++... ..+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~ 147 (279)
T 3fdn_A 75 YGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGE 147 (279)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSC
T ss_pred hheEecCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCC
Confidence 99999999999999999999999998542 4589999999999999999999955 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ....
T Consensus 148 ~~l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~ 216 (279)
T 3fdn_A 148 LKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETY 216 (279)
T ss_dssp EEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHH
T ss_pred EEEEeccccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HHHH
Confidence 99999999865543322 134679999999999998999999999999999999999999975322 1112
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......... +......+.+++.+||+.||.+|||+.++++
T Consensus 217 ~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 217 KRISRVEFTF-----------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHHTCCCC-----------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCC-----------CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 2221111111 0111234889999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=333.51 Aligned_cols=257 Identities=22% Similarity=0.326 Sum_probs=206.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+..||||++..... ..+.+.+|+.++++++||||+++
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~iv~l 248 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSM---------------SVEAFLAEANVMKTLQHDKLVKL 248 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTSB---------------CHHHHHHHHHHHTTCCCTTBCCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCCc---------------cHHHHHHHHHHHhhCCCCCEeeE
Confidence 6789999999999999999999876 688899999854321 15678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++. ....++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.
T Consensus 249 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~ 322 (454)
T 1qcf_A 249 HAVVT-KEPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLV 322 (454)
T ss_dssp EEEEC-SSSCEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCC
T ss_pred EEEEe-CCccEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCc
Confidence 99886 567899999999999999995422 235788999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++......... ......+|..|+|||++....++.++||||||+++|||++ |..||.+... ......
T Consensus 323 ~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----~~~~~~ 397 (454)
T 1qcf_A 323 CKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRA 397 (454)
T ss_dssp EEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHH
T ss_pred EEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 999999999876432211 1123345788999999998899999999999999999999 9999975322 122222
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
+ ........ +...+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 398 i---~~~~~~~~----------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 398 L---ERGYRMPR----------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp H---HHTCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred H---HcCCCCCC----------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 2 22211110 1112344889999999999999999999999998863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.66 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=204.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+ .|+.||||++.... ....+.+|+.++++++||||+++
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~---~~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~~ 251 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQL 251 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEESSCT----------------TSHHHHHHHHHHHTCCCTTBCCE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe---cCCeEEEEEeCCch----------------HHHHHHHHHHHHHhccCCCEEEE
Confidence 568999999999999999999986 47899999985432 14578899999999999999999
Q ss_pred hceeecCC-CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 119 LARVVRPD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 119 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
++++.+.. ..++||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++
T Consensus 252 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~ 326 (450)
T 1k9a_A 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDN 326 (450)
T ss_dssp EEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTS
T ss_pred EEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCC
Confidence 99987765 789999999999999999653 3345799999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
.+||+|||++........ ...+++.|+|||++.+..++.++||||||+++|||++ |..||..... .....
T Consensus 327 ~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~~ 397 (450)
T 1k9a_A 327 VAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVP 397 (450)
T ss_dssp CEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT----TTHHH
T ss_pred CEEEeeCCCccccccccc-----CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence 999999999875432211 2255788999999999999999999999999999998 9999975432 12222
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+ ....... .+..+...+.+++.+||+.||++|||+.++++.|++++
T Consensus 398 ~i---~~~~~~~----------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 398 RV---EKGYKMD----------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp HH---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HcCCCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22 1111111 01122344889999999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=318.05 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=197.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|++. .+|+.||+|++....... .....+.+|+.++++++||||++++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~ 68 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDDP------------VIKKIALREIRMLKQLKHPNLVNLL 68 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCCCC-H------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceEeeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccccch------------HHHHHHHHHHHHHHhCCCCCccchh
Confidence 368999999999999999999865 479999999885443221 1255788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+.+..++||||+++++|.+++ .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~ 141 (311)
T 4agu_A 69 EVFRRKRRLHLVFEYCDHTVLHELD----RYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVI 141 (311)
T ss_dssp EEEEETTEEEEEEECCSEEHHHHHH----HTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred heeecCCeEEEEEEeCCCchHHHHH----hhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCE
Confidence 9999999999999999999998887 34466999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++.......... ....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.... .....+
T Consensus 142 kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~ 215 (311)
T 4agu_A 142 KLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV----DQLYLI 215 (311)
T ss_dssp EECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHH
T ss_pred EEeeCCCchhccCccccc--CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence 999999998765332221 13467999999999876 56799999999999999999999999764321 111111
Q ss_pred HHHhhcC-----------------CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSE-----------------NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... ...............+.....+.+++.+||+.||++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 216 RKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred HHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1111100 000000000000001123345889999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=318.24 Aligned_cols=262 Identities=20% Similarity=0.242 Sum_probs=196.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+++.||+|++....... ......+.+|+.++.+++||||+++
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~ 77 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADLARD-----------PSFYLRFRREAQNAAALNHPAIVAV 77 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTTTTS-----------HHHHHHHHHHHTTCCCCCCTTBCCE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccccCC-----------HHHHHHHHHHHHHHHcCCCCCcceE
Confidence 4688999999999999999999865 489999999985543211 1225678999999999999999999
Q ss_pred hceeecCCCc----eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 119 LARVVRPDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 119 ~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++...... ++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~ 150 (311)
T 3ork_A 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMIS 150 (311)
T ss_dssp EEEEEEEETTEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE
T ss_pred EEeeeccCCCCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEc
Confidence 9998876654 999999999999999954 346899999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 151 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------ 224 (311)
T 3ork_A 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------ 224 (311)
T ss_dssp TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------
T ss_pred CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------
Confidence 9999999999999876543221 222235689999999999999999999999999999999999999975432
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR-CMLS 333 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il-~~L~ 333 (337)
................. . .......+.+++.+||+.||.+||++.+++ ..+.
T Consensus 225 -~~~~~~~~~~~~~~~~~---~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 225 -VSVAYQHVREDPIPPSA---R----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp -HHHHHHHHHCCCCCHHH---H----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -HHHHHHHhcCCCCCccc---c----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 11222222222111100 0 011234488999999999999999766554 4443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=310.72 Aligned_cols=256 Identities=24% Similarity=0.306 Sum_probs=199.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|++. .++..+|+|++...... .....+.+|+.+++.++||||+++
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~ 85 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQ-------------VPMEQIEAEIEVLKSLDHPNIIKI 85 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCC-------------SCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhheeecceeccCCCeEEEEEEEc-cCCceEEEEEeeccccc-------------hhHHHHHHHHHHHHhCCCchHHhH
Confidence 3478999999999999999999865 48999999998653211 115678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec---C
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID---D 195 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~---~ 195 (337)
++++.+....++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++ .
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~ 162 (285)
T 3is5_A 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSP 162 (285)
T ss_dssp EEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSST
T ss_pred HHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCC
Confidence 99999999999999999999999999766555677999999999999999999999665 99999999999994 5
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++.++|+|||++......... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... .
T Consensus 163 ~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------~ 231 (285)
T 3is5_A 163 HSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------E 231 (285)
T ss_dssp TCCEEECCCCCCCC-------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------H
T ss_pred CCCEEEEeeecceecCCcccC---cCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCH-------H
Confidence 678999999999766543222 23468999999999864 678999999999999999999999975321 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.................. . ....+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~----~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 232 EVQQKATYKEPNYAVECR----P----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHHCCCCCCC--C----C----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHhhhccCCcccccccC----c----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111111110000 0 1234789999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=318.64 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=209.6
Q ss_pred ccCcccccccccccccceEEeeeecCC----CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|.+.+.||+|+||.||+|.+... .+..||+|.+...... .....+.+|+.++..+ +||
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~ 110 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-------------DEKEALMSELKIMSHLGQHE 110 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCCCT
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-------------HHHHHHHHHHHHHHhhcCCC
Confidence 578999999999999999999986531 2247999998543321 1256788999999999 899
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ----------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h 183 (337)
||+++++++.+++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|
T Consensus 111 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 187 (333)
T 2i1m_A 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIH 187 (333)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred CeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---ccc
Confidence 999999999999999999999999999999965432 1346899999999999999999999665 999
Q ss_pred CCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCC
Q 036970 184 RDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPS 262 (337)
Q Consensus 184 ~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf 262 (337)
+||||+||+++.++.++|+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 188 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 267 (333)
T 2i1m_A 188 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267 (333)
T ss_dssp SCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999986644333222333456788999999998899999999999999999998 88998
Q ss_pred CCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 263 DDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+.... ............... . ......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 268 ~~~~~~---~~~~~~~~~~~~~~~-~------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 268 PGILVN---SKFYKLVKDGYQMAQ-P------------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp TTCCSS---HHHHHHHHHTCCCCC-C------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccchh---HHHHHHHhcCCCCCC-C------------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 754321 112222222111110 0 011234889999999999999999999999998763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=334.99 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=209.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|++. .++..||||.+..... ..+.+.+|+.++++++||||+++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~l 281 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQL 281 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCSSSS---------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecCccc---------------chHHHHHHHHHHHhcCCCCEeeE
Confidence 5678999999999999999999876 3689999999854321 14578999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++++|.+++.. .....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.
T Consensus 282 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~ 356 (495)
T 1opk_A 282 LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHL 356 (495)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEEecCCcEEEEEEccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCc
Confidence 9999999999999999999999999965 23456899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||..... ....+.
T Consensus 357 ~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~----~~~~~~ 431 (495)
T 1opk_A 357 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYEL 431 (495)
T ss_dssp EEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHHHH
T ss_pred EEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 999999999876543222 2223455788999999998889999999999999999999 9999875432 122222
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+.... ... .+......+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 432 ~~~~~---~~~----------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 432 LEKDY---RME----------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp HHTTC---CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHcCC---CCC----------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 22111 110 0112224488999999999999999999999999876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=323.57 Aligned_cols=250 Identities=23% Similarity=0.228 Sum_probs=193.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHH-hcCCCCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIIT-AGQVRHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~ni~~ 117 (337)
..++|++++.||+|+||.||+|++. .++..||+|++.+...... .....+.+|..+ ++.++||||++
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~-----------~~~~~~~~e~~~ll~~~~hp~Iv~ 103 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKK-----------KEEKHIMSERNVLLKNVKHPFLVG 103 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC------------------------CCBCCCCCTTBCC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhh-----------HHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4689999999999999999999976 4889999999965432111 113456667766 56789999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+.+..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++.++
T Consensus 104 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g 176 (373)
T 2r5t_A 104 LHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQG 176 (373)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCC
Confidence 99999999999999999999999999854 345899999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++||+|||++........ .....+||+.|+|||++.+..++.++|+||||+++|||++|..||..... .+.
T Consensus 177 ~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~ 247 (373)
T 2r5t_A 177 HIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEM 247 (373)
T ss_dssp CEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HHH
T ss_pred CEEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHH
Confidence 999999999976432221 12245789999999999999999999999999999999999999975322 222
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 327 (337)
...+....... . +.....+.+++.+||+.||.+||++.+
T Consensus 248 ~~~i~~~~~~~---~--------~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 248 YDNILNKPLQL---K--------PNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHSCCCC---C--------SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHhcccCC---C--------CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 33333222111 1 111234889999999999999999853
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=311.11 Aligned_cols=252 Identities=17% Similarity=0.264 Sum_probs=199.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCC-------cEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSG-------RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 111 (337)
..++|.+.+.||+|+||.||+|++.. ++ ..|++|.+..... ...+.+.+|+.++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~~~~va~K~~~~~~~--------------~~~~~~~~E~~~l~~l~ 70 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRRE-VGDYGQLHETEVLLKVLDKAHR--------------NYSESFFEAASMMSKLS 70 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEE-ECGGGCEEEEEEEEEEECGGGG--------------GGHHHHHHHHHHHHTSC
T ss_pred chhHeeeeeeeccCCCceEEEEEEec-ccccccccchhhhhhhcccccH--------------HHHHHHHHHHHHHHhCC
Confidence 46899999999999999999998653 33 5799999854321 11567889999999999
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
||||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 71 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NI 144 (289)
T 4fvq_A 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNI 144 (289)
T ss_dssp CTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred CCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceE
Confidence 99999999999999999999999999999999964 3344899999999999999999999665 99999999999
Q ss_pred EecCCCc--------EEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCC-CC
Q 036970 192 LIDDDME--------ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGK-FP 261 (337)
Q Consensus 192 l~~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~-~p 261 (337)
+++.++. ++|+|||++....... ...+|+.|+|||++.+ ..++.++||||||+++|+|++|. +|
T Consensus 145 ll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 145 LLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp EEEECCBGGGTBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEecCCcccccccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9998877 9999999986543221 2356888999999987 67899999999999999999965 44
Q ss_pred CCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 262 SDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
|..... . ................+ ..+.+++.+||+.||++|||+.++++.|+++-
T Consensus 219 ~~~~~~----~---~~~~~~~~~~~~~~~~~------------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 219 LSALDS----Q---RKLQFYEDRHQLPAPKA------------AELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp TTTSCH----H---HHHHHHHTTCCCCCCSS------------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred ccccch----H---HHHHHhhccCCCCCCCC------------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 443211 1 11111111111111111 12789999999999999999999999998863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=321.31 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=189.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+++.||+|++..... .+.+.+|+.+++.++||||+++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~~ 113 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQK-GTQKPYALKVLKKTVD----------------KKIVRTEIGVLLRLSHPNIIKL 113 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEC--------------------------CHHHHHCCCTTBCCE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccchh----------------HHHHHHHHHHHHhCCCCCCcce
Confidence 4678999999999999999999876 4789999999854321 3457789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC---
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--- 195 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~--- 195 (337)
++++.+....++||||+++++|.+++ ...+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~ 186 (349)
T 2w4o_A 114 KEIFETPTEISLVLELVTGGELFDRI----VEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAP 186 (349)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHH----TTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSST
T ss_pred eeeEecCCeEEEEEEeCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCC
Confidence 99999999999999999999999998 44566899999999999999999999665 999999999999975
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.... .
T Consensus 187 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~ 257 (349)
T 2w4o_A 187 DAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------Q 257 (349)
T ss_dssp TCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------H
T ss_pred CCCEEEccCccccccCccccc---ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------H
Confidence 889999999998765433221 2346899999999999989999999999999999999999999653221 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............. .. ..+......+.+++.+||+.||++|||+.++++
T Consensus 258 ~~~~~i~~~~~~~---~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 258 FMFRRILNCEYYF---IS----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHHTTCCCC---CT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCCcc---CC----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1222222221110 00 111222345889999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=314.20 Aligned_cols=254 Identities=19% Similarity=0.253 Sum_probs=197.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||.||+|++. .+|+.||||++...... ...+.+.+|+.++++++||||++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~~~ 70 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRE-------------LAREKVMREVKALAKLEHPGIVRYF 70 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCSTT-------------THHHHHHHHHHHHTSCCCTTBCCEE
T ss_pred hhcCceeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCCch-------------hHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 468999999999999999999875 48999999998543211 1256789999999999999999999
Q ss_pred ceeecCCC---------------------------------------------------------ceEEEEeecCCCHHH
Q 036970 120 ARVVRPDC---------------------------------------------------------DLLVYEFRRNGSLQD 142 (337)
Q Consensus 120 ~~~~~~~~---------------------------------------------------------~~lv~e~~~~~~L~~ 142 (337)
+++.+... .++||||+++++|.+
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 150 (332)
T 3qd2_B 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150 (332)
T ss_dssp EEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHH
T ss_pred EEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHH
Confidence 98866442 689999999999999
Q ss_pred HHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcc------
Q 036970 143 ILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR------ 216 (337)
Q Consensus 143 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~------ 216 (337)
++.... .....++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 151 ~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~ 226 (332)
T 3qd2_B 151 WMNRRC-SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226 (332)
T ss_dssp HHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC---------
T ss_pred HHhccc-CccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccc
Confidence 996532 2344677788999999999999999665 999999999999999999999999999876544211
Q ss_pred ----cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCcccc
Q 036970 217 ----TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTID 292 (337)
Q Consensus 217 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (337)
.......||+.|+|||++.+..++.++||||||+++|+|++|..|+... ............ .
T Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~~~~~~-~---- 292 (332)
T 3qd2_B 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDVRNLKF-P---- 292 (332)
T ss_dssp -----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHHHTTCC-C----
T ss_pred ccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHhhccCC-C----
Confidence 1222456899999999999999999999999999999999987764211 111111111111 1
Q ss_pred ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 293 SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 293 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.........+.+++.+||+.||++|||+.++++
T Consensus 293 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 293 -----LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp -----HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred -----cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 112333455789999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=332.32 Aligned_cols=257 Identities=18% Similarity=0.226 Sum_probs=202.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+++.||+|++.+...... . ....+.+|+.++..++||||+++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~-----~------~~~~~~~E~~il~~l~hp~Iv~l 134 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKR-----S------DSAFFWEERDIMAFANSPWVVQL 134 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHT-----C------CCSTHHHHHHHHHHCCCTTBCCE
T ss_pred CccccEEEEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhhhhh-----H------HHHHHHHHHHHHHhCCCCCCCeE
Confidence 5789999999999999999999876 4899999999864322110 0 02357789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 135 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCC
Confidence 9999999999999999999999999843 35899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCC----CCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA----LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
+||+|||++.......... ....+||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.... ...
T Consensus 207 ikL~DFG~a~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~ 282 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTY 282 (410)
T ss_dssp EEECCCTTCEECCTTSEEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH
T ss_pred EEEeccceeEeeccCCccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHH
Confidence 9999999998765443222 22467999999999998765 788999999999999999999999754321 111
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEE--RPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~il~ 330 (337)
............+.. ...+..+.+||.+||+.+|.+ ||++++|++
T Consensus 283 ~~i~~~~~~~~~p~~-----------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 283 SKIMNHKNSLTFPDD-----------NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHTHHHHCCCCTT-----------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHhccccccCCCc-----------ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111111111111110 011234889999999999988 999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=332.43 Aligned_cols=260 Identities=18% Similarity=0.194 Sum_probs=203.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||+||+|++. .+++.||+|++.+...... . ....+.+|..++..++||||+++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~~~~-----~------~~~~~~~E~~il~~~~hp~Iv~l 139 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKR-----A------ETACFREERDVLVNGDSKWITTL 139 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHT-----T------TTCCHHHHHHHHHHSCTTTBCCE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHhhhH-----H------HHHHHHHHHHHHHhCCCCCEEEE
Confidence 5789999999999999999999976 4789999999865322111 0 12347789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCC
Confidence 9999999999999999999999999953 2456999999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
+||+|||++........... ...+||+.|+|||++. ...++.++||||||+++|||++|..||.+.... ..
T Consensus 214 vkL~DFGla~~~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~ 289 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ET 289 (437)
T ss_dssp EEECCCTTCEECCTTSCEEC-CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH
T ss_pred EEEcchhhhhhcccCCCccc-ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HH
Confidence 99999999976654433221 2357899999999987 456899999999999999999999999754321 11
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEE--RPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~il~ 330 (337)
....+........+.. .......+.+||.+||..+|+. ||+++++++
T Consensus 290 ~~~i~~~~~~~~~p~~----------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 290 YGKIMNHKERFQFPTQ----------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHHTHHHHCCCCSS----------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HHhhhhccccccCCcc----------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111111111111111 0112234889999999888888 999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=311.03 Aligned_cols=261 Identities=21% Similarity=0.240 Sum_probs=198.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
.-++|++.+.||+|+||.||+|++. .+++.||+|++....... ......+.+|+.++..++||||+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~hp~iv~~ 99 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETLSSD-----------PVFRTRMQREARTAGRLQEPHVVPI 99 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGGGGS-----------HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCcccccC-----------HHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 4589999999999999999999865 478999999985433221 1225678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++++||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~ 172 (309)
T 2h34_A 100 HDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDF 172 (309)
T ss_dssp EEEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSC
T ss_pred EEEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCC
Confidence 9999999999999999999999999954 246899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ..+
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~ 243 (309)
T 2h34_A 173 AYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------SVM 243 (309)
T ss_dssp EEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHH
T ss_pred EEEecCccCcccccccccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHH
Confidence 9999999987665432221 1234679999999999998999999999999999999999999975322 111
Q ss_pred HHHhhcCCC-CccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhhh
Q 036970 279 RNVMTSENP-SRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-NSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~il~~L~~~ 335 (337)
........+ ..... +.....+.+++.+||+.||++|| |++++++.|.+.
T Consensus 244 ~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 244 GAHINQAIPRPSTVR--------PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp HHHHHSCCCCGGGTS--------TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred HHHhccCCCCccccC--------CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 222222111 11111 11223488999999999999999 999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=332.32 Aligned_cols=253 Identities=20% Similarity=0.244 Sum_probs=195.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|++........ .....+.+|+.+++.++||||+++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~l 213 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAK-----------DEVAHTLTENRVLQNSRHPFLTAL 213 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHC------------------------CCCCCSCTTSCCE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEc-CCCCEEEEEEEEhhhhhhh-----------HHHHHHHHHHHHHHhCCCCeEeeE
Confidence 3578999999999999999999865 4899999999864322111 114567789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCcEEecCCC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHM-SHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~~~h~di~~~nil~~~~~ 197 (337)
++++.+.+..++||||+++++|.+++.. .+.+++..+..++.||+.||.|||+ .+ ++||||||+||+++.++
T Consensus 214 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~ 286 (446)
T 4ejn_A 214 KYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDG 286 (446)
T ss_dssp EEEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSS
T ss_pred EEEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCC
Confidence 9999999999999999999999999854 3468999999999999999999996 55 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...
T Consensus 287 ~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~ 357 (446)
T 4ejn_A 287 HIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKL 357 (446)
T ss_dssp CEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred CEEEccCCCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHH
Confidence 9999999999764332222 2245789999999999999999999999999999999999999965322 122
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
........... + ......+.++|.+||++||++|| |+.++++
T Consensus 358 ~~~i~~~~~~~---p--------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 358 FELILMEEIRF---P--------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHCCCCC---C--------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHhCCCCC---C--------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 22222222110 0 11123488999999999999999 9999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=309.21 Aligned_cols=255 Identities=20% Similarity=0.280 Sum_probs=203.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
-.++|++.+.||+|+||.||+|.+. .+|..||+|++........ ....+.+|+.++++++||||+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~ 70 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSAR------------DFQKLEREARICRKLQHPNIVRL 70 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCHH------------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEc-CCCceEEEEEeecccCCHH------------HHHHHHHHHHHHHHcCCCCcCeE
Confidence 3589999999999999999999865 4899999999865433221 14678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...+++|||+++++|.+.+.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 71 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~ 143 (284)
T 3kk8_A 71 HDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK 143 (284)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSST
T ss_pred EEEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCC
Confidence 9999999999999999999999998844 355899999999999999999999665 999999999999986655
Q ss_pred ---EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ---ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ---~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++|+|||++......... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+... .
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~--- 213 (284)
T 3kk8_A 144 GAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----H--- 213 (284)
T ss_dssp TCCEEECCCTTCEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H---
T ss_pred CCcEEEeeceeeEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----h---
Confidence 999999999776543322 235789999999999999999999999999999999999999965322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.............. .. ........+.+++.+||+.||++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~---~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 214 RLYAQIKAGAYDYP---SP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHHHTCCCCC---TT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhccccCC---ch----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11222221111110 00 01112234889999999999999999999976
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=312.77 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=196.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|+||.||+|++ .++.||+|.+.... ....+.+|+.++++++||||++++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~hp~iv~~~ 67 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIESES----------------ERKAFIVELRQLSRVNHPNIVKLY 67 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE---TTEEEEEEECSSTT----------------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE---CCeeEEEEEecChh----------------HHHHHHHHHHHHhcCCCCCcCeEE
Confidence 47899999999999999999986 57889999984321 145788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc-
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME- 198 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~- 198 (337)
+++.+ ..++||||+++++|.+++... .....++...++.++.|++.||.|||+.+..|++|+||||+||+++.++.
T Consensus 68 ~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 144 (307)
T 2eva_A 68 GACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144 (307)
T ss_dssp EBCTT--TTEEEEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTE
T ss_pred EEEcC--CcEEEEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCE
Confidence 98874 589999999999999999542 12234788999999999999999999632256999999999999998876
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+||+|||++........ ...||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 145 ~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~ 214 (307)
T 2eva_A 145 LKICDFGTACDIQTHMT-----NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIM 214 (307)
T ss_dssp EEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHH
T ss_pred EEEcccccccccccccc-----cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHH
Confidence 79999999876543221 235799999999999989999999999999999999999999753221 11222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
........+.. . ......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 215 ~~~~~~~~~~~------~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 215 WAVHNGTRPPL------I----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp HHHHTTCCCCC------B----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred HHHhcCCCCCc------c----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 22222221111 0 111234889999999999999999999999998864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.08 Aligned_cols=255 Identities=18% Similarity=0.247 Sum_probs=194.1
Q ss_pred ccCcccccccccccccceEEeeeec--CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|++++.||+|+||.||+|+.. ..+|+.||+|++........ ......+.+|+.+++.++||||+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv 84 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN----------AKDTAHTKAERNILEEVKHPFIV 84 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------------HHHHHHHCCCTTBC
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHHhCCCCCcc
Confidence 3578999999999999999999863 24789999999865432111 01144677899999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.+++..++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 85 DLIYAFQTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQ 157 (327)
T ss_dssp CEEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTT
T ss_pred ceeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCC
Confidence 999999999999999999999999999854 345899999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~ 228 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KK 228 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HH
T ss_pred CcEEEEeCCcccccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HH
Confidence 99999999998764332221 1235789999999999998999999999999999999999999975322 12
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
............ +......+.+++.+||+.||++|| ++.++++
T Consensus 229 ~~~~i~~~~~~~-----------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 229 TIDKILKCKLNL-----------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHTCCCC-----------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHhCCCCC-----------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 222222221111 011223488999999999999999 6777764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=315.43 Aligned_cols=265 Identities=20% Similarity=0.294 Sum_probs=208.8
Q ss_pred ccCcccccccccccccceEEeeee----cCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAEL----PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|++.+.||+|+||.||+|++ ...+++.||+|++...... .....+.+|+.++.++ +||
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~hp 91 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------------SEHRALMSELKILIHIGHHL 91 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCCCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-------------HHHHHHHHHHHHHHhcccCC
Confidence 678999999999999999999985 2347789999998543321 1245788999999999 799
Q ss_pred ChhhhhceeecCC-CceEEEEeecCCCHHHHHHhhhcC------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 036970 114 NIVPLLARVVRPD-CDLLVYEFRRNGSLQDILYDVSQG------------RRELDWLARHRIARGIASGLEYLHMSHRPR 180 (337)
Q Consensus 114 ni~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 180 (337)
||+++++++...+ ..+++|||+++++|.+++...... ...+++..++.++.|++.||.|||+.+
T Consensus 92 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--- 168 (316)
T 2xir_A 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--- 168 (316)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred CeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 9999999987754 589999999999999999653321 123889999999999999999999665
Q ss_pred ceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CC
Q 036970 181 IIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GK 259 (337)
Q Consensus 181 ~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~ 259 (337)
++|+||||+||+++.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999987655433333334567889999999999899999999999999999998 99
Q ss_pred CCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 260 FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 260 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.||..... .......+.. ...... +......+.+++.+||+.||.+|||+.++++.|+++
T Consensus 249 ~p~~~~~~---~~~~~~~~~~---~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 249 SPYPGVKI---DEEFCRRLKE---GTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CSSTTCCC---SHHHHHHHHH---TCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccch---hHHHHHHhcc---CccCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99975432 1111121111 111110 011123488999999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=314.87 Aligned_cols=262 Identities=21% Similarity=0.300 Sum_probs=201.3
Q ss_pred ccCcccccccccccccceEEeeeecCCC--CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSS--GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
...+|++.+.||+|+||+||+|++...+ +..+++|.+..... ......+.+|+.++++++||||+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv 89 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-------------IGEVSQFLTEGIIMKDFSHPNVL 89 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-------------HHHHHHHHHHHHHHHTCCCTTBC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-------------HHHHHHHHHHHHHHHhCCCCCEe
Confidence 5688999999999999999999864322 34588888754221 12256788999999999999999
Q ss_pred hhhceee-cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 117 PLLARVV-RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 117 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
++++++. .++..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 90 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~ 163 (298)
T 3f66_A 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDE 163 (298)
T ss_dssp CCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred eeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECC
Confidence 9999854 45678999999999999999953 3456899999999999999999999665 999999999999999
Q ss_pred CCcEEEecccccccCCCCCcc--cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccc
Q 036970 196 DMEARISEFGLAKQIPNGRTR--TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEM 272 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~ 272 (337)
++.++|+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ +.+||..... .
T Consensus 164 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~ 239 (298)
T 3f66_A 164 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----F 239 (298)
T ss_dssp TCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT----T
T ss_pred CCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH----H
Confidence 999999999999876543221 12224456788999999999899999999999999999999 5566654322 1
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
...... ........ +......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 240 ~~~~~~---~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 240 DITVYL---LQGRRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp THHHHH---HTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH---hcCCCCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 122211 11111110 0111234889999999999999999999999998863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=309.65 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=202.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+++.||+|+...... ...+.+|+.+++.++|++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~i~~ 69 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPT 69 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC-------------------CCCHHHHHHHHHHHTTSTTCCC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEc-CCCceEEEEeeccccc----------------chHHHHHHHHHHHhcCCCCCCe
Confidence 5689999999999999999999865 4899999998644321 2247789999999988887776
Q ss_pred hcee-ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe---c
Q 036970 119 LARV-VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---D 194 (337)
Q Consensus 119 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~---~ 194 (337)
+..+ .+....+++|||+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||++ +
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~ 142 (296)
T 4hgt_A 70 IRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK 142 (296)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGG
T ss_pred eeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccC
Confidence 6655 5566779999999 9999999854 3456999999999999999999999665 9999999999999 7
Q ss_pred CCCcEEEecccccccCCCCCcc-----cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 195 DDMEARISEFGLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
.++.+||+|||++......... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 143 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 4hgt_A 143 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh
Confidence 8899999999999876543221 12224578999999999999999999999999999999999999998654433
Q ss_pred ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
................. . . .... .+..+.+++..||+.||++|||+.++++.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~-~-~----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 223 KRQKYERISEKKMSTPI-E-V----LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SSSHHHHHHHHHHHSCH-H-H----HTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccccchh-h-h----hhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 33333333322221110 0 0 0001 1234889999999999999999999999998763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=334.63 Aligned_cols=255 Identities=25% Similarity=0.291 Sum_probs=206.0
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|.+.+.||+|+||.||+|++. .+|+.||+|++........ .....+.+|+.+++.++||||++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~~~~-----------~~~~~~~~E~~iL~~l~hp~Iv~l~ 251 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKR-----------KGYQGAMVEKKILAKVHSRFIVSLA 251 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHhhhh-----------HHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 488999999999999999999875 4899999999865432111 1145788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+....++||||+++|+|.+++.........+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 252 ~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~v 328 (543)
T 3c4z_A 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNV 328 (543)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred EEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCE
Confidence 9999999999999999999999999765444567999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++.......... ....||+.|+|||++.+..++.++|+||||+++|||++|..||........ ......
T Consensus 329 kL~DFGla~~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~~~~ 403 (543)
T 3c4z_A 329 RISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQ 403 (543)
T ss_dssp EECCCTTCEECCTTCCCB--CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHHHHH
T ss_pred EEeecceeeeccCCCccc--ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHHHHH
Confidence 999999998765433221 235789999999999999999999999999999999999999976432211 122233
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
......... +......+.+++.+||++||++||++
T Consensus 404 ~i~~~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 404 RVLEQAVTY-----------PDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHHCCCCC-----------CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred HHhhcccCC-----------CcccCHHHHHHHHHhccCCHhHCCCC
Confidence 333222111 11123448899999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=308.20 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=203.2
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|+||.||+|++. .+++.||+|++...... .....+.+|+.+++.++||||++++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~ 71 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAV-------------DCPENIKKEICINKMLNHENVVKFY 71 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGCT-------------THHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ecceEEEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeeccch-------------hhhHHHHHHHHHHHhcCCCCceeee
Confidence 478999999999999999999865 48999999998543221 1146788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.++...++|+||+++++|.+++ .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 144 (276)
T 2yex_A 72 GHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNL 144 (276)
T ss_dssp EEEEETTEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred eEEEcCCEEEEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCE
Confidence 9999999999999999999999988 44567999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+|+|||++................|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...... ......+.
T Consensus 145 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~ 222 (276)
T 2yex_A 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWK 222 (276)
T ss_dssp EECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHHH
T ss_pred EEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhh
Confidence 9999999876543322222334578999999999987765 67899999999999999999999754321 11111111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... .........+.+++.+||+.||++|||+.++++
T Consensus 223 ----~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 223 ----EKKTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TTCTTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hccccc---------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 111100 011122344889999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=319.37 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=202.2
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
...++|++++.||+|+||.||+|++. .+++.||+|++............ ......+.+|+.+++.++||||++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~Iv~ 93 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIE------DPKLGKVTLEIAILSRVEHANIIK 93 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTTSEEE------ETTTEEEEHHHHHHTTCCCTTBCC
T ss_pred ccccceEEEeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccccccc------hHHHHHHHHHHHHHHhCCCCCEee
Confidence 35689999999999999999999865 48999999998665432111000 011335677999999999999999
Q ss_pred hhceeecCCCceEEEEeecCC-CHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNG-SLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
+++++.+.+..++||||+.+| +|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 94 VLDIFENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAED 166 (335)
T ss_dssp EEEEEECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EEEEEeeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCC
Confidence 999999999999999999766 9999983 4456999999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+.+||+|||++.......... ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......
T Consensus 167 ~~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------ 237 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGKLFY---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------ 237 (335)
T ss_dssp SCEEECCCTTCEECCTTCCBC---EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------
T ss_pred CcEEEeecccceECCCCCcee---ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------
Confidence 999999999998765443322 3468999999999988776 778999999999999999999997532200
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........ .....+.+++.+||+.||++|||+.++++
T Consensus 238 ------~~~~~~~~------------~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 238 ------EAAIHPPY------------LVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp ------TTCCCCSS------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------hhccCCCc------------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000110 11234889999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=314.32 Aligned_cols=265 Identities=21% Similarity=0.256 Sum_probs=205.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|++..... .....+.+|+.+++.++||||+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~~ 91 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCHEQ--------------QDREEAQREADMHRLFNHPNILRL 91 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEESSH--------------HHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred CCeEEEEEEEecCCCCeEEEEEEec-CCCcEEEEEEEecCCH--------------HHHHHHHHHHHHHhhcCCCCeeeE
Confidence 5689999999999999999999865 4899999998854322 115678899999999999999999
Q ss_pred hceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 119 LARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 119 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++.. ....++|+||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~ 168 (317)
T 2buj_A 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLG 168 (317)
T ss_dssp CEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred EEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc
Confidence 999873 34678999999999999999876666788999999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcc-------cccccccCcccccCCccccCCC---CCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 195 DDMEARISEFGLAKQIPNGRTR-------TTTWSLAETVGYIAPECHQTVA---LSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
.++.++|+|||++......... .......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||..
T Consensus 169 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 9999999999988765322111 0111335689999999987654 68899999999999999999999864
Q ss_pred cccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
..... ......... ..... ........+.+++.+||+.||++|||+.++++.|+.++
T Consensus 249 ~~~~~--~~~~~~~~~---~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 249 VFQKG--DSVALAVQN---QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHTT--SCHHHHHHC---C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhccc--chhhHHhhc---cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 22111 111111111 00000 00112234899999999999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=316.70 Aligned_cols=247 Identities=21% Similarity=0.256 Sum_probs=194.0
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecC
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 125 (337)
.+.||+|+||.||+|++. .+|..||+|++...... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 94 ~~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 158 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGMK--------------DKEEVKNEISVMNQLDHANLIQLYDAFESK 158 (373)
T ss_dssp EEECC-----CEEEEEET-TTCCEEEEEEEECCSHH--------------HHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ceEEecCcCEEEEEEEEc-CCCcEEEEEEEcccccc--------------cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 568999999999999865 48999999998654321 145788999999999999999999999999
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe--cCCCcEEEec
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI--DDDMEARISE 203 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~--~~~~~~kl~D 203 (337)
+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||++ +.++.+||+|
T Consensus 159 ~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~D 232 (373)
T 2x4f_A 159 NDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIID 232 (373)
T ss_dssp SEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEe
Confidence 999999999999999998854 3346899999999999999999999665 9999999999999 5667899999
Q ss_pred ccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhh
Q 036970 204 FGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT 283 (337)
Q Consensus 204 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 283 (337)
||++.......... ...||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.......
T Consensus 233 FG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~ 302 (373)
T 2x4f_A 233 FGLARRYKPREKLK---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-------AETLNNILA 302 (373)
T ss_dssp CSSCEECCTTCBCC---CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHH
T ss_pred CCCceecCCccccc---cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh
Confidence 99998765443322 34689999999999988899999999999999999999999975422 122222222
Q ss_pred cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 284 SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..... ... ........+.+++.+||+.||.+|||+.++++
T Consensus 303 ~~~~~---~~~----~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 303 CRWDL---EDE----EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TCCCS---CSG----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCC---Chh----hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22111 000 11122345899999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=307.67 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=203.3
Q ss_pred ccCcccccccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..-.|...+.||+|+||+||+|++.. .++..+|+|.+...... ...+.+.+|+.+++.++||||+
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv 85 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-------------QQVEAFLREGLLMRGLNHPNVL 85 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-------------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-------------HHHHHHHHHHHHHHhCCCCCee
Confidence 45677788999999999999998642 23447999998542221 1256788999999999999999
Q ss_pred hhhceeecCCCc-eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 117 PLLARVVRPDCD-LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 117 ~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
++++++.+.+.. ++++||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 86 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~ 159 (298)
T 3pls_A 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDE 159 (298)
T ss_dssp CCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred eEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 999999876655 999999999999999943 3466899999999999999999999665 999999999999999
Q ss_pred CCcEEEecccccccCCCCCc--ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCC-CCCcccccccc
Q 036970 196 DMEARISEFGLAKQIPNGRT--RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP-SDDFFQHTKEM 272 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~p-f~~~~~~~~~~ 272 (337)
++.++|+|||++........ ........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |... ...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~----~~~ 235 (298)
T 3pls_A 160 SFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----DPF 235 (298)
T ss_dssp TCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CGG
T ss_pred CCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC----CHH
Confidence 99999999999986644321 1122234668899999999999999999999999999999996655 4332 122
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
......... ..... +......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 236 ~~~~~~~~~---~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 236 DLTHFLAQG---RRLPQ----------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp GHHHHHHTT---CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhhcC---CCCCC----------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 222222221 11110 0111234889999999999999999999999998863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=325.53 Aligned_cols=273 Identities=19% Similarity=0.242 Sum_probs=211.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||+||+|++. .+|+.||+|++...... .....+.+|+.+++.++||||+++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~ 72 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFL-------------RPVDVQMREFEVLKKLNHKNIVKL 72 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGG-------------SCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEEC-CCCcEEEEEEecccccc-------------chHHHHHHHHHHHHhcCCCCCCeE
Confidence 3578999999999999999999875 47999999998543221 114567889999999999999999
Q ss_pred hceeecCC--CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe---
Q 036970 119 LARVVRPD--CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI--- 193 (337)
Q Consensus 119 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~--- 193 (337)
++++.+.. ..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++|+||||+||++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 148 (396)
T 4eut_A 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148 (396)
T ss_dssp EEEEECTTTCCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEEC
T ss_pred EEeeccCCCCeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeec
Confidence 99998765 66999999999999999854222 233899999999999999999999665 9999999999999
Q ss_pred -cCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC--------CCCCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 194 -DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT--------VALSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 194 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
+.++.+||+|||++.......... ...||+.|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 149 ~~~~~~~kL~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 149 EDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp TTSCEEEEECCGGGCEECCCGGGSS---CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCceeEEEecCCCceEccCCCccc---cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 777789999999998765433222 3568999999999865 4577899999999999999999999975
Q ss_pred cccccccchHHHHHHHHhhcCCCCccc--------------cccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTI--------------DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... .+.+.......+....- ...............+.+++..||+.||++|||+.++++
T Consensus 226 ~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 226 FEGPRRN---KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp TTCTTTC---HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcccch---HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 4332222 23333333332221100 001111233566778999999999999999999999999
Q ss_pred HHhhh
Q 036970 331 MLSQI 335 (337)
Q Consensus 331 ~L~~~ 335 (337)
.+.++
T Consensus 303 ~l~~i 307 (396)
T 4eut_A 303 ETSDI 307 (396)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=313.61 Aligned_cols=259 Identities=22% Similarity=0.267 Sum_probs=206.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|.+........ ......+.+.+|+.++++++||||+++
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 80 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRAS--------RRGVSREEIEREVSILRQVLHHNVITL 80 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSSSC--------SSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhccEEEeeEeeecCCEEEEEEEEC-CCCeEEEEEEEeccccccc--------ccchhHHHHHHHHHHHHhCCCCCcceE
Confidence 3578999999999999999999865 4899999999865432110 001125678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC-
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM- 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~- 197 (337)
++++.+....++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~ 153 (321)
T 2a2a_A 81 HDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNI 153 (321)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTS
T ss_pred EEEEecCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCC
Confidence 999999999999999999999999994 3456899999999999999999999665 99999999999999887
Q ss_pred ---cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 198 ---EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 198 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
.++|+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------- 223 (321)
T 2a2a_A 154 PIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------- 223 (321)
T ss_dssp SSCCEEECCCTTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------
T ss_pred CcCCEEEccCccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------
Confidence 7999999999876543222 234689999999999998999999999999999999999999965322
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+........... .+.... ......+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~i~~~~~~---~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 224 QETLANITSVSYD---FDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHHTTCCC---CCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhcccc---cChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1222222221111 111110 112244889999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.21 Aligned_cols=269 Identities=20% Similarity=0.253 Sum_probs=209.4
Q ss_pred hccCcccccccccccccceEEeeee---cCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAEL---PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
-..++|++++.||+|+||.||+|++ ...++..||+|++...... ....+.+|+.++++++|||
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~~ 85 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--------------QQRDFQREIQILKALHSDF 85 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH--------------HHHHHHHHHHHHHTCCCTT
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH--------------HHHHHHHHHHHHHhcCCCc
Confidence 3568999999999999999999985 3457899999998544321 1456889999999999999
Q ss_pred hhhhhceee--cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 115 IVPLLARVV--RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 115 i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
|+++++++. +....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 86 i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl 159 (327)
T 3lxl_A 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNIL 159 (327)
T ss_dssp BCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred eeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEE
Confidence 999999887 445678999999999999999653 235899999999999999999999665 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc---
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH--- 268 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~--- 268 (337)
++.++.++|+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 160 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 239 (327)
T 3lxl_A 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239 (327)
T ss_dssp EEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred ECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh
Confidence 999999999999999876543322 2223446788899999999988999999999999999999999998643221
Q ss_pred -----cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 269 -----TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 269 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.................... .+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 240 MMGCERDVPALSRLLELLEEGQRLP----------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HCC----CCHHHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hcccccccccHHHHHHHhhcccCCC----------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111111111111111111 11122344889999999999999999999999998763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=320.29 Aligned_cols=280 Identities=17% Similarity=0.146 Sum_probs=201.1
Q ss_pred ccCcccccccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|.+.+.||+|+||.||+|++.. .++..+|+|............... ........+.+|+..+..++||||+
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~---~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKF---YQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHH---HHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHH---HHHHhhhHHHHHHHhhccccccCcc
Confidence 45899999999999999999998752 267889999987653211110000 0000124577899999999999999
Q ss_pred hhhceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 117 PLLARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 117 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++++.+ ....++||||+ +++|.+++. ..+.+++..++.++.||+.||.|||+.+ ++|+||||+||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 183 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISG----QNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLL 183 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCB----GGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEE
Confidence 99999987 67789999999 999999983 3347999999999999999999999665 999999999999
Q ss_pred ecCCC--cEEEecccccccCCCCCc-----ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 193 IDDDM--EARISEFGLAKQIPNGRT-----RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 193 ~~~~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
++.++ .+||+|||++........ ........||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99877 999999999976643211 11113457899999999999988999999999999999999999999643
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
... ...............+... ..... ....+..+.+++..||+.||++|||+.+|++.|+++.
T Consensus 264 ~~~---~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 264 LKD---PVAVQTAKTNLLDELPQSV-LKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TTC---HHHHHHHHHHHHHTTTHHH-HHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccc---cHHHHHHHHhhcccccHHH-Hhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 211 1111111111111111110 00000 0012234899999999999999999999999998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=313.01 Aligned_cols=261 Identities=23% Similarity=0.376 Sum_probs=200.6
Q ss_pred ccCcccccccccccccceEEeeeecCCC---CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSS---GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
..++|.+.+.||+|+||.||+|++...+ +..||+|.+...... .....+.+|+.+++.++||||
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i 108 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-------------KQRVDFLGEAGIMGQFSHHNI 108 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHTCCCTTB
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-------------HHHHHHHHHHHHHHhCCCCCC
Confidence 4688999999999999999999875322 346999998543221 124578899999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~ 182 (333)
T 1mqb_A 109 IRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNS 182 (333)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred CcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECC
Confidence 9999999999999999999999999999854 3456899999999999999999999665 999999999999999
Q ss_pred CCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 196 DMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
++.++|+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------ 256 (333)
T 1mqb_A 183 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------ 256 (333)
T ss_dssp TCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------
T ss_pred CCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------
Confidence 999999999999876543221 11222345778999999998899999999999999999998 9999865322
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.+............. +......+.+++.+||+.||++|||+.++++.|+++
T Consensus 257 -~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 257 -HEVMKAINDGFRLPT----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -HHHHHHHHTTCCCCC----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHCCCcCCC----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 122222222211111 011223488999999999999999999999999876
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=335.48 Aligned_cols=258 Identities=25% Similarity=0.320 Sum_probs=206.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|++........ .....+.+|+.++..++||||+++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~~~~-----------~~~~~~~~E~~iL~~l~hp~Iv~l 249 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKR-----------KGEAMALNEKQILEKVNSRFVVSL 249 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhhhhh-----------HHHHHHHHHHHHHHHcCCCCEeeE
Confidence 4588999999999999999999875 4899999999965432111 114568899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+.+..++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 250 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~ 324 (576)
T 2acx_A 250 AYAYETKDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGH 324 (576)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSC
T ss_pred EEEEeeCCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCC
Confidence 9999999999999999999999999854 23345899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+||+|||++.......... ...||+.|+|||++.+..++.++||||||+++|+|++|..||..............
T Consensus 325 vKL~DFGla~~~~~~~~~~---~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~-- 399 (576)
T 2acx_A 325 IRISDLGLAVHVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-- 399 (576)
T ss_dssp EEECCCTTCEECCTTCCEE---CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH--
T ss_pred eEEEecccceecccCcccc---ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH--
Confidence 9999999998765443222 34789999999999998999999999999999999999999976433222222222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
........ + +......+.++|.+||+.||++|| ++.++++
T Consensus 400 -~i~~~~~~---~--------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 400 -LVKEVPEE---Y--------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -HHHHCCCC---C--------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -Hhhccccc---C--------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 22211111 0 011223489999999999999999 6788764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=314.29 Aligned_cols=268 Identities=20% Similarity=0.223 Sum_probs=196.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC---CCCCh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV---RHRNI 115 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~ni 115 (337)
..++|++++.||+|+||+||+|++. .+++.||+|++........ .......+.+|+.+++.+ +||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~h~ni 76 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVPNGGGG---------GGGLPISTVREVALLRRLEAFEHPNV 76 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECT-TTCCEEEEEEEEEECCCTT---------SSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred cccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEeccccccc---------ccccchhHHHHHHHHHHHhhcCCCCe
Confidence 4679999999999999999999864 4899999999864332110 000123455666666666 59999
Q ss_pred hhhhceeecCC-----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 116 VPLLARVVRPD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 116 ~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
+++++++.... ..++++||+. ++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~N 150 (308)
T 3g33_A 77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPEN 150 (308)
T ss_dssp CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTT
T ss_pred EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 99999998765 3689999996 599999854 23344899999999999999999999665 9999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
|+++.++.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 151 il~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--- 224 (308)
T 3g33_A 151 ILVTSGGTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--- 224 (308)
T ss_dssp EEECTTSCEEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---
T ss_pred EEEcCCCCEEEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 99999999999999999876543322 235779999999999999999999999999999999999999975432
Q ss_pred cchHHHHHHHHhhcCCCCccccccc------c--------CCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDSKL------I--------GNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+........ ........ . ....+.....+.+++.+||+.||++|||+.++++
T Consensus 225 -~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 225 -ADQLGKIFDLIGLPP-EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp -HHHHHHHHHHHCCCC-TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHHHHhCCCC-hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111122222211111 11000000 0 0001122355889999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=308.46 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=206.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|++..... ...+.+|+.+++.++|++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~i~~ 69 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPT 69 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEESCSS----------------CCHHHHHHHHHHHHTTSTTCCC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCcc----------------hhHHHHHHHHHHHhhcCCCCCc
Confidence 5689999999999999999999865 4899999998754321 2357889999999988887666
Q ss_pred hcee-ecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe---c
Q 036970 119 LARV-VRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---D 194 (337)
Q Consensus 119 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~---~ 194 (337)
+..+ .++...++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+||++ +
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 142 (296)
T 3uzp_A 70 IRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK 142 (296)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGG
T ss_pred cccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCC
Confidence 6655 5566779999999 8999999953 3356999999999999999999999665 9999999999999 4
Q ss_pred CCCcEEEecccccccCCCCCcc-----cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 195 DDMEARISEFGLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
.++.+||+|||++......... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 143 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 3uzp_A 143 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh
Confidence 8889999999999876543221 11234578999999999999999999999999999999999999998654433
Q ss_pred ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
................. . . .... .+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~-~-~----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 223 KRQKYERISEKKMSTPI-E-V----LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SSSHHHHHHHHHHHSCH-H-H----HTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhhhhcccccCCch-H-H----HHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 33333333322221110 0 0 0001 1234889999999999999999999999998763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=304.99 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=201.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+. .++..+++|.+....... ...+.+|+.++++++||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~--------------~~~~~~E~~~l~~l~h~~i~~~ 71 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVED--------------VDRFKQEIEIMKSLDHPNIIRL 71 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCSC--------------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhccch--------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 3578999999999999999999865 478899999985432211 4578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe---cC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---DD 195 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~---~~ 195 (337)
++++.+....++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++|+||+|+||++ +.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 144 (277)
T 3f3z_A 72 YETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSP 144 (277)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSST
T ss_pred EEEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCC
Confidence 9999999999999999999999998854 345899999999999999999999665 9999999999999 78
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++.++|+|||++.......... ...||+.|+|||.+.+. ++.++||||||+++|+|++|..||..... .
T Consensus 145 ~~~~~l~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~ 213 (277)
T 3f3z_A 145 DSPLKLIDFGLAARFKPGKMMR---TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-------S 213 (277)
T ss_dssp TCCEEECCCTTCEECCTTSCBC---CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------H
T ss_pred CCcEEEEecccceeccCccchh---ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-------H
Confidence 8899999999997765443322 34689999999998764 89999999999999999999999975322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+............. .. ........+.+++.+||+.||++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~---~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 214 EVMLKIREGTFTFP---EK----DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHHHCCCCCC---HH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhCCCCCC---ch----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22222222211110 00 00012345889999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=311.42 Aligned_cols=267 Identities=22% Similarity=0.328 Sum_probs=199.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHh--cCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITA--GQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l--~~l~h~ni~ 116 (337)
..++|++.+.||+|+||.||+|++ .++.||+|++.... ......|..++ ..++||||+
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~~~h~~i~ 94 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTE-----------------EASWFRETEIYQTVLMRHENIL 94 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEGGG-----------------HHHHHHHHHHHTSTTCCCTTBC
T ss_pred cccceEEEeEeecCCCeEEEEEEE---CCceEEEEEEeccc-----------------cchhhhHHHHHHHHhhcCCCee
Confidence 357999999999999999999986 58999999984332 12333344444 445899999
Q ss_pred hhhceeecC----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceeCCCC
Q 036970 117 PLLARVVRP----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH-----RPRIIHRDIQ 187 (337)
Q Consensus 117 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----~~~~~h~di~ 187 (337)
++++++.+. ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.. +.|++|+|||
T Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp CEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCC
T ss_pred eEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccc
Confidence 999999887 678999999999999999943 35899999999999999999999550 1159999999
Q ss_pred CCcEEecCCCcEEEecccccccCCCCCccc--ccccccCcccccCCccccCCCCCCc------ccchhHhHHHHHHHhC-
Q 036970 188 PANVLIDDDMEARISEFGLAKQIPNGRTRT--TTWSLAETVGYIAPECHQTVALSDK------CDIYSFGVLLAVLMMG- 258 (337)
Q Consensus 188 ~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~------~DvwslG~vl~~l~~g- 258 (337)
|+||+++.++.+||+|||++.......... ......||+.|+|||++.+...+.. +||||||+++|||++|
T Consensus 170 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 999999999999999999997664332211 1123578999999999988766665 9999999999999999
Q ss_pred ---------CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 259 ---------KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 259 ---------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
..||........ ..... ............+... .........+.+++.+||+.||++|||+.+++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 250 VSGGIVEEYQLPYHDLVPSDP--SYEDM-REIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp CBTTBCCCCCCTTTTTSCSSC--CHHHH-HHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CcccccccccccHhhhcCCCC--chhhh-HHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 666654332221 11222 2222111111111111 11235667799999999999999999999999
Q ss_pred HHHhhhh
Q 036970 330 CMLSQIQ 336 (337)
Q Consensus 330 ~~L~~~~ 336 (337)
+.|+++.
T Consensus 324 ~~L~~l~ 330 (337)
T 3mdy_A 324 KTLAKMS 330 (337)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=307.66 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=183.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|.+........ .....+.+|+.+++.++||||+++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~ 76 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAMYKA-----------GMVQRVQNEVKIHCQLKHPSILEL 76 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHTTBCCTTBCCE
T ss_pred ccccceeeeeecCCCceEEEEEEEc-cCCceEEEEEeehhhhhhh-----------hHHHHHHHHHHHHHhCCCCCeEeE
Confidence 4578999999999999999999865 4899999999854332111 114678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~ 150 (278)
T 3cok_A 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMN 150 (278)
T ss_dssp EEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCC
T ss_pred EEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCC
Confidence 9999999999999999999999999853 3467899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++.......... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||....... ..
T Consensus 151 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~ 221 (278)
T 3cok_A 151 IKIADFGLATQLKMPHEKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-------TL 221 (278)
T ss_dssp EEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------
T ss_pred EEEEeecceeeccCCCCcc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-------HH
Confidence 9999999998765332211 13467999999999999889999999999999999999999997532211 01
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........ .. +......+.+++.+||+.||++|||+.++++
T Consensus 222 ~~~~~~~~-------~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 222 NKVVLADY-------EM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCSSCC-------CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhhccc-------CC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11110000 00 1112244889999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=331.01 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=202.1
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|++. .+++.||+|++....... .....+.+|+.++++++||||++++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~ 87 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKN------------KDTSTILREVELLKKLDHPNIMKLF 87 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHHBC------------SCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hcceEEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEecccccc------------hHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 478999999999999999999865 489999999985432211 0146788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec---CC
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID---DD 196 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~---~~ 196 (337)
+++.+....++||||+.+++|.+.+.. .+.+++..++.++.||+.||.|||+.+ ++||||||+||+++ .+
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 160 (486)
T 3mwu_A 88 EILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKD 160 (486)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTT
T ss_pred EEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCC
Confidence 999999999999999999999998854 346899999999999999999999665 99999999999995 45
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+.+||+|||++......... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... .+
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~ 229 (486)
T 3mwu_A 161 CDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YD 229 (486)
T ss_dssp CCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH
T ss_pred CCEEEEECCcCeECCCCCcc---CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH
Confidence 67999999999876543222 23478999999999986 589999999999999999999999965322 22
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.............. ..+...+..+.++|.+||+.||++|||+.++++
T Consensus 230 ~~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 230 ILKRVETGKYAFDL-------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHHHTCCCSCS-------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHhCCCCCCC-------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22333322221110 111223345889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=316.50 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=193.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC--CChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH--RNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~ 116 (337)
..++|++++.||+|+||.||+|.+. +++.||+|++....... .....+.+|+.++..++| |||+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~~~iv 72 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADN------------QTLDSYRNEIAYLNKLQQHSDKII 72 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCH------------HHHHHHHHHHHHHHHHTTTCTTBC
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccch------------HHHHHHHHHHHHHHhhhhcCCceE
Confidence 4578999999999999999999864 79999999986443221 225678999999999976 9999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.++...++|||+ .+++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++||||||+||+++ +
T Consensus 73 ~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~ 143 (343)
T 3dbq_A 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-D 143 (343)
T ss_dssp CEEEEEECSSEEEEEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-T
T ss_pred EEeeeEeeCCEEEEEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-C
Confidence 999999999999999995 57899999954 456899999999999999999999665 99999999999997 5
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccC-----------CCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-----------VALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
+.+||+|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 144 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 144 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 7899999999987754443333335678999999999865 56888999999999999999999999753
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. ............... ..+ .. ....+.+++..||+.||.+|||+.++++
T Consensus 224 ~~------~~~~~~~~~~~~~~~-~~~----~~----~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 224 IN------QISKLHAIIDPNHEI-EFP----DI----PEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CS------HHHHHHHHHCTTSCC-CCC----CC----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hh------HHHHHHHHhcCCccc-CCc----cc----CCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 22 111122222111111 011 01 1234889999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=324.51 Aligned_cols=266 Identities=22% Similarity=0.261 Sum_probs=194.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|.+. .+|+.||||++....... .....+.+|+.+++.++||||+++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~l 126 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIISL 126 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEESGGGSH------------HHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEECccccCh------------HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 4588999999999999999999865 489999999996543221 115678899999999999999999
Q ss_pred hceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++.... ..++||||+++ +|.+.+. ..+++..++.++.||+.||.|||+.+ ++||||||+||+
T Consensus 127 ~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIl 196 (464)
T 3ttj_A 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 196 (464)
T ss_dssp SEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred EEEEccCCccccCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEE
Confidence 99997654 35999999966 5766662 23899999999999999999999665 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
++.++.+||+|||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+........
T Consensus 197 l~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~ 273 (464)
T 3ttj_A 197 VKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273 (464)
T ss_dssp ECTTSCEEECCCCCC-----CCCC-------CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EeCCCCEEEEEEEeeeecCCCccc---CCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999876543222 23578999999999999999999999999999999999999997643211000
Q ss_pred hHHH---------------HHHHHhhcCCCCcc------cccccc---CCChHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 036970 273 SFVQ---------------WMRNVMTSENPSRT------IDSKLI---GNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328 (337)
Q Consensus 273 ~~~~---------------~~~~~~~~~~~~~~------~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 328 (337)
...+ .............. +..... ..........+.+|+.+||+.||++|||+.|+
T Consensus 274 ~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 353 (464)
T 3ttj_A 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353 (464)
T ss_dssp HHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0000 00011111100000 000000 00111225668999999999999999999998
Q ss_pred HH
Q 036970 329 RC 330 (337)
Q Consensus 329 l~ 330 (337)
++
T Consensus 354 L~ 355 (464)
T 3ttj_A 354 LQ 355 (464)
T ss_dssp HT
T ss_pred hc
Confidence 75
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=305.21 Aligned_cols=260 Identities=18% Similarity=0.264 Sum_probs=202.3
Q ss_pred ccCcccccccccccccceEEeeeecCC--CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|.+.+.||+|+||+||+|++... .+..||+|.+...... ...+.+.+|+.+++.++||||+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~ 76 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-------------DNKEKFMSEAVIMKNLDHPHIV 76 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-------------HHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-------------hHHHHHHHHHHHHHhCCCCCcc
Confidence 568999999999999999999986532 3456999998543221 1256788999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.+ +..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 77 ~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 149 (281)
T 3cc6_A 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASP 149 (281)
T ss_dssp CEEEEECS-SSCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEET
T ss_pred eEEEEEcC-CCCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCC
Confidence 99998765 4568999999999999999652 345899999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~ 275 (337)
+.++|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....
T Consensus 150 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~----~~~~ 224 (281)
T 3cc6_A 150 ECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN----KDVI 224 (281)
T ss_dssp TEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG----GGHH
T ss_pred CcEEeCccCCCcccccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh----HHHH
Confidence 999999999998765433222 123456788999999998899999999999999999998 9999965322 1222
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
..+... ..... +......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 225 ~~~~~~---~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 225 GVLEKG---DRLPK----------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp HHHHHT---CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcC---CCCCC----------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 222211 11110 0111234889999999999999999999999998763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=309.57 Aligned_cols=260 Identities=22% Similarity=0.267 Sum_probs=203.1
Q ss_pred ccCcccccc-cccccccceEEeeeec-CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLE-KIRSCWNGEVYKAELP-GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~-~lg~G~~g~vy~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|.+.+ .||+|+||.||+|.+. ...++.||+|++...... ......+.+|+.+++.++||||+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~ 81 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------------PALKDELLAEANVMQQLDNPYIV 81 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------------CHHHHHHHHHHHHHHTCCCTTBC
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC------------HHHHHHHHHHHHHHHhCCCCCEE
Confidence 457899888 9999999999999643 236789999998543221 11256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++ +....++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+
T Consensus 82 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~ 153 (291)
T 1xbb_A 82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQ 153 (291)
T ss_dssp CEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred EEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCC
Confidence 999998 56678999999999999999954 355899999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchH
Q 036970 197 MEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~ 274 (337)
+.++|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~ 229 (291)
T 1xbb_A 154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEV 229 (291)
T ss_dssp TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHH
T ss_pred CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHH
Confidence 99999999999876543322 22223345788999999988888999999999999999999 9999975422 111
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.. .......+. . +......+.+++.+||+.||++|||+.++++.|+++
T Consensus 230 ~~---~~~~~~~~~--~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 230 TA---MLEKGERMG--C--------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HH---HHHTTCCCC--C--------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HH---HHHcCCCCC--C--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 12 121111111 0 111234488999999999999999999999999876
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=308.17 Aligned_cols=257 Identities=23% Similarity=0.323 Sum_probs=191.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||+||+|++. .+|+.||+|++........ ....+..+...++.++||||+++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~~~~~~~~~~h~~iv~~ 71 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATVNSQE------------QKRLLMDLDISMRTVDCPFTVTF 71 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEC---CHHH------------HHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEec-CCCeEEEEEEeecccCcHH------------HHHHHHHHHHHHHhCCCCeEEEE
Confidence 4689999999999999999999865 4899999999854432211 13345556666888899999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCCceeCCCCCCcEEecCCC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMS-HRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~~~h~di~~~nil~~~~~ 197 (337)
++++.+++..++||||++ ++|.+++.........+++..++.++.|++.||.|||+. + ++|+||||+||+++.++
T Consensus 72 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~ 147 (290)
T 3fme_A 72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALG 147 (290)
T ss_dssp EEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTC
T ss_pred eeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCC
Confidence 999999999999999996 489888876666677899999999999999999999965 5 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccc----cCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH----QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
.++|+|||++.......... ...||+.|+|||.+ .+..++.++||||||+++|+|++|..||..... .
T Consensus 148 ~~kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~ 219 (290)
T 3fme_A 148 QVKMCDFGISGYLVDDVAKD---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----P 219 (290)
T ss_dssp CEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----H
T ss_pred CEEEeecCCccccccccccc---ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----h
Confidence 99999999997765432222 23679999999996 455788999999999999999999999974321 1
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
. ...........+... .......+.+++.+||+.||++|||+.++++
T Consensus 220 ~-~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 220 F-QQLKQVVEEPSPQLP---------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp H-HHHHHHHHSCCCCCC---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred H-HHHHHHhccCCCCcc---------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 112222222221111 0112234889999999999999999999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=322.66 Aligned_cols=254 Identities=20% Similarity=0.262 Sum_probs=191.0
Q ss_pred ccCccccc-ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHh-cCCCCCChh
Q 036970 39 KEDCFASL-EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITA-GQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~-~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~ni~ 116 (337)
..++|.+. +.||+|+||+||+|++. .+|+.||||++... ..+.+|+.++ +..+||||+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~-~~~~~vAiK~~~~~-------------------~~~~~E~~~~~~~~~hp~iv 118 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-------------------PKARREVELHWRASQCPHIV 118 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECS-------------------HHHHHHHHHHHHHTTSTTBC
T ss_pred ccccceeccceeeeccCeEEEEEEEC-CCCCEEEEEEeCcc-------------------hhHHHHHHHHHHhcCCCCcc
Confidence 34677776 68999999999999865 48999999998421 2455677766 445899999
Q ss_pred hhhceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 117 PLLARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 117 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++++.. ....++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ ++||||||+||+
T Consensus 119 ~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nil 193 (400)
T 1nxk_A 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLL 193 (400)
T ss_dssp CEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred eEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEE
Confidence 99998875 5668999999999999999954 22346999999999999999999999665 999999999999
Q ss_pred ecC---CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 193 IDD---DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 193 ~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
++. ++.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 194 l~~~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 270 (400)
T 1nxk_A 194 YTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_dssp ESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS
T ss_pred EecCCCCccEEEEecccccccCCCCcc---ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 997 788999999999865433221 23577999999999999999999999999999999999999997654322
Q ss_pred ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........+... .... . ...+......+.++|.+||+.||++|||+.++++
T Consensus 271 ~~~~~~~~i~~~---~~~~---~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 271 ISPGMKTRIRMG---QYEF---P----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp SCCSHHHHHHHT---CCCC---C----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHcC---cccC---C----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 222222222211 1100 0 0011122345889999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=307.68 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=205.2
Q ss_pred ccCcccccc-cccccccceEEeeeec-CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLE-KIRSCWNGEVYKAELP-GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~-~lg~G~~g~vy~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|.+.. .||+|+||.||+|.+. ..++..||+|++..... ......+.+|+.+++.++||||+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~ 73 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-------------KADTEEMMREAQIMHQLDNPYIV 73 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-------------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc-------------hhHHHHHHHHHHHHHhCCCCCEe
Confidence 456777776 9999999999999853 23678899999855321 12256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++ ..+..++||||+++++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+
T Consensus 74 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~ 146 (287)
T 1u59_A 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNR 146 (287)
T ss_dssp CEEEEE-ESSSEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEET
T ss_pred EEEEEe-cCCCcEEEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCC
Confidence 999999 4566899999999999999983 24456999999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchH
Q 036970 197 MEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~ 274 (337)
+.++|+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 147 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~ 222 (287)
T 1u59_A 147 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEV 222 (287)
T ss_dssp TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHH
T ss_pred CCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HHH
Confidence 99999999999876543222 22223456889999999988889999999999999999998 9999975432 122
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.. .......+. . +......+.+++..||+.||++|||+.++++.|+++
T Consensus 223 ~~---~i~~~~~~~--~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 223 MA---FIEQGKRME--C--------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp HH---HHHTTCCCC--C--------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HHhcCCcCC--C--------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22 222221111 0 112234488999999999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=330.25 Aligned_cols=256 Identities=24% Similarity=0.352 Sum_probs=200.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+. .+..||||++...... .+.+.+|+.++++++||||+++
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hp~iv~~ 244 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLVQL 244 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCCCC---------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 5688999999999999999999976 5678999998543211 3568899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+ ...++||||+++|+|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 245 ~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~ 318 (452)
T 1fmk_A 245 YAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLV 318 (452)
T ss_dssp EEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCC
Confidence 999876 6789999999999999999542 2245899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+... .+.
T Consensus 319 ~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~ 390 (452)
T 1fmk_A 319 CKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REV 390 (452)
T ss_dssp EEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHH
T ss_pred EEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence 999999999876533221 1223456788999999998899999999999999999999 8999875322 122
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
........... .+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 391 ~~~i~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 391 LDQVERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp HHHHHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred HHHHHcCCCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22222221111 0112234488999999999999999999999999876
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=307.99 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=204.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|++. .+++.||+|++....... ....+.+.+|+.+++.++||||+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~ 80 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLK-----------PHQREKMSMEISIHRSLAHQHVVGF 80 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCS-----------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccceEEEEEEeecCCEEEEEEEEC-CCCceEEEEEechhhccC-----------HHHHHHHHHHHHHHHhCCCCCEeee
Confidence 4578999999999999999999865 478999999985543211 1225678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 153 (294)
T 2rku_A 81 HGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLE 153 (294)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred eeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCC
Confidence 9999999999999999999999998844 346899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++.......... ....||+.|+|||.+.+..++.++|+||||+++|+|++|..||..... .+..
T Consensus 154 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~ 224 (294)
T 2rku_A 154 VKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETY 224 (294)
T ss_dssp EEECCCTTCEECCSTTCCB--CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHH
T ss_pred EEEEeccCceecccCcccc--ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHH
Confidence 9999999998764332221 235679999999999998899999999999999999999999975322 1112
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... +. ......+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~---~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 225 LRIKKNEYS---IP--------KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHTTCCC---CC--------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHhhccCC---Cc--------cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 222211111 00 111234889999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=321.95 Aligned_cols=205 Identities=22% Similarity=0.378 Sum_probs=161.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
..++|++++.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.++..+. ||||++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~------------~~~~~~~~E~~~l~~l~~h~niv~ 73 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDAFQNS------------TDAQRTFREIMILTELSGHENIVN 73 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEET-TTCCEEEEEEECC--CCH------------HHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEEC-CCCCEEEEEEecccccCh------------HHHHHHHHHHHHHHhccCCCCCCe
Confidence 3578999999999999999999865 489999999985432211 11456788999999996 999999
Q ss_pred hhceeecCC--CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 118 LLARVVRPD--CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 118 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++...+ ..++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 74 l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~ 144 (388)
T 3oz6_A 74 LLNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNA 144 (388)
T ss_dssp EEEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred eeeEEecCCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcC
Confidence 999997544 6799999996 589998843 36899999999999999999999665 999999999999999
Q ss_pred CCcEEEecccccccCCCCCc-------------------ccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHH
Q 036970 196 DMEARISEFGLAKQIPNGRT-------------------RTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVL 255 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~-------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l 255 (337)
++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 145 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 224 (388)
T 3oz6_A 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224 (388)
T ss_dssp TCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred CCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHH
Confidence 99999999999976532110 111223578999999999887 5789999999999999999
Q ss_pred HhCCCCCCCc
Q 036970 256 MMGKFPSDDF 265 (337)
Q Consensus 256 ~~g~~pf~~~ 265 (337)
++|.+||.+.
T Consensus 225 l~g~~pf~~~ 234 (388)
T 3oz6_A 225 LCGKPIFPGS 234 (388)
T ss_dssp HHSSCSCCCS
T ss_pred HhCCCCCCCC
Confidence 9999999754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=314.22 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=203.0
Q ss_pred ccCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++++.||+|+||.||+|++. ..++..||+|.+...... .....+.+|+.++++++|||
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~ 94 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-------------QDELDFLMEALIISKFNHQN 94 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH-------------HHHHHHHHHHHHHHHCCCTT
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch-------------hhHHHHHHHHHHHhhCCCCC
Confidence 5689999999999999999999842 236788999998533221 11457888999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcC---CCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG---RRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
|+++++++.+....++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||
T Consensus 95 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NI 171 (327)
T 2yfx_A 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNC 171 (327)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHE
Confidence 999999999999999999999999999999764322 245899999999999999999999665 99999999999
Q ss_pred EecC---CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCccc
Q 036970 192 LIDD---DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQ 267 (337)
Q Consensus 192 l~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~ 267 (337)
+++. +..++|+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 172 li~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 9984 44699999999875543333222234467889999999988889999999999999999998 8899865321
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
. .............. +......+.+++.+||+.||.+|||+.++++.|..+.
T Consensus 252 ----~---~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 252 ----Q---EVLEFVTSGGRMDP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ----H---HHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----H---HHHHHHhcCCCCCC----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1 22222222211110 0112234889999999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=320.67 Aligned_cols=255 Identities=21% Similarity=0.262 Sum_probs=198.9
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCCh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNI 115 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 115 (337)
....++|++.+.||+|+||.||+|++. .+|+.||+|++..... ...+|+.++.++ +||||
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~------------------~~~~E~~~l~~~~~hp~i 78 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSKR------------------DPTEEIEILLRYGQHPNI 78 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTTC------------------CCHHHHHHHHHHTTSTTB
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEcccC------------------ChHHHHHHHHHhcCCCCc
Confidence 345688999999999999999999865 4899999999854321 123467777666 79999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++++.++...++||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ ++||||||+||++..
T Consensus 79 v~~~~~~~~~~~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~ 151 (342)
T 2qr7_A 79 ITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVD 151 (342)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESS
T ss_pred CeEEEEEEcCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEec
Confidence 999999999999999999999999999984 4456999999999999999999999665 999999999999854
Q ss_pred C----CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 196 D----MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 196 ~----~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
. +.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---- 225 (342)
T 2qr7_A 152 ESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD---- 225 (342)
T ss_dssp SSCSGGGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT----
T ss_pred CCCCcCeEEEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc----
Confidence 3 35999999999866433221 1235789999999999888889999999999999999999999975321
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....+............ ....+......+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~i~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 226 DTPEEILARIGSGKFSL-------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp SCHHHHHHHHHHCCCCC-------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHccCCccc-------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 12222333333222111 01112223345889999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=305.85 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=203.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .++..||+|++........ .....+.+|+.+++.++||||+++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~ 79 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLEKE-----------GVEHQLRREIEIQSHLRHPNILRM 79 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhhceeeheecCCCCeEEEEEEEc-CCCcEEEEEEEcccccchH-----------HHHHHHHHHHHHHhcCCCCCEeeE
Confidence 3578999999999999999999865 4789999999865432111 114578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+.+..++||||+++++|.+++... +.+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.
T Consensus 80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~ 152 (284)
T 2vgo_A 80 YNYFHDRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGE 152 (284)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCC
T ss_pred EEEEEcCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCC
Confidence 99999999999999999999999998542 4589999999999999999999955 5999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++........ ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ....
T Consensus 153 ~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~ 221 (284)
T 2vgo_A 153 LKIADFGWSVHAPSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------TETH 221 (284)
T ss_dssp EEECCCTTCEECSSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHH
T ss_pred EEEecccccccCccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-------hHHH
Confidence 99999999866543221 234679999999999998999999999999999999999999975322 1112
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... ++ ......+.+++.+||+.||.+|||+.++++
T Consensus 222 ~~~~~~~~~---~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 222 RRIVNVDLK---FP--------PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHTTCCC---CC--------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhccccC---CC--------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 222221111 00 112234889999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=318.37 Aligned_cols=267 Identities=24% Similarity=0.238 Sum_probs=201.8
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
.+..++|++.+.||+|+||.||+|++. .++..||+|++........ .......+.+|+.+++.++||||+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpniv 91 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIRQI---------NPKDVERIKTEVRLMKKLHHPNIA 91 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHC------------CHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhheeecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhccc---------CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 446789999999999999999999865 4899999999865432110 011256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------------------------------CCCcCCHHHHH
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------------------------------GRRELDWLARH 160 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------~~~~l~~~~~~ 160 (337)
++++++.+.+..++||||+++++|.+++..... ....+++..++
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred eeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 999999999999999999999999998842111 12234677888
Q ss_pred HHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC--cEEEecccccccCCCCC--cccccccccCcccccCCccccC
Q 036970 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM--EARISEFGLAKQIPNGR--TRTTTWSLAETVGYIAPECHQT 236 (337)
Q Consensus 161 ~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~ 236 (337)
.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||++....... .........||+.|+|||++.+
T Consensus 172 ~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 172 NIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 99999999999999665 99999999999998766 89999999997653221 1112224578999999999875
Q ss_pred --CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHh
Q 036970 237 --VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFC 314 (337)
Q Consensus 237 --~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 314 (337)
..++.++||||||+++|+|++|..||..... .+.............. .........+.+++.+|
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND-------ADTISQVLNKKLCFEN-------PNYNVLSPLARDLLSNL 314 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCTTS-------GGGGGSCHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcccccCC-------cccccCCHHHHHHHHHH
Confidence 5788999999999999999999999975432 1222223222211110 01112234588999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 036970 315 TFDDPEERPNSKDVRC 330 (337)
Q Consensus 315 l~~~p~~Rps~~~il~ 330 (337)
|+.||.+|||+.++++
T Consensus 315 l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 315 LNRNVDERFDAMRALQ 330 (345)
T ss_dssp SCSCTTTSCCHHHHHH
T ss_pred cCCChhHCCCHHHHhc
Confidence 9999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=320.59 Aligned_cols=265 Identities=22% Similarity=0.304 Sum_probs=203.4
Q ss_pred Ccc-cccccccccccceEEeeeec---CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 41 DCF-ASLEKIRSCWNGEVYKAELP---GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 41 ~~~-~~~~~lg~G~~g~vy~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
++| ++++.||+|+||+||++++. ..+++.||+|++..... ......+.+|+.+++.++||||+
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv 96 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-------------PQHRSGWKQEIDILRTLYHEHII 96 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-------------hHHHHHHHHHHHHHHhCCCcchh
Confidence 344 99999999999999887642 23789999999854322 11256789999999999999999
Q ss_pred hhhceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 117 PLLARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 117 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++++.+. ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~ 168 (318)
T 3lxp_A 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLD 168 (318)
T ss_dssp CEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred hEEEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEc
Confidence 999999874 567899999999999999832 34899999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCc-ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc-----
Q 036970 195 DDMEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH----- 268 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~----- 268 (337)
.++.++|+|||++........ ........+|..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 169 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~ 248 (318)
T 3lxp_A 169 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248 (318)
T ss_dssp TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred CCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh
Confidence 999999999999987754432 22233456788899999999988999999999999999999999998653211
Q ss_pred ---cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 269 ---TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 269 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.......... ......... ..+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 249 ~~~~~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 249 GIAQGQMTVLRLT-ELLERGERL---------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp CSCCHHHHHHHHH-HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccchhHHHHH-HHHhcccCC---------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0001111111 111111110 011122345899999999999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=317.92 Aligned_cols=268 Identities=22% Similarity=0.312 Sum_probs=199.4
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
...++|++++.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.++||||++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~ 88 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESDDDK------------MVKKIAMREIKLLKQLRHENLVN 88 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCSSCH------------HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhhheeeeEEeecCCEEEEEEEEC-CCCceEEEEEEecCCCch------------HHHHHHHHHHHHHhhCCCCCEee
Confidence 36789999999999999999999865 479999999985443221 12456789999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+.+..++||||+++++|.++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~ 161 (331)
T 4aaa_A 89 LLEVCKKKKRWYLVFEFVDHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSG 161 (331)
T ss_dssp EEEEEEETTEEEEEEECCSEEHHHHHH----HSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred EEEEeecCCEEEEEEecCCcchHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCC
Confidence 999999999999999999998888876 33456999999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
.++|+|||++.......... ....||+.|+|||++.+. .++.++||||||+++|+|++|..||....... ....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~ 236 (331)
T 4aaa_A 162 VVKLCDFGFARTLAAPGEVY--DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID---QLYH 236 (331)
T ss_dssp CEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH
T ss_pred cEEEEeCCCceeecCCcccc--CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHH
Confidence 99999999997664432221 234679999999999875 68999999999999999999999997543211 1111
Q ss_pred HHHH----------Hhh------cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRN----------VMT------SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~----------~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.... ... .................+.....+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 237 IMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1100 000 00000000000000011123456899999999999999999998875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=314.91 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=200.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+++.||+|+||+||+|++. .+|+.||+|++....... ......+.+|+.++++++||||+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpniv~~ 119 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQKLRHPNTIQY 119 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEESCSSCH-----------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEc-cCCeEEEEEEEccccccc-----------hHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 4577999999999999999999865 489999999986443211 1224678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+. |+|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 120 ~~~~~~~~~~~lv~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 192 (348)
T 1u5q_A 120 RGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 192 (348)
T ss_dssp EEEEEETTEEEEEEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTE
T ss_pred EEEEEECCeEEEEEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCC
Confidence 999999999999999996 5888887542 356899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+||+|||++...... ....||+.|+|||++. ...++.++||||||+++|+|++|..||..... .
T Consensus 193 ~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~ 259 (348)
T 1u5q_A 193 VKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------M 259 (348)
T ss_dssp EEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------H
T ss_pred EEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------H
Confidence 999999999765432 1347899999999984 45789999999999999999999999865322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...........+.. .. . .....+.+++.+||+.||++|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~-~~-----~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 260 SALYHIAQNESPAL-QS-----G---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHHHHSCCCCC-CC-----T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCCCCC-CC-----C---CCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 22222222222111 00 1 11234789999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=313.43 Aligned_cols=263 Identities=21% Similarity=0.275 Sum_probs=205.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.|++|.+....... .....+.+|+.++++++||||+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~ 70 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTE------------AEKQMLVSEVNLLRELKHPNIVRY 70 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTTCCH------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred chhheeeehhccCCCCcEEEEEEEC-CCCcEEEEEEEEcccCCH------------HHHHHHHHHHHHHHhcCCCCCCeE
Confidence 4579999999999999999999865 489999999986543221 125678999999999999999999
Q ss_pred hceeec--CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC--CCCceeCCCCCCcEEec
Q 036970 119 LARVVR--PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH--RPRIIHRDIQPANVLID 194 (337)
Q Consensus 119 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~~~h~di~~~nil~~ 194 (337)
++++.+ ....++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ..+++|+||+|+||+++
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~ 150 (279)
T 2w5a_A 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150 (279)
T ss_dssp EEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC
T ss_pred EEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc
Confidence 998754 56789999999999999999876666677999999999999999999999543 12399999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
.++.++|+|||++.......... ....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... .
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~-- 222 (279)
T 2w5a_A 151 GKQNVKLGDFGLARILNHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----K-- 222 (279)
T ss_dssp SSSCEEECCCCHHHHC---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----H--
T ss_pred CCCCEEEecCchheeeccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----H--
Confidence 99999999999987764432211 134678999999999998899999999999999999999999975422 1
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
............. ++ ......+.+++.+||+.||++|||+.++++.+.
T Consensus 223 -~~~~~i~~~~~~~--~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 223 -ELAGKIREGKFRR--IP--------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -HHHHHHHHTCCCC--CC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -HHHHHHhhccccc--CC--------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1222222222111 11 112234889999999999999999999997654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=312.49 Aligned_cols=260 Identities=21% Similarity=0.274 Sum_probs=202.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEE--EEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCCh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVI--TIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNI 115 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 115 (337)
..++|++.+.||+|+||.||+|++.. ++..+ ++|.+...... .....+.+|+.+++++ +||||
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~v~iK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~hp~i 88 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASK-------------DDHRDFAGELEVLCKLGHHPNI 88 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC-------------------CHHHHHHHHHTTCCCCTTB
T ss_pred cHHHccceeeeecCCCceEEEEEEcc-CCcccceeeeeeccccch-------------HHHHHHHHHHHHHHhccCCCch
Confidence 34789999999999999999998753 56644 88887532211 1145688999999999 89999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhh------------cCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVS------------QGRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h 183 (337)
+++++++.+.+..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ ++|
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 165 (327)
T 1fvr_A 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIH 165 (327)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred hhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccC
Confidence 999999999999999999999999999996532 22357999999999999999999999655 999
Q ss_pred CCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCC
Q 036970 184 RDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPS 262 (337)
Q Consensus 184 ~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf 262 (337)
+||||+||+++.++.++|+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 166 ~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf 242 (327)
T 1fvr_A 166 RDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242 (327)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCccceEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999874432211 112355788999999998889999999999999999998 99999
Q ss_pred CCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 263 DDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
..... .+............. +......+.+++.+||+.||++|||+.++++.|+++
T Consensus 243 ~~~~~-------~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 243 CGMTC-------AELYEKLPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp TTCCH-------HHHHHHGGGTCCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcH-------HHHHHHhhcCCCCCC----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 75422 122222222111110 111223488999999999999999999999999876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=321.13 Aligned_cols=207 Identities=25% Similarity=0.283 Sum_probs=169.4
Q ss_pred hhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 36 FLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 36 ~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.....++|++++.||+|+||.||+|++. .+++.||||++....... .....+.+|+.+++.++||||
T Consensus 21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~nI 87 (432)
T 3n9x_A 21 NVHVPDNYIIKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFEDL------------IDCKRILREITILNRLKSDYI 87 (432)
T ss_dssp GCCCCTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSTTTSH------------HHHHHHHHHHHHHHHCCCTTB
T ss_pred cceecCCEEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCchhcCh------------HHHHHHHHHHHHHHHcCCCCc
Confidence 3456799999999999999999999865 489999999985432211 115678899999999999999
Q ss_pred hhhhceeecC-----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 116 VPLLARVVRP-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 116 ~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
+++++++... ...++||||++ ++|.+++. ....+++..++.++.||+.||.|||+.+ ++||||||+|
T Consensus 88 v~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~N 159 (432)
T 3n9x_A 88 IRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPAN 159 (432)
T ss_dssp CCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred ceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHH
Confidence 9999999776 56799999995 59999983 4566999999999999999999999665 9999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcc--------------------cccccccCcccccCCccc-cCCCCCCcccchhHh
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTR--------------------TTTWSLAETVGYIAPECH-QTVALSDKCDIYSFG 249 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG 249 (337)
|+++.++.+||+|||++......... .......||+.|+|||++ ....++.++||||||
T Consensus 160 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG 239 (432)
T 3n9x_A 160 CLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239 (432)
T ss_dssp EEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHH
T ss_pred eEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHH
Confidence 99999999999999999876533211 112356789999999986 556699999999999
Q ss_pred HHHHHHHhCCCCCC
Q 036970 250 VLLAVLMMGKFPSD 263 (337)
Q Consensus 250 ~vl~~l~~g~~pf~ 263 (337)
|++|||++|..||.
T Consensus 240 ~il~ell~g~~p~~ 253 (432)
T 3n9x_A 240 CIFAELLNMLQSHI 253 (432)
T ss_dssp HHHHHHHTTCTTTC
T ss_pred HHHHHHHhcccccc
Confidence 99999998665554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=330.66 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=205.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|++...... .......+.+|+.++++++||||+++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpniv~~ 91 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVK-----------QKTDKESLLREVQLLKQLDHPNIMKL 91 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCC-----------BSSCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccCceEEeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhcc-----------cchHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3478999999999999999999865 48999999998543221 11125678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe---cC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---DD 195 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~---~~ 195 (337)
++++.+....++||||+.+++|.+++. ..+.+++..++.++.||+.||.|||+.+ ++|+||||+||++ +.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 164 (484)
T 3nyv_A 92 YEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 164 (484)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSST
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCC
Confidence 999999999999999999999999983 4466999999999999999999999665 9999999999999 46
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++.+||+|||++.......... ...||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... .
T Consensus 165 ~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~ 233 (484)
T 3nyv_A 165 DANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------Y 233 (484)
T ss_dssp TCCEEECCTTHHHHBCCCCSHH---HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------H
T ss_pred CCcEEEEeeeeeEEcccccccc---cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------H
Confidence 7889999999998765443322 3468999999999877 689999999999999999999999975322 2
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+............. . ..+...+..+.++|.+||++||++|||+.++++
T Consensus 234 ~~~~~i~~~~~~~~-~------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 234 DILKKVEKGKYTFE-L------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHHCCCCCC-S------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCCCC-C------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 22233332221111 0 111223445889999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=318.86 Aligned_cols=253 Identities=20% Similarity=0.305 Sum_probs=194.1
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC--CCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--HRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~ 117 (337)
.++|++++.||+|+||.||+|.+. .++.||||++....... .....+.+|+.++..++ ||||++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~~------------~~~~~~~~Ei~~l~~l~~~~~~iv~ 120 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADN------------QTLDSYRNEIAYLNKLQQHSDKIIR 120 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCCH------------HHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred CCceEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEecccccH------------HHHHHHHHHHHHHHHcccCCCeEEE
Confidence 456999999999999999999865 59999999986543211 12567899999999996 599999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++..+...++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+||+++ ++
T Consensus 121 ~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~ 191 (390)
T 2zmd_A 121 LYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DG 191 (390)
T ss_dssp EEEEEECSSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SS
T ss_pred EEEEEecCCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CC
Confidence 9999999999999999 557899999854 34689999999999999999999955 499999999999995 57
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccC-----------CCCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-----------VALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
.+||+|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 999999999987654433323334578999999999865 368889999999999999999999997532
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
. ....+.......... ..+. .. ...+.+++.+||+.||++|||+.++++
T Consensus 272 ~------~~~~~~~~~~~~~~~-~~~~----~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 272 N------QISKLHAIIDPNHEI-EFPD----IP----EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp C------HHHHHHHHHCTTSCC-CCCC----CS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H------HHHHHHHHhCccccC-CCCc----cc----hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1 112222222221111 0110 11 234889999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=308.56 Aligned_cols=247 Identities=18% Similarity=0.226 Sum_probs=191.1
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLL 119 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~ 119 (337)
++|+++++||+|+||+||+|++. .+|+.||||++......... ......|+..+..+ +||||++++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~------------~~~~~~e~~~~~~~~~h~~iv~l~ 123 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKD------------RARKLAEVGSHEKVGQHPCCVRLE 123 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSCCSHHH------------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hheeeeheeccCCCeEEEEEEEC-CCCeEEEEEEecccccChHH------------HHHHHHHHHHHHHhcCCCcEEEEE
Confidence 78999999999999999999865 48999999987543322111 33445555555544 899999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 124 QAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCE
T ss_pred EEEEeCCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCE
Confidence 9999999999999999 67999988653 346999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++.......... ...||+.|+|||++.+ .++.++||||||+++|+|++|..|+..... ..
T Consensus 197 kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~ 262 (311)
T 3p1a_A 197 KLGDFGLLVELGTAGAGE---VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQ 262 (311)
T ss_dssp EECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HH
T ss_pred EEccceeeeecccCCCCc---ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HH
Confidence 999999987765433222 3468999999999887 789999999999999999999766543211 11
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
. +....... .. .......+.+++.+||+.||++|||+.++++
T Consensus 263 ~-~~~~~~~~----~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 263 Q-LRQGYLPP----EF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp H-HTTTCCCH----HH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H-HhccCCCc----cc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1 11111111 11 1112345899999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=305.67 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=203.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|.+. ++..||+|.+...... .+.+.+|+.+++.++||||+++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~~ 73 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMS---------------PDAFLAEANLMKQLQHQRLVRL 73 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSSC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCccc---------------HHHHHHHHHHHHhCCCcCcceE
Confidence 5689999999999999999999875 6788999998543211 4578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+ +..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 74 ~~~~~~-~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~ 147 (279)
T 1qpc_A 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLS 147 (279)
T ss_dssp EEEECS-SSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred EEEEcC-CCcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCC
Confidence 998764 5689999999999999998432 1125899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... . +.
T Consensus 148 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~---~~ 219 (279)
T 1qpc_A 148 CKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----P---EV 219 (279)
T ss_dssp EEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----H---HH
T ss_pred EEECCCcccccccCccccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----H---HH
Confidence 9999999998765433221 223456788999999998889999999999999999999 8999875322 1 12
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
............ +......+.+++.+||+.||++|||+.++++.|+++
T Consensus 220 ~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 220 IQNLERGYRMVR----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp HHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcccCCCC----------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 222221111110 111224488999999999999999999999999876
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=323.01 Aligned_cols=259 Identities=20% Similarity=0.205 Sum_probs=201.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|++.+...... .....+.+|..++..++||||+++
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~~~~~-----------~~~~~~~~E~~il~~~~hp~Iv~l 126 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKR-----------GEVSCFREERDVLVNGDRRWITQL 126 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHH-----------GGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhH-----------HHHHHHHHHHHHHHhcCCCCeeeE
Confidence 5689999999999999999999875 4899999999865332111 113457789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.+++
T Consensus 127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCC
Confidence 99999999999999999999999999643 246899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCcccc-------CCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-------TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
+||+|||++.......... ....+||+.|+|||++. ...++.++|+||||+++|||++|..||......
T Consensus 201 vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--- 276 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--- 276 (412)
T ss_dssp EEECCCTTCEECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---
T ss_pred EEEeechhheeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---
Confidence 9999999998765443322 12357899999999987 356899999999999999999999999754321
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEER---PNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~il~ 330 (337)
...............+. . ....+..+.++|.+||. +|.+| |+++++++
T Consensus 277 ~~~~~i~~~~~~~~~p~--~--------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 277 ETYGKIVHYKEHLSLPL--V--------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHHTHHHHCCCC--------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHHhcccCcCCCc--c--------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11111111111111110 0 01122348999999999 99998 58888864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=307.77 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=202.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|.+.... ..+.+|+.+++.++||||+++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~------------------~~~~~e~~~l~~l~h~~i~~~ 69 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN------------------EKAEREVKALAKLDHVNIVHY 69 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEET-TTCCEEEEEEEECCS------------------GGGHHHHHHHHHCCCTTBCCE
T ss_pred hccccceeeeeccCCceEEEEEEEc-CCCeEEEEEEecccc------------------HHHHHHHHHHHhCCCCCEEEE
Confidence 3578999999999999999999865 489999999985432 245679999999999999999
Q ss_pred hceeec----------------CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 036970 119 LARVVR----------------PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRII 182 (337)
Q Consensus 119 ~~~~~~----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~ 182 (337)
++++.. ....++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~ 144 (284)
T 2a19_B 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LI 144 (284)
T ss_dssp EEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred eeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 998864 34578999999999999999653 2356899999999999999999999665 99
Q ss_pred eCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCC
Q 036970 183 HRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPS 262 (337)
Q Consensus 183 h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf 262 (337)
|+||+|+||+++.++.++|+|||++.......... ...+++.|+|||.+.+..++.++||||||+++|+|++|..|+
T Consensus 145 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred eccCCHHHEEEcCCCCEEECcchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 99999999999999999999999988765443222 346799999999999989999999999999999999999886
Q ss_pred CCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 263 DDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
... ...... .........+ ...+.+++.+||+.||.+|||+.++++.|..++
T Consensus 222 ~~~---------~~~~~~-~~~~~~~~~~------------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 222 FET---------SKFFTD-LRDGIISDIF------------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHH---------HHHHHH-HHTTCCCTTS------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred hhH---------HHHHHH-hhcccccccC------------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 321 111111 1122111111 133789999999999999999999999998875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=314.91 Aligned_cols=273 Identities=24% Similarity=0.320 Sum_probs=196.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++ +++.||+|++...... ......|+..+..++||||+++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~---------------~~~~e~~~~~~~~~~h~~i~~~ 72 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANRQ---------------NFINEKNIYRVPLMEHDNIARF 72 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGGHH---------------HHHHHHHHHTSTTCCCTTBCCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccchh---------------hHHHHHHHHHHHhccCcchhhh
Confidence 357999999999999999999975 6899999998543211 1122345555666899999999
Q ss_pred hceeec-----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC------CCCceeCCCC
Q 036970 119 LARVVR-----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH------RPRIIHRDIQ 187 (337)
Q Consensus 119 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------~~~~~h~di~ 187 (337)
++.+.. ....++||||+++++|.+++.. ...++..++.++.|++.||.|||+.. +.|++|+|||
T Consensus 73 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dik 147 (336)
T 3g2f_A 73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147 (336)
T ss_dssp EEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCS
T ss_pred eecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccc
Confidence 875532 2245899999999999999943 23588899999999999999999550 0159999999
Q ss_pred CCcEEecCCCcEEEecccccccCCCCCc------ccccccccCcccccCCccccC-------CCCCCcccchhHhHHHHH
Q 036970 188 PANVLIDDDMEARISEFGLAKQIPNGRT------RTTTWSLAETVGYIAPECHQT-------VALSDKCDIYSFGVLLAV 254 (337)
Q Consensus 188 ~~nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~vl~~ 254 (337)
|+||+++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 148 p~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~e 227 (336)
T 3g2f_A 148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227 (336)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHH
Confidence 9999999999999999999987653321 112224568999999999987 356678999999999999
Q ss_pred HHhCCCCCCCccc-ccccch---------HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC
Q 036970 255 LMMGKFPSDDFFQ-HTKEMS---------FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324 (337)
Q Consensus 255 l~~g~~pf~~~~~-~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 324 (337)
|++|..||..... ...... .................++.. ..........+.++|.+||+.||++|||
T Consensus 228 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (336)
T 3g2f_A 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLT 305 (336)
T ss_dssp HHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred HHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcc
Confidence 9999877643221 111111 111111111111111111111 1223345667999999999999999999
Q ss_pred HHHHHHHHhhhh
Q 036970 325 SKDVRCMLSQIQ 336 (337)
Q Consensus 325 ~~~il~~L~~~~ 336 (337)
+.++++.|+++-
T Consensus 306 ~~e~l~~L~~ll 317 (336)
T 3g2f_A 306 AQXAEERMAELM 317 (336)
T ss_dssp HHHHHHHHHHHH
T ss_pred hHHHHHHHHHHH
Confidence 999999998864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=313.58 Aligned_cols=261 Identities=24% Similarity=0.318 Sum_probs=194.9
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
...++|++++.||+|+||.||+|.+. .+|+.||||++....... .....+.+|+.+++.++||||++
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~ 88 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSE------------LFAKRAYRELRLLKHMRHENVIG 88 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSH------------HHHHHHHHHHHHHHHCCBTTBCC
T ss_pred eecceEEEeEEeeecCCeEEEEEEEC-CCCCEEEEEEeCccccCH------------HHHHHHHHHHHHHHhCCCcCCCC
Confidence 35789999999999999999999865 489999999985433211 12567889999999999999999
Q ss_pred hhceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 118 LLARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 118 ~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
+++++.... ..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ ++|+||||+||
T Consensus 89 l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NI 159 (367)
T 1cm8_A 89 LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNL 159 (367)
T ss_dssp CSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred ceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHE
Confidence 999998764 359999999 7899999853 45899999999999999999999665 99999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
+++.++.+||+|||++........ ...+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....
T Consensus 160 ll~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-- 232 (367)
T 1cm8_A 160 AVNEDCELKILDFGLARQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-- 232 (367)
T ss_dssp EECTTCCEEECCCTTCEECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred EEcCCCCEEEEeeecccccccccC-----cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 999999999999999987543321 3467999999999887 67899999999999999999999999754321
Q ss_pred cchHHHHHHHHhhcCCCCcc------------------ccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTSENPSRT------------------IDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+..... .++... ..........+.....+.+|+.+||+.||++|||+.++++
T Consensus 233 --~~l~~i~~~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 233 --DQLKEIMKVTG-TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp --HHHHHHHHHHC-CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHHHHHHhcC-CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 11111111110 000000 0000000111122345889999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=303.27 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=198.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
....|++.+.||+|+||.||+|.+. .++..|++|.+........ ....+.+|+.+++.++||||+++
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~iv~~ 90 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKS------------ERQRFKEEAEMLKGLQHPNIVRF 90 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHH------------HHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEec-CCceEEEEEEecchhhCHH------------HHHHHHHHHHHHHhCCCCCeeee
Confidence 4566899999999999999999865 4889999999865433221 25678899999999999999999
Q ss_pred hceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCcEE
Q 036970 119 LARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPR--IIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--~~h~di~~~nil 192 (337)
++++.. ....++||||+++++|.+++.. .+.+++..++.++.|++.||.||| ..+ ++|+||+|+||+
T Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil 163 (290)
T 1t4h_A 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp EEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEE
T ss_pred eeeeccccCCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEE
Confidence 998875 3457999999999999999954 356899999999999999999999 555 999999999999
Q ss_pred ec-CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 193 ID-DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++ .++.++|+|||++......... ...||+.|+|||.+.+ .++.++||||||+++|+|++|..||.....
T Consensus 164 ~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---- 234 (290)
T 1t4h_A 164 ITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---- 234 (290)
T ss_dssp ESSTTSCEEECCTTGGGGCCTTSBE----ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----
T ss_pred EECCCCCEEEeeCCCcccccccccc----cccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc----
Confidence 98 7889999999999765433222 3468999999998875 589999999999999999999999965322
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............ .....+. .. ...+.+++.+||+.||++|||+.++++
T Consensus 235 --~~~~~~~~~~~~-~~~~~~~----~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 235 --AAQIYRRVTSGV-KPASFDK----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --HHHHHHHHTTTC-CCGGGGG----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHhccC-CccccCC----CC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 122222222221 1111111 11 134889999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=311.27 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=196.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++ .|+.||+|.+..... .+.+.+|+.++++++||||+++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~h~~iv~~ 79 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT----------------AQAFLAEASVMTQLRHSNLVQL 79 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC------------------HHHHHTHHHHTTCCCTTBCCE
T ss_pred ChhhceEEeEEecCCCceEEEEEE---cCCEEEEEEecchhH----------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 468999999999999999999986 588999999854321 4578899999999999999999
Q ss_pred hceeecC-CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 119 LARVVRP-DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 119 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
++++.+. +..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 154 (278)
T 1byg_A 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDN 154 (278)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred EEEEEcCCCceEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCC
Confidence 9987554 57899999999999999996532 234789999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
.++|+|||++........ ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .....
T Consensus 155 ~~~l~Dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~ 225 (278)
T 1byg_A 155 VAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVP 225 (278)
T ss_dssp CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHH
T ss_pred cEEEeecccccccccccc-----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence 999999999876543221 2356888999999998889999999999999999998 9999875322 11111
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
......... . +......+.+++.+||+.||++|||+.++++.|++++
T Consensus 226 ---~~~~~~~~~------~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 226 ---RVEKGYKMD------A----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ---HHTTTCCCC------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHhcCCCCC------C----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 111111110 0 1112234889999999999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=329.07 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=197.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|++. .++..||+|++........ ....+.+|+.+++.++||||++++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~hpniv~~~ 102 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTS------------SNSKLLEEVAVLKLLDHPNIMKLY 102 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEET-TTCCEEEEEEEEC-----C------------TTHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEEC-CCCcEEEEEEEeccccCch------------HHHHHHHHHHHHHhCCCCCCCeEE
Confidence 457999999999999999999865 4899999999865432111 145788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC---
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD--- 196 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~--- 196 (337)
+++.+....++||||+++++|.+.+.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++..
T Consensus 103 ~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 175 (494)
T 3lij_A 103 DFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKD 175 (494)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTT
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCC
Confidence 999999999999999999999998844 345899999999999999999999665 9999999999999764
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+.+||+|||++......... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... .+
T Consensus 176 ~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~ 244 (494)
T 3lij_A 176 ALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QE 244 (494)
T ss_dssp CCEEECCCTTCEECBTTBCB---CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH
T ss_pred CcEEEEECCCCeECCCCccc---cccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HH
Confidence 45999999999776543322 23578999999999864 689999999999999999999999975422 22
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............. . ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 245 ~~~~i~~~~~~~~---~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 245 ILRKVEKGKYTFD---S----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHHTCCCCC---S----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCCCCCC---c----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 2333322221110 0 011122345889999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=313.26 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=204.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|++. .+++.|++|++....... ....+.+.+|+.+++.++||||+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~ 106 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLK-----------PHQREKMSMEISIHRSLAHQHVVGF 106 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCS-----------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhhhcC-----------HHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 5689999999999999999999865 478999999986443211 1225678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 179 (335)
T 2owb_A 107 HGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLE 179 (335)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCC
T ss_pred EEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCC
Confidence 9999999999999999999999998854 346899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++.......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+..
T Consensus 180 ~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~ 250 (335)
T 2owb_A 180 VKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETY 250 (335)
T ss_dssp EEECCCTTCEECCSTTCCB--CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHH
T ss_pred EEEeeccCceecccCcccc--cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHH
Confidence 9999999998765332221 235689999999999998899999999999999999999999975321 1111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......... . ......+.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~---~--------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 251 LRIKKNEYSI---P--------KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHTCCCC---C--------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHhcCCCCC---C--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1221111110 0 011234789999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=311.95 Aligned_cols=269 Identities=22% Similarity=0.318 Sum_probs=207.0
Q ss_pred ccCcccccccccccccceEEeeee---cCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAEL---PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
..++|++++.||+|+||.||+|++ ...+|+.||+|++..... .....+.+|+.+++.++||||
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i 104 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--------------EHLRDFEREIEILKSLQHDNI 104 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS--------------HHHHHHHHHHHHHHTCCCTTB
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCCCe
Confidence 567899999999999999999985 234789999999854321 125678999999999999999
Q ss_pred hhhhceeecCC--CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 116 VPLLARVVRPD--CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 116 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++++++...+ ..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 105 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli 178 (326)
T 2w1i_A 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILV 178 (326)
T ss_dssp CCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred eeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEE
Confidence 99999887654 67999999999999999954 2345899999999999999999999655 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc----
Q 036970 194 DDDMEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH---- 268 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~---- 268 (337)
+.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 179 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~ 258 (326)
T 2w1i_A 179 ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258 (326)
T ss_dssp EETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHH
T ss_pred cCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHh
Confidence 99999999999999876544321 1222345677899999999888999999999999999999999997642110
Q ss_pred ----cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 269 ----TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 269 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.........+........... .+......+.+++.+||+.||++|||+.++++.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 259 IGNDKQGQMIVFHLIELLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HCTTCCTHHHHHHHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccccchhhhHHHHHHHhhcCCCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000001111111111111100 01122344889999999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=324.75 Aligned_cols=199 Identities=24% Similarity=0.357 Sum_probs=154.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.||||++....... .....+.+|+.+++.++||||+++
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l 117 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRVFEDL------------IDCKRILREIAILNRLNHDHVVKV 117 (458)
T ss_dssp SCTTEEECCC-------CEEEEEEC-C--CEEEEEEECSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCCCeEEeeEeeecCCeEEEEEEEC-CCCcEEEEEEechhhcCH------------HHHHHHHHHHHHHHhCCCCCCCce
Confidence 4589999999999999999999865 489999999985432211 115678899999999999999999
Q ss_pred hceeecC-----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 119 LARVVRP-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 119 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
++++... ...++||||+ +++|.+++ .....+++..++.++.||+.||.|||+.+ ++||||||+||++
T Consensus 118 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl 189 (458)
T 3rp9_A 118 LDIVIPKDVEKFDELYVVLEIA-DSDFKKLF----RTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLV 189 (458)
T ss_dssp EEECCCSCTTTCCCEEEEECCC-SEEHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEE
T ss_pred EEEEecCCcccCceEEEEEecc-ccchhhhc----ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEE
Confidence 9998543 5679999998 56899988 34567999999999999999999999665 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcc-------------------------cccccccCcccccCCccc-cCCCCCCcccchh
Q 036970 194 DDDMEARISEFGLAKQIPNGRTR-------------------------TTTWSLAETVGYIAPECH-QTVALSDKCDIYS 247 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws 247 (337)
+.++.+||+|||++......... .......||+.|+|||++ ....++.++||||
T Consensus 190 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwS 269 (458)
T 3rp9_A 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWS 269 (458)
T ss_dssp CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHH
T ss_pred CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHH
Confidence 99999999999999876432110 112245779999999976 4567999999999
Q ss_pred HhHHHHHHHhC
Q 036970 248 FGVLLAVLMMG 258 (337)
Q Consensus 248 lG~vl~~l~~g 258 (337)
|||++|||++|
T Consensus 270 lG~il~elltg 280 (458)
T 3rp9_A 270 IGCIFAELLNM 280 (458)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHHh
Confidence 99999999993
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=320.48 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=192.8
Q ss_pred cCcccccccccccccceEEeeeecCCC--CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSS--GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
...|.+.+.||+|+||+||+|++...+ +..||+|.+..... ......+.+|+.++++++||||++
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~il~~l~hpnIv~ 154 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-------------IGEVSQFLTEGIIMKDFSHPNVLS 154 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC-------------SHHHHHHHHHHTTSTTCCCTTBCC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC-------------HHHHHHHHHHHHHHHhCCCCCcce
Confidence 346788899999999999999864323 34688998743211 122567899999999999999999
Q ss_pred hhceeec-CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 118 LLARVVR-PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 118 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
+++++.+ ++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 228 (373)
T 3c1x_A 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEK 228 (373)
T ss_dssp CCEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred EEEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCC
Confidence 9998754 5678999999999999999943 3456889999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcc--cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 197 MEARISEFGLAKQIPNGRTR--TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
+.+||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||..... ..
T Consensus 229 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~----~~ 304 (373)
T 3c1x_A 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FD 304 (373)
T ss_dssp CCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS----SC
T ss_pred CCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH----HH
Confidence 99999999999866433221 11223456788999999999899999999999999999999 6778765322 11
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
....+ ........ +......+.+++.+||+.||++|||+.++++.|+++
T Consensus 305 ~~~~~---~~~~~~~~----------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 305 ITVYL---LQGRRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp HHHHH---HTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH---HcCCCCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22222 11111110 011223488999999999999999999999999876
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=317.26 Aligned_cols=264 Identities=20% Similarity=0.235 Sum_probs=193.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||+||+|++. .+++.||+|++....... .....+.+|+.++++++||||+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~ 98 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDT-VTNETVAIKRIRLEHEEE------------GVPGTAIREVSLLKELQHRNIIEL 98 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECCCCC--------------------CHHHHHHGGGCCCTTBCCE
T ss_pred chhhEEEEEEEEecCCeEEEEEEEC-CCCceEEEEEEccccccc------------ccchhHHHHHHHHHHcCCCCcceE
Confidence 5689999999999999999999865 489999999985443211 114467789999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec----
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID---- 194 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~---- 194 (337)
++++.++...++||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++
T Consensus 99 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 99 KSVIHHNHRLHLIFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp EEEEEETTEEEEEEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC---
T ss_pred EEEEecCCEEEEEEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCC
Confidence 9999999999999999974 99999843 345899999999999999999999665 99999999999995
Q ss_pred -CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 195 -DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 195 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
..+.+||+|||++.......... ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||..... .
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~ 244 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----I 244 (329)
T ss_dssp --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred CccceEEECcCCCccccCCccccc--CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----H
Confidence 44559999999997664332221 134679999999999875 489999999999999999999999975322 1
Q ss_pred hHHHHHHHHhhcCCCCcccc------------ccccCCChHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWMRNVMTSENPSRTID------------SKLIGNGYEE-----QMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+........ ..... +......... ....+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 245 DQLFKIFEVLGLPD-DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHHHCCCC-TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhCCCc-hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 11111111111110 00000 0000000010 2345889999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=303.38 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=195.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+++.||+|+||.||+|++. .+|+.|++|++....... .+....+.+|+..++.++||||+++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~ 76 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKIRS-----------LDVVGKIKREIQNLKLFRHPHIIKL 76 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred eeccEEEEeeecCCCCeEEEEEEEC-CCCceEEEEEeccccccc-----------hhHHHHHHHHHHHHhcCCCCCEeEE
Confidence 4578999999999999999999865 489999999985432211 1125678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 149 (276)
T 2h6d_A 77 YQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMN 149 (276)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSC
T ss_pred EEEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCC
Confidence 9999999999999999999999999954 245899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++|+|||++.......... ...+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||..... ...
T Consensus 150 ~~l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~ 219 (276)
T 2h6d_A 150 AKIADFGLSNMMSDGEFLR---TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTL 219 (276)
T ss_dssp EEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred EEEeecccccccCCCccee---cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHH
Confidence 9999999998765433222 3467899999999988765 5789999999999999999999965321 112
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........... + ......+.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~~~~~~~~---~--------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 220 FKKIRGGVFYI---P--------EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHHCCCCC---C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhhcCcccC---c--------hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 22222111110 0 111234889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=306.95 Aligned_cols=264 Identities=25% Similarity=0.317 Sum_probs=199.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCc--EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGR--VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|++.+.||+|+||+||+|++...+++ .||+|++...... .......+.+|+.++++++||||+
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~ 84 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----------QPEAMDDFIREVNAMHSLDHRNLI 84 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------------CHHHHHHHHHHHHHHHCCCTTBC
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-----------CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 568999999999999999999986543443 6899988543221 112256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.++. .++|+||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+
T Consensus 85 ~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~ 157 (291)
T 1u46_A 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATR 157 (291)
T ss_dssp CEEEEECSSS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEET
T ss_pred cEEEEEccCC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCC
Confidence 9999988765 88999999999999998653 345899999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchH
Q 036970 197 MEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~ 274 (337)
+.++|+|||++......... .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------- 230 (291)
T 1u46_A 158 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------- 230 (291)
T ss_dssp TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------
T ss_pred CCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------
Confidence 99999999999876543322 12223456788999999988888999999999999999999 9999975422
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+............. . +......+.+++.+||+.||++|||+.++++.|.+++
T Consensus 231 ~~~~~~~~~~~~~~~-~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 231 SQILHKIDKEGERLP-R--------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HHHHHHHHTSCCCCC-C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHccCCCCC-C--------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 122222222221110 0 1112344889999999999999999999999998874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=306.81 Aligned_cols=252 Identities=26% Similarity=0.357 Sum_probs=198.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|.+. .+|+.||+|.+..... ...+.+|+.++..++||||+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~----------------~~~~~~e~~~l~~l~h~~i~~~ 89 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVESD----------------LQEIIKEISIMQQCDSPHVVKY 89 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEET-TTCCEEEEEEEETTSC----------------CHHHHHHHHHHHTCCCTTBCCE
T ss_pred chhhhhhheeeccCCCeEEEEEEEC-CCCCEEEEEecCchHH----------------HHHHHHHHHHHHhCCCCCCccE
Confidence 6789999999999999999999865 4799999999854321 3568889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 163 (314)
T 3com_A 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGH 163 (314)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred EEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCC
Confidence 9999999999999999999999999853 2456899999999999999999999655 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++......... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ....
T Consensus 164 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~ 234 (314)
T 3com_A 164 AKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------MRAI 234 (314)
T ss_dssp EEECCCTTCEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHH
T ss_pred EEEeecccchhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------HHHH
Confidence 999999999765433221 1234679999999999998999999999999999999999999975322 1111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........+... .+......+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 235 FMIPTNPPPTFR--------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHSCCCCCS--------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHhcCCCcccC--------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111112111110 11112345889999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=305.17 Aligned_cols=251 Identities=28% Similarity=0.396 Sum_probs=204.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+++.||+|++...... .....+.+|+.++..++||||+++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~ 85 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAE-------------DEIEDIQQEITVLSQCDSPYVTKY 85 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEETTTCS-------------TTHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEEC-CCCcEEEEEEecccccH-------------HHHHHHHHHHHHHHhCCCCCEeEE
Confidence 5688999999999999999999865 48999999998543221 125678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.++...++||||+++++|.+++. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 157 (303)
T 3a7i_A 86 YGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGE 157 (303)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEecCCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCC
Confidence 999999999999999999999999982 356899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
++|+|||++.......... ....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... . ...
T Consensus 158 ~kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~---~~~ 228 (303)
T 3a7i_A 158 VKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----M---KVL 228 (303)
T ss_dssp EEECCCTTCEECBTTBCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----H---HHH
T ss_pred EEEeecccceecCcccccc--CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----H---HHH
Confidence 9999999997765432221 235679999999999998999999999999999999999999875322 1 111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........+. ..... ...+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~~~~~~~------~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 229 FLIPKNNPPT------LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HHHHHSCCCC------CCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhhcCCCCC------Ccccc----CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111111 11111 234889999999999999999999976
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=314.35 Aligned_cols=200 Identities=23% Similarity=0.286 Sum_probs=172.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-----CC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-----HR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~ 113 (337)
..++|++++.||+|+||+||+|++. .+++.||+|++..... ....+..|+.+++.+. ||
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNIKK---------------YTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSCHH---------------HHHHHHHHHHHHHHTCCCSTTGG
T ss_pred ecCEEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEeccchh---------------hhhhhHHHHHHHHHhcccCCCCC
Confidence 5689999999999999999999875 4889999999853221 1345667888888775 99
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
||+++++++...+..++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+.+ ++|+||||+||++
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 170 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILL 170 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEE
Confidence 9999999999999999999999 8899999965 23345899999999999999999999665 9999999999999
Q ss_pred cC-------------------------CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhH
Q 036970 194 DD-------------------------DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSF 248 (337)
Q Consensus 194 ~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 248 (337)
+. ++.+||+|||++........ ...||+.|+|||++.+..++.++|||||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG-----SIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC-----SCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCc-----CccCcccccCcHHHcCCCCCCccchHHH
Confidence 75 78899999999976543222 3567999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCc
Q 036970 249 GVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 249 G~vl~~l~~g~~pf~~~ 265 (337)
|+++|+|++|..||...
T Consensus 246 G~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHSSCSCCCS
T ss_pred HHHHHHHHHCCCCCCCC
Confidence 99999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=314.26 Aligned_cols=262 Identities=18% Similarity=0.213 Sum_probs=194.2
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|.+++.||+|+||+||+|++. .+++.||+|++........ ...+.+|+.+++.++||||+++++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~-------------~~~~~~E~~~l~~l~h~~iv~~~~ 67 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGA-------------PCTAIREVSLLKDLKHANIVTLHD 67 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECC-------------------CCCCCCCHHHHSCCCCTTBCCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEeccccccc-------------chhHHHHHHHHHhcCCCCCCeeee
Confidence 68999999999999999999865 4899999999854322110 113446999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+++..++||||++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 68 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~k 140 (324)
T 3mtl_A 68 IIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELK 140 (324)
T ss_dssp EEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEE
Confidence 9999999999999996 589988854 3456899999999999999999999665 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||++......... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+... ......+.
T Consensus 141 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~ 214 (324)
T 3mtl_A 141 LADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV----EEQLHFIF 214 (324)
T ss_dssp ECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred EccCcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 9999998765433221 113467999999999876 5689999999999999999999999976432 22222222
Q ss_pred HHhhcCCCCcccccccc-----------------CCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLI-----------------GNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... ....+.... ....+.....+.+++.+||+.||++|||+.++++
T Consensus 215 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 215 RILGTPT-EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHCCCC-TTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhCCCC-hHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 2222111 111110000 0001112345889999999999999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=309.00 Aligned_cols=250 Identities=20% Similarity=0.270 Sum_probs=198.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|++.+.||+|+||+||+|++. .+++.||+|++........ ....+.+|+..+..+ +||||++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~------------~~~~~~~e~~~~~~l~~h~~iv~ 75 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGSV------------DEQNALREVYAHAVLGQHSHVVR 75 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCCTTSH------------HHHHHHHHHHHHHHSCSCTTBCC
T ss_pred ccchhhhhhhhcCCCceEEEEEEEc-CCCceEEEEEecccccccH------------HHHHHHHHHHHHHHhCCCCCeee
Confidence 3578999999999999999999865 4899999999865432221 145678899999888 8999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC-
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD- 196 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~- 196 (337)
+++++.+.+..++||||+++++|.+++.........+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~ 152 (289)
T 1x8b_A 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTS 152 (289)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---
T ss_pred eeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCC
Confidence 999999999999999999999999999765554567999999999999999999999665 9999999999999844
Q ss_pred ------------------CcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHh
Q 036970 197 ------------------MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMM 257 (337)
Q Consensus 197 ------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~ 257 (337)
..++|+|||.+........ ..||+.|+|||.+.+. .++.++||||||+++|+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (289)
T 1x8b_A 153 IPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226 (289)
T ss_dssp -----------------CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred CCcccccccccccccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence 4799999999887654322 3579999999999876 56679999999999999999
Q ss_pred CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 258 GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 258 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
|.+|+.... . .........+. +. ......+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~------~----~~~~~~~~~~~--~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 227 AEPLPRNGD------Q----WHEIRQGRLPR--IP--------QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCCCSSSH------H----HHHHHTTCCCC--CS--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCcchh------H----HHHHHcCCCCC--CC--------cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 998764321 1 11111111111 01 111234889999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=315.89 Aligned_cols=259 Identities=23% Similarity=0.357 Sum_probs=202.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .++..||+|++...... .....+.+|+.+++.++||||+++
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~ 96 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGF 96 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECCCCH-------------HHHHHHHHHHGGGGGCCCTTBCCE
T ss_pred ccccceeeeeecCCCCeEEEEEEEC-CCCcEEEEEEeccccCH-------------HHHHHHHHHHHHHHHCCCCCEEEE
Confidence 4678999999999999999999865 48999999998654221 125678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ |++|+||||+||+++.++.
T Consensus 97 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~ 170 (360)
T 3eqc_A 97 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGE 170 (360)
T ss_dssp EEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCC
T ss_pred eEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCC
Confidence 9999999999999999999999999954 245899999999999999999999641 4999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc-------
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE------- 271 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~------- 271 (337)
++|+|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 171 ~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 246 (360)
T 3eqc_A 171 IKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246 (360)
T ss_dssp EEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---
T ss_pred EEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence 999999998654221 112347899999999999999999999999999999999999999753221100
Q ss_pred ----------------------------chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC
Q 036970 272 ----------------------------MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP 323 (337)
Q Consensus 272 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 323 (337)
....+..........+.. ........+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rp 317 (360)
T 3eqc_A 247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL---------PSGVFSLEFQDFVNKCLIKNPAERA 317 (360)
T ss_dssp ---------------------------CCCHHHHHHHHHHSCCCCC---------CTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred cccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCC---------CcccccHHHHHHHHHHhhcChhhCC
Confidence 000011111111111100 0011233588999999999999999
Q ss_pred CHHHHHH
Q 036970 324 NSKDVRC 330 (337)
Q Consensus 324 s~~~il~ 330 (337)
|+.++++
T Consensus 318 t~~ell~ 324 (360)
T 3eqc_A 318 DLKQLMV 324 (360)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=307.32 Aligned_cols=263 Identities=21% Similarity=0.280 Sum_probs=196.3
Q ss_pred ccCccccc-ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChh
Q 036970 39 KEDCFASL-EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~-~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~ 116 (337)
..++|++. +.||+|+||.||+|++. .+++.||+|++..... .....+.+|+.++.++ +||||+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~~~~h~~i~ 74 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPG--------------HIRSRVFREVEMLYQCQGHRNVL 74 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECS-SSCCEEEEEEEECCSS--------------CCHHHHHHHHHHHHHTCCCTTBC
T ss_pred cceeEEecCceecCCceEEEEEEEEc-CCCcEEEEEEEeeCcc--------------hhHHHHHHHHHHHHHhcCCCCee
Confidence 45788885 78999999999999855 4899999999854321 1145788999999885 799999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.+++..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~ 147 (316)
T 2ac3_A 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHP 147 (316)
T ss_dssp CEEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCS
T ss_pred eEEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccC
Confidence 999999999999999999999999999954 346899999999999999999999665 9999999999999977
Q ss_pred Cc---EEEecccccccCCCCCc-----ccccccccCcccccCCccccC-----CCCCCcccchhHhHHHHHHHhCCCCCC
Q 036970 197 ME---ARISEFGLAKQIPNGRT-----RTTTWSLAETVGYIAPECHQT-----VALSDKCDIYSFGVLLAVLMMGKFPSD 263 (337)
Q Consensus 197 ~~---~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~~l~~g~~pf~ 263 (337)
+. +||+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp SSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence 66 99999999876542211 111123458999999999875 457899999999999999999999997
Q ss_pred Ccccccccc-------h-HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 264 DFFQHTKEM-------S-FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 264 ~~~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... . ............... +... .......+.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~---~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEF---PDKD----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCCCSCSCC----CCHHHHHHHHHHHHHCCCCC---CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccccccccccchhHHHHHHHHHhccCccc---Cchh----cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 643221100 0 111122222211110 0000 0112345889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.67 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=201.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|+||.||+|++. .+|+.||+|.+........ ......+.+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSS--------RRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTC--------SSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEc-CCCCeeehHHhhhcccccc--------ccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 367999999999999999999865 4799999999865432211 0011256789999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC--
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-- 197 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-- 197 (337)
+++.+....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 147 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVP 147 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSS
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCC
Confidence 999999999999999999999999954 346899999999999999999999665 99999999999998776
Q ss_pred --cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 198 --EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 198 --~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
.++|+|||++.......... ...+++.|+|||.+.+..++.++||||||+++|+|++|..||..... .
T Consensus 148 ~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~ 217 (283)
T 3bhy_A 148 NPRIKLIDFGIAHKIEAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------Q 217 (283)
T ss_dssp SCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------H
T ss_pred CCceEEEecccceeccCCCccc---ccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------H
Confidence 89999999998765432221 34679999999999998999999999999999999999999975322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+........... .+... .......+.+++.+||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~~---~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 218 ETLTNISAVNYD---FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHHHTTCCC---CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhHhcccC---Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 112222111111 01111 1112344889999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.34 Aligned_cols=264 Identities=14% Similarity=0.138 Sum_probs=200.6
Q ss_pred cCcccccccccccccceEEeeeecCC-------CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGS-------SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 112 (337)
.++|++.+.||+|+||.||+|++... .++.||+|.+... ..+.+|+.++++++|
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------------~~~~~E~~~l~~l~h 101 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------------GRLFNEQNFFQRAAK 101 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------------STHHHHHHHHHHHCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------------chHHHHHHHHHHhcc
Confidence 58999999999999999999987632 4889999998532 247789999999999
Q ss_pred CChhhh---------------hceeec-CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC
Q 036970 113 RNIVPL---------------LARVVR-PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMS 176 (337)
Q Consensus 113 ~ni~~~---------------~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 176 (337)
|||+++ ++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.
T Consensus 102 ~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~ 178 (352)
T 2jii_A 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN 178 (352)
T ss_dssp HHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999984 445554 66789999999 99999999642 235699999999999999999999966
Q ss_pred CCCCceeCCCCCCcEEecCCC--cEEEecccccccCCCCCcc-----cccccccCcccccCCccccCCCCCCcccchhHh
Q 036970 177 HRPRIIHRDIQPANVLIDDDM--EARISEFGLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQTVALSDKCDIYSFG 249 (337)
Q Consensus 177 ~~~~~~h~di~~~nil~~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG 249 (337)
+ ++|+||||+||+++.++ .++|+|||++......... .......||+.|+|||++.+..++.++||||||
T Consensus 179 ~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 255 (352)
T 2jii_A 179 E---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG 255 (352)
T ss_dssp T---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred C---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHH
Confidence 5 99999999999999988 8999999999776532211 111234789999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 250 VLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 250 ~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
+++|+|++|..||..... ................ . ...+... ........+.+++.+||+.||++|||+.+++
T Consensus 256 ~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~-~-~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 328 (352)
T 2jii_A 256 YCMLKWLYGFLPWTNCLP--NTEDIMKQKQKFVDKP-G-PFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLR 328 (352)
T ss_dssp HHHHHHHHSCCTTGGGTT--CHHHHHHHHHHHHHSC-C-CEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHHhCCCCcccCCc--CHHHHHHHHHhccCCh-h-hhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHH
Confidence 999999999999975432 1122222222222111 1 1111000 0011124488999999999999999999999
Q ss_pred HHHhhh
Q 036970 330 CMLSQI 335 (337)
Q Consensus 330 ~~L~~~ 335 (337)
+.|+++
T Consensus 329 ~~L~~~ 334 (352)
T 2jii_A 329 NNLEAL 334 (352)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=306.56 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=200.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|++. .+|+.||+|.+....... ...+.+|+.+++.++||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~ 71 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPAFR--------------DSSLENEIAVLKKIKHENIVTL 71 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC--------------------HHHHHHHHHHHCCCTTBCCE
T ss_pred hhccceeeeeccCCCCceEEEEEEC-CCCCEEEEEEEecccccc--------------hHHHHHHHHHHHhCCCCCeeeh
Confidence 3578999999999999999999865 489999999986432211 3467889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe---cC
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---DD 195 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~---~~ 195 (337)
++++.+....++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++|+||+|+||++ +.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~ 144 (304)
T 2jam_A 72 EDIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEE 144 (304)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSST
T ss_pred hhhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCC
Confidence 9999999999999999999999999854 345899999999999999999999665 9999999999999 67
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++.++|+|||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|..||..... .
T Consensus 145 ~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~ 213 (304)
T 2jam_A 145 NSKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------S 213 (304)
T ss_dssp TCCEEBCSCSTTCCCCCBTT----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------H
T ss_pred CCCEEEccCCcceecCCCcc----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------H
Confidence 88999999999876443211 134679999999999998999999999999999999999999965322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............. ... .+......+.+++.+||+.||++|||+.++++
T Consensus 214 ~~~~~i~~~~~~~---~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 214 KLFEKIKEGYYEF---ESP----FWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHHCCCCC---CTT----TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCCC---Ccc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1222222221110 001 11122344889999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=318.93 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=192.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|.+. .+++.||+|++......... .........+.+|+.++++++||||+++
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~hpniv~l 205 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGS------AREADPALNVETEIEILKKLNHPCIIKI 205 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC--------------CCHHHHHHHHHHCCCTTBCCC
T ss_pred hhccEEEEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhcccc------cccchhHHHHHHHHHHHHhCCCCCEeeE
Confidence 4689999999999999999999865 48899999998654321110 0001113357889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC-
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM- 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~- 197 (337)
++++.. ...++||||+++++|.+++ ...+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 206 ~~~~~~-~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 206 KNFFDA-EDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CEEEES-SEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred EEEEec-CceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence 999865 4578999999999999887 45667999999999999999999999665 99999999999997544
Q ss_pred --cEEEecccccccCCCCCcccccccccCcccccCCccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 198 --EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT---VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 198 --~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
.+||+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ..
T Consensus 278 ~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~ 351 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QV 351 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS---SC
T ss_pred cceEEEeecccceecCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc---hH
Confidence 5999999999876543222 23578999999999864 5678899999999999999999999975322 11
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+.. ..... .+. .+......+.+++.+||+.||++|||+.++++
T Consensus 352 ~~~~~i~~---~~~~~---~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 352 SLKDQITS---GKYNF---IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CHHHHHHT---TCCCC---CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhc---CCCCC---Cch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 12222111 11100 000 01112345899999999999999999999886
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=326.56 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=201.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+++.||+|+||+||+|++. .++..||+|++.......... ...........+.+.+|+.++++++||||+++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRY-SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEC-----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccceEEEeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhcccccc-cccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4688999999999999999999865 488999999987654321110 00011111225678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC-
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM- 197 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~- 197 (337)
++++.+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 9999999999999999999999999854 345999999999999999999999665 99999999999999775
Q ss_pred --cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 198 --EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 198 --~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
.+||+|||++.......... ...||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... .
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~ 253 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND-------Q 253 (504)
T ss_dssp CSSEEECCCTTCEECCTTSCBC---CCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------H
T ss_pred CccEEEEECCCCEEcCCCCccc---cccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------H
Confidence 69999999998765443222 3478999999999875 689999999999999999999999975432 2
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+............. . ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 254 ~~~~~i~~~~~~~~---~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 254 DIIKKVEKGKYYFD---F----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHHCCCCCC---H----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCCCC---c----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22333322221110 0 001122345899999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=314.64 Aligned_cols=269 Identities=21% Similarity=0.225 Sum_probs=195.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|++......... ......+.+|+.+++.++||||+++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAK---------DGINRTALREIKLLQELSHPNIIGL 77 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC---------------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred HhcccEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCcchhh---------hhhhHHHHHHHHHHhhCCCCCCCeE
Confidence 4688999999999999999999865 47999999998543321110 0112467889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++ +|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 150 (346)
T 1ua2_A 78 LDAFGHKSNISLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGV 150 (346)
T ss_dssp EEEECCTTCCEEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred EEEEeeCCceEEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCC
Confidence 9999999999999999976 8888873 23456889999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++.......... ....+|+.|+|||++.+. .++.++||||||+++|+|++|.+||.+... ......
T Consensus 151 ~kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----~~~~~~ 224 (346)
T 1ua2_A 151 LKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTR 224 (346)
T ss_dssp EEECCCGGGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH
T ss_pred EEEEecccceeccCCcccC--CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHH
Confidence 9999999998765332221 235679999999998764 478899999999999999999999875422 111111
Q ss_pred HHHHhhcCCCCcc-----ccccc----cCCC-----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRT-----IDSKL----IGNG-----YEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~-----~~~~~----~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+............ ..... .... .......+.+++.+||+.||++|||+.++++
T Consensus 225 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1111111111000 00000 0000 0122356899999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=307.39 Aligned_cols=265 Identities=26% Similarity=0.359 Sum_probs=186.3
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
-..++|++.+.||+|+||.||+|++. .+++.||+|.+...... .....+.+|+.+++.++||||++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~ 77 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEKCQ-------------TSMDELLKEIQAMSQCHHPNIVS 77 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC-----------------------------CCCCCCCTTBCC
T ss_pred cchhhhhhhheeccccceEEEEEEEC-CCCcEEEEEEEEhhhcc-------------hhHHHHHHHHHHHhhcCCCCEee
Confidence 35689999999999999999999854 47899999988543211 11456888999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhc----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ----GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~ 154 (303)
T 2vwi_A 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILL 154 (303)
T ss_dssp EEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEE
T ss_pred EEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEE
Confidence 99999999999999999999999999865322 2456899999999999999999999665 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCc---ccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 194 DDDMEARISEFGLAKQIPNGRT---RTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
+.++.++|+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 155 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 233 (303)
T 2vwi_A 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM- 233 (303)
T ss_dssp CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-
T ss_pred cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-
Confidence 9999999999999876543221 111223568999999999876 46899999999999999999999999764321
Q ss_pred ccchHHHHHHHHhhcCCCC---ccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 270 KEMSFVQWMRNVMTSENPS---RTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. .........+. ...+...... ....+.+++.+||+.||++|||+.++++
T Consensus 234 ---~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 234 ---KV---LMLTLQNDPPSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ---GH---HHHHHTSSCCCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---hH---HHHHhccCCCccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 11111111111 0011111111 2234889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=301.00 Aligned_cols=256 Identities=20% Similarity=0.233 Sum_probs=198.2
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|+||.||+|.+. .++..|++|++........ ......+.+|+.+++.++||||++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~ 72 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDS-ETLCRRAVKILKKKKLRRI----------PNGEANVKKEIQLLRRLRHKNVIQLV 72 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBT-TTCCEEEEEEECHHHHHHS----------TTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceeEeeEEecCCCeEEEEEEEC-CCCcEEEEEEecccccccc----------chhHHHHHHHHHHHHhcCCCCeeEEE
Confidence 478999999999999999999865 4889999999865432110 11256789999999999999999999
Q ss_pred ceee--cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 120 ARVV--RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 120 ~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++. +....++||||++++ |.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~ 146 (305)
T 2wtk_C 73 DVLYNEEKQKMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGG 146 (305)
T ss_dssp EEEECC---CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEEcCCCCeEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCC
Confidence 9984 455789999999776 77777542 3456899999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCC--CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA--LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
.++|+|||++................||+.|+|||++.+.. ++.++||||||+++|+|++|..||..... .
T Consensus 147 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~ 219 (305)
T 2wtk_C 147 TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------Y 219 (305)
T ss_dssp CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------H
T ss_pred cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------H
Confidence 99999999998765433333333457899999999987654 37789999999999999999999975321 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+............ ... ....+.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~~i~~~~~~~-------~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 220 KLFENIGKGSYAI-------PGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHHHHCCCCC-------CSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHhcCCCCC-------CCc----cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2222222221110 011 1234889999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=331.15 Aligned_cols=260 Identities=20% Similarity=0.270 Sum_probs=199.9
Q ss_pred ccCcccccc-cccccccceEEeeeecC-CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLE-KIRSCWNGEVYKAELPG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~-~lg~G~~g~vy~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..+++.+.. .||+|+||.||+|.+.. .++..||||++..... ....+.+.+|+.++++++||||+
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~~E~~il~~l~hpniv 399 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-------------KADTEEMMREAQIMHQLDNPYIV 399 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-------------STTHHHHHHHHHHHTTCCCTTBC
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-------------hHHHHHHHHHHHHHHhCCCCCEe
Confidence 344555555 89999999999998653 2567799999854321 11256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.. +..++||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.+
T Consensus 400 ~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~ 472 (613)
T 2ozo_A 400 RLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNR 472 (613)
T ss_dssp CEEEEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET
T ss_pred eEEEEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCC
Confidence 99999976 568999999999999999842 3456999999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCc-ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchH
Q 036970 197 MEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~ 274 (337)
+.+||+|||++........ ........+++.|+|||++.+..++.++||||||+++|||++ |..||..... ...
T Consensus 473 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~ 548 (613)
T 2ozo_A 473 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEV 548 (613)
T ss_dssp TEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS----HHH
T ss_pred CcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHH
Confidence 9999999999987653322 111222344688999999998899999999999999999998 9999976432 222
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
... ........ .+..+...+.+++..||+.||++|||+.+|++.|+.+
T Consensus 549 ~~~---i~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 549 MAF---IEQGKRME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HHH---HHTTCCCC----------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHH---HHcCCCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222 22221111 0112234488999999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=310.21 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=203.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcC--CCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQ--VRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~ 116 (337)
..++|.+.+.||+|+||.||+|++ +|+.||+|++.... ...+.+|..++.. ++||||+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~l~h~ni~ 99 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE-----------------ERSWFREAEIYQTVMLRHENIL 99 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGGG-----------------HHHHHHHHHHHHHSCCCCTTBC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCchh-----------------HHHHHHHHHHHHHhhcCCCcEE
Confidence 357999999999999999999986 58999999984321 2345666666665 7999999
Q ss_pred hhhceeecCC----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceeC
Q 036970 117 PLLARVVRPD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH--------MSHRPRIIHR 184 (337)
Q Consensus 117 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~~~~h~ 184 (337)
++++++.... ..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ ++|+
T Consensus 100 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~ 171 (342)
T 1b6c_B 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHR 171 (342)
T ss_dssp CEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECS
T ss_pred EEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeC
Confidence 9999998876 78999999999999999953 35899999999999999999999 555 9999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCCCccc--ccccccCcccccCCccccCCC------CCCcccchhHhHHHHHHH
Q 036970 185 DIQPANVLIDDDMEARISEFGLAKQIPNGRTRT--TTWSLAETVGYIAPECHQTVA------LSDKCDIYSFGVLLAVLM 256 (337)
Q Consensus 185 di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslG~vl~~l~ 256 (337)
||||+||+++.++.++|+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|+
T Consensus 172 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 999999999999999999999997664432211 222457899999999987752 336899999999999999
Q ss_pred hC----------CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 036970 257 MG----------KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326 (337)
Q Consensus 257 ~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 326 (337)
+| ..||...... ............... ....+.... ........+.+++.+||+.||++|||+.
T Consensus 252 tg~~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ 325 (342)
T 1b6c_B 252 RRCSIGGIHEDYQLPYYDLVPS--DPSVEEMRKVVCEQK-LRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTAL 325 (342)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCS--SCCHHHHHHHHTTSC-CCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred hccCcCCcccccccCccccCcC--cccHHHHHHHHHHHH-hCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHH
Confidence 99 7787654321 222222222222211 111111111 1235566799999999999999999999
Q ss_pred HHHHHHhhhh
Q 036970 327 DVRCMLSQIQ 336 (337)
Q Consensus 327 ~il~~L~~~~ 336 (337)
++++.|+++.
T Consensus 326 ~i~~~L~~i~ 335 (342)
T 1b6c_B 326 RIKKTLSQLS 335 (342)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=312.28 Aligned_cols=255 Identities=12% Similarity=0.077 Sum_probs=200.2
Q ss_pred ccCcccccccccccccceEEeeee----cCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC---
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAEL----PGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--- 111 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--- 111 (337)
..++|.+.+.||+|+||+||+|.+ ...+++.||+|++.... ...+..|+.+++.++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~l~~~~ 125 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------------PWEFYIGTQLMERLKPSM 125 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------------HHHHHHHHHHHHHSCGGG
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------------hhHHHHHHHHHHHhhhhh
Confidence 467899999999999999999952 23478999999985432 335666777666665
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc-CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ-GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
|+||+++++++..++..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. |++||||||+|
T Consensus 126 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~N 202 (365)
T 3e7e_A 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDN 202 (365)
T ss_dssp GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGG
T ss_pred hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHH
Confidence 99999999999999999999999999999999976543 356799999999999999999999955 49999999999
Q ss_pred EEecC-----------CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCC
Q 036970 191 VLIDD-----------DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK 259 (337)
Q Consensus 191 il~~~-----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~ 259 (337)
|+++. ++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 282 (365)
T 3e7e_A 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282 (365)
T ss_dssp EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 99998 8999999999997654322222333567899999999999999999999999999999999999
Q ss_pred CCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhhh
Q 036970 260 FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEER-PNSKDVRCMLSQI 335 (337)
Q Consensus 260 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-ps~~~il~~L~~~ 335 (337)
.||......... +...+.... ....+.+++..||+.+|.+| |++.++.+.|.++
T Consensus 283 ~pf~~~~~~~~~-------------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 283 YMKVKNEGGECK-------------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp CCCEEEETTEEE-------------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred CccccCCCCcee-------------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 998543221000 000000001 12347788889999999999 5788888777654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=319.95 Aligned_cols=261 Identities=19% Similarity=0.234 Sum_probs=196.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|++..... ...+|+.+++.++||||+++
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~~------------------~~~~E~~il~~l~hpnIv~l 65 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDPR------------------YKNRELDIMKVLDHVNIIKL 65 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEET-TTCCEEEEEEEECCTT------------------SCCHHHHHHTTCCCTTBCCE
T ss_pred ccceEEEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCcc------------------hHHHHHHHHHHcCCCCccch
Confidence 4689999999999999999999865 4899999999854321 12369999999999999999
Q ss_pred hceeecC--------------------------------------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHH
Q 036970 119 LARVVRP--------------------------------------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 160 (337)
Q Consensus 119 ~~~~~~~--------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 160 (337)
++++... ...++||||++ ++|.+.+.........+++..++
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~ 144 (383)
T 3eb0_A 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLIS 144 (383)
T ss_dssp EEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHH
T ss_pred hheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHH
Confidence 9998543 33789999997 58888887766677889999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec-CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-C
Q 036970 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-A 238 (337)
Q Consensus 161 ~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 238 (337)
.++.||+.||.|||+. |++|+||||+||+++ .++.+||+|||++.......... ...+|+.|+|||.+.+. .
T Consensus 145 ~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~ 218 (383)
T 3eb0_A 145 IYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATE 218 (383)
T ss_dssp HHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCC
Confidence 9999999999999955 599999999999998 68899999999998764433222 34678999999998775 4
Q ss_pred CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcC-----------CCCccccccccCCC-----hHH
Q 036970 239 LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE-----------NPSRTIDSKLIGNG-----YEE 302 (337)
Q Consensus 239 ~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-----~~~ 302 (337)
++.++||||||+++|+|++|..||.+..... .+...+ ...... .....+. ...... +..
T Consensus 219 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 293 (383)
T 3eb0_A 219 YTPSIDLWSIGCVFGELILGKPLFSGETSID---QLVRII-QIMGTPTKEQMIRMNPHYTEVRFP-TLKAKDWRKILPEG 293 (383)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH-HHHCCCCHHHHHHHCTTC--CCCC-CCCCCCHHHHSCTT
T ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChHH---HHHHHH-HHhCCCCHHHHHHhCcccccccCC-ccCcccHHhhCCCC
Confidence 8999999999999999999999997643211 111111 111000 0000000 000011 111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 303 QMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 303 ~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....+.+++.+||+.||++|||+.++++
T Consensus 294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 294 TPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2345899999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=317.87 Aligned_cols=248 Identities=12% Similarity=0.091 Sum_probs=188.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHH---HHhcCCCCCCh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI---ITAGQVRHRNI 115 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~ni 115 (337)
..++|++.+.||+|+||+||+|++. .+|+.||||++...... .......+.+|+ ..++.++||||
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~~l~hpni 138 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERP-----------PSNAIKQMKEEVLRLRLLRGIKNQKQ 138 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-C-----------CTTHHHHHHHHHHGGGGSTTCCSHHH
T ss_pred CCceEEEcceeecCCCEEEEEEEEC-CCCcEEEEEEEeecccc-----------chHHHHHHHHHHHHHHhccccCCHHH
Confidence 3588999999999999999999864 47999999998643221 111256788999 56666689999
Q ss_pred hhhh-------ceeecCC-----------------CceEEEEeecCCCHHHHHHhhhc---CCCcCCHHHHHHHHHHHHH
Q 036970 116 VPLL-------ARVVRPD-----------------CDLLVYEFRRNGSLQDILYDVSQ---GRRELDWLARHRIARGIAS 168 (337)
Q Consensus 116 ~~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~ 168 (337)
++++ +++.+.+ ..+++|||+ +|+|.+++..... ....+++..++.++.||+.
T Consensus 139 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~ 217 (377)
T 3byv_A 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217 (377)
T ss_dssp HHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHH
Confidence 9999 5555543 278999999 6799999965321 1223445888899999999
Q ss_pred HHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-----------
Q 036970 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV----------- 237 (337)
Q Consensus 169 ~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------- 237 (337)
||.|||+.+ ++|+||||+||+++.++.+||+|||++...... .....| +.|+|||++.+.
T Consensus 218 aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 288 (377)
T 3byv_A 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRT 288 (377)
T ss_dssp HHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred HHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccc
Confidence 999999665 999999999999999999999999999864321 123466 899999999887
Q ss_pred CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCC
Q 036970 238 ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFD 317 (337)
Q Consensus 238 ~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 317 (337)
.++.++||||||+++|+|++|..||........... .. .. .......+.+++.+||+.
T Consensus 289 ~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~-------~~-~~--------------~~~~~~~~~~li~~~L~~ 346 (377)
T 3byv_A 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW-------IF-RS--------------CKNIPQPVRALLEGFLRY 346 (377)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG-------GG-SS--------------CCCCCHHHHHHHHHHTCS
T ss_pred cCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh-------hh-hh--------------ccCCCHHHHHHHHHHcCC
Confidence 799999999999999999999999965332110000 00 00 011123488999999999
Q ss_pred CCCCCCCHHHHHH
Q 036970 318 DPEERPNSKDVRC 330 (337)
Q Consensus 318 ~p~~Rps~~~il~ 330 (337)
||++|||+.++++
T Consensus 347 dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 347 PKEDRLLPLQAME 359 (377)
T ss_dssp SGGGCCCHHHHHT
T ss_pred CchhCCCHHHHhh
Confidence 9999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=334.88 Aligned_cols=252 Identities=21% Similarity=0.221 Sum_probs=203.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|++++.||+|+||.||+|++. .+++.||||++.+...... ...+.+..|..++..+ +||+|++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~~~~-----------~~~~~~~~E~~~l~~~~~~~~i~~ 406 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQD-----------DDVECTMVEKRVLALPGKPPFLTQ 406 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHHHHT-----------TTTHHHHHHHHHHTCTTCCTTBCC
T ss_pred cccceEEEEEEccCCCEEEEEEEEC-CCCcEEEEEEEeccccccH-----------HHHHHHHHHHHHHHhccCCCeEEE
Confidence 3578999999999999999999976 4889999999865322111 1145678899999988 7999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+.+..++||||+++|+|.+++... +.+++..++.++.||+.||.|||+.+ ++||||||+||+++.++
T Consensus 407 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g 479 (674)
T 3pfq_A 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 479 (674)
T ss_dssp EEEECBCSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSS
T ss_pred EEEEEEeCCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCC
Confidence 999999999999999999999999999542 45999999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
++||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|..||.+... .+.
T Consensus 480 ~ikL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~ 550 (674)
T 3pfq_A 480 HIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DEL 550 (674)
T ss_dssp CEEECCCTTCEECCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred cEEEeecceeeccccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHH
Confidence 9999999999764332221 2246889999999999999999999999999999999999999975322 233
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS-----KDVR 329 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~il 329 (337)
...+....... +......+.+||.+||++||++||++ ++|+
T Consensus 551 ~~~i~~~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 551 FQSIMEHNVAY-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp HHHHHSSCCCC-----------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred HHHHHhCCCCC-----------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 33333322111 11123448999999999999999997 6665
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=331.21 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=205.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+..||||++...... .+.+.+|+.++++++||||+++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hpniv~~ 327 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLVQL 327 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTSSC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred chhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCCCC---------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 5688999999999999999999976 5678999998543211 3568899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+ ...++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.
T Consensus 328 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~ 401 (535)
T 2h8h_A 328 YAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLV 401 (535)
T ss_dssp EEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCc
Confidence 999876 6789999999999999999542 2245899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~ 277 (337)
+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.+... .+.
T Consensus 402 ~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~ 473 (535)
T 2h8h_A 402 CKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REV 473 (535)
T ss_dssp EEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHH
T ss_pred EEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence 99999999987653221 11223455788999999998899999999999999999999 8999875322 122
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
........... .+..+...+.++|.+||+.||++|||+.+|++.|+++
T Consensus 474 ~~~i~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 474 LDQVERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp HHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22222221111 0112234488999999999999999999999999876
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.16 Aligned_cols=268 Identities=22% Similarity=0.275 Sum_probs=200.9
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
...++|++++.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.++||||++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~ 80 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKE------------GFPITALREIKILQLLKHENVVN 80 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSSCSS------------SSCHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccceeEEEEEecCCCcEEEEEEEC-CCCCEEEEEEEecccccc------------cchHHHHHHHHHHHhccCCCccc
Confidence 34689999999999999999999865 489999999985443211 11346778999999999999999
Q ss_pred hhceeecC--------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCC
Q 036970 118 LLARVVRP--------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189 (337)
Q Consensus 118 ~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ 189 (337)
+++++.+. +..++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+.+ ++|+||||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~ 153 (351)
T 3mi9_A 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAA 153 (351)
T ss_dssp EEEEEEEC--------CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred HhheeeccccccccCCceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHH
Confidence 99998874 457899999965 77777743 4456999999999999999999999665 999999999
Q ss_pred cEEecCCCcEEEecccccccCCCCCc--ccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 190 NVLIDDDMEARISEFGLAKQIPNGRT--RTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 190 nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
||+++.++.++|+|||++........ ........||+.|+|||++.+. .++.++||||||+++|+|++|..||.+..
T Consensus 154 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 154 NVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp GEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred HEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999986643221 1222245779999999998764 57999999999999999999999997643
Q ss_pred cccccchHHHHHHHHhhcCCCCcccccc-------------ccCCChHHH------HHHHHHHHHHhcCCCCCCCCCHHH
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSK-------------LIGNGYEEQ------MLLVLKIACFCTFDDPEERPNSKD 327 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~------~~~l~~li~~~l~~~p~~Rps~~~ 327 (337)
. ......+........+. ..... ......... ...+.+++.+||+.||++|||+.+
T Consensus 234 ~----~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 234 E----QHQLALISQLCGSITPE-VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp H----HHHHHHHHHHHCCCCTT-TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred h----HHHHHHHHHHhCCCChh-hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 2 22222222222211111 10000 000001111 234889999999999999999999
Q ss_pred HHH
Q 036970 328 VRC 330 (337)
Q Consensus 328 il~ 330 (337)
+++
T Consensus 309 ~l~ 311 (351)
T 3mi9_A 309 ALN 311 (351)
T ss_dssp HHT
T ss_pred HhC
Confidence 875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=309.57 Aligned_cols=263 Identities=21% Similarity=0.255 Sum_probs=191.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|.+. .+++.||+|++....... .....+.+|+.+++.++||||+++
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~ 89 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIIGL 89 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhheeEeeeeEecCCEEEEEEEEC-CCCceEEEEEeccccCCh------------HHHHHHHHHHHHHHhcCCCCccce
Confidence 4589999999999999999999865 489999999986533211 125578899999999999999999
Q ss_pred hceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++.... ..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl 159 (371)
T 2xrw_A 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 159 (371)
T ss_dssp EEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred EEeeccccccccccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEE
Confidence 99998765 56999999965 7888873 24889999999999999999999665 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
++.++.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.....
T Consensus 160 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--- 233 (371)
T 2xrw_A 160 VKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--- 233 (371)
T ss_dssp ECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred EcCCCCEEEEEeeccccccccccc---CCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 999999999999999766433221 23477999999999999999999999999999999999999997543210
Q ss_pred hHHHH------------------HHHHhhcCCCCcc------cccccc---CCChHHHHHHHHHHHHHhcCCCCCCCCCH
Q 036970 273 SFVQW------------------MRNVMTSENPSRT------IDSKLI---GNGYEEQMLLVLKIACFCTFDDPEERPNS 325 (337)
Q Consensus 273 ~~~~~------------------~~~~~~~~~~~~~------~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 325 (337)
..... ............. +..... ..........+.+|+.+||+.||++|||+
T Consensus 234 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 313 (371)
T 2xrw_A 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313 (371)
T ss_dssp HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH
Confidence 00000 0000001100000 000000 00112235679999999999999999999
Q ss_pred HHHHH
Q 036970 326 KDVRC 330 (337)
Q Consensus 326 ~~il~ 330 (337)
.++++
T Consensus 314 ~e~l~ 318 (371)
T 2xrw_A 314 DEALQ 318 (371)
T ss_dssp HHHHH
T ss_pred HHHhC
Confidence 99986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.46 Aligned_cols=258 Identities=22% Similarity=0.281 Sum_probs=185.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
...+|++.+.||+|+||.||+|++. .+++.||+|++...... ....+.+|+..+.++. ||||++
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~~h~~iv~ 90 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSNEEE--------------KNRAIIQEVCFMKKLSGHPNIVQ 90 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEESSHH--------------HHHHHHHHHHHHHHHTTSTTBCC
T ss_pred cCceEEEEEEEccCCceEEEEEEEC-CCCcEEEEEEecCCchH--------------HHHHHHHHHHHHHHhccCCChhh
Confidence 4568999999999999999999865 48999999988543221 1456888999999995 999999
Q ss_pred hhceee--------cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCC
Q 036970 118 LLARVV--------RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPR--IIHRDIQ 187 (337)
Q Consensus 118 ~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--~~h~di~ 187 (337)
+++++. .....++++||++ |+|.+++.... ....+++..++.++.||+.||.||| ..+ ++|+|||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dik 165 (337)
T 3ll6_A 91 FCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLK 165 (337)
T ss_dssp EEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCC
T ss_pred ccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCC
Confidence 999884 2334689999995 68999886543 3456999999999999999999999 556 9999999
Q ss_pred CCcEEecCCCcEEEecccccccCCCCCccc----------ccccccCcccccCCccc---cCCCCCCcccchhHhHHHHH
Q 036970 188 PANVLIDDDMEARISEFGLAKQIPNGRTRT----------TTWSLAETVGYIAPECH---QTVALSDKCDIYSFGVLLAV 254 (337)
Q Consensus 188 ~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslG~vl~~ 254 (337)
|+||+++.++.++|+|||++.......... ......+|+.|+|||++ .+..++.++||||||+++|+
T Consensus 166 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~e 245 (337)
T 3ll6_A 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245 (337)
T ss_dssp GGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHH
T ss_pred cccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHH
Confidence 999999999999999999998765432211 11134578999999998 56678889999999999999
Q ss_pred HHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhh
Q 036970 255 LMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQ 334 (337)
Q Consensus 255 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~ 334 (337)
|++|..||...... ........ ..... .. ...+.+++.+||+.||.+|||+.++++.|.+
T Consensus 246 l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~--------~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 246 LCFRQHPFEDGAKL-------RIVNGKYS-IPPHD--------TQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp HHHSSCCC-------------------CC-CCTTC--------CS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHhCCCCCcchhHH-------HhhcCccc-CCccc--------cc----chHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 99999999643211 11111110 01111 11 1227889999999999999999999999987
Q ss_pred hh
Q 036970 335 IQ 336 (337)
Q Consensus 335 ~~ 336 (337)
+.
T Consensus 306 ~~ 307 (337)
T 3ll6_A 306 IA 307 (337)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=304.86 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=199.1
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
+...++|++++.||+|+||.||+|++. .++..|++|.+..... .....+.+|+.++..++||||+
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~ 79 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSE--------------EELEDYIVEIEILATCDHPYIV 79 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEET-TTCCEEEEEEEC------------------CCHHHHHHHHHHHHHCCCTTBC
T ss_pred cCCccceeecceeccCCCeEEEEEEEc-CCCcEEEEEEecCCCH--------------HHHHHHHHHHHHHhcCCCCCEe
Confidence 456789999999999999999999875 4789999999854321 1156788999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.+++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 153 (302)
T 2j7t_A 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLE 153 (302)
T ss_dssp CEEEEEECC-CEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTT
T ss_pred eeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCC
Confidence 9999999999999999999999999998542 345899999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccc-----cCCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH-----QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
+.++|+|||++....... .......||+.|+|||.+ .+..++.++||||||+++|+|++|..||.....
T Consensus 154 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---- 227 (302)
T 2j7t_A 154 GDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---- 227 (302)
T ss_dssp SCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----
T ss_pred CCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----
Confidence 999999999875322111 111234678999999998 356788999999999999999999999875432
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............+.... +......+.+++.+||+.||++|||+.++++
T Consensus 228 ---~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 228 ---MRVLLKIAKSDPPTLLT--------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---HHHHHHHHHSCCCCCSS--------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---HHHHHHHhccCCcccCC--------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 12222222222221111 1122345889999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=305.56 Aligned_cols=261 Identities=19% Similarity=0.227 Sum_probs=198.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
..++|++++.||+|+||+||+|++. .+++.||+|++.... ...+.+|+.+++.++ ||||++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-----------------~~~~~~E~~~l~~l~~~~~i~~ 95 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPVK-----------------KKKIKREIKILENLRGGPNIIT 95 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSCC-----------------HHHHHHHHHHHHHHTTSTTBCC
T ss_pred CCCceEEEEEecccCCeEEEEEEEC-CCCcEEEEEEecccc-----------------hHHHHHHHHHHHHcCCCCCEEE
Confidence 5789999999999999999999865 489999999985322 356889999999996 999999
Q ss_pred hhceeec--CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 118 LLARVVR--PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 118 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++.+ ....++||||+++++|.+++. .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 96 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~ 165 (330)
T 3nsz_A 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDH 165 (330)
T ss_dssp EEEEEECTTTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred eeeeeccCCCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcC
Confidence 9999988 567799999999999999872 3889999999999999999999665 999999999999997
Q ss_pred CC-cEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc--
Q 036970 196 DM-EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE-- 271 (337)
Q Consensus 196 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~-- 271 (337)
++ .++|+|||++.......... ...+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.........
T Consensus 166 ~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~ 242 (330)
T 3nsz_A 166 EHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242 (330)
T ss_dssp TTTEEEECCCTTCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred CCCEEEEEeCCCceEcCCCCccc---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence 76 89999999998665433222 3467899999999877 56899999999999999999999998542211000
Q ss_pred --------chHHHHHHHHhh----------cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 --------MSFVQWMRNVMT----------SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 --------~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+..... .......................+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000001000000 00000000011111112223456899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=306.54 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=194.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|++...... ...+.+|+.+++++ +||||++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~---------------~~~~~~e~~~l~~l~~h~~i~~ 85 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTGDE---------------EEEIKQEINMLKKYSHHRNIAT 85 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSST---------------THHHHHHHHHHHHHCCSTTBCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEEC-CCCCeEEEEEEecCccc---------------HHHHHHHHHHHHhccCCCCeee
Confidence 7899999999999999999999865 48999999998543211 35678899999998 7999999
Q ss_pred hhceeec------CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 118 LLARVVR------PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 118 ~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
+++++.. ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||+|+||
T Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NI 160 (326)
T 2x7f_A 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNV 160 (326)
T ss_dssp EEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGE
T ss_pred eeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHE
Confidence 9999987 45779999999999999999653 2356899999999999999999999665 99999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
+++.++.++|+|||++......... .....|++.|+|||++. +..++.++||||||+++|+|++|..||.+..
T Consensus 161 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 161 LLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEcCCCCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999999998766433221 12346799999999987 4568899999999999999999999996532
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
. ............+. ... . .....+.+++.+||+.||.+|||+.++++
T Consensus 239 ~-------~~~~~~~~~~~~~~-~~~-----~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 239 P-------MRALFLIPRNPAPR-LKS-----K---KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp H-------HHHHHHHHHSCCCC-CSC-----S---CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-------HHHHHHhhcCcccc-CCc-----c---ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 2 11111122221111 101 1 11234889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=312.03 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=183.7
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
....++|++++.||+|+||.||+|.+. .+|+.||||++....... .....+.+|+.+++.++||||+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv 91 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSI------------IHAKRTYRELRLLKHMKHENVI 91 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEET-TTTEEEEEEECSSTTSSH------------HHHHHHHHHHHHHHHCCCTTBC
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEEC-CCCCEEEEEEeCccccCH------------HHHHHHHHHHHHHHhCCCCCCC
Confidence 345699999999999999999999865 489999999985432211 1255788999999999999999
Q ss_pred hhhceeecC------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 117 PLLARVVRP------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 117 ~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
++++++... ...++++|++ +++|.+++. .+.+++..++.++.||+.||.|||+.+ ++|+||||+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~N 162 (367)
T 2fst_X 92 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSN 162 (367)
T ss_dssp CCSEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhh
Confidence 999998754 5579999999 779999883 256999999999999999999999665 9999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
|+++.++.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 163 Ill~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-- 235 (367)
T 2fst_X 163 LAVNEDCELKILDFGLARHTADEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-- 235 (367)
T ss_dssp EEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred EEECCCCCEEEeeccccccccccC-----CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 999999999999999997654321 13467999999999877 6789999999999999999999999976432
Q ss_pred ccchHHHHHHHHhhcCCCCccccc--------------cccCCCh----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDS--------------KLIGNGY----EEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+...... +....+.. ....... +.....+.+|+.+||+.||++|||+.++++
T Consensus 236 --~~~l~~i~~~~g~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 236 --IDQLKLILRLVGT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp --HHHHHHHHHHHCS-CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHHHhCC-CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 1111111111110 00000000 0000000 111245889999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=318.17 Aligned_cols=263 Identities=21% Similarity=0.252 Sum_probs=204.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC-CChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH-RNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~ 117 (337)
..++|++++.||+|+||.||+|++. .+++.||||++..... ...+.+|+.+++.++| +++..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~----------------~~~~~~E~~il~~L~~~~~i~~ 67 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTK----------------HPQLLYESKIYRILQGGTGIPN 67 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTCS----------------SCCHHHHHHHHHHTTTSTTCCC
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEEC-CCCcEEEEEEeccccc----------------cHHHHHHHHHHHHhcCCCCCCe
Confidence 3589999999999999999999865 4899999998744321 2247789999999976 55555
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe---c
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI---D 194 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~---~ 194 (337)
+..++.+....++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||++ +
T Consensus 68 i~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~ 140 (483)
T 3sv0_A 68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGR 140 (483)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGG
T ss_pred EEEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCC
Confidence 666667777889999999 9999999954 2456999999999999999999999665 9999999999999 5
Q ss_pred CCCcEEEecccccccCCCCCcc-----cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 195 DDMEARISEFGLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~ 220 (483)
T 3sv0_A 141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (483)
T ss_dssp GTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence 8889999999999876543221 12224678999999999999999999999999999999999999998654332
Q ss_pred ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
....+........... .. .+.... ...+.+++..||+.+|.+||++.+|++.|+++
T Consensus 221 ~~~~~~~i~~~~~~~~-~~-----~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 221 KKQKYEKISEKKVATS-IE-----ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHHHHHHHHHHSC-HH-----HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhhcccccc-HH-----HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2222222222221111 00 000111 23489999999999999999999999999876
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=311.53 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=203.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..++|++.+.||+|++|.||+|++. .+|+.||||++......... .........+.+|+.+++.+ +||||++
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSP------EQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCCH------HHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred hhhhcccceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccCH------HHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999999875 37999999998654311000 01112256788999999999 7999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 99999999999999999999999999854 346899999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccC------CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT------VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
.++|+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 238 ~ikl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---- 310 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---- 310 (365)
T ss_dssp CEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred CEEEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----
Confidence 9999999998876543322 23578999999999863 3578899999999999999999999965321
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............... ... +......+.+++.+||+.||++|||+.++++
T Consensus 311 ---~~~~~~i~~~~~~~~---~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 ---ILMLRMIMEGQYQFS---SPE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHHHHHTCCCCC---HHH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHHhCCCCCC---Ccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112222222111110 000 0112244889999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.98 Aligned_cols=263 Identities=19% Similarity=0.215 Sum_probs=198.7
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
...++|++++.||+|+||.||+|++. .++..||+|++...... .....+.+|+.++++++||||++
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~ 89 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPFEHQ-------------TYCQRTLREIKILLRFRHENIIG 89 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCTTCH-------------HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEEC-CCCeEEEEEEeccccCc-------------HHHHHHHHHHHHHHhcCCCCCcc
Confidence 34679999999999999999999865 48999999998532211 11467889999999999999999
Q ss_pred hhceeecC-----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 118 LLARVVRP-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 118 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
+++++... ...++|+||+. ++|.+++.. +.+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl 160 (364)
T 3qyz_A 90 INDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLL 160 (364)
T ss_dssp CCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred ceeEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEE
Confidence 99998765 35799999996 589998843 35899999999999999999999665 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCccc-ccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRT-TTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
++.++.++|+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.....
T Consensus 161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~- 239 (364)
T 3qyz_A 161 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD- 239 (364)
T ss_dssp ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-
T ss_pred ECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-
Confidence 9999999999999998765332211 12245789999999986554 58999999999999999999999997643211
Q ss_pred cchHHHHHHHHhhcCC--------------------CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTSEN--------------------PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....+........ ........ ...+.....+.+++.+||+.||++|||+.++++
T Consensus 240 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 240 ---QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN---RLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp ---HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH---HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHH---HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111111111000 00000000 000112345889999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=315.90 Aligned_cols=259 Identities=21% Similarity=0.285 Sum_probs=200.2
Q ss_pred cCcccccccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIV 116 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~ 116 (337)
.++|++++.||+|+||.||+|+... .+++.||+|++........ ......+.+|+.++..+ +||||+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~~h~~iv 122 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----------AKTTEHTRTERQVLEHIRQSPFLV 122 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----------ESSGGGCCCHHHHHHHHHTCTTBC
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh----------hhHHHHHHHHHHHHHHccCCCcee
Confidence 3799999999999999999998632 3789999999854322100 00123456688888888 699999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 195 (355)
T 1vzo_A 123 TLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSN 195 (355)
T ss_dssp CEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred EEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC
Confidence 999999999999999999999999999954 245899999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV--ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
+.+||+|||++.......... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||....... ..
T Consensus 196 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~ 271 (355)
T 1vzo_A 196 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQ 271 (355)
T ss_dssp SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CH
T ss_pred CcEEEeeCCCCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc---hH
Confidence 999999999997654332222 2245789999999999863 47889999999999999999999997533221 22
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
.............. +......+.+++.+||+.||++|| |+.++++
T Consensus 272 ~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 272 AEISRRILKSEPPY-----------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HHHHHHHHHCCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHHhccCCCC-----------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 22333333222211 111223488999999999999999 8999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=309.07 Aligned_cols=257 Identities=16% Similarity=0.227 Sum_probs=199.0
Q ss_pred ccCccccc-ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChh
Q 036970 39 KEDCFASL-EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~-~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~ 116 (337)
..++|.+. +.||+|+||.||+|++. .+++.||+|++....... .....+.+|+.++..+ .||||+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~~iv 92 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQ------------DCRAEILHEIAVLELAKSCPRVI 92 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESEETTE------------ECHHHHHHHHHHHHHTTTCTTBC
T ss_pred hhhEEeeccceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhhcch------------HHHHHHHHHHHHHHhccCCCCEE
Confidence 35677777 89999999999999865 489999999986543211 1145788999999999 579999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC-
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD- 195 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~- 195 (337)
++++++.+....++||||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 93 NLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSI 167 (327)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCB
T ss_pred EEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecC
Confidence 999999999999999999999999998732 23467999999999999999999999665 999999999999997
Q ss_pred --CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 196 --DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 196 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
++.++|+|||++.......... ...||+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~- 239 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHACELR---EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----Q- 239 (327)
T ss_dssp TTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H-
T ss_pred CCCCcEEEeeCccccccCCccccc---cccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----h-
Confidence 7899999999998765432221 34789999999999999999999999999999999999999965322 1
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............. .. .........+.+++.+||+.||++|||+.++++
T Consensus 240 --~~~~~i~~~~~~~---~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 240 --ETYLNISQVNVDY---SE----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp --HHHHHHHHTCCCC---CT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --HHHHHHHhccccc---Cc----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1111111111100 00 111122344889999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=304.80 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=196.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|++. .+++.||+|++......... .........+.+|+.+++.++||||+++
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 80 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGS------AREADPALNVETEIEILKKLNHPCIIKI 80 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECC---------------------CHHHHHHHHHHCCCTTBCCE
T ss_pred hhhceeEeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhcc------cccchhhhhHHHHHHHHHhCCCCCCceE
Confidence 3578999999999999999999865 48899999998654321110 0011113457889999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++..+. .++||||+++++|.+++ .....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHH----STTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSS
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCC
Confidence 99987665 89999999999999988 45567999999999999999999999665 999999999999987654
Q ss_pred ---EEEecccccccCCCCCcccccccccCcccccCCcccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 199 ---ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ---TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 199 ---~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
++|+|||++......... ....||+.|+|||++. ...++.++||||||+++|+|++|..||...... .
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~ 226 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ---V 226 (322)
T ss_dssp SCCEEECCCTTCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS---S
T ss_pred CCeEEEccCccceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH---H
Confidence 999999999876543221 1346799999999974 456889999999999999999999999754321 1
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+.. ..... .+.. +......+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~---~~~~~---~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 SLKDQITS---GKYNF---IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CHHHHHHH---TCCCC---CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHh---Ccccc---Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 12222211 11100 0000 1112345889999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=315.30 Aligned_cols=261 Identities=22% Similarity=0.238 Sum_probs=193.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
...+|.+.+.||+|+||.||+|++. .+..+|+|++..... ...+|+.+++.++||||+++
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~~------------------~~~~E~~il~~l~h~niv~l 97 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDKR------------------FKNRELQIMRIVKHPNVVDL 97 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCTT------------------SCCHHHHHHHTCCCTTBCCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCcc------------------hHHHHHHHHHhCCCCCcceE
Confidence 4578999999999999999999876 455589998854321 12369999999999999999
Q ss_pred hceeecCCC------ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPDC------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++..... .++||||+++ ++.+.+.........+++..++.++.||+.||.|||+.+ ++||||||+||+
T Consensus 98 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nil 173 (394)
T 4e7w_A 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLL 173 (394)
T ss_dssp EEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred EEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEE
Confidence 999865443 6899999976 455555444445677999999999999999999999665 999999999999
Q ss_pred ec-CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 193 ID-DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 193 ~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
++ .++.+||+|||++.......... ...+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.....
T Consensus 174 l~~~~~~~kL~DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~- 249 (394)
T 4e7w_A 174 LDPPSGVLKLIDFGSAKILIAGEPNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID- 249 (394)
T ss_dssp EETTTTEEEECCCTTCEECCTTCCCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred EcCCCCcEEEeeCCCcccccCCCCCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 99 78999999999998764433222 34679999999998765 58999999999999999999999997643211
Q ss_pred cchHHHHHHHHhhc-----------CCCCccccc----cccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTS-----------ENPSRTIDS----KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~-----------~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+...+. .+.. ......+.. .............+.+|+.+||+.||++|||+.++++
T Consensus 250 --~l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 250 --QLVEIIK-VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp --HHHHHHH-HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHHHH-HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 1111111 1000 000000000 0000001112345899999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=312.83 Aligned_cols=264 Identities=18% Similarity=0.183 Sum_probs=200.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC--------
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-------- 111 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------- 111 (337)
.++|++.+.||+|+||+||+|++. .+++.||+|++..... ....+.+|+.+++.++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~~~~~~ 99 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSAEH---------------YTETALDEIRLLKSVRNSDPNDPN 99 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCHH---------------HHHHHHHHHHHHHHHHHSCTTCGG
T ss_pred CCeEEEEEEeeecCCeeEEEEEec-CCCeEEEEEEEecCCc---------------chHHHHHHHHHHHHHhhcCCCCCC
Confidence 588999999999999999999865 4899999999853321 1456788999888885
Q ss_pred CCChhhhhceee----cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 036970 112 HRNIVPLLARVV----RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQ 187 (337)
Q Consensus 112 h~ni~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~ 187 (337)
|+||+++++++. +....++||||+ +++|.+.+.. .....+++..++.++.||+.||.|||++. |++|||||
T Consensus 100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDik 174 (397)
T 1wak_A 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIK 174 (397)
T ss_dssp GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCS
T ss_pred cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCC
Confidence 788999999987 556789999999 6677777644 23356999999999999999999999651 49999999
Q ss_pred CCcEEecCCC-------------------------------------------------cEEEecccccccCCCCCcccc
Q 036970 188 PANVLIDDDM-------------------------------------------------EARISEFGLAKQIPNGRTRTT 218 (337)
Q Consensus 188 ~~nil~~~~~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~ 218 (337)
|+||+++.++ .++|+|||++........
T Consensus 175 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~--- 251 (397)
T 1wak_A 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT--- 251 (397)
T ss_dssp GGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC---
T ss_pred HHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc---
Confidence 9999998765 799999999977643322
Q ss_pred cccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc--hHHHHHHHHhhcCCCCcc------
Q 036970 219 TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM--SFVQWMRNVMTSENPSRT------ 290 (337)
Q Consensus 219 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~------ 290 (337)
...||+.|+|||++.+..++.++||||||+++|+|++|..||.......... .....+...... .+...
T Consensus 252 --~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~ 328 (397)
T 1wak_A 252 --EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK-VPRKLIVAGKY 328 (397)
T ss_dssp --SCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCS-CCHHHHHHCTT
T ss_pred --cCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCC-CChHHhhcccc
Confidence 3467999999999999999999999999999999999999997644322211 111111111111 10000
Q ss_pred ----cccc-------------------ccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 291 ----IDSK-------------------LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 291 ----~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+... ............+.+|+.+||+.||++|||+.++++
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000 001224556678999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.59 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=204.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|++........ .........+.+.+|+.+++++. ||||++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSF-----SAEEVQELREATLKEVDILRKVSGHPNIIQ 88 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTC-----CHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred hhhccceeeeecCCCceEEEEEEEc-CcCceEEEEEEeccccccc-----CHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence 4689999999999999999999875 4899999999865431100 00011122567889999999995 999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.++...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 89 LKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM 161 (298)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred eeeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCC
Confidence 99999999999999999999999999954 346899999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCcccc------CCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ------TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
.++|+|||++......... ....+++.|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---- 234 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---- 234 (298)
T ss_dssp CEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred cEEEecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----
Confidence 9999999999776543322 2346799999999875 44678899999999999999999999865321
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............... ..........+.+++.+||+.||++|||+.++++
T Consensus 235 ---~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 ---MLMLRMIMSGNYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---HHHHHHHHHTCCCCC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHhcCCcccC-------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 122222222211110 0111223345899999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=314.43 Aligned_cols=261 Identities=23% Similarity=0.277 Sum_probs=194.8
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
..+|++.+.||+|+||.||+|++. .+|+.||||++..... ...+|+.+++.++||||++++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~~------------------~~~~E~~il~~l~hpniv~l~ 113 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR------------------FKNRELQIMRKLDHCNIVRLR 113 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECCTT------------------SCCHHHHHHHTCCCTTBCCEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccch------------------hHHHHHHHHHHcCCCCcccee
Confidence 457999999999999999999875 4799999999854311 123699999999999999999
Q ss_pred ceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 120 ARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 120 ~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++.... ..++||||+++ +|.+.+.........+++..++.++.||+.||.|||+. |++||||||+||++
T Consensus 114 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl 189 (420)
T 1j1b_A 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLL 189 (420)
T ss_dssp EEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEE
T ss_pred eEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEE
Confidence 9885422 35799999965 67777766555667899999999999999999999955 59999999999999
Q ss_pred cCC-CcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 194 DDD-MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 194 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
+.+ +.+||+|||++......... ....+|+.|+|||++.+. .++.++|||||||++|||++|..||.+....
T Consensus 190 ~~~~~~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--- 263 (420)
T 1j1b_A 190 DPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--- 263 (420)
T ss_dssp ETTTTEEEECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred eCCCCeEEeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 955 56899999999876443222 134679999999998765 6899999999999999999999999764321
Q ss_pred chHHHHHHHH----------hhcCCCCccccccccCCCh-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNV----------MTSENPSRTIDSKLIGNGY-----EEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+.+.+... .........+ +.+....+ ......+.+|+.+||+.||.+|||+.++++
T Consensus 264 ~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 264 DQLVEIIKVLGTPTREQIREMNPNYTEFKF-PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHCSCCCCCCC-CCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhCCCCHHHHHhhChhhhhhcc-CccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1111111110 0000000000 11111111 112356899999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=313.58 Aligned_cols=200 Identities=20% Similarity=0.224 Sum_probs=168.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC------CC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV------RH 112 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h 112 (337)
...+|++++.||+|+||+||+|.+. .+++.||+|++...... ...+.+|+.+++.+ .|
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~~~~---------------~~~~~~E~~~l~~l~~~~~~~~ 158 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNEKRF---------------HRQAAEEIRILEHLRKQDKDNT 158 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEET-TTTEEEEEEEECSCHHH---------------HHHHHHHHHHHHHHHTTCTTSC
T ss_pred ccCcEEEEEEcccCccEEEEEEEEC-CCCcEEEEEEECCccch---------------HHHHHHHHHHHHHHhhccccCC
Confidence 4578999999999999999999865 47999999998643221 23444555555544 67
Q ss_pred CChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
+||+++++++......++||||+. ++|.+++.. .....+++..++.++.||+.||.|||+.+ ++||||||+||+
T Consensus 159 ~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIL 232 (429)
T 3kvw_A 159 MNVIHMLENFTFRNHICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENIL 232 (429)
T ss_dssp SCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEE
T ss_pred cCEEEEEeecccCCeEEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeE
Confidence 899999999999999999999995 689999865 33345899999999999999999999665 999999999999
Q ss_pred ecCCCc--EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 193 IDDDME--ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 193 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
++.++. +||+|||++........ ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 233 l~~~~~~~vkL~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 233 LKQQGRSGIKVIDFGSSCYEHQRVY-----TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ESSTTSCCEEECCCTTCEETTCCCC-----SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EccCCCcceEEeecccceecCCccc-----ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 998887 99999999876543322 347799999999999999999999999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=306.18 Aligned_cols=259 Identities=23% Similarity=0.289 Sum_probs=195.1
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
...++|.+.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.++||||++
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~ 105 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSE------------IFAKRAYRELLLLKHMQHENVIG 105 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccEEEEeEEecCCCeEEEEEEEC-CCCCEEEEEEecccccch------------hHHHHHHHHHHHHHhcCCCCchh
Confidence 35689999999999999999999865 489999999986543221 12567889999999999999999
Q ss_pred hhceeecCCCc------eEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 118 LLARVVRPDCD------LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 118 ~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
+++++...... ++||||+. ++|.+.+ ...+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 106 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NI 175 (371)
T 4exu_A 106 LLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNL 175 (371)
T ss_dssp CSEEECSCSSSTTCCCCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred hhhheeccCCcccceeEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHe
Confidence 99999887665 99999996 5787776 234899999999999999999999665 99999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
+++.++.++|+|||++........ ...||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....
T Consensus 176 ll~~~~~~kL~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-- 248 (371)
T 4exu_A 176 AVNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-- 248 (371)
T ss_dssp EECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred EECCCCCEEEEecCcccccccCcC-----CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--
Confidence 999999999999999976543322 3467999999999887 67899999999999999999999999754321
Q ss_pred cchHHHHHHHHhhcCCCCcccccc---------------ccCC----ChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDSK---------------LIGN----GYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+.... +.+....... .... ..+.....+.+++.+||+.||++|||+.++++
T Consensus 249 --~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 249 --DQLTQILKVT--GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp --HHHHHHHHHH--CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred --HHHHHHHHHh--CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 1111111100 0000000000 0000 01112355899999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=306.46 Aligned_cols=269 Identities=20% Similarity=0.267 Sum_probs=198.9
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC---CCC
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV---RHR 113 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~ 113 (337)
..+.++|++++.||+|+||.||+|++...+|+.||+|++......... ...+.+|+.+++.+ +||
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~------------~~~~~~e~~~l~~l~~~~h~ 74 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------------PLSTIREVAVLRHLETFEHP 74 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------------BCTHHHHHHHHHHHHHTCCT
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC------------CchhhHHHHHHHhhhccCCC
Confidence 346789999999999999999999975457899999998654321100 12344566655555 899
Q ss_pred Chhhhhceee-----cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 036970 114 NIVPLLARVV-----RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188 (337)
Q Consensus 114 ni~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~ 188 (337)
||+++++++. .....++|+||++ ++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|
T Consensus 75 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp 148 (326)
T 1blx_A 75 NVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKP 148 (326)
T ss_dssp TBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred CeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCH
Confidence 9999999987 4567799999996 6999998652 3345899999999999999999999665 99999999
Q ss_pred CcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc
Q 036970 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268 (337)
Q Consensus 189 ~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~ 268 (337)
+||+++.++.++|+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 149 ~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~- 224 (326)
T 1blx_A 149 QNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD- 224 (326)
T ss_dssp GGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred HHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-
Confidence 99999999999999999987654322 12235779999999999998999999999999999999999999975432
Q ss_pred cccchHHHHHHHHhhcCCCC----------ccccc---cccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 269 TKEMSFVQWMRNVMTSENPS----------RTIDS---KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~----------~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+.......... ..+.. .............+.+++.+||+.||++|||+.++++
T Consensus 225 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 225 ---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp ---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111111111100000 00000 0000111222345889999999999999999999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=311.91 Aligned_cols=258 Identities=10% Similarity=0.013 Sum_probs=179.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHH---HHHhcCCCCCCh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSE---IITAGQVRHRNI 115 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~ni 115 (337)
...+|.+.+.||+|+||.||+|++. .+|+.||+|++....... ......+.+| +..++. +||||
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~~~~l~~-~hp~i 126 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENS-----------RSELERLHEATFAAARLLG-ESPEE 126 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCSTTH-----------HHHHHHHHHHHHHHHHHHC------
T ss_pred CceeeeeeeeccCCCCEEEEEEEEC-CCCceeEEEEEEeccccc-----------ccHHHHHHHHHHHHHHhcc-cChhh
Confidence 4556999999999999999999865 489999999997654321 1124567777 455666 79998
Q ss_pred hhhh-------ceeecC-----------------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHH------HHHHHH
Q 036970 116 VPLL-------ARVVRP-----------------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR------HRIARG 165 (337)
Q Consensus 116 ~~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~------~~~~~~ 165 (337)
++++ +++... ...++||||++ ++|.+++..... .++...+ +.++.|
T Consensus 127 v~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~q 202 (371)
T 3q60_A 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQ 202 (371)
T ss_dssp -----CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHH
T ss_pred hhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHH
Confidence 8855 333332 23699999997 799999976422 2344445 677899
Q ss_pred HHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC--CCCCCcc
Q 036970 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT--VALSDKC 243 (337)
Q Consensus 166 i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~ 243 (337)
|+.||.|||+++ ++||||||+||+++.++.+||+|||++........ ...+|+.|+|||++.+ ..++.++
T Consensus 203 i~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~ 274 (371)
T 3q60_A 203 LIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHAL 274 (371)
T ss_dssp HHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHH
T ss_pred HHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccc
Confidence 999999999665 99999999999999999999999999986643221 2355799999999987 6789999
Q ss_pred cchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC
Q 036970 244 DIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP 323 (337)
Q Consensus 244 DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 323 (337)
||||||+++|+|++|..||.......... .........................+.+++.+||+.||++||
T Consensus 275 DiwSlG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 345 (371)
T 3q60_A 275 NAWQLGLSIYRVWCLFLPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345 (371)
T ss_dssp HHHHHHHHHHHHHHSSCSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCC
T ss_pred cHHHHHHHHHHHHhCCCCCCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCC
Confidence 99999999999999999997653211000 000000000000111111122334588999999999999999
Q ss_pred CHHHHHH
Q 036970 324 NSKDVRC 330 (337)
Q Consensus 324 s~~~il~ 330 (337)
|+.++++
T Consensus 346 t~~e~l~ 352 (371)
T 3q60_A 346 LPLEAME 352 (371)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=329.89 Aligned_cols=252 Identities=22% Similarity=0.273 Sum_probs=195.5
Q ss_pred ccccccccceEEeeeec-CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELP-GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 125 (337)
+.||+|+||.||+|.+. ...++.||||++....... .....+.+|+.++.+++||||+++++++..
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~------------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP------------ALKDELLAEANVMQQLDNPYIVRMIGICEA- 441 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG------------GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH------------HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 47999999999999653 2357889999985432211 125679999999999999999999999865
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTT
T ss_pred CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcC
Confidence 457899999999999999943 456899999999999999999999665 9999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhh
Q 036970 206 LAKQIPNGRT-RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMT 283 (337)
Q Consensus 206 ~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 283 (337)
++........ ........+|+.|+|||++.+..++.++||||||+++|||++ |..||.+... ...... ...
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~---i~~ 587 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAM---LEK 587 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHH---HHT
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH---HHc
Confidence 9987654322 122223355788999999999999999999999999999998 9999975432 112222 222
Q ss_pred cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 284 SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
...... +......+.+++..||+.||++|||+.+|++.|+++
T Consensus 588 ~~~~~~----------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 588 GERMGC----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TCCCCC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCC----------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 211110 111234488999999999999999999999999876
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=298.27 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=201.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+++.|++|++....... .....+.+|+.++++++||||+++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~ 86 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKN------------KDTSTILREVELLKKLDHPNIMKL 86 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGBSS------------SCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccccch------------HHHHHHHHHHHHHHhccCCCccEE
Confidence 4579999999999999999999865 489999999985433211 115678899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC--
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-- 196 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~-- 196 (337)
++++.+....++|+||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~ 159 (287)
T 2wei_A 87 FEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEK 159 (287)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSST
T ss_pred EEEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCC
Confidence 9999999999999999999999998854 245899999999999999999999665 9999999999999754
Q ss_pred -CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 -MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+.++|+|||++.......... ...+++.|+|||.+.+ .++.++||||||+++|+|++|..||..... .
T Consensus 160 ~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~ 228 (287)
T 2wei_A 160 DCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------Y 228 (287)
T ss_dssp TCCEEECSTTGGGTBCCCSSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------H
T ss_pred cccEEEeccCcceeecCCCccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------H
Confidence 469999999988765432221 2356889999999876 488999999999999999999999875322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.............. .+ ........+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~-~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 229 DILKRVETGKYAFD-LP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHHCCCCCC-SG------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCCC-ch------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 22222222221111 00 01112344889999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=296.00 Aligned_cols=255 Identities=24% Similarity=0.283 Sum_probs=196.3
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
-++|.....||+|+||.||+|++. .++..||+|.+..... .....+.+|+.+++.++||||++++
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~ 85 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERDS--------------RYSQPLHEEIALHKHLKHKNIVQYL 85 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEET-TTCCEEEEEEEECCCC-----------------HHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEEC-CCCeEEEEEEccCCch--------------HHHHHHHHHHHHHHhCCCCCEeeEe
Confidence 455666679999999999999865 4889999999854321 1145788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC-CCc
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DME 198 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~-~~~ 198 (337)
+++.+.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 161 (295)
T 2clq_A 86 GSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGV 161 (295)
T ss_dssp EEEEETTEEEEEEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCC
T ss_pred eEEEeCCcEEEEEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCC
Confidence 9999999999999999999999998653 22345678899999999999999999665 999999999999987 899
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCC--CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA--LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
++|+|||++......... .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||...... . ..
T Consensus 162 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~-~~ 234 (295)
T 2clq_A 162 LKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP----Q-AA 234 (295)
T ss_dssp EEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH----H-HH
T ss_pred EEEeecccccccCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch----h-HH
Confidence 999999999776533221 12346799999999987653 788999999999999999999998643211 1 11
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..........+. . +......+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~------~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 235 MFKVGMFKVHPE------I----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHCCCCC------C----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHhhcccccccc------c----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111111 1 1112234889999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=306.96 Aligned_cols=259 Identities=21% Similarity=0.293 Sum_probs=196.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. ..+++|++....... .....+.+|+.++++++||||+++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNE------------DQLKAFKREVMAYRQTRHENVVLF 94 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCC------------CCCCCCCTTGGGGTTCCCTTBCCC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCH------------HHHHHHHHHHHHHhcCCCCCEeEE
Confidence 5689999999999999999999864 248999885432211 012346679999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++++||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++ ++.
T Consensus 95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~ 167 (319)
T 2y4i_B 95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGK 167 (319)
T ss_dssp CEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---C
T ss_pred EEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCC
Confidence 9999999999999999999999999832 3346899999999999999999999665 99999999999998 679
Q ss_pred EEEecccccccCCCCC---cccccccccCcccccCCccccC---------CCCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 199 ARISEFGLAKQIPNGR---TRTTTWSLAETVGYIAPECHQT---------VALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
++|+|||++....... .........|++.|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999987653221 1112223457899999999875 347889999999999999999999997532
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
. ............+.. ... . ....+.+++..||+.||++|||+.++++.|+++.
T Consensus 248 ~-------~~~~~~~~~~~~~~~-~~~----~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 248 A-------EAIIWQMGTGMKPNL-SQI----G----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp H-------HHHHHHHHTTCCCCC-CCS----S----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred H-------HHHHHHhccCCCCCC-CcC----C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 2 122222222211111 000 0 1122889999999999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.51 Aligned_cols=202 Identities=22% Similarity=0.227 Sum_probs=168.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CC----
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HR---- 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~---- 113 (337)
..++|++.+.||+|+||+||+|++. .+++.||||++..... ....+..|+.+++.++ |+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~~~~~ 115 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNKKA---------------FLNQAQIEVRLLELMNKHDTEMK 115 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSSHH---------------HHHHHHHHHHHHHHHHHCSSGGG
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEc-CCCcEEEEEEEeccHH---------------HHHHHHHHHHHHHHHHhcccccc
Confidence 4689999999999999999999865 4889999999854321 1345666777777764 44
Q ss_pred -ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 114 -NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 114 -ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
+|+++++++...+..++||||+. ++|.+++... ....+++..+..++.|++.||.|||++ ..|++||||||+||+
T Consensus 116 ~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIl 191 (382)
T 2vx3_A 116 YYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENIL 191 (382)
T ss_dssp GGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEE
T ss_pred eeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEE
Confidence 48888999999999999999995 5999998652 335589999999999999999999954 346999999999999
Q ss_pred ec--CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 193 ID--DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 193 ~~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
++ .++.+||+|||++........ ...||+.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 192 l~~~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 192 LCNPKRSAIKIVDFGSSCQLGQRIY-----QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ESSTTSCCEEECCCTTCEETTCCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EecCCCCcEEEEeccCceecccccc-----cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 95 477899999999987643322 357799999999999999999999999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=301.53 Aligned_cols=261 Identities=18% Similarity=0.237 Sum_probs=200.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCC-----
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR----- 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~----- 113 (337)
..++|++.+.||+|+||.||+|.+...+++.||+|++..... ....+.+|+.+++.++|+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~~~~~ 76 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR---------------YCEAARSEIQVLEHLNTTDPNST 76 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH---------------HHHHHHHHHHHHHHHHHHCTTCT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc---------------hhHHHHHHHHHHHHhhhcCCCCc
Confidence 357999999999999999999987555889999999853321 134567777777777544
Q ss_pred -ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 114 -NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 114 -ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
+++++++++.+.+..++||||+ +++|.+++.. ....++++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil 150 (339)
T 1z57_A 77 FRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENIL 150 (339)
T ss_dssp TCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred eeeEeeecccccCCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence 5899999999999999999999 8899999865 33346899999999999999999999665 999999999999
Q ss_pred ecC-------------------CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHH
Q 036970 193 IDD-------------------DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLA 253 (337)
Q Consensus 193 ~~~-------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~ 253 (337)
++. ++.++|+|||++........ ...||+.|+|||++.+..++.++||||||+++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (339)
T 1z57_A 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS-----TLVSTRHYRAPEVILALGWSQPCDVWSIGCILI 225 (339)
T ss_dssp ESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCC-----SSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHH
T ss_pred EeccccccccCCccccccccccCCCceEeeCcccccCccccc-----cccCCccccChHHhhCCCCCcchhhHHHHHHHH
Confidence 987 66899999999876543221 346799999999999999999999999999999
Q ss_pred HHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCcccc-------------------------------ccccCCChHH
Q 036970 254 VLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTID-------------------------------SKLIGNGYEE 302 (337)
Q Consensus 254 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 302 (337)
+|++|..||..... ......+....... +..... ..........
T Consensus 226 el~~g~~pf~~~~~----~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (339)
T 1z57_A 226 EYYLGFTVFPTHDS----KEHLAMMERILGPL-PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300 (339)
T ss_dssp HHHHSSCSCCCSCH----HHHHHHHHHHHCSC-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSH
T ss_pred HHHhCCCCCCCCCh----HHHHHHHHHHhCCC-CHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchh
Confidence 99999999975432 11122222221110 000000 0000112234
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 303 QMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 303 ~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....+.+++.+||+.||++|||+.++++
T Consensus 301 ~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 301 EHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 5667999999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=327.21 Aligned_cols=259 Identities=20% Similarity=0.273 Sum_probs=202.1
Q ss_pred ccCcccccccccccccceEEeeeecC--CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|++.+.||+|+||.||+|++.. ..+..||+|....... ....+.+.+|+.++++++||||+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~HpnIv 454 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-------------DSVREKFLQEALTMRQFDHPHIV 454 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-------------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-------------HHHHHHHHHHHHHHHhCCCCCCC
Confidence 45789999999999999999998753 2356799998743221 11256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++. ++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 455 ~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~ 527 (656)
T 2j0j_A 455 KLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSN 527 (656)
T ss_dssp CEEEEEC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET
T ss_pred eEEEEEe-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCC
Confidence 9999885 4568999999999999999954 3345899999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~ 275 (337)
+.+||+|||++........... ....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+... .
T Consensus 528 ~~vkL~DFG~a~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-------~ 599 (656)
T 2j0j_A 528 DCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------N 599 (656)
T ss_dssp TEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------H
T ss_pred CCEEEEecCCCeecCCCcceec-cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-------H
Confidence 9999999999987654432221 13456788999999998899999999999999999997 8999875422 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+............ + +......+.+++.+||+.||++|||+.++++.|+++
T Consensus 600 ~~~~~i~~~~~~~--~--------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 600 DVIGRIENGERLP--M--------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp HHHHHHHHTCCCC--C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCC--C--------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2222222222111 0 111224488999999999999999999999999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=309.13 Aligned_cols=273 Identities=18% Similarity=0.190 Sum_probs=193.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|.+. +|..||+|++.......... ...........+.+|+.++++++||||+++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTV---NILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCE---EGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred hccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchh---hhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 6899999999999999999999865 69999999986543321100 000111224678999999999999999999
Q ss_pred hceeecC-----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 119 LARVVRP-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 119 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
++++... ...++||||++ ++|.+++. .....+++..++.++.||+.||.|||+.+ ++|+||||+||++
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 9998543 35699999996 58888874 34457999999999999999999999665 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
+.++.++|+|||++......... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---- 240 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---- 240 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred cCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH----
Confidence 99999999999999754433222 23467899999999877 67899999999999999999999999764321
Q ss_pred hHHHHHHHHhhcCC------------------CCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWMRNVMTSEN------------------PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+........ ..............+.....+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111110000 00000000000001112345889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=305.11 Aligned_cols=267 Identities=21% Similarity=0.211 Sum_probs=188.9
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
....++|++.+.||+|+||.||+|++. .+|..||+|++...... .....+++..+..++||||+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~---------------~~~~~~~~~~l~~l~h~niv 82 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDPRF---------------RNRELQIMQDLAVLHHPNIV 82 (360)
T ss_dssp HHHHTTEEEC----------CEEEEET-TTCCEEEEEEEECCTTC---------------CCHHHHHHHHHHHHCCTTBC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEecCccc---------------cHHHHHHHHHHHhcCCCCcc
Confidence 345689999999999999999999865 48999999988543211 22455677777888999999
Q ss_pred hhhceeecCCC-------ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHh--cCCCCCceeCCCC
Q 036970 117 PLLARVVRPDC-------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH--MSHRPRIIHRDIQ 187 (337)
Q Consensus 117 ~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~~~~~~h~di~ 187 (337)
++++++..... .++||||+++ +|.+.+.........+++..++.++.|++.||.||| +.+ ++|+|||
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlk 158 (360)
T 3e3p_A 83 QLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIK 158 (360)
T ss_dssp CEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCC
T ss_pred cHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCC
Confidence 99999976443 6899999965 676666555556778999999999999999999999 665 9999999
Q ss_pred CCcEEecC-CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 188 PANVLIDD-DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-LSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 188 ~~nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
|+||+++. ++.+||+|||++.......... ...||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.
T Consensus 159 p~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 159 PHNVLVNEADGTLKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp GGGEEEETTTTEEEECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEEeCCCCcEEEeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 99999996 8999999999998765443322 346799999999986654 899999999999999999999999764
Q ss_pred ccccccchHHHHHHHHhhc-----------CCC-Cccccc------cccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 036970 266 FQHTKEMSFVQWMRNVMTS-----------ENP-SRTIDS------KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~-----------~~~-~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 327 (337)
... ........ .... ... ...... .............+.+++.+||+.||.+|||+.+
T Consensus 236 ~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 311 (360)
T 3e3p_A 236 NSA---GQLHEIVR-VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311 (360)
T ss_dssp SHH---HHHHHHHH-HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ChH---HHHHHHHH-HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence 321 11111111 1100 000 000000 0001111123456999999999999999999999
Q ss_pred HHH
Q 036970 328 VRC 330 (337)
Q Consensus 328 il~ 330 (337)
+++
T Consensus 312 ~l~ 314 (360)
T 3e3p_A 312 ALC 314 (360)
T ss_dssp HTT
T ss_pred Hhc
Confidence 975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=311.97 Aligned_cols=271 Identities=19% Similarity=0.208 Sum_probs=183.4
Q ss_pred ccCcccc-cccccccccceEEeeeecC-CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFAS-LEKIRSCWNGEVYKAELPG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~-~~~lg~G~~g~vy~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..+.|++ +++||+|+||+||+|++.. .++..||+|++..... ...+.+|+.+++.++||||+
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------------~~~~~~E~~~l~~l~hpniv 81 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----------------SMSACREIALLRELKHPNVI 81 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----------------CHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----------------CHHHHHHHHHHHhcCCCCee
Confidence 3466776 4589999999999998642 3688999999853321 33577899999999999999
Q ss_pred hhhceeec--CCCceEEEEeecCCCHHHHHHhhhc-----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCC
Q 036970 117 PLLARVVR--PDCDLLVYEFRRNGSLQDILYDVSQ-----GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189 (337)
Q Consensus 117 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ 189 (337)
++++++.. +...++||||+. ++|.+++..... ....+++..++.++.||+.||.|||+.+ ++||||||+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~ 157 (405)
T 3rgf_A 82 SLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPA 157 (405)
T ss_dssp CCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred eEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHH
Confidence 99999954 667899999996 478888754332 2235899999999999999999999665 999999999
Q ss_pred cEEe----cCCCcEEEecccccccCCCCCc-ccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCC
Q 036970 190 NVLI----DDDMEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSD 263 (337)
Q Consensus 190 nil~----~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~ 263 (337)
||++ +.++.+||+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 158 NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 158 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp GEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999 6778999999999987654321 1222345789999999999874 48999999999999999999999997
Q ss_pred Cccccc-----ccchHHHHHHHHhhcCCCCcccccc----------------ccC-CChH--------HHHHHHHHHHHH
Q 036970 264 DFFQHT-----KEMSFVQWMRNVMTSENPSRTIDSK----------------LIG-NGYE--------EQMLLVLKIACF 313 (337)
Q Consensus 264 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~-~~~~--------~~~~~l~~li~~ 313 (337)
...... ........+...+.... ....... ... .... .....+.+||.+
T Consensus 238 ~~~~~~~~~~~~~~~~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~ 316 (405)
T 3rgf_A 238 CRQEDIKTSNPYHHDQLDRIFNVMGFPA-DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316 (405)
T ss_dssp CCC------CCCCHHHHHHHHHHHCCCC-TTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHH
T ss_pred CccccccccccchHHHHHHHHHhhCCCC-hhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHH
Confidence 543210 01111111111111111 1000000 000 0000 002347899999
Q ss_pred hcCCCCCCCCCHHHHHH
Q 036970 314 CTFDDPEERPNSKDVRC 330 (337)
Q Consensus 314 ~l~~~p~~Rps~~~il~ 330 (337)
||+.||.+|||+.++++
T Consensus 317 ~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 317 LLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred HccCCcccCCCHHHHhc
Confidence 99999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=303.90 Aligned_cols=273 Identities=17% Similarity=0.246 Sum_probs=204.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHh---hcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELI---KQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
..++|.+.+.||+|+||.||+|++ +|+.||+|.+........... .............+.+|+.++++++||||
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 358999999999999999999986 899999999865432211000 00000011112689999999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHH------HHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDI------LYDVSQGRRELDWLARHRIARGIASGLEYLHM-SHRPRIIHRDIQP 188 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~~~h~di~~ 188 (337)
+++++++.+.+..++||||+++++|.++ +.. .....+++..++.++.|++.||.|||+ .+ ++|+||+|
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p 180 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKP 180 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCG
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCCh
Confidence 9999999999999999999999999988 421 125679999999999999999999996 55 99999999
Q ss_pred CcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCC-cccchhHhHHHHHHHhCCCCCCCcc
Q 036970 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSD-KCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 189 ~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
+||+++.++.++|+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|+|++|..||....
T Consensus 181 ~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 181 SNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp GGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999776433 12245789999999999887 5666 8999999999999999999997543
Q ss_pred cccccchHHHHHHHHhhcCCCCcccccc---------ccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSK---------LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. .+......... .....+.. ............+.+++.+||+.||++|||+.++++
T Consensus 257 ~~------~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SL------VELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CS------HHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cH------HHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 21 12222222111 11110000 000001223345899999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=300.83 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=179.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHH-HhcCCCCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEII-TAGQVRHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~ni~~ 117 (337)
..++|++++.||+|+||.||+|.+. .+|+.||+|++....... ....+..|+. +++.++||||++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~~~~h~niv~ 85 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTVDEK-------------EQKQLLMDLDVVMRSSDCPYIVQ 85 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEET-TTTEEEEEEEEECCCCHH-------------HHHHHHHHHHHHHSSCCCTTBCC
T ss_pred CHHHhhehheeccCCCEEEEEEEEc-CCCCEEEEEEeecccCch-------------HHHHHHHHHHHHHHcCCCCcEee
Confidence 4689999999999999999999865 489999999986543211 1334555555 778889999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhh-cCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCCceeCCCCCCcEEecC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVS-QGRRELDWLARHRIARGIASGLEYLHMS-HRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~~~h~di~~~nil~~~ 195 (337)
+++++.+++..++||||+++ +|.+++.... .....+++..++.++.|++.||.|||+. + ++|+||+|+||+++.
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~ 161 (327)
T 3aln_A 86 FYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDR 161 (327)
T ss_dssp EEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEET
T ss_pred eeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcC
Confidence 99999999999999999975 7888775432 2356789999999999999999999965 5 999999999999999
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccc----cCCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH----QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++.+||+|||++.......... ...||+.|+|||++ .+..++.++||||||+++|+|++|..||......
T Consensus 162 ~~~~kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 235 (327)
T 3aln_A 162 SGNIKLCDFGISGQLVDSIAKT---RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--- 235 (327)
T ss_dssp TTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred CCCEEEccCCCceecccccccc---cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH---
Confidence 9999999999997765432221 23679999999998 4556899999999999999999999999753210
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+..........+ .+...........+.+++.+||+.||++|||+.++++
T Consensus 236 ---~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 236 ---FDQLTQVVKGDPP------QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -------CCCCCSCCC------CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHhcCCCC------CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0111111111110 0111111122345889999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=298.65 Aligned_cols=254 Identities=21% Similarity=0.309 Sum_probs=192.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC--CCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--HRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~ 116 (337)
..++|++++.||+|+||.||+|.+. +++.||+|++....... .....+.+|+.++.+++ ||||+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADN------------QTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCH------------HHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccc------------cchHHHHHHHHHHHhccccCCceE
Confidence 4678999999999999999999865 68999999986543221 12567889999999996 59999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.++...+++|| +.+++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++
T Consensus 92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~- 162 (313)
T 3cek_A 92 RLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD- 162 (313)
T ss_dssp CEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-
T ss_pred EEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-
Confidence 99999999999999999 457899999953 356899999999999999999999665 999999999999965
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccC-----------CCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-----------VALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
+.++|+|||++................|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 7999999999987654433323334578999999999876 46788999999999999999999999753
Q ss_pred ccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 266 FQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. ............... .+. ... ...+.+++.+||+.||++|||+.++++
T Consensus 243 ~~------~~~~~~~~~~~~~~~-~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 243 IN------QISKLHAIIDPNHEI-EFP----DIP----EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CS------HHHHHHHHHCTTSCC-CCC----CCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH------HHHHHHHHHhccccc-CCc----ccc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 22 111222222211111 011 011 234889999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.15 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=191.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|.+.... .....+.+|+.+++.++||||+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---------------~~~~~~~~E~~~l~~l~h~~i~~~ 67 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHTE---------------EKLSTILSEVMLLASLNHQYVVRY 67 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEEH---------------HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccccchhhheeccCCcEEEEEEEEc-CCCeEEEEEEEeccH---------------HHHHHHHHHHHHHHhcCchHHHHH
Confidence 4578999999999999999999865 489999999985321 114678899999999999999999
Q ss_pred hceeec-------------CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCC
Q 036970 119 LARVVR-------------PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRD 185 (337)
Q Consensus 119 ~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~d 185 (337)
++++.+ ....++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~d 141 (303)
T 1zy4_A 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRD 141 (303)
T ss_dssp EEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 998865 3456899999999999999954 3456788999999999999999999665 99999
Q ss_pred CCCCcEEecCCCcEEEecccccccCCCCCc------------ccccccccCcccccCCccccCC-CCCCcccchhHhHHH
Q 036970 186 IQPANVLIDDDMEARISEFGLAKQIPNGRT------------RTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLL 252 (337)
Q Consensus 186 i~~~nil~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl 252 (337)
|+|+||+++.++.++|+|||++........ ........||+.|+|||++.+. .++.++||||||+++
T Consensus 142 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 221 (303)
T 1zy4_A 142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221 (303)
T ss_dssp CCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHH
T ss_pred CCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHH
Confidence 999999999999999999999987643211 1112245678999999999865 689999999999999
Q ss_pred HHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 253 AVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 253 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
|+|++ ||.... .............. .+++.. .......+.+++.+||+.||++|||+.++++
T Consensus 222 ~~l~~---p~~~~~------~~~~~~~~~~~~~~---~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 222 FEMIY---PFSTGM------ERVNILKKLRSVSI---EFPPDF----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHS---CCSSHH------HHHHHHHHHHSTTC---CCCTTC----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHh---ccCCch------hHHHHHHhcccccc---ccCccc----cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 99998 554211 11122222221111 111111 1222344789999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=301.74 Aligned_cols=265 Identities=19% Similarity=0.229 Sum_probs=196.8
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++.+.||+|+||.||+|++. .+|+.||+|++...... .....+.+|+.+++.++||||+++
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~ 74 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDKP-------------LFALRTLREIKILKHFKHENIITI 74 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCSSH-------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceEEeeEEcCCCCeEEEEEEEC-CCCcEEEEEeecccccc-------------hHHHHHHHHHHHHHhCcCCCcCCe
Confidence 5689999999999999999999865 47999999998532211 114567899999999999999999
Q ss_pred hceeecC-----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 119 LARVVRP-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 119 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
++++... ...++|+||+. ++|.+++.. +.+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 75 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~ 145 (353)
T 2b9h_A 75 FNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLI 145 (353)
T ss_dssp EEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred eeeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEE
Confidence 9987764 66799999996 589998843 45899999999999999999999665 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCccc--------ccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCC
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRT--------TTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDD 264 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~ 264 (337)
+.++.++|+|||++.......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999998765322111 1123467999999998765 6789999999999999999999999975
Q ss_pred cccccccchHHHHHHHHhhcCCCCcccc------------------ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTID------------------SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 326 (337)
.... .....+.............. ........+.....+.+++.+||+.||++|||+.
T Consensus 226 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (353)
T 2b9h_A 226 RDYR----HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301 (353)
T ss_dssp SSHH----HHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCcH----HHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence 4321 11111111111100000000 0000000112234588999999999999999999
Q ss_pred HHHH
Q 036970 327 DVRC 330 (337)
Q Consensus 327 ~il~ 330 (337)
++++
T Consensus 302 ell~ 305 (353)
T 2b9h_A 302 EALE 305 (353)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=306.35 Aligned_cols=266 Identities=19% Similarity=0.217 Sum_probs=196.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-------
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR------- 111 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------- 111 (337)
..++|.+.+.||+|+||+||+|++. .+++.||+|++..... ....+.+|+.+++.+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~~~~~ 80 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDKV---------------YTEAAEDEIKLLQRVNDADNTKE 80 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCHH---------------HHHHHHHHHHHHHHHHHTCCSHH
T ss_pred cCCeEEEEEeeeecCCeEEEEEEec-CCCcEEEEEEecCCcc---------------chhhhhHHHHHHHHhhcccccch
Confidence 3579999999999999999999865 4899999999854321 1345677888887775
Q ss_pred ----CCChhhhhceeecCC----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 036970 112 ----HRNIVPLLARVVRPD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIH 183 (337)
Q Consensus 112 ----h~ni~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h 183 (337)
||||+++++++...+ ..++++|++ +++|.+++... ....+++..++.++.||+.||.|||+.. |++|
T Consensus 81 ~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH 155 (373)
T 1q8y_A 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIH 155 (373)
T ss_dssp HHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEEC
T ss_pred hccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEe
Confidence 899999999988654 678999999 88999998653 3345899999999999999999999650 4999
Q ss_pred CCCCCCcEEec------CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh
Q 036970 184 RDIQPANVLID------DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM 257 (337)
Q Consensus 184 ~di~~~nil~~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~ 257 (337)
+||||+||+++ ..+.++|+|||++........ ...||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 156 ~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 230 (373)
T 1q8y_A 156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230 (373)
T ss_dssp SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cCCChHHeEEeccCCCcCcceEEEcccccccccCCCCC-----CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHh
Confidence 99999999995 334799999999976643322 3467999999999999999999999999999999999
Q ss_pred CCCCCCCcccccccchH--HHHHHHHhhcCCC------------------Cccccc----------cccCCChHHHHHHH
Q 036970 258 GKFPSDDFFQHTKEMSF--VQWMRNVMTSENP------------------SRTIDS----------KLIGNGYEEQMLLV 307 (337)
Q Consensus 258 g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~------------------~~~~~~----------~~~~~~~~~~~~~l 307 (337)
|..||............ ...+...+...+. ...+.. ......+......+
T Consensus 231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (373)
T 1q8y_A 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310 (373)
T ss_dssp SSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHH
T ss_pred CCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHH
Confidence 99999864332211111 1111111111000 000000 00012235567789
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHH
Q 036970 308 LKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 308 ~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.++|.+||+.||++|||+.++++
T Consensus 311 ~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 311 SDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHHhccCccccCCHHHHhh
Confidence 99999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.84 Aligned_cols=254 Identities=21% Similarity=0.273 Sum_probs=170.5
Q ss_pred ccCcccccc-cccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 39 KEDCFASLE-KIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~-~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
..++|.+.+ .||+|+||.||+|++. .+|+.||+|++..... ........++.+.||||++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~------------------~~~e~~~~~~~~~h~~i~~ 86 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHR-RTGQKCALKLLYDSPK------------------ARQEVDHHWQASGGPHIVC 86 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESSHH------------------HHHHHHHHHHHTTSTTBCC
T ss_pred ccceeEecceeeeeCCCeEEEEEEEC-CCCCEEEEEEecCcHH------------------HHHHHHHHHHhcCCCChHH
Confidence 457899865 6999999999999865 4899999999854321 1111223345568999999
Q ss_pred hhceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 118 LLARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 118 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++++.. ....++||||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll 161 (336)
T 3fhr_A 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLY 161 (336)
T ss_dssp EEEEEEEEETTEEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred HHHHHhhccCCCceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999876 4457999999999999999954 23357999999999999999999999665 9999999999999
Q ss_pred cC---CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 194 DD---DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 194 ~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
+. ++.++|+|||++......... ...+|+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 162 ~~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 162 TSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp SCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred EecCCCceEEEeccccceeccccccc----cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 86 455999999999765433221 34679999999999888899999999999999999999999975433211
Q ss_pred cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............... . ...+......+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~------~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 238 SPGMKRRIRLGQYGF------P----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -------------CC------C----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHhhhcccccc------C----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111111100000 0 0111122345889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=297.93 Aligned_cols=261 Identities=19% Similarity=0.248 Sum_probs=189.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++. .+|+.||+|++..... .....+.+|+.+++.++||||+++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~ 73 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLTDP--------------QSVKHALREIKIIRRLDHDNIVKV 73 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEET-TTTEEEEEEEEECCSH--------------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCceeEEEEeccCCCeEEEEEEEC-CCCeEEEEEEEecCCh--------------HHHHHHHHHHHHHHhcCCCCeeEE
Confidence 5689999999999999999999865 4799999998854321 115678899999999999999999
Q ss_pred hceee--------------cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 036970 119 LARVV--------------RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHR 184 (337)
Q Consensus 119 ~~~~~--------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~ 184 (337)
++++. +....++||||++ ++|.+++ ..+.+++..++.++.|++.||.|||+.+ ++|+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 144 (320)
T 2i6l_A 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL-----EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHR 144 (320)
T ss_dssp EEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCC
T ss_pred EEeccccccccccccccccccCceeEEeeccC-CCHHHHh-----hcCCccHHHHHHHHHHHHHHHHHHHhCC---EecC
Confidence 98874 3456789999997 5999998 2356899999999999999999999665 9999
Q ss_pred CCCCCcEEec-CCCcEEEecccccccCCCCCc-ccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCC
Q 036970 185 DIQPANVLID-DDMEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 185 di~~~nil~~-~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~p 261 (337)
||||+||+++ .++.+||+|||++........ ........+|..|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 145 dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (320)
T 2i6l_A 145 DLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224 (320)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence 9999999997 567899999999987643211 111223456889999998865 5788999999999999999999999
Q ss_pred CCCcccccccchHHHHHHHHhhcCCCCc-------------ccccccc------CCChHHHHHHHHHHHHHhcCCCCCCC
Q 036970 262 SDDFFQHTKEMSFVQWMRNVMTSENPSR-------------TIDSKLI------GNGYEEQMLLVLKIACFCTFDDPEER 322 (337)
Q Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~R 322 (337)
|...... . ............. .+..... ....+.....+.+++.+||+.||++|
T Consensus 225 f~~~~~~----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 225 FAGAHEL----E---QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp SCCSSHH----H---HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred CCCCCHH----H---HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcccc
Confidence 9754321 1 1111111000000 0000000 00001123558999999999999999
Q ss_pred CCHHHHHH
Q 036970 323 PNSKDVRC 330 (337)
Q Consensus 323 ps~~~il~ 330 (337)
||+.++++
T Consensus 298 pt~~ell~ 305 (320)
T 2i6l_A 298 LTAEEALS 305 (320)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhC
Confidence 99999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=299.27 Aligned_cols=258 Identities=22% Similarity=0.270 Sum_probs=194.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|.+.+.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.++||||+++
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~ 88 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSE------------IFAKRAYRELLLLKHMQHENVIGL 88 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEESSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred cCceEEEeeeEecCCCeEEEEEEEC-CCCCEEEEEEecccccch------------HHHHHHHHHHHHHHhcCCCCcccH
Confidence 4689999999999999999999865 489999999985533211 125678899999999999999999
Q ss_pred hceeecCCC------ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPDC------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++..... .++||||+. ++|.+++ ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+
T Consensus 89 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl 158 (353)
T 3coi_A 89 LDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLA 158 (353)
T ss_dssp SEEECSCSSGGGCCCCEEEEECCS-EEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEE
T ss_pred hheEecccccccceeEEEEecccc-CCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEe
Confidence 999987754 399999996 5887776 134899999999999999999999665 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++.++.++|+|||++....... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....
T Consensus 159 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--- 230 (353)
T 3coi_A 159 VNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--- 230 (353)
T ss_dssp ECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---
T ss_pred ECCCCcEEEeecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 9999999999999997654321 13467999999999877 67899999999999999999999999754321
Q ss_pred chHHHHHHHHhhc-------------------CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTS-------------------ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.....+...... ..+.. ... ......+.....+.+++.+||+.||++|||+.++++
T Consensus 231 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 231 -DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT-PRK-DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp -HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBC-SSC-CTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCC-CCc-cHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111110000 00000 000 001111223455899999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.86 Aligned_cols=263 Identities=18% Similarity=0.264 Sum_probs=185.7
Q ss_pred hhhhhhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC
Q 036970 32 EDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111 (337)
Q Consensus 32 ~~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 111 (337)
....+....++|++++.||+|+||.||+|++. .+|+.||+|++........ ....+..+..+++.++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~~~~~~~~~~ 82 (318)
T 2dyl_A 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEE------------NKRILMDLDVVLKSHD 82 (318)
T ss_dssp SSSEEECCGGGEEEEEEC------CEEEEEET-TTCCEEEEEEEETTSCHHH------------HHHHHHHHHHHHHTTT
T ss_pred cchhhhhhhccccccceeeecCCeeEEEEEEe-cCCeEEEEEEecccccchH------------HHHHHHHHHHHHHhcC
Confidence 33444456789999999999999999999875 4899999999865432221 1334455556788889
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcE
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANV 191 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ni 191 (337)
||||+++++++.+++..++||||+ ++.+..+... ....+++..++.++.|++.||.|||+. .|++|+||+|+||
T Consensus 83 h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Ni 156 (318)
T 2dyl_A 83 CPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNI 156 (318)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGE
T ss_pred CCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHE
Confidence 999999999999999999999999 5556655532 235689999999999999999999963 1499999999999
Q ss_pred EecCCCcEEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCcc
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDFF 266 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~ 266 (337)
+++.++.++|+|||++......... ....+++.|+|||.+. ...++.++||||||+++|+|++|..||....
T Consensus 157 l~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (318)
T 2dyl_A 157 LLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233 (318)
T ss_dssp EECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EECCCCCEEEEECCCchhccCCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999998765443222 1346799999999984 4568889999999999999999999997532
Q ss_pred cccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 267 QHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
. .............+..... ......+.+++.+||+.||.+|||+.++++
T Consensus 234 ~------~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 234 T------DFEVLTKVLQEEPPLLPGH--------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp S------HHHHHHHHHHSCCCCCCSS--------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c------cHHHHHHHhccCCCCCCcc--------CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 1222223333322211100 011234889999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=298.52 Aligned_cols=261 Identities=16% Similarity=0.194 Sum_probs=197.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC----
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN---- 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n---- 114 (337)
..++|++.+.||+|+||.||+|.+....+..||+|++..... ....+.+|+.+++.++|++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~~~~~ 81 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---------------YREAARLEINVLKKIKEKDKENK 81 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH---------------HHHHHHHHHHHHHHHHHHCTTSC
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc---------------chhHHHHHHHHHHHHhhcCCCCc
Confidence 358999999999999999999987653457899999854321 1345677888888776554
Q ss_pred --hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 115 --IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 115 --i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++.+.+++...+..++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+. |++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIl 155 (355)
T 2eu9_A 82 FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENIL 155 (355)
T ss_dssp SCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEE
T ss_pred eeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence 888899999999999999999 6678777754 3335689999999999999999999955 5999999999999
Q ss_pred e-------------------cCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHH
Q 036970 193 I-------------------DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLA 253 (337)
Q Consensus 193 ~-------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~ 253 (337)
+ +.++.++|+|||++........ ...||+.|+|||++.+..++.++||||||+++|
T Consensus 156 l~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 230 (355)
T 2eu9_A 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT-----TIVATRHYRPPEVILELGWAQPCDVWSIGCILF 230 (355)
T ss_dssp ESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred EecccccccccccccccccccCCCcEEEeecCcccccccccc-----CCcCCCcccCCeeeecCCCCCccchHHHHHHHH
Confidence 9 5678999999999976443222 346899999999999999999999999999999
Q ss_pred HHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccc----------cc---------------------cccCCChHH
Q 036970 254 VLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTI----------DS---------------------KLIGNGYEE 302 (337)
Q Consensus 254 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~---------------------~~~~~~~~~ 302 (337)
+|++|..||..... ......+...... .+.... .. .........
T Consensus 231 el~~g~~pf~~~~~----~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (355)
T 2eu9_A 231 EYYRGFTLFQTHEN----REHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305 (355)
T ss_dssp HHHHSSCSCCCSSH----HHHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSH
T ss_pred HHHhCCCCCCCCCH----HHHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccch
Confidence 99999999975432 1111122222111 110000 00 000111223
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 303 QMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 303 ~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....+.+++.+||+.||++|||+.++++
T Consensus 306 ~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 306 EHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 4557899999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=300.01 Aligned_cols=248 Identities=20% Similarity=0.262 Sum_probs=196.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC--CCChh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--HRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~ 116 (337)
..++|++.+.||+|+||.||+|++. .+++.||+|++.......... ......+.+|+.+++.++ |+||+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGE--------LPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCEEE--------CTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred ccCceEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhhhh--------hhhhhHHHHHHHHHHhhccCCCCce
Confidence 4688999999999999999999865 489999999986543221100 001234567888888885 69999
Q ss_pred hhhceeecCCCceEEEEeecC-CCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec-
Q 036970 117 PLLARVVRPDCDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID- 194 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~- 194 (337)
++++++.+.+..++++|++.+ ++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL 184 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeC
Confidence 999999999999999999975 899999854 356899999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
.++.+||+|||++......... ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------ 254 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 254 (320)
T ss_dssp TTTEEEECCCTTCEECCSSCBC----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------
T ss_pred CCCCEEEeeCcccccccccccc----CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------
Confidence 7789999999999876543222 3468999999999887665 6788999999999999999999964311
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... ... . ....+.+++.+||+.||++|||+.++++
T Consensus 255 -------~~~~~~~---~~~----~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 -------IIRGQVF---FRQ----R----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------HHHCCCC---CSS----C----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------hhccccc---ccc----c----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111110 000 1 1234889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=305.25 Aligned_cols=256 Identities=22% Similarity=0.282 Sum_probs=185.2
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
..+.|...+.||+|+||+||.+... +|+.||||++.... .+.+.+|+.++..+ +||||++
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~--~g~~vAvK~~~~~~-----------------~~~~~~E~~~l~~l~~HpnIv~ 73 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDF-----------------CDIALMEIKLLTESDDHPNVIR 73 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEES--SSSEEEEEEEEGGG-----------------HHHHHHHHHHHHHHTTSTTBCC
T ss_pred hhheeeccCeEeeCCCeEEEEEEEE--CCeEEEEEEEcHHH-----------------HHHHHHHHHHHHhccCCCCcCe
Confidence 3456677799999999999876443 79999999985321 33567899999876 8999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCc---CCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRE---LDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~---l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
+++++.++...++||||++ ++|.+++......... .++..++.++.||+.||.|||+.+ ++||||||+||+++
T Consensus 74 ~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~ 149 (434)
T 2rio_A 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVS 149 (434)
T ss_dssp EEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE
T ss_pred EEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEe
Confidence 9999999999999999995 5999999543221111 123345789999999999999665 99999999999997
Q ss_pred CC-------------CcEEEecccccccCCCCCcc--cccccccCcccccCCccccC-------CCCCCcccchhHhHHH
Q 036970 195 DD-------------MEARISEFGLAKQIPNGRTR--TTTWSLAETVGYIAPECHQT-------VALSDKCDIYSFGVLL 252 (337)
Q Consensus 195 ~~-------------~~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~vl 252 (337)
.+ +.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il 229 (434)
T 2rio_A 150 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229 (434)
T ss_dssp CCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHH
T ss_pred cCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHH
Confidence 54 47999999999876543221 11223578999999999876 5688999999999999
Q ss_pred HHHHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 253 AVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 253 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
|+|++ |..||.+.... ...... ....... ............+.+++.+||+.||++|||+.++++
T Consensus 230 ~ellt~g~~Pf~~~~~~-----~~~i~~----~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 230 YYILSKGKHPFGDKYSR-----ESNIIR----GIFSLDE----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTTSCCTTCSTTTH-----HHHHHH----TCCCCCC----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCCCCCchhh-----HHHHhc----CCCCccc----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 99999 89999753321 111111 1111110 011123455677999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.69 Aligned_cols=248 Identities=17% Similarity=0.190 Sum_probs=187.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC----CCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV----RHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~n 114 (337)
..++|++.+.||+|+||.||+|++. .+++.||+|++........... .....+.+|+.++.++ +|||
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~~h~~ 99 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSPL--------SDSVTCPLEVALLWKVGAGGGHPG 99 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC----------------CCCCHHHHHHHHHHSSCCCSS
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEecccccccccc--------hhhHHHHHHHHHHHhhcccCCCCC
Confidence 4689999999999999999999864 4889999999865433211100 0122355677777777 8999
Q ss_pred hhhhhceeecCCCceEEEEe-ecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 115 IVPLLARVVRPDCDLLVYEF-RRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
|+++++++.+.+..++|+|+ +.+++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILI 172 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEE
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEE
Confidence 99999999999999999999 788999999954 345899999999999999999999665 9999999999999
Q ss_pred c-CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 194 D-DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALS-DKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 194 ~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
+ .++.++|+|||++......... ...|+..|+|||++.+..+. .++||||||+++|+|++|..||.....
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 244 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDEPYT----DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---- 244 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSSCBC----CCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred eCCCCeEEEEEcchhhhcccCccc----ccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----
Confidence 9 8899999999998876543222 34679999999998876664 489999999999999999999864211
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
. ...... + +......+.+++.+||+.||++|||+.++++
T Consensus 245 -----~----~~~~~~---~--------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -----I----LEAELH---F--------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -----H----HHTCCC---C--------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----H----hhhccC---C--------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111100 0 0112234889999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=315.22 Aligned_cols=268 Identities=20% Similarity=0.218 Sum_probs=195.0
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|+||.||+|.+. .+|..||+|++..... ......+.+|+.+++.++||||++++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~~~-------------~~~~~~~~~Ei~iL~~L~HpnIV~l~ 78 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQELS-------------PKNRERWCLEIQIMKKLNHPNVVSAR 78 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSCCC-------------HHHHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred CCCeEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEecccCC-------------HHHHHHHHHHHHHHHhCCCCCCCcee
Confidence 378999999999999999999865 4899999999854322 11256788999999999999999999
Q ss_pred ceeec------CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 120 ARVVR------PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 120 ~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++.. ++..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 79 ~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl 154 (676)
T 3qa8_A 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVL 154 (676)
T ss_dssp ECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEE
T ss_pred eeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEe
Confidence 88765 667799999999999999996532 2335888999999999999999999665 9999999999999
Q ss_pred cCCCc---EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 194 DDDME---ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 194 ~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
+.++. ++|+|||++......... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+......
T Consensus 155 ~~~g~~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~ 231 (676)
T 3qa8_A 155 QPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231 (676)
T ss_dssp ECCSSSCEEEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH
T ss_pred ecCCCceeEEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh
Confidence 97665 899999999876544332 235789999999999999999999999999999999999999965321000
Q ss_pred -cchHH-HHHHHHhhcCCCCc--cccc--cccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 036970 271 -EMSFV-QWMRNVMTSENPSR--TIDS--KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328 (337)
Q Consensus 271 -~~~~~-~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 328 (337)
..... .............. .... .............+.+++..||+.||++|||+.++
T Consensus 232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000 00000000000000 0000 01112233456679999999999999999999773
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=302.67 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=184.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
...+|.+.+.||+|+||+|+..... +|+.||||++..... ..+.+|+.+++.+ +||||++
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~--~~~~vAvK~~~~~~~-----------------~~~~~E~~~l~~l~~HpnIv~ 82 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECF-----------------SFADREVQLLRESDEHPNVIR 82 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEES--SSSEEEEEEECTTTE-----------------EECHHHHHHHHHSCCCTTBCC
T ss_pred ccEEEecCCeeecCcCEEEEEEEEe--CCeEEEEEEECHHHH-----------------HHHHHHHHHHHhccCCCCcCe
Confidence 5678999999999999996544333 799999999853221 1245689999988 7999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC--
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-- 195 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~-- 195 (337)
+++++.+....++||||+. ++|.+++.. .....+...++.++.||+.||.|||+.+ ++||||||+||+++.
T Consensus 83 l~~~~~~~~~~~lv~E~~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~ 155 (432)
T 3p23_A 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPN 155 (432)
T ss_dssp EEEEEEETTEEEEEEECCS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCB
T ss_pred EEEEEecCCEEEEEEECCC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCC
Confidence 9999999999999999995 599999854 2233445566789999999999999665 999999999999953
Q ss_pred ---CCcEEEecccccccCCCCCc-ccccccccCcccccCCccccC---CCCCCcccchhHhHHHHHHHh-CCCCCCCccc
Q 036970 196 ---DMEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQT---VALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQ 267 (337)
Q Consensus 196 ---~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~ 267 (337)
...++|+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 156 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~ 235 (432)
T 3p23_A 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235 (432)
T ss_dssp TTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred CCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence 23588999999987654321 122234578999999999974 567889999999999999999 8899864322
Q ss_pred ccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... ......... ........+.+++.+||+.||++|||+.++++
T Consensus 236 --------~~~~~~~-~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 236 --------RQANILL-GACSLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --------HHHHHHT-TCCCCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------HHHHHHh-ccCCccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111111 111111111 11233455789999999999999999999983
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=281.55 Aligned_cols=235 Identities=13% Similarity=0.102 Sum_probs=181.2
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|+||.||+|++. .+|+.||+|++....... ......+.+|+..+.+++||||++++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~hp~iv~~~ 97 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQGVLP-----------DDVLQETLSRTLRLSRIDKPGVARVL 97 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTCCSC-----------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEec-CCCceEEEEEECcccccC-----------HHHHHHHHHHHHHHhcCCCCCcceee
Confidence 378999999999999999999865 479999999996543211 12256789999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++||||+++++|.+++. . + .....+..++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~----~-~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~ 168 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVAD----T-S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDV 168 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHT----T-C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCE
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHh----c-C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCE
Confidence 99999999999999999999999982 2 2 355678889999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
+|++++ |++ .++.++||||||+++|+|++|..||.+............
T Consensus 169 kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~--- 216 (286)
T 3uqc_A 169 VLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER--- 216 (286)
T ss_dssp EECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB---
T ss_pred EEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH---
Confidence 998543 223 357889999999999999999999976432110000000
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
........ .... .......+.+++.+||+.||++| |+.++++.|.++.
T Consensus 217 -~~~~~~~~---~~~~----~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 217 -DTAGQPIE---PADI----DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp -CTTSCBCC---HHHH----CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred -HhccCCCC---hhhc----ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 00000000 0000 01122448899999999999999 9999999998764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=314.65 Aligned_cols=241 Identities=20% Similarity=0.228 Sum_probs=192.1
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|+||.||+|.+...+|+.||||++...... .....+.+|+.++.+++||||++++
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~ 145 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-------------EAQAMAMAERQFLAEVVHPSIVQIF 145 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH-------------HHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH-------------HHHHHHHHHHHHHHhcCCCCcCeEe
Confidence 489999999999999999999876447899999988543221 1245788999999999999999999
Q ss_pred ceeecCCC-----ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 120 ARVVRPDC-----DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 120 ~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
+++.+.+. .++||||+++++|.+++. . .+++..++.++.||+.||.|||+.+ ++|+||||+||+++
T Consensus 146 ~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~----~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~ 216 (681)
T 2pzi_A 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----Q--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLT 216 (681)
T ss_dssp EEEEEECTTSCEEEEEEEECCCCEECC--------C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred eeEeecCCCCCceeEEEEEeCCCCcHHHHHh----C--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEe
Confidence 99988766 699999999999998772 2 6899999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
.+ .+||+|||++...... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||.+......
T Consensus 217 ~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---- 284 (681)
T 2pzi_A 217 EE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---- 284 (681)
T ss_dssp SS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----
T ss_pred CC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----
Confidence 85 9999999999876543 234689999999998775 48899999999999999999998765322100
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-SKDVRCMLSQ 334 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~il~~L~~ 334 (337)
+. ..........+.++|.+||++||++||+ ++++.+.|..
T Consensus 285 ------------~~--------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 ------------PE--------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------------CT--------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------------cc--------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 0111122345889999999999999995 5666665544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=278.37 Aligned_cols=231 Identities=19% Similarity=0.279 Sum_probs=176.3
Q ss_pred ccCccccc-ccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHh-cCCCCCChh
Q 036970 39 KEDCFASL-EKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITA-GQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~-~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~ni~ 116 (337)
..++|.+. +.||+|+||.||+|.+. .+++.||+|++.. ...+.+|+.++ +.++||||+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~-------------------~~~~~~e~~~~~~~~~h~~i~ 74 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQD-------------------CPKARREVELHWRASQCPHIV 74 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEC-------------------SHHHHHHHHHHHHHTTSTTBC
T ss_pred cccchhhcCcccccCCCeEEEEEEEc-CCCcEEEEEEecc-------------------cHHHHHHHHHHHHhccCCCch
Confidence 45778887 78999999999999865 4899999999843 22456677777 555899999
Q ss_pred hhhceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 117 PLLARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 117 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
++++++.. ....++||||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil 149 (299)
T 3m2w_A 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLL 149 (299)
T ss_dssp CEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred hHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 99999877 6678999999999999999965 33456999999999999999999999665 999999999999
Q ss_pred ecC---CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 193 IDD---DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 193 ~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
++. ++.++|+|||++.... +..++.++||||||+++|+|++|..||.......
T Consensus 150 ~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 205 (299)
T 3m2w_A 150 YTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205 (299)
T ss_dssp ESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----
T ss_pred EecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh
Confidence 997 7889999999875432 2346778999999999999999999996532211
Q ss_pred ccchHHHHHHHHhhcCCCCcccccc--ccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDSK--LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.. ........... ............+.+++.+||+.||++|||+.++++
T Consensus 206 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 206 IS------------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp --------------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hh------------HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 00000000000 000000122455899999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=293.72 Aligned_cols=248 Identities=13% Similarity=0.098 Sum_probs=181.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC-CChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH-RNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~ 117 (337)
...+|...+.||+|+||.||+|++. .+|+.||||++....... ....+.+.+|+.+++.+.| +|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~~~~-----------~~~~~~~~~E~~~~~~l~~~~~~~~ 143 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPP-----------SNAIKQMKEEVLRLRLLRGIKNQKQ 143 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEECCSCC---------------CCHHHHHHHHGGGGSTTCCSHHH
T ss_pred CceeEEEecccccCCCEEEEEEEec-CCCCceEEEEEecCCCcc-----------HHHHHHHHHHHHHHHhhccCCCHHH
Confidence 3456888999999999999999865 489999999885332211 1125678899999999977 44333
Q ss_pred hhce---------------------eec-----CCCceEEEEeecCCCHHHHHHhh---hcCCCcCCHHHHHHHHHHHHH
Q 036970 118 LLAR---------------------VVR-----PDCDLLVYEFRRNGSLQDILYDV---SQGRRELDWLARHRIARGIAS 168 (337)
Q Consensus 118 ~~~~---------------------~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~l~~~~~~~~~~~i~~ 168 (337)
...+ +.. ....+++|+++ +++|.+++... ......+++..++.++.|++.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~ 222 (413)
T 3dzo_A 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222 (413)
T ss_dssp HHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHH
T ss_pred HHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHH
Confidence 2222 111 12346777766 67999988533 234566888899999999999
Q ss_pred HHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccc----------cCCC
Q 036970 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH----------QTVA 238 (337)
Q Consensus 169 ~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~ 238 (337)
||.|||+.+ ++||||||+||+++.++.+||+|||++...... .....| +.|+|||++ ....
T Consensus 223 aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 293 (413)
T 3dzo_A 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTL 293 (413)
T ss_dssp HHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEE
T ss_pred HHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcC
Confidence 999999665 999999999999999999999999998765432 223466 899999998 5556
Q ss_pred CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCC
Q 036970 239 LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDD 318 (337)
Q Consensus 239 ~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 318 (337)
++.++||||||+++|+|++|..||........... ..... ...+..+.+++.+||+.|
T Consensus 294 ~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~-------~~~~~---------------~~~~~~~~~li~~~l~~d 351 (413)
T 3dzo_A 294 MTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW-------IFRSC---------------KNIPQPVRALLEGFLRYP 351 (413)
T ss_dssp ECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG-------GGSSC---------------CCCCHHHHHHHHHHTCSS
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH-------HHhhc---------------ccCCHHHHHHHHHHccCC
Confidence 88899999999999999999999976432111000 00000 011244899999999999
Q ss_pred CCCCCCHHHHHH
Q 036970 319 PEERPNSKDVRC 330 (337)
Q Consensus 319 p~~Rps~~~il~ 330 (337)
|++|||+.++++
T Consensus 352 P~~Rpt~~~~l~ 363 (413)
T 3dzo_A 352 KEDRLLPLQAME 363 (413)
T ss_dssp GGGSCCHHHHTT
T ss_pred hhhCcCHHHHHh
Confidence 999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=284.33 Aligned_cols=251 Identities=13% Similarity=0.091 Sum_probs=185.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-------
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR------- 111 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------- 111 (337)
..++|++++.||+|+||+||+|++ +|+.||+|++........ ..........+.+|+.+++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~~l~~~~~ 88 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLV------NGSHQKTFEEILPEIIISKELSLLSGEVC 88 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCB------TTBCCBCHHHHHHHHHHHHHHHHGGGCSS
T ss_pred ccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCcccc------ccccchhHHHHHHHHHHHHHHHHhhcccc
Confidence 357899999999999999999986 689999999965432100 0001111456777888777775
Q ss_pred -------------------CCChhhhhceeec-------------CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHH
Q 036970 112 -------------------HRNIVPLLARVVR-------------PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159 (337)
Q Consensus 112 -------------------h~ni~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 159 (337)
||||+++++++.+ ....++||||+++|++.+.+ ..+.+++..+
T Consensus 89 ~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~-----~~~~~~~~~~ 163 (336)
T 2vuw_A 89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATA 163 (336)
T ss_dssp SBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGG-----TTTCCCHHHH
T ss_pred ccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHH-----HhcCCCHHHH
Confidence 7778888887775 77889999999999766655 1256899999
Q ss_pred HHHHHHHHHHHHHHh-cCCCCCceeCCCCCCcEEecCCC--------------------cEEEecccccccCCCCCcccc
Q 036970 160 HRIARGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDM--------------------EARISEFGLAKQIPNGRTRTT 218 (337)
Q Consensus 160 ~~~~~~i~~~l~~lh-~~~~~~~~h~di~~~nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~ 218 (337)
+.++.||+.||.||| +.+ ++||||||+||+++.++ .+||+|||+++.....
T Consensus 164 ~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----- 235 (336)
T 2vuw_A 164 KSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----
T ss_pred HHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----
Confidence 999999999999999 887 99999999999999887 8999999999865432
Q ss_pred cccccCcccccCCccccCCCCCCcccchhHhHH-HHHHHhCCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccC
Q 036970 219 TWSLAETVGYIAPECHQTVALSDKCDIYSFGVL-LAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIG 297 (337)
Q Consensus 219 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~v-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (337)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.... .................. ...
T Consensus 236 --~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~----~~~ 302 (336)
T 2vuw_A 236 --IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMTFKTK----CNT 302 (336)
T ss_dssp --EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCCCSSC----CCS
T ss_pred --cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhccCcc----cch
Confidence 247899999999998866 889999998777 777888988874210 001111112211111110 011
Q ss_pred CChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 298 NGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 298 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
..+......+.+||.+||+.| |+.+++
T Consensus 303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 303 PAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 124456778999999999976 999887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-31 Score=253.57 Aligned_cols=195 Identities=18% Similarity=0.083 Sum_probs=130.7
Q ss_pred ccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhhhhceeecCCC
Q 036970 49 IRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRPDC 127 (337)
Q Consensus 49 lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~ 127 (337)
.+.|+.|....++.. ..|..|++|.+........ ..........+++.+|+.+|+++ .|+||+++++++++++.
T Consensus 242 ~~~~~~~~h~~~rr~-~fg~~~~~K~~~~~~~~~~----~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRY-FFGEDYVCKFFYYDMPHGI----LTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp -C--------CCEEE-EECSSEEEEEEESSCSTTC----SCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred cccCCcccccccccc-cccceeEEEEEeccccccc----chhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 456777766666532 4789999999865432110 00011122356799999999999 79999999999999999
Q ss_pred ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccccc
Q 036970 128 DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207 (337)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~ 207 (337)
.||||||++|++|.+.+. ..++++.. .++.||+.||.|+|+++ |+||||||+|||++.++.+||+|||++
T Consensus 317 ~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlA 386 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSI 386 (569)
T ss_dssp EEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred EEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccC
Confidence 999999999999999994 34566664 48999999999999665 999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCC
Q 036970 208 KQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 208 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~p 261 (337)
+......... ...+||+.|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus 387 r~~~~~~~~~--~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 387 VTTPQDCSWP--TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ESCC---CCS--HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eeCCCCCccc--cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 8765433222 23578999999999987 456789999999998776555433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-28 Score=227.78 Aligned_cols=193 Identities=16% Similarity=0.115 Sum_probs=146.7
Q ss_pred cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceee
Q 036970 44 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV 123 (337)
Q Consensus 44 ~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 123 (337)
...+.||+|+||.||+|+. .+..+++|............ ......+.+.+|+.++++++||||+++..++.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~------~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 409 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERL------DENIRKSRTAREARYLALVKDFGIPAPYIFDV 409 (540)
T ss_dssp ---------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHH------HHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE
T ss_pred CCCCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhh------hhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE
Confidence 4467899999999999954 68889999875433211110 01112456899999999999999997777777
Q ss_pred cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEec
Q 036970 124 RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 203 (337)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~D 203 (337)
.....++||||+++++|.+++.. +..++.|++.+|.|||+++ ++||||||+||+++. .+||+|
T Consensus 410 ~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 410 DLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp ETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECC
T ss_pred eCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEE
Confidence 78888999999999999999832 4679999999999999665 999999999999999 999999
Q ss_pred ccccccCCCCCccc-----ccccccCcccccCCccccC--CCCCCcccchhHhHHHHHHHhCCCCC
Q 036970 204 FGLAKQIPNGRTRT-----TTWSLAETVGYIAPECHQT--VALSDKCDIYSFGVLLAVLMMGKFPS 262 (337)
Q Consensus 204 fg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~vl~~l~~g~~pf 262 (337)
||+++......... ......||+.|+|||++.. ..|+...|+||..+-..+-+.++.+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99998875532221 1224678999999999987 56788899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-23 Score=181.93 Aligned_cols=162 Identities=11% Similarity=0.013 Sum_probs=117.1
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhc----CCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQ----DSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
....|.+++.||.|+||.||+|++ .+|+.||+|.+............. ...+.......+.+|+.+++.++ |
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred CCeEEEecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 344555669999999999999997 489999999985432211000000 00011123567899999999998 5
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
+++.+++.. +..++||||+++++|.+ + .. .....++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l----~~------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-V----RV------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-C----CC------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-c----ch------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 667775544 56799999999999987 4 11 123469999999999999655 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccC
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT 236 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 236 (337)
++.++|+|||++.. +..+.|||.+..
T Consensus 228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999853 334577877643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.1e-19 Score=153.02 Aligned_cols=153 Identities=16% Similarity=0.167 Sum_probs=107.3
Q ss_pred CcccccccccccccceEEeeeecCCCCcE--EEEEEeeccchhhHH---HhhcC-------CcchhhhHHHHHHHHHHhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRV--ITIKKVIQPLKSEAE---LIKQD-------SEPLHHKMIQIQSEIITAG 108 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~--vaiK~~~~~~~~~~~---~~~~~-------~~~~~~~~~~~~~E~~~l~ 108 (337)
.-|.+.+.||+|+||.||+|.+. .+|+. ||||+.......... ....+ ..........+.+|+..+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 34678899999999999999873 27888 999987543211110 00000 0001112346888999999
Q ss_pred CCCCCCh--hhhhceeecCCCceEEEEeecC-C----CHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHh-cCCCCC
Q 036970 109 QVRHRNI--VPLLARVVRPDCDLLVYEFRRN-G----SLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH-MSHRPR 180 (337)
Q Consensus 109 ~l~h~ni--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~ 180 (337)
.+.|+++ +..+. ....++||||+.+ | +|.+.... .++..+..++.|++.+|.+|| +.+
T Consensus 126 ~l~~~~i~~p~~~~----~~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g--- 191 (258)
T 1zth_A 126 RAKEAGVSVPQPYT----YMKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE--- 191 (258)
T ss_dssp HHHHTTCCCCCEEE----EETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---
T ss_pred HHHhCCCCCCeEEE----cCCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---
Confidence 9987764 22222 1367899999942 3 67666421 224456789999999999999 887
Q ss_pred ceeCCCCCCcEEecCCCcEEEecccccccC
Q 036970 181 IIHRDIQPANVLIDDDMEARISEFGLAKQI 210 (337)
Q Consensus 181 ~~h~di~~~nil~~~~~~~kl~Dfg~~~~~ 210 (337)
++|+||||+||+++. .++|+|||++...
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999998 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-18 Score=154.34 Aligned_cols=154 Identities=10% Similarity=0.080 Sum_probs=98.6
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHH-----hhcCCcc---hhhhHHHHHHHHHHhcCCCC
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAEL-----IKQDSEP---LHHKMIQIQSEIITAGQVRH 112 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~E~~~l~~l~h 112 (337)
.=|.++..||.|++|.||+|... +|+.||||+........... +...... .........+|...|.++.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 44899999999999999999865 79999999875432211000 0000000 00001112345555555533
Q ss_pred CChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 113 RNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 113 ~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
.++... ..+ .....++||||++|++|.++. . . .....++.|++.+|.+||+.+ ++||||||.|||
T Consensus 173 ~gv~vp-~p~-~~~~~~LVME~i~G~~L~~l~----~----~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL 237 (397)
T 4gyi_A 173 EGFPVP-EPI-AQSRHTIVMSLVDALPMRQVS----S----V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL 237 (397)
T ss_dssp TTCSCC-CEE-EEETTEEEEECCSCEEGGGCC----C----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred cCCCCC-eee-eccCceEEEEecCCccHhhhc----c----c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence 332211 111 112357999999988876543 1 1 123568899999999999555 999999999999
Q ss_pred ecCCC----------cEEEecccccccCC
Q 036970 193 IDDDM----------EARISEFGLAKQIP 211 (337)
Q Consensus 193 ~~~~~----------~~kl~Dfg~~~~~~ 211 (337)
+++++ .+.|+||+-+....
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EeCCCCcccccccccceEEEEeCCcccCC
Confidence 98776 38999999876544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=3.7e-12 Score=109.07 Aligned_cols=142 Identities=12% Similarity=0.094 Sum_probs=107.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLL 119 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~ 119 (337)
++|.+...++.|+.+.||.+.. .+..+++|......... ...+.+|+.+++.+. +.++.+++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~~--------------~~~~~~E~~~l~~l~~~~~vP~v~ 76 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGT--------------TYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTTS--------------TTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred ccceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCCC--------------HHHHHHHHHHHHHHhcCCCCCeEE
Confidence 5688889999999999999973 47889999985421100 224777888888773 67788899
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC----------------------
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH---------------------- 177 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---------------------- 177 (337)
+++.+.+..++||||++|.+|.+.+ . +......++.+++.++..||+..
T Consensus 77 ~~~~~~~~~~lv~e~i~G~~l~~~~----~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (263)
T 3tm0_A 77 HFERHDGWSNLLMSEADGVLCSEEY----E-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN 147 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHC----C-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred EEEecCCceEEEEEecCCeehhhcc----C-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHh
Confidence 9888888899999999999987653 1 11223468889999999999710
Q ss_pred ----------------------------------CCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 178 ----------------------------------RPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 178 ----------------------------------~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876556799998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.2e-10 Score=99.22 Aligned_cols=138 Identities=14% Similarity=0.145 Sum_probs=95.2
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC--hhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN--IVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~ 117 (337)
..++.+....+.|..+.||++... +|..+++|...... ...+.+|+..++.+.+.+ +.+
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~--~g~~~vlK~~~~~~-----------------~~~~~~E~~~l~~l~~~~~~vP~ 79 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGA-----------------LNELQDEAARLSWLATTGVPCAA 79 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECT--TSCCEEEEEECSCT-----------------TSCHHHHHHHHHHHHTTTCCBCC
T ss_pred cCCCceEecccCCCCceEEEEecC--CCCeEEEEeCCccc-----------------chhhhHHHHHHHHHHhCCCCCCe
Confidence 345665444446667999999643 67889999874321 124667887777774334 556
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC--------------------
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH-------------------- 177 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-------------------- 177 (337)
++.+...++..++||||++|.+|. . .. .. ...++.+++..+..||+..
T Consensus 80 ~~~~~~~~~~~~~v~e~i~G~~l~--~----~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~ 147 (264)
T 1nd4_A 80 VLDVVTEAGRDWLLLGEVPGQDLL--S----SH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTR 147 (264)
T ss_dssp EEEEEECSSCEEEEEECCSSEETT--T----SC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHH
T ss_pred EEEeccCCCCCEEEEEecCCcccC--c----Cc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHH
Confidence 788888777889999999988774 2 11 11 1246677777777777532
Q ss_pred -----------------------------------CCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 178 -----------------------------------RPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 178 -----------------------------------~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
..+++|+|++|.||++++++.+.|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 148 MEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999876556799999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=9.4e-10 Score=98.49 Aligned_cols=146 Identities=13% Similarity=0.132 Sum_probs=104.7
Q ss_pred cccccccccccccceEEeeeecCCCCcEEEEEEee--ccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC--CCChhh
Q 036970 42 CFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVI--QPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--HRNIVP 117 (337)
Q Consensus 42 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~ 117 (337)
....++.|+.|.++.||++.. .+..+++|+.. ...... ....+.+|+.+++.|. +.++++
T Consensus 39 ~~~~~~~l~~G~sn~~y~v~~---~~~~~vlr~~~~p~~~~~~-------------~~~~~~~E~~~l~~L~~~~vpvP~ 102 (359)
T 3dxp_A 39 GPLSVEQFKGGQSNPTFKLVT---PGQTYVMRAKPGPKSKLLP-------------SAHAIEREYRVMDALAGTDVPVAK 102 (359)
T ss_dssp CCCEEEECCC-CCSCEEEEEC---SSCEEEEECCCC-----------------------CHHHHHHHHHHHTTSSSCCCC
T ss_pred CCceEEEcCCcccceEEEEEE---CCceEEEEeCCCCCCCCCC-------------cHHHHHHHHHHHHHhhcCCCCCCc
Confidence 344578899999999999975 35678888875 221100 0235677888888885 455778
Q ss_pred hhceeecC---CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC-----------------
Q 036970 118 LLARVVRP---DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH----------------- 177 (337)
Q Consensus 118 ~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~----------------- 177 (337)
++.++.+. +..++||||++|..+.+.. ...++......++.+++..|..||+..
T Consensus 103 ~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3dxp_A 103 MYALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQ 176 (359)
T ss_dssp EEEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHH
T ss_pred EEEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchH
Confidence 88877766 4578999999987764321 123677788889999999999999631
Q ss_pred --------------------------------------CCCceeCCCCCCcEEecCCCc--EEEeccccccc
Q 036970 178 --------------------------------------RPRIIHRDIQPANVLIDDDME--ARISEFGLAKQ 209 (337)
Q Consensus 178 --------------------------------------~~~~~h~di~~~nil~~~~~~--~kl~Dfg~~~~ 209 (337)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 177 RQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246899999999999997653 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=2e-09 Score=94.02 Aligned_cols=187 Identities=16% Similarity=0.147 Sum_probs=114.7
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCC--hhhhhcee
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRN--IVPLLARV 122 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n--i~~~~~~~ 122 (337)
++.++.|..+.||.+. ..+++|...... ....+.+|...++.+ .+.. +.+.+...
T Consensus 25 i~~~~~G~~n~v~~v~------~~~vlR~~~~~~----------------~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~ 82 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN------RDFIFKFPKHSR----------------GSTNLFNEVNILKRIHNKLPLPIPEVVFTG 82 (304)
T ss_dssp CCEEEECSSEEEEEST------TSEEEEEESSHH----------------HHHHHHHHHHHHHHHTTSSSSCCCCEEEEC
T ss_pred eEecCCCCcceEEEEC------CEEEEEecCCcc----------------hHHHHHHHHHHHHHHHhcCCCCCCceEeec
Confidence 4668999999999874 348888864321 145678888888776 3322 33444333
Q ss_pred ecCC---CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC----------------------
Q 036970 123 VRPD---CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH---------------------- 177 (337)
Q Consensus 123 ~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---------------------- 177 (337)
.... ..|+||++++|.+|.+... ..++......++.+++..+..||+..
T Consensus 83 ~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (304)
T 3sg8_A 83 MPSETYQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKK 156 (304)
T ss_dssp CCCSSCSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHH
T ss_pred CCCCCCCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHH
Confidence 3332 3489999999988765431 23566666777777777777777511
Q ss_pred ---------------------------------CCCceeCCCCCCcEEecC--CCcEEEecccccccCCCCCcccccccc
Q 036970 178 ---------------------------------RPRIIHRDIQPANVLIDD--DMEARISEFGLAKQIPNGRTRTTTWSL 222 (337)
Q Consensus 178 ---------------------------------~~~~~h~di~~~nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 222 (337)
...++|+|++|.||+++. ...+.|+||+.+...............
T Consensus 157 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~ 236 (304)
T 3sg8_A 157 IKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED 236 (304)
T ss_dssp HHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT
T ss_pred HHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh
Confidence 134799999999999998 456789999987643221000000000
Q ss_pred ---cCc-------ccc--cC-CccccCCCCCCcccchhHhHHHHHHHhCCCCC
Q 036970 223 ---AET-------VGY--IA-PECHQTVALSDKCDIYSFGVLLAVLMMGKFPS 262 (337)
Q Consensus 223 ---~g~-------~~y--~a-PE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf 262 (337)
.+. ..| .. |+.... .....+.|+++.+++.+.+|..+|
T Consensus 237 ~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 237 DEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred ccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 001 01 111100 111258999999999999998774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=9.7e-07 Score=75.39 Aligned_cols=135 Identities=13% Similarity=0.117 Sum_probs=92.0
Q ss_pred cccccccc-eEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhhceeecC
Q 036970 48 KIRSCWNG-EVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLLARVVRP 125 (337)
Q Consensus 48 ~lg~G~~g-~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~ 125 (337)
.+..|..| .||..... ..+..+++|...... ...+.+|...|+.+. +-.+.+++.++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~-~~~~~~~lk~~~~~~-----------------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~ 92 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGK-PNAPELFLKHGKGSV-----------------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTP 92 (272)
T ss_dssp EEECSSSSCEEEEEECC-TTCCCEEEEEEETHH-----------------HHHHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred EccCCCcCCeEEEEEec-CCCeEEEEEECCCCC-----------------HhHHHHHHHHHHHhccCCCcCeEEEEEEEC
Confidence 34445555 58887643 356788999864321 335677888877773 34467888888888
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC----------------------------
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH---------------------------- 177 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---------------------------- 177 (337)
+..++|||+++|.++.+.... .......+..++...|.-||+..
T Consensus 93 ~~~~lvme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (272)
T 4gkh_A 93 DDAWLLTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDA 164 (272)
T ss_dssp TEEEEEEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCG
T ss_pred CeEEEEEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhh
Confidence 889999999999887776522 11122345566666666666321
Q ss_pred ---------------------------CCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 178 ---------------------------RPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 178 ---------------------------~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 165 SDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999987667799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=2.9e-06 Score=73.92 Aligned_cols=136 Identities=18% Similarity=0.104 Sum_probs=87.0
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCC---Chhhhhcee
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR---NIVPLLARV 122 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---ni~~~~~~~ 122 (337)
+..++.|....||.. |..+++|+..... ....+.+|..+++.+.+. .+.+.+.+.
T Consensus 24 v~~l~~G~~n~v~~v------g~~~VlR~~~~~~----------------~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~ 81 (306)
T 3tdw_A 24 VESLGEGFRNYAILV------NGDWVFRFPKSQQ----------------GADELNKEIQLLPLLVGCVKVNIPQYVYIG 81 (306)
T ss_dssp EEEEEECSSEEEEEE------TTTEEEEEESSHH----------------HHHHHHHHHHHHHHHTTTCSSBCCCEEEEE
T ss_pred eeecCCCcceeEEEE------CCEEEEEecCCch----------------HHHHHHHHHHHHHHHHhcCCCCCCCeEeec
Confidence 466788888899988 4568888752211 145688899999888542 245555555
Q ss_pred e-cCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC-------------------------
Q 036970 123 V-RPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMS------------------------- 176 (337)
Q Consensus 123 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~------------------------- 176 (337)
. ..+..+++||+++|..+.+... ..++......++.++...|..||+.
T Consensus 82 ~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~ 155 (306)
T 3tdw_A 82 KRSDGNPFVGYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEA 155 (306)
T ss_dssp ECTTSCEEEEEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHH
T ss_pred ccCCCceEEEEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHH
Confidence 3 4456789999999887765321 0123333333334444333333321
Q ss_pred --------------------------------CCCCceeCCCCCCcEEecC---CCcE-EEeccccccc
Q 036970 177 --------------------------------HRPRIIHRDIQPANVLIDD---DMEA-RISEFGLAKQ 209 (337)
Q Consensus 177 --------------------------------~~~~~~h~di~~~nil~~~---~~~~-kl~Dfg~~~~ 209 (337)
....++|+|+.+.||+++. ++.+ .|+||+.+..
T Consensus 156 ~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 156 VEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335799999999999997 4554 7999987643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=1.2e-05 Score=71.55 Aligned_cols=86 Identities=2% Similarity=-0.089 Sum_probs=51.2
Q ss_pred cccccc-cccccceEEeeeec--CC---CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-C--CC
Q 036970 44 ASLEKI-RSCWNGEVYKAELP--GS---SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-H--RN 114 (337)
Q Consensus 44 ~~~~~l-g~G~~g~vy~~~~~--~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~n 114 (337)
...+.| +.|..+.+|..... .. ++..+++|........ .... ...+.+|+..++.|. + -.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~-----~~~~------~~~~~~E~~~l~~L~~~~~vp 91 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDV-----PVFP------TYRLDHQFEVIRLVGELTDVP 91 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGC-----CSSS------CCCHHHHHHHHHHHHHHCCSC
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcc-----ccCc------hhHHHHHHHHHHHHhhcCCCC
Confidence 345677 88999999988642 00 1677888876432100 0000 123556666666663 2 34
Q ss_pred hhhhhceeecC---CCceEEEEeecCCCH
Q 036970 115 IVPLLARVVRP---DCDLLVYEFRRNGSL 140 (337)
Q Consensus 115 i~~~~~~~~~~---~~~~lv~e~~~~~~L 140 (337)
+.+++.+..+. +..++||||++|..+
T Consensus 92 vP~v~~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 92 VPRVRWIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred CCcEEEEccCCCccCCceEEEEecCCCCh
Confidence 66667666554 356899999987554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00011 Score=64.70 Aligned_cols=31 Identities=16% Similarity=0.414 Sum_probs=27.2
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 4569999999999999877889999999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00019 Score=64.68 Aligned_cols=106 Identities=14% Similarity=0.095 Sum_probs=56.1
Q ss_pred CcccCCccchhhhhhhhccCcc-----cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhh
Q 036970 22 PTIFSPLIEKEDLAFLKKEDCF-----ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHK 96 (337)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~~~-----~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~ 96 (337)
|..|.+.-.+.-..+++..+.+ ...+.||.|..+.||.+... .+++.+++|........... ... ..
T Consensus 6 ~~~~~~l~~~~v~~~l~~~~~~~~~~~~~~~~lg~G~~n~vyrv~~~-~~~~~~vvK~~~~~~r~~~~----~~~---~~ 77 (397)
T 2olc_A 6 TPLYETLNESSAVALAVKLGLFPSKSTLTCQEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGE----SWP---LT 77 (397)
T ss_dssp CCCCCCCCHHHHHHHHHHTTC-----CCEEEECCSSSSEEEEEEEC-----CEEEEEEECCC-----------CC---CC
T ss_pred CcccccCCHHHHHHHHHhcCcCCCCCceEEEECCCCceEEEEEEEEC-CCCcEEEEEecchhhcccCC----CCc---Cc
Confidence 3445555555555555522211 23678999999999999754 25678999986532110000 000 00
Q ss_pred HHHHHHHHHHhcCCCC--CC-hhhhhceeecCCCceEEEEeecC
Q 036970 97 MIQIQSEIITAGQVRH--RN-IVPLLARVVRPDCDLLVYEFRRN 137 (337)
Q Consensus 97 ~~~~~~E~~~l~~l~h--~n-i~~~~~~~~~~~~~~lv~e~~~~ 137 (337)
...+..|...++.+.. +. +.+++. .+....++|||++++
T Consensus 78 ~~r~~~E~~~L~~l~~~~~~~vP~~~~--~d~~~~~lvmE~l~g 119 (397)
T 2olc_A 78 IDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTVMEDLSH 119 (397)
T ss_dssp TTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEEECCCTT
T ss_pred HHHHHHHHHHHHHhhhhCCCCcCeEEE--EcCCccEEEEEeCCC
Confidence 2345667777766521 22 334443 234567899999976
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00042 Score=56.18 Aligned_cols=103 Identities=14% Similarity=0.033 Sum_probs=68.2
Q ss_pred CCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCccc
Q 036970 138 GSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT 217 (337)
Q Consensus 138 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 217 (337)
-+|.+.+.. -++++++.++|.++.|.+.+|.-+-.... -...=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 378998854 45789999999999999999877621111 11233457999999999998764 1110
Q ss_pred ccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCC
Q 036970 218 TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 218 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~p 261 (337)
.....+.|||... ...+.+.-|||||+++|..+-...|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123467888763 3446778899999999999987766
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.0002 Score=62.36 Aligned_cols=77 Identities=12% Similarity=0.005 Sum_probs=57.6
Q ss_pred cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC---CCChhhhhc
Q 036970 44 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR---HRNIVPLLA 120 (337)
Q Consensus 44 ~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~~ 120 (337)
...+.|+.|....+|.... ++..+++|...... ...+..|...|+.|. ...+++.+.
T Consensus 39 ~~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~~-----------------~~~~~~E~~~L~~L~~~~~v~VP~vl~ 98 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND---EVQTVFVKINERSY-----------------RSMFRAEADQLALLAKTNSINVPLVYG 98 (312)
T ss_dssp CEEEEECCSSSSEEEEEES---SSCEEEEEEEEGGG-----------------HHHHHHHHHHHHHHHHTTSSBCCCEEE
T ss_pred eeeEEeCCccceeeeEEEE---CCCeEEEEeCCccc-----------------HHHHHHHHHHHHHHHhhCCCCcceEEE
Confidence 4457789999999999973 57788899874321 345677877777773 356778888
Q ss_pred eeecCCCceEEEEeecCCCH
Q 036970 121 RVVRPDCDLLVYEFRRNGSL 140 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L 140 (337)
+....+..++||||+++..+
T Consensus 99 ~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 99 IGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECSSEEEEEEECCCCCCC
T ss_pred EeecCCceEEEEEeccCCCC
Confidence 88777888999999988653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00044 Score=59.39 Aligned_cols=79 Identities=13% Similarity=0.119 Sum_probs=52.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-C--CChhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-H--RNIVP 117 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~ni~~ 117 (337)
....-++.+|.|..+.||+.+.. +|+.|++|+........ ...+..|...|+.|. . -.+++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~--------------~~~~~~Ea~~L~~L~~~~~vpvP~ 78 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA--DGTPLFVKALPDDAPAL--------------DGLFRAEALGLDWLGRSFGSPVPQ 78 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCC--------------TTHHHHHHHHHHHHTCSTTCCSCC
T ss_pred CCeEEEEecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcch--------------hhHHHHHHHHHHHHHhhCCCCcce
Confidence 34556788999999999999875 89999999864332110 224667887777663 2 12344
Q ss_pred hhceeecCCCceEEEEeecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGS 139 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~ 139 (337)
++.+ +..+++|||++++.
T Consensus 79 v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 79 VAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEE----ETTEEEEECCCCCC
T ss_pred EEec----cCceEEEEeecccC
Confidence 4432 23578999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0014 Score=59.57 Aligned_cols=31 Identities=16% Similarity=0.364 Sum_probs=27.0
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEeccccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~ 209 (337)
...++|+|+++.||+++.++ +.++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 45699999999999999776 99999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0023 Score=55.17 Aligned_cols=31 Identities=19% Similarity=0.129 Sum_probs=25.4
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEeccccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~ 209 (337)
...++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 6667889999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0022 Score=56.15 Aligned_cols=32 Identities=25% Similarity=0.332 Sum_probs=27.2
Q ss_pred CCCceeCCCCCCcEEecCC----CcEEEeccccccc
Q 036970 178 RPRIIHRDIQPANVLIDDD----MEARISEFGLAKQ 209 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~----~~~kl~Dfg~~~~ 209 (337)
...++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4469999999999999874 6799999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0094 Score=51.71 Aligned_cols=30 Identities=27% Similarity=0.344 Sum_probs=25.4
Q ss_pred CCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 179 PRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 179 ~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
.+++|+|+.+.||+++++..+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 468999999999999987556799998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.56 E-value=0.017 Score=50.28 Aligned_cols=30 Identities=20% Similarity=0.276 Sum_probs=25.2
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEeccccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~ 209 (337)
...++|+|+++.||+++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 34589999999999999 4 899999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.012 Score=52.44 Aligned_cols=144 Identities=13% Similarity=0.136 Sum_probs=78.9
Q ss_pred cccccccccceEEeeeecC------CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhh
Q 036970 46 LEKIRSCWNGEVYKAELPG------SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPL 118 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~ 118 (337)
++.|..|-...+|+..... .++..+++|+...... ....+.+|..+++.|. +.-..++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---------------~~~~~~rE~~vl~~L~~~gv~P~l 119 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---------------GVDSLVLESVMFAILAERSLGPQL 119 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---------------CHHHHHHHHHHHHHHHHTTSSCCE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---------------hHHHHHHHHHHHHHHHhcCCCCeE
Confidence 4567788889999997531 1357899998633110 0334567888887773 2222455
Q ss_pred hceeecCCCceEEEEeecCCCHH--------------HHHHhhhcC----CCcCC--HHHHHHHHHHHHH----------
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQ--------------DILYDVSQG----RRELD--WLARHRIARGIAS---------- 168 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~--------------~~l~~~~~~----~~~l~--~~~~~~~~~~i~~---------- 168 (337)
++.+.+ .+|+||++|..|. +.+...... .++.. +..+.++..++-.
T Consensus 120 l~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~ 195 (379)
T 3feg_A 120 YGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMN 195 (379)
T ss_dssp EEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCC
T ss_pred EEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhh
Confidence 554433 3899999875432 111111111 11122 3444455544322
Q ss_pred ---------HHHH----HhcC-CCCCceeCCCCCCcEEecCC----CcEEEecccccc
Q 036970 169 ---------GLEY----LHMS-HRPRIIHRDIQPANVLIDDD----MEARISEFGLAK 208 (337)
Q Consensus 169 ---------~l~~----lh~~-~~~~~~h~di~~~nil~~~~----~~~kl~Dfg~~~ 208 (337)
.+.. |... ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 196 ~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 196 LLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1222 2222 13358999999999999876 689999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.05 E-value=0.022 Score=51.68 Aligned_cols=74 Identities=9% Similarity=0.141 Sum_probs=45.2
Q ss_pred ccccccccccceEEeeeecCC------CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh-hh
Q 036970 45 SLEKIRSCWNGEVYKAELPGS------SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI-VP 117 (337)
Q Consensus 45 ~~~~lg~G~~g~vy~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~ 117 (337)
.++.|+.|....+|++..... .+..+++|+...+.. .+.+.+|..+++.|...++ ++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~----------------~~~li~E~~~l~~L~~~g~~P~ 140 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----------------ESHLVAESVIFTLLSERHLGPK 140 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----------------HHHHHHHHHHHHHHHHTTSSSC
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc----------------HHHHHHHHHHHHHHHhCCCCCc
Confidence 356788888899999986421 257888998743211 1234467777776632233 44
Q ss_pred hhceeecCCCceEEEEeecCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNG 138 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~ 138 (337)
+++.+.+ .+|+||++|.
T Consensus 141 l~~~~~~----g~v~e~l~G~ 157 (429)
T 1nw1_A 141 LYGIFSG----GRLEEYIPSR 157 (429)
T ss_dssp EEEEETT----EEEECCCCEE
T ss_pred EEEEeCC----CEEEEEeCCc
Confidence 5544332 3889998763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.91 E-value=0.3 Score=42.64 Aligned_cols=32 Identities=22% Similarity=0.353 Sum_probs=27.2
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEeccccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~ 209 (337)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34689999999999999878899999976643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.56 E-value=0.11 Score=47.47 Aligned_cols=74 Identities=12% Similarity=0.042 Sum_probs=43.4
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh-hhhhceeec
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI-VPLLARVVR 124 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~~~~~~~ 124 (337)
++.|+.|-...+|++.... .+..+++|+...... . .....+|..+++.|...++ .++++.+.
T Consensus 113 i~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~--------~-------~idR~~E~~vl~~L~~~gl~P~ll~~~~- 175 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS-KQAKYLIRLYGPKTD--------E-------IINREREKKISCILYNKNIAKKIYVFFT- 175 (458)
T ss_dssp EEEECC--CEEEEEEEETT-TTEEEEEEEECC-CC--------S-------CSCHHHHHHHHHHHTTSSSBCCEEEEET-
T ss_pred EEEcCCCeEeEEEEEEECC-CCceEEEEECCCChh--------h-------hcCHHHHHHHHHHHHhcCCCCCEEEEeC-
Confidence 4667888889999998641 247888888643210 0 0012467777777754344 45555542
Q ss_pred CCCceEEEEeecCCC
Q 036970 125 PDCDLLVYEFRRNGS 139 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~ 139 (337)
..+|+||++|.+
T Consensus 176 ---~G~v~e~I~G~~ 187 (458)
T 2qg7_A 176 ---NGRIEEFMDGYA 187 (458)
T ss_dssp ---TEEEEECCCSEE
T ss_pred ---CeEEEEeeCCcc
Confidence 235999998643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.74 E-value=0.21 Score=45.14 Aligned_cols=29 Identities=21% Similarity=0.392 Sum_probs=25.4
Q ss_pred CCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 179 PRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 179 ~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
..++|+|+.+.||+ +.++.+.++||..+.
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 35899999999999 777889999998774
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=82.83 E-value=0.61 Score=41.03 Aligned_cols=29 Identities=21% Similarity=0.358 Sum_probs=24.0
Q ss_pred CCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 179 PRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 179 ~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
..++|+|+.+.||+++++ .+.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~-~~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNK-CLRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC--CEEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCC-cEEEEEecCCC
Confidence 458999999999999865 48999998764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.09 E-value=0.14 Score=46.91 Aligned_cols=65 Identities=5% Similarity=-0.087 Sum_probs=17.9
Q ss_pred cccccccccccceEEeeeecCCCCcEEEE------EEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 44 ASLEKIRSCWNGEVYKAELPGSSGRVITI------KKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 44 ~~~~~lg~G~~g~vy~~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.+.+.|| ||.||+|.+.. ...+||+ |....... ..+....+.+|..++..++|||+++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~-~~~~Vav~~~~~~K~~~~~~~------------~~e~~~~~~rea~l~~~~~H~niv~ 208 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK-KHMPVLKETHDERDSTGQDGV------------SEKRLTSLVRRATLKENEQIPKYEK 208 (463)
T ss_dssp CSTTTSS---BCCC----------CCBGGGC-----------------------------------------------CB
T ss_pred cccccCC---chhhhcccccc-cCCchhhhhccCccccccccc------------cccccccccccccccccccccccCC
Confidence 4456666 99999998753 3456777 44322111 1122456778888888899999999
Q ss_pred hhceeec
Q 036970 118 LLARVVR 124 (337)
Q Consensus 118 ~~~~~~~ 124 (337)
.+++...
T Consensus 209 ~h~f~~~ 215 (463)
T 3cxl_A 209 IHNFKVH 215 (463)
T ss_dssp CCCEEEE
T ss_pred CcceEEe
Confidence 8886643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.35 E-value=1.5 Score=35.29 Aligned_cols=118 Identities=12% Similarity=0.043 Sum_probs=76.1
Q ss_pred CCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 111 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
.||+++.. .+-.+++... +.|-...+...|- .-+..+...+++++.+|+....++++ -+|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~--~~y~~~~~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQ--IHYDINDNHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEE--EEECCCTTSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEE--EEEEcCcccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57777765 4555555444 4443333333331 23458889999999999887755541 4677899999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
++++.++.+++.-.|+... ++|. ..+...=.-..=|++..+++++..|...
T Consensus 110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 9999999999987765322 2222 1122222345667888899998887654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 337 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-34 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-47
Identities = 56/285 (19%), Positives = 115/285 (40%), Gaps = 38/285 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYK + G + +K + + P ++ ++E+ + RH N
Sbjct: 22 GTVYKGKWHGD----VAVK------------MLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ + +V ++ SL L+ + + + + IAR A G++YLH
Sbjct: 66 ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
IIHRD++ N+ + +D+ +I +FGLA L+ ++ ++APE
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 235 QT---VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTI 291
+ S + D+Y+FG++L LM G+ P + ++ + ++ S +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-------INNRDQIIFMVGRGYLSPDL 231
Query: 292 DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
+ + + M ++ C +ERP + + +
Sbjct: 232 SK--VRSNCPKAM---KRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-45
Identities = 57/302 (18%), Positives = 113/302 (37%), Gaps = 29/302 (9%)
Query: 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMI 98
K+D F + ++ + G V+K SG V+ K I + +P
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKL-----------IHLEIKPAIRN-- 49
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 158
QI E+ + IV + E GSL +L +
Sbjct: 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQI 105
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTT 218
+++ + GL YL + +I+HRD++P+N+L++ E ++ +FG++ Q+ + +
Sbjct: 106 LGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 219 TWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278
T Y++PE Q S + DI+S G+ L + +G++P E+ F +
Sbjct: 164 ----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
Query: 279 RNVMT-----SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333
P R + S + + + +L S + + ++
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279
Query: 334 QI 335
+
Sbjct: 280 KC 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-44
Identities = 56/278 (20%), Positives = 109/278 (39%), Gaps = 36/278 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G K S G+++ K++ +EAE + SE+ +++H N
Sbjct: 18 GRCQKIRRK-SDGKILVWKELDYGSMTEAE------------KQMLVSEVNLLRELKHPN 64
Query: 115 IVPLLARVVRPDCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
IV R++ L V E+ G L ++ ++ R+ LD R+ + L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 173 LHMSHR--PRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
H ++HRD++PANV +D ++ +FGLA+ + + + T Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182
Query: 231 PECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRT 290
PE ++ ++K DI+S G LL L P S + + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-------FSQKELAGKIREGKFRR-- 233
Query: 291 IDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
I Y +++ ++ RP+ +++
Sbjct: 234 -----IPYRYSDELNEIIT-RMLNL--KDYHRPSVEEI 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-42
Identities = 60/303 (19%), Positives = 112/303 (36%), Gaps = 44/303 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV++ + G + +K S E + ++EI +RH N
Sbjct: 17 GEVWRGKW---RGEEVAVKI----FSSREE-----------RSWFREAEIYQTVMLRHEN 58
Query: 115 IVPLLARVVRPDCDL----LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
I+ +A + + LV ++ +GSL D L R + ++A ASGL
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGL 113
Query: 171 EYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR--TRTTTWSLA 223
+LHM +P I HRD++ N+L+ + I++ GLA + +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 224 ETVGYIAPEC------HQTVALSDKCDIYSFGVLLAVLMMGKFPSD---DFFQHTKEMSF 274
T Y+APE + + DIY+ G++ + D+ ++
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 275 VQWMRNVMTSENPSRTIDSKLIGNGYE-EQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333
M + + + E + ++ KI C + + R + ++ LS
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
Query: 334 QIQ 336
Q+
Sbjct: 294 QLS 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 2e-41
Identities = 59/297 (19%), Positives = 115/297 (38%), Gaps = 43/297 (14%)
Query: 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHK 96
L ED + + ++ G+VYKA+ + + K I SE +
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKV-----------IDTKSE---EE 52
Query: 97 MIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 156
+ EI H NIV LL + ++ EF G++ ++ + R L
Sbjct: 53 LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTE 109
Query: 157 LARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR 216
+ + L YLH +IIHRD++ N+L D + ++++FG++ + R
Sbjct: 110 SQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166
Query: 217 TTTWSLAETVGYIAPECHQTVALSD-----KCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271
++ T ++APE D K D++S G+ L + + P +
Sbjct: 167 RDSF--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE------- 217
Query: 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
++ ++ + + SE P+ S+ N + + K C + + R + +
Sbjct: 218 LNPMRVLLKIAKSEPPTLAQPSRWSSNFKD----FLKK----CLEKNVDARWTTSQL 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-41
Identities = 63/283 (22%), Positives = 106/283 (37%), Gaps = 46/283 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+V + G + +K + ++ +E Q+RH N
Sbjct: 21 GDVMLGDY---RGNKVAVKCIKNDATAQ----------------AFLAEASVMTQLRHSN 61
Query: 115 IVPLLARVVRPDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
+V LL +V L +V E+ GSL D L S+GR L + + + +EYL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
+HRD+ NVL+ +D A++S+FGL K+ + + V + APE
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEA 171
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293
+ S K D++SFG+LL + + V + + P +
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228
Query: 294 KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
V ++ C D RP+ +R L I+
Sbjct: 229 -------------VYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 4e-41
Identities = 61/295 (20%), Positives = 113/295 (38%), Gaps = 40/295 (13%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQI 100
+ +E++ + GEV+ G + +K + Q S +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQGSMSPDAFLA------------- 57
Query: 101 QSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 160
E Q++H+ +V L A VV + ++ E+ NGSL D L +L
Sbjct: 58 --EANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLL 112
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
+A IA G+ ++ IHRD++ AN+L+ D + +I++FGLA+ I +
Sbjct: 113 DMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE- 168
Query: 221 SLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280
+ + APE + K D++SFG+LL ++ + +Q +
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVIQNLER 225
Query: 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
P + + ++ C + PE+RP +R +L
Sbjct: 226 GYRMVRPDNCPEE-------------LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-41
Identities = 60/274 (21%), Positives = 110/274 (40%), Gaps = 41/274 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY A S ++ +K + + +A + Q ++ E+ +RH N
Sbjct: 20 GNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQ-----------LRREVEIQSHLRHPN 67
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ L L+ E+ G++ L Q + D +A+ L Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 123
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
R+IHRDI+P N+L+ E +I++FG + P+ R +L T+ Y+ PE
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMI 176
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSK 294
+ +K D++S GVL ++GK P + ++ + + + E +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-------NTYQETYKRISRVEFTFPDFVT- 228
Query: 295 LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
E L+ + +P +RP ++V
Sbjct: 229 ------EGARDLISR----LLKHNPSQRPMLREV 252
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 8e-41
Identities = 54/282 (19%), Positives = 102/282 (36%), Gaps = 42/282 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V + G + IK + + SE E I+ E + H
Sbjct: 18 GVVKYGKWRG--QYDVAIKMIKEGSMSEDEFIE---------------EAKVMMNLSHEK 60
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V L + ++ E+ NG L + L + R + + + +EYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+ +HRD+ N L++D ++S+FGL++ + + ++ V + PE
Sbjct: 118 S---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVL 173
Query: 235 QTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293
S K DI++FGVL+ + +GK P ++ + + + P +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 294 KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
V I C + +ERP K + + +
Sbjct: 230 -------------VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (359), Expect = 9e-41
Identities = 54/319 (16%), Positives = 113/319 (35%), Gaps = 56/319 (17%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHK 96
+ + I G V++A PG ++ +K + + ++ +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ------------ 60
Query: 97 MIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD---------- 146
Q E + + NIV LL L++E+ G L + L
Sbjct: 61 -ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 147 ----------VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196
S G L + IAR +A+G+ YL + +HRD+ N L+ ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGEN 176
Query: 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLM 256
M +I++FGL++ I + + A + ++ PE + + D++++GV+L +
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 257 MGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTF 316
+ + ++R+ P + + C
Sbjct: 237 SYGLQ---PYYGMAHEEVIYYVRDGNILACPENCPLE-------------LYNLMRLCWS 280
Query: 317 DDPEERPNSKDVRCMLSQI 335
P +RP+ + +L ++
Sbjct: 281 KLPADRPSFCSIHRILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 2e-40
Identities = 60/300 (20%), Positives = 115/300 (38%), Gaps = 40/300 (13%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIK-KVIQPLKSEAELIKQDSEPLHHKMIQ 99
C + I + GEV L R I + K ++ +E +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR------------D 73
Query: 100 IQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 159
SE GQ H N++ L V + +++ EF NGSL L Q + +
Sbjct: 74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQL 130
Query: 160 HRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGR---TR 216
+ RGIA+G++YL +HRD+ N+L++ ++ ++S+FGL++ + + T
Sbjct: 131 VGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187
Query: 217 TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFV 275
T+ + + APE Q + D++S+G+++ +M G+ P + +
Sbjct: 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMTNQDVI 243
Query: 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ P + + ++ C D RP + L ++
Sbjct: 244 NAIEQDYRLPPPMDCPSA-------------LHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-40
Identities = 55/287 (19%), Positives = 103/287 (35%), Gaps = 38/287 (13%)
Query: 55 GEVYKAELPGSSGRVITIK-KVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G VY L + G+ I K + + E+ Q +E I H
Sbjct: 41 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS------------QFLTEGIIMKDFSHP 88
Query: 114 NIVPLLARVVRPD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEY 172
N++ LL +R + L+V + ++G L++ + +A G+
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGM-- 143
Query: 173 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE--TVGYIA 230
+ +HRD+ N ++D+ ++++FGLA+ + + + V ++A
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 231 PECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRT 290
E QT + K D++SFGVLL LM P + ++ P
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVNTFDITVYLLQGRRLLQPEYC 259
Query: 291 IDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
D + ++ C E RP+ ++ +S I
Sbjct: 260 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-40
Identities = 62/276 (22%), Positives = 105/276 (38%), Gaps = 37/276 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV A + + +K V +K + + I+ EI + H N
Sbjct: 19 GEVQLAVNR-VTEEAVAVKIV--DMKRAVDCPEN-----------IKKEICINKMLNHEN 64
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V + L E+ G L D + + + R + +G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
I HRDI+P N+L+D+ +IS+FGLA + T+ Y+APE
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 235 QTVALSD-KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293
+ D++S G++L ++ G+ P + Q + + T NP + IDS
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 294 KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329
+ L+ KI +P R D++
Sbjct: 235 APLA--------LLHKILVE----NPSARITIPDIK 258
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-40
Identities = 68/338 (20%), Positives = 125/338 (36%), Gaps = 49/338 (14%)
Query: 16 GSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKV 75
GS D + DL + + + + S G+V A G S ++I+
Sbjct: 12 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71
Query: 76 IQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRPDCDLLVYEF 134
++ LK +A+ + + SE+ Q+ H NIV LL L++E+
Sbjct: 72 VKMLKEKAD---------SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 122
Query: 135 RRNGSLQDILY-------------------DVSQGRRELDWLARHRIARGIASGLEYLHM 175
G L + L + + L + A +A G+E+L
Sbjct: 123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE- 181
Query: 176 SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ 235
+HRD+ NVL+ +I +FGLA+ I + + V ++APE
Sbjct: 182 --FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239
Query: 236 TVALSDKCDIYSFGVLLA-VLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSK 294
+ K D++S+G+LL + +G P + + +F + ++N + P +
Sbjct: 240 EGIYTIKSDVWSYGILLWEIFSLGVNP---YPGIPVDANFYKLIQNGFKMDQPFYATEE- 295
Query: 295 LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332
+ I C D +RP+ ++ L
Sbjct: 296 ------------IYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 9e-40
Identities = 50/279 (17%), Positives = 106/279 (37%), Gaps = 43/279 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
VYK + + ++ +++E + + E ++H N
Sbjct: 23 KTVYKGLDTET-TVEVAWCELQDRKLTKSE------------RQRFKEEAEMLKGLQHPN 69
Query: 115 IVPLL----ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
IV + V C +LV E +G+L+ L + + + R I GL
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGL 125
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDD-DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
++LH + P IIHRD++ N+ I +I + GLA + + T ++
Sbjct: 126 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFM 180
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSR 289
APE ++ + D+Y+FG+ + + ++P + + + + + + + +
Sbjct: 181 APEMYEE-KYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDK 236
Query: 290 TIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
++ +I C + +ER + KD+
Sbjct: 237 VAIPEVK------------EIIEGCIRQNKDERYSIKDL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 1e-39
Identities = 63/304 (20%), Positives = 111/304 (36%), Gaps = 49/304 (16%)
Query: 28 LIEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIK 87
L K+D E F+ L +I G VY A + V+ IKK +
Sbjct: 7 LFFKDDP-----EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKK-----------MS 49
Query: 88 QDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDV 147
+ + K I E+ ++RH N + +R LV E+ + +
Sbjct: 50 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH- 108
Query: 148 SQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 207
++ L + + G GL YLH +IHRD++ N+L+ + ++ +FG A
Sbjct: 109 ---KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162
Query: 208 KQIPNGRTRTTTWSLAETVGYIAPE---CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDD 264
+ S T ++APE K D++S G+ L K P
Sbjct: 163 SIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--- 213
Query: 265 FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN 324
+ M + ++ +E+P+ L + E + C P++RP
Sbjct: 214 -LFNMNAM---SALYHIAQNESPA------LQSGHWSEYFRNFVDS---CLQKIPQDRPT 260
Query: 325 SKDV 328
S+ +
Sbjct: 261 SEVL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-39
Identities = 57/283 (20%), Positives = 97/283 (34%), Gaps = 38/283 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V K K+++ ++ L + + +E Q+ +
Sbjct: 21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-----------LLAEANVMQQLDNPY 69
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV ++ + + +LV E G L L R + + ++ G++YL
Sbjct: 70 IVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE 124
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPEC 233
S+ +HRD+ NVL+ A+IS+FGL+K + V + APEC
Sbjct: 125 ESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 234 HQTVALSDKCDIYSFGVLL-AVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTID 292
S K D++SFGVL+ G+ P ++ K + P+
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP----YRGMKGSEVTAMLEKGERMGCPAGCPR 237
Query: 293 SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ + C D E RP V L
Sbjct: 238 E-------------MYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 2e-39
Identities = 55/281 (19%), Positives = 107/281 (38%), Gaps = 38/281 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEVY+ + +K +K+D+ + + E +++H N
Sbjct: 31 GEVYEGVWKKY-SLTVAVKT-----------LKEDTMEVE----EFLKEAAVMKEIKHPN 74
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V LL R ++ EF G+L D L + R+E+ + +A I+S +EYL
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+ IHRD+ N L+ ++ ++++FGL++ + + + APE
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESL 188
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSK 294
S K D+++FGVLL + + + + E P +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRMERPEGCPEK- 244
Query: 295 LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
V ++ C +P +RP+ ++ +
Sbjct: 245 ------------VYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-39
Identities = 58/302 (19%), Positives = 114/302 (37%), Gaps = 38/302 (12%)
Query: 36 FLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHH 95
FLK+++ + ++ G V + ++ KV++ +A+
Sbjct: 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE--------- 54
Query: 96 KMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELD 155
++ E Q+ + IV L+ V + + +LV E G L L R E+
Sbjct: 55 ---EMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVG---KREEIP 107
Query: 156 WLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-PNGR 214
+ ++ G++YL +HRD+ NVL+ + A+IS+FGL+K + +
Sbjct: 108 VSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164
Query: 215 TRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLM-MGKFPSDDFFQHTKEMS 273
T + + + APEC S + D++S+GV + + G+ P ++ K
Sbjct: 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPE 220
Query: 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333
+ ++ E P + + C E+RP+ V +
Sbjct: 221 VMAFIEQGKRMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMR 267
Query: 334 QI 335
Sbjct: 268 AC 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-39
Identities = 56/291 (19%), Positives = 108/291 (37%), Gaps = 40/291 (13%)
Query: 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEII 105
+++I S G V+ + + IK + + SE + I+ E
Sbjct: 10 VQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMSEEDFIE---------------EAE 52
Query: 106 TAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARG 165
++ H +V L + LV+EF +G L D + R +
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLD 109
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAET 225
+ G+ YL +IHRD+ N L+ ++ ++S+FG+ + + + + T++
Sbjct: 110 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFP 165
Query: 226 VGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSE 285
V + +PE S K D++SFGVL+ + +++ V+ +
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDISTGFRLY 222
Query: 286 NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
P V +I C + PE+RP + L++I
Sbjct: 223 KPRLASTH-------------VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-39
Identities = 61/295 (20%), Positives = 110/295 (37%), Gaps = 40/295 (13%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQI 100
+ K+ GEV+ G + IK + S ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTMSPEAFLQ------------- 61
Query: 101 QSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 160
E ++RH +V L A VV + +V E+ GSL D + + + L
Sbjct: 62 --EAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLV 116
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
+A IASG+ Y+ +HRD++ AN+L+ +++ ++++FGLA+ I +
Sbjct: 117 DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ- 172
Query: 221 SLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280
+ + APE + K D++SFG+LL L + + +
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVER 229
Query: 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
P +S + + C C +PEERP + ++ L
Sbjct: 230 GYRMPCPPECPES-------------LHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-39
Identities = 63/327 (19%), Positives = 118/327 (36%), Gaps = 57/327 (17%)
Query: 22 PTIFSPLIEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKS 81
PTI+ P+++ D+ F + I G+V KA + R+ K ++ S
Sbjct: 1 PTIY-PVLDWNDIKFQ---------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 50
Query: 82 EAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVPLLARVVRPDCDLLVYEFRRNGSL 140
+ + E+ ++ H NI+ LL L E+ +G+L
Sbjct: 51 KDD------------HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 98
Query: 141 QDILYD------------VSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQP 188
D L + L A +A G++YL + + IHRD+
Sbjct: 99 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAA 155
Query: 189 ANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSF 248
N+L+ ++ A+I++FGL++ +T V ++A E + D++S+
Sbjct: 156 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRL---PVRWMAIESLNYSVYTTNSDVWSY 212
Query: 249 GVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVL 308
GVLL ++ + + + E P D V
Sbjct: 213 GVLLWEIVSLGGT---PYCGMTCAELYEKLPQGYRLEKPLNCDDE-------------VY 256
Query: 309 KIACFCTFDDPEERPNSKDVRCMLSQI 335
+ C + P ERP+ + L+++
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-39
Identities = 59/298 (19%), Positives = 117/298 (39%), Gaps = 37/298 (12%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIK--KVIQPLKSEAELIKQDSEPLHHKMI 98
C + I + GEVYK L SSG+ K ++ +E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV------------ 54
Query: 99 QIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 158
E GQ H NI+ L + + +++ E+ NG+L L + E L
Sbjct: 55 DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQ 111
Query: 159 RHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT- 217
+ RGIA+G++Y +HRD+ N+L++ ++ ++S+FGL++ + + T
Sbjct: 112 LVGMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168
Query: 218 TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277
TT + + APE + D++SFG+++ +M + ++
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---PYWELSNHEVMKA 225
Query: 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ + P + + ++ C + RP D+ +L ++
Sbjct: 226 INDGFRLPTP-------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-38
Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 40/274 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY A ++G+ + I+++ + + ELI EI+ + ++ N
Sbjct: 34 GTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIIN--------------EILVMRENKNPN 78
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L + D +V E+ GSL D++ +D + R LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
++IHRDI+ N+L+ D ++++FG QI +++ +T T ++APE
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVV 188
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSK 294
A K DI+S G++ ++ G+ P + + ++ + + T+ P K
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-------ENPLRALYLIATNGTPELQNPEK 241
Query: 295 LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
L + + C D E+R ++K++
Sbjct: 242 L----SAIFRDFLNR----CLDMDVEKRGSAKEL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-37
Identities = 55/300 (18%), Positives = 102/300 (34%), Gaps = 50/300 (16%)
Query: 55 GEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV 110
G+V +A G + + +K +K + + + SE+ +
Sbjct: 37 GKVVEATAYGLIKSDAAMTVAVKM-----------LKPSAHLTERE--ALMSELKVLSYL 83
Query: 111 -RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYD--------------VSQGRRELD 155
H NIV LL L++ E+ G L + L + LD
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 156 WLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT 215
+ +A G+ +L IHRD+ N+L+ +I +FGLA+ I N
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275
+ V ++APE + + D++S+G+ L L + + F
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--PYPGMPVDSKFY 258
Query: 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ ++ +P + I C DP +RP K + ++ +
Sbjct: 259 KMIKEGFRMLSPEHAPAE-------------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 6e-37
Identities = 53/301 (17%), Positives = 103/301 (34%), Gaps = 39/301 (12%)
Query: 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKM 97
K+ + F + + V A ++ R IK +++ +K+
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLAREL-ATSREYAIKI-----------LEKRHIIKENKV 52
Query: 98 IQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 157
+ E ++ H V L + + +NG L + +
Sbjct: 53 PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-------F 105
Query: 158 ARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT 217
A + L H IIHRD++P N+L+++DM +I++FG AK + +
Sbjct: 106 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165
Query: 218 TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277
S T Y++PE + D+++ G ++ L+ G P F+ E
Sbjct: 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEY---LI 218
Query: 278 MRNVMTSE-NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
+ ++ E + K LV K+ D +R +++
Sbjct: 219 FQKIIKLEYDFPEKFFPKARD--------LVEKLLVL----DATKRLGCEEMEGYGPLKA 266
Query: 337 H 337
H
Sbjct: 267 H 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-36
Identities = 57/305 (18%), Positives = 101/305 (33%), Gaps = 35/305 (11%)
Query: 35 AFLK--KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEP 92
A L+ KE F ++ + S G VYK G + I I+ L+
Sbjct: 1 ALLRILKETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATS-------- 51
Query: 93 LHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRR 152
+I E V + ++ LL + L+ + G L D + + +
Sbjct: 52 -PKANKEILDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVR---EHKD 106
Query: 153 ELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPN 212
+ IA G+ YL R++HRD+ NVL+ +I++FGLAK +
Sbjct: 107 NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163
Query: 213 GRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272
+ ++A E + + D++S+GV + LM +
Sbjct: 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPAS 220
Query: 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCML 332
+ P V I C D + RP +++
Sbjct: 221 EISSILEKGERLPQPPICTID-------------VYMIMVKCWMIDADSRPKFRELIIEF 267
Query: 333 SQIQH 337
S++
Sbjct: 268 SKMAR 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-36
Identities = 60/300 (20%), Positives = 111/300 (37%), Gaps = 51/300 (17%)
Query: 55 GEVYKAELPG------SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAG 108
G+V AE G + + +K + S+ + + SE+
Sbjct: 27 GQVVLAEAIGLDKDKPNRVTKVAVKML-------------KSDATEKDLSDLISEMEMMK 73
Query: 109 QV-RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILY------------DVSQGRRELD 155
+ +H+NI+ LL + ++ E+ G+L++ L +L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 156 WLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRT 215
A +A G+EYL + IHRD+ NVL+ +D +I++FGLA+ I +
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 216 RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275
T + V ++APE + + D++SFGVLL + +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPVEELF 247
Query: 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ ++ + PS + + + C P +RP K + L +I
Sbjct: 248 KLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-35
Identities = 49/293 (16%), Positives = 102/293 (34%), Gaps = 42/293 (14%)
Query: 55 GEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV 110
G VY+ G + IK V + + I+ +E +
Sbjct: 34 GMVYEGVAKGVVKDEPETRVAIKTV-------------NEAASMRERIEFLNEASVMKEF 80
Query: 111 RHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQG------RRELDWLARHRIAR 164
++V LL V + L++ E G L+ L + ++A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 165 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAE 224
IA G+ YL+ + +HRD+ N ++ +D +I +FG+ + I
Sbjct: 141 EIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 225 TVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTS 284
V +++PE + + D++SFGV+L + +Q ++++
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEGGLL 254
Query: 285 ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQH 337
+ P D + ++ C +P+ RP+ ++ + +
Sbjct: 255 DKPDNCPDM-------------LFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-34
Identities = 64/293 (21%), Positives = 101/293 (34%), Gaps = 34/293 (11%)
Query: 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEII 105
LEK+ G V + E SG+ +++ +K D M E+
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC---------LKPDVLSQPEAMDDFIREVN 63
Query: 106 TAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARG 165
+ HRN++ L VV +V E GSL D L + R A
Sbjct: 64 AMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQ 119
Query: 166 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTR-TTTWSLAE 224
+A G+ YL R IHRD+ N+L+ +I +FGL + +P
Sbjct: 120 VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 225 TVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMT 283
+ APE +T S D + FGV L + G+ P ++ Q + +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-------LNGSQILHKIDK 229
Query: 284 SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336
+ + + C PE+RP +R L + Q
Sbjct: 230 EGERL------PRPEDCPQDI---YNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 125 bits (316), Expect = 6e-34
Identities = 55/276 (19%), Positives = 104/276 (37%), Gaps = 40/276 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V++ ++G K V+ P +S+ E ++ EI T +RH
Sbjct: 40 GVVHRVTER-ATGNNFAAKFVMTPHESDKE--------------TVRKEIQTMSVLRHPT 84
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+V L + +++YEF G L + + D ++ R + GL ++
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHM- 140
Query: 175 MSHRPRIIHRDIQPANVLI--DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
H +H D++P N++ E ++ +FGL + ++ T T + APE
Sbjct: 141 --HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPE 195
Query: 233 CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTID 292
+ + D++S GVL +L+ G P + + +RNV + + +D
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-------ENDDETLRNVKSCD---WNMD 245
Query: 293 SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
E+ + K+ DP R
Sbjct: 246 DSAFSGISEDGKDFIRKLLLA----DPNTRMTIHQA 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-33
Identities = 54/282 (19%), Positives = 107/282 (37%), Gaps = 37/282 (13%)
Query: 55 GEVYKAELPGSSGRVITIK-KVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHR 113
G+V++ + + K + S++ + E +T Q H
Sbjct: 21 GDVHQGIYMSPENPALAVAIKTCKNCTSDSV------------REKFLQEALTMRQFDHP 68
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
+IV L+ V+ + ++ E G L+ L + LD + A +++ L YL
Sbjct: 69 HIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYL 124
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
R +HRDI NVL+ + ++ +FGL++ + + + + ++APE
Sbjct: 125 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPES 180
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293
+ D++ FGV + ++M ++ + ++ + N T+ S
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 294 KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
L+ K C DP RP +++ LS I
Sbjct: 241 ------------LMTK----CWAYDPSRRPRFTELKAQLSTI 266
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 2e-33
Identities = 60/276 (21%), Positives = 103/276 (37%), Gaps = 41/276 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V++ SS + K V + + ++ EI RHRN
Sbjct: 19 GIVHRCVET-SSKKTYMAKFVKVKGTDQ---------------VLVKKEISILNIARHRN 62
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ L + ++++EF + + + + EL+ + L++LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
I H DI+P N++ + I EFG A+Q+ G ++ Y APE
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPE 173
Query: 233 CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTID 292
HQ +S D++S G L+ VL+ G P F Q + N+M N T D
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAETNQ---QIIENIM---NAEYTFD 223
Query: 293 SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ E M V ++ + + R + +
Sbjct: 224 EEAFKEISIEAMDFVDRLLVK----ERKSRMTASEA 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 9e-33
Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 38/273 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+V+ AE + + IK + + + + ++ + + + + H
Sbjct: 16 GKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVEC----------TMVEKRVLSLAWEHPF 64
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+ + + V E+ G L + Q + D A I GL++LH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
I++RD++ N+L+D D +I++FG+ K+ G +T T+ T YIAPE
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDYIAPEIL 175
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSK 294
+ D +SFGVLL +++G+ P F E +R M + R ++ +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIR--MDNPFYPRWLEKE 229
Query: 295 LIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD 327
L++K F +PE+R +
Sbjct: 230 AKD--------LLVK--LFVR--EPEKRLGVRG 250
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-32
Identities = 56/298 (18%), Positives = 108/298 (36%), Gaps = 47/298 (15%)
Query: 55 GEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV 110
G+V +A+ G ++ R + +K +K+ + H+ + + I
Sbjct: 27 GQVIEADAFGIDKTATCRTVAVKM-----------LKEGATHSEHRAL-MSELKILIHIG 74
Query: 111 RHRNIVPLLARVVRPDCDL-LVYEFRRNGSLQDILYD------------VSQGRRELDWL 157
H N+V LL +P L ++ EF + G+L L + L
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 158 ARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRT 217
+ +A G+E+L + IHRD+ N+L+ + +I +FGLA+ I
Sbjct: 135 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 218 TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277
+ ++APE + + D++SFGVLL + + + F +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFCRR 249
Query: 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
++ P T + + C +P +RP ++ L +
Sbjct: 250 LKEGTRMRAPDYTTPE-------------MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 118 bits (297), Expect = 2e-31
Identities = 52/276 (18%), Positives = 98/276 (35%), Gaps = 40/276 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V++ ++GRV K + P + +++EI Q+ H
Sbjct: 43 GVVHRCVEK-ATGRVFVAKFINTPYPLDKY--------------TVKNEISIMNQLHHPK 87
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
++ L +L+ EF G L D + + ++ R GL+++
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHM- 143
Query: 175 MSHRPRIIHRDIQPANVLID--DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
H I+H DI+P N++ + +I +FGLA ++ T + APE
Sbjct: 144 --HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPE 198
Query: 233 CHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTID 292
+ D+++ GVL VL+ G P F ++ +Q ++ D
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQNVKRC------DWEFD 248
Query: 293 SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ E + + +P +R D
Sbjct: 249 EDAFSSVSPEAKDFIKNLLQK----EPRKRLTVHDA 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 117 bits (293), Expect = 3e-31
Identities = 58/281 (20%), Positives = 108/281 (38%), Gaps = 37/281 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HR 113
V + + + +K + +E + E+ +V H
Sbjct: 17 SVVRRCIHK-PTCKEYAVKII-----DVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYL 173
NI+ L LV++ + G L D L + L +I R + + L
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICAL 126
Query: 174 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
H + I+HRD++P N+L+DDDM ++++FG + Q+ G T Y+APE
Sbjct: 127 H---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG---TPSYLAPEI 180
Query: 234 HQTVAL------SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENP 287
+ + D++S GV++ L+ G P F H K+M +R +M +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQM---LMLRMIM---SG 230
Query: 288 SRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ S + + LV + P++R +++
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVSRFLVV----QPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (294), Expect = 3e-31
Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 41/277 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
EV AE + +++ IK + + L K +++EI +++H N
Sbjct: 23 SEVILAEDK-RTQKLVAIKCI-------------AKKALEGKEGSMENEIAVLHKIKHPN 68
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L L+ + G L D + + + R+ + ++YLH
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLH 124
Query: 175 MSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
I+HRD++P N+L D+D + IS+FGL+K G +T T GY+AP
Sbjct: 125 DLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST---ACGTPGYVAP 178
Query: 232 ECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTI 291
E S D +S GV+ +L+ G P D + + ++ +E
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-------ENDAKLFEQILKAE---YEF 228
Query: 292 DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
DS + + + DPE+R +
Sbjct: 229 DSPYWDDISDSAKDFIRH----LMEKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 115 bits (290), Expect = 6e-31
Identities = 55/289 (19%), Positives = 112/289 (38%), Gaps = 39/289 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
EV+ A R + +K + L + + + E A + H
Sbjct: 21 SEVHLARDL-RLHRDVAVKVLRADLARDPSFYLR-----------FRREAQNAAALNHPA 68
Query: 115 IVPLLARVVRPDCDL----LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGL 170
IV + +V E+ +L+DI++ + + L
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQAL 124
Query: 171 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-PNGRTRTTTWSLAETVGYI 229
+ H + IIHRD++PAN++I ++ +FG+A+ I +G + T T ++ T Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSR 289
+PE + ++ + D+YS G +L ++ G+ P S V + +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-------DSPVSVAYQHVREDPIPP 234
Query: 290 TIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS-KDVRCMLSQIQH 337
+ + + + +VLK +PE R + ++R L ++ +
Sbjct: 235 SARHEGLSADLDA---VVLK----ALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 2e-30
Identities = 52/289 (17%), Positives = 97/289 (33%), Gaps = 41/289 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G++Y ++G + IK K Q+ E ++
Sbjct: 21 GDIYLGTDI-AAGEEVAIKLECVKTKHP----------------QLHIESKIYKMMQGGV 63
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+P + ++ SL + R+ +A + S +EY+H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 175 MSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKQIPNGRTRTTTW-----SLAETV 226
IHRD++P N L+ I +FGLAK+ + RT +L T
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 227 GYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286
Y + H + S + D+ S G +L +G P TK + + M
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---- 233
Query: 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ +++ GY + L C +++P+ +R + +
Sbjct: 234 ---STPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 3e-29
Identities = 48/233 (20%), Positives = 89/233 (38%), Gaps = 31/233 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V+ +GR +K + + + + ++ E + V H
Sbjct: 18 GRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEH-----------TNDERLMLSIVTHPF 65
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ + ++ ++ G L +L + A + LEYLH
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLH 121
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
II+RD++P N+L+D + +I++FG AK +P+ YIAPE
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGT-----PDYIAPEVV 173
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENP 287
T + D +SFG+L+ ++ G P F + M + ++ +E
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTM---KTYEKILNAELR 219
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (278), Expect = 4e-29
Identities = 40/291 (13%), Positives = 97/291 (33%), Gaps = 43/291 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G +++ + + + IK P Q++ E T +
Sbjct: 19 GVIFEGTNL-LNNQQVAIKFE----------------PRRSDAPQLRDEYRTYKLLAGCT 61
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+P + + ++ SL+D+L R+ A+ + + ++ +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 175 MSHRPRIIHRDIQPANVLIDDDME-----ARISEFGLAKQIPNGRTRTTTW-----SLAE 224
+++RDI+P N LI + +FG+ K + T+ +L+
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 225 TVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTS 284
T Y++ H S + D+ + G + + G P T + + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-- 233
Query: 285 ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335
+ + + G+ E+ + + P+ ++ + S++
Sbjct: 234 -----STPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFSKV 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 112 bits (280), Expect = 7e-29
Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 23/236 (9%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEVY +G++ +K + K ++ + ++ L+ ++ +
Sbjct: 18 GEVYGCRKA-DTGKMYAMKCL---DKKRIKMKQGETLALNERI-----MLSLVSTGDCPF 68
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV + PD + + G L L A I GLE++H
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH 124
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+++RD++PAN+L+D+ RIS+ GLA + + T GY+APE
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG----THGYMAPEVL 177
Query: 235 QT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSR 289
Q VA D +S G +L L+ G P TK+ + M M E P
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTLTMAVELPDS 231
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 8e-29
Identities = 62/310 (20%), Positives = 119/310 (38%), Gaps = 46/310 (14%)
Query: 23 TIFSPLIEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSE 82
T+F +E++ +D + + E++ S V K S+G K +
Sbjct: 1 TVFR----QENV-----DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFI------- 43
Query: 83 AELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQD 142
+ + S I+ E+ +++H N++ L +L+ E G L D
Sbjct: 44 -KKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 143 ILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR-- 200
L + + L + I +G+ + H +I H D++P N+++ D +
Sbjct: 103 FLAE----KESLTEEEATEFLKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 201 --ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMG 258
I +FGLA +I G + T ++APE L + D++S GV+ +L+ G
Sbjct: 156 IKIIDFGLAHKIDFGNEFKNIFG---TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212
Query: 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDD 318
P F TK+ + E+ + S L + + ++ D
Sbjct: 213 ASP---FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD-------FIRRLLVK----D 258
Query: 319 PEERPNSKDV 328
P++R +D
Sbjct: 259 PKKRMTIQDS 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-28
Identities = 56/288 (19%), Positives = 106/288 (36%), Gaps = 32/288 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+V+KA + GR + +K+V E + E + + + H N
Sbjct: 21 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE------VAVLRHL---ETFEHPN 71
Query: 115 IVPLLARVVRPDCD-----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASG 169
+V L D LV+E + + + + G
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRG 128
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYI 229
L++LH R++HRD++P N+L+ + ++++FGLA+ T+ T+ Y
Sbjct: 129 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 182
Query: 230 APECHQTVALSDKCDIYSFGVLLAVLMMGKFP---SDDFFQHTKEMSFV------QWMRN 280
APE + + D++S G + A + K S D Q K + + W R+
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
V + ++ I + L + C +P +R ++
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 7e-28
Identities = 50/282 (17%), Positives = 99/282 (35%), Gaps = 46/282 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRHR 113
G+V + + +K + + + E+ + +
Sbjct: 26 GKVLQIFNK-RTQEKFALKML-------------------QDCPKARREVELHWRASQCP 65
Query: 114 NIVPLL----ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASG 169
+IV ++ C L+V E G L + D +G + I + I
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEA 123
Query: 170 LEYLHMSHRPRIIHRDIQPANVLIDDDME---ARISEFGLAKQIPNGRTRTTTWSLAETV 226
++YLH I HRD++P N+L ++++FG AK+ + + TT T
Sbjct: 124 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTP 177
Query: 227 GYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286
Y+APE CD++S GV++ +L+ G P F+ + + +
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQY 234
Query: 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ + + + +LK +P +R +
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKT-------EPTQRMTITEF 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 1e-27
Identities = 59/285 (20%), Positives = 99/285 (34%), Gaps = 30/285 (10%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
VYKA ++ +++ IKK+ +SEA+ EI ++ H N
Sbjct: 12 ATVYKARDK-NTNQIVAIKKIKLGHRSEAK---------DGINRTALREIKLLQELSHPN 61
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ LL LV++F I L GLEYLH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+ I+HRD++P N+L+D++ ++++FGLAK + T T Y APE
Sbjct: 118 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VVTRWYRAPELL 172
Query: 235 QTVALSD-KCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTI 291
+ D+++ G +LA L++ P D + +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 292 DSKLIGNGYEEQMLLVLKIACFCTFD--------DPEERPNSKDV 328
D + + + A D +P R +
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-27
Identities = 54/277 (19%), Positives = 95/277 (34%), Gaps = 43/277 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY S + IK V E + I E + + ++ ++
Sbjct: 18 GSVYSGIRV-SDNLPVAIKHV------EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
++ LL RPD +L+ E L+D R L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 175 MSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPEC 233
++HRDI+ N+LID + E ++ +FG + + T T Y PE
Sbjct: 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEW 180
Query: 234 HQTVALSDK-CDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTID 292
+ + ++S G+LL ++ G P F+H +E+ Q S I
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQRVSSECQHLIR 236
Query: 293 SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329
C P +RP ++++
Sbjct: 237 W--------------------CLALRPSDRPTFEEIQ 253
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-27
Identities = 58/287 (20%), Positives = 101/287 (35%), Gaps = 42/287 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VY+A+L SG ++ IKK + QD E+ ++ H N
Sbjct: 34 GVVYQAKLC-DSGELVAIKK-----------VLQDKR-------FKNRELQIMRKLDHCN 74
Query: 115 IVPLLARVVRPDCD------LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
IV L LV ++ + S+ ++ L + +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFR 133
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKQIPNGRTRTTTWSLAETVG 227
L Y+ H I HRDI+P N+L+D D ++ +FG AKQ+ G + +
Sbjct: 134 SLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRY 187
Query: 228 YIAP-ECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSEN 286
Y AP + D++S G +LA L++G+ F + + ++
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGV---DQLVEIIKVLG 240
Query: 287 PSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKD-VRCML 332
+ + Y E +K + P P + +L
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 7e-27
Identities = 52/293 (17%), Positives = 107/293 (36%), Gaps = 41/293 (13%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V A + + IKK I + + + EI + RH N
Sbjct: 22 GMVCSAYDN-VNKVRVAIKK-----------ISPFEHQTYCQ--RTLREIKILLRFRHEN 67
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
I+ + + P + + + + LY + + + L I GL+Y+H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 126
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQI-PNGRTRTTTWSLAETVGYIAPEC 233
++HRD++P+N+L++ + +I +FGLA+ P+ T Y APE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 234 HQTVALSD-KCDIYSFGVLLAVLMMGKFP-----------------SDDFFQHTKEMSFV 275
DI+S G +LA ++ + + + +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
+ +++ + ++ ++L N + + L+ K+ F +P +R +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF----NPHKRIEVEQA 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 4e-26
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 21/207 (10%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G+V ++GR +K ++++ ++ +E RH
Sbjct: 19 GKVILVREK-ATGRYYAMKI-----------LRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+ L D V E+ G L L R A + L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFYGAEIVSALE 119
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
H +++RDI+ N+++D D +I++FGL K+ + T + T Y+APE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVL 177
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFP 261
+ D + GV++ +M G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 100 bits (250), Expect = 4e-25
Identities = 59/286 (20%), Positives = 103/286 (36%), Gaps = 35/286 (12%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYKA+ G +KK+ + E EI +++H N
Sbjct: 16 GVVYKAQNN--YGETFALKKIRLEKEDE------------GIPSTTIREISILKELKHSN 61
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L + +LV+E + + L+ + + +G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH 117
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
R++HRD++P N+LI+ + E +I++FGLA+ G T+ Y AP+
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVL 172
Query: 235 Q-TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDS 293
+ S DI+S G + A ++ G + + M + + + P+ T
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 294 KLIGNGYEEQMLLVLKIACFCTFD-----------DPEERPNSKDV 328
K N + L DP +R +K
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (252), Expect = 5e-25
Identities = 48/240 (20%), Positives = 88/240 (36%), Gaps = 28/240 (11%)
Query: 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQI 100
D F ++ + + G V + SG +K + + + + I+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEH-----------T 88
Query: 101 QSEIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 160
+E V +V L +V E+ G + L
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHAR 144
Query: 161 RIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW 220
A I EYLH +I+RD++P N+LID ++++FG AK++ TW
Sbjct: 145 FYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTW 196
Query: 221 SLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280
+L T +APE + + D ++ GVL+ + G P F + + + + +
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVS 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 5e-24
Identities = 61/290 (21%), Positives = 110/290 (37%), Gaps = 41/290 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G VYKA +G V+ +KK+ ++E EI ++ H N
Sbjct: 16 GVVYKARNK-LTGEVVALKKIRLDTETE------------GVPSTAIREISLLKELNHPN 62
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV LL + + LV+EF + + + + + GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE-C 233
R++HRD++P N+LI+ + ++++FGLA+ T T+ Y APE
Sbjct: 120 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEIL 174
Query: 234 HQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTI 291
S DI+S G + A ++ + FP D + + + +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 292 D-------------SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
D SK++ E+ L+ ++ + DP +R ++K
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY----DPNKRISAKAA 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 6e-24
Identities = 54/286 (18%), Positives = 102/286 (35%), Gaps = 33/286 (11%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V+KA+ + ++ +K+V E EI +++H+N
Sbjct: 16 GTVFKAKNR-ETHEIVALKRVRLDDDDEGVPS------------SALREICLLKELKHKN 62
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
IV L + LV+EF QD+ +LD + GL + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+ ++HRD++P N+LI+ + E +++ FGLA+ R + +
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGK---FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTI 291
S D++S G + A L FP +D K + + + ++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 292 DSKLIGNGYEEQMLLVLKIACFCTFD---------DPEERPNSKDV 328
D K L+ + T +P +R ++++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (242), Expect = 7e-24
Identities = 56/302 (18%), Positives = 107/302 (35%), Gaps = 51/302 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
GEV+KA +G+ + +KKV+ + E I EI ++H N
Sbjct: 24 GEVFKARHR-KTGQKVALKKVLMENEKEGF------------PITALREIKILQLLKHEN 70
Query: 115 IVPLLARVVRPDCD--------LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGI 166
+V L+ LV++F + + + R+ + +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQML 126
Query: 167 ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTW--SLAE 224
+GL Y+H R +I+HRD++ ANVLI D ++++FGLA+ + +
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 225 TVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEMSFV------ 275
T+ Y PE D++ G ++A + + +S +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 276 ---------QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326
+ + + R + +L + L ++ DP +R +S
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID-KLLVL--DPAQRIDSD 300
Query: 327 DV 328
D
Sbjct: 301 DA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 2e-23
Identities = 45/228 (19%), Positives = 85/228 (37%), Gaps = 24/228 (10%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V A +G + IKK+ +P +SE + E+ +RH N
Sbjct: 32 GAVCSAVDG-RTGAKVAIKKLYRPFQSELFAK------------RAYRELRLLKHMRHEN 78
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
++ LL + +F +L + + GL Y+H
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
+ HRD++P N+ +++D E +I +FGLA+Q + T
Sbjct: 139 AAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT----RWYRAPEVIL 191
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVM 282
+ + DI+S G ++A ++ GK F+ + + ++ + V
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHLDQLKEIMKVT 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 91.8 bits (227), Expect = 9e-22
Identities = 54/243 (22%), Positives = 98/243 (40%), Gaps = 39/243 (16%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEI-ITAGQVRHR 113
EV++A ++ + +K +++P+K + +I+ EI I
Sbjct: 49 SEVFEAINI-TNNEKVVVK-ILKPVKKK----------------KIKREIKILENLRGGP 90
Query: 114 NIVPLLARVVRPDCDL--LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
NI+ L V P LV+E N + + + L I L+
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALD 143
Query: 172 YLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIA 230
Y H I+HRD++P NV+ID + + R+ ++GLA+ G+ + + +
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA---SRYFKG 197
Query: 231 PECHQTVALSD-KCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSR 289
PE + D D++S G +LA ++ K P FF + + V+ +E+
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTEDLYD 254
Query: 290 TID 292
ID
Sbjct: 255 YID 257
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 2e-21
Identities = 55/276 (19%), Positives = 107/276 (38%), Gaps = 37/276 (13%)
Query: 55 GEVYKAELPGS--SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH 112
G+V+ +G++ +K + + I Q ++ H ++E +R
Sbjct: 38 GKVFLVRKISGHDTGKLYAMKVL------KKATIVQKAKTTEH----TRTERQVLEHIRQ 87
Query: 113 R-NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLE 171
+V L L+ ++ G L L + + H + + +
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHL-------SQRERFTEHEVQIYVGEIVL 140
Query: 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAP 231
L H+ II+RDI+ N+L+D + +++FGL+K+ T + T+ Y+AP
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAP 199
Query: 232 ECHQT--VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPSR 289
+ + D +S GVL+ L+ G P F ++ S + R ++ SE P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQAEISRRILKSEPPYP 256
Query: 290 TIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNS 325
S L + L+ ++ DP++R
Sbjct: 257 QEMSALAKD-------LIQRLLMK----DPKKRLGC 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.5 bits (205), Expect = 1e-18
Identities = 51/240 (21%), Positives = 89/240 (37%), Gaps = 36/240 (15%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V A R + IKK+ +P +++ + E++ V H+N
Sbjct: 31 GIVCAAYDA-VLDRNVAIKKLSRPFQNQTH------------AKRAYRELVLMKCVNHKN 77
Query: 115 IVPLLARVVRPDCD------LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIAS 168
I+ LL LV E Q I + ELD + +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLC 130
Query: 169 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGY 228
G+++LH + IHRD++P+N+++ D +I +FGLA+ T T Y
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYY 184
Query: 229 IAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMTSENPS 288
APE + + DI+S G ++ ++ K F + + + + P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNKVIEQLGTPCPE 240
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.0 bits (204), Expect = 1e-18
Identities = 53/291 (18%), Positives = 104/291 (35%), Gaps = 41/291 (14%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
G V A +G + +KK+ +P +S + E+ ++H N
Sbjct: 32 GSVCAAFDT-KTGLRVAVKKLSRPFQSIIH------------AKRTYRELRLLKHMKHEN 78
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
++ LL + L + ++L + I GL+Y+H
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECH 234
IIHRD++P+N+ +++D E +I +FGLA+ + T
Sbjct: 139 ---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEIML 191
Query: 235 QTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEM-----SFVQWMRNVMTSENP 287
+ + DI+S G ++A L+ G+ FP D K + + + ++SE+
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 288 SRTID----------SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDV 328
I + + + L+ K+ D ++R +
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL----DSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.8 bits (203), Expect = 2e-18
Identities = 45/256 (17%), Positives = 96/256 (37%), Gaps = 11/256 (4%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V+ A+ + + +K +++ K E + + + L ++ + +
Sbjct: 27 STVWLAKDM-VNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVN---DADNTKEDSMGANH 81
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR-HRIARGIASGLEYL 173
I+ LL + + +++L + + L +I++ + GL+Y+
Sbjct: 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 141
Query: 174 HMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPE 232
H R IIH DI+P NVL++ D + + +A + +T Y +PE
Sbjct: 142 H--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPE 199
Query: 233 CHQTVALSDKCDIYSFGVLLAVLMMGK--FPSDDFFQHTKEMSFVQWMRNVMTSENPSRT 290
DI+S L+ L+ G F D+ +TK+ + + ++
Sbjct: 200 VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLL 259
Query: 291 IDSKLIGNGYEEQMLL 306
+ K + + LL
Sbjct: 260 RNGKYTRTFFNSRGLL 275
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.9 bits (139), Expect = 1e-10
Identities = 21/158 (13%), Positives = 46/158 (29%), Gaps = 17/158 (10%)
Query: 55 GEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114
V+ +K K K+ E + + I + + R
Sbjct: 14 SAVFNCYSE--KFGECVVKF----HKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLH 174
+ L + VY + N L + ++ + + I + +
Sbjct: 68 LQKL-----QGLAVPKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPN 212
I+H D+ NVL+ + I +F + ++
Sbjct: 121 ---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGE 154
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 337 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.96 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.72 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=378.49 Aligned_cols=255 Identities=21% Similarity=0.308 Sum_probs=203.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|++. .+|+.||+|++....... ..+.+.+|+.++++++||||++++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~-------------~~~~~~~Ei~~l~~l~HpnIv~~~ 69 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVD-------------CPENIKKEICINKMLNHENVVKFY 69 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC--------------------CHHHHHHHHHTCCCTTBCCEE
T ss_pred CcceEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcch-------------HHHHHHHHHHHHHhCCCCCEeeEe
Confidence 468999999999999999999876 489999999986543211 134688999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++|||||++|+|.+++ .....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 70 ~~~~~~~~~~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~ 142 (271)
T d1nvra_ 70 GHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNL 142 (271)
T ss_dssp EEEEETTEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred eeeccCceeEEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCE
Confidence 9999999999999999999999998 45567999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....
T Consensus 143 KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~--- 217 (271)
T d1nvra_ 143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYS--- 217 (271)
T ss_dssp EECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT--SHHHH---
T ss_pred EEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH--HHHHH---
Confidence 9999999987654433333445689999999999988776 56799999999999999999999653221 11111
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
... ...... ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 218 -~~~-~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 218 -DWK-EKKTYL--------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -HHH-TTCTTS--------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHh-cCCCCC--------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 111111 111122345789999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-55 Score=373.91 Aligned_cols=250 Identities=23% Similarity=0.309 Sum_probs=206.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
-++|++++.||+|+||+||+|++. .+|+.||+|++.+...... .....+.+|+.+++.++||||++++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~hpnIv~~~ 72 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKA-----------GVEHQLRREVEIQSHLRHPNILRLY 72 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHHccCh-----------HHHHHHHHHHHHHHhcCCCCCCeEE
Confidence 368999999999999999999976 4899999999865432211 1156788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++|||||++|+|.+++.. .+.+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 73 ~~~~~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~ 145 (263)
T d2j4za1 73 GYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGEL 145 (263)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCE
Confidence 999999999999999999999999953 356999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++......... ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+...
T Consensus 146 kl~DFG~a~~~~~~~~~----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~ 214 (263)
T d2j4za1 146 KIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYK 214 (263)
T ss_dssp EECCCCSCSCCCCCCCE----ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH
T ss_pred eecccceeeecCCCccc----ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHH
Confidence 99999999876543322 35789999999999999999999999999999999999999965322 22233
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......... + ...+..+.+++.+||++||++|||+.|+++
T Consensus 215 ~i~~~~~~~---p--------~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 215 RISRVEFTF---P--------DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHTTCCCC---C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCC---C--------ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 333222111 1 112234889999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=375.79 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=206.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||+||+|++. .+|+.||+|++...... ..+.+.+|+.++++++||||+++
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~~~--------------~~~~~~~E~~il~~l~HpnIv~~ 82 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQP--------------KKELIINEILVMRENKNPNIVNY 82 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGGCS--------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEecccCh--------------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 3568999999999999999999865 48999999998543211 14578899999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..++|||||++|+|.+++.. +.+++..++.++.||+.||.|||+++ ++||||||+||+++.+++
T Consensus 83 ~~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~ 154 (293)
T d1yhwa1 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGS 154 (293)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred eEEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCc
Confidence 9999999999999999999999998743 35999999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+||+|||++.......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+
T Consensus 155 vkl~DFG~a~~~~~~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~ 225 (293)
T d1yhwa1 155 VKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRAL 225 (293)
T ss_dssp EEECCCTTCEECCSTTCCB--CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHH
T ss_pred Eeeccchhheeeccccccc--cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-------HHHH
Confidence 9999999998765433222 245789999999999999999999999999999999999999965322 1222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........+.... +......+.++|.+||++||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 226 YLIATNGTPELQN--------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHCSCCCSS--------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHhCCCCCCCC--------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222222221111 1222345889999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-55 Score=375.13 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=198.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|++. .+|+.||+|.+........ ..+.+.+|+.++++++||||++++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIv~~~ 69 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEA------------EKQMLVSEVNLLRELKHPNIVRYY 69 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSCHH------------HHHHHHHHHHHTTSCCCTTBCCEE
T ss_pred chhCEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhCCHH------------HHHHHHHHHHHHHHCCCCCEeeEE
Confidence 468999999999999999999865 4899999999865433222 156789999999999999999999
Q ss_pred ceeec--CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC--CCCceeCCCCCCcEEecC
Q 036970 120 ARVVR--PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH--RPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 120 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~~~h~di~~~nil~~~ 195 (337)
+++.+ ++..++|||||++|+|.+++.........+++..++.++.||+.||.|||+.+ ..+++||||||+||+++.
T Consensus 70 ~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~ 149 (269)
T d2java1 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149 (269)
T ss_dssp EEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT
T ss_pred EEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC
Confidence 99865 45679999999999999999776556678999999999999999999999753 235999999999999999
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+... .
T Consensus 150 ~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~ 220 (269)
T d2java1 150 KQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------K 220 (269)
T ss_dssp TSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------H
T ss_pred CCcEEEeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------H
Confidence 999999999999876543222 1235789999999999999999999999999999999999999975322 1
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+............ ++ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 221 ~~~~~i~~~~~~~--~~--------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 221 ELAGKIREGKFRR--IP--------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHTCCCC--CC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCCC--CC--------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2222222222211 11 112234889999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=369.01 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=200.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|.+++.||+|+||+||+|+++ ..||||++....... ...+.+.+|+.++++++||||++++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~------------~~~~~~~~E~~~l~~l~HpnIv~~~ 70 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTP------------QQLQAFKNEVGVLRKTRHVNILLFM 70 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCT------------THHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCH------------HHHHHHHHHHHHHHhCCCCCEeeee
Confidence 578999999999999999999753 359999985432211 2256899999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+ ...++|||||++|+|.+++.. ....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+
T Consensus 71 ~~~~~-~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~ 143 (276)
T d1uwha_ 71 GYSTA-PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTV 143 (276)
T ss_dssp EEECS-SSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSE
T ss_pred EEEec-cEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCE
Confidence 98754 568999999999999999853 3456999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCC---CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV---ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
||+|||++................||+.|+|||++.+. .++.++||||||+++|||++|..||.+... ......
T Consensus 144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~---~~~~~~ 220 (276)
T d1uwha_ 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIF 220 (276)
T ss_dssp EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHH
T ss_pred EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh---HHHHHH
Confidence 99999999876544333333456789999999998653 478899999999999999999999975422 111111
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+.. ...... . ... +...+..+.+++.+||+.||++|||+.+|++.|+.|+
T Consensus 221 ~~~~---~~~~p~-~-~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 221 MVGR---GYLSPD-L-SKV----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp HHHH---TSCCCC-G-GGS----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhc---CCCCCc-c-hhc----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111 111111 0 011 1122345889999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-54 Score=373.95 Aligned_cols=271 Identities=21% Similarity=0.284 Sum_probs=215.6
Q ss_pred cccCCccchhhhhhhhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHH
Q 036970 23 TIFSPLIEKEDLAFLKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQS 102 (337)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (337)
.|.+|..+++++. .++|++.+.||+|+||+||+|++. .+|+.||||++..... ..+++.+
T Consensus 3 ~p~~p~~~~wei~----~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~---------------~~~~~~~ 62 (287)
T d1opja_ 3 DPSSPNYDKWEME----RTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTM---------------EVEEFLK 62 (287)
T ss_dssp CTTSTTCCTTBCC----GGGEEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTTCS---------------CHHHHHH
T ss_pred CCCCCCCcccEec----HHHeEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCccc---------------hHHHHHH
Confidence 3555666555433 478999999999999999999876 3789999999853321 1457899
Q ss_pred HHHHhcCCCCCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 036970 103 EIITAGQVRHRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRII 182 (337)
Q Consensus 103 E~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~ 182 (337)
|+.++++++||||+++++++.+++..++||||+++|+|.+++.. .....+++..+..++.||+.||.|||+++ ++
T Consensus 63 E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---ii 137 (287)
T d1opja_ 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 137 (287)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999999999999999999865 34567999999999999999999999665 99
Q ss_pred eCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCC
Q 036970 183 HRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPS 262 (337)
Q Consensus 183 h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf 262 (337)
||||||+|||++.++.+||+|||+++......... .....|++.|+|||++.+..++.++||||||+++|||++|..||
T Consensus 138 HrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCccccCeEEECCCCcEEEccccceeecCCCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765443322 22345788999999999999999999999999999999987765
Q ss_pred CCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 263 DDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.... ......+.+.. ...+. . +...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 217 ~~~~---~~~~~~~~i~~---~~~~~------~----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 217 YPGI---DLSQVYELLEK---DYRME------R----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp STTC---CHHHHHHHHHT---TCCCC------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCcc---hHHHHHHHHhc---CCCCC------C----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 4321 11112222211 11111 0 111234489999999999999999999999999876
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=368.60 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=198.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|++. +++.||||++...... .+.+.+|+.++++++||||++++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~---------------~~~~~~E~~~l~~l~HpnIv~~~ 66 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQLY 66 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSSSC---------------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCCcCc---------------HHHHHHHHHHHHhcCCCCccccc
Confidence 468999999999999999999976 6788999998543221 35688999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 67 g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~ 140 (263)
T d1sm2a_ 67 GVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 140 (263)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCE
T ss_pred ceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCe
Confidence 999999999999999999999999843 4466899999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCC-CCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK-FPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~-~pf~~~~~~~~~~~~~~~~ 278 (337)
||+|||+++.......... ....||+.|+|||++.+..++.++||||||+++|||+++. +||... .. .+..
T Consensus 141 Kl~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----~~---~~~~ 212 (263)
T d1sm2a_ 141 KVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SN---SEVV 212 (263)
T ss_dssp EECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----CH---HHHH
T ss_pred EecccchheeccCCCceee-cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----CH---HHHH
Confidence 9999999987654433222 2356799999999999999999999999999999999954 554432 11 2222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
........+.. + ......+.+++.+||+.||++|||+++|++.|++|.
T Consensus 213 ~~i~~~~~~~~---p-------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 213 EDISTGFRLYK---P-------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHHHTCCCCC---C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCC---c-------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 22222222111 0 111234889999999999999999999999999885
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=375.38 Aligned_cols=253 Identities=20% Similarity=0.246 Sum_probs=203.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|++. .+|+.||||++........ .....+.+|+.++++++||||++++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~HpnIv~l~ 74 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKE-----------NKVPYVTRERDVMSRLDHPFFVKLY 74 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccCH-----------HHHHHHHHHHHHHHHcCCCCeeEEE
Confidence 478999999999999999999875 4899999999865432111 1156789999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~v 147 (288)
T d1uu3a_ 75 FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHI 147 (288)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceE
Confidence 999999999999999999999999843 356999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++................||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+...
T Consensus 148 kl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~ 220 (288)
T d1uu3a_ 148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQ 220 (288)
T ss_dssp EECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred EecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------HHHHH
Confidence 99999999877644333333356799999999999999999999999999999999999999975322 22223
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
........ ++. ..+..+.+||.+||++||++|||++|++
T Consensus 221 ~i~~~~~~---~p~--------~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 221 KIIKLEYD---FPE--------KFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp HHHTTCCC---CCT--------TCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred HHHcCCCC---CCc--------cCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 33322211 111 1223488999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=373.39 Aligned_cols=256 Identities=20% Similarity=0.266 Sum_probs=205.8
Q ss_pred hhccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 37 LKKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 37 l~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
++..+.|++++.||+|+||+||+|++. .+|..||+|++...... ..+.+.+|+.++++++||||+
T Consensus 8 ~~p~d~Y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~--------------~~~~~~~E~~il~~l~HpnIv 72 (288)
T d2jfla1 8 LNPEDFWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEE--------------ELEDYMVEIDILASCDHPNIV 72 (288)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSSSG--------------GGGGTHHHHHHHHHCCCTTBC
T ss_pred CCcccCeEEeEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCCHH--------------HHHHHHHHHHHHHhCCCCCCC
Confidence 345678999999999999999999876 48999999998543221 144678899999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.+++..++|||||++|+|.+++.. ..+.+++..+..++.||+.||.|||+++ ++||||||+||+++.+
T Consensus 73 ~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~ 146 (288)
T d2jfla1 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLD 146 (288)
T ss_dssp CEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred eEEEEEeeCCeEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCC
Confidence 999999999999999999999999998754 2356999999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCcccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQ-----TVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
+.+||+|||++........ ......||+.|+|||++. ...++.++|||||||++|+|++|..||.+....
T Consensus 147 ~~~Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--- 221 (288)
T d2jfla1 147 GDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--- 221 (288)
T ss_dssp SCEEECCCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---
T ss_pred CCEEEEechhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---
Confidence 9999999999865432211 122457899999999984 445789999999999999999999999764321
Q ss_pred chHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+.+........+.... +...+..+.+||.+||++||++|||+.|+++
T Consensus 222 ----~~~~~i~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 222 ----RVLLKIAKSEPPTLAQ--------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----GHHHHHHHSCCCCCSS--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----HHHHHHHcCCCCCCCc--------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222333333222111 1223345889999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-53 Score=369.54 Aligned_cols=260 Identities=21% Similarity=0.335 Sum_probs=198.3
Q ss_pred cCcccccccccccccceEEeeeecCCC--CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSS--GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.++|++.+.||+|+||+||+|++.... ...||||.+...... .....+.+|+.++++++||||++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~ 91 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-------------KQRRDFLSEASIMGQFDHPNVIH 91 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-------------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-------------HHHHHHHHHHHHHHhCCCCCCcc
Confidence 578999999999999999999875322 235888887543321 12567899999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+++..++|||||++|+|.+++.. ..+.+++..+..++.||+.||.|||+++ ++||||||+||+++.++
T Consensus 92 l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~ 165 (299)
T d1jpaa_ 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNL 165 (299)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTC
T ss_pred EEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCC
Confidence 99999999999999999999999998843 3456999999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCccc---ccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 198 EARISEFGLAKQIPNGRTRT---TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 166 ~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------ 239 (299)
T d1jpaa_ 166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------ 239 (299)
T ss_dssp CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------
T ss_pred cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH------
Confidence 99999999998765432221 1223456899999999999999999999999999999998 8999875422
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.+....+.....+.. +...+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 240 -~~~~~~i~~~~~~~~----------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 240 -QDVINAIEQDYRLPP----------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -HHHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCC----------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222333332222211 112234488999999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=381.84 Aligned_cols=203 Identities=25% Similarity=0.397 Sum_probs=176.6
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
+.++|++++.||+|+||+||+|++. .+|+.||+|++...... ....++.+|+.++++++||||+++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~l 69 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGF 69 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEET-TTTEEEEEEEEECCCCT-------------THHHHHHHHGGGGGGCCCTTBCCE
T ss_pred CccCCEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEChhhCH-------------HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 5689999999999999999999875 48999999998543221 114678999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+....++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+.+ |++||||||+||+++.++.
T Consensus 70 ~~~~~~~~~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~ 143 (322)
T d1s9ja_ 70 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGE 143 (322)
T ss_dssp EEEEECSSEEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCC
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCC
Confidence 9999999999999999999999999954 345999999999999999999999631 4999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCc
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDF 265 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~ 265 (337)
+||+|||++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 144 vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 144 IKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp EEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred EEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999865322 112458999999999999999999999999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-53 Score=370.70 Aligned_cols=253 Identities=24% Similarity=0.287 Sum_probs=191.3
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.+.|++++.||+|+||+||+|++. .+|+.||+|++....... ....+.+|+.++++++||||++++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~-------------~~~~~~~Ei~il~~l~HpnIv~l~ 73 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALEG-------------KEGSMENEIAVLHKIKHPNIVALD 73 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC-----------------------CHHHHHHHTCCCTTBCCEE
T ss_pred ccceEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHhhh-------------HHHHHHHHHHHHHhCCCCCCCcEE
Confidence 467999999999999999999876 489999999986543321 134678899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec---CC
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID---DD 196 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~---~~ 196 (337)
+++.+++..++|||||++|+|.+++. ..+.+++..+..++.||+.||.|||+++ ++||||||+||++. ++
T Consensus 74 ~~~~~~~~~~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~ 146 (307)
T d1a06a_ 74 DIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDED 146 (307)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTT
T ss_pred EEEEECCEEEEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCC
Confidence 99999999999999999999999994 4567999999999999999999999665 99999999999995 57
Q ss_pred CcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 197 MEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
+.+||+|||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+
T Consensus 147 ~~vkl~DFG~a~~~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~ 216 (307)
T d1a06a_ 147 SKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-------AK 216 (307)
T ss_dssp CCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HH
T ss_pred ceEEEeccceeEEccCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-------HH
Confidence 88999999999866443322 235789999999999999999999999999999999999999975322 12
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............ +.. .++..+..+.+++.+||++||++|||++|+++
T Consensus 217 ~~~~i~~~~~~~---~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 217 LFEQILKAEYEF---DSP----YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHTTCCCC---CTT----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCC---CCc----cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 222333222111 111 11122345889999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=358.64 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=197.7
Q ss_pred cCcc-cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 40 EDCF-ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 40 ~~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
.++| ++.++||+|+||+||+|++. .++..||+|.+........ ..+.+.+|+.++++++||||+++
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIv~~ 73 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKS------------ERQRFKEEAEMLKGLQHPNIVRF 73 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHH------------HHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHH------------HHHHHHHHHHHHHhCCCCCeeeE
Confidence 3455 66778999999999999876 4889999999865432221 15678999999999999999999
Q ss_pred hceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 119 LARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 119 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++.+ +...++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +.+++||||||+||+++
T Consensus 74 ~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~ 148 (270)
T d1t4ha_ 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFIT 148 (270)
T ss_dssp EEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEES
T ss_pred EEEEeeccccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceee
Confidence 999865 3456899999999999999954 35689999999999999999999954 23399999999999997
Q ss_pred -CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 195 -DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
.++.+||+|||++........ ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...
T Consensus 149 ~~~~~~Kl~DFGla~~~~~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~------ 217 (270)
T d1t4ha_ 149 GPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------ 217 (270)
T ss_dssp STTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------
T ss_pred CCCCCEEEeecCcceeccCCcc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc------
Confidence 578999999999976443322 24578999999999876 699999999999999999999999964321
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............. ...++. .. ...+.+++.+||++||++|||+.|+++
T Consensus 218 ~~~~~~~i~~~~~-~~~~~~----~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 218 AAQIYRRVTSGVK-PASFDK----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHHTTTCC-CGGGGG----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCC-CcccCc----cC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1222223322221 111111 11 223889999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-53 Score=370.87 Aligned_cols=250 Identities=23% Similarity=0.310 Sum_probs=202.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.+.|+.++.||+|+||+||+|++. .+|+.||||++....... ......+.+|+.++++++||||++++
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~-----------~~~~~~~~~Ei~il~~l~HpnIv~~~ 81 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQKLRHPNTIQYR 81 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCH-----------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhhccC-----------HHHHHHHHHHHHHHHHCCCCCEeeEE
Confidence 456999999999999999999865 489999999986543322 12256789999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++|||||.+|+|..++. ..+++++..++.++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~iv~E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~ 154 (309)
T d1u5ra_ 82 GCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLV 154 (309)
T ss_dssp EEEEETTEEEEEEECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEE
T ss_pred EEEEECCEEEEEEEecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCE
Confidence 99999999999999999998876653 3456999999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT---VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~ 276 (337)
||+|||++...... ....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+... .+
T Consensus 155 Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~ 221 (309)
T d1u5ra_ 155 KLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS 221 (309)
T ss_dssp EECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HH
T ss_pred EEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HH
Confidence 99999999765432 23578999999999864 3589999999999999999999999965322 22
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+........+.. .+ ...+..+.+||.+||++||++|||+.++++
T Consensus 222 ~~~~i~~~~~~~~-~~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 222 ALYHIAQNESPAL-QS--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHSCCCCC-SC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHhCCCCCC-CC--------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2333333322211 11 111234889999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=359.06 Aligned_cols=255 Identities=20% Similarity=0.293 Sum_probs=209.3
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|+++ ++..||||++...... .+.+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~~~---------------~~~~~~Ev~~~~~l~HpnIv~~~ 65 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMNLSHEKLVQLY 65 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSSSC---------------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCcCC---------------HHHHHHHHHHHHhcCCCceeeEE
Confidence 478999999999999999999975 7889999998654321 35688999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 66 g~~~~~~~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~ 139 (258)
T d1k2pa_ 66 GVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVV 139 (258)
T ss_dssp EEECCSSSEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCE
T ss_pred EEEeeCCceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcE
Confidence 999999999999999999999999743 4456899999999999999999999655 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~ 278 (337)
||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||..... . +..
T Consensus 140 kl~DfG~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----~---~~~ 211 (258)
T d1k2pa_ 140 KVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----S---ETA 211 (258)
T ss_dssp EECCCSSCCBCSSSSCCC-CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----H---HHH
T ss_pred EECcchhheeccCCCcee-ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----H---HHH
Confidence 999999998765443322 224578999999999999999999999999999999998 7999976432 1 222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
........+. .+ ......+.+++.+||+.||++|||+++|++.|.++
T Consensus 212 ~~i~~~~~~~---~p-------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 212 EHIAQGLRLY---RP-------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHTTCCCC---CC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHhCCCCC---Cc-------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2222221111 11 11123488999999999999999999999988654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=363.88 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=203.5
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||+||+|+++ +++.||||++...... .+.+.+|+.++++++||||+++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~---------------~~~~~~E~~~l~~l~HpnIv~~ 73 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMS---------------PDAFLAEANLMKQLQHQRLVRL 73 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSSC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCcCC---------------HHHHHHHHHHHHhCCCCCEeEE
Confidence 3578999999999999999999976 6789999998533211 4578999999999999999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+ +..++||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.
T Consensus 74 ~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~ 147 (272)
T d1qpca_ 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLS 147 (272)
T ss_dssp EEEECS-SSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred Eeeecc-CCeEEEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccc
Confidence 998765 5679999999999999987432 2235899999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
+||+|||+++......... .....||+.|+|||++.+..++.++||||||+++|||++|..|+.... .. .+..
T Consensus 148 ~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~---~~---~~~~ 220 (272)
T d1qpca_ 148 CKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TN---PEVI 220 (272)
T ss_dssp EEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CH---HHHH
T ss_pred eeeccccceEEccCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC---CH---HHHH
Confidence 9999999998775443322 224577899999999998899999999999999999999765543221 11 2222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
........+.. +...+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 221 ~~i~~~~~~~~----------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 221 QNLERGYRMVR----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCC----------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 22222221111 111223488999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=370.03 Aligned_cols=263 Identities=23% Similarity=0.279 Sum_probs=206.1
Q ss_pred ccCcccccccccccccceEEeeeecCCC----CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSS----GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|++++.||+|+||+||+|++...+ +..||+|.+...... .....+.+|+.++.++ +||
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~Hp 101 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-------------SEREALMSELKMMTQLGSHE 101 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------CHHHHHHHHHHHHHCCCT
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH-------------HHHHHHHHHHHHHHHhcCCC
Confidence 4578999999999999999999875322 246899987543221 1145788999999988 899
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc-------------------CCCcCCHHHHHHHHHHHHHHHHHHh
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ-------------------GRRELDWLARHRIARGIASGLEYLH 174 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~l~~~~~~~~~~~i~~~l~~lh 174 (337)
||+++++++.+.+..++|||||++|+|.+++..... ....+++..++.++.||+.||.|||
T Consensus 102 nIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH 181 (325)
T d1rjba_ 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181 (325)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred cEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999965322 1245899999999999999999999
Q ss_pred cCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHH
Q 036970 175 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAV 254 (337)
Q Consensus 175 ~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~ 254 (337)
+++ ++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++||
T Consensus 182 ~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~e 258 (325)
T d1rjba_ 182 FKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258 (325)
T ss_dssp HTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHH
Confidence 665 99999999999999999999999999987655444333334567999999999999999999999999999999
Q ss_pred HHh-CCCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 036970 255 LMM-GKFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLS 333 (337)
Q Consensus 255 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~ 333 (337)
|++ |..||.+... ...+.+.+... ..+. .+...+..+.+||.+||+.||++|||+++|++.|.
T Consensus 259 mlt~g~~Pf~~~~~---~~~~~~~~~~~---~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 259 IFSLGVNPYPGIPV---DANFYKLIQNG---FKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HTTTSCCSSTTCCC---SHHHHHHHHTT---CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCCH---HHHHHHHHhcC---CCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 997 8999975432 12222222221 1111 01112345899999999999999999999999984
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=361.27 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=197.3
Q ss_pred ccccccccceEEeeeecC-CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeecC
Q 036970 47 EKIRSCWNGEVYKAELPG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVRP 125 (337)
Q Consensus 47 ~~lg~G~~g~vy~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 125 (337)
++||+|+||+||+|.+.. ..++.||||++....... ...+.+.+|+.++++++||||+++++++.+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~------------~~~~~~~~E~~il~~l~HpnIv~~~g~~~~- 79 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP------------ALKDELLAEANVMQQLDNPYIVRMIGICEA- 79 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C------------HHHHHHHHHHHHHHTCCCTTBCCEEEEEES-
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCH------------HHHHHHHHHHHHHHhCCCCCCceEEEEecc-
Confidence 579999999999998642 356789999985432211 125679999999999999999999999865
Q ss_pred CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEeccc
Q 036970 126 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 205 (337)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg 205 (337)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFG 152 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 152 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchh
Confidence 457899999999999999843 456999999999999999999999665 9999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHHHHHHHhh
Q 036970 206 LAKQIPNGRT-RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQWMRNVMT 283 (337)
Q Consensus 206 ~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 283 (337)
+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |..||.+... ..... ....
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~---~i~~ 225 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTA---MLEK 225 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHH---HHHT
T ss_pred hhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----HHHHH---HHHc
Confidence 9987654332 223334578999999999999999999999999999999998 8999975422 12222 2222
Q ss_pred cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 284 SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
...+.. +...+..+.+|+.+||+.||++|||+++|++.|+..
T Consensus 226 ~~~~~~----------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 226 GERMGC----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCCCC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCC----------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 222111 111224488999999999999999999999888753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=359.03 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=199.5
Q ss_pred cCcccccccccccccceEEeeeecCCCC---cEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSG---RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
.++|++.+.||+|+||+||+|.++..++ ..||||++....... ....+.+|+.++.+++||||+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-------------~~~~~~~E~~il~~l~H~nIv 72 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-------------QRVDFLGEAGIMGQFSHHNII 72 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-------------HHHHHHHHHHHHHTCCCTTBC
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-------------HHHHHHHHHHHHHhcCCCCEe
Confidence 4679999999999999999998764322 479999985433211 145788999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.+....+++|||+.++++.+++.. ....+++..+..++.||+.||.|||+++ ++||||||+|||++.+
T Consensus 73 ~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~ 146 (283)
T d1mqba_ 73 RLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSN 146 (283)
T ss_dssp CEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred eeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCC
Confidence 999999999999999999999999988754 4456999999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCc-ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 197 MEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
+.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||+++..|+.... .. .
T Consensus 147 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~~---~ 220 (283)
T d1mqba_ 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SN---H 220 (283)
T ss_dssp CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CH---H
T ss_pred CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC---CH---H
Confidence 9999999999987654322 122224567999999999999999999999999999999999766653221 11 2
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
+..........+.. +...+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 221 ~~~~~i~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 221 EVMKAINDGFRLPT----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHHHHHHTTCCCCC----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCC----------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 22222222222111 111224488999999999999999999999999876
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.6e-52 Score=369.92 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=206.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
-++|++++.||+|+||.||+|++. .+|+.||||++....... .+.+.+|+.++++++||||++++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~~~~--------------~~~~~~E~~il~~l~HpnIv~~~ 89 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESD--------------KETVRKEIQTMSVLRHPTLVNLH 89 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCSHHH--------------HHHHHHHHHHHHHTCCTTBCCEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccchhh--------------HHHHHHHHHHHHhCCCCCCCcEE
Confidence 468999999999999999999865 489999999986543221 45688999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec--CCC
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID--DDM 197 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~--~~~ 197 (337)
+++.+++..++|||||++|+|.+++.. ....+++..+..++.||+.||.|||+++ ++||||||+||+++ .++
T Consensus 90 ~~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~ 163 (350)
T d1koaa2 90 DAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSN 163 (350)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSC
T ss_pred EEEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCC
Confidence 999999999999999999999999832 3456999999999999999999999665 99999999999996 457
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.+||+|||++.......... ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.
T Consensus 164 ~vkL~DFG~a~~~~~~~~~~---~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~ 233 (350)
T d1koaa2 164 ELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DET 233 (350)
T ss_dssp CEEECCCTTCEECCTTSCEE---EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred eEEEeecchheecccccccc---eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHH
Confidence 89999999998775443332 35789999999999999999999999999999999999999965321 223
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+..+........ . ......+..+.+||.+||++||++|||+.|+++
T Consensus 234 ~~~i~~~~~~~~---~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 234 LRNVKSCDWNMD---D----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHHTCCCSC---C----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCC---c----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 333332222111 0 111222345889999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6e-52 Score=369.42 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=206.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
-++|++++.||+|+||.||+|++. .+|+.||+|++....... ...+.+|+.++++++||||++++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~--------------~~~~~~Ei~il~~l~HpnIv~~~ 92 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLD--------------KYTVKNEISIMNQLHHPKLINLH 92 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHH--------------HHHHHHHHHHHTTCCSTTBCCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECCcchhH--------------HHHHHHHHHHHHhCCCCCCCcEE
Confidence 367999999999999999999865 489999999986543321 34678999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec--CCC
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID--DDM 197 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~--~~~ 197 (337)
+++.+++..++|||||++|+|.+++. .....+++..++.++.||+.||.|||+++ ++||||||+|||++ .++
T Consensus 93 ~~~~~~~~~~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~ 166 (352)
T d1koba_ 93 DAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKAS 166 (352)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCC
T ss_pred EEEEECCEEEEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCC
Confidence 99999999999999999999988772 33456999999999999999999999665 99999999999998 578
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.+||+|||++.......... ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.
T Consensus 167 ~vkL~DFGla~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~ 236 (352)
T d1koba_ 167 SVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LET 236 (352)
T ss_dssp CEEECCCTTCEECCTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHH
T ss_pred eEEEeecccceecCCCCcee---eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHH
Confidence 99999999998876543332 34789999999999999999999999999999999999999975322 222
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+..+....... +. ..+...+..+.+||.+||++||.+|||+.|+++
T Consensus 237 ~~~i~~~~~~~---~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 237 LQNVKRCDWEF---DE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHCCCCC---CS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCCC---Cc----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23333222111 01 111222344889999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=360.24 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=205.3
Q ss_pred ccCcccccc-cccccccceEEeeeecC-CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChh
Q 036970 39 KEDCFASLE-KIRSCWNGEVYKAELPG-SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIV 116 (337)
Q Consensus 39 ~~~~~~~~~-~lg~G~~g~vy~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~ 116 (337)
..++|.+.. +||+|+||+||+|.+.. .++..||||++...... ...+.+.+|+.++++++||||+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-------------~~~~~~~~E~~il~~l~HpnIv 72 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------------ADTEEMMREAQIMHQLDNPYIV 72 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-------------HHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-------------HHHHHHHHHHHHHHhCCCCCEe
Confidence 346777777 49999999999997643 24567999998543221 1256789999999999999999
Q ss_pred hhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCC
Q 036970 117 PLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD 196 (337)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~ 196 (337)
++++++.+ +..++||||+++|+|.+++. .....+++..+..++.||+.||.|||+++ ++||||||+||+++.+
T Consensus 73 ~l~g~~~~-~~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~ 145 (285)
T d1u59a_ 73 RLIGVCQA-EALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNR 145 (285)
T ss_dssp CEEEEEES-SSEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEET
T ss_pred eEeeeecc-CeEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccC
Confidence 99999875 46799999999999999873 34467999999999999999999999665 9999999999999999
Q ss_pred CcEEEecccccccCCCCCcc-cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchH
Q 036970 197 MEARISEFGLAKQIPNGRTR-TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~ 274 (337)
+.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |..||.+... ...
T Consensus 146 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----~~~ 221 (285)
T d1u59a_ 146 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEV 221 (285)
T ss_dssp TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHH
T ss_pred CceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH----HHH
Confidence 99999999999877644332 22234567899999999999899999999999999999998 8999975432 222
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
. ..+.....+.. ++..+..+.+|+.+||+.||++|||+.+|.+.|+.+
T Consensus 222 ~---~~i~~~~~~~~----------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 222 M---AFIEQGKRMEC----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp H---HHHHTTCCCCC----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHHcCCCCCC----------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2 22222222211 111224488999999999999999999999988754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=365.05 Aligned_cols=252 Identities=21% Similarity=0.246 Sum_probs=206.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
-++|++++.||+|+||.||+|++. .+|+.||+|++.+...... .....+.+|+.+|++++||||++++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~~~~-----------~~~~~~~~E~~il~~l~hp~Iv~l~ 71 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAK-----------DEVAHTVTESRVLQNTRHPFLTALK 71 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEchhhccCH-----------HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 368999999999999999999865 4899999999965432211 1156788999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++.+|.+
T Consensus 72 ~~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~v 144 (337)
T d1o6la_ 72 YAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred eeeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCE
Confidence 999999999999999999999999854 456899999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++......... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+...
T Consensus 145 kl~DFG~a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~ 215 (337)
T d1o6la_ 145 KITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFE 215 (337)
T ss_dssp EECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred EEeecccccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-------HHHHH
Confidence 99999999876543222 2246889999999999999999999999999999999999999976432 22223
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il~ 330 (337)
......... + ...+..+.+||.+||++||++||+ ++++++
T Consensus 216 ~i~~~~~~~---p--------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 216 LILMEEIRF---P--------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHCCCCC---C--------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHhcCCCCC---C--------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 333222111 1 112234889999999999999995 777764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-52 Score=361.94 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=207.4
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|++. .+|+.||||++.+...... ......+.+.+|+.++++++||||++++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSS--------RRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTC--------SSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcchh--------hhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 478999999999999999999875 4899999999865443211 1111256799999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC--
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-- 197 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~-- 197 (337)
+++.+++..++|||||++|+|.+++.. .+.+++..++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~ 152 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVP 152 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSS
T ss_pred EEEEECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCc
Confidence 999999999999999999999999954 346999999999999999999999665 99999999999998766
Q ss_pred --cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 198 --EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 198 --~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
.+|++|||++.......... ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .
T Consensus 153 ~~~vkl~DfG~a~~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~ 222 (293)
T d1jksa_ 153 KPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------Q 222 (293)
T ss_dssp SCCEEECCCTTCEECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------H
T ss_pred ccceEecchhhhhhcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------H
Confidence 59999999998765443322 35789999999999999999999999999999999999999975322 2
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+............ .... ++..+..+.++|.+||++||++|||++++++
T Consensus 223 ~~~~~i~~~~~~~---~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 223 ETLANVSAVNYEF---EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHTTCCCC---CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCC---Cchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222332222111 0000 1122345889999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-51 Score=361.42 Aligned_cols=268 Identities=21% Similarity=0.328 Sum_probs=213.1
Q ss_pred hh-ccCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC
Q 036970 37 LK-KEDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR 111 (337)
Q Consensus 37 l~-~~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 111 (337)
++ +.++|++++.||+|+||+||+|++++ .+++.||||++...... .....+.+|+.++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-------------~~~~~~~~E~~il~~l~ 74 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------------DMQADFQREAALMAEFD 74 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-------------HHHHHHHHHHHHHHTCC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-------------HHHHHHHHHHHHHHhcC
Confidence 55 56899999999999999999998653 35688999998543321 12567899999999999
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc--------------------CCCcCCHHHHHHHHHHHHHHHH
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ--------------------GRRELDWLARHRIARGIASGLE 171 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~~i~~~l~ 171 (337)
||||+++++++.+....++++||+++|+|.+++..... ....+++..+..++.|++.||.
T Consensus 75 h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ 154 (301)
T d1lufa_ 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 154 (301)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred CCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999999999965321 1345889999999999999999
Q ss_pred HHhcCCCCCceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHH
Q 036970 172 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVL 251 (337)
Q Consensus 172 ~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~v 251 (337)
|||+.+ ++||||||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||++
T Consensus 155 ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvv 231 (301)
T d1lufa_ 155 YLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 231 (301)
T ss_dssp HHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred hcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhh
Confidence 999665 99999999999999999999999999976644433333334567899999999999999999999999999
Q ss_pred HHHHHhCC-CCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 252 LAVLMMGK-FPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 252 l~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
+|||++|. +||..... .+....+.....+.. + ...+..+.+|+.+||+.||++|||+.+|++
T Consensus 232 l~ell~~~~~p~~~~~~-------~e~~~~v~~~~~~~~--p--------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 232 LWEIFSYGLQPYYGMAH-------EEVIYYVRDGNILAC--P--------ENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHTTTCCTTTTSCH-------HHHHHHHHTTCCCCC--C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCCCCCCH-------HHHHHHHHcCCCCCC--C--------ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999996 56654322 222333332222211 1 112234889999999999999999999999
Q ss_pred HHhhhhC
Q 036970 331 MLSQIQH 337 (337)
Q Consensus 331 ~L~~~~~ 337 (337)
.|++|..
T Consensus 295 ~L~~i~~ 301 (301)
T d1lufa_ 295 ILQRMCE 301 (301)
T ss_dssp HHHHTTC
T ss_pred HHHHhcC
Confidence 9999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-51 Score=357.36 Aligned_cols=265 Identities=20% Similarity=0.262 Sum_probs=205.0
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++.+.||+|+||+||+|++. .+|+.||||++....... ......+.+|+.+++.++||||++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~-----------~~~~~~~~~E~~~l~~~~hpniv~~~ 73 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARD-----------PSFYLRFRREAQNAAALNHPAIVAVY 73 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTTTC-----------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEchhhccC-----------HHHHHHHHHHHHHHHhcCCCCCCccc
Confidence 578999999999999999999865 489999999985543221 22356789999999999999999999
Q ss_pred ceeecCCC----ceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 120 ARVVRPDC----DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 120 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++...+. .|+||||+++++|.+++.. .+.+++..+..++.||+.||.|||+++ ++||||||+||+++.
T Consensus 74 ~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISA 146 (277)
T ss_dssp EEEEEECSSSEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred ceeeeccCCCceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCc
Confidence 99987543 6899999999999998843 356999999999999999999999665 999999999999999
Q ss_pred CCcEEEecccccccCCCCCc-ccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 196 DMEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
++..+++|||.+........ ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 147 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------- 219 (277)
T d1o6ya_ 147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------- 219 (277)
T ss_dssp TSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------
T ss_pred cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------
Confidence 99999999998876543322 2223345789999999999999999999999999999999999999975322
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhhhhC
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-NSKDVRCMLSQIQH 337 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~il~~L~~~~~ 337 (337)
.+............... ..+..+..+.++|.+||++||++|| |++++++.|.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~-------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 220 VSVAYQHVREDPIPPSA-------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHHHHHHCCCCCGGG-------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcCCCCCch-------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 22333333333221110 0111224488999999999999999 89999999988753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-51 Score=360.71 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=205.0
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||+||+|+++ .+|+.||||++........ ...+.+.+|+.++++++||||+++++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~HpnIv~~~~ 71 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRL-----------KQVEHTNDERLMLSIVTHPFIIRMWG 71 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCH-----------HHHHHHHHHHHHHHhccCcChhheee
Confidence 67999999999999999999875 4899999999865432211 11567889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+++..++||||+++|+|..++. ....+++..+..++.||+.||.|||++ |++||||||+||+++.++.+|
T Consensus 72 ~~~~~~~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vk 144 (316)
T d1fota_ 72 TFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK 144 (316)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred eEeeCCeeeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEE
Confidence 9999999999999999999999884 445688999999999999999999955 499999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++........ ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+....
T Consensus 145 L~DFG~a~~~~~~~~-----~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~ 212 (316)
T d1fota_ 145 ITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEK 212 (316)
T ss_dssp ECCCSSCEECSSCBC-----CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHH
T ss_pred EecCccceEeccccc-----cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHHHHH
Confidence 999999987654322 45789999999999999999999999999999999999999975322 233333
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
+....... + +..+..+.+++.+||++||.+|+ |++++++
T Consensus 213 i~~~~~~~---p--------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 213 ILNAELRF---P--------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHCCCCC---C--------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHcCCCCC---C--------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 33332211 1 11123488999999999999996 8998875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=353.90 Aligned_cols=263 Identities=24% Similarity=0.303 Sum_probs=199.6
Q ss_pred cCcccccccccccccceEEeeeecCCCC--cEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSG--RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.++|++++.||+|+||+||+|++...++ ..||||++....... .+..+.+.+|+.++++++||||++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-----------~~~~~~~~~Ei~~l~~l~H~nIv~ 75 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----------PEAMDDFIREVNAMHSLDHRNLIR 75 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------------CHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-----------HHHHHHHHHHHHHHHhCCCCCEEE
Confidence 5779999999999999999998754444 468999885433221 122567999999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+ ...++||||++++++.+++.. ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++
T Consensus 76 ~~g~~~~-~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~ 148 (273)
T d1u46a_ 76 LYGVVLT-PPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD 148 (273)
T ss_dssp EEEEECS-SSCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred EEEEEee-cchheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhcccccc
Confidence 9999976 467899999999999998754 2346999999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCccc-ccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHH
Q 036970 198 EARISEFGLAKQIPNGRTRT-TTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~ 275 (337)
.+||+|||++.......... ......||..|+|||.+.+..++.++||||||+++|||++ |..||.+... .
T Consensus 149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~ 221 (273)
T d1u46a_ 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------S 221 (273)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------H
T ss_pred ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------H
Confidence 99999999998875543322 2223456889999999999999999999999999999998 8999875422 2
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
+....+...+.... . +...+..+.+|+.+||++||++|||+.+|.+.|.+.|
T Consensus 222 ~~~~~i~~~~~~~~-~--------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 222 QILHKIDKEGERLP-R--------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp HHHHHHHTSCCCCC-C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHhCCCCCC-C--------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 23333333221111 0 1112234889999999999999999999999998865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=350.54 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=197.0
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||.||+|++ .|+.||||++..+.. .+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~~~~----------------~~~~~~E~~~l~~l~HpnIv~~ 65 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT----------------AQAFLAEASVMTQLRHSNLVQL 65 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC------------------HHHHHTHHHHTTCCCTTBCCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE---CCeEEEEEEECcHHH----------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 346799999999999999999987 578999999854321 4578899999999999999999
Q ss_pred hceeec-CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 119 LARVVR-PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 119 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
++++.+ .+..++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++
T Consensus 66 ~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~ 140 (262)
T d1byga_ 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDN 140 (262)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred EEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCC
Confidence 999865 45689999999999999999652 2345899999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
.++++|||++........ ...+|..|+|||++.+..++.++||||||+++|||++ |.+||..... .....
T Consensus 141 ~~kl~dfg~s~~~~~~~~-----~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~~~~ 211 (262)
T d1byga_ 141 VAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVP 211 (262)
T ss_dssp CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHH
T ss_pred CEeecccccceecCCCCc-----cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----HHHHH
Confidence 999999999976543322 2356889999999999899999999999999999998 6788764322 22222
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.+ .....+. . +......+.+++.+||+.||++|||+.++++.|++|+
T Consensus 212 ~i---~~~~~~~------~----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 212 RV---EKGYKMD------A----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HH---TTTCCCC------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HcCCCCC------C----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 22 2222111 1 1111234889999999999999999999999999886
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-50 Score=360.85 Aligned_cols=248 Identities=19% Similarity=0.192 Sum_probs=205.2
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||.||+|+++ .+|+.||||++........ ...+.+.+|+.+++.++||||+++++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~hpnIv~~~~ 108 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKL-----------KQIEHTLNEKRILQAVNFPFLVKLEF 108 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCH-----------HHHHHHHHHHHHHHHcCCCcEeeccc
Confidence 68999999999999999999875 4899999999864332111 11567899999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+....++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+|
T Consensus 109 ~~~~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ik 181 (350)
T d1rdqe_ 109 SFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ccccccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEE
Confidence 99999999999999999999999854 346999999999999999999999665 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|+|||++........ ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......
T Consensus 182 L~DFG~a~~~~~~~~-----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~ 249 (350)
T d1rdqe_ 182 VTDFGFAKRVKGRTW-----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEK 249 (350)
T ss_dssp ECCCTTCEECSSCBC-----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH
T ss_pred eeeceeeeecccccc-----cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHH
Confidence 999999987653322 35789999999999999999999999999999999999999975321 223333
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERP-----NSKDVRC 330 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~ 330 (337)
+....... +...+..+.++|.+||++||.+|+ |++++++
T Consensus 250 i~~~~~~~-----------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 250 IVSGKVRF-----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHCCCCC-----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HhcCCCCC-----------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 33322211 111223488999999999999994 8999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=352.85 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=197.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|++++.||+|+||+||+|+++ ++..||||++...... .+.+.+|+.++++++||||++++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~~~~---------------~~~~~~E~~~l~~l~h~nIv~~~ 78 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLVQLY 78 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC---------------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECcccCC---------------HHHHHHHHHHHHhcccCCEeEEE
Confidence 468999999999999999999876 6678999998533221 35789999999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+ +..++||||+++|+|..++... ..+.+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 79 g~~~~-~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~ 152 (285)
T d1fmka3 79 AVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVC 152 (285)
T ss_dssp EEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEec-CCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcE
Confidence 99854 5689999999999999988542 2345899999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||+++......... .....||+.|+|||++....++.++||||||+++|||++|..|+.... .. .+.+.
T Consensus 153 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~---~~---~~~~~ 225 (285)
T d1fmka3 153 KVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VN---REVLD 225 (285)
T ss_dssp EECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CH---HHHHH
T ss_pred EEcccchhhhccCCCcee-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC---CH---HHHHH
Confidence 999999998764333222 223568999999999999999999999999999999999766654321 11 22222
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.......+. .+ ......+.+++.+||+.||++|||+++|+++|.++
T Consensus 226 ~i~~~~~~~--~~--------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 226 QVERGYRMP--CP--------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp HHHTTCCCC--CC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred HHHhcCCCC--CC--------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 222221111 11 11223488999999999999999999999998764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=349.64 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=195.5
Q ss_pred cCcccccccccccccceEEeeeecCCC--CcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSS--GRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
.++|++++.||+|+||.||+|++.... +..||||.+..... ......+.+|+.++++++||||++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-------------~~~~~~~~~E~~~l~~l~HpnIv~ 72 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-------------DSVREKFLQEALTMRQFDHPHIVK 72 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-------------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-------------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 468999999999999999999875322 45688888743221 122567899999999999999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++. ++..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++
T Consensus 73 l~~~~~-~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~ 145 (273)
T d1mp8a_ 73 LIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSND 145 (273)
T ss_dssp EEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETT
T ss_pred EEEEEe-cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCC
Confidence 999986 4678999999999999998753 4456899999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccchHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMSFVQ 276 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~ 276 (337)
.+||+|||++........... ....||+.|+|||++.+..++.++||||||+++|||++ |.+||.+... .....
T Consensus 146 ~~Kl~DfG~a~~~~~~~~~~~-~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~----~~~~~ 220 (273)
T d1mp8a_ 146 CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIG 220 (273)
T ss_dssp EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHH
T ss_pred cEEEccchhheeccCCcceec-cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH----HHHHH
Confidence 999999999987654332222 23567899999999999999999999999999999998 8899876432 22222
Q ss_pred HHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 277 WMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
. ......+. + ++..+..+.+||.+||+.||++|||+.+|++.|++|.
T Consensus 221 ~---i~~~~~~~--~--------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 221 R---IENGERLP--M--------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp H---HHTTCCCC--C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HHcCCCCC--C--------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2 22222211 1 1122345899999999999999999999999998763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=355.40 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=200.9
Q ss_pred ccCcccccccccccccceEEeeeecCCCCc----EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRN 114 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 114 (337)
..++|++++.||+|+||+||+|++.. +|+ .||+|.+..... ....+.+.+|+.++++++|||
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~Hpn 72 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATS-------------PKANKEILDEAYVMASVDNPH 72 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC-----------------CTHHHHHHHHHHHHHCCCTT
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEeccccC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 34689999999999999999998753 454 578887743211 112567899999999999999
Q ss_pred hhhhhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 115 IVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 115 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
|+++++++.++ ..++++|++.+++|.+++.. ....+++..+..++.||+.||.|||+++ ++||||||+||+++
T Consensus 73 Iv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~ 145 (317)
T d1xkka_ 73 VCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVK 145 (317)
T ss_dssp BCCEEEEEESS-SEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred EeeEEEEEecC-CeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeC
Confidence 99999999875 56788999999999998754 4567999999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCcccccccch
Q 036970 195 DDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-GKFPSDDFFQHTKEMS 273 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g~~pf~~~~~~~~~~~ 273 (337)
.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||+| |.+||.+... ..
T Consensus 146 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~----~~ 221 (317)
T d1xkka_ 146 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE 221 (317)
T ss_dssp ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG----GG
T ss_pred CCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH----HH
Confidence 999999999999987765444333334568999999999999999999999999999999998 7888875432 22
Q ss_pred HHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 274 FVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
....+... ..+.. ++.....+.+++.+||+.||++|||+.+|++.|.++
T Consensus 222 ~~~~i~~~---~~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 222 ISSILEKG---ERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHHHHHHT---CCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcC---CCCCC----------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 23333222 21111 111223488999999999999999999999998776
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.1e-50 Score=359.37 Aligned_cols=256 Identities=21% Similarity=0.236 Sum_probs=200.3
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
-++|++++.||+|+||.||+|++. .+|+.||||++.......... ........+++.+++.++||||++++
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~~~~--------~~~~~~e~~~~~~l~~~~hpnIv~l~ 73 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQG--------ETLALNERIMLSLVSTGDCPFIVCMS 73 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHTC--------HHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEEC-CCCCEEEEEEEchHHcchhhH--------HHHHHHHHHHHHHHhcCCCCcEEEEE
Confidence 368999999999999999999865 489999999986543321110 00122234457888889999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+.+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~i 146 (364)
T d1omwa3 74 YAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHV 146 (364)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCE
T ss_pred EEEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcE
Confidence 999999999999999999999999954 356899999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWM 278 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~ 278 (337)
||+|||++......... ...||+.|+|||++.. ..++.++|||||||++|+|++|..||..... .......
T Consensus 147 Kl~DFGla~~~~~~~~~----~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~ 218 (364)
T d1omwa3 147 RISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEID 218 (364)
T ss_dssp EECCCTTCEECSSSCCC----SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS----SCHHHHH
T ss_pred EEeeeceeeecCCCccc----ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 99999999876544332 3578999999999864 5689999999999999999999999976432 1122222
Q ss_pred HHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 036970 279 RNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVRC 330 (337)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il~ 330 (337)
......... ++ ...+..+.+||.+||++||++||| ++++++
T Consensus 219 ~~~~~~~~~---~~--------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 219 RMTLTMAVE---LP--------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHSSSCCCC---CC--------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HhcccCCCC---CC--------CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 222211111 11 112234889999999999999999 687764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-50 Score=348.09 Aligned_cols=261 Identities=21% Similarity=0.302 Sum_probs=206.6
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPL 118 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~ 118 (337)
.++|++.+.||+|+||+||+|++. .+|+.||||++......... ........+.+.+|+.++++++ ||||+++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 75 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFS-----AEEVQELREATLKEVDILRKVSGHPNIIQL 75 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCC-----HHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred cccCEEceEEecCcCeEEEEEEEC-CCCCEEEEEEEecccccchh-----HHHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 378999999999999999999865 48999999998664332100 0111222567889999999996 9999999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCc
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 198 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~ 198 (337)
++++.+++..|+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ ++||||||+||+++.++.
T Consensus 76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 76 KDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 148 (277)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EeecccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCC
Confidence 9999999999999999999999999954 346999999999999999999999665 999999999999999999
Q ss_pred EEEecccccccCCCCCcccccccccCcccccCCccccC------CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 199 ARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT------VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
+||+|||++.......... ...||+.|+|||.+.+ ..++.++||||+||++|+|++|..||.+...
T Consensus 149 ~kl~DFG~a~~~~~~~~~~---~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----- 220 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----- 220 (277)
T ss_dssp EEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred eEEccchheeEccCCCcee---eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-----
Confidence 9999999998775433322 3578999999998753 3468899999999999999999999975432
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............... ....+..+..+.+++.+||++||++|||++++++
T Consensus 221 --~~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 221 --MLMLRMIMSGNYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --HHHHHHHHHTCCCCC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHHHHHHHhCCCCCC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 122222332221110 0112223345899999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=356.67 Aligned_cols=250 Identities=21% Similarity=0.281 Sum_probs=201.0
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhc-CCCCCChhhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAG-QVRHRNIVPLL 119 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~ni~~~~ 119 (337)
++|++++.||+|+||+||+|++. .+|+.||||++.+...... ...+.+..|..++. .++||||++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~~~~-----------~~~~~~~~e~~~l~~~~~hp~Iv~~~ 69 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMD-----------DDVECTMVEKRVLSLAWEHPFLTHMF 69 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CCeEEeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhccCh-----------HHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence 68999999999999999999876 4899999999965332111 11445666666654 68999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
+++.+++..|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++++
T Consensus 70 ~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~ 142 (320)
T d1xjda_ 70 CTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHI 142 (320)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred EEEccCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCce
Confidence 999999999999999999999999954 345899999999999999999999665 9999999999999999999
Q ss_pred EEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
||+|||++.......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+...
T Consensus 143 kl~DFG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~ 213 (320)
T d1xjda_ 143 KIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFH 213 (320)
T ss_dssp EECCCTTCBCCCCTTCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred eccccchhhhcccccccc--cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence 999999998665433222 235789999999999999999999999999999999999999975322 22222
Q ss_pred HHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 036970 280 NVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSK-DVR 329 (337)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~il 329 (337)
......... + ...+..+.+||.+||++||++|||+. +++
T Consensus 214 ~i~~~~~~~---p--------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 214 SIRMDNPFY---P--------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp HHHHCCCCC---C--------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHcCCCCC---C--------ccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 333222211 1 11123488999999999999999985 665
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=352.29 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=204.5
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
-++|.+++.||+|+||+||+|++. .+|+.||+|++...... ...+.+|+.+|+.++||||++++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~~~---------------~~~~~~Ei~il~~l~HpnIv~~~ 67 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKGTD---------------QVLVKKEISILNIARHRNILHLH 67 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCTHH---------------HHHHHHHHHHHHHSCCTTBCCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEcCCccc---------------HHHHHHHHHHHHhCCCCCCCeEE
Confidence 478999999999999999999865 48999999998554321 34578899999999999999999
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC--CC
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--DM 197 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~--~~ 197 (337)
+++.+++..|+|||||++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++. ..
T Consensus 68 ~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~ 141 (321)
T d1tkia_ 68 ESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSS 141 (321)
T ss_dssp EEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCce
Confidence 999999999999999999999999832 3346999999999999999999999665 999999999999984 45
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQW 277 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~ 277 (337)
.++|+|||++.......... ...+|+.|+|||...+..++.++|||||||++|+|++|..||..... .+.
T Consensus 142 ~ikl~DFG~~~~~~~~~~~~---~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~ 211 (321)
T d1tkia_ 142 TIKIIEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQI 211 (321)
T ss_dssp CEEECCCTTCEECCTTCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHH
T ss_pred EEEEcccchhhccccCCccc---ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-------HHH
Confidence 79999999998765443322 34679999999999999999999999999999999999999975432 223
Q ss_pred HHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 278 MRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...+....... +... +...+..+.+||.+||.+||++|||+.|+++
T Consensus 212 ~~~i~~~~~~~---~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 212 IENIMNAEYTF---DEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHTCCCC---CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCC---Chhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33333322111 1100 1112344889999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=350.13 Aligned_cols=264 Identities=20% Similarity=0.278 Sum_probs=197.4
Q ss_pred cCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCC
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRN 114 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 114 (337)
.++|++++.||+|+||.||+|++.. .+++.||||++....... ....+.+|...+.++ +|+|
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-------------~~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------------EHRALMSELKILIHIGHHLN 78 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-------------HHHHHHHHHHHHHHHCCCTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-------------HHHHHHHHHHHHHhhcCCCe
Confidence 4789999999999999999998642 246789999985432211 144667777777776 6899
Q ss_pred hhhhhceeecC-CCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 036970 115 IVPLLARVVRP-DCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRPRI 181 (337)
Q Consensus 115 i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~ 181 (337)
|+.+++++.+. ...++|||||++|+|.+++..... ....+++..+..++.||+.||.|||+++ +
T Consensus 79 iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---i 155 (299)
T d1ywna1 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 155 (299)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 99999987664 467999999999999999965432 1345899999999999999999999665 9
Q ss_pred eeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCC-C
Q 036970 182 IHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK-F 260 (337)
Q Consensus 182 ~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~-~ 260 (337)
+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+++. +
T Consensus 156 vHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~ 235 (299)
T d1ywna1 156 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235 (299)
T ss_dssp CCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCC
Confidence 999999999999999999999999998765544443334567899999999999999999999999999999999875 5
Q ss_pred CCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 261 PSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 261 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
||..... ...+...+... ..+.. +...+..+.+++.+||+.||++|||+.++++.|++|
T Consensus 236 p~~~~~~---~~~~~~~~~~~---~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 236 PYPGVKI---DEEFCRRLKEG---TRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp SSTTCCC---SHHHHHHHHHT---CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCH---HHHHHHHHhcC---CCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 7754322 12222222221 11110 111223488999999999999999999999999876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=349.81 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=206.9
Q ss_pred ccCcccccccccccccceEEeeeecC------CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-C
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPG------SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-R 111 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 111 (337)
..++|++++.||+|+||.||+|++.. .++..||||++....... ....+.+|...+.++ +
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-------------~~~~~~~e~~~l~~~~~ 77 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-------------DLSDLISEMEMMKMIGK 77 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-------------HHHHHHHHHHHHHHHCC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-------------HHHHHHHHHHHHHHhcC
Confidence 45799999999999999999998642 134579999986543321 145678888888887 8
Q ss_pred CCChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 036970 112 HRNIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIARGIASGLEYLHMSHRP 179 (337)
Q Consensus 112 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 179 (337)
||||+++++++.+++..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+
T Consensus 78 HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-- 155 (299)
T d1fgka_ 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-- 155 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--
Confidence 99999999999999999999999999999999965321 2356899999999999999999999666
Q ss_pred CceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHh-C
Q 036970 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMM-G 258 (337)
Q Consensus 180 ~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~-g 258 (337)
++||||||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |
T Consensus 156 -ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g 234 (299)
T d1fgka_ 156 -CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234 (299)
T ss_dssp -CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCC
Confidence 99999999999999999999999999987765544444445678999999999999999999999999999999998 6
Q ss_pred CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.+||.+... .+..........+.. + ...+..+.+||.+||+.||++|||+.+|++.|++|
T Consensus 235 ~~p~~~~~~-------~~~~~~i~~~~~~~~--p--------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 235 GSPYPGVPV-------EELFKLLKEGHRMDK--P--------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp CCSSTTCCH-------HHHHHHHHTTCCCCC--C--------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCH-------HHHHHHHHcCCCCCC--C--------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 888864322 122222222222111 1 11223489999999999999999999999999886
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=354.72 Aligned_cols=253 Identities=20% Similarity=0.280 Sum_probs=196.6
Q ss_pred cCcccccc-cccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcC-CCCCChhh
Q 036970 40 EDCFASLE-KIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQ-VRHRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~-~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~ni~~ 117 (337)
.++|.++. .||+|+||+||+|++. .+|+.||||++.. ...+.+|+.++.+ .+||||++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~-------------------~~~~~~E~~~~~~~~~hpnIv~ 69 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQD-------------------CPKARREVELHWRASQCPHIVR 69 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEC-------------------SHHHHHHHHHHHHHTTSTTBCC
T ss_pred ccCEEEeeEEeeeccCeEEEEEEEC-CCCCEEEEEEECC-------------------cHHHHHHHHHHHHhcCCCCCCe
Confidence 46899875 5999999999999865 4899999999843 2346678887654 48999999
Q ss_pred hhceeec----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 118 LLARVVR----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 118 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++++.+ +...|+|||||++|+|.+++.. .+...+++..++.++.||+.||.|||+.+ ++||||||+||++
T Consensus 70 l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll 144 (335)
T d2ozaa1 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLY 144 (335)
T ss_dssp EEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred EEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccc
Confidence 9999875 4567999999999999999954 23457999999999999999999999665 9999999999999
Q ss_pred cC---CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 194 DD---DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 194 ~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
+. .+.+||+|||++.......... ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 145 ~~~~~~~~~Kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~ 221 (335)
T d2ozaa1 145 TSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221 (335)
T ss_dssp SCSSTTCCEEECCCTTCEECCCCCCCC---CCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred ccccccccccccccceeeeccCCCccc---cccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence 85 4579999999998765443322 35789999999999999999999999999999999999999965322111
Q ss_pred cchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...+........ . ..........+..+.+||.+||++||++|||+.++++
T Consensus 222 ----~~~~~~~i~~~~--~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 222 ----SPGMKTRIRMGQ--Y----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----------CCCSCS--S----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHHHHHHhcCC--C----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 010100000000 0 0111122344566999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=345.75 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=199.0
Q ss_pred cccccccccceEEeeeecCCCC--cEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceee
Q 036970 46 LEKIRSCWNGEVYKAELPGSSG--RVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVV 123 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 123 (337)
.++||+|+||+||+|++...++ ..||||++..... ....+.+.+|+.++++++||||+++++++.
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 98 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-------------IGEVSQFLTEGIIMKDFSHPNVLSLLGICL 98 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-------------HHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-------------HHHHHHHHHHHHHHHhCCCCCEeEEeEEEE
Confidence 5789999999999999764333 3589998853221 122568999999999999999999999987
Q ss_pred c-CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEe
Q 036970 124 R-PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 202 (337)
Q Consensus 124 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~ 202 (337)
+ +...++|||||++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 99 ~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~ 172 (311)
T d1r0pa_ 99 RSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVA 172 (311)
T ss_dssp ETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEe
Confidence 5 4578999999999999999843 4456788889999999999999999665 9999999999999999999999
Q ss_pred cccccccCCCCCcc--cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHH
Q 036970 203 EFGLAKQIPNGRTR--TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRN 280 (337)
Q Consensus 203 Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 280 (337)
|||+++........ .......||+.|+|||.+....++.++||||||+++|||++|..||..... .......
T Consensus 173 DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~---~~~~~~~--- 246 (311)
T d1r0pa_ 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVY--- 246 (311)
T ss_dssp SSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHH---
T ss_pred cccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC---HHHHHHH---
Confidence 99999876543222 222245678999999999999999999999999999999998888754321 1122222
Q ss_pred HhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 281 VMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
......+.. + ......+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 247 i~~g~~~~~---p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 247 LLQGRRLLQ---P-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp HHTTCCCCC---C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCC---c-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 222222211 0 111234889999999999999999999999998874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=348.15 Aligned_cols=263 Identities=22% Similarity=0.208 Sum_probs=195.4
Q ss_pred ccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhceeec
Q 036970 45 SLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLARVVR 124 (337)
Q Consensus 45 ~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 124 (337)
.+++||+|+||+||+|++. .+|+.||||++......... ......+.+|+.++++++||||+++++++.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~---------~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~ 71 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAK---------DGINRTALREIKLLQELSHPNIIGLLDAFGH 71 (299)
T ss_dssp EEEEEEEETTEEEEEEECS-SCCSEEEEEEC---------------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cceEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhhhhhh---------HHHHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 4688999999999999865 48999999998544322110 0113468899999999999999999999999
Q ss_pred CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEEEecc
Q 036970 125 PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 204 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~kl~Df 204 (337)
++..++||||+.++++.... .....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+||
T Consensus 72 ~~~~~ivmE~~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DF 144 (299)
T d1ua2a_ 72 KSNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF 144 (299)
T ss_dssp TTCCEEEEECCSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCceeehhhhhcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccC
Confidence 99999999999887666554 45667899999999999999999999665 999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHHHHhh
Q 036970 205 GLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMRNVMT 283 (337)
Q Consensus 205 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 283 (337)
|++.......... ....||+.|+|||++... .++.++|||||||++|||++|.+||.+... .+....+.....
T Consensus 145 G~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~----~~~l~~i~~~~~ 218 (299)
T d1ua2a_ 145 GLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIFETLG 218 (299)
T ss_dssp GGGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHC
T ss_pred ccccccCCCcccc--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH----HHHHHHHHHhcC
Confidence 9998765433222 235789999999998654 579999999999999999999999975432 122222222221
Q ss_pred cCCCCccccc----------cccCCC----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 284 SENPSRTIDS----------KLIGNG----YEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 284 ~~~~~~~~~~----------~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........+. ...... .+.....+.+|+.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 1111000000 000000 0122356899999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=346.57 Aligned_cols=264 Identities=19% Similarity=0.285 Sum_probs=212.8
Q ss_pred cCcccccccccccccceEEeeeecC----CCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI 115 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 115 (337)
.++|.+++.||+|+||+||+|+++. .++..||||++...... .....+.+|+.++++++||||
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~-------------~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-------------RERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-------------HHHHHHHHHHHHGGGCCCTTB
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh-------------HHHHHHHHHHHHHHHcCCCCE
Confidence 5899999999999999999998642 24678999998543221 114578999999999999999
Q ss_pred hhhhceeecCCCceEEEEeecCCCHHHHHHhhhc------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCC
Q 036970 116 VPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ------GRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPA 189 (337)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~ 189 (337)
+++++++..+...++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+++ ++||||||+
T Consensus 86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~ 162 (308)
T d1p4oa_ 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAAR 162 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGG
T ss_pred eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCC
Confidence 9999999999999999999999999999865431 2345789999999999999999999665 999999999
Q ss_pred cEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCC-CCCCCcccc
Q 036970 190 NVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK-FPSDDFFQH 268 (337)
Q Consensus 190 nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~-~pf~~~~~~ 268 (337)
||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++|. +||.+..
T Consensus 163 NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-- 240 (308)
T d1p4oa_ 163 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-- 240 (308)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--
T ss_pred ceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--
Confidence 9999999999999999998775554444444557799999999999999999999999999999999985 6765432
Q ss_pred cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 269 TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
..+..........+.. +...+..+.+++.+||+.||++|||+.+|++.|++..
T Consensus 241 -----~~~~~~~i~~~~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 241 -----NEQVLRFVMEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp -----HHHHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -----HHHHHHHHHhCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2233333333222211 1112245999999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=349.13 Aligned_cols=259 Identities=21% Similarity=0.265 Sum_probs=203.4
Q ss_pred CcccccccccccccceEEeeeecCCCCc--EEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCCChhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGR--VITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHRNIVP 117 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~ 117 (337)
++|++.+.||+|+||+||+|++.. +|. .||||.+...... +..+.+.+|+.++.++ +||||++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~HpnIv~ 75 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASK-------------DDHRDFAGELEVLCKLGHHPNIIN 75 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC-------------------CHHHHHHHHHTTCCCCTTBCC
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcccCh-------------HHHHHHHHHHHHHHhccCCCCEee
Confidence 788999999999999999999763 554 4677776432221 1145789999999999 7999999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhh------------hcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDV------------SQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRD 185 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~d 185 (337)
+++++.+.+..++||||+++|+|.+++... ......+++..++.++.||+.||.|||+.+ ++|||
T Consensus 76 ~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrD 152 (309)
T d1fvra_ 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 152 (309)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred EEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccc
Confidence 999999999999999999999999998643 123467999999999999999999999665 99999
Q ss_pred CCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCC-CCCCC
Q 036970 186 IQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGK-FPSDD 264 (337)
Q Consensus 186 i~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~-~pf~~ 264 (337)
|||+|||++.++.+||+|||++......... ....||..|+|||.+.+..++.++||||||+++|||++|. +||.+
T Consensus 153 lkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 153 LAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp CSGGGEEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccceEEEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999765433222 2346799999999999999999999999999999999976 56654
Q ss_pred cccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhhh
Q 036970 265 FFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQIQ 336 (337)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~~ 336 (337)
.. ..+....+.....+.. +...+..+.+||.+||+.||++|||+++|++.|+++.
T Consensus 230 ~~-------~~~~~~~i~~~~~~~~----------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 230 MT-------CAELYEKLPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp CC-------HHHHHHHGGGTCCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-------HHHHHHHHHhcCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 32 2233333332222211 1112234899999999999999999999999998863
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=346.18 Aligned_cols=265 Identities=21% Similarity=0.284 Sum_probs=211.7
Q ss_pred ccCcccccccccccccceEEeeeec----CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CCC
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RHR 113 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 113 (337)
..++|++++.||+|+||.||+|++. ..+++.||||++...... .....+.+|+.++..+ +||
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-------------~~~~~~~~E~~~~~~l~~Hp 87 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-------------TEREALMSELKVLSYLGNHM 87 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCCCT
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-------------HHHHHHHHHHHHHHhccCCC
Confidence 4579999999999999999999853 346789999998543221 1245788999999999 699
Q ss_pred ChhhhhceeecCCCceEEEEeecCCCHHHHHHhhhc--------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 036970 114 NIVPLLARVVRPDCDLLVYEFRRNGSLQDILYDVSQ--------------GRRELDWLARHRIARGIASGLEYLHMSHRP 179 (337)
Q Consensus 114 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 179 (337)
||+++++++.+.+..+++||||++|+|.+++..... ....+++..+..++.||+.||.|||+++
T Consensus 88 nIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-- 165 (311)
T d1t46a_ 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-- 165 (311)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 999999999999999999999999999999975432 2346899999999999999999999665
Q ss_pred CceeCCCCCCcEEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhC-
Q 036970 180 RIIHRDIQPANVLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMG- 258 (337)
Q Consensus 180 ~~~h~di~~~nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g- 258 (337)
++||||||+||+++.++.++++|||.+................||+.|+|||++.+..++.++||||||+++|||+++
T Consensus 166 -ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g 244 (311)
T d1t46a_ 166 -CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (311)
T ss_dssp -CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred -eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence 999999999999999999999999999887655444444456889999999999999999999999999999999995
Q ss_pred CCCCCCcccccccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 259 KFPSDDFFQHTKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
.+||.... ....+.+.+........+ ...+..+.+||.+||+.||.+|||+++|+++|+++
T Consensus 245 ~p~~~~~~---~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 245 SSPYPGMP---VDSKFYKMIKEGFRMLSP-------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp CCSSTTCC---SSHHHHHHHHHTCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCC---HHHHHHHHHhcCCCCCCc-------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 45554322 222233333322211111 11224489999999999999999999999999763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=345.86 Aligned_cols=264 Identities=22% Similarity=0.252 Sum_probs=198.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||+||+|++. .+|+.||+|++....... ....++.+|+.++++++||||+++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~------------~~~~~~~~Ei~il~~l~Hp~Iv~~~~ 68 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETE------------GVPSTAIREISLLKELNHPNIVKLLD 68 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------------------CCHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCEeccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcCh------------HHHHHHHHHHHHHHhCCCCcEEEecc
Confidence 68999999999999999999875 489999999985432211 11457889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+++..++||||+.+ ++.+++.. ...+.+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~iv~e~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~k 142 (298)
T d1gz8a_ 69 VIHTENKLYLVFEFLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIK 142 (298)
T ss_dssp EEEETTEEEEEEECCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccccceeEEEeecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcce
Confidence 99999999999999965 45555433 34566999999999999999999999665 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||.+......... .....||+.|+|||.+.... ++.++|+||||+++|+|++|..||.+... ........
T Consensus 143 l~DFG~a~~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~- 216 (298)
T d1gz8a_ 143 LADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIF- 216 (298)
T ss_dssp ECSTTHHHHHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH-
T ss_pred eccCCcceeccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHH-
Confidence 9999999776543322 22357899999999877765 57899999999999999999999975322 11111111
Q ss_pred HHhhcCCCCccccc------------cccCCC----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRTIDS------------KLIGNG----YEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~~~~------------~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... ....... ...... ....+..+.+|+.+||..||++|||+.|+++
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 217 RTLGTP-DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp HHHCCC-CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhcCCC-chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111110 0000000 000000 1122356889999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=342.34 Aligned_cols=269 Identities=23% Similarity=0.289 Sum_probs=201.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
.+|.+.+.||+|+||.||+|++ +|+.||||++...... ......|+..+.+++||||+++++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~~~---------------~~~~e~ei~~~~~~~HpnIv~~~~ 64 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREER---------------SWFREAEIYQTVMLRHENILGFIA 64 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGGHH---------------HHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccchh---------------HHHHHHHHHHHhhCCCCcCcceEE
Confidence 5678889999999999999986 6899999998433211 223445777778889999999999
Q ss_pred eeecCC----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceeCCCCCCcE
Q 036970 121 RVVRPD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMS-----HRPRIIHRDIQPANV 191 (337)
Q Consensus 121 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-----~~~~~~h~di~~~ni 191 (337)
++.+.+ ..++||||+++|+|.++++. ..+++..++.++.|++.||.|+|+. ..++++||||||+||
T Consensus 65 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NI 139 (303)
T d1vjya_ 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139 (303)
T ss_dssp EEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGE
T ss_pred EEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccce
Confidence 998754 46899999999999999954 3589999999999999999999964 134699999999999
Q ss_pred EecCCCcEEEecccccccCCCCCc--ccccccccCcccccCCccccCCC------CCCcccchhHhHHHHHHHhCCCCCC
Q 036970 192 LIDDDMEARISEFGLAKQIPNGRT--RTTTWSLAETVGYIAPECHQTVA------LSDKCDIYSFGVLLAVLMMGKFPSD 263 (337)
Q Consensus 192 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslG~vl~~l~~g~~pf~ 263 (337)
+++.++.+||+|||++........ ........||+.|+|||++.+.. ++.++||||||+++|||++|..||.
T Consensus 140 Ll~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred EEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 999999999999999987644322 11223467899999999987653 5678999999999999999998875
Q ss_pred Cccccc--------ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 264 DFFQHT--------KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 264 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
...... ....... .............+.. ..........+.+|+.+||+.||++|||+.||++.|++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 220 IHEDYQLPYYDLVPSDPSVEE-MRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp BCCCCCCTTTTTSCSSCCHHH-HHHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccchhhcccccchHHH-HHHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 422110 1112222 2222222111111111 112334556799999999999999999999999999988
Q ss_pred h
Q 036970 336 Q 336 (337)
Q Consensus 336 ~ 336 (337)
.
T Consensus 296 ~ 296 (303)
T d1vjya_ 296 S 296 (303)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.5e-49 Score=341.28 Aligned_cols=263 Identities=22% Similarity=0.247 Sum_probs=198.2
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||+||+|+++ +|+.||||++....... ....++.+|+.++++++||||+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~------------~~~~~~~~E~~il~~l~hpnIv~~~~ 67 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDE------------GIPSTTIREISILKELKHSNIVKLYD 67 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGG------------CCCHHHHHHHHGGGGCCCTTBCCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcCh------------HHHHHHHHHHHHHHhCCCCcEEeeee
Confidence 68999999999999999999875 88999999985543221 11467889999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+++..++++|++.++.+..+. ...+.+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+|
T Consensus 68 ~~~~~~~~~i~~e~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~k 140 (286)
T d1ob3a_ 68 VIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELK 140 (286)
T ss_dssp EEECSSCEEEEEECCSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ecccCCceeEEEEeehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEE
Confidence 999999999999999776665555 45677999999999999999999999655 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
++|||.+........... ...+++.|+|||.+.+. .++.++||||||+++|||++|..||.+.... +....+.
T Consensus 141 l~DfG~a~~~~~~~~~~~--~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~----~~~~~i~ 214 (286)
T d1ob3a_ 141 IADFGLARAFGIPVRKYT--HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA----DQLMRIF 214 (286)
T ss_dssp ECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHH
T ss_pred ecccccceecccCccccc--eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH----HHHHHHH
Confidence 999999987654332222 34678999999998765 5689999999999999999999999754321 1111111
Q ss_pred HHhhcCCCCcc------------c---cccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSRT------------I---DSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~~------------~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
........... . ...............+.+++.+||++||++|||++|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111100000 0 000000011122345889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=343.54 Aligned_cols=266 Identities=18% Similarity=0.224 Sum_probs=195.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC---CCCCh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV---RHRNI 115 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~ni 115 (337)
..++|++++.||+|+||+||+|++...+++.||||++......... ...+.+|+.+++.| +||||
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~------------~~~~~~E~~~l~~l~~~~HpnI 72 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------------PLSTIREVAVLRHLETFEHPNV 72 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------------BCTHHHHHHHHHHHHHTCCTTB
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH------------HHHHHHHHHHHHHHhhcCCCCc
Confidence 4589999999999999999999975445778999998654322110 12345666666555 79999
Q ss_pred hhhhceeec-----CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 116 VPLLARVVR-----PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 116 ~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
+++++++.. ....++++||++++++..... .....+++..++.++.|++.||+|||+++ ++||||||+|
T Consensus 73 v~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~N 146 (305)
T d1blxa_ 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN 146 (305)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred ceeeeeecccccccCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccE
Confidence 999999853 345689999998776654432 35566899999999999999999999665 9999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTK 270 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~ 270 (337)
|+++.++.+||+|||++........ .....||+.|+|||++.+..++.++||||+||++|||++|..||.+....
T Consensus 147 ILi~~~~~~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-- 221 (305)
T d1blxa_ 147 ILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-- 221 (305)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred EEEcCCCCeeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--
Confidence 9999999999999999876543322 23468899999999999999999999999999999999999999754321
Q ss_pred cchHHHHHHHHhhcCCCCccccc--------------cccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 271 EMSFVQWMRNVMTSENPSRTIDS--------------KLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
..+.. +...... +.....+. .............+.+|+.+||++||++|||+.|+++
T Consensus 222 -~~~~~-i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 222 -DQLGK-ILDVIGL-PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp -HHHHH-HHHHHCC-CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHH-HHHhhCC-CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11111 1111111 00000000 0000011122345889999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=341.55 Aligned_cols=247 Identities=20% Similarity=0.254 Sum_probs=195.2
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC--CCChhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--HRNIVP 117 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~ 117 (337)
.++|++.+.||+|+||+||+|++. .+|+.||||++.......... .....++.+|+.++++++ ||||++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~--------~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGE--------LPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEE--------CTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhh--------hhHHHHHHHHHHHHHHhccCCCCccE
Confidence 578999999999999999999865 489999999986543221100 001224567999998886 899999
Q ss_pred hhceeecCCCceEEEEeecC-CCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC-
Q 036970 118 LLARVVRPDCDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD- 195 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~- 195 (337)
+++++.+++..++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~ 146 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 146 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETT
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecC
Confidence 99999999999999999975 678888743 356999999999999999999999665 999999999999985
Q ss_pred CCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCcccccccchH
Q 036970 196 DMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVAL-SDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSF 274 (337)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~ 274 (337)
++.+||+|||++........ ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 147 ~~~vkl~DFG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------- 215 (273)
T d1xwsa_ 147 RGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------- 215 (273)
T ss_dssp TTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred CCeEEECccccceecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------
Confidence 47899999999976543322 23578999999999987765 5678999999999999999999975311
Q ss_pred HHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 275 VQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
....... +.+ ..+..+.++|.+||++||++|||++|+++
T Consensus 216 ------i~~~~~~---~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 ------IIRGQVF---FRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------HHHCCCC---CSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HhhcccC---CCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111111 111 11234889999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=332.47 Aligned_cols=268 Identities=22% Similarity=0.256 Sum_probs=197.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||+||+|++. .+|+.||||++....... ....++.+|+.+|++++||||+++
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~------------~~~~~~~~E~~il~~l~h~nii~~ 74 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKE------------GFPITALREIKILQLLKHENVVNL 74 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC----CTT------------SSCHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccCCEEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcch------------HHHHHHHHHHHHHHHhcCCCccce
Confidence 3589999999999999999999865 489999999985433211 114568899999999999999999
Q ss_pred hceeec--------CCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 036970 119 LARVVR--------PDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPAN 190 (337)
Q Consensus 119 ~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~n 190 (337)
++++.. .+..+++|||+.++.+.... .....+++..++.++.||+.||.|||+++ ++||||||+|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~N 147 (318)
T d3blha1 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAAN 147 (318)
T ss_dssp EEEEEC----------CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EeeeecccccccccCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchh
Confidence 998865 34578999999776555443 45567899999999999999999999665 9999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCc--ccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCccc
Q 036970 191 VLIDDDMEARISEFGLAKQIPNGRT--RTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQ 267 (337)
Q Consensus 191 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~ 267 (337)
|+++.++.+||+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 148 ILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~- 226 (318)
T d3blha1 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT- 226 (318)
T ss_dssp EEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-
T ss_pred eeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-
Confidence 9999999999999999976653322 1222345789999999998765 68999999999999999999999997532
Q ss_pred ccccchHHHHHHHHhhcCCCCcc--cc---------cccc-CCChHH------HHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 268 HTKEMSFVQWMRNVMTSENPSRT--ID---------SKLI-GNGYEE------QMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~--~~---------~~~~-~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
.......+............ .. .... ...... ....+.+|+.+||+.||++|||++|++
T Consensus 227 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 227 ---EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp ---HHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ---HHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 22222222222221111100 00 0000 001111 123577899999999999999999998
Q ss_pred H
Q 036970 330 C 330 (337)
Q Consensus 330 ~ 330 (337)
+
T Consensus 304 ~ 304 (318)
T d3blha1 304 N 304 (318)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=334.06 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=192.4
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|++++.||+|+||+||+|++. .+|+.||||++....... .....+.+|+.+|+.++||||+++
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~------------~~~~~~~~Ei~il~~l~hpniv~l 82 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSE------------LFAKRAYRELRLLKHMRHENVIGL 82 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSH------------HHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEchhhcCh------------HHHHHHHHHHHHHHhcCCCCeeEE
Confidence 4689999999999999999999865 489999999986433221 125678899999999999999999
Q ss_pred hceeecCC------CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 119 LARVVRPD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 119 ~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
+++|...+ ..++||||+ +.+|..+++ ...+++..++.++.||+.||.|||+++ ++||||||+||+
T Consensus 83 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL 153 (346)
T d1cm8a_ 83 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLA 153 (346)
T ss_dssp SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred EEEeccCccccccceEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhh
Confidence 99998755 469999999 667877763 245999999999999999999999665 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++.++.+|++|||++........ ...||+.|+|||++.+. .++.++||||+||++|+|++|..||.+....
T Consensus 154 ~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--- 225 (346)
T d1cm8a_ 154 VNEDCELKILDFGLARQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--- 225 (346)
T ss_dssp ECTTCCEEECCCTTCEECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred cccccccccccccceeccCCccc-----cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH---
Confidence 99999999999999987654432 35789999999998765 5689999999999999999999999754221
Q ss_pred chHHHHHHHHhhc----------------------CCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 036970 272 MSFVQWMRNVMTS----------------------ENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVR 329 (337)
Q Consensus 272 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 329 (337)
............ ........ .. .......+.+||.+||..||++|||+.|++
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~s~~~~dli~~mL~~dP~~R~ta~eiL 299 (346)
T d1cm8a_ 226 -DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SI----LTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299 (346)
T ss_dssp -HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GT----CTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred -HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchH-Hh----ccCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 111111100000 00000000 01 111223478999999999999999999998
Q ss_pred H
Q 036970 330 C 330 (337)
Q Consensus 330 ~ 330 (337)
+
T Consensus 300 ~ 300 (346)
T d1cm8a_ 300 A 300 (346)
T ss_dssp H
T ss_pred c
Confidence 6
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=338.55 Aligned_cols=261 Identities=22% Similarity=0.238 Sum_probs=192.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
-+|+.+++||+|+||+||+|++. .+|+.||||++..... ...+|+.++++++||||+++++
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~------------------~~~~Ei~il~~l~h~niv~~~~ 80 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR------------------FKNRELQIMRKLDHCNIVRLRY 80 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSS------------------SCCHHHHHHHHCCCTTBCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccch------------------HHHHHHHHHHhcCCCCCCcEEE
Confidence 37999999999999999999976 4899999999854321 1236999999999999999999
Q ss_pred eeecC------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 121 RVVRP------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 121 ~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++... ...++||||++++ +.+.+.........+++..++.++.||+.||+|||+++ ++||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~ 156 (350)
T d1q5ka_ 81 FFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLD 156 (350)
T ss_dssp EEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEEC
T ss_pred EEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEe
Confidence 98643 2358999999765 54444444456677999999999999999999999554 99999999999999
Q ss_pred CCC-cEEEecccccccCCCCCcccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 195 DDM-EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 195 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
.++ .+||+|||++.......... ...||+.|+|||.+.+ ..++.++||||+||++|||++|..||.......
T Consensus 157 ~~~~~~kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--- 230 (350)
T d1q5ka_ 157 PDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--- 230 (350)
T ss_dssp TTTCCEEECCCTTCEECCTTSCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---
T ss_pred cCCCceeEecccchhhccCCcccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH---
Confidence 765 89999999998765443322 3578999999998765 468999999999999999999999997543211
Q ss_pred hHHHHH-----------HHHhh---cCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWM-----------RNVMT---SENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~-----------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.+.... ..... .................+.....+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 11000 00000000000001111223345889999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=332.35 Aligned_cols=262 Identities=19% Similarity=0.227 Sum_probs=193.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
..++|+++++||+|+||+||+|.+. .+|+.||||++...... .....+.+|+.+|++++||||+++
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~-------------~~~~~~~~Ei~il~~l~hp~iv~~ 71 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFEHQ-------------TYCQRTLREIKILLRFRHENIIGI 71 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEET-TTCSEEEEEEECCTTCH-------------HHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEEC-CCCcEEEEEEEehhcCh-------------HHHHHHHHHHHHHHHcCCCCCCcE
Confidence 4578999999999999999999865 58999999998543211 114578899999999999999999
Q ss_pred hceeecCC----CceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec
Q 036970 119 LARVVRPD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID 194 (337)
Q Consensus 119 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~ 194 (337)
++++.... ..+++++++.+++|.+++.. ..+++..++.++.|++.||+|||+++ ++||||||+||+++
T Consensus 72 ~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~ 143 (345)
T d1pmea_ 72 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 143 (345)
T ss_dssp CEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred EEEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEEC
Confidence 99987653 23455666779999999843 35899999999999999999999665 99999999999999
Q ss_pred CCCcEEEecccccccCCCCCc-ccccccccCcccccCCccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCcccccccc
Q 036970 195 DDMEARISEFGLAKQIPNGRT-RTTTWSLAETVGYIAPECHQT-VALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM 272 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~ 272 (337)
.++.+||+|||++........ ........||+.|+|||++.. ..++.++||||+|+++|+|++|..||......
T Consensus 144 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~---- 219 (345)
T d1pmea_ 144 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---- 219 (345)
T ss_dssp TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred CCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH----
Confidence 999999999999976643322 112234578999999999855 45788999999999999999999999754321
Q ss_pred hHHHHHHHHhhcC--------------------CCCcccc-ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWMRNVMTSE--------------------NPSRTID-SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~~~~~~~~--------------------~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
............. ......+ ... .+.....+.+|+.+||+.||.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL----FPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH----CTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHh----CCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111000 0000000 000 0111235889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=325.16 Aligned_cols=265 Identities=20% Similarity=0.201 Sum_probs=203.4
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhhc
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLLA 120 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~ 120 (337)
++|++++.||+|+||+||+|++. .+|+.||||++....... ....++.+|+.+++.++||||+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~------------~~~~~~~~E~~il~~l~h~niv~~~~ 68 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDE------------GVPSSALREICLLKELKHKNIVRLHD 68 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSST------------THHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhhCCh------------HHHHHHHHHHHHHHhcCcCCEEeecc
Confidence 68999999999999999999876 489999999985443211 12568899999999999999999999
Q ss_pred eeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcEE
Q 036970 121 RVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 200 (337)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~k 200 (337)
++.+....+++++++.+++|..++ ...+.+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~iv~~~~~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~k 141 (292)
T d1unla_ 69 VLHSDKKLTLVFEFCDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEECSSEEEEEEECCSEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEE
T ss_pred ccccccceeEEeeecccccccccc----ccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCcee
Confidence 999999999999999998888777 34567899999999999999999999665 99999999999999999999
Q ss_pred EecccccccCCCCCcccccccccCcccccCCccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 036970 201 ISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVA-LSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFVQWMR 279 (337)
Q Consensus 201 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~ 279 (337)
|+|||.+........... ...+++.|+|||.+.... ++.++|||||||++|||++|..||.... ........+.
T Consensus 142 l~DFG~a~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~---~~~~~~~~~~ 216 (292)
T d1unla_ 142 LANFGLARAFGIPVRCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIF 216 (292)
T ss_dssp ECCCTTCEECCSCCSCCC--SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS---SHHHHHHHHH
T ss_pred eeecchhhcccCCCccce--eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC---CHHHHHHHHH
Confidence 999999987654433222 345678899999987765 6899999999999999999999974321 1111222222
Q ss_pred HHhhcCCCCc--------------ccc-ccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 280 NVMTSENPSR--------------TID-SKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 280 ~~~~~~~~~~--------------~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
.......... ... ..............+.+|+.+||+.||.+|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2211110000 000 00011112223345889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=329.09 Aligned_cols=263 Identities=22% Similarity=0.278 Sum_probs=197.3
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPL 118 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 118 (337)
-.++|++++.||+|+||.||+|++. .+|+.||||++..... ..++..|+.+++.++|+|++..
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~----------------~~~~~~E~~i~~~l~~~~~i~~ 67 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPT 67 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCTT----------------SCCHHHHHHHHHHSTTSTTCCC
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhcc----------------CHHHHHHHHHHHHccCCCcccE
Confidence 3468999999999999999999865 4899999998754321 2246789999999987765554
Q ss_pred -hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEec---
Q 036970 119 -LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLID--- 194 (337)
Q Consensus 119 -~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~--- 194 (337)
..++.+++..++||||+ +++|.+.+.. ..+.+++..+..++.|++.||+|||+++ ++||||||+||+++
T Consensus 68 ~~~~~~~~~~~~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~ 140 (299)
T d1ckia_ 68 IRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK 140 (299)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGG
T ss_pred EEEEEecCCEEEEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccC
Confidence 55556777888999999 5677776643 4456999999999999999999999665 99999999999986
Q ss_pred CCCcEEEecccccccCCCCCcc-----cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCccccc
Q 036970 195 DDMEARISEFGLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHT 269 (337)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~ 269 (337)
.+..++++|||++......... .......||+.|+|||.+.+..++.++|||||||++|||++|..||.......
T Consensus 141 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 141 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp GTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred CCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 4557999999999876543221 22234578999999999999999999999999999999999999997654433
Q ss_pred ccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 270 KEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
................ .. . .... .+..+.+++..||+.||++||+++++.+.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~-~~-~----~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 221 KRQKYERISEKKMSTP-IE-V----LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ----HHHHHHHHHHSC-HH-H----HTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHhhcccCCCC-hh-H----hccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 2222222222221111 00 0 0011 123388999999999999999999999988764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.5e-46 Score=322.22 Aligned_cols=262 Identities=16% Similarity=0.167 Sum_probs=202.9
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPL 118 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~ 118 (337)
.++|++++.||+|+||+||+|++. .+|+.||||++..... ...+.+|+..+..|. |+|++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~i~~~ 66 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRSD----------------APQLRDEYRTYKLLAGCTGIPNV 66 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCTT----------------SCCHHHHHHHHHHTTTCTTCCCE
T ss_pred CCceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEccccC----------------cHHHHHHHHHHHHhcCCCCCCEE
Confidence 468999999999999999999865 4899999998744321 124667888888885 4899999
Q ss_pred hceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC---
Q 036970 119 LARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--- 195 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~--- 195 (337)
++++.++...++||||+ +++|.+++.. ....++...+..++.|++.||.|||+. |++||||||+||+++.
T Consensus 67 ~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~ 139 (293)
T d1csna_ 67 YYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNS 139 (293)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSS
T ss_pred EEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCccc
Confidence 99999999999999999 7899998854 345689999999999999999999955 5999999999999974
Q ss_pred --CCcEEEecccccccCCCCCcc-----cccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccc
Q 036970 196 --DMEARISEFGLAKQIPNGRTR-----TTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQH 268 (337)
Q Consensus 196 --~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~ 268 (337)
++.++|+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|..||.+....
T Consensus 140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 578999999999876433211 1233467999999999999999999999999999999999999999764432
Q ss_pred cccchHHHHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhhh
Q 036970 269 TKEMSFVQWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRCMLSQI 335 (337)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~L~~~ 335 (337)
............... ..+. .+....+ ..+.+++..|++.+|++||+++.+.+.|.++
T Consensus 220 ~~~~~~~~i~~~~~~-~~~~-----~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 220 TNKQKYERIGEKKQS-TPLR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHHHHHHHHHHHHHH-SCHH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hHHHHHHHHHhccCC-CChH-----HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 222222222111111 1110 0111112 3388899999999999999999999988764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.1e-46 Score=330.16 Aligned_cols=261 Identities=20% Similarity=0.242 Sum_probs=195.7
Q ss_pred ccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhh
Q 036970 39 KEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVP 117 (337)
Q Consensus 39 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~ 117 (337)
..++|+++++||+|+||+||+|++. .+|+.||||++.... ..++.+|+.+|+.+. ||||++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~-----------------~~~~~~Ei~il~~l~~hpnIv~ 94 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPVK-----------------KKKIKREIKILENLRGGPNIIT 94 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSSC-----------------HHHHHHHHHHHHHHTTSTTBCC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEECHHH-----------------HHHHHHHHHHHHhccCCCCCcE
Confidence 4578999999999999999999865 489999999984322 456788999999995 999999
Q ss_pred hhceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecC
Q 036970 118 LLARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 195 (337)
Q Consensus 118 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~ 195 (337)
+++++... ...++||||+.+++|..+. +.+++..+..++.||+.||.|||+++ ++||||||+||+++.
T Consensus 95 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~ 164 (328)
T d3bqca1 95 LADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDH 164 (328)
T ss_dssp EEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred EEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcC
Confidence 99998743 5689999999999986653 45999999999999999999999665 999999999999986
Q ss_pred CC-cEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCcccccccc-
Q 036970 196 DM-EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEM- 272 (337)
Q Consensus 196 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~- 272 (337)
++ .++|+|||++.......... ...+|+.|+|||.+.+. .++.++|+||+||++|++++|..||..........
T Consensus 165 ~~~~vkl~DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~ 241 (328)
T d3bqca1 165 EHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241 (328)
T ss_dssp TTTEEEECCGGGCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred CCCeeeecccccceeccCCCccc---ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence 55 58999999998765443322 34779999999998775 47999999999999999999999986532211000
Q ss_pred hHHHHH--------HHHhhcC-----------CCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 273 SFVQWM--------RNVMTSE-----------NPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 273 ~~~~~~--------~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
...... ....... .....................+.+||.+||+.||++|||++|+++
T Consensus 242 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0000000 000000000111112223355889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=330.45 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=190.1
Q ss_pred cCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 40 EDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 40 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.++|+++++||+|+||+||+|++. .+|+.||||++........ ...++.+|+.++++++||||++++
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~-~t~~~vAvK~i~~~~~~~~------------~~~~~~~Ei~il~~l~hpnIv~~~ 82 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQT------------HAKRAYRELVLMKCVNHKNIISLL 82 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEET-TTTEEEEEEEEESTTSSHH------------HHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred cCCeEEEEEeecCcCeEEEEEEEC-CCCCEEEEEEEChhhcCHH------------HHHHHHHHHHHHHhcCCCCeeEEE
Confidence 368999999999999999999865 4899999999965543222 155788999999999999999999
Q ss_pred ceeecC------CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEe
Q 036970 120 ARVVRP------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLI 193 (337)
Q Consensus 120 ~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~ 193 (337)
+++... ...|+||||+.++ +.+.+ ...+++..++.++.||+.||.|||+.+ ++||||||+||++
T Consensus 83 ~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~ 152 (355)
T d2b1pa1 83 NVFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 152 (355)
T ss_dssp EEECSCCSTTTCCEEEEEEECCSEE-HHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred EEEecccccccCceeEEEEeccchH-HHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcccccc
Confidence 999643 5679999999665 54444 135899999999999999999999655 9999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCCCCCcccccccch
Q 036970 194 DDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMS 273 (337)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~ 273 (337)
+.++.++++|||++.......... ...+|+.|+|||++.+..++.++||||+||++++|++|..||.+.... ..
T Consensus 153 ~~~~~~kl~df~~~~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~---~~ 226 (355)
T d2b1pa1 153 KSDCTLKILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQ 226 (355)
T ss_dssp CTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH
T ss_pred ccccceeeechhhhhccccccccc---cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH---HH
Confidence 999999999999987765443332 346799999999999999999999999999999999999999653211 11
Q ss_pred HHHHH------------------HHHhhcCCCCc------cccccc---cCCChHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 036970 274 FVQWM------------------RNVMTSENPSR------TIDSKL---IGNGYEEQMLLVLKIACFCTFDDPEERPNSK 326 (337)
Q Consensus 274 ~~~~~------------------~~~~~~~~~~~------~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 326 (337)
....+ ........... .+.... ........+..+.+|+.+||..||++|||++
T Consensus 227 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~ 306 (355)
T d2b1pa1 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_dssp HHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 11111 11111111000 000000 1112334567799999999999999999999
Q ss_pred HHHH
Q 036970 327 DVRC 330 (337)
Q Consensus 327 ~il~ 330 (337)
|+++
T Consensus 307 elL~ 310 (355)
T d2b1pa1 307 DALQ 310 (355)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=332.29 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=200.3
Q ss_pred CcccccccccccccceEEeeeec--CCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCC-CChhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRH-RNIVP 117 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~ 117 (337)
++|++++.||+|+||+||+|++. ..+|+.||+|++........ ....+.+.+|+.++++++| |||++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~----------~~~~~~~~~E~~il~~l~h~pnIv~ 93 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----------AKTTEHTRTERQVLEHIRQSPFLVT 93 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----------ESSGGGCCCHHHHHHHHHTCTTBCC
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc----------hHHHHHHHHHHHHHHhccCCCeEEE
Confidence 77999999999999999999863 23689999999865432110 0013457789999999966 89999
Q ss_pred hhceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCC
Q 036970 118 LLARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 197 (337)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~ 197 (337)
+++++.+....++++||+.+++|.+++.. .+.+++..+..++.||+.||.|||+++ ++||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~ 166 (322)
T d1vzoa_ 94 LHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNG 166 (322)
T ss_dssp EEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred eeeeeccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCC
Confidence 99999999999999999999999999854 345788999999999999999999665 99999999999999999
Q ss_pred cEEEecccccccCCCCCcccccccccCcccccCCccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCcccccccchHH
Q 036970 198 EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV--ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKEMSFV 275 (337)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~~~~~ 275 (337)
.++|+|||++..+....... .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||......... .
T Consensus 167 ~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~ 242 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---A 242 (322)
T ss_dssp CEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---H
T ss_pred CEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 99999999998765443322 2245789999999998764 4688999999999999999999999765432222 2
Q ss_pred HHHHHHhhcCCCCccccccccCCChHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 036970 276 QWMRNVMTSENPSRTIDSKLIGNGYEEQMLLVLKIACFCTFDDPEERPN-----SKDVRC 330 (337)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~il~ 330 (337)
...........+. +...+..+.+++.+||++||++||| ++|+++
T Consensus 243 ~i~~~~~~~~~~~-----------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 243 EISRRILKSEPPY-----------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHCCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHhcccCCCCC-----------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2222222222111 1112344889999999999999995 788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=324.40 Aligned_cols=262 Identities=20% Similarity=0.291 Sum_probs=194.1
Q ss_pred hccCcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCChhh
Q 036970 38 KKEDCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNIVP 117 (337)
Q Consensus 38 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~ 117 (337)
+.+++|++++.||+|+||+||+|++. .+|+.||||++........ ...++.+|+.++++++||||++
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~------------~~~~~~~Ei~il~~l~h~~iv~ 81 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSII------------HAKRTYRELRLLKHMKHENVIG 81 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEET-TTTEEEEEEECSCTTSSHH------------HHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECchhcChH------------HHHHHHHHHHHHHhcCCCCeee
Confidence 45789999999999999999999865 4899999999864432211 1457889999999999999999
Q ss_pred hhceeecC-----CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEE
Q 036970 118 LLARVVRP-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVL 192 (337)
Q Consensus 118 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil 192 (337)
+++++... ...+++++++.+++|.+++ ..+.+++..++.++.||+.||+|||+++ ++||||||+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~-----~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NIL 153 (348)
T d2gfsa1 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLA 153 (348)
T ss_dssp CSEEECSCSSTTTCCCCEEEEECCSEEHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred EEEEEeeccccccCceEEEEEeecCCchhhhc-----ccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccc
Confidence 99998643 3446777888899999998 2346999999999999999999999665 999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcccccccccCcccccCCccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCccccccc
Q 036970 193 IDDDMEARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTV-ALSDKCDIYSFGVLLAVLMMGKFPSDDFFQHTKE 271 (337)
Q Consensus 193 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~vl~~l~~g~~pf~~~~~~~~~ 271 (337)
++.++.++++|||++...... .....|++.|+|||...+. .++.++|||||||++|+|++|..||.+...
T Consensus 154 i~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---- 224 (348)
T d2gfsa1 154 VNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---- 224 (348)
T ss_dssp ECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----
T ss_pred ccccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH----
Confidence 999999999999998765332 2235678999999987765 468899999999999999999999975422
Q ss_pred chHHHHHHHHhhcCCCCcccc--------------ccccCCC----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 036970 272 MSFVQWMRNVMTSENPSRTID--------------SKLIGNG----YEEQMLLVLKIACFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 330 (337)
......+...... ....... ....... .......+.+||.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 225 IDQLKLILRLVGT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHHHHHHCC-CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhcCC-CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 1111111111100 0000000 0000000 0112345889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-40 Score=293.01 Aligned_cols=266 Identities=19% Similarity=0.164 Sum_probs=185.8
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC---------
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--------- 111 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------- 111 (337)
++|+++++||+|+||+||+|++. .+|+.||||++.+.... .+.+.+|+.+++.++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~~~~---------------~~~~~~Ei~~l~~l~~~~~~~~~~ 76 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDKVY---------------TEAAEDEIKLLQRVNDADNTKEDS 76 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCHHH---------------HHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred CcEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeccccc---------------hHHHHHHHHHHHHhcchhhhhhhh
Confidence 56999999999999999999865 48999999998654321 235566777766664
Q ss_pred --CCChhhhhceeecC--CCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 036970 112 --HRNIVPLLARVVRP--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQ 187 (337)
Q Consensus 112 --h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~ 187 (337)
|+||+++++++... ...+++++++..+....... .......+++..++.++.||+.||.|||+. .|++|||||
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlK 153 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIK 153 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCS
T ss_pred cCcCceEEEEEEeeeccccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCC
Confidence 57888888887654 34456666664443322221 224556789999999999999999999962 249999999
Q ss_pred CCcEEecCCC------cEEEecccccccCCCCCcccccccccCcccccCCccccCCCCCCcccchhHhHHHHHHHhCCCC
Q 036970 188 PANVLIDDDM------EARISEFGLAKQIPNGRTRTTTWSLAETVGYIAPECHQTVALSDKCDIYSFGVLLAVLMMGKFP 261 (337)
Q Consensus 188 ~~nil~~~~~------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~vl~~l~~g~~p 261 (337)
|+||+++.++ .++++|||.+....... ....||+.|+|||++.+..++.++|+||+|+++++|++|..|
T Consensus 154 p~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 228 (362)
T d1q8ya_ 154 PENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228 (362)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred hhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCC
Confidence 9999998654 38999999987654322 245789999999999999999999999999999999999999
Q ss_pred CCCcccccccchHHHHHH--HHhhc------------------CCCCccccc----------cccCCChHHHHHHHHHHH
Q 036970 262 SDDFFQHTKEMSFVQWMR--NVMTS------------------ENPSRTIDS----------KLIGNGYEEQMLLVLKIA 311 (337)
Q Consensus 262 f~~~~~~~~~~~~~~~~~--~~~~~------------------~~~~~~~~~----------~~~~~~~~~~~~~l~~li 311 (337)
|................. ..+.. ......+.. .............+.+|+
T Consensus 229 F~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 308 (362)
T d1q8ya_ 229 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308 (362)
T ss_dssp C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred CCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHH
Confidence 976433221111111111 11100 000000000 001122355677899999
Q ss_pred HHhcCCCCCCCCCHHHHHH
Q 036970 312 CFCTFDDPEERPNSKDVRC 330 (337)
Q Consensus 312 ~~~l~~~p~~Rps~~~il~ 330 (337)
.+||..||.+|||++|+++
T Consensus 309 ~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 309 SPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp GGGGCSSTTTCBCHHHHHT
T ss_pred HHHCCCChhHCcCHHHHhc
Confidence 9999999999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=9.4e-24 Score=171.01 Aligned_cols=177 Identities=12% Similarity=0.045 Sum_probs=118.9
Q ss_pred cccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhh----cCCcchhhhHHHHHHHHHHhcCCCCCChhhhh
Q 036970 44 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIK----QDSEPLHHKMIQIQSEIITAGQVRHRNIVPLL 119 (337)
Q Consensus 44 ~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~ 119 (337)
.+++.||+|+||+||+|++. +|+.||||++............ ..............+|...+.++.|.+++..+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred hhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999875 7999999987543221110000 00011111234456788899999999988766
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCcEEecCCCcE
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 199 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~~~h~di~~~nil~~~~~~~ 199 (337)
++. ..+++|||+++..+.+ ++......++.|++.++.|||+++ ++|+||||+||+++++ .+
T Consensus 81 ~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred Eec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 432 3479999998754422 334455679999999999999665 9999999999999965 58
Q ss_pred EEecccccccCCCCCcccccccccCcccccCC------ccccCCCCCCcccchhHhHHH
Q 036970 200 RISEFGLAKQIPNGRTRTTTWSLAETVGYIAP------ECHQTVALSDKCDIYSFGVLL 252 (337)
Q Consensus 200 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP------E~~~~~~~~~~~DvwslG~vl 252 (337)
+|+|||.+.......... |... +.+ ...|+.++|+||+.--+
T Consensus 142 ~liDFG~a~~~~~~~~~~----------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWRE----------ILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHHH----------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcHH----------HHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999999987654332211 1111 111 24578889999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=1.3e-07 Score=78.38 Aligned_cols=142 Identities=12% Similarity=0.090 Sum_probs=91.6
Q ss_pred CcccccccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC-CCChhhhh
Q 036970 41 DCFASLEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR-HRNIVPLL 119 (337)
Q Consensus 41 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~ 119 (337)
+.|+..+..+-++.+.||... . +++.+++|......... ...+.+|...++.+. +-.+.+++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~-~--~~~~~vlk~~~~~~~~~--------------~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV-G--ENENLYLKMTDSRYKGT--------------TYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE-C--SSCEEEEEEECGGGTTS--------------TTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred hceEEEEcCCCCCCCcEEEEE-e--CCCeEEEEEcCCCcccc--------------hhhHHHHHHHHHHHhccCCCCcEE
Confidence 466666665556667899886 2 67778888875432211 223556766665552 43456777
Q ss_pred ceeecCCCceEEEEeecCCCHHHHHHhhhcCCCcCCHHHHHHHHHHHHHHHHHHhcCC----------------------
Q 036970 120 ARVVRPDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIARGIASGLEYLHMSH---------------------- 177 (337)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---------------------- 177 (337)
.+..+++..++||++++|.++.+... +......++.++...+..||+..
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~~~---------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN 147 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHTT---------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred EEEecCCceEEEEEeccccccccccc---------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence 77778888899999998877755431 11112234455555555555321
Q ss_pred ----------------------------------CCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 178 ----------------------------------RPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 178 ----------------------------------~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
...++|+|+.|.||++++++.+.|.||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137999999999999987666799998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.96 E-value=7.1e-06 Score=67.19 Aligned_cols=74 Identities=14% Similarity=0.120 Sum_probs=47.4
Q ss_pred cccccc-cceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCC--CCChhhhhceeec
Q 036970 48 KIRSCW-NGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVR--HRNIVPLLARVVR 124 (337)
Q Consensus 48 ~lg~G~-~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~ 124 (337)
.+..|. .+.||....+ .+..+++|...... ...+..|...++.+. .-.+.+++.+..+
T Consensus 17 ~~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~-----------------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~ 77 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGA-----------------LNELQDEAARLSWLATTGVPCAAVLDVVTE 77 (255)
T ss_dssp ECSCTTSSCEEEEEECT--TSCCEEEEEECSCT-----------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC--CCCEEEEEeCCccC-----------------HhHHHHHHHHHHHHHhcCCCCCceeeeccc
Confidence 334444 3678988754 67778888763321 113455666665552 2346677777788
Q ss_pred CCCceEEEEeecCCCH
Q 036970 125 PDCDLLVYEFRRNGSL 140 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L 140 (337)
++..++||++++|.++
T Consensus 78 ~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 78 AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SSCEEEEEECCSSEET
T ss_pred ccceEEEEEeeecccc
Confidence 8888999999987544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=2.2e-05 Score=68.65 Aligned_cols=84 Identities=13% Similarity=0.045 Sum_probs=46.6
Q ss_pred cccccccccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCC-CC--CChhhhhcee
Q 036970 46 LEKIRSCWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQV-RH--RNIVPLLARV 122 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h--~ni~~~~~~~ 122 (337)
.+.||.|....||.+... .+++.+++|.-........ .. ......+...|...++.+ .+ ..+++++ +
T Consensus 31 ~~eig~G~~N~vfrV~~~-~~~~svivKqa~p~~r~~g-----~~--~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~--~ 100 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVG-----ES--WPLTIDRARIESSALIRQGEHVPHLVPRVF--Y 100 (392)
T ss_dssp EEECCSSSSEEEEEEEC-----CEEEEEEECCGGGC-------CC--CCCCTTHHHHHHHHHHHHHTTCGGGSCCEE--E
T ss_pred EEEeCCCceEeEEEEEeC-CCCeEEEEecCCchhcccC-----CC--CCCCHHHHHHHHHHHHHhhhhCCCCcceEE--E
Confidence 567999999999999754 3577899997543211100 00 000123445566666655 22 2234444 3
Q ss_pred ecCCCceEEEEeecCCC
Q 036970 123 VRPDCDLLVYEFRRNGS 139 (337)
Q Consensus 123 ~~~~~~~lv~e~~~~~~ 139 (337)
.+....+++||++.+..
T Consensus 101 ~d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 101 SDTEMAVTVMEDLSHLK 117 (392)
T ss_dssp EETTTTEEEECCCTTSE
T ss_pred EcCCCCEEEEeccCCcc
Confidence 45556789999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.54 E-value=0.0036 Score=52.54 Aligned_cols=139 Identities=14% Similarity=0.127 Sum_probs=74.5
Q ss_pred cccceEEeeeecCCCCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh-----hhh--hceeec
Q 036970 52 CWNGEVYKAELPGSSGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI-----VPL--LARVVR 124 (337)
Q Consensus 52 G~~g~vy~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----~~~--~~~~~~ 124 (337)
+....||.++.. +|..|++|+....... .+++..|...+..|...++ +.. -..+..
T Consensus 33 s~EN~vy~v~~~--dg~~~VlK~~rp~~~s---------------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~ 95 (325)
T d1zyla1 33 SYENRVYQFQDE--DRRRFVVKFYRPERWT---------------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH 95 (325)
T ss_dssp CSSSEEEEECCT--TCCCEEEEEECTTTSC---------------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE
T ss_pred cccceeEEEEcC--CCCEEEEEEeCCCCCC---------------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeee
Confidence 445789999865 8899999987543221 3455566666665532122 111 122334
Q ss_pred CCCceEEEEeecCCCH-----HHH------H---HhhhcC-----CCcCCHH----------------------HHHHHH
Q 036970 125 PDCDLLVYEFRRNGSL-----QDI------L---YDVSQG-----RRELDWL----------------------ARHRIA 163 (337)
Q Consensus 125 ~~~~~lv~e~~~~~~L-----~~~------l---~~~~~~-----~~~l~~~----------------------~~~~~~ 163 (337)
++..+.+++++.|..+ ..+ + +..... ....... .....+
T Consensus 96 ~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (325)
T d1zyla1 96 QGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKAT 175 (325)
T ss_dssp TTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHH
T ss_pred eeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHH
Confidence 5566788898865321 111 1 111000 0111111 122233
Q ss_pred HHHHHHHHHHh-cCCCCCceeCCCCCCcEEecCCCcEEEeccccccc
Q 036970 164 RGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKQ 209 (337)
Q Consensus 164 ~~i~~~l~~lh-~~~~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~~ 209 (337)
.++...+.-.- +....+++|+|+.+.||+++++ ..+.||+.+..
T Consensus 176 ~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 176 DELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 44444333322 2224568999999999999753 45899998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.06 E-value=0.009 Score=49.64 Aligned_cols=31 Identities=26% Similarity=0.323 Sum_probs=26.9
Q ss_pred CCCceeCCCCCCcEEecCCCcEEEecccccc
Q 036970 178 RPRIIHRDIQPANVLIDDDMEARISEFGLAK 208 (337)
Q Consensus 178 ~~~~~h~di~~~nil~~~~~~~kl~Dfg~~~ 208 (337)
..|++|+|+.+.|++++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4479999999999999988777899999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.72 E-value=0.0094 Score=51.38 Aligned_cols=74 Identities=9% Similarity=0.149 Sum_probs=46.2
Q ss_pred cccccccccceEEeeeecCC------CCcEEEEEEeeccchhhHHHhhcCCcchhhhHHHHHHHHHHhcCCCCCCh-hhh
Q 036970 46 LEKIRSCWNGEVYKAELPGS------SGRVITIKKVIQPLKSEAELIKQDSEPLHHKMIQIQSEIITAGQVRHRNI-VPL 118 (337)
Q Consensus 46 ~~~lg~G~~g~vy~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~~ 118 (337)
++.|+.|-...+|++..... .+..|++++...... .....+|..+++.+.-.++ .++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~----------------~idr~~E~~i~~~ls~~gl~Pkl 110 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----------------ESHLVAESVIFTLLSERHLGPKL 110 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----------------HHHHHHHHHHHHHHHHTTSSSCE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch----------------hhHHHHHHHHHHHHHhCCCCCeE
Confidence 56788899999999986521 345677777653221 1234567777777632244 455
Q ss_pred hceeecCCCceEEEEeecCCC
Q 036970 119 LARVVRPDCDLLVYEFRRNGS 139 (337)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~ 139 (337)
++++. ..+|+||+++..
T Consensus 111 l~~~~----~g~I~efi~g~~ 127 (395)
T d1nw1a_ 111 YGIFS----GGRLEEYIPSRP 127 (395)
T ss_dssp EEEET----TEEEECCCCEEE
T ss_pred EEEcC----CceEEEEecccc
Confidence 55543 257899987643
|